Cloning	O
and	O
characterization	O
of	O
the	O
mouse	B-GGP
Mcoln1	I-GGP
gene	B-SO
reveals	O
an	O
alternatively	B-SO
spliced	I-SO
transcript	I-SO
not	O
seen	O
in	O
humans	B-Taxon

Abstract	O

Background	O

Mucolipidosis	O
type	O
IV	O
(	O
MLIV	O
)	O
is	O
an	O
autosomal	B-GO
recessive	O
lysosomal	B-GO
storage	O
disorder	O
characterized	O
by	O
severe	O
neurologic	O
and	O
ophthalmologic	O
abnormalities	O
.	O

Recently	O
the	O
MLIV	B-GGP
gene	B-SO
,	O
MCOLN1	B-GGP
,	O
has	O
been	O
identified	O
as	O
a	O
new	O
member	O
of	O
the	O
transient	O
receptor	O
potential	O
(	O
TRP	O
)	O
cation	B-CHEBI
channel	O
superfamily	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
the	O
mouse	B-Taxon
homologue	B-SO
,	O
Mcoln1	B-GGP
,	O
and	O
report	O
a	O
novel	O
splice	B-SO
variant	I-SO
that	O
is	O
not	O
seen	O
in	O
humans	B-Taxon
.	O

Results	O

The	O
human	B-Taxon
and	O
mouse	B-Taxon
genes	B-SO
display	O
a	O
high	O
degree	B-SO
of	I-SO
synteny	I-SO
.	O

Mcoln1	B-GGP
shows	O
91	O
%	O
amino	B-CHEBI
acid	I-CHEBI
and	O
86	O
%	O
nucleotide	B-CHEBI
identity	O
to	O
MCOLN1	B-GGP
.	O

Also	O
,	O
Mcoln1	B-GGP
maps	O
to	O
chromosome	B-GO
8	O
and	O
contains	O
an	O
open	B-SO
reading	I-SO
frame	I-SO
of	O
580	O
amino	B-CHEBI
acids	I-CHEBI
,	O
with	O
a	O
transcript	B-SO
length	O
of	O
approximately	O
2	O
kb	O
encoded	O
by	O
14	O
exons	B-SO
,	O
similar	O
to	O
its	O
human	B-Taxon
counterpart	B-SO
.	O

The	O
transcript	B-SO
that	O
results	O
from	O
murine	B-Taxon
specific	O
alternative	O
splicing	O
encodes	O
a	O
611	O
amino	B-CHEBI
acid	I-CHEBI
protein	B-CHEBI
that	O
differs	O
at	O
the	O
c	B-SO
-	I-SO
terminus	I-SO
.	O

Conclusions	O

Mcoln1	B-GGP
is	O
highly	O
similar	O
to	O
MCOLN1	B-GGP
,	O
especially	O
in	O
the	O
transmembrane	B-GO
domains	B-SO
and	O
ion	B-CHEBI
pore	O
region	B-SO
.	O

Also	O
,	O
the	O
late	B-GO
endosomal	I-GO
/	O
lysosomal	B-GO
targeting	O
signal	B-SO
is	O
conserved	B-SO
,	O
supporting	O
the	O
hypothesis	O
that	O
the	O
protein	B-CHEBI
is	O
localized	O
to	O
these	O
vesicle	B-GO
membranes	I-GO
.	O

To	O
date	O
,	O
there	O
are	O
very	O
few	O
reports	O
describing	O
species	O
-	O
specific	O
splice	B-SO
variants	I-SO
.	O

While	O
identification	O
of	O
Mcoln1	B-GGP
is	O
crucial	O
to	O
the	O
development	O
of	O
mouse	B-Taxon
models	O
for	O
MLIV	O
,	O
the	O
fact	O
that	O
there	O
are	O
two	O
transcripts	B-SO
in	O
mice	B-Taxon
suggests	O
an	O
additional	O
or	O
alternate	O
function	O
of	O
the	O
gene	B-SO
that	O
may	O
complicate	O
phenotypic	O
assessment	O
.	O

Background	O

Mucolipidosis	O
type	O
IV	O
(	O
MLIV	O
;	O
MIM	O
252650	O
)	O
is	O
an	O
autosomal	B-GO
recessive	O
lysosomal	B-GO
storage	O
disorder	O
that	O
is	O
characterized	O
by	O
corneal	O
clouding	O
,	O
delayed	O
psychomotor	O
development	O
,	O
and	O
mental	O
retardation	O
that	O
usually	O
presents	O
during	O
the	O
first	O
year	O
of	O
life	O
[	O
1	O
]	O
.	O

Another	O
interesting	O
clinical	O
characteristic	O
is	O
that	O
patients	O
are	O
constitutively	O
achlorhydric	O
with	O
associated	O
hypergastremia	O
[	O
2	O
]	O
.	O

Patients	O
with	O
MLIV	O
do	O
not	O
show	O
mucopolysaccharide	B-CHEBI
excretion	O
,	O
skeletal	O
changes	O
,	O
or	O
organomegaly	O
like	O
the	O
other	O
mucolipidoses	O
.	O

Abnormal	O
lysosomal	B-GO
storage	O
bodies	O
and	O
large	O
vacuoles	B-GO
have	O
been	O
found	O
in	O
skin	O
and	O
conjuctival	O
biopsies	O
using	O
electron	O
-	O
microscopy	O
and	O
,	O
prior	O
to	O
gene	B-SO
identification	O
,	O
served	O
as	O
the	O
only	O
means	O
of	O
diagnosis	O
[	O
3	O
-	O
5	O
]	O
.	O

A	O
recent	O
report	O
estimates	O
that	O
the	O
carrier	O
frequency	O
of	O
MLIV	O
in	O
the	O
Ashkenazi	O
Jewish	O
population	O
is	O
1	O
in	O
100	O
,	O
and	O
mutations	B-SO
have	O
been	O
reported	O
in	O
Jewish	O
and	O
non	O
-	O
Jewish	O
families	O
[	O
6	O
-	O
9	O
]	O
.	O

The	O
human	B-Taxon
gene	B-SO
MCOLN1	B-GGP
(	O
GenBank	O
#	O
AF287270	O
)	O
maps	O
to	O
chromosome	B-GO
19p13	O
.	O
2	O
-	O
13	O
.	O
3	O
and	O
encodes	O
a	O
novel	O
protein	B-CHEBI
that	O
is	O
a	O
member	O
of	O
the	O
transient	O
receptor	O
potential	O
(	O
TRP	O
)	O
cation	B-CHEBI
channel	O
gene	B-SO
superfamily	O
[	O
7	O
-	O
10	O
]	O
.	O

Protein	B-CHEBI
trafficking	O
studies	O
suggest	O
that	O
MLIV	O
is	O
the	O
result	O
of	O
a	O
defect	O
in	O
the	O
late	O
endocytic	O
pathway	O
,	O
contrary	O
to	O
the	O
other	O
mucolipidoses	O
which	O
are	O
typically	O
caused	O
by	O
defective	O
lysosomal	B-GO
hydrolases	O
[	O
11	O
,	O
12	O
]	O
.	O

Recent	O
work	O
in	O
Caenorhabditis	B-Taxon
elegans	I-Taxon
supports	O
this	O
hypothesis	O
.	O

Loss	O
of	O
function	O
mutants	B-SO
of	O
the	O
MCOLN1	B-GGP
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
homologue	B-SO
,	O
cup	B-GGP
-	I-GGP
5	I-GGP
,	O
result	O
in	O
an	O
increased	O
rate	O
of	O
endocytosis	O
,	O
accumulation	O
of	O
large	O
vacuoles	B-GO
,	O
and	O
a	O
decreased	O
rate	O
of	O
endocytosed	O
protein	B-CHEBI
breakdown	O
;	O
while	O
over	O
-	O
expression	O
of	O
this	O
gene	B-SO
reverses	O
the	O
phenotype	O
[	O
13	O
]	O
.	O

Cloning	O
and	O
characterization	O
of	O
the	O
mouse	B-Taxon
homologue	B-SO
of	O
MCOLN1	B-GGP
is	O
crucial	O
for	O
the	O
development	O
of	O
mouse	B-Taxon
models	O
of	O
MLIV	O
to	O
further	O
study	O
this	O
disorder	O
.	O

Results	O
and	O
discussion	O

Cloning	O
and	O
mapping	O
of	O
the	O
mouse	B-Taxon
homologue	B-SO
Mcoln1	B-GGP

In	O
order	O
to	O
clone	O
the	O
mouse	B-Taxon
homologue	B-SO
of	O
MCOLN1	B-GGP
,	O
the	O
human	B-Taxon
amino	B-SO
acid	I-SO
sequence	I-SO
was	O
compared	O
to	O
the	O
high	O
throughput	O
genomic	B-SO
sequence	I-SO
(	O
HTGS	O
)	O
database	O
using	O
TBLASTN	O
,	O
which	O
identified	O
the	O
mouse	B-Taxon
BAC	B-SO
clone	B-SO
RPCI	O
-	O
23	O
_	O
387H4	O
(	O
GB	O
No	O
.	O
AC079544	O
.	O
1	O
)	O
.	O

Correspondence	O
with	O
the	O
Joint	O
Genome	B-SO
Institute	O
and	O
the	O
Lawrence	O
Livermore	O
National	O
Laboratory	O
(	O
LLNL	O
)	O
Human	B-Taxon
Genome	B-SO
Center	O
confirmed	O
the	O
location	B-SO
of	O
this	O
BAC	B-SO
to	O
mouse	B-Taxon
chromosome	B-GO
8	O
and	O
allowed	O
us	O
to	O
construct	O
a	O
physical	B-SO
map	I-SO
of	O
this	O
region	B-SO
[	O
14	O
]	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

The	O
BAC	B-SO
sequence	I-SO
was	O
then	O
compared	O
to	O
the	O
mouse	B-Taxon
EST	B-SO
database	O
using	O
BLASTN	O
,	O
and	O
multiple	O
ESTs	B-SO
and	O
their	O
corresponding	O
I	O
.	O
M	O
.	O
A	O
.	O
G	O
.	O
E	O
.	O
clones	B-SO
were	O
identified	O
.	O

Figure	O
1	O

Physical	B-SO
and	I-SO
transcript	I-SO
map	I-SO
of	O
the	O
Mcoln1	B-GGP
gene	B-SO
region	B-SO
.	O

(	O
A	O
)	O
Physical	B-SO
map	I-SO
showing	O
a	O
590	O
kb	O
segment	B-SO
of	I-SO
mouse	I-SO
chromosome	I-SO
8	O
syntenous	B-SO
to	O
human	B-Taxon
chromosome	B-GO
19	O
,	O
anchored	O
by	O
the	O
genes	B-SO
Insr	B-GGP
and	O
Nte	B-GGP
.	O

The	O
region	B-SO
is	O
covered	O
by	O
three	O
BACs	B-SO
:	O
RPCI	O
-	O
23	O
_	O
334D24	O
(	O
AC087153	O
)	O
,	O
RPCI	O
-	O
23	O
_	O
312B8	O
(	O
AC087150	O
)	O
,	O
and	O
RPCI	O
-	O
23	O
_	O
387H4	O
(	O
AC079544	O
)	O
.	O

(	O
B	O
)	O
The	O
transcript	B-SO
map	O
of	O
Mcoln1	B-GGP
shows	O
14	O
exons	B-SO
,	O
and	O
the	O
locations	B-SO
of	O
the	O
probes	B-SO
used	O
in	O
this	O
study	O
are	O
illustrated	O
.	O

The	O
map	O
also	O
shows	O
the	O
expanded	O
exon	B-SO
13	O
in	O
the	O
alternatively	B-SO
spliced	I-SO
transcript	I-SO
(	O
hashed	O
box	O
)	O
.	O

UniGene	O
cluster	O
Mm	O
.	O
39099	O
is	O
the	O
homologue	B-SO
of	O
the	O
human	B-Taxon
zinc	B-CHEBI
finger	O
gene	B-SO
(	O
AC001252	O
)	O
.	O

It	O
should	O
be	O
noted	O
that	O
the	O
scale	O
of	O
the	O
transcript	B-SO
map	O
is	O
in	O
reference	O
to	O
the	O
201	O
kb	O
scale	O
of	O
BAC	B-SO
RPCI	O
-	O
23	O
_	O
387H4	O
.	O

Three	O
clones	B-SO
(	O
ID	O
Nos	O
.	O
604971	O
,	O
1228665	O
,	O
1247566	O
)	O
from	O
the	O
UniGene	O
cluster	O
Mm	O
.	O

8356	O
were	O
obtained	O
,	O
sequenced	O
,	O
and	O
assembled	O
into	O
a	O
2	O
kb	O
transcript	B-SO
with	O
an	O
open	B-SO
reading	I-SO
frame	I-SO
of	O
580	O
amino	B-CHEBI
acids	I-CHEBI
designated	O
Mcoln1	B-GGP
(	O
GB	O
No	O
.	O
AF302010	O
)	O
.	O

Comparison	O
of	O
the	O
cDNA	B-SO
sequence	I-SO
to	O
the	O
BAC	B-SO
clone	B-SO
showed	O
that	O
the	O
gene	B-SO
consists	O
of	O
14	O
exons	B-SO
.	O

We	O
then	O
created	O
a	O
transcript	B-SO
map	O
of	O
the	O
Mcoln1	B-GGP
region	B-SO
of	I-SO
mouse	I-SO
chromosome	I-SO
8	O
(	O
Fig	O
.	O
1B	O
)	O
,	O
noting	O
the	O
presence	O
of	O
the	O
UniGene	O
Cluster	O
Mm	O
.	O

39099	O
,	O
a	O
homologue	B-SO
of	O
the	O
human	B-Taxon
zinc	B-CHEBI
finger	O
gene	B-SO
(	O
GB	O
No	O
.	O
AC001252	O
)	O
that	O
terminates	O
approximately	O
1	O
.	O
8	O
kb	O
before	O
the	O
start	O
of	O
Mcoln1	B-GGP
;	O
and	O
Nte	B-GGP
,	O
the	O
mouse	B-Taxon
homologue	B-SO
of	O
the	O
human	B-GGP
neuropathy	I-GGP
target	I-GGP
esterase	I-GGP
gene	I-GGP
(	I-GGP
NTE	I-GGP
)	O
beginning	O
130	O
base	B-SO
pairs	I-SO
after	O
the	O
polyadenylation	B-SO
signal	I-SO
for	O
Mcoln1	B-GGP
.	O

The	O
transcript	B-SO
map	O
of	O
the	O
region	B-SO
surrounding	O
Mcoln1	B-GGP
is	O
similar	O
to	O
the	O
corresponding	O
region	B-SO
of	O
the	O
homologous	B-SO
human	I-SO
MCOLN1	I-SO
region	I-SO
[	O
15	O
]	O
,	O
and	O
the	O
presence	O
of	O
the	O
zinc	B-CHEBI
finger	O
gene	B-SO
and	O
Nte	B-GGP
confirms	O
and	O
extends	O
the	O
region	B-SO
of	I-SO
synteny	I-SO
between	O
human	B-Taxon
chromosome	B-GO
19	O
and	O
mouse	B-Taxon
chromosome	B-GO
8	O
.	O

Characterization	O
of	O
Mcoln1	B-GGP

Comparison	O
of	O
the	O
mouse	B-Taxon
and	O
human	B-Taxon
peptide	B-SO
sequences	I-SO
showed	O
91	O
%	O
identity	O
(	O
Fig	O
.	O
2	O
)	O
.	O

The	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
homologue	B-SO
cup	B-GGP
-	I-GGP
5	I-GGP
shows	O
34	O
%	O
identity	O
with	O
Mcoln1	B-GGP
and	O
BLASTP	O
analysis	O
of	O
Mcoln1	B-GGP
identified	O
a	O
putative	O
Drosophila	B-Taxon
melanogaster	I-Taxon
homologue	B-SO
that	O
shows	O
38	O
%	O
identity	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Interestingly	O
,	O
two	O
MCOLN1	B-GGP
amino	B-CHEBI
acid	I-CHEBI
substitutions	B-SO
that	O
result	O
in	O
MLIV	O
occur	O
at	O
conserved	B-SO
amino	B-CHEBI
acids	I-CHEBI
.	O

TMPred	O
analysis	O
predicts	O
a	O
protein	B-CHEBI
structure	O
that	O
is	O
nearly	O
identical	O
to	O
MCOLN1	B-GGP
,	O
containing	O
6	O
transmembrane	B-GO
domains	B-SO
with	O
the	O
N	B-SO
-	I-SO
and	I-SO
C	I-SO
-	I-SO
termini	I-SO
residing	O
in	O
the	O
cytoplasm	B-GO
(	O
Fig	O
.	O
2	O
)	O
[	O
9	O
]	O
.	O

Figure	O
2	O

Peptide	B-SO
sequence	I-SO
comparison	O
of	O
Mcoln1	B-GGP
to	O
human	B-Taxon
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
,	O
and	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
(	O
cup	B-GGP
-	I-GGP
5	I-GGP
)	O
homologues	B-SO
.	O

Blue	O
lines	O
indicate	O
transmembrane	B-GO
domains	B-SO
,	O
the	O
red	O
box	O
surrounds	O
the	O
putative	O
channel	O
pore	O
,	O
the	O
orange	O
box	O
surrounds	O
the	O
putative	O
late	B-GO
endosomal	I-GO
/	O
lysosomal	B-GO
targeting	O
signal	B-SO
.	O

Expression	O
analysis	O
of	O
Mcoln1	B-GGP

Mouse	B-Taxon
adult	O
multiple	O
tissue	O
and	O
embryonic	O
Northern	O
blots	O
were	O
hybridized	O
using	O
a	O
probe	B-SO
generated	O
from	O
mouse	B-Taxon
exon	B-SO
2	O
(	O
probe	B-SO
1	O
,	O
Fig	O
.	O
1B	O
)	O
,	O
yielding	O
a	O
band	O
of	O
approximately	O
2	O
.	O
4	O
kb	O
(	O
isoform	B-SO
1	O
)	O
,	O
as	O
expected	O
,	O
and	O
a	O
less	O
abundant	O
and	O
unexpected	O
4	O
.	O
4	O
kb	O
band	O
(	O
isoform	B-SO
2	O
)	O
(	O
Figs	O
.	O
3A	O
&	O
3B	O
)	O
.	O

The	O
2	O
.	O
4	O
kb	O
band	O
shows	O
ubiquitous	O
but	O
variable	O
expression	O
,	O
with	O
the	O
highest	O
expression	O
in	O
brain	O
,	O
liver	O
and	O
kidney	O
.	O

The	O
fetal	O
tissue	O
blot	O
shows	O
decreasing	O
levels	O
of	O
the	O
2	O
.	O
4	O
kb	O
message	B-SO
with	O
increasing	O
gestational	O
age	O
.	O

Since	O
the	O
human	B-GGP
MCOLN1	I-GGP
gene	B-SO
encodes	O
a	O
single	O
transcript	B-SO
[	O
7	O
-	O
9	O
]	O
,	O
we	O
carried	O
out	O
additional	O
hybridizations	O
with	O
probes	B-SO
generated	O
from	O
various	O
regions	B-SO
of	I-SO
the	I-SO
coding	I-SO
sequence	I-SO
and	I-SO
3	I-SO
'	I-SO
UTR	I-SO
,	O
and	O
all	O
probes	B-SO
identified	O
the	O
same	O
two	O
transcripts	B-SO
in	O
the	O
mouse	B-Taxon
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
order	O
to	O
verify	O
the	O
presence	O
of	O
a	O
single	O
mouse	B-Taxon
locus	B-SO
,	O
we	O
hybridized	O
a	O
mouse	B-Taxon
Southern	O
blot	O
with	O
the	O
exon	B-SO
2	O
probe	B-SO
.	O

Four	O
different	O
restriction	O
enzymes	B-SO
were	O
used	O
,	O
and	O
only	O
the	O
expected	O
size	O
bands	O
for	O
the	O
chromosome	B-SO
8	I-SO
locus	I-SO
were	O
detected	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
3	O

Northern	O
analysis	O
of	O
Mcoln1	B-GGP
.	O

(	O
A	O
)	O
Mouse	B-Taxon
fetal	O
tissue	O
Northern	O
and	O
(	O
B	O
)	O
mouse	B-Taxon
multiple	O
tissue	O
Northern	O
blots	O
(	O
Clontech	O
)	O
hybridized	O
with	O
a	O
probe	B-SO
generated	O
from	O
exon	B-SO
2	O
(	O
probe	B-SO
1	O
,	O
Fig	O
.	O
1B	O
)	O
.	O

(	O
C	O
)	O
Hybridization	O
of	O
the	O
multiple	O
tissue	O
blot	O
with	O
a	O
probe	B-SO
from	O
the	O
alternatively	O
spliced	O
segment	B-SO
of	I-SO
exon	I-SO
13	O
(	O
probe	B-SO
2	O
,	O
Fig	O
.	O
1B	O
)	O
.	O

beta	B-GGP
-	I-GGP
Actin	I-GGP
control	O
hybridization	O
is	O
shown	O
below	O
each	O
blot	O
.	O

Characterization	O
of	O
the	O
Mcoln1	B-GGP
alternative	B-SO
splice	I-SO
variant	I-SO

In	O
order	O
to	O
determine	O
the	O
coding	B-SO
sequence	I-SO
for	O
the	O
larger	O
transcript	B-SO
,	O
we	O
searched	O
the	O
mouse	B-Taxon
EST	B-SO
database	O
using	O
each	O
intron	B-SO
as	O
well	O
as	O
the	O
genomic	B-SO
sequence	I-SO
flanking	O
the	O
Mcoln1	B-GGP
gene	B-SO
.	O

Two	O
ESTs	B-SO
were	O
identified	O
that	O
contained	O
sequence	B-SO
from	O
intron	B-SO
12	O
(	O
GB	O
No	O
.	O
AI430291	O
and	O
AA874645	O
)	O
,	O
and	O
the	O
corresponding	O
clones	B-SO
were	O
sequenced	O
.	O

Clone	B-SO
408619	O
(	O
ESTs	B-SO
:	O
GB	O
No	O
.	O
AI430291	O
,	O
AI429558	O
)	O
begins	O
approximately	O
1	O
.	O
1	O
kb	O
before	O
exon	B-SO
13	O
and	O
continues	O
through	O
the	O
exon	B-SO
and	O
splices	O
correctly	O
to	O
exon	B-SO
14	O
.	O

Clone	B-SO
1281641	O
(	O
EST	B-SO
:	O
GB	O
No	O
.	O
AA874645	O
)	O
begins	O
175	O
bp	B-SO
before	O
exon	B-SO
13	O
and	O
also	O
splices	O
correctly	O
to	O
exon	B-SO
14	O
.	O

A	O
mouse	B-Taxon
multiple	O
tissue	O
Northern	O
was	O
hybridized	O
using	O
a	O
probe	B-SO
generated	O
from	O
the	O
putative	O
intron	B-SO
sequence	I-SO
in	O
clone	B-SO
408619	O
(	O
Probe	B-SO
2	O
,	O
Fig	O
.	O
1B	O
)	O
,	O
which	O
detected	O
only	O
the	O
4	O
.	O
4	O
kb	O
band	O
(	O
Fig	O
.	O
3C	O
)	O
.	O

In	O
order	O
to	O
determine	O
the	O
sequence	B-SO
of	O
the	O
entire	O
transcript	B-SO
,	O
RT	O
-	O
PCR	O
using	O
primers	B-SO
in	O
exons	B-SO
10	O
and	O
11	O
paired	O
with	O
a	O
primer	B-SO
in	O
intron	B-SO
12	O
was	O
performed	O
using	O
BALB	O
/	O
c	O
mouse	B-Taxon
brain	O
total	O
RNA	B-SO
and	O
the	O
resulting	O
products	B-SO
sequenced	O
.	O

These	O
products	B-SO
show	O
that	O
the	O
larger	O
transcript	B-SO
is	O
due	O
to	O
an	O
alternative	O
splice	O
event	O
that	O
results	O
in	O
an	O
expanded	O
exon	B-SO
13	O
.	O

Specifically	O
,	O
exon	B-SO
12	O
splices	O
at	O
bp	B-SO
436	O
of	O
intron	B-SO
12	O
,	O
creating	O
a	O
large	O
1614	O
bp	B-SO
exon	B-SO
13	O
that	O
splices	O
correctly	O
to	O
exon	B-SO
14	O
.	O

The	O
open	B-SO
reading	I-SO
frame	I-SO
of	O
this	O
alternatively	B-SO
spliced	I-SO
transcript	I-SO
is	O
611	O
amino	B-CHEBI
acids	I-CHEBI
,	O
28	O
amino	B-CHEBI
acids	I-CHEBI
longer	O
than	O
the	O
message	B-SO
encoded	O
by	O
the	O
2	O
.	O
4	O
kb	O
transcript	B-SO
.	O

TMPred	O
analysis	O
predicts	O
that	O
isoform	B-SO
2	O
encodes	O
a	O
protein	B-CHEBI
identical	O
in	O
structure	O
to	O
Mcoln1	B-GGP
,	O
possessing	O
6	O
transmembrane	B-GO
domains	B-SO
and	O
a	O
channel	O
pore	O
,	O
however	O
the	O
protein	B-CHEBI
sequences	B-SO
diverge	O
at	O
amino	B-CHEBI
acid	I-CHEBI
526	O
.	O

The	O
55	O
amino	B-CHEBI
acid	I-CHEBI
C	B-SO
-	I-SO
terminal	I-SO
cytoplasmic	I-SO
tail	I-SO
encoded	O
by	O
the	O
2	O
.	O
4	O
kb	O
transcript	B-SO
is	O
completely	O
different	O
from	O
the	O
86	O
amino	B-SO
acid	I-SO
tail	I-SO
encoded	O
by	O
the	O
murine	B-Taxon
specific	O
4	O
.	O
4	O
kb	O
transcript	B-SO
(	O
Fig	O
.	O
4	O
)	O
.	O

Clontech	O
Mouse	B-Taxon
RNA	B-SO
Master	O
Blots	O
were	O
hybridized	O
with	O
the	O
exon	B-SO
2	O
and	O
intron	B-SO
12	O
probes	B-SO
mentioned	O
above	O
in	O
an	O
attempt	O
to	O
determine	O
if	O
these	O
two	O
transcripts	B-SO
showed	O
differences	O
in	O
expression	O
patterns	O
,	O
however	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
22	O
tissues	O
represented	O
(	O
data	O
not	O
shown	O
)	O
.	O

Figure	O
4	O

Peptide	B-SO
sequence	I-SO
comparison	O
of	O
the	O
two	O
alternatively	B-SO
spliced	I-SO
Mcoln1	I-SO
isoforms	I-SO
.	O

The	O
green	O
box	O
surrounds	O
the	O
divergent	O
c	B-SO
-	I-SO
terminal	I-SO
cytoplasmic	I-SO
tails	I-SO
.	O

The	O
blue	O
lines	O
indicate	O
the	O
transmembrane	B-GO
domains	B-SO
.	O

Next	O
,	O
we	O
directly	O
compared	O
the	O
nucleotide	B-SO
and	I-SO
amino	I-SO
acid	I-SO
sequence	I-SO
of	O
the	O
alternatively	B-SO
spliced	I-SO
mouse	I-SO
transcript	I-SO
to	O
the	O
entire	O
human	B-GGP
MCOLN1	I-GGP
genomic	B-SO
sequence	I-SO
and	O
found	O
no	O
significant	O
similarity	O
.	O

As	O
mentioned	O
previously	O
,	O
Northern	O
blots	O
performed	O
with	O
human	B-GGP
MCOLN1	I-GGP
probes	B-SO
show	O
only	O
one	O
2	O
.	O
4	O
kb	O
transcript	B-SO
.	O

In	O
addition	O
,	O
we	O
hybridized	O
a	O
human	B-Taxon
multiple	O
tissue	O
Northern	O
and	O
human	B-Taxon
Southern	O
with	O
a	O
probe	B-SO
in	O
human	B-Taxon
intron	B-SO
12	O
that	O
is	O
adjacent	B-SO
to	O
exon	B-SO
13	O
.	O

The	O
probe	B-SO
was	O
located	O
in	O
the	O
region	B-SO
syntenic	B-SO
to	O
that	O
which	O
encodes	O
the	O
alternate	B-SO
mouse	I-SO
transcript	I-SO
.	O

Only	O
the	O
expected	O
bands	O
were	O
detected	O
on	O
the	O
Southern	O
and	O
no	O
bands	O
were	O
detected	O
on	O
the	O
Northern	O
,	O
confirming	O
that	O
this	O
alternative	B-SO
transcript	I-SO
is	O
specific	O
to	O
murine	B-GGP
Mcoln1	I-GGP
.	O

Recent	O
BLASTP	O
analysis	O
of	O
the	O
alternate	B-SO
Mcoln1	I-SO
transcript	I-SO
yields	O
a	O
match	B-SO
to	O
a	O
putative	O
145	O
amino	B-CHEBI
acid	I-CHEBI
anonymous	O
protein	B-CHEBI
(	O
GB	O
No	O
.	O
BAB25862	O
)	O
predicted	B-SO
from	O
a	O
RIKEN	O
clone	B-SO
.	O

It	O
is	O
obvious	O
from	O
our	O
results	O
,	O
however	O
,	O
that	O
the	O
identification	O
of	O
this	O
sequence	B-SO
as	O
a	O
full	O
-	O
length	O
protein	B-CHEBI
is	O
incorrect	O
since	O
probes	B-SO
unique	O
to	O
the	O
clone	B-SO
,	O
as	O
well	O
as	O
probes	B-SO
containing	O
the	O
Mcoln1	B-GGP
coding	B-SO
sequence	I-SO
,	O
identify	O
the	O
same	O
transcripts	B-SO
.	O

Conclusions	O

Comparison	O
of	O
Mcoln1	B-GGP
isoform	B-SO
1	O
to	O
its	O
human	B-Taxon
homologue	B-SO
shows	O
striking	O
similarity	O
at	O
both	O
the	O
amino	B-CHEBI
acid	I-CHEBI
and	O
nucleotide	B-CHEBI
level	O
.	O

All	O
six	O
of	O
the	O
transmembrane	B-GO
domains	B-SO
,	O
as	O
well	O
as	O
the	O
putative	O
cation	B-CHEBI
channel	O
are	O
highly	O
conserved	B-SO
.	O

The	O
putative	O
di	O
-	O
leucine	B-CHEBI
(	O
L	B-CHEBI
-	O
L	B-CHEBI
-	O
X	B-CHEBI
-	O
X	B-CHEBI
)	O
motif	O
at	O
the	O
C	B-SO
-	I-SO
terminus	I-SO
,	O
which	O
may	O
act	O
as	O
a	O
late	B-GO
endosomal	I-GO
/	O
lysosomal	B-GO
targeting	O
signal	B-SO
,	O
is	O
also	O
conserved	B-SO
[	O
9	O
]	O
.	O

This	O
speculation	O
is	O
supported	O
by	O
work	O
with	O
cup	B-GGP
-	I-GGP
5	I-GGP
[	O
13	O
]	O
,	O
the	O
c	B-Taxon
.	I-Taxon
elegans	I-Taxon
homologue	B-SO
of	O
MCOLN1	B-GGP
,	O
since	O
cellular	B-CL
localization	O
studies	O
suggest	O
that	O
the	O
protein	B-CHEBI
is	O
found	O
in	O
the	O
late	B-GO
endosomes	I-GO
and	O
/	O
or	O
lysosomes	B-GO
.	O

The	O
mouse	B-GGP
Mcoln1	I-GGP
gene	B-SO
has	O
two	O
alternatively	B-SO
spliced	I-SO
isoforms	I-SO
,	O
with	O
isoform	B-SO
2	O
having	O
a	O
different	O
c	B-SO
-	I-SO
terminal	I-SO
cytoplasmic	I-SO
tail	I-SO
.	O

The	O
unique	O
86	O
amino	B-CHEBI
acid	I-CHEBI
c	B-SO
-	I-SO
terminal	I-SO
tail	I-SO
lacks	O
the	O
lysosomal	B-GO
targeting	O
signal	B-SO
and	O
does	O
not	O
contain	O
any	O
conserved	B-SO
domains	B-SO
when	O
compared	O
against	O
the	O
current	O
profile	O
databases	O
.	O

We	O
speculate	O
that	O
this	O
protein	B-CHEBI
may	O
have	O
similar	O
channel	O
function	O
but	O
an	O
alternate	O
subcellular	O
localization	O
,	O
but	O
this	O
must	O
be	O
proven	O
once	O
isoform	B-SO
-	O
specific	O
antibodies	B-GO
are	O
raised	O
.	O

However	O
,	O
our	O
results	O
suggest	O
that	O
phenotypic	O
assessment	O
of	O
Mcoln1	B-GGP
knock	O
-	O
out	O
mice	B-Taxon
may	O
be	O
complicated	O
and	O
that	O
care	O
must	O
be	O
taken	O
when	O
interpreting	O
data	O
on	O
mouse	B-Taxon
gene	B-SO
expression	O
and	O
phenotype	O
.	O

Interestingly	O
,	O
the	O
second	O
Mcoln1	B-GGP
isoform	B-SO
is	O
not	O
seen	O
in	O
humans	B-Taxon
and	O
the	O
sequence	B-SO
of	O
the	O
alternatively	O
spliced	O
region	B-SO
is	O
not	O
conserved	B-SO
between	O
man	B-Taxon
and	O
mouse	B-Taxon
.	O

To	O
date	O
,	O
very	O
few	O
genes	B-SO
have	O
been	O
reported	O
that	O
show	O
species	O
specific	O
alternative	B-SO
splice	I-SO
variants	I-SO
.	O

MOG	B-GGP
,	O
myelin	B-GGP
/	I-GGP
oligodendrocyte	I-GGP
glycoprotein	I-GGP
,	O
has	O
many	O
different	B-SO
splice	I-SO
variants	I-SO
in	O
humans	B-Taxon
that	O
are	O
not	O
found	O
in	O
mice	B-Taxon
[	O
17	O
]	O
.	O

ATP11B	B-GGP
,	O
a	O
P	O
-	O
type	O
ATPase	O
,	O
has	O
a	O
rabbit	B-Taxon
-	O
specific	O
splice	B-SO
variant	I-SO
that	O
deletes	B-SO
a	O
transmembrane	B-GO
domain	B-SO
and	O
therefore	O
likely	O
alters	O
the	O
putative	O
function	O
of	O
the	O
protein	B-CHEBI
[	O
18	O
]	O
.	O

Sequencing	O
of	O
the	O
human	B-Taxon
genome	B-SO
has	O
led	O
to	O
estimates	O
of	O
approximately	O
32	O
,	O
000	O
genes	B-SO
,	O
a	O
total	O
surprise	O
given	O
the	O
previous	O
significantly	O
higher	O
estimates	O
that	O
were	O
based	O
on	O
the	O
number	O
of	O
expressed	B-SO
sequence	I-SO
tags	I-SO
(	O
ESTs	B-SO
)	O
in	O
the	O
public	O
databases	O
.	O

This	O
apparent	O
disparity	O
suggests	O
a	O
major	O
role	O
for	O
alternative	O
splicing	O
in	O
creating	O
genetic	B-SO
complexity	O
,	O
and	O
has	O
brought	O
the	O
study	O
of	O
splicing	O
regulation	O
to	O
the	O
forefront	O
of	O
molecular	O
genetics	O
.	O

It	O
is	O
likely	O
that	O
an	O
abundance	O
of	O
species	O
-	O
specific	O
splice	B-SO
variants	I-SO
will	O
be	O
identified	O
as	O
the	O
characterization	O
of	O
alternatively	B-SO
spliced	I-SO
transcripts	I-SO
progresses	O
.	O

Materials	O
and	O
methods	O

Bioinformatics	O

We	O
conducted	O
database	O
searches	O
using	O
BLAST	O
and	O
Draft	O
Human	B-Taxon
Genome	B-SO
Browser	O
.	O

Sequences	B-SO
from	O
UniGene	O
were	O
used	O
to	O
confirm	O
the	O
Mcoln1	B-GGP
sequence	B-SO
.	O

We	O
performed	O
motif	O
searches	O
using	O
ProfileScan	O
and	O
TMPred	O
and	O
alignment	O
of	O
protein	B-CHEBI
sequences	B-SO
using	O
Pileup	O
(	O
GCG	O
)	O
and	O
Boxshade	O
.	O

DNA	B-SO
Sequencing	O

I	O
.	O
M	O
.	O
A	O
.	O
G	O
.	O
E	O
.	O

Clones	B-SO
were	O
purchased	O
from	O
Research	O
Genetics	O
(	O
Huntsville	O
,	O
AL	O
)	O
.	O

Sequencing	O
was	O
performed	O
using	O
the	O
AmpliCycle	O
sequencing	O
kit	O
from	O
Applied	O
Biosystems	O
(	O
Foster	O
City	O
,	O
CA	O
)	O
on	O
a	O
Genomyx	O
LR	O
programmable	O
DNA	B-SO
sequencer	O
.	O

RT	O
-	O
PCR	O
Reaction	O

BALB	O
/	O
c	O
mouse	B-Taxon
brain	O
total	O
RNA	B-SO
was	O
purchased	O
from	O
Clontech	O
Laboratories	O
(	O
Palo	O
Alto	O
,	O
CA	O
)	O
and	O
made	O
to	O
a	O
1	O
mu	O
g	O
/	O
ml	O
concentration	O
.	O

This	O
RNA	B-SO
was	O
used	O
as	O
a	O
template	O
to	O
create	O
cDNA	B-SO
via	O
RT	O
-	O
PCR	O
using	O
random	B-SO
hexamers	O
and	O
oligo	B-SO
dT	O
primer	B-SO
.	O

The	O
RT	O
product	B-SO
was	O
used	O
to	O
confirm	O
the	O
alternatively	B-SO
spliced	I-SO
form	I-SO
using	O
primers	B-SO
:	O
5	O
'	O
-	O
CATCTACCTGGGCTATTGC	O
-	O
3	O
'	O
(	O
forward	B-SO
)	O
and	O
5	O
'	O
-	O
GCTCTCAGGTGGTGGACAC	O
-	O
3	O
'	O
(	O
reverse	B-SO
)	O
in	O
a	O
PCR	O
reaction	O
with	O
an	O
annealing	O
temperature	O
of	O
61	O
degrees	O
C	O
.	O

Southern	O
Blot	O
Analysis	O

Total	O
mouse	B-Taxon
genomic	B-SO
DNA	I-SO
was	O
digested	O
using	O
EcoRI	O
,	O
BamHI	O
,	O
PstI	O
,	O
and	O
XbaI	O
.	O

The	O
digests	O
were	O
electrophoresed	O
on	O
a	O
1	O
%	O
agarose	B-CHEBI
gel	O
at	O
60V	O
overnight	O
and	O
were	O
transferred	O
onto	O
a	O
Hybond	O
N	O
+	O
membrane	O
from	O
Amersham	O
Pharmacia	O
Biotech	O
(	O
Piscataway	O
,	O
NJ	O
)	O
.	O

A	O
32P	B-CHEBI
-	O
dATP	B-CHEBI
labeled	O
PCR	O
fragment	B-SO
of	I-SO
the	I-SO
Mcoln1	I-SO
coding	I-SO
region	I-SO
corresponding	O
to	O
exon	B-SO
2	O
was	O
used	O
as	O
a	O
probe	B-SO
(	O
primers	B-SO
5	O
'	O
-	O
CCCCACAGAAGAGGAAGAC	O
-	O
3	O
'	O
(	O
forward	B-SO
)	O
and	O
5	O
'	O
-	O
AGATCTTGACCACCTGCAG	O
-	O
3	O
'	O
(	O
reverse	B-SO
)	O
with	O
an	O
annealing	O
temperature	O
of	O
59	O
degrees	O
C	O
)	O
.	O

Hybridization	O
and	O
washes	O
were	O
carried	O
out	O
in	O
standard	O
conditions	O
[	O
16	O
]	O
.	O

Northern	O
Blot	O
Analysis	O

Mouse	B-Taxon
embryo	O
multiple	O
-	O
tissue	O
northern	O
blot	O
and	O
mouse	B-Taxon
adult	O
multiple	O
-	O
tissue	O
northern	O
blot	O
filters	O
were	O
purchased	O
from	O
Clontech	O
Laboratories	O
(	O
Palo	O
Alto	O
,	O
CA	O
)	O
.	O

The	O
filters	O
were	O
hybridized	O
with	O
the	O
32P	B-CHEBI
-	O
dATP	B-CHEBI
labeled	O
DNA	B-SO
fragment	B-SO
of	I-SO
Mcoln1	I-SO
coding	I-SO
region	I-SO
corresponding	O
to	O
exon	B-SO
2	O
(	O
see	O
above	O
)	O
.	O

For	O
the	O
alternative	O
transcript	B-SO
,	O
a	O
probe	B-SO
was	O
generated	O
in	O
the	O
region	B-SO
between	O
exons	B-SO
12	O
and	O
13	O
with	O
primers	B-SO
5	O
'	O
-	O
GTGTCCACCACCTGAGAG	O
-	O
3	O
'	O
(	O
forward	B-SO
)	O
and	O
5	O
'	O
-	O
GAAGTAGCATTCCTGCAGGC	O
-	O
3	O
'	O
(	O
reverse	B-SO
)	O
with	O
an	O
annealing	O
temperature	O
of	O
62	O
degrees	O
C	O
.	O

The	O
filters	O
were	O
then	O
hybridized	O
with	O
beta	B-GGP
-	I-GGP
actin	I-GGP
probes	B-SO
.	O

Hybridizations	O
and	O
washes	O
were	O
carried	O
out	O
in	O
standard	O
conditions	O
,	O
with	O
the	O
stripping	O
of	O
previously	O
bound	O
probes	B-SO
in	O
between	O
[	O
16	O
]	O
.	O

Acknowledgements	O

This	O
work	O
was	O
supported	O
by	O
grant	O
NS39995	O
.	O

Dorsoventral	O
Patterning	O
of	O
the	O
Mouse	B-Taxon
Coat	O
by	O
Tbx15	B-GGP

Abstract	O

Many	O
members	O
of	O
the	O
animal	B-Taxon
kingdom	O
display	O
coat	O
or	O
skin	O
color	O
differences	O
along	O
their	O
dorsoventral	O
axis	O
.	O

To	O
determine	O
the	O
mechanisms	O
that	O
control	O
regional	O
differences	O
in	O
pigmentation	O
,	O
we	O
have	O
studied	O
how	O
a	O
classical	O
mouse	B-Taxon
mutation	B-SO
,	O
droopy	O
ear	O
(	O
deH	O
)	O
,	O
affects	O
dorsoventral	O
skin	O
characteristics	O
,	O
especially	O
those	O
under	O
control	O
of	O
the	O
Agouti	B-GGP
gene	B-SO
.	O

Mice	B-Taxon
carrying	O
the	O
Agouti	B-GGP
allele	B-SO
black	O
-	O
and	O
-	O
tan	O
(	O
at	O
)	O
normally	O
have	O
a	O
sharp	O
boundary	O
between	O
dorsal	O
black	O
hair	O
and	O
yellow	O
ventral	O
hair	O
;	O
the	O
deH	O
mutation	B-SO
raises	O
the	O
pigmentation	O
boundary	O
,	O
producing	O
an	O
apparent	O
dorsal	O
-	O
to	O
-	O
ventral	O
transformation	O
.	O

We	O
identify	O
a	O
216	O
kb	O
deletion	B-SO
in	O
deH	O
that	O
removes	B-SO
all	O
but	O
the	O
first	O
exon	O
of	O
the	O
Tbx15	B-GGP
gene	B-SO
,	O
whose	O
embryonic	O
expression	O
in	O
developing	O
mesenchyme	O
correlates	O
with	O
pigmentary	B-CHEBI
and	O
skeletal	O
malformations	O
observed	O
in	O
deH	O
/	O
deH	O
animals	B-Taxon
.	O

Construction	O
of	O
a	O
targeted	O
allele	B-SO
of	O
Tbx15	B-GGP
confirmed	O
that	O
the	O
deH	O
phenotype	O
was	O
caused	O
by	O
Tbx15	B-GGP
loss	O
of	O
function	O
.	O

Early	O
embryonic	O
expression	O
of	O
Tbx15	B-GGP
in	O
dorsal	O
mesenchyme	O
is	O
complementary	O
to	O
Agouti	B-GGP
expression	O
in	O
ventral	O
mesenchyme	O
;	O
in	O
the	O
absence	O
of	O
Tbx15	B-GGP
,	O
expression	O
of	O
Agouti	B-GGP
in	O
both	O
embryos	O
and	O
postnatal	O
animals	B-Taxon
is	O
displaced	O
dorsally	O
.	O

Transplantation	O
experiments	O
demonstrate	O
that	O
positional	O
identity	O
of	O
the	O
skin	O
with	O
regard	O
to	O
dorsoventral	O
pigmentation	O
differences	O
is	O
acquired	O
by	O
E12	O
.	O
5	O
,	O
which	O
is	O
shortly	O
after	O
early	O
embryonic	O
expression	O
of	O
Tbx15	B-GGP
.	O

Fate	O
-	O
mapping	O
studies	O
show	O
that	O
the	O
dorsoventral	O
pigmentation	O
boundary	O
is	O
not	O
in	O
register	O
with	O
a	O
previously	O
identified	O
dermal	O
cell	B-CL
lineage	O
boundary	O
,	O
but	O
rather	O
with	O
the	O
limb	O
dorsoventral	O
boundary	O
.	O

Embryonic	O
expression	O
of	O
Tbx15	B-GGP
in	O
dorsolateral	O
mesenchyme	O
provides	O
an	O
instructional	O
cue	O
required	O
to	O
establish	O
the	O
future	O
positional	O
identity	O
of	O
dorsal	O
dermis	O
.	O

These	O
findings	O
represent	O
a	O
novel	O
role	O
for	O
T	O
-	O
box	O
gene	B-SO
action	O
in	O
embryonic	O
development	O
,	O
identify	O
a	O
previously	O
unappreciated	O
aspect	O
of	O
dorsoventral	O
patterning	O
that	O
is	O
widely	O
represented	O
in	O
furred	O
mammals	B-Taxon
,	O
and	O
provide	O
insight	O
into	O
the	O
mechanisms	O
that	O
underlie	O
region	O
-	O
specific	O
differences	O
in	O
body	O
morphology	O
.	O

Introduction	O

A	O
fundamental	O
question	O
in	O
developmental	O
biology	O
is	O
how	O
adjacent	O
regions	O
of	O
the	O
vertebrate	B-Taxon
body	O
acquire	O
differences	O
in	O
their	O
appearance	O
or	O
morphology	O
.	O

Mechanisms	O
that	O
establish	O
the	O
general	O
body	O
plan	O
make	O
use	O
of	O
a	O
relatively	O
small	O
number	O
of	O
signaling	O
pathways	O
shared	O
among	O
all	O
animals	B-Taxon
(	O
reviewed	O
in	O
Pires	O
-	O
daSilva	O
and	O
Sommer	O
2003	O
)	O
,	O
but	O
the	O
extent	O
to	O
which	O
these	O
pathways	O
control	O
finer	O
differences	O
between	O
body	O
regions	O
is	O
not	O
clear	O
.	O

Among	O
vertebrates	B-Taxon
,	O
differences	O
in	O
the	O
shape	O
or	O
number	O
of	O
skeletal	O
elements	O
,	O
altered	O
morphology	O
of	O
epidermal	O
appendages	O
,	O
and	O
variation	O
in	O
pigment	B-CHEBI
distribution	O
combine	O
to	O
produce	O
the	O
majority	O
of	O
what	O
distinguishes	O
one	O
animal	B-Taxon
from	O
another	O
.	O

Among	O
these	O
,	O
pigment	B-CHEBI
patterns	O
are	O
an	O
excellent	O
system	O
to	O
investigate	O
how	O
morphological	O
differences	O
arise	O
,	O
both	O
for	O
different	O
regions	O
of	O
the	O
body	O
within	O
a	O
species	O
and	O
for	O
different	O
animals	B-Taxon
from	O
closely	O
related	O
species	O
.	O

In	O
natural	O
environments	O
,	O
color	O
variation	O
is	O
a	O
nearly	O
universal	O
mechanism	O
for	O
recognition	O
,	O
camouflage	O
,	O
or	O
both	O
;	O
consequently	O
,	O
a	O
large	O
number	O
of	O
pigment	B-CHEBI
patterns	O
have	O
been	O
characterized	O
from	O
an	O
evolutionary	O
and	O
ecological	O
perspective	O
(	O
Boughman	O
2001	O
;	O
Jiggins	O
et	O
al	O
.	O
2001	O
)	O
.	O

In	O
the	O
laboratory	O
,	O
color	O
variation	O
has	O
been	O
the	O
subject	O
of	O
vertebrate	B-Taxon
genetics	O
for	O
more	O
than	O
a	O
century	O
(	O
Searle	O
1968	O
;	O
Silvers	O
1979	O
)	O
,	O
and	O
many	O
pigmentary	B-CHEBI
components	O
have	O
been	O
identified	O
whose	O
actions	O
are	O
understood	O
in	O
a	O
cellular	B-CL
or	O
organ	O
-	O
based	O
context	O
(	O
reviewed	O
in	O
Bennett	O
and	O
Lamoreux	O
2003	O
)	O
.	O

Several	O
mechanisms	O
may	O
contribute	O
to	O
regional	O
differences	O
in	O
vertebrate	B-Taxon
pigmentation	O
.	O

In	O
the	O
embryo	O
,	O
alterations	O
in	O
the	O
determination	O
or	O
migration	O
of	O
melanoblasts	B-CL
from	O
the	O
neural	O
crest	O
affect	O
the	O
number	O
or	O
distribution	O
of	O
pigment	B-CL
cells	I-CL
in	O
the	O
skin	O
(	O
reviewed	O
in	O
Reedy	O
et	O
al	O
.	O
1998	O
)	O
.	O

Within	O
hair	O
follicles	O
,	O
paracrine	O
signals	O
control	O
the	O
type	O
of	O
pigment	B-CHEBI
made	O
in	O
specific	O
regions	O
of	O
the	O
body	O
or	O
at	O
specific	O
times	O
during	O
the	O
hair	O
cycle	O
(	O
reviewed	O
in	O
Furumura	O
et	O
al	O
.	O
1996	O
;	O
Barsh	O
et	O
al	O
.	O
2000	O
)	O
.	O

Finally	O
,	O
movement	O
of	O
pigment	B-GO
granules	I-GO
within	O
melanocytes	B-CL
or	O
from	O
melanocytes	B-CL
to	O
keratinocytes	B-CL
makes	O
use	O
of	O
cellular	B-CL
machinery	O
that	O
is	O
shared	O
by	O
a	O
variety	O
of	O
cell	B-CL
types	O
,	O
but	O
that	O
can	O
vary	O
in	O
different	O
regions	O
of	O
the	O
body	O
(	O
reviewed	O
in	O
Marks	O
and	O
Seabra	O
2001	O
)	O
.	O

However	O
,	O
for	O
all	O
of	O
these	O
mechanisms	O
--	O
white	O
spotting	O
,	O
pigment	B-CHEBI
-	O
type	O
switching	O
,	O
and	O
melanosome	B-GO
biogenesis	O
--	O
more	O
is	O
known	O
about	O
the	O
identity	O
of	O
the	O
molecular	B-CHEBI
components	O
than	O
their	O
spatial	O
and	O
temporal	O
control	O
.	O

One	O
of	O
the	O
most	O
obvious	O
aspects	O
of	O
regional	O
color	O
variation	O
in	O
vertebrates	B-Taxon
is	O
a	O
dark	O
dorsal	O
surface	O
juxtaposed	O
to	O
a	O
light	O
ventral	O
surface	O
,	O
apparent	O
in	O
the	O
color	O
of	O
skin	O
,	O
scales	O
,	O
feathers	O
,	O
or	O
hair	O
,	O
in	O
which	O
the	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
compartments	O
is	O
often	O
sharp	O
and	O
lies	O
in	O
register	O
with	O
the	O
limbs	O
.	O

In	O
rodents	B-Taxon
and	O
probably	O
other	O
mammals	B-Taxon
,	O
this	O
dorsoventral	O
difference	O
in	O
hair	O
color	O
is	O
brought	O
about	O
by	O
differences	O
in	O
pigment	B-CHEBI
type	O
as	O
determined	O
by	O
allelic	B-SO
variation	O
of	O
the	O
Agouti	B-GGP
gene	B-SO
(	O
Bultman	O
et	O
al	O
.	O
1992	O
;	O
Miller	O
et	O
al	O
.	O
1993	O
)	O
.	O

Secreted	O
by	O
dermal	B-CL
papilla	I-CL
cells	I-CL
within	O
each	O
hair	O
follicle	O
(	O
Millar	O
et	O
al	O
.	O
1995	O
)	O
,	O
Agouti	B-GGP
protein	B-CHEBI
causes	O
melanocytes	B-CL
in	O
that	O
follicle	O
to	O
switch	O
from	O
the	O
production	O
of	O
brown	O
/	O
black	O
eumelanin	B-CHEBI
to	O
red	O
/	O
yellow	O
pheomelanin	O
.	O

Agouti	B-GGP
protein	B-CHEBI
has	O
a	O
short	O
radius	O
of	O
action	O
(	O
Silvers	O
and	O
Russel	O
1955	O
)	O
and	O
can	O
be	O
switched	O
on	O
and	O
off	O
during	O
a	O
single	O
hair	O
cycle	O
(	O
Bultman	O
et	O
al	O
.	O
1992	O
,	O
1994	O
;	O
Miller	O
et	O
al	O
.	O
1993	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
;	O
thus	O
,	O
its	O
regulated	O
expression	O
is	O
thought	O
to	O
be	O
responsible	O
for	O
the	O
cream	O
-	O
colored	O
or	O
yellow	O
ventral	O
surface	O
of	O
mice	B-Taxon
carrying	O
the	O
black	O
-	O
and	O
-	O
tan	O
(	O
at	O
)	O
allele	B-SO
and	O
for	O
the	O
yellow	O
markings	O
around	O
the	O
feet	O
,	O
ears	O
,	O
or	O
head	O
,	O
i	O
.	O
e	O
.	O
,	O
tan	O
points	O
or	O
head	O
spots	O
,	O
of	O
certain	O
dog	B-Taxon
breeds	O
.	O

In	O
laboratory	O
mice	B-Taxon
,	O
previous	O
studies	O
from	O
our	O
group	O
and	O
others	O
identified	O
two	O
predominant	O
Agouti	B-GGP
mRNA	B-CHEBI
isoforms	B-SO
that	O
differ	O
by	O
virtue	O
of	O
their	O
transcriptional	B-SO
initiation	I-SO
site	I-SO
and	O
5	B-SO
'	I-SO
untranslated	I-SO
exons	I-SO
.	O

A	O
"	O
hair	O
cycle	O
-	O
specific	O
"	O
transcript	B-SO
is	O
expressed	O
in	O
both	O
dorsal	O
and	O
ventral	O
skin	O
for	O
2	O
-	O
3	O
days	O
during	O
early	O
hair	O
growth	O
,	O
while	O
a	O
"	O
ventral	O
-	O
specific	O
"	O
transcript	B-SO
is	O
expressed	O
throughout	O
the	O
entire	O
period	O
of	O
active	O
hair	O
growth	O
,	O
but	O
only	O
in	O
ventral	O
skin	O
(	O
Bultman	O
et	O
al	O
.	O
1994	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
.	O

Animals	B-Taxon
carrying	O
the	O
at	O
allele	B-SO
express	O
only	O
the	O
ventral	O
-	O
specific	O
Agouti	B-GGP
transcript	B-SO
(	O
Bultman	O
et	O
al	O
.	O
1994	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
and	O
have	O
black	O
dorsal	O
hairs	O
and	O
cream	O
-	O
colored	O
to	O
yellow	O
ventral	O
hairs	O
,	O
with	O
a	O
sharp	O
boundary	O
at	O
the	O
level	O
of	O
the	O
limb	O
-	O
body	O
wall	O
articulations	O
and	O
in	O
the	O
middle	O
of	O
the	O
whisker	O
pad	O
.	O

Ventral	O
-	O
specific	O
Agouti	B-GGP
isoforms	B-SO
are	O
also	O
expressed	O
in	O
developing	O
skin	O
from	O
embryonic	O
day	O
10	O
.	O
5	O
(	O
E10	O
.	O
5	O
)	O
and	O
beyond	O
and	O
may	O
play	O
a	O
role	O
in	O
pigment	B-CL
cell	I-CL
differentiation	O
(	O
Millar	O
et	O
al	O
.	O
1995	O
)	O
.	O

Thus	O
,	O
regulatory	B-SO
elements	I-SO
for	O
ventral	O
-	O
specific	O
Agouti	B-GGP
isoforms	B-SO
are	O
responsive	O
to	O
dorsoventral	O
positional	O
cues	O
established	O
in	O
the	O
embryo	O
and	O
whose	O
effects	O
persist	O
after	O
birth	O
.	O

The	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
color	O
compartments	O
in	O
at	O
/	O
at	O
mice	B-Taxon
bears	O
superficial	O
resemblance	O
to	O
dorsoventral	O
boundaries	O
apparent	O
for	O
many	O
other	O
mammals	B-Taxon
,	O
but	O
morphogenetic	O
differences	O
between	O
dorsal	O
and	O
ventral	O
skin	O
seem	O
likely	O
to	O
include	O
more	O
elements	O
than	O
the	O
type	O
of	O
pigment	B-CHEBI
made	O
by	O
hair	O
follicle	O
melanocytes	B-CL
.	O

In	O
particular	O
,	O
dermis	O
of	O
the	O
flank	O
has	O
at	O
least	O
two	O
distinct	O
origins	O
:	O
dermatomal	O
derivatives	O
of	O
somites	O
and	O
loose	O
mesenchyme	O
derived	O
from	O
the	O
lateral	O
plate	O
mesoderm	O
(	O
Mauger	O
1972	O
;	O
Christ	O
et	O
al	O
.	O
1983	O
;	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
;	O
these	O
lineages	O
are	O
established	O
early	O
in	O
development	O
and	O
could	O
,	O
in	O
principle	O
,	O
set	O
up	O
compartments	O
whose	O
identity	O
contributes	O
to	O
dorsoventral	O
differences	O
in	O
adult	O
skin	O
.	O

To	O
better	O
understand	O
the	O
mechanisms	O
that	O
give	O
rise	O
to	O
differences	O
between	O
dorsal	O
and	O
ventral	O
skin	O
and	O
to	O
the	O
boundary	O
between	O
them	O
,	O
we	O
have	O
determined	O
how	O
several	O
morphologic	O
characteristics	O
vary	O
along	O
the	O
dorsoventral	O
axis	O
of	O
the	O
mouse	B-Taxon
and	O
how	O
these	O
characteristics	O
correspond	O
to	O
ventral	O
-	O
specific	O
Agouti	B-GGP
expression	O
and	O
the	O
lineage	O
boundary	O
that	O
distinguishes	O
somite	O
from	O
lateral	O
plate	O
derivatives	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
apparent	O
uniformity	O
of	O
the	O
dorsoventral	O
boundary	O
represents	O
the	O
sum	O
of	O
independent	O
mechanisms	O
that	O
affect	O
melanocyte	B-CL
density	O
and	O
/	O
or	O
differentiation	O
,	O
pigment	B-CHEBI
-	O
type	O
synthesis	O
,	O
and	O
hair	O
length	O
;	O
surprisingly	O
,	O
none	O
of	O
these	O
coincide	O
with	O
the	O
somite	O
-	O
lateral	O
plate	O
lineage	O
boundary	O
.	O

We	O
also	O
make	O
use	O
of	O
a	O
classical	O
mouse	B-Taxon
mutation	B-SO
,	O
droopy	O
ear	O
(	O
Curry	O
1959	O
)	O
,	O
that	O
produces	O
a	O
dorsal	O
-	O
to	O
-	O
ventral	O
transformation	O
of	O
flank	O
coat	O
color	O
by	O
allowing	O
expansion	O
of	O
the	O
ventral	O
-	O
specific	O
Agouti	B-GGP
transcript	B-SO
.	O

By	O
positional	B-SO
cloning	O
and	O
gene	B-SO
targeting	O
,	O
we	O
identify	O
an	O
allele	B-SO
of	O
droopy	B-GGP
ear	I-GGP
,	O
deH	O
,	O
as	O
a	O
loss	O
of	O
function	O
for	O
Tbx15	B-GGP
,	O
which	O
encodes	O
a	O
T	O
-	O
box	O
transcription	O
factor	O
expressed	O
in	O
a	O
dynamic	O
and	O
spatially	O
restricted	O
manner	O
in	O
the	O
developing	O
skin	O
and	O
musculoskeletal	O
system	O
.	O

Embryonic	O
expression	O
and	O
transplantation	O
studies	O
suggest	O
that	O
Tbx15	B-GGP
is	O
required	O
to	O
establish	O
certain	O
characteristics	O
of	O
dorsal	O
patterning	O
in	O
mesenchymal	B-CL
cells	I-CL
of	O
the	O
developing	O
flank	O
.	O

These	O
results	O
identify	O
a	O
previously	O
unappreciated	O
aspect	O
of	O
dorsoventral	O
patterning	O
that	O
is	O
widely	O
represented	O
in	O
furred	O
mammals	B-Taxon
and	O
provide	O
insight	O
into	O
the	O
mechanisms	O
that	O
underlie	O
region	O
-	O
specific	O
differences	O
in	O
body	O
morphology	O
.	O

Results	O

Morphological	O
Components	O
of	O
Dorsoventral	O
Skin	O
Differences	O

Besides	O
the	O
obvious	O
change	O
in	O
hair	O
color	O
that	O
frequently	O
distinguishes	O
dorsal	O
from	O
ventral	O
skin	O
,	O
casual	O
observation	O
suggests	O
there	O
are	O
additional	O
differences	O
in	O
hair	O
length	O
,	O
distribution	O
of	O
hair	O
type	O
,	O
and	O
skin	O
thickness	O
.	O

Furthermore	O
,	O
dorsoventral	O
differences	O
in	O
pigmentation	O
can	O
represent	O
differences	O
in	O
the	O
number	O
and	O
/	O
or	O
differentiated	O
state	O
of	O
pigment	B-CL
cells	I-CL
,	O
as	O
well	O
as	O
the	O
type	O
of	O
pigment	B-CHEBI
synthesized	O
in	O
response	O
to	O
expression	O
of	O
Agouti	B-GGP
.	O

In	O
particular	O
,	O
ventral	O
hair	O
of	O
at	O
/	O
at	O
animals	B-Taxon
can	O
vary	O
from	O
cream	O
-	O
colored	O
to	O
reddish	O
-	O
yellow	O
depending	O
on	O
age	O
,	O
strain	O
background	O
,	O
and	O
position	O
along	O
the	O
dorsoventral	O
axis	O
.	O

To	O
evaluate	O
the	O
relationship	O
among	O
these	O
components	O
,	O
we	O
compared	O
their	O
features	O
among	O
mice	B-Taxon
of	O
different	O
Agouti	B-GGP
genotypes	B-SO
.	O

Semiquantitative	O
measurements	O
of	O
hair	O
length	O
plotted	O
as	O
a	O
function	O
of	O
dorsoventral	O
position	O
reveal	O
that	O
the	O
apparent	O
sharp	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
pigment	B-CHEBI
compartments	O
in	O
at	O
/	O
at	O
mice	B-Taxon
coincides	O
with	O
a	O
more	O
gradual	O
change	O
in	O
both	O
hair	O
color	O
and	O
hair	O
length	O
(	O
Figure	O
1A	O
-	O
1D	O
)	O
.	O

Within	O
the	O
region	O
of	O
transition	O
from	O
dorsum	O
to	O
ventrum	O
(	O
Figure	O
1B	O
)	O
,	O
flank	O
hairs	O
from	O
at	O
/	O
at	O
mice	B-Taxon
become	O
progressively	O
shorter	O
and	O
exhibit	O
increasing	O
amounts	O
of	O
pheomelanin	O
deposition	O
progressing	O
from	O
the	O
tip	O
to	O
the	O
base	O
of	O
the	O
hair	O
.	O

However	O
,	O
the	O
region	O
of	O
transition	O
for	O
hair	O
length	O
is	O
considerably	O
broader	O
than	O
that	O
for	O
pigmentation	O
and	O
independent	O
of	O
Agouti	B-GGP
genotype	B-SO
.	O

Although	O
hair	O
-	O
cycle	O
timing	O
varies	O
along	O
the	O
rostrocaudal	O
axis	O
,	O
measurements	O
of	O
absolute	O
hair	O
length	O
for	O
mice	B-Taxon
matched	O
for	O
age	O
and	O
rostrocaudal	O
level	O
are	O
remarkably	O
similar	O
(	O
Figure	O
1D	O
)	O
.	O

Furthermore	O
,	O
measurements	O
of	O
relative	O
hair	O
length	O
for	O
animals	B-Taxon
of	O
different	O
age	O
,	O
size	O
,	O
and	O
Agouti	B-GGP
genotype	B-SO
also	O
are	O
very	O
similar	O
when	O
normalized	O
to	O
body	O
circumference	O
(	O
Figure	O
1C	O
)	O
.	O

Taken	O
together	O
,	O
these	O
observations	O
indicate	O
that	O
variation	O
of	O
hair	O
length	O
along	O
the	O
dorsoventral	O
axis	O
is	O
stereotyped	O
and	O
maintained	O
through	O
multiple	O
hair	O
cycles	O
,	O
with	O
a	O
transition	O
in	O
hair	O
length	O
that	O
is	O
gradual	O
and	O
encompasses	O
the	O
pigment	B-CHEBI
-	O
type	O
transition	O
in	O
at	O
/	O
at	O
mice	B-Taxon
.	O

Dorsal	O
and	O
ventral	O
skin	O
develop	O
at	O
different	O
rates	O
.	O

Transverse	O
sections	O
of	O
skin	O
at	O
postnatal	O
day	O
4	O
.	O
5	O
(	O
P4	O
.	O
5	O
)	O
exhibit	O
dorsal	O
hair	O
follicles	O
that	O
are	O
noticeably	O
more	O
developed	O
than	O
ventral	O
hair	O
follicles	O
,	O
along	O
with	O
a	O
gradual	O
dorsoventral	O
decrease	O
in	O
dermal	O
thickness	O
(	O
Figure	O
1F	O
)	O
.	O

However	O
,	O
differences	O
in	O
skin	O
thickness	O
disappear	O
by	O
3	O
-	O
4	O
wk	O
of	O
age	O
(	O
Forsthoefel	O
et	O
al	O
.	O
1966	O
)	O
,	O
and	O
,	O
overall	O
,	O
the	O
proportion	O
of	O
different	O
hair	O
types	O
is	O
also	O
similar	O
in	O
dorsa	O
and	O
ventra	O
of	O
adult	O
mice	B-Taxon
.	O

In	O
age	O
-	O
matched	O
inbred	O
mice	B-Taxon
,	O
we	O
observed	O
a	O
small	O
decrease	O
in	O
the	O
ratio	O
of	O
undercoat	O
hairs	O
(	O
zigzags	O
)	O
to	O
overcoat	O
hairs	O
(	O
auchenes	O
,	O
awls	O
,	O
and	O
guard	O
hairs	O
)	O
in	O
dorsum	O
compared	O
to	O
ventrum	O
(	O
Figure	O
1E	O
)	O
,	O
but	O
there	O
was	O
no	O
consistent	O
difference	O
in	O
hair	O
-	O
type	O
distribution	O
for	O
outbred	O
mice	B-Taxon
(	O
data	O
not	O
shown	O
)	O
.	O

Differences	O
between	O
dorsal	O
and	O
ventral	O
pigmentation	O
of	O
at	O
/	O
at	O
mice	B-Taxon
are	O
usually	O
attributed	O
to	O
pigment	B-CHEBI
-	O
type	O
differences	O
caused	O
by	O
ventral	O
-	O
specific	O
expression	O
of	O
Agouti	B-GGP
,	O
but	O
animals	B-Taxon
homozygous	O
for	O
a	O
null	O
allele	B-SO
of	O
Agouti	B-GGP
,	O
extreme	O
nonagouti	O
(	O
ae	O
)	O
,	O
have	O
ventral	O
hairs	O
that	O
contain	O
less	O
melanin	B-CHEBI
than	O
dorsal	O
hairs	O
,	O
giving	O
a	O
slightly	O
paler	O
appearance	O
to	O
the	O
ventral	O
coat	O
(	O
Figure	O
1G	O
)	O
.	O

Using	O
DOPA	B-CHEBI
staining	O
as	O
an	O
indicator	O
of	O
tyrosinase	B-GGP
activity	O
,	O
we	O
observed	O
a	O
gradual	O
dorsoventral	O
transition	O
in	O
isolated	O
dermis	O
preparations	O
from	O
P4	O
.	O
5	O
ae	O
/	O
ae	O
mice	B-Taxon
(	O
Figure	O
1G	O
)	O
.	O

By	O
contrast	O
,	O
skin	O
from	O
at	O
/	O
at	O
mice	B-Taxon
reveal	O
an	O
abrupt	O
dorsoventral	O
transition	O
of	O
DOPA	B-CHEBI
staining	O
,	O
which	O
probably	O
reflects	O
the	O
additive	O
effects	O
of	O
reduced	O
melanin	B-CHEBI
content	O
(	O
as	O
in	O
ae	O
/	O
ae	O
mice	B-Taxon
)	O
and	O
downregulation	O
of	O
tyrosinase	B-GGP
activity	O
induced	O
by	O
Agouti	B-GGP
.	O

Melanin	B-CHEBI
content	O
of	O
individual	O
hairs	O
is	O
likely	O
to	O
be	O
influenced	O
both	O
by	O
the	O
number	O
of	O
pigment	B-CL
cells	I-CL
and	O
their	O
follicular	O
environment	O
.	O

Regardless	O
,	O
dorsoventral	O
differences	O
in	O
hair	O
pigment	B-CHEBI
content	O
of	O
ae	O
/	O
ae	O
mice	B-Taxon
persist	O
throughout	O
multiple	O
hair	O
cycles	O
into	O
adulthood	O
,	O
similar	O
to	O
hair	O
length	O
(	O
but	O
unlike	O
skin	O
thickness	O
)	O
.	O

Thus	O
,	O
at	O
least	O
three	O
characteristics	O
distinguish	O
dorsal	O
from	O
ventral	O
skin	O
:	O
differences	O
in	O
pigment	B-CHEBI
-	O
type	O
synthesis	O
(	O
depending	O
on	O
Agouti	B-GGP
genotype	B-SO
)	O
,	O
differences	O
in	O
hair	O
length	O
,	O
and	O
differences	O
in	O
melanin	B-CHEBI
content	O
.	O

Ventralization	O
of	O
Skin	O
Morphology	O
by	O
the	O
droopy	B-GGP
ear	I-GGP
Mutation	B-SO

Named	O
after	O
its	O
effects	O
on	O
craniofacial	O
morphology	O
,	O
droopy	O
ear	O
is	O
a	O
recessive	O
mutation	B-SO
on	O
mouse	B-Taxon
Chromosome	B-GO
3	O
;	O
the	O
original	O
allele	B-SO
described	O
more	O
than	O
40	O
years	O
ago	O
by	O
Curry	O
(	O
1959	O
)	O
is	O
extinct	O
,	O
but	O
a	O
spontaneous	O
remutation	O
that	O
occurred	O
in	O
Harwell	O
,	O
deH	O
,	O
is	O
available	O
through	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
.	O

External	O
craniofacial	O
malformations	O
are	O
the	O
most	O
obvious	O
characteristic	O
of	O
deH	O
/	O
deH	O
animals	B-Taxon
,	O
including	O
widely	O
spaced	O
eyes	O
,	O
small	O
palpebral	O
fissures	O
,	O
a	O
broad	O
nasal	O
area	O
,	O
and	O
a	O
shortened	O
skull	O
held	O
in	O
an	O
elevated	O
position	O
,	O
which	O
presumably	O
causes	O
or	O
contributes	O
to	O
the	O
abnormal	O
position	O
of	O
the	O
ears	O
.	O

We	O
became	O
interested	O
in	O
droopy	B-GGP
ear	I-GGP
because	O
the	O
original	O
allele	B-SO
was	O
described	O
to	O
affect	O
pigment	B-CHEBI
pattern	O
in	O
a	O
way	O
that	O
suggests	O
a	O
possible	O
dorsal	O
to	O
ventral	O
transformation	O
:	O
"	O
On	O
a	O
genetic	B-SO
background	O
(	O
at	O
and	O
AW	O
)	O
which	O
causes	O
the	O
belly	O
hair	O
to	O
be	O
lighter	O
than	O
the	O
back	O
hair	O
,	O
the	O
belly	O
hair	O
comes	O
up	O
farther	O
round	O
the	O
sides	O
of	O
the	O
body	O
and	O
face	O
"	O
(	O
Curry	O
1959	O
)	O
.	O

An	O
abnormal	O
dorsoventral	O
pigment	B-CHEBI
pattern	O
is	O
readily	O
apparent	O
in	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
mice	B-Taxon
,	O
but	O
comparison	O
to	O
nonmutant	O
animals	B-Taxon
is	O
more	O
accurately	O
described	O
in	O
terms	O
of	O
ventral	O
,	O
lateral	O
,	O
and	O
dorsal	O
regions	O
(	O
Figures	O
1G	O
and	O
2A	O
)	O
.	O

The	O
ventral	O
region	O
has	O
short	O
hairs	O
with	O
a	O
gray	O
base	O
and	O
cream	O
-	O
colored	O
tip	O
whose	O
boundary	O
coincides	O
with	O
the	O
limb	O
-	O
body	O
wall	O
junction	O
;	O
both	O
the	O
appearance	O
of	O
this	O
region	O
and	O
position	O
of	O
the	O
boundary	O
are	O
approximately	O
similar	O
in	O
at	O
/	O
at	O
compared	O
to	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
mice	B-Taxon
.	O

The	O
lateral	O
region	O
contains	O
yellow	O
hairs	O
of	O
progressively	O
increasing	O
length	O
;	O
in	O
at	O
/	O
at	O
mice	B-Taxon
,	O
the	O
lateral	O
region	O
appears	O
as	O
a	O
thin	O
yellow	O
stripe	O
along	O
the	O
flank	O
,	O
but	O
in	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
mice	B-Taxon
,	O
the	O
lateral	O
region	O
is	O
considerably	O
expanded	O
with	O
a	O
diffuse	O
boundary	O
along	O
the	O
dorsal	O
flank	O
,	O
and	O
a	O
dorsal	O
eumelanic	B-CHEBI
region	O
whose	O
size	O
is	O
correspondingly	O
reduced	O
(	O
Figure	O
2A	O
and	O
2B	O
)	O
.	O

Total	O
body	O
size	O
is	O
smaller	O
in	O
mutant	B-SO
compared	O
to	O
nonmutant	O
animals	B-Taxon
,	O
but	O
the	O
proportion	O
of	O
body	O
circumference	O
occupied	O
by	O
the	O
lateral	O
region	O
in	O
mutant	B-SO
animals	B-Taxon
is	O
increased	O
about	O
2	O
-	O
fold	O
,	O
from	O
11	O
.	O
9	O
%	O
to	O
22	O
.	O
2	O
%	O
(	O
Figure	O
2C	O
)	O
.	O

The	O
proportion	O
of	O
the	O
ventral	O
cream	O
-	O
colored	O
region	O
is	O
also	O
expanded	O
a	O
small	O
amount	O
,	O
47	O
.	O
9	O
%	O
in	O
mutant	B-SO
compared	O
to	O
37	O
.	O
8	O
%	O
in	O
nonmutant	O
animals	B-Taxon
,	O
but	O
expansion	O
of	O
the	O
lateral	O
region	O
,	O
which	O
occurs	O
at	O
all	O
levels	O
of	O
the	O
body	O
,	O
including	O
the	O
limbs	O
and	O
the	O
cranium	O
(	O
but	O
not	O
the	O
whisker	O
pad	O
)	O
,	O
is	O
the	O
major	O
feature	O
responsible	O
for	O
the	O
ventralized	O
appearance	O
caused	O
by	O
deH	O
.	O

To	O
investigate	O
whether	O
deH	O
affects	O
other	O
dorsoventral	O
skin	O
characteristics	O
besides	O
pigment	B-CHEBI
-	O
type	O
switching	O
,	O
we	O
examined	O
its	O
effects	O
on	O
hair	O
length	O
and	O
pigmentation	O
in	O
an	O
ae	O
/	O
ae	O
background	O
.	O

Overall	O
,	O
deH	O
causes	O
a	O
small	O
but	O
consistent	O
reduction	O
in	O
hair	O
length	O
in	O
both	O
dorsum	O
and	O
ventrum	O
;	O
when	O
mutant	B-SO
and	O
nonmutant	O
animals	B-Taxon
are	O
normalized	O
for	O
body	O
circumference	O
,	O
reduced	O
hair	O
length	O
is	O
most	O
apparent	O
in	O
the	O
lateral	O
region	O
(	O
Figure	O
2E	O
)	O
.	O

Adult	O
ae	O
/	O
ae	O
;	O
deH	O
/	O
deH	O
animals	B-Taxon
exhibit	O
body	O
-	O
size	O
reduction	O
and	O
skeletal	O
abnormalities	O
,	O
but	O
display	O
no	O
coat	O
-	O
color	O
phenotype	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
ae	O
/	O
ae	O
and	O
ae	O
/	O
ae	O
;	O
deH	O
/	O
deH	O
neonates	O
are	O
clearly	O
distinguishable	O
in	O
the	O
first	O
few	O
days	O
after	O
birth	O
,	O
when	O
a	O
dorsoventral	O
gradient	O
of	O
melanogenic	O
activity	O
is	O
apparent	O
under	O
the	O
skin	O
(	O
Figure	O
2D	O
)	O
.	O

At	O
this	O
stage	O
,	O
melanoblast	B-CL
migration	O
from	O
the	O
neural	O
crest	O
is	O
mostly	O
complete	O
,	O
but	O
there	O
is	O
a	O
dorsoventral	O
gradient	O
in	O
melanocyte	B-CL
differentiation	O
and	O
pigment	B-CHEBI
synthesis	O
.	O

The	O
skin	O
of	O
ae	O
/	O
ae	O
neonates	O
appears	O
uniformly	O
dark	O
over	O
the	O
entire	O
dorsum	O
,	O
but	O
in	O
ae	O
/	O
ae	O
;	O
deH	O
/	O
deH	O
neonates	O
,	O
the	O
area	O
of	O
dark	O
skin	O
is	O
more	O
restricted	O
,	O
particularly	O
above	O
the	O
limbs	O
,	O
and	O
resembles	O
the	O
pattern	O
of	O
dorsal	O
eumelanin	B-CHEBI
in	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
adult	O
animals	B-Taxon
.	O

Taken	O
together	O
,	O
these	O
observations	O
suggest	O
that	O
deH	O
interferes	O
with	O
the	O
establishment	O
of	O
dorsoventral	O
patterning	O
during	O
skin	O
development	O
by	O
causing	O
dorsal	O
expansion	O
of	O
a	O
lateral	O
region	O
that	O
is	O
normally	O
3	O
-	O
5	O
mm	O
in	O
width	O
.	O

This	O
same	O
region	O
may	O
serve	O
as	O
a	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
skin	O
by	O
inhibiting	O
melanocyte	B-CL
differentiation	O
,	O
by	O
promoting	O
pheomelanin	O
synthesis	O
,	O
and	O
by	O
supporting	O
a	O
progressive	O
increase	O
in	O
hair	O
growth	O
from	O
ventrum	O
to	O
dorsum	O
.	O

As	O
described	O
below	O
,	O
the	O
gene	B-SO
defective	O
in	O
deH	O
,	O
Tbx15	B-GGP
,	O
is	O
normally	O
expressed	O
in	O
the	O
dorsal	O
region	O
and	O
therefore	O
is	O
likely	O
to	O
play	O
a	O
role	O
in	O
establishing	O
the	O
size	O
and	O
dorsal	O
extent	O
of	O
the	O
lateral	O
region	O
.	O

Positional	B-SO
Cloning	O
of	O
deH	O

As	O
a	O
visible	O
marker	O
,	O
early	O
linkage	O
studies	O
with	O
the	O
original	O
droopy	B-GGP
ear	I-GGP
allele	B-SO
or	O
the	O
deH	O
allele	B-SO
identified	O
a	O
map	B-SO
position	B-SO
in	O
the	O
middle	O
of	O
Chromosome	B-GO
3	O
,	O
distal	O
to	O
matted	B-GGP
and	O
proximal	O
to	O
Varitint	B-GGP
-	I-GGP
waddler	I-GGP
(	O
Carter	O
and	O
Falconer	O
1951	O
;	O
Curry	O
1959	O
;	O
Lane	O
and	O
Eicher	O
1979	O
;	O
Holmes	O
et	O
al	O
.	O
1981	O
)	O
.	O

We	O
used	O
an	O
F2	O
intercross	O
with	O
CAST	O
/	O
Ei	O
mice	B-Taxon
to	O
localize	O
deH	O
to	O
a	O
0	O
.	O
1	O
cM	O
interval	B-SO
between	O
D3Mit213	O
and	O
16	O
.	O
MMHAP32FLF1	O
,	O
which	O
was	O
refined	O
by	O
development	O
of	O
a	O
bacterial	B-SO
artificial	I-SO
chromosome	I-SO
(	O
BAC	B-SO
)	O
contig	B-SO
and	O
additional	O
markers	O
to	O
a	O
1	O
.	O
4	O
Mb	O
region	B-SO
that	O
contained	O
eight	O
genes	B-SO
,	O
including	O
Tbx15	B-GGP
(	O
Figure	O
3A	O
)	O
.	O

We	O
considered	O
Tbx15	B-GGP
as	O
an	O
excellent	O
candidate	O
for	O
the	O
skeletal	O
abnormalities	O
caused	O
by	O
deH	O
,	O
based	O
on	O
studies	O
by	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
,	O
who	O
described	O
its	O
embryonic	O
expression	O
in	O
the	O
craniofacial	O
region	O
and	O
developing	O
limbs	O
.	O

Using	O
sequence	B-SO
information	O
from	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
and	O
the	O
partially	B-SO
completed	I-SO
mouse	B-Taxon
genome	B-SO
sequence	I-SO
,	O
we	O
found	O
that	O
portions	B-SO
of	I-SO
several	I-SO
Tbx15	I-SO
exons	I-SO
could	O
not	O
be	O
amplified	O
from	O
deH	O
/	O
deH	O
genomic	B-SO
DNA	I-SO
.	O

The	O
same	O
gene	B-SO
was	O
initially	O
referred	O
to	O
as	O
Tbx8	B-GGP
(	O
Wattler	O
et	O
al	O
.	O
1998	O
)	O
and	O
then	O
later	O
renamed	O
Tbx14	B-GGP
,	O
but	O
is	O
currently	O
referred	O
to	O
in	O
several	O
vertebrate	B-Taxon
genomes	B-SO
as	O
Tbx15	B-GGP
(	O
Agulnik	O
et	O
al	O
.	O
1998	O
;	O
Begemann	O
et	O
al	O
.	O
2002	O
)	O
.	O

By	O
comparing	O
the	O
sequence	B-SO
of	O
a	O
1	O
.	O
3	O
kb	O
junction	B-SO
fragment	B-SO
amplified	O
from	O
deH	O
/	O
deH	O
genomic	B-SO
DNA	I-SO
to	O
publicly	O
available	O
mouse	B-Taxon
genome	B-SO
sequence	I-SO
,	O
we	O
identified	O
a	O
216	O
kb	O
deletion	B-SO
that	O
extends	O
from	O
Tbx15	B-GGP
intron	B-SO
1	O
to	O
148	O
kb	O
downstream	O
of	O
the	O
polyadenylation	B-SO
sequence	I-SO
in	O
a	O
region	B-SO
annotated	O
as	O
a	O
mannose	B-GGP
-	I-GGP
6	I-GGP
-	I-GGP
phosphate	I-GGP
receptor	I-GGP
pseudogene	B-SO
,	O
M6pr	B-GGP
-	O
ps	B-SO
(	O
Figure	O
3B	O
and	O
3C	O
)	O
.	O

(	O
Ludwig	O
et	O
al	O
.	O
1992	O
)	O
.	O

By	O
Northern	O
blot	O
analysis	O
,	O
we	O
identified	O
a	O
fusion	B-SO
transcript	B-SO
produced	O
from	O
the	O
deH	O
chromosome	B-GO
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
the	O
deletion	B-SO
removes	B-SO
534	O
of	O
the	O
602	O
amino	B-CHEBI
acids	I-CHEBI
encoded	O
by	O
Tbx15	B-GGP
(	O
including	O
the	O
T	O
-	O
box	O
DNA	B-SO
-	O
binding	O
domain	B-SO
)	O
,	O
deH	O
/	O
+	B-SO
animals	B-Taxon
are	O
grossly	O
normal	O
,	O
and	O
the	O
phenotype	O
of	O
deH	O
/	O
deH	O
animals	B-Taxon
is	O
identical	O
to	O
that	O
described	O
for	O
the	O
original	O
allele	B-SO
.	O

In	O
addition	O
,	O
other	O
than	O
M6pr	B-GGP
-	O
ps	B-SO
,	O
no	O
other	O
genes	B-SO
or	O
transcripts	B-SO
have	O
been	O
annotated	O
to	O
the	O
216	O
kb	O
deletion	B-SO
.	O

While	O
the	O
positional	B-SO
cloning	O
work	O
was	O
underway	O
,	O
one	O
of	O
us	O
(	O
A	O
.	O
Russ	O
)	O
generated	O
an	O
independent	O
mutation	B-SO
of	O
Tbx15	B-GGP
by	O
gene	B-SO
targeting	O
in	O
embryonic	O
stem	B-CL
cells	I-CL
.	O

The	O
targeted	O
allele	B-SO
,	O
Tbx15LacZ	O
,	O
carries	O
an	O
IRES	B-SO
-	O
LacZ	O
-	O
neo	O
cDNA	B-SO
cassette	B-SO
that	O
disrupts	O
the	O
open	B-SO
reading	I-SO
frame	I-SO
at	O
codon	B-SO
154	O
early	O
in	O
the	O
T	O
-	O
box	O
domain	B-SO
(	O
Figure	O
3D	O
)	O
.	O

Animals	B-Taxon
heterozygous	O
for	O
the	O
targeted	O
allele	B-SO
are	O
completely	O
normal	O
with	O
regard	O
to	O
size	O
,	O
skeletal	O
morphology	O
,	O
and	O
hair	O
-	O
color	O
distribution	O
,	O
but	O
Tbx15LacZ	O
/	O
Tbx15LacZ	O
homozygotes	O
were	O
noted	O
to	O
exhibit	O
reduced	O
body	O
size	O
and	O
an	O
abnormal	O
craniofacial	O
appearance	O
identical	O
to	O
that	O
caused	O
by	O
deH	O
.	O

We	O
generated	O
Tbx15LacZ	O
/	O
deH	O
compound	O
heterozygotes	O
;	O
on	O
an	O
Aw	O
/	O
at	O
background	O
,	O
these	O
animals	B-Taxon
exhibited	O
the	O
same	O
abnormal	O
restriction	O
of	O
dorsal	O
pigmentation	O
at	O
P3	O
.	O
5	O
and	O
expanded	O
yellow	O
flank	O
area	O
as	O
described	O
above	O
for	O
deH	O
/	O
deH	O
animals	B-Taxon
(	O
see	O
Figure	O
2	O
)	O
.	O

These	O
observations	O
demonstrate	O
that	O
the	O
pigmentary	B-CHEBI
and	O
craniofacial	O
characteristics	O
of	O
deH	O
are	O
caused	O
by	O
loss	O
of	O
function	O
for	O
Tbx15	B-GGP
.	O

Expression	O
of	O
Tbx15	B-GGP
and	O
Agouti	B-GGP

Previous	O
studies	O
by	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
using	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
described	O
expression	O
of	O
Tbx15	B-GGP
as	O
first	O
detectable	O
at	O
E9	O
.	O
5	O
in	O
the	O
limb	O
buds	O
,	O
progressing	O
to	O
the	O
branchial	O
arches	O
,	O
flanks	O
,	O
and	O
craniofacial	O
regions	O
through	O
E12	O
.	O
5	O
.	O

To	O
investigate	O
this	O
pattern	O
in	O
more	O
detail	O
,	O
we	O
hybridized	O
a	O
Tbx15	B-GGP
mRNA	B-CHEBI
probe	B-SO
to	O
a	O
series	O
of	O
transverse	O
sections	O
at	O
E12	O
.	O
5	O
and	O
observed	O
expression	O
in	O
multiple	O
mesenchymal	O
tissues	O
of	O
the	O
head	O
,	O
trunk	O
,	O
and	O
developing	O
limbs	O
(	O
Figure	O
4A	O
)	O
,	O
much	O
of	O
which	O
is	O
consistent	O
with	O
the	O
skull	O
,	O
cervical	O
vertebrae	O
,	O
and	O
limb	O
malformations	O
reported	O
for	O
mice	B-Taxon
carrying	O
the	O
original	O
droopy	B-GGP
ear	I-GGP
allele	B-SO
.	O

We	O
were	O
particularly	O
interested	O
in	O
determining	O
the	O
exact	O
nature	O
of	O
the	O
embryonic	O
flank	O
expression	O
relative	O
to	O
the	O
ventralized	O
phenotype	O
of	O
adult	O
deH	O
/	O
deH	O
mice	B-Taxon
.	O

Transverse	O
abdominal	O
sections	O
from	O
different	O
times	O
during	O
development	O
reveal	O
a	O
dorsolateral	O
band	O
of	O
expression	O
in	O
the	O
superficial	O
mesenchyme	O
at	O
E11	O
.	O
5	O
that	O
broadens	O
both	O
dorsally	O
and	O
ventrally	O
over	O
the	O
next	O
several	O
days	O
(	O
Figure	O
4B	O
)	O
.	O

By	O
E13	O
.	O
5	O
,	O
the	O
developing	O
dermis	O
has	O
become	O
separated	O
from	O
the	O
loose	O
mesenchyme	O
by	O
a	O
subcutaneous	O
muscle	O
layer	O
;	O
Tbx15	B-GGP
is	O
expressed	O
in	O
all	O
of	O
these	O
layers	O
as	O
well	O
as	O
the	O
underlying	O
abdominal	O
muscles	O
.	O

In	O
P3	O
.	O
5	O
skin	O
,	O
Tbx15	B-GGP
is	O
expressed	O
in	O
both	O
dorsal	O
and	O
ventral	O
skin	O
,	O
most	O
strongly	O
in	O
the	O
condensed	O
upper	O
dermis	O
and	O
developing	O
dermal	O
sheaths	O
of	O
hair	O
follicles	O
;	O
faint	O
expression	O
can	O
also	O
be	O
detected	O
in	O
rare	O
dermal	B-CL
papillae	I-CL
cells	I-CL
(	O
Figure	O
4B	O
)	O
.	O

Although	O
the	O
effects	O
of	O
Agouti	B-GGP
on	O
pigment	B-CHEBI
-	O
type	O
switching	O
occur	O
during	O
postnatal	O
hair	O
growth	O
,	O
the	O
ventral	O
-	O
specific	O
isoform	B-SO
of	O
Agouti	B-GGP
is	O
expressed	O
in	O
developing	O
skin	O
beginning	O
at	O
E11	O
.	O
5	O
.	O

We	O
compared	O
adjacent	O
sections	O
hybridized	O
with	O
probes	B-SO
for	O
Tbx15	B-GGP
and	O
Agouti	B-GGP
and	O
observed	O
complementary	O
patterns	O
at	O
E12	O
.	O
5	O
,	O
with	O
expression	O
of	O
Agouti	B-GGP
in	O
ventral	O
skin	O
and	O
expression	O
of	O
Tbx15	B-GGP
in	O
dorsal	O
skin	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

The	O
junction	O
between	O
expression	O
domains	O
is	O
indistinct	O
,	O
and	O
by	O
E14	O
.	O
5	O
,	O
Tbx15	B-GGP
expression	O
extends	O
ventrally	O
and	O
overlaps	O
extensively	O
with	O
Agouti	B-GGP
expression	O
(	O
Figure	O
5C	O
and	O
5D	O
)	O
.	O

We	O
also	O
examined	O
the	O
effect	O
of	O
deH	O
on	O
expression	O
of	O
Agouti	B-GGP
and	O
found	O
no	O
difference	O
between	O
mutant	B-SO
and	O
nonmutant	O
at	O
E12	O
.	O
5	O
or	O
E13	O
.	O
5	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
at	O
E14	O
.	O
5	O
,	O
the	O
normal	O
ventral	O
-	O
to	O
-	O
dorsal	O
gradient	O
of	O
Agouti	B-GGP
expression	O
appeared	O
to	O
extend	O
more	O
dorsally	O
in	O
deH	O
/	O
deH	O
embryos	O
(	O
Figure	O
6A	O
)	O
.	O

In	O
P4	O
.	O
5	O
skin	O
,	O
expression	O
of	O
Agouti	B-GGP
is	O
also	O
extended	O
dorsally	O
in	O
deH	O
/	O
deH	O
animals	B-Taxon
and	O
is	O
most	O
apparent	O
in	O
the	O
midflank	O
region	O
within	O
the	O
upper	O
dermis	O
and	O
dermal	B-CL
papillae	I-CL
cells	I-CL
(	O
Figure	O
6B	O
)	O
.	O

Thus	O
,	O
while	O
the	O
pigmentation	O
phenotype	O
of	O
deH	O
/	O
deH	O
mice	B-Taxon
can	O
be	O
explained	O
,	O
not	O
surprisingly	O
,	O
by	O
dorsal	O
extension	O
of	O
Agouti	B-GGP
expression	O
after	O
birth	O
,	O
patterned	O
expression	O
of	O
Tbx15	B-GGP
and	O
Agouti	B-GGP
are	O
apparent	O
some	O
10	O
days	O
earlier	O
,	O
between	O
E12	O
.	O
5	O
and	O
E13	O
.	O
5	O
,	O
and	O
the	O
effects	O
of	O
Tbx15	B-GGP
deficiency	O
on	O
expression	O
of	O
Agouti	B-GGP
can	O
be	O
detected	O
by	O
E14	O
.	O
5	O
.	O

Relationship	O
of	O
Embryonic	O
Tbx15	B-GGP
Expression	O
to	O
Dorsal	O
and	O
Ventral	O
Pigmentation	O
Domains	O

The	O
observations	O
described	O
above	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
transient	O
expression	O
of	O
Tbx15	B-GGP
in	O
the	O
embryonic	O
dorsal	O
flank	O
is	O
required	O
to	O
establish	O
positional	O
identity	O
of	O
the	O
future	O
dermis	O
,	O
at	O
least	O
with	O
respect	O
to	O
pigment	B-CHEBI
-	O
type	O
synthesis	O
caused	O
by	O
the	O
ventral	O
-	O
specific	O
Agouti	B-GGP
isoform	B-SO
.	O

To	O
further	O
investigate	O
this	O
hypothesis	O
,	O
we	O
carried	O
out	O
transplantation	O
experiments	O
in	O
which	O
pieces	O
of	O
embryonic	O
skin	O
were	O
isolated	O
from	O
different	O
dorsoventral	O
positions	O
.	O

We	O
evaluated	O
the	O
embryonic	O
skin	O
fragments	O
for	O
their	O
potential	O
to	O
give	O
rise	O
to	O
different	O
hair	O
colors	O
and	O
for	O
their	O
expression	O
of	O
Tbx15	B-GGP
and	O
Agouti	B-GGP
.	O

Previous	O
studies	O
by	O
Silvers	O
and	O
colleagues	O
(	O
Poole	O
and	O
Silvers	O
1976	O
)	O
showed	O
that	O
dorsal	O
and	O
ventral	O
skin	O
isolated	O
from	O
at	O
/	O
at	O
embryos	O
gives	O
rise	O
to	O
black	O
and	O
yellow	O
hair	O
,	O
respectively	O
,	O
when	O
transplanted	O
into	O
testis	O
and	O
allowed	O
to	O
develop	O
for	O
several	O
weeks	O
.	O

Furthermore	O
,	O
dermal	O
-	O
epidermal	O
recombination	O
experiments	O
carried	O
out	O
at	O
E14	O
.	O
5	O
demonstrated	O
that	O
positional	O
identity	O
is	O
carried	O
by	O
the	O
embryonic	O
dermis	O
.	O

In	O
a	O
variation	O
on	O
this	O
experiment	O
,	O
we	O
divided	O
embryonic	O
skin	O
from	O
at	O
/	O
a	O
embryos	O
into	O
dorsal	O
,	O
flank	O
,	O
and	O
ventral	O
pieces	O
and	O
analyzed	O
the	O
different	O
pieces	O
for	O
their	O
ability	O
to	O
give	O
rise	O
to	O
black	O
or	O
yellow	O
hair	O
after	O
testis	O
transplantation	O
,	O
and	O
,	O
in	O
parallel	O
,	O
for	O
gene	B-SO
expression	O
using	O
in	O
situ	O
hybridization	O
.	O

For	O
the	O
purposes	O
of	O
a	O
reproducible	O
morphologic	O
boundary	O
,	O
we	O
divided	O
flank	O
from	O
ventral	O
skin	O
based	O
on	O
a	O
change	O
in	O
skin	O
thickness	O
and	O
divided	O
dorsal	O
from	O
flank	O
skin	O
at	O
the	O
level	O
of	O
an	O
ectodermal	O
notch	O
that	O
lies	O
at	O
the	O
same	O
level	O
as	O
the	O
ventral	O
extent	O
of	O
the	O
myotome	O
(	O
Figure	O
7	O
)	O
(	O
Huang	O
and	O
Christ	O
2000	O
;	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Sudo	O
et	O
al	O
.	O
2001	O
;	O
Burke	O
and	O
Nowicki	O
2003	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
.	O

We	O
found	O
that	O
E12	O
.	O
5	O
is	O
the	O
earliest	O
time	O
at	O
which	O
embryonic	O
ventral	O
skin	O
is	O
able	O
to	O
produce	O
hair	O
when	O
transplanted	O
to	O
the	O
testis	O
.	O

Of	O
the	O
grafts	O
that	O
produced	O
hair	O
,	O
ventral	O
skin	O
gave	O
rise	O
to	O
yellow	O
hair	O
(	O
n	O
=	O
3	O
)	O
,	O
and	O
dorsal	O
skin	O
gave	O
rise	O
to	O
black	O
hair	O
(	O
n	O
=	O
4	O
)	O
.	O

Transplantation	O
of	O
flank	O
skin	O
gave	O
rise	O
to	O
a	O
patch	O
of	O
yellow	O
hair	O
juxtaposed	O
against	O
a	O
patch	O
of	O
black	O
hair	O
in	O
85	O
%	O
of	O
the	O
successful	O
grafts	O
(	O
n	O
=	O
13	O
)	O
;	O
the	O
remaining	O
two	O
flank	O
grafts	O
produced	O
solely	O
black	O
or	O
yellow	O
hair	O
.	O

In	O
no	O
case	O
did	O
we	O
observe	O
intermingling	O
of	O
black	O
and	O
yellow	O
hairs	O
.	O

As	O
predicted	O
from	O
the	O
experiments	O
using	O
tissue	O
sections	O
(	O
see	O
Figures	O
5	O
and	O
6	O
)	O
,	O
dorsal	O
pieces	O
expressed	O
Tbx15	B-GGP
but	O
not	O
Agouti	B-GGP
,	O
while	O
flank	O
pieces	O
expressed	O
both	O
genes	B-SO
(	O
see	O
Figure	O
7	O
)	O
.	O

Thus	O
,	O
dorsoventral	O
identity	O
for	O
adult	O
pigmentation	O
is	O
established	O
by	O
the	O
time	O
when	O
patterned	O
expression	O
becomes	O
apparent	O
for	O
Tbx15	B-GGP
and	O
Agouti	B-GGP
(	O
E11	O
.	O
5	O
-	O
E12	O
.	O
5	O
)	O
;	O
furthermore	O
,	O
positional	O
identity	O
is	O
maintained	O
throughout	O
later	O
stages	O
of	O
skin	O
development	O
,	O
even	O
though	O
expression	O
of	O
Tbx15	B-GGP
broadens	O
to	O
include	O
ventral	O
as	O
well	O
as	O
dorsal	O
skin	O
.	O

Relationship	O
of	O
the	O
Dorsoventral	O
Pigment	B-CHEBI
Boundary	O
to	O
Lineage	O
Compartments	O
and	O
the	O
Lateral	O
Somitic	O
Frontier	O

The	O
ectodermal	O
notch	O
that	O
we	O
used	O
to	O
mark	O
the	O
boundary	O
between	O
embryonic	O
dorsum	O
and	O
embryonic	O
flank	O
is	O
a	O
characteristic	O
feature	O
in	O
vertebrate	B-Taxon
embryos	O
.	O

In	O
cell	B-CL
lineage	O
studies	O
carried	O
out	O
in	O
the	O
chick	O
system	O
,	O
the	O
notch	O
serves	O
as	O
a	O
landmark	O
for	O
the	O
boundary	O
between	O
dermis	O
derived	O
from	O
somitic	O
mesoderm	O
and	O
dermis	O
derived	O
from	O
lateral	O
plate	O
mesoderm	O
and	O
has	O
been	O
termed	O
the	O
"	O
lateral	O
somitic	O
frontier	O
"	O
(	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Sudo	O
et	O
al	O
.	O
2001	O
;	O
Burke	O
and	O
Nowicki	O
2003	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
.	O

Although	O
fate	O
-	O
mapping	O
studies	O
have	O
not	O
been	O
carried	O
out	O
in	O
mammalian	B-Taxon
embryos	O
,	O
somite	O
-	O
and	O
lateral	O
plate	O
-	O
derived	O
mesoderm	O
could	O
give	O
rise	O
to	O
precursors	O
for	O
dermis	O
dorsal	O
and	O
ventral	O
to	O
the	O
limb	O
-	O
body	O
wall	O
junction	O
,	O
respectively	O
.	O

However	O
,	O
this	O
notion	O
conflicts	O
with	O
our	O
observation	O
that	O
the	O
future	O
pigmentation	O
boundary	O
lies	O
ventral	O
to	O
the	O
ectodermal	O
notch	O
(	O
see	O
Figure	O
7	O
)	O
.	O

To	O
examine	O
directly	O
the	O
relationship	O
between	O
the	O
pigmentation	O
boundary	O
and	O
dermis	O
derived	O
from	O
lateral	O
plate	O
mesoderm	O
,	O
we	O
made	O
use	O
of	O
a	O
Cre	O
transgene	B-SO
driven	O
by	O
the	O
Hoxb6	B-GGP
promoter	B-SO
that	O
was	O
developed	O
by	O
Kuehn	O
and	O
colleagues	O
(	O
Lowe	O
et	O
al	O
.	O
2000	O
)	O
.	O

As	O
described	O
by	O
Lowe	O
et	O
al	O
.	O

(	O
2000	O
)	O
,	O
midgestation	O
embryos	O
carrying	O
both	O
the	O
Hoxb6	B-GGP
-	O
Cre	O
transgene	B-SO
and	O
the	O
R26R	O
lacZ	O
reporter	O
gene	B-SO
(	O
Soriano	O
1999	O
)	O
exhibit	O
X	O
-	O
Gal	O
staining	O
in	O
lateral	O
plate	O
mesoderm	O
but	O
not	O
somite	O
-	O
derived	O
mesoderm	O
of	O
the	O
trunk	O
.	O

In	O
whole	O
-	O
mount	O
skin	O
preparations	O
from	O
P1	O
.	O
5	O
or	O
P4	O
.	O
5	O
neonatal	O
animals	B-Taxon
,	O
we	O
observed	O
a	O
ventral	O
band	O
of	O
dark	O
X	O
-	O
Gal	O
staining	O
corresponding	O
to	O
lateral	O
plate	O
-	O
derived	O
dermis	O
,	O
which	O
represents	O
63	O
%	O
of	O
the	O
total	O
circumference	O
(	O
Figure	O
8A	O
)	O
.	O

However	O
,	O
in	O
parallel	O
preparations	O
from	O
at	O
/	O
at	O
mice	B-Taxon
,	O
the	O
ventral	O
pheomelanin	O
domain	O
represents	O
47	O
%	O
of	O
the	O
total	O
skin	O
circumference	O
;	O
therefore	O
,	O
the	O
proportions	O
of	O
total	O
skin	O
circumference	O
occupied	O
by	O
dorsal	O
eumelanin	B-CHEBI
and	O
somite	O
-	O
derived	O
dermis	O
are	O
53	O
%	O
and	O
37	O
%	O
,	O
respectively	O
(	O
Figure	O
8B	O
)	O
.	O

These	O
results	O
indicate	O
that	O
the	O
pigmentation	O
boundary	O
is	O
clearly	O
distinct	O
from	O
,	O
and	O
more	O
ventral	O
to	O
,	O
the	O
boundary	O
between	O
lateral	O
plate	O
-	O
and	O
somite	O
-	O
derived	O
dermis	O
.	O

Because	O
the	O
pigmentation	O
boundary	O
lies	O
in	O
register	O
with	O
the	O
limb	O
-	O
body	O
wall	O
junction	O
(	O
see	O
Figure	O
2	O
)	O
,	O
we	O
wondered	O
whether	O
mechanisms	O
used	O
for	O
dorsoventral	O
limb	O
patterning	O
might	O
be	O
related	O
to	O
those	O
used	O
to	O
establish	O
the	O
pigmentation	O
boundary	O
.	O

In	O
the	O
developing	O
limb	O
,	O
Engrailed1	B-GGP
(	O
En1	B-GGP
)	O
,	O
Wnt7a	B-GGP
,	O
and	O
Lmx1b	B-GGP
are	O
part	O
of	O
a	O
network	O
whose	O
restricted	O
domains	O
of	O
expression	O
help	O
to	O
establish	O
dorsoventral	O
identity	O
(	O
reviewed	O
in	O
Niswander	O
2003	O
)	O
.	O

En1	B-GGP
is	O
transiently	O
expressed	O
in	O
the	O
developing	O
flank	O
;	O
at	O
E11	O
.	O
5	O
,	O
transverse	O
abdominal	O
sections	O
reveal	O
domains	O
in	O
the	O
neural	O
tube	O
,	O
somite	O
-	O
derived	O
mesenchyme	O
,	O
and	O
the	O
ventral	O
body	O
wall	O
(	O
Figure	O
8C	O
)	O
.	O

An	O
adjacent	O
section	O
hybridized	O
with	O
Tbx15	B-GGP
reveals	O
a	O
complementary	O
pattern	O
in	O
the	O
flank	O
,	O
which	O
provides	O
additional	O
evidence	O
for	O
developmental	O
mechanisms	O
that	O
establish	O
a	O
pigmentation	O
boundary	O
entirely	O
within	O
lateral	O
plate	O
mesoderm	O
and	O
independent	O
of	O
lineage	O
restrictions	O
imposed	O
by	O
the	O
lateral	O
somitic	O
frontier	O
.	O

Discussion	O

Several	O
mutations	B-SO
and	O
genes	B-SO
have	O
been	O
identified	O
that	O
affect	O
the	O
pattern	O
of	O
hair	O
follicle	O
development	O
,	O
but	O
Tbx15	B-GGP
is	O
the	O
only	O
gene	B-SO
of	O
which	O
we	O
are	O
aware	O
that	O
affects	O
the	O
pattern	O
of	O
hair	O
pigmentation	O
in	O
different	O
body	O
regions	O
.	O

Ventral	O
areas	O
that	O
normally	O
produce	O
yellow	O
hair	O
in	O
the	O
trunk	O
,	O
limbs	O
,	O
and	O
craniofacial	O
regions	O
are	O
expanded	O
in	O
deH	O
/	O
deH	O
mice	B-Taxon
and	O
,	O
in	O
the	O
trunk	O
at	O
least	O
,	O
represent	O
inappropriate	O
dorsal	O
expression	O
of	O
an	O
Agouti	B-GGP
mRNA	B-CHEBI
isoform	B-SO
that	O
is	O
normally	O
restricted	O
to	O
ventral	O
skin	O
.	O

The	O
deH	O
allele	B-SO
is	O
caused	O
by	O
a	O
large	O
deletion	B-SO
that	O
removes	B-SO
most	O
of	O
the	O
Tbx15	B-GGP
coding	B-SO
sequence	I-SO
,	O
but	O
the	O
pleiotropic	O
phenotype	O
is	O
caused	O
by	O
a	O
simple	O
loss	O
of	O
function	O
for	O
Tbx15	B-GGP
rather	O
than	O
a	O
dominant	O
-	O
negative	O
or	O
contiguous	O
gene	B-SO
effect	O
.	O

In	O
particular	O
,	O
there	O
is	O
no	O
heterozygous	O
phenotype	O
,	O
no	O
other	O
genes	B-SO
lie	O
within	O
or	O
close	O
to	O
the	O
deletion	B-SO
breakpoints	I-SO
,	O
and	O
the	O
expression	O
pattern	O
of	O
Tbx15	B-GGP
is	O
consistent	O
with	O
the	O
spectrum	O
of	O
phenotypic	O
abnormalities	O
in	O
both	O
the	O
original	O
de	B-GGP
allele	B-SO
and	O
the	O
deH	O
allele	B-SO
.	O

Finally	O
,	O
a	O
Tbx15	B-GGP
targeted	O
allele	B-SO
has	O
the	O
same	O
phenotype	O
as	O
deH	O
.	O

Our	O
results	O
suggest	O
that	O
patterned	O
expression	O
of	O
Tbx15	B-GGP
provides	O
an	O
instructional	O
cue	O
required	O
to	O
establish	O
the	O
future	O
identity	O
of	O
dorsal	O
dermis	O
with	O
regard	O
to	O
pigmentary	B-CHEBI
and	O
hair	O
length	O
patterning	O
.	O

The	O
ventral	O
edge	O
of	O
Tbx15	B-GGP
expression	O
in	O
the	O
developing	O
flank	O
does	O
not	O
correspond	O
to	O
a	O
known	O
lineage	O
compartment	O
,	O
but	O
,	O
like	O
limb	O
development	O
,	O
occurs	O
within	O
lateral	O
plate	O
mesoderm	O
.	O

These	O
findings	O
represent	O
a	O
novel	O
role	O
for	O
T	O
-	O
box	O
gene	B-SO
action	O
in	O
embryonic	O
development	O
and	O
provide	O
evidence	O
for	O
a	O
previously	O
unappreciated	O
complexity	O
to	O
acquisition	O
of	O
dorsoventral	O
positional	O
identity	O
in	O
mammalian	B-Taxon
skin	O
.	O

Distinct	O
Morphologic	O
Regions	O
Represent	O
the	O
Sum	O
of	O
Different	O
Gradients	O

The	O
visual	O
boundary	O
between	O
dorsal	O
and	O
ventral	O
skin	O
in	O
at	O
/	O
at	O
mice	B-Taxon
is	O
reminiscent	O
of	O
other	O
systems	O
in	O
which	O
adjacent	O
compartments	O
enforce	O
a	O
binary	O
choice	O
between	O
alternative	O
patterns	O
of	O
gene	B-SO
expression	O
and	O
cell	B-CL
fate	O
(	O
reviewed	O
in	O
Dahmann	O
and	O
Basler	O
1999	O
)	O
.	O

However	O
,	O
Agouti	B-GGP
mRNA	B-CHEBI
in	O
both	O
embryonic	O
and	O
postnatal	O
skin	O
is	O
distributed	O
along	O
a	O
gradient	O
whose	O
dorsal	O
boundary	O
is	O
indistinct	O
and	O
overlaps	O
with	O
two	O
additional	O
gradients	O
recognized	O
by	O
their	O
effects	O
on	O
hair	O
length	O
and	O
histochemical	O
staining	O
for	O
melanocytes	B-CL
.	O

The	O
three	O
gradients	O
are	O
close	O
but	O
not	O
congruent	O
,	O
and	O
it	O
is	O
their	O
proximity	O
that	O
gives	O
rise	O
to	O
the	O
superficial	O
distinction	O
between	O
dorsal	O
and	O
ventral	O
skin	O
of	O
at	O
/	O
at	O
mice	B-Taxon
.	O

Indeed	O
,	O
slight	O
differences	O
between	O
the	O
regions	O
of	O
transition	O
for	O
pigment	B-CHEBI
-	O
type	O
switching	O
and	O
pigment	B-CHEBI
content	O
give	O
rise	O
to	O
a	O
subtle	O
yellow	O
stripe	O
along	O
the	O
flank	O
(	O
see	O
Figures	O
1	O
,	O
2	O
,	O
and	O
9A	O
)	O
.	O

Levels	O
of	O
Agouti	B-GGP
mRNA	B-CHEBI
remain	O
high	O
throughout	O
the	O
entire	O
ventrum	O
,	O
but	O
hair	O
pigment	B-CHEBI
content	O
is	O
reduced	O
,	O
giving	O
rise	O
to	O
a	O
cream	O
-	O
colored	O
region	O
in	O
the	O
ventrum	O
that	O
,	O
depending	O
on	O
age	O
and	O
genetic	B-SO
backgrounds	O
,	O
may	O
appear	O
more	O
or	O
less	O
distinct	O
from	O
the	O
yellow	O
flank	O
stripe	O
.	O

Loss	O
of	O
Tbx15	B-GGP
affects	O
dorsoventral	O
transitions	O
of	O
hair	O
length	O
,	O
pigment	B-CHEBI
content	O
,	O
and	O
expression	O
of	O
the	O
ventral	O
-	O
specific	O
Agouti	B-GGP
isoform	B-SO
;	O
however	O
,	O
the	O
former	O
two	O
effects	O
are	O
subtle	O
and	O
contribute	O
little	O
,	O
if	O
at	O
all	O
,	O
to	O
the	O
abnormal	O
pigmentation	O
of	O
adult	O
deH	O
/	O
deH	O
mice	B-Taxon
.	O

Thus	O
,	O
despite	O
the	O
abnormal	O
pattern	O
of	O
dark	O
skin	O
in	O
neonatal	O
deH	O
/	O
deH	O
mice	B-Taxon
(	O
e	O
.	O
g	O
.	O
,	O
Figure	O
2D	O
)	O
,	O
the	O
most	O
obvious	O
feature	O
in	O
adults	O
is	O
dorsal	O
displacement	O
of	O
the	O
"	O
boundary	O
"	O
between	O
black	O
and	O
yellow	O
hair	O
(	O
Figure	O
9A	O
)	O
.	O

Genetics	O
of	O
Tbx15	B-GGP

Named	O
for	O
the	O
presence	O
of	O
a	O
DNA	B-SO
-	O
binding	O
domain	B-SO
first	O
identified	O
in	O
the	O
mouse	B-GGP
Brachyury	I-GGP
gene	B-SO
(	O
haploinsufficiency	O
causes	O
a	O
short	O
tail	O
)	O
,	O
T	O
box	O
-	O
containing	O
genes	B-SO
have	O
been	O
identified	O
as	O
developmental	O
regulators	O
in	O
a	O
wide	O
spectrum	O
of	O
tissues	O
and	O
multicellular	O
organisms	B-Taxon
(	O
reviewed	O
in	O
Papaioannou	O
2001	O
)	O
.	O

The	O
Tbx15	B-GGP
subfamily	O
,	O
which	O
also	O
includes	O
Tbx18	B-GGP
and	O
Tbx22	B-GGP
,	O
is	O
likely	O
to	O
have	O
arisen	O
during	O
early	O
chordate	B-Taxon
evolution	O
since	O
there	O
is	O
a	O
single	O
gene	B-SO
in	O
amphioxus	B-Taxon
but	O
no	O
obvious	O
homolog	B-SO
in	O
the	O
fly	B-Taxon
genome	B-SO
(	O
Ruvinsky	O
et	O
al	O
.	O
2000	O
)	O
.	O

Consistent	O
with	O
this	O
relationship	O
,	O
the	O
three	O
genes	B-SO
are	O
expressed	O
in	O
partially	O
overlapping	O
patterns	O
that	O
include	O
anterior	O
somites	O
(	O
Tbx18	B-GGP
and	O
Tbx22	B-GGP
)	O
,	O
limb	O
mesenchyme	O
(	O
Tbx15	B-GGP
and	O
Tbx18	B-GGP
)	O
,	O
and	O
craniofacial	O
mesenchyme	O
(	O
all	O
three	O
genes	B-SO
,	O
Tbx15	B-GGP
more	O
broadly	O
than	O
Tbx18	B-GGP
or	O
Tbx22	B-GGP
)	O
(	O
Agulnik	O
et	O
al	O
.	O
1998	O
;	O
Kraus	O
et	O
al	O
.	O
2001	O
;	O
Braybrook	O
et	O
al	O
.	O
2002	O
;	O
Bush	O
et	O
al	O
.	O
2002	O
;	O
Herr	O
et	O
al	O
.	O
2003	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
an	O
ancestral	O
gene	B-SO
for	O
Tbx15	B-GGP
,	O
Tbx18	B-GGP
,	O
and	O
Tbx22	B-GGP
may	O
have	O
been	O
important	O
for	O
craniofacial	O
development	O
in	O
cephalochordates	B-Taxon
,	O
with	O
acquisition	O
of	O
additional	O
expression	O
patterns	O
and	O
developmental	O
functions	O
in	O
the	O
limb	O
and	O
the	O
trunk	O
during	O
early	O
vertebrate	B-Taxon
evolution	O
.	O

Expression	O
of	O
Tbx18	B-GGP
and	O
Tbx22	B-GGP
has	O
not	O
been	O
reported	O
in	O
embryonic	O
flank	O
mesenchyme	O
,	O
which	O
suggests	O
that	O
Tbx15	B-GGP
is	O
the	O
only	O
family	O
member	O
involved	O
in	O
establishing	O
the	O
dorsoventral	O
identity	O
of	O
the	O
trunk	O
.	O

However	O
,	O
it	O
would	O
not	O
be	O
surprising	O
to	O
find	O
some	O
degree	O
of	O
functional	O
redundancy	O
in	O
animals	B-Taxon
mutated	B-SO
for	O
two	O
or	O
three	O
of	O
the	O
subfamily	O
members	O
in	O
other	O
body	O
regions	O
,	O
particularly	O
the	O
limbs	O
and	O
the	O
head	O
.	O

For	O
example	O
,	O
mutations	B-SO
in	O
Tbx22	B-GGP
cause	O
the	O
human	B-Taxon
syndrome	O
X	B-GO
-	O
linked	O
cleft	O
palate	O
and	O
ankyloglossia	O
(	O
Braybrook	O
et	O
al	O
.	O
2001	O
)	O
.	O

Despite	O
high	O
levels	O
of	O
Tbx22	B-GGP
expression	O
in	O
periocular	O
embryonic	O
mesenchyme	O
(	O
Braybrook	O
et	O
al	O
.	O
2002	O
;	O
Bush	O
et	O
al	O
.	O
2002	O
;	O
Herr	O
et	O
al	O
.	O
2003	O
)	O
,	O
the	O
condition	O
does	O
not	O
affect	O
the	O
eye	O
,	O
perhaps	O
because	O
residual	O
activity	O
is	O
provided	O
by	O
Tbx15	B-GGP
in	O
the	O
same	O
region	O
.	O

In	O
an	O
initial	O
description	O
of	O
the	O
expression	O
and	O
map	B-SO
location	B-SO
of	O
mouse	B-GGP
Tbx15	I-GGP
,	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
suggested	O
human	B-GGP
Tbx15	I-GGP
that	O
lies	O
on	O
Chromosome	B-GO
1p11	O
.	O
1	O
as	O
a	O
candidate	O
for	O
acromegaloid	O
facial	O
appearance	O
(	O
AFA	O
)	O
syndrome	O
,	O
for	O
which	O
there	O
is	O
a	O
weak	O
positive	O
LOD	O
score	O
to	O
Chromosome	B-GO
1p	O
(	O
Hughes	O
et	O
al	O
.	O
1985	O
)	O
.	O

Originally	O
described	O
as	O
a	O
rare	O
autosomal	B-GO
-	O
dominant	O
syndrome	O
with	O
progressive	O
facial	O
coarsening	O
,	O
overgrowth	O
of	O
the	O
intraoral	O
mucosa	O
,	O
and	O
large	O
,	O
doughy	O
hands	O
,	O
more	O
recent	O
case	O
reports	O
describe	O
macrosomia	O
,	O
macrocephaly	O
,	O
or	O
both	O
and	O
generalized	O
hypertrichosis	O
with	O
progressive	O
coarsening	O
(	O
Dallapiccola	O
et	O
al	O
.	O
1992	O
;	O
Irvine	O
et	O
al	O
.	O
1996	O
;	O
da	O
Silva	O
et	O
al	O
.	O
1998	O
;	O
Zelante	O
et	O
al	O
.	O
2000	O
)	O
.	O

The	O
deH	O
phenotype	O
exhibits	O
little	O
overlap	O
with	O
these	O
features	O
;	O
instead	O
,	O
we	O
suggest	O
a	O
more	O
likely	O
candidate	O
for	O
mutations	B-SO
of	O
human	B-GGP
TBX15	I-GGP
would	O
be	O
frontofacionasal	O
syndrome	O
,	O
an	O
unmapped	O
autosomal	B-GO
recessive	O
condition	O
characterized	O
by	O
brachycephaly	O
,	O
blepharophimosis	O
,	O
and	O
midface	O
hypoplasia	O
(	O
Reardon	O
et	O
al	O
.	O
1994	O
)	O
.	O

Two	O
of	O
us	O
(	O
S	O
.	O
Kuijper	O
and	O
F	O
.	O
Meijlink	O
)	O
became	O
interested	O
in	O
the	O
deH	O
mutation	B-SO
because	O
of	O
its	O
effects	O
on	O
skeletal	O
development	O
(	O
Curry	O
1959	O
)	O
and	O
the	O
possibility	O
that	O
the	O
aristaless	O
-	O
related	O
gene	B-SO
Alx3	B-GGP
might	O
be	O
allelic	B-SO
with	O
droopy	B-GGP
ear	I-GGP
(	O
ten	O
Berge	O
et	O
al	O
.	O
1998	O
)	O
.	O

In	O
spite	O
of	O
similarities	O
between	O
skeletal	O
phenotypes	O
of	O
deH	O
and	O
Alx3	B-GGP
or	O
Alx4	B-GGP
mutants	B-SO
,	O
subsequent	O
experiments	O
(	O
unpublished	O
data	O
)	O
excluded	O
allelism	O
of	O
Alx3	B-GGP
and	O
deH	O
,	O
and	O
a	O
full	O
description	O
of	O
the	O
Tbx15	B-GGP
skeletal	O
phenotype	O
will	O
be	O
published	O
elsewhere	O
.	O

Developmental	O
Mechanism	O
of	O
Tbx15	B-GGP
Expression	O
and	O
Action	O
in	O
the	O
Skin	O

Our	O
attention	O
to	O
the	O
role	O
of	O
Tbx15	B-GGP
in	O
pigment	B-CHEBI
patterning	O
was	O
motivated	O
by	O
the	O
effects	O
of	O
Agouti	B-GGP
in	O
postnatal	O
animals	B-Taxon
.	O

However	O
,	O
Agouti	B-GGP
is	O
also	O
expressed	O
in	O
the	O
embryo	O
,	O
where	O
it	O
provides	O
a	O
convenient	O
marker	O
of	O
ventral	O
dermis	O
identity	O
.	O

Because	O
an	O
expanded	O
domain	O
of	O
embryonic	O
Agouti	B-GGP
expression	O
in	O
deH	O
/	O
deH	O
animals	B-Taxon
is	O
detectable	O
by	O
E14	O
.	O
5	O
,	O
the	O
effects	O
of	O
Tbx15	B-GGP
on	O
dorsoventral	O
patterning	O
must	O
occur	O
prior	O
to	O
this	O
time	O
.	O

Among	O
other	O
T	O
-	O
box	O
genes	B-SO
whose	O
developmental	O
actions	O
are	O
at	O
least	O
partially	O
understood	O
,	O
two	O
general	O
themes	O
have	O
emerged	O
,	O
one	O
focused	O
on	O
the	O
ability	O
to	O
specify	O
alternative	O
fates	O
for	O
an	O
undifferentiated	O
group	O
of	O
precursor	O
cells	B-CL
and	O
another	O
focused	O
on	O
the	O
ability	O
to	O
support	O
proliferative	O
expansion	O
of	O
a	O
cell	B-CL
population	O
whose	O
fate	O
is	O
already	O
determined	O
(	O
reviewed	O
in	O
Tada	O
and	O
Smith	O
2001	O
)	O
.	O

Either	O
mechanism	O
may	O
apply	O
to	O
the	O
apparent	O
dorsal	O
-	O
to	O
-	O
ventral	O
transformation	O
in	O
deH	O
/	O
deH	O
mice	B-Taxon
.	O

For	O
example	O
,	O
while	O
the	O
expanded	O
domain	O
of	O
Agouti	B-GGP
expression	O
in	O
postnatal	O
deH	O
/	O
deH	O
animals	B-Taxon
can	O
be	O
traced	O
to	O
events	O
that	O
occur	O
between	O
E11	O
.	O
5	O
and	O
E13	O
.	O
5	O
,	O
the	O
underlying	O
cause	O
may	O
be	O
that	O
embryonic	O
cells	B-CL
in	O
dorsolateral	O
mesenchyme	O
acquire	O
a	O
ventral	O
rather	O
than	O
dorsal	O
identity	O
or	O
that	O
those	O
cells	B-CL
fail	O
to	O
proliferate	O
normally	O
,	O
followed	O
by	O
compensatory	O
expansion	O
of	O
ventral	O
cells	B-CL
.	O

Cell	B-CL
lineage	O
studies	O
should	O
provide	O
a	O
definitive	O
answer	O
,	O
but	O
we	O
favor	O
the	O
latter	O
hypothesis	O
,	O
because	O
measurements	O
of	O
dorsoventral	O
regions	O
according	O
to	O
hair	O
color	O
in	O
deH	O
/	O
deH	O
mice	B-Taxon
revealed	O
a	O
small	O
increase	O
of	O
the	O
cream	O
-	O
colored	O
ventral	O
region	O
in	O
addition	O
to	O
the	O
approximate	O
doubling	O
of	O
the	O
yellow	O
flank	O
region	O
(	O
see	O
Figure	O
2	O
)	O
.	O

In	O
embryonic	O
mesenchyme	O
,	O
expression	O
of	O
Tbx15	B-GGP
and	O
Agouti	B-GGP
are	O
complementary	O
,	O
and	O
it	O
is	O
possible	O
that	O
Tbx15	B-GGP
acts	O
directly	O
to	O
inhibit	O
Agouti	B-GGP
transcription	O
in	O
dorsolateral	O
mesenchyme	O
.	O

However	O
,	O
the	O
ability	O
of	O
Tbx15	B-GGP
to	O
suppress	O
expression	O
of	O
the	O
ventral	O
-	O
specific	O
Agouti	B-GGP
isoform	B-SO
in	O
postnatal	O
mice	B-Taxon
is	O
likely	O
to	O
be	O
indirect	O
,	O
since	O
postnatal	O
expression	O
of	O
Tbx15	B-GGP
occurs	O
broadly	O
along	O
the	O
dorsoventral	O
axis	O
and	O
overlaps	O
extensively	O
with	O
that	O
of	O
Agouti	B-GGP
.	O

In	O
either	O
case	O
,	O
the	O
targets	O
of	O
Tbx15	B-GGP
action	O
in	O
the	O
skin	O
include	O
genes	B-SO
in	O
addition	O
to	O
Agouti	B-GGP
,	O
since	O
hair	O
length	O
and	O
melanocyte	B-CL
distribution	O
exhibit	O
a	O
demonstrable	O
,	O
albeit	O
subtle	O
,	O
alteration	O
in	O
animals	B-Taxon
that	O
carry	O
a	O
null	O
Agouti	B-GGP
allele	B-SO
.	O

One	O
potential	O
target	O
is	O
Alx4	B-GGP
,	O
which	O
,	O
like	O
Agouti	B-GGP
,	O
is	O
expressed	O
in	O
ventral	O
embryonic	O
mesenchyme	O
,	O
and	O
,	O
when	O
mutated	B-SO
,	O
affects	O
hair	O
-	O
follicle	O
as	O
well	O
as	O
limb	O
and	O
craniofacial	O
development	O
(	O
Qu	O
et	O
al	O
.	O
1997	O
,	O
1998	O
;	O
Wu	O
et	O
al	O
.	O
2000	O
;	O
Wuyts	O
et	O
al	O
.	O
2000	O
;	O
Mavrogiannis	O
et	O
al	O
.	O
2001	O
)	O
.	O

However	O
,	O
expression	O
of	O
ventral	O
markers	O
such	O
as	O
Alx4	B-GGP
,	O
as	O
well	O
as	O
Alx3	B-GGP
and	O
Msx2	B-GGP
,	O
appears	O
to	O
be	O
unaffected	O
at	O
E11	O
.	O
5	O
in	O
deH	O
/	O
deH	O
embryos	O
(	O
data	O
not	O
shown	O
)	O
.	O

Differences	O
and	O
Similarities	O
to	O
Dorsoventral	O
Limb	O
Patterning	O

Loss	O
of	O
Tbx15	B-GGP
also	O
affects	O
regional	O
distribution	O
of	O
hair	O
color	O
in	O
the	O
limbs	O
,	O
with	O
areas	O
that	O
would	O
normally	O
produce	O
black	O
hair	O
giving	O
rise	O
to	O
yellow	O
hair	O
instead	O
.	O

However	O
,	O
neither	O
normal	O
patterns	O
of	O
pigment	B-CHEBI
-	O
type	O
synthesis	O
in	O
the	O
limb	O
nor	O
their	O
disruption	O
in	O
deH	O
/	O
deH	O
mice	B-Taxon
correspond	O
to	O
obvious	O
developmental	O
compartments	O
.	O

Furthermore	O
,	O
losses	O
of	O
function	O
for	O
En1	B-GGP
or	O
Wnt7a	B-GGP
,	O
which	O
cause	O
a	O
partial	O
transformation	O
of	O
the	O
distal	O
limb	O
from	O
dorsum	O
to	O
ventrum	O
(	O
Loomis	O
et	O
al	O
.	O
1996	O
)	O
or	O
ventrum	O
to	O
dorsum	O
(	O
Parr	O
and	O
McMahon	O
1995	O
)	O
,	O
respectively	O
,	O
have	O
no	O
effect	O
on	O
regional	O
patterns	O
of	O
Agouti	B-GGP
expression	O
or	O
distribution	O
of	O
hair	O
-	O
color	O
regions	O
(	O
Y	O
.	O
Chen	O
,	O
unpublished	O
data	O
)	O
.	O

(	O
Ectopic	O
pigmentation	O
of	O
the	O
ventral	O
footpads	O
that	O
develops	O
in	O
En1	B-GGP
mutant	B-SO
mice	B-Taxon
is	O
unrelated	O
to	O
pigment	B-CHEBI
-	O
type	O
synthesis	O
and	O
instead	O
likely	O
reflects	O
a	O
requirement	O
for	O
En1	B-GGP
,	O
independent	O
of	O
Wnt7a	B-GGP
,	O
to	O
repress	O
migration	O
or	O
proliferation	O
(	O
or	O
both	O
)	O
of	O
pigment	B-CL
cells	I-CL
in	O
ventral	O
epidermis	O
[	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
]	O
.	O
)	O

These	O
considerations	O
notwithstanding	O
,	O
control	O
of	O
dorsoventral	O
trunk	O
pattern	O
by	O
Tbx15	B-GGP
shares	O
certain	O
features	O
with	O
control	O
of	O
dorsoventral	O
limb	O
patterning	O
by	O
Lmx1b	B-GGP
,	O
a	O
LIM	O
domain	B-SO
transcription	O
factor	O
that	O
acts	O
downstream	O
of	O
Wnt7a	B-GGP
and	O
En1	B-GGP
(	O
Riddle	O
et	O
al	O
.	O
1995	O
;	O
Vogel	O
et	O
al	O
.	O
1995	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Logan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
;	O
Chen	O
and	O
Johnson	O
2002	O
)	O
.	O

Both	O
Tbx15	B-GGP
and	O
Lmx1b	B-GGP
act	O
autonomously	O
in	O
mesenchymal	B-CL
cells	I-CL
to	O
promote	O
a	O
dorsal	O
identity	O
,	O
yet	O
have	O
expression	O
domains	O
that	O
do	O
not	O
correspond	O
to	O
cell	B-CL
lineage	O
compartments	O
in	O
the	O
flank	O
(	O
Tbx15	B-GGP
)	O
or	O
the	O
limb	O
(	O
Lmx1b	B-GGP
)	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
)	O
.	O

In	O
the	O
case	O
of	O
Lmx1b	B-GGP
,	O
its	O
expression	O
in	O
the	O
distal	O
limb	O
depends	O
on	O
Wnt7a	B-GGP
produced	O
in	O
the	O
overlying	O
dorsal	O
ectoderm	O
(	O
Riddle	O
et	O
al	O
.	O
1995	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
)	O
.	O

Wnt7a	B-GGP
,	O
in	O
turn	O
,	O
is	O
restricted	O
to	O
dorsal	O
ectoderm	O
by	O
En1	B-GGP
in	O
the	O
ventral	O
ectoderm	O
(	O
Loomis	O
et	O
al	O
.	O
1996	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Logan	O
et	O
al	O
.	O
1997	O
)	O
,	O
whose	O
expression	O
marks	O
a	O
lineage	O
boundary	O
coincident	O
with	O
the	O
dorsoventral	O
midline	O
of	O
the	O
apical	O
ectodermal	O
ridge	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
;	O
Kimmel	O
et	O
al	O
.	O
2000	O
)	O
.	O

As	O
described	O
above	O
,	O
En1	B-GGP
or	O
Wnt7a	B-GGP
mutations	B-SO
have	O
not	O
been	O
reported	O
to	O
affect	O
patterns	O
of	O
hair	O
-	O
color	O
distribution	O
(	O
C	O
.	O
Loomis	O
,	O
personal	O
communication	O
;	O
Parr	O
and	O
McMahon	O
1995	O
;	O
Loomis	O
et	O
al	O
.	O
1996	O
)	O
.	O

However	O
,	O
the	O
essential	O
theme	O
that	O
ectodermal	O
lineage	O
compartments	O
control	O
the	O
fate	O
of	O
underlying	O
mesenchyme	O
in	O
developing	O
limbs	O
may	O
apply	O
to	O
the	O
trunk	O
as	O
well	O
as	O
the	O
limb	O
.	O

The	O
mammary	O
glands	O
also	O
develop	O
at	O
a	O
stereotyped	O
dorsoventral	O
position	O
and	O
depend	O
on	O
epithelial	O
-	O
mesenchymal	O
interactions	O
.	O

However	O
,	O
the	O
number	O
and	O
apparent	O
position	O
of	O
the	O
mammary	O
glands	O
are	O
normal	O
in	O
deH	O
/	O
deH	O
animals	B-Taxon
,	O
indicating	O
the	O
existence	O
of	O
additional	O
mechanisms	O
that	O
control	O
dorsoventral	O
patterning	O
in	O
the	O
trunk	O
as	O
well	O
as	O
in	O
the	O
limbs	O
.	O

These	O
ideas	O
are	O
summarized	O
in	O
the	O
model	O
shown	O
in	O
Figure	O
9B	O
.	O

We	O
speculate	O
that	O
a	O
diffusible	O
signal	O
from	O
dorsal	O
trunk	O
ectoderm	O
,	O
at	O
or	O
prior	O
to	O
E11	O
.	O
5	O
,	O
promotes	O
expression	O
of	O
Tbx15	B-GGP
in	O
dorsal	O
trunk	O
mesenchyme	O
,	O
which	O
then	O
establishes	O
dorsal	O
positional	O
identity	O
of	O
those	O
cells	B-CL
as	O
manifested	O
by	O
differences	O
in	O
Agouti	B-GGP
expression	O
,	O
pigment	B-CL
-	I-CL
cell	I-CL
development	O
,	O
and	O
hair	O
growth	O
.	O

Because	O
the	O
ventral	O
limit	O
of	O
Tbx15	B-GGP
expression	O
corresponds	O
to	O
the	O
dorsal	O
limit	O
of	O
En1	B-GGP
expression	O
and	O
because	O
the	O
normal	O
position	O
of	O
the	O
pigmentation	O
boundary	O
lies	O
approximately	O
in	O
register	O
with	O
the	O
limb	O
-	O
bud	O
outgrowths	O
,	O
we	O
depict	O
the	O
position	O
of	O
a	O
putative	O
dorsoventral	O
boundary	O
in	O
trunk	O
ectoderm	O
as	O
coincident	O
with	O
the	O
limb	O
dorsoventral	O
boundary	O
.	O

This	O
model	O
is	O
consistent	O
with	O
studies	O
in	O
the	O
chick	O
,	O
where	O
distinct	O
dorsal	O
and	O
ventral	O
lineage	O
compartments	O
exist	O
for	O
ectoderm	O
in	O
both	O
the	O
limb	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
;	O
Kimmel	O
et	O
al	O
.	O
2000	O
)	O
and	O
interlimb	O
regions	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
)	O
,	O
but	O
not	O
for	O
limb	O
mesoderm	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
)	O
.	O

In	O
fact	O
,	O
the	O
same	O
mechanism	O
that	O
determines	O
dorsoventral	O
position	O
of	O
the	O
limbs	O
and	O
the	O
apical	O
ectodermal	O
ridge	O
may	O
also	O
act	O
on	O
expression	O
of	O
Tbx15	B-GGP
in	O
the	O
trunk	O
,	O
since	O
ectopic	O
limbs	O
induced	O
in	O
the	O
interlimb	O
region	O
by	O
application	O
of	O
FGF	O
beads	O
develop	O
along	O
a	O
single	O
line	O
that	O
is	O
coincident	O
with	O
normal	O
limb	O
buds	O
(	O
and	O
the	O
future	O
pigmentation	O
boundary	O
)	O
(	O
Cohn	O
et	O
al	O
.	O
1995	O
;	O
Crossley	O
et	O
al	O
.	O
1996	O
;	O
Vogel	O
et	O
al	O
.	O
1996	O
;	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
)	O
.	O

Our	O
model	O
predicts	O
that	O
ectopic	O
expression	O
of	O
Tbx15	B-GGP
in	O
ventral	O
mesenchyme	O
should	O
give	O
rise	O
to	O
a	O
dorsalized	O
pigmentation	O
phenotype	O
and	O
could	O
be	O
tested	O
with	O
gain	O
-	O
of	O
-	O
function	O
approaches	O
.	O

However	O
,	O
Tbx15	B-GGP
expression	O
is	O
very	O
dynamic	O
and	O
is	O
restricted	O
to	O
dorsal	O
mesoderm	O
only	O
from	O
E11	O
.	O
5	O
to	O
E13	O
.	O
5	O
.	O

It	O
is	O
possible	O
that	O
Tbx15	B-GGP
influences	O
skin	O
patterning	O
in	O
a	O
very	O
narrow	O
window	O
of	O
development	O
;	O
alternatively	O
,	O
establishment	O
of	O
dorsal	O
identity	O
by	O
Tbx15	B-GGP
may	O
require	O
another	O
as	O
-	O
yet	O
-	O
unidentified	O
factor	O
that	O
is	O
only	O
present	O
in	O
the	O
mesenchyme	O
underlying	O
dorsal	O
ectoderm	O
.	O

Pigmentation	O
Patterns	O
and	O
Tbx15	B-GGP
in	O
Other	O
Mammals	B-Taxon

The	O
lateral	O
somitic	O
frontier	O
,	O
defined	O
as	O
the	O
lineage	O
boundary	O
between	O
somite	O
-	O
derived	O
versus	O
lateral	O
plate	O
-	O
derived	O
mesoderm	O
,	O
is	O
established	O
during	O
somitogenesis	O
early	O
in	O
development	O
(	O
Mauger	O
1972	O
;	O
Christ	O
et	O
al	O
.	O
1983	O
;	O
Olivera	O
-	O
Martinez	O
et	O
al	O
.	O
2000	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
,	O
but	O
remains	O
distinct	O
in	O
postnatal	O
animals	B-Taxon
despite	O
the	O
potential	O
for	O
extensive	O
cell	B-CL
mixing	O
(	O
see	O
Figure	O
8	O
)	O
.	O

However	O
,	O
our	O
transplantation	O
and	O
fate	O
-	O
mapping	O
studies	O
demonstrate	O
that	O
the	O
lateral	O
somitic	O
frontier	O
lies	O
dorsal	O
to	O
the	O
pigmentation	O
boundary	O
and	O
does	O
not	O
obviously	O
correlate	O
with	O
a	O
difference	O
in	O
skin	O
morphology	O
.	O

An	O
additional	O
dorsoventral	O
domain	O
that	O
is	O
not	O
externally	O
apparent	O
has	O
emerged	O
from	O
studies	O
of	O
Msx1	B-GGP
,	O
whose	O
expression	O
marks	O
a	O
subgroup	O
of	O
somite	O
-	O
derived	O
mesenchymal	B-CL
cells	I-CL
that	O
contribute	O
to	O
dermis	O
in	O
a	O
narrow	O
stripe	O
along	O
the	O
paraspinal	O
region	O
(	O
Houzelstein	O
et	O
al	O
.	O
2000	O
)	O
.	O

Thus	O
,	O
there	O
exist	O
at	O
least	O
three	O
distinct	O
boundaries	O
in	O
postnatal	O
mammalian	B-Taxon
skin	O
that	O
are	O
parallel	O
to	O
the	O
sagittal	O
plane	O
,	O
marked	O
by	O
differences	O
in	O
pigment	B-CHEBI
-	O
type	O
synthesis	O
,	O
differences	O
in	O
cell	B-CL
lineage	O
,	O
and	O
differences	O
in	O
expression	O
of	O
Msx1	B-GGP
.	O

In	O
rodents	B-Taxon
,	O
only	O
the	O
pigmentation	O
boundary	O
is	O
evident	O
externally	O
,	O
but	O
many	O
mammals	B-Taxon
have	O
more	O
complicated	O
patterns	O
of	O
hair	O
type	O
,	O
length	O
,	O
and	O
/	O
or	O
color	O
that	O
vary	O
along	O
the	O
dorsoventral	O
axis	O
.	O

Raccoons	B-Taxon
,	O
squirrels	O
,	O
skunks	B-Taxon
,	O
and	O
many	O
different	O
ungulates	O
exhibit	O
lateral	O
stripes	O
whose	O
developmental	O
origins	O
have	O
not	O
been	O
investigated	O
,	O
but	O
may	O
correspond	O
to	O
the	O
lateral	O
somitic	O
frontier	O
,	O
the	O
paraspinal	O
Msx1	B-GGP
compartment	O
,	O
or	O
an	O
interaction	O
between	O
these	O
domains	O
.	O

The	O
effect	O
of	O
Tbx15	B-GGP
on	O
pigmentation	O
in	O
laboratory	O
mice	B-Taxon
is	O
reminiscent	O
of	O
coat	O
-	O
color	O
patterns	O
in	O
both	O
selected	O
and	O
natural	O
populations	O
of	O
other	O
mammals	B-Taxon
.	O

Saddle	O
markings	O
are	O
common	O
in	O
some	O
dog	B-Taxon
breeds	O
,	O
such	O
as	O
German	O
shepherds	O
,	O
and	O
in	O
certain	O
populations	O
of	O
Peromyscus	B-Taxon
polionotus	I-Taxon
,	O
in	O
which	O
a	O
dorsal	O
extension	O
of	O
ventral	O
depigmentation	O
provides	O
an	O
adaptive	O
advantage	O
to	O
subspecies	O
that	O
live	O
on	O
white	O
sand	O
reefs	O
(	O
Blair	O
1951	O
;	O
Kaufman	O
1974	O
;	O
Belk	O
and	O
Smith	O
1996	O
)	O
.	O

Neither	O
German	O
shepherds	O
nor	O
deer	B-Taxon
mice	I-Taxon
have	O
craniofacial	O
characteristics	O
similar	O
to	O
the	O
deH	O
mutation	B-SO
,	O
but	O
the	O
pigmentation	O
patterns	O
in	O
these	O
animals	B-Taxon
could	O
represent	O
alterations	O
in	O
the	O
regulation	O
or	O
action	O
of	O
Tbx15	B-GGP
activity	O
.	O

From	O
the	O
opposite	O
perspective	O
,	O
the	O
effects	O
of	O
Tbx15	B-GGP
on	O
coat	O
color	O
are	O
only	O
apparent	O
in	O
certain	O
genetic	B-SO
backgrounds	O
and	O
may	O
not	O
be	O
evident	O
at	O
all	O
in	O
mammals	B-Taxon
that	O
lack	O
dorsoventral	O
pigmentation	O
patterns	O
.	O

Studying	O
the	O
sequence	B-SO
and	O
expression	O
of	O
Tbx15	B-GGP
in	O
other	O
vertebrates	B-Taxon
may	O
provide	O
additional	O
insight	O
into	O
patterns	O
that	O
affect	O
the	O
skeleton	O
as	O
well	O
as	O
the	O
pigmentary	B-CHEBI
system	O
.	O

Materials	O
and	O
Methods	O

Mice	B-Taxon

All	O
mice	B-Taxon
were	O
obtained	O
originally	O
from	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
,	O
except	O
the	O
BA	O
strain	O
(	O
Stanford	O
Veterinary	O
Services	O
Center	O
,	O
Stanford	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
Hoxb6	B-GGP
-	O
Cre	O
transgenic	B-SO
mice	B-Taxon
(	O
kindly	O
provided	O
by	O
M	O
.	O
Kuehn	O
of	O
the	O
National	O
Institutes	O
of	O
Health	O
,	O
Bethesda	O
,	O
Maryland	O
,	O
United	O
States	O
)	O
,	O
mice	B-Taxon
carrying	O
the	O
R26R	O
lacZ	O
reporter	O
allele	B-SO
(	O
kindly	O
provided	O
by	O
P	O
.	O
Soriano	O
,	O
Fred	O
Hutchinson	O
Cancer	O
Research	O
Center	O
,	O
Seattle	O
,	O
Washington	O
,	O
United	O
States	O
)	O
,	O
and	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
ae	O
/	O
ae	O
mice	B-Taxon
(	O
kindly	O
provided	O
by	O
L	O
.	O
Siracusa	O
,	O
Jefferson	O
Medical	O
College	O
,	O
Philadelphia	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
.	O

The	O
deH	O
mutation	B-SO
arose	O
in	O
the	O
1960s	O
in	O
Harwell	O
,	O
probably	O
on	O
the	O
BN	O
strain	O
background	O
(	O
C	O
.	O
Beechey	O
,	O
personal	O
communication	O
)	O
.	O

We	O
obtained	O
deH	O
on	O
a	O
B6	O
/	O
EiC3H	O
background	O
,	O
introduced	B-SO
the	O
at	O
allele	B-SO
from	O
the	O
BTBR	O
strain	O
,	O
and	O
have	O
maintained	O
the	O
line	O
as	O
a	O
mixed	O
deH	O
/	O
+	B-SO
x	O
deH	O
/	O
+	B-SO
intercross	O
stock	O
with	O
periodic	O
outcrossing	O
to	O
BTBR	O
or	O
B6	O
.	O

For	O
timed	O
matings	O
,	O
the	O
morning	O
of	O
the	O
plug	O
was	O
considered	O
E0	O
.	O
5	O
.	O

Postnatally	O
,	O
the	O
day	O
of	O
birth	O
was	O
considered	O
to	O
be	O
P0	O
.	O
5	O
.	O

Phenotypic	O
analysis	O

For	O
measurements	O
of	O
hair	O
length	O
and	O
color	O
,	O
the	O
entire	O
interlimb	O
region	O
of	O
skin	O
was	O
first	O
dissected	O
with	O
a	O
single	O
incision	O
at	O
the	O
dorsal	O
midline	O
and	O
preserved	O
with	O
powdered	O
sodium	B-CHEBI
bicarbonate	I-CHEBI
.	O

Slices	O
2	O
-	O
2	O
.	O
5	O
mm	O
in	O
width	O
were	O
then	O
prepared	O
parallel	O
to	O
the	O
dorsoventral	O
axis	O
,	O
hair	O
length	O
boundaries	O
determined	O
from	O
electronic	O
images	O
with	O
Adobe	O
Photoshop	O
(	O
San	O
Jose	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
and	O
measurements	O
obtained	O
using	O
ImageJ	O
(	O
National	O
Institutes	O
of	O
Health	O
)	O
.	O

This	O
approach	O
samples	O
awls	O
and	O
auchenes	O
,	O
because	O
they	O
are	O
much	O
thicker	O
and	O
therefore	O
visually	O
more	O
predominant	O
than	O
zigzag	O
underhairs	O
.	O

To	O
assess	O
dorsoventral	O
variation	O
in	O
hair	O
-	O
type	O
distribution	O
,	O
several	O
hundred	O
hairs	O
were	O
plucked	O
from	O
the	O
middorsum	O
or	O
midventrum	O
of	O
8	O
-	O
wk	O
-	O
old	O
male	O
BA	O
strain	O
animals	B-Taxon
,	O
then	O
sorted	O
and	O
categorized	O
using	O
a	O
dissection	O
microscope	O
.	O

No	O
attempt	O
was	O
made	O
to	O
distinguish	O
between	O
awls	O
and	O
auchenes	O
.	O

For	O
skin	O
histology	O
,	O
12	O
mu	O
m	O
sections	O
from	O
paraffin	O
-	O
embedded	O
tissue	O
were	O
stained	O
with	O
hematoxylin	O
and	O
eosin	O
.	O

For	O
DOPA	B-CHEBI
staining	O
,	O
the	O
dermis	O
and	O
epidermis	O
were	O
split	O
after	O
3	O
h	O
of	O
incubation	O
in	O
2	O
M	O
sodium	B-CHEBI
bromide	B-CHEBI
at	O
37	O
degrees	O
C	O
(	O
this	O
preparation	O
causes	O
most	O
hair	O
follicles	O
to	O
remain	O
with	O
the	O
dermis	O
)	O
,	O
individually	O
fixed	O
for	O
1	O
h	O
,	O
then	O
rinsed	O
and	O
stained	O
with	O
0	O
.	O
1	O
%	O
L	B-CHEBI
-	I-CHEBI
DOPA	I-CHEBI
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
,	O
0	O
.	O
1	O
M	O
sodium	B-CHEBI
phosphate	I-CHEBI
buffer	O
(	O
pH	O
6	O
.	O
8	O
)	O
for	O
5	O
h	O
at	O
37	O
degrees	O
C	O
in	O
the	O
dark	O
,	O
changing	O
the	O
staining	O
solution	O
after	O
1	O
h	O
.	O

The	O
samples	O
were	O
then	O
fixed	O
overnight	O
,	O
dehydrated	O
,	O
and	O
mounted	O
.	O

This	O
method	O
is	O
sufficient	O
to	O
stain	O
interfollicular	O
melanocytes	B-CL
without	O
creating	O
a	O
high	O
background	O
.	O

The	O
fixative	O
used	O
was	O
always	O
4	O
%	O
paraformaldehyde	O
.	O

Positional	B-SO
cloning	O

A	O
high	O
-	O
resolution	O
map	B-SO
for	O
deH	O
was	O
generated	O
from	O
an	O
intersubspecific	O
intercross	O
between	O
deH	O
/	O
deH	O
and	O
CAST	O
/	O
Ei	O
mice	B-Taxon
.	O

We	O
initially	O
localized	O
deH	O
to	O
a	O
1	O
cM	O
interval	B-SO
between	O
D3Mit233	O
and	O
D3Mit11	O
.	O

F2	O
animals	B-Taxon
carrying	O
recombinant	O
chromosomes	B-GO
between	O
these	O
markers	O
whose	O
genotype	B-SO
at	O
de	B-GGP
was	O
indeterminate	O
(	O
deH	O
/	O
+	B-SO
or	O
+	B-SO
/	O
+	B-SO
)	O
were	O
progeny	O
-	O
tested	O
by	O
crossing	O
to	O
deH	O
/	O
deH	O
animals	B-Taxon
.	O

Further	O
genetic	B-SO
mapping	O
established	O
a	O
minimal	O
region	B-SO
of	O
0	O
.	O
1	O
cM	O
between	O
D3Mit213	O
and	O
16	O
.	O
MMHAP32FLF1	O
;	O
these	O
markers	O
were	O
used	O
to	O
initiate	O
construction	O
of	O
a	O
physical	B-SO
map	I-SO
with	O
BAC	B-SO
genomic	B-SO
clones	I-SO
(	O
Research	O
Genetics	O
,	O
Huntsville	O
,	O
Alabama	O
,	O
United	O
States	O
,	O
and	O
Genome	B-SO
Systems	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

End	B-SO
sequence	I-SO
from	I-SO
those	I-SO
BACs	I-SO
was	O
used	O
to	O
develop	O
SSCP	O
markers	O
M1	O
to	O
M3	O
,	O
as	O
depicted	O
in	O
Figure	O
3	O
,	O
and	O
to	O
establish	O
a	O
minimal	O
physical	O
interval	B-SO
of	O
1	O
.	O
4	O
Mb	O
.	O

Primer	B-SO
pairs	O
used	O
were	O
TTCCCTCCAATAAGTTCTGGGTACC	O
and	O
AAGCTTGCTGCTCTGGATTCCATTTGTAG	O
for	O
M1	O
,	O
CCTTCATTTTTTTTTCAAGTAAAA	O
and	O
AAGCTTGGCTTAGTCCCAGTGGC	O
for	O
M2	O
,	O
CCTCCAGGAAGATCTACTAGGCAC	O
and	O
ATGGAAAAAAAAAAGTAAGATTGAAAG	O
for	O
M3	O
,	O
and	O
TGGTTATCGATCTGTGGACCATTC	O
and	O
AAGTGAGAGAGCAGGATGGACCAC	O
for	O
M4	O
(	O
the	O
M4	O
marker	O
represents	O
STS	B-SO
16	O
.	O
MMHAP32FLF1	O
)	O
.	O

Genomic	B-SO
sequence	I-SO
and	O
annotations	O
were	O
obtained	O
from	O
the	O
UCSC	O
Genome	B-SO
Browser	O
February	O
2003	O
assembly	B-SO
version	B-SO
mm3	O
(	O
http	O
:	O
/	O
/	O
genome	B-SO
.	O
ucsc	O
.	O
edu	O
)	O
;	O
the	O
1	O
.	O
4	O
Mb	O
interval	B-SO
between	O
M1	O
and	O
M4	O
contains	O
eight	O
genes	B-SO
:	O
four	O
hydroxysteroid	B-CHEBI
dehydrogenase	O
isomerases	O
,	O
Hsd3b3	B-GGP
,	O
Hsd3b2	B-GGP
,	O
Hsd3b6	B-GGP
,	O
and	O
Hsd3b1	B-GGP
;	O
an	O
hydroacid	B-CHEBI
oxidase	O
,	O
Hao3	B-GGP
;	O
a	O
tryptophanyl	B-CHEBI
-	I-CHEBI
tRNA	I-CHEBI
synthetase	O
,	O
Wars2	B-GGP
;	O
a	O
T	O
-	O
box	O
gene	B-SO
,	O
Tbx15	B-GGP
;	O
and	O
a	O
novel	O
gene	B-SO
,	O
4931427F14Rik	B-GGP
.	O

In	O
the	O
genome	B-SO
sequence	I-SO
,	O
M1	O
primers	B-SO
correspond	O
to	O
AGGCCTCCAATAAGTTCTGGGTACC	O
and	O
AAGCTTGCTCTCTGGATTCCATTTGTAG	O
,	O
the	O
M2	O
reverse	B-SO
primer	I-SO
corresponds	O
to	O
AAGCTTGGCTTTAGTCCCAGTGGGC	O
,	O
and	O
the	O
M3	O
primers	B-SO
correspond	O
to	O
CCTCCAGGAAGAATCTACTAGGCAC	O
and	O
AATGAAAAAAAAAAAAGTAAGATTGAAAG	O
.	O

Minor	O
differences	O
among	O
the	O
sequences	B-SO
of	O
the	O
primers	B-SO
we	O
obtained	O
from	O
the	O
BAC	B-SO
ends	I-SO
and	O
the	O
public	O
genome	B-SO
sequence	I-SO
may	O
represent	O
strain	O
differences	O
or	O
sequencing	O
errors	O
on	O
the	O
BAC	B-SO
DNA	B-SO
.	O

A	O
multiplex	O
genotyping	O
assay	O
was	O
developed	O
to	O
genotype	O
for	O
the	O
deH	O
deletion	B-SO
using	O
primers	B-SO
GGAGCAGATCCAATTGCTTT	O
,	O
TCCATAGCCCATCTTCACAA	O
,	O
and	O
CATGTCCACTTCTGCTTCCA	O
.	O

This	O
PCR	O
assay	O
produces	O
a	O
392	O
bp	B-SO
product	B-SO
from	O
the	O
deH	O
chromosome	B-GO
and	O
a	O
595	O
bp	B-SO
product	B-SO
from	O
the	O
nonmutant	O
chromosome	B-GO
.	O

Gene	B-SO
targeting	O

A	O
targeted	O
allele	B-SO
of	O
Tbx15	B-GGP
was	O
constructed	O
using	O
the	O
same	O
approach	O
described	O
in	O
Russ	O
et	O
al	O
.	O

(	O
2000	O
)	O
.	O

In	O
brief	O
,	O
an	O
IRES	B-SO
-	O
LacZ	O
-	O
neo	O
cassette	B-SO
with	O
5	O
'	O
and	O
3	O
'	O
homology	O
arms	O
of	O
3	O
.	O
5	O
kb	O
and	O
1	O
.	O
8	O
kb	O
was	O
inserted	B-SO
into	O
a	O
unique	O
BamHI	O
site	B-SO
that	O
lies	O
479	O
nucleotides	B-CHEBI
downstream	O
of	O
the	O
transcriptional	O
initiation	O
site	B-SO
(	O
relative	O
to	O
the	O
mRNA	B-CHEBI
sequence	I-CHEBI
)	O
in	O
exon	B-SO
3	O
.	O

Positive	O
ES	O
clones	B-SO
were	O
injected	O
into	O
B6	O
blastocysts	O
,	O
and	O
chimeric	O
founders	O
crossed	O
to	O
either	O
B6	O
mice	B-Taxon
or	O
to	O
deH	O
/	O
+	B-SO
animals	B-Taxon
.	O

In	O
situ	O
hybridization	O

In	O
situ	O
hybridization	O
was	O
carried	O
out	O
on	O
12	O
-	O
mu	O
m	O
paraffin	O
sections	O
using	O
digoxigenin	B-CHEBI
-	O
labeled	O
RNA	B-SO
probes	B-SO
(	O
Roche	O
Diagnostics	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
according	O
to	O
standard	O
protocols	O
(	O
Wilkinson	O
and	O
Nieto	O
1993	O
)	O
.	O

Embryos	O
and	O
postnatal	O
skin	O
samples	O
were	O
obtained	O
from	O
intercrosses	O
of	O
deH	O
/	O
+	B-SO
mice	B-Taxon
.	O

Embryos	O
E13	O
.	O
5	O
or	O
younger	O
were	O
fixed	O
for	O
24	O
h	O
;	O
those	O
older	O
than	O
E13	O
.	O
5	O
and	O
postnatal	O
skin	O
were	O
fixed	O
for	O
36	O
-	O
48	O
h	O
prior	O
to	O
embedding	O
.	O

The	O
Tbx15	B-GGP
probe	B-SO
was	O
generated	O
by	O
RT	O
-	O
PCR	O
using	O
primers	B-SO
GGCGGCTAAAATGAGTGAAC	O
and	O
TGCCTGCTTTGGTGATGAT	O
(	O
corresponds	O
to	O
exons	B-SO
1	O
and	O
2	O
)	O
,	O
and	O
the	O
En1	B-GGP
probe	B-SO
was	O
generated	O
by	O
PCR	O
from	O
genomic	B-SO
DNA	I-SO
using	O
primers	B-SO
ACGCACCAGGAAGCTAAAGA	O
and	O
AGCAACGAAAACGAAACTGG	O
(	O
located	O
in	O
the	O
last	O
exon	B-SO
)	O
.	O

The	O
Agouti	B-GGP
probe	B-SO
corresponds	O
to	O
the	O
protein	B-CHEBI
-	O
coding	B-SO
sequence	I-SO
.	O

Embryonic	O
skin	O
transplantation	O

(	O
BTBR	O
-	O
at	O
/	O
at	O
x	O
B6	O
-	O
a	O
/	O
a	O
)	O
F1	O
embryos	O
at	O
E12	O
.	O
5	O
were	O
dissected	O
in	O
sterile	O
Tyrode	O
'	O
s	O
solution	O
,	O
and	O
embryonic	O
skin	O
was	O
divided	O
into	O
dorsal	O
,	O
flank	O
,	O
and	O
ventral	O
pieces	O
,	O
each	O
1	O
-	O
2	O
mm2	O
in	O
size	O
,	O
as	O
shown	O
in	O
Figure	O
7	O
.	O

Skin	O
fragments	O
were	O
grafted	O
to	O
the	O
testes	O
of	O
congenic	O
animals	B-Taxon
as	O
follows	O
.	O

After	O
anesthetization	O
with	O
2	O
.	O
5	O
%	O
Avertin	O
,	O
a	O
1	O
.	O
5	O
-	O
cm	O
incision	O
in	O
the	O
skin	O
and	O
body	O
wall	O
was	O
made	O
at	O
a	O
point	O
level	O
with	O
the	O
top	O
of	O
the	O
limbs	O
.	O

The	O
fat	O
pads	O
were	O
pulled	O
out	O
and	O
laid	O
on	O
the	O
outside	O
of	O
the	O
body	O
,	O
exposing	O
the	O
testes	O
.	O

Forceps	O
were	O
used	O
to	O
introduce	O
a	O
small	O
hole	O
in	O
the	O
testis	O
capsule	O
through	O
which	O
a	O
piece	O
of	O
dissected	O
embryonic	O
skin	O
was	O
inserted	O
,	O
the	O
testes	O
were	O
then	O
replaced	O
into	O
the	O
abdominal	O
cavity	O
,	O
and	O
the	O
wound	O
was	O
closed	O
in	O
both	O
the	O
body	O
wall	O
and	O
the	O
skin	O
.	O

After	O
21	O
days	O
,	O
mice	B-Taxon
that	O
received	O
grafts	O
were	O
sacrificed	O
and	O
the	O
resulting	O
hair	O
was	O
dissected	O
from	O
the	O
testes	O
and	O
examined	O
.	O

Fate	O
-	O
mapping	O
the	O
lateral	O
somitic	O
frontier	O

The	O
Hoxb6	B-GGP
-	O
Cre	O
transgene	B-SO
described	O
by	O
Kuehn	O
and	O
colleagues	O
(	O
Lowe	O
et	O
al	O
.	O
2000	O
)	O
is	O
expressed	O
in	O
the	O
lateral	O
plate	O
but	O
not	O
the	O
somitic	O
mesoderm	O
of	O
the	O
trunk	O
,	O
beginning	O
at	O
E9	O
.	O
5	O
.	O

Animals	B-Taxon
doubly	O
heterozygous	O
for	O
this	O
transgene	B-SO
and	O
the	O
R26R	O
reporter	O
gene	B-SO
were	O
used	O
as	O
a	O
source	O
of	O
whole	O
skin	O
at	O
P1	O
.	O
5	O
or	O
P4	O
.	O
5	O
.	O

Skin	O
sections	O
parallel	O
to	O
the	O
dorsoventral	O
axis	O
were	O
prepared	O
with	O
a	O
single	O
incision	O
along	O
the	O
ventral	O
midline	O
and	O
stained	O
for	O
beta	O
-	O
galactosidase	O
activity	O
using	O
standard	O
protocols	O
at	O
room	O
temperature	O
.	O

The	O
P1	O
.	O
5	O
sample	O
was	O
stained	O
overnight	O
and	O
the	O
P4	O
.	O
5	O
samples	O
were	O
stained	O
for	O
5	O
.	O
5	O
h	O
.	O

Similar	O
nonstained	O
skin	O
sections	O
were	O
prepared	O
from	O
animals	B-Taxon
carrying	O
the	O
at	O
allele	B-SO
.	O

Images	O
of	O
the	O
different	O
skin	O
fragments	O
were	O
aligned	O
and	O
scaled	O
,	O
and	O
the	O
relative	O
position	O
of	O
the	O
somite	O
-	O
lateral	O
plate	O
and	O
the	O
pigmentation	O
boundaries	O
were	O
measured	O
using	O
ImageJ	O
.	O

Supporting	O
Information	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
/	O
index	O
.	O
html	O
)	O
accession	O
numbers	O
discussed	O
in	O
this	O
paper	O
are	O
for	O
4931427F14Rik	B-GGP
(	O
AK016477	O
)	O
,	O
Agouti	B-GGP
gene	B-SO
(	O
L06451	O
)	O
,	O
Alx3	B-GGP
(	O
U96109	O
)	O
,	O
Alx4	B-GGP
(	O
AF001465	O
)	O
,	O
En1	B-GGP
(	O
L12703	O
)	O
,	O
M6pr	B-GGP
-	O
ps	O
(	O
X64069	O
)	O
,	O
Tbx14	B-GGP
(	O
AF013282	O
)	O
,	O
Tbx15	B-GGP
(	O
AF041822	O
)	O
,	O
Tbx18	B-GGP
(	O
AF306666	O
)	O
,	O
and	O
Tbx22	B-GGP
(	O
NM	O
_	O
145224	O
)	O
.	O

The	O
OMIM	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
omim	O
/	O
)	O
accession	O
numbers	O
discussed	O
in	O
this	O
paper	O
are	O
for	O
acromegaloid	O
facial	O
appearance	O
(	O
MIM	O
102150	O
)	O
,	O
frontofacionasal	O
syndrome	O
(	O
MIM	O
229400	O
)	O
and	O
human	B-Taxon
syndrome	O
X	B-GO
-	O
linked	O
cleft	O
palate	O
and	O
ankyloglossia	O
(	O
MIM	O
303400	O
)	O
.	O

Acknowledgements	O

We	O
thank	O
Colin	O
Beechey	O
and	O
Bruce	O
Cattanach	O
for	O
providing	O
information	O
about	O
the	O
origin	O
of	O
deH	O
,	O
Cindy	O
Loomis	O
for	O
communicating	O
unpublished	O
results	O
,	O
and	O
Michael	O
Kuehn	O
for	O
providing	O
Hoxb6	B-GGP
-	O
Cre	O
transgenic	B-SO
mice	B-Taxon
.	O

We	O
are	O
especially	O
grateful	O
to	O
Hirotake	O
Ono	O
for	O
discussion	O
,	O
to	O
Hermie	O
Manuel	O
and	O
to	O
Carla	O
Kroon	O
-	O
Veenboer	O
for	O
technical	O
help	O
,	O
and	O
to	O
David	O
Kingsley	O
for	O
first	O
drawing	O
our	O
attention	O
to	O
the	O
effects	O
of	O
droopy	B-GGP
ear	I-GGP
on	O
pigmentation	O
.	O

SIC	O
is	O
supported	O
by	O
a	O
grant	O
from	O
The	O
Donald	O
E	O
.	O
and	O
Delia	O
B	O
.	O
Baxter	O
Foundation	O
.	O

GSB	O
is	O
an	O
associate	O
investigator	O
of	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
.	O

Abbreviations	O

ae	O
-	O
extreme	O
nonagouti	O
allele	B-SO

AFA	O
-	O
acromegaloid	O
facial	O
appearance	O

at	O
-	O
black	O
-	O
and	O
-	O
tan	O
allele	B-SO

AW	O
-	O
white	O
-	O
bellied	O
Agouti	B-GGP
allele	B-SO

B6	O
-	O
C57BL	O
/	O
6J	O
mice	B-Taxon

BAC	B-SO
-	O
bacterial	B-SO
artificial	I-SO
chromosome	I-SO

deH	O
-	O
droopy	B-GGP
ear	I-GGP
allele	B-SO
that	O
arose	O
in	O
Harwell	O

E10	O
.	O
5	O
-	O
embryonic	O
day	O
10	O
.	O
5	O

En1	B-GGP
-	O
Engrailed1	B-GGP

M6pr	B-GGP
-	O
ps	B-SO
-	O
mannose	B-GGP
-	I-GGP
6	I-GGP
-	I-GGP
phosphate	I-GGP
receptor	I-GGP
pseudogene	B-SO

P4	O
.	O
5	O
-	O
postnatal	O
day	O
4	O
.	O
5	O

Tbx15	B-GGP
-	O
T	B-GGP
-	I-GGP
box	I-GGP
gene	I-GGP
15	I-GGP

Figures	O
and	O
Tables	O

Figure	O
1	O

Dorsoventral	O
Skin	O
Characteristics	O

(	O
A	O
)	O
Skin	O
slices	O
from	O
animals	B-Taxon
of	O
different	O
age	O
and	O
genotype	B-SO
demonstrate	O
similar	O
patterns	O
of	O
hair	O
-	O
length	O
variation	O
along	O
the	O
dorsoventral	O
axis	O
(	O
scale	O
bar	O
=	O
1	O
cm	O
)	O
.	O

(	O
B	O
)	O
Enlarged	O
area	O
from	O
(	O
A	O
)	O
,	O
demonstrating	O
the	O
transition	O
in	O
hair	O
length	O
and	O
color	O
in	O
at	O
/	O
at	O
mice	B-Taxon
(	O
scale	O
bar	O
=	O
0	O
.	O
375	O
cm	O
)	O
.	O

(	O
C	O
)	O
Proportional	O
hair	O
length	O
for	O
(	O
A	O
)	O
plotted	O
as	O
a	O
function	O
of	O
relative	O
position	O
along	O
the	O
dorsoventral	O
axis	O
.	O

(	O
D	O
)	O
Hair	O
length	O
plotted	O
as	O
a	O
function	O
of	O
absolute	O
position	O
along	O
the	O
dorsoventral	O
axis	O
for	O
8	O
-	O
wk	O
-	O
old	O
BA	O
strain	O
mice	B-Taxon
.	O

(	O
E	O
)	O
Proportion	O
of	O
zigzag	O
hairs	O
(	O
+/-	O
SEM	O
)	O
differs	O
slightly	O
between	O
dorsum	O
and	O
ventrum	O
of	O
inbred	O
mice	B-Taxon
(	O
p	O
<	O
0	O
.	O
0001	O
,	O
chi	O
2	O
test	O
,	O
n	O
=	O
1	O
,	O
958	O
,	O
1	O
,	O
477	O
,	O
1	O
,	O
579	O
,	O
1	O
,	O
502	O
)	O
.	O

(	O
F	O
)	O
Differences	O
in	O
dorsal	O
and	O
ventral	O
skin	O
development	O
at	O
P4	O
.	O
5	O
(	O
scale	O
bar	O
=	O
1	O
mm	O
,	O
upper	O
;	O
200	O
mu	O
m	O
,	O
lower	O
)	O
.	O

(	O
G	O
)	O
Differences	O
in	O
hair	O
melanin	B-CHEBI
content	O
and	O
DOPA	B-CHEBI
staining	O
for	O
dorsum	O
(	O
d	O
)	O
,	O
flank	O
(	O
f	O
)	O
,	O
and	O
ventrum	O
(	O
v	O
)	O
in	O
ae	O
/	O
ae	O
and	O
at	O
/	O
at	O
mice	B-Taxon
.	O

The	O
upper	O
panel	O
also	O
demonstrates	O
a	O
cream	O
-	O
colored	O
appearance	O
of	O
the	O
at	O
/	O
at	O
ventrum	O
.	O

The	O
middle	O
panel	O
shows	O
representative	O
awls	O
(	O
scale	O
bar	O
=	O
100	O
mu	O
m	O
)	O
.	O

The	O
lower	O
panel	O
shows	O
DOPA	B-CHEBI
-	O
stained	O
dermis	O
(	O
scale	O
bar	O
=	O
200	O
mu	O
m	O
)	O
.	O

Figure	O
2	O

The	O
deH	O
Pigmentation	O
Phenotype	O

(	O
A	O
)	O
10	O
-	O
wk	O
-	O
old	O
deH	O
/	O
deH	O
and	O
nonmutant	O
animals	B-Taxon
on	O
a	O
at	O
background	O
.	O

A	O
thin	O
stripe	O
of	O
yellow	O
hair	O
normally	O
separates	O
the	O
dorsal	O
black	O
hairs	O
from	O
the	O
ventral	O
cream	O
hairs	O
.	O

In	O
deH	O
,	O
the	O
yellow	O
stripe	O
is	O
extended	O
dorsally	O
,	O
and	O
the	O
boundary	O
between	O
the	O
yellow	O
and	O
the	O
black	O
hairs	O
is	O
fuzzier	O
.	O

(	O
B	O
)	O
Skin	O
slices	O
taken	O
from	O
1	O
.	O
5	O
-	O
mo	O
-	O
old	O
deH	O
/	O
deH	O
and	O
nonmutant	O
littermates	O
(	O
scale	O
bar	O
=	O
0	O
.	O
5	O
cm	O
)	O
.	O

(	O
C	O
)	O
Proportion	O
of	O
total	O
skin	O
area	O
as	O
determined	O
by	O
observation	O
of	O
pelts	O
taken	O
from	O
the	O
interlimb	O
region	O
.	O

The	O
proportion	O
occupied	O
by	O
the	O
yellow	O
lateral	O
compartment	O
(	O
+/-	O
SEM	O
)	O
differs	O
between	O
mutant	B-SO
and	O
nonmutant	O
littermate	O
flanks	O
(	O
p	O
<	O
0	O
.	O
0005	O
,	O
paired	O
t	O
-	O
test	O
,	O
n	O
=	O
6	O
pairs	O
)	O
.	O

There	O
is	O
also	O
(	O
data	O
not	O
shown	O
)	O
a	O
small	O
increase	O
in	O
the	O
proportion	O
of	O
total	O
skin	O
area	O
occupied	O
by	O
the	O
ventral	O
cream	O
-	O
colored	O
compartment	O
,	O
47	O
.	O
9	O
%	O
in	O
mutant	B-SO
compared	O
to	O
37	O
.	O
8	O
%	O
in	O
nonmutant	O
(	O
p	O
<	O
0	O
.	O
005	O
,	O
paired	O
t	O
-	O
test	O
,	O
n	O
=	O
6	O
pairs	O
)	O
.	O

(	O
D	O
)	O
On	O
an	O
ae	O
/	O
ae	O
background	O
,	O
the	O
extent	O
of	O
dorsal	O
skin	O
pigmentation	O
is	O
reduced	O
in	O
deH	O
/	O
deH	O
neonates	O
(	O
P3	O
.	O
5	O
)	O
.	O

(	O
E	O
)	O
Hair	O
length	O
in	O
a	O
representative	O
pair	O
of	O
1	O
.	O
5	O
-	O
mo	O
-	O
old	O
deH	O
/	O
deH	O
and	O
nonmutant	O
littermates	O
,	O
averaged	O
over	O
three	O
skin	O
slices	O
at	O
different	O
rostrocaudal	O
levels	O
,	O
and	O
plotted	O
as	O
a	O
function	O
of	O
the	O
absolute	O
distance	O
from	O
middorsum	O
or	O
the	O
percentage	O
of	O
total	O
slice	O
length	O
.	O

Figure	O
3	O

Molecular	B-CHEBI
Genetics	O
of	O
deH	O
and	O
Tbx15	B-GGP

(	O
A	O
)	O
Genetic	B-SO
and	O
physical	B-SO
map	I-SO
,	O
as	O
described	O
in	O
the	O
text	O
.	O

Markers	O
M1	O
to	O
M3	O
are	O
SSCP	O
markers	O
generated	O
from	O
a	O
BAC	B-SO
contig	B-SO
of	O
the	O
region	B-SO
;	O
marker	O
M4	O
is	O
STS	B-SO
16	O
.	O
MMHAP32FLF1	O
and	O
was	O
also	O
used	O
as	O
an	O
SSCP	O
marker	O
.	O

M2	O
and	O
M3	O
,	O
which	O
flank	B-SO
the	O
Tbx15	B-GGP
and	O
M6pr	B-GGP
-	O
ps	B-SO
on	O
the	O
UCSC	O
genome	B-SO
browser	O
map	B-SO
and	O
lie	O
634	O
kb	O
apart	O
,	O
were	O
nonrecombinant	O
with	O
deH	O
in	O
2340	O
meioses	O
.	O

(	O
B	O
)	O
The	O
deH	O
mutation	B-SO
is	O
a	O
deletion	B-SO
that	O
starts	O
in	O
Tbx15	B-GGP
intron	B-SO
1	O
and	O
ends	O
in	O
the	O
M6pr	B-GGP
-	O
ps	B-SO
.	O

(	O
C	O
)	O
Sequence	B-SO
of	O
deletion	B-SO
breakpoints	I-SO
.	O

(	O
D	O
)	O
Diagram	O
of	O
Tbx15LacZ	O
allele	B-SO
constructed	O
by	O
gene	B-SO
targeting	O
.	O

As	O
described	O
in	O
the	O
text	O
,	O
this	O
allele	B-SO
is	O
predicted	O
to	O
give	O
rise	O
to	O
a	O
protein	B-CHEBI
truncated	O
after	O
approximately	O
154	O
codons	B-SO
and	O
is	O
lacking	O
critical	O
residues	B-CHEBI
of	O
the	O
T	O
box	O
.	O

Heterozygotes	O
for	O
the	O
targeted	O
allele	B-SO
exhibit	O
normal	O
size	O
,	O
morphology	O
,	O
and	O
hair	O
-	O
color	O
patterns	O
,	O
but	O
homozygotes	O
and	O
Tbx15LacZ	O
/	O
deH	O
compound	O
heterozygotes	O
are	O
identical	O
to	O
deH	O
homozygotes	O
.	O

Figure	O
4	O

Developmental	O
Expression	O
of	O
Tbx15	B-GGP

(	O
A	O
)	O
At	O
E12	O
.	O
5	O
,	O
transverse	O
sections	O
at	O
different	O
levels	O
show	O
expression	O
in	O
head	O
mesenchyme	O
(	O
a	O
and	O
b	O
)	O
;	O
myotome	O
,	O
occipital	O
,	O
and	O
periocular	O
mesenchyme	O
(	O
b	O
)	O
;	O
palatal	O
shelf	O
,	O
cervical	O
sclerotome	O
,	O
and	O
nasal	O
cartilage	O
(	O
c	O
)	O
;	O
maxillary	O
and	O
mandibular	O
processes	O
(	O
d	O
)	O
;	O
limbs	O
(	O
e	O
)	O
;	O
and	O
myotome	O
and	O
lateral	O
mesenchyme	O
(	O
e	O
and	O
f	O
)	O
(	O
scale	O
bars	O
=	O
500	O
mu	O
m	O
)	O
.	O

(	O
B	O
)	O
Transverse	O
sections	O
through	O
the	O
flank	O
at	O
different	O
times	O
show	O
expression	O
in	O
lateral	O
mesenchyme	O
(	O
E11	O
.	O
5	O
)	O
,	O
expanding	O
dorsally	O
at	O
E12	O
.	O
5	O
,	O
and	O
both	O
ventrally	O
and	O
dorsally	O
at	O
E13	O
.	O
5	O
,	O
detectable	O
in	O
loose	O
mesenchyme	O
underlying	O
the	O
dermis	O
and	O
the	O
abdominal	O
and	O
subcutaneous	O
muscles	O
(	O
scale	O
bar	O
=	O
500	O
mu	O
m	O
)	O
.	O

At	O
P3	O
.	O
5	O
,	O
Tbx15	B-GGP
is	O
expressed	O
in	O
the	O
entire	O
dermis	O
and	O
is	O
most	O
strongly	O
expressed	O
in	O
dermal	O
sheaths	O
(	O
scale	O
bar	O
=	O
200	O
mu	O
m	O
)	O
.	O

Figure	O
5	O

Embryonic	O
Expression	O
of	O
Tbx15	B-GGP
Compared	O
to	O
Agouti	B-GGP
in	O
at	O
/	O
at	O
Mice	B-Taxon

(	O
A	O
and	O
C	O
)	O
Tbx15	B-GGP
.	O

(	O
B	O
and	O
D	O
)	O
Agouti	B-GGP
.	O

At	O
E12	O
.	O
5	O
,	O
expression	O
of	O
Tbx15	B-GGP
in	O
dorsal	O
skin	O
is	O
approximately	O
complementary	O
to	O
that	O
of	O
Agouti	B-GGP
in	O
ventral	O
skin	O
.	O

At	O
E14	O
.	O
5	O
,	O
the	O
levels	O
of	O
expression	O
for	O
both	O
genes	B-SO
are	O
lower	O
,	O
but	O
Tbx15	B-GGP
expression	O
has	O
expanded	O
ventrally	O
and	O
overlaps	O
extensively	O
with	O
that	O
of	O
Agouti	B-GGP
.	O

In	O
all	O
four	O
panels	O
,	O
arrows	O
mark	O
the	O
approximate	O
ventral	O
limit	O
of	O
Tbx15	B-GGP
and	O
the	O
approximate	O
dorsal	O
limit	O
of	O
Agouti	B-GGP
(	O
scale	O
bars	O
=	O
500	O
mu	O
m	O
)	O
.	O

Figure	O
6	O

Effect	O
of	O
deH	O
on	O
Agouti	B-GGP
Expression	O

Comparable	O
sections	O
from	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
and	O
at	O
/	O
at	O
;	O
+	B-SO
/	O
+	B-SO
littermates	O
.	O

(	O
A	O
)	O
At	O
E14	O
.	O
5	O
,	O
deH	O
/	O
deH	O
embryos	O
have	O
a	O
smaller	O
body	O
cavity	O
and	O
loose	O
skin	O
within	O
which	O
Agouti	B-GGP
expression	O
appears	O
to	O
be	O
shifted	O
dorsally	O
,	O
as	O
marked	O
by	O
arrows	O
(	O
scale	O
bars	O
=	O
500	O
mu	O
m	O
)	O
.	O

(	O
B	O
)	O
At	O
P4	O
.	O
5	O
,	O
Agouti	B-GGP
expression	O
in	O
both	O
dorsal	O
and	O
ventral	O
skin	O
is	O
similar	O
in	O
deH	O
/	O
deH	O
compared	O
to	O
nonmutant	O
,	O
but	O
in	O
the	O
midflank	O
region	O
,	O
there	O
is	O
increased	O
Agouti	B-GGP
expression	O
in	O
deH	O
/	O
deH	O
,	O
especially	O
in	O
the	O
upper	O
dermis	O
(	O
scale	O
bars	O
=	O
200	O
mu	O
m	O
)	O
.	O

Sections	O
shown	O
are	O
representative	O
of	O
two	O
mutant	B-SO
and	O
two	O
nonmutant	O
samples	O
examined	O
at	O
each	O
time	O
.	O

Figure	O
7	O

Embryonic	O
Establishment	O
of	O
Dorsoventral	O
Skin	O
Patterning	O

Pieces	O
of	O
skin	O
from	O
dorsal	O
,	O
flank	O
,	O
and	O
ventral	O
regions	O
of	O
at	O
/	O
a	O
E12	O
.	O
5	O
embryos	O
were	O
transplanted	O
into	O
the	O
testes	O
of	O
congenic	O
animals	B-Taxon
as	O
described	O
in	O
the	O
text	O
.	O

Hair	O
color	O
of	O
the	O
grafts	O
was	O
examined	O
3	O
wk	O
later	O
.	O

Grafts	O
of	O
ventral	O
embryonic	O
skin	O
(	O
n	O
=	O
3	O
)	O
produced	O
yellow	O
hairs	O
,	O
dorsal	O
embryonic	O
skin	O
(	O
n	O
=	O
4	O
)	O
produced	O
black	O
hairs	O
,	O
and	O
flank	O
embryonic	O
skin	O
produced	O
mostly	O
(	O
13	O
out	O
of	O
15	O
)	O
black	O
and	O
yellow	O
hairs	O
in	O
distinct	O
regions	O
as	O
shown	O
.	O

In	O
parallel	O
,	O
in	O
situ	O
hybridization	O
studies	O
revealed	O
that	O
the	O
embryonic	O
flank	O
contains	O
the	O
boundary	O
of	O
expression	O
between	O
Agouti	B-GGP
and	O
Tbx15	B-GGP
(	O
scale	O
bars	O
=	O
1	O
mm	O
for	O
hairs	O
and	O
200	O
mu	O
m	O
for	O
in	O
situ	O
hybridization	O
results	O
)	O
.	O

Figure	O
8	O

Comparison	O
of	O
the	O
Dorsoventral	O
at	O
/	O
at	O
Pigmentation	O
Boundary	O
to	O
the	O
Lateral	O
Somitic	O
Frontier	O

(	O
A	O
)	O
Dorsoventral	O
slices	O
of	O
skin	O
from	O
at	O
the	O
midtrunk	O
region	O
prepared	O
such	O
that	O
the	O
dorsal	O
midline	O
lies	O
in	O
the	O
center	O
of	O
the	O
slice	O
.	O

Sections	O
were	O
taken	O
at	O
P1	O
.	O
5	O
(	O
a	O
)	O
or	O
P4	O
.	O
5	O
(	O
b	O
-	O
e	O
)	O
from	O
at	O
/	O
at	O
or	O
R26R	O
/	O
+	B-SO
;	O
Tg	B-SO
.	O
Hoxb6	B-GGP
-	O
Cre	O
/	O
+	B-SO
mice	B-Taxon
(	O
the	O
latter	O
were	O
stained	O
with	O
X	O
-	O
Gal	O
)	O
,	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

For	O
purposes	O
of	O
comparison	O
,	O
images	O
were	O
proportionally	O
scaled	O
.	O

The	O
boundary	O
of	O
X	O
-	O
Gal	O
staining	O
marks	O
dermis	O
derived	O
from	O
lateral	O
plate	O
versus	O
dermis	O
derived	O
from	O
mesoderm	O
(	O
the	O
lateral	O
somitic	O
frontier	O
)	O
and	O
lies	O
more	O
dorsal	O
than	O
the	O
at	O
/	O
at	O
pigmentation	O
boundary	O
.	O

(	O
B	O
)	O
Quantitation	O
of	O
mean	O
(	O
+/-	O
SEM	O
)	O
dorsal	O
pigmentation	O
area	O
(	O
n	O
=	O
5	O
)	O
and	O
somite	O
-	O
derived	O
dermis	O
area	O
(	O
n	O
=	O
3	O
)	O
shows	O
a	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
005	O
,	O
t	O
-	O
test	O
)	O
.	O

(	O
C	O
)	O
RNA	B-SO
in	O
situ	O
hybridization	O
showing	O
that	O
Tbx15	B-GGP
expression	O
at	O
E11	O
.	O
5	O
is	O
complementary	O
to	O
En1	B-GGP
expression	O
on	O
the	O
flank	O
(	O
scale	O
bars	O
=	O
200	O
mu	O
m	O
)	O
.	O

The	O
arrow	O
indicates	O
the	O
boundary	O
between	O
the	O
expression	O
domains	O
of	O
the	O
two	O
genes	B-SO
.	O

Figure	O
9	O

Model	O
for	O
Acquisition	O
of	O
Dorsoventral	O
Patterning	O
in	O
the	O
Trunk	O
and	O
the	O
Role	O
of	O
Tbx15	B-GGP

(	O
A	O
)	O
A	O
tricolor	O
pigmentation	O
pattern	O
is	O
generated	O
by	O
the	O
combination	O
of	O
distinct	O
mechanisms	O
that	O
affect	O
distribution	O
of	O
Agouti	B-GGP
mRNA	B-CHEBI
and	O
histochemical	O
staining	O
for	O
melanocytes	B-CL
;	O
effects	O
of	O
the	O
latter	O
mechanism	O
by	O
itself	O
are	O
evident	O
in	O
ae	O
/	O
ae	O
mice	B-Taxon
(	O
see	O
Figure	O
1	O
)	O
.	O

In	O
at	O
/	O
at	O
mice	B-Taxon
,	O
reduced	O
hair	O
melanocyte	B-CL
activity	O
and	O
high	O
levels	O
of	O
Agouti	B-GGP
mRNA	B-CHEBI
in	O
the	O
ventrum	O
lead	O
to	O
a	O
cream	O
color	O
;	O
as	O
melanocyte	B-CL
activity	O
gradually	O
increases	O
towards	O
the	O
dorsum	O
,	O
a	O
lateral	O
stripe	O
is	O
apparent	O
on	O
the	O
flank	O
.	O

The	O
distributions	O
of	O
Agouti	B-GGP
mRNA	B-CHEBI
and	O
histochemical	O
staining	O
for	O
melanocytes	B-CL
are	O
both	O
affected	O
by	O
Tbx15	B-GGP
and	O
are	O
externally	O
evident	O
by	O
a	O
widening	O
of	O
the	O
lateral	O
stripe	O
and	O
an	O
increased	O
proportion	O
of	O
total	O
skin	O
occupied	O
by	O
the	O
cream	O
-	O
colored	O
area	O
.	O

(	O
B	O
)	O
The	O
lateral	O
yellow	O
stripe	O
in	O
at	O
/	O
at	O
mice	B-Taxon
lies	O
at	O
the	O
same	O
level	O
as	O
the	O
limb	O
dorsoventral	O
boundary	O
.	O

As	O
described	O
in	O
the	O
text	O
,	O
we	O
propose	O
that	O
distinct	O
dorsoventral	O
compartments	O
in	O
ectoderm	O
of	O
the	O
trunk	O
provide	O
an	O
instructional	O
cue	O
to	O
the	O
mesoderm	O
,	O
leading	O
to	O
expression	O
of	O
Tbx15	B-GGP
in	O
dorsal	O
trunk	O
mesenchyme	O
and	O
acquisition	O
of	O
dorsal	O
dermis	O
character	O
.	O

In	O
the	O
absence	O
of	O
Tbx15	B-GGP
,	O
dorsal	O
mesenchyme	O
assumes	O
ventral	O
characteristics	O
instead	O
.	O

Footnotes	O

Conflicts	O
of	O
interest	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
conflicts	O
of	O
interest	O
exist	O
.	O

Author	O
contributions	O
.	O

SIC	O
and	O
GSB	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

SIC	O
,	O
CDVR	O
,	O
CC	O
,	O
AR	O
,	O
and	O
SK	O
performed	O
the	O
experiments	O
.	O

SIC	O
,	O
CDVR	O
,	O
CC	O
,	O
SK	O
,	O
and	O
FM	O
analyzed	O
the	O
data	O
.	O

YC	O
and	O
AR	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

SIC	O
and	O
GSB	O
wrote	O
the	O
paper	O
.	O

Academic	O
Editor	O
:	O
Brigid	O
L	O
.	O

M	O
.	O

Hogan	O
,	O
Duke	O
University	O
Medical	O
Center	O

Late	O
gestational	O
lung	O
hypoplasia	O
in	O
a	O
mouse	B-Taxon
model	O
of	O
the	O
Smith	O
-	O
Lemli	O
-	O
Opitz	O
syndrome	O

Abstract	O

Background	O

Normal	O
post	O
-	O
squalene	B-CHEBI
cholesterol	B-CHEBI
biosynthesis	O
is	O
important	O
for	O
mammalian	B-Taxon
embryonic	O
development	O
.	O

Neonatal	O
mice	B-Taxon
lacking	O
functional	O
dehydrocholesterol	B-GGP
Delta	I-GGP
7	I-GGP
-	I-GGP
reductase	I-GGP
(	O
Dhcr7	B-GGP
)	O
,	O
a	O
model	O
for	O
the	O
human	B-Taxon
disease	O
of	O
Smith	O
-	O
Lemli	O
-	O
Opitz	O
syndrome	O
,	O
die	O
within	O
24	O
hours	O
of	O
birth	O
.	O

Although	O
they	O
have	O
a	O
number	O
of	O
biochemical	O
and	O
structural	O
abnormalities	O
,	O
one	O
cause	O
of	O
death	O
is	O
from	O
apparent	O
respiratory	O
failure	O
due	O
to	O
developmental	O
pulmonary	O
abnormalities	O
.	O

Results	O

In	O
this	O
study	O
,	O
we	O
characterized	O
further	O
the	O
role	O
of	O
cholesterol	B-CHEBI
deficiency	O
in	O
lung	O
development	O
of	O
these	O
mice	B-Taxon
.	O

Significant	O
growth	O
retardation	O
,	O
beginning	O
at	O
E14	O
.	O
5	O
~	O
E16	O
.	O
5	O
,	O
was	O
observed	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

Normal	O
lobation	O
but	O
smaller	O
lungs	O
with	O
a	O
significant	O
decrease	O
in	O
lung	O
-	O
to	O
-	O
body	O
weight	O
ratio	O
was	O
noted	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
,	O
compared	O
to	O
controls	O
.	O

Lung	O
branching	O
morphogenesis	O
was	O
comparable	O
between	O
Dhcr7	B-GGP
-	O
/	O
-	O
and	O
controls	O
at	O
early	O
stages	O
,	O
but	O
delayed	O
saccular	O
development	O
was	O
visible	O
in	O
all	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
from	O
E17	O
.	O
5	O
onwards	O
.	O

Impaired	O
pre	O
-	O
alveolar	O
development	O
of	O
varying	O
severity	O
,	O
inhibited	O
cell	B-CL
proliferation	O
,	O
delayed	O
differentiation	O
of	O
type	O
I	O
alveolar	O
epithelial	B-CL
cells	I-CL
(	O
AECs	O
)	O
and	O
delayed	O
vascular	O
development	O
were	O
all	O
evident	O
in	O
knockout	O
lungs	O
.	O

Differentiation	O
of	O
type	O
II	O
AECs	O
was	O
apparently	O
normal	O
as	O
judged	O
by	O
surfactant	B-CHEBI
protein	B-CHEBI
(	O
SP	O
)	O
mRNAs	B-CHEBI
and	O
SP	B-GGP
-	I-GGP
C	I-GGP
immunostaining	O
.	O

A	O
significant	O
amount	O
of	O
cholesterol	B-CHEBI
was	O
detectable	O
in	O
knockout	O
lungs	O
,	O
implicating	O
some	O
maternal	O
transfer	O
of	O
cholesterol	B-CHEBI
.	O

No	O
significant	O
differences	O
of	O
the	O
spatial	O
-	O
temporal	O
localization	O
of	O
sonic	B-GGP
hedgehog	I-GGP
(	O
Shh	B-GGP
)	O
or	O
its	O
downstream	O
targets	O
by	O
immunohistochemistry	O
were	O
detected	O
between	O
knockout	O
and	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
and	O
Shh	B-GGP
autoprocessing	O
occurred	O
normally	O
in	O
tissues	O
from	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

Conclusion	O

Our	O
data	O
indicated	O
that	O
cholesterol	B-CHEBI
deficiency	O
caused	O
by	O
Dhcr7	B-GGP
null	O
was	O
associated	O
with	O
a	O
distinct	O
lung	O
saccular	O
hypoplasia	O
,	O
characterized	O
by	O
failure	O
to	O
terminally	O
differentiate	O
alveolar	O
sacs	O
,	O
a	O
delayed	O
differentiation	O
of	O
type	O
I	O
AECs	O
and	O
an	O
immature	O
vascular	O
network	O
at	O
late	O
gestational	O
stages	O
.	O

The	O
molecular	B-CHEBI
mechanism	O
of	O
impaired	O
lung	O
development	O
associated	O
with	O
sterol	B-CHEBI
deficiency	O
by	O
Dhcr7	B-GGP
loss	O
is	O
still	O
unknown	O
,	O
but	O
these	O
results	O
do	O
not	O
support	O
the	O
involvement	O
of	O
dysregulated	O
Shh	B-GGP
-	O
Patched	O
-	O
Gli	O
pathway	O
in	O
causing	O
this	O
defect	O
.	O

Background	O

Cholesterol	B-CHEBI
is	O
a	O
necessary	O
membrane	B-GO
constituent	O
of	O
all	O
mammalian	B-Taxon
,	O
reptile	B-Taxon
and	O
avian	B-Taxon
cells	B-CL
,	O
as	O
well	O
as	O
a	O
few	O
other	O
organisms	B-Taxon
,	O
but	O
not	O
all	O
eukaryotic	B-Taxon
organisms	I-Taxon
.	O

In	O
the	O
latter	O
cases	O
,	O
such	O
as	O
plants	B-Taxon
and	O
fungi	B-Taxon
,	O
cholesterol	B-CHEBI
-	O
like	O
sterols	B-CHEBI
(	O
phytosterols	B-CHEBI
,	O
ergosterol	B-CHEBI
etc	O
.	O
)	O
seem	O
to	O
substitute	O
for	O
cholesterol	B-CHEBI
.	O

The	O
precise	O
need	O
for	O
sterols	B-CHEBI
in	O
biological	B-GO
membranes	I-GO
still	O
remains	O
poorly	O
defined	O
,	O
though	O
its	O
link	O
with	O
microdomains	O
(	O
variously	O
termed	O
rafts	O
,	O
caveoli	B-GO
etc	O
.	O
)	O
may	O
be	O
part	O
of	O
the	O
answer	O
[	O
1	O
]	O
.	O

Although	O
the	O
accumulation	O
of	O
cholesterol	B-CHEBI
in	O
atherosclerotic	O
plaques	O
has	O
led	O
to	O
the	O
concept	O
that	O
'	O
too	O
much	O
'	O
cholesterol	B-CHEBI
may	O
be	O
deleterious	O
,	O
too	O
little	O
cholesterol	B-CHEBI
has	O
now	O
been	O
proven	O
pathophysiological	O
for	O
abnormal	O
embryonic	O
development	O
.	O

Smith	O
-	O
Lemli	O
-	O
Opitz	O
syndrome	O
(	O
SLOS	O
,	O
MIM	O
270400	O
)	O
,	O
a	O
relative	O
common	O
dysmorphology	O
disorder	O
,	O
is	O
caused	O
by	O
mutations	B-SO
in	O
DHCR7	B-GGP
[	O
2	O
-	O
5	O
]	O
,	O
which	O
encodes	O
for	O
7	B-GGP
-	I-GGP
dehydrocholesterol	I-GGP
Delta	I-GGP
7	I-GGP
-	I-GGP
reductase	I-GGP
and	O
catalyzes	O
a	O
final	O
step	O
of	O
cholesterol	B-CHEBI
biosynthesis	O
.	O

Recognition	O
of	O
other	O
dysmorphology	O
syndromes	O
caused	O
by	O
defects	O
in	O
the	O
post	O
-	O
squalene	B-CHEBI
cholesterol	B-CHEBI
biosynthesis	O
pathway	O
,	O
such	O
as	O
desmosterolosis	O
,	O
lathosterolosis	O
,	O
X	B-GO
-	O
linked	O
chondrodysplasia	O
punctanta	O
and	O
CHILD	O
syndrome	O
[	O
6	O
-	O
15	O
]	O
,	O
has	O
strengthened	O
this	O
concept	O
.	O

Genetic	B-SO
disruption	O
of	O
the	O
Dhcr7	B-GGP
results	O
in	O
neonatal	O
lethality	O
[	O
16	O
]	O
.	O

Neonatal	O
mice	B-Taxon
homozygous	O
for	O
the	O
Dhcr7	B-GGP
gene	B-SO
disruption	O
are	O
deficient	O
in	O
cholesterol	B-CHEBI
and	O
have	O
increased	O
accumulation	O
of	O
the	O
cholesterol	B-CHEBI
precursor	O
7	O
-	O
dehydrocholesterol	O
(	O
7DHC	O
)	O
.	O

Although	O
no	O
embryonic	O
lethality	O
was	O
noted	O
,	O
these	O
knockout	O
pups	O
exhibited	O
a	O
number	O
of	O
developmental	O
abnormalities	O
and	O
died	O
within	O
24	O
h	O
after	O
birth	O
.	O

A	O
similar	O
mouse	B-Taxon
SLOS	O
model	O
,	O
generated	O
by	O
replacing	B-SO
exons	B-SO
3	O
,	O
4	O
and	O
part	B-SO
of	I-SO
exon	I-SO
5	O
of	O
the	O
murine	B-GGP
Dhcr7	I-GGP
gene	B-SO
,	O
with	O
similar	O
biochemical	O
and	O
structural	O
defects	O
and	O
a	O
100	O
%	O
neonatal	O
lethality	O
,	O
has	O
also	O
been	O
reported	O
[	O
17	O
]	O
.	O

Poor	O
lung	O
development	O
or	O
diffuse	O
lung	O
alveolar	O
atelectasis	O
with	O
cyanotic	O
and	O
lethargic	O
breathing	O
are	O
consistent	O
between	O
both	O
Dhcr7	B-GGP
null	O
models	O
[	O
16	O
,	O
17	O
]	O
,	O
and	O
therefore	O
is	O
the	O
likely	O
reason	O
for	O
the	O
respiratory	O
insufficiency	O
and	O
subsequent	O
death	O
of	O
Dhcr7	B-GGP
-	O
/	O
-	O
pups	O
.	O

These	O
Dhcr7	B-GGP
knockout	O
mice	B-Taxon
are	O
models	O
for	O
human	B-Taxon
SLOS	O
,	O
especially	O
the	O
more	O
severely	O
affected	O
patients	O
,	O
since	O
early	O
postnatal	O
lethality	O
with	O
respiratory	O
failure	O
has	O
been	O
reported	O
in	O
severe	O
SLOS	O
cases	O
[	O
4	O
,	O
5	O
]	O
.	O

Developmental	O
lung	O
abnormalities	O
are	O
also	O
relatively	O
common	O
in	O
SLOS	O
patients	O
,	O
including	O
pulmonary	O
hypoplasia	O
,	O
abnormal	O
pulmonary	O
lobation	O
and	O
pulmonary	O
arteries	O
,	O
anomalies	O
of	O
laryngeal	O
and	O
tracheal	O
development	O
[	O
18	O
]	O
.	O

Mammalian	B-Taxon
lung	O
is	O
unique	O
in	O
that	O
it	O
is	O
fully	O
developed	O
,	O
but	O
does	O
not	O
function	O
for	O
gas	O
exchange	O
until	O
at	O
the	O
moment	O
of	O
birth	O
;	O
the	O
majority	O
of	O
structural	O
development	O
and	O
maturation	O
takes	O
place	O
in	O
utero	O
.	O

Lung	O
development	O
is	O
a	O
complex	O
process	O
that	O
involves	O
branching	O
morphogenesis	O
of	O
epithelium	O
,	O
interstitial	O
development	O
including	O
vasculogenesis	O
,	O
cellular	B-CL
differentiation	O
,	O
biochemical	O
maturation	O
and	O
physical	O
growth	O
.	O

Four	O
stages	O
of	O
mouse	B-Taxon
lung	O
development	O
have	O
been	O
described	O
,	O
based	O
upon	O
the	O
histological	O
appearances	O
of	O
lung	O
;	O
pseudoglandular	O
,	O
canalicular	O
,	O
terminal	O
saccular	O
and	O
alveolar	O
stages	O
[	O
19	O
]	O
.	O

Impaired	O
hedgehog	O
function	O
has	O
been	O
proposed	O
as	O
a	O
mechanism	O
underlying	O
malformations	O
found	O
in	O
SLOS	O
.	O

Hedgehog	O
family	O
members	O
play	O
diverse	O
roles	O
in	O
embryonic	O
development	O
,	O
and	O
cholesterol	B-CHEBI
is	O
necessary	O
for	O
maturation	O
of	O
these	O
morphogens	O
[	O
20	O
-	O
23	O
]	O
.	O

The	O
sonic	B-GGP
hedgehog	I-GGP
(	O
Shh	B-GGP
)	O
signaling	O
cascade	O
has	O
been	O
shown	O
to	O
play	O
a	O
central	O
role	O
in	O
lung	O
development	O
[	O
24	O
-	O
26	O
]	O
.	O

Loss	O
of	O
Shh	B-GGP
function	O
resulted	O
in	O
severe	O
lung	O
defects	O
associated	O
with	O
loss	O
of	O
branching	O
morphogenesis	O
,	O
but	O
preserved	O
proximal	O
-	O
to	O
-	O
distal	O
differentiation	O
of	O
lung	O
epithelium	O
[	O
24	O
]	O
.	O

Overexpression	O
of	O
Shh	B-GGP
in	O
the	O
distal	O
lung	O
epithelium	O
resulted	O
in	O
the	O
absence	O
of	O
functional	O
alveoli	O
and	O
an	O
increase	O
in	O
interstitial	O
tissue	O
caused	O
by	O
an	O
increased	O
proliferation	O
of	O
both	O
epithelial	B-CL
and	I-CL
mesenchyme	I-CL
cells	I-CL
[	O
26	O
]	O
.	O

Mice	B-Taxon
with	O
Shh	B-GGP
overexpression	O
died	O
less	O
than	O
24	O
h	O
after	O
birth	O
,	O
probably	O
owing	O
to	O
respiratory	O
failure	O
.	O

It	O
has	O
been	O
reported	O
that	O
inhibition	O
of	O
cholesterol	B-CHEBI
biosynthesis	O
by	O
chemical	B-CHEBI
inhibitors	I-CHEBI
of	O
Dhcr7	B-GGP
also	O
led	O
to	O
a	O
disturbance	O
of	O
the	O
Shh	B-GGP
signaling	O
with	O
abnormal	O
embryogenesis	O
[	O
27	O
,	O
28	O
]	O
,	O
and	O
severe	O
sterol	B-CHEBI
deprivation	O
can	O
indeed	O
inhibit	O
the	O
processing	O
of	O
transfected	O
Shh	B-GGP
in	O
cultured	O
mammalian	B-Taxon
cells	B-CL
[	O
29	O
]	O
.	O

In	O
the	O
present	O
studies	O
,	O
we	O
characterized	O
lung	O
development	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
from	O
E10	O
.	O
5	O
to	O
birth	O
.	O

Our	O
results	O
showed	O
that	O
cholesterol	B-CHEBI
deficiency	O
,	O
caused	O
by	O
loss	O
of	O
Dhcr7	B-GGP
activity	O
,	O
did	O
not	O
alter	O
lung	O
branching	O
morphogenesis	O
(	O
early	O
gestational	O
stages	O
,	O
E9	O
.	O
5	O
to	O
E14	O
.	O
5	O
)	O
.	O

However	O
,	O
lung	O
saccular	O
development	O
was	O
impaired	O
,	O
with	O
arrested	O
or	O
partially	O
developed	O
epithelial	O
tubules	O
and	O
delayed	O
vascular	O
development	O
.	O

Differentiation	O
of	O
type	O
II	O
alveolar	O
epithelial	B-CL
cells	I-CL
(	O
AECs	O
)	O
appeared	O
normal	O
but	O
differentiation	O
of	O
type	O
I	O
AECs	O
was	O
severely	O
impaired	O
.	O

Therefore	O
,	O
cholesterol	B-CHEBI
deficiency	O
resulted	O
in	O
a	O
distinct	O
late	O
gestational	O
lung	O
hypoplasia	O
,	O
characterized	O
by	O
impaired	O
sacculation	O
with	O
delayed	O
type	O
I	O
AECs	O
differentiation	O
and	O
immature	O
vascular	O
development	O
.	O

However	O
,	O
this	O
study	O
does	O
not	O
support	O
the	O
concept	O
that	O
the	O
perturbation	O
of	O
Shh	B-GGP
-	O
Patched	O
-	O
Gli	O
pathway	O
was	O
involved	O
in	O
the	O
pathogenesis	O
of	O
developmental	O
lung	O
hypoplasia	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

Patterns	O
of	O
expression	O
of	O
Shh	B-GGP
signaling	O
cascade	O
members	O
were	O
not	O
altered	O
,	O
and	O
processing	O
of	O
Shh	B-GGP
appeared	O
normal	O
.	O

Results	O

Body	O
growth	O
retardation	O
at	O
late	O
gestation	O
stage	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O

Dhcr7	B-GGP
-	O
/	O
-	O
mice	B-Taxon
were	O
born	O
in	O
the	O
expected	O
Mendelian	O
ratios	O
from	O
heterozygous	O
parents	O
,	O
but	O
all	O
of	O
these	O
pups	O
died	O
within	O
24	O
h	O
and	O
most	O
within	O
14	O
h	O
of	O
birth	O
[	O
16	O
]	O
.	O

At	O
birth	O
,	O
they	O
were	O
clearly	O
smaller	O
than	O
wild	B-SO
-	I-SO
type	I-SO
or	O
heterozygous	O
littermates	O
.	O

An	O
experienced	O
investigator	O
can	O
pick	O
out	O
knockout	O
pups	O
based	O
on	O
this	O
along	O
with	O
presence	O
of	O
hypoxia	O
and	O
their	O
lack	O
of	O
spontaneous	O
movement	O
.	O

The	O
breathing	O
frequency	O
in	O
P0	O
Dhcr7	B-GGP
-	O
/	O
-	O
pups	O
was	O
markedly	O
slower	O
than	O
control	O
littermates	O
(	O
34	O
+/-	O
7	O
breaths	O
/	O
min	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
,	O
n	O
=	O
10	O
vs	O
.	O
92	O
+/-	O
16	O
breaths	O
/	O
min	O
in	O
controls	O
,	O
n	O
=	O
32	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
the	O
breathing	O
was	O
observed	O
to	O
be	O
more	O
irregular	O
and	O
shallow	O
,	O
with	O
long	O
periods	O
of	O
apnea	O
.	O

To	O
determine	O
the	O
gestational	O
stage	O
at	O
which	O
growth	O
of	O
the	O
knockout	O
embryos	O
was	O
affected	O
,	O
embryos	O
were	O
harvested	O
at	O
various	O
stages	O
of	O
gestation	O
and	O
their	O
body	O
lengths	O
compared	O
between	O
Dhcr7	B-GGP
-	O
/	O
-	O
and	O
controls	O
.	O

A	O
linear	O
increase	O
in	O
body	O
length	O
from	O
E9	O
.	O
5	O
to	O
E19	O
.	O
5	O
in	O
control	O
embryos	O
was	O
observed	O
(	O
Fig	O
.	O
1	O
)	O
.	O

No	O
significant	O
differences	O
in	O
body	O
length	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
heterozygous	O
embryos	O
were	O
noted	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
contrast	O
,	O
knockout	O
embryos	O
showed	O
comparable	O
body	O
length	O
growth	O
until	O
E14	O
.	O
5	O
~	O
E16	O
.	O
5	O
,	O
then	O
began	O
to	O
show	O
a	O
slower	O
increase	O
in	O
length	O
,	O
such	O
that	O
by	O
E17	O
.	O
5	O
,	O
this	O
was	O
statistically	O
significant	O
(	O
18	O
.	O
87	O
+/-	O
1	O
.	O
29	O
mm	O
in	O
controls	O
,	O
n	O
=	O
15	O
compared	O
to	O
16	O
.	O
69	O
+/-	O
1	O
.	O
05	O
mm	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
,	O
n	O
=	O
7	O
,	O
p	O
<	O
0	O
.	O
05	O
,	O
Fig	O
.	O
1	O
)	O
.	O

Figure	O
1	O

Body	O
length	O
growth	O
curves	O
.	O

Body	O
length	O
growth	O
vs	O
.	O
gestational	O
days	O
is	O
as	O
shown	O
.	O

Control	O
embryos	O
(	O
filled	O
triangles	O
,	O
wild	B-SO
-	I-SO
type	I-SO
and	O
heterozygous	O
embryos	O
were	O
pooled	O
together	O
as	O
there	O
were	O
no	O
differences	O
between	O
these	O
two	O
groups	O
)	O
and	O
knockout	O
embryos	O
(	O
filled	O
circles	O
)	O
were	O
as	O
shown	O
.	O

The	O
growth	O
curve	O
showed	O
a	O
linear	O
increase	O
from	O
E9	O
.	O
5	O
to	O
E19	O
.	O
5	O
in	O
controls	O
,	O
but	O
deviated	O
at	O
~	O
E14	O
.	O
5	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

Body	O
lengths	O
at	O
E17	O
.	O
5	O
(	O
18	O
.	O
87	O
+/-	O
1	O
.	O
29	O
mm	O
in	O
controls	O
,	O
n	O
=	O
15	O
vs	O
.	O
16	O
.	O
69	O
+/-	O
1	O
.	O
05	O
mm	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
,	O
n	O
=	O
7	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
E18	O
.	O
5	O
(	O
21	O
.	O
35	O
+/-	O
1	O
.	O
05	O
mm	O
in	O
controls	O
,	O
n	O
=	O
15	O
vs	O
.	O
19	O
.	O
38	O
+/-	O
0	O
.	O
9	O
mm	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
,	O
n	O
=	O
5	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
E19	O
.	O
5	O
(	O
23	O
.	O
4	O
+/-	O
0	O
.	O
97	O
mm	O
in	O
controls	O
,	O
n	O
=	O
13	O
vs	O
.	O
20	O
.	O
3	O
+/-	O
0	O
.	O
44	O
mm	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
,	O
n	O
=	O
4	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
were	O
significantly	O
decreased	O
,	O
compared	O
to	O
those	O
in	O
controls	O
.	O

Results	O
are	O
expressed	O
as	O
mean	O
+/-	O
s	O
.	O
d	O
.	O

Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
at	O
late	O
stages	O
displayed	O
pulmonary	O
hypoplasia	O
with	O
delayed	O
saccular	O
development	O

Wet	O
lung	O
weights	O
,	O
as	O
well	O
as	O
lung	O
to	O
body	O
weight	O
ratios	O
were	O
significantly	O
lower	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
at	O
E18	O
.	O
5	O
compared	O
to	O
those	O
in	O
wild	B-SO
-	I-SO
type	I-SO
but	O
not	O
at	O
E13	O
.	O
5	O
(	O
Table	O
1	O
)	O
.	O

Both	O
body	O
and	O
lung	O
weights	O
were	O
reduced	O
,	O
but	O
lungs	O
seemed	O
to	O
be	O
more	O
affected	O
.	O

A	O
representative	O
figure	O
of	O
embryos	O
at	O
E10	O
.	O
5	O
and	O
of	O
the	O
pups	O
at	O
birth	O
was	O
shown	O
in	O
Fig	O
.	O

2A	O
and	O
2B	O
.	O

Table	O
1	O

Whole	O
body	O
and	O
lung	O
weights	O
of	O
mouse	B-Taxon
embryos	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
compared	O
to	O
Dhcr7	B-GGP
+	B-SO
/	O
+	B-SO
.	O

BW	O
,	O
body	O
weight	O
;	O
LW	O
,	O
lung	O
weight	O
.	O

Figure	O
2	O

Embryonic	O
size	O
,	O
lung	O
morphology	O
and	O
histology	O
at	O
various	O
stages	O
of	O
development	O
.	O

Panel	O
A	O
shows	O
the	O
size	O
and	O
general	O
morphology	O
of	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
Dhcr7	B-GGP
-	O
/	O
-	O
(	O
-	O
/	O
-	O
)	O
embryos	O
at	O
E10	O
.	O
5	O
,	O
without	O
significant	O
difference	O
.	O

At	O
P0	O
,	O
the	O
knockout	O
pups	O
were	O
significantly	O
smaller	O
and	O
appeared	O
hypoxic	O
(	O
panel	O
B	O
)	O
.	O

Panel	O
C	O
shows	O
dorsal	O
views	O
of	O
lungs	O
from	O
knockout	O
and	O
wild	B-SO
-	I-SO
type	I-SO
at	O
E13	O
.	O
5	O
and	O
panel	O
D	O
those	O
at	O
P0	O
.	O

Cross	O
-	O
sectional	O
examination	O
at	O
the	O
cardiopulmonary	O
level	O
at	O
E	O
20	O
.	O
5	O
(	O
prior	O
to	O
birth	O
)	O
showed	O
normal	O
lobar	O
septation	O
,	O
but	O
lungs	O
from	O
knockout	O
animals	B-Taxon
were	O
smaller	O
in	O
size	O
and	O
had	O
less	O
distal	O
sac	O
space	O
(	O
cf	O
.	O
panels	O
E	O
and	O
F	O
)	O
.	O

Original	O
magnification	O
:	O
Panels	O
A	O
and	O
C	O
,	O
2X	O
;	O
panels	O
B	O
and	O
D	O
,	O
0	O
.	O
7X	O
;	O
E	O
and	O
F	O
,	O
2X	O
.	O

Labels	O
:	O
r	O
,	O
right	O
;	O
l	O
,	O
left	O
;	O
b	O
,	O
bronchial	O
;	O
br	O
,	O
bronchiole	O
;	O
e	O
,	O
esophagus	O
;	O
pa	O
,	O
pulmonary	O
artery	O
;	O
ra	O
,	O
right	O
atrium	O
;	O
la	O
,	O
left	O
atrium	O
;	O
rv	O
,	O
right	O
ventricle	O
;	O
lv	O
,	O
left	O
ventricle	O
.	O

We	O
examined	O
the	O
lungs	O
for	O
any	O
gross	O
morphological	O
abnormalities	O
.	O

The	O
overall	O
organogenesis	O
of	O
lungs	O
was	O
preserved	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
pups	O
;	O
four	O
right	O
lung	O
lobes	O
and	O
a	O
single	O
left	O
lobe	O
flanking	O
the	O
heart	O
were	O
easily	O
seen	O
on	O
external	O
examination	O
at	O
birth	O
(	O
Fig	O
.	O
2D	O
)	O
.	O

Examination	O
for	O
lobation	O
at	O
E13	O
.	O
5	O
also	O
showed	O
comparable	O
gross	O
anatomy	O
(	O
Fig	O
.	O
2C	O
)	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
embryos	O
.	O

Histological	O
analyses	O
of	O
the	O
cardiopulmonary	O
structures	O
at	O
E20	O
.	O
5	O
,	O
taken	O
just	O
before	O
birth	O
to	O
avoid	O
artifacts	O
from	O
lack	O
of	O
lung	O
inflation	O
,	O
also	O
confirmed	O
normal	O
gross	O
anatomic	O
development	O
(	O
Fig	O
.	O
2E	O
and	O
2F	O
)	O
.	O

Additionally	O
,	O
no	O
cardiac	O
defects	O
were	O
identified	O
and	O
this	O
was	O
confirmed	O
by	O
more	O
detailed	O
histological	O
analyses	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
despite	O
the	O
obvious	O
hypoxia	O
frequently	O
observed	O
at	O
birth	O
of	O
the	O
knockout	O
pups	O
,	O
major	O
cardiac	O
structural	O
abnormalities	O
were	O
not	O
observed	O
to	O
account	O
for	O
this	O
phenotype	O
.	O

No	O
distinguishable	O
morphological	O
differences	O
were	O
discernable	O
between	O
Dhcr7	B-GGP
-	O
/	O
-	O
and	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
at	O
E10	O
.	O
5	O
,	O
E13	O
.	O
5	O
,	O
E14	O
.	O
5	O
and	O
E16	O
.	O
5	O
at	O
low	O
(	O
10X	O
)	O
or	O
high	O
(	O
40X	O
)	O
magnifications	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
a	O
-	O
h	O
,	O
data	O
for	O
E10	O
.	O
5	O
and	O
E13	O
.	O
5	O
not	O
shown	O
)	O
.	O

However	O
,	O
from	O
E17	O
.	O
5	O
onwards	O
,	O
lungs	O
from	O
knockout	O
embryos	O
appeared	O
to	O
have	O
less	O
saccular	O
space	O
and	O
relatively	O
more	O
mesenchyme	O
compared	O
to	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
I	O
-	O
x	O
)	O
.	O

Lungs	O
from	O
control	O
animals	B-Taxon
showed	O
normal	O
progression	O
with	O
formation	O
of	O
sac	O
-	O
like	O
structures	O
,	O
the	O
precursors	O
of	O
the	O
alveoli	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
i	O
,	O
m	O
,	O
q	O
and	O
u	O
)	O
.	O

In	O
lungs	O
from	O
knockout	O
embryos	O
,	O
expansion	O
of	O
epithelial	O
tubules	O
occurred	O
but	O
was	O
significantly	O
delayed	O
(	O
Fig	O
.	O
3	O
,	O
cf	O
.	O
panel	O
A	O
:	O
j	O
,	O
n	O
,	O
r	O
,	O
v	O
with	O
i	O
,	O
m	O
,	O
q	O
and	O
u	O
)	O
.	O

Morphometric	O
measurements	O
of	O
lung	O
sections	O
at	O
E17	O
.	O
5	O
,	O
E18	O
.	O
5	O
,	O
E20	O
.	O
5	O
and	O
in	O
lungs	O
from	O
neonates	O
showed	O
that	O
the	O
proportion	O
of	O
terminal	O
sac	O
space	O
area	O
was	O
significantly	O
decreased	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
,	O
compared	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
B	O
)	O
.	O

Interstitial	O
mesenchyme	O
appeared	O
thicker	O
and	O
the	O
lungs	O
had	O
less	O
septation	O
compared	O
to	O
control	O
lungs	O
.	O

This	O
'	O
thickening	O
'	O
of	O
the	O
alveoli	O
may	O
explain	O
the	O
hypoxia	O
frequently	O
seen	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
pups	O
at	O
birth	O
.	O

Figure	O
3	O

Histological	O
analyses	O
of	O
lungs	O
at	O
various	O
embryonic	O
stages	O
.	O

Panel	O
A	O
indicates	O
lung	O
sections	O
stained	O
with	O
H	O
and	O
E	O
,	O
and	O
taken	O
at	O
various	O
gestational	O
stages	O
as	O
indicated	O
.	O

The	O
first	O
two	O
columns	O
are	O
at	O
lower	O
magnification	O
(	O
10X	O
)	O
and	O
the	O
last	O
two	O
columns	O
at	O
higher	O
magnification	O
(	O
40X	O
)	O
.	O

The	O
first	O
and	O
third	O
columns	O
are	O
representative	O
sections	O
from	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
embryos	O
and	O
the	O
second	O
and	O
fourth	O
columns	O
from	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

No	O
differences	O
were	O
visible	O
at	O
E14	O
.	O
5	O
or	O
E16	O
.	O
5	O
(	O
panel	O
A	O
,	O
a	O
-	O
h	O
)	O
.	O

Significant	O
differences	O
were	O
visible	O
from	O
E17	O
.	O
5	O
onwards	O
(	O
panel	O
A	O
,	O
i	O
-	O
x	O
)	O
.	O

Distal	O
tubules	O
showed	O
dilation	O
and	O
mesenchyme	O
thinning	O
,	O
with	O
progression	O
of	O
septation	O
in	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
(	O
panel	O
A	O
,	O
i	O
,	O
m	O
and	O
q	O
)	O
,	O
whereas	O
the	O
knockout	O
lungs	O
showed	O
less	O
saccular	O
structures	O
and	O
more	O
mesenchyme	O
(	O
panel	O
A	O
,	O
j	O
,	O
n	O
and	O
r	O
)	O
.	O

At	O
higher	O
magnifications	O
of	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
(	O
panel	O
A	O
,	O
k	O
,	O
o	O
and	O
s	O
)	O
,	O
developing	O
pre	O
-	O
alveoli	O
and	O
thinning	O
mesenchyme	O
(	O
arrowheads	O
)	O
were	O
seen	O
but	O
sections	O
from	O
knockout	O
embryos	O
showed	O
a	O
delay	O
in	O
this	O
sequence	O
of	O
development	O
(	O
panel	O
A	O
,	O
l	O
,	O
p	O
and	O
t	O
)	O
.	O

At	O
birth	O
,	O
lungs	O
from	O
knockout	O
pups	O
showed	O
deficient	O
septation	O
and	O
thick	O
-	O
walled	O
mesenchyme	O
(	O
panel	O
A	O
,	O
x	O
,	O
arrowheads	O
)	O
.	O

Labels	O
:	O
de	O
,	O
distal	O
epithelium	O
;	O
m	O
,	O
mesenchyme	O
;	O
PA	O
,	O
pulmonary	O
artery	O
;	O
a	O
,	O
pre	O
-	O
alveoli	O
;	O
b	O
,	O
bronchi	O
.	O

Panel	O
B	O
shows	O
the	O
morphometric	O
analyses	O
of	O
lung	O
terminal	O
sac	O
spaces	O
in	O
lungs	O
at	O
various	O
gestational	O
stages	O
.	O

A	O
significant	O
reduction	O
in	O
the	O
terminal	O
sac	O
space	O
was	O
noted	O
from	O
E17	O
.	O
5	O
onwards	O
.	O

Results	O
are	O
expressed	O
as	O
mean	O
+/-	O
s	O
.	O
d	O
.	O

Attenuated	O
cell	B-CL
proliferation	O
in	O
late	O
gestational	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O

Does	O
the	O
loss	O
of	O
normal	O
cholesterol	B-CHEBI
biosynthesis	O
lead	O
to	O
abnormalities	O
of	O
cell	B-CL
proliferation	O
/	O
division	O
or	O
cell	B-CL
death	O
?	O

Cell	B-CL
proliferation	O
was	O
examined	O
by	O
immunostaining	O
for	O
PCNA	B-GGP
and	O
also	O
by	O
BrdU	O
incorporation	B-SO
.	O

Both	O
PCNA	B-GGP
and	O
BrdU	O
staining	O
of	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
lungs	O
at	O
early	O
gestational	O
stages	O
(	O
E13	O
.	O
5	O
and	O
E14	O
.	O
5	O
)	O
showed	O
comparable	O
patterns	O
(	O
Fig	O
.	O
4	O
,	O
panels	O
A	O
-	O
D	O
)	O
.	O

However	O
,	O
a	O
clear	O
reduction	O
of	O
PCNA	B-GGP
and	O
BrdU	O
labeling	O
was	O
visualized	O
in	O
distal	O
lungs	O
of	O
knockout	O
embryos	O
at	O
late	O
gestational	O
stages	O
(	O
E18	O
.	O
5	O
and	O
E20	O
.	O
5	O
,	O
Fig	O
.	O
4	O
,	O
panels	O
E	O
-	O
H	O
)	O
.	O

Attenuated	O
PCNA	B-GGP
labeling	O
was	O
also	O
noted	O
in	O
knockout	O
hearts	O
at	O
term	O
(	O
Fig	O
.	O
4	O
,	O
cf	O
.	O
panels	O
I	O
and	O
J	O
)	O
.	O

When	O
lungs	O
were	O
stained	O
for	O
pHH3	O
,	O
a	O
marker	O
of	O
active	O
cell	B-CL
division	O
,	O
a	O
clear	O
reduction	O
of	O
pHH3	O
expression	O
in	O
the	O
epithelium	O
of	O
knockout	O
lung	O
was	O
observed	O
at	O
E20	O
.	O
5	O
but	O
not	O
at	O
E14	O
.	O
5	O
(	O
Fig	O
.	O
4	O
,	O
panels	O
K	O
,	O
L	O
,	O
O	O
and	O
P	O
)	O
.	O

In	O
contrast	O
,	O
using	O
the	O
TUNEL	O
assay	O
,	O
no	O
apparent	O
differences	O
in	O
cell	B-CL
apoptosis	O
rates	O
were	O
observed	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
lungs	O
at	O
E18	O
.	O
5	O
(	O
Fig	O
.	O
4	O
,	O
cf	O
.	O
panels	O
M	O
and	O
N	O
)	O
.	O

Thus	O
,	O
at	O
the	O
late	O
gestational	O
stages	O
,	O
cell	B-CL
proliferation	O
/	O
division	O
was	O
impaired	O
in	O
knockout	O
embryos	O
with	O
no	O
increase	O
in	O
cell	B-CL
death	O
rates	O
.	O

Figure	O
4	O

Analyses	O
of	O
cell	B-CL
proliferation	O
,	O
cell	B-CL
division	O
and	O
cell	B-CL
death	O
.	O

Cell	B-CL
proliferation	O
(	O
PCNA	B-GGP
:	O
panels	O
A	O
,	O
B	O
,	O
E	O
and	O
F	O
;	O
BrdU	O
:	O
panels	O
C	O
,	O
D	O
,	O
G	O
and	O
H	O
)	O
,	O
cell	B-CL
division	O
(	O
pHH3	O
:	O
panels	O
K	O
,	O
L	O
,	O
O	O
and	O
P	O
)	O
and	O
cell	B-CL
death	O
(	O
TUNEL	O
:	O
panels	O
M	O
and	O
N	O
)	O
were	O
analyzed	O
by	O
immunostaining	O
on	O
lung	O
sections	O
at	O
early	O
and	O
late	O
gestational	O
stages	O
.	O

Both	O
PCNA	B-GGP
and	O
BrdU	O
labeled	O
cells	B-CL
in	I-CL
both	I-CL
epithelial	I-CL
and	I-CL
mesenchymal	I-CL
regions	I-CL
were	O
comparable	O
at	O
early	O
stages	O
(	O
E14	O
.	O
5	O
for	O
PCNA	B-GGP
and	O
E13	O
.	O
5	O
for	O
BrdU	O
)	O
between	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
lungs	O
.	O

Positively	O
stained	O
cells	B-CL
in	O
distal	O
lungs	O
at	O
late	O
stage	O
(	O
E20	O
.	O
5	O
for	O
PCNA	B-GGP
and	O
E18	O
.	O
5	O
for	O
BrdU	O
)	O
from	O
knockout	O
lungs	O
were	O
markedly	O
reduced	O
,	O
compared	O
with	O
wild	B-SO
-	I-SO
type	I-SO
.	O

PCNA	B-GGP
labeling	O
of	O
cardiac	O
muscle	O
was	O
also	O
attenuated	O
in	O
knockout	O
embryos	O
at	O
E20	O
.	O
5	O
(	O
cf	O
.	O
panels	O
I	O
and	O
J	O
)	O
.	O

No	O
apparent	O
differences	O
in	O
TUNEL	O
immunostaining	O
were	O
observed	O
in	O
lung	O
sections	O
at	O
E18	O
.	O
5	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
.	O

The	O
pHH3	O
immunostaining	O
was	O
comparable	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
lungs	O
at	O
E14	O
.	O
5	O
,	O
and	O
the	O
lungs	O
from	O
wild	B-SO
-	I-SO
type	I-SO
at	O
E20	O
.	O
5	O
showed	O
a	O
high	O
index	O
of	O
positive	O
cells	B-CL
,	O
whereas	O
lungs	O
from	O
knockout	O
showed	O
a	O
apparent	O
reduced	O
staining	O
pattern	O
.	O

Note	O
the	O
dividing	O
cells	B-CL
are	O
mainly	O
epithelial	O
.	O

Original	O
magnification	O
:	O
A	O
-	O
D	O
and	O
G	O
-	O
N	O
are	O
20X	O
;	O
E	O
,	O
F	O
,	O
O	O
and	O
P	O
are	O
40X	O
.	O

Sterol	B-CHEBI
content	O
of	O
developing	O
lungs	O
in	O
Dhcr7	B-GGP
deficient	O
mice	O

Markedly	O
elevated	O
7	O
-	O
DHC	O
/	O
8	O
-	O
DHC	O
levels	O
and	O
reduced	O
body	O
cholesterol	B-CHEBI
levels	O
have	O
been	O
reported	O
previously	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
P0	O
mice	B-Taxon
[	O
16	O
,	O
17	O
]	O
.	O

A	O
significant	O
amount	O
of	O
cholesterol	B-CHEBI
was	O
detectable	O
in	O
lungs	O
of	O
Dhcr7	B-GGP
-	O
/	O
-	O
mice	B-Taxon
,	O
comprising	O
~	O
60	O
%	O
and	O
~	O
30	O
%	O
of	O
total	O
tissue	O
sterols	B-CHEBI
at	O
E13	O
.	O
5	O
and	O
neonate	O
,	O
respectively	O
.	O

In	O
contrast	O
to	O
the	O
doubling	O
of	O
cholesterol	B-CHEBI
in	O
the	O
lungs	O
of	O
wild	B-SO
type	I-SO
embryos	O
(	O
1	O
.	O
82	O
mg	O
/	O
g	O
tissue	O
at	O
E13	O
.	O
5	O
to	O
3	O
.	O
55	O
mg	O
/	O
g	O
tissue	O
at	O
P0	O
)	O
,	O
cholesterol	B-CHEBI
content	O
in	O
the	O
lungs	O
of	O
Dhcr7	B-GGP
null	O
embryos	O
remained	O
at	O
almost	O
constant	O
low	O
levels	O
between	O
E13	O
.	O
5	O
and	O
P0	O
gestational	O
stages	O
(	O
Fig	O
.	O
5	O
)	O
.	O

There	O
was	O
a	O
progressive	O
increase	O
in	O
7	O
-	O
DHC	O
and	O
8	O
-	O
DHC	O
;	O
the	O
latter	O
is	O
generated	O
as	O
a	O
spontaneous	O
isomerization	O
from	O
the	O
former	O
.	O

Total	O
sterols	B-CHEBI
at	O
birth	O
were	O
reduced	O
in	O
lungs	O
of	O
the	O
Dhcr7	B-GGP
null	O
mice	B-Taxon
,	O
but	O
were	O
only	O
lower	O
by	O
~	O
30	O
%	O
(	O
Fig	O
.	O
5	O
,	O
see	O
values	O
for	O
P0	O
mice	B-Taxon
)	O
.	O

Figure	O
5	O

Sterol	B-CHEBI
analyses	O
of	O
embryonic	O
lungs	O
.	O

Sterol	B-CHEBI
contents	O
,	O
including	O
cholesterol	B-CHEBI
(	O
black	O
bars	O
)	O
and	O
7DHC	O
/	O
8DHC	O
(	O
white	O
bars	O
)	O
,	O
were	O
quantitated	O
by	O
GC	O
-	O
MS	O
in	O
the	O
lungs	O
from	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

Results	O
are	O
expressed	O
as	O
mean	O
+/-	O
s	O
.	O
d	O
and	O
the	O
number	O
of	O
lungs	O
analyzed	O
is	O
as	O
indicated	O
.	O

Total	O
sterols	B-CHEBI
were	O
lower	O
at	O
all	O
stages	O
in	O
knockout	O
lungs	O
,	O
with	O
almost	O
no	O
increase	O
in	O
cholesterol	B-CHEBI
content	O
with	O
time	O
(	O
black	O
bars	O
)	O
,	O
but	O
there	O
was	O
a	O
progressive	O
increment	O
in	O
the	O
precursor	O
sterols	B-CHEBI
,	O
7DHC	O
/	O
8DHC	O
(	O
open	O
bars	O
)	O
,	O
with	O
increasing	O
gestation	O
.	O

Cholesterol	B-CHEBI
is	O
absolutely	O
required	O
for	O
steroid	B-CHEBI
hormone	I-CHEBI
synthesis	O
by	O
the	O
adrenal	O
glands	O
.	O

Adrenal	O
insufficiency	O
,	O
as	O
has	O
been	O
reported	O
in	O
some	O
severe	O
cases	O
of	O
SLOS	O
patients	O
,	O
could	O
be	O
responsible	O
for	O
the	O
lung	O
hypoplasia	O
and	O
perinatal	O
lethality	O
[	O
30	O
]	O
.	O

Steroids	B-CHEBI
,	O
but	O
particularly	O
corticosteroids	B-CHEBI
,	O
are	O
necessary	O
for	O
lung	O
maturation	O
,	O
especially	O
the	O
synthesis	O
and	O
secretion	O
of	O
surfactant	B-CHEBI
components	O
[	O
31	O
]	O
.	O

We	O
determined	O
plasma	O
corticosterone	B-CHEBI
levels	O
in	O
P0	O
mice	B-Taxon
within	O
12	O
h	O
of	O
birth	O
.	O

Wild	B-SO
type	I-SO
P0	O
mice	B-Taxon
had	O
corticosterone	B-CHEBI
levels	O
of	O
158	O
+/-	O
50	O
ng	O
/	O
ml	O
(	O
n	O
=	O
11	O
)	O
,	O
compared	O
with	O
225	O
+/-	O
50	O
ng	O
/	O
ml	O
(	O
n	O
=	O
7	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
P0	O
mice	B-Taxon
.	O

Thus	O
,	O
the	O
corticosterone	B-CHEBI
levels	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
mice	B-Taxon
were	O
not	O
decreased	O
,	O
but	O
increased	O
by	O
~	O
40	O
%	O
.	O

However	O
,	O
since	O
these	O
P0	O
mice	B-Taxon
were	O
dying	O
,	O
perhaps	O
this	O
increase	O
was	O
sub	O
-	O
optimal	O
given	O
the	O
stress	O
.	O

Nevertheless	O
,	O
an	O
absolute	O
lack	O
of	O
corticosterone	B-CHEBI
was	O
not	O
present	O
in	O
these	O
knockout	O
pups	O
.	O

To	O
further	O
rule	O
out	O
any	O
effects	O
of	O
corticosterone	B-CHEBI
deficiency	O
on	O
lung	O
immaturity	O
,	O
we	O
examined	O
lungs	O
for	O
surfactant	B-CHEBI
protein	B-CHEBI
expression	O
.	O

Surfactant	B-GGP
protein	I-GGP
C	I-GGP
,	O
as	O
determined	O
by	O
IHC	O
,	O
was	O
comparable	O
in	O
lung	O
sections	O
from	O
wild	B-SO
-	I-SO
type	I-SO
or	O
Dhcr7	B-GGP
null	O
embryos	O
at	O
either	O
E18	O
.	O
5	O
or	O
at	O
E20	O
.	O
5	O
gestational	O
ages	O
(	O
Fig	O
.	O
6	O
,	O
panel	O
A	O
)	O
.	O

Northern	O
analyses	O
for	O
SP	B-GGP
-	I-GGP
A	I-GGP
,	O
SP	B-GGP
-	I-GGP
B	I-GGP
,	O
SP	B-GGP
-	I-GGP
C	I-GGP
or	O
SP	B-GGP
-	I-GGP
D	I-GGP
showed	O
no	O
significantly	O
differences	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
Dhcr7	B-GGP
null	O
mice	B-Taxon
at	O
term	O
(	O
Fig	O
.	O
6	O
,	O
panel	O
B	O
)	O
.	O

Thus	O
,	O
surfactant	B-CHEBI
protein	B-CHEBI
expression	O
was	O
not	O
altered	O
by	O
Dhcr7	B-GGP
deficiency	O
.	O

Figure	O
6	O

Surfactant	B-CHEBI
protein	B-CHEBI
expression	O
in	O
lungs	O
.	O

Panel	O
A	O
shows	O
the	O
immunostaining	O
patterns	O
for	O
SP	B-GGP
-	I-GGP
C	I-GGP
in	O
lungs	O
at	O
E18	O
.	O
5	O
and	O
E20	O
.	O
5	O
from	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

No	O
significant	O
differences	O
in	O
the	O
patterns	O
of	O
SP	B-GGP
-	I-GGP
C	I-GGP
staining	O
were	O
evident	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
lungs	O
(	O
panel	O
A	O
,	O
a	O
-	O
d	O
)	O
.	O

Note	O
that	O
the	O
underdeveloped	O
epithelial	O
tubules	O
in	O
knockout	O
lungs	O
also	O
expressed	O
SP	B-GGP
-	I-GGP
C	I-GGP
(	O
panel	O
A	O
,	O
b	O
and	O
d	O
,	O
arrowheads	O
)	O
,	O
indicating	O
normal	O
type	O
II	O
AECs	O
differentiation	O
.	O

Original	O
magnification	O
:	O
10X	O
.	O

Panel	O
B	O
,	O
left	O
-	O
hand	O
panel	O
,	O
shows	O
a	O
representative	O
result	O
from	O
Northern	O
analyses	O
of	O
total	O
RNA	B-SO
from	O
wild	B-SO
-	I-SO
type	I-SO
,	O
heterozygous	O
and	O
knockout	O
P0	O
lungs	O
for	O
SP	B-GGP
-	I-GGP
A	I-GGP
,	O
SP	B-GGP
-	I-GGP
B	I-GGP
,	O
SP	B-GGP
-	I-GGP
C	I-GGP
and	O
SP	B-GGP
-	I-GGP
D	I-GGP
expression	O
.	O

Densitometry	O
analyses	O
showed	O
the	O
relative	O
expression	O
(	O
n	O
=	O
3	O
,	O
mean	O
+/-	O
s	O
.	O
d	O
.	O
)	O
of	O
these	O
surfactant	B-CHEBI
protein	B-CHEBI
mRNAs	B-CHEBI
were	O
not	O
significantly	O
different	O
between	O
these	O
three	O
genotypes	B-SO
.	O

Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
showed	O
abnormal	O
differentiation	O
of	O
type	O
I	O
alveolar	O
epithelial	B-CL
cells	I-CL
(	O
AECs	O
)	O

At	O
E20	O
.	O
5	O
,	O
the	O
distal	O
lung	O
of	O
wild	B-SO
type	I-SO
embryos	O
consisted	O
of	O
saccular	O
structures	O
lined	O
by	O
flat	O
type	O
I	O
AECs	O
,	O
and	O
by	O
cuboidal	O
surfactant	B-CHEBI
-	O
producing	O
type	O
II	O
AECs	O
(	O
Fig	O
.	O
7A	O
)	O
.	O

In	O
contrast	O
,	O
the	O
formation	O
of	O
these	O
typical	O
saccules	O
was	O
impaired	O
in	O
Dhcr7	B-GGP
deficient	O
lungs	O
.	O

Instead	O
,	O
these	O
saccular	O
structures	O
were	O
lined	O
by	O
a	O
low	O
columnar	O
epithelium	O
that	O
lacked	O
flattened	O
type	O
I	O
-	O
like	O
cells	B-CL
with	O
the	O
presence	O
of	O
many	O
undeveloped	O
or	O
arrested	O
epithelial	O
tubules	O
(	O
Fig	O
.	O
7B	O
)	O
.	O

Consistent	O
with	O
disruption	O
of	O
type	O
I	O
AECs	O
differentiation	O
was	O
the	O
dramatic	O
reduction	O
of	O
expression	O
of	O
T1	B-GGP
alpha	I-GGP
,	O
an	O
apical	B-GO
membrane	I-GO
protein	B-CHEBI
marker	O
of	O
lung	O
type	O
I	O
AECs	O
(	O
Fig	O
.	O
7	O
,	O
cf	O
.	O
panels	O
C	O
and	O
D	O
)	O
.	O

Decreased	O
immunostaining	O
for	O
AQP5	B-GGP
,	O
another	O
type	O
I	O
AEC	O
marker	O
,	O
was	O
also	O
noted	O
in	O
Dhcr7	B-GGP
deficient	O
lungs	O
at	O
E20	O
.	O
5	O
,	O
compared	O
to	O
control	O
lungs	O
(	O
Fig	O
.	O
7	O
,	O
cf	O
.	O
panels	O
E	O
and	O
F	O
)	O
.	O

Megalin	B-GGP
,	O
a	O
low	B-GGP
density	I-GGP
lipoprotein	I-GGP
receptor	I-GGP
(	O
LDLR	B-GGP
)	O
gene	B-SO
family	O
member	O
,	O
is	O
expressed	O
by	O
embryonic	O
epithelial	B-CL
cells	I-CL
and	O
can	O
function	O
as	O
an	O
endocytic	O
Shh	B-GGP
receptor	O
[	O
32	O
]	O
.	O

Megalin	B-GGP
was	O
highly	O
expressed	O
on	O
the	O
distal	O
epithelium	O
at	O
E20	O
.	O
5	O
from	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
,	O
as	O
well	O
as	O
type	O
I	O
AECs	O
lining	O
the	O
developed	O
saccules	O
(	O
Fig	O
.	O
7G	O
)	O
.	O

In	O
contrast	O
,	O
though	O
megalin	B-GGP
staining	O
was	O
detected	O
in	O
developing	O
saccules	O
in	O
knockout	O
embryonic	O
lungs	O
,	O
its	O
expression	O
was	O
confined	O
to	O
undifferentiated	O
cuboidal	O
cells	B-CL
(	O
Fig	O
.	O
7H	O
)	O
,	O
further	O
indicating	O
a	O
delay	O
in	O
type	O
I	O
AECs	O
differentiation	O
in	O
the	O
knockout	O
lungs	O
.	O

Figure	O
7	O

Characterization	O
of	O
type	O
I	O
AECs	O
differentiation	O
.	O

The	O
normal	O
distal	O
saccules	O
of	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
at	O
near	O
term	O
(	O
E20	O
.	O
5	O
)	O
showed	O
typical	O
type	O
I	O
(	O
t1	O
)	O
and	O
type	O
II	O
(	O
t2	O
)	O
epithelial	B-CL
cells	I-CL
(	O
panel	O
A	O
,	O
arrowheads	O
)	O
,	O
but	O
knockout	O
(	O
-	O
/	O
-	O
)	O
littermate	O
lungs	O
showed	O
less	O
developed	O
saccules	O
lined	O
by	O
columnar	O
epithelial	B-CL
cells	I-CL
(	O
panel	O
B	O
,	O
black	O
arrowheads	O
)	O
,	O
with	O
partially	O
arrested	O
tubules	O
in	O
the	O
distal	O
lung	O
(	O
panel	O
B	O
,	O
green	O
arrowheads	O
)	O
.	O

Immunostaining	O
for	O
type	O
I	O
cell	B-CL
markers	O
T1	B-GGP
alpha	I-GGP
and	O
AQP5	B-GGP
demonstrated	O
an	O
intense	O
staining	O
in	O
flat	O
epithelial	B-CL
cells	I-CL
in	I-CL
wild	I-CL
-	I-CL
type	I-CL
lungs	I-CL
at	O
E20	O
.	O
5	O
(	O
panels	O
C	O
and	O
E	O
,	O
arrowheads	O
)	O
.	O

In	O
contrast	O
,	O
in	O
knockout	O
littermate	O
lungs	O
,	O
T1	B-GGP
alpha	I-GGP
and	O
AQP5	B-GGP
staining	O
was	O
dramatically	O
decreased	O
(	O
panels	O
D	O
and	O
F	O
,	O
arrowheads	O
)	O
.	O

Megalin	B-GGP
expression	O
(	O
Meg	B-GGP
)	O
was	O
detected	O
in	O
the	O
airway	O
epithelial	B-CL
cells	I-CL
,	O
but	O
not	O
in	O
proximal	O
bronchiole	O
epithelial	B-CL
cells	I-CL
(	I-CL
data	I-CL
not	I-CL
shown	I-CL
)	I-CL
in	I-CL
the	I-CL
lungs	I-CL
from	O
both	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
at	O
E20	O
.	O
5	O
.	O

The	O
elongated	O
megalin	B-GGP
-	O
positive	O
epithelial	B-CL
cells	I-CL
,	O
lining	O
the	O
normally	O
developed	O
sacculi	O
,	O
were	O
readily	O
evident	O
in	O
many	O
areas	O
of	O
the	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
.	O

In	O
contrast	O
,	O
the	O
terminal	O
epithelial	B-CL
cells	I-CL
positively	O
stained	O
by	O
megalin	B-GGP
antibodies	B-GO
in	O
knockout	O
lungs	O
were	O
comprised	O
mainly	O
of	O
undifferentiated	O
cuboidal	O
cells	B-CL
(	O
compare	O
the	O
arrowheads	O
in	O
G	O
and	O
H	O
)	O
.	O

Original	O
magnification	O
:	O
A	O
,	O
B	O
,	O
G	O
and	O
H	O
are	O
60X	O
,	O
C	O
-	O
F	O
are	O
40X	O
.	O

Delayed	O
vascular	O
development	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O

There	O
is	O
a	O
close	O
relationship	O
between	O
blood	O
vessel	O
development	O
and	O
lung	O
structural	O
development	O
.	O

At	O
later	O
lung	O
developmental	O
stages	O
,	O
timed	O
capillary	O
bed	O
development	O
is	O
essential	O
for	O
the	O
formation	O
of	O
mature	O
alveolar	O
gas	O
-	O
exchange	O
,	O
with	O
a	O
loss	O
of	O
mesenchyme	O
separating	O
the	O
capillary	O
beds	O
and	O
the	O
AECs	O
[	O
19	O
]	O
.	O

In	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
at	O
late	O
gestational	O
stages	O
,	O
the	O
relative	O
abundance	O
of	O
mesenchyme	O
was	O
consistent	O
with	O
the	O
general	O
arrest	O
in	O
sacculation	O
.	O

To	O
investigate	O
whether	O
the	O
delayed	O
lung	O
sacculation	O
also	O
involved	O
abnormal	O
blood	O
vessel	O
development	O
,	O
immunostaining	O
for	O
the	O
alpha	O
-	O
isoform	B-SO
of	O
caveolin	B-GGP
-	I-GGP
1	I-GGP
(	O
cav	O
-	O
1	O
alpha	O
)	O
and	O
platelet	B-GGP
endothelial	I-GGP
cell	I-GGP
adhesion	I-GGP
molecular	I-GGP
(	O
PECAM	B-GGP
-	I-GGP
1	I-GGP
)	O
were	O
performed	O
on	O
sections	O
from	O
wild	B-SO
-	I-SO
type	I-SO
and	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
.	O

In	O
the	O
developing	O
lung	O
,	O
cav	O
-	O
1	O
alpha	O
is	O
expressed	O
strictly	O
in	O
the	O
endothelium	O
of	O
developing	O
capillary	O
and	O
blood	O
vessels	O
.	O

Cav	O
-	O
1	O
alpha	O
is	O
present	O
in	O
the	O
terminally	O
differentiated	O
type	O
I	O
AECs	O
,	O
but	O
is	O
not	O
detectable	O
in	O
its	O
progenitors	O
or	O
type	O
II	O
AECs	O
[	O
33	O
]	O
.	O

At	O
E14	O
.	O
5	O
,	O
both	O
the	O
epithelium	O
and	O
mesenchyme	O
were	O
negative	O
for	O
cav	O
-	O
1	O
alpha	O
staining	O
,	O
and	O
cav	O
-	O
1	O
alpha	O
was	O
detected	O
in	O
the	O
developing	O
blood	O
vessels	O
and	O
capillaries	O
,	O
with	O
no	O
differences	O
observed	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
(	O
Fig	O
.	O
8	O
,	O
panels	O
A	O
and	O
B	O
)	O
.	O

Cav	O
-	O
1	O
alpha	O
immunostaining	O
demonstrated	O
that	O
the	O
vascular	O
development	O
proceeded	O
rapidly	O
during	O
saccular	O
stages	O
in	O
normal	O
lungs	O
(	O
E17	O
.	O
5	O
and	O
E20	O
.	O
5	O
)	O
.	O

In	O
near	O
-	O
term	O
normal	O
lungs	O
(	O
E20	O
.	O
5	O
)	O
,	O
an	O
extensive	O
vascular	O
network	O
,	O
associated	O
with	O
markedly	O
thinned	O
septation	O
walls	O
of	O
well	O
-	O
developed	O
alveoli	O
and	O
close	O
apposition	O
to	O
flat	O
type	O
I	O
AECs	O
,	O
was	O
observed	O
(	O
Fig	O
.	O
8	O
,	O
panels	O
C	O
and	O
E	O
)	O
.	O

In	O
contrast	O
,	O
the	O
cav	O
-	O
1	O
alpha	O
patterns	O
in	O
lungs	O
from	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
revealed	O
a	O
relatively	O
undeveloped	O
pulmonary	O
capillary	O
bed	O
(	O
Fig	O
.	O
8	O
,	O
panels	O
D	O
and	O
F	O
)	O
.	O

At	O
E20	O
.	O
5	O
,	O
cav	O
-	O
1	O
alpha	O
stained	O
cells	B-CL
in	O
knockout	O
lungs	O
were	O
embedded	O
in	O
a	O
relatively	O
thick	O
mesenchyme	O
surrounding	O
undeveloped	O
epithelial	O
tubules	O
,	O
and	O
these	O
epithelial	B-CL
cells	I-CL
remained	O
cuboidal	O
,	O
instead	O
of	O
flattening	O
out	O
(	O
Fig	O
.	O
8	O
,	O
panel	O
F	O
)	O
.	O

PECAM	B-GGP
-	I-GGP
1	I-GGP
staining	O
at	O
E20	O
.	O
5	O
confirmed	O
the	O
delayed	O
lung	O
vascular	O
development	O
at	O
these	O
late	O
gestational	O
stages	O
in	O
Dhcr7	B-GGP
deficient	O
embryos	O
(	O
Fig	O
.	O
8	O
,	O
cf	O
.	O
panels	O
G	O
and	O
H	O
)	O
.	O

Figure	O
8	O

Immunostaining	O
patterns	O
for	O
caveolin	O
-	O
1	O
alpha	O
and	O
PECAM	B-GGP
-	I-GGP
1	I-GGP
in	O
lung	O
sections	O
.	O

Cav	O
-	O
1	O
alpha	O
staining	O
was	O
compared	O
at	O
E14	O
.	O
5	O
,	O
E17	O
.	O
5	O
and	O
E20	O
.	O
5	O
stages	O
of	O
development	O
.	O

Both	O
the	O
epithelium	O
and	O
mesenchyme	O
were	O
negative	O
for	O
cav	O
-	O
1	O
alpha	O
at	O
E14	O
.	O
5	O
.	O

Developing	O
blood	O
vessels	O
(	O
red	O
arrowheads	O
)	O
and	O
capillaries	O
(	O
arrows	O
)	O
(	O
panels	O
A	O
and	O
B	O
)	O
were	O
stained	O
positively	O
for	O
cav	O
-	O
1	O
alpha	O
,	O
but	O
the	O
staining	O
patterns	O
between	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
lungs	O
were	O
not	O
altered	O
.	O

Cav	O
-	O
1	O
alpha	O
was	O
also	O
detected	O
at	O
the	O
proximal	O
bronchiole	O
sub	O
-	O
epithelial	O
matrices	O
(	O
panels	O
A	O
-	O
D	O
,	O
black	O
arrowheads	O
)	O
.	O

At	O
E17	O
.	O
5	O
,	O
the	O
airway	O
epithelium	O
,	O
negative	O
for	O
cav	O
-	O
1	O
alpha	O
staining	O
,	O
was	O
surrounded	O
by	O
rings	O
of	O
cav	O
-	O
1	O
alpha	O
positively	O
stained	O
capillary	O
networks	O
(	O
panels	O
C	O
and	O
D	O
,	O
arrows	O
)	O
.	O

Cav	O
-	O
1	O
alpha	O
expression	O
patterns	O
in	O
lungs	O
from	O
knockout	O
embryos	O
at	O
E17	O
.	O
5	O
were	O
similar	O
to	O
wild	B-SO
-	I-SO
type	I-SO
embryos	O
,	O
but	O
relative	O
less	O
capillary	O
bed	O
was	O
noted	O
in	O
knockout	O
lungs	O
(	O
cf	O
.	O
panels	O
C	O
and	O
D	O
)	O
.	O

At	O
E20	O
.	O
5	O
of	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
,	O
both	O
cav	O
-	O
1	O
alpha	O
and	O
PECAM	B-GGP
-	I-GGP
1	I-GGP
staining	O
demonstrated	O
an	O
extensive	O
vascular	O
network	O
in	O
the	O
well	O
developed	O
saccules	O
,	O
with	O
staining	O
observed	O
in	O
close	O
proximity	O
to	O
flat	O
epithelial	B-CL
cells	I-CL
lining	O
the	O
air	O
spaces	O
(	O
panels	O
E	O
and	O
G	O
,	O
arrows	O
)	O
.	O

However	O
,	O
delayed	O
vascular	O
development	O
was	O
observed	O
in	O
knockout	O
lungs	O
,	O
showing	O
capillaries	O
(	O
panels	O
F	O
and	O
H	O
,	O
arrows	O
)	O
of	O
the	O
knockout	O
lungs	O
at	O
E20	O
.	O
5	O
were	O
embedded	O
in	O
a	O
relatively	O
thick	O
mesenchyme	O
around	O
the	O
undeveloped	O
epithelial	O
tubules	O
in	O
which	O
the	O
epithelial	B-CL
cells	I-CL
were	O
remained	O
cuboidal	O
(	O
arrowheads	O
)	O
.	O

Original	O
magnification	O
:	O
A	O
-	O
D	O
are	O
20X	O
;	O
E	O
-	O
H	O
are	O
40X	O
.	O

Is	O
the	O
pattern	O
of	O
sonic	B-GGP
hedgehog	I-GGP
expression	O
or	O
signaling	O
altered	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
?	O

Shh	B-GGP
is	O
critical	O
for	O
normal	O
embryonic	O
development	O
and	O
its	O
autoprocessing	O
,	O
resulting	O
in	O
a	O
cholesterol	B-CHEBI
molecule	I-CHEBI
covalently	O
attached	O
at	O
its	O
C	B-SO
-	I-SO
terminus	I-SO
,	O
is	O
a	O
necessary	O
step	O
for	O
its	O
regulated	O
signaling	O
function	O
[	O
23	O
,	O
34	O
]	O
.	O

Thus	O
,	O
disruption	O
of	O
cholesterol	B-CHEBI
biosynthesis	O
could	O
conceivably	O
disrupt	O
its	O
pattern	O
of	O
distribution	O
and	O
thus	O
affect	O
normal	O
development	O
.	O

To	O
determine	O
whether	O
aberrant	O
expression	O
of	O
Shh	B-GGP
contributed	O
to	O
the	O
Dhcr7	B-GGP
-	O
/	O
-	O
lung	O
phenotype	O
,	O
distribution	O
of	O
Shh	B-GGP
in	O
the	O
Dhcr7	B-GGP
-	O
/	O
-	O
and	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
was	O
assessed	O
from	O
E10	O
.	O
5	O
to	O
P0	O
by	O
IHC	O
using	O
Shh	B-GGP
-	O
N	B-CHEBI
peptide	B-SO
antibody	B-GO
.	O

At	O
E10	O
.	O
5	O
,	O
the	O
distribution	O
of	O
Shh	B-GGP
was	O
detected	O
in	O
the	O
epithelial	B-CL
cells	I-CL
of	O
lung	O
buds	O
(	O
Fig	O
.	O
9	O
,	O
left	O
panel	O
:	O
C	O
and	O
D	O
)	O
,	O
as	O
well	O
as	O
in	O
the	O
more	O
typical	O
Shh	B-GGP
-	O
expressing	O
locations	O
,	O
such	O
as	O
the	O
floor	O
plate	O
,	O
notochord	O
and	O
mid	O
gut	O
(	O
Fig	O
.	O
9	O
,	O
left	O
panel	O
:	O
A	O
-	O
D	O
)	O
.	O

Importantly	O
,	O
no	O
differences	O
between	O
Dhcr7	B-GGP
-	O
/	O
-	O
and	O
control	O
embryos	O
were	O
noted	O
.	O

Likewise	O
,	O
examination	O
of	O
lung	O
sections	O
from	O
increasing	O
gestational	O
ages	O
through	O
to	O
birth	O
showed	O
no	O
significant	O
differences	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
Dhcr7	B-GGP
deficient	O
tissues	O
.	O

The	O
patterns	O
of	O
staining	O
observed	O
were	O
comparable	O
to	O
those	O
previously	O
reported	O
for	O
Shh	B-GGP
in	O
mouse	B-Taxon
lungs	O
[	O
25	O
]	O
.	O

Figure	O
9	O

Shh	B-GGP
and	O
Ptch	O
expression	O
patterns	O
at	O
different	O
gestational	O
stages	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
and	O
wild	B-SO
-	I-SO
type	I-SO
mice	B-Taxon
.	O

Left	O
panel	O
shows	O
the	O
Shh	B-GGP
immunostaining	O
patterns	O
using	O
an	O
antibody	B-GO
to	O
Shh	B-GGP
N	B-CHEBI
-	O
peptide	B-SO
at	O
various	O
gestational	O
stages	O
as	O
indicated	O
by	O
the	O
legend	O
on	O
the	O
y	O
-	O
axis	O
.	O

There	O
were	O
no	O
significant	O
differences	O
noted	O
at	O
any	O
of	O
the	O
stages	O
examined	O
between	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
.	O

At	O
E10	O
.	O
5	O
,	O
Shh	B-GGP
was	O
detected	O
in	O
the	O
floor	O
plate	O
(	O
fp	O
)	O
,	O
notochord	O
(	O
nc	O
)	O
(	O
A	O
and	O
B	O
)	O
,	O
mid	O
-	O
gut	O
(	O
mg	O
)	O
and	O
the	O
epithelial	O
buds	O
of	O
lungs	O
(	O
lb	O
)	O
(	O
C	O
and	O
D	O
)	O
.	O

Shh	B-GGP
staining	O
was	O
restricted	O
to	O
epithelial	B-CL
cells	I-CL
in	O
the	O
distal	O
region	O
of	O
the	O
primordial	O
tubes	O
of	O
lungs	O
at	O
E13	O
.	O
5	O
and	O
E15	O
.	O
5	O
.	O

Note	O
that	O
proximal	O
epithelial	B-CL
cells	I-CL
of	O
primordial	O
tubes	O
were	O
not	O
immunostained	O
for	O
Shh	B-GGP
(	O
E	O
and	O
F	O
,	O
arrows	O
)	O
.	O

Shh	B-GGP
was	O
detected	O
in	O
the	O
lung	B-CL
epithelial	I-CL
cells	I-CL
on	O
E18	O
.	O
5	O
,	O
and	O
mainly	O
in	O
the	O
conducting	O
airways	O
in	O
the	O
neonates	O
.	O

Original	O
magnifications	O
:	O
A	O
~	O
H	O
,	O
K	O
and	O
L	O
are	O
10X	O
,	O
I	O
and	O
J	O
are	O
20X	O
.	O

Right	O
panel	O
shows	O
the	O
patterns	O
of	O
Ptch	O
IHC	O
at	O
various	O
gestational	O
stages	O
.	O

Immunostaining	O
of	O
Ptch	O
from	O
E13	O
.	O
5	O
to	O
P	O
0	O
confirmed	O
concordance	O
with	O
Shh	B-GGP
expression	O
and	O
was	O
not	O
significantly	O
different	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
embryos	O
.	O

Note	O
that	O
the	O
proximal	O
epithelial	B-CL
cells	I-CL
of	O
primordial	O
tubes	O
were	O
also	O
not	O
immunostained	O
for	O
Ptch	O
at	O
E13	O
.	O
5	O
lungs	O
(	O
arrows	O
)	O
.	O

Original	O
magnifications	O
:	O
A	O
~	O
F	O
,	O
I	O
and	O
J	O
are	O
10X	O
.	O

G	O
and	O
H	O
are	O
20X	O
.	O

To	O
further	O
investigate	O
Shh	B-GGP
signaling	O
in	O
these	O
embryos	O
,	O
we	O
examined	O
the	O
patterns	O
of	O
expression	O
of	O
Patched	O
(	O
Ptch	O
)	O
,	O
a	O
cognate	O
receptor	O
for	O
Shh	B-GGP
and	O
one	O
whose	O
expression	O
is	O
also	O
regulated	O
by	O
Shh	B-GGP
signaling	O
.	O

The	O
patterns	O
of	O
Ptch	O
in	O
lung	O
sections	O
from	O
various	O
gestational	O
stages	O
were	O
also	O
indistinguishable	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
embryos	O
(	O
Fig	O
.	O
9	O
,	O
right	O
panels	O
)	O
.	O

The	O
expression	O
of	O
Ptch	O
was	O
in	O
concordance	O
with	O
that	O
of	O
Shh	B-GGP
(	O
Fig	O
9	O
,	O
left	O
and	O
right	O
panels	O
)	O
,	O
showing	O
lung	B-CL
epithelial	I-CL
cell	I-CL
expression	O
.	O

Downstream	O
of	O
the	O
Shh	B-GGP
-	O
Ptch	O
signaling	O
cascade	O
are	O
proteins	B-CHEBI
such	O
as	O
smoothened	B-GGP
(	O
Smo	B-GGP
)	O
,	O
and	O
Gli	O
proteins	B-CHEBI
,	O
key	O
regulators	O
of	O
target	O
-	O
gene	B-SO
expression	O
in	O
response	O
to	O
Shh	B-GGP
signaling	O
.	O

No	O
differences	O
in	O
expression	O
patterns	O
for	O
Smo	B-GGP
(	O
Fig	O
.	O
10	O
,	O
upper	O
panels	O
)	O
,	O
Gli1	B-GGP
(	O
Fig	O
.	O
10	O
,	O
middle	O
panels	O
)	O
or	O
Gli3	B-GGP
(	O
Fig	O
.	O
10	O
,	O
bottom	O
panels	O
)	O
were	O
noted	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
knockout	O
lungs	O
at	O
E13	O
.	O
5	O
,	O
E15	O
.	O
5	O
and	O
E17	O
.	O
5	O
gestational	O
days	O
.	O

Figure	O
10	O

Comparisons	O
of	O
Smo	B-GGP
,	O
Gli1	B-GGP
and	O
Gli3	B-GGP
expression	O
in	O
lung	O
sections	O
.	O

Smoothened	B-GGP
(	O
Smo	B-GGP
,	O
upper	O
panel	O
)	O
,	O
Gli1	B-GGP
(	O
middle	O
panel	O
)	O
and	O
Gli3	B-GGP
(	O
bottom	O
panel	O
)	O
showed	O
a	O
pattern	O
of	O
distribution	O
similar	O
to	O
that	O
seen	O
with	O
Shh	B-GGP
and	O
Ptch	O
(	O
compare	O
to	O
Fig	O
.	O
7	O
)	O
.	O

No	O
differences	O
between	O
wild	B-SO
-	I-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
knockout	O
(	O
-	O
/	O
-	O
)	O
embryos	O
were	O
evident	O
.	O

Original	O
magnifications	O
:	O
20X	O
.	O

Shh	B-GGP
protein	B-CHEBI
processing	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O

Since	O
Shh	B-GGP
expression	O
,	O
as	O
well	O
as	O
some	O
of	O
the	O
Shh	B-GGP
signaling	O
components	O
appeared	O
to	O
be	O
normal	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
,	O
endogenous	O
autoprocessing	O
of	O
Shh	B-GGP
to	O
generate	O
a	O
cholesterol	B-CHEBI
-	O
modified	O
N	B-SO
-	I-SO
terminal	I-SO
fragment	B-SO
of	O
Shh	B-GGP
(	O
Shh	B-GGP
-	O
Np	O
)	O
was	O
evaluated	O
.	O

COS	O
-	O
1	O
cells	B-CL
,	O
transfected	O
with	O
full	O
length	O
Shh	B-GGP
cDNA	B-SO
(	O
capable	O
of	O
endogenous	O
autocleavage	O
)	O
or	O
a	O
truncated	O
Shh	B-GGP
cDNA	B-SO
(	O
Shh	B-GGP
-	O
N	B-CHEBI
,	O
expression	O
of	O
the	O
shorter	O
form	B-SO
constitutively	O
)	O
were	O
used	O
as	O
controls	O
(	O
Fig	O
.	O
11	O
,	O
tracks	O
1	O
and	O
2	O
)	O
.	O

Transfection	O
of	O
the	O
full	O
-	O
length	O
cDNA	B-SO
for	O
Shh	B-GGP
led	O
to	O
the	O
detection	O
of	O
an	O
~	O
20	O
kD	O
protein	B-CHEBI
that	O
corresponds	O
with	O
the	O
cleaved	O
and	O
tailed	O
Shh	B-GGP
(	O
Fig	O
.	O
11	O
,	O
track	O
1	O
)	O
,	O
as	O
previously	O
described	O
[	O
35	O
]	O
.	O

Transfection	O
of	O
COS	O
cells	B-CL
with	O
the	O
constitutive	O
truncated	O
Shh	B-GGP
-	O
N	B-CHEBI
cDNA	B-SO
led	O
to	O
two	O
slower	O
migrating	O
bands	O
that	O
correspond	O
to	O
truncated	O
Shh	B-GGP
,	O
but	O
which	O
are	O
thought	O
to	O
be	O
generated	O
by	O
differences	O
in	O
lipid	B-CHEBI
modifications	O
,	O
as	O
previously	O
demonstrated	O
[	O
35	O
]	O
.	O

In	O
tissue	O
lysates	O
from	O
wild	B-SO
-	I-SO
type	I-SO
,	O
Dhcr7	B-GGP
+	B-SO
/	O
-	O
and	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
at	O
E11	O
.	O
5	O
,	O
a	O
band	O
running	O
at	O
the	O
same	O
position	O
as	O
Shh	B-GGP
-	O
Np	O
(	O
autocleaved	O
and	O
tailed	O
)	O
was	O
detected	O
in	O
all	O
of	O
the	O
lysates	O
.	O

There	O
were	O
no	O
distinguishable	O
differences	O
between	O
Dhcr7	B-GGP
-	O
/	O
-	O
and	O
the	O
wild	B-SO
-	I-SO
type	I-SO
samples	O
,	O
suggesting	O
that	O
Shh	B-GGP
autoprocessing	O
occurred	O
normally	O
,	O
despite	O
an	O
absolute	O
deficiency	O
of	O
cholesterol	B-CHEBI
in	O
knockout	O
embryos	O
.	O

More	O
importantly	O
,	O
no	O
band	O
corresponding	O
to	O
a	O
full	B-GGP
-	I-GGP
length	I-GGP
Shh	I-GGP
(	O
~	O
45	O
kD	O
)	O
was	O
present	O
in	O
the	O
lung	O
lysates	O
from	O
the	O
knockout	O
embryos	O
,	O
suggesting	O
that	O
processing	O
of	O
Shh	B-GGP
was	O
not	O
impaired	O
.	O

Figure	O
11	O

Shh	B-GGP
protein	B-CHEBI
autoprocessing	O
in	O
mouse	B-Taxon
embryos	O
.	O

Western	O
blotting	O
of	O
lysates	O
from	O
wild	B-SO
-	I-SO
type	I-SO
(	O
track	O
3	O
)	O
,	O
heterozygous	O
(	O
track	O
4	O
)	O
and	O
knockout	O
(	O
track	O
5	O
)	O
embryos	O
at	O
E11	O
.	O
5	O
,	O
or	O
COS1	O
cells	B-CL
transfected	O
with	O
Shh	B-GGP
(	O
track	O
1	O
)	O
or	O
Shh	B-GGP
-	O
N	B-CHEBI
(	O
track	O
2	O
)	O
were	O
probed	O
with	O
anti	O
-	O
Shh	B-GGP
-	O
N19	O
antibodies	B-GO
.	O

20	O
mu	O
g	O
of	O
lysate	O
proteins	B-CHEBI
from	O
Shh	B-GGP
transfected	O
COS1	O
cells	B-CL
and	O
75	O
mu	O
g	O
from	O
embryos	O
was	O
loaded	O
.	O

Both	O
unprocessed	O
(	O
Shh	B-GGP
,	O
upper	O
arrow	O
~	O
45	O
kDa	O
,	O
faint	O
signal	O
)	O
and	O
processed	O
(	O
Shh	B-GGP
-	O
Np	O
,	O
lowest	O
arrow	O
,	O
strong	O
signal	O
,	O
track	O
1	O
)	O
forms	B-SO
of	O
Shh	B-GGP
were	O
detected	O
from	O
Shh	B-GGP
transfected	O
COS1	O
cells	B-CL
.	O

The	O
two	O
slower	O
migrating	O
bands	O
in	O
Shh	B-GGP
-	O
N	B-CHEBI
transfected	O
COS1	O
cells	B-CL
(	O
track	O
2	O
)	O
represented	O
Shh	B-GGP
-	O
N	B-CHEBI
proteins	B-CHEBI
with	O
different	O
lipid	B-CHEBI
modifications	O
at	O
its	O
N	B-SO
terminus	I-SO
.	O

A	O
major	O
band	O
running	O
at	O
the	O
same	O
position	O
as	O
processed	O
Shh	B-GGP
was	O
detected	O
in	O
lysates	O
from	O
all	O
the	O
embryos	O
(	O
tracks	O
3	O
-	O
5	O
)	O
.	O

Importantly	O
,	O
no	O
significant	O
amounts	O
of	O
unprocessed	O
or	O
aberrantly	O
migrating	O
Shh	B-GGP
proteins	B-CHEBI
were	O
detected	O
in	O
lysates	O
from	O
knockout	O
embryos	O
at	O
this	O
stage	O
.	O

Discussion	O

The	O
elucidation	O
that	O
SLOS	O
is	O
caused	O
by	O
a	O
defect	O
in	O
an	O
enzyme	B-SO
necessary	O
for	O
cholesterol	B-CHEBI
biosynthesis	O
has	O
improved	O
our	O
understanding	O
of	O
embryonic	O
development	O
.	O

This	O
discovery	O
has	O
led	O
to	O
the	O
identification	O
of	O
other	O
disorders	O
of	O
embryonic	O
development	O
caused	O
by	O
mutations	B-SO
in	O
genes	B-SO
encoding	O
other	O
enzymes	B-SO
in	O
the	O
post	O
-	O
squalene	B-CHEBI
steps	O
of	O
cholesterol	B-CHEBI
biosynthesis	O
.	O

Although	O
these	O
genetic	B-SO
studies	O
now	O
implicate	O
the	O
need	O
for	O
normal	O
cholesterol	B-CHEBI
synthesis	O
,	O
the	O
mechanistic	O
role	O
(	O
s	O
)	O
of	O
cholesterol	B-CHEBI
in	O
normal	O
embryonic	O
development	O
remains	O
to	O
be	O
clarified	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
report	O
the	O
characterization	O
of	O
lung	O
development	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

Although	O
cardiac	O
abnormalities	O
are	O
common	O
in	O
human	B-Taxon
SLOS	O
[	O
36	O
]	O
,	O
no	O
structural	O
abnormalities	O
of	O
the	O
heart	O
or	O
the	O
great	O
vessels	O
were	O
observed	O
in	O
the	O
Dhcr7	B-GGP
-	O
/	O
-	O
pups	O
.	O

Lung	O
development	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
at	O
the	O
early	O
stages	O
,	O
from	O
lung	O
bud	O
formation	O
to	O
canalicular	O
stage	O
,	O
was	O
morphologically	O
similar	O
to	O
controls	O
.	O

Instead	O
,	O
a	O
distinct	O
lung	O
hypoplasia	O
at	O
the	O
saccular	O
stage	O
,	O
characterized	O
by	O
arrested	O
or	O
partially	O
developed	O
distal	O
epithelial	O
tubules	O
,	O
reduced	O
terminal	O
sac	O
space	O
,	O
delayed	O
type	O
I	O
AECs	O
differentiation	O
and	O
delayed	O
vascular	O
development	O
,	O
was	O
consistently	O
observed	O
at	O
late	O
gestational	O
stages	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

At	O
late	O
stages	O
of	O
normal	O
fetal	O
development	O
,	O
the	O
mammalian	B-Taxon
alveolar	O
epithelium	O
undergoes	O
an	O
abrupt	O
differentiation	O
as	O
a	O
part	O
of	O
the	O
preparation	O
of	O
the	O
lungs	O
for	O
the	O
postnatal	O
demands	O
of	O
gas	O
exchange	O
[	O
37	O
]	O
.	O

Both	O
type	O
II	O
AECs	O
,	O
producing	O
pulmonary	O
surfactants	B-CHEBI
,	O
and	O
type	O
I	O
AECs	O
,	O
lining	O
the	O
expanded	O
alveoli	O
,	O
are	O
important	O
for	O
alveolar	O
maturation	O
.	O

In	O
addition	O
,	O
the	O
vascular	O
development	O
of	O
alveoli	O
is	O
also	O
essential	O
for	O
normal	O
lung	O
morphogenesis	O
at	O
late	O
gestational	O
stages	O
[	O
19	O
]	O
.	O

We	O
show	O
here	O
that	O
the	O
differentiation	O
of	O
type	O
I	O
AECs	O
but	O
not	O
type	O
II	O
AECs	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
was	O
blocked	O
or	O
delayed	O
,	O
as	O
indicated	O
by	O
fewer	O
flattened	O
type	O
I	O
cells	B-CL
and	O
by	O
reduced	O
expression	O
of	O
markers	O
of	O
type	O
I	O
AECs	O
,	O
T1	B-GGP
alpha	I-GGP
and	O
AQP5	B-GGP
.	O

Delayed	O
vascular	O
development	O
was	O
also	O
involved	O
in	O
the	O
delayed	O
sacculation	O
of	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
.	O

Additionally	O
,	O
the	O
mesenchyme	O
separating	O
the	O
AECs	O
from	O
the	O
vascular	O
beds	O
remained	O
thickened	O
.	O

In	O
support	O
of	O
normal	O
differentiation	O
of	O
type	O
II	O
AECs	O
,	O
no	O
alteration	O
in	O
the	O
gene	B-SO
expression	O
patterns	O
for	O
surfactant	B-GGP
proteins	I-GGP
A	I-GGP
,	I-GGP
B	I-GGP
,	I-GGP
C	I-GGP
or	I-GGP
D	I-GGP
was	O
noted	O
,	O
nor	O
was	O
the	O
pattern	O
of	O
distribution	O
of	O
SP	B-GGP
-	I-GGP
C	I-GGP
altered	O
in	O
lungs	O
from	O
knockout	O
embryos	O
.	O

Thus	O
,	O
impaired	O
gas	O
exchange	O
,	O
as	O
opposed	O
to	O
poor	O
inflation	O
and	O
alveolar	O
tension	O
,	O
may	O
be	O
the	O
cause	O
of	O
respiratory	O
failure	O
in	O
these	O
pups	O
.	O

Loss	O
of	O
functional	O
Dhcr7	B-GGP
led	O
to	O
a	O
retardation	O
of	O
embryonic	O
growth	O
from	O
E14	O
.	O
5	O
~	O
E16	O
.	O
5	O
onwards	O
.	O

By	O
this	O
stage	O
,	O
cholesterol	B-CHEBI
levels	O
were	O
already	O
lower	O
and	O
its	O
immediate	O
precursor	O
,	O
7	O
-	O
DHC	O
,	O
elevated	O
in	O
the	O
lungs	O
(	O
this	O
study	O
)	O
as	O
well	O
as	O
in	O
the	O
whole	O
body	O
[	O
16	O
,	O
17	O
]	O
.	O

Intrauterine	O
growth	O
retardation	O
(	O
IUGR	O
)	O
followed	O
by	O
postnatal	O
failure	O
to	O
thrive	O
is	O
a	O
universally	O
observed	O
phenotype	O
in	O
SLOS	O
patients	O
[	O
2	O
,	O
18	O
]	O
.	O

We	O
showed	O
here	O
that	O
body	O
length	O
was	O
significantly	O
reduced	O
at	O
later	O
stages	O
of	O
gestation	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
animals	B-Taxon
,	O
compared	O
to	O
controls	O
.	O

Whole	O
body	O
weights	O
and	O
fresh	O
lung	O
weights	O
(	O
as	O
well	O
as	O
brain	O
,	O
heart	O
and	O
kidney	O
,	O
data	O
not	O
shown	O
)	O
at	O
late	O
gestational	O
stages	O
were	O
also	O
lower	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

Interestingly	O
,	O
the	O
lower	O
lung	O
/	O
body	O
ratios	O
at	O
E18	O
.	O
5	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
compared	O
to	O
wild	B-SO
-	I-SO
type	I-SO
suggested	O
a	O
disproportionate	O
inhibition	O
of	O
lung	O
growth	O
than	O
other	O
organs	O
.	O

Cell	B-CL
proliferation	O
and	O
division	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
lungs	O
were	O
markedly	O
arrested	O
without	O
apparent	O
increase	O
in	O
cell	B-CL
apoptosis	O
.	O

Therefore	O
,	O
it	O
appears	O
that	O
growth	O
retardation	O
caused	O
by	O
cholesterol	B-CHEBI
deficiency	O
was	O
primarily	O
because	O
of	O
an	O
inhibition	O
of	O
cell	B-CL
growth	O
and	O
proliferation	O
,	O
rather	O
than	O
an	O
increase	O
in	O
cell	B-CL
death	O
.	O

Cholesterol	B-CHEBI
is	O
present	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
,	O
as	O
it	O
is	O
in	O
Sc5d	B-GGP
-	O
/	O
-	O
(	O
lathosterolosis	O
)	O
and	O
Dhcr24	B-GGP
-	O
/	O
-	O
(	O
desmosterolosis	O
)	O
embryos	O
[	O
15	O
,	O
38	O
]	O
.	O

Total	O
sterols	B-CHEBI
and	O
cholesterol	B-CHEBI
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryonic	O
lungs	O
(	O
as	O
well	O
as	O
in	O
brain	O
and	O
liver	O
,	O
data	O
not	O
shown	O
)	O
were	O
reduced	O
and	O
7DHC	O
/	O
8DHC	O
elevated	O
,	O
but	O
a	O
significant	O
amount	O
of	O
cholesterol	B-CHEBI
was	O
detectable	O
,	O
comprising	O
~	O
60	O
%	O
and	O
~	O
30	O
%	O
of	O
total	O
tissue	O
sterols	B-CHEBI
at	O
E13	O
.	O
5	O
and	O
neonate	O
,	O
respectively	O
.	O

Fetal	O
cholesterol	B-CHEBI
can	O
either	O
be	O
synthesized	O
endogenously	O
in	O
fetal	O
tissues	O
or	O
accrued	O
from	O
extra	O
-	O
embryonic	O
tissues	O
such	O
as	O
maternal	O
serum	O
,	O
placenta	O
,	O
and	O
yolk	O
sac	O
[	O
39	O
]	O
.	O

Since	O
these	O
mice	B-Taxon
theoretically	O
can	O
not	O
synthesize	O
cholesterol	B-CHEBI
,	O
any	O
accumulation	O
of	O
cholesterol	B-CHEBI
must	O
be	O
derived	O
from	O
the	O
maternal	O
sources	O
.	O

Interestingly	O
,	O
Dhcr24	B-GGP
null	O
mice	B-Taxon
are	O
viable	O
but	O
contained	O
almost	O
no	O
cholesterol	B-CHEBI
in	O
plasma	O
and	O
tissues	O
at	O
3	O
-	O
months	O
,	O
whereas	O
cholesterol	B-CHEBI
content	O
in	O
Dhcr24	B-GGP
null	O
embryo	O
tissues	O
accounts	O
for	O
~	O
60	O
%	O
at	O
E11	O
.	O
5	O
and	O
~	O
30	O
%	O
at	O
E17	O
.	O
5	O
,	O
of	O
total	O
tissue	O
sterols	B-CHEBI
[	O
38	O
]	O
.	O

These	O
results	O
,	O
as	O
well	O
as	O
this	O
study	O
,	O
suggest	O
that	O
a	O
considerable	O
amount	O
of	O
maternal	O
cholesterol	B-CHEBI
can	O
be	O
transferred	O
to	O
the	O
murine	B-Taxon
fetus	O
.	O

One	O
explanation	O
of	O
why	O
the	O
Dhcr24	B-GGP
-	O
/	O
-	O
mice	B-Taxon
are	O
developmentally	O
normal	O
but	O
Dhcr7	B-GGP
-	O
/	O
-	O
mice	B-Taxon
are	O
affected	O
may	O
be	O
because	O
desmosterol	B-CHEBI
can	O
functionally	O
substitute	O
for	O
cholesterol	B-CHEBI
,	O
whereas	O
the	O
other	O
cholesterol	B-CHEBI
precursors	O
can	O
not	O
.	O

Although	O
a	O
mechanistic	O
understanding	O
of	O
why	O
a	O
deficiency	O
in	O
cholesterol	B-CHEBI
biosynthesis	O
leads	O
to	O
abnormal	O
embryonic	O
development	O
is	O
lacking	O
,	O
a	O
frequently	O
advanced	O
explanation	O
has	O
been	O
that	O
Shh	B-GGP
signaling	O
,	O
involved	O
in	O
early	O
developmental	O
patterning	O
,	O
may	O
be	O
disrupted	O
.	O

In	O
the	O
developing	O
lung	O
primordium	O
,	O
Shh	B-GGP
is	O
expressed	O
initially	O
at	O
E9	O
and	O
promotes	O
branching	O
morphogenesis	O
,	O
which	O
is	O
impaired	O
in	O
Shh	B-GGP
knockout	O
mice	B-Taxon
[	O
24	O
]	O
,	O
suggesting	O
that	O
Shh	B-GGP
,	O
secreted	O
by	O
the	O
epithelium	O
,	O
is	O
critical	O
for	O
branching	O
morphogenesis	O
.	O

In	O
this	O
study	O
,	O
the	O
lack	O
of	O
evidence	O
of	O
abnormal	O
lung	O
branching	O
morphogenesis	O
in	O
the	O
early	O
stages	O
,	O
but	O
a	O
consistent	O
delayed	O
maturation	O
of	O
the	O
gas	O
-	O
exchange	O
region	O
of	O
the	O
lung	O
in	O
the	O
saccular	O
period	O
of	O
development	O
of	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
was	O
observed	O
,	O
suggesting	O
early	O
Shh	B-GGP
signaling	O
was	O
normal	O
.	O

Shh	B-GGP
protein	B-CHEBI
expression	O
and	O
autoprocessing	O
at	O
E11	O
.	O
5	O
was	O
indistinguishable	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
.	O

Additionally	O
,	O
although	O
these	O
experiments	O
were	O
not	O
quantitative	O
,	O
the	O
abundance	O
of	O
Shh	B-GGP
appeared	O
unchanged	O
between	O
these	O
genotypes	B-SO
.	O

Thus	O
,	O
it	O
is	O
possible	O
that	O
the	O
cholesterol	B-CHEBI
levels	O
(	O
roughly	O
50	O
%	O
of	O
normal	O
levels	O
)	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
were	O
enough	O
for	O
completion	O
of	O
Shh	B-GGP
autoprocessing	O
or	O
7DHC	O
accumulated	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryonic	O
tissues	O
can	O
also	O
participate	O
efficiently	O
as	O
a	O
sterol	B-CHEBI
adduct	O
in	O
the	O
Shh	B-GGP
processing	O
reaction	O
[	O
20	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
also	O
examined	O
the	O
Shh	B-GGP
signaling	O
pathway	O
by	O
immunohistochemistry	O
of	O
known	O
key	O
components	O
of	O
this	O
pathway	O
,	O
such	O
as	O
patched	O
,	O
smoothened	B-GGP
and	O
Gli	O
proteins	B-CHEBI
.	O

Shh	B-GGP
signaling	O
leads	O
to	O
the	O
activation	O
of	O
transcription	O
and	O
increased	O
protein	B-CHEBI
levels	O
of	O
these	O
components	O
[	O
40	O
-	O
42	O
]	O
.	O

If	O
Shh	B-GGP
signaling	O
were	O
defective	O
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
,	O
these	O
could	O
have	O
resulted	O
in	O
abnormalities	O
of	O
the	O
staining	O
patterns	O
of	O
these	O
components	O
,	O
but	O
no	O
such	O
disturbance	O
was	O
detected	O
.	O

Indeed	O
,	O
the	O
patterns	O
of	O
protein	B-CHEBI
expression	O
seemed	O
comparable	O
and	O
indistinguishable	O
from	O
wild	B-SO
-	I-SO
type	I-SO
embryos	O
at	O
all	O
stages	O
of	O
lung	O
development	O
examined	O
.	O

In	O
a	O
recent	O
in	O
vitro	O
study	O
[	O
43	O
]	O
,	O
mouse	B-Taxon
embryonic	O
fibroblasts	B-CL
(	O
MEFs	O
)	O
from	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryos	O
,	O
grown	O
in	O
lipid	O
-	O
depleted	O
culture	O
and	O
transiently	O
treated	O
with	O
cyclodextrin	B-CHEBI
,	O
showed	O
no	O
affect	O
on	O
Shh	B-GGP
processing	O
.	O

However	O
,	O
a	O
deficiency	O
in	O
their	O
ability	O
to	O
respond	O
to	O
Shh	B-GGP
activation	O
,	O
as	O
judged	O
by	O
reporter	O
gene	B-SO
expression	O
,	O
was	O
demonstrable	O
.	O

In	O
contrast	O
,	O
when	O
CHO	O
cells	B-CL
,	O
that	O
stably	O
expressed	O
Shh	B-GGP
,	O
were	O
subjected	O
to	O
sterol	B-CHEBI
deprivation	O
,	O
an	O
arrest	O
of	O
Shh	B-GGP
autoprocessing	O
was	O
clearly	O
demonstrable	O
[	O
29	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
did	O
not	O
detect	O
unprocessed	O
Shh	B-GGP
in	O
Dhcr7	B-GGP
-	O
/	O
-	O
embryonic	O
tissues	O
at	O
E11	O
.	O
5	O
.	O

Subtle	O
differences	O
in	O
Shh	B-GGP
signal	O
transduction	O
can	O
not	O
be	O
excluded	O
by	O
the	O
present	O
study	O
.	O

However	O
,	O
we	O
favor	O
a	O
model	O
whereby	O
the	O
loss	O
of	O
normal	O
cholesterol	B-CHEBI
biosynthesis	O
is	O
important	O
,	O
not	O
so	O
much	O
for	O
Shh	B-GGP
autocleavage	O
,	O
as	O
for	O
the	O
loss	O
of	O
the	O
correct	O
plasma	B-GO
membrane	I-GO
milieu	O
.	O

Since	O
the	O
loss	O
of	O
cholesterol	B-CHEBI
content	O
in	O
the	O
plasma	B-GO
membrane	I-GO
(	O
and	O
perhaps	O
any	O
membrane	B-GO
)	O
is	O
likely	O
to	O
alter	O
the	O
function	O
of	O
receptors	O
more	O
sensitive	O
to	O
this	O
,	O
loss	O
of	O
normal	O
cholesterol	B-CHEBI
synthesis	O
may	O
cause	O
a	O
loss	O
of	O
signal	O
transduction	O
of	O
a	O
host	O
of	O
such	O
pathways	O
.	O

Thus	O
,	O
this	O
effect	O
may	O
not	O
be	O
limited	O
to	O
the	O
Shh	B-GGP
pathway	O
and	O
other	O
targets	O
may	O
be	O
more	O
important	O
.	O

This	O
hypothesis	O
is	O
amenable	O
to	O
testing	O
in	O
the	O
Dhcr7	B-GGP
null	O
mice	B-Taxon
.	O

Conclusion	O

Cholesterol	B-CHEBI
deficiency	O
caused	O
by	O
Dhcr7	B-GGP
deficiency	O
in	O
mice	B-Taxon
resulted	O
in	O
,	O
along	O
with	O
IUGR	O
,	O
a	O
distinct	O
lung	O
saccular	O
hypoplasia	O
with	O
impaired	O
differentiation	O
of	O
type	O
I	O
but	O
not	O
type	O
II	O
AECs	O
and	O
delayed	O
associated	O
vascular	O
development	O
.	O

Loss	O
of	O
the	O
correct	O
amounts	O
of	O
cholesterol	B-CHEBI
in	O
the	O
membranes	B-GO
may	O
perturb	O
those	O
receptors	O
that	O
depend	O
upon	O
cholesterol	B-CHEBI
for	O
efficient	O
signal	O
transduction	O
.	O

Further	O
investigation	O
of	O
which	O
transcriptional	O
and	O
signal	O
transduction	O
pathways	O
are	O
more	O
significantly	O
affected	O
by	O
the	O
loss	O
of	O
Dhcr7	B-GGP
will	O
be	O
critical	O
to	O
elucidate	O
the	O
mechanism	O
of	O
lung	O
hypoplasia	O
of	O
this	O
model	O
,	O
as	O
well	O
as	O
the	O
role	O
of	O
cholesterol	B-CHEBI
in	O
embryonic	O
development	O
.	O

Methods	O

Animals	B-Taxon

All	O
mice	B-Taxon
were	O
housed	O
in	O
an	O
animal	B-Taxon
facility	O
at	O
22	O
degrees	O
C	O
with	O
a	O
12	O
h	O
light	O
~	O
12	O
h	O
dark	O
cycle	O
and	O
all	O
protocols	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	B-Taxon
Welfare	O
Committee	O
.	O

Dhcr7	B-GGP
heterozygous	O
animals	B-Taxon
used	O
in	O
this	O
study	O
have	O
been	O
backcrossed	O
onto	O
a	O
C57BL	O
/	O
6J	O
background	O
for	O
11	O
successive	O
generations	O
.	O

The	O
presence	O
of	O
vaginal	O
plugs	O
was	O
considered	O
as	O
embryonic	O
day	O
(	O
E	O
)	O
0	O
.	O
5	O
.	O

Timed	O
pregnant	O
females	O
were	O
sacrificed	O
,	O
embryos	O
dissected	O
from	O
the	O
uteri	O
and	O
placed	O
in	O
1X	O
PBS	O
.	O

Crown	O
-	O
rump	O
lengths	O
of	O
the	O
embryos	O
were	O
measured	O
by	O
use	O
of	O
an	O
electronic	O
digital	O
caliper	O
and	O
embryos	O
weighed	O
,	O
after	O
blotting	O
off	O
excess	O
fluid	O
.	O

Each	O
lung	O
was	O
removed	O
intact	O
from	O
the	O
thoracic	O
cavity	O
,	O
blotted	O
free	O
of	O
excess	O
fluid	O
,	O
and	O
weighed	O
.	O

Mice	B-Taxon
were	O
classified	O
as	O
P0	O
when	O
birth	O
was	O
witnessed	O
and	O
their	O
breathing	O
activities	O
visualized	O
under	O
a	O
dissecting	O
microscope	O
.	O

Digital	O
images	O
of	O
embryos	O
or	O
lungs	O
were	O
captured	O
using	O
a	O
Zeiss	O
-	O
1000	O
dissecting	O
microscope	O
.	O

Genotyping	O
was	O
performed	O
by	O
PCR	O
,	O
as	O
described	O
previously	O
[	O
16	O
]	O
.	O

And	O
in	O
selective	O
cases	O
,	O
Southern	O
blotting	O
was	O
performed	O
for	O
confirmation	O
of	O
Dhcr7	B-GGP
genotype	B-SO
.	O

Biochemical	O
measurements	O

Tissue	O
sterol	B-CHEBI
compositions	O
were	O
analyzed	O
by	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
(	O
GC	O
-	O
MS	O
)	O
as	O
described	O
previously	O
[	O
2	O
,	O
44	O
]	O
.	O

Serum	O
corticosterone	B-CHEBI
levels	O
were	O
measured	O
by	O
radioimmunoassay	O
(	O
RIA	O
)	O
on	O
the	O
blood	O
obtained	O
from	O
decapitated	O
neonates	O
by	O
a	O
commercial	O
source	O
(	O
DRTC	O
hormone	B-CHEBI
Assay	O
Core	O
Lab	O
,	O
Vanderbilt	O
University	O
,	O
TN	O
)	O
.	O

Histology	O
and	O
Immunohistochemistry	O

Thoracic	O
parts	O
from	O
embryos	O
or	O
P0	O
mice	B-Taxon
were	O
fixed	O
in	O
either	O
Amsterdam	O
'	O
s	O
fixative	O
(	O
methanol	B-CHEBI
:	O
acetone	B-CHEBI
:	O
acetic	B-CHEBI
acid	I-CHEBI
:	O
water	B-CHEBI
,	O
35	O
:	O
35	O
:	O
5	O
:	O
25	O
v	O
/	O
v	O
)	O
or	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
.	O

Tissues	O
were	O
fixed	O
overnight	O
at	O
room	O
temperature	O
(	O
RT	O
)	O
,	O
rinsed	O
in	O
PBS	O
,	O
dehydrated	O
in	O
a	O
graded	O
ethanol	B-CHEBI
series	O
,	O
cleared	O
in	O
toluene	B-CHEBI
and	O
embedded	O
in	O
paraffin	O
.	O

Five	O
mu	O
m	O
sections	O
were	O
mounted	O
on	O
Superfrost	O
-	O
Plus	O
slides	O
(	O
VWR	O
,	O
West	O
Chester	O
,	O
PA	O
)	O
for	O
histological	O
or	O
immunohistochemistry	O
(	O
IHC	O
)	O
analyses	O
.	O

IHC	O
was	O
performed	O
using	O
an	O
indirect	O
method	O
.	O

After	O
deparaffination	O
in	O
xylene	B-CHEBI
and	O
rehydration	O
through	O
a	O
graded	O
series	O
of	O
ethanol	B-CHEBI
,	O
sections	O
were	O
heated	O
at	O
95	O
degrees	O
C	O
in	O
10	O
mM	O
sodium	B-CHEBI
citrate	B-CHEBI
(	O
pH	O
6	O
.	O
0	O
)	O
for	O
an	O
initial	O
15	O
min	O
and	O
for	O
three	O
successive	O
5	O
-	O
min	O
periods	O
[	O
25	O
]	O
.	O

After	O
cooling	O
,	O
the	O
sections	O
were	O
treated	O
with	O
hydrogen	B-CHEBI
peroxide	I-CHEBI
(	O
3	O
%	O
v	O
/	O
v	O
in	O
PBS	O
,	O
pH7	O
.	O
4	O
)	O
for	O
10	O
min	O
and	O
rinsed	O
in	O
the	O
PBS	O
.	O

Sections	O
were	O
blocked	O
with	O
5	O
%	O
normal	O
serum	O
for	O
2	O
h	O
,	O
washed	O
in	O
PBS	O
and	O
incubated	O
with	O
antibodies	B-GO
against	O
Shh	B-GGP
-	O
N19	O
(	O
1	O
:	O
100	O
)	O
,	O
Patched	O
(	O
1	O
:	O
100	O
)	O
,	O
Smo	B-GGP
-	O
N19	O
(	O
1	O
:	O
100	O
)	O
,	O
Gli1	B-GGP
(	O
1	O
:	O
100	O
)	O
,	O
Gli3	B-GGP
-	O
N19	O
(	O
1	O
:	O
100	O
)	O
,	O
SP	B-GGP
-	I-GGP
C	I-GGP
C19	O
(	O
1	O
:	O
200	O
)	O
,	O
caveolin	O
1	O
alpha	O
-	O
N20	O
(	O
1	O
:	O
200	O
)	O
,	O
aquaporin	B-GGP
5	I-GGP
(	O
AQP5	B-GGP
,	O
1	O
:	O
200	O
)	O
,	O
megalin	B-GGP
(	O
1	O
:	O
200	O
)	O
,	O
PECAM	B-GGP
-	I-GGP
1	I-GGP
(	O
1	O
:	O
200	O
)	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
CA	O
)	O
or	O
T1	B-GGP
alpha	I-GGP
(	O
mAB	O
8	O
.	O
1	O
.	O
1	O
,	O
1	O
:	O
1000	O
dilution	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
Iowa	O
City	O
,	O
IA	O
)	O
overnight	O
at	O
4	O
degrees	O
C	O
in	O
a	O
humidified	O
chamber	O
.	O

The	O
sections	O
were	O
washed	O
in	O
PBS	O
,	O
incubated	O
with	O
biotinylated	O
secondary	O
antibodies	B-GO
(	O
1	O
:	O
1000	O
~	O
1	O
:	O
5000	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
in	O
PBS	O
for	O
2	O
h	O
at	O
RT	O
,	O
incubated	O
with	O
HRP	O
-	O
streptavidin	O
complex	O
for	O
30	O
min	O
,	O
rinsed	O
in	O
PBS	O
and	O
visualized	O
using	O
a	O
Metal	B-CHEBI
Enhanced	O
Diaminobenzidine	O
(	O
DAB	O
)	O
Substrate	O
Kit	O
(	O
Pierce	O
,	O
Rockford	O
,	O
IL	O
)	O
.	O

Digital	O
images	O
were	O
collected	O
using	O
a	O
Polaroid	O
Digital	O
Microscope	O
Camera	O
mounted	O
on	O
an	O
Olympus	O
BX40	O
microscope	O
.	O

Lung	O
morphometry	O

Terminal	O
saccular	O
space	O
areas	O
were	O
measured	O
using	O
NIH	O
Image	O
software	O
(	O
NIH	O
,	O
Bethesda	O
,	O
MD	O
)	O
as	O
previously	O
described	O
[	O
45	O
]	O
.	O

Multiple	O
measurements	O
were	O
performed	O
on	O
randomly	O
selected	O
0	O
.	O
04	O
-	O
mm2	O
fields	O
located	O
in	O
the	O
distal	O
part	O
of	O
the	O
lung	O
sections	O
.	O

The	O
proportion	O
of	O
lung	O
comprising	O
terminal	O
saccular	O
spaces	O
was	O
calculated	O
as	O
a	O
percentage	O
of	O
the	O
total	O
examined	O
area	O
of	O
the	O
lung	O
section	O
.	O

Three	O
animals	B-Taxon
per	O
genotype	B-SO
were	O
examined	O
.	O

Assessment	O
of	O
cell	B-CL
proliferation	O
/	O
Division	O
/	O
death	O

Changes	O
in	O
cell	B-CL
proliferation	O
and	O
division	O
were	O
assessed	O
by	O
proliferating	B-GGP
cell	I-GGP
nuclear	I-GGP
antigen	I-GGP
(	O
PCNA	B-GGP
)	O
IHC	O
,	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
incorporation	B-SO
and	O
phosphorylated	O
histone	B-CHEBI
H3	O
(	O
pHH3	O
)	O
IHC	O
.	O

The	O
PCNA	B-GGP
(	O
1	O
:	O
2000	O
)	O
and	O
pHH3	O
-	O
Ser28	O
(	O
1	O
:	O
200	O
)	O
antibodies	B-GO
were	O
obtained	O
from	O
Santa	O
Cruz	O
Biotechnology	O
.	O

For	O
BrdU	O
incorporation	B-SO
,	O
timed	O
pregnant	O
mice	B-Taxon
at	O
E18	O
.	O
5	O
were	O
injected	O
intra	O
-	O
peritoneally	O
with	O
100	O
mu	O
g	O
/	O
gm	O
body	O
weight	O
of	O
BrdU	O
(	O
Sigma	O
,	O
St	O
Louis	O
,	O
MO	O
)	O
2	O
h	O
prior	O
to	O
sacrifice	O
,	O
embryos	O
dissected	O
from	O
uteri	O
and	O
processed	O
as	O
described	O
above	O
.	O

Sections	O
were	O
stained	O
with	O
a	O
monoclonal	O
anti	O
-	O
BrdU	O
antibody	B-GO
(	O
1	O
:	O
100	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
Iowa	O
City	O
,	O
IA	O
)	O
and	O
visualized	O
with	O
a	O
Cy2	O
-	O
conjugated	O
rabbit	B-Taxon
anti	O
-	O
mouse	B-Taxon
antibody	B-GO
using	O
a	O
laser	O
-	O
scanning	O
confocal	O
microscope	O
.	O

Cell	B-CL
death	O
was	O
investigated	O
by	O
terminal	B-GGP
deoxynucleotidyltransferase	I-GGP
-	O
mediated	O
dUTP	B-CHEBI
nick	O
-	O
end	O
labeling	O
(	O
TUNEL	O
)	O
using	O
the	O
Fluorescein	O
In	O
Situ	O
Cell	B-CL
Death	O
Detection	O
Kit	O
(	O
Roche	O
,	O
Indianapolis	O
,	O
IN	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Western	O
blotting	O

Sample	O
preparation	O
and	O
western	O
blotting	O
was	O
performed	O
according	O
to	O
Kawakami	O
et	O
al	O
with	O
some	O
minor	O
modifications	O
[	O
35	O
]	O
.	O

Briefly	O
,	O
3	O
embryos	O
from	O
each	O
genotype	B-SO
were	O
pooled	O
,	O
homogenized	O
in	O
ice	O
cold	O
lysis	O
buffer	O
(	O
50	O
mM	O
Tris	B-CHEBI
-	O
pH8	O
.	O
0	O
,	O
150	O
mM	O
NaCl	B-CHEBI
,	O
2	O
mM	O
EDTA	B-CHEBI
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
0	O
.	O
5	O
mM	O
DTT	B-CHEBI
,	O
1	O
mM	O
PMSF	B-CHEBI
and	O
2	O
mu	O
g	O
/	O
ml	O
each	O
of	O
aprotinin	O
,	O
leupeptin	O
and	O
pepstatin	O
A	O
)	O
with	O
a	O
tissue	O
homogenizer	O
(	O
PRO	O
Scientific	O
Inc	O
.	O
,	O
Oxford	O
,	O
CT	O
)	O
using	O
three	O
pulses	O
of	O
10	O
seconds	O
each	O
and	O
then	O
subjected	O
to	O
Dounce	O
homogenizer	O
by	O
10	O
strokes	O
.	O

The	O
homogenates	O
were	O
centrifuged	O
at	O
10	O
,	O
000	O
g	O
for	O
30	O
minutes	O
at	O
4	O
degrees	O
C	O
,	O
supernatants	O
collected	O
,	O
protein	B-CHEBI
concentration	O
determined	O
and	O
used	O
for	O
western	O
blotting	O
.	O

COS1	O
cells	B-CL
were	O
transfected	O
using	O
Superfect	O
transfection	O
reagent	B-CHEBI
(	O
Qiagen	O
,	O
Valencia	O
,	O
CA	O
)	O
with	O
expression	O
constructs	B-SO
encoding	O
either	O
the	O
full	B-GGP
-	I-GGP
length	I-GGP
Shh	I-GGP
or	O
the	O
N	B-SO
-	I-SO
terminal	I-SO
fragment	B-SO
of	O
Shh	B-GGP
without	O
post	O
-	O
translational	O
modifications	B-SO
(	O
constructs	B-SO
kindly	O
provided	O
by	O
Dr	O
.	O
Pao	O
-	O
Tien	O
Chuang	O
,	O
Cardiovascular	O
Research	O
Institute	O
,	O
University	O
of	O
California	O
,	O
San	O
Francisco	O
,	O
CA	O
)	O
,	O
harvested	O
3	O
days	O
after	O
transfection	O
and	O
protein	B-CHEBI
extracts	O
prepared	O
as	O
described	O
above	O
.	O

Protein	B-CHEBI
concentration	O
was	O
determined	O
using	O
Bio	O
-	O
Rad	O
protein	B-CHEBI
assay	O
kit	O
(	O
BioRad	O
,	O
Hercules	O
,	O
CA	O
)	O
and	O
20	O
mu	O
g	O
(	O
COS1	O
cells	B-CL
)	O
and	O
75	O
mu	O
g	O
(	O
embryos	O
)	O
of	O
lysates	O
separated	O
by	O
15	O
%	O
SDS	B-CHEBI
-	O
PAGE	O
,	O
transferred	O
onto	O
nitrocellulose	O
membrane	O
,	O
incubated	O
with	O
primary	O
antibody	B-GO
(	O
Shh	B-GGP
-	O
N19	O
,	O
1	O
:	O
100	O
)	O
for	O
2	O
hours	O
,	O
followed	O
by	O
donkey	B-Taxon
anti	O
-	O
goat	O
HRP	O
second	O
antibody	B-GO
(	O
1	O
:	O
1000	O
)	O
and	O
visualized	O
by	O
chemiluminescent	O
detection	O
according	O
to	O
manufacturer	O
'	O
s	O
protocols	O
(	O
Perkin	O
-	O
Elmer	O
Life	O
Sciences	O
,	O
Boston	O
MA	O
)	O
.	O

Northern	O
blotting	O

Northern	O
blotting	O
was	O
performed	O
as	O
previously	O
described	O
[	O
46	O
]	O
,	O
using	O
total	O
RNA	B-SO
(	O
20	O
mu	O
g	O
)	O
from	O
P0	O
mice	B-Taxon
lungs	O
.	O

The	O
cDNA	B-SO
probes	B-SO
for	O
SP	B-GGP
-	I-GGP
A	I-GGP
,	O
SP	B-GGP
-	I-GGP
B	I-GGP
and	O
SP	B-GGP
-	I-GGP
C	I-GGP
were	O
kindly	O
provided	O
by	O
Dr	O
.	O
Jeffery	O
Whitsett	O
(	O
Division	O
of	O
Pulmonary	O
Biology	O
,	O
Cincinnati	O
Children	O
'	O
s	O
Hospital	O
Medical	O
Center	O
,	O
Cincinnati	O
,	O
Ohio	O
)	O
.	O

A	O
cDNA	B-SO
probe	B-SO
for	O
SP	B-GGP
-	I-GGP
D	I-GGP
was	O
amplified	O
by	O
RT	O
-	O
PCR	O
,	O
using	O
murine	B-Taxon
SP	B-GGP
-	I-GGP
D	I-GGP
cDNA	B-SO
specific	O
primers	B-SO
(	O
sense	O
5	O
'	O
-	O
TGCCTGGTCGTGATGGACG	O
-	O
3	O
'	O
,	O
and	O
antisense	B-SO
5	O
'	O
-	O
AGCACTGTCTGGAAGCCCGC	O
-	O
3	O
'	O
)	O
and	O
confirmed	O
by	O
sequencing	O
.	O

Author	O
'	O
s	O
contributions	O

HY	O
designed	O
the	O
experiments	O
.	O

HY	O
,	O
ALP	O
and	O
JLC	O
performed	O
experiments	O
.	O

GST	O
analyzed	O
tissue	O
sterols	B-CHEBI
by	O
GC	O
-	O
MS	O
and	O
JO	O
performed	O
lung	O
morphometric	O
analyses	O
.	O

HY	O
,	O
AW	O
and	O
SBP	O
analyzed	O
the	O
data	O
.	O

HY	O
and	O
SBP	O
prepared	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
Jeffery	O
Whitsett	O
for	O
providing	O
cDNA	B-SO
probes	B-SO
for	O
SP	B-GGP
-	I-GGP
A	I-GGP
,	O
SP	B-GGP
-	I-GGP
B	I-GGP
and	O
SP	B-GGP
-	I-GGP
C	I-GGP
and	O
Pao	O
-	O
Tien	O
Chuang	O
for	O
the	O
Shh	B-GGP
and	O
Shh	B-GGP
-	O
N	B-CHEBI
plasmids	B-SO
.	O

This	O
research	O
was	O
supported	O
by	O
a	O
Beginning	O
Grant	O
-	O
in	O
-	O
Aid	O
0160349U	O
from	O
the	O
American	O
Heart	O
Association	O
,	O
Mid	O
-	O
Atlantic	O
Consortium	O
(	O
HY	O
)	O
;	O
NIH	O
PO1	O
HL52813	O
and	O
NIH	O
PO1	O
HD39946	O
(	O
AW	O
)	O
and	O
NIH	O
HL68660	O
(	O
SBP	O
)	O
.	O

Dopamine	B-GGP
D2	I-GGP
receptors	I-GGP
mediate	O
two	O
-	O
odor	O
discrimination	O
and	O
reversal	O
learning	O
in	O
C57BL	O
/	O
6	O
mice	B-Taxon

Abstract	O

Background	O

Dopamine	B-CHEBI
modulation	O
of	O
neuronal	B-CL
signaling	O
in	O
the	O
frontal	O
cortex	O
,	O
midbrain	O
,	O
and	O
striatum	O
is	O
essential	O
for	O
processing	O
and	O
integrating	O
diverse	O
external	O
sensory	O
stimuli	O
and	O
attaching	O
salience	O
to	O
environmental	O
cues	O
that	O
signal	O
causal	O
relationships	O
,	O
thereby	O
guiding	O
goal	O
-	O
directed	O
,	O
adaptable	O
behaviors	O
.	O

At	O
the	O
cellular	B-CL
level	O
,	O
dopamine	B-CHEBI
signaling	O
is	O
mediated	O
through	O
D1	B-GGP
-	I-GGP
like	I-GGP
or	I-GGP
D2	I-GGP
-	I-GGP
like	I-GGP
receptors	I-GGP
.	O

Although	O
a	O
role	O
for	O
D1	B-GGP
-	I-GGP
like	I-GGP
receptors	I-GGP
in	O
a	O
variety	O
of	O
goal	O
-	O
directed	O
behaviors	O
has	O
been	O
identified	O
,	O
an	O
explicit	O
involvement	O
of	O
D2	B-GGP
receptors	I-GGP
has	O
not	O
been	O
clearly	O
established	O
.	O

To	O
determine	O
whether	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
-	O
mediated	O
signaling	O
contributes	O
to	O
associative	O
and	O
reversal	O
learning	O
,	O
we	O
compared	O
C57Bl	O
/	O
6J	O
mice	B-Taxon
that	O
completely	O
lack	O
functional	O
dopamine	B-GGP
D2	I-GGP
receptors	I-GGP
to	O
wild	B-SO
-	I-SO
type	I-SO
mice	B-Taxon
with	O
respect	O
to	O
their	O
ability	O
to	O
attach	O
appropriate	O
salience	O
to	O
external	O
stimuli	O
(	O
stimulus	O
discrimination	O
)	O
and	O
disengage	O
from	O
inappropriate	O
behavioral	O
strategies	O
when	O
reinforcement	O
contingencies	O
change	O
(	O
e	O
.	O
g	O
.	O
reversal	O
learning	O
)	O
.	O

Results	O

Mildly	O
food	B-CHEBI
-	O
deprived	O
female	O
wild	B-SO
-	I-SO
type	I-SO
and	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
deficient	O
mice	B-Taxon
rapidly	O
learned	O
to	O
retrieve	O
and	O
consume	O
visible	O
food	B-CHEBI
reinforcers	O
from	O
a	O
small	O
plastic	O
dish	O
.	O

Furthermore	O
,	O
both	O
genotypes	B-SO
readily	O
learned	O
to	O
dig	O
through	O
the	O
same	O
dish	O
filled	O
with	O
sterile	O
sand	O
in	O
order	O
to	O
locate	O
a	O
buried	O
food	B-CHEBI
pellet	O
.	O

However	O
,	O
the	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
deficient	O
mice	B-Taxon
required	O
significantly	O
more	O
trials	O
than	O
wild	B-SO
-	I-SO
type	I-SO
mice	B-Taxon
to	O
discriminate	O
between	O
two	O
dishes	O
,	O
each	O
filled	O
with	O
a	O
different	O
scented	O
sand	O
,	O
and	O
to	O
associate	O
one	O
of	O
the	O
two	O
odors	O
with	O
the	O
presence	O
of	O
a	O
reinforcer	O
(	O
food	B-CHEBI
)	O
.	O

In	O
addition	O
,	O
the	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
deficient	O
mice	B-Taxon
repeatedly	O
fail	O
to	O
alter	O
their	O
response	O
patterns	O
during	O
reversal	O
trials	O
where	O
the	O
reinforcement	O
rules	O
were	O
inverted	O
.	O

Conclusions	O

Inbred	O
C57Bl	O
/	O
6J	O
mice	B-Taxon
that	O
develop	O
in	O
the	O
complete	O
absence	O
of	O
functional	O
dopamine	B-GGP
D2	I-GGP
receptors	I-GGP
are	O
capable	O
of	O
olfaction	O
but	O
display	O
an	O
impaired	O
ability	O
to	O
acquire	O
odor	O
-	O
driven	O
reinforcement	O
contingencies	O
.	O

Furthermore	O
,	O
the	O
ability	O
of	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
deficient	O
mice	B-Taxon
to	O
adjust	O
their	O
responding	O
to	O
a	O
previously	O
reinforced	O
stimulus	O
when	O
unexpected	O
outcomes	O
are	O
encountered	O
is	O
significantly	O
impaired	O
.	O

These	O
findings	O
suggest	O
that	O
signaling	O
mediated	O
by	O
the	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
is	O
important	O
for	O
regulating	O
associative	O
and	O
reversal	O
learning	O
and	O
may	O
have	O
implications	O
for	O
the	O
treatment	O
of	O
human	B-Taxon
attention	O
disorders	O
.	O

Background	O

Reinforcement	O
-	O
mediated	O
associative	O
learning	O
,	O
or	O
the	O
ability	O
to	O
ascribe	O
deterministic	O
relationships	O
between	O
environmental	O
stimuli	O
that	O
signal	O
the	O
probability	O
of	O
receiving	O
a	O
primary	O
reinforcer	O
(	O
e	O
.	O
g	O
.	O
food	B-CHEBI
)	O
,	O
has	O
been	O
divided	O
into	O
3	O
components	O
or	O
stages	O
[	O
1	O
]	O
.	O

The	O
first	O
,	O
unlearned	O
stage	O
is	O
the	O
organism	B-Taxon
'	O
s	O
experience	O
with	O
a	O
primary	O
reinforcer	O
that	O
elicits	O
some	O
unlearned	O
/	O
innate	O
physiological	O
response	O
(	O
e	O
.	O
g	O
.	O
palatability	O
of	O
a	O
food	B-CHEBI
or	O
satiety	O
)	O
.	O

The	O
second	O
phase	O
involves	O
the	O
attachment	O
of	O
salience	O
to	O
external	O
stimuli	O
(	O
discriminative	O
stimuli	O
)	O
that	O
signal	O
whether	O
the	O
delivery	O
of	O
a	O
primary	O
reinforcer	O
will	O
or	O
will	O
not	O
occur	O
based	O
on	O
some	O
emitted	O
behavior	O
(	O
e	O
.	O
g	O
.	O
a	O
rodent	B-Taxon
lever	O
presses	O
for	O
food	B-CHEBI
pellets	O
only	O
when	O
a	O
stimulus	O
light	O
is	O
illuminated	O
in	O
an	O
operant	O
chamber	O
)	O
.	O

Finally	O
,	O
there	O
is	O
the	O
maintenance	O
of	O
associative	O
learning	O
relationships	O
over	O
time	O
(	O
a	O
stimulus	O
light	O
always	O
signifies	O
a	O
food	B-CHEBI
pellet	O
is	O
available	O
subsequent	O
to	O
a	O
lever	O
press	O
)	O
[	O
see	O
refs	O
.	O
[	O
1	O
,	O
2	O
]	O
for	O
review	O
]	O
.	O

Berridge	O
and	O
Robinson	O
[	O
1	O
]	O
have	O
proposed	O
that	O
dopamine	B-CHEBI
plays	O
a	O
pivotal	O
role	O
in	O
the	O
second	O
phase	O
of	O
reinforcement	O
-	O
mediated	O
associative	O
learning	O
by	O
molding	O
the	O
"	O
incentive	O
salience	O
"	O
or	O
learned	O
motivational	O
properties	O
of	O
conditioned	O
stimuli	O
.	O

In	O
support	O
of	O
this	O
view	O
are	O
several	O
studies	O
demonstrating	O
that	O
the	O
disruption	O
of	O
dopamine	B-CHEBI
signaling	O
via	O
acute	O
blockade	O
of	O
dopamine	B-CHEBI
receptors	O
with	O
dopamine	B-CHEBI
receptor	I-CHEBI
antagonists	I-CHEBI
[	O
3	O
-	O
9	O
]	O
or	O
6	O
-	O
OHDA	O
lesions	O
[	O
1	O
,	O
10	O
,	O
11	O
]	O
do	O
not	O
disrupt	O
phase	O
1	O
,	O
the	O
palatability	O
or	O
primary	O
reinforcing	O
characteristics	O
of	O
a	O
natural	O
reinforcer	O
(	O
e	O
.	O
g	O
.	O
palatability	O
)	O
but	O
disrupt	O
phase	O
2	O
,	O
the	O
formation	O
of	O
incentive	O
salience	O
.	O

Dopamine	B-CHEBI
signaling	O
is	O
mediated	O
at	O
the	O
cellular	B-CL
level	O
by	O
two	O
major	O
subclasses	O
of	O
G	O
-	O
protein	O
coupled	O
receptors	O
that	O
are	O
referred	O
to	O
as	O
D	B-GGP
-	I-GGP
1	I-GGP
like	I-GGP
(	O
D1aR	B-GGP
,	O
D1b	B-GGP
/	O
5R	O
)	O
or	O
D	B-GGP
-	I-GGP
2	I-GGP
like	I-GGP
(	O
D2R	B-GGP
,	O
D3R	B-GGP
,	O
D4R	B-GGP
)	O
[	O
12	O
,	O
13	O
]	O
.	O

Although	O
individual	O
genes	B-SO
code	O
for	O
each	O
dopamine	B-CHEBI
receptor	O
subtype	O
,	O
there	O
is	O
considerable	O
pharmacological	O
overlap	O
between	O
D1	B-GGP
-	I-GGP
like	I-GGP
and	I-GGP
D2	I-GGP
-	I-GGP
like	I-GGP
receptors	I-GGP
.	O

Several	O
studies	O
have	O
used	O
pharmacological	O
manipulations	O
to	O
investigate	O
the	O
contribution	O
of	O
dopamine	B-CHEBI
receptor	O
subtypes	O
in	O
various	O
stages	O
of	O
associative	O
learning	O
[	O
1	O
,	O
2	O
,	O
14	O
]	O
.	O

Currently	O
it	O
is	O
held	O
that	O
excitatory	O
dopamine	B-GGP
D1Rs	I-GGP
mediate	O
the	O
acquisition	O
and	O
expression	O
of	O
several	O
conditioned	O
behaviors	O
involving	O
food	B-CHEBI
reinforcers	O
[	O
e	O
.	O
g	O
.	O
[	O
6	O
,	O
7	O
]	O
]	O
as	O
well	O
as	O
responding	O
for	O
conditioned	O
cues	O
predictive	O
of	O
cocaine	B-CHEBI
delivery	O
[	O
9	O
]	O
-	O
consistent	O
with	O
the	O
interpretation	O
that	O
D1R	B-GGP
mediated	O
signaling	O
might	O
modulate	O
the	O
maintenance	O
of	O
stimulus	O
-	O
response	O
outcomes	O
.	O

Despite	O
a	O
growing	O
literature	O
demonstrating	O
disrupted	O
associative	O
learning	O
following	O
acute	O
manipulations	O
of	O
dopamine	B-GGP
D1R	I-GGP
signaling	O
during	O
acquisition	O
of	O
associative	O
learning	O
tasks	O
with	O
food	B-CHEBI
[	O
e	O
.	O
g	O
.	O
[	O
6	O
,	O
7	O
]	O
]	O
,	O
the	O
actual	O
contribution	O
of	O
D2R	B-GGP
-	O
mediated	O
signaling	O
on	O
acquisition	O
and	O
maintenance	O
of	O
associative	O
learning	O
in	O
rodents	B-Taxon
is	O
unresolved	O
.	O

While	O
D2R	B-GGP
antagonists	B-CHEBI
have	O
been	O
used	O
in	O
the	O
context	O
of	O
rodent	B-Taxon
associative	O
learning	O
paradigms	O
,	O
their	O
lack	O
of	O
receptor	O
subtype	O
specificity	O
[	O
13	O
]	O
and	O
motor	O
-	O
disrupting	O
effects	O
[	O
6	O
,	O
8	O
]	O
have	O
prevented	O
a	O
rigorous	O
examination	O
of	O
the	O
actual	O
role	O
this	O
dopamine	B-CHEBI
receptor	O
subtype	O
plays	O
in	O
associative	O
and	O
reversal	O
learning	O
in	O
the	O
context	O
of	O
an	O
operant	O
behavior	O
.	O

Past	O
experiments	O
seeking	O
to	O
explore	O
the	O
possible	O
involvement	O
of	O
dopamine	B-GGP
D2Rs	I-GGP
in	O
associative	O
learning	O
have	O
utilized	O
low	O
to	O
moderate	O
doses	O
of	O
drugs	B-CHEBI
[	O
2	O
,	O
5	O
,	O
6	O
]	O
and	O
site	O
-	O
specific	O
administration	O
[	O
7	O
,	O
9	O
]	O
in	O
order	O
to	O
avoid	O
the	O
confounding	O
effect	O
that	O
locomotor	O
disruption	O
associated	O
with	O
acute	O
D2R	B-GGP
blockade	O
can	O
have	O
on	O
learning	O
performance	O
in	O
rodents	B-Taxon
.	O

Besides	O
their	O
lack	O
of	O
receptor	O
subtype	O
specificity	O
,	O
an	O
acute	O
exposure	O
to	O
commercially	O
available	O
D2	B-GGP
receptor	I-GGP
antagonists	B-CHEBI
fails	O
to	O
completely	O
block	O
signaling	O
mediated	O
solely	O
by	O
D2Rs	B-GGP
.	O

Moreover	O
,	O
acute	O
dosing	O
does	O
not	O
recapitulate	O
the	O
marked	O
learning	O
deficits	O
produced	O
in	O
rodents	B-Taxon
[	O
15	O
,	O
16	O
]	O
by	O
chronic	O
exposure	O
to	O
dopamine	B-CHEBI
D2R	I-CHEBI
antagonists	I-CHEBI
[	O
6	O
,	O
7	O
]	O
.	O

The	O
influence	O
of	O
dopamine	B-GGP
D2R	I-GGP
-	O
mediated	O
signaling	O
on	O
reversal	O
learning	O
is	O
also	O
poorly	O
understood	O
.	O

Reversal	O
learning	O
can	O
be	O
conceptualized	O
as	O
the	O
ability	O
to	O
recognize	O
an	O
unexpected	O
consequence	O
to	O
a	O
previously	O
established	O
associative	O
learning	O
rule	O
and	O
then	O
alter	O
response	O
strategies	O
accordingly	O
[	O
17	O
,	O
18	O
]	O
.	O

Reversal	O
learning	O
in	O
rodents	B-Taxon
can	O
serve	O
as	O
an	O
index	O
of	O
learning	O
adaptability	O
and	O
alertness	O
that	O
correlates	O
with	O
human	B-Taxon
attentional	O
-	O
shift	O
paradigms	O
[	O
17	O
,	O
18	O
]	O
.	O

Additionally	O
,	O
a	O
previous	O
report	O
demonstrated	O
that	O
excitotoxic	O
lesions	O
of	O
terminal	B-GO
field	O
targets	O
of	O
mesocortical	O
dopamine	B-CHEBI
have	O
been	O
shown	O
to	O
disrupt	O
reversal	O
learning	O
[	O
19	O
]	O
.	O

Administration	O
of	O
the	O
D2R	B-GGP
/	O
D3R	B-GGP
antagonist	B-CHEBI
,	O
sulpiride	O
,	O
impairs	O
spatial	O
reversal	O
leaning	O
in	O
mice	B-Taxon
[	O
20	O
]	O
and	O
has	O
also	O
been	O
shown	O
to	O
impair	O
attention	O
and	O
the	O
cognitive	O
performances	O
of	O
healthy	O
human	B-Taxon
volunteers	O
[	O
21	O
]	O
.	O

Moreover	O
an	O
inverse	O
relationship	O
between	O
lower	O
dopamine	B-GGP
D2R	I-GGP
levels	O
and	O
compulsive	O
behavior	O
in	O
human	B-Taxon
subjects	O
has	O
been	O
reported	O
[	O
22	O
]	O
.	O

Taken	O
together	O
these	O
findings	O
suggest	O
that	O
D2R	B-GGP
-	O
mediated	O
signaling	O
could	O
play	O
a	O
critical	O
role	O
in	O
reversal	O
learning	O
but	O
are	O
insufficient	O
to	O
prove	O
it	O
.	O

In	O
an	O
effort	O
to	O
establish	O
the	O
contribution	O
of	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
-	O
mediated	O
signaling	O
to	O
associative	O
and	O
non	O
-	O
spatial	O
reversal	O
learning	O
in	O
adult	O
mice	B-Taxon
,	O
we	O
compared	O
mice	B-Taxon
[	O
23	O
]	O
that	O
had	O
developed	O
in	O
the	O
complete	O
absence	O
of	O
all	O
functional	O
dopamine	B-GGP
D2	I-GGP
receptors	I-GGP
(	O
D2R	B-GGP
-	O
/	O
-	O
)	O
to	O
wild	B-SO
-	I-SO
type	I-SO
littermates	O
(	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
)	O
in	O
a	O
go	O
/	O
no	O
-	O
go	O
operant	O
learning	O
procedure	O
that	O
measures	O
primary	O
reinforcement	O
,	O
sensory	O
processing	O
,	O
and	O
reversal	O
learning	O
[	O
17	O
-	O
19	O
]	O
.	O

Here	O
we	O
report	O
that	O
dopamine	B-GGP
D2R	I-GGP
-	O
mediated	O
signaling	O
must	O
be	O
intact	O
if	O
a	O
mouse	B-Taxon
is	O
to	O
efficiently	O
learn	O
to	O
associate	O
a	O
food	B-CHEBI
reinforcer	O
with	O
a	O
specific	O
odor	O
and	O
then	O
adaptively	O
disengage	O
inappropriate	O
behavioral	O
strategies	O
following	O
the	O
reversal	O
of	O
reinforcement	O
contingencies	O
.	O

Results	O

Both	O
wild	B-SO
-	I-SO
type	I-SO
and	O
D2R	B-GGP
deficient	O
mice	B-Taxon
learn	O
operant	O
behaviors	O
equally	O
well	O

Mildly	O
food	B-CHEBI
-	O
deprived	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
and	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
readily	O
learned	O
to	O
locate	O
and	O
consume	O
food	B-CHEBI
pellets	O
during	O
both	O
training	O
sessions	O
.	O

Figure	O
1	O
depicts	O
the	O
latency	O
for	O
both	O
genotypes	B-SO
to	O
ambulate	O
to	O
a	O
dish	O
to	O
retrieve	O
an	O
unhidden	O
food	B-CHEBI
pellet	O
.	O

There	O
were	O
no	O
differences	O
between	O
genotypes	B-SO
to	O
retrieve	O
the	O
reinforcers	O
(	O
F1	O
,	O
59	O
=	O
0	O
.	O
2	O
,	O
p	O
>	O
0	O
.	O
65	O
)	O
,	O
and	O
both	O
groups	O
significantly	O
decreased	O
the	O
amount	O
of	O
time	O
necessary	O
to	O
perform	O
this	O
task	O
along	O
successive	O
trials	O
(	O
F4	O
,	O
59	O
=	O
5	O
.	O
74	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Figure	O
2	O
depicts	O
the	O
latency	O
to	O
dig	O
for	O
the	O
food	B-CHEBI
pellet	O
buried	O
in	O
a	O
single	O
dish	O
filled	O
with	O
unscented	O
sand	O
.	O

No	O
genotype	B-SO
differences	O
were	O
found	O
in	O
the	O
ability	O
to	O
dig	O
through	O
unscented	O
sand	O
for	O
a	O
hidden	O
food	B-CHEBI
pellet	O
(	O
F1	O
,	O
128	O
=	O
1	O
.	O
26	O
,	O
p	O
>	O
0	O
.	O
27	O
)	O
.	O

Wild	B-SO
-	I-SO
type	I-SO
mice	B-Taxon
outperform	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
in	O
an	O
odor	O
-	O
driven	O
,	O
stimulus	O
-	O
discrimination	O
,	O
operant	O
task	O

To	O
master	O
the	O
odor	O
-	O
driven	O
stimulus	O
discrimination	O
task	O
,	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
required	O
significantly	O
more	O
trials	O
(	O
Fig	O
.	O
3A	O
:	O
t	O
(	O
14	O
)	O
=	O
2	O
.	O
20	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
committed	O
more	O
errors	O
(	O
Fig	O
.	O
3B	O
:	O
t	O
(	O
14	O
)	O
=	O
2	O
.	O
92	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
than	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
to	O
learn	O
to	O
associate	O
a	O
specific	O
odor	O
with	O
the	O
presence	O
or	O
absence	O
of	O
the	O
food	B-CHEBI
reinforcer	O
.	O

However	O
,	O
both	O
genotypes	B-SO
did	O
learn	O
the	O
task	O
and	O
eventually	O
maintained	O
accurate	O
discrimination	O
for	O
a	O
minimum	O
of	O
8	O
correct	O
responses	O
out	O
of	O
10	O
trials	O
.	O

Mice	B-Taxon
lacking	O
dopamine	B-GGP
D2	I-GGP
receptors	I-GGP
engage	O
in	O
unreinforced	O
behavior	O
in	O
a	O
perseverative	O
manner	O
following	O
reversal	O
of	O
reinforcement	O
contingencies	O

D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
repeatedly	O
failed	O
to	O
inhibit	O
previously	O
established	O
learning	O
contingencies	O
during	O
reversal	O
trials	O
(	O
Fig	O
.	O
4A	O
:	O
t	O
(	O
14	O
)	O
=	O
3	O
.	O
54	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
committed	O
significantly	O
more	O
reversal	O
errors	O
than	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
Fig	O
.	O
4B	O
:	O
t	O
(	O
14	O
)	O
=	O
3	O
.	O
18	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Categorical	O
division	O
of	O
reversal	O
errors	O
(	O
Ferry	O
et	O
al	O
.	O
,	O
2000	O
)	O
-	O
digging	O
in	O
the	O
dish	O
that	O
did	O
not	O
contain	O
the	O
food	B-CHEBI
pellet	O
(	O
S	O
-	O
)	O
(	O
error	O
of	O
commission	O
;	O
Fig	O
.	O
5A	O
)	O
versus	O
failing	O
to	O
respond	O
within	O
3	O
-	O
min	O
of	O
presentation	O
(	O
error	O
of	O
omission	O
;	O
Fig	O
.	O
5B	O
)	O
revealed	O
that	O
both	O
genotypes	B-SO
chiefly	O
committed	O
errors	O
of	O
commission	O
versus	O
errors	O
of	O
omission	O
(	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
,	O
U	O
=	O
0	O
.	O
00	O
;	O
p	O
<	O
0	O
.	O
01	O
;	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
U	O
=	O
9	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
committed	O
more	O
commission	O
errors	O
than	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
U	O
=	O
5	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
there	O
were	O
no	O
differences	O
between	O
D2R	B-GGP
-	O
/	O
-	O
and	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
in	O
omission	O
errors	O
(	O
U	O
=	O
27	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
65	O
)	O
.	O

Moreover	O
,	O
the	O
number	O
of	O
commission	O
errors	O
committed	O
during	O
the	O
first	O
reversal	O
session	O
(	O
an	O
index	O
of	O
stimulus	O
bound	O
perseveration	O
,	O
where	O
all	O
animals	B-Taxon
are	O
responding	O
to	O
the	O
reversed	O
contingencies	O
for	O
the	O
first	O
time	O
;	O
Fig	O
.	O
6	O
)	O
indicated	O
a	O
deficit	O
in	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
compared	O
to	O
the	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
U	O
=	O
8	O
.	O
5	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Finally	O
,	O
in	O
an	O
attempt	O
to	O
assess	O
whether	O
perseveration	O
occurred	O
across	O
multiple	O
reversal	O
sessions	O
(	O
Fig	O
.	O
7	O
)	O
,	O
we	O
analyzed	O
the	O
number	O
of	O
commission	O
errors	O
emitted	O
before	O
relearning	O
the	O
reinforcement	O
contingencies	O
during	O
the	O
reversal	O
sessions	O
.	O

The	O
data	O
depicted	O
were	O
collected	O
from	O
subjects	O
that	O
had	O
not	O
achieved	O
the	O
80	O
%	O
performance	O
criterion	O
.	O

Therefore	O
,	O
the	O
number	O
of	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
represented	O
in	O
session	O
#	O
1	O
is	O
8	O
,	O
in	O
session	O
#	O
2	O
n	O
=	O
8	O
,	O
session	O
#	O
3	O
n	O
=	O
6	O
(	O
2	O
mice	B-Taxon
met	O
our	O
criterion	O
)	O
,	O
in	O
session	O
#	O
4	O
n	O
=	O
5	O
(	O
three	O
met	O
the	O
criterion	O
)	O
.	O

Following	O
session	O
5	O
,	O
the	O
remaining	O
5	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
had	O
met	O
criteria	O
.	O

For	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
,	O
each	O
point	O
on	O
the	O
graph	O
represents	O
8	O
subjects	O
.	O

None	O
of	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
achieved	O
the	O
criterion	O
of	O
80	O
%	O
accuracy	O
by	O
session	O
5	O
.	O

For	O
the	O
overall	O
2	O
-	O
way	O
ANOVA	O
,	O
there	O
was	O
a	O
significant	O
difference	O
between	O
genotypes	B-SO
for	O
the	O
number	O
of	O
perseverative	O
errors	O
(	O
F1	O
,	O
51	O
=	O
16	O
.	O
61	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
determine	O
the	O
contribution	O
of	O
dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
-	O
mediated	O
signaling	O
to	O
the	O
various	O
stages	O
of	O
associative	O
and	O
reversal	O
learning	O
.	O

D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
demonstrated	O
that	O
they	O
were	O
capable	O
of	O
learning	O
to	O
locate	O
and	O
consume	O
food	B-CHEBI
pellets	O
,	O
indicating	O
that	O
their	O
locomotor	O
behavior	O
was	O
not	O
detectably	O
disrupted	O
and	O
their	O
primary	O
motivation	O
to	O
obtain	O
a	O
natural	O
reinforcer	O
(	O
food	B-CHEBI
pellet	O
)	O
was	O
undisturbed	O
.	O

Rather	O
,	O
the	O
impaired	O
ability	O
of	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
to	O
assign	O
appropriate	O
discriminative	O
stimulus	O
relationships	O
in	O
an	O
operant	O
discrimination	O
task	O
argues	O
that	O
D2R	B-GGP
-	O
mediated	O
signaling	O
contributes	O
to	O
the	O
neuronal	B-CL
processes	O
involved	O
in	O
attaching	O
salience	O
to	O
environmental	O
stimuli	O
.	O

The	O
deficient	O
capacity	O
of	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
to	O
disengage	O
inappropriate	O
decision	O
strategies	O
strongly	O
argues	O
that	O
mesolimbic	O
dopamine	B-CHEBI
signaling	O
,	O
mediated	O
by	O
dopamine	B-GGP
D2Rs	I-GGP
is	O
essential	O
for	O
efficient	O
reversal	O
learning	O
to	O
occur	O
.	O

Mice	B-Taxon
with	O
or	O
without	O
intact	O
dopamine	B-GGP
D2R	I-GGP
-	O
mediated	O
signaling	O
displayed	O
similar	O
decreases	O
in	O
latencies	O
to	O
retrieve	O
unhidden	O
food	B-CHEBI
pellets	O
(	O
Fig	O
.	O
1	O
)	O
and	O
learned	O
to	O
dig	O
for	O
food	B-CHEBI
buried	O
in	O
unscented	O
sand	O
(	O
Fig	O
.	O
2	O
)	O
.	O

These	O
findings	O
are	O
in	O
complete	O
agreement	O
with	O
earlier	O
studies	O
that	O
utilized	O
rats	B-Taxon
and	O
fairly	O
selective	O
D2R	B-GGP
antagonists	B-CHEBI
[	O
3	O
-	O
8	O
]	O
,	O
as	O
well	O
as	O
even	O
very	O
extensive	O
6	O
-	O
OHDA	O
lesions	O
[	O
1	O
,	O
10	O
,	O
11	O
]	O
in	O
associative	O
and	O
operant	O
learning	O
paradigms	O
.	O

Our	O
results	O
add	O
to	O
a	O
growing	O
literature	O
demonstrating	O
a	O
negligible	O
role	O
of	O
dopamine	B-CHEBI
,	O
and	O
now	O
,	O
specifically	O
,	O
D2Rs	B-GGP
in	O
the	O
unconditioned	O
or	O
hedonic	O
value	O
of	O
natural	O
(	O
food	B-CHEBI
)	O
reinforcers	O
[	O
1	O
,	O
2	O
]	O
.	O

The	O
comparatively	O
poor	O
skill	O
of	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
during	O
discrimination	O
trials	O
suggests	O
a	O
role	O
for	O
D2Rs	B-GGP
in	O
acquisition	O
of	O
appropriate	O
S	O
+	O
/	O
S	O
-	O
relationships	O
in	O
operant	O
associative	O
learning	O
.	O

Several	O
studies	O
have	O
demonstrated	O
that	O
both	O
the	O
acquisition	O
[	O
6	O
,	O
7	O
]	O
and	O
expression	O
[	O
9	O
]	O
of	O
associative	O
learning	O
are	O
mediated	O
by	O
dopamine	B-GGP
D1Rs	I-GGP
.	O

Most	O
literature	O
reviews	O
identify	O
dopamine	B-GGP
D1Rs	I-GGP
with	O
dopamine	B-CHEBI
-	O
mediated	O
learning	O
and	O
D2Rs	B-GGP
with	O
motor	O
related	O
behaviors	O
[	O
e	O
.	O
g	O
.	O
[	O
24	O
]	O
]	O
.	O

Moreover	O
,	O
it	O
has	O
been	O
reported	O
that	O
acute	O
administration	O
of	O
the	O
dopamine	B-CHEBI
D2	I-CHEBI
/	I-CHEBI
3	I-CHEBI
antagonist	I-CHEBI
,	O
raclopride	O
,	O
actually	O
improves	O
acquisition	O
of	O
food	B-CHEBI
-	O
motivated	O
associative	O
learning	O
[	O
6	O
]	O
.	O

However	O
,	O
only	O
acute	O
administrations	O
of	O
antagonists	B-CHEBI
were	O
given	O
,	O
and	O
learning	O
was	O
not	O
measured	O
during	O
complete	O
D1R	B-GGP
or	O
D2R	B-GGP
blockade	O
[	O
6	O
]	O
.	O

Significantly	O
,	O
the	O
reports	O
cited	O
above	O
failed	O
to	O
address	O
the	O
technical	O
limitations	O
of	O
the	O
approach	O
:	O
i	O
.	O
e	O
.	O
that	O
the	O
antagonists	B-CHEBI
used	O
lack	O
adequate	O
subtype	O
specificity	O
and	O
only	O
partially	O
blocked	O
D2R	B-GGP
-	O
mediated	O
signaling	O
thus	O
making	O
it	O
impossible	O
to	O
rigorously	O
assess	O
the	O
role	O
of	O
D2R	B-GGP
-	O
mediated	O
signaling	O
in	O
associative	O
and	O
reversal	O
learning	O
.	O

Additionally	O
,	O
none	O
of	O
these	O
studies	O
addressed	O
the	O
observation	O
that	O
the	O
effects	O
of	O
D2R	B-GGP
antagonists	B-CHEBI
on	O
locomotion	O
and	O
learning	O
depend	O
on	O
whether	O
exposure	O
is	O
chronic	O
or	O
acute	O
[	O
e	O
.	O
g	O
.	O
[	O
15	O
,	O
16	O
]	O
]	O
.	O

That	O
D2R	B-GGP
-	O
mediated	O
signaling	O
orchestrates	O
just	O
motor	O
components	O
of	O
learning	O
is	O
a	O
conclusion	O
that	O
is	O
potentially	O
biased	O
due	O
to	O
the	O
practice	O
of	O
avoiding	O
doses	O
of	O
drugs	B-CHEBI
that	O
induce	O
catalepsy	O
(	O
and	O
therefore	O
measuring	O
only	O
partial	O
blockade	O
of	O
dopamine	B-GGP
D2Rs	I-GGP
)	O
and	O
single	O
administrations	O
[	O
e	O
.	O
g	O
.	O
[	O
3	O
]	O
]	O
.	O

Quite	O
possibly	O
,	O
the	O
functional	O
role	O
of	O
D2Rs	B-GGP
in	O
associative	O
learning	O
might	O
be	O
masked	O
because	O
of	O
this	O
concern	O
about	O
locomotor	O
disruption	O
[	O
2	O
,	O
6	O
,	O
8	O
]	O
.	O

Doses	O
of	O
raclopride	O
as	O
low	O
as	O
0	O
.	O
5	O
mg	O
/	O
kg	O
significantly	O
disrupt	O
motor	O
behavior	O
[	O
25	O
]	O
,	O
although	O
this	O
peripheral	O
dose	O
is	O
consistently	O
used	O
in	O
learning	O
paradigms	O
[	O
e	O
.	O
g	O
.	O
[	O
6	O
]	O
]	O
.	O

One	O
might	O
then	O
ask	O
:	O
"	O
How	O
then	O
could	O
the	O
role	O
of	O
D2Rs	B-GGP
in	O
associative	O
learning	O
be	O
dissociated	O
from	O
motor	O
behavior	O
?	O
"	O
Seminal	O
experiments	O
[	O
26	O
-	O
28	O
]	O
have	O
clearly	O
demonstrated	O
that	O
repeated	O
administration	O
of	O
catalepsy	O
-	O
inducing	O
doses	O
of	O
D2R	B-GGP
antagonists	B-CHEBI
in	O
rodents	B-Taxon
actually	O
leads	O
to	O
a	O
striking	O
behavioral	O
tolerance	O
to	O
catalepsy	O
.	O

These	O
doses	O
have	O
been	O
shown	O
to	O
occupy	O
well	O
over	O
80	O
%	O
of	O
available	O
D2Rs	B-GGP
[	O
29	O
]	O
.	O

Future	O
experiments	O
measuring	O
acquisition	O
of	O
associative	O
learning	O
in	O
rodents	B-Taxon
that	O
received	O
chronic	O
administration	O
of	O
D2R	B-GGP
antagonists	B-CHEBI
and	O
demonstrated	O
behavioral	O
tolerance	O
to	O
their	O
motor	O
disrupting	O
effects	O
would	O
be	O
a	O
logical	O
test	O
of	O
this	O
hypothesis	O
.	O

However	O
,	O
the	O
realization	O
that	O
multiple	O
dopamine	B-CHEBI
receptor	O
subtypes	O
would	O
be	O
concurrently	O
targeted	O
with	O
the	O
presently	O
commercially	O
available	O
antagonists	B-CHEBI
,	O
such	O
as	O
D2Rs	B-GGP
,	O
D3Rs	B-GGP
,	O
and	O
D4Rs	B-GGP
would	O
have	O
to	O
be	O
rectified	O
.	O

We	O
would	O
argue	O
that	O
the	O
most	O
parsimonious	O
approach	O
at	O
this	O
time	O
is	O
to	O
utilize	O
mice	B-Taxon
that	O
have	O
been	O
genetically	B-SO
altered	B-SO
such	O
that	O
they	O
are	O
lacking	O
one	O
or	O
both	O
functional	O
alleles	B-SO
of	O
the	O
specific	O
receptor	O
of	O
interest	O
.	O

While	O
they	O
do	O
have	O
their	O
limitations	O
(	O
e	O
.	O
g	O
.	O
developmental	O
compensation	O
and	O
strain	O
effects	O
in	O
mouse	B-Taxon
lines	O
not	O
backcrossed	O
adequately	O
to	O
a	O
parental	O
strain	O
for	O
a	O
minimum	O
of	O
10	O
generations	O
)	O
,	O
use	O
of	O
our	O
inbred	O
(	O
N20	O
generation	O
)	O
animals	B-Taxon
in	O
the	O
present	O
study	O
(	O
where	O
no	O
differences	O
in	O
locomotor	O
behavior	O
were	O
detected	O
between	O
D2R	B-GGP
-	O
/	O
-	O
and	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
;	O
Figs	O
.	O
1	O
&	O
2	O
)	O
revealed	O
a	O
previously	O
unappreciated	O
role	O
of	O
D2R	B-GGP
-	O
mediated	O
signaling	O
in	O
associative	O
learning	O
and	O
attention	O
that	O
could	O
not	O
be	O
measured	O
with	O
the	O
currently	O
available	O
,	O
acutely	O
administered	O
D2R	B-GGP
antagonists	B-CHEBI
.	O

A	O
cursory	O
analysis	O
of	O
our	O
data	O
might	O
suggest	O
to	O
some	O
that	O
the	O
genetic	B-SO
manipulation	O
of	O
the	O
drd2	B-GGP
locus	B-SO
conferred	O
a	O
gross	O
olfactory	O
impairment	O
to	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
.	O

Rather	O
,	O
we	O
argue	O
that	O
this	O
is	O
not	O
likely	O
because	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
did	O
learn	O
to	O
retrieve	O
the	O
food	B-CHEBI
pellets	O
from	O
the	O
dishes	O
and	O
eventually	O
learned	O
to	O
accurately	O
discriminate	O
odors	O
.	O

Recent	O
electrophysiological	O
data	O
demonstrate	O
that	O
dopamine	B-GGP
D2R	I-GGP
'	I-GGP
s	I-GGP
are	O
located	O
on	O
glutamatergic	B-CHEBI
terminal	O
axons	B-GO
of	O
olfactory	O
nerves	O
and	O
depress	O
excitatory	O
input	O
of	O
the	O
olfactory	O
nerve	O
to	O
the	O
mitral	O
cells	B-CL
of	O
the	O
olfactory	O
bulb	O
[	O
30	O
,	O
31	O
]	O
.	O

Consequently	O
,	O
our	O
data	O
,	O
and	O
data	O
from	O
other	O
studies	O
,	O
suggest	O
that	O
the	O
complete	O
lack	O
of	O
D2Rs	B-GGP
in	O
the	O
olfactory	O
bulb	O
does	O
not	O
prevent	O
transduction	O
of	O
olfactory	O
stimuli	O
;	O
rather	O
it	O
affects	O
the	O
ability	O
to	O
habituate	O
,	O
or	O
tune	O
,	O
olfactory	O
nerve	O
activity	O
associated	O
with	O
repeatedly	O
encountered	O
concentrations	O
of	O
chemical	B-CHEBI
stimuli	O
[	O
32	O
]	O
.	O

The	O
performance	O
of	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
during	O
reversal	O
learning	O
is	O
deficient	O
revealing	O
a	O
role	O
for	O
dopamine	B-GGP
D2R	I-GGP
-	O
mediated	O
signaling	O
in	O
tasks	O
requiring	O
behavioral	O
flexibility	O

Perseverative	O
behavioral	O
patterns	O
characterized	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
relative	O
to	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
during	O
reversal	O
learning	O
sessions	O
(	O
Figure	O
4	O
)	O
,	O
manifested	O
during	O
early	O
reversal	O
trials	O
(	O
Figure	O
6	O
)	O
and	O
persisted	O
across	O
several	O
sessions	O
(	O
Figure	O
7	O
)	O
.	O

These	O
findings	O
are	O
significant	O
because	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
respond	O
to	O
food	B-CHEBI
reinforcers	O
and	O
ultimately	O
form	O
and	O
maintain	O
odor	O
-	O
driven	O
S	O
+	O
/	O
S	O
-	O
relationships	O
(	O
a	O
putative	O
D1R	B-GGP
-	O
mediated	O
behavior	O
[	O
6	O
]	O
)	O
just	O
as	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
both	O
groups	O
achieved	O
>=	O
80	O
%	O
discrimination	O
accuracy	O
,	O
the	O
dopamine	B-GGP
D1Rs	I-GGP
in	O
our	O
mice	B-Taxon
were	O
not	O
targeted	O
)	O
.	O

A	O
future	O
extension	O
of	O
this	O
study	O
would	O
be	O
to	O
test	O
performance	O
over	O
a	O
fixed	O
number	O
of	O
trials	O
and	O
determine	O
patterns	O
of	O
error	O
rates	O
during	O
acquisition	O
of	O
the	O
discrimination	O
and	O
reversal	O
learning	O
tasks	O
.	O

This	O
manipulation	O
would	O
control	O
the	O
number	O
of	O
errors	O
based	O
on	O
trials	O
performed	O
to	O
determine	O
if	O
the	O
apparent	O
difference	O
in	O
absolute	O
number	O
of	O
errors	O
demonstrated	O
by	O
the	O
mutant	B-SO
mice	B-Taxon
(	O
the	O
putative	O
performance	O
deficit	O
)	O
is	O
simply	O
a	O
reflection	O
of	O
extra	O
trials	O
.	O

Nonetheless	O
,	O
the	O
inability	O
of	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
to	O
disengage	O
from	O
previously	O
established	O
S	O
+	O
/	O
S	O
-	O
contingencies	O
(	O
responding	O
to	O
a	O
discriminative	O
stimulus	O
;	O
Fig	O
.	O
4	O
)	O
strongly	O
argues	O
that	O
mesolimbic	O
dopamine	B-CHEBI
,	O
and	O
in	O
particular	O
dopamine	B-GGP
D2R	I-GGP
-	O
mediated	O
signaling	O
,	O
modulates	O
the	O
process	O
of	O
alerting	O
the	O
subject	O
that	O
familiar	O
contingencies	O
are	O
now	O
associated	O
unexpected	O
consequences	O
.	O

Schultz	O
and	O
colleagues	O
have	O
demonstrated	O
that	O
dopamine	B-CL
cells	I-CL
display	O
consistent	O
tonic	O
firing	O
patterns	O
during	O
maintenance	O
of	O
associative	O
learning	O
tasks	O
[	O
33	O
]	O
.	O

However	O
,	O
phasic	O
burst	O
activity	O
of	O
dopaminergic	B-CL
cells	I-CL
occurs	O
when	O
discrepancies	O
between	O
predicted	O
and	O
actual	O
reinforcement	O
contingencies	O
transpire	O
[	O
14	O
]	O
.	O

This	O
robust	O
increase	O
of	O
dopaminergic	B-CL
cell	I-CL
activation	O
in	O
response	O
to	O
unpredicted	O
outcomes	O
has	O
been	O
referred	O
to	O
as	O
an	O
"	O
error	O
"	O
signal	O
[	O
14	O
]	O
.	O

To	O
date	O
,	O
the	O
molecular	B-CHEBI
basis	O
of	O
this	O
error	O
signal	O
has	O
not	O
been	O
identified	O
.	O

The	O
inability	O
of	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
to	O
desist	O
responding	O
to	O
a	O
previously	O
reinforced	O
stimulus	O
suggests	O
that	O
the	O
dopamine	B-GGP
D2R	I-GGP
might	O
in	O
fact	O
be	O
the	O
focal	O
point	O
of	O
this	O
error	O
-	O
signaling	O
cascade	O
.	O

Electrophysiological	O
data	O
further	O
support	O
the	O
hypothesis	O
that	O
signaling	O
mediated	O
by	O
dopamine	B-GGP
D2Rs	I-GGP
tunes	O
D1R	B-GGP
-	O
mediated	O
mesocorticolimbic	O
output	O
.	O

Calabresi	O
et	O
al	O
.	O

[	O
34	O
]	O
demonstrated	O
that	O
tetanic	O
stimulation	O
of	O
dorsal	O
striatum	O
slices	O
prepared	O
from	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
is	O
associated	O
with	O
enhanced	O
EPSP	O
and	O
as	O
a	O
result	O
increased	O
striatal	O
synaptic	B-GO
efficacy	O
.	O

In	O
contrast	O
,	O
stimulation	O
of	O
dorsal	O
striatum	O
slices	O
from	O
wild	B-SO
-	I-SO
type	I-SO
mice	B-Taxon
resulted	O
in	O
IPSP	O
activity	O
,	O
long	O
-	O
term	O
depression	O
,	O
and	O
decreased	O
neuronal	B-CL
activity	O
of	O
striatal	O
efferents	O
[	O
34	O
]	O
.	O

Carlsson	O
and	O
colleagues	O
[	O
35	O
]	O
have	O
speculated	O
that	O
dopamine	B-GGP
D2R	I-GGP
stimulation	O
in	O
the	O
striatum	O
serves	O
to	O
"	O
brake	O
"	O
or	O
diminish	O
excitatory	O
corticostriatal	O
signaling	O
and	O
plasticity	O
.	O

Indeed	O
,	O
perseverative	O
behavior	O
is	O
associated	O
with	O
over	O
activity	O
of	O
the	O
dorsal	O
striatum	O
in	O
rodents	B-Taxon
[	O
36	O
]	O
and	O
over	O
activity	O
of	O
the	O
caudate	O
in	O
patients	O
with	O
ADHD	O
[	O
37	O
]	O
and	O
a	O
strong	O
inverse	O
correlation	O
of	O
D2R	B-GGP
binding	O
with	O
compulsive	O
behavior	O
has	O
been	O
reported	O
[	O
22	O
]	O
.	O

Importantly	O
,	O
our	O
data	O
indicate	O
that	O
the	O
poor	O
performances	O
displayed	O
by	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
are	O
manifestations	O
of	O
reversal	O
learning	O
deficits	O
and	O
not	O
gross	O
motivational	O
or	O
sensory	O
impairments	O
.	O

We	O
therefore	O
argue	O
that	O
D2Rs	B-GGP
participate	O
in	O
signaling	O
or	O
alerting	O
the	O
organism	B-Taxon
of	O
learning	O
contingency	O
changes	O
during	O
reversal	O
learning	O
and	O
sculpt	O
ongoing	O
goal	O
-	O
directed	O
behavior	O
.	O

Conclusions	O

This	O
study	O
demonstrates	O
that	O
signaling	O
by	O
dopamine	B-GGP
D2Rs	I-GGP
does	O
not	O
mediate	O
the	O
hedonic	O
value	O
of	O
reinforcers	O
,	O
supporting	O
and	O
refining	O
earlier	O
findings	O
[	O
1	O
,	O
2	O
]	O
.	O

However	O
,	O
mice	B-Taxon
completely	O
deficient	O
in	O
D2Rs	B-GGP
demonstrated	O
disrupted	O
acquisition	O
of	O
discriminative	O
stimulus	O
relationships	O
and	O
an	O
impaired	O
ability	O
to	O
recognize	O
changes	O
in	O
behavioral	O
determinants	O
.	O

Therefore	O
,	O
we	O
suggest	O
that	O
during	O
associative	O
learning	O
or	O
when	O
unexpected	O
reinforcement	O
outcomes	O
are	O
modified	O
(	O
reversal	O
learning	O
)	O
dopamine	B-CHEBI
-	O
driven	O
reinforcement	O
impulses	O
involve	O
signaling	O
mediated	O
by	O
dopamine	B-GGP
D2Rs	I-GGP
.	O

In	O
the	O
course	O
of	O
associative	O
learning	O
,	O
striatal	O
synapses	B-GO
[	O
38	O
]	O
receive	O
experience	O
-	O
driven	O
gain	O
[	O
7	O
]	O
,	O
thus	O
permitting	O
newly	O
established	O
reinforcement	O
-	O
mediated	O
signals	O
to	O
traverse	O
ascending	O
efferents	O
en	O
route	O
to	O
the	O
frontal	O
cortex	O
,	O
completing	O
a	O
functional	O
limbic	O
/	O
motor	O
circuit	O
[	O
39	O
-	O
41	O
]	O
.	O

Possibly	O
,	O
the	O
lack	O
of	O
dopamine	B-GGP
D2R	I-GGP
-	O
mediated	O
signaling	O
prevents	O
refinement	O
of	O
the	O
corticostriatal	O
reinforcement	O
circuits	O
in	O
the	O
brains	O
of	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
,	O
thus	O
impairing	O
their	O
ability	O
to	O
form	O
S	O
+	O
/	O
S	O
-	O
contingencies	O
and	O
disengage	O
inappropriate	O
dopamine	B-GGP
D1R	I-GGP
-	O
mediated	O
associative	O
responding	O
when	O
unexpected	O
consequences	O
to	O
goal	O
-	O
directed	O
behaviors	O
happened	O
.	O

Consequently	O
,	O
we	O
are	O
compelled	O
to	O
conclude	O
that	O
the	O
perseverative	O
performance	O
deficits	O
demonstrated	O
by	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
in	O
the	O
tasks	O
used	O
in	O
the	O
present	O
study	O
reveal	O
a	O
previously	O
unreported	O
role	O
for	O
D2Rs	B-GGP
in	O
associative	O
and	O
reversal	O
learning	O
.	O

Methods	O

Subjects	O

The	O
sixteen	O
,	O
8	O
-	O
10	O
week	O
old	O
,	O
25	O
-	O
30	O
g	O
mice	B-Taxon
(	O
8	O
per	O
genotype	B-SO
)	O
used	O
in	O
this	O
study	O
were	O
the	O
congenic	O
offspring	O
of	O
breeders	O
that	O
were	O
descendants	O
of	O
the	O
original	O
F2	O
hybrid	O
(	O
129	O
/	O
Sv	O
x	O
C57BL	O
/	O
6J	O
;	O
Kelly	O
et	O
al	O
.	O
,	O
1997	O
)	O
that	O
was	O
backcrossed	O
to	O
inbred	O
C57Bl	O
/	O
6J	O
stock	O
(	O
Jackson	O
Laboratories	O
,	O
ME	O
)	O
.	O

This	O
breeding	O
strategy	O
was	O
repeated	O
for	O
20	O
successive	O
generations	O
with	O
the	O
gender	O
of	O
the	O
donor	O
/	O
mutant	B-SO
alternating	O
with	O
each	O
generation	O
.	O

All	O
experimental	O
subjects	O
were	O
genotyped	O
by	O
PCR	O
as	O
previously	O
described	O
[	O
23	O
]	O
.	O

All	O
testing	O
occured	O
randomly	O
across	O
estrous	O
cycles	O
.	O

The	O
Department	O
of	O
Comparative	O
Medicine	O
at	O
Oregon	O
Health	O
and	O
Science	O
University	O
approved	O
all	O
protocols	O
,	O
and	O
all	O
animals	B-Taxon
were	O
maintained	O
in	O
accordance	O
to	O
National	O
Institutes	O
of	O
Health	O
'	O
s	O
Guide	O
for	O
the	O
Care	O
and	O
Use	O
of	O
Laboratory	O
Animals	B-Taxon
.	O

Experimental	O
procedures	O

Odor	O
discrimination	O
training	O
and	O
testing	O

A	O
2	O
-	O
odor	O
discrimination	O
paradigm	O
was	O
chosen	O
because	O
it	O
permits	O
a	O
measure	O
of	O
attentional	O
focus	O
in	O
goal	O
-	O
directed	O
behavior	O
.	O

Odor	O
discrimination	O
was	O
chosen	O
as	O
the	O
particular	O
task	O
because	O
it	O
is	O
a	O
highly	O
robust	O
behavior	O
in	O
rodents	B-Taxon
[	O
18	O
]	O
.	O

To	O
minimize	O
experimental	O
error	O
,	O
the	O
experimenter	O
was	O
blind	O
to	O
genotype	B-SO
during	O
testing	O
.	O

Mice	B-Taxon
were	O
mildly	O
food	B-CHEBI
deprived	O
to	O
approximately	O
85	O
%	O
ad	O
libitum	O
weight	O
.	O

Dopamine	B-GGP
D2R	I-GGP
-	I-GGP
/	I-GGP
-	I-GGP
and	I-GGP
D2R	I-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
n	O
=	O
8	O
per	O
group	O
)	O
were	O
initially	O
trained	O
to	O
ambulate	O
the	O
length	O
of	O
a	O
polyvinyl	O
mouse	B-Taxon
cage	O
(	O
30	O
-	O
cm	O
)	O
to	O
retrieve	O
~	O
30	O
-	O
mg	O
of	O
Pico	O
(R)	O
fat	O
supplemented	O
rodent	B-Taxon
food	B-CHEBI
located	O
in	O
a	O
small	O
plastic	O
cup	O
(	O
3	O
-	O
cm	O
)	O
attached	O
to	O
the	O
floor	O
of	O
the	O
testing	O
apparatus	O
with	O
Velcro	O
.	O

Each	O
subject	O
received	O
five	O
trials	O
,	O
and	O
the	O
latency	O
to	O
locate	O
and	O
start	O
to	O
consume	O
the	O
food	B-CHEBI
pellet	O
was	O
recorded	O
manually	O
with	O
a	O
standard	O
hand	O
-	O
held	O
stopwatch	O
.	O

Twenty	O
-	O
four	O
hours	O
later	O
subjects	O
were	O
trained	O
to	O
ambulate	O
towards	O
and	O
dig	O
through	O
the	O
same	O
3	O
-	O
cm	O
dish	O
filled	O
with	O
sterile	O
sand	O
to	O
locate	O
a	O
food	B-CHEBI
pellet	O
buried	O
underneath	O
the	O
sand	O
.	O

Subjects	O
received	O
10	O
trials	O
.	O

If	O
a	O
mouse	B-Taxon
failed	O
to	O
locate	O
a	O
food	B-CHEBI
pellet	O
within	O
10	O
-	O
min	O
of	O
the	O
first	O
trial	O
,	O
an	O
additional	O
food	B-CHEBI
pellet	O
was	O
dropped	O
on	O
top	O
of	O
the	O
dish	O
.	O

This	O
manipulation	O
usually	O
ensured	O
that	O
a	O
subject	O
would	O
dig	O
through	O
the	O
sand	O
to	O
locate	O
the	O
original	O
pellet	O
and	O
learn	O
this	O
task	O
.	O

The	O
next	O
day	O
,	O
mice	B-Taxon
were	O
presented	O
to	O
the	O
testing	O
apparatus	O
that	O
now	O
contained	O
2	O
dishes	O
,	O
each	O
filled	O
with	O
different	O
scented	O
sand	O
.	O

One	O
odor	O
signaled	O
that	O
a	O
food	B-CHEBI
reinforcer	O
was	O
buried	O
in	O
that	O
particular	O
dish	O
(	O
S	O
+	O
)	O
while	O
the	O
other	O
odor	O
signaled	O
that	O
no	O
reinforcer	O
was	O
contained	O
within	O
that	O
particular	O
dish	O
(	O
S	O
-	O
)	O
.	O

The	O
sand	O
was	O
scented	O
by	O
adding	O
0	O
.	O
80	O
grams	O
of	O
either	O
cinnamon	O
or	O
dill	B-Taxon
weed	O
to	O
98	O
.	O
8	O
grams	O
of	O
autoclaved	O
playground	O
sand	O
purchased	O
from	O
a	O
local	O
farm	O
and	O
garden	O
store	O
.	O

Finally	O
,	O
0	O
.	O
40	O
grams	O
of	O
finely	O
ground	O
food	B-CHEBI
was	O
mixed	O
with	O
the	O
scented	O
sand	O
in	O
order	O
to	O
mask	O
any	O
odor	O
emitted	O
by	O
the	O
food	B-CHEBI
reinforcer	O
in	O
the	O
S	O
+	O
dish	O
.	O

This	O
final	O
mixture	O
did	O
not	O
appear	O
to	O
be	O
palatable	O
to	O
the	O
subjects	O
.	O

A	O
trial	O
terminated	O
when	O
the	O
mouse	B-Taxon
:	O
dug	O
in	O
the	O
correct	O
dish	O
and	O
consumed	O
the	O
hidden	O
pellet	O
,	O
or	O
began	O
to	O
dig	O
in	O
the	O
incorrect	O
dish	O
.	O

Digging	O
was	O
considered	O
the	O
actual	O
physical	O
displacement	O
of	O
sand	O
with	O
the	O
forepaws	O
and	O
/	O
or	O
snout	O
.	O

Placing	O
forelimbs	O
on	O
either	O
of	O
the	O
dishes	O
and	O
sniffing	O
was	O
not	O
considered	O
digging	O
and	O
was	O
not	O
penalized	O
or	O
scored	O
.	O

Each	O
completed	O
trial	O
was	O
separated	O
by	O
a	O
20	O
-	O
sec	O
inter	O
-	O
trial	O
-	O
interval	O
(	O
ITI	O
)	O
.	O

Preliminary	O
experiments	O
demonstrated	O
that	O
an	O
extended	O
time	O
-	O
out	O
period	O
following	O
an	O
incorrect	O
response	O
was	O
not	O
required	O
to	O
ensure	O
goal	O
-	O
directed	O
behavior	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
or	O
mutant	B-SO
mice	B-Taxon
for	O
this	O
particular	O
task	O
(	O
data	O
not	O
shown	O
)	O
.	O

Therefore	O
,	O
the	O
20	O
-	O
sec	O
ITI	O
was	O
used	O
to	O
separate	O
all	O
trials	O
(	O
successful	O
and	O
unsuccessful	O
)	O
.	O

The	O
S	O
+	O
and	O
S	O
-	O
scents	O
were	O
counterbalanced	O
across	O
subjects	O
in	O
order	O
to	O
control	O
for	O
potential	O
scent	O
bias	O
(	O
pilot	O
data	O
suggest	O
there	O
are	O
no	O
biases	O
,	O
data	O
not	O
shown	O
)	O
.	O

Following	O
accurate	O
discrimination	O
,	O
defined	O
as	O
8	O
correct	O
retrievals	O
across	O
10	O
consecutive	O
trials	O
,	O
reversal	O
trials	O
began	O
.	O

Reversal	O
learning	O
measurement	O

We	O
next	O
investigated	O
the	O
contribution	O
of	O
dopamine	B-GGP
D2Rs	I-GGP
to	O
reversal	O
learning	O
behavior	O
by	O
inverting	O
the	O
reinforcement	O
contingencies	O
-	O
now	O
the	O
former	O
S	O
+	O
signaled	O
no	O
reinforcer	O
and	O
the	O
previous	O
S	O
-	O
now	O
indicated	O
reinforcement	O
availability	O
.	O

This	O
manipulation	O
permits	O
an	O
evaluation	O
of	O
the	O
ability	O
to	O
inhibit	O
responses	O
to	O
previously	O
reinforced	O
discriminative	O
stimuli	O
[	O
18	O
]	O
.	O

The	O
number	O
of	O
trials	O
necessary	O
to	O
establish	O
8	O
out	O
of	O
10	O
accurate	O
responses	O
was	O
our	O
definition	O
of	O
successful	O
reversal	O
learning	O
.	O

Data	O
analysis	O

The	O
latency	O
to	O
retrieve	O
a	O
pellet	O
from	O
an	O
empty	O
dish	O
,	O
the	O
latency	O
to	O
dig	O
through	O
a	O
dish	O
filled	O
with	O
unscented	O
sand	O
,	O
and	O
the	O
number	O
of	O
errors	O
of	O
commission	O
committed	O
across	O
the	O
reversal	O
sessions	O
were	O
analyzed	O
with	O
2	O
-	O
way	O
analyses	O
of	O
variance	O
(	O
genotype	B-SO
x	O
trials	O
)	O
.	O

The	O
number	O
of	O
trials	O
necessary	O
to	O
attain	O
criterion	O
performance	O
in	O
odor	O
discrimination	O
(	O
8	O
correct	O
responses	O
across	O
10	O
consecutive	O
trials	O
)	O
and	O
errors	O
committed	O
while	O
learning	O
the	O
discrimination	O
tasks	O
were	O
separated	O
as	O
individual	O
testing	O
phases	O
(	O
e	O
.	O
g	O
.	O
odor	O
discrimination	O
and	O
reversal	O
learning	O
)	O
and	O
analyzed	O
separately	O
with	O
unpaired	O
2	O
-	O
tailed	O
t	O
-	O
tests	O
.	O

Significance	O
was	O
established	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Errors	O
committed	O
during	O
reversal	O
trials	O
were	O
further	O
categorically	O
separated	O
as	O
errors	O
of	O
commission	O
(	O
failing	O
to	O
withhold	O
responding	O
to	O
S	O
-	O
)	O
and	O
errors	O
of	O
omission	O
(	O
failing	O
to	O
dig	O
in	O
either	O
dish	O
after	O
3	O
-	O
min	O
had	O
expired	O
)	O
.	O

Categorical	O
errors	O
and	O
number	O
of	O
commission	O
errors	O
committed	O
during	O
the	O
first	O
reversal	O
learning	O
session	O
were	O
analyzed	O
between	O
groups	O
with	O
nonparametric	O
Mann	O
-	O
Whitney	O
U	O
tests	O
.	O

Authors	O
'	O
contributions	O

PJK	O
designed	O
and	O
ran	O
all	O
of	O
the	O
experiments	O
,	O
analyzed	O
the	O
data	O
,	O
and	O
co	O
-	O
wrote	O
the	O
manuscript	O
.	O

DKG	O
oversaw	O
and	O
facilitated	O
the	O
experiments	O
and	O
co	O
-	O
wrote	O
the	O
manuscript	O
.	O

Acknowledgements	O

This	O
study	O
was	O
supported	O
by	O
grants	O
DA07262	O
(	O
PJK	O
)	O
,	O
DA12062	O
(	O
DKG	O
)	O
,	O
and	O
MH067497	O
(	O
DKG	O
)	O
.	O

We	O
thank	O
Katherine	O
M	O
.	O
Suchland	O
for	O
her	O
excellent	O
technical	O
assistance	O
.	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Mice	B-Taxon
lacking	O
dopamine	B-GGP
D2	I-GGP
receptors	I-GGP
acquire	O
a	O
goal	O
-	O
directed	O
behavior	O
similar	O
to	O
wild	B-SO
-	I-SO
type	I-SO
mice	B-Taxon
.	O

Both	O
genotypes	B-SO
readily	O
learned	O
to	O
retrieve	O
food	B-CHEBI
pellets	O
from	O
a	O
small	O
dish	O
and	O
significantly	O
decreased	O
their	O
latencies	O
to	O
perform	O
this	O
task	O
across	O
trials	O
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Figure	O
2	O

Wild	B-SO
-	I-SO
type	I-SO
and	O
D2R	B-GGP
-	O
deficient	O
mice	B-Taxon
perform	O
the	O
digging	O
task	O
equally	O
well	O
.	O

No	O
differences	O
in	O
responding	O
as	O
a	O
function	O
of	O
genotype	B-SO
were	O
found	O
,	O
and	O
similar	O
latencies	O
to	O
retrieve	O
the	O
reinforcer	O
were	O
seen	O
.	O

These	O
response	O
patterns	O
suggest	O
that	O
the	O
training	O
from	O
the	O
previous	O
day	O
influenced	O
behavior	O
,	O
demonstrating	O
that	O
both	O
genotypes	B-SO
are	O
capable	O
of	O
learning	O
and	O
retaining	O
goal	O
-	O
directed	O
behaviors	O
.	O

Figure	O
3	O

Dopamine	B-GGP
D2	I-GGP
receptor	I-GGP
-	O
mediated	O
signaling	O
contributes	O
to	O
the	O
acquisition	O
of	O
odor	O
discrimination	O
/	O
associative	O
learning	O
.	O

Wild	B-SO
-	I-SO
type	I-SO
(	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
)	O
mice	B-Taxon
outperformed	O
(	O
mean	O
+	O
standard	O
error	O
)	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
during	O
acquisition	O
of	O
(	O
A	O
)	O
odor	O
discrimination	O
(	O
*	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
(	O
B	O
)	O
committed	O
significantly	O
fewer	O
discrimination	O
errors	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
during	O
the	O
discrimination	O
task	O
.	O

Figure	O
4	O

D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
perseverate	O
in	O
unreinforced	O
behavior	O
during	O
reversal	O
learning	O
trials	O
.	O

The	O
number	O
of	O
necessary	O
trials	O
(	O
mean	O
+	O
standard	O
error	O
)	O
to	O
(	O
A	O
)	O
demonstrate	O
reversal	O
learning	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
and	O
(	O
B	O
)	O
reversal	O
errors	O
committed	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
by	O
D2R	B-GGP
-	O
/	O
-	O
and	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
.	O

Figure	O
5	O

Reversal	O
learning	O
measures	O
reveal	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
emit	O
significantly	O
more	O
errors	O
of	O
commission	O
but	O
not	O
errors	O
of	O
omission	O
than	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
.	O

Response	O
patterns	O
(	O
mean	O
+	O
standard	O
error	O
)	O
by	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
are	O
more	O
suggestive	O
of	O
stimulus	O
bound	O
perseveration	O
and	O
not	O
extinction	O
.	O

D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
committed	O
significantly	O
more	O
errors	O
of	O
commission	O
(	O
A	O
)	O
than	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
but	O
no	O
differences	O
in	O
errors	O
of	O
omission	O
(	O
B	O
)	O
were	O
observed	O
between	O
genotypes	B-SO
(	O
p	O
>	O
0	O
.	O
6	O
)	O
.	O

Figure	O
6	O

Mice	B-Taxon
lacking	O
functional	O
D2Rs	B-GGP
display	O
an	O
inability	O
to	O
withhold	O
inappropriate	O
responses	O
.	O

Response	O
patterns	O
during	O
first	O
10	O
reversal	O
trials	O
reveal	O
deficits	O
in	O
mice	B-Taxon
lacking	O
D2Rs	B-GGP
.	O

When	O
the	O
mice	B-Taxon
encountered	O
the	O
inverted	O
reinforcement	O
contingencies	O
during	O
the	O
first	O
reversal	O
learning	O
session	O
,	O
the	O
D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
demonstrated	O
an	O
almost	O
complete	O
inability	O
to	O
inhibit	O
responding	O
to	O
previously	O
reinforced	O
stimuli	O
compared	O
to	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Figure	O
7	O

D2R	B-GGP
-	O
/	O
-	O
mice	B-Taxon
commit	O
significantly	O
more	O
perseverative	O
errors	O
across	O
reversal	O
sessions	O
than	O
wild	B-SO
-	I-SO
type	I-SO
mice	B-Taxon
.	O

An	O
analysis	O
of	O
the	O
time	O
course	O
of	O
responding	O
for	O
errors	O
of	O
commission	O
across	O
the	O
first	O
four	O
reversal	O
sessions	O
revealed	O
that	O
the	O
D2R	B-GGP
-	O
/	O
-	O
committed	O
several	O
more	O
errors	O
of	O
commission	O
than	O
the	O
D2R	B-GGP
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Structure	O
-	O
function	O
evolution	O
of	O
the	O
Transforming	O
acidic	B-CHEBI
coiled	B-SO
coil	I-SO
genes	B-SO
revealed	O
by	O
analysis	O
of	O
phylogenetically	O
diverse	O
organisms	B-Taxon

Abstract	O

Background	O

Examination	O
of	O
ancient	O
gene	B-SO
families	O
can	O
provide	O
an	O
insight	O
into	O
how	O
the	O
evolution	O
of	O
gene	B-SO
structure	O
can	O
relate	O
to	O
function	O
.	O

Functional	O
homologs	B-SO
of	O
the	O
evolutionarily	B-SO
conserved	I-SO
transforming	O
acidic	B-CHEBI
coiled	B-SO
coil	I-SO
(	O
TACC	O
)	O
gene	B-SO
family	O
are	O
present	O
in	O
organisms	B-Taxon
from	O
yeast	B-Taxon
to	O
man	B-Taxon
.	O

However	O
,	O
correlations	O
between	O
functional	O
interactions	O
and	O
the	O
evolution	O
of	O
these	O
proteins	B-CHEBI
have	O
yet	O
to	O
be	O
determined	O
.	O

Results	O

We	O
have	O
performed	O
an	O
extensive	O
database	O
analysis	O
to	O
determine	O
the	O
genomic	B-SO
and	I-SO
cDNA	I-SO
sequences	I-SO
of	O
the	O
TACCs	O
from	O
phylogenetically	O
diverse	O
organisms	B-Taxon
.	O

This	O
analysis	O
has	O
determined	O
the	O
phylogenetic	O
relationship	O
of	O
the	O
TACC	O
proteins	B-CHEBI
to	O
other	O
coiled	B-SO
coil	I-SO
proteins	B-CHEBI
,	O
the	O
resolution	O
of	O
the	O
placement	O
of	O
the	O
rabbit	B-Taxon
TACC4	O
as	O
the	O
orthologue	B-SO
of	O
human	B-GGP
TACC3	I-GGP
,	O
and	O
RHAMM	B-GGP
as	O
a	O
distinct	O
family	O
of	O
coiled	B-SO
coil	I-SO
proteins	B-CHEBI
.	O

We	O
have	O
also	O
extended	O
the	O
analysis	O
of	O
the	O
TACCs	O
to	O
the	O
interaction	O
databases	O
of	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
and	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
to	O
identify	O
potentially	O
novel	O
TACC	O
interactions	O
.	O

The	O
validity	O
of	O
this	O
modeling	O
was	O
confirmed	O
independently	O
by	O
the	O
demonstration	O
of	O
direct	O
binding	O
of	O
human	B-GGP
TACC2	I-GGP
to	O
the	O
nuclear	B-GO
hormone	B-CHEBI
receptor	O
RXR	B-GGP
beta	I-GGP
.	O

Conclusion	O

The	O
data	O
so	O
far	O
suggest	O
that	O
the	O
ancestral	O
TACC	O
protein	B-CHEBI
played	O
a	O
role	O
in	O
centrosomal	B-GO
/	O
mitotic	O
spindle	B-GO
dynamics	O
.	O

TACC	O
proteins	B-CHEBI
were	O
then	O
recruited	O
to	O
complexes	B-GO
involved	O
in	O
protein	B-CHEBI
translation	O
,	O
RNA	B-SO
processing	O
and	O
transcription	O
by	O
interactions	O
with	O
specific	O
bridging	O
proteins	B-CHEBI
.	O

However	O
,	O
during	O
evolution	O
,	O
the	O
TACC	O
proteins	B-CHEBI
have	O
now	O
acquired	O
the	O
ability	O
to	O
directly	O
interact	O
with	O
components	O
of	O
these	O
complexes	B-GO
(	O
such	O
as	O
the	O
LSm	O
proteins	B-CHEBI
,	O
nuclear	B-GO
hormone	B-CHEBI
receptors	O
,	O
GAS41	B-GGP
,	O
and	O
transcription	O
factors	O
)	O
.	O

This	O
suggests	O
that	O
the	O
function	O
of	O
the	O
TACC	O
proteins	B-CHEBI
may	O
have	O
evolved	O
from	O
performing	O
assembly	O
or	O
coordination	O
functions	O
in	O
the	O
centrosome	B-GO
to	O
include	O
a	O
more	O
intimate	O
role	O
in	O
the	O
functional	O
evolution	O
of	O
chromatin	B-GO
remodeling	O
,	O
transcriptional	O
and	O
posttranscriptional	O
complexes	B-GO
in	O
the	O
cell	B-CL
.	O

Background	O

The	O
evolution	O
of	O
complex	O
organisms	B-Taxon
has	O
been	O
associated	O
with	O
the	O
generation	O
of	O
gene	B-SO
families	O
by	O
the	O
continual	O
duplication	B-SO
of	O
an	O
initial	O
relatively	O
small	O
set	O
of	O
ancestral	O
genes	B-SO
.	O

Through	O
this	O
process	O
,	O
followed	O
by	O
subsequent	O
mutation	B-SO
,	O
reduplication	O
and	O
exon	B-SO
shuffling	O
between	O
gene	B-SO
families	O
,	O
genes	B-SO
have	O
evolved	O
both	O
discrete	O
,	O
and	O
partially	O
redundant	O
functions	O
with	O
their	O
related	O
family	O
members	O
.	O

With	O
the	O
completion	O
of	O
the	O
genome	B-SO
sequencing	O
projects	O
of	O
human	B-Taxon
,	O
mouse	B-Taxon
,	O
rat	B-Taxon
,	O
fruit	B-Taxon
fly	I-Taxon
and	O
nematodes	B-Taxon
,	O
we	O
are	O
now	O
in	O
a	O
position	O
to	O
ask	O
fundamental	O
questions	O
in	O
regard	O
to	O
how	O
genes	B-SO
interact	O
in	O
the	O
context	O
of	O
the	O
whole	O
organism	B-Taxon
.	O

Thus	O
,	O
with	O
the	O
appropriate	O
application	O
of	O
bioinformatics	O
,	O
it	O
is	O
now	O
possible	O
to	O
trace	O
the	O
lineage	O
of	O
particular	O
genes	B-SO
and	O
gene	B-SO
families	O
,	O
with	O
related	O
gene	B-SO
families	O
in	O
other	O
organisms	B-Taxon
.	O

Furthermore	O
,	O
with	O
the	O
growing	O
amount	O
of	O
large	O
-	O
scale	O
proteomic	O
and	O
genomic	B-SO
data	O
becoming	O
publicly	O
available	O
,	O
this	O
analysis	O
can	O
now	O
be	O
extended	O
to	O
reveal	O
the	O
complex	O
interplay	O
between	O
evolution	O
of	O
gene	B-SO
structure	O
and	O
protein	B-CHEBI
function	O
.	O

The	O
first	O
Transforming	O
acidic	B-CHEBI
coiled	B-SO
coil	I-SO
gene	B-SO
,	O
TACC1	B-GGP
,	O
was	O
identified	O
during	O
the	O
development	O
of	O
an	O
expression	O
map	O
of	O
the	O
proximal	O
short	O
arm	B-SO
of	I-SO
human	I-SO
chromosome	I-SO
8	O
[	O
1	O
]	O
.	O

Two	O
additional	O
TACC	O
family	O
members	O
were	O
subsequently	O
identified	O
and	O
mapped	O
to	O
paralogous	B-SO
chromosomal	I-SO
regions	I-SO
on	O
human	B-Taxon
chromosomes	B-GO
4p16	O
and	O
10q26	O
,	O
physically	O
close	O
to	O
members	O
of	O
the	O
FGFR	B-GGP
gene	B-SO
family	O
[	O
1	O
-	O
3	O
]	O
.	O

This	O
mapping	O
data	O
,	O
together	O
with	O
identification	O
of	O
a	O
single	O
TACC	O
gene	B-SO
in	O
the	O
protostomes	B-Taxon
Caenorhabitis	B-Taxon
elegans	I-Taxon
,	O
and	O
Drosophila	B-Taxon
melanogaster	I-Taxon
[	O
4	O
-	O
6	O
]	O
,	O
led	O
to	O
the	O
speculation	O
that	O
the	O
ancestral	O
FGFR	B-GGP
and	O
TACC	O
genes	B-SO
were	O
located	O
physically	O
close	O
to	O
each	O
other	O
.	O

Thus	O
,	O
during	O
the	O
evolution	O
of	O
vertebrates	B-Taxon
,	O
subsequent	O
successive	O
duplications	B-SO
of	O
the	O
ancestral	O
gene	B-SO
cluster	I-SO
have	O
given	O
rise	O
to	O
three	O
TACC	O
family	O
members	O
located	O
close	O
to	O
FGFR	B-GGP
genes	B-SO
in	O
humans	B-Taxon
.	O

In	O
accordance	O
with	O
the	O
proposed	O
quadruplication	O
of	O
the	O
vertebrate	B-Taxon
genome	B-SO
during	O
evolution	O
,	O
there	O
is	O
a	O
fourth	O
FGFR	B-GGP
family	O
member	O
in	O
vertebrates	B-Taxon
,	O
raising	O
the	O
question	O
of	O
whether	O
a	O
fourth	O
TACC	O
gene	B-SO
is	O
associated	O
with	O
FGFR4	B-GGP
in	O
vertebrate	B-Taxon
genomes	B-SO
.	O

To	O
date	O
,	O
only	O
three	O
active	O
TACC	O
genes	B-SO
have	O
been	O
cloned	O
in	O
humans	B-Taxon
[	O
1	O
-	O
3	O
]	O
,	O
one	O
in	O
each	O
of	O
mouse	B-Taxon
[	O
7	O
]	O
,	O
Xenopus	B-Taxon
laevis	I-Taxon
[	O
8	O
]	O
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
[	O
4	O
]	O
,	O
and	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
[	O
5	O
,	O
6	O
]	O
.	O

Although	O
two	O
additional	O
new	O
candidate	O
TACC	O
family	O
members	O
,	O
Oryctolagus	B-Taxon
cuniculus	I-Taxon
TACC4	O
[	O
9	O
]	O
and	O
human	B-GGP
RHAMM	I-GGP
[	O
10	O
]	O
have	O
been	O
proposed	O
,	O
their	O
true	O
identity	O
and	O
placement	O
in	O
the	O
evolution	O
of	O
the	O
TACC	O
family	O
is	O
under	O
debate	O
.	O

Thus	O
,	O
the	O
identification	O
and	O
functional	O
characterization	O
of	O
new	O
members	O
of	O
the	O
TACC	O
family	O
in	O
other	O
organisms	B-Taxon
,	O
alternatively	B-SO
spliced	I-SO
isoforms	I-SO
of	O
each	O
TACC	O
and	O
comparison	O
of	O
the	O
phylogenetic	O
relationship	O
of	O
these	O
genes	B-SO
relative	O
to	O
other	O
members	O
of	O
the	O
coiled	B-SO
coil	I-SO
superfamily	O
will	O
resolve	O
this	O
issue	O
and	O
provide	O
clues	O
to	O
the	O
evolution	O
of	O
TACC	O
function	O
.	O

Results	O
and	O
Discussion	O

In	O
silico	O
identification	O
of	O
TACC	O
family	O
members	O
from	O
vertebrate	B-Taxon
and	O
invertebrate	O
lineages	O

Sequence	B-SO
similarity	O
searches	O
of	O
the	O
publicly	O
available	O
genome	B-SO
databases	O
with	O
the	O
BLAST	O
and	O
TBLAST	O
programs	O
were	O
performed	O
to	O
identify	O
TACC	O
and	O
RHAMM	B-GGP
orthologues	B-SO
,	O
and	O
other	O
members	O
of	O
the	O
coiled	B-SO
coil	I-SO
superfamily	O
in	O
a	O
diverse	O
set	O
of	O
species	O
(	O
Fig	O
.	O
1	O
)	O
.	O

This	O
identified	O
the	O
complete	O
sequence	B-SO
of	O
the	O
TACC	O
genes	B-SO
in	O
representatives	O
of	O
five	O
major	O
phylogenetically	O
distinct	O
clades	O
.	O

Where	O
possible	O
,	O
the	O
construction	O
of	O
the	O
TACC	O
sequences	B-SO
from	O
these	O
organisms	B-Taxon
was	O
also	O
confirmed	O
by	O
the	O
analysis	O
of	O
the	O
cDNA	B-SO
databases	O
.	O

Several	O
partial	B-SO
sequences	B-SO
in	O
other	O
vertebrate	B-Taxon
species	O
,	O
the	O
echinodermate	B-Taxon
Strongylocentrotus	B-Taxon
purpuratus	I-Taxon
and	O
the	O
protostome	B-Taxon
insect	B-Taxon
Anopheles	B-Taxon
gambiae	I-Taxon
were	O
also	O
identified	O
,	O
suggesting	O
an	O
ancient	O
conservation	B-SO
of	O
the	O
TACC	O
genes	B-SO
in	O
metazoan	B-Taxon
lineages	O
.	O

However	O
,	O
due	O
to	O
the	O
relative	O
infancy	O
of	O
the	O
cDNA	B-SO
/	O
genome	B-SO
projects	O
for	O
these	O
latter	O
organisms	B-Taxon
,	O
complete	O
characterization	O
of	O
these	O
TACC	O
genes	B-SO
could	O
not	O
be	O
undertaken	O
.	O

No	O
conclusion	O
could	O
be	O
made	O
about	O
the	O
existence	O
of	O
TACC	O
-	O
like	O
sequence	B-SO
in	O
non	O
-	O
bilaterian	B-Taxon
metazoans	B-Taxon
,	O
such	O
as	O
Cnidaria	B-Taxon
or	O
Porifera	B-Taxon
,	O
due	O
to	O
the	O
paucity	O
of	O
sequence	B-SO
information	O
for	O
these	O
organisms	B-Taxon
,	O
and	O
additional	O
definitive	O
sequences	B-SO
with	O
a	O
defined	O
TACC	O
domain	B-SO
could	O
not	O
be	O
found	O
in	O
other	O
non	O
-	O
metazoan	B-Taxon
organisms	B-Taxon
.	O

Figure	O
1	O

Phylogenetic	O
analysis	O
of	O
the	O
TACC	O
family	O
members	O
compared	O
to	O
other	O
coiled	B-SO
coil	I-SO
proteins	B-CHEBI
.	O

The	O
phylogenetic	O
tree	O
was	O
constructed	O
as	O
described	O
in	O
the	O
Methods	O
section	O
.	O

The	O
TACC	O
family	O
defines	O
a	O
separate	O
subfamily	O
of	O
coiled	B-SO
coil	I-SO
containing	O
proteins	B-CHEBI
,	O
distinct	O
from	O
other	O
coiled	B-SO
coil	I-SO
families	O
such	O
as	O
the	O
keratins	O
,	O
RHAMM	B-GGP
and	O
tropomyosins	O
.	O

Note	O
that	O
the	O
RHAMM	B-GGP
proteins	B-CHEBI
form	O
a	O
separate	O
branch	O
more	O
closely	O
related	O
to	O
the	O
tropomyosins	O
and	O
kinesin	O
like	O
proteins	B-CHEBI
(	O
KLP	O
)	O
,	O
than	O
the	O
TACC	O
proteins	B-CHEBI
.	O

At	O
the	O
base	O
of	O
the	O
chordate	B-Taxon
branch	O
of	O
life	O
,	O
a	O
single	O
TACC	O
gene	B-SO
was	O
identified	O
in	O
the	O
genome	B-SO
of	O
the	O
urochordate	B-Taxon
Ciona	B-Taxon
intestinalis	I-Taxon
[	O
11	O
]	O
,	O
and	O
a	O
partial	B-SO
TACC	O
sequence	B-SO
from	O
an	O
analysis	O
of	O
the	O
Halocynthia	B-Taxon
rortezi	I-Taxon
EST	B-SO
database	O
[	O
12	O
]	O
.	O

This	O
confirms	O
the	O
original	O
assumption	O
that	O
a	O
single	O
TACC	O
gene	B-SO
was	O
present	O
in	O
the	O
chordate	B-Taxon
ancestor	O
.	O

The	O
next	O
major	O
event	O
in	O
the	O
evolution	O
of	O
the	O
chordate	B-Taxon
genome	B-SO
has	O
been	O
suggested	O
to	O
have	O
occurred	O
687	O
+/-	O
155	O
.	O
7	O
million	O
years	O
ago	O
(	O
MYA	O
)	O
,	O
with	O
the	O
first	O
duplication	B-SO
of	O
the	O
chordate	B-Taxon
genome	B-SO
,	O
and	O
a	O
second	O
duplication	B-SO
occurring	O
shortly	O
thereafter	O
.	O

Thus	O
,	O
if	O
the	O
TACC	O
genes	B-SO
were	O
duplicated	O
at	O
both	O
events	O
,	O
we	O
would	O
expect	O
to	O
identify	O
four	O
TACC	O
genes	B-SO
in	O
the	O
most	O
"	O
primitive	O
"	O
compact	O
vertebrate	B-Taxon
genome	B-SO
sequenced	O
to	O
date	O
,	O
the	O
pufferfish	B-Taxon
Takifugu	B-Taxon
rubripes	I-Taxon
,	O
with	O
three	O
genes	B-SO
corresponding	O
to	O
the	O
human	B-GGP
TACC1	I-GGP
-	O
3	O
,	O
and	O
,	O
in	O
keeping	O
with	O
the	O
proposed	O
model	O
for	O
genomic	B-SO
duplication	B-SO
of	O
the	O
chromosomal	B-SO
loci	I-SO
for	O
the	O
TACC	O
genes	B-SO
(	O
discussed	O
below	O
)	O
,	O
a	O
possible	O
fourth	O
gene	B-SO
deriving	O
from	O
the	O
TACC3	B-GGP
ancestor	O
.	O

Indeed	O
,	O
four	O
TACC	O
genes	B-SO
were	O
identified	O
in	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
.	O

Of	O
these	O
,	O
two	O
genes	B-SO
corresponded	O
to	O
the	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
orthologues	B-SO
of	O
human	B-GGP
TACC2	I-GGP
and	I-GGP
TACC3	I-GGP
.	O

However	O
,	O
the	O
other	O
two	O
genes	B-SO
,	O
trTACC1A	B-GGP
and	O
trTACC1B	B-GGP
are	O
clearly	O
most	O
related	O
to	O
TACC1	B-GGP
(	O
Fig	O
.	O
1	O
)	O
.	O

Although	O
trTACC1A	B-GGP
is	O
highly	O
homologous	B-SO
to	O
trTACC1B	B-GGP
,	O
the	O
latter	O
encodes	O
a	O
significantly	O
smaller	O
predicted	B-SO
protein	B-CHEBI
.	O

The	O
trTACC1B	B-GGP
gene	B-SO
is	O
encoded	O
by	O
15	O
exons	B-SO
over	O
approximately	O
7	O
kb	O
of	O
the	O
Takifugu	B-Taxon
Scaffold	B-SO
191	O
(	O
see	O
below	O
)	O
.	O

A	O
search	O
of	O
this	O
region	B-SO
using	O
the	O
trTACC1A	B-GGP
sequence	B-SO
and	O
gene	B-SO
prediction	O
software	O
has	O
so	O
far	O
failed	O
to	O
identify	O
additional	O
exons	B-SO
of	O
trTACC1B	B-GGP
.	O

However	O
,	O
given	O
the	O
intron	B-SO
/	O
exon	B-SO
structure	O
of	O
this	O
apparently	O
complete	O
gene	B-SO
,	O
it	O
appears	O
likely	O
that	O
trTACC1B	B-GGP
is	O
active	O
in	O
the	O
pufferfish	B-Taxon
,	O
and	O
presumably	O
fulfils	O
either	O
a	O
temporal	O
-	O
spatial	O
specific	O
function	O
within	O
the	O
organism	B-Taxon
,	O
or	O
a	O
distinct	O
function	O
from	O
the	O
larger	O
trTACC1A	B-GGP
product	O
within	O
the	O
cell	B-CL
.	O

Thus	O
,	O
based	O
upon	O
the	O
surrounding	O
chromosomal	B-SO
loci	I-SO
(	O
see	O
below	O
)	O
,	O
the	O
trTACC1A	B-GGP
and	O
trTACC1B	B-GGP
genes	B-SO
appear	O
to	O
have	O
arisen	O
from	O
the	O
duplication	B-SO
of	O
the	O
chromosomal	B-SO
segment	I-SO
containing	O
the	O
teleost	B-Taxon
TACC1	B-GGP
ancestor	O
,	O
during	O
the	O
additional	O
partial	O
genomic	B-SO
duplication	B-SO
that	O
occurred	O
in	O
the	O
teleost	B-Taxon
lineage	O
.	O

Therefore	O
,	O
this	O
analysis	O
of	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
does	O
not	O
support	O
the	O
hypothesis	O
that	O
the	O
region	B-SO
surrounding	O
the	O
TACC3	B-GGP
ancestor	O
was	O
included	O
in	O
the	O
second	O
round	O
of	O
vertebrate	B-Taxon
genomic	B-SO
duplication	B-SO
.	O

Examination	O
of	O
higher	O
vertebrates	B-Taxon
led	O
to	O
the	O
identification	O
of	O
splice	B-SO
variants	I-SO
of	O
TACC1	B-GGP
and	O
TACC2	B-GGP
in	O
Mus	B-Taxon
musculus	I-Taxon
,	O
and	O
the	O
assembly	O
of	O
the	O
previously	O
unidentified	O
orthologues	B-SO
of	O
TACC1	B-GGP
-	O
3	O
from	O
Rattus	B-Taxon
norvegus	I-Taxon
.	O

In	O
addition	O
,	O
the	O
TACC1X	O
sequence	B-SO
was	O
found	O
on	O
mouse	B-Taxon
chromosome	B-GO
X	I-GO
.	O

This	O
gene	B-SO
is	O
clearly	O
related	O
to	O
the	O
mouse	B-GGP
TACC1	I-GGP
,	O
however	O
,	O
further	O
examination	O
revealed	O
a	O
mouse	B-Taxon
B1	O
repeat	B-SO
distributed	O
over	O
the	O
length	O
of	O
the	O
proposed	O
intron	B-SO
.	O

In	O
addition	O
,	O
no	O
expression	O
of	O
TACC1X	O
was	O
detected	O
in	O
mouse	B-Taxon
RNA	B-SO
by	O
rt	O
-	O
PCR	O
analysis	O
(	O
data	O
not	O
shown	O
)	O
,	O
suggesting	O
that	O
this	O
sequence	B-SO
is	O
a	O
processed	B-SO
pseudogene	I-SO
.	O

Similarly	O
,	O
TACC1	B-GGP
pseudogenes	B-SO
also	O
exist	O
spread	O
over	O
22	O
kb	O
of	O
the	O
centromeric	B-GO
region	I-GO
of	I-GO
human	I-GO
chromosome	I-GO
10	O
and	O
,	O
in	O
8q21	O
,	O
a	O
shorter	O
region	B-SO
86	O
%	O
identical	O
to	O
the	O
final	O
359	O
bp	B-SO
of	O
the	O
TACC1	B-GGP
3	B-SO
'	I-SO
untranslated	I-SO
region	I-SO
.	O

No	O
pseudogenes	B-SO
corresponding	O
to	O
TACC2	B-GGP
or	O
TACC3	B-GGP
were	O
identified	O
in	O
any	O
mammalian	B-Taxon
species	O
.	O

Characterization	O
of	O
vertebrate	B-Taxon
TACC3	B-GGP
orthologues	B-SO

Based	O
upon	O
current	O
functional	O
analysis	O
,	O
the	O
characterization	O
of	O
TACC3	B-GGP
orthologues	B-SO
is	O
likely	O
to	O
be	O
pivotal	O
to	O
understanding	O
the	O
sequence	B-SO
and	O
functional	O
evolution	O
of	O
the	O
TACC	O
gene	B-SO
family	O
.	O

As	O
indicated	O
below	O
,	O
the	O
chromosomal	B-SO
region	I-SO
containing	O
the	O
TACC	O
gene	B-SO
precursors	O
was	O
duplicated	O
twice	O
during	O
vertebrate	B-Taxon
evolution	O
.	O

Although	O
the	O
analysis	O
of	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
,	O
rodents	B-Taxon
and	O
humans	B-Taxon
so	O
far	O
suggests	O
that	O
the	O
vertebrate	B-Taxon
TACC3	B-GGP
precursor	O
was	O
not	O
included	O
in	O
the	O
second	O
round	O
of	O
genomic	B-SO
duplication	B-SO
,	O
it	O
could	O
not	O
be	O
excluded	O
that	O
a	O
TACC4	O
gene	B-SO
may	O
have	O
been	O
lost	B-SO
during	O
the	O
evolution	O
of	O
these	O
lineages	O
.	O

The	O
cloning	O
of	O
a	O
new	O
member	O
of	O
the	O
TACC	O
family	O
in	O
Oryctolagus	B-Taxon
cuniculus	I-Taxon
has	O
added	O
to	O
this	O
controversy	O
[	O
9	O
]	O
.	O

Designated	O
TACC4	O
,	O
the	O
1	O
.	O
5	O
kb	O
cDNA	B-SO
was	O
highly	O
related	O
,	O
but	O
proposed	O
to	O
be	O
distinct	O
from	O
TACC3	B-GGP
.	O

However	O
,	O
Northern	O
blot	O
data	O
suggested	O
that	O
this	O
gene	B-SO
produces	O
a	O
single	O
2	O
.	O
3	O
kb	O
transcript	B-SO
[	O
9	O
]	O
,	O
indicating	O
that	O
the	O
cloned	O
cDNA	B-SO
was	O
incomplete	B-SO
.	O

The	O
degree	O
of	O
similarity	O
to	O
the	O
published	O
sequence	B-SO
of	O
human	B-GGP
and	I-GGP
mouse	I-GGP
TACC3	I-GGP
suggested	O
to	O
us	O
that	O
TACC4	O
actually	O
represents	O
a	O
partial	B-SO
rabbit	B-GGP
TACC3	I-GGP
cDNA	B-SO
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
set	O
out	O
to	O
clone	O
the	O
complete	O
rabbit	B-GGP
TACC3	I-GGP
sequence	B-SO
,	O
based	O
upon	O
the	O
known	B-SO
features	B-SO
of	O
human	B-GGP
and	I-GGP
mouse	I-GGP
TACC3	I-GGP
.	O

We	O
have	O
previously	O
noted	O
that	O
the	O
N	B-SO
-	I-SO
terminal	I-SO
and	I-SO
C	I-SO
-	I-SO
terminal	I-SO
regions	I-SO
of	O
the	O
human	B-GGP
and	I-GGP
mouse	I-GGP
TACC3	I-GGP
proteins	B-CHEBI
are	O
highly	O
conserved	B-SO
(	O
[	O
2	O
]	O
,	O
see	O
below	O
)	O
.	O

Therefore	O
,	O
based	O
upon	O
the	O
sequence	B-SO
identity	O
between	O
these	O
genes	B-SO
,	O
we	O
designed	O
a	O
consensus	B-SO
oligonucleotide	B-SO
primer	B-SO
,	O
T3con2	O
,	O
that	O
would	O
be	O
suitable	O
for	O
the	O
identification	O
of	O
the	O
region	B-SO
containing	O
the	O
initiator	O
methionine	B-CHEBI
of	O
the	O
TACC3	B-GGP
cDNAs	B-SO
from	O
primates	B-Taxon
and	O
rodents	B-Taxon
.	O

Using	O
this	O
primer	B-SO
,	O
in	O
combination	O
with	O
the	O
TACC4	O
-	O
specific	O
RACE	O
primer	B-SO
(	O
RACE2	O
)	O
,	O
initially	O
used	O
by	O
Steadman	O
et	O
al	O
[	O
9	O
]	O
,	O
we	O
isolated	O
a	O
1	O
.	O
5	O
kb	O
PCR	B-SO
product	I-SO
from	O
rabbit	B-Taxon
brain	O
cDNA	B-SO
by	O
rt	O
-	O
PCR	O
.	O

In	O
combination	O
with	O
3	O
'	O
RACE	O
,	O
this	O
generated	O
a	O
consensus	B-SO
cDNA	B-SO
of	O
2283	O
bp	B-SO
which	O
corresponds	O
to	O
the	O
transcript	B-SO
size	O
of	O
2	O
.	O
3	O
kb	O
detected	O
by	O
the	O
"	O
TACC4	O
"	O
sequence	B-SO
reported	O
in	O
Figure	O
4	O
of	O
Steadman	O
et	O
al	O
[	O
9	O
]	O
.	O

Thus	O
,	O
while	O
it	O
remains	O
possible	O
that	O
the	O
"	O
TACC4	O
"	O
sequence	B-SO
is	O
an	O
alternative	B-SO
splice	I-SO
product	I-SO
,	O
or	O
is	O
the	O
product	O
of	O
reduplication	O
of	O
the	O
TACC3	B-GGP
gene	B-SO
(	O
events	O
that	O
would	O
be	O
specific	O
to	O
the	O
rabbit	B-Taxon
)	O
,	O
the	O
only	O
transcript	B-SO
detected	O
in	O
rabbit	B-Taxon
RNA	B-SO
corresponds	O
to	O
the	O
predicted	B-SO
transcript	B-SO
size	O
of	O
the	O
TACC3	B-GGP
sequence	B-SO
that	O
we	O
have	O
identified	O
here	O
.	O

Furthermore	O
,	O
the	O
string	B-SO
of	I-SO
nucleotides	I-SO
found	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
"	O
TACC4	O
"	O
sequence	B-SO
is	O
also	O
found	O
at	O
the	O
5	O
'	O
ends	O
of	O
a	O
number	O
of	O
cDNA	B-SO
sequences	I-SO
(	O
e	O
.	O
g	O
.	O
U82468	O
,	O
NM	O
_	O
023500	O
)	O
,	O
that	O
were	O
isolated	O
by	O
5	O
'	O
RACE	O
,	O
suggesting	O
that	O
they	O
may	O
correspond	O
to	O
an	O
artefact	O
of	O
the	O
5	O
'	O
RACE	O
methodology	O
used	O
in	O
their	O
construction	O
.	O

The	O
rabbit	B-Taxon
"	O
TACC4	O
"	O
and	O
the	O
rabbit	B-GGP
TACC3	I-GGP
sequence	B-SO
that	O
we	O
have	O
isolated	O
are	O
also	O
found	O
on	O
the	O
same	O
branch	O
of	O
the	O
TACC	O
phylogenetic	O
tree	O
with	O
the	O
other	O
TACC3	B-GGP
orthologues	B-SO
,	O
including	O
maskin	B-GGP
(	I-GGP
Xenopus	I-GGP
laevis	I-GGP
)	I-GGP
,	O
and	O
the	O
newly	O
identified	O
TACC3	B-GGP
sequences	B-SO
in	O
Rattus	B-Taxon
norvegus	I-Taxon
,	O
Gallus	B-Taxon
gallus	I-Taxon
,	O
Silurana	B-Taxon
tropicalis	I-Taxon
,	O
Danio	B-Taxon
rerio	I-Taxon
and	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
,	O
reported	O
in	O
this	O
manuscript	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Thus	O
,	O
it	O
is	O
not	O
in	O
a	O
separate	O
branch	O
that	O
may	O
be	O
expected	O
if	O
the	O
sequence	B-SO
was	O
a	O
distinct	O
TACC	O
family	O
member	O
.	O

Placement	O
of	O
the	O
RHAMM	B-GGP
gene	B-SO
in	O
the	O
phylogeny	O
of	O
the	O
coiled	B-SO
coil	I-SO
gene	B-SO
family	O

Human	B-GGP
RHAMM	I-GGP
has	O
also	O
been	O
proposed	O
to	O
be	O
the	O
missing	O
fourth	O
member	O
of	O
the	O
TACC	O
family	O
[	O
10	O
]	O
.	O

Evidence	O
used	O
in	O
support	O
of	O
this	O
claim	O
included	O
its	O
chromosomal	B-SO
location	I-SO
on	O
5q32	O
in	O
humans	B-Taxon
(	O
discussed	O
below	O
)	O
,	O
its	O
sequence	B-SO
similarity	O
in	O
its	O
coiled	B-SO
coil	I-SO
domain	B-SO
to	O
the	O
TACC	O
domain	B-SO
and	O
the	O
subcellular	O
localization	O
of	O
the	O
RHAMM	B-GGP
protein	B-CHEBI
in	O
the	O
centrosome	B-GO
.	O

However	O
,	O
if	O
RHAMM	B-GGP
were	O
a	O
bona	O
fide	O
TACC	O
family	O
member	O
,	O
then	O
we	O
would	O
predict	O
its	O
evolution	O
would	O
be	O
similar	O
to	O
those	O
of	O
other	O
TACC	O
family	O
members	O
,	O
and	O
fit	O
with	O
the	O
proposed	O
evolution	O
of	O
the	O
vertebrate	B-Taxon
genome	B-SO
.	O

Thus	O
,	O
we	O
set	O
out	O
to	O
identify	O
RHAMM	B-GGP
orthologues	B-SO
and	O
related	O
genes	B-SO
in	O
metazoans	B-Taxon
,	O
so	O
that	O
a	O
more	O
complete	O
phylogeny	O
of	O
the	O
coiled	B-SO
coil	I-SO
super	O
family	O
could	O
be	O
generated	O
.	O

We	O
identified	O
a	O
single	O
RHAMM	B-GGP
gene	B-SO
in	O
all	O
deuterostomes	B-Taxon
for	O
which	O
cDNA	B-SO
and	I-SO
/	I-SO
or	I-SO
genomic	I-SO
sequence	I-SO
was	O
available	O
,	O
including	O
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
.	O

No	O
RHAMM	B-GGP
gene	B-SO
was	O
identified	O
in	O
insects	B-Taxon
or	O
nematodes	B-Taxon
.	O

This	O
indicates	O
that	O
the	O
RHAMM	B-GGP
/	O
TACC	O
genes	B-SO
diverged	O
after	O
the	O
protostome	B-Taxon
/	O
deuterostome	B-Taxon
split	O
833	O
-	O
933	O
MYA	O
,	O
but	O
prior	O
to	O
the	O
echinodermata	B-Taxon
/	O
urochordate	B-Taxon
divergence	O
(	O
>	O
750	O
MYA	O
)	O
.	O

Significantly	O
,	O
sequence	B-SO
and	O
phylogenetic	O
analysis	O
of	O
coiled	B-SO
coil	I-SO
proteins	B-CHEBI
(	O
Fig	O
.	O
1	O
)	O
clearly	O
shows	O
that	O
RHAMM	B-GGP
does	O
not	O
contain	O
a	O
TACC	O
domain	B-SO
and	O
instead	O
forms	O
a	O
distinct	O
family	O
of	O
proteins	B-CHEBI
in	O
the	O
coiled	B-SO
coil	I-SO
superfamily	O
,	O
and	O
is	O
not	O
a	O
direct	O
descendant	O
of	O
the	O
ancestral	O
TACC	O
gene	B-SO
.	O

Evolution	O
of	O
the	O
chromosomal	B-SO
segments	I-SO
containing	O
the	O
TACC	O
genes	B-SO

The	O
phylogenetic	O
tree	O
of	O
the	O
FGFR	B-GGP
genes	B-SO
closely	O
resembles	O
that	O
of	O
the	O
vertebrate	B-Taxon
TACC1	B-GGP
-	O
3	O
genes	B-SO
.	O

Recently	O
,	O
detailed	O
analyses	O
of	O
the	O
chromosomal	B-SO
regions	I-SO
containing	O
the	O
FGFR	B-GGP
gene	B-SO
family	O
in	O
humans	B-Taxon
,	O
mouse	B-Taxon
and	O
the	O
arthopod	B-Taxon
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
have	O
revealed	O
the	O
conservation	B-SO
of	O
paralogous	B-SO
chromosomal	I-SO
segments	I-SO
between	O
these	O
organisms	B-Taxon
(	O
Fig	O
.	O
2	O
,	O
[	O
13	O
]	O
,	O
Table	O
1	O
[	O
see	O
Additional	O
file	O
1	O
]	O
)	O
.	O

This	O
has	O
provided	O
further	O
support	O
that	O
an	O
ancient	O
chromosomal	B-SO
segment	I-SO
was	O
duplicated	O
twice	O
during	O
vertebrate	B-Taxon
evolution	O
,	O
with	O
the	O
first	O
duplication	B-SO
that	O
gave	O
rise	O
to	O
the	O
human	B-Taxon
chromosome	B-GO
4p16	O
/	O
5q32	O
-	O
ter	O
and	O
human	B-Taxon
chromosome	B-GO
8p	O
/	O
10q23	O
-	O
ter	O
ancestors	O
occurring	O
in	O
the	O
early	O
stages	O
after	O
the	O
invertebrate	O
divergence	O
.	O

This	O
suggests	O
that	O
the	O
ancestral	O
FGFR	B-GGP
-	O
TACC	O
gene	B-SO
pair	O
most	O
probably	O
arose	O
prior	O
to	O
the	O
initial	O
duplication	B-SO
and	O
subsequent	O
divergence	O
of	O
these	O
paralogous	B-SO
chromosomal	I-SO
segments	I-SO
,	O
estimated	O
to	O
have	O
occurred	O
687	O
+/-	O
155	O
.	O
7	O
MYA	O
.	O

This	O
has	O
raised	O
the	O
suggestion	O
that	O
a	O
fourth	O
TACC	O
gene	B-SO
in	O
vertebrates	B-Taxon
would	O
reside	O
in	O
the	O
same	O
chromosomal	B-SO
region	I-SO
as	O
FGFR4	B-GGP
.	O

Indeed	O
this	O
hypothesis	O
has	O
been	O
used	O
in	O
support	O
for	O
the	O
RHAMM	B-GGP
gene	B-SO
as	O
a	O
member	O
of	O
the	O
TACC	O
family	O
[	O
10	O
]	O
.	O

Human	B-GGP
RHAMM	I-GGP
maps	O
to	O
chromosome	B-GO
5q32	O
in	O
a	O
region	B-SO
bounded	O
by	O
GPX3	B-GGP
and	O
NKX2E	B-GGP
.	O

These	O
loci	B-SO
separate	O
two	O
clusters	B-SO
of	I-SO
genes	I-SO
on	O
human	B-Taxon
chromosome	B-GO
5	O
that	O
are	O
paralogous	B-SO
with	O
4p16	O
.	O

Interestingly	O
,	O
these	O
three	O
clusters	B-SO
are	O
located	O
on	O
different	O
chromosomes	B-GO
in	O
mouse	B-Taxon
and	O
rat	B-Taxon
(	O
Fig	O
.	O
2	O
)	O
,	O
further	O
suggesting	O
that	O
this	O
cluster	B-SO
of	I-SO
genes	I-SO
was	O
transposed	O
into	O
this	O
region	B-SO
after	O
the	O
primate	B-Taxon
/	O
rodent	B-Taxon
divergence	O
.	O

Figure	O
2	O

Linear	O
organization	O
of	O
gene	B-SO
clusters	I-SO
centering	O
upon	O
the	O
chromosomal	B-SO
loci	I-SO
of	O
the	O
FGFR	B-GGP
genes	B-SO
in	O
humans	B-Taxon
.	O

Paralogous	B-SO
genes	B-SO
present	O
in	O
at	O
least	O
two	O
of	O
the	O
four	O
loci	B-SO
are	O
shown	O
,	O
with	O
the	O
exception	O
of	O
the	O
region	B-SO
between	O
GPX3	B-GGP
and	O
NKX2E	B-GGP
on	O
chromosome	B-GO
5	O
,	O
which	O
appears	O
to	O
represent	O
a	O
series	O
of	O
intervening	O
genes	B-SO
inserted	B-SO
after	O
duplication	B-SO
of	O
the	O
4p16	O
/	O
5q32	O
-	O
35	O
clusters	B-SO
,	O
and	O
genes	B-SO
mentioned	O
in	O
Fig	O
.	O

3	O
.	O

Corresponding	O
syntenic	B-SO
mouse	I-SO
chromosomal	I-SO
regions	I-SO
(	O
mm	O
*	O
)	O
are	O
indicated	O
.	O

Takifugu	B-Taxon
rubripes	I-Taxon
scaffolds	B-SO
are	O
shown	O
(	O
TR	O
*	O
)	O
that	O
contain	O
more	O
than	O
one	O
homologous	B-SO
gene	B-SO
from	O
these	O
clusters	B-SO
.	O

Further	O
details	O
on	O
the	O
location	B-SO
of	O
paralogous	B-SO
genes	B-SO
can	O
be	O
found	O
in	O
[	O
see	O
Additional	O
file	O
1	O
]	O
.	O

Because	O
the	O
conservation	B-SO
of	O
gene	B-SO
order	O
can	O
also	O
provide	O
clues	O
to	O
the	O
evolution	O
of	O
gene	B-SO
regulation	O
,	O
we	O
next	O
attempted	O
to	O
trace	O
the	O
evolution	O
of	O
these	O
paralogous	B-SO
segments	I-SO
by	O
examining	O
the	O
genome	B-SO
of	O
the	O
tunicate	B-Taxon
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
[	O
11	O
]	O
and	O
the	O
most	O
"	O
primitive	O
"	O
compact	O
vertebrate	B-Taxon
genome	B-SO
sequenced	O
to	O
date	O
,	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
[	O
14	O
]	O
.	O

Although	O
not	O
fully	O
assembled	O
,	O
examination	O
of	O
the	O
genome	B-SO
of	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
confirmed	O
the	O
presence	O
of	O
chromosomal	B-SO
segments	I-SO
paralogous	B-SO
to	O
those	O
found	O
in	O
higher	O
vertebrates	B-Taxon
(	O
Fig	O
.	O
2	O
)	O
.	O

For	O
instance	O
,	O
the	O
orthologues	B-SO
of	O
GPRK2L	B-GGP
and	O
RGS12	B-GGP
are	O
found	O
on	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
scaffold	B-SO
290	O
(	O
emb	O
|	O
CAAB01000290	O
.	O
1	O
)	O
,	O
and	O
within	O
300	O
kb	O
of	O
each	O
other	O
in	O
human	B-Taxon
4p16	O
.	O

The	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
orthologues	B-SO
of	O
FGFR3	B-GGP
,	O
LETM1	O
and	O
WHSC1	O
are	O
located	O
on	O
the	O
same	O
166	O
kb	O
genomic	B-SO
scaffold	B-SO
251	O
(	O
emb	O
|	O
CAAB01000166	O
.	O
1	O
)	O
.	O

Significantly	O
,	O
the	O
three	O
human	B-Taxon
orthologues	B-SO
of	O
these	O
genes	B-SO
are	O
also	O
located	O
within	O
300	O
kb	O
of	O
each	O
other	O
on	O
4p16	O
.	O

Furthermore	O
,	O
TACC3	B-GGP
and	O
FGFRL	B-GGP
map	O
to	O
the	O
overlapping	B-SO
scaffolds	B-SO
1184	O
/	O
4669	O
(	O
emb	O
|	O
CAAB01004668	O
)	O
.	O

Similarly	O
,	O
elements	O
of	O
these	O
gene	B-SO
clusters	I-SO
,	O
extending	O
from	O
HMP19	B-GGP
to	O
GPRK6	B-GGP
in	O
human	B-Taxon
chromosome	B-GO
5q34	O
-	O
ter	O
are	O
also	O
found	O
in	O
the	O
pufferfish	B-Taxon
,	O
with	O
the	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
orthologues	B-SO
of	O
NSD1	B-GGP
,	O
FGFR4	B-GGP
and	O
a	O
RAB	O
-	O
like	O
gene	B-SO
mapping	O
on	O
scaffold	B-SO
407	O
(	O
emb	O
|	O
CAAB01000407	O
)	O
.	O

However	O
,	O
there	O
is	O
no	O
evidence	O
for	O
a	O
gene	B-SO
corresponding	O
to	O
a	O
TACC4	O
gene	B-SO
in	O
any	O
of	O
these	O
clusters	B-SO
.	O

As	O
noted	O
above	O
,	O
phylogenetic	O
analysis	O
of	O
the	O
TACC	O
sequences	B-SO
indicate	O
that	O
there	O
are	O
two	O
TACC1	B-GGP
related	O
genes	B-SO
in	O
the	O
pufferfish	B-Taxon
.	O

trTACC1B	B-GGP
is	O
located	O
on	O
the	O
180	O
kb	O
scaffold	B-SO
191	O
(	O
emb	O
|	O
CAAB01000191	O
.	O
1	O
)	O
,	O
which	O
also	O
contains	O
the	O
orthologues	B-SO
of	O
several	O
genes	B-SO
located	O
in	O
human	B-Taxon
chromosome	B-GO
8p21	O
-	O
11	O
.	O

Thus	O
,	O
this	O
scaffold	B-SO
represents	O
the	O
more	O
"	O
developed	O
"	O
TACC1	B-GGP
chromosomal	B-SO
segment	I-SO
that	O
is	O
evident	O
in	O
higher	O
vertebrates	B-Taxon
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
trTACC1A	B-GGP
gene	B-SO
is	O
located	O
in	O
the	O
396	O
kb	O
scaffold	B-SO
12	O
(	O
emb	O
|	O
CAAB010012	O
.	O
1	O
)	O
.	O

This	O
scaffold	B-SO
also	O
contains	O
the	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
orthologues	B-SO
of	O
MSX1	B-GGP
,	O
STX18	B-GGP
,	O
D4S234E	B-GGP
and	O
the	O
predicted	B-SO
gene	I-SO
LOC118711	B-GGP
,	O
in	O
addition	O
to	O
sequences	B-SO
with	I-SO
homology	I-SO
to	O
LOXL	B-GGP
,	O
EVC	B-GGP
,	O
LOC159291	B-GGP
,	O
and	O
the	O
LDB	O
family	O
.	O

Thus	O
,	O
scaffold	B-SO
12	O
contains	O
genes	B-SO
found	O
in	O
the	O
regions	B-SO
of	I-SO
human	I-SO
chromosome	I-SO
4	O
and	O
10	O
that	O
also	O
contain	O
the	O
loci	B-SO
for	O
TACC3	B-GGP
and	O
TACC2	B-GGP
,	O
respectively	O
,	O
and	O
may	O
therefore	O
more	O
closely	O
resemble	O
the	O
genomic	B-SO
organization	O
resulting	O
from	O
the	O
initial	O
duplication	B-SO
of	O
the	O
ancestral	O
paralogous	B-SO
chromosomal	I-SO
segment	I-SO
.	O

Conserved	B-SO
paralogous	B-SO
clusters	B-SO
may	O
result	O
from	O
the	O
initial	O
clustering	B-SO
of	I-SO
the	I-SO
genes	I-SO
in	O
a	O
relatively	O
small	O
ancestral	O
genomic	B-SO
contig	B-SO
.	O

Some	O
evidence	O
for	O
the	O
existence	O
of	O
"	O
protoclusters	O
"	O
that	O
could	O
correspond	O
to	O
the	O
paralogous	B-SO
chromosomal	I-SO
segments	I-SO
noted	O
in	O
higher	O
vertebrates	B-Taxon
is	O
present	O
in	O
the	O
genome	B-SO
of	O
the	O
urochordate	B-Taxon
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
[	O
11	O
]	O
.	O

For	O
instance	O
,	O
the	O
orthologues	B-SO
of	O
FGFR	B-GGP
,	O
and	O
WHSC1	O
,	O
carboxypeptidase	B-GGP
Z	I-GGP
and	O
FLJ25359	O
cluster	B-SO
within	O
an	O
85	O
kb	O
region	B-SO
of	O
the	O
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
genome	B-SO
and	O
the	O
human	B-Taxon
orthologues	B-SO
are	O
still	O
maintained	O
in	O
paralogous	B-SO
segments	I-SO
of	O
4p16	O
,	O
8p	O
and	O
10q	O
(	O
Fig	O
.	O
3	O
,	O
[	O
see	O
Additional	O
file	O
1	O
]	O
)	O
.	O

However	O
,	O
it	O
should	O
be	O
noted	O
that	O
no	O
clusters	B-SO
of	I-SO
genes	I-SO
from	O
the	O
vertebrate	B-Taxon
paralogous	B-SO
segments	I-SO
are	O
locate	O
close	O
to	O
the	O
TACC	O
or	O
RHAMM	B-GGP
genes	I-GGP
of	I-GGP
C	I-GGP
.	I-GGP
intestinalis	I-GGP
,	O
indicating	O
that	O
the	O
formation	O
of	O
the	O
much	O
larger	O
paralogous	B-SO
segments	I-SO
encompassing	O
the	O
FGFR	B-GGP
-	O
TACC	O
genes	B-SO
formed	O
later	O
in	O
evolutionary	O
time	O
,	O
or	O
conversely	O
have	O
been	O
subject	O
to	O
extensive	O
rearrangement	O
in	O
tunicates	B-Taxon
.	O

In	O
combination	O
with	O
the	O
examination	O
of	O
the	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
genome	B-SO
,	O
this	O
also	O
provides	O
additional	O
evidence	O
that	O
either	O
the	O
second	O
round	O
of	O
duplication	B-SO
of	O
the	O
chromosomal	B-SO
segment	I-SO
that	O
contained	O
the	O
FGFR3	B-GGP
/	O
4	O
ancestor	O
did	O
not	O
include	O
a	O
TACC	O
gene	B-SO
,	O
or	O
that	O
such	O
a	O
gene	B-SO
was	O
lost	O
very	O
early	O
in	O
vertebrate	B-Taxon
evolution	O
,	O
prior	O
to	O
the	O
divergence	O
of	O
the	O
Gnanthostome	B-Taxon
lineages	O
.	O

However	O
,	O
the	O
final	O
resolution	O
of	O
the	O
initial	O
evolution	O
of	O
these	O
paralogous	B-SO
segment	I-SO
will	O
await	O
the	O
sequencing	O
of	O
the	O
amphioxus	B-Taxon
and	O
lamprey	B-Taxon
genomes	B-SO
,	O
which	O
only	O
have	O
one	O
FGFR	B-GGP
gene	B-SO
,	O
and	O
therefore	O
should	O
only	O
contain	O
one	O
copy	O
of	O
the	O
other	O
corresponding	O
genes	B-SO
in	O
this	O
conserved	B-SO
segment	I-SO
.	O

Figure	O
3	O

Formation	O
of	O
protoclusters	O
in	O
Takifugu	B-Taxon
rubripes	I-Taxon
and	O
Ciona	B-Taxon
intestinalis	I-Taxon
:	O
(	O
A	O
)	O
:	O
Structure	O
of	O
the	O
genomic	B-SO
scaffolds	B-SO
containing	O
the	O
Takifugu	B-GGP
rubripes	I-GGP
trTACC1A	I-GGP
and	I-GGP
trTACC1B	I-GGP
genes	B-SO
.	O

Scaffold	B-SO
12	O
,	O
the	O
site	B-SO
for	O
the	O
trTACC1A	B-GGP
gene	B-SO
contains	O
genes	B-SO
found	O
with	O
either	O
homologues	B-SO
or	O
orthologues	B-SO
on	O
the	O
distal	O
long	O
arm	B-SO
of	I-SO
human	I-SO
chromosome	I-SO
10	O
and	O
4p16	O
.	O

This	O
scaffold	B-SO
,	O
therefore	O
,	O
has	O
some	O
of	O
the	O
characteristics	O
of	O
the	O
predicted	B-SO
immediate	O
ancestor	O
of	O
the	O
TACC1	B-GGP
/	O
TACC2	B-GGP
chromosomal	B-SO
segment	I-SO
.	O

trTACC1B	B-GGP
is	O
found	O
on	O
scaffold	B-SO
191	O
,	O
which	O
contains	O
orthologues	B-SO
of	O
genes	B-SO
found	O
in	O
the	O
proximal	O
short	O
arm	B-SO
of	I-SO
human	I-SO
chromosome	I-SO
8	O
.	O

(	O
B	O
)	O
:	O
Ciona	B-Taxon
intestinalis	I-Taxon
clusters	B-SO
containing	O
genes	B-SO
found	O
in	O
paralogous	B-SO
segments	I-SO
on	O
human	B-Taxon
8	O
,	O
4p16	O
,	O
10q	O
and	O
5q	O
.	O

Figure	O
4	O

Genomic	B-SO
structure	O
of	O
the	O
TACC	O
genes	B-SO
.	O

Conserved	B-SO
regions	I-SO
known	O
to	O
bind	O
protein	B-CHEBI
factors	O
in	O
all	O
human	B-Taxon
TACC	O
proteins	B-CHEBI
are	O
shown	O
.	O

The	O
SDP	O
repeat	B-SO
of	O
human	B-GGP
TACC1	I-GGP
-	O
3	O
is	O
known	O
to	O
bind	O
GAS41	B-GGP
(	O
[	O
3	O
,	O
15	O
]	O
and	O
data	O
not	O
shown	O
)	O
.	O

The	O
TACC	O
domain	B-SO
binds	O
ch	B-GGP
-	I-GGP
TOG	I-GGP
and	O
members	O
of	O
the	O
Aurora	O
kinases	O
in	O
all	O
species	O
examined	O
to	O
date	O
.	O

This	O
motif	O
is	O
characteristically	O
encoded	O
by	O
the	O
3	O
'	O
exons	B-SO
of	O
the	O
TACC	O
genes	B-SO
.	O

The	O
size	O
of	O
the	O
largest	O
isoform	B-SO
for	O
each	O
gene	B-SO
is	O
shown	O
.	O

Comparative	O
genomic	B-SO
structure	O
of	O
the	O
TACC	O
family	O

The	O
genomic	B-SO
DNA	I-SO
sequences	I-SO
corresponding	O
to	O
the	O
orthologous	B-SO
TACC	O
genes	B-SO
of	O
human	B-Taxon
,	O
mouse	B-Taxon
,	O
rat	B-Taxon
,	O
pufferfish	B-Taxon
,	O
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
and	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
were	O
extracted	O
and	O
analyzed	O
by	O
Genescan	O
and	O
BLAST	O
to	O
determine	O
the	O
genomic	B-SO
structure	O
of	O
each	O
TACC	O
gene	B-SO
.	O

In	O
some	O
cases	O
,	O
for	O
rat	B-Taxon
and	O
pufferfish	B-Taxon
,	O
exons	B-SO
were	O
added	B-SO
or	O
modified	B-SO
based	O
on	O
the	O
best	O
similarity	O
of	O
translated	O
peptides	B-SO
to	O
the	O
corresponding	O
mouse	B-Taxon
and	O
human	B-Taxon
proteins	B-CHEBI
.	O

For	O
regions	B-SO
with	O
low	O
sequence	B-SO
similarity	O
in	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
,	O
genomic	B-SO
sequences	I-SO
from	O
the	O
fresh	O
water	O
pufferfish	B-Taxon
,	O
Tetraodon	B-Taxon
nigroviridis	I-Taxon
were	O
used	O
as	O
additional	O
means	O
to	O
verify	O
the	O
predicted	B-SO
exons	B-SO
.	O

The	O
general	O
structure	O
of	O
the	O
TACC	O
genes	B-SO
and	O
proteins	B-CHEBI
is	O
depicted	O
in	O
Fig	O
.	O

4	O
.	O

The	O
main	O
conserved	B-SO
feature	B-SO
of	O
the	O
TACC	O
family	O
,	O
the	O
TACC	O
domain	B-SO
,	O
is	O
located	O
at	O
the	O
carboxy	B-SO
terminus	I-SO
of	O
the	O
protein	B-CHEBI
.	O

In	O
the	O
case	O
of	O
the	O
C	B-GGP
.	I-GGP
elegans	I-GGP
TAC	I-GGP
protein	B-CHEBI
,	O
this	O
structure	O
comprises	O
the	O
majority	O
of	O
the	O
protein	B-CHEBI
and	O
is	O
encoded	O
by	O
two	O
of	O
the	O
three	O
exons	B-SO
of	O
the	O
gene	B-SO
.	O

In	O
the	O
higher	O
organisms	B-Taxon
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
,	O
and	O
the	O
deuterostomes	B-Taxon
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
to	O
human	B-Taxon
,	O
this	O
feature	B-SO
is	O
also	O
encoded	O
by	O
the	O
final	O
exons	B-SO
of	O
the	O
gene	B-SO
(	O
five	O
in	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
,	O
seven	O
in	O
the	O
deuterostome	B-Taxon
genes	B-SO
)	O
.	O

Outside	O
of	O
the	O
TACC	O
domain	B-SO
,	O
however	O
,	O
TACC	O
family	O
members	O
show	O
relatively	O
little	O
homology	B-SO
.	O

It	O
is	O
interesting	O
that	O
each	O
TACC	O
gene	B-SO
contains	O
one	O
large	O
exon	B-SO
,	O
which	O
shows	O
considerable	O
variability	O
between	O
TACC	O
orthologues	B-SO
,	O
and	O
constitutes	O
the	O
main	O
difference	O
between	O
the	O
TACC3	B-GGP
genes	B-SO
in	O
the	O
vertebrates	B-Taxon
(	O
see	O
below	O
)	O
.	O

In	O
deuterostomes	B-Taxon
,	O
this	O
exon	B-SO
contains	O
the	O
SDP	O
repeat	B-SO
(	O
or	O
in	O
the	O
case	O
of	O
the	O
murine	B-Taxon
TACC3	B-GGP
'	I-GGP
s	I-GGP
,	O
a	O
rodent	B-Taxon
-	O
specific	O
24	O
amino	B-CHEBI
acid	I-CHEBI
repeat	B-SO
)	O
,	O
which	O
is	O
responsible	O
for	O
the	O
binding	O
of	O
the	O
SWI	B-GO
/	I-GO
SNF	I-GO
chromatin	I-GO
remodeling	I-GO
complex	I-GO
component	O
GAS41	B-GGP
[	O
15	O
,	O
16	O
]	O
.	O

Of	O
the	O
vertebrate	B-Taxon
TACC	O
proteins	B-CHEBI
,	O
the	O
TACC3	B-GGP
orthologues	B-SO
show	O
the	O
greatest	O
variability	O
in	O
size	O
and	O
sequence	B-SO
,	O
ranging	O
in	O
size	O
from	O
599	O
amino	B-CHEBI
acids	I-CHEBI
for	O
the	O
rat	B-GGP
TACC3	I-GGP
protein	B-CHEBI
,	O
to	O
942	O
amino	B-CHEBI
acids	I-CHEBI
in	O
the	O
Danio	B-Taxon
rerio	I-Taxon
protein	B-CHEBI
.	O

The	O
reasons	O
for	O
these	O
differences	O
are	O
apparent	O
from	O
the	O
genomic	B-SO
structure	O
of	O
the	O
TACC3	B-GGP
orthologues	B-SO
.	O

TACC3	B-GGP
can	O
be	O
divided	O
into	O
three	O
sections	O
:	O
a	O
conserved	B-SO
N	I-SO
-	I-SO
terminal	I-SO
region	I-SO
(	O
CNTR	O
)	O
of	O
108	O
amino	B-CHEBI
acids	I-CHEBI
,	O
encoded	O
by	O
exons	B-SO
2	O
and	O
3	O
in	O
each	O
vertebrate	B-Taxon
TACC3	B-GGP
gene	B-SO
,	O
the	O
conserved	B-SO
TACC	O
domain	B-SO
distributed	O
over	O
the	O
final	O
seven	O
exons	B-SO
,	O
and	O
a	O
highly	O
variable	O
central	O
region	B-SO
.	O

The	O
lack	O
of	O
conservation	B-SO
in	O
both	O
size	O
and	O
sequence	B-SO
of	O
the	O
central	O
portion	B-SO
of	O
the	O
TACC3	B-GGP
proteins	B-CHEBI
of	O
human	B-Taxon
and	O
mouse	B-Taxon
has	O
been	O
previously	O
noted	O
,	O
and	O
accounts	O
for	O
the	O
major	O
difference	O
between	O
these	O
two	O
orthologues	B-SO
[	O
2	O
]	O
.	O

The	O
majority	O
of	O
this	O
central	O
portion	B-SO
,	O
which	O
contains	O
the	O
SDP	O
repeat	B-SO
motifs	I-SO
,	O
is	O
encoded	O
by	O
one	O
exon	B-SO
in	O
human	B-Taxon
and	O
the	O
pufferfish	B-Taxon
(	O
emb	O
|	O
CAAB01001184	O
)	O
.	O

In	O
rodents	B-Taxon
,	O
however	O
,	O
this	O
region	B-SO
is	O
almost	O
entirely	O
composed	O
of	O
seven	O
24	O
amino	B-CHEBI
acid	I-CHEBI
repeats	B-SO
,	O
which	O
are	O
located	O
in	O
a	O
single	O
exon	B-SO
of	O
the	O
mouse	B-GGP
and	I-GGP
rat	I-GGP
TACC3	I-GGP
genes	B-SO
.	O

It	O
has	O
been	O
previously	O
reported	O
that	O
there	O
are	O
four	O
mouse	B-GGP
TACC3	I-GGP
splice	B-SO
variants	I-SO
that	O
differ	O
in	O
the	O
number	O
of	O
these	O
repeats	B-SO
[	O
2	O
,	O
7	O
,	O
17	O
]	O
.	O

As	O
these	O
repeats	B-SO
are	O
present	O
in	O
a	O
single	O
exon	B-SO
,	O
it	O
appears	O
likely	O
that	O
these	O
different	O
sequences	B-SO
may	O
be	O
the	O
result	O
of	O
the	O
DNA	B-SO
polymerases	O
used	O
in	O
the	O
cDNA	B-SO
synthesis	O
and	O
/	O
or	O
PCR	O
reaction	O
stuttering	O
through	O
the	O
repeat	B-SO
motif	I-SO
.	O

The	O
correct	O
sequence	B-SO
,	O
reported	O
by	O
Sadek	O
et	O
al	O
[	O
7	O
]	O
,	O
is	O
the	O
one	O
used	O
throughout	O
the	O
entirety	O
of	O
this	O
manuscript	O
.	O

These	O
repeats	B-SO
are	O
not	O
evident	O
in	O
the	O
rabbit	B-Taxon
protein	B-CHEBI
,	O
or	O
any	O
other	O
TACC	O
protein	B-CHEBI
,	O
and	O
may	O
indicate	O
that	O
the	O
rodent	B-Taxon
TACC3	B-GGP
has	O
evolved	O
distinct	O
functions	O
,	O
as	O
has	O
already	O
been	O
noted	O
for	O
the	O
amphibian	B-Taxon
Xenopus	B-Taxon
TACC3	B-GGP
,	O
maskin	B-GGP
[	O
8	O
]	O
.	O

Alternative	O
splicing	O
in	O
vertebrate	B-Taxon
TACC	O
genes	B-SO

Whereas	O
exon	B-SO
shuffling	O
can	O
drive	O
the	O
functional	O
diversification	O
of	O
gene	B-SO
families	O
over	O
evolutionary	O
time	O
,	O
the	O
temporal	O
and	O
/	O
or	O
tissue	O
specific	O
alternative	O
splicing	O
of	O
a	O
gene	B-SO
can	O
give	O
rise	O
to	O
functional	O
diversification	O
of	O
a	O
single	O
gene	B-SO
during	O
the	O
development	O
of	O
an	O
organism	B-Taxon
.	O

Although	O
no	O
alternative	O
splicing	O
of	O
TACC3	B-GGP
has	O
been	O
clearly	O
documented	O
,	O
both	O
temporal	O
and	O
tissue	O
specific	O
splicing	O
is	O
observed	O
in	O
the	O
TACC1	B-GGP
and	O
TACC2	B-GGP
genes	B-SO
.	O

In	O
the	O
case	O
of	O
TACC2	B-GGP
,	O
an	O
additional	O
large	O
(	O
5	O
kb	O
)	O
exon	B-SO
accounts	O
for	O
the	O
main	O
difference	O
between	O
the	O
major	O
splice	B-SO
variants	I-SO
of	O
the	O
vertebrate	B-Taxon
TACC2	B-GGP
genes	B-SO
[	O
3	O
]	O
.	O

The	O
alternative	O
splicing	O
of	O
this	O
exon	B-SO
suggests	O
a	O
major	O
functional	O
difference	O
between	O
the	O
two	O
TACC2	B-GGP
isoforms	B-SO
,	O
TACC2s	O
and	O
TACC2l	O
[	O
3	O
]	O
,	O
as	O
well	O
as	O
a	O
significant	O
difference	O
between	O
TACC2	B-GGP
and	O
its	O
closest	O
TACC	O
family	O
relative	O
,	O
TACC1	B-GGP
.	O

However	O
,	O
the	O
function	O
of	O
this	O
region	B-SO
of	O
the	O
TACC2l	O
isoform	B-SO
is	O
current	O
unknown	O
.	O

Alternative	O
splicing	O
,	O
together	O
with	O
differential	O
promoter	B-SO
usage	O
has	O
already	O
been	O
noted	O
for	O
the	O
human	B-GGP
TACC1	I-GGP
gene	B-SO
[	O
18	O
,	O
19	O
]	O
.	O

In	O
addition	O
,	O
as	O
shown	O
in	O
Fig	O
.	O

5	O
,	O
we	O
have	O
identified	O
additional	O
TACC1	B-GGP
isoforms	B-SO
that	O
result	O
from	O
alternative	O
splicing	O
of	O
exons	B-SO
1b	O
-	O
4a	O
.	O

The	O
functions	O
of	O
these	O
different	B-SO
isoforms	I-SO
are	O
unknown	O
,	O
however	O
the	O
region	B-SO
deleted	B-SO
from	O
the	O
shorter	O
variants	B-SO
can	O
include	O
the	O
binding	B-SO
site	I-SO
for	O
LSm7	B-GGP
[	O
20	O
]	O
(	O
variants	B-SO
C	O
,	O
D	O
,	O
F	O
-	O
I	O
)	O
,	O
and	O
/	O
or	O
the	O
nuclear	B-GO
localization	O
signals	B-SO
and	O
binding	B-SO
site	I-SO
for	O
GAS41	B-GGP
[	O
15	O
]	O
and	O
PCTAIRE2BP	B-GGP
[	O
20	O
]	O
(	O
isoforms	B-SO
B	O
-	O
D	O
,	O
S	O
)	O
.	O

One	O
of	O
these	O
isoforms	B-SO
,	O
TACC1S	O
is	O
localized	O
exclusively	O
to	O
the	O
cytoplasm	B-GO
[	O
19	O
]	O
,	O
suggesting	O
that	O
the	O
shorter	O
isoforms	B-SO
would	O
not	O
be	O
able	O
to	O
interact	O
with	O
elements	O
of	O
the	O
chomatin	B-GO
remodeling	O
and	O
/	O
or	O
RNA	B-SO
processing	O
machinery	O
in	O
the	O
nucleus	B-GO
.	O

Thus	O
,	O
changes	O
in	O
the	O
complement	O
of	O
TACC1	B-GGP
isoforms	B-SO
in	O
the	O
cell	B-CL
may	O
result	O
in	O
alterations	O
in	O
cellular	B-CL
RNA	B-SO
metabolism	O
at	O
multiple	O
levels	O
,	O
and	O
may	O
account	O
for	O
the	O
observation	O
that	O
TACC1D	O
and	O
TACC1F	O
isoforms	B-SO
are	O
associated	O
with	O
tumorigenic	O
changes	O
in	O
gastric	O
mucosa	O
[	O
18	O
]	O
.	O

Figure	O
5	O

Alternative	O
splicing	O
of	O
the	O
human	B-GGP
TACC1	I-GGP
gene	B-SO
.	O

(	O
A	O
)	O
:	O
Seven	O
splice	B-SO
variants	I-SO
have	O
been	O
identified	O
for	O
human	B-GGP
TACC1	I-GGP
(	O
A	O
-	O
F	O
and	O
S	O
)	O
.	O

We	O
have	O
also	O
identified	O
additional	O
splice	B-SO
variants	I-SO
(	O
G	O
-	O
I	O
)	O
from	O
database	O
analysis	O
and	O
rt	O
-	O
PCR	O
analysis	O
of	O
human	B-Taxon
brain	O
RNA	B-SO
.	O

(	O
B	O
)	O
:	O
Alternative	O
splicing	O
of	O
TACC1	B-GGP
in	O
the	O
human	B-Taxon
brain	O
.	O

rt	O
-	O
PCR	O
analysis	O
confirms	O
splicing	O
of	O
the	O
untranslated	B-SO
exon	I-SO
1a	O
to	O
exon	B-SO
1	O
,	O
with	O
retention	O
of	O
the	O
originally	O
defined	O
start	O
methionine	B-CHEBI
(	O
GB	O
:	O
NP	O
_	O
006274	O
)	O
(	O
Variant	B-SO
A	O
*	O
,	O
lanes	O
1	O
and	O
3	O
)	O
.	O

Exon	B-SO
1a	O
also	O
splices	O
to	O
exon	B-SO
2	O
,	O
removing	B-SO
the	O
L	B-GGP
-	I-GGP
Sm7	I-GGP
binding	O
motif	O
(	O
variant	B-SO
I	O
,	O
lanes	O
3	O
,	O
12	O
and	O
13	O
)	O
.	O

Variants	B-SO
that	O
functionally	O
delete	B-SO
exons	B-SO
2	O
and	O
/	O
or	O
3	O
,	O
such	O
as	O
variant	B-SO
C	O
(	O
lane	O
15	O
)	O
also	O
remove	B-SO
the	O
predicted	B-SO
nuclear	B-GO
localization	O
signals	B-SO
,	O
and	O
the	O
binding	O
domains	B-SO
for	O
GAS41	B-GGP
and	O
PCTAIRE2BP	B-GGP
.	O

These	O
variants	B-SO
would	O
retain	O
the	O
TACC	O
domain	B-SO
,	O
and	O
therefore	O
the	O
potential	O
to	O
bind	O
to	O
ch	B-GGP
-	I-GGP
TOG	I-GGP
and	O
Aurora	B-GGP
A	I-GGP
kinase	I-GGP
in	O
the	O
centrosome	B-GO
.	O

Lane	O
1	O
:	O
EF	O
/	O
X1R	O
,	O
Lane	O
2	O
:	O
EF	O
/	O
BX647R	O
,	O
Lane	O
3	O
:	O
EF	O
/	O
6SPR	O
,	O
Lane	O
4	O
:	O
EF	O
/	O
1DR	O
,	O
Lane	O
5	O
,	O
EF	O
/	O
128R	O
,	O
Lane	O
6	O
X3F	O
/	O
X1R	O
,	O
Lane	O
7	O
:	O
X3F	O
/	O
BX647R	O
,	O
Lane	O
8	O
:	O
X3F	O
/	O
6SPR	O
,	O
Lane	O
9	O
:	O
X3F	O
/	O
1DR	O
,	O
Lane	O
10	O
,	O
X3F	O
/	O
128R	O
,	O
Lane	O
11	O
:	O
1DF	O
/	O
X1R	O
,	O
Lane	O
12	O
:	O
1DF	O
/	O
BX647R	O
,	O
Lane	O
13	O
:	O
1DF	O
/	O
6SPR	O
,	O
Lane	O
14	O
:	O
1DF	O
/	O
1DR	O
,	O
Lane	O
15	O
:	O
1DF	O
/	O
128R	O
,	O
Lane	O
16	O
:	O
Biorad	O
1	O
kb	O
+	O
Size	O
ladder	O
.	O

In	O
silico	O
modeling	O
of	O
the	O
evolution	O
of	O
TACC	O
protein	B-CHEBI
function	O

The	O
protein	B-CHEBI
and	O
genomic	B-SO
structure	O
of	O
the	O
present	O
day	O
TACC	O
family	O
members	O
suggests	O
that	O
the	O
function	O
of	O
the	O
ancestral	O
TACC	O
protein	B-CHEBI
was	O
mediated	O
solely	O
through	O
the	O
interactions	O
of	O
the	O
conserved	B-SO
TACC	O
domain	B-SO
.	O

Using	O
an	O
in	O
silico	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interaction	O
model	O
based	O
upon	O
known	O
mitotic	O
spindle	B-GO
and	O
centrosomal	B-GO
components	O
,	O
we	O
have	O
previously	O
predicted	O
a	O
number	O
of	O
additional	O
interactions	O
that	O
could	O
be	O
conserved	O
between	O
a	O
functional	O
TACC	O
homologue	B-SO
in	O
yeast	B-Taxon
,	O
spc	B-GGP
-	I-GGP
72	I-GGP
,	O
and	O
one	O
or	O
more	O
human	B-Taxon
TACC	O
proteins	B-CHEBI
[	O
21	O
]	O
.	O

Thus	O
,	O
it	O
is	O
known	O
that	O
all	O
the	O
TACC	O
proteins	B-CHEBI
examined	O
to	O
date	O
interact	O
,	O
via	O
the	O
TACC	O
domain	B-SO
,	O
with	O
the	O
microtubule	B-GO
/	O
centrosomal	B-GO
proteins	B-CHEBI
of	O
the	O
stu2	B-GGP
/	O
msps	B-GGP
/	O
ch	B-GGP
-	I-GGP
TOG	I-GGP
family	O
[	O
5	O
,	O
6	O
,	O
22	O
-	O
24	O
]	O
,	O
and	O
with	O
the	O
Aurora	O
kinases	O
[	O
20	O
,	O
21	O
,	O
25	O
]	O
.	O

These	O
interactions	O
are	O
required	O
for	O
the	O
accumulation	O
of	O
the	O
D	O
-	O
TACC	O
,	O
spc72	O
,	O
ceTAC1	O
and	O
TACC3	B-GGP
proteins	B-CHEBI
to	O
the	O
centrosome	B-GO
[	O
5	O
,	O
6	O
,	O
22	O
-	O
24	O
]	O
.	O

Hence	O
,	O
this	O
functional	O
interaction	O
with	O
the	O
centrosome	B-GO
and	O
mitotic	O
spindle	B-GO
is	O
likely	O
to	O
represent	O
the	O
ancient	O
,	O
conserved	O
function	O
of	O
the	O
TACC	O
family	O
.	O

However	O
,	O
it	O
is	O
apparent	O
that	O
the	O
human	B-Taxon
TACC	O
proteins	B-CHEBI
also	O
differ	O
in	O
their	O
ability	O
to	O
interact	O
with	O
the	O
Aurora	O
kinases	O
.	O

For	O
instance	O
,	O
TACC1	B-GGP
and	O
TACC3	B-GGP
interact	O
with	O
Aurora	B-GGP
A	I-GGP
kinase	I-GGP
,	O
whereas	O
TACC2	B-GGP
interacts	O
with	O
Aurora	B-GGP
C	I-GGP
kinase	I-GGP
[	O
21	O
]	O
,	O
suggesting	O
a	O
degree	O
of	O
functional	O
specialization	O
in	O
the	O
derivatives	O
of	O
the	O
ancestral	O
chordate	B-Taxon
TACC	O
,	O
after	O
the	O
radiation	O
of	O
the	O
vertebrate	B-Taxon
TACC	O
genes	B-SO
.	O

The	O
localization	O
of	O
the	O
vertebrate	B-Taxon
TACC	O
proteins	B-CHEBI
in	O
the	O
interphase	O
nucleus	B-GO
[	O
15	O
,	O
26	O
,	O
27	O
]	O
suggests	O
that	O
they	O
have	O
additional	O
functions	O
outside	O
their	O
ancient	O
role	O
in	O
the	O
centrosome	B-GO
and	O
microtubule	B-GO
dynamics	O
.	O

Thus	O
,	O
it	O
seems	O
likely	O
that	O
TACC	O
family	O
members	O
in	O
protostomes	B-Taxon
and	O
deuterostomes	B-Taxon
have	O
integrated	O
new	O
unique	O
functions	O
as	O
the	O
evolving	O
TACC	O
genes	B-SO
acquired	O
additional	O
exons	B-SO
.	O

The	O
results	O
of	O
the	O
pilot	O
large	O
-	O
scale	O
proteomic	O
analysis	O
in	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
and	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
provide	O
further	O
suggestive	O
evidence	O
to	O
this	O
functional	O
evolution	O
.	O

Yeast	B-Taxon
two	O
hybrid	O
analysis	O
indicates	O
that	O
ceTAC	B-GGP
directly	O
binds	O
to	O
C	B-GGP
.	I-GGP
elegans	I-GGP
lin15A	I-GGP
,	I-GGP
lin36	I-GGP
and	I-GGP
lin37	I-GGP
[	O
28	O
]	O
.	O

These	O
proteins	B-CHEBI
bridge	O
ceTAC	B-GGP
to	O
other	O
elements	O
of	O
the	O
cytoskeleton	B-GO
and	O
microtubule	B-GO
network	O
,	O
as	O
well	O
as	O
to	O
components	O
of	O
the	O
ribosome	B-GO
,	O
the	O
histone	B-CHEBI
deacetylase	O
chromatin	B-GO
remodeling	O
machinery	O
such	O
as	O
egr	B-GGP
-	I-GGP
1	I-GGP
and	O
lin	B-GGP
-	I-GGP
53	I-GGP
(	O
the	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
homologues	B-SO
of	O
the	O
human	B-GGP
MTA	I-GGP
-	I-GGP
1	I-GGP
and	I-GGP
RbAP48	I-GGP
)	O
,	O
and	O
to	O
transcription	O
factors	O
such	O
as	O
the	O
PAL1	B-GGP
homeobox	O
and	O
the	O
nuclear	B-GO
hormone	B-CHEBI
receptor	O
nhr	B-GGP
-	I-GGP
86	I-GGP
[	O
28	O
]	O
(	O
Fig	O
.	O
6A	O
)	O
.	O

Similarly	O
,	O
large	O
scale	O
proteomics	O
[	O
29	O
]	O
has	O
shown	O
that	O
Drosophila	B-GGP
TACC	I-GGP
interacts	O
with	O
two	O
proteins	B-CHEBI
,	O
the	O
RNA	B-SO
binding	O
protein	B-CHEBI
TBPH	B-GGP
and	O
CG14540	B-GGP
(	O
Fig	O
.	O
6B	O
)	O
,	O
and	O
thus	O
indirectly	O
with	O
the	O
Drosophila	B-Taxon
SWI	B-GO
/	I-GO
SNF	I-GO
chromatin	I-GO
remodeling	I-GO
complex	I-GO
and	O
DNA	B-SO
damage	O
repair	O
machinery	O
.	O

Significantly	O
,	O
the	O
ceTAC	B-GGP
protein	B-CHEBI
has	O
also	O
recently	O
been	O
implicated	O
in	O
DNA	B-SO
repair	O
through	O
its	O
direct	O
interaction	O
with	O
the	O
C	B-GGP
.	I-GGP
elegans	I-GGP
BARD1	I-GGP
orthologue	B-SO
[	O
30	O
]	O
.	O

It	O
should	O
be	O
noted	O
that	O
a	O
number	O
of	O
interactions	O
with	O
the	O
TACC	O
proteins	B-CHEBI
from	O
these	O
organisms	B-Taxon
have	O
probably	O
been	O
missed	O
by	O
these	O
large	O
scale	O
methods	O
,	O
including	O
the	O
well	O
documented	O
direct	O
interactions	O
with	O
the	O
aurora	O
kinases	O
and	O
the	O
stu2	B-GGP
/	O
msps	B-GGP
/	O
ch	B-GGP
-	I-GGP
TOG	I-GGP
family	O
.	O

Figure	O
6	O

Functional	O
evolution	O
of	O
the	O
TACC	O
proteins	B-CHEBI
modeled	O
in	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
and	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
.	O

(	O
A	O
)	O
.	O

C	B-Taxon
.	I-Taxon
elegans	I-Taxon
interaction	O
map	O
shows	O
empirically	O
defined	O
interactions	O
of	O
ceTAC	B-GGP
,	O
and	O
extrapolated	O
interactions	O
defined	O
by	O
[	O
28	O
]	O
.	O

(	O
B	O
)	O
:	O
Using	O
the	O
BIND	O
database	O
[	O
29	O
]	O
,	O
DTACC	B-GGP
directly	O
binds	O
to	O
TBPH	B-GGP
and	O
CG14540	B-GGP
,	O
and	O
thus	O
indirectly	O
to	O
chromatin	B-GO
remodeling	I-GO
complexes	I-GO
(	O
SWI	B-GO
/	I-GO
SNF	I-GO
and	O
histone	B-CHEBI
acetyltransferases	O
)	O
,	O
DNA	B-SO
damage	O
repair	O
machinery	O
(	O
via	O
RAD23	B-GGP
)	O
,	O
and	O
RNA	B-SO
splicing	O
,	O
transport	O
and	O
translational	O
machinery	O
.	O

(	O
C	O
)	O
:	O
Predicted	O
interaction	O
map	O
for	O
vertebrate	B-Taxon
TACCs	O
,	O
based	O
upon	O
ceTAC	B-GGP
,	O
suggests	O
an	O
indirect	O
interaction	O
with	O
the	O
nuclear	B-GO
hormone	B-CHEBI
receptor	O
RXR	B-GGP
beta	I-GGP
.	O

It	O
is	O
also	O
of	O
interest	O
that	O
this	O
predicts	O
a	O
functional	O
interaction	O
with	O
the	O
LDB	O
family	O
,	O
members	O
of	O
which	O
are	O
also	O
found	O
in	O
TACC	O
containing	O
paralogous	B-SO
segments	I-SO
noted	O
in	O
Figs	O
2	O
,	O
3	O
and	O
Additional	O
file	O
1	O
.	O

(	O
D	O
)	O
:	O
Predicted	O
TACC	O
interaction	O
map	O
based	O
upon	O
DTACC	B-GGP
.	O

(	O
E	O
)	O
:	O
Vertebrate	B-Taxon
TACC	O
interactions	O
identified	O
to	O
date	O
.	O

?	O
denotes	O
uncertainty	O
over	O
the	O
identity	O
of	O
a	O
functional	O
vertebrate	B-Taxon
homologue	B-SO
.	O

In	O
C	O
,	O
D	O
and	O
E	O
,	O
'	O
*	O
'	O
denotes	O
one	O
or	O
more	O
members	O
of	O
the	O
TACC	O
or	O
Aurora	O
kinase	O
family	O
.	O

Because	O
of	O
the	O
evolutionary	B-SO
conservation	I-SO
of	O
the	O
TACC	O
domain	B-SO
,	O
we	O
would	O
predict	O
that	O
some	O
of	O
the	O
functional	O
interactions	O
seen	O
in	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
and	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
would	O
be	O
observed	O
in	O
higher	O
animals	B-Taxon
.	O

Phylogenetic	O
profiling	O
from	O
these	O
interaction	O
maps	O
suggests	O
two	O
similar	O
sets	O
of	O
predicted	O
interactions	O
for	O
vertebrate	B-Taxon
TACCs	O
(	O
Fig	O
.	O
6C	O
and	O
6D	O
)	O
.	O

Strikingly	O
,	O
however	O
,	O
the	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
specific	O
proteins	B-CHEBI
lin15A	B-GGP
,	O
lin36	B-GGP
and	O
lin37	B-GGP
do	O
not	O
have	O
readily	O
discernible	O
homologues	B-SO
in	O
vertebrates	B-Taxon
or	O
Drosophila	B-Taxon
,	O
although	O
the	O
presence	O
of	O
a	O
zinc	B-CHEBI
finger	O
domain	B-SO
in	O
lin36	B-GGP
may	O
suggest	O
that	O
this	O
protein	B-CHEBI
is	O
involved	O
directly	O
in	O
transcription	O
or	O
perform	O
an	O
adaptor	O
role	O
similar	O
to	O
LIM	O
containing	O
proteins	B-CHEBI
.	O

For	O
the	O
DTACC	B-GGP
interacting	O
proteins	B-CHEBI
,	O
TBPH	B-GGP
corresponds	O
to	O
TDP43	B-GGP
,	O
a	O
protein	B-CHEBI
implicated	O
in	O
transcriptional	O
regulation	O
and	O
splicing	O
[	O
31	O
,	O
32	O
]	O
.	O

However	O
,	O
the	O
assignment	O
of	O
the	O
human	B-Taxon
homologue	B-SO
of	O
CG14540	B-GGP
is	O
less	O
clear	O
,	O
with	O
the	O
closest	O
matches	B-SO
in	O
the	O
human	B-Taxon
databases	O
corresponding	O
to	O
glutamine	B-CHEBI
rich	O
transcription	O
factors	O
such	O
as	O
CREB	B-GGP
and	O
the	O
G	B-CHEBI
-	O
box	O
binding	O
factor	O
.	O

Comparison	O
of	O
modeled	O
with	O
experimentally	O
defined	O
interactions	O
of	O
the	O
vertebrate	B-Taxon
TACC	O
proteins	B-CHEBI

The	O
interaction	O
data	O
for	O
the	O
vertebrate	B-Taxon
TACCs	O
is	O
relatively	O
limited	O
;	O
however	O
,	O
interaction	O
networks	O
are	O
now	O
beginning	O
to	O
emerge	O
.	O

The	O
results	O
of	O
our	O
functional	O
analysis	O
,	O
as	O
well	O
as	O
other	O
published	O
data	O
clearly	O
indicate	O
that	O
the	O
vertebrate	B-Taxon
TACCs	O
interact	O
with	O
proteins	B-CHEBI
that	O
can	O
be	O
divided	O
into	O
two	O
broad	O
categories	O
:	O
1	O
)	O
proteins	B-CHEBI
with	O
roles	O
in	O
centrosome	B-GO
/	O
mitotic	O
spindle	B-GO
dynamics	O
,	O
and	O
2	O
)	O
proteins	B-CHEBI
involved	O
in	O
gene	B-SO
regulation	O
,	O
either	O
at	O
the	O
level	O
of	O
transcription	O
,	O
or	O
subsequent	O
RNA	B-SO
processing	O
and	O
translation	O
[	O
3	O
,	O
5	O
-	O
7	O
,	O
15	O
,	O
19	O
-	O
21	O
,	O
24	O
,	O
25	O
,	O
33	O
,	O
34	O
]	O
.	O

Many	O
of	O
these	O
proteins	B-CHEBI
do	O
not	O
appear	O
to	O
interact	O
directly	O
with	O
the	O
protostome	O
TACCs	O
,	O
but	O
would	O
be	O
expected	O
to	O
be	O
in	O
the	O
same	O
protein	B-GO
complex	I-GO
(	O
Fig	O
.	O
6C	O
,	O
6D	O
)	O
.	O

Significant	O
analysis	O
of	O
the	O
association	O
of	O
the	O
TACCs	O
with	O
the	O
centrosome	B-GO
and	O
the	O
dynamics	O
of	O
mitotic	O
spindle	B-GO
assembly	O
from	O
yeast	B-Taxon
to	O
humans	O
has	O
been	O
published	O
[	O
5	O
,	O
6	O
,	O
21	O
-	O
24	O
]	O
.	O

From	O
this	O
analysis	O
,	O
it	O
seems	O
likely	O
that	O
the	O
vertebrate	B-Taxon
TACC3	B-GGP
protein	B-CHEBI
has	O
retained	O
this	O
direct	O
ancestral	O
function	O
,	O
based	O
upon	O
its	O
location	O
in	O
these	O
structures	O
during	O
mitosis	O
[	O
27	O
]	O
,	O
its	O
strong	O
interaction	O
with	O
Aurora	B-GGP
Kinase	I-GGP
A	I-GGP
,	O
and	O
the	O
observation	O
that	O
it	O
is	O
the	O
only	O
human	B-Taxon
TACC	O
protein	B-CHEBI
phosphorylated	O
by	O
this	O
enzyme	B-SO
[	O
21	O
]	O
.	O

However	O
,	O
the	O
variability	O
of	O
the	O
central	O
domain	B-SO
of	O
the	O
vertebrate	B-Taxon
orthologues	B-SO
,	O
suggests	O
that	O
TACC3	B-GGP
may	O
also	O
have	O
acquired	O
additional	O
,	O
and	O
in	O
some	O
instances	O
,	O
species	O
-	O
specific	O
functions	O
.	O

For	O
instance	O
,	O
in	O
X	B-Taxon
.	I-Taxon
laevis	I-Taxon
,	O
the	O
maskin	B-GGP
protein	B-CHEBI
has	O
acquired	O
a	O
binding	B-SO
site	I-SO
for	I-SO
the	I-SO
eIF4E	I-SO
protein	I-SO
,	O
and	O
thus	O
a	O
function	O
in	O
the	O
coordinated	O
control	O
of	O
polyadenylation	O
and	O
translation	O
in	O
the	O
Xenopus	B-Taxon
oocyte	B-CL
[	O
8	O
,	O
35	O
]	O
.	O

A	O
recent	O
study	O
has	O
suggested	O
that	O
this	O
function	O
may	O
be	O
unique	O
to	O
maskin	B-GGP
:	O
although	O
it	O
is	O
unclear	O
whether	O
the	O
other	O
vertebrate	B-Taxon
TACC3	B-GGP
proteins	B-CHEBI
interact	O
with	O
the	O
eIF4E	B-GGP
/	O
CPEB	O
complex	B-GO
,	O
the	O
human	B-Taxon
TACC1A	O
isoform	B-SO
is	O
unable	O
to	O
interact	O
with	O
the	O
eIF4E	B-GGP
/	O
CPEB	B-GGP
complex	B-GO
.	O

Instead	O
,	O
some	O
TACC1	B-GGP
isoforms	B-SO
have	O
evolved	O
a	O
related	O
,	O
but	O
distinct	O
function	O
by	O
directly	O
interacting	O
with	O
elements	O
of	O
the	O
RNA	B-SO
splicing	O
and	O
transport	O
machinery	O
[	O
19	O
]	O
.	O

To	O
further	O
characterize	O
the	O
evolving	O
functions	O
of	O
the	O
TACC	O
proteins	B-CHEBI
,	O
we	O
have	O
used	O
an	O
unbiased	O
yeast	B-Taxon
two	O
hybrid	O
screening	O
method	O
to	O
identify	O
proteins	B-CHEBI
that	O
bind	O
to	O
the	O
human	B-Taxon
TACC	O
proteins	B-CHEBI
[	O
3	O
,	O
34	O
]	O
.	O

In	O
a	O
screen	O
of	O
a	O
MATCHMAKER	O
fetal	O
brain	O
library	O
(	O
BD	O
Biosciences	O
Clontech	O
)	O
,	O
in	O
addition	O
to	O
isolating	O
the	O
histone	B-CHEBI
acetyltransferase	O
hGCN5L2	B-GGP
[	O
34	O
]	O
,	O
we	O
also	O
identified	O
the	O
beta	O
3	O
isoform	B-SO
of	O
retinoid	B-GGP
-	I-GGP
X	I-GGP
receptor	I-GGP
beta	I-GGP
as	O
a	O
protein	B-CHEBI
that	O
interacts	O
with	O
the	O
TACC	O
domain	B-SO
of	O
TACC2	B-GGP
.	O

As	O
shown	O
in	O
Fig	O
.	O

7	O
,	O
this	O
interaction	O
is	O
confirmed	O
in	O
vitro	O
by	O
GST	B-GGP
-	O
pull	O
down	O
analysis	O
.	O

Significantly	O
,	O
RXR	B-GGP
beta	I-GGP
is	O
a	O
close	O
family	O
relative	O
of	O
the	O
nuclear	B-GO
hormone	B-CHEBI
receptor	O
,	O
nhr	B-GGP
-	I-GGP
86	I-GGP
,	O
from	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
,	O
which	O
interacts	O
with	O
the	O
ceTAC	B-GGP
binding	O
protein	B-CHEBI
lin36	B-GGP
(	O
Fig	O
.	O
6A	O
)	O
.	O

This	O
suggests	O
that	O
while	O
protostome	B-Taxon
TACCs	O
may	O
require	O
additional	O
protein	B-CHEBI
factors	O
to	O
interact	O
with	O
such	O
components	O
,	O
the	O
TACCs	O
in	O
higher	O
organisms	B-Taxon
may	O
have	O
evolved	O
the	O
ability	O
to	O
directly	O
interact	O
with	O
some	O
of	O
the	O
proteins	B-CHEBI
in	O
the	O
predicted	O
interaction	O
map	O
(	O
Fig	O
.	O
6E	O
)	O
.	O

Indeed	O
,	O
this	O
appears	O
to	O
be	O
directly	O
linked	O
to	O
the	O
acquisition	O
of	O
new	O
domains	B-SO
and	O
duplication	B-SO
of	O
the	O
chordate	B-Taxon
TACC	O
precursor	O
.	O

In	O
fact	O
,	O
the	O
first	O
identified	O
function	O
of	O
a	O
vertebrate	B-Taxon
TACC	O
protein	B-CHEBI
was	O
as	O
a	O
transcriptional	O
coactivator	O
acting	O
through	O
a	O
direct	O
interaction	O
with	O
the	O
ARNT	B-GGP
transcription	I-GGP
factor	I-GGP
[	O
7	O
]	O
.	O

It	O
is	O
also	O
intriguing	O
that	O
the	O
deuterostome	B-Taxon
specific	O
SDP	O
repeat	B-SO
interacts	O
with	O
GAS41	B-GGP
,	O
a	O
component	O
/	O
accessory	O
factor	O
of	O
the	O
human	B-Taxon
SWI	B-GO
/	I-GO
SNF	I-GO
chromatin	I-GO
remodeling	I-GO
complex	I-GO
[	O
3	O
,	O
15	O
]	O
.	O

Although	O
there	O
is	O
a	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
homologue	B-SO
of	O
GAS41	B-GGP
,	O
dmGAS41	B-GGP
,	O
the	O
large	O
scale	O
proteomic	O
interaction	O
database	O
does	O
not	O
indicate	O
a	O
direct	O
interaction	O
of	O
dmGAS41	B-GGP
with	O
DTACC	B-GGP
.	O

This	O
may	O
be	O
due	O
to	O
the	O
lack	O
of	O
the	O
SDP	O
repeat	B-SO
region	I-SO
in	O
the	O
Drosophila	B-GGP
TACC	I-GGP
protein	B-CHEBI
.	O

This	O
further	O
suggests	O
that	O
the	O
vertebrate	B-Taxon
TACCs	O
have	O
gained	O
the	O
specific	O
ability	O
to	O
direct	O
interact	O
with	O
transcriptional	B-GO
regulatory	I-GO
complexes	I-GO
,	O
and	O
that	O
bridging	O
protein	B-CHEBI
(	I-CHEBI
s	I-CHEBI
)	I-CHEBI
are	O
no	O
longer	O
required	O
.	O

Thus	O
,	O
where	O
the	O
ceTAC	B-GGP
protein	B-CHEBI
is	O
only	O
composed	O
of	O
the	O
TACC	O
domain	B-SO
,	O
the	O
significantly	O
larger	O
TACC	O
family	O
members	O
in	O
higher	O
protostomes	B-Taxon
and	O
deuterostomes	B-Taxon
may	O
have	O
integrated	O
one	O
or	O
more	O
functions	O
of	O
the	O
bridging	O
protein	B-CHEBI
(	O
in	O
this	O
case	O
lin15A	B-GGP
,	O
lin36	B-GGP
or	O
lin37	B-GGP
)	O
.	O

This	O
may	O
also	O
explain	O
the	O
absence	O
of	O
lin15A	B-GGP
,	O
lin36	B-GGP
and	O
lin37	B-GGP
homologues	B-SO
in	O
higher	O
organisms	B-Taxon
,	O
as	O
they	O
were	O
no	O
longer	O
under	O
selective	O
evolutionary	O
pressure	O
to	O
remain	O
within	O
the	O
complex	B-GO
,	O
and	O
thus	O
lost	O
in	O
the	O
evolving	O
genome	B-SO
.	O

Figure	O
7	O

In	O
vitro	O
interaction	O
of	O
RXR	O
beta	O
3	O
and	O
TACC2s	B-GGP
.	O

Top	O
panel	O
:	O
Autoradiograph	O
of	O
12	O
%	O
SDS	B-CHEBI
polyacrylamide	O
gel	O
with	O
in	O
vitro	O
translated	O
RXR	O
beta	O
3	O
construct	B-SO
pulled	O
down	O
with	O
GST	B-GGP
-	O
TACC2	B-GGP
(	O
Lane	O
1	O
)	O
or	O
GST	B-GGP
(	O
Lane	O
2	O
)	O
;	O
Lane	O
3	O
:	O
5	O
%	O
input	O
of	O
in	O
vitro	O
translated	O
RXR	B-GGP
-	I-GGP
beta	I-GGP
protein	B-CHEBI
.	O

Bottom	O
two	O
panels	O
represent	O
Coomassie	O
blue	O
stained	O
gels	O
of	O
pull	O
down	O
experiment	O
showing	O
loading	O
of	O
GST	B-GGP
-	O
TACC2	B-GGP
and	O
GST	B-GGP
.	O

Conclusion	O

Proposed	O
functional	O
evolution	O
of	O
the	O
TACC	O
family	O

Examination	O
of	O
the	O
evolution	O
of	O
ancient	O
gene	B-SO
families	O
provides	O
an	O
insight	O
into	O
how	O
gene	B-SO
structure	O
relates	O
to	O
function	O
.	O

We	O
have	O
presented	O
above	O
,	O
a	O
detailed	O
examination	O
of	O
one	O
such	O
gene	B-SO
family	O
.	O

The	O
data	O
so	O
far	O
suggest	O
that	O
the	O
functional	O
TACC	O
homologue	B-SO
in	O
yeast	B-Taxon
(	O
spc72	B-GGP
)	O
has	O
a	O
specific	O
role	O
in	O
centrosomal	B-GO
/	O
mitotic	O
spindle	B-GO
dynamics	O
[	O
21	O
,	O
22	O
]	O
.	O

This	O
ancient	O
TACC	O
function	O
is	O
conserved	O
throughout	O
evolution	O
in	O
both	O
protostomes	B-Taxon
and	O
deuterostomes	B-Taxon
.	O

In	O
addition	O
,	O
the	O
TACC	O
proteins	B-CHEBI
of	O
lower	O
organisms	B-Taxon
appear	O
to	O
interact	O
with	O
bridging	O
proteins	B-CHEBI
that	O
are	O
components	O
of	O
several	O
different	O
protein	B-GO
complexes	I-GO
involved	O
in	O
DNA	B-SO
damage	O
repair	O
,	O
protein	B-CHEBI
translation	O
,	O
RNA	B-SO
processing	O
and	O
transcription	O
.	O

However	O
,	O
over	O
the	O
process	O
of	O
evolutionary	O
time	O
,	O
with	O
the	O
acquisition	O
of	O
new	O
domains	B-SO
and	O
duplication	B-SO
of	O
the	O
chordate	B-Taxon
TACC	O
precursor	O
,	O
the	O
chordate	B-Taxon
TACC	O
proteins	B-CHEBI
have	O
acquired	O
the	O
ability	O
to	O
directly	O
interact	O
with	O
some	O
of	O
the	O
other	O
components	O
of	O
these	O
complexes	B-GO
(	O
such	O
as	O
the	O
LSm	O
proteins	B-CHEBI
,	O
nuclear	B-GO
hormone	B-CHEBI
receptors	O
,	O
GAS41	B-GGP
,	O
accessory	O
proteins	B-CHEBI
and	O
transcription	O
factors	O
)	O
,	O
and	O
thus	O
evolved	O
additional	O
functions	O
within	O
these	O
complexes	B-GO
.	O

Indeed	O
,	O
the	O
first	O
assigned	O
function	O
of	O
a	O
vertebrate	B-Taxon
TACC	O
protein	B-CHEBI
,	O
mouse	B-GGP
TACC3	I-GGP
,	O
was	O
as	O
a	O
transcriptional	O
coactivator	O
of	O
the	O
ARNT	B-GGP
mediated	O
transcriptional	O
response	O
to	O
hypoxia	O
and	O
polyaromatic	B-CHEBI
hydrocarbons	I-CHEBI
[	O
7	O
]	O
.	O

Mouse	B-GGP
TACC3	I-GGP
has	O
also	O
been	O
reported	O
to	O
interact	O
with	O
the	O
transcription	O
factor	O
STAT5	B-GGP
[	O
33	O
]	O
.	O

Recently	O
,	O
we	O
have	O
demonstrated	O
that	O
TACC2	B-GGP
and	O
TACC3	B-GGP
can	O
bind	O
to	O
nuclear	B-GO
histone	B-CHEBI
acetyltransferases	O
[	O
34	O
]	O
,	O
further	O
confirming	O
a	O
more	O
direct	O
role	O
for	O
the	O
TACC	O
proteins	B-CHEBI
in	O
transcriptional	O
and	O
chromatin	B-GO
remodeling	O
events	O
.	O

Interestingly	O
although	O
all	O
human	B-Taxon
TACC	O
proteins	B-CHEBI
can	O
directly	O
interact	O
with	O
the	O
histone	B-CHEBI
acetyltransferase	O
pCAF	B-GGP
in	O
vitro	O
,	O
the	O
TACC1	B-GGP
isoforms	B-SO
expressed	O
in	O
human	B-Taxon
breast	O
cancer	O
cells	B-CL
do	O
not	O
interact	O
with	O
this	O
histone	B-CHEBI
acetylase	O
[	O
34	O
]	O
.	O

This	O
may	O
be	O
attributable	O
to	O
the	O
proposed	O
function	O
of	O
the	O
Exon	B-SO
1	O
containing	O
TACC1	B-GGP
variants	B-SO
in	O
RNA	B-SO
processing	O
,	O
via	O
the	O
interaction	O
with	O
LSm	B-GGP
-	I-GGP
7	I-GGP
and	O
SmG	B-GGP
[	O
19	O
]	O
.	O

Thus	O
,	O
alternative	O
splicing	O
of	O
the	O
TACC1	B-GGP
gene	B-SO
adds	O
further	O
diversity	O
to	O
TACC1	B-GGP
function	O
,	O
as	O
the	O
deletion	B-SO
of	O
specific	O
exons	B-SO
and	O
their	O
associated	O
binding	O
domains	B-SO
will	O
change	O
the	O
potential	O
protein	B-GO
complexes	I-GO
with	O
which	O
they	O
can	O
associate	O
,	O
either	O
directly	O
,	O
or	O
by	O
redirecting	O
the	O
splice	B-SO
variants	I-SO
to	O
different	O
subcellular	O
compartments	O
.	O

With	O
the	O
duplication	B-SO
of	O
the	O
TACC1	B-GGP
/	O
TACC2	B-GGP
ancestor	O
,	O
it	O
is	O
apparent	O
that	O
an	O
even	O
greater	O
functional	O
diversity	O
may	O
have	O
been	O
introduced	O
into	O
the	O
TACC	O
family	O
.	O

The	O
TACC2	B-GGP
protein	B-CHEBI
retains	O
the	O
ability	O
of	O
TACC3	B-GGP
to	O
interact	O
with	O
GAS41	B-GGP
,	O
INI1	B-GGP
,	O
histone	B-CHEBI
acetyltransferases	O
and	O
transcription	O
factors	O
(	O
in	O
this	O
case	O
,	O
RXR	B-GGP
beta	I-GGP
)	O
(	O
Fig	O
.	O
7	O
)	O
[	O
3	O
,	O
34	O
]	O
.	O

However	O
,	O
the	O
tissue	O
specific	O
splicing	O
of	O
the	O
5	O
kb	O
exon	B-SO
in	O
the	O
TACC2l	O
isoform	B-SO
[	O
3	O
]	O
indicates	O
that	O
this	O
protein	B-CHEBI
has	O
several	O
temporal	O
and	O
tissue	O
specific	O
functions	O
yet	O
to	O
be	O
identified	O
.	O

Methods	O

Compilation	O
and	O
assembly	O
of	O
previously	O
uncharacterized	O
TACC	O
cDNAs	B-SO
and	O
genes	B-SO

Corresponding	O
orthologous	B-SO
sequences	I-SO
for	O
TACC	O
,	O
RHAMM	B-GGP
,	O
KLP	O
,	O
KIF	O
,	O
TPM	O
and	O
keratins	O
families	O
were	O
identified	O
initially	O
using	O
the	O
TBLASTN	O
program	O
[	O
36	O
]	O
to	O
search	O
the	O
published	O
genomic	B-SO
and	O
cDNA	B-SO
databases	O
.	O

For	O
Takifugu	B-Taxon
rubripes	I-Taxon
,	O
gene	B-SO
predictions	O
were	O
produced	O
by	O
the	O
Ensembl	O
automated	O
pipeline	O
[	O
37	O
]	O
and	O
the	O
JGI	O
blast	O
server	O
.	O

DNA	B-SO
sequences	I-SO
covering	O
the	O
homology	B-SO
regions	I-SO
were	O
extracted	O
and	O
analyzed	O
by	O
Genscan	O
to	O
obtain	O
potential	O
exons	B-SO
.	O

In	O
some	O
cases	O
,	O
exons	B-SO
were	O
added	B-SO
or	O
modified	B-SO
based	O
on	O
the	O
best	O
similarity	O
of	O
translated	O
peptides	B-SO
to	O
the	O
corresponding	O
mouse	B-Taxon
and	O
human	B-Taxon
proteins	B-CHEBI
.	O

For	O
regions	B-SO
with	O
low	O
sequence	B-SO
similarity	O
,	O
genomic	B-SO
sequences	I-SO
from	O
the	O
fresh	O
water	O
pufferfish	B-Taxon
,	O
Tetraodon	B-Taxon
nigroviridis	I-Taxon
were	O
used	O
as	O
additional	O
means	O
to	O
verify	O
the	O
predicted	B-SO
exons	B-SO
.	O

Due	O
to	O
the	O
variability	O
of	O
the	O
central	O
region	B-SO
of	O
vertebrate	B-Taxon
TACC3	B-GGP
cDNAs	B-SO
(	O
see	O
text	O
)	O
,	O
to	O
further	O
confirm	O
prediction	O
of	O
the	O
Takifugu	B-GGP
rubripes	I-GGP
TACC3	I-GGP
,	O
full	O
length	O
cDNAs	B-SO
corresponding	O
to	O
the	O
Danio	B-GGP
rerio	I-GGP
TACC3	I-GGP
(	O
IMAGE	O
clones	B-SO
2639991	O
,	O
2640369	O
and	O
3724452	O
)	O
were	O
also	O
obtained	O
from	O
A	O
.	O
T	O
.	O
C	O
.	O
C	O
.	O
and	O
fully	O
sequenced	O
.	O

Potential	O
paralogous	B-SO
chromosomal	I-SO
segments	I-SO
and	O
scaffold	B-SO
were	O
identified	O
by	O
searching	O
the	O
public	O
databases	O
deposited	O
at	O
NCBI	O
and	O
at	O
the	O
Human	B-Taxon
Genome	B-SO
Mapping	O
Project	O
,	O
Cambridge	O
UK	O
.	O

Cloning	O
of	O
vertebrate	B-Taxon
TACC	O
cDNAs	B-SO

The	O
rabbit	B-GGP
TACC3	I-GGP
was	O
cloned	O
by	O
rt	O
-	O
PCR	O
using	O
the	O
"	O
TACC4	O
"	O
specific	O
primer	B-SO
T4RACE2	O
[	O
9	O
]	O
(	O
5	O
'	O
-	O
cccgaactgctccaggtaatcgatctc	O
-	O
3	O
'	O
)	O
and	O
a	O
consensus	B-SO
primer	B-SO
,	O
T3con2	O
,	O
designed	B-SO
to	O
the	O
region	B-SO
encompassing	O
the	O
vertebrate	B-Taxon
TACC3	B-GGP
initiator	O
methionine	B-CHEBI
(	O
5	O
'	O
-	O
tatgagtctgcaggtcttaaacgac	O
-	O
3	O
'	O
)	O
.	O

For	O
cloning	O
the	O
mouse	B-Taxon
Tacc1X	O
cDNA	B-SO
,	O
the	O
primers	B-SO
used	O
were	O
based	O
upon	O
the	O
genomic	B-SO
sequence	I-SO
reported	O
,	O
and	O
the	O
sequence	B-SO
of	O
the	O
IMAGE	O
cDNA	B-SO
clone	I-SO
4933429K08	O
:	O
T1XF	O
(	O
5	O
'	O
-	O
ccatgttcagtcattggcaggtc	O
-	O
3	O
'	O
)	O
,	O
T1XF2	O
(	O
5	O
'	O
-	O
ctgcagaaccaacagttcaag	O
-	O
3	O
'	O
)	O
,	O
T1XR1	O
(	O
5	O
'	O
-	O
agatctgtgacatcacagctc	O
-	O
3	O
'	O
)	O
,	O
T1XR2	O
(	O
5	O
'	O
-	O
ctcgagtcagttagtcttatccagctt	O
-	O
3	O
'	O
)	O
,	O
BB617F	O
(	O
5	O
'	O
-	O
accaccaacttgagtacctg	O
-	O
3	O
'	O
)	O
and	O
BB617R	O
(	O
5	O
'	O
-	O
gtatcttgaactgttggttctg	O
-	O
3	O
'	O
)	O
.	O

For	O
analysis	O
of	O
TACC1	B-GGP
splice	B-SO
variants	I-SO
,	O
the	O
forward	B-SO
primers	I-SO
used	O
were	O
located	O
in	O
exon	B-SO
1b	O
:	O
EF	O
(	O
5	O
'	O
-	O
gagagatgcgaaatcagcg	O
-	O
3	O
'	O
)	O
,	O
Exon	B-SO
1d	O
:	O
X3F	O
(	O
5	O
'	O
-	O
agtcaaagaaggcatctgcag	O
-	O
3	O
'	O
)	O
,	O
Exon	B-SO
1a	O
:	O
1DF	O
(	O
5	O
'	O
-	O
ccaagttctgcgccatggg	O
-	O
3	O
'	O
)	O
.	O

The	O
reverse	B-SO
primers	I-SO
used	O
were	O
:	O
Exon	B-SO
1	O
:	O
X1R	O
(	O
5	O
'	O
-	O
ggatttggtctcggcttgcgaatc	O
-	O
3	O
'	O
)	O
,	O
Exon	B-SO
2	O
:	O
BX647R	O
(	O
5	O
'	O
-	O
cttgtgattcttggcttttgg	O
-	O
3	O
'	O
)	O
,	O
Exon	B-SO
3	O
:	O
6SPR	O
(	O
5	O
'	O
-	O
gtcatcgcctcgtcctggagggc	O
-	O
3	O
'	O
)	O
,	O
Exon	B-SO
4a	O
:	O
1DR	O
(	O
5	O
'	O
-	O
aatttcacttgttcagtagtc	O
-	O
3	O
'	O
)	O
,	O
Exon	B-SO
5	O
:	O
128R	O
(	O
5	O
'	O
-	O
cctgcttctgaggatgaaaacgc	O
-	O
3	O
'	O
)	O
.	O

Rabbit	B-Taxon
brain	O
poly	B-SO
A	I-SO
+	I-SO
mRNA	B-CHEBI
,	O
mouse	B-Taxon
testis	O
and	O
human	B-Taxon
brain	O
total	O
RNA	B-SO
were	O
obtained	O
from	O
BD	O
Bioscience	O
Clontech	O
(	O
Palo	O
Alto	O
,	O
CA	O
,	O
U	O
.	O
S	O
.	O
A	O
.	O
)	O
.	O

Reverse	O
transcription	O
and	O
PCR	O
was	O
performed	O
as	O
previously	O
described	O
,	O
using	O
either	O
1	O
mu	O
g	O
of	O
total	O
RNA	B-SO
or	O
50	O
ng	O
of	O
poly	B-SO
A	I-SO
+	I-SO
mRNA	B-CHEBI
as	O
template	O
for	O
first	O
strand	B-SO
cDNA	B-SO
synthesis	O
.	O

PCR	B-SO
products	I-SO
were	O
cloned	O
into	O
pCR2	O
.	O
1	O
(	O
Invitrogen	O
,	O
Carlsbad	O
CA	O
,	O
U	O
.	O
S	O
.	O
A	O
.	O
)	O
and	O
transformed	O
into	O
Inv	O
alpha	O
F	O
'	O
competent	O
cells	B-CL
.	O

Plasmid	B-SO
inserts	B-SO
were	O
sequenced	O
by	O
the	O
Roswell	O
Park	O
Cancer	O
Institute	O
Biopolymer	O
Core	O
Facility	O
.	O

Deposition	O
of	O
nucleotide	B-SO
sequences	I-SO

Sequences	B-SO
from	O
this	O
article	O
have	O
been	O
deposited	O
in	O
the	O
GenBank	O
database	O
with	O
the	O
following	O
accession	O
numbers	O
:	O
Homo	B-GGP
sapiens	I-GGP
TACC1	I-GGP
short	O
isoform	B-SO
S	O
(	O
AY177411	O
)	O
,	O
Mus	B-GGP
musculus	I-GGP
TACC1	I-GGP
short	O
isoform	B-SO
S	O
(	O
AY177412	O
)	O
,	O
Mus	B-GGP
musculus	I-GGP
TACC1	I-GGP
long	O
isoform	B-SO
A	O
(	O
AY177413	O
)	O
,	O
Mus	B-Taxon
musculus	I-Taxon
TACC2s	O
(	O
AY177410	O
)	O
,	O
Oryctolagus	B-GGP
cuniculus	I-GGP
TACC3	I-GGP
(	O
AY161270	O
)	O
,	O
Danio	B-GGP
rerio	I-GGP
TACC3	I-GGP
(	O
AY170618	O
)	O
.	O

Annotations	O
submitted	O
to	O
the	O
Third	O
party	O
annotation	O
database	O
at	O
NCBI	O
are	O
as	O
follows	O
:	O
Rattus	B-GGP
norvegus	I-GGP
TACC1	I-GGP
long	O
isoform	B-SO
A	O
(	O
BK001653	O
)	O
,	O
Takifugu	B-GGP
rubripes	I-GGP
TACC1A	I-GGP
(	O
BK000666	O
/	O
BK000667	O
)	O
,	O
Takifugu	B-GGP
rubripes	I-GGP
TACC1B	I-GGP
(	O
BK000664	O
)	O
,	O
Mus	B-Taxon
musculus	I-Taxon
TACC2l	O
(	O
BK001495	O
)	O
,	O
Rattus	B-Taxon
norvegus	I-Taxon
TACC2l	O
(	O
BK001658	O
)	O
,	O
Rattus	B-Taxon
norvegus	I-Taxon
TACC2s	O
(	O
BK001657	O
)	O
,	O
Takifugu	B-Taxon
rubripes	I-Taxon
TACC2l	O
(	O
BK000690	O
)	O
,	O
Rattus	B-GGP
norvegus	I-GGP
TACC3	I-GGP
(	O
BK001491	O
)	O
,	O
Gallus	B-GGP
gallus	I-GGP
TACC3	I-GGP
(	O
BK001482	O
)	O
,	O
Silurana	B-GGP
tropicalis	I-GGP
TACC3	I-GGP
(	O
BK001481	O
)	O
,	O
Takifugu	B-GGP
rubripes	I-GGP
TACC3	I-GGP
(	O
BK000649	O
)	O
,	O
Takifugu	B-GGP
rubripes	I-GGP
RHAMM	I-GGP
(	O
BK000676	O
)	O
,	O
Ciona	B-GGP
intestinalis	I-GGP
RHAMM	I-GGP
(	O
BK001479	O
)	O
,	O
Takifugu	B-GGP
rubripes	I-GGP
Keratin	I-GGP
(	O
BK000677	O
)	O
,	O
Takifugu	B-GGP
rubripes	I-GGP
TPM1	I-GGP
(	O
BAC10576	O
)	O
,	O
Ciona	B-GGP
intestinalis	I-GGP
Kif3b	I-GGP
(	O
BK001492	O
)	O
,	O
Ciona	B-GGP
intestinalis	I-GGP
klp2	I-GGP
(	O
BK001493	O
)	O
.	O

Phylogenetic	O
analysis	O

In	O
order	O
to	O
examine	O
evolutionary	O
relationships	O
of	O
proteins	B-CHEBI
containing	O
coiled	B-SO
coil	I-SO
domains	B-SO
,	O
protein	B-CHEBI
sequences	B-SO
representing	O
the	O
major	O
members	O
of	O
this	O
super	O
family	O
,	O
including	O
TACC	O
,	O
RHAMM	B-GGP
,	O
KLP	O
,	O
keratin	O
and	O
tropomyosin	O
from	O
available	O
vertebrates	B-Taxon
and	O
their	O
recognizable	O
orthologues	B-SO
from	O
the	O
urochordate	B-Taxon
Ciona	B-Taxon
intestinalis	I-Taxon
,	O
Drosophila	B-Taxon
melanogaster	I-Taxon
,	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
and	O
Saccharomyces	B-Taxon
cerevisiae	I-Taxon
were	O
either	O
directly	O
retrieved	O
from	O
NCBI	O
sequence	B-SO
databases	O
,	O
newly	O
predicted	O
or	O
isolated	O
(	O
see	O
above	O
)	O
.	O

Species	O
abbreviations	O
are	O
as	O
follows	O
:	O
hs	B-Taxon
(	O
Homo	B-Taxon
sapiens	I-Taxon
)	O
,	O
mm	B-Taxon
(	O
Mus	B-Taxon
musculus	I-Taxon
)	O
,	O
rn	B-Taxon
(	O
Rattus	B-Taxon
norvegus	I-Taxon
)	O
,	O
oc	B-Taxon
(	O
Oryctolagus	B-Taxon
cuniculus	I-Taxon
)	O
,	O
gg	B-Taxon
(	O
Gallus	B-Taxon
gallus	I-Taxon
)	O
,	O
xl	B-Taxon
(	O
Xenopus	B-Taxon
laevis	I-Taxon
)	O
,	O
st	B-Taxon
(	O
Silurana	B-Taxon
tropicalis	I-Taxon
)	O
,	O
tr	B-Taxon
(	O
Takifugu	B-Taxon
rubripes	I-Taxon
)	O
,	O
dr	B-Taxon
(	O
Danio	B-Taxon
rerio	I-Taxon
)	O
,	O
ci	B-Taxon
(	O
Ciona	B-Taxon
intestinalis	I-Taxon
)	O
,	O
dm	B-Taxon
(	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
)	O
,	O
ce	B-Taxon
(	O
C	B-Taxon
.	I-Taxon
elegans	I-Taxon
)	O
,	O
sc	B-Taxon
(	O
Saccharomyces	B-Taxon
cerevisiae	I-Taxon
)	O
.	O

The	O
sequences	B-SO
identified	O
above	O
and	O
the	O
following	O
protein	B-CHEBI
or	O
predicted	B-SO
translations	O
were	O
used	O
for	O
phylogenetic	O
analysis	O
:	O
hsTACC1A	O
(	O
NP	O
_	O
006274	O
)	O
,	O
hsTACC2l	O
(	O
AAO62630	O
)	O
hsTACC2s	O
(	O
AAO62629	O
)	O
,	O
hsTACC3	B-GGP
(	O
NP	O
_	O
006333	O
)	O
,	O
mmTACC3	B-GGP
(	O
Q9JJ11	O
)	O
,	O
xlMaskin	B-GGP
(	O
Q9PTG8	O
)	O
,	O
dmTACC	B-GGP
(	O
AAF52099	O
)	O
,	O
ceTAC1	B-GGP
(	O
NP	O
_	O
497059	O
)	O
,	O
scSPC72	B-GGP
(	O
NP	O
_	O
009352	O
)	O
,	O
hsRHAMM	B-GGP
(	O
NP	O
_	O
036616	O
)	O
,	O
mmRHAMM	B-GGP
(	O
NP	O
_	O
038580	O
)	O
,	O
rnRHAMM	B-GGP
(	O
NP	O
_	O
037096	O
)	O
,	O
drRHAMM	B-GGP
(	O
AAQ97980	O
)	O
,	O
hsKeratin	B-GGP
(	O
CAB76828	O
)	O
,	O
mmKeratin	O
(	O
A61368	O
)	O
,	O
rnKeratin	O
(	O
XP	O
_	O
235679	O
)	O
,	O
hsTPM1	B-GGP
(	O
NP	O
_	O
000357	O
)	O
,	O
mmTPM1	B-GGP
(	O
NP	O
_	O
077745	O
)	O
,	O
rnTPM1	B-GGP
(	O
NP	O
_	O
62004	O
,	O
drTPM1	B-GGP
(	O
NP	O
_	O
571180	O
)	O
dmTPM1	B-GGP
(	O
P06754	O
)	O
,	O
ceTPM	B-GGP
(	O
NP	O
_	O
493540	O
)	O
scTPM1	B-GGP
(	O
P17536	O
)	O
,	O
hsKLP2	B-GGP
(	O
BAB03309	O
)	O
,	O
rnKIF15	B-GGP
(	O
AAP44513	O
)	O
,	O
xlKLP2	B-GGP
(	O
CAA08879	O
)	O
,	O
dmKLP2	B-GGP
(	O
NP	O
_	O
476818	O
)	O
,	O
ceKLP18	B-GGP
(	O
AA034669	O
)	O
,	O
hsKIF3A	B-GGP
(	O
Q9Y496	O
)	O
,	O
mmKIF3A	B-GGP
(	O
NP	O
_	O
032469	O
)	O
,	O
rnKIF3A	B-GGP
(	O
XP	O
_	O
340797	O
)	O
,	O
xlKIF3A	B-GGP
(	O
CAA08879	O
)	O
,	O
ceKLP11	B-GGP
(	O
NP	O
_	O
741473	O
)	O
,	O
ciKIF3	O
(	O
ci0100148992	O
)	O
,	O
hsKIF3B	B-GGP
(	O
NP	O
_	O
004789	O
)	O
,	O
mmKIF3B	B-GGP
(	O
NP	O
_	O
004789	O
)	O
,	O
rnKIF3B	B-GGP
(	O
XP	O
_	O
215883	O
)	O
,	O
dmKIF3B	B-GGP
(	O
NP	O
_	O
524029	O
)	O
,	O
hsKIF3C	B-GGP
(	O
NP	O
_	O
002245	O
)	O
,	O
mmKIF3C	B-GGP
(	O
NP	O
_	O
032471	O
)	O
,	O
rnKIF3C	B-GGP
(	O
NP	O
_	O
445938	O
)	O
,	O
dmKIF3C	B-GGP
(	O
NP	O
_	O
651939	O
)	O
.	O

These	O
protein	B-CHEBI
sequences	B-SO
were	O
initially	O
aligned	O
with	O
CLUSTAL	O
X	O
[	O
38	O
]	O
.	O

Minor	O
adjustments	O
to	O
certain	O
regions	B-SO
of	O
the	O
alignment	O
for	O
optimization	O
purposes	O
were	O
made	O
based	O
on	O
pairwise	O
alignments	O
,	O
the	O
output	O
saved	O
in	O
PHYLIP	O
format	O
,	O
after	O
which	O
,	O
the	O
distances	O
between	O
proteins	B-CHEBI
were	O
calculated	O
using	O
Poisson	O
correction	O
and	O
the	O
Unrooted	O
trees	O
were	O
inferred	O
with	O
the	O
NJ	O
method	O
and	O
then	O
displayed	O
using	O
TreeView	O
[	O
39	O
]	O
.	O

Bootstrap	O
values	O
above	O
700	O
for	O
1000	O
trials	O
are	O
shown	O
at	O
the	O
node	O
.	O

To	O
validate	O
the	O
tree	O
,	O
the	O
same	O
sequence	B-SO
set	O
was	O
analyzed	O
with	O
tools	O
in	O
the	O
PHYLIP	O
package	O
[	O
40	O
]	O
,	O
using	O
PRODIST	O
followed	O
by	O
FITCH	O
or	O
NEIGNBOR	O
and	O
tree	O
displaying	O
using	O
TreeView	O
.	O

This	O
additional	O
method	O
produced	O
trees	O
with	O
essentially	O
the	O
same	O
topology	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
vitro	O
interaction	O
of	O
TACC2	B-GGP
and	O
RXR	O
beta	O
3	O

The	O
TACC2	B-GGP
cDNA	B-SO
was	O
cloned	O
into	O
GST	B-GGP
fusion	B-SO
vector	B-SO
pGEX5X2	O
(	O
Amersham	O
Biosciences	O
,	O
Piscataway	O
,	O
NJ	O
,	O
USA	O
)	O
.	O

GST	B-GGP
and	O
GST	B-GGP
-	O
TACC2	B-GGP
proteins	B-CHEBI
were	O
expressed	O
in	O
E	B-Taxon
.	I-Taxon
coli	I-Taxon
BL21	O
(	O
DE3	O
)	O
plys	O
"	O
S	O
"	O
with	O
1	O
mM	O
IPTG	O
at	O
37	O
degrees	O
C	O
shaker	O
for	O
2	O
hrs	O
.	O

Cells	B-CL
(	O
50	O
ml	O
)	O
were	O
harvested	O
and	O
resuspended	O
in	O
5	O
ml	O
of	O
20	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	B-CHEBI
,	O
1	O
mM	O
EDTA	B-CHEBI
pH8	O
.	O
0	O
,	O
Protease	B-CHEBI
inhibitor	I-CHEBI
set	O
III	O
(	O
Calbiochem	O
)	O
.	O

The	O
cells	B-CL
were	O
lysed	O
by	O
sonication	O
and	O
lysate	O
cleared	O
by	O
centrifugation	O
at	O
7500	O
rpm	O
at	O
4	O
degrees	O
C	O
for	O
15	O
min	O
.	O

The	O
cleared	O
lysate	O
was	O
immobilized	O
on	O
glutathione	B-CHEBI
sepharose	O
beads	O
in	O
3	O
ml	O
of	O
20	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	B-CHEBI
,	O
1	O
mM	O
EDTA	B-CHEBI
pH8	O
.	O
0	O
)	O
.	O

RXR	O
beta	O
3	O
cDNA	B-SO
was	O
cloned	O
into	O
pET	O
28C	O
(	O
+	O
)	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
)	O
and	O
protein	B-CHEBI
synthesized	O
by	O
TNT	O
quick	O
coupled	O
transcription	O
/	O
translation	O
system	O
kit	O
(	O
Promega	O
)	O
and	O
radiolabeled	O
with	O
35S	B-CHEBI
methionine	B-CHEBI
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
.	O

100	O
mu	O
l	O
of	O
in	O
vitro	O
translated	O
RXR	O
beta	O
3	O
protein	B-CHEBI
in	O
1	O
ml	O
of	O
20	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	B-CHEBI
,	O
1	O
mM	O
EDTA	B-CHEBI
pH8	O
.	O
0	O
was	O
incubated	O
at	O
4	O
degrees	O
C	O
with	O
immobilized	O
GST	B-GGP
-	O
TACC2	B-GGP
or	O
GST	B-GGP
for	O
90	O
min	O
.	O

Unbound	O
RXR	O
beta	O
3	O
was	O
removed	O
by	O
washing	O
three	O
times	O
with	O
20	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
pH	O
.	O
8	O
.	O
0	O
,	O
200	O
mM	O
NaCl	B-CHEBI
,	O
1	O
mM	O
EDTA	B-CHEBI
pH8	O
.	O
0	O
.	O

Bound	O
proteins	B-CHEBI
were	O
eluted	O
from	O
the	O
beads	O
at	O
room	O
temperature	O
for	O
10	O
min	O
in	O
elution	O
buffer	O
(	O
100	O
mM	O
Tris	B-CHEBI
HCl	B-CHEBI
,	O
pH8	O
.	O
0	O
,	O
20	O
mM	O
reduced	O
glutathione	B-CHEBI
)	O
.	O

The	O
proteins	B-CHEBI
were	O
analyzed	O
on	O
12	O
%	O
SDS	B-CHEBI
polyacrylamide	O
gels	O
.	O

Coomassie	O
blue	O
staining	O
verified	O
equal	O
loading	O
of	O
GST	B-GGP
fusion	B-SO
protein	B-CHEBI
.	O

Dried	O
gels	O
were	O
autoradiographed	O
.	O

Authors	O
'	O
contributions	O

I	O
.	O
H	O
.	O
S	O
performed	O
most	O
of	O
the	O
sequence	B-SO
analysis	O
and	O
drafted	O
the	O
assembly	B-SO
of	I-SO
the	I-SO
TACC	I-SO
,	I-SO
KLP	I-SO
,	I-SO
KIF	I-SO
and	I-SO
RHAMM	I-SO
sequences	I-SO
.	O

I	O
.	O
H	O
.	O
S	O
.	O
performed	O
the	O
cDNA	B-SO
isolation	O
of	O
the	O
rabbit	B-GGP
TACC3	I-GGP
cDNA	B-SO
.	O

AK	O
identified	O
potential	O
TACC1	B-GGP
splice	B-SO
variants	I-SO
,	O
and	O
the	O
interaction	O
between	O
RXR	O
beta	O
3	O
and	O
TACC2	B-GGP
.	O

A	O
.	O
M	O
.	O
characterized	O
mouse	B-Taxon
TACC	O
orthologues	B-SO
.	O

P	O
.	O
L	O
.	O
performed	O
the	O
identification	O
and	O
assembly	O
of	O
T	B-Taxon
.	I-Taxon
rubripes	I-Taxon
gene	B-SO
sequences	I-SO
,	O
and	O
the	O
phylogenetic	O
analysis	O
.	O

I	O
.	O
H	O
.	O
S	O
.	O
conceived	O
and	O
designed	O
the	O
project	O
and	O
drafted	O
the	O
complete	O
manuscript	O
.	O

Supplementary	O
Material	O

Additional	O
file	O
1	O

Location	O
of	O
paralogous	B-SO
genes	B-SO
found	O
on	O
human	B-Taxon
4p16	O
,	O
5q31	O
-	O
ter	O
,	O
10q23	O
-	O
ter	O
,	O
8p	O
and	O
chromosome	B-GO
2	O
.	O

Positions	B-SO
of	O
genes	B-SO
are	O
given	O
in	O
Mb	O
from	O
the	O
telomere	B-SO
of	O
the	O
short	O
arm	B-SO
of	I-SO
the	I-SO
chromosome	I-SO
.	O

Blue	O
highlighted	O
genes	B-SO
(	O
five	O
copies	O
)	O
are	O
found	O
in	O
all	O
four	O
paralogous	B-SO
segments	I-SO
,	O
and	O
the	O
partially	O
duplicated	O
segment	B-SO
on	I-SO
chromosome	I-SO
2	O
.	O

Green	O
highlighted	O
genes	B-SO
are	O
found	O
in	O
either	O
all	O
four	O
paralogous	B-SO
segments	I-SO
,	O
or	O
three	O
of	O
the	O
segments	B-SO
and	O
the	O
partially	O
duplicated	O
region	B-SO
on	I-SO
chromosome	I-SO
2	O
.	O

Pink	O
highlighted	O
genes	B-SO
have	O
paralogues	B-SO
in	O
three	O
of	O
the	O
segments	B-SO
,	O
suggesting	O
either	O
loss	B-SO
of	O
the	O
fourth	O
copy	O
or	O
exclusion	O
of	O
one	O
paralogue	B-SO
from	O
the	O
second	O
round	O
of	O
duplication	B-SO
.	O

Black	O
highlighted	O
genes	B-SO
(	O
two	O
paralogues	B-SO
)	O
are	O
found	O
in	O
only	O
one	O
of	O
the	O
derivatives	O
of	O
the	O
second	O
round	O
of	O
genome	B-SO
duplication	B-SO
,	O
suggesting	O
complete	O
exclusion	O
of	O
both	O
copies	O
from	O
the	O
second	O
round	O
of	O
duplication	B-SO
.	O

Purple	O
highlighted	O
genes	B-SO
(	O
two	O
paralogues	B-SO
)	O
were	O
duplicated	O
at	O
the	O
second	O
round	O
of	O
genome	B-SO
duplication	B-SO
,	O
or	O
from	O
interchromosomal	O
recombination	O
between	O
paralogous	B-SO
clusters	B-SO
.	O

Click	O
here	O
for	O
file	O

Acknowledgements	O

We	O
wish	O
to	O
thank	O
Dr	O
.	O
Sei	O
-	O
ichi	O
Matsui	O
for	O
his	O
assistance	O
and	O
input	O
in	O
the	O
preparation	O
of	O
this	O
manuscript	O
.	O

This	O
work	O
was	O
supported	O
in	O
part	O
by	O
developmental	O
funds	O
support	O
from	O
the	O
Roswell	O
Park	O
Cancer	O
Institute	O
,	O
and	O
Core	O
grant	O
2P30CA016056	O
-	O
27	O
from	O
the	O
National	O
Cancer	O
Institute	O
.	O

Fog2	B-GGP
Is	O
Required	O
for	O
Normal	O
Diaphragm	O
and	O
Lung	O
Development	O
in	O
Mice	B-Taxon
and	O
Humans	B-Taxon

Abstract	O

Congenital	O
diaphragmatic	O
hernia	O
and	O
other	O
congenital	O
diaphragmatic	O
defects	O
are	O
associated	O
with	O
significant	O
mortality	O
and	O
morbidity	O
in	O
neonates	O
;	O
however	O
,	O
the	O
molecular	B-CHEBI
basis	O
of	O
these	O
developmental	O
anomalies	O
is	O
unknown	O
.	O

In	O
an	O
analysis	O
of	O
E18	O
.	O
5	O
embryos	O
derived	O
from	O
mice	B-Taxon
treated	O
with	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	I-CHEBI
,	O
we	O
identified	O
a	O
mutation	B-SO
that	O
causes	O
pulmonary	O
hypoplasia	O
and	O
abnormal	O
diaphragmatic	O
development	O
.	O

Fog2	B-GGP
(	O
Zfpm2	B-GGP
)	O
maps	O
within	O
the	O
recombinant	O
interval	B-SO
carrying	O
the	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	I-CHEBI
-	O
induced	O
mutation	B-SO
,	O
and	O
DNA	B-SO
sequencing	O
of	O
Fog2	B-GGP
identified	O
a	O
mutation	B-SO
in	O
a	O
splice	B-SO
donor	I-SO
site	I-SO
that	O
generates	O
an	O
abnormal	O
transcript	B-SO
encoding	O
a	O
truncated	O
protein	B-CHEBI
.	O

Human	B-Taxon
autopsy	O
cases	O
with	O
diaphragmatic	O
defect	O
and	O
pulmonary	O
hypoplasia	O
were	O
evaluated	O
for	O
mutations	B-SO
in	O
FOG2	B-GGP
.	O

Sequence	B-SO
analysis	O
revealed	O
a	O
de	B-SO
novo	I-SO
mutation	B-SO
resulting	O
in	O
a	O
premature	O
stop	B-SO
codon	I-SO
in	O
a	O
child	O
who	O
died	O
on	O
the	O
first	O
day	O
of	O
life	O
secondary	O
to	O
severe	O
bilateral	O
pulmonary	O
hypoplasia	O
and	O
an	O
abnormally	O
muscularized	O
diaphragm	O
.	O

Using	O
a	O
phenotype	O
-	O
driven	O
approach	O
,	O
we	O
have	O
established	O
that	O
Fog2	B-GGP
is	O
required	O
for	O
normal	O
diaphragm	O
and	O
lung	O
development	O
,	O
a	O
role	O
that	O
has	O
not	O
been	O
previously	O
appreciated	O
.	O

FOG2	B-GGP
is	O
the	O
first	O
gene	B-SO
implicated	O
in	O
the	O
pathogenesis	O
of	O
nonsyndromic	O
human	B-Taxon
congenital	O
diaphragmatic	O
defects	O
,	O
and	O
its	O
necessity	O
for	O
pulmonary	O
development	O
validates	O
the	O
hypothesis	O
that	O
neonates	O
with	O
congenital	O
diaphragmatic	O
hernia	O
may	O
also	O
have	O
primary	O
pulmonary	O
developmental	O
abnormalities	O
.	O

Synopsis	O

Birth	O
defects	O
involving	O
the	O
diaphragm	O
are	O
as	O
common	O
and	O
as	O
serious	O
as	O
genetic	B-SO
disorders	O
such	O
as	O
cystic	O
fibrosis	O
,	O
yet	O
the	O
underlying	O
causes	O
of	O
these	O
defects	O
are	O
unknown	O
.	O

Most	O
babies	O
born	O
with	O
diaphragmatic	O
defects	O
have	O
very	O
small	O
lungs	O
,	O
and	O
many	O
die	O
in	O
the	O
newborn	O
period	O
with	O
severe	O
breathing	O
difficulties	O
.	O

It	O
is	O
unknown	O
whether	O
the	O
small	O
lungs	O
occur	O
because	O
these	O
children	O
have	O
a	O
diaphragmatic	O
defect	O
,	O
or	O
whether	O
some	O
patients	O
might	O
have	O
a	O
genetic	B-SO
abnormality	O
that	O
affects	O
the	O
development	O
of	O
both	O
the	O
lung	O
and	O
the	O
diaphragm	O
simultaneously	O
.	O

In	O
a	O
screen	O
of	O
fetal	O
mice	B-Taxon
carrying	O
chemically	B-CHEBI
induced	O
genetic	B-SO
mutations	B-SO
,	O
the	O
authors	O
found	O
that	O
a	O
mutation	B-SO
in	O
the	O
gene	B-SO
Fog2	B-GGP
(	O
Friend	B-GGP
of	I-GGP
gata	I-GGP
2	I-GGP
)	O
,	O
causes	O
abnormal	O
diaphragm	O
development	O
and	O
small	O
lungs	O
.	O

The	O
lungs	O
have	O
a	O
primary	O
developmental	O
abnormality	O
that	O
includes	O
the	O
specific	O
loss	O
of	O
one	O
lung	O
lobe	O
.	O

Based	O
on	O
this	O
result	O
,	O
the	O
authors	O
studied	O
children	O
affected	O
with	O
diaphragmatic	O
abnormalities	O
,	O
and	O
identified	O
one	O
human	B-Taxon
baby	O
with	O
a	O
serious	O
mutation	B-SO
in	O
the	O
human	B-Taxon
gene	B-SO
FOG2	B-GGP
who	O
died	O
at	O
five	O
hours	O
of	O
life	O
with	O
severe	O
breathing	O
difficulties	O
,	O
a	O
diaphragmatic	O
defect	O
,	O
and	O
small	O
lungs	O
.	O

The	O
authors	O
have	O
established	O
that	O
Fog2	B-GGP
is	O
necessary	O
for	O
both	O
diaphragm	O
and	O
lung	O
development	O
in	O
mice	B-Taxon
and	O
in	O
humans	B-Taxon
.	O

This	O
is	O
the	O
first	O
known	O
cause	O
of	O
a	O
nonsyndromic	O
congenital	O
diaphragmatic	O
defect	O
and	O
establishes	O
that	O
some	O
patients	O
may	O
have	O
a	O
primary	O
developmental	O
abnormality	O
of	O
both	O
the	O
lung	O
and	O
the	O
diaphragm	O
.	O

Introduction	O

Congenital	O
diaphragmatic	O
defects	O
are	O
a	O
spectrum	O
of	O
relatively	O
common	O
birth	O
defects	O
.	O

The	O
Bochdalek	O
or	O
posterolateral	O
hernias	O
(	O
often	O
referred	O
to	O
as	O
congenital	O
diaphragmatic	O
hernia	O
[	O
CDH	O
]	O
)	O
occur	O
in	O
1	O
/	O
3	O
,	O
000	O
live	O
births	O
[	O
1	O
]	O
,	O
and	O
although	O
these	O
are	O
the	O
most	O
common	O
type	O
of	O
diaphragmatic	O
defect	O
presenting	O
at	O
birth	O
,	O
diaphragmatic	O
aplasia	O
and	O
diaphragmatic	O
muscularization	O
defects	O
(	O
eventrations	O
)	O
may	O
have	O
a	O
similar	O
clinical	O
presentation	O
.	O

Making	O
specific	O
anatomic	O
distinctions	O
among	O
these	O
types	O
of	O
defects	O
can	O
be	O
difficult	O
without	O
direct	O
gross	O
(	O
intraoperative	O
or	O
postmortem	O
)	O
examination	O
.	O

Pulmonary	O
hypoplasia	O
associated	O
with	O
these	O
diaphragmatic	O
defects	O
causes	O
severe	O
mortality	O
and	O
morbidity	O
.	O

The	O
pathogenesis	O
and	O
developmental	O
relationship	O
between	O
diaphragmatic	O
defects	O
and	O
pulmonary	O
hypoplasia	O
is	O
not	O
understood	O
.	O

Although	O
advances	O
in	O
the	O
medical	O
management	O
of	O
pulmonary	O
hypoplasia	O
may	O
have	O
decreased	O
the	O
mortality	O
associated	O
with	O
CDH	O
patients	O
who	O
survive	O
to	O
receive	O
care	O
at	O
high	O
-	O
volume	O
centers	O
[	O
2	O
,	O
3	O
]	O
,	O
the	O
population	O
-	O
based	O
mortality	O
has	O
been	O
reported	O
to	O
be	O
as	O
great	O
as	O
62	O
%	O
,	O
and	O
there	O
are	O
a	O
large	O
number	O
of	O
deaths	O
prior	O
to	O
birth	O
or	O
to	O
transfer	O
to	O
a	O
tertiary	O
care	O
facility	O
[	O
4	O
]	O
.	O

As	O
these	O
patients	O
commonly	O
present	O
with	O
severe	O
respiratory	O
failure	O
at	O
birth	O
,	O
therapy	O
has	O
been	O
centered	O
around	O
developing	O
better	O
methods	O
to	O
provide	O
ventilatory	O
support	O
while	O
not	O
producing	O
further	O
lung	O
injury	O
.	O

Extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
)	O
is	O
used	O
in	O
some	O
centers	O
to	O
provide	O
an	O
extended	O
period	O
of	O
cardiopulmonary	O
bypass	O
[	O
5	O
,	O
6	O
]	O
,	O
while	O
other	O
centers	O
have	O
success	O
using	O
other	O
ventilatory	O
support	O
techniques	O
[	O
7	O
]	O
.	O

The	O
morbidity	O
in	O
those	O
who	O
survive	O
is	O
high	O
,	O
and	O
many	O
patients	O
survive	O
with	O
chronic	O
respiratory	O
insufficiency	O
,	O
cognitive	O
and	O
neuromotor	O
deficits	O
,	O
and	O
hearing	O
loss	O
as	O
a	O
result	O
of	O
necessary	O
intensive	O
interventions	O
and	O
associated	O
structural	O
and	O
irreversible	O
developmental	O
abnormalities	O
[	O
8	O
-	O
11	O
]	O
.	O

To	O
date	O
,	O
there	O
have	O
been	O
no	O
specific	O
mutations	B-SO
found	O
to	O
be	O
associated	O
with	O
nonsyndromic	O
diaphragmatic	O
defects	O
and	O
pulmonary	O
hypoplasia	O
in	O
humans	B-Taxon
.	O

The	O
heritability	O
of	O
these	O
defects	O
is	O
unclear	O
,	O
as	O
the	O
high	O
morbidity	O
and	O
mortality	O
limit	O
the	O
collection	O
of	O
multigenerational	O
families	O
for	O
analysis	O
.	O

The	O
genetic	B-SO
etiologies	O
are	O
likely	O
to	O
be	O
complex	O
and	O
probably	O
arise	O
from	O
different	O
mutations	B-SO
in	O
various	O
parts	O
of	O
the	O
molecular	B-CHEBI
developmental	O
pathways	O
required	O
for	O
diaphragmatic	O
development	O
.	O

Indeed	O
,	O
there	O
are	O
numerous	O
reports	O
implicating	O
different	O
chromosomal	B-GO
abnormalities	O
in	O
the	O
pathogenesis	O
of	O
CDH	O
[	O
12	O
,	O
13	O
]	O
.	O

Given	O
the	O
difficulty	O
of	O
studying	O
lethal	O
developmental	O
abnormalities	O
in	O
humans	B-Taxon
,	O
it	O
is	O
of	O
great	O
potential	O
utility	O
to	O
develop	O
animal	B-Taxon
models	O
of	O
human	B-Taxon
birth	O
defects	O
,	O
as	O
the	O
specific	O
genetic	B-SO
abnormalities	O
found	O
in	O
animal	B-Taxon
models	O
can	O
then	O
be	O
investigated	O
in	O
human	B-Taxon
populations	O
.	O

We	O
screened	O
mice	B-Taxon
treated	O
with	O
the	O
chemical	B-CHEBI
mutagen	I-CHEBI
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	I-CHEBI
(	O
ENU	B-CHEBI
)	O
for	O
lines	O
with	O
developmental	O
defects	O
that	O
present	O
in	O
the	O
perinatal	O
period	O
[	O
14	O
]	O
.	O

From	O
this	O
screen	O
,	O
we	O
identified	O
a	O
line	O
of	O
mice	B-Taxon
carrying	O
a	O
recessive	O
mutation	B-SO
that	O
results	O
in	O
primary	O
pulmonary	O
hypoplasia	O
and	O
abnormal	O
diaphragmatic	O
and	O
cardiac	O
development	O
.	O

Positional	B-SO
cloning	O
analysis	O
identified	O
Fog2	B-GGP
(	O
Zfpm2	B-GGP
)	O
as	O
a	O
likely	O
candidate	O
,	O
and	O
DNA	B-SO
sequencing	O
revealed	O
a	O
mutation	B-SO
in	O
a	O
splice	B-SO
donor	I-SO
site	I-SO
that	O
generates	O
an	O
abnormal	O
transcript	B-SO
encoding	O
a	O
truncated	O
protein	B-CHEBI
.	O

This	O
result	O
suggested	O
that	O
we	O
examine	O
the	O
orthologous	B-SO
gene	B-SO
in	O
humans	B-Taxon
with	O
similar	O
developmental	O
defects	O
,	O
and	O
we	O
report	O
the	O
finding	O
of	O
a	O
de	B-SO
novo	I-SO
nonsense	O
mutation	B-SO
in	O
FOG2	B-GGP
in	O
a	O
patient	O
who	O
died	O
at	O
birth	O
with	O
a	O
diaphragmatic	O
defect	O
and	O
severe	O
pulmonary	O
hypoplasia	O
.	O

This	O
is	O
the	O
first	O
reported	O
mutation	B-SO
associated	O
with	O
these	O
abnormalities	O
in	O
a	O
human	B-Taxon
.	O

We	O
present	O
additional	O
data	O
that	O
provide	O
direct	O
evidence	O
that	O
pulmonary	O
hypoplasia	O
may	O
be	O
a	O
primary	O
component	O
of	O
this	O
spectrum	O
of	O
disorders	O
.	O

Results	O

Identification	O
of	O
the	O
little	O
lung	O
Mutation	B-SO
in	O
Fog2	B-GGP

We	O
screened	O
third	O
-	O
generation	O
progeny	O
of	O
ENU	B-CHEBI
-	O
mutagenized	O
mice	B-Taxon
at	O
embryonic	O
day	O
18	O
.	O
5	O
(	O
E18	O
.	O
5	O
)	O
for	O
abnormal	O
developmental	O
phenotypes	O
[	O
14	O
]	O
.	O

One	O
line	O
of	O
mice	B-Taxon
was	O
found	O
to	O
have	O
multiple	O
embryos	O
in	O
independent	O
litters	O
that	O
displayed	O
pulmonary	O
hypoplasia	O
and	O
a	O
thin	O
diaphragm	O
.	O

The	O
mutation	B-SO
,	O
which	O
we	O
called	O
little	O
lung	O
(	O
lil	O
)	O
,	O
was	O
mapped	O
to	O
Chromosome	B-GO
15	O
by	O
utilizing	O
a	O
strategy	O
of	O
interval	B-SO
haplotype	B-SO
analysis	O
(	O
data	O
not	O
shown	O
)	O
[	O
15	O
]	O
.	O

For	O
high	O
-	O
resolution	O
mapping	O
,	O
F2	O
progeny	O
from	O
two	O
crosses	O
were	O
analyzed	O
.	O

In	O
450	O
progeny	O
of	O
an	O
intercross	O
of	O
F1	O
(	O
A	O
/	O
J	O
x	O
FVB	O
/	O
N	O
)	O
lil	O
/	O
+	O
mice	B-Taxon
,	O
the	O
interval	B-SO
containing	O
the	O
mutation	B-SO
was	O
defined	O
by	O
19	O
recombinants	O
between	O
D15Mit220	O
and	O
D15Mit154	O
.	O

Because	O
of	O
the	O
lack	O
of	O
informative	O
markers	O
within	O
this	O
interval	B-SO
,	O
an	O
additional	O
39	O
F2	O
progeny	O
from	O
an	O
A	O
/	O
J	O
x	O
C57BL	O
/	O
6J	O
cross	O
were	O
tested	O
.	O

The	O
identification	O
of	O
two	O
recombinants	O
established	O
D15Mit85	O
as	O
the	O
proximal	O
and	O
D15Mit5	O
as	O
the	O
distal	O
flanking	O
markers	O
.	O

The	O
lil	O
phenotype	O
was	O
identified	O
at	O
E18	O
.	O
5	O
to	O
have	O
bilateral	O
pulmonary	O
hypoplasia	O
and	O
an	O
abnormal	O
diaphragm	O
.	O

Pulmonary	O
hypoplasia	O
was	O
apparent	O
in	O
all	O
mutant	B-SO
mice	B-Taxon
that	O
survived	O
to	O
birth	O
.	O

In	O
a	O
comparison	O
between	O
wild	B-SO
-	I-SO
type	I-SO
and	O
mutant	B-SO
mice	B-Taxon
found	O
dead	O
on	O
day	O
one	O
of	O
life	O
,	O
body	O
weights	O
were	O
not	O
different	O
;	O
however	O
,	O
the	O
lung	O
weights	O
were	O
significantly	O
lower	O
in	O
the	O
mutant	B-SO
mice	B-Taxon
.	O

The	O
average	O
mutant	B-SO
lung	O
weight	O
was	O
9	O
.	O
6	O
+/-	O
2	O
.	O
5	O
mg	O
while	O
the	O
average	O
wild	B-SO
-	I-SO
type	I-SO
lung	O
weight	O
was	O
26	O
.	O
4	O
+/-	O
4	O
.	O
6	O
mg	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

All	O
lungs	O
from	O
mutant	B-SO
mice	B-Taxon
were	O
lacking	O
an	O
accessory	O
lobe	O
on	O
the	O
right	O
side	O
and	O
had	O
underdevelopment	O
of	O
the	O
anterior	O
right	O
middle	O
lobe	O
(	O
Figure	O
1A	O
)	O
.	O

Diaphragms	O
from	O
mutant	B-SO
lil	O
mice	B-Taxon
were	O
intact	O
,	O
but	O
muscularization	O
was	O
absent	O
in	O
the	O
dorsal	O
regions	O
.	O

Myotubules	O
were	O
present	O
in	O
a	O
limited	O
and	O
abnormal	O
distribution	O
.	O

More	O
specifically	O
,	O
myotubules	O
normally	O
radiate	O
in	O
a	O
mediolateral	O
fashion	O
to	O
meet	O
the	O
lateral	O
body	O
walls	O
,	O
with	O
a	O
normal	O
paucity	O
of	O
muscle	O
fibers	O
in	O
the	O
central	O
tendonous	O
region	O
.	O

In	O
the	O
mutant	B-SO
diaphragm	O
,	O
myotubules	O
radiated	O
in	O
a	O
dorsal	O
-	O
ventral	O
orientation	O
,	O
and	O
muscle	O
tissue	O
did	O
not	O
meet	O
the	O
entire	O
surface	O
of	O
the	O
body	O
walls	O
(	O
Figure	O
1B	O
)	O
.	O

The	O
number	O
of	O
lil	O
mutant	B-SO
mice	B-Taxon
that	O
survived	O
to	O
birth	O
was	O
less	O
than	O
5	O
%	O
of	O
total	O
progeny	O
,	O
rather	O
than	O
the	O
25	O
%	O
expected	O
for	O
a	O
recessive	O
mutation	B-SO
.	O

We	O
evaluated	O
litters	O
at	O
different	O
embryonic	O
time	O
points	O
to	O
determine	O
whether	O
the	O
reduced	O
number	O
was	O
due	O
to	O
intra	O
-	O
uterine	O
demise	O
.	O

Litters	O
were	O
collected	O
at	O
E12	O
.	O
5	O
,	O
13	O
.	O
5	O
,	O
15	O
.	O
5	O
,	O
17	O
.	O
5	O
,	O
and	O
18	O
.	O
5	O
,	O
and	O
embryos	O
were	O
genotyped	O
and	O
evaluated	O
for	O
evidence	O
of	O
intra	O
-	O
uterine	O
demise	O
,	O
including	O
growth	O
retardation	O
,	O
pallor	O
,	O
and	O
tissue	O
friability	O
.	O
lil	O
embryos	O
had	O
a	O
progressively	O
higher	O
rate	O
of	O
demise	O
between	O
E13	O
.	O
5	O
and	O
E15	O
.	O
5	O
.	O

At	O
E12	O
.	O
5	O
,	O
20	O
out	O
of	O
87	O
(	O
23	O
%	O
)	O
were	O
homozygous	O
for	O
the	O
mutation	B-SO
,	O
and	O
all	O
of	O
these	O
appeared	O
viable	O
.	O

At	O
E13	O
.	O
5	O
,	O
13	O
of	O
49	O
(	O
27	O
%	O
)	O
were	O
mutant	B-SO
and	O
two	O
had	O
died	O
.	O

At	O
E15	O
.	O
5	O
,	O
22	O
out	O
of	O
91	O
(	O
24	O
%	O
)	O
were	O
mutant	B-SO
and	O
the	O
majority	O
of	O
mutant	B-SO
embryos	O
(	O
17	O
out	O
of	O
the	O
22	O
)	O
had	O
died	O
.	O

By	O
E18	O
.	O
5	O
,	O
nine	O
of	O
29	O
embryos	O
(	O
31	O
%	O
)	O
were	O
homozygous	O
for	O
the	O
mutation	B-SO
,	O
of	O
which	O
only	O
one	O
embryo	O
was	O
viable	O
.	O

Diaphragmatic	O
muscularization	O
was	O
abnormal	O
in	O
all	O
mutant	B-SO
mice	B-Taxon
examined	O
(	O
n	O
>	O
25	O
)	O
.	O

Pulmonary	O
hypoplasia	O
was	O
observed	O
in	O
100	O
%	O
of	O
mutants	B-SO
evaluated	O
for	O
that	O
phenotype	O
between	O
E11	O
.	O
5	O
and	O
birth	O
(	O
n	O
>	O
50	O
)	O
.	O

Examination	O
of	O
cardiac	O
morphology	O
showed	O
that	O
hearts	O
from	O
E15	O
.	O
5	O
lil	O
mutant	B-SO
mice	B-Taxon
had	O
a	O
variety	O
of	O
developmental	O
defects	O
,	O
including	O
enlarged	O
and	O
abnormally	O
developed	O
endocardial	O
cushions	O
,	O
a	O
double	O
-	O
outlet	O
right	O
ventricle	O
,	O
and	O
a	O
complete	O
atrioventricular	O
canal	O
.	O

The	O
myocardium	O
was	O
also	O
poorly	O
developed	O
,	O
with	O
thinning	O
of	O
the	O
outer	O
compact	O
layer	O
and	O
decreased	O
vascularity	O
.	O

The	O
cohort	O
of	O
mutant	B-SO
mice	B-Taxon
that	O
survived	O
to	O
birth	O
also	O
had	O
cardiac	O
malformations	O
including	O
atrioventricular	O
-	O
canal	O
-	O
type	O
ventricular	O
septal	O
defects	O
,	O
ostium	O
primum	O
atrial	O
septal	O
defects	O
,	O
and	O
enlarged	O
atria	O
(	O
data	O
not	O
shown	O
)	O
.	O

All	O
mutants	B-SO
specifically	O
evaluated	O
for	O
a	O
cardiac	O
phenotype	O
(	O
n	O
=	O
10	O
)	O
had	O
abnormal	O
cardiac	O
development	O
.	O

Examination	O
of	O
the	O
3	O
-	O
Mb	O
region	B-SO
between	O
D15Mit85	O
and	O
D15Mit5	O
in	O
DNA	B-SO
sequence	I-SO
databases	O
revealed	O
three	O
predicted	B-SO
genes	I-SO
and	O
four	O
known	B-SO
genes	B-SO
,	O
including	O
Fog2	B-GGP
.	O

Targeted	O
mutations	B-SO
of	O
Fog2	B-GGP
have	O
cardiac	O
defects	O
strikingly	O
similar	O
to	O
those	O
we	O
identified	O
in	O
lil	O
mutant	B-SO
mice	B-Taxon
,	O
including	O
atrioventricular	O
canal	O
defects	O
,	O
thinned	O
myocardium	O
,	O
and	O
absent	O
coronary	O
vasculature	O
[	O
16	O
]	O
.	O

RT	O
-	O
PCR	O
amplification	O
of	O
the	O
proximal	O
portion	B-SO
of	O
Fog2	B-GGP
revealed	O
longer	O
transcripts	B-SO
in	O
the	O
lil	O
mutant	B-SO
than	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
embryos	O
(	O
Figure	O
2A	O
)	O
.	O

Sequencing	O
of	O
the	O
mutant	B-SO
transcript	B-SO
revealed	O
a	O
point	B-SO
mutation	I-SO
(	I-SO
from	I-SO
thymine	I-SO
to	I-SO
cytosine	I-SO
)	O
2	O
bp	B-SO
after	O
position	B-SO
301	O
,	O
which	O
is	O
in	O
the	O
splice	B-SO
donor	I-SO
site	I-SO
at	O
the	O
end	O
of	O
the	O
third	O
exon	B-SO
.	O

This	O
mutation	B-SO
causes	O
a	O
splicing	O
defect	O
that	O
results	O
in	O
the	O
insertion	B-SO
of	O
85	O
bp	B-SO
of	O
intronic	B-SO
sequence	I-SO
into	O
the	O
mutant	B-SO
transcript	B-SO
,	O
and	O
introduces	O
a	O
stop	B-SO
codon	I-SO
that	O
generates	O
a	O
severely	O
truncated	O
protein	B-CHEBI
product	I-CHEBI
(	O
Figure	O
2B	O
)	O
.	O

Heterozygous	O
lil	O
mutant	B-SO
mice	B-Taxon
were	O
crossed	O
with	O
a	O
Fog2	B-GGP
+	O
/	O
-	O
(	O
null	O
allele	B-SO
)	O
mutant	B-SO
generated	O
by	O
gene	B-SO
targeting	O
[	O
16	O
]	O
.	O

Doubly	O
heterozygous	O
mice	B-Taxon
had	O
an	O
embryonic	O
lethal	O
phenotype	O
;	O
this	O
failure	O
to	O
complement	O
proves	O
that	O
lil	O
is	O
a	O
mutation	B-SO
in	O
Fog2	B-GGP
.	O

The	O
variable	O
phenotype	O
of	O
lil	O
mice	B-Taxon
(	O
relative	O
to	O
that	O
found	O
for	O
the	O
Fog2	B-GGP
null	O
mutant	B-SO
)	O
is	O
likely	O
due	O
to	O
the	O
generation	O
of	O
a	O
low	O
level	O
of	O
normal	O
transcript	B-SO
despite	O
the	O
presence	O
of	O
the	O
splice	B-SO
site	I-SO
mutation	B-SO
.	O

Lung	O
and	O
Diaphragm	O
Development	O
in	O
the	O
Fog2	B-GGP
Mutant	B-SO
Mouse	B-Taxon

Experiments	O
were	O
conducted	O
to	O
evaluate	O
the	O
role	O
of	O
Fog2	B-GGP
in	O
pulmonary	O
and	O
diaphragmatic	O
development	O
.	O

The	O
pulmonary	O
phenotype	O
is	O
characterized	O
by	O
diffuse	O
hypoplasia	O
and	O
specific	O
loss	O
of	O
the	O
accessory	O
lobe	O
and	O
a	O
portion	O
of	O
the	O
right	O
middle	O
lobe	O
.	O

It	O
is	O
well	O
established	O
that	O
abnormalities	O
in	O
either	O
diaphragmatic	O
development	O
or	O
fetal	O
breathing	O
can	O
result	O
in	O
a	O
secondary	O
pulmonary	O
hypoplasia	O
,	O
although	O
loss	O
of	O
normal	O
structure	O
has	O
never	O
been	O
documented	O
in	O
this	O
context	O
[	O
17	O
,	O
18	O
]	O
.	O

Fog2	B-GGP
is	O
expressed	O
diffusely	O
in	O
the	O
pulmonary	O
mesenchyme	O
during	O
the	O
period	O
of	O
branching	O
morphogenesis	O
,	O
while	O
later	O
expression	O
is	O
restricted	O
to	O
the	O
smooth	O
muscles	O
of	O
airways	O
and	O
pulmonary	O
vessels	O
(	O
Figure	O
3	O
)	O
.	O

This	O
,	O
and	O
the	O
observation	O
that	O
lungs	O
appeared	O
small	O
on	O
transverse	O
sections	O
evaluated	O
prior	O
to	O
diaphragmatic	O
muscularization	O
or	O
function	O
,	O
suggests	O
that	O
the	O
pulmonary	O
hypoplasia	O
occurs	O
independently	O
of	O
the	O
diaphragmatic	O
defect	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
lungs	O
were	O
dissected	O
from	O
Fog2	B-GGP
-	O
/	O
-	O
mice	B-Taxon
and	O
littermate	O
controls	O
before	O
the	O
onset	O
of	O
fetal	O
diaphragmatic	O
motion	O
.	O

Fog2	B-GGP
-	O
/	O
-	O
mice	B-Taxon
were	O
used	O
for	O
this	O
experiment	O
,	O
as	O
we	O
wanted	O
to	O
avoid	O
potential	O
phenotypic	O
variance	O
from	O
the	O
lil	O
hypomorphic	O
mutation	B-SO
.	O

Lungs	O
dissected	O
at	O
E12	O
from	O
Fog2	B-GGP
-	O
/	O
-	O
embryos	O
were	O
smaller	O
in	O
size	O
and	O
lacked	O
the	O
development	O
of	O
an	O
accessory	O
lobe	O
.	O

In	O
11	O
viable	O
Fog2	B-GGP
-	O
/	O
-	O
lung	O
culture	O
explants	O
,	O
there	O
was	O
never	O
development	O
of	O
an	O
accessory	O
lobe	O
,	O
and	O
the	O
weights	O
of	O
mutant	B-SO
lungs	O
cultured	O
for	O
5	O
d	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
littermate	O
controls	O
(	O
Figure	O
4	O
)	O
.	O

These	O
data	O
demonstrate	O
that	O
the	O
pulmonary	O
hypoplasia	O
in	O
Fog2	B-GGP
mutant	B-SO
mice	B-Taxon
is	O
a	O
primary	O
defect	O
.	O

Branching	O
in	O
the	O
unaffected	O
lobes	O
appeared	O
to	O
be	O
delayed	O
by	O
6	O
-	O
12	O
h	O
,	O
but	O
all	O
mutants	B-SO
developed	O
an	O
intricate	O
branching	O
pattern	O
in	O
the	O
unaffected	O
lobes	O
after	O
culture	O
for	O
5	O
d	O
.	O

Because	O
the	O
Fog2	B-GGP
phenotype	O
is	O
striking	O
for	O
specific	O
lobar	O
loss	O
,	O
the	O
spatial	O
pattern	O
of	O
Fog2	B-GGP
expression	O
was	O
evaluated	O
in	O
normal	O
embryos	O
during	O
the	O
period	O
of	O
early	O
lobar	O
establishment	O
to	O
determine	O
whether	O
Fog2	B-GGP
expression	O
is	O
specifically	O
different	O
at	O
these	O
lobar	O
buds	O
.	O

Expression	O
was	O
evaluated	O
in	O
mice	B-Taxon
carrying	O
a	O
lacZ	O
gene	B-SO
incorporated	B-SO
into	O
the	O
Fog2	B-GGP
locus	B-SO
(	O
S	O
.	O
Tevosian	O
,	O
unpublished	O
data	O
)	O
.	O

In	O
nine	O
mice	B-Taxon
examined	O
at	O
E11	O
.	O
5	O
,	O
all	O
lungs	O
showed	O
a	O
specific	O
enhancement	O
of	O
Fog2	B-GGP
expression	O
in	O
the	O
mesenchyme	O
surrounding	O
the	O
accessory	O
bud	O
and	O
the	O
right	O
middle	O
lobe	O
bud	O
,	O
which	O
are	O
the	O
lobes	O
that	O
do	O
not	O
develop	O
normally	O
in	O
Fog2	B-GGP
mutant	B-SO
mice	B-Taxon
(	O
Figure	O
5	O
)	O
.	O

By	O
E12	O
.	O
5	O
,	O
expression	O
was	O
diffuse	O
in	O
the	O
pulmonary	O
mesenchyme	O
,	O
as	O
was	O
seen	O
previously	O
with	O
in	O
situ	O
hybridization	O
on	O
tissue	O
sections	O
.	O

Diaphragms	O
from	O
Fog2	B-GGP
lil	O
mice	B-Taxon
show	O
an	O
intact	O
membrane	O
with	O
a	O
defect	O
in	O
muscular	O
patterning	O
(	O
see	O
Figure	O
1B	O
)	O
.	O

The	O
membranous	O
portion	O
of	O
the	O
diaphragm	O
is	O
populated	O
by	O
a	O
migratory	O
population	O
of	O
muscle	B-CL
precursor	I-CL
cells	I-CL
,	O
much	O
like	O
the	O
limbs	O
[	O
19	O
,	O
20	O
]	O
.	O

Mice	B-Taxon
with	O
defects	O
in	O
genes	B-SO
known	O
to	O
be	O
important	O
for	O
the	O
control	O
of	O
this	O
process	O
have	O
intact	O
but	O
amuscular	O
diaphragms	O
[	O
17	O
,	O
21	O
,	O
22	O
]	O
.	O

Hepatocyte	B-GGP
growth	I-GGP
factor	I-GGP
/	O
Scatter	B-GGP
factor	I-GGP
(	O
HGF	B-GGP
)	O
is	O
one	O
potential	O
candidate	O
responsible	O
for	O
the	O
guidance	O
of	O
muscle	B-CL
precursors	I-CL
to	O
the	O
membranous	O
diaphragm	O
.	O

It	O
has	O
been	O
shown	O
that	O
HGF	B-GGP
is	O
expressed	O
along	O
this	O
anatomic	O
pathway	O
[	O
23	O
]	O
,	O
and	O
mice	B-Taxon
with	O
absence	O
of	O
the	O
HGF	B-GGP
receptor	I-GGP
c	B-GGP
-	I-GGP
Met	I-GGP
fail	O
to	O
form	O
muscularized	O
pleuroperitoneal	O
folds	O
(	O
PPFs	O
)	O
,	O
and	O
thus	O
have	O
amuscular	O
diaphragms	O
[	O
24	O
,	O
25	O
]	O
.	O

Fog2	B-GGP
is	O
expressed	O
diffusely	O
in	O
the	O
early	O
amuscular	O
diaphragm	O
at	O
E11	O
.	O
5	O
as	O
well	O
as	O
in	O
the	O
later	O
muscularized	O
diaphragm	O
(	O
see	O
Figure	O
3C	O
and	O
3D	O
)	O
.	O

Pax3	B-GGP
and	O
MyoD	B-GGP
,	O
transcription	O
factors	O
required	O
for	O
appropriate	O
migration	O
and	O
determination	O
of	O
myogenic	B-CL
precursors	I-CL
,	O
were	O
detected	O
in	O
the	O
PPFs	O
of	O
Fog2	B-GGP
lil	O
mice	B-Taxon
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
in	O
situ	O
expression	O
analysis	O
demonstrated	O
that	O
the	O
expression	O
of	O
HGF	B-GGP
in	O
the	O
region	O
where	O
this	O
structure	O
meets	O
the	O
membranous	O
diaphragm	O
was	O
markedly	O
reduced	O
in	O
Fog2	B-GGP
mutant	B-SO
mice	B-Taxon
(	O
Figure	O
6	O
)	O
.	O

We	O
hypothesize	O
that	O
Fog2	B-GGP
is	O
required	O
(	O
either	O
directly	O
or	O
indirectly	O
)	O
for	O
the	O
induction	O
of	O
HGF	B-GGP
in	O
the	O
developing	O
diaphragm	O
,	O
and	O
dysregulation	O
of	O
HGF	B-GGP
patterning	O
along	O
the	O
path	O
of	O
muscle	B-CL
precursor	I-CL
cell	I-CL
migration	O
between	O
the	O
PPF	O
and	O
the	O
diaphragm	O
accounts	O
for	O
the	O
abnormal	O
phenotype	O
in	O
these	O
mice	B-Taxon
.	O

FOG2	B-GGP
Mutation	B-SO
in	O
a	O
Patient	O
with	O
Diaphragm	O
and	O
Lung	O
Abnormalities	O

FOG2	B-GGP
sequence	B-SO
analysis	O
was	O
performed	O
on	O
autopsy	O
tissue	O
from	O
30	O
of	O
32	O
deceased	O
children	O
with	O
an	O
anatomic	O
diagnosis	O
of	O
diaphragmatic	O
defect	O
evaluated	O
at	O
the	O
Children	O
'	O
s	O
Hospital	O
in	O
Boston	O
,	O
Massachusetts	O
,	O
between	O
1993	O
and	O
2003	O
.	O

Autopsy	O
reports	O
were	O
reviewed	O
to	O
determine	O
the	O
specific	O
diagnoses	O
.	O

Of	O
these	O
30	O
cases	O
,	O
17	O
(	O
57	O
%	O
)	O
had	O
Bochdalek	O
CDH	O
,	O
two	O
(	O
7	O
%	O
)	O
had	O
diaphragmatic	O
agenesis	O
,	O
seven	O
(	O
23	O
%	O
)	O
had	O
diaphragmatic	O
eventration	O
/	O
muscularization	O
defects	O
(	O
without	O
Bochdalek	O
CDH	O
)	O
,	O
and	O
four	O
(	O
13	O
%	O
)	O
had	O
Bochdalek	O
hernia	O
of	O
one	O
hemidiaphragm	O
and	O
eventration	O
of	O
the	O
other	O
.	O

Pulmonary	O
hypoplasia	O
was	O
assessed	O
using	O
lung	O
/	O
body	O
weight	O
ratio	O
and	O
radial	O
alveolar	O
counts	O
[	O
26	O
]	O
.	O

The	O
material	O
available	O
for	O
review	O
included	O
written	O
reports	O
and	O
histologic	O
slides	O
in	O
all	O
cases	O
and	O
gross	O
kodachromes	O
in	O
a	O
subset	O
of	O
cases	O
.	O

One	O
child	O
carried	O
a	O
highly	O
significant	O
FOG2	B-GGP
sequence	B-SO
change	I-SO
.	O

The	O
patient	O
was	O
a	O
full	O
-	O
term	O
3	O
,	O
500	O
-	O
g	O
baby	O
girl	O
who	O
developed	O
severe	O
respiratory	O
failure	O
at	O
birth	O
and	O
died	O
after	O
5	O
h	O
of	O
resuscitation	O
.	O

Antemortem	O
radiographs	O
showed	O
opacified	O
lung	O
fields	O
and	O
possible	O
bowel	O
in	O
the	O
chest	O
.	O

The	O
patient	O
'	O
s	O
clinical	O
diagnosis	O
was	O
CDH	O
.	O

Review	O
of	O
autopsy	O
material	O
revealed	O
severe	O
bilateral	O
pulmonary	O
hypoplasia	O
(	O
combined	O
lung	O
weight	O
,	O
11	O
.	O
1	O
g	O
;	O
expected	O
for	O
body	O
length	O
/	O
weight	O
,	O
46	O
.	O
8	O
+/-	O
26	O
.	O
2	O
g	O
;	O
[	O
27	O
]	O
)	O
,	O
most	O
markedly	O
involving	O
the	O
left	O
lung	O
.	O

The	O
lung	O
/	O
body	O
weight	O
ratio	O
was	O
0	O
.	O
0037	O
(	O
expected	O
>	O
0	O
.	O
010	O
)	O
[	O
28	O
]	O
.	O

There	O
were	O
a	O
reduced	O
number	O
of	O
bronchial	O
generations	O
,	O
and	O
the	O
radial	O
alveolar	O
count	O
was	O
2	O
-	O
3	O
(	O
expected	O
=	O
5	O
)	O
[	O
29	O
]	O
.	O

There	O
were	O
incomplete	O
lung	O
fissures	O
bilaterally	O
.	O

A	O
deep	O
posterior	O
diaphragmatic	O
eventration	O
was	O
present	O
on	O
the	O
left	O
side	O
.	O

Additionally	O
,	O
two	O
muscularized	O
ligamentous	O
bands	O
resembling	O
diaphragmatic	O
remnants	O
encircled	O
the	O
left	O
lobe	O
of	O
the	O
liver	O
,	O
creating	O
an	O
abnormal	O
fissured	O
liver	O
contour	O
.	O

Away	O
from	O
the	O
eventration	O
,	O
the	O
diaphragm	O
appeared	O
well	O
muscularized	O
,	O
measuring	O
0	O
.	O
3	O
cm	O
in	O
thickness	O
.	O

A	O
complete	O
autopsy	O
revealed	O
no	O
other	O
malformations	O
;	O
the	O
heart	O
was	O
determined	O
to	O
be	O
grossly	O
normal	O
and	O
was	O
donated	O
for	O
valve	O
harvest	O
.	O

Sequence	B-SO
analysis	O
revealed	O
a	O
cytosine	B-CHEBI
to	O
thymine	B-CHEBI
heterozygous	O
change	B-SO
in	O
exon	B-SO
4	O
that	O
changes	B-SO
the	O
112th	O
amino	B-CHEBI
acid	I-CHEBI
from	O
arginine	B-CHEBI
to	O
a	O
stop	B-SO
codon	I-SO
.	O

This	O
mutation	B-SO
produces	O
a	O
severely	O
truncated	O
peptide	B-SO
that	O
does	O
not	O
contain	O
zinc	B-CHEBI
finger	O
domains	B-SO
(	O
Figure	O
7	O
)	O
.	O

This	O
base	B-SO
change	B-SO
was	O
not	O
present	O
in	O
the	O
analysis	O
of	O
DNA	B-SO
from	O
400	O
normal	O
adults	O
.	O

To	O
assess	O
the	O
likelihood	O
that	O
the	O
mutation	B-SO
was	O
causal	O
for	O
the	O
developmental	O
phenotype	O
,	O
we	O
examined	O
both	O
parents	O
.	O

Paternity	O
was	O
confirmed	O
,	O
and	O
sequence	B-SO
analysis	O
revealed	O
that	O
the	O
neither	O
parent	O
carried	O
this	O
mutation	B-SO
,	O
proving	O
that	O
the	O
patient	O
had	O
a	O
de	B-SO
novo	I-SO
mutation	B-SO
in	O
FOG2	B-GGP
(	O
Figure	O
7	O
)	O
.	O

Discussion	O

Congenital	O
diaphragmatic	O
defects	O
are	O
a	O
heterogeneous	O
group	O
of	O
disorders	O
of	O
unknown	O
etiology	O
.	O

The	O
defects	O
that	O
present	O
in	O
the	O
pre	O
-	O
or	O
perinatal	O
period	O
include	O
Bochdalek	O
hernia	O
,	O
diaphragmatic	O
aplasia	O
,	O
and	O
various	O
degrees	O
of	O
muscularization	O
defects	O
or	O
eventrations	O
.	O

Different	O
types	O
of	O
defects	O
occur	O
in	O
the	O
same	O
patients	O
or	O
in	O
siblings	O
,	O
suggesting	O
these	O
represent	O
variable	O
expression	O
of	O
the	O
same	O
underlying	O
pathogenesis	O
[	O
30	O
,	O
31	O
]	O
.	O

Clinical	O
differentiation	O
between	O
these	O
defects	O
may	O
be	O
very	O
difficult	O
,	O
as	O
the	O
residual	O
membranous	O
diaphragm	O
of	O
a	O
muscularization	O
defect	O
is	O
thin	O
and	O
may	O
not	O
be	O
easily	O
visible	O
on	O
prenatal	O
ultrasound	O
or	O
postnatal	O
chest	O
radiographs	O
[	O
32	O
]	O
.	O

Although	O
diaphragmatic	O
muscularization	O
defects	O
were	O
historically	O
considered	O
to	O
be	O
predictive	O
of	O
a	O
good	O
outcome	O
,	O
there	O
have	O
been	O
inadequate	O
population	O
-	O
based	O
studies	O
that	O
include	O
fetal	O
or	O
neonatal	O
cases	O
and	O
autopsy	O
diagnoses	O
to	O
make	O
this	O
conclusion	O
definitive	O
.	O

In	O
fact	O
,	O
the	O
series	O
of	O
patients	O
we	O
report	O
here	O
and	O
the	O
published	O
literature	O
indicate	O
that	O
an	O
eventration	O
defect	O
may	O
be	O
associated	O
with	O
displacement	O
of	O
abdominal	O
contents	O
and	O
also	O
with	O
severe	O
pulmonary	O
hypoplasia	O
and	O
respiratory	O
insufficiency	O
[	O
33	O
,	O
34	O
]	O
.	O

Numerous	O
chromosome	B-GO
abnormalities	O
have	O
been	O
found	O
in	O
association	O
with	O
congenital	O
diaphragm	O
abnormalities	O
[	O
12	O
,	O
35	O
]	O
.	O

Human	B-GGP
FOG2	I-GGP
maps	O
to	O
Chromosome	B-GO
8q23	O
.	O
1	O
,	O
and	O
,	O
importantly	O
,	O
several	O
patients	O
with	O
diaphragm	O
defects	O
and	O
rearrangements	O
involving	O
this	O
locus	B-SO
have	O
been	O
reported	O
.	O

Specifically	O
,	O
there	O
are	O
three	O
unrelated	O
CDH	O
patients	O
with	O
cytogenetically	O
balanced	O
translocations	B-SO
at	O
or	O
near	O
the	O
FOG2	B-GGP
locus	B-SO
[	O
36	O
,	O
37	O
]	O
.	O

Additionally	O
,	O
two	O
patients	O
with	O
deletions	B-SO
apparently	O
encompassing	O
the	O
FOG2	B-GGP
locus	B-SO
have	O
died	O
from	O
multiple	O
congenital	O
anomalies	O
including	O
CDH	O
[	O
38	O
-	O
40	O
]	O
.	O

Inactivation	O
of	O
this	O
gene	B-SO
due	O
to	O
chromosomal	B-GO
rearrangement	O
or	O
deletion	B-SO
would	O
result	O
in	O
a	O
heterozygous	O
null	O
mutation	B-SO
similar	O
to	O
that	O
found	O
in	O
the	O
patient	O
we	O
report	O
.	O

Because	O
the	O
FOG2	B-GGP
mutation	B-SO
we	O
report	O
is	O
de	B-SO
novo	I-SO
and	O
the	O
phenotypes	O
of	O
the	O
pulmonary	O
and	O
diaphragmatic	O
defects	O
are	O
similar	O
between	O
mouse	B-Taxon
and	O
human	B-Taxon
,	O
we	O
suggest	O
that	O
this	O
mutation	B-SO
in	O
FOG2	B-GGP
is	O
the	O
first	O
reported	O
cause	O
of	O
a	O
human	B-Taxon
developmental	O
diaphragmatic	O
and	O
pulmonary	O
defect	O
.	O

In	O
contrast	O
to	O
the	O
affected	O
child	O
,	O
mice	B-Taxon
heterozygous	O
for	O
a	O
null	O
mutation	B-SO
of	O
Fog2	B-GGP
appear	O
normal	O
.	O

However	O
,	O
there	O
is	O
ample	O
precedent	O
for	O
the	O
observation	O
that	O
haploinsufficiency	O
of	O
a	O
gene	B-SO
with	O
developmental	O
functions	O
is	O
much	O
less	O
well	O
tolerated	O
in	O
humans	B-Taxon
than	O
mice	B-Taxon
[	O
41	O
]	O
.	O

It	O
is	O
unclear	O
how	O
the	O
Fog2	B-GGP
diaphragmatic	O
defect	O
relates	O
to	O
the	O
more	O
common	O
Bochdalek	O
CDH	O
,	O
as	O
the	O
pathogenic	O
mechanisms	O
for	O
both	O
are	O
largely	O
unknown	O
.	O

Muscle	B-CL
precursors	I-CL
destined	O
to	O
populate	O
the	O
diaphragm	O
migrate	O
from	O
the	O
lateral	O
dermomyotome	O
of	O
cervical	O
somites	O
.	O

Prior	O
to	O
migration	O
onto	O
the	O
diaphragm	O
,	O
they	O
populate	O
the	O
PPF	O
,	O
a	O
wedge	O
-	O
shaped	O
tissue	O
that	O
tapers	O
medially	O
from	O
the	O
lateral	O
body	O
wall	O
to	O
the	O
esophageal	O
mesentery	O
and	O
fuses	O
ventrally	O
with	O
the	O
septum	O
transversum	O
[	O
42	O
]	O
.	O

Muscle	B-CL
precursors	I-CL
reach	O
the	O
PPF	O
by	O
E11	O
,	O
where	O
they	O
proliferate	O
,	O
differentiate	O
,	O
and	O
then	O
migrate	O
toward	O
the	O
dorsolateral	O
costal	O
,	O
sternal	O
costal	O
,	O
and	O
crural	O
regions	O
of	O
the	O
developing	O
diaphragm	O
.	O

Thus	O
,	O
a	O
defect	O
in	O
PPF	O
formation	O
subsequently	O
results	O
in	O
the	O
abnormal	O
formation	O
of	O
the	O
diaphragm	O
[	O
43	O
]	O
.	O

We	O
have	O
shown	O
that	O
the	O
Fog2	B-GGP
mutant	B-SO
does	O
have	O
an	O
abnormal	O
pattern	O
of	O
HGF	B-GGP
expression	O
in	O
the	O
region	O
through	O
which	O
muscle	B-CL
precursor	I-CL
cells	I-CL
migrate	O
onto	O
the	O
developing	O
diaphragm	O
.	O

This	O
finding	O
may	O
account	O
for	O
the	O
abnormally	O
patterned	O
muscle	O
that	O
develops	O
in	O
the	O
Fog2	B-GGP
mutant	B-SO
diaphragm	O
.	O

Although	O
Pax3	B-GGP
and	O
MyoD	B-GGP
expression	O
is	O
detected	O
in	O
the	O
PPF	O
,	O
a	O
detailed	O
analysis	O
of	O
transcription	O
factors	O
responsible	O
for	O
muscle	B-CL
precursor	I-CL
cell	I-CL
migration	O
and	O
differentiation	O
will	O
need	O
to	O
be	O
completed	O
both	O
in	O
the	O
PPF	O
and	O
along	O
the	O
pathway	O
of	O
muscle	B-CL
precursor	I-CL
cell	I-CL
migration	O
between	O
the	O
PPF	O
and	O
the	O
membranous	O
diaphragm	O
.	O

Fog2	B-GGP
can	O
interact	O
with	O
any	O
of	O
the	O
Gata	O
factors	O
,	O
Gatas	B-GGP
1	I-GGP
-	I-GGP
6	I-GGP
,	O
as	O
well	O
as	O
other	O
transcription	O
factors	O
such	O
as	O
CoupTFII	B-GGP
[	O
44	O
,	O
45	O
]	O
.	O

It	O
is	O
known	O
that	O
a	O
Fog2	B-GGP
-	O
Gata4	B-GGP
interaction	O
is	O
critical	O
for	O
normal	O
cardiac	O
and	O
gonadal	O
development	O
,	O
but	O
interacting	O
factors	O
in	O
the	O
lung	O
and	O
diaphragm	O
have	O
not	O
yet	O
been	O
determined	O
.	O

The	O
severity	O
of	O
pulmonary	O
hypoplasia	O
in	O
the	O
patient	O
we	O
report	O
was	O
out	O
of	O
proportion	O
to	O
that	O
of	O
the	O
diaphragm	O
defect	O
.	O

Pulmonary	O
hypoplasia	O
is	O
associated	O
with	O
abnormal	O
diaphragmatic	O
anatomy	O
or	O
function	O
,	O
and	O
is	O
known	O
to	O
occur	O
as	O
a	O
secondary	O
developmental	O
defect	O
in	O
models	O
of	O
diaphragmatic	O
dysfunction	O
such	O
as	O
complete	O
amuscularization	O
[	O
17	O
]	O
or	O
phrenic	O
nerve	O
disruption	O
[	O
46	O
]	O
.	O

It	O
occurs	O
in	O
a	O
surgical	O
model	O
of	O
CDH	O
in	O
which	O
a	O
hernia	O
is	O
physically	O
created	O
in	O
an	O
in	O
utero	O
lamb	B-Taxon
[	O
47	O
,	O
48	O
]	O
.	O

However	O
,	O
the	O
possibility	O
that	O
primary	O
pulmonary	O
developmental	O
abnormalities	O
occur	O
with	O
,	O
rather	O
than	O
secondary	O
to	O
,	O
diaphragmatic	O
defects	O
has	O
been	O
suggested	O
by	O
others	O
based	O
on	O
a	O
teratogenic	O
model	O
of	O
CDH	O
[	O
49	O
-	O
51	O
]	O
and	O
has	O
long	O
been	O
suspected	O
by	O
clinicians	O
who	O
care	O
for	O
these	O
patients	O
.	O

In	O
addition	O
,	O
the	O
high	O
incidence	O
of	O
lobar	O
abnormalities	O
associated	O
with	O
CDH	O
[	O
52	O
]	O
supports	O
the	O
possibility	O
that	O
this	O
disorder	O
can	O
be	O
associated	O
with	O
a	O
primary	O
developmental	O
pulmonary	O
abnormality	O
.	O

Our	O
analysis	O
of	O
mice	B-Taxon
carrying	O
mutations	B-SO
of	O
Fog2	B-GGP
proves	O
that	O
there	O
is	O
a	O
primary	O
defect	O
in	O
lung	O
development	O
that	O
results	O
in	O
specific	O
loss	O
of	O
the	O
accessory	O
lobe	O
and	O
partial	O
loss	O
of	O
the	O
right	O
middle	O
lobe	O
.	O

The	O
specific	O
lobar	O
defects	O
prompted	O
us	O
to	O
evaluate	O
Fog2	B-GGP
expression	O
at	O
the	O
time	O
of	O
early	O
lobar	O
budding	O
.	O

While	O
Fog2	B-GGP
expression	O
is	O
diffuse	O
in	O
the	O
pulmonary	O
mesenchyme	O
after	O
lobar	O
structure	O
is	O
well	O
established	O
(	O
E12	O
.	O
5	O
)	O
,	O
it	O
is	O
more	O
focally	O
expressed	O
in	O
the	O
mesenchyme	O
surrounding	O
the	O
right	O
middle	O
lobe	O
and	O
accessory	O
buds	O
as	O
these	O
lobes	O
form	O
.	O

This	O
matches	O
the	O
phenotype	O
of	O
right	O
middle	O
lobe	O
and	O
accessory	O
lobe	O
loss	O
,	O
and	O
suggests	O
that	O
Fog2	B-GGP
has	O
a	O
specific	O
patterning	O
role	O
in	O
establishment	O
of	O
these	O
lobes	O
.	O

It	O
is	O
less	O
clear	O
whether	O
loss	O
of	O
Fog2	B-GGP
results	O
in	O
a	O
global	O
branching	O
defect	O
,	O
as	O
Fog2	B-GGP
lungs	O
appear	O
to	O
have	O
a	O
slight	O
developmental	O
delay	O
,	O
which	O
could	O
result	O
from	O
many	O
causes	O
.	O

Cultured	O
Fog2	B-GGP
lungs	O
do	O
develop	O
an	O
intricate	O
branching	O
pattern	O
in	O
the	O
unaffected	O
lobes	O
that	O
appears	O
similar	O
in	O
the	O
pattern	O
to	O
wild	B-SO
-	I-SO
type	I-SO
lungs	O
after	O
5	O
d	O
in	O
culture	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
a	O
mutation	B-SO
of	O
Fog2	B-GGP
in	O
the	O
mouse	B-Taxon
causes	O
the	O
phenotype	O
of	O
abnormal	O
diaphragmatic	O
muscularization	O
and	O
primary	O
pulmonary	O
hypoplasia	O
.	O

We	O
furthermore	O
demonstrate	O
that	O
a	O
mutation	B-SO
in	O
this	O
gene	B-SO
is	O
associated	O
with	O
a	O
lethal	O
defect	O
in	O
lung	O
and	O
diaphragm	O
development	O
in	O
a	O
child	O
.	O

It	O
is	O
notable	O
that	O
,	O
despite	O
extensive	O
analysis	O
of	O
Fog2	B-GGP
biology	O
and	O
the	O
generation	O
of	O
a	O
Fog2	B-GGP
knock	O
-	O
out	O
mouse	B-Taxon
,	O
its	O
role	O
in	O
diaphragm	O
and	O
lung	O
development	O
was	O
previously	O
not	O
recognized	O
.	O

It	O
is	O
only	O
as	O
a	O
consequence	O
of	O
phenotype	O
-	O
driven	O
analyses	O
such	O
as	O
those	O
we	O
are	O
pursuing	O
that	O
one	O
has	O
the	O
opportunity	O
to	O
assay	O
all	O
of	O
the	O
potential	O
molecular	B-CHEBI
derangements	O
that	O
may	O
result	O
in	O
human	B-Taxon
disease	O
.	O

Materials	O
and	O
Methods	O

These	O
investigations	O
were	O
conducted	O
with	O
approval	O
of	O
the	O
institutional	O
review	O
board	O
for	O
Children	O
'	O
s	O
Hospital	O
,	O
Boston	O
,	O
and	O
Brigham	O
and	O
Women	O
'	O
s	O
Hospital	O
,	O
Boston	O
.	O

Animal	B-Taxon
use	O
was	O
approved	O
by	O
the	O
Center	O
for	O
Animal	B-Taxon
Resources	O
and	O
Comparative	O
Medicine	O
(	O
Harvard	O
Medical	O
School	O
)	O
.	O

Genetic	B-SO
mapping	O
of	O
the	O
mouse	B-Taxon
mutation	B-SO
lil	O
.	O

The	O
lil	O
mutation	B-SO
was	O
identified	O
as	O
described	O
in	O
results	O
.	O

Wild	B-SO
-	I-SO
type	I-SO
FVB	O
/	O
N	O
and	O
C57BL	O
/	O
6J	O
mice	B-Taxon
used	O
for	O
genetic	B-SO
crosses	O
were	O
obtained	O
from	O
the	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
)	O
.	O

Mice	B-Taxon
carrying	O
a	O
null	O
mutation	B-SO
of	O
Fog2	B-GGP
generated	O
by	O
gene	B-SO
targeting	O
[	O
16	O
]	O
were	O
the	O
generous	O
gift	O
of	O
Dr	O
.	O
Stuart	O
Orkin	O
.	O

Developmental	O
analysis	O
of	O
mice	B-Taxon
.	O

Timed	O
pregnancies	O
were	O
set	O
up	O
for	O
collection	O
of	O
E11	O
.	O
5	O
-	O
E17	O
.	O
5	O
embryos	O
.	O

Embryos	O
were	O
fixed	O
,	O
dehydrated	O
,	O
and	O
embedded	O
in	O
paraffin	O
prior	O
to	O
sectioning	O
.	O

In	O
older	O
embryos	O
,	O
a	O
median	O
sternotomy	O
was	O
performed	O
under	O
microscopic	O
guidance	O
,	O
and	O
diaphragm	O
,	O
lungs	O
,	O
and	O
heart	O
were	O
examined	O
.	O

The	O
lungs	O
and	O
tracheobronchial	O
tree	O
were	O
removed	O
and	O
weighed	O
.	O

Whole	O
diaphragms	O
were	O
isolated	O
from	O
fixed	O
thoracic	O
tissue	O
from	O
E15	O
.	O
5	O
and	O
E17	O
.	O
5	O
embryos	O
.	O

For	O
lung	O
explant	O
culture	O
,	O
lungs	O
were	O
dissected	O
from	O
fresh	O
embryos	O
at	O
E11	O
.	O
5	O
and	O
E12	O
.	O
5	O
and	O
placed	O
on	O
porous	O
24	O
-	O
mm	O
(	O
0	O
.	O
4	O
-	O
mu	O
)	O
polyester	B-CHEBI
membranes	O
floated	O
in	O
wells	O
containing	O
2	O
ml	O
of	O
Dulbecco	O
'	O
s	O
modified	O
Eagle	O
'	O
s	O
medium	O
,	O
nutrient	B-CHEBI
mixture	O
F	O
-	O
12	O
(	O
11039	O
-	O
021	O
,	O
Gibco	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
supplemented	O
with	O
10	O
%	O
fetal	O
bovine	B-Taxon
serum	O
,	O
0	O
.	O
3	O
mg	O
/	O
ml	O
L	B-CHEBI
-	I-CHEBI
glutamine	I-CHEBI
,	O
100	O
units	O
/	O
ml	O
penicillin	B-CHEBI
,	O
100	O
mcg	O
/	O
ml	O
streptomycin	B-CHEBI
,	O
and	O
0	O
.	O
25	O
mcg	O
/	O
ml	O
amphotericin	O
B	O
.	O

Lung	O
explants	O
were	O
cultured	O
at	O
37	O
degrees	O
C	O
in	O
95	O
%	O
air	O
/	O
5	O
%	O
CO2	B-CHEBI
for	O
up	O
to	O
5	O
d	O
.	O

They	O
were	O
photographed	O
daily	O
with	O
a	O
dissecting	O
microscope	O
(	O
MZ12	O
.	O
5	O
,	O
Leica	O
,	O
Wetzlar	O
,	O
Germany	O
)	O
equipped	O
with	O
a	O
Leica	O
DC500	O
digital	O
camera	O
.	O

Transgenic	B-SO
mice	B-Taxon
carrying	O
the	O
lacZ	O
gene	B-SO
driven	O
by	O
the	O
Fog2	B-GGP
promoter	B-SO
have	O
been	O
developed	O
by	O
S	O
.	O

Tevosian	O
.	O

In	O
these	O
animals	B-Taxon
,	O
the	O
lacZ	O
gene	B-SO
is	O
incorporated	B-SO
(	O
"	O
knocked	O
-	O
in	O
"	O
)	O
into	O
the	O
Fog2	B-GGP
locus	B-SO
to	O
allow	O
beta	O
-	O
galactosidase	O
expression	O
as	O
a	O
fusion	B-SO
protein	B-CHEBI
in	O
frame	B-SO
with	O
the	O
first	O
235	O
amino	B-CHEBI
acids	I-CHEBI
of	O
the	O
FOG2	B-GGP
protein	B-CHEBI
.	O

The	O
Fog2	B-GGP
-	O
lacZ	O
module	O
is	O
followed	O
by	O
an	O
ires	B-SO
-	O
eGFP	O
cassette	B-SO
.	O

This	O
creates	O
a	O
null	O
allele	B-SO
of	O
Fog2	B-GGP
gene	B-SO
.	O

The	O
Fog2	B-GGP
-	O
LacZ	O
-	O
eGFP	O
construct	B-SO
was	O
linearized	O
with	O
KspI	O
and	O
electroporated	O
into	O
the	O
CJ7	O
ES	O
cells	B-CL
.	O

The	O
correctly	O
targeted	O
clone	O
was	O
selected	O
by	O
the	O
Southern	O
blot	O
analysis	O
and	O
injected	O
into	O
C57BL	O
/	O
6J	O
blastocysts	O
.	O

Fog2	B-GGP
-	O
lacZ	O
-	O
eGFP	O
animals	B-Taxon
were	O
maintained	O
on	O
the	O
mixed	O
C57BL	O
/	O
6J	O
/	O
129	O
background	O
.	O

lacZ	O
Expression	O
in	O
whole	O
dissected	O
embryonic	O
lungs	O
was	O
analyzed	O
by	O
staining	O
for	O
beta	O
-	O
galactosidase	O
activity	O
with	O
X	O
-	O
gal	O
after	O
fixation	O
for	O
30	O
min	O
.	O

RT	O
-	O
PCR	O
and	O
sequence	B-SO
analysis	O
in	O
the	O
mouse	B-Taxon
.	O

RNA	B-SO
was	O
extracted	O
by	O
standard	O
techniques	O
from	O
thoracic	O
embryonic	O
tissue	O
.	O

RT	O
-	O
PCR	O
was	O
performed	O
using	O
six	O
primer	B-SO
sets	O
designed	B-SO
to	O
cover	O
the	O
Fog2	B-GGP
gene	B-SO
.	O

RT	O
-	O
PCR	O
was	O
repeated	O
with	O
radiolabeled	B-CHEBI
primers	B-SO
to	O
amplify	O
an	O
abnormally	O
spliced	O
region	B-SO
of	I-SO
the	I-SO
gene	I-SO
(	O
Table	O
S1	O
)	O
,	O
and	O
the	O
product	B-SO
was	O
run	O
on	O
a	O
denaturing	O
sequencing	O
gel	O
according	O
to	O
standard	O
techniques	O
.	O

The	O
RT	O
-	O
PCR	B-SO
product	I-SO
was	O
cloned	O
into	O
pCR2	O
.	O
1	O
vector	B-SO
using	O
TOPO	O
TA	O
Cloning	O
Kit	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
sequenced	O
using	O
gene	B-SO
-	O
specific	O
primers	B-SO
.	O

Sequence	B-SO
analysis	O
was	O
done	O
using	O
Sequencher	O
4	O
.	O
1	O
(	O
Gene	B-SO
Codes	O
,	O
Ann	O
Arbor	O
,	O
Michigan	O
,	O
United	O
States	O
)	O
.	O

In	O
situ	O
hybridization	O
.	O

After	O
dehydration	O
and	O
embedding	O
in	O
paraffin	O
wax	O
,	O
10	O
-	O
mu	O
sections	O
were	O
subjected	O
to	O
radioactive	O
in	O
situ	O
hybridization	O
as	O
described	O
[	O
53	O
]	O
.	O

Probes	B-SO
labeled	O
with	O
35S	B-CHEBI
were	O
prepared	O
by	O
run	O
-	O
off	O
transcription	O
of	O
linearized	O
plasmid	B-SO
templates	O
and	O
hybridized	O
to	O
tissue	O
sections	O
.	O

Nuclei	B-GO
were	O
counterstained	O
with	O
Hoescht	O
33258	O
,	O
and	O
signal	O
was	O
imaged	O
using	O
fluorescent	O
and	O
darkfield	O
microscopy	O
.	O

Human	B-Taxon
DNA	B-SO
extraction	I-SO
and	I-SO
sequence	I-SO
analysis	O
.	O

DNA	B-SO
was	O
isolated	O
from	O
paraffin	O
blocks	O
by	O
phenol	B-CHEBI
-	O
chloroform	B-CHEBI
extraction	O
[	O
54	O
,	O
55	O
]	O
,	O
and	O
from	O
frozen	O
tissues	O
by	O
standard	O
techniques	O
.	O

Primers	B-SO
were	O
designed	O
to	O
amplify	O
FOG2	B-GGP
coding	B-SO
exons	I-SO
plus	O
50	O
bp	B-SO
of	O
flanking	B-SO
upstream	I-SO
and	I-SO
downstream	I-SO
sequence	I-SO
.	O

PCR	O
amplification	O
and	O
sequencing	O
were	O
performed	O
by	O
standard	O
methods	O
.	O

Primer	B-SO
sequences	I-SO
used	O
are	O
listed	O
in	O
Table	O
S2	O
.	O

Sequence	B-SO
analysis	O
was	O
done	O
with	O
Sequencher	O
4	O
.	O
1	O
(	O
Gene	B-SO
Codes	O
)	O
.	O

DNA	B-SO
from	O
the	O
parents	O
of	O
one	O
autopsy	O
patient	O
was	O
extracted	O
from	O
fresh	O
blood	O
samples	O
.	O

A	O
second	O
set	O
of	O
blood	O
samples	O
was	O
sent	O
to	O
an	O
outside	O
CLIA	O
-	O
certified	O
laboratory	O
for	O
DNA	B-SO
extraction	O
,	O
PCR	O
,	O
sequencing	O
,	O
and	O
analysis	O
.	O

Paternity	O
testing	O
was	O
performed	O
by	O
the	O
outside	O
laboratory	O
using	O
a	O
standard	O
panel	O
of	O
markers	O
.	O

SNP	B-SO
genotyping	O
was	O
done	O
using	O
Harvard	O
Partners	O
Center	O
for	O
Genetics	O
and	O
Genomics	O
genotyping	O
core	O
facility	O
(	O
Cambridge	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Supporting	O
Information	O

Table	O
S1	O

Primers	B-SO
for	O
RT	O
-	O
PCR	O
(	O
Mouse	B-Taxon
)	O
:	O
Amplification	O
of	O
Abnormal	O
Transcript	B-SO
in	O
Fog2	B-GGP
Mutant	B-SO
(	O
lil	O
)	O
Mice	B-Taxon

(	O
26	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S2	O

Human	B-Taxon
Primers	B-SO
for	O
Amplification	O
of	O
FOG2	B-GGP
Coding	B-SO
Sequence	I-SO
from	O
Genomic	B-SO
DNA	I-SO

(	O
46	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

This	O
manuscript	O
is	O
dedicated	O
to	O
Baby	O
Lucy	O
and	O
her	O
parents	O
for	O
the	O
contribution	O
that	O
they	O
have	O
made	O
to	O
helping	O
us	O
to	O
understand	O
developmental	O
diaphragmatic	O
and	O
lung	O
defects	O
.	O

This	O
work	O
was	O
funded	O
by	O
National	O
Institute	O
of	O
Child	O
Health	O
and	O
Human	B-Taxon
Development	O
(	O
NIHCD	O
)	O
grant	O
HD36404	O
(	O
DRB	O
)	O
and	O
the	O
Hearst	O
Foundation	O
(	O
KGA	O
)	O
.	O

KGA	O
also	O
received	O
salary	O
support	O
from	O
NICHD	O
grant	O
T32HD040129	O
-	O
02	O
.	O

We	O
would	O
like	O
to	O
thank	O
Stuart	O
Orkin	O
,	O
M	O
.	O

D	O
.	O
,	O
for	O
the	O
generous	O
gift	O
of	O
his	O
Fog2	B-GGP
-	O
/	O
-	O
mice	B-Taxon
.	O

We	O
would	O
also	O
like	O
to	O
thank	O
Raju	O
Kucherlapati	O
,	O
Ph	O
.	O

D	O
.	O
,	O
and	O
Birgit	O
Funke	O
,	O
Ph	O
.	O

D	O
.	O
,	O
for	O
providing	O
control	O
DNA	B-SO
samples	O
.	O

Abbreviations	O

CDH	O
-	O
congenital	O
diaphragmatic	O
hernia	O

E	O
[	O
number	O
]	O
-	O
embryonic	O
day	O
[	O
number	O
]	O

ENU	B-CHEBI
-	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	I-CHEBI

HGF	B-GGP
-	O
Hepatocyte	B-GGP
growth	I-GGP
factor	I-GGP
/	O
Scatter	B-GGP
factor	I-GGP

lil	O
-	O
little	O
lung	O

PPF	O
-	O
pleuroperitoneal	O
fold	O

Figures	O

Figure	O
1	O

Abnormal	O
Pulmonary	O
and	O
Diaphragmatic	O
Development	O
in	O
the	O
lil	O
Mouse	B-Taxon

(	O
A	O
)	O
The	O
mutant	B-SO
hypoplastic	O
lung	O
(	O
right	O
)	O
lacks	O
the	O
development	O
of	O
the	O
accessory	O
lobe	O
and	O
the	O
anterior	O
portion	O
of	O
the	O
right	O
middle	O
lobe	O
(	O
marked	O
with	O
arrows	O
on	O
the	O
control	O
sample	O
on	O
the	O
left	O
)	O
.	O

(	O
B	O
)	O
Whole	O
diaphragms	O
show	O
a	O
lack	O
of	O
normal	O
muscularization	O
in	O
the	O
posterolateral	O
regions	O
and	O
the	O
peripheral	O
regions	O
of	O
the	O
mutant	B-SO
diaphragm	O
(	O
control	O
on	O
left	O
and	O
lil	O
diaphragm	O
on	O
the	O
right	O
)	O
.	O

Figure	O
2	O

The	O
ENU	B-CHEBI
-	O
Induced	O
lil	O
Mutation	B-SO
in	O
Fog2	B-GGP
is	O
a	O
Splice	B-SO
Site	I-SO
Mutation	B-SO

(	O
A	O
)	O
RT	O
-	O
PCR	O
revealed	O
a	O
lengthened	O
transcript	B-SO
in	O
mice	B-Taxon
with	O
the	O
lil	O
phenotype	O
:	O
the	O
first	O
band	O
is	O
a	O
lil	O
mouse	B-Taxon
,	O
and	O
the	O
second	O
band	O
is	O
a	O
control	O
mouse	B-Taxon
.	O

(	O
B	O
)	O
Sequencing	O
Fog2	B-GGP
revealed	O
a	O
splice	B-SO
site	I-SO
mutation	B-SO
that	O
causes	O
the	O
insertion	B-SO
of	O
85	O
bp	B-SO
of	O
intronic	B-SO
sequence	I-SO
in	O
the	O
mutant	B-SO
mouse	B-Taxon
.	O

This	O
results	O
in	O
a	O
premature	O
stop	B-SO
codon	I-SO
prior	O
to	O
zinc	B-CHEBI
finger	O
transcription	O
.	O

Figure	O
3	O

Fog2	B-GGP
Is	O
Expressed	O
in	O
the	O
Developing	O
Lung	O
and	O
Diaphragm	O

Fog2	B-GGP
is	O
expressed	O
in	O
the	O
diffuse	O
pulmonary	O
mesenchyme	O
at	O
E13	O
.	O
5	O
(	O
A	O
)	O
(	O
arrow	O
shows	O
mesenchyme	O
)	O
and	O
is	O
restricted	O
to	O
the	O
bronchial	O
and	O
vascular	O
smooth	O
muscle	O
(	O
sm	O
)	O
at	O
E16	O
.	O
5	O
(	O
B	O
)	O
.	O

Fog2	B-GGP
is	O
expressed	O
diffusely	O
in	O
the	O
developing	O
diaphragm	O
(	O
Dia	O
)	O
both	O
prior	O
to	O
(	O
E11	O
.	O
5	O
)	O
(	O
C	O
)	O
and	O
after	O
muscularization	O
(	O
E13	O
.	O
5	O
)	O
(	O
D	O
)	O
.	O

Figure	O
4	O

Fog2	B-GGP
Is	O
Necessary	O
for	O
Primary	O
Lung	O
Development	O

Fog2	B-GGP
null	O
lungs	O
removed	O
prior	O
to	O
diaphragmatic	O
muscularization	O
and	O
grown	O
in	O
vitro	O
show	O
no	O
accessory	O
lobe	O
development	O
.	O

Accessory	O
lobe	O
is	O
labeled	O
with	O
black	O
arrow	O
in	O
control	O
littermate	O
lungs	O
.	O

Figure	O
5	O

Fog2	B-GGP
Expression	O
in	O
Embryonic	O
Non	O
-	O
Mutant	B-SO
Lungs	O

In	O
embryonic	O
non	O
-	O
mutant	B-SO
lungs	O
,	O
Fog2	B-GGP
is	O
most	O
highly	O
expressed	O
at	O
the	O
tips	O
of	O
the	O
accessory	O
(	O
single	O
arrows	O
)	O
and	O
right	O
middle	O
lobes	O
(	O
double	O
arrows	O
)	O
at	O
E11	O
.	O
25	O
(	O
A	O
)	O
and	O
E11	O
.	O
75	O
(	O
B	O
)	O
,	O
while	O
expression	O
is	O
diffuse	O
by	O
E12	O
.	O
75	O
(	O
C	O
)	O
.	O

Figure	O
6	O

HGF	B-GGP
Patterning	O
Is	O
Abnormal	O
in	O
Fog2	B-GGP
Null	O
Mice	B-Taxon

In	O
situ	O
hybridization	O
of	O
HGF	B-GGP
in	O
E12	O
.	O
5	O
wild	B-SO
-	I-SO
type	I-SO
(	O
A	O
)	O
and	O
Fog2	B-GGP
-	O
/	O
-	O
(	O
B	O
)	O
embryos	O
demonstrates	O
decreased	O
expression	O
in	O
the	O
region	O
where	O
the	O
PPF	O
meets	O
the	O
membranous	O
diaphragm	O
.	O

Li	O
,	O
liver	O
;	O
Lu	O
,	O
lung	O
.	O

Figure	O
7	O

FOG2	B-GGP
Mutation	B-SO
in	O
a	O
Patient	O
with	O
Diaphragm	O
and	O
Lung	O
Abnormalities	O

Sequencing	O
revealed	O
a	O
de	B-SO
novo	I-SO
heterozygote	O
nonsense	O
mutation	B-SO
in	O
a	O
patient	O
who	O
died	O
at	O
birth	O
with	O
severe	O
pulmonary	O
hypoplasia	O
and	O
a	O
posterior	O
deep	O
diaphragmatic	O
eventration	O
.	O

She	O
was	O
clinically	O
diagnosed	O
with	O
CDH	O
.	O

This	O
nonsense	O
mutation	B-SO
occurs	O
prior	O
to	O
the	O
functional	O
zinc	B-CHEBI
finger	O
domains	B-SO
.	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Author	O
contributions	O
.	O

KGA	O
,	O
JJG	O
,	O
and	O
DRB	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

KGA	O
,	O
BJH	O
,	O
HH	O
,	O
SGT	O
,	O
LK	O
,	O
CR	O
,	O
RPB	O
,	O
and	O
JAE	O
performed	O
the	O
experiments	O
.	O

KGA	O
,	O
BJH	O
,	O
HH	O
,	O
LK	O
,	O
CR	O
,	O
JAE	O
,	O
JJG	O
,	O
and	O
DRB	O
analyzed	O
the	O
data	O
.	O

KGA	O
,	O
SOV	O
,	O
SGT	O
,	O
BRP	O
,	O
JAE	O
,	O
JJG	O
,	O
and	O
DRB	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

KGA	O
and	O
DRB	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Ackerman	O
KG	O
,	O
Herron	O
BJ	O
,	O
Vargas	O
SO	O
,	O
Huang	O
H	O
,	O
Tevosian	O
SG	O
,	O
et	O
al	O
.	O

(	O
2005	O
)	O
Fog2	B-GGP
is	O
required	O
for	O
normal	O
diaphragm	O
and	O
lung	O
development	O
in	O
mice	B-Taxon
and	O
humans	B-Taxon
.	O

PLoS	O
Genet	O
1	O
(	O
1	O
)	O
:	O
e10	O
.	O

A	O
Hybrid	O
Photoreceptor	B-CL
Expressing	O
Both	O
Rod	B-CL
and	O
Cone	B-CL
Genes	B-SO
in	O
a	O
Mouse	B-Taxon
Model	O
of	O
Enhanced	O
S	O
-	O
Cone	B-CL
Syndrome	O

Abstract	O

Rod	B-CL
and	I-CL
cone	I-CL
photoreceptors	I-CL
subserve	O
vision	O
under	O
dim	O
and	O
bright	O
light	O
conditions	O
,	O
respectively	O
.	O

The	O
differences	O
in	O
their	O
function	O
are	O
thought	O
to	O
stem	O
from	O
their	O
different	O
gene	B-SO
expression	O
patterns	O
,	O
morphologies	O
,	O
and	O
synaptic	B-GO
connectivities	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
examined	O
the	O
photoreceptor	B-CL
cells	I-CL
of	O
the	O
retinal	O
degeneration	O
7	O
(	O
rd7	O
)	O
mutant	B-SO
mouse	B-Taxon
,	O
a	O
model	O
for	O
the	O
human	B-Taxon
enhanced	O
S	O
-	O
cone	B-CL
syndrome	O
(	O
ESCS	O
)	O
.	O

This	O
mutant	B-SO
carries	O
a	O
spontaneous	O
deletion	B-SO
in	O
the	O
mouse	B-Taxon
ortholog	B-SO
of	O
NR2E3	B-GGP
,	O
an	O
orphan	O
nuclear	B-GO
receptor	O
transcription	O
factor	O
mutated	B-SO
in	O
ESCS	O
.	O

Employing	O
microarray	O
and	O
in	O
situ	O
hybridization	O
analysis	O
we	O
have	O
found	O
that	O
the	O
rd7	O
retina	O
contains	O
a	O
modestly	O
increased	O
number	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cells	B-CL
that	O
ultrastructurally	O
appear	O
to	O
be	O
normal	O
cones	B-CL
.	O

Strikingly	O
,	O
the	O
majority	O
of	O
the	O
photoreceptors	B-CL
in	I-CL
the	I-CL
rd7	I-CL
retina	I-CL
represent	O
a	O
morphologically	O
hybrid	O
cell	B-CL
type	O
that	O
expresses	O
both	O
rod	B-CL
-	O
and	O
cone	B-CL
-	O
specific	O
genes	B-SO
.	O

In	O
addition	O
,	O
in	O
situ	O
hybridization	O
screening	O
of	O
genes	B-SO
shown	O
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
by	O
microarray	O
identified	O
ten	O
new	O
cone	B-CL
-	O
specific	O
or	O
cone	B-CL
-	O
enriched	O
genes	B-SO
with	O
a	O
wide	O
range	O
of	O
biochemical	O
functions	O
,	O
including	O
two	O
genes	B-SO
specifically	O
involved	O
in	O
glucose	B-CHEBI
/	O
glycogen	B-CHEBI
metabolism	O
.	O

We	O
suggest	O
that	O
the	O
abnormal	O
electroretinograms	O
,	O
slow	O
retinal	O
degeneration	O
,	O
and	O
retinal	O
dysmorphology	O
seen	O
in	O
humans	B-Taxon
with	O
ESCS	O
may	O
,	O
in	O
part	O
,	O
be	O
attributable	O
to	O
the	O
aberrant	O
function	O
of	O
a	O
hybrid	O
photoreceptor	B-CL
cell	I-CL
type	O
similar	O
to	O
that	O
identified	O
in	O
this	O
study	O
.	O

The	O
functional	O
diversity	O
of	O
the	O
novel	O
cone	B-CL
-	O
specific	O
genes	B-SO
identified	O
here	O
indicates	O
molecular	B-CHEBI
differences	O
between	O
rods	B-CL
and	O
cones	B-CL
extending	O
far	O
beyond	O
those	O
previously	O
discovered	O
.	O

Synopsis	O

Vision	O
begins	O
with	O
light	O
entering	O
the	O
eye	O
.	O

This	O
light	O
is	O
projected	O
onto	O
the	O
retina	O
,	O
a	O
thin	O
neural	O
structure	O
lining	O
the	O
inside	O
of	O
the	O
eye	O
.	O

Photoreceptors	B-CL
,	O
among	O
the	O
most	O
important	O
cell	B-CL
types	O
in	O
the	O
retina	O
,	O
are	O
the	O
first	O
to	O
receive	O
the	O
incoming	O
rays	O
of	O
light	O
.	O

In	O
mammals	B-Taxon
,	O
there	O
are	O
two	O
types	O
of	O
photoreceptors	B-CL
:	O
rods	B-CL
and	O
cones	B-CL
.	O

Rods	B-CL
are	O
specialized	O
for	O
nighttime	O
vision	O
,	O
and	O
cones	B-CL
for	O
daytime	O
and	O
color	O
vision	O
.	O

In	O
this	O
study	O
,	O
the	O
authors	O
examined	O
the	O
photoreceptors	B-CL
of	O
a	O
mouse	B-Taxon
with	O
a	O
gene	B-SO
mutation	B-SO
that	O
causes	O
photoreceptors	B-CL
to	O
develop	O
abnormally	O
.	O

Humans	B-Taxon
with	O
a	O
similar	O
mutation	B-SO
have	O
a	O
form	O
of	O
blindness	O
called	O
enhanced	O
S	O
-	O
cone	B-CL
syndrome	O
(	O
ESCS	O
)	O
.	O

Surprisingly	O
,	O
the	O
majority	O
of	O
photoreceptors	B-CL
in	O
this	O
mutant	B-SO
mouse	B-Taxon
were	O
found	O
to	O
have	O
features	O
of	O
both	O
normal	O
rods	B-CL
and	O
cones	B-CL
.	O

It	O
is	O
possible	O
that	O
the	O
abnormal	O
features	O
of	O
these	O
photoreceptors	B-CL
predispose	O
them	O
to	O
undergo	O
premature	O
death	O
.	O

If	O
this	O
model	O
accurately	O
reflects	O
the	O
situation	O
in	O
human	B-Taxon
patients	O
with	O
ESCS	O
,	O
it	O
may	O
provide	O
an	O
explanation	O
for	O
the	O
loss	O
of	O
vision	O
seen	O
in	O
this	O
disease	O
.	O

This	O
study	O
also	O
elucidated	O
previously	O
unknown	O
molecular	B-CHEBI
differences	O
between	O
normal	O
rods	B-CL
and	O
cones	B-CL
.	O

This	O
new	O
knowledge	O
may	O
contribute	O
to	O
a	O
better	O
overall	O
understanding	O
of	O
the	O
mechanisms	O
underlying	O
night	O
,	O
day	O
,	O
and	O
color	O
vision	O
.	O

Introduction	O

Enhanced	O
S	O
-	O
cone	B-CL
syndrome	O
(	O
ESCS	O
)	O
is	O
an	O
unusual	O
disease	O
of	O
photoreceptors	B-CL
that	O
includes	O
night	O
blindness	O
(	O
suggestive	O
of	O
rod	B-CL
dysfunction	O
)	O
,	O
an	O
abnormal	O
electroretinogram	O
(	O
ERG	O
)	O
with	O
a	O
waveform	O
that	O
is	O
nearly	O
identical	O
under	O
both	O
light	O
and	O
dark	O
adaptation	O
,	O
and	O
an	O
increased	O
sensitivity	O
of	O
the	O
ERG	O
to	O
short	O
-	O
wavelength	O
light	O
[	O
1	O
,	O
2	O
]	O
.	O

The	O
disease	O
is	O
caused	O
by	O
mutations	B-SO
in	O
the	O
orphan	O
nuclear	B-GO
receptor	O
transcription	O
factor	O
NR2E3	B-GGP
(	O
also	O
known	O
as	O
photoreceptor	B-GGP
nuclear	I-GGP
receptor	I-GGP
)	O
,	O
which	O
is	O
expressed	O
exclusively	O
in	O
rods	B-CL
[	O
3	O
,	O
4	O
]	O
.	O

Recent	O
human	B-Taxon
genetic	B-SO
studies	O
have	O
also	O
demonstrated	O
mutations	B-SO
in	O
this	O
gene	B-SO
in	O
Goldmann	O
-	O
Favre	O
syndrome	O
and	O
many	O
cases	O
of	O
clumped	O
pigmentary	O
retinal	O
degeneration	O
[	O
5	O
]	O
.	O

The	O
initial	O
reports	O
of	O
patients	O
with	O
ESCS	O
attributed	O
the	O
unusual	O
ERG	O
to	O
an	O
abnormally	O
functioning	O
rod	B-CL
photoreceptor	I-CL
system	O
with	O
persistent	O
activity	O
under	O
light	O
adaptation	O
[	O
6	O
-	O
8	O
]	O
.	O

Subsequent	O
studies	O
,	O
however	O
,	O
concluded	O
that	O
the	O
ERG	O
was	O
due	O
to	O
supernumerary	O
short	O
-	O
wavelength	O
(	O
"	O
blue	O
"	O
)	O
cone	B-CL
photoreceptors	I-CL
(	O
S	O
-	O
cones	B-CL
)	O
in	O
these	O
patients	O
[	O
1	O
,	O
2	O
,	O
9	O
-	O
11	O
]	O
.	O

Histopathologic	O
analysis	O
of	O
a	O
retina	O
from	O
a	O
human	B-Taxon
patient	O
with	O
ESCS	O
and	O
extensive	O
retinal	O
degeneration	O
demonstrated	O
an	O
absence	O
of	O
rhodopsin	B-GGP
-	O
positive	O
cells	B-CL
and	O
an	O
increase	O
in	O
the	O
number	O
of	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
-	O
expressing	O
cells	B-CL
.	O

Nevertheless	O
,	O
the	O
overall	O
density	O
of	O
cones	B-CL
was	O
only	O
modestly	O
increased	O
in	O
this	O
patient	O
(	O
approximately	O
2	O
-	O
fold	O
)	O
,	O
suggesting	O
that	O
there	O
might	O
be	O
additional	O
factors	O
that	O
contribute	O
to	O
the	O
very	O
large	O
,	O
light	O
-	O
adapted	O
ERG	O
seen	O
in	O
this	O
disease	O
.	O

In	O
addition	O
to	O
the	O
ERG	O
findings	O
,	O
patients	O
with	O
ESCS	O
have	O
dysmorphic	O
retinas	O
with	O
rosette	O
formation	O
in	O
the	O
outer	O
nuclear	O
layer	O
(	O
ONL	O
)	O
where	O
photoreceptor	B-CL
cell	I-CL
bodies	O
reside	O
,	O
and	O
a	O
slow	O
retinal	O
degeneration	O
that	O
can	O
ultimately	O
lead	O
to	O
complete	O
blindness	O
[	O
12	O
-	O
14	O
]	O
.	O

Mutations	B-SO
in	O
the	O
mouse	B-Taxon
ortholog	B-SO
of	O
NR2E3	B-GGP
have	O
been	O
identified	O
in	O
the	O
spontaneous	O
mutant	B-SO
retinal	O
degeneration	O
7	O
(	O
rd7	O
)	O
[	O
15	O
]	O
.	O

This	O
mutant	B-SO
demonstrates	O
slow	O
retinal	O
degeneration	O
and	O
abnormal	O
lamination	O
of	O
the	O
ONL	O
with	O
rosette	O
formation	O
[	O
15	O
,	O
16	O
]	O
.	O

Curiously	O
,	O
the	O
ERG	O
of	O
the	O
mouse	B-Taxon
under	O
both	O
light	O
and	O
dark	O
adaptation	O
has	O
been	O
reported	O
to	O
be	O
normal	O
,	O
showing	O
progressive	O
attenuation	O
with	O
time	O
,	O
presumably	O
due	O
to	O
degenerative	O
cell	B-CL
loss	O
[	O
15	O
]	O
.	O

A	O
prior	O
study	O
showed	O
a	O
2	O
-	O
to	O
3	O
-	O
fold	O
increase	O
in	O
the	O
number	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
in	O
the	O
rd7	O
retina	O
compared	O
to	O
wild	B-SO
type	I-SO
[	O
17	O
]	O
.	O

In	O
addition	O
,	O
two	O
groups	O
recently	O
reported	O
derepression	O
of	O
additional	O
cone	B-CL
genes	B-SO
in	O
the	O
rd7	O
mutant	B-SO
[	O
18	O
,	O
19	O
]	O
.	O

In	O
order	O
to	O
better	O
understand	O
the	O
mechanistic	O
basis	O
of	O
ESCS	O
,	O
we	O
undertook	O
a	O
molecular	B-CHEBI
and	O
ultrastructural	O
analysis	O
of	O
the	O
photoreceptors	B-CL
of	O
the	O
rd7	O
mutant	B-SO
mouse	B-Taxon
.	O

Microarray	O
and	O
in	O
situ	O
hybridization	O
analyses	O
revealed	O
a	O
modest	O
increase	O
in	O
the	O
number	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
and	O
widespread	O
derepression	O
of	O
many	O
cone	B-CL
-	O
specific	O
genes	B-SO
within	O
rod	B-CL
photoreceptor	I-CL
cells	I-CL
.	O

Ultrastructural	O
studies	O
demonstrated	O
that	O
the	O
cells	B-CL
that	O
coexpress	O
rod	B-CL
and	O
cone	B-CL
genes	B-SO
in	O
the	O
rd7	O
retina	O
represent	O
a	O
morphologically	O
hybrid	O
cell	B-CL
type	O
,	O
intermediate	O
between	O
normal	O
rods	B-CL
and	O
cones	B-CL
.	O

Results	O

Widespread	O
Up	O
-	O
Regulation	O
of	O
Cone	B-CL
Genes	B-SO
in	O
the	O
rd7	O
Mutant	B-SO
Retina	O

In	O
an	O
initial	O
analysis	O
of	O
the	O
rd7	O
mutant	B-SO
,	O
homozygous	O
mutant	B-SO
retinas	O
were	O
compared	O
with	O
wild	B-SO
-	I-SO
type	I-SO
controls	O
at	O
multiple	O
postnatal	O
time	O
points	O
using	O
both	O
cDNA	B-SO
and	O
Affymetrix	O
microarrays	O
.	O

The	O
cDNA	B-SO
microarray	O
used	O
in	O
this	O
study	O
contains	O
approximately	O
12	O
,	O
000	O
different	O
cDNAs	B-SO
largely	O
derived	O
from	O
the	O
retina	O
and	O
nervous	O
system	O
,	O
and	O
the	O
Affymetrix	O
microarray	O
contains	O
over	O
34	O
,	O
000	O
genes	B-SO
.	O

Experiments	O
at	O
all	O
timepoints	O
were	O
carried	O
out	O
in	O
triplicate	O
,	O
and	O
stringent	O
criteria	O
were	O
applied	O
in	O
deciding	O
whether	O
a	O
given	O
gene	B-SO
was	O
up	O
-	O
or	O
down	O
-	O
regulated	O
in	O
the	O
mutant	B-SO
(	O
see	O
Materials	O
and	O
Methods	O
for	O
details	O
)	O
.	O

These	O
experiments	O
demonstrated	O
widespread	O
up	O
-	O
regulation	O
of	O
cone	B-CL
-	O
specific	O
and	O
cone	B-CL
-	O
enriched	O
genes	B-SO
in	O
the	O
rd7	O
retina	O
,	O
especially	O
by	O
postnatal	O
day	O
14	O
(	O
P14	O
)	O
and	O
P21	O
(	O
Figure	O
1	O
)	O
.	O

Most	O
known	B-SO
cone	B-CL
-	O
specific	O
or	O
cone	B-CL
-	O
enriched	O
genes	B-SO
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
mutant	B-SO
(	O
Figure	O
1	O
,	O
genes	B-SO
G1	O
-	O
G15	O
)	O
.	O

The	O
majority	O
of	O
these	O
genes	B-SO
represent	O
components	O
of	O
the	O
phototransduction	O
cascade	O
(	O
e	O
.	O
g	O
.	O
,	O
opsins	B-GGP
,	O
transducins	O
,	O
and	O
phosphodiesterase	B-GO
subunits	O
)	O
.	O

In	O
addition	O
to	O
these	O
genes	B-SO
,	O
several	O
novel	O
cone	B-CL
-	O
specific	O
genes	B-SO
of	O
unknown	O
function	O
recently	O
identified	O
in	O
our	O
lab	O
were	O
also	O
up	O
-	O
regulated	O
(	O
Figure	O
1	O
,	O
genes	B-SO
G16	O
,	O
G17	O
,	O
G21	O
,	O
and	O
G24	O
;	O
unpublished	O
data	O
)	O
.	O

Finally	O
,	O
a	O
wide	O
range	O
of	O
other	O
genes	B-SO
,	O
most	O
with	O
no	O
previously	O
recognized	O
role	O
in	O
the	O
retina	O
,	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	B-SO
(	O
Figure	O
1	O
,	O
G26	O
-	O
G53	O
;	O
Tables	O
S1	O
and	O
S2	O
;	O
Figures	O
S1	O
-	O
S7	O
)	O
.	O

Nr2e3	B-GGP
expression	O
is	O
first	O
detectable	O
by	O
in	O
situ	O
hybridization	O
around	O
embryonic	O
day	O
18	O
(	O
E18	O
)	O
;	O
it	O
then	O
peaks	O
around	O
P6	O
and	O
subsequently	O
decreases	O
to	O
adult	O
levels	O
by	O
P21	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
accordance	O
with	O
this	O
time	O
course	O
of	O
expression	O
,	O
almost	O
no	O
gene	B-SO
expression	O
changes	O
were	O
found	O
at	O
P0	O
,	O
with	O
progressively	O
more	O
changes	O
at	O
later	O
timepoints	O
(	O
Figure	O
1	O
)	O
.	O

One	O
exception	O
to	O
this	O
statement	O
is	O
the	O
gene	B-SO
RIKEN	B-GGP
cDNA	I-GGP
4933409K07	I-GGP
(	O
Figure	O
1	O
,	O
gene	B-SO
G47	O
)	O
,	O
which	O
was	O
the	O
only	O
gene	B-SO
shown	O
to	O
be	O
up	O
-	O
regulated	O
at	O
all	O
timepoints	O
examined	O
.	O

Additional	O
discussion	O
of	O
this	O
gene	B-SO
and	O
its	O
unusual	O
expression	O
pattern	O
will	O
be	O
presented	O
below	O
.	O

Two	O
Distinct	O
Patterns	O
of	O
Cone	B-CL
Gene	B-SO
Derepression	O
in	O
rd7	O

In	O
order	O
to	O
confirm	O
these	O
microarray	O
results	O
,	O
an	O
in	O
situ	O
hybridization	O
analysis	O
of	O
the	O
putative	O
up	O
-	O
regulated	O
cone	B-CL
genes	B-SO
was	O
carried	O
out	O
in	O
which	O
the	O
rd7	O
mutant	B-SO
retina	O
was	O
compared	O
with	O
age	O
-	O
matched	O
,	O
wild	B-SO
-	I-SO
type	I-SO
controls	O
.	O

We	O
found	O
that	O
the	O
majority	O
of	O
the	O
cone	B-CL
-	O
specific	O
genes	B-SO
that	O
were	O
up	O
-	O
regulated	O
in	O
microarray	O
experiments	O
were	O
derepressed	O
when	O
assessed	O
by	O
in	O
situ	O
hybridization	O
(	O
Figure	O
2	O
)	O
.	O

There	O
were	O
two	O
major	O
patterns	O
of	O
cone	B-CL
gene	B-SO
derepression	O
.	O

The	O
more	O
common	O
pattern	O
(	O
type	O
I	O
)	O
manifested	O
itself	O
as	O
ectopic	O
gene	B-SO
expression	O
throughout	O
the	O
ONL	O
,	O
consistent	O
with	O
gene	B-SO
expression	O
in	O
all	O
photoreceptors	B-CL
(	O
Figure	O
2	O
;	O
upper	O
left	O
photomicrographs	O
)	O
.	O

Typical	O
examples	O
of	O
this	O
pattern	O
of	O
derepression	O
are	O
shown	O
in	O
Figure	O
2	O
,	O
and	O
many	O
more	O
are	O
available	O
in	O
Table	O
S1	O
.	O

This	O
pattern	O
of	O
expression	O
contrasts	O
sharply	O
with	O
the	O
usual	O
pattern	O
of	O
cone	B-CL
gene	B-SO
expression	O
,	O
which	O
consists	O
of	O
scattered	O
cells	B-CL
localized	O
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
(	O
Figure	O
2	O
)	O
.	O

The	O
second	O
category	O
of	O
cone	B-CL
gene	B-SO
derepression	O
(	O
type	O
II	O
)	O
consisted	O
of	O
a	O
patchy	O
,	O
salt	O
-	O
and	O
-	O
pepper	O
pattern	O
of	O
ectopic	O
expression	O
in	O
which	O
individual	O
positive	O
cells	B-CL
were	O
scattered	O
throughout	O
the	O
ONL	O
(	O
Figure	O
2	O
,	O
upper	O
right	O
photomicrographs	O
;	O
Table	O
S1	O
)	O
.	O

Although	O
numerous	O
positive	O
cells	B-CL
were	O
present	O
in	O
the	O
rd7	O
retina	O
(	O
particularly	O
in	O
the	O
ventral	O
portion	O
)	O
,	O
there	O
were	O
clearly	O
many	O
interspersed	O
cells	B-CL
that	O
showed	O
a	O
complete	O
absence	O
of	O
expression	O
.	O

In	O
order	O
to	O
rule	O
out	O
the	O
possibility	O
that	O
these	O
scattered	O
positive	O
cells	B-CL
were	O
simply	O
the	O
normal	O
complement	O
of	O
cones	B-CL
that	O
had	O
failed	O
to	O
localize	O
their	O
cell	B-GO
bodies	I-GO
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
,	O
the	O
number	O
of	O
positive	O
cells	B-CL
in	O
the	O
rd7	O
retina	O
was	O
quantitated	O
by	O
dissociated	O
cell	B-CL
in	O
situ	O
hybridization	O
.	O

Dissociated	O
cell	B-CL
in	O
situ	O
hybridization	O
was	O
performed	O
using	O
a	O
probe	B-SO
for	O
the	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
gene	B-SO
(	O
Opn1sw	B-GGP
)	O
,	O
which	O
shows	O
type	O
II	O
derepression	O
(	O
Figures	O
2	O
and	O
3A	O
-	O
3C	O
)	O
.	O

S	B-GGP
-	I-GGP
opsin	I-GGP
was	O
expressed	O
in	O
3	O
.	O
2	O
%	O
of	O
retinal	O
cells	B-CL
in	O
the	O
rd7	O
mutant	B-SO
(	O
66	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
out	O
of	O
2	O
,	O
056	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	B-CHEBI
[	O
DAPI	O
]	O
-	O
positive	O
cells	B-CL
)	O
.	O

This	O
value	O
is	O
approximately	O
2	O
-	O
fold	O
greater	O
than	O
the	O
percentage	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
identified	O
in	O
wild	B-SO
-	I-SO
type	I-SO
control	O
retinas	O
,	O
1	O
.	O
65	O
%	O
(	O
54	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
out	O
of	O
3	O
,	O
271	O
DAPI	O
-	O
positive	O
cells	B-CL
)	O
,	O
and	O
accords	O
well	O
with	O
the	O
previously	O
reported	O
value	O
of	O
2	O
-	O
to	O
3	O
-	O
fold	O
more	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
in	O
rd7	O
compared	O
to	O
wild	B-SO
type	I-SO
arrived	O
at	O
by	O
antibody	B-GO
staining	O
of	O
tissue	O
sections	O
[	O
17	O
]	O
.	O

Previous	O
studies	O
have	O
estimated	O
that	O
the	O
total	O
number	O
of	O
cones	B-CL
in	O
the	O
mouse	B-Taxon
retina	O
is	O
2	O
%	O
of	O
all	O
retinal	O
cells	B-CL
[	O
20	O
]	O
,	O
and	O
that	O
S	B-GGP
-	I-GGP
opsin	I-GGP
is	O
largely	O
repressed	O
in	O
cones	B-CL
in	O
the	O
dorsal	O
third	O
of	O
the	O
retina	O
[	O
21	O
]	O
.	O

The	O
estimate	O
of	O
1	O
.	O
65	O
%	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
is	O
in	O
agreement	O
with	O
these	O
data	O
.	O

The	O
fact	O
that	O
only	O
3	O
.	O
2	O
%	O
of	O
all	O
retinal	O
cells	B-CL
are	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
in	O
the	O
rd7	O
mutant	B-SO
also	O
confirms	O
that	O
the	O
majority	O
of	O
the	O
photoreceptors	B-CL
(	O
which	O
make	O
up	O
just	O
over	O
70	O
%	O
of	O
the	O
cells	B-CL
in	O
the	O
adult	O
mouse	B-Taxon
retina	O
)	O
do	O
not	O
express	O
this	O
gene	B-SO
.	O

In	O
order	O
to	O
assess	O
whether	O
these	O
supernumerary	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cells	B-CL
coexpressed	O
rod	B-CL
-	O
specific	O
markers	O
,	O
a	O
double	O
antibody	B-GO
staining	O
for	O
S	B-GGP
-	I-GGP
opsin	I-GGP
and	O
rhodopsin	B-GGP
was	O
performed	O
.	O

This	O
study	O
showed	O
mutually	O
exclusive	O
domains	O
of	O
expression	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
and	O
rhodopsin	B-GGP
in	O
the	O
photoreceptor	B-GO
outer	I-GO
segments	I-GO
(	O
Figure	O
3D	O
-	O
3F	O
)	O
.	O

This	O
finding	O
suggests	O
that	O
the	O
supernumerary	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cells	B-CL
in	O
the	O
rd7	O
retina	O
may	O
represent	O
normal	O
"	O
blue	O
"	O
cones	B-CL
.	O

Novel	O
Cone	B-CL
-	O
Specific	O
Genes	B-SO
Are	O
Derepressed	O
in	O
rd7	O

Given	O
that	O
the	O
majority	O
of	O
known	B-SO
cone	B-CL
-	O
specific	O
genes	B-SO
showed	O
marked	O
derepression	O
in	O
the	O
rd7	O
mutant	B-SO
,	O
additional	O
candidate	O
genes	B-SO
up	O
-	O
regulated	O
on	O
microarray	O
analysis	O
were	O
evaluated	O
for	O
cone	B-CL
-	O
specific	O
expression	O
.	O

In	O
situ	O
hybridization	O
was	O
performed	O
on	O
an	O
additional	O
45	O
up	O
-	O
regulated	O
genes	B-SO
,	O
confirming	O
that	O
21	O
of	O
them	O
were	O
derepressed	O
.	O

Of	O
these	O
,	O
at	O
least	O
ten	O
showed	O
a	O
definite	O
cone	B-CL
-	O
specific	O
or	O
cone	B-CL
-	O
enriched	O
pattern	O
of	O
expression	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
(	O
Figure	O
1	O
,	O
genes	B-SO
G26	O
-	O
G35	O
)	O
.	O

Several	O
examples	O
are	O
given	O
in	O
Figure	O
4	O
.	O

Note	O
that	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
,	O
there	O
is	O
a	O
relatively	O
weak	O
pattern	O
of	O
scattered	O
positive	O
cells	B-CL
at	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
,	O
consistent	O
with	O
a	O
cone	B-CL
-	O
specific	O
pattern	O
of	O
expression	O
.	O

All	O
of	O
these	O
genes	B-SO
show	O
marked	O
derepression	O
in	O
the	O
rd7	O
retina	O
.	O

A	O
number	O
of	O
these	O
novel	O
cone	B-CL
-	O
specific	O
genes	B-SO
showed	O
a	O
striking	O
localization	O
of	O
their	O
transcripts	B-SO
to	O
the	O
photoreceptor	B-GO
inner	I-GO
segment	I-GO
(	O
e	O
.	O
g	O
.	O
,	O
Bub1b	B-GGP
and	O
Tcta	B-GGP
)	O
.	O

This	O
localization	O
manifests	O
in	O
a	O
section	O
in	O
situ	O
hybridization	O
as	O
a	O
dark	O
band	O
of	O
staining	O
just	O
beyond	O
the	O
outer	O
edge	O
of	O
the	O
ONL	O
immediately	O
underlying	O
the	O
outer	B-GO
segment	I-GO
layer	O
.	O

Although	O
such	O
a	O
pattern	O
of	O
transcript	B-SO
localization	O
is	O
commonly	O
seen	O
in	O
many	O
rod	B-CL
-	O
specific	O
genes	B-SO
(	O
e	O
.	O
g	O
.	O
,	O
Rho	B-GGP
in	O
Figure	O
2	O
;	O
Pcdh21	B-GGP
,	O
Rbp3	B-GGP
,	O
and	O
Cnga1	B-GGP
in	O
Table	O
S2	O
)	O
,	O
it	O
is	O
not	O
easily	O
appreciated	O
in	O
cone	B-CL
-	O
specific	O
genes	B-SO
,	O
possibly	O
due	O
to	O
the	O
relative	O
scarcity	O
of	O
cones	B-CL
in	O
the	O
mouse	B-Taxon
.	O

In	O
the	O
rd7	O
mutant	B-SO
retina	O
in	O
which	O
such	O
genes	B-SO
are	O
widely	O
derepressed	O
,	O
such	O
a	O
pattern	O
of	O
transcript	B-SO
localization	O
often	O
becomes	O
apparent	O
.	O

In	O
addition	O
to	O
the	O
ten	O
genes	B-SO
that	O
showed	O
cone	B-CL
-	O
specific	O
expression	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
,	O
another	O
11	O
novel	O
genes	B-SO
were	O
derepressed	O
in	O
the	O
rd7	O
retina	O
by	O
in	O
situ	O
hybridization	O
(	O
Figure	O
1	O
,	O
genes	B-SO
G36	O
-	O
G46	O
)	O
.	O

Some	O
of	O
these	O
genes	B-SO
showed	O
faint	O
expression	O
in	O
a	O
cone	B-CL
-	O
like	O
distribution	O
(	O
see	O
Table	O
S1	O
,	O
genes	B-SO
G36	O
,	O
G40	O
,	O
and	O
G44	O
)	O
,	O
and	O
one	O
appeared	O
to	O
be	O
expressed	O
throughout	O
the	O
ONL	O
but	O
at	O
greater	O
levels	O
in	O
cones	B-CL
than	O
in	O
rods	B-CL
(	O
Table	O
S1	O
,	O
gene	B-SO
G37	O
)	O
.	O

The	O
remainder	O
of	O
the	O
up	O
-	O
regulated	O
genes	B-SO
did	O
not	O
have	O
detectable	O
cone	B-CL
staining	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
.	O

Despite	O
this	O
apparent	O
absence	O
of	O
cone	B-CL
staining	O
,	O
the	O
pattern	O
of	O
derepression	O
in	O
rd7	O
suggests	O
that	O
these	O
genes	B-SO
may	O
also	O
be	O
novel	O
cone	B-CL
-	O
specific	O
genes	B-SO
,	O
albeit	O
expressed	O
at	O
levels	O
below	O
the	O
sensitivity	O
threshold	O
of	O
our	O
in	O
situ	O
hybridization	O
assay	O
.	O

In	O
most	O
cases	O
,	O
the	O
novel	O
cone	B-CL
genes	B-SO
identified	O
in	O
this	O
study	O
appear	O
to	O
have	O
a	O
type	O
I	O
pattern	O
of	O
derepression	O
.	O

However	O
,	O
due	O
to	O
the	O
weakness	O
of	O
the	O
signal	O
in	O
some	O
cases	O
,	O
or	O
transcript	B-SO
localization	O
to	O
the	O
inner	B-GO
segment	I-GO
in	O
others	O
,	O
it	O
was	O
not	O
always	O
possible	O
to	O
determine	O
with	O
confidence	O
which	O
of	O
the	O
two	O
patterns	O
of	O
derepression	O
(	O
if	O
either	O
)	O
each	O
of	O
these	O
genes	B-SO
displayed	O
.	O

In	O
terms	O
of	O
functional	O
categorization	O
,	O
the	O
novel	O
cone	B-CL
genes	B-SO
cover	O
a	O
broad	O
range	O
including	O
glucose	B-CHEBI
metabolism	O
(	O
Pygm	B-GGP
and	O
Glo1	B-GGP
)	O
,	O
fatty	B-CHEBI
acid	I-CHEBI
metabolism	O
(	O
Elovl2	B-GGP
)	O
,	O
DNA	B-SO
repair	O
(	O
Smug1	B-GGP
)	O
,	O
cell	B-CL
cycle	O
/	O
chromosome	B-GO
segregation	O
(	O
Bub1b	B-GGP
)	O
,	O
carcinogenesis	O
(	O
Tcta	B-GGP
)	O
,	O
endothelial	O
biology	O
(	O
Ece1	B-GGP
)	O
,	O
cytoskeletal	B-GO
function	O
(	O
Ebp4	O
.	O
1l1	O
)	O
,	O
and	O
even	O
otolith	O
formation	O
(	O
Otop3	B-GGP
)	O
.	O

A	O
relatively	O
frequent	O
finding	O
among	O
both	O
previously	O
identified	O
cone	B-CL
-	O
specific	O
genes	B-SO
,	O
as	O
well	O
as	O
in	O
some	O
of	O
those	O
identified	O
in	O
the	O
present	O
study	O
,	O
is	O
the	O
occurrence	O
of	O
gene	B-SO
expression	O
in	O
an	O
early	O
photoreceptor	B-CL
precursor	O
pattern	O
(	O
Figure	O
5	O
)	O
.	O

This	O
pattern	O
of	O
expression	O
consists	O
of	O
positive	O
staining	O
by	O
in	O
situ	O
hybridization	O
specifically	O
at	O
the	O
scleral	O
border	O
of	O
the	O
retina	O
during	O
prenatal	O
timepoints	O
(	O
in	O
the	O
range	O
of	O
E13	O
-	O
E18	O
)	O
.	O

Gnb3	B-GGP
and	O
Thrb2	B-GGP
are	O
two	O
examples	O
of	O
known	B-SO
cone	B-CL
genes	B-SO
with	O
this	O
early	O
pattern	O
of	O
expression	O
(	O
Figure	O
5	O
)	O
.	O

Two	O
of	O
the	O
11	O
novel	O
cone	B-CL
genes	B-SO
identified	O
in	O
this	O
study	O
also	O
have	O
this	O
early	O
photoreceptor	B-CL
pattern	O
of	O
expression	O
(	O
Ece1	B-GGP
and	O
Otop3	B-GGP
)	O
.	O

Intriguingly	O
,	O
three	O
genes	B-SO
shown	O
to	O
be	O
up	O
-	O
regulated	O
in	O
rd7	O
on	O
microarray	O
,	O
but	O
that	O
had	O
either	O
no	O
detectable	O
signal	O
by	O
in	O
situ	O
hybridization	O
at	O
adult	O
stages	O
or	O
no	O
apparent	O
change	O
in	O
expression	O
by	O
in	O
situ	O
hybridization	O
between	O
wild	B-SO
type	I-SO
and	O
rd7	O
,	O
also	O
showed	O
this	O
early	O
photoreceptor	B-CL
pattern	O
(	O
Figure	O
1	O
,	O
genes	B-SO
G48	O
-	O
G50	O
)	O
.	O

The	O
embryonic	O
expression	O
pattern	O
of	O
two	O
of	O
these	O
genes	B-SO
is	O
shown	O
in	O
Figure	O
5	O
(	O
the	O
embryonic	O
in	O
situ	O
hybridization	O
for	O
the	O
third	O
,	O
G50	O
,	O
can	O
be	O
found	O
in	O
Table	O
S1	O
)	O
.	O

Although	O
the	O
significance	O
of	O
such	O
early	O
photoreceptor	B-CL
expression	O
is	O
not	O
known	O
,	O
it	O
is	O
possible	O
that	O
these	O
genes	B-SO
may	O
also	O
be	O
cone	B-CL
-	O
specific	O
but	O
are	O
expressed	O
at	O
undetectably	O
low	O
levels	O
in	O
the	O
adult	O
.	O

M	B-GGP
-	I-GGP
Opsin	I-GGP
and	O
Thyroid	B-GGP
Hormone	I-GGP
Receptor	I-GGP
beta	I-GGP
2	I-GGP
Are	O
Unchanged	O
in	O
the	O
rd7	O
Mutant	B-SO

Only	O
two	O
cone	B-CL
-	O
specific	O
genes	B-SO
failed	O
to	O
show	O
any	O
change	O
in	O
expression	O
by	O
either	O
microarray	O
or	O
in	O
situ	O
hybridization	O
in	O
the	O
rd7	O
mutant	B-SO
:	O
M	B-GGP
-	I-GGP
opsin	I-GGP
(	O
Opn1mw	B-GGP
)	O
and	O
thyroid	B-GGP
hormone	I-GGP
receptor	I-GGP
beta	I-GGP
2	I-GGP
(	O
Thrb2	B-GGP
)	O
(	O
Figure	O
S8	O
)	O
.	O

This	O
result	O
is	O
particularly	O
notable	O
because	O
Thrb2	B-GGP
is	O
absolutely	O
required	O
for	O
the	O
expression	O
of	O
M	B-GGP
-	I-GGP
opsin	I-GGP
[	O
22	O
]	O
.	O

Furthermore	O
,	O
the	O
repression	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
expression	O
in	O
the	O
dorsal	O
third	O
of	O
the	O
mouse	B-Taxon
retina	O
is	O
thought	O
to	O
depend	O
,	O
at	O
least	O
in	O
part	O
,	O
on	O
Thrb2	B-GGP
since	O
S	B-GGP
-	I-GGP
opsin	I-GGP
shows	O
dorsal	O
derepression	O
in	O
the	O
Thrb2	B-GGP
mutant	B-SO
[	O
22	O
]	O
.	O

Despite	O
the	O
derepression	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
seen	O
in	O
the	O
ventral	O
portion	O
of	O
the	O
rd7	O
retina	O
,	O
the	O
normal	O
dorsal	O
repression	O
of	O
this	O
gene	B-SO
is	O
still	O
present	O
in	O
this	O
mutant	B-SO
(	O
unpublished	O
data	O
)	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
normal	O
expression	O
pattern	O
and	O
function	O
of	O
Thrb2	B-GGP
in	O
the	O
rd7	O
mutant	B-SO
.	O

One	O
further	O
finding	O
to	O
note	O
is	O
that	O
the	O
cell	B-GO
bodies	I-GO
of	O
the	O
M	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
appear	O
to	O
be	O
scattered	O
throughout	O
the	O
ONL	O
in	O
the	O
rd7	O
mutant	B-SO
at	O
P14	O
(	O
Figure	O
S8	O
)	O
.	O

Despite	O
this	O
fact	O
,	O
their	O
overall	O
number	O
does	O
not	O
appear	O
to	O
be	O
increased	O
relative	O
to	O
wild	B-SO
-	I-SO
type	I-SO
.	O

In	O
addition	O
,	O
by	O
P28	O
,	O
the	O
M	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cell	B-GO
bodies	I-GO
in	O
rd7	O
appear	O
to	O
have	O
relocated	O
to	O
their	O
normal	O
position	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
(	O
Figure	O
S8	O
)	O
.	O

It	O
is	O
known	O
that	O
until	O
P11	O
,	O
the	O
cell	B-GO
bodies	I-GO
of	O
cone	B-CL
photoreceptors	I-CL
in	O
the	O
mouse	B-Taxon
are	O
normally	O
dispersed	O
throughout	O
the	O
ONL	O
,	O
only	O
to	O
relocate	O
subsequently	O
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
around	O
P12	O
[	O
23	O
]	O
.	O

It	O
is	O
possible	O
that	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
,	O
there	O
is	O
a	O
short	O
delay	O
in	O
the	O
relocation	O
of	O
the	O
M	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cone	O
cell	B-GO
bodies	I-GO
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
.	O

Rod	B-CL
Genes	B-SO
Are	O
Only	O
Modestly	O
and	O
Temporarily	O
Affected	O
in	O
rd7	O

In	O
sharp	O
contrast	O
to	O
changes	O
in	O
cone	B-CL
gene	B-SO
expression	O
,	O
rod	B-CL
-	O
specific	O
genes	B-SO
were	O
much	O
less	O
severely	O
affected	O
in	O
the	O
rd7	O
mutant	B-SO
.	O

Microarray	O
and	O
in	O
situ	O
hybridization	O
analysis	O
of	O
numerous	O
rod	B-CL
genes	B-SO
failed	O
to	O
reveal	O
marked	O
changes	O
in	O
expression	O
levels	O
at	O
P14	O
and	O
P21	O
(	O
see	O
Figure	O
2	O
,	O
lower	O
left	O
photomicrographs	O
;	O
Table	O
S2	O
)	O
.	O

In	O
addition	O
to	O
the	O
three	O
rod	B-CL
genes	B-SO
depicted	O
in	O
Figure	O
2	O
,	O
in	O
situ	O
hybridization	O
analysis	O
on	O
an	O
additional	O
19	O
rod	B-CL
-	O
specific	O
and	O
pan	O
-	O
photoreceptor	B-CL
genes	B-SO
demonstrated	O
only	O
a	O
very	O
mild	O
diminution	O
of	O
expression	O
in	O
two	O
of	O
these	O
genes	B-SO
,	O
gucy2e	B-GGP
and	O
Rgs9	B-GGP
,	O
at	O
P14	O
,	O
and	O
an	O
increase	O
in	O
expression	O
in	O
two	O
,	O
Nr2e3	B-GGP
,	O
and	O
Cnga1	B-GGP
(	O
Table	O
S2	O
)	O
.	O

Despite	O
the	O
minimal	O
changes	O
in	O
rod	B-CL
gene	B-SO
expression	O
at	O
later	O
postnatal	O
timepoints	O
,	O
there	O
was	O
evidence	O
of	O
a	O
significant	O
delay	O
in	O
the	O
onset	O
of	O
rhodopsin	B-GGP
(	O
Rho	B-GGP
)	O
expression	O
in	O
rd7	O
mutants	B-SO
relative	O
to	O
wild	B-SO
-	I-SO
type	I-SO
.	O

Microarray	O
analysis	O
at	O
P6	O
demonstrated	O
five	O
cDNA	B-SO
spots	O
that	O
were	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
experiments	O
.	O

Of	O
these	O
spots	O
,	O
three	O
corresponded	O
to	O
rhodopsin	B-GGP
(	O
Table	O
S3	O
)	O
.	O

In	O
situ	O
hybridization	O
analysis	O
of	O
several	O
rod	B-CL
-	O
specific	O
genes	B-SO
at	O
P6	O
revealed	O
that	O
rhodopsin	B-GGP
alone	O
showed	O
a	O
markedly	O
lower	O
level	O
of	O
expression	O
compared	O
to	O
wild	B-SO
type	I-SO
(	O
Figure	O
6	O
;	O
unpublished	O
data	O
)	O
.	O

Despite	O
this	O
modest	O
delay	O
in	O
the	O
onset	O
of	O
rhodopsin	B-GGP
expression	O
,	O
by	O
P14	O
the	O
gene	B-SO
had	O
attained	O
nearly	O
normal	O
levels	O
in	O
the	O
rd7	O
mutant	B-SO
(	O
see	O
Figure	O
2	O
,	O
lower	O
left	O
photomicrographs	O
)	O
.	O

This	O
latter	O
finding	O
suggests	O
that	O
all	O
the	O
rod	B-CL
-	O
and	O
many	O
cone	B-CL
-	O
specific	O
genes	B-SO
are	O
coexpressed	O
in	O
the	O
majority	O
of	O
photoreceptors	B-CL
in	O
the	O
rd7	O
mutant	B-SO
.	O

Changes	O
in	O
Retinal	O
Transcription	O
Factor	O
and	O
M	O
u	O
ller	O
Glial	O
Gene	B-SO
Expression	O
in	O
rd7	O

Analysis	O
of	O
several	O
photoreceptor	B-CL
transcription	O
factors	O
in	O
the	O
rd7	O
mutant	B-SO
indicated	O
that	O
the	O
levels	O
of	O
Crx	B-GGP
and	O
Nrl	B-GGP
are	O
unaffected	O
in	O
the	O
mutant	B-SO
at	O
P14	O
(	O
see	O
Figure	O
2	O
,	O
lower	O
right	O
photomicrographs	O
)	O
.	O

Nrl	B-GGP
is	O
a	O
rod	B-CL
-	O
specific	O
,	O
basic	B-CHEBI
leucine	B-CHEBI
zipper	O
transcription	O
factor	O
required	O
for	O
the	O
activation	O
of	O
many	O
rod	B-CL
-	O
specific	O
genes	B-SO
and	O
the	O
repression	O
of	O
most	O
cone	B-CL
-	O
specific	O
genes	B-SO
in	O
rods	B-CL
[	O
24	O
]	O
.	O

Nrl	B-GGP
is	O
known	O
to	O
be	O
genetically	B-SO
upstream	O
of	O
Nr2e3	B-GGP
and	O
is	O
required	O
for	O
its	O
expression	O
[	O
24	O
]	O
.	O

Crx	B-GGP
is	O
a	O
homeobox	O
transcription	O
factor	O
expressed	O
in	O
both	O
rods	B-CL
and	O
cones	B-CL
and	O
is	O
required	O
for	O
the	O
expression	O
of	O
a	O
variety	O
of	O
rod	B-CL
-	O
and	O
cone	B-CL
-	O
specific	O
genes	B-SO
[	O
25	O
]	O
.	O

In	O
contrast	O
to	O
what	O
is	O
seen	O
in	O
the	O
Nrl	B-GGP
mutant	B-SO
,	O
Nr2e3	B-GGP
expression	O
is	O
unchanged	O
in	O
Crx	B-GGP
mutant	B-SO
homozygotes	O
(	O
unpublished	O
data	O
)	O
.	O

Strikingly	O
,	O
Nr2e3	B-GGP
itself	O
was	O
markedly	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	B-SO
both	O
by	O
microarray	O
and	O
in	O
situ	O
hybridization	O
(	O
see	O
Figure	O
2	O
,	O
lower	O
right	O
photomicrographs	O
;	O
Table	O
S2	O
)	O
.	O

The	O
rd7	O
mutant	B-SO
carries	O
a	O
deletion	B-SO
in	O
Nr2e3	B-GGP
that	O
removes	B-SO
portions	B-SO
of	O
both	O
the	O
DNA	B-SO
-	O
binding	O
and	O
ligand	O
-	O
binding	O
domains	B-SO
[	O
15	O
]	O
.	O

Although	O
this	O
deletion	B-SO
most	O
likely	O
creates	O
a	O
null	O
allele	B-SO
,	O
a	O
residual	O
transcript	B-SO
is	O
clearly	O
present	O
and	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	B-SO
.	O

This	O
finding	O
suggests	O
that	O
Nr2e3	B-GGP
is	O
required	O
for	O
repression	O
of	O
its	O
own	O
transcription	O
.	O

One	O
gene	B-SO
,	O
RIKEN	B-GGP
cDNA	I-GGP
4933409K07	I-GGP
(	O
Figure	O
1	O
,	O
gene	B-SO
G47	O
)	O
,	O
was	O
found	O
to	O
be	O
up	O
-	O
regulated	O
on	O
microarray	O
at	O
all	O
four	O
timepoints	O
examined	O
.	O

This	O
gene	B-SO
showed	O
a	O
unique	O
pattern	O
of	O
expression	O
in	O
the	O
adult	O
rd7	O
mutant	B-SO
retina	O
.	O

Whereas	O
there	O
was	O
only	O
a	O
barely	O
detectable	O
hint	O
of	O
expression	O
in	O
the	O
inner	O
nuclear	O
layer	O
(	O
INL	O
)	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
,	O
this	O
gene	B-SO
showed	O
strong	O
expression	O
in	O
the	O
middle	O
and	O
vitreal	O
thirds	O
of	O
the	O
INL	O
as	O
well	O
as	O
patchy	O
expression	O
in	O
the	O
ganglion	O
cell	B-CL
layer	O
(	O
GCL	O
)	O
and	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
in	O
rd7	O
(	O
see	O
Table	O
S1	O
)	O
.	O

This	O
in	O
situ	O
hybridization	O
pattern	O
is	O
consistent	O
with	O
staining	O
in	O
M	B-CL
u	I-CL
ller	I-CL
glia	I-CL
,	O
the	O
principal	O
glial	B-CL
cell	I-CL
type	O
of	O
the	O
mouse	B-Taxon
retina	O
.	O

One	O
possible	O
interpretation	O
of	O
this	O
unusual	O
expression	O
pattern	O
is	O
that	O
it	O
represents	O
an	O
early	O
reaction	O
of	O
M	O
u	O
ller	O
glia	O
to	O
injury	O
in	O
this	O
mutant	B-SO
.	O

The	O
Majority	O
of	O
the	O
Photoreceptors	B-CL
in	O
the	O
rd7	O
Retina	O
Represent	O
a	O
Morphologically	O
Hybrid	O
Cell	B-CL
Type	O

In	O
order	O
to	O
assess	O
the	O
morphologic	O
effects	O
of	O
the	O
above	O
gene	B-SO
expression	O
changes	O
,	O
the	O
ultrastructure	O
of	O
the	O
photoreceptor	B-CL
cell	I-CL
bodies	O
in	O
the	O
rd7	O
mutant	B-SO
was	O
examined	O
.	O

The	O
cell	B-GO
bodies	I-GO
were	O
chosen	O
for	O
evaluation	O
rather	O
than	O
the	O
outer	B-GO
segments	I-GO
,	O
since	O
in	O
the	O
mouse	B-Taxon
,	O
the	O
ultrastructural	O
differences	O
between	O
rod	B-CL
and	O
cone	B-CL
somata	O
are	O
much	O
greater	O
than	O
are	O
the	O
differences	O
between	O
the	O
outer	B-GO
segments	I-GO
[	O
26	O
]	O
.	O

In	O
the	O
wild	B-SO
-	I-SO
type	I-SO
mouse	B-Taxon
,	O
cone	O
cell	B-GO
bodies	I-GO
are	O
aligned	O
along	O
the	O
scleral	O
border	O
of	O
the	O
ONL	O
,	O
and	O
they	O
are	O
larger	O
than	O
those	O
of	O
rods	B-CL
.	O

They	O
have	O
a	O
smaller	O
,	O
more	O
irregular	O
mass	O
of	O
nuclear	B-GO
heterochromatin	I-GO
that	O
is	O
often	O
broken	O
up	O
into	O
multiple	O
discrete	O
clumps	O
connected	O
by	O
thin	O
threads	O
.	O

They	O
also	O
have	O
more	O
abundant	O
electron	B-CHEBI
-	O
lucent	O
euchromatin	B-GO
than	O
rods	B-CL
.	O

Lastly	O
,	O
they	O
frequently	O
have	O
a	O
patch	O
of	O
organelle	B-GO
-	O
rich	O
cytoplasm	B-GO
next	O
to	O
their	O
nuclei	B-GO
,	O
usually	O
containing	O
large	O
mitochondria	B-GO
[	O
26	O
]	O
.	O

Analysis	O
of	O
toluidine	O
blue	O
-	O
stained	O
semi	O
-	O
thin	O
sections	O
revealed	O
that	O
such	O
cone	B-CL
-	O
like	O
cells	B-CL
were	O
present	O
in	O
greater	O
abundance	O
in	O
the	O
rd7	O
retina	O
than	O
in	O
wild	B-SO
-	I-SO
type	I-SO
,	O
and	O
that	O
their	O
somata	B-GO
were	O
scattered	O
throughout	O
the	O
ONL	O
(	O
Figure	O
7	O
)	O
.	O

A	O
comparison	O
between	O
the	O
distribution	O
of	O
these	O
cells	B-CL
and	O
those	O
expressing	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
strongly	O
suggests	O
that	O
they	O
represent	O
the	O
same	O
cell	B-CL
population	O
(	O
compare	O
Figure	O
7D	O
and	O
7F	O
)	O
.	O

Analysis	O
of	O
the	O
nuclear	B-GO
morphology	O
of	O
dissociated	O
retinal	O
cells	B-CL
stained	O
for	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
by	O
dissociated	O
cell	B-CL
in	O
situ	O
hybridization	O
confirmed	O
that	O
this	O
is	O
the	O
case	O
(	O
unpublished	O
data	O
)	O
.	O

These	O
findings	O
,	O
along	O
with	O
the	O
absence	O
of	O
rhodopsin	B-GGP
staining	O
in	O
these	O
cells	B-CL
(	O
see	O
Figure	O
3D	O
-	O
3F	O
)	O
,	O
suggest	O
that	O
these	O
"	O
cone	B-CL
-	O
like	O
"	O
cells	B-CL
in	O
the	O
rd7	O
mutant	B-SO
retina	O
may	O
represent	O
supernumerary	O
normal	O
cones	B-CL
with	O
an	O
abnormal	O
localization	O
of	O
their	O
cell	B-GO
bodies	I-GO
.	O

In	O
contrast	O
to	O
the	O
cone	O
cell	B-GO
body	I-GO
,	O
the	O
wild	B-SO
-	I-SO
type	I-SO
rod	B-CL
soma	B-GO
is	O
small	O
and	O
nearly	O
round	O
.	O

It	O
has	O
a	O
single	O
,	O
large	O
clump	O
of	O
dense	O
heterochromatin	B-GO
,	O
a	O
thin	O
rim	O
of	O
moderately	O
electron	B-CHEBI
-	O
dense	O
euchromatin	B-GO
,	O
and	O
very	O
scant	O
juxtanuclear	B-GO
cytoplasm	I-GO
without	O
organelles	B-GO
[	O
26	O
,	O
27	O
]	O
.	O

The	O
second	O
cell	B-CL
population	O
in	O
the	O
ONL	O
of	O
the	O
rd7	O
retina	O
has	O
some	O
of	O
the	O
nuclear	B-GO
features	O
of	O
normal	O
rods	B-CL
,	O
such	O
as	O
a	O
single	O
,	O
dense	O
mass	O
of	O
heterochromatin	B-GO
and	O
moderately	O
electron	B-CHEBI
-	O
dense	O
euchromatin	B-GO
(	O
Figure	O
7H	O
)	O
;	O
yet	O
these	O
cells	B-CL
also	O
show	O
features	O
of	O
cones	B-CL
.	O

First	O
,	O
the	O
euchromatin	B-GO
is	O
,	O
on	O
average	O
,	O
more	O
abundant	O
in	O
these	O
cells	B-CL
than	O
in	O
wild	B-SO
-	I-SO
type	I-SO
rods	B-CL
(	O
compare	O
Figure	O
7G	O
and	O
7H	O
)	O
.	O

In	O
addition	O
,	O
comparison	O
of	O
the	O
diagrammatic	O
representation	O
of	O
the	O
wild	B-SO
-	I-SO
type	I-SO
and	O
rd7	O
ONLs	O
suggests	O
that	O
the	O
average	O
area	O
of	O
the	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
negative	O
cells	B-CL
in	O
rd7	O
is	O
greater	O
than	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
(	O
Figure	O
7C	O
and	O
7D	O
)	O
.	O

In	O
order	O
to	O
confirm	O
this	O
impression	O
,	O
we	O
quantitated	O
the	O
area	O
of	O
50	O
wild	B-SO
-	I-SO
type	I-SO
and	O
50	O
mutant	B-SO
rod	B-CL
-	O
like	O
cell	B-GO
bodies	I-GO
(	O
see	O
Materials	O
and	O
Methods	O
for	O
details	O
)	O
.	O

This	O
experiment	O
confirmed	O
that	O
the	O
average	O
area	O
of	O
the	O
rod	B-CL
-	O
like	O
somata	B-GO
in	O
rd7	O
is	O
approximately	O
30	O
%	O
larger	O
than	O
that	O
of	O
wild	B-SO
-	I-SO
type	I-SO
rod	B-CL
somata	B-GO
(	O
mean	O
area	O
in	O
rd7	O
was	O
9	O
.	O
75	O
+/-	O
1	O
.	O
36	O
(	O
standard	O
deviation	O
)	O
mu	O
m2	O
,	O
compared	O
to	O
wild	B-SO
-	I-SO
type	I-SO
rods	B-CL
,	O
with	O
7	O
.	O
53	O
+/-	O
0	O
.	O
72	O
mu	O
m2	O
;	O
n	O
=	O
50	O
;	O
p	O
=	O
7	O
.	O
6	O
x	O
10	O
-	O
16	O
,	O
Student	O
'	O
s	O
t	O
-	O
test	O
)	O
.	O

It	O
is	O
also	O
notable	O
that	O
the	O
standard	O
deviation	O
of	O
the	O
somal	B-GO
area	O
is	O
nearly	O
twice	O
as	O
great	O
in	O
rd7	O
than	O
in	O
wild	B-SO
-	I-SO
type	I-SO
,	O
confirming	O
the	O
subjective	O
impression	O
of	O
greater	O
variability	O
in	O
somal	O
size	O
and	O
shape	O
in	O
the	O
mutant	B-SO
compared	O
to	O
the	O
wild	B-SO
-	I-SO
type	I-SO
(	O
compare	O
Figure	O
7C	O
and	O
7D	O
)	O
.	O

Lastly	O
,	O
38	O
%	O
(	O
19	O
/	O
50	O
)	O
of	O
the	O
rd7	O
photoreceptors	B-CL
selected	O
for	O
somal	B-GO
area	O
quantitation	O
had	O
prominent	O
juxtanuclear	B-GO
mitochondria	B-GO
(	O
red	O
arrow	O
in	O
Figure	O
7H	O
;	O
unpublished	O
data	O
)	O
.	O

Such	O
juxtanuclear	B-GO
organelles	B-GO
are	O
only	O
very	O
rarely	O
seen	O
in	O
normal	O
rods	B-CL
(	O
1	O
.	O
5	O
%	O
;	O
six	O
out	O
of	O
399	O
cells	B-CL
counted	O
)	O
,	O
but	O
are	O
common	O
in	O
cones	B-CL
(	O
yellow	O
arrow	O
in	O
Figure	O
7H	O
)	O
.	O

In	O
conclusion	O
,	O
it	O
is	O
clear	O
that	O
this	O
second	O
cell	B-CL
population	O
in	O
the	O
rd7	O
retina	O
has	O
morphological	O
features	O
of	O
both	O
normal	O
rods	B-CL
and	O
cones	B-CL
consistent	O
with	O
the	O
coexpression	O
of	O
many	O
rod	B-CL
-	O
and	O
cone	B-CL
-	O
specific	O
genes	B-SO
in	O
these	O
cells	B-CL
.	O

Discussion	O

In	O
this	O
paper	O
we	O
have	O
determined	O
that	O
the	O
primary	O
role	O
of	O
the	O
rod	B-CL
-	O
specific	O
transcription	O
factor	O
,	O
Nr2e3	B-GGP
,	O
is	O
to	O
maintain	O
cone	B-CL
genes	B-SO
transcriptionally	O
silent	O
within	O
rods	B-CL
.	O

We	O
have	O
identified	O
two	O
patterns	O
of	O
cone	B-CL
gene	B-SO
derepression	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
,	O
in	O
agreement	O
with	O
a	O
previous	O
report	O
by	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
.	O

The	O
first	O
pattern	O
of	O
derepression	O
identified	O
(	O
type	O
I	O
)	O
consists	O
of	O
ectopic	O
expression	O
of	O
cone	B-CL
genes	B-SO
in	O
the	O
vast	O
majority	O
of	O
cells	B-CL
in	O
the	O
ONL	O
.	O

These	O
cells	B-CL
were	O
also	O
shown	O
to	O
coexpress	O
all	O
rod	B-CL
genes	B-SO
tested	O
.	O

Consistent	O
with	O
the	O
hybrid	O
pattern	O
of	O
gene	B-SO
expression	O
in	O
these	O
cells	B-CL
,	O
electron	B-CHEBI
microscopic	O
analysis	O
revealed	O
them	O
to	O
be	O
morphologically	O
intermediate	O
between	O
normal	O
rods	B-CL
and	O
cones	B-CL
.	O

Although	O
genes	B-SO
showing	O
type	O
I	O
derepression	O
demonstrated	O
staining	O
in	O
the	O
majority	O
of	O
cells	B-CL
in	O
the	O
ONL	O
,	O
two	O
lines	O
of	O
evidence	O
suggest	O
that	O
these	O
genes	B-SO
are	O
not	O
completely	O
derepressed	O
in	O
these	O
cells	B-CL
when	O
compared	O
to	O
their	O
expression	O
in	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cones	B-CL
.	O

First	O
,	O
close	O
evaluation	O
of	O
the	O
staining	O
pattern	O
of	O
a	O
number	O
of	O
type	O
I	O
genes	B-SO
in	O
the	O
rd7	O
mutant	B-SO
retina	O
(	O
e	O
.	O
g	O
.	O
,	O
see	O
Table	O
S1	O
,	O
genes	B-SO
G9	O
,	O
G19	O
,	O
and	O
G24	O
)	O
,	O
reveals	O
that	O
,	O
in	O
addition	O
to	O
the	O
background	O
staining	O
throughout	O
the	O
ONL	O
,	O
there	O
is	O
a	O
more	O
darkly	O
staining	O
subpopulation	O
of	O
cells	B-CL
scattered	O
throughout	O
this	O
layer	O
in	O
a	O
distribution	O
corresponding	O
to	O
that	O
of	O
the	O
supernumerary	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
-	O
expressing	O
cells	B-CL
.	O

This	O
pattern	O
of	O
staining	O
suggests	O
that	O
these	O
genes	B-SO
are	O
more	O
highly	O
expressed	O
in	O
S	B-GGP
-	I-GGP
opsin	I-GGP
expressing	O
cells	B-CL
than	O
in	O
the	O
hybrid	O
cells	B-CL
of	O
the	O
rd7	O
retina	O
.	O

The	O
second	O
line	O
of	O
evidence	O
derives	O
from	O
a	O
comparison	O
of	O
the	O
expression	O
pattern	O
of	O
many	O
type	O
I	O
genes	B-SO
in	O
rd7	O
and	O
Nrl	B-GGP
-	O
/	O
-	O
mutant	B-SO
backgrounds	O
.	O

As	O
mentioned	O
above	O
,	O
Nrl	B-GGP
is	O
a	O
retinal	O
transcription	O
factor	O
that	O
,	O
when	O
mutated	B-SO
,	O
results	O
in	O
en	O
masse	O
conversion	O
of	O
rods	B-CL
into	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cones	B-CL
[	O
24	O
]	O
.	O

It	O
can	O
be	O
inferred	O
from	O
this	O
fact	O
that	O
Nrl	B-GGP
is	O
absolutely	O
required	O
for	O
the	O
normal	O
silencing	O
of	O
cone	B-CL
-	O
specific	O
genes	B-SO
in	O
rods	B-CL
.	O

In	O
the	O
Nrl	B-GGP
homozygous	O
mutant	B-SO
,	O
there	O
is	O
a	O
stronger	O
and	O
more	O
uniform	O
derepression	O
of	O
many	O
cone	B-CL
-	O
specific	O
genes	B-SO
throughout	O
the	O
ONL	O
than	O
is	O
seen	O
in	O
the	O
rd7	O
retina	O
(	O
unpublished	O
data	O
)	O
.	O

This	O
finding	O
further	O
suggests	O
that	O
,	O
in	O
addition	O
to	O
its	O
repression	O
of	O
cone	B-CL
gene	B-SO
expression	O
via	O
induction	O
of	O
Nr2e3	B-GGP
expression	O
,	O
Nrl	B-GGP
exerts	O
an	O
additional	O
level	O
of	O
negative	O
control	O
over	O
cone	B-CL
genes	B-SO
either	O
directly	O
or	O
via	O
a	O
second	O
,	O
as	O
yet	O
uncharacterized	O
,	O
repressor	O
.	O

The	O
second	O
pattern	O
of	O
derepression	O
seen	O
in	O
the	O
rd7	O
retina	O
(	O
type	O
II	O
)	O
,	O
is	O
represented	O
by	O
a	O
scattered	O
population	O
of	O
cells	B-CL
throughout	O
the	O
ONL	O
that	O
shows	O
derepression	O
of	O
several	O
cone	B-CL
-	O
specific	O
genes	B-SO
,	O
including	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
.	O

By	O
ultrastructural	O
criteria	O
,	O
these	O
cells	B-CL
appear	O
to	O
be	O
normal	O
cones	B-CL
,	O
albeit	O
with	O
displaced	O
cell	B-GO
bodies	I-GO
.	O

Quantitation	O
of	O
these	O
supernumerary	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
indicates	O
that	O
they	O
are	O
approximately	O
2	O
-	O
fold	O
more	O
abundant	O
than	O
in	O
normal	O
retina	O
,	O
consistent	O
with	O
previous	O
antibody	B-GO
studies	O
[	O
17	O
]	O
.	O

Two	O
recent	O
studies	O
have	O
presented	O
data	O
that	O
are	O
consistent	O
with	O
many	O
of	O
the	O
findings	O
in	O
our	O
study	O
[	O
18	O
,	O
19	O
]	O
.	O

Both	O
studies	O
showed	O
that	O
cone	B-CL
genes	B-SO
in	O
addition	O
to	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
are	O
derepressed	O
in	O
the	O
mouse	B-Taxon
rd7	O
mutant	B-SO
.	O

In	O
addition	O
,	O
Peng	O
et	O
al	O
.	O

[	O
19	O
]	O
found	O
by	O
RT	O
-	O
PCR	O
that	O
the	O
levels	O
of	O
several	O
rod	B-CL
-	O
specific	O
genes	B-SO
,	O
including	O
rhodopsin	B-GGP
,	O
were	O
modestly	O
reduced	O
in	O
rd7	O
at	O
P28	O
.	O

Our	O
in	O
situ	O
hybridization	O
data	O
suggest	O
that	O
rhodopsin	B-GGP
expression	O
is	O
markedly	O
reduced	O
at	O
P6	O
,	O
but	O
that	O
it	O
attains	O
levels	O
indistinguishable	O
from	O
wild	B-SO
-	I-SO
type	I-SO
by	O
P14	O
.	O

Since	O
the	O
change	O
in	O
rhodopsin	B-GGP
levels	O
identified	O
by	O
Peng	O
et	O
al	O
.	O
were	O
relatively	O
small	O
(	O
an	O
approximately	O
15	O
%	O
reduction	O
)	O
,	O
it	O
is	O
not	O
surprising	O
that	O
such	O
a	O
difference	O
was	O
not	O
detected	O
by	O
in	O
situ	O
hybridization	O
.	O

The	O
overall	O
finding	O
of	O
modest	O
reductions	O
in	O
rod	B-CL
-	O
specific	O
gene	B-SO
expression	O
is	O
entirely	O
in	O
keeping	O
with	O
the	O
results	O
of	O
the	O
present	O
study	O
.	O

In	O
addition	O
to	O
demonstrating	O
derepression	O
of	O
a	O
range	O
of	O
known	B-SO
cone	B-CL
-	O
specific	O
genes	B-SO
in	O
rd7	O
mutants	B-SO
,	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
showed	O
up	O
-	O
regulation	O
by	O
Northern	O
blot	O
of	O
two	O
additional	O
genes	B-SO
in	O
the	O
rd7	O
mutant	B-SO
,	O
Elovl2	B-GGP
and	O
Fabp7	B-GGP
.	O

These	O
two	O
genes	B-SO
were	O
also	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
rd7	O
in	O
the	O
present	O
study	O
(	O
see	O
Figure	O
1	O
;	O
Table	O
S1	O
)	O
.	O

Although	O
we	O
found	O
Elovl2	B-GGP
to	O
have	O
a	O
cone	B-CL
-	O
enriched	O
pattern	O
of	O
expression	O
(	O
see	O
Figure	O
1	O
)	O
,	O
in	O
situ	O
hybridization	O
analysis	O
of	O
Fabp7	B-GGP
failed	O
to	O
show	O
a	O
signal	O
in	O
wild	B-SO
-	I-SO
type	I-SO
or	O
mutant	B-SO
retina	O
(	O
unpublished	O
data	O
)	O
.	O

Nevertheless	O
,	O
previous	O
studies	O
have	O
suggested	O
that	O
Fabp7	B-GGP
is	O
expressed	O
in	O
radial	B-CL
glia	I-CL
and	O
immature	O
astrocytes	B-CL
in	O
the	O
brain	O
[	O
28	O
-	O
30	O
]	O
.	O

Given	O
the	O
expression	O
pattern	O
elsewhere	O
in	O
the	O
nervous	O
system	O
,	O
it	O
is	O
possible	O
that	O
Fabp7	B-GGP
is	O
up	O
-	O
regulated	O
in	O
M	B-CL
u	I-CL
ller	I-CL
glia	I-CL
in	O
the	O
rd7	O
retina	O
in	O
response	O
to	O
injury	O
in	O
a	O
manner	O
akin	O
to	O
the	O
novel	O
M	B-CL
u	I-CL
ller	I-CL
glial	I-CL
gene	B-SO
identified	O
in	O
this	O
study	O
,	O
RIKEN	B-GGP
cDNA	I-GGP
4933409K07	I-GGP
(	O
Figure	O
1	O
,	O
gene	B-SO
G47	O
)	O
.	O

Indirect	O
support	O
for	O
this	O
idea	O
is	O
provided	O
by	O
the	O
observation	O
that	O
Fabp7	B-GGP
is	O
up	O
-	O
regulated	O
by	O
microarray	O
analysis	O
in	O
Nrl	B-GGP
and	O
Crx	B-GGP
mutant	B-SO
retinas	O
as	O
well	O
(	O
unpublished	O
data	O
)	O
,	O
suggesting	O
that	O
this	O
change	O
may	O
represent	O
a	O
generalized	O
response	O
to	O
injury	O
in	O
the	O
retina	O
rather	O
than	O
derepression	O
of	O
a	O
cone	B-CL
-	O
enriched	O
gene	B-SO
.	O

The	O
study	O
by	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
made	O
two	O
further	O
observations	O
worthy	O
of	O
note	O
.	O

First	O
,	O
they	O
identified	O
a	O
zebrafish	B-Taxon
homolog	B-SO
of	O
Nr2e3	B-GGP
and	O
showed	O
it	O
to	O
be	O
expressed	O
in	O
photoreceptors	B-CL
.	O

Interestingly	O
,	O
they	O
showed	O
that	O
this	O
homolog	B-SO
appears	O
to	O
have	O
a	O
pan	O
-	O
photoreceptor	B-CL
pattern	O
of	O
expression	O
early	O
in	O
development	O
that	O
later	O
resolves	O
into	O
a	O
rod	B-CL
-	O
specific	O
pattern	O
of	O
expression	O
.	O

This	O
early	O
expression	O
in	O
cones	B-CL
may	O
represent	O
a	O
mechanism	O
whereby	O
the	O
expression	O
of	O
cone	B-CL
-	O
specific	O
gene	B-SO
products	O
is	O
temporarily	O
repressed	O
.	O

It	O
will	O
be	O
important	O
to	O
determine	O
the	O
extent	O
to	O
which	O
the	O
function	O
of	O
Nr2e3	B-GGP
has	O
been	O
conserved	O
in	O
the	O
retina	O
of	O
such	O
a	O
distantly	O
related	O
organism	B-Taxon
.	O

Secondly	O
,	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
used	O
an	O
in	O
vitro	O
oligonucleotide	B-SO
selection	O
protocol	O
to	O
determine	O
the	O
preferred	O
binding	B-SO
site	I-SO
for	O
Nr2e3	B-GGP
.	O

This	O
information	O
will	O
be	O
very	O
useful	O
for	O
future	O
bioinformatic	O
analyses	O
of	O
Nr2e3	B-GGP
target	O
genes	B-SO
.	O

The	O
gene	B-SO
expression	O
changes	O
identified	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
in	O
the	O
present	O
study	O
suggest	O
the	O
scheme	O
of	O
gene	B-SO
regulation	O
in	O
mouse	B-Taxon
rods	B-CL
depicted	O
in	O
Figure	O
8	O
.	O

As	O
this	O
diagram	O
implies	O
,	O
there	O
appear	O
to	O
be	O
at	O
least	O
two	O
different	O
repressors	O
of	O
cone	B-CL
genes	B-SO
within	O
rods	B-CL
,	O
Nr2e3	B-GGP
and	O
either	O
Nrl	B-GGP
itself	O
or	O
an	O
additional	O
unknown	O
transcription	O
factor	O
downstream	O
of	O
Nrl	B-GGP
,	O
here	O
termed	O
"	O
transcription	O
factor	O
X	O
.	O
"	O
In	O
fact	O
,	O
it	O
appears	O
that	O
the	O
differences	O
between	O
type	O
I	O
and	O
type	O
II	O
cone	B-CL
genes	B-SO
may	O
simply	O
depend	O
on	O
which	O
repressor	O
--	O
Nr2e3	B-GGP
or	O
transcription	O
factor	O
X	O
--	O
is	O
primarily	O
responsible	O
for	O
the	O
regulation	O
of	O
the	O
gene	B-SO
in	O
question	O
.	O

In	O
the	O
case	O
of	O
type	O
I	O
genes	B-SO
,	O
Nr2e3	B-GGP
is	O
the	O
primary	O
repressor	O
and	O
transcription	O
factor	O
X	O
is	O
of	O
secondary	O
importance	O
.	O

In	O
the	O
case	O
of	O
type	O
II	O
genes	B-SO
,	O
transcription	O
factor	O
X	O
exerts	O
the	O
major	O
repressive	O
effect	O
on	O
transcription	O
,	O
and	O
Nr2e3	B-GGP
plays	O
a	O
lesser	O
,	O
but	O
still	O
important	O
role	O
.	O

In	O
contrast	O
to	O
the	O
marked	O
derepression	O
of	O
the	O
vast	O
majority	O
of	O
cone	B-CL
-	O
specific	O
genes	B-SO
in	O
the	O
rd7	O
mutant	B-SO
,	O
two	O
genes	B-SO
stand	O
out	O
as	O
being	O
unaffected	O
by	O
the	O
mutation	B-SO
:	O
the	O
gene	B-SO
encoding	O
M	B-GGP
-	I-GGP
opsin	I-GGP
and	O
Thrb2	B-GGP
.	O

As	O
Thrb2	B-GGP
is	O
known	O
to	O
be	O
required	O
for	O
the	O
expression	O
of	O
M	B-GGP
-	I-GGP
opsin	I-GGP
[	O
22	O
]	O
,	O
the	O
absence	O
of	O
supernumerary	O
M	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
may	O
simply	O
be	O
a	O
consequence	O
of	O
the	O
fact	O
that	O
Thrb2	B-GGP
expression	O
is	O
unchanged	O
in	O
the	O
rd7	O
mutant	B-SO
.	O

Further	O
support	O
for	O
this	O
idea	O
has	O
been	O
provided	O
by	O
recent	O
work	O
in	O
our	O
lab	O
showing	O
widespread	O
derepression	O
of	O
cone	B-CL
genes	B-SO
in	O
the	O
Notch1	B-GGP
-	O
/	O
-	O
retina	O
(	O
unpublished	O
data	O
)	O
.	O

In	O
contrast	O
to	O
the	O
rd7	O
mutant	B-SO
,	O
Notch1	B-GGP
-	O
/	O
-	O
retinas	O
show	O
marked	O
derepression	O
of	O
Thrb2	B-GGP
and	O
a	O
corresponding	O
derepression	O
of	O
the	O
gene	B-SO
that	O
encodes	O
M	B-GGP
-	I-GGP
opsin	I-GGP
.	O

An	O
additional	O
observation	O
suggesting	O
that	O
M	B-GGP
-	I-GGP
opsin	I-GGP
and	O
S	B-GGP
-	I-GGP
opsin	I-GGP
are	O
controlled	O
by	O
different	O
mechanisms	O
comes	O
from	O
in	O
vitro	O
experiments	O
[	O
31	O
,	O
32	O
]	O
.	O

While	O
explanted	O
P3	O
retinas	O
express	O
S	B-GGP
-	I-GGP
opsin	I-GGP
and	O
M	B-GGP
-	I-GGP
opsin	I-GGP
with	O
normal	O
kinetics	O
,	O
explanted	O
P0	O
retinas	O
express	O
only	O
S	B-GGP
-	I-GGP
opsin	I-GGP
[	O
32	O
]	O
.	O

The	O
factor	O
(	O
s	O
)	O
controlling	O
these	O
differences	O
are	O
unknown	O
,	O
but	O
may	O
be	O
intrinsic	O
,	O
as	O
cocultures	O
of	O
older	O
and	O
younger	O
retinas	O
,	O
conditioned	O
media	O
from	O
older	O
retinas	O
,	O
and	O
addition	O
of	O
a	O
variety	O
of	O
small	O
molecules	B-CHEBI
were	O
unable	O
to	O
promote	O
the	O
expression	O
of	O
M	B-GGP
-	I-GGP
opsin	I-GGP
in	O
the	O
P0	O
-	O
initiated	O
cultures	O
[	O
32	O
]	O
.	O

In	O
contrast	O
to	O
our	O
findings	O
,	O
Peng	O
et	O
al	O
.	O

[	O
19	O
]	O
reported	O
that	O
M	B-GGP
-	I-GGP
opsin	I-GGP
expression	O
is	O
mildly	O
increased	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
.	O

It	O
is	O
possible	O
that	O
a	O
subtle	O
increase	O
in	O
M	B-GGP
-	I-GGP
opsin	I-GGP
transcript	B-SO
levels	O
does	O
occur	O
in	O
the	O
rd7	O
retina	O
,	O
and	O
that	O
this	O
difference	O
could	O
not	O
be	O
detected	O
by	O
in	O
situ	O
hybridization	O
.	O

Since	O
virtually	O
all	O
M	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cells	B-CL
are	O
localized	O
at	O
the	O
outer	O
edge	O
of	O
the	O
ONL	O
by	O
P28	O
in	O
the	O
rd7	O
mutant	B-SO
(	O
Figure	O
S8	O
)	O
,	O
any	O
increase	O
in	O
M	B-GGP
-	I-GGP
opsin	I-GGP
transcript	B-SO
in	O
the	O
mutant	B-SO
must	O
have	O
occurred	O
in	O
cells	B-CL
in	O
that	O
location	O
.	O

A	O
variety	O
of	O
novel	O
cone	B-CL
-	O
specific	O
or	O
cone	B-CL
-	O
enriched	O
genes	B-SO
were	O
characterized	O
in	O
this	O
study	O
.	O

One	O
of	O
these	O
genes	B-SO
,	O
Pygm	B-GGP
,	O
is	O
involved	O
in	O
glycogen	B-CHEBI
/	O
glucose	B-CHEBI
metabolism	O
,	O
and	O
a	O
second	O
,	O
Glo1	B-GGP
,	O
is	O
required	O
for	O
detoxification	O
of	O
methylglyoxal	B-CHEBI
,	O
a	O
byproduct	B-CHEBI
of	O
glycolysis	O
[	O
33	O
]	O
.	O

A	O
third	O
gene	B-SO
involved	O
in	O
glucose	B-CHEBI
metabolism	O
,	O
hexokinase	B-GGP
2	I-GGP
(	O
Hk2	B-GGP
)	O
,	O
is	O
also	O
derepressed	O
in	O
the	O
rd7	O
mutant	B-SO
and	O
shows	O
a	O
pattern	O
of	O
expression	O
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
,	O
suggesting	O
greater	O
expression	O
in	O
cones	B-CL
than	O
in	O
rods	B-CL
(	O
see	O
Figure	O
1	O
;	O
Table	O
S1	O
)	O
.	O

A	O
fourth	O
gene	B-SO
involved	O
in	O
glucose	B-CHEBI
metabolism	O
,	O
glucokinase	B-GGP
regulatory	I-GGP
protein	I-GGP
(	O
Gckr	B-GGP
)	O
,	O
was	O
found	O
to	O
be	O
increased	O
in	O
three	O
out	O
of	O
three	O
microarrays	O
at	O
P21	O
but	O
was	O
not	O
tested	O
by	O
in	O
situ	O
hybridization	O
(	O
Table	O
S4	O
)	O
.	O

The	O
increased	O
expression	O
of	O
Gckr	B-GGP
in	O
rd7	O
mutant	B-SO
retina	O
suggests	O
that	O
it	O
too	O
may	O
be	O
a	O
cone	B-CL
-	O
enriched	O
gene	B-SO
.	O

A	O
previous	O
study	O
found	O
that	O
two	O
of	O
these	O
genes	B-SO
,	O
Pygm	B-GGP
and	O
Hk2	B-GGP
,	O
have	O
markedly	O
elevated	O
tag	O
levels	O
in	O
an	O
ONL	O
-	O
specific	O
serial	O
analysis	O
of	O
gene	B-SO
expression	O
library	O
consistent	O
with	O
their	O
being	O
highly	O
enriched	O
in	O
wild	B-SO
-	I-SO
type	I-SO
photoreceptors	B-CL
[	O
34	O
]	O
.	O

Furthermore	O
,	O
prior	O
studies	O
have	O
suggested	O
differences	O
in	O
glycogen	B-CHEBI
and	O
glucose	B-CHEBI
metabolism	O
between	O
primate	B-Taxon
rods	B-CL
and	O
cones	B-CL
[	O
35	O
]	O
.	O

Our	O
findings	O
lend	O
further	O
support	O
to	O
this	O
concept	O
.	O

Interestingly	O
,	O
Pygm	B-GGP
has	O
been	O
implicated	O
in	O
human	B-Taxon
disease	O
.	O

Mutations	B-SO
in	O
this	O
gene	B-SO
underlie	O
McArdle	O
'	O
s	O
disease	O
(	O
glycogen	B-CHEBI
storage	O
disease	O
type	O
V	O
)	O
,	O
the	O
symptoms	O
of	O
which	O
include	O
exercise	O
intolerance	O
,	O
muscle	O
cramps	O
,	O
and	O
myoglobinuria	O
[	O
36	O
]	O
.	O

To	O
our	O
knowledge	O
,	O
no	O
abnormalities	O
of	O
retinal	O
function	O
have	O
been	O
reported	O
.	O

One	O
of	O
the	O
most	O
curious	O
findings	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
was	O
the	O
occurrence	O
of	O
two	O
different	O
types	O
of	O
changes	O
:	O
an	O
increase	O
in	O
the	O
number	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cones	B-CL
and	O
a	O
transformation	O
of	O
rods	B-CL
into	O
hybrid	O
photoreceptors	B-CL
.	O

It	O
is	O
known	O
that	O
Nr2e3	B-GGP
is	O
expressed	O
only	O
in	O
rods	B-CL
,	O
and	O
the	O
transcript	B-SO
is	O
first	O
detectable	O
in	O
postmitotic	O
cells	B-CL
(	O
J	O
.	O
Trimarchi	O
and	O
CLC	O
,	O
unpublished	O
data	O
)	O
.	O

Assuming	O
that	O
Nr2e3	B-GGP
acts	O
cell	B-CL
autonomously	O
,	O
we	O
can	O
conclude	O
that	O
the	O
supernumerary	O
S	B-GGP
-	I-GGP
cone	I-GGP
-	O
positive	O
cells	B-CL
and	O
the	O
hybrid	O
photoreceptors	B-CL
identified	O
in	O
the	O
rd7	O
retina	O
were	O
redirected	O
to	O
these	O
fates	O
from	O
postmitotic	O
cells	B-CL
that	O
were	O
destined	O
to	O
become	O
rods	B-CL
.	O

This	O
conclusion	O
raises	O
this	O
question	O
:	O
Why	O
does	O
loss	O
of	O
a	O
single	O
transcription	O
factor	O
within	O
rod	B-CL
precursors	O
lead	O
to	O
two	O
alternative	O
fates	O
--	O
a	O
hybrid	O
cell	B-CL
type	O
on	O
the	O
one	O
hand	O
and	O
apparently	O
normal	O
S	O
-	O
cones	B-CL
on	O
the	O
other	O
?	O

There	O
are	O
at	O
least	O
two	O
possible	O
explanations	O
for	O
these	O
differences	O
.	O

First	O
,	O
it	O
is	O
possible	O
that	O
there	O
are	O
two	O
distinct	O
types	O
of	O
rod	B-CL
precursor	O
;	O
loss	O
of	O
Nr2e3	B-GGP
in	O
one	O
leads	O
to	O
S	O
-	O
cone	B-CL
fate	O
and	O
in	O
the	O
other	O
results	O
in	O
a	O
hybrid	O
cell	B-CL
type	O
.	O

In	O
fact	O
,	O
there	O
is	O
experimental	O
evidence	O
from	O
the	O
rat	B-Taxon
to	O
support	O
the	O
conclusion	O
that	O
early	O
-	O
born	O
and	O
late	O
-	O
born	O
rods	B-CL
are	O
intrinsically	O
different	O
[	O
37	O
]	O
.	O

One	O
test	O
of	O
the	O
hypothesis	O
that	O
there	O
are	O
two	O
temporally	O
distinct	O
rod	B-CL
precursor	O
populations	O
would	O
be	O
to	O
carry	O
out	O
birthdating	O
experiments	O
to	O
determine	O
whether	O
the	O
supernumerary	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
in	O
the	O
rd7	O
retina	O
derived	O
exclusively	O
from	O
an	O
early	O
-	O
or	O
late	O
-	O
born	O
population	O
.	O

Of	O
course	O
,	O
if	O
this	O
were	O
not	O
the	O
case	O
,	O
this	O
experiment	O
could	O
not	O
rule	O
out	O
the	O
possibility	O
that	O
molecularly	B-CHEBI
distinct	O
populations	O
of	O
rod	B-CL
precursors	O
are	O
present	O
simultaneously	O
in	O
the	O
developing	O
retina	O
.	O

An	O
alternative	O
explanation	O
would	O
be	O
that	O
there	O
is	O
only	O
a	O
single	O
,	O
homogeneous	O
population	O
of	O
postmitotic	O
rod	B-CL
precursors	O
in	O
the	O
mouse	B-Taxon
,	O
and	O
a	O
stochastic	O
event	O
triggers	O
assumption	O
of	O
the	O
S	O
-	O
cone	B-CL
fate	O
in	O
a	O
small	O
subpopulation	O
of	O
these	O
cells	B-CL
in	O
the	O
rd7	O
mutant	B-SO
.	O

Recent	O
studies	O
in	O
a	O
variety	O
of	O
experiment	O
systems	O
suggest	O
that	O
such	O
a	O
stochastic	O
,	O
all	O
-	O
or	O
-	O
none	O
mechanism	O
of	O
gene	B-SO
activation	O
is	O
commonplace	O
[	O
38	O
-	O
44	O
]	O
.	O

In	O
this	O
scenario	O
,	O
the	O
absence	O
of	O
Nr2e3	B-GGP
would	O
alter	O
the	O
probability	O
that	O
an	O
unknown	O
master	O
control	O
gene	B-SO
is	O
expressed	O
in	O
rod	B-CL
precursors	O
.	O

Once	O
this	O
event	O
takes	O
place	O
,	O
it	O
would	O
initiate	O
an	O
irreversible	O
program	O
of	O
differentiation	O
toward	O
S	O
-	O
cone	B-CL
fate	O
,	O
albeit	O
at	O
a	O
relatively	O
low	O
frequency	O
.	O

In	O
this	O
way	O
,	O
a	O
subset	O
of	O
cells	B-CL
from	O
an	O
initially	O
homogeneous	O
population	O
would	O
select	O
the	O
S	O
-	O
cone	B-CL
fate	O
in	O
an	O
entirely	O
probabilistic	O
manner	O
.	O

Human	B-Taxon
patients	O
with	O
ESCS	O
display	O
three	O
types	O
of	O
abnormality	O
attributable	O
to	O
the	O
retina	O
:	O
(	O
1	O
)	O
an	O
atypical	O
ERG	O
waveform	O
that	O
is	O
preferentially	O
sensitive	O
to	O
short	O
-	O
wavelength	O
light	O
,	O
(	O
2	O
)	O
slowly	O
progressive	O
retinal	O
degeneration	O
,	O
and	O
(	O
3	O
)	O
abnormal	O
retinal	O
lamination	O
with	O
rosette	O
formation	O
[	O
1	O
,	O
12	O
,	O
13	O
]	O
.	O

The	O
rd7	O
mutant	B-SO
mice	B-Taxon
also	O
demonstrate	O
the	O
latter	O
two	O
defects	O
,	O
but	O
have	O
a	O
normal	O
ERG	O
[	O
15	O
,	O
45	O
]	O
.	O

These	O
similarities	O
and	O
differences	O
between	O
the	O
two	O
species	O
help	O
to	O
explain	O
the	O
possible	O
mechanistic	O
basis	O
of	O
the	O
ESCS	O
.	O

The	O
fact	O
that	O
the	O
rd7	O
mouse	B-Taxon
has	O
a	O
normal	O
ERG	O
strongly	O
suggests	O
that	O
the	O
aberrant	O
ERG	O
in	O
ESCS	O
is	O
not	O
attributable	O
to	O
the	O
activity	O
of	O
a	O
hybrid	O
photoreceptor	B-CL
identical	O
to	O
that	O
found	O
in	O
this	O
study	O
.	O

Namely	O
,	O
the	O
signal	O
is	O
unlikely	O
to	O
derive	O
from	O
a	O
population	O
of	O
cells	B-CL
coexpressing	O
both	O
rod	B-CL
and	O
cone	B-CL
genes	B-SO
but	O
whose	O
photopigment	O
is	O
rhodopsin	B-GGP
and	O
not	O
S	B-GGP
-	I-GGP
cone	I-GGP
opsin	I-GGP
.	O

This	O
conclusion	O
is	O
consistent	O
with	O
the	O
evidence	O
from	O
human	B-Taxon
ESCS	O
patients	O
indicating	O
a	O
markedly	O
reduced	O
rod	B-CL
system	O
and	O
a	O
lack	O
of	O
measurable	O
rhodopsin	B-GGP
by	O
reflection	O
densitometry	O
[	O
1	O
,	O
2	O
,	O
10	O
,	O
11	O
]	O
.	O

It	O
is	O
also	O
unlikely	O
that	O
we	O
would	O
fail	O
to	O
detect	O
an	O
ESCS	O
-	O
like	O
ERG	O
signal	O
in	O
mice	B-Taxon
if	O
it	O
were	O
present	O
,	O
as	O
such	O
a	O
signal	O
has	O
been	O
demonstrated	O
in	O
the	O
Nrl	B-GGP
mutant	B-SO
mouse	B-Taxon
,	O
which	O
has	O
a	O
near	O
total	O
transformation	O
of	O
all	O
its	O
rods	B-CL
into	O
blue	O
cones	B-CL
[	O
24	O
]	O
.	O

These	O
findings	O
,	O
however	O
,	O
do	O
not	O
rule	O
out	O
the	O
possibility	O
that	O
the	O
abnormal	O
human	B-Taxon
ERG	O
derives	O
from	O
a	O
hybrid	O
photoreceptor	B-CL
cell	I-CL
type	O
that	O
also	O
expresses	O
S	B-GGP
-	I-GGP
opsin	I-GGP
.	O

It	O
is	O
possible	O
that	O
there	O
are	O
gene	B-SO
regulatory	O
differences	O
between	O
mice	B-Taxon
and	O
humans	B-Taxon
such	O
that	O
in	O
human	B-GGP
NR2E3	I-GGP
mutants	B-SO
,	O
S	B-GGP
-	I-GGP
opsin	I-GGP
shows	O
a	O
type	O
I	O
pattern	O
of	O
derepression	O
rather	O
than	O
a	O
type	O
II	O
as	O
in	O
seen	O
in	O
the	O
rd7	O
mouse	B-Taxon
,	O
and	O
is	O
therefore	O
expressed	O
in	O
all	O
of	O
the	O
hybrid	O
photoreceptor	B-CL
cells	I-CL
.	O

Alternatively	O
,	O
the	O
ratio	O
of	O
supernumerary	O
S	O
-	O
cones	B-CL
to	O
hybrid	O
photoreceptors	B-CL
produced	O
in	O
the	O
retina	O
of	O
ESCS	O
patients	O
might	O
be	O
such	O
that	O
a	O
higher	O
percentage	O
of	O
the	O
presumptive	O
rods	B-CL
in	O
ESCS	O
patients	O
become	O
S	O
-	O
cones	B-CL
rather	O
than	O
hybrid	O
photoreceptors	B-CL
.	O

As	O
discussed	O
above	O
,	O
this	O
ratio	O
could	O
depend	O
either	O
on	O
the	O
relative	O
percentages	O
of	O
two	O
distinct	O
rod	B-CL
precursor	O
populations	O
or	O
on	O
stochastic	O
effects	O
on	O
regulatory	O
gene	B-SO
expression	O
.	O

In	O
contrast	O
to	O
the	O
ERG	O
differences	O
between	O
mouse	B-Taxon
rd7	O
and	O
human	B-GGP
NR2E3	I-GGP
mutants	B-SO
,	O
both	O
species	O
demonstrate	O
slow	O
retinal	O
degeneration	O
.	O

It	O
is	O
possible	O
that	O
this	O
degeneration	O
is	O
attributable	O
to	O
the	O
abnormal	O
function	O
of	O
the	O
hybrid	O
photoreceptor	B-CL
cell	I-CL
type	O
characterized	O
in	O
the	O
present	O
study	O
.	O

The	O
coexpression	O
of	O
both	O
rod	B-CL
and	O
cone	B-CL
genes	B-SO
in	O
the	O
same	O
cell	B-CL
could	O
predispose	O
the	O
cell	B-CL
to	O
apoptosis	O
.	O

The	O
final	O
common	O
feature	O
between	O
mouse	B-Taxon
rd7	O
and	O
human	B-GGP
NR2E3	I-GGP
mutants	B-SO
is	O
the	O
presence	O
of	O
an	O
abnormally	O
laminated	O
retina	O
with	O
waviness	O
and	O
rosette	O
formation	O
in	O
the	O
ONL	O
[	O
12	O
-	O
15	O
]	O
.	O

The	O
cause	O
of	O
this	O
abnormality	O
is	O
not	O
known	O
,	O
but	O
it	O
is	O
possibly	O
related	O
to	O
defects	O
in	O
photoreceptor	B-CL
cell	I-CL
polarity	O
in	O
the	O
rd7	O
mutant	B-SO
.	O

Rosette	O
formation	O
and	O
abnormally	O
wavy	O
epithelia	O
are	O
common	O
sequelae	O
of	O
defects	O
in	O
pathways	O
controlling	O
cell	B-CL
polarity	O
[	O
46	O
,	O
47	O
]	O
.	O

In	O
particular	O
,	O
loss	O
-	O
of	O
-	O
function	O
mutations	B-SO
in	O
the	O
polarity	O
gene	B-SO
crumbs	B-GGP
(	O
CRB1	B-GGP
)	O
have	O
been	O
shown	O
to	O
cause	O
morphological	O
abnormalities	O
of	O
the	O
ONL	O
in	O
both	O
humans	B-Taxon
and	O
mice	B-Taxon
,	O
including	O
rosette	O
formation	O
in	O
mice	B-Taxon
very	O
similar	O
to	O
that	O
seen	O
in	O
the	O
rd7	O
mutant	B-SO
[	O
48	O
,	O
49	O
]	O
.	O

Interestingly	O
,	O
Sharon	O
et	O
al	O
.	O

[	O
5	O
]	O
have	O
recently	O
pointed	O
out	O
additional	O
features	O
shared	O
by	O
patients	O
with	O
CRB1	B-GGP
mutations	B-SO
and	O
mutations	B-SO
in	O
NR2E3	B-GGP
,	O
including	O
hyperopic	O
refractive	O
errors	O
and	O
a	O
distinctive	O
pattern	O
of	O
clumped	O
pigmentation	O
in	O
the	O
retina	O
.	O

In	O
the	O
present	O
study	O
we	O
found	O
the	O
mouse	B-Taxon
crumbs	B-GGP
ortholog	B-SO
to	O
be	O
up	O
-	O
regulated	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
by	O
microarray	O
,	O
consistent	O
with	O
its	O
higher	O
expression	O
level	O
in	O
cones	B-CL
than	O
in	O
rods	B-CL
[	O
50	O
]	O
.	O

Although	O
we	O
were	O
unable	O
to	O
confirm	O
this	O
finding	O
by	O
in	O
situ	O
hybridization	O
due	O
to	O
the	O
weakness	O
of	O
the	O
signal	O
,	O
it	O
is	O
possible	O
that	O
the	O
up	O
-	O
regulation	O
of	O
crumbs	B-GGP
in	O
the	O
retina	O
is	O
the	O
cause	O
of	O
the	O
lamination	O
defects	O
seen	O
in	O
the	O
rd7	O
mutant	B-SO
.	O

Overexpression	O
of	O
wild	B-SO
-	I-SO
type	I-SO
crumbs	B-GGP
in	O
Drosophila	B-Taxon
has	O
been	O
shown	O
to	O
cause	O
polarity	O
defects	O
leading	O
to	O
waviness	O
of	O
epithelia	O
and	O
even	O
to	O
misalignment	O
of	O
nuclei	B-GO
within	O
photoreceptors	B-CL
analogous	O
to	O
what	O
is	O
seen	O
in	O
the	O
rd7	O
retina	O
[	O
47	O
,	O
51	O
]	O
.	O

Future	O
experiments	O
will	O
address	O
this	O
question	O
by	O
overexpressing	O
full	O
-	O
length	O
Crb1	B-GGP
in	O
a	O
wild	B-SO
-	I-SO
type	I-SO
background	O
.	O

One	O
further	O
point	O
worthy	O
of	O
note	O
is	O
the	O
striking	O
similarity	O
between	O
the	O
hybrid	O
photoreceptor	B-CL
identified	O
in	O
this	O
study	O
and	O
a	O
naturally	O
occurring	O
photoreceptor	B-CL
found	O
in	O
ground	B-Taxon
squirrels	I-Taxon
.	O

The	O
"	O
rods	B-CL
"	O
of	O
this	O
species	O
have	O
electrophysiologic	O
,	O
molecular	B-CHEBI
,	O
and	O
ultrastructural	O
features	O
of	O
both	O
rods	B-CL
and	O
cones	B-CL
[	O
52	O
-	O
58	O
]	O
.	O

Although	O
these	O
unusual	O
findings	O
have	O
been	O
difficult	O
to	O
interpret	O
under	O
the	O
usual	O
assumptions	O
of	O
"	O
duplicity	O
theory	O
"	O
[	O
56	O
]	O
,	O
we	O
would	O
like	O
to	O
suggest	O
that	O
ground	B-Taxon
squirrels	I-Taxon
may	O
have	O
experienced	O
a	O
naturally	O
occurring	O
down	O
-	O
regulation	O
or	O
loss	O
of	O
Nr2e3	B-GGP
expression	O
in	O
their	O
"	O
rods	B-CL
"	O
that	O
transformed	O
them	O
into	O
a	O
hybrid	O
photoreceptor	B-CL
cell	I-CL
type	O
.	O

The	O
adaptive	O
significance	O
of	O
such	O
a	O
change	O
,	O
if	O
any	O
,	O
is	O
unknown	O
,	O
and	O
it	O
may	O
simply	O
be	O
due	O
to	O
relaxation	O
of	O
selective	O
pressure	O
for	O
night	O
vision	O
in	O
this	O
strictly	O
diurnal	O
species	O
.	O

Materials	O
and	O
Methods	O

Mutant	B-SO
mice	B-Taxon
.	O

Nr2e3rd7	O
mutant	B-SO
mice	B-Taxon
were	O
obtained	O
from	O
Jackson	O
Laboratories	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
United	O
States	O
;	O
stock	O
#	O
004643	O
)	O
and	O
maintained	O
on	O
a	O
C57BL	O
/	O
6	O
background	O
.	O

All	O
control	O
mice	B-Taxon
were	O
C57BL	O
/	O
6	O
.	O

Microarray	O
analysis	O
.	O

Total	O
retinal	O
RNA	B-SO
samples	O
were	O
isolated	O
from	O
P0	O
,	O
P6	O
,	O
P14	O
,	O
and	O
P21	O
Nr2e3	B-GGP
mutant	B-SO
mice	B-Taxon
using	O
the	O
Trizol	O
reagent	B-CHEBI
(	O
Gibco	O
,	O
San	O
Diego	O
,	O
California	O
.	O
United	O
States	O
)	O
.	O

Total	O
retinal	O
RNA	B-SO
samples	O
from	O
age	O
-	O
matched	O
wild	B-SO
-	I-SO
type	I-SO
C57BL	O
/	O
6	O
mice	B-Taxon
were	O
used	O
as	O
controls	O
.	O

Individual	O
total	O
RNA	B-SO
samples	O
were	O
derived	O
from	O
four	O
retinas	O
(	O
pooled	O
from	O
two	O
animals	B-Taxon
)	O
.	O

All	O
microarray	O
experiments	O
were	O
performed	O
in	O
triplicate	O
,	O
in	O
each	O
case	O
with	O
separate	O
RNA	B-SO
preparations	O
.	O

Microarray	O
experiments	O
with	O
cDNAs	B-SO
were	O
performed	O
with	O
the	O
P0	O
,	O
P6	O
,	O
and	O
P14	O
derived	O
samples	O
.	O

Probes	B-SO
were	O
labeled	O
with	O
either	O
Cy3	O
or	O
Cy5	O
using	O
the	O
Array	O
900	O
kit	O
from	O
Genisphere	O
(	O
Hatfield	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
starting	O
with	O
5	O
mu	O
g	O
of	O
total	O
RNA	B-SO
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Wild	B-SO
-	I-SO
type	I-SO
control	O
probes	B-SO
were	O
compared	O
to	O
mutant	B-SO
on	O
the	O
same	O
microarray	O
.	O

In	O
two	O
of	O
the	O
three	O
replicates	O
,	O
the	O
mutant	B-SO
probe	B-SO
was	O
labeled	O
with	O
Cy3	O
and	O
the	O
wild	B-SO
type	I-SO
with	O
Cy5	O
,	O
and	O
in	O
the	O
third	O
replicate	O
the	O
dyes	O
were	O
swapped	O
.	O

Labeled	O
probe	B-SO
was	O
hybridized	O
to	O
microarray	O
slides	O
spotted	O
with	O
approximately	O
11	O
,	O
500	O
cDNA	B-SO
clones	I-SO
from	O
the	O
brain	O
molecular	B-CHEBI
anatomy	O
project	O
library	O
(	O
kind	O
gift	O
of	O
B	O
.	O
Soares	O
,	O
University	O
of	O
Iowa	O
;	O
see	O
http	O
:	O
/	O
/	O
trans	O
.	O
nih	O
.	O
gov	O
/	O
bmap	O
/	O
index	O
.	O
htm	O
for	O
details	O
)	O
and	O
500	O
cDNA	B-SO
clones	I-SO
from	O
our	O
lab	O
collection	O
.	O

Slides	O
were	O
printed	O
and	O
hybridized	O
as	O
described	O
[	O
59	O
,	O
60	O
]	O
.	O

After	O
hybridization	O
and	O
washing	O
of	O
slides	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Genisphere	O
)	O
,	O
the	O
slides	O
were	O
scanned	O
on	O
an	O
Axon	O
Instruments	O
(	O
Union	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
GenePix	O
4000	O
scanner	O
and	O
images	O
were	O
analyzed	O
using	O
the	O
accompanying	O
GenePix	O
Pro	O
software	O
package	O
.	O

The	O
complete	O
raw	O
cDNA	B-SO
microarray	O
data	O
set	O
are	O
available	O
in	O
Tables	O
S6	O
-	O
S14	O
.	O

Two	O
types	O
of	O
normalization	O
were	O
performed	O
on	O
the	O
raw	O
intensity	O
scores	O
derived	O
from	O
the	O
GenePix	O
Pro	O
analysis	O
.	O

First	O
,	O
for	O
a	O
given	O
experiment	O
,	O
the	O
average	O
intensity	O
of	O
all	O
the	O
spots	O
in	O
the	O
weaker	O
of	O
the	O
two	O
channels	O
(	O
Cy3	O
or	O
Cy5	O
)	O
was	O
normalized	O
to	O
those	O
in	O
the	O
stronger	O
channel	O
.	O

Second	O
,	O
in	O
a	O
given	O
set	O
of	O
experiments	O
done	O
in	O
triplicate	O
at	O
a	O
particular	O
time	O
point	O
,	O
the	O
two	O
experiments	O
with	O
the	O
weaker	O
average	O
signal	O
intensity	O
over	O
all	O
spots	O
were	O
normalized	O
to	O
those	O
in	O
the	O
third	O
microarray	O
with	O
the	O
strongest	O
average	O
signal	O
intensity	O
.	O

All	O
spots	O
with	O
signal	O
levels	O
equal	O
to	O
or	O
below	O
background	O
were	O
removed	O
from	O
the	O
analysis	O
.	O

The	O
resulting	O
files	O
contained	O
on	O
average	O
about	O
6	O
,	O
000	O
spots	O
.	O

These	O
files	O
were	O
then	O
sorted	O
according	O
to	O
Cy3	O
/	O
Cy5	O
signal	O
intensity	O
,	O
and	O
those	O
spots	O
with	O
the	O
10	O
%	O
highest	O
and	O
10	O
%	O
lowest	O
intensity	O
ratios	O
(	O
approximately	O
600	O
spots	O
/	O
experiment	O
)	O
were	O
compared	O
across	O
the	O
three	O
experiments	O
at	O
a	O
given	O
time	O
point	O
using	O
custom	O
Perl	O
scripts	O
(	O
available	O
upon	O
request	O
from	O
JCC	O
)	O
.	O

All	O
spots	O
which	O
were	O
present	O
in	O
the	O
top	O
10	O
%	O
most	O
up	O
-	O
or	O
down	O
-	O
regulated	O
genes	B-SO
in	O
two	O
out	O
of	O
three	O
or	O
three	O
out	O
of	O
three	O
experiments	O
were	O
recorded	O
(	O
the	O
latter	O
are	O
listed	O
in	O
Table	O
S3	O
)	O
.	O

Microarray	O
analysis	O
of	O
the	O
P21	O
retinas	O
was	O
performed	O
on	O
Affymetrix	O
mouse	B-Taxon
genome	B-SO
430	O
2	O
.	O
0	O
GeneChip	O
array	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

A	O
total	O
of	O
six	O
microarray	O
hybridizations	O
were	O
performed	O
:	O
three	O
with	O
probes	B-SO
derived	O
from	O
mutant	B-SO
RNA	B-SO
and	O
three	O
from	O
wild	B-SO
-	I-SO
type	I-SO
.	O

Probes	B-SO
were	O
synthesized	O
starting	O
with	O
10	O
mu	O
g	O
of	O
total	O
RNA	B-SO
for	O
each	O
sample	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Affymetrix	O
)	O
.	O

Hybridization	O
,	O
washing	O
,	O
and	O
scanning	O
of	O
the	O
microarrays	O
were	O
all	O
performed	O
at	O
the	O
Bauer	O
Center	O
for	O
Genomics	O
Research	O
at	O
Harvard	O
University	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Affymetrix	O
)	O
.	O

Initial	O
data	O
analysis	O
was	O
carried	O
out	O
using	O
the	O
GeneChip	O
Operating	O
System	O
(	O
GCOS	O
)	O
software	O
from	O
Affymetrix	O
.	O

Pairwise	O
comparisons	O
were	O
made	O
between	O
individual	O
mutant	B-SO
microarray	O
results	O
and	O
controls	O
.	O

All	O
genes	B-SO
were	O
removed	O
from	O
the	O
analysis	O
for	O
which	O
"	O
absent	O
"	O
calls	O
were	O
made	O
by	O
the	O
software	O
for	O
both	O
the	O
wild	B-SO
-	I-SO
type	I-SO
and	O
mutant	B-SO
samples	O
being	O
compared	O
.	O

The	O
remaining	O
gene	B-SO
lists	O
contained	O
approximately	O
26	O
,	O
000	O
transcripts	B-SO
.	O

These	O
lists	O
were	O
then	O
sorted	O
according	O
to	O
the	O
mutant	B-SO
-	O
to	O
-	O
wild	B-SO
-	I-SO
type	I-SO
"	O
signal	O
log	O
ratio	O
"	O
in	O
order	O
to	O
identify	O
the	O
most	O
markedly	O
up	O
-	O
and	O
down	O
-	O
regulated	O
genes	B-SO
.	O

The	O
top	O
500	O
most	O
up	O
-	O
and	O
down	O
-	O
regulated	O
transcripts	B-SO
(	O
approximately	O
2	O
%	O
of	O
all	O
genes	B-SO
in	O
each	O
case	O
)	O
from	O
each	O
of	O
the	O
three	O
pairwise	O
comparisons	O
between	O
mutant	B-SO
and	O
wild	B-SO
-	I-SO
type	I-SO
were	O
compared	O
using	O
custom	O
Perl	O
scripts	O
(	O
available	O
upon	O
request	O
from	O
JCC	O
)	O
to	O
identify	O
those	O
genes	B-SO
that	O
were	O
present	O
in	O
two	O
or	O
three	O
out	O
of	O
three	O
lists	O
.	O

Those	O
genes	B-SO
that	O
were	O
up	O
-	O
or	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
experiments	O
were	O
recorded	O
(	O
Tables	O
S4	O
and	O
S5	O
)	O
.	O

The	O
complete	O
pairwise	O
Affymetrix	O
microarray	O
datasets	O
are	O
available	O
in	O
Tables	O
S15	O
-	O
S17	O
.	O

In	O
Situ	O
hybridization	O
.	O

Section	O
in	O
situ	O
hybridization	O
was	O
performed	O
as	O
previously	O
described	O
[	O
61	O
]	O
using	O
20	O
-	O
mu	O
m	O
cryosections	O
from	O
OCT	O
-	O
embedded	O
tissue	O
or	O
4	O
-	O
mu	O
m	O
paraffin	O
sections	O
.	O

All	O
in	O
situ	O
hybridizations	O
were	O
performed	O
with	O
the	O
mutant	B-SO
and	O
wild	B-SO
-	I-SO
type	I-SO
control	O
sections	O
on	O
the	O
same	O
glass	O
slide	O
.	O

Riboprobes	O
labeled	O
with	O
digoxygenin	B-CHEBI
-	O
tagged	O
UTP	B-CHEBI
(	O
Roche	O
,	O
Basel	O
,	O
Switzerland	O
)	O
were	O
detected	O
with	O
NBT	O
/	O
BCIP	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

The	O
sources	O
of	O
the	O
individual	O
riboprobes	O
used	O
in	O
this	O
study	O
are	O
described	O
in	O
Tables	O
S1	O
and	O
S2	O
.	O

Dissociated	O
cell	B-CL
in	O
situ	O
hybridization	O
was	O
performed	O
as	O
described	O
previously	O
[	O
62	O
]	O
using	O
the	O
same	O
S	B-GGP
-	I-GGP
opsin	I-GGP
digoxygenin	B-CHEBI
-	O
labeled	O
probe	B-SO
used	O
for	O
section	O
in	O
situ	O
hybridization	O
.	O

All	O
images	O
were	O
captured	O
on	O
a	O
compound	O
microscope	O
(	O
Eclipse	O
e1000	O
;	O
Nikon	O
,	O
Tokyo	O
,	O
Japan	O
)	O
using	O
a	O
CCD	O
camera	O
(	O
DXM1200F	O
,	O
Nikon	O
)	O
.	O

S	B-GGP
-	I-GGP
opsin	I-GGP
positive	O
cells	B-CL
were	O
quantitated	O
on	O
dissociated	O
cell	B-CL
in	O
situ	O
hybridization	O
as	O
previously	O
described	O
[	O
62	O
]	O
.	O

Twenty	O
fields	O
were	O
quantitated	O
in	O
this	O
manner	O
at	O
200	O
x	O
magnification	O
for	O
both	O
rd7	O
and	O
wild	B-SO
-	I-SO
type	I-SO
retinas	O
.	O

Immunohistochemistry	O
.	O

For	O
antibody	B-GO
staining	O
,	O
cryosections	O
were	O
prepared	O
and	O
stained	O
as	O
described	O
previously	O
[	O
63	O
]	O
.	O

Primary	O
antibodies	B-GO
used	O
were	O
a	O
polyclonal	O
anti	O
-	O
blue	B-GGP
opsin	I-GGP
raised	O
in	O
rabbit	B-Taxon
(	O
1	O
:	O
300	O
;	O
Chemicon	O
International	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
;	O
AB5407	O
)	O
and	O
a	O
mouse	B-Taxon
monoclonal	O
anti	O
-	O
rhodopsin	B-GGP
(	O
1	O
:	O
200	O
;	O
rho4D2	O
)	O
.	O

Secondary	O
antibodies	B-GO
used	O
were	O
Cy2	O
-	O
or	O
Cy3	O
-	O
conjugated	O
goat	B-Taxon
anti	O
-	O
rabbit	B-Taxon
and	O
anti	O
-	O
mouse	B-Taxon
(	O
1	O
:	O
500	O
;	O
Jackson	O
Immunologicals	O
,	O
West	O
Grove	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
.	O

Following	O
antibody	B-GO
staining	O
,	O
4	O
'	O
-	O
DAPI	O
was	O
applied	O
to	O
stain	O
nuclei	B-GO
(	O
Sigma	O
)	O
,	O
and	O
the	O
sections	O
were	O
coverslipped	O
and	O
mounted	O
in	O
Gel	O
/	O
Mount	O
(	O
Biomeda	O
,	O
Foster	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Electron	B-CHEBI
microscopy	O
.	O

This	O
protocol	O
was	O
adapted	O
from	O
one	O
used	O
by	O
Raviola	O
[	O
64	O
]	O
with	O
some	O
modifications	O
derived	O
from	O
Carter	O
-	O
Dawson	O
and	O
Lavail	O
[	O
26	O
]	O
.	O

Four	O
adult	O
wild	B-SO
-	I-SO
type	I-SO
and	O
four	O
mutant	B-SO
animals	B-Taxon
were	O
deeply	O
anesthetized	O
by	O
intraperitoneal	O
injection	O
of	O
Avertin	O
and	O
the	O
eyes	O
were	O
then	O
removed	O
.	O

The	O
cornea	O
was	O
gently	O
punctured	O
with	O
sharp	O
forceps	O
and	O
excised	O
with	O
iridectomy	O
scissors	O
.	O

The	O
eye	O
was	O
then	O
transferred	O
to	O
a	O
solution	O
of	O
2	O
%	O
paraformaldehyde	O
/	O
2	O
%	O
glutaraldehyde	O
in	O
cacodylate	B-CHEBI
buffer	O
(	O
0	O
.	O
1	O
M	O
cacodylic	B-CHEBI
acid	I-CHEBI
;	O
0	O
.	O
1	O
%	O
calcium	B-CHEBI
chloride	I-CHEBI
)	O
.	O

The	O
lens	O
was	O
gently	O
removed	O
and	O
the	O
eyecup	O
allowed	O
to	O
fix	O
for	O
2	O
h	O
at	O
room	O
temperature	O
.	O

The	O
fixed	O
eye	O
was	O
then	O
placed	O
on	O
dental	O
wax	O
and	O
sectioned	O
in	O
the	O
midline	O
with	O
a	O
fresh	O
razor	O
blade	O
(	O
half	O
of	O
the	O
retinas	O
were	O
sectioned	O
along	O
the	O
D	O
-	O
V	O
axis	O
and	O
half	O
along	O
the	O
nasal	O
-	O
temporal	O
axis	O
)	O
.	O

The	O
retinas	O
(	O
and	O
attached	O
retinal	O
pigment	B-CHEBI
epithelium	O
)	O
were	O
carefully	O
dissected	O
away	O
from	O
the	O
sclera	O
,	O
which	O
was	O
discarded	O
.	O

The	O
retinas	O
were	O
then	O
rinsed	O
four	O
times	O
for	O
15	O
min	O
each	O
with	O
Sorenson	O
'	O
s	O
buffer	O
(	O
pH	O
7	O
.	O
4	O
)	O
.	O

They	O
were	O
then	O
stained	O
for	O
2	O
h	O
at	O
4	O
degrees	O
C	O
with	O
1	O
%	O
osmium	B-CHEBI
tetroxide	O
in	O
1	O
.	O
5	O
%	O
potassium	B-CHEBI
ferrocyanide	I-CHEBI
.	O

Next	O
,	O
the	O
retinas	O
were	O
rinsed	O
four	O
times	O
for	O
15	O
min	O
in	O
maleate	B-CHEBI
buffer	O
(	O
pH	O
5	O
.	O
1	O
)	O
and	O
then	O
stained	O
for	O
2	O
h	O
at	O
room	O
temperature	O
with	O
1	O
%	O
uranyl	B-CHEBI
acetate	B-CHEBI
in	O
maleate	B-CHEBI
buffer	O
(	O
pH	O
6	O
.	O
2	O
)	O
.	O

They	O
were	O
then	O
washed	O
four	O
times	O
for	O
15	O
min	O
with	O
maleate	B-CHEBI
buffer	O
(	O
pH	O
5	O
.	O
1	O
)	O
;	O
once	O
for	O
10	O
min	O
with	O
70	O
%	O
ethanol	B-CHEBI
;	O
once	O
for	O
10	O
min	O
with	O
95	O
%	O
ethanol	B-CHEBI
;	O
and	O
four	O
times	O
for	O
30	O
min	O
with	O
100	O
%	O
ethanol	B-CHEBI
.	O

Next	O
,	O
the	O
retinas	O
were	O
washed	O
three	O
times	O
over	O
one	O
hour	O
with	O
propylene	B-CHEBI
oxide	I-CHEBI
and	O
then	O
embedded	O
in	O
TAAB	O
812	O
Resin	O
(	O
Marivac	O
,	O
Quebec	O
,	O
Canada	O
)	O
for	O
1	O
-	O
2	O
d	O
in	O
a	O
60	O
degrees	O
C	O
oven	O
.	O

Semi	O
-	O
thin	O
sections	O
were	O
cut	O
at	O
a	O
thickness	O
of	O
0	O
.	O
5	O
mu	O
m	O
and	O
stained	O
with	O
1	O
%	O
toluidine	O
blue	O
in	O
1	O
%	O
sodium	B-CHEBI
borate	I-CHEBI
buffer	O
.	O

Images	O
of	O
semi	O
-	O
thin	O
sections	O
from	O
the	O
mutant	B-SO
retina	O
were	O
taken	O
within	O
the	O
ventral	O
two	O
-	O
thirds	O
of	O
the	O
retina	O
where	O
the	O
majority	O
of	O
the	O
supernumerary	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
expressing	O
cells	B-CL
reside	O
.	O

Wild	B-SO
-	I-SO
type	I-SO
images	O
were	O
taken	O
in	O
comparable	O
regions	O
.	O

Sections	O
for	O
electron	B-CHEBI
microscopy	O
were	O
cut	O
at	O
a	O
thickness	O
of	O
95	O
nm	O
,	O
placed	O
on	O
grids	O
,	O
and	O
poststained	O
with	O
2	O
%	O
uranyl	B-CHEBI
acetate	B-CHEBI
followed	O
by	O
0	O
.	O
2	O
%	O
lead	B-CHEBI
citrate	B-CHEBI
.	O

All	O
sections	O
were	O
cut	O
in	O
a	O
plane	O
perpendicular	O
to	O
the	O
plane	O
of	O
the	O
photoreceptor	B-CL
layer	O
.	O

They	O
were	O
then	O
visualized	O
on	O
a	O
Jeol	O
1200EX	O
electron	B-CHEBI
microscope	O
(	O
Jeol	O
,	O
Tokyo	O
,	O
Japan	O
)	O
.	O

The	O
electron	B-CHEBI
microscopic	O
images	O
in	O
Figure	O
7	O
derive	O
from	O
the	O
ventral	O
two	O
-	O
thirds	O
of	O
the	O
wild	B-SO
-	I-SO
type	I-SO
and	O
mutant	B-SO
retinas	O
.	O

The	O
area	O
of	O
the	O
cell	B-GO
bodies	I-GO
of	O
the	O
rods	B-CL
and	O
"	O
rod	B-CL
-	O
like	O
"	O
cells	B-CL
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
and	O
mutant	B-SO
ONLs	O
,	O
respectively	O
,	O
were	O
quantitated	O
in	O
the	O
following	O
manner	O
.	O

First	O
,	O
ten	O
fields	O
within	O
the	O
ONL	O
were	O
chosen	O
at	O
random	O
at	O
1	O
,	O
000	O
x	O
magnification	O
and	O
then	O
photographed	O
at	O
4	O
,	O
000	O
x	O
magnification	O
for	O
each	O
of	O
the	O
two	O
genotypes	B-SO
.	O

Such	O
images	O
typically	O
contained	O
35	O
-	O
45	O
cell	B-GO
bodies	I-GO
.	O

In	O
order	O
to	O
quantitate	O
only	O
the	O
area	O
of	O
those	O
cell	B-GO
bodies	I-GO
that	O
were	O
cut	O
as	O
near	O
to	O
the	O
midline	O
of	O
the	O
cell	B-CL
as	O
possible	O
(	O
i	O
.	O
e	O
.	O
,	O
in	O
order	O
to	O
obtain	O
the	O
maximal	O
cross	O
-	O
sectional	O
area	O
)	O
the	O
five	O
cells	B-CL
with	O
the	O
largest	O
apparent	O
area	O
in	O
each	O
photograph	O
were	O
chosen	O
by	O
eye	O
and	O
the	O
outline	O
of	O
the	O
cell	B-GO
membranes	I-GO
were	O
traced	O
onto	O
white	O
paper	O
.	O

These	O
tracings	O
were	O
scanned	O
along	O
with	O
the	O
size	O
bar	O
from	O
the	O
electron	B-CHEBI
micrographs	O
,	O
and	O
the	O
areas	O
of	O
the	O
resulting	O
digital	O
images	O
were	O
quantitated	O
using	O
Scion	O
Image	O
software	O
(	O
NIH	O
Image	O
,	O
http	O
:	O
/	O
/	O
rsb	O
.	O
info	O
.	O
nih	O
.	O
gov	O
/	O
nih	O
-	O
image	O
)	O
.	O

A	O
total	O
of	O
50	O
cells	B-CL
of	O
each	O
genotype	B-SO
were	O
quantitated	O
in	O
this	O
manner	O
.	O

In	O
addition	O
,	O
in	O
order	O
to	O
evaluate	O
the	O
percentage	O
of	O
rods	B-CL
in	O
the	O
wild	B-SO
-	I-SO
type	I-SO
retina	O
that	O
had	O
any	O
juxtanuclear	B-GO
mitochondria	B-GO
,	O
all	O
rods	B-CL
within	O
all	O
ten	O
images	O
were	O
counted	O
as	O
were	O
the	O
number	O
of	O
cells	B-CL
showing	O
juxtanuclear	B-GO
organelles	B-GO
.	O

A	O
total	O
of	O
six	O
out	O
of	O
399	O
wild	B-SO
-	I-SO
type	I-SO
rods	B-CL
(	O
1	O
.	O
5	O
%	O
)	O
possessed	O
a	O
juxtanuclear	B-GO
organelle	B-GO
.	O

This	O
analysis	O
permitted	O
us	O
to	O
evaluate	O
the	O
wild	B-SO
-	I-SO
type	I-SO
rods	B-CL
for	O
juxtanuclear	B-GO
mitochondria	B-GO
at	O
multiple	O
planes	O
of	O
section	O
;	O
however	O
,	O
serial	O
sections	O
of	O
individual	O
cell	B-GO
bodies	I-GO
were	O
not	O
performed	O
.	O

Supporting	O
Information	O

Figures	O
S1	O
-	O
S7	O
show	O
the	O
in	O
situ	O
hybridization	O
images	O
of	O
all	O
genes	B-SO
discussed	O
in	O
the	O
paper	O
(	O
see	O
Tables	O
S1	O
and	O
S2	O
)	O
.	O

All	O
paired	O
images	O
(	O
which	O
show	O
the	O
wild	B-SO
-	I-SO
type	I-SO
control	O
on	O
the	O
left	O
and	O
the	O
rd7	O
mutant	B-SO
retina	O
on	O
the	O
right	O
)	O
are	O
labeled	O
in	O
the	O
lower	O
left	O
-	O
hand	O
corner	O
with	O
the	O
gene	B-SO
symbol	O
followed	O
by	O
the	O
age	O
of	O
the	O
retinas	O
in	O
question	O
(	O
P6	O
,	O
P14	O
,	O
P28	O
,	O
or	O
adult	O
)	O
.	O

Unpaired	O
images	O
represent	O
prenatal	O
time	O
points	O
and	O
are	O
labeled	O
with	O
the	O
gene	B-SO
symbol	O
of	O
the	O
gene	B-SO
in	O
question	O
(	O
"	O
wt	B-SO
"	O
indicates	O
that	O
the	O
retina	O
is	O
from	O
a	O
wild	B-SO
-	I-SO
type	I-SO
animal	B-Taxon
)	O
and	O
a	O
designation	O
of	O
the	O
embryonic	O
day	O
from	O
which	O
the	O
retina	O
derives	O
(	O
e	O
.	O
g	O
.	O
,	O
e17	O
.	O
5	O
=	O
embryonic	O
day	O
17	O
.	O
5	O
)	O
.	O

Figure	O
S1	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G1	O
-	O
G13	O
in	O
Table	O
S1	O

(	O
3	O
.	O
1	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G14	O
-	O
G25	O
in	O
Table	O
S1	O

(	O
2	O
.	O
4	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G26	O
-	O
G35	O
in	O
Table	O
S1	O

(	O
2	O
.	O
1	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G36	O
-	O
G46	O
in	O
Table	O
S1	O

(	O
2	O
.	O
0	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S5	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
G47	O
-	O
G53	O
in	O
Table	O
S1	O

(	O
1	O
.	O
7	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S6	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
Genes	B-SO
1	O
-	O
11	O
in	O
Table	O
S2	O

(	O
2	O
.	O
9	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S7	O

In	O
Situ	O
Hybridization	O
Images	O
for	O
Genes	B-SO
12	O
-	O
22	O
in	O
Table	O
S2	O

(	O
3	O
.	O
2	O
MB	O
JPG	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S8	O

In	O
Situ	O
Hybridization	O
Results	O
for	O
M	B-GGP
-	I-GGP
Opsin	I-GGP
and	O
Thrb2	B-GGP

Note	O
that	O
the	O
M	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
are	O
scattered	O
throughout	O
the	O
ONL	O
at	O
P14	O
,	O
but	O
appear	O
to	O
have	O
migrated	O
to	O
the	O
scleral	O
edge	O
of	O
the	O
ONL	O
by	O
P28	O
.	O

There	O
is	O
no	O
change	O
in	O
the	O
number	O
of	O
M	B-GGP
-	I-GGP
opsin	I-GGP
-	O
or	O
Thrb2	B-GGP
-	O
positive	O
cells	B-CL
in	O
the	O
rd7	O
mutant	B-SO
.	O

(	O
2	O
.	O
1	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

Cone	B-CL
-	O
Specific	O
and	O
Cone	B-CL
-	O
Enriched	O
Genes	B-SO
Evaluated	O
in	O
the	O
rd7	O
Mutant	B-SO
by	O
Microarray	O
and	O
In	O
Situ	O
Hybridization	O

This	O
table	O
is	O
a	O
supplemental	O
version	O
of	O
Figure	O
1	O
.	O

"	O
Figure	O
Number	O
"	O
indicates	O
which	O
figure	O
(	O
Figure	O
S1	O
-	O
S5	O
)	O
contains	O
the	O
in	O
situ	O
hybridization	O
images	O
corresponding	O
to	O
the	O
gene	B-SO
in	O
question	O
.	O

"	O
Lab	O
Clone	B-SO
Information	O
"	O
indicates	O
the	O
region	B-SO
of	I-SO
the	I-SO
gene	I-SO
in	O
question	O
from	O
which	O
the	O
probe	B-SO
used	O
for	O
in	O
situ	O
hybridization	O
was	O
derived	O
.	O

All	O
abbreviations	O
are	O
as	O
indicated	O
in	O
Figure	O
1	O
.	O

(	O
26	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S2	O

Rod	B-CL
Genes	B-SO
Evaluated	O
in	O
the	O
rd7	O
Mutant	B-SO
by	O
In	O
Situ	O
Hybridization	O

This	O
table	O
contains	O
details	O
about	O
the	O
in	O
situ	O
hybridization	O
patterns	O
of	O
22	O
genes	B-SO
(	O
many	O
of	O
which	O
are	O
rod	B-CL
-	O
specific	O
)	O
evaluated	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
.	O

"	O
Figure	O
Number	O
"	O
indicates	O
which	O
figure	O
(	O
Figure	O
S6	O
or	O
S7	O
)	O
contains	O
the	O
in	O
situ	O
hybridization	O
images	O
corresponding	O
to	O
the	O
gene	B-SO
in	O
question	O
.	O

"	O
Lab	O
Clone	B-SO
Information	O
"	O
indicates	O
the	O
region	B-SO
of	I-SO
the	I-SO
gene	I-SO
in	O
question	O
from	O
which	O
the	O
probe	B-SO
used	O
for	O
in	O
situ	O
hybridization	O
was	O
derived	O
.	O

The	O
color	O
coding	O
of	O
the	O
in	O
situ	O
hybridization	O
results	O
under	O
"	O
In	O
Situ	O
Pattern	O
"	O
is	O
as	O
follows	O
:	O
dark	O
green	O
,	O
markedly	O
down	O
-	O
regulated	O
;	O
light	O
green	O
,	O
mildly	O
down	O
-	O
regulated	O
;	O
red	O
,	O
markedly	O
up	O
-	O
regulated	O
;	O
orange	O
,	O
mildly	O
up	O
-	O
regulated	O
.	O

(	O
20	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S3	O

Summary	O
of	O
cDNA	B-SO
Microarray	O
Results	O
from	O
P0	O
,	O
P6	O
,	O
and	O
P14	O

The	O
spots	O
listed	O
in	O
this	O
table	O
represent	O
those	O
that	O
were	O
either	O
up	O
-	O
or	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarray	O
experiments	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

The	O
Cy3	O
/	O
Cy5	O
signal	O
ratios	O
are	O
indicated	O
for	O
all	O
three	O
microarray	O
experiments	O
at	O
each	O
time	O
point	O
.	O

Note	O
that	O
the	O
Cy3	O
/	O
Cy5	O
ratios	O
for	O
"	O
Microarray	O
#	O
3	O
"	O
are	O
reversed	O
relative	O
to	O
the	O
other	O
two	O
,	O
since	O
the	O
fluorescent	B-CHEBI
tag	I-CHEBI
used	O
to	O
label	O
wild	B-SO
-	I-SO
type	I-SO
and	O
mutant	B-SO
RNA	B-SO
was	O
swapped	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

(	O
22	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S4	O

Summary	O
of	O
Genes	B-SO
Up	O
-	O
Regulated	O
in	O
rd7	O
Mutant	B-SO
Retina	O
at	O
P21	O
by	O
Affymetrix	O
Microarray	O

Only	O
genes	B-SO
that	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarray	O
experiments	O
(	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
)	O
are	O
listed	O
.	O

"	O
Nr2e3	B-GGP
signal	O
"	O
and	O
"	O
C57BL	O
/	O
6	O
signal	O
"	O
represent	O
the	O
average	O
signal	O
for	O
that	O
transcript	B-SO
in	O
all	O
three	O
microarray	O
experiments	O
.	O

(	O
92	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S5	O

Summary	O
of	O
Genes	B-SO
Down	O
-	O
Regulated	O
in	O
rd7	O
Mutant	B-SO
Retina	O
at	O
P21	O
by	O
Affymetrix	O
Microarray	O

Only	O
genes	B-SO
that	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarray	O
experiments	O
(	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
)	O
are	O
listed	O
.	O

"	O
Nr2e3	B-GGP
signal	O
"	O
and	O
"	O
C57BL	O
/	O
6	O
signal	O
"	O
represent	O
the	O
average	O
signal	O
for	O
that	O
transcript	B-SO
in	O
all	O
three	O
microarray	O
experiments	O
.	O

(	O
58	O
KB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S6	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P0	O
(	O
I	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S7	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P0	O
(	O
II	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S8	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P0	O
(	O
III	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S9	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P6	O
(	O
I	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S10	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P6	O
(	O
II	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S11	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P6	O
(	O
III	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S12	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P14	O
(	O
I	O
)	O

(	O
5	O
.	O
5	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S13	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P14	O
(	O
II	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S14	O

Raw	O
cDNA	B-SO
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P14	O
(	O
III	O
)	O

(	O
5	O
.	O
6	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S15	O

Raw	O
Affymetrix	O
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P21	O
(	O
I	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S16	O

Raw	O
Affymetrix	O
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P21	O
(	O
II	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S17	O

Raw	O
Affymetrix	O
Microarray	O
Data	O
for	O
rd7	O
versus	O
Wild	B-SO
-	I-SO
Type	I-SO
Comparison	O
at	O
P21	O
(	O
III	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Acknowledgements	O

We	O
are	O
grateful	O
to	O
E	O
.	O

Raviola	O
and	O
T	O
.	O

Reese	O
for	O
help	O
with	O
electron	B-CHEBI
microscopy	O
and	O
to	O
A	O
.	O

Jadhav	O
and	O
J	O
.	O

Trimarchi	O
for	O
access	O
to	O
unpublished	O
data	O
and	O
reagents	B-CHEBI
.	O

Thanks	O
to	O
A	O
.	O

Jadhav	O
,	O
J	O
.	O

Trimarchi	O
,	O
D	O
.	O

Kim	O
,	O
and	O
T	O
.	O

Cherry	O
for	O
helpful	O
comments	O
on	O
the	O
manuscript	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Howard	O
Hughes	O
Medical	O
Institute	O
and	O
grants	O
from	O
the	O
National	O
Institutes	O
of	O
Health	O
(	O
EY014822	O
to	O
JCC	O
and	O
EY009676	O
to	O
CLC	O
)	O
.	O

Thanks	O
to	O
A	O
.	O

Swaroop	O
for	O
providing	O
us	O
with	O
Nrl	B-GGP
mutant	B-SO
mice	B-Taxon
.	O

Abbreviations	O

DAPI	O
-	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	B-CHEBI

E	O
[	O
number	O
]	O
-	O
embryonic	O
day	O
[	O
number	O
]	O

ERG	O
-	O
electroretinogram	O

ESCS	O
-	O
enhanced	O
S	O
-	O
cone	B-CL
syndrome	O

GCL	O
-	O
ganglion	O
cell	B-CL
layer	O

INL	O
-	O
inner	O
nuclear	O
layer	O

ONL	O
-	O
outer	O
nuclear	O
layer	O

P	O
[	O
number	O
]	O
-	O
postnatal	O
day	O
[	O
number	O
]	O

Figures	O

Figure	O
1	O

Cone	B-CL
-	O
Specific	O
and	O
Cone	B-CL
-	O
Enriched	O
Genes	B-SO
Evaluated	O
in	O
the	O
rd7	O
Mutant	B-SO
by	O
Microarray	O
and	O
In	O
Situ	O
Hybridization	O

The	O
color	O
coding	O
of	O
text	O
in	O
the	O
column	O
"	O
Gene	O
Name	O
"	O
is	O
as	O
follows	O
:	O
light	O
blue	O
(	O
G1	O
-	O
G15	O
)	O
,	O
genes	B-SO
previously	O
reported	O
in	O
the	O
literature	O
to	O
have	O
cone	B-CL
-	O
specific	O
or	O
cone	B-CL
-	O
enriched	O
patterns	O
of	O
expression	O
;	O
yellow	O
(	O
G16	O
-	O
G25	O
)	O
,	O
novel	O
cone	B-CL
genes	B-SO
identified	O
in	O
an	O
unrelated	O
study	O
(	O
unpublished	O
data	O
)	O
;	O
dark	O
green	O
(	O
G26	O
-	O
G36	O
)	O
,	O
novel	O
cone	B-CL
genes	B-SO
identified	O
in	O
the	O
present	O
study	O
that	O
were	O
up	O
-	O
regulated	O
in	O
rd7	O
;	O
light	O
green	O
(	O
G37	O
-	O
G46	O
)	O
,	O
additional	O
genes	B-SO
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
rd7	O
by	O
microarray	O
in	O
the	O
present	O
study	O
but	O
that	O
had	O
either	O
weak	O
or	O
inapparent	O
cone	B-CL
-	O
specific	O
signal	O
on	O
in	O
situ	O
hybridization	O
;	O
white	O
(	O
G47	O
-	O
G53	O
)	O
,	O
additional	O
genes	B-SO
up	O
-	O
regulated	O
by	O
microarray	O
at	O
two	O
different	O
timepoints	O
but	O
with	O
either	O
unusual	O
expression	O
patterns	O
or	O
nonconfirmatory	O
in	O
situ	O
hybridizations	O
.	O

The	O
column	O
"	O
ID	O
"	O
contains	O
identifiers	O
used	O
in	O
the	O
present	O
paper	O
to	O
refer	O
to	O
specific	O
genes	B-SO
.	O

"	O
GenBank	O
ID	O
"	O
contains	O
the	O
GenBank	O
accession	O
number	O
of	O
the	O
clone	B-SO
used	O
to	O
make	O
the	O
probe	B-SO
for	O
in	O
situ	O
hybridization	O
.	O

Within	O
this	O
column	O
,	O
"	O
lab	O
clone	B-SO
"	O
indicates	O
that	O
the	O
probe	B-SO
used	O
for	O
in	O
situ	O
hybridization	O
derived	O
from	O
a	O
clone	B-SO
in	O
our	O
laboratory	O
.	O

The	O
region	B-SO
of	I-SO
the	I-SO
gene	I-SO
to	O
which	O
it	O
corresponds	O
is	O
indicated	O
in	O
Table	O
S1	O
.	O

Columns	O
"	O
P0	O
"	O
through	O
"	O
P21	O
"	O
contain	O
the	O
results	O
of	O
microarray	O
experiments	O
at	O
the	O
given	O
postnatal	O
dates	O
.	O

P0	O
,	O
P6	O
,	O
and	O
P14	O
time	O
points	O
represent	O
analyses	O
on	O
cDNA	B-SO
microarrays	O
;	O
the	O
P21	O
time	O
point	O
represents	O
data	O
from	O
an	O
Affymetrix	O
microarray	O
(	O
mouse	B-Taxon
genome	B-SO
432	O
2	O
.	O
0	O
)	O
.	O

A	O
red	O
cell	B-CL
with	O
a	O
single	O
up	O
arrow	O
indicates	O
that	O
the	O
gene	B-SO
in	O
question	O
was	O
up	O
-	O
regulated	O
in	O
three	O
out	O
of	O
three	O
microarrays	O
at	O
that	O
time	O
point	O
(	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
)	O
.	O

Those	O
cells	B-CL
labeled	O
orange	O
with	O
a	O
single	O
up	O
arrow	O
and	O
asterisk	O
indicate	O
that	O
the	O
gene	B-SO
in	O
question	O
was	O
up	O
-	O
regulated	O
in	O
two	O
out	O
of	O
three	O
microarrays	O
at	O
that	O
time	O
point	O
.	O

The	O
column	O
"	O
In	O
Situ	O
"	O
lists	O
the	O
type	O
of	O
derepression	O
seen	O
for	O
the	O
gene	B-SO
in	O
question	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
(	O
type	O
I	O
and	O
type	O
II	O
are	O
described	O
in	O
the	O
main	O
text	O
)	O
.	O

Genes	B-SO
designated	O
"	O
unclassified	O
"	O
represent	O
patterns	O
of	O
derepression	O
that	O
were	O
difficult	O
to	O
classify	O
as	O
either	O
type	O
I	O
or	O
type	O
II	O
(	O
see	O
main	O
text	O
for	O
more	O
details	O
)	O
.	O

"	O
Wild	B-SO
type	I-SO
"	O
in	O
this	O
column	O
indicates	O
that	O
the	O
in	O
situ	O
hybridization	O
pattern	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
was	O
not	O
different	O
from	O
the	O
wild	B-SO
-	I-SO
type	I-SO
pattern	O
;	O
and	O
"	O
special	O
"	O
indicates	O
a	O
special	O
pattern	O
of	O
expression	O
discussed	O
more	O
fully	O
in	O
the	O
main	O
text	O
.	O

The	O
column	O
"	O
Expression	O
Pattern	O
"	O
contains	O
a	O
concise	O
description	O
of	O
the	O
wild	B-SO
-	I-SO
type	I-SO
expression	O
pattern	O
of	O
the	O
gene	B-SO
in	O
question	O
.	O

In	O
the	O
case	O
of	O
genes	B-SO
for	O
which	O
no	O
signal	O
was	O
obtained	O
on	O
in	O
situ	O
hybridization	O
in	O
the	O
present	O
study	O
,	O
the	O
specified	O
expression	O
pattern	O
derives	O
from	O
reports	O
in	O
the	O
literature	O
.	O

Within	O
this	O
column	O
,	O
"	O
cone	B-CL
>	O
rod	B-CL
"	O
indicates	O
that	O
the	O
gene	B-SO
is	O
expressed	O
in	O
all	O
photoreceptors	B-CL
,	O
but	O
at	O
higher	O
levels	O
in	O
cones	B-CL
than	O
rods	B-CL
;	O
"	O
cone	B-CL
?	O
"	O
indicates	O
very	O
weak	O
staining	O
in	O
a	O
cone	B-CL
-	O
like	O
distribution	O
.	O

BP	B-CL
,	O
bipolar	B-CL
cells	I-CL
;	O
EP	O
,	O
early	O
photoreceptor	B-CL
expression	O
pattern	O
;	O
IS	B-GO
,	O
inner	B-GO
core	I-GO
segment	I-GO
localization	O
;	O
MG	B-CL
,	O
M	B-CL
u	I-CL
ller	I-CL
glia	I-CL
;	O
N	O
/	O
A	O
,	O
not	O
available	O
on	O
the	O
microarray	O
;	O
NS	O
,	O
no	O
signal	O
detected	O
on	O
in	O
situ	O
hybridization	O
;	O
RPE	O
,	O
retinal	O
pigment	B-CHEBI
epithelium	O
.	O

Figure	O
2	O

Cone	B-CL
and	O
Rod	B-CL
Gene	B-SO
Expression	O
in	O
the	O
rd7	O
Mutant	B-SO
at	O
P14	O

The	O
upper	O
sets	O
of	O
photomicrographs	O
demonstrate	O
examples	O
of	O
type	O
I	O
and	O
type	O
II	O
cone	B-CL
gene	B-SO
derepression	O
in	O
the	O
rd7	O
mutant	B-SO
retina	O
as	O
explained	O
in	O
the	O
main	O
text	O
.	O

The	O
bottom	O
left	O
images	O
show	O
several	O
rod	B-CL
-	O
specific	O
genes	B-SO
that	O
are	O
essentially	O
unchanged	O
in	O
the	O
rd7	O
background	O
at	O
P14	O
.	O

The	O
bottom	O
right	O
images	O
show	O
the	O
expression	O
pattern	O
of	O
three	O
photoreceptor	B-CL
transcription	O
factors	O
in	O
the	O
rd7	O
mutant	B-SO
.	O

Abbreviations	O
in	O
the	O
lower	O
left	O
hand	O
corner	O
of	O
each	O
pair	O
of	O
panels	O
represent	O
the	O
gene	B-SO
symbols	O
summarized	O
in	O
Figure	O
1	O
.	O

Figure	O
3	O

S	B-GGP
-	I-GGP
Opsin	I-GGP
Dissociated	O
Cell	B-CL
In	O
Situ	O
Hybridization	O
and	O
S	B-GGP
-	I-GGP
Opsin	I-GGP
/	O
Rhodopsin	B-GGP
Antibody	B-GO
Staining	O
on	O
rd7	O
Mutant	B-SO
Retina	O

(	O
A	O
-	O
C	O
)	O
A	O
dissociated	O
cell	B-CL
in	O
situ	O
hybridization	O
with	O
an	O
S	B-GGP
-	I-GGP
opsin	I-GGP
probe	B-SO
(	O
red	O
)	O
on	O
dissociated	O
rd7	O
mutant	B-SO
retinal	O
cells	B-CL
stained	O
with	O
DAPI	O
(	O
blue	O
)	O
.	O

(	O
C	O
)	O
shows	O
the	O
merged	O
images	O
.	O

(	O
D	O
-	O
F	O
)	O
The	O
outer	O
nuclear	O
layer	O
of	O
an	O
rd7	O
mutant	B-SO
retina	O
stained	O
by	O
antibody	B-GO
for	O
S	B-GGP
-	I-GGP
opsin	I-GGP
(	O
red	O
)	O
and	O
rhodopsin	B-GGP
(	O
green	O
)	O
.	O

The	O
scleral	O
edge	O
of	O
the	O
outer	O
nuclear	O
layer	O
is	O
up	O
.	O

DAPI	O
staining	O
is	O
in	O
blue	O
.	O

(	O
F	O
)	O
shows	O
the	O
merged	O
images	O
.	O

Insets	O
are	O
higher	O
-	O
power	O
images	O
of	O
the	O
outer	B-GO
segments	I-GO
showing	O
non	O
-	O
overlap	O
of	O
S	B-GGP
-	I-GGP
opsin	I-GGP
and	O
rhodopsin	B-GGP
staining	O
in	O
the	O
mutant	B-SO
.	O

Figure	O
4	O

Expression	O
Patterns	O
of	O
Several	O
Novel	O
Cone	B-CL
Genes	B-SO
Up	O
-	O
Regulated	O
in	O
rd7	O

In	O
the	O
wild	B-SO
-	I-SO
type	I-SO
images	O
(	O
wt	B-SO
)	O
,	O
note	O
the	O
scattered	O
,	O
weakly	O
positive	O
cells	B-CL
at	O
the	O
scleral	O
edge	O
of	O
the	O
outer	O
nuclear	O
layer	O
in	O
a	O
cone	B-CL
distribution	O
.	O

All	O
of	O
the	O
genes	B-SO
show	O
marked	O
up	O
-	O
regulation	O
in	O
the	O
rd7	O
mutant	B-SO
.	O

Bub1b	B-GGP
and	O
Tcta	B-GGP
show	O
transcript	B-SO
localization	O
predominantly	O
to	O
the	O
inner	B-GO
segment	I-GO
of	I-GO
the	I-GO
photoreceptors	I-GO
.	O

Retinas	O
are	O
oriented	O
such	O
that	O
the	O
scleral	O
edge	O
is	O
up	O
.	O

Figure	O
5	O

Some	O
of	O
the	O
Genes	B-SO
Up	O
-	O
Regulated	O
in	O
rd7	O
Show	O
an	O
Early	O
Photoreceptor	B-CL
Pattern	O
of	O
Expression	O

Gnb3	B-GGP
and	O
Thrb2	B-GGP
are	O
both	O
previously	O
characterized	O
cone	B-CL
genes	B-SO
that	O
show	O
staining	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
embryonic	O
mouse	B-Taxon
retina	O
in	O
cells	B-CL
that	O
will	O
differentiate	O
into	O
photoreceptors	B-CL
.	O

Ece1	B-GGP
and	O
Otop3	B-GGP
are	O
two	O
novel	O
cone	B-CL
genes	B-SO
identified	O
in	O
this	O
study	O
that	O
were	O
up	O
-	O
regulated	O
in	O
rd7	O
and	O
also	O
showed	O
an	O
early	O
photoreceptor	B-CL
pattern	O
of	O
expression	O
.	O

Prdm1	B-GGP
and	O
RIKEN	O
cDNA	B-SO
1300018I05	O
(	O
Figure	O
1	O
,	O
genes	B-SO
G48	O
and	O
G49	O
,	O
respectively	O
)	O
are	O
two	O
other	O
genes	B-SO
that	O
had	O
either	O
undetectable	O
signal	O
(	O
Prdm1	B-GGP
)	O
or	O
no	O
apparent	O
change	O
in	O
expression	O
pattern	O
in	O
adult	O
rd7	O
mutants	B-SO
(	O
RIKEN	O
cDNA	B-SO
1300018I05	O
)	O
,	O
but	O
which	O
also	O
showed	O
staining	O
in	O
the	O
embryonic	O
retina	O
in	O
a	O
presumptive	O
photoreceptor	B-CL
pattern	O
.	O

All	O
images	O
are	O
from	O
E17	O
.	O
5	O
retina	O
except	O
Gnb3	B-GGP
,	O
which	O
was	O
from	O
E16	O
.	O

Figure	O
6	O

The	O
Onset	O
of	O
rhodopsin	B-GGP
Expression	O
Is	O
Delayed	O
in	O
the	O
rd7	O
Mutant	B-SO
Retina	O

Note	O
the	O
nearly	O
undetectable	O
staining	O
for	O
rhodopsin	B-GGP
in	O
this	O
P6	O
mutant	B-SO
retina	O
(	O
top	O
right	O
)	O
.	O

The	O
majority	O
of	O
rod	B-CL
-	O
specific	O
genes	B-SO
did	O
not	O
show	O
this	O
delay	O
in	O
expression	O
onset	O
,	O
as	O
indicated	O
by	O
the	O
normal	O
amount	O
of	O
staining	O
for	O
Pde6a	B-GGP
in	O
the	O
mutant	B-SO
at	O
P6	O
(	O
bottom	O
images	O
)	O
.	O

Figure	O
7	O

The	O
rd7	O
Mutant	B-SO
Retina	O
Contains	O
a	O
Morphologically	O
Hybrid	O
Photoreceptor	B-CL
Cell	I-CL
Type	O
in	O
Addition	O
to	O
Supernumerary	O
S	B-GGP
-	I-GGP
Opsin	I-GGP
-	O
Positive	O
Cones	B-CL

(	O
A	O
and	O
B	O
)	O
Toluidine	O
blue	O
-	O
stained	O
semi	O
-	O
thin	O
sections	O
of	O
the	O
outer	O
nuclear	O
layer	O
(	O
scleral	O
edge	O
oriented	O
up	O
)	O
.	O

(	O
C	O
and	O
D	O
)	O
Hand	O
-	O
drawn	O
diagrams	O
of	O
the	O
cells	B-CL
in	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
,	O
respectively	O
.	O

Cells	B-CL
with	O
the	O
nuclear	B-GO
features	O
of	O
cones	B-CL
are	O
highlighted	O
in	O
blue	O
.	O

Note	O
that	O
the	O
number	O
of	O
such	O
cells	B-CL
is	O
greater	O
in	O
the	O
mutant	B-SO
,	O
and	O
their	O
cell	B-GO
bodies	I-GO
are	O
scattered	O
throughout	O
the	O
outer	O
nuclear	O
layer	O
.	O

In	O
addition	O
,	O
the	O
overall	O
columnar	O
architecture	O
of	O
the	O
outer	O
nuclear	O
layer	O
seen	O
in	O
the	O
wild	B-SO
type	I-SO
is	O
disrupted	O
in	O
this	O
portion	O
of	O
the	O
mutant	B-SO
retina	O
.	O

Other	O
portions	O
of	O
the	O
mutant	B-SO
retina	O
with	O
fewer	O
supernumerary	O
cone	B-CL
cells	I-CL
,	O
however	O
,	O
retain	O
the	O
normal	O
columnar	O
appearance	O
(	O
unpublished	O
data	O
)	O
.	O

(	O
E	O
and	O
F	O
)	O
Images	O
of	O
the	O
outer	O
nuclear	O
layer	O
(	O
scleral	O
edge	O
up	O
)	O
stained	O
by	O
in	O
situ	O
hybridization	O
for	O
S	B-GGP
-	I-GGP
opsin	I-GGP
.	O

Note	O
the	O
typical	O
pattern	O
of	O
staining	O
at	O
the	O
scleral	O
edge	O
of	O
the	O
outer	O
nuclear	O
layer	O
in	O
the	O
wild	B-SO
type	I-SO
.	O

The	O
rd7	O
mutant	B-SO
retina	O
shows	O
supernumerary	O
S	B-GGP
-	I-GGP
opsin	I-GGP
-	O
positive	O
cells	B-CL
scattered	O
throughout	O
the	O
outer	O
nuclear	O
layer	O
in	O
a	O
distribution	O
very	O
similar	O
to	O
the	O
supernumerary	O
cone	B-CL
cells	I-CL
seen	O
in	O
(	O
B	O
)	O
.	O

Since	O
images	O
(	O
E	O
)	O
and	O
(	O
F	O
)	O
derive	O
from	O
different	O
retinas	O
than	O
those	O
depicted	O
in	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
,	O
the	O
location	O
of	O
the	O
individual	O
cells	B-CL
do	O
not	O
correspond	O
.	O

(	O
G	O
and	O
H	O
)	O
Electron	B-CHEBI
micrographs	O
of	O
the	O
outer	O
nuclear	O
layer	O
(	O
10	O
,	O
000	O
x	O
magnification	O
)	O
.	O

Note	O
the	O
uniform	O
distribution	O
of	O
rod	O
cell	B-GO
bodies	I-GO
in	O
the	O
wild	B-SO
type	I-SO
(	O
G	O
)	O
.	O

The	O
cell	B-GO
bodies	I-GO
are	O
nearly	O
round	O
and	O
consist	O
almost	O
exclusively	O
of	O
a	O
nucleus	B-GO
with	O
a	O
single	O
,	O
dense	O
mass	O
of	O
heterochromatin	B-GO
.	O

In	O
the	O
rd7	O
mutant	B-SO
(	O
H	O
)	O
,	O
two	O
types	O
of	O
cell	B-CL
are	O
shown	O
.	O

The	O
ovoid	O
one	O
with	O
a	O
lesser	O
quantity	O
of	O
heterochromatin	B-GO
,	O
paler	O
euchromatin	B-GO
,	O
and	O
two	O
juxtanuclear	B-GO
mitochondria	B-GO
(	O
yellow	O
arrow	O
)	O
represents	O
a	O
typical	O
cone	O
cell	B-GO
body	I-GO
.	O

The	O
adjacent	O
cell	B-CL
with	O
a	O
more	O
"	O
rod	B-CL
-	O
like	O
"	O
mass	O
of	O
heterochromatin	B-GO
and	O
a	O
single	O
juxtanuclear	B-GO
mitochondrion	B-GO
(	O
red	O
arrow	O
)	O
represents	O
one	O
of	O
the	O
hybrid	O
photoreceptors	B-CL
discussed	O
more	O
fully	O
in	O
the	O
main	O
text	O
.	O

Figure	O
8	O

A	O
Partial	O
View	O
of	O
the	O
Rod	B-CL
Photoreceptor	I-CL
Transcriptional	O
Regulatory	O
Network	O

Note	O
that	O
green	O
lines	O
indicate	O
activation	O
,	O
and	O
yellow	O
and	O
red	O
lines	O
indicate	O
weak	O
and	O
strong	O
repression	O
,	O
respectively	O
.	O

The	O
dotted	O
lines	O
associated	O
with	O
a	O
question	O
mark	O
indicate	O
that	O
it	O
is	O
not	O
known	O
whether	O
Nrl	B-GGP
directly	O
represses	O
the	O
target	O
genes	B-SO
in	O
question	O
or	O
whether	O
its	O
repression	O
is	O
mediated	O
by	O
a	O
downstream	O
transcription	O
factor	O
(	O
"	O
X	O
"	O
)	O
.	O

Note	O
that	O
Nr2e3	B-GGP
appears	O
to	O
negatively	O
regulate	O
its	O
own	O
transcription	O
.	O

The	O
regulatory	O
linkages	O
depicted	O
in	O
this	O
diagram	O
are	O
not	O
necessarily	O
direct	O
.	O

The	O
weak	O
activation	O
of	O
some	O
rod	B-CL
-	O
specific	O
genes	B-SO
by	O
Nr2e3	B-GGP
is	O
omitted	O
from	O
this	O
diagram	O
for	O
clarity	O
.	O

Also	O
not	O
shown	O
is	O
the	O
role	O
of	O
other	O
photoreceptor	B-CL
transcription	O
factors	O
,	O
such	O
as	O
Crx	B-GGP
.	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Author	O
contributions	O
.	O

JCC	O
and	O
CLC	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

JCC	O
performed	O
the	O
experiments	O
.	O

JCC	O
and	O
CLC	O
analyzed	O
the	O
data	O
.	O

JCC	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

JCC	O
and	O
CLC	O
wrote	O
the	O
paper	O
.	O

Citation	O
:	O
Corbo	O
JC	O
,	O
Cepko	O
CL	O
(	O
2005	O
)	O
A	O
hybrid	O
photoreceptor	B-CL
expressing	O
both	O
rod	B-CL
and	O
cone	B-CL
genes	B-SO
in	O
a	O
mouse	B-Taxon
model	O
of	O
enhanced	O
s	O
-	O
cone	B-CL
syndrome	O
.	O

PLoS	O
Genet	O
1	O
(	O
2	O
)	O
:	O
e11	O
.	O

Production	O
and	O
characterization	O
of	O
murine	B-Taxon
models	O
of	O
classic	O
and	O
intermediate	O
maple	B-Taxon
syrup	O
urine	O
disease	O

Abstract	O

Background	O

Maple	B-Taxon
Syrup	O
Urine	O
Disease	O
(	O
MSUD	O
)	O
is	O
an	O
inborn	O
error	O
of	O
metabolism	O
caused	O
by	O
a	O
deficiency	O
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	I-GO
.	O

MSUD	O
has	O
several	O
clinical	O
phenotypes	O
depending	O
on	O
the	O
degree	O
of	O
enzyme	B-SO
deficiency	O
.	O

Current	O
treatments	O
are	O
not	O
satisfactory	O
and	O
require	O
new	O
approaches	O
to	O
combat	O
this	O
disease	O
.	O

A	O
major	O
hurdle	O
in	O
developing	O
new	O
treatments	O
has	O
been	O
the	O
lack	O
of	O
a	O
suitable	O
animal	B-Taxon
model	O
.	O

Methods	O

To	O
create	O
a	O
murine	B-Taxon
model	O
of	O
classic	O
MSUD	O
,	O
we	O
used	O
gene	B-SO
targeting	O
and	O
embryonic	O
stem	B-CL
cell	I-CL
technologies	O
to	O
create	O
a	O
mouse	B-Taxon
line	O
that	O
lacked	O
a	O
functional	O
E2	B-GGP
subunit	I-GGP
gene	B-SO
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	I-GO
.	O

To	O
create	O
a	O
murine	B-Taxon
model	O
of	O
intermediate	O
MSUD	O
,	O
we	O
used	O
transgenic	B-SO
technology	O
to	O
express	O
a	O
human	B-GGP
E2	I-GGP
cDNA	B-SO
on	O
the	O
knockout	O
background	O
.	O

Mice	B-Taxon
of	O
both	O
models	O
were	O
characterized	O
at	O
the	O
molecular	B-CHEBI
,	O
biochemical	O
,	O
and	O
whole	O
animal	B-Taxon
levels	O
.	O

Results	O

By	O
disrupting	O
the	O
E2	B-GGP
subunit	I-GGP
gene	B-SO
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	I-GO
,	O
we	O
created	O
a	O
gene	B-SO
knockout	O
mouse	B-Taxon
model	O
of	O
classic	O
MSUD	O
.	O

The	O
homozygous	O
knockout	O
mice	B-Taxon
lacked	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	I-GO
activity	O
,	O
E2	B-GGP
immunoreactivity	O
,	O
and	O
had	O
a	O
3	O
-	O
fold	O
increase	O
in	O
circulating	O
branched	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	I-CHEBI
.	O

These	O
metabolic	O
derangements	O
resulted	O
in	O
neonatal	O
lethality	O
.	O

Transgenic	B-SO
expression	O
of	O
a	O
human	B-GGP
E2	I-GGP
cDNA	B-SO
in	O
the	O
liver	O
of	O
the	O
E2	B-GGP
knockout	O
animals	B-Taxon
produced	O
a	O
model	O
of	O
intermediate	O
MSUD	O
.	O

Branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	I-GO
activity	O
was	O
5	O
-	O
6	O
%	O
of	O
normal	O
and	O
was	O
sufficient	O
to	O
allow	O
survival	O
,	O
but	O
was	O
insufficient	O
to	O
normalize	O
circulating	O
branched	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	I-CHEBI
levels	O
,	O
which	O
were	O
intermediate	O
between	O
wildtype	B-SO
and	O
the	O
classic	O
MSUD	O
mouse	B-Taxon
model	O
.	O

Conclusion	O

These	O
mice	B-Taxon
represent	O
important	O
animal	B-Taxon
models	O
that	O
closely	O
approximate	O
the	O
phenotype	O
of	O
humans	B-Taxon
with	O
the	O
classic	O
and	O
intermediate	O
forms	O
of	O
MSUD	O
.	O

These	O
animals	B-Taxon
provide	O
useful	O
models	O
to	O
further	O
characterize	O
the	O
pathogenesis	O
of	O
MSUD	O
,	O
as	O
well	O
as	O
models	O
to	O
test	O
novel	O
therapeutic	O
strategies	O
,	O
such	O
as	O
gene	B-SO
and	O
cellular	B-CL
therapies	O
,	O
to	O
treat	O
this	O
devastating	O
metabolic	O
disease	O
.	O

Background	O

Maple	B-Taxon
Syrup	O
Urine	O
Disease	O
(	O
MSUD	O
)	O
is	O
a	O
genetic	B-SO
disorder	O
caused	O
by	O
a	O
deficiency	O
of	O
branched	B-GO
-	I-GO
chain	I-GO
keto	I-GO
acid	I-GO
dehydrogenase	I-GO
(	O
BCKDH	B-GO
)	O
,	O
a	O
mitochondrial	B-GO
multienzyme	O
complex	B-GO
responsible	O
for	O
the	O
oxidative	O
decarboxylation	O
of	O
branched	O
-	O
chain	O
keto	B-CHEBI
acids	B-CHEBI
derived	O
from	O
branched	B-CHEBI
-	I-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	I-CHEBI
(	O
BCAA	B-CHEBI
)	O
,	O
leucine	B-CHEBI
,	O
isoleucine	B-CHEBI
and	O
valine	B-CHEBI
(	O
for	O
review	O
,	O
see	O
:	O
[	O
1	O
]	O
)	O
.	O

Patients	O
with	O
MSUD	O
,	O
depending	O
on	O
the	O
mutation	B-SO
,	O
show	O
variable	O
degrees	O
of	O
enzyme	B-SO
deficiency	O
leading	O
to	O
several	O
different	O
clinical	O
phenotypes	O
[	O
1	O
]	O
.	O

Approximately	O
75	O
%	O
of	O
MSUD	O
patients	O
have	O
the	O
classic	O
form	O
of	O
the	O
disease	O
with	O
BCKDH	B-GO
activity	O
in	O
the	O
range	O
of	O
0	O
-	O
2	O
%	O
of	O
normal	O
[	O
1	O
]	O
.	O

These	O
patients	O
show	O
markedly	O
elevated	O
levels	O
of	O
BCAA	B-CHEBI
in	O
blood	O
and	O
other	O
body	O
fluids	O
[	O
1	O
]	O
.	O

Besides	O
the	O
classic	O
form	O
,	O
there	O
are	O
other	O
variants	O
of	O
the	O
disease	O
.	O

Patients	O
with	O
the	O
intermediate	O
form	O
of	O
the	O
disease	O
show	O
BCKDH	B-GO
activity	O
in	O
the	O
range	O
of	O
3	O
-	O
30	O
%	O
of	O
normal	O
.	O

In	O
such	O
patients	O
the	O
onset	O
of	O
the	O
disease	O
is	O
delayed	O
,	O
but	O
there	O
are	O
persistently	O
elevated	O
levels	O
of	O
BCAA	B-CHEBI
[	O
1	O
]	O
.	O

Patients	O
with	O
the	O
intermittent	O
form	O
of	O
MSUD	O
show	O
BCKDH	B-GO
activity	O
in	O
the	O
range	O
of	O
5	O
-	O
20	O
%	O
and	O
during	O
the	O
asymptomatic	O
phase	O
the	O
blood	O
BCAA	B-CHEBI
levels	O
are	O
normal	O
[	O
1	O
]	O
.	O

The	O
overall	O
incidence	O
of	O
MSUD	O
in	O
the	O
general	O
population	O
is	O
1	O
:	O
185	O
,	O
000	O
[	O
1	O
]	O
,	O
and	O
in	O
certain	O
population	O
groups	O
,	O
such	O
as	O
Mennonites	O
of	O
Pennsylvania	O
,	O
the	O
incidence	O
is	O
estimated	O
to	O
be	O
as	O
high	O
as	O
1	O
:	O
176	O
[	O
2	O
]	O
.	O

The	O
BCKDH	B-GO
complex	I-GO
,	O
the	O
deficient	O
enzyme	B-SO
in	O
MSUD	O
,	O
consists	O
of	O
three	O
catalytic	O
proteins	B-CHEBI
,	O
a	O
decarboxylase	O
(	O
E1	O
)	O
,	O
a	O
dihydrolipoyl	B-GGP
transacylase	I-GGP
(	O
E2	B-GGP
)	O
,	O
and	O
a	O
dihydrolipoyl	B-GGP
dehydrogenase	I-GGP
(	O
E3	B-GGP
)	O
.	O

The	O
E1	O
component	O
is	O
a	O
heterotetramer	O
composed	O
of	O
two	O
alpha	B-GGP
and	I-GGP
two	I-GGP
beta	I-GGP
subunits	I-GGP
[	O
3	O
]	O
.	O

The	O
E1	O
and	O
E2	B-GGP
components	O
are	O
specific	O
to	O
BCKDH	B-GO
,	O
whereas	O
E3	B-GGP
is	O
also	O
used	O
by	O
pyruvate	B-GO
and	I-GO
alpha	I-GO
-	I-GO
ketoglutarate	I-GO
dehydrogenase	I-GO
complexes	I-GO
[	O
3	O
]	O
and	O
the	O
glycine	B-GO
cleavage	I-GO
system	I-GO
[	O
4	O
]	O
.	O

BCKDH	B-GO
is	O
also	O
associated	O
with	O
two	O
regulatory	O
proteins	B-CHEBI
,	O
a	O
specific	O
kinase	O
and	O
a	O
phosphatase	O
which	O
regulate	O
the	O
activity	O
of	O
this	O
enzyme	B-SO
through	O
a	O
phosphorylation	O
(	O
inactivation	O
)	O
and	O
dephosphorylation	O
(	O
activation	O
)	O
cycle	O
of	O
the	O
E1	B-GGP
alpha	I-GGP
subunit	I-GGP
[	O
5	O
,	O
6	O
]	O
.	O

Mutations	B-SO
in	O
the	O
genes	B-SO
of	O
the	O
E1	O
and	O
E2	B-GGP
subunits	I-GGP
of	I-GGP
BCKDH	I-GGP
have	O
been	O
described	O
,	O
however	O
,	O
the	O
majority	O
of	O
MSUD	O
mutations	B-SO
identified	O
thus	O
far	O
are	O
in	O
the	O
E2	B-GGP
subunit	I-GGP
[	O
1	O
,	O
7	O
]	O
.	O

To	O
date	O
,	O
cases	O
of	O
MSUD	O
have	O
not	O
been	O
associated	O
with	O
defects	O
in	O
the	O
regulatory	O
kinase	O
and	O
phosphatase	O
[	O
1	O
]	O
.	O

Current	O
management	O
of	O
MSUD	O
patients	O
relies	O
on	O
a	O
strict	O
lifelong	O
dietary	O
restriction	O
of	O
protein	B-CHEBI
or	O
BCAA	B-CHEBI
[	O
1	O
,	O
8	O
]	O
.	O

Such	O
a	O
dietary	O
management	O
of	O
the	O
disease	O
,	O
however	O
,	O
is	O
not	O
entirely	O
satisfactory	O
especially	O
in	O
times	O
of	O
metabolic	O
decompensation	O
due	O
to	O
infection	O
,	O
injuries	O
and	O
other	O
stressors	O
.	O

In	O
spite	O
of	O
dietary	O
intervention	O
,	O
there	O
is	O
significant	O
mortality	O
associated	O
with	O
MSUD	O
and	O
there	O
is	O
a	O
high	O
incidence	O
of	O
mental	O
retardation	O
in	O
survivors	O
[	O
9	O
]	O
.	O

Because	O
of	O
the	O
central	O
role	O
of	O
the	O
liver	O
in	O
amino	B-CHEBI
acid	I-CHEBI
metabolism	O
and	O
moderate	O
/	O
high	O
levels	O
of	O
BCKDH	B-GO
activity	O
in	O
human	B-Taxon
liver	O
[	O
10	O
-	O
12	O
]	O
,	O
a	O
few	O
cases	O
of	O
MSUD	O
have	O
recently	O
been	O
treated	O
by	O
liver	O
transplantation	O
[	O
13	O
-	O
16	O
]	O
.	O

While	O
the	O
short	O
-	O
term	O
outcome	O
of	O
liver	O
transplantation	O
is	O
encouraging	O
,	O
long	O
-	O
term	O
effects	O
of	O
this	O
approach	O
are	O
not	O
known	O
.	O

However	O
,	O
these	O
patients	O
are	O
now	O
required	O
to	O
take	O
immunosuppressant	B-CHEBI
drugs	I-CHEBI
for	O
the	O
rest	O
of	O
their	O
lives	O
,	O
often	O
with	O
undesirable	O
side	O
effects	O
.	O

Moreover	O
,	O
the	O
cost	O
associated	O
with	O
liver	O
transplantation	O
and	O
the	O
availability	O
of	O
donor	O
livers	O
are	O
additional	O
limiting	O
factors	O
for	O
the	O
practicality	O
of	O
treatment	O
of	O
this	O
disease	O
.	O

Because	O
of	O
the	O
current	O
unsatisfactory	O
options	O
for	O
the	O
treatment	O
of	O
MSUD	O
,	O
there	O
is	O
a	O
need	O
for	O
improved	O
therapies	O
to	O
combat	O
this	O
disease	O
.	O

An	O
obstacle	O
to	O
developing	O
novel	O
treatments	O
for	O
MSUD	O
has	O
been	O
the	O
lack	O
of	O
a	O
suitable	O
animal	B-Taxon
model	O
to	O
perform	O
necessary	O
preclinical	O
studies	O
.	O

Although	O
a	O
Hereford	O
calf	O
model	O
with	O
MSUD	O
has	O
been	O
described	O
[	O
17	O
-	O
19	O
]	O
,	O
this	O
model	O
is	O
neither	O
readily	O
available	O
nor	O
practical	O
to	O
perform	O
preclinical	O
studies	O
.	O

Furthermore	O
,	O
comparison	O
of	O
this	O
animal	B-Taxon
model	O
with	O
human	B-Taxon
MSUD	O
has	O
shown	O
some	O
differences	O
in	O
the	O
pathology	O
of	O
the	O
disease	O
[	O
1	O
]	O
,	O
making	O
this	O
animal	B-Taxon
a	O
less	O
desirable	O
model	O
for	O
the	O
human	B-Taxon
disease	O
.	O

Recently	O
,	O
a	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	I-CHEBI
(	O
ENU	B-CHEBI
)	O
-	O
induced	O
mutant	B-SO
mouse	B-Taxon
that	O
phenotypically	O
resembles	O
human	B-Taxon
MSUD	O
has	O
been	O
described	O
[	O
20	O
]	O
.	O

However	O
,	O
the	O
mutation	B-SO
in	O
this	O
model	O
disrupts	O
a	O
splice	B-SO
site	I-SO
in	O
the	O
mitochondrial	B-GGP
branched	I-GGP
-	I-GGP
chain	I-GGP
aminotransferase	I-GGP
(	I-GGP
BCAT	I-GGP
)	O
gene	B-SO
,	O
not	O
in	O
BCKDH	B-GO
,	O
the	O
deficient	O
enzyme	B-SO
in	O
MSUD	O
.	O

Because	O
the	O
mutation	B-SO
is	O
not	O
in	O
BCKDH	B-GO
,	O
the	O
validity	O
of	O
this	O
mutant	B-SO
mouse	B-Taxon
line	O
for	O
modeling	O
human	B-Taxon
MSUD	O
is	O
questionable	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
create	O
genetically	B-SO
engineered	O
murine	B-Taxon
models	O
of	O
MSUD	O
that	O
mimic	O
the	O
pathology	O
of	O
the	O
classic	O
and	O
intermediate	O
variant	O
forms	O
of	O
the	O
human	B-Taxon
disease	O
.	O

The	O
classic	O
model	O
was	O
created	O
by	O
targeted	O
inactivation	O
of	O
the	O
E2	B-GGP
subunit	I-GGP
of	I-GGP
BCKDH	I-GGP
by	O
homologous	O
recombination	O
in	O
embryonic	O
stem	B-CL
(	I-CL
ES	I-CL
)	I-CL
cells	I-CL
.	O

The	O
model	O
of	O
intermediate	O
MSUD	O
was	O
created	O
by	O
partial	O
transgenic	B-SO
rescue	O
of	O
the	O
E2	B-GGP
gene	B-SO
knockout	O
.	O

This	O
report	O
describes	O
the	O
generation	O
and	O
characterization	O
of	O
these	O
murine	B-Taxon
models	O
of	O
MSUD	O
.	O

These	O
models	O
will	O
allow	O
for	O
the	O
development	O
of	O
novel	O
treatment	O
approaches	O
,	O
such	O
as	O
gene	B-SO
or	O
stem	B-CL
cell	I-CL
therapies	O
,	O
to	O
ultimately	O
cure	O
MSUD	O
.	O

Methods	O

All	O
studies	O
involving	O
animals	B-Taxon
were	O
reviewed	O
and	O
approved	O
by	O
the	O
University	O
of	O
Pittsburgh	O
'	O
s	O
Institutional	O
Animal	B-Taxon
Care	O
and	O
Use	O
Committee	O
.	O

Gene	B-SO
knockout	O
production	O

A	O
genomic	B-SO
DNA	I-SO
subclone	O
of	O
Strain	O
129	O
/	O
SvJ	O
DNA	B-SO
that	O
contained	O
a	O
portion	B-SO
of	I-SO
Exons	I-SO
4	O
and	O
5	O
of	O
the	O
E2	B-GGP
gene	B-SO
and	O
flanking	O
DNA	B-SO
was	O
obtained	O
from	O
a	O
P1	O
phage	O
library	O
from	O
Genome	B-SO
Systems	O
,	O
Inc	O
.	O
,	O
(	O
St	O
.	O
Louis	O
,	O
MO	O
;	O
'	O
3	O
-	O
Hit	O
Mouse	B-Taxon
ES	O
Library	O
'	O
)	O
.	O

A	O
positive	O
/	O
negative	O
replacement	B-SO
type	O
gene	B-SO
targeting	O
vector	B-SO
[	O
21	O
]	O
was	O
created	O
by	O
replacing	B-SO
a	O
1	O
.	O
67	O
kb	O
EcoRV	O
-	O
Smal	O
fragment	B-SO
that	O
included	O
a	O
portion	B-SO
of	I-SO
Exon	I-SO
4	O
and	O
all	O
of	O
Exon	B-SO
5	O
with	O
the	O
PGKneo	O
marker	O
gene	B-SO
(	O
See	O
Fig	O
.	O
1A	O
)	O
from	O
the	O
pPNT	O
vector	B-SO
[	O
22	O
]	O
.	O

The	O
targeting	O
construct	B-SO
was	O
linearized	O
with	O
NotI	O
and	O
electroporated	O
into	O
R1	O
ES	O
cells	B-CL
[	O
23	O
]	O
under	O
conditions	O
described	O
previously	O
[	O
24	O
]	O
.	O

ES	O
cells	B-CL
were	O
selected	O
with	O
G418	O
(	O
300	O
mu	O
g	O
/	O
ml	O
;	O
Life	O
Technologies	O
Inc	O
.	O
,	O
Gaithersburg	O
,	O
MD	O
)	O
and	O
gancyclovir	O
(	O
2	O
mu	O
M	O
;	O
gift	O
of	O
Syntex	O
,	O
Palo	O
Alto	O
,	O
CA	O
)	O
.	O

Doubly	O
resistant	O
clones	O
were	O
screened	O
for	O
gene	B-SO
targeting	O
by	O
Southern	O
blot	O
analysis	O
of	O
BglI	O
digested	O
genomic	B-SO
DNA	I-SO
.	O

Blots	O
were	O
hybridized	O
with	O
an	O
Exon	B-SO
6	O
specific	O
probe	B-SO
that	O
was	O
external	O
to	O
the	O
gene	B-SO
targeting	O
construct	B-SO
.	O

Correctly	O
targeted	O
ES	O
cells	B-CL
were	O
injected	O
into	O
C57BL	O
/	O
6J	O
blastocysts	O
to	O
produce	O
chimeric	O
mice	B-Taxon
using	O
standard	O
procedures	O
.	O

Heterozygous	O
offspring	O
from	O
germline	O
competent	O
chimeras	O
were	O
intercrossed	O
to	O
produce	O
wild	B-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
,	O
heterozygous	O
(	O
+	B-SO
/	O
-	O
)	O
and	O
homozygous	O
knockout	O
(	O
-	O
/	O
-	O
)	O
mice	B-Taxon
.	O

At	O
all	O
generations	O
,	O
+	B-SO
/	O
-	O
breeding	O
pairs	O
were	O
used	O
.	O

Results	O
presented	O
here	O
are	O
from	O
mice	B-Taxon
derived	O
from	O
the	O
F2	O
+	O
generations	O
.	O

All	O
animals	B-Taxon
were	O
of	O
a	O
mixed	O
C57BL	O
/	O
6J	O
x	O
Strain	O
129Sv	O
/	O
SvJ	O
genetic	B-SO
background	O
.	O

Figure	O
1	O

E2	B-GGP
gene	B-SO
knockout	O
mouse	B-Taxon
production	O
.	O

A	O
,	O
Gene	B-SO
targeting	O
strategy	O
used	O
for	O
targeting	O
the	O
E2	B-GGP
locus	B-SO
in	O
mouse	B-Taxon
ES	O
cells	B-CL
.	O

The	O
targeting	O
construct	B-SO
was	O
designed	O
to	O
delete	B-SO
1	O
.	O
67	O
kb	O
of	O
sequence	B-SO
between	O
an	O
EcoRV	O
site	B-SO
in	I-SO
Exon	I-SO
4	O
and	O
a	O
Smal	O
site	B-SO
in	O
intron	B-SO
5	O
.	O

The	O
wild	B-SO
type	I-SO
E2	B-GGP
gene	B-SO
contains	O
an	O
~	O
16	O
kb	O
BglI	O
restriction	B-SO
fragment	I-SO
that	O
hybridizes	O
to	O
the	O
Exon	B-SO
6	O
specific	O
probe	B-SO
.	O

A	O
correctly	O
targeted	O
E2	B-GGP
locus	B-SO
harbors	O
an	O
~	O
11	O
kb	O
BglI	O
restriction	B-SO
fragment	I-SO
that	O
hybridizes	O
to	O
the	O
same	O
probe	B-SO
.	O

Note	O
that	O
the	O
probe	B-SO
will	O
not	O
detect	O
random	O
integration	B-SO
of	O
the	O
targeting	O
vector	B-SO
because	O
it	O
is	O
external	O
to	O
the	O
targeting	O
vector	B-SO
.	O

B	O
,	O
Southern	O
blot	O
analysis	O
of	O
Bgll	O
digested	O
genomic	B-SO
DNA	I-SO
derived	O
from	O
the	O
parental	O
wild	B-SO
type	I-SO
ES	O
cell	B-CL
line	O
(	O
R1	O
)	O
,	O
a	O
heterozygous	O
targeted	O
ES	O
cell	B-CL
line	O
(	O
362	O
)	O
,	O
and	O
from	O
wild	B-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
,	O
heterozygous	O
(	O
+	B-SO
/	O
-	O
)	O
and	O
homozygous	O
knockout	O
(	O
-	O
/	O
-	O
)	O
mice	B-Taxon
.	O

The	O
blot	O
was	O
hybridized	O
with	O
an	O
Exon	B-SO
6	O
specific	O
probe	B-SO
.	O

C	O
,	O
Immunohistochemical	O
analysis	O
of	O
fresh	O
frozen	O
liver	O
sections	O
from	O
control	O
(	O
+	B-SO
/	O
+	B-SO
)	O
and	O
E2	B-GGP
knockout	O
(	O
-	O
/	O
-	O
)	O
postnatal	O
day	O
1	O
mouse	B-Taxon
pups	O
.	O

Sections	O
were	O
stained	O
for	O
E2	B-GGP
using	O
an	O
E2	B-GGP
specific	O
antibody	B-GO
(	O
green	O
)	O
and	O
a	O
nuclear	B-GO
stain	O
(	O
blue	O
)	O
.	O

Note	O
the	O
complete	O
absence	O
of	O
E2	B-GGP
immunoreactivity	O
in	O
the	O
section	O
from	O
the	O
knockout	O
mouse	B-Taxon
.	O

D	O
,	O
Similar	O
results	O
were	O
observed	O
upon	O
immunohistochemical	O
analysis	O
of	O
primary	O
mouse	B-Taxon
embryonic	O
fibroblasts	B-CL
(	O
MEFs	O
)	O
.	O

Note	O
that	O
the	O
readily	O
detectable	O
signal	O
for	O
E2	B-GGP
in	O
the	O
control	O
cells	B-CL
was	O
present	O
in	O
a	O
pattern	O
characteristic	O
of	O
mitochondria	B-GO
,	O
the	O
subcellular	O
location	O
of	O
BCKDH	B-GO
.	O

Production	O
of	O
transgenic	B-SO
mice	B-Taxon

Standard	O
molecular	B-CHEBI
techniques	O
were	O
used	O
to	O
assemble	O
the	O
transgenic	B-SO
construct	B-SO
,	O
pTRE	O
-	O
E2	B-GGP
.	O

This	O
transgene	B-SO
contains	O
the	O
tetracycline	B-CHEBI
responsive	O
hCMV	B-Taxon
*	O
-	O
1	O
promoter	B-SO
[	O
consisting	O
of	O
the	O
tetracycline	B-CHEBI
responsive	O
element	B-SO
(	O
TRE	O
)	O
and	O
a	O
minimal	O
hCMV	B-Taxon
promoter	B-SO
]	O
[	O
25	O
]	O
from	O
pTRE2	O
(	O
Clontech	O
Inc	O
.	O
,	O
Mt	O
.	O
View	O
,	O
CA	O
)	O
,	O
a	O
chimeric	O
intron	B-SO
from	O
pCI	O
(	O
Promega	O
)	O
to	O
increase	O
message	B-SO
stability	O
and	O
expression	O
[	O
26	O
,	O
27	O
]	O
,	O
a	O
Kozak	O
consensus	B-SO
sequence	I-SO
at	O
the	O
initiation	B-SO
codon	I-SO
to	O
optimize	O
translation	O
[	O
28	O
]	O
,	O
the	O
human	B-GGP
E2	I-GGP
cDNA	B-SO
which	O
has	O
been	O
modified	B-SO
to	O
contain	O
a	O
4	O
x	O
alanine	B-CHEBI
linker	O
followed	O
by	O
a	O
c	B-GGP
-	I-GGP
myc	I-GGP
epitope	B-SO
tag	O
at	O
the	O
carboxy	B-SO
terminus	I-SO
to	O
facilitate	O
detection	O
,	O
and	O
an	O
SV40	B-Taxon
late	O
polyadenylation	B-SO
sequence	I-SO
from	O
pCI	O
for	O
enhanced	O
mRNA	B-CHEBI
stability	O
and	O
translation	O
.	O

The	O
2	O
.	O
48	O
kb	O
TRE	O
-	O
E2	B-GGP
transgene	B-SO
was	O
purified	O
from	O
vector	B-SO
sequences	I-SO
following	O
digestion	O
with	O
XhoI	O
and	O
BamHI	O
and	O
injected	O
into	O
C57BL	O
/	O
6J	O
or	O
C57BL	O
/	O
6J	O
x	O
Strain	O
129SvEv	O
mouse	B-Taxon
embryos	O
at	O
the	O
transgenic	B-SO
core	O
facilities	O
of	O
the	O
University	O
of	O
Pittsburgh	O
and	O
the	O
University	O
of	O
Cincinnati	O
,	O
respectively	O
.	O

Genomic	B-SO
DNA	I-SO
from	O
the	O
tail	O
of	O
mice	B-Taxon
was	O
screened	O
by	O
Southern	O
blot	O
analysis	O
following	O
digestion	O
with	O
EcoRI	O
and	O
hybridization	O
to	O
an	O
~	O
400	O
bp	B-SO
probe	B-SO
derived	O
from	O
the	O
SV40	B-Taxon
portion	B-SO
of	O
the	O
TRE	O
-	O
E2	B-GGP
transgene	B-SO
.	O

Production	O
of	O
intermediate	O
MSUD	O
murine	B-Taxon
model	O

The	O
various	O
TRE	O
-	O
E2	B-GGP
transgenic	B-SO
lines	O
produced	O
were	O
mated	O
independently	O
to	O
mice	B-Taxon
that	O
were	O
heterozygous	O
for	O
both	O
the	O
E2	B-GGP
knockout	O
and	O
the	O
LAP	B-GGP
-	O
tTA	O
transgene	B-SO
[	O
Tg	B-SO
(	O
tTALap	O
)	O
Bjd	O
/	O
J	O
;	O
Stock	O
3272	O
;	O
The	O
Jackson	O
Laboratory	O
,	O
Bar	O
Harbor	O
,	O
ME	O
;	O
NMRI	O
x	O
FVB	O
x	O
C57BL	O
/	O
6J	O
background	O
]	O
.	O

Interbreeding	O
of	O
animals	B-Taxon
that	O
were	O
heterozygous	O
for	O
both	O
transgenes	B-SO
and	O
the	O
knockout	O
resulted	O
in	O
the	O
production	O
of	O
mice	B-Taxon
with	O
a	O
variety	O
of	O
genotypes	B-SO
including	O
some	O
animals	B-Taxon
that	O
were	O
homozygous	O
for	O
the	O
knockout	O
and	O
were	O
positive	O
for	O
both	O
transgenes	B-SO
(	O
we	O
refer	O
to	O
this	O
genotype	B-SO
as	O
the	O
"	O
rescue	B-SO
"	O
genotype	B-SO
)	O
.	O

If	O
our	O
strategy	O
for	O
rescuing	O
the	O
neonatal	O
lethal	O
phenotype	O
of	O
the	O
knockout	O
were	O
successful	O
,	O
then	O
those	O
homozygous	O
knockout	O
animals	B-Taxon
that	O
had	O
both	O
transgenes	B-SO
would	O
survive	O
beyond	O
the	O
neonatal	O
period	O
.	O

Genotyping	O

All	O
mice	B-Taxon
were	O
genotyped	O
by	O
Southern	O
blot	O
analysis	O
.	O

Genomic	B-SO
DNAs	I-SO
prepared	O
from	O
tail	O
snips	O
were	O
digested	O
with	O
an	O
appropriate	O
restriction	O
enzyme	B-SO
,	O
size	O
fractionated	O
by	O
agarose	B-CHEBI
gel	O
electrophoresis	O
,	O
blotted	O
to	O
nylon	B-CHEBI
,	O
and	O
probed	O
using	O
standard	O
procedures	O
.	O

Immunohistochemistry	O

Primary	O
mouse	B-Taxon
embryonic	O
fibroblasts	B-CL
were	O
prepared	O
from	O
embryonic	O
day	O
~	O
16	O
.	O
5	O
-	O
18	O
.	O
5	O
fetuses	O
as	O
described	O
[	O
29	O
]	O
.	O

Fibroblasts	B-CL
were	O
passed	O
onto	O
glass	O
,	O
fixed	O
in	O
2	O
%	O
paraformaldehyde	O
in	O
PBS	O
for	O
10	O
minutes	O
,	O
permeabilized	O
in	O
2	O
%	O
paraformaldehyde	O
containing	O
0	O
.	O
1	O
%	O
Triton	O
X100	O
for	O
10	O
minutes	O
and	O
washed	O
three	O
times	O
in	O
PBS	O
containing	O
0	O
.	O
5	O
%	O
BSA	B-GGP
and	O
0	O
.	O
15	O
%	O
glycine	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
(	O
Buffer	O
A	O
)	O
.	O

Following	O
a	O
30	O
min	O
incubation	O
with	O
purified	O
goat	B-Taxon
IgG	O
(	O
50	O
(	O
mu	O
g	O
/	O
ml	O
)	O
at	O
25	O
degrees	O
C	O
and	O
three	O
additional	O
washes	O
with	O
Buffer	O
A	O
,	O
cells	B-CL
were	O
incubated	O
for	O
60	O
min	O
with	O
E2	B-GGP
-	O
specific	O
antiserum	O
[	O
30	O
]	O
at	O
1	O
mu	O
g	O
/	O
ml	O
followed	O
by	O
three	O
washes	O
in	O
Buffer	O
A	O
and	O
60	O
minute	O
incubation	O
in	O
fluorescently	B-CHEBI
labeled	I-CHEBI
second	O
antibody	B-GO
(	O
1	O
-	O
2	O
mu	O
g	O
/	O
ml	O
)	O
.	O

The	O
cells	B-CL
were	O
then	O
washed	O
six	O
times	O
(	O
5	O
min	O
/	O
wash	O
)	O
in	O
Buffer	O
A	O
and	O
then	O
mounted	O
in	O
gelvatol	B-CHEBI
(	O
Monsanto	O
,	O
St	O
Louis	O
)	O
.	O

When	O
livers	O
from	O
newborn	O
pups	O
were	O
examined	O
,	O
fixation	O
was	O
by	O
immersion	O
in	O
2	O
%	O
paraformaldehyde	O
followed	O
by	O
cryoprotection	O
and	O
shock	O
freezing	O
in	O
liquid	O
nitrogen	B-CHEBI
cooled	O
isopentane	B-CHEBI
and	O
sectioning	O
(	O
5	O
microns	O
)	O
.	O

Otherwise	O
processing	O
was	O
as	O
for	O
the	O
cells	B-CL
above	O
(	O
without	O
the	O
fixation	O
and	O
permabilization	O
steps	O
)	O
.	O

Amino	B-CHEBI
acid	I-CHEBI
analysis	O

Blood	O
was	O
collected	O
from	O
the	O
retroorbital	O
sinus	O
or	O
tail	O
vein	O
of	O
mice	B-Taxon
and	O
spotted	O
on	O
a	O
filter	O
paper	O
routinely	O
used	O
for	O
blood	O
amino	B-CHEBI
acid	I-CHEBI
analysis	O
for	O
prenatal	O
screening	O
.	O

Concentrations	O
of	O
BCAA	B-CHEBI
and	O
other	O
amino	B-CHEBI
acids	I-CHEBI
in	O
blood	O
were	O
determined	O
by	O
tandem	O
mass	O
spectrometry	O
(	O
Pediatrix	O
Screening	O
,	O
Bridgeville	O
,	O
PA	O
)	O
.	O

Assay	O
of	O
BCKDH	B-GO
activity	O

Livers	O
were	O
removed	O
,	O
frozen	O
in	O
liquid	O
nitrogen	B-CHEBI
,	O
and	O
stored	O
at	O
-	O
80	O
degrees	O
C	O
.	O

At	O
the	O
time	O
of	O
enzyme	B-SO
assay	O
,	O
livers	O
were	O
thawed	O
,	O
and	O
homogenized	O
(	O
1	O
:	O
9	O
,	O
w	O
/	O
v	O
)	O
in	O
0	O
.	O
25	O
M	O
sucrose	B-CHEBI
,	O
10	O
mM	O
Tris	B-CHEBI
-	O
HC1	B-CHEBI
,	O
pH	O
7	O
.	O
4	O
.	O

Liver	O
homogenates	O
were	O
centrifuged	O
at	O
600	O
x	O
g	O
for	O
10	O
min	O
at	O
4	O
degrees	O
C	O
and	O
the	O
supernatant	O
fraction	B-GO
was	O
saved	O
to	O
determine	O
the	O
BCKDH	B-GO
activity	O
.	O

The	O
use	O
of	O
tissue	O
homogenates	O
was	O
necessitated	O
by	O
the	O
limited	O
availability	O
of	O
liver	O
tissue	O
,	O
particularly	O
from	O
newborn	O
pups	O
.	O

BCKDH	B-GO
activity	O
was	O
determined	O
by	O
measuring	O
the	O
release	O
of	O
14CO2	O
from	O
alpha	B-CHEBI
-	I-CHEBI
keto	I-CHEBI
[	I-CHEBI
1	I-CHEBI
-	I-CHEBI
14C	I-CHEBI
]	I-CHEBI
isocaproate	I-CHEBI
as	O
described	O
previously	O
[	O
31	O
]	O
.	O

The	O
complete	O
reaction	O
mixture	O
contained	O
(	O
final	O
volume	O
1	O
ml	O
)	O
30	O
mM	O
potassium	B-CHEBI
phosphate	B-CHEBI
buffer	O
,	O
pH	O
7	O
.	O
4	O
,	O
0	O
.	O
20	O
mM	O
alpha	B-CHEBI
-	I-CHEBI
ketoisocaproate	I-CHEBI
,	O
0	O
.	O
40	O
mM	O
CoASH	B-CHEBI
,	O
0	O
.	O
40	O
mM	O
thiamin	B-CHEBI
pyrophosphate	I-CHEBI
,	O
2	O
mM	O
NAD	B-CHEBI
+	I-CHEBI
,	O
2	O
mM	O
dithiothreitol	B-CHEBI
,	O
5	O
mM	O
Mg2	B-CHEBI
+	I-CHEBI
,	O
approximately	O
250	O
,	O
000	O
DPM	O
of	O
alpha	B-CHEBI
-	I-CHEBI
keto	I-CHEBI
[	I-CHEBI
1	I-CHEBI
-	I-CHEBI
14C	I-CHEBI
]	I-CHEBI
isocaproate	I-CHEBI
,	O
and	O
0	O
.	O
10	O
ml	O
of	O
liver	O
homogenate	O
(	O
2	O
-	O
3	O
mg	O
protein	B-CHEBI
)	O
.	O

Assays	O
were	O
carried	O
out	O
for	O
15	O
min	O
at	O
37	O
degrees	O
C	O
,	O
14CO2	O
was	O
trapped	O
in	O
hydroxide	B-CHEBI
of	O
Hyamine	O
,	O
and	O
radioactivity	O
was	O
determined	O
by	O
liquid	O
scintillation	O
spectrometry	O
.	O

Western	O
blot	O
analysis	O

Protein	B-CHEBI
extracts	O
were	O
isolated	O
from	O
homogenized	O
liver	O
(	O
freshly	O
harvested	O
and	O
flash	O
frozen	O
)	O
of	O
wildtype	B-SO
,	O
Line	O
525A	O
,	O
and	O
Line	O
A	O
transgenic	B-SO
mice	B-Taxon
.	O

Protein	B-CHEBI
(	O
25	O
mu	O
g	O
per	O
sample	O
)	O
was	O
analyzed	O
by	O
electrophoresis	O
on	O
a	O
10	O
%	O
SDS	B-CHEBI
-	O
PAGE	O
Ready	O
Gel	O
(	O
Bio	O
-	O
Rad	O
,	O
Hercules	O
,	O
CA	O
)	O
and	O
transferred	O
to	O
PVDF	O
membrane	O
(	O
Sequi	O
-	O
Blot	O
;	O
Bio	O
-	O
Rad	O
)	O
via	O
electroblotting	O
.	O

All	O
blots	O
were	O
probed	O
for	O
E2	B-GGP
protein	B-CHEBI
using	O
polyclonal	O
rabbit	B-Taxon
E2	B-GGP
antisera	O
(	O
1	O
:	O
5	O
,	O
000	O
)	O
,	O
which	O
detects	O
both	O
mouse	B-GGP
(	I-GGP
~	I-GGP
47	I-GGP
kD	I-GGP
)	I-GGP
and	I-GGP
human	I-GGP
(	I-GGP
~	I-GGP
54	I-GGP
kD	I-GGP
)	I-GGP
E2	I-GGP
subunits	I-GGP
(	O
[	O
30	O
]	O
;	O
gift	O
from	O
Dr	O
.	O
Susan	O
Hutson	O
,	O
Wake	O
Forest	O
University	O
)	O
.	O

Blots	O
were	O
re	O
-	O
probed	O
with	O
a	O
rabbit	B-Taxon
anti	O
-	O
c	B-GGP
-	I-GGP
myc	I-GGP
tag	O
antibody	B-GO
(	O
1	O
:	O
10	O
,	O
000	O
;	O
abCam	O
,	O
Cambridge	O
,	O
MA	O
;	O
cat	O
.	O
#	O
ab9106	O
-	O
100	O
)	O
.	O

Blots	O
were	O
also	O
re	O
-	O
probed	O
with	O
an	O
antibody	B-GO
for	O
beta	B-GGP
-	I-GGP
actin	I-GGP
(	O
43	O
kD	O
;	O
1	O
:	O
10	O
,	O
000	O
;	O
abCam	O
;	O
cat	O
.	O
#	O
ab8227	O
-	O
50	O
)	O
to	O
allow	O
for	O
loading	O
comparisons	O
.	O

A	O
goat	B-Taxon
anti	O
-	O
rabbit	B-Taxon
secondary	O
antibody	B-GO
conjugated	O
to	O
horseradish	B-Taxon
peroxidase	O
(	O
1	O
:	O
10	O
,	O
000	O
;	O
Novus	O
,	O
Littleton	O
,	O
CO	O
;	O
cat	O
.	O
#	O
NB730	O
-	O
H	O
)	O
was	O
used	O
for	O
detection	O
using	O
the	O
Western	O
Lightning	O
chemiluminescence	O
reagent	B-CHEBI
(	O
Perkin	O
Elmer	O
,	O
Boston	O
,	O
MA	O
)	O
and	O
exposed	O
to	O
X	O
-	O
ray	O
film	O
.	O

Statistical	O
analyses	O

All	O
BCAA	B-CHEBI
and	O
BCKDH	B-GO
enzyme	B-SO
activity	O
data	O
are	O
presented	O
as	O
the	O
mean	O
+	O
/	O
-	O
the	O
standard	O
error	O
of	O
the	O
mean	O
(	O
S	O
.	O
E	O
.	O
M	O
.	O
)	O
.	O

Differences	O
between	O
genotypes	B-SO
were	O
compared	O
by	O
Student	O
'	O
s	O
t	O
test	O
[	O
32	O
]	O
.	O

Results	O

Production	O
of	O
E2	B-GGP
gene	B-SO
knockout	O
mice	B-Taxon

To	O
create	O
E2	B-GGP
knockout	O
mice	B-Taxon
,	O
we	O
used	O
gene	B-SO
targeting	O
in	O
mouse	B-Taxon
ES	O
cells	B-CL
to	O
disrupt	O
the	O
E2	B-GGP
gene	B-SO
.	O

The	O
overall	O
strategy	O
for	O
disrupting	O
the	O
E2	B-GGP
gene	B-SO
is	O
illustrated	O
in	O
Fig	O
.	O

1A	O
.	O

The	O
gene	B-SO
targeting	O
construct	B-SO
was	O
designed	O
to	O
replace	B-SO
a	O
1	O
.	O
67	O
kb	O
EcoRV	O
/	O
Smal	O
genomic	B-SO
DNA	I-SO
fragment	B-SO
encompassing	O
part	B-SO
of	I-SO
Exon	I-SO
4	O
and	O
all	O
of	O
Exon	B-SO
5	O
with	O
the	O
PGKneo	O
selectable	O
marker	O
cassette	B-SO
.	O

Of	O
522	O
ES	O
cell	B-CL
clones	O
screened	O
for	O
targeting	O
by	O
Southern	O
blot	O
analysis	O
,	O
29	O
(	O
5	O
%	O
)	O
displayed	O
the	O
predicted	B-SO
restriction	B-SO
fragment	I-SO
length	I-SO
polymorphisms	I-SO
indicative	O
of	O
gene	B-SO
targeting	O
at	O
the	O
E2	B-GGP
locus	B-SO
.	O

As	O
illustrated	O
in	O
Fig	O
.	O

1A	O
and	O
1B	O
,	O
an	O
E2	B-GGP
Exon	B-SO
6	O
specific	O
probe	B-SO
,	O
which	O
is	O
external	O
to	O
the	O
targeting	O
construct	B-SO
,	O
hybridizes	O
to	O
only	O
a	O
~	O
16	O
kb	O
BglI	O
restriction	B-SO
fragment	I-SO
from	O
the	O
wild	B-SO
type	I-SO
allele	B-SO
in	O
the	O
parental	O
R1	O
ES	O
cell	B-CL
line	O
.	O

In	O
correctly	O
targeted	O
ES	O
cells	B-CL
,	O
this	O
probe	B-SO
also	O
hybridizes	O
to	O
a	O
~	O
11	O
kb	O
BglI	O
restriction	B-SO
fragment	I-SO
.	O

Targeting	O
was	O
confirmed	O
with	O
several	O
additional	O
restriction	O
enzymes	B-SO
and	O
probes	B-SO
(	O
data	O
not	O
shown	O
)	O
.	O

Correctly	O
targeted	O
ES	O
cells	B-CL
were	O
microinjected	O
into	O
blastocysts	O
to	O
produce	O
chimeric	O
mice	B-Taxon
.	O

Chimerics	O
were	O
bred	O
to	O
C57BL	O
/	O
6J	O
mice	B-Taxon
.	O

Following	O
germline	O
transmission	O
of	O
the	O
targeted	O
allele	B-SO
,	O
heterozygous	O
mice	B-Taxon
were	O
interbred	O
to	O
produce	O
wild	B-SO
type	I-SO
(	O
+	B-SO
/	O
+	B-SO
)	O
,	O
heterozygous	O
(	O
+	B-SO
/	O
-	O
)	O
and	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
animals	B-Taxon
.	O

Mice	B-Taxon
were	O
genotyped	O
by	O
Southern	O
blot	O
analysis	O
.	O

The	O
Exon	B-SO
6	O
specific	O
probe	B-SO
hybridized	O
to	O
only	O
a	O
~	O
16	O
kb	O
BglI	O
restriction	B-SO
fragment	I-SO
in	O
+	B-SO
/	O
+	B-SO
mice	B-Taxon
,	O
a	O
~	O
11	O
kb	O
BglI	O
fragment	B-SO
in	O
-	O
/	O
-	O
mice	B-Taxon
,	O
and	O
to	O
both	O
of	O
these	O
fragments	B-SO
in	O
+	B-SO
/	O
-	O
mice	B-Taxon
(	O
Fig	O
.	O
1B	O
)	O
.	O

Mice	B-Taxon
homozygous	O
for	O
the	O
E2	B-GGP
mutation	B-SO
were	O
born	O
at	O
the	O
expected	O
frequency	O
.	O

Genotype	B-SO
analysis	O
of	O
pups	O
derived	O
from	O
+	B-SO
/	O
-	O
by	O
+	B-SO
/	O
-	O
matings	O
revealed	O
that	O
+	B-SO
/	O
+	B-SO
,	O
+	B-SO
/	O
-	O
,	O
and	O
-	O
/	O
-	O
mice	B-Taxon
were	O
present	O
at	O
nearly	O
the	O
expected	O
1	O
:	O
2	O
:	O
1	O
frequency	O
.	O

Of	O
the	O
initial	O
60	O
animals	B-Taxon
genotyped	O
,	O
19	O
(	O
32	O
%	O
)	O
were	O
+	B-SO
/	O
+	B-SO
,	O
27	O
(	O
45	O
%	O
)	O
were	O
+	B-SO
/	O
-	O
,	O
and	O
14	O
(	O
23	O
%	O
)	O
were	O
-	O
/	O
-	O
.	O

Thus	O
,	O
the	O
E2	B-GGP
gene	B-SO
was	O
dispensable	O
for	O
normal	O
embryonic	O
development	O
.	O

However	O
,	O
as	O
expected	O
,	O
nearly	O
all	O
homozygous	O
mice	B-Taxon
died	O
in	O
the	O
perinatal	O
period	O
.	O

Immediately	O
following	O
birth	O
,	O
homozygous	O
pups	O
were	O
indistinguishable	O
from	O
their	O
+	B-SO
/	O
+	B-SO
and	O
+	B-SO
/	O
-	O
littermates	O
;	O
they	O
were	O
vigorous	O
,	O
active	O
and	O
able	O
to	O
suckle	O
.	O

By	O
mid	O
to	O
late	O
day	O
on	O
postnatal	O
day	O
one	O
,	O
most	O
-	O
/	O
-	O
pups	O
became	O
moribund	O
and	O
were	O
readily	O
identifiable	O
as	O
they	O
were	O
lethargic	O
,	O
pale	O
,	O
and	O
exhibited	O
gasping	O
respiratory	O
movements	O
.	O

With	O
few	O
exceptions	O
,	O
-	O
/	O
-	O
pups	O
died	O
within	O
72	O
hours	O
of	O
birth	O
.	O

We	O
have	O
observed	O
one	O
rare	O
-	O
/	O
-	O
pup	O
that	O
survived	O
to	O
postnatal	O
day	O
13	O
.	O

The	O
reason	O
for	O
the	O
prolonged	O
survival	O
of	O
this	O
pup	O
is	O
unknown	O
.	O

E2	B-GGP
deficient	O
mice	B-Taxon
accurately	O
model	O
classic	O
MSUD	O

To	O
demonstrate	O
that	O
the	O
gene	B-SO
targeting	O
event	O
created	O
a	O
true	O
E2	B-GGP
null	O
allele	B-SO
,	O
we	O
determined	O
BCKDH	B-GO
activity	O
in	O
liver	O
homogenates	O
of	O
postnatal	O
day	O
1	O
mouse	B-Taxon
pups	O
derived	O
from	O
+	B-SO
/	O
-	O
by	O
+	B-SO
/	O
-	O
mating	O
pairs	O
.	O

As	O
shown	O
in	O
Figure	O
2A	O
,	O
the	O
BCKDH	B-GO
activity	O
in	O
+	B-SO
/	O
+	B-SO
mice	B-Taxon
was	O
readily	O
detectable	O
.	O

In	O
marked	O
contrast	O
,	O
BCKDH	B-GO
activity	O
was	O
completely	O
absent	O
in	O
-	O
/	O
-	O
mouse	B-Taxon
livers	O
.	O

As	O
expected	O
,	O
homogenates	O
from	O
+	B-SO
/	O
-	O
mice	B-Taxon
had	O
approximately	O
half	O
the	O
activity	O
of	O
their	O
+	B-SO
/	O
+	B-SO
littermates	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
results	O
from	O
-	O
/	O
-	O
mice	B-Taxon
are	O
similar	O
to	O
that	O
observed	O
in	O
humans	B-Taxon
with	O
classic	O
MSUD	O
[	O
1	O
]	O
.	O

Figure	O
2	O

Biochemical	O
characterization	O
of	O
the	O
classic	O
MSUD	O
murine	B-Taxon
model	O
.	O

A	O
,	O
BCKDH	B-GO
enzyme	B-SO
activity	O
in	O
liver	O
of	O
newborn	O
wild	B-SO
type	I-SO
control	O
(	O
+	B-SO
/	O
+	B-SO
)	O
,	O
heterozygous	O
(	O
+	B-SO
/	O
-	O
)	O
,	O
and	O
homozygous	O
(	O
-	O
/	O
-	O
)	O
knockout	O
mice	B-Taxon
.	O

Enzyme	B-SO
activity	O
was	O
significantly	O
reduced	O
in	O
+	B-SO
/	O
-	O
liver	O
compared	O
to	O
+	B-SO
/	O
+	B-SO
,	O
and	O
was	O
below	O
the	O
level	O
of	O
detection	O
in	O
-	O
/	O
-	O
liver	O
.	O

B	O
,	O
Total	O
BCAA	B-CHEBI
concentrations	O
in	O
blood	O
of	O
mice	B-Taxon
.	O

Total	O
BCAA	B-CHEBI
represent	O
the	O
sum	O
of	O
leucine	B-CHEBI
,	O
isoleucine	B-CHEBI
,	O
and	O
valine	B-CHEBI
.	O

Total	O
BCAA	B-CHEBI
concentrations	O
in	O
blood	O
from	O
-	O
/	O
-	O
mice	B-Taxon
were	O
significantly	O
elevated	O
compared	O
to	O
+	B-SO
/	O
+	B-SO
and	O
+	B-SO
/	O
-	O
.	O

C	O
,	O
Ratio	O
of	O
total	O
BCAA	B-CHEBI
to	O
alanine	B-CHEBI
in	O
blood	O
of	O
mice	B-Taxon
.	O

This	O
ratio	O
was	O
significantly	O
elevated	O
in	O
-	O
/	O
-	O
mice	B-Taxon
compared	O
to	O
+	B-SO
/	O
+	B-SO
and	O
+	B-SO
/	O
-	O
mice	B-Taxon
.	O

The	O
numbers	O
on	O
the	O
bars	O
indicates	O
the	O
number	O
of	O
mice	B-Taxon
analyzed	O
.	O

*	O
,	O
Significantly	O
different	O
from	O
+	B-SO
/	O
+	B-SO
(	O
P	O
<	O
0	O
.	O
001	O
)	O
;	O
*	O
*	O
,	O
significantly	O
different	O
from	O
+	B-SO
/	O
+	B-SO
and	O
+	B-SO
/	O
-	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

Immunohistochemistry	O
with	O
an	O
E2	B-GGP
specific	O
antibody	B-GO
was	O
used	O
to	O
examine	O
E2	B-GGP
protein	B-CHEBI
in	O
the	O
mice	B-Taxon
.	O

As	O
shown	O
in	O
Figure	O
1C	O
and	O
1D	O
,	O
immunoreactive	O
E2	B-GGP
protein	B-CHEBI
was	O
abundant	O
in	O
liver	O
and	O
embryonic	O
fibroblasts	B-CL
of	O
+	B-SO
/	O
+	B-SO
mice	B-Taxon
.	O

In	O
marked	O
contrast	O
,	O
immunoreactive	O
E2	B-GGP
protein	B-CHEBI
was	O
absent	O
in	O
these	O
same	O
tissues	O
of	O
-	O
/	O
-	O
mice	B-Taxon
.	O

Homozygous	O
E2	B-GGP
knockout	O
mice	B-Taxon
had	O
a	O
nearly	O
3	O
-	O
fold	O
increase	O
in	O
blood	O
(	O
Figure	O
2B	O
)	O
and	O
urine	O
(	O
data	O
not	O
shown	O
)	O
levels	O
of	O
BCAA	B-CHEBI
(	O
sum	O
of	O
leucine	B-CHEBI
,	O
isoleucine	B-CHEBI
,	O
and	O
valine	B-CHEBI
)	O
as	O
compared	O
to	O
their	O
+	B-SO
/	O
+	B-SO
littermates	O
.	O

Because	O
amino	B-CHEBI
acids	I-CHEBI
were	O
analyzed	O
by	O
tandem	O
mass	O
spectrometry	O
,	O
the	O
sum	O
of	O
BCAA	B-CHEBI
shown	O
in	O
Figure	O
2B	O
also	O
may	O
include	O
alloisoleucine	B-CHEBI
that	O
may	O
have	O
been	O
produced	O
in	O
-	O
/	O
-	O
MSUD	O
mice	B-Taxon
.	O

The	O
metabolism	O
of	O
BCAA	B-CHEBI
is	O
linked	O
with	O
the	O
synthesis	O
of	O
alanine	B-CHEBI
,	O
glutamate	B-CHEBI
,	O
and	O
glutamine	B-CHEBI
[	O
33	O
]	O
.	O

Because	O
of	O
impaired	O
metabolism	O
of	O
BCAA	B-CHEBI
in	O
MSUD	O
mice	B-Taxon
,	O
and	O
to	O
further	O
characterize	O
the	O
abnormal	O
biochemistry	O
in	O
this	O
model	O
,	O
we	O
analyzed	O
the	O
blood	O
levels	O
of	O
the	O
alanine	B-CHEBI
,	O
glutamate	B-CHEBI
,	O
and	O
glutamine	B-CHEBI
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
levels	O
of	O
all	O
three	O
amino	B-CHEBI
acids	I-CHEBI
in	O
homozygous	O
mice	B-Taxon
were	O
markedly	O
lower	O
than	O
the	O
levels	O
in	O
+	B-SO
/	O
+	B-SO
or	O
+	B-SO
/	O
-	O
mice	B-Taxon
.	O

The	O
levels	O
of	O
these	O
amino	B-CHEBI
acids	I-CHEBI
in	O
the	O
+	B-SO
/	O
-	O
mice	B-Taxon
were	O
comparable	O
to	O
those	O
in	O
+	B-SO
/	O
+	B-SO
mice	B-Taxon
(	O
Table	O
1	O
)	O
.	O

Because	O
of	O
the	O
abnormal	O
decrease	O
in	O
the	O
blood	O
alanine	B-CHEBI
level	O
and	O
marked	O
rise	O
in	O
blood	O
BCAA	B-CHEBI
levels	O
that	O
are	O
characteristic	O
of	O
MSUD	O
,	O
a	O
recent	O
report	O
on	O
MSUD	O
patients	O
has	O
suggested	O
that	O
the	O
ratio	O
of	O
BCAA	B-CHEBI
/	O
alanine	B-CHEBI
provides	O
a	O
more	O
sensitive	O
measure	O
of	O
the	O
abnormal	O
biochemistry	O
of	O
MSUD	O
than	O
BCAA	B-CHEBI
level	O
alone	O
[	O
8	O
]	O
.	O

Therefore	O
,	O
we	O
also	O
expressed	O
the	O
amino	B-CHEBI
acid	I-CHEBI
results	O
as	O
BCAA	B-CHEBI
/	O
alanine	B-CHEBI
ratio	O
.	O

As	O
shown	O
in	O
Figure	O
2C	O
,	O
this	O
ratio	O
in	O
-	O
/	O
-	O
pups	O
was	O
more	O
than	O
6	O
-	O
fold	O
higher	O
than	O
+	B-SO
/	O
+	B-SO
or	O
+	B-SO
/	O
-	O
littermates	O
.	O

These	O
blood	O
amino	B-CHEBI
acid	I-CHEBI
results	O
are	O
consistent	O
with	O
the	O
concentrations	O
seen	O
in	O
patients	O
with	O
MSUD	O
[	O
1	O
,	O
8	O
,	O
15	O
]	O
.	O

Table	O
1	O

Summary	O
of	O
additional	O
blood	O
amino	B-CHEBI
acid	I-CHEBI
levels	O
in	O
the	O
classic	O
MSUD	O
model	O
and	O
control	O
littermates	O
as	O
determined	O
by	O
tandem	O
mass	O
spectrometry	O
.	O

All	O
samples	O
were	O
collected	O
on	O
the	O
day	O
of	O
birth	O
.	O

All	O
values	O
are	O
mean	O
+	O
/	O
-	O
SEM	O
.	O

*	O
:	O
Significantly	O
different	O
from	O
+	B-SO
/	O
+	B-SO
and	O
+	B-SO
/	O
-	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

In	O
summary	O
,	O
E2	B-GGP
knockout	O
mice	B-Taxon
lack	O
BCKDH	B-GO
enzymatic	B-SO
activity	O
,	O
E2	B-GGP
immunoreactivity	O
,	O
and	O
have	O
markedly	O
elevated	O
levels	O
of	O
BCAA	B-CHEBI
in	O
the	O
blood	O
and	O
urine	O
.	O

These	O
metabolic	O
derangements	O
ultimately	O
result	O
in	O
neonatal	O
lethality	O
.	O

These	O
phenotypes	O
are	O
remarkably	O
similar	O
to	O
that	O
observed	O
in	O
humans	B-Taxon
with	O
the	O
classic	O
form	O
of	O
MSUD	O
.	O

Thus	O
,	O
E2	B-GGP
knockout	O
mice	B-Taxon
closely	O
model	O
classic	O
MSUD	O
.	O

Knockout	O
mice	B-Taxon
expressing	O
a	O
human	B-GGP
E2	I-GGP
transgene	B-SO
model	O
a	O
variant	O
form	O
of	O
MSUD	O
that	O
mimics	O
intermediate	O
MSUD	O

To	O
create	O
a	O
murine	B-Taxon
model	O
of	O
the	O
intermediate	O
variant	O
form	O
of	O
MSUD	O
,	O
we	O
used	O
a	O
transgenic	B-SO
strategy	O
to	O
rescue	O
the	O
severe	O
elevation	O
of	O
BCAA	B-CHEBI
and	O
neonatal	O
lethality	O
that	O
occurs	O
in	O
the	O
classic	O
MSUD	O
mouse	B-Taxon
model	O
.	O

Our	O
strategy	O
was	O
composed	O
of	O
a	O
two	O
part	O
transgenic	B-SO
system	O
to	O
express	O
human	B-GGP
E2	I-GGP
in	O
liver	O
on	O
the	O
E2	B-GGP
knockout	O
background	O
.	O

This	O
bi	O
-	O
transgenic	B-SO
system	O
consisted	O
of	O
a	O
LAP	B-GGP
-	O
tTA	O
transgene	B-SO
and	O
a	O
TRE	O
-	O
E2	B-GGP
transgene	B-SO
(	O
Fig	O
.	O
3A	O
)	O
.	O

The	O
LAP	B-GGP
-	O
tTA	O
transgene	B-SO
[	O
34	O
]	O
directs	O
high	O
levels	O
of	O
liver	O
specific	O
expression	O
of	O
the	O
tetracycline	B-CHEBI
-	O
controlled	O
transactivator	O
(	O
tTA	O
)	O
,	O
a	O
transcription	O
factor	O
that	O
stimulates	O
expression	O
of	O
promoters	B-SO
that	O
harbor	O
a	O
transactivator	O
response	O
element	B-SO
(	O
TRE	O
)	O
.	O

The	O
TRE	O
-	O
E2	B-GGP
transgene	B-SO
was	O
designed	O
to	O
express	O
a	O
human	B-GGP
E2	I-GGP
cDNA	B-SO
from	O
a	O
TRE	O
containing	O
minimal	O
promoter	B-SO
upon	O
stimulation	O
by	O
tTA	O
.	O

Figure	O
3	O

Transgenic	B-SO
mouse	B-Taxon
production	O
and	O
characterization	O
.	O

A	O
,	O
Transgenic	B-SO
strategy	O
used	O
to	O
produce	O
mice	B-Taxon
that	O
express	O
human	B-GGP
E2	I-GGP
.	O

LAP	B-GGP
-	O
tTA	O
transgenic	B-SO
mice	B-Taxon
have	O
been	O
previously	O
described	O
[	O
34	O
]	O
.	O

These	O
mice	B-Taxon
express	O
the	O
tetracycline	B-CHEBI
-	O
controlled	O
transactivator	O
(	O
tTA	O
)	O
from	O
the	O
liver	O
specific	O
LAP	B-GGP
promoter	B-SO
.	O

The	O
TRE	O
-	O
E2	B-GGP
transgene	B-SO
contains	O
the	O
tetracycline	B-CHEBI
response	O
element	B-SO
(	O
TRE	O
)	O
as	O
part	O
of	O
the	O
promoter	B-SO
,	O
a	O
synthetic	B-SO
intron	B-SO
(	O
thin	O
line	O
)	O
,	O
the	O
human	B-GGP
E2	I-GGP
cDNA	B-SO
,	O
an	O
alanine	B-CHEBI
spacer	O
,	O
a	O
c	B-GGP
-	I-GGP
myc	I-GGP
epitope	B-SO
tag	O
,	O
and	O
SV40	B-Taxon
derived	O
polyadenylation	B-SO
sequence	I-SO
.	O

This	O
construct	B-SO
was	O
used	O
to	O
create	O
several	O
lines	O
of	O
transgenic	B-SO
mice	B-Taxon
.	O

B	O
,	O
Western	O
blot	O
analysis	O
of	O
E2	B-GGP
protein	B-CHEBI
in	O
liver	O
of	O
control	O
and	O
intermediate	O
MSUD	O
mice	B-Taxon
.	O

Note	O
that	O
the	O
amount	O
of	O
human	B-GGP
E2	I-GGP
protein	B-CHEBI
(	O
predicted	O
MW	O
~	O
54	O
Kd	O
)	O
in	O
mice	B-Taxon
from	O
Lines	O
A	O
and	O
525	O
A	O
was	O
variable	O
but	O
in	O
many	O
of	O
the	O
animals	B-Taxon
the	O
amount	O
was	O
similar	O
to	O
the	O
amount	O
of	O
mouse	B-GGP
E2	I-GGP
(	O
MW	O
=	O
~	O
47	O
Kd	O
)	O
in	O
control	O
animals	B-Taxon
.	O

Re	O
-	O
probing	O
with	O
a	O
c	B-GGP
-	I-GGP
myc	I-GGP
tag	O
antibody	B-GO
confirmed	O
the	O
presence	O
of	O
the	O
transgene	B-SO
derived	O
,	O
c	B-GGP
-	I-GGP
myc	I-GGP
tagged	O
,	O
human	B-GGP
E2	I-GGP
in	O
transgenic	B-SO
mice	B-Taxon
but	O
not	O
in	O
controls	O
.	O

Western	O
blot	O
analysis	O
of	O
brain	O
(	O
C	O
)	O
,	O
kidney	O
(	O
D	O
)	O
,	O
and	O
muscle	O
(	O
E	O
)	O
revealed	O
negligible	O
amounts	O
of	O
transgene	B-SO
derived	O
E2	B-GGP
in	O
those	O
tissues	O
.	O

All	O
blots	O
were	O
re	O
-	O
probed	O
with	O
an	O
actin	B-GGP
antibody	B-GO
to	O
allow	O
amount	O
of	O
protein	B-CHEBI
loaded	O
in	O
each	O
lane	O
to	O
be	O
compared	O
.	O

LAP	B-GGP
-	O
tTA	O
mice	B-Taxon
were	O
previously	O
produced	O
and	O
characterized	O
by	O
the	O
Bujard	O
laboratory	O
[	O
34	O
]	O
.	O

Pronuclear	B-GO
microinjection	O
was	O
used	O
to	O
produce	O
transgenic	B-SO
mice	B-Taxon
that	O
harbored	O
the	O
TRE	O
-	O
E2	B-GGP
transgene	B-SO
.	O

From	O
injections	O
at	O
the	O
University	O
of	O
Pittsburgh	O
,	O
2	O
transgene	B-SO
positive	O
founders	O
were	O
identified	O
that	O
led	O
to	O
the	O
generation	O
of	O
3	O
different	O
transgenic	B-SO
lines	O
(	O
Lines	O
A	O
,	O
B	O
,	O
&	O
D	O
)	O
.	O

From	O
the	O
injections	O
at	O
the	O
University	O
of	O
Cincinnati	O
,	O
we	O
obtained	O
8	O
transgene	B-SO
positive	O
founders	O
.	O

Subsequent	O
breeding	O
of	O
these	O
founders	O
revealed	O
that	O
many	O
of	O
the	O
animals	B-Taxon
had	O
multiple	O
transgene	B-SO
insertion	B-SO
sites	I-SO
that	O
segregated	O
.	O

We	O
established	O
a	O
total	O
of	O
15	O
different	O
transgenic	B-SO
lines	O
from	O
these	O
founders	O
.	O

Limited	O
resources	O
allowed	O
us	O
to	O
only	O
focus	O
on	O
a	O
total	O
of	O
9	O
of	O
these	O
lines	O
.	O

These	O
lines	O
differed	O
substantially	O
in	O
transgene	B-SO
copy	O
number	O
as	O
compared	O
by	O
Southern	O
blot	O
analysis	O
of	O
tail	O
DNA	B-SO
(	O
data	O
not	O
shown	O
)	O
.	O

Transgenic	B-SO
TRE	O
-	O
E2	B-GGP
mice	B-Taxon
from	O
each	O
line	O
(	O
either	O
founders	O
or	O
F1	O
offspring	O
)	O
were	O
crossed	O
to	O
mice	B-Taxon
that	O
were	O
positive	O
for	O
the	O
LAP	B-GGP
-	O
tTA	O
transgene	B-SO
and	O
were	O
heterozygous	O
for	O
the	O
E2	B-GGP
knockout	O
.	O

Ultimately	O
,	O
breeding	O
pairs	O
were	O
used	O
in	O
which	O
the	O
mice	B-Taxon
were	O
heterozygous	O
for	O
the	O
LAP	B-GGP
-	O
tTA	O
transgene	B-SO
,	O
the	O
TRE	O
-	O
E2	B-GGP
transgene	B-SO
,	O
and	O
the	O
E2	B-GGP
knockout	O
.	O

To	O
efficiently	O
screen	O
for	O
the	O
ability	O
of	O
the	O
transgenes	B-SO
to	O
rescue	O
the	O
knockout	O
from	O
neonatal	O
lethality	O
,	O
we	O
genotyped	O
litters	O
at	O
weaning	O
.	O

This	O
breeding	O
strategy	O
is	O
expected	O
to	O
result	O
in	O
a	O
theoretical	O
maximum	O
of	O
animals	B-Taxon
with	O
the	O
rescue	B-SO
genotype	B-SO
(	O
i	O
.	O
e	O
.	O
,	O
homozygous	O
E2	B-GGP
knockout	O
and	O
positive	O
for	O
both	O
transgenes	B-SO
)	O
of	O
14	O
%	O
.	O

Fig	O
.	O

4A	O
shows	O
the	O
percentage	O
of	O
mice	B-Taxon
alive	O
at	O
weaning	O
with	O
the	O
rescue	B-SO
genotype	B-SO
from	O
each	O
transgenic	B-SO
line	O
tested	O
.	O

Considerable	O
variability	O
was	O
observed	O
between	O
lines	O
.	O

The	O
line	O
with	O
the	O
highest	O
percentage	O
of	O
rescue	O
mice	B-Taxon
at	O
weaning	O
was	O
line	O
525	O
A	O
.	O

Approximately	O
10	O
%	O
of	O
weaned	O
,	O
surviving	O
pups	O
from	O
this	O
line	O
had	O
the	O
rescue	B-SO
genotype	B-SO
.	O

Thus	O
,	O
the	O
525A	O
transgene	B-SO
appears	O
to	O
be	O
highly	O
effective	O
at	O
rescuing	O
the	O
neonatal	O
lethal	O
phenotype	O
of	O
the	O
E2	B-GGP
knockout	O
.	O

In	O
contrast	O
,	O
line	O
520B	O
completely	O
failed	O
to	O
rescue	O
the	O
neonatal	O
lethal	O
phenotype	O
.	O

All	O
other	O
lines	O
tested	O
produced	O
surviving	O
rescue	O
animals	B-Taxon
at	O
a	O
frequency	O
between	O
1	O
and	O
5	O
%	O
of	O
weaned	O
pups	O
.	O

Figure	O
4	O

Characterization	O
of	O
the	O
intermediate	O
MSUD	O
murine	B-Taxon
model	O
.	O

A	O
,	O
Survival	O
analysis	O
of	O
transgenic	B-SO
rescue	O
lines	O
.	O

Presented	O
are	O
percentages	O
of	O
mice	B-Taxon
alive	O
at	O
weaning	O
from	O
each	O
transgenic	B-SO
line	O
tested	O
that	O
had	O
the	O
rescue	B-SO
genotype	B-SO
(	O
i	O
.	O
e	O
.	O
,	O
homozygous	O
for	O
knockout	O
of	O
endogenous	O
E2	B-GGP
and	O
positive	O
for	O
both	O
the	O
LAP	B-GGP
-	O
tTA	O
and	O
TRE	O
-	O
E2	B-GGP
transgenes	B-SO
)	O
.	O

Also	O
plotted	O
is	O
the	O
theoretical	O
maximum	O
frequency	O
at	O
which	O
this	O
genotype	B-SO
is	O
expected	O
in	O
this	O
population	O
of	O
animals	B-Taxon
.	O

The	O
numbers	O
on	O
the	O
bars	O
indicates	O
the	O
numbers	O
of	O
observations	O
for	O
each	O
line	O
.	O

B	O
,	O
Ratio	O
of	O
total	O
BCAA	B-CHEBI
to	O
alanine	B-CHEBI
in	O
blood	O
of	O
mice	B-Taxon
from	O
controls	O
and	O
Lines	O
A	O
and	O
525A	O
.	O

Total	O
BCAA	B-CHEBI
represent	O
the	O
sum	O
of	O
leucine	B-CHEBI
,	O
isoleucine	B-CHEBI
,	O
and	O
valine	B-CHEBI
.	O

BCAA	B-CHEBI
/	O
alanine	B-CHEBI
values	O
were	O
significantly	O
greater	O
for	O
Lines	O
A	O
and	O
525A	O
compared	O
to	O
controls	O
at	O
all	O
ages	O
tested	O
.	O

The	O
numbers	O
on	O
the	O
bars	O
indicates	O
the	O
numbers	O
of	O
samples	O
analyzed	O
.	O

*	O
,	O
P	O
<=	O
0	O
.	O
01	O
;	O
*	O
*	O
,	O
P	O
<	O
0	O
.	O
005	O
.	O

C	O
,	O
BCKDH	B-GO
enzyme	B-SO
activity	O
in	O
liver	O
of	O
control	O
and	O
Lines	O
A	O
and	O
525A	O
mice	B-Taxon
.	O

*	O
,	O
P	O
<=	O
0	O
.	O
001	O
;	O
*	O
*	O
,	O
P	O
<=	O
0	O
.	O
0001	O
.	O

D	O
,	O
Survival	O
curves	O
for	O
mice	B-Taxon
from	O
Lines	O
A	O
and	O
525A	O
.	O

Rescue	B-SO
mice	B-Taxon
alive	O
at	O
weaning	O
were	O
monitored	O
until	O
they	O
were	O
moribund	O
and	O
subsequently	O
sacrificed	O
or	O
were	O
found	O
dead	O
in	O
their	O
cages	O
.	O

Lines	O
A	O
and	O
525A	O
were	O
selected	O
for	O
detailed	O
characterization	O
.	O

Fig	O
.	O

4B	O
shows	O
the	O
results	O
of	O
blood	O
amino	B-CHEBI
acid	I-CHEBI
analysis	O
presented	O
as	O
a	O
ratio	O
of	O
total	O
BCAA	B-CHEBI
to	O
alanine	B-CHEBI
.	O

The	O
BCAA	B-CHEBI
/	O
alanine	B-CHEBI
values	O
for	O
mice	B-Taxon
from	O
both	O
lines	O
were	O
significantly	O
elevated	O
compared	O
to	O
controls	O
for	O
all	O
of	O
the	O
time	O
points	O
analyzed	O
.	O

Note	O
that	O
the	O
BCAA	B-CHEBI
/	O
alanine	B-CHEBI
values	O
for	O
the	O
transgenic	B-SO
mice	B-Taxon
are	O
intermediate	O
between	O
controls	O
and	O
knockouts	O
(	O
see	O
Figure	O
2C	O
)	O
.	O

Blood	O
levels	O
of	O
alanine	B-CHEBI
,	O
glutamate	B-CHEBI
,	O
and	O
glutamine	B-CHEBI
were	O
reduced	O
in	O
Line	O
A	O
mice	B-Taxon
,	O
as	O
was	O
glutamate	B-CHEBI
in	O
Line	O
525A	O
mice	B-Taxon
,	O
compared	O
to	O
controls	O
(	O
Table	O
2	O
)	O
.	O

Table	O
2	O

Summary	O
of	O
additional	O
blood	O
amino	B-CHEBI
acid	I-CHEBI
levels	O
in	O
the	O
intermediate	O
MSUD	O
model	O
and	O
littermate	O
controls	O
as	O
determined	O
by	O
tandem	O
mass	O
spectrometry	O
.	O

Samples	O
were	O
collected	O
from	O
mice	B-Taxon
that	O
were	O
4	O
-	O
6	O
weeks	O
of	O
age	O
.	O

All	O
values	O
are	O
mean	O
+	O
/	O
-	O
SEM	O
.	O

*	O
:	O
Significantly	O
different	O
from	O
control	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

*	O
*	O
:	O
Significantly	O
different	O
from	O
control	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

*	O
*	O
*	O
:	O
Significantly	O
different	O
from	O
Line	O
525A	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Because	O
the	O
LAP	B-GGP
-	O
tTA	O
mice	B-Taxon
that	O
were	O
used	O
to	O
drive	O
expression	O
of	O
transgenic	B-SO
human	B-GGP
E2	I-GGP
have	O
been	O
demonstrated	O
to	O
produce	O
liver	O
specific	O
expression	O
[	O
34	O
]	O
,	O
BCKDH	B-GO
enzyme	B-SO
activity	O
and	O
production	O
of	O
human	B-GGP
E2	I-GGP
protein	B-CHEBI
in	O
liver	O
of	O
Lines	O
A	O
and	O
525A	O
was	O
examined	O
.	O

BCKDH	B-GO
enzymatic	B-SO
activity	O
in	O
liver	O
from	O
Lines	O
A	O
and	O
525A	O
was	O
~	O
6	O
and	O
5	O
%	O
,	O
respectively	O
,	O
of	O
the	O
enzymatic	B-SO
activity	O
present	O
in	O
control	O
liver	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

As	O
shown	O
in	O
Fig	O
.	O

3B	O
,	O
the	O
amount	O
of	O
human	B-GGP
E2	I-GGP
(	O
predicted	O
MW	O
~	O
54	O
Kd	O
)	O
in	O
these	O
transgenic	B-SO
mice	B-Taxon
was	O
quite	O
variable	O
between	O
mice	B-Taxon
.	O

In	O
some	O
of	O
these	O
transgenic	B-SO
mice	B-Taxon
,	O
the	O
level	O
of	O
human	B-GGP
E2	I-GGP
was	O
approximately	O
equal	O
to	O
the	O
amount	O
of	O
mouse	B-GGP
E2	I-GGP
(	O
~	O
47	O
Kd	O
)	O
produced	O
in	O
liver	O
of	O
nontransgenic	O
control	O
mice	B-Taxon
.	O

The	O
observations	O
that	O
these	O
near	O
normal	O
amounts	O
of	O
E2	B-GGP
protein	B-CHEBI
result	O
in	O
only	O
~	O
5	O
-	O
6	O
%	O
of	O
normal	O
BCKDH	B-GO
enzyme	B-SO
activity	O
suggest	O
that	O
transgene	B-SO
derived	O
E2	B-GGP
is	O
functioning	O
at	O
a	O
suboptimal	O
level	O
.	O

It	O
is	O
probable	O
that	O
the	O
c	B-GGP
-	I-GGP
myc	I-GGP
tag	O
at	O
the	O
carboxy	B-SO
terminus	I-SO
of	O
the	O
transgene	B-SO
derived	O
human	B-GGP
E2	I-GGP
interfered	O
with	O
enzymatic	B-SO
activity	O
.	O

This	O
interpretation	O
is	O
consistent	O
with	O
previous	O
studies	O
which	O
have	O
revealed	O
that	O
the	O
carboxy	B-SO
terminus	I-SO
of	O
an	O
analogous	O
subunit	O
of	O
the	O
pyruvate	B-GO
dehydrogenase	I-GO
complex	I-GO
is	O
essential	O
for	O
subunit	O
interactions	O
[	O
35	O
]	O
and	O
insertion	B-SO
of	O
a	O
Hisx6	O
tag	O
on	O
the	O
carboxy	B-SO
terminus	I-SO
of	O
an	O
analogous	O
E	B-Taxon
.	I-Taxon
coli	I-Taxon
subunit	O
interfered	O
with	O
normal	O
subunit	O
assembly	O
[	O
36	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
human	B-GGP
E2	I-GGP
was	O
not	O
fully	O
functional	O
when	O
complexed	O
with	O
mouse	B-GGP
E1	I-GGP
and	I-GGP
E3	I-GGP
subunits	I-GGP
.	O

Human	B-GGP
E2	I-GGP
shares	O
~	O
88	O
%	O
identity	O
to	O
mouse	B-GGP
E2	I-GGP
at	O
the	O
amino	B-CHEBI
acid	I-CHEBI
level	O
.	O

We	O
also	O
used	O
western	O
blot	O
analysis	O
to	O
analyze	O
expression	O
of	O
the	O
E2	B-GGP
transgene	B-SO
in	O
brain	O
,	O
kidney	O
and	O
muscle	O
.	O

As	O
shown	O
in	O
Figure	O
3C	O
,	O
D	O
and	O
3E	O
respectively	O
,	O
expression	O
of	O
E2	B-GGP
is	O
negligible	O
in	O
those	O
tissues	O
.	O

Long	O
-	O
term	O
survival	O
of	O
the	O
mice	B-Taxon
from	O
these	O
two	O
transgenic	B-SO
lines	O
that	O
survived	O
beyond	O
weaning	O
is	O
plotted	O
in	O
Fig	O
.	O

4D	O
.	O

Although	O
survival	O
data	O
for	O
control	O
animals	B-Taxon
was	O
not	O
collected	O
,	O
it	O
is	O
readily	O
apparent	O
that	O
survival	O
of	O
the	O
rescue	O
mice	B-Taxon
was	O
compromised	O
.	O

By	O
16	O
weeks	O
,	O
all	O
mice	B-Taxon
of	O
Line	O
A	O
were	O
moribund	O
and	O
humanely	O
sacrificed	O
,	O
or	O
were	O
found	O
dead	O
in	O
their	O
cage	O
.	O

Survival	O
of	O
Line	O
525A	O
appeared	O
to	O
be	O
somewhat	O
better	O
.	O

At	O
20	O
weeks	O
of	O
age	O
,	O
~	O
12	O
%	O
of	O
mice	B-Taxon
(	O
2	O
of	O
16	O
)	O
were	O
still	O
alive	O
.	O

These	O
two	O
rare	O
survivors	O
died	O
at	O
40	O
and	O
60	O
weeks	O
of	O
age	O
.	O

In	O
summary	O
,	O
these	O
surviving	O
mice	B-Taxon
had	O
BCAA	B-CHEBI
/	O
alanine	B-CHEBI
ratios	O
that	O
were	O
intermediate	O
between	O
controls	O
and	O
knockouts	O
and	O
they	O
expressed	O
~	O
5	O
-	O
6	O
%	O
of	O
normal	O
BCKDH	B-GO
enzyme	B-SO
activity	O
in	O
the	O
liver	O
.	O

These	O
phenotypic	O
observations	O
are	O
remarkably	O
similar	O
to	O
the	O
clinical	O
phenotype	O
observed	O
in	O
MSUD	O
patients	O
with	O
the	O
intermediate	O
form	O
of	O
the	O
disease	O
[	O
1	O
]	O
.	O

Thus	O
,	O
these	O
rescue	O
mice	B-Taxon
represent	O
a	O
very	O
useful	O
model	O
of	O
the	O
intermediate	O
MSUD	O
phenotype	O
.	O

Discussion	O

A	O
major	O
hurdle	O
in	O
developing	O
new	O
treatments	O
for	O
MSUD	O
has	O
been	O
the	O
lack	O
of	O
a	O
practical	O
,	O
accurate	O
animal	B-Taxon
model	O
of	O
the	O
disease	O
.	O

This	O
hurdle	O
has	O
now	O
been	O
overcome	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
development	O
and	O
characterization	O
of	O
two	O
genetically	B-SO
engineered	O
mouse	B-Taxon
models	O
that	O
are	O
phenotypically	O
very	O
similar	O
to	O
MSUD	O
patients	O
with	O
the	O
classic	O
and	O
intermediate	O
forms	O
of	O
the	O
disease	O
.	O

Our	O
model	O
of	O
classic	O
MSUD	O
was	O
created	O
by	O
gene	B-SO
knockout	O
of	O
the	O
E2	B-GGP
subunit	I-GGP
of	I-GGP
BCKDH	I-GGP
.	O

The	O
phenotype	O
of	O
these	O
knockout	O
animals	B-Taxon
is	O
strikingly	O
similar	O
to	O
humans	B-Taxon
with	O
classic	O
MSUD	O
.	O

Knockout	O
mice	B-Taxon
were	O
born	O
at	O
the	O
expected	O
frequency	O
and	O
appeared	O
normal	O
at	O
birth	O
.	O

Within	O
a	O
day	O
of	O
birth	O
and	O
following	O
suckling	O
,	O
blood	O
levels	O
of	O
BCAA	B-CHEBI
were	O
markedly	O
elevated	O
.	O

Concomitantly	O
,	O
levels	O
of	O
the	O
amino	B-CHEBI
acids	I-CHEBI
alanine	B-CHEBI
,	O
glutamate	B-CHEBI
,	O
and	O
glutamine	B-CHEBI
,	O
whose	O
synthesis	O
is	O
linked	O
with	O
normal	O
metabolism	O
of	O
BCAA	B-CHEBI
,	O
were	O
decreased	O
(	O
Table	O
1	O
)	O
.	O

The	O
activity	O
of	O
BCKDH	B-GO
in	O
livers	O
of	O
homozygous	O
knockout	O
mouse	B-Taxon
pups	O
was	O
undetectable	O
,	O
accounting	O
for	O
the	O
accumulation	O
of	O
unmetabolized	O
BCAA	B-CHEBI
.	O

Immunoreactive	O
E2	B-GGP
protein	B-CHEBI
was	O
absent	O
in	O
liver	O
and	O
fibroblasts	B-CL
of	O
homozygous	O
pups	O
.	O

The	O
phenotypic	O
behavior	O
of	O
homozygous	O
mouse	B-Taxon
pups	O
resembles	O
symptoms	O
seen	O
in	O
newborn	O
classic	O
MSUD	O
patients	O
.	O

These	O
include	O
signs	O
of	O
neurologic	O
dysfunction	O
such	O
as	O
seizures	O
,	O
stupor	O
,	O
lethargy	O
,	O
loss	O
of	O
motor	O
activity	O
,	O
and	O
respiratory	O
difficulties	O
[	O
1	O
]	O
.	O

These	O
neurologic	O
symptoms	O
may	O
result	O
from	O
reduced	O
levels	O
of	O
glutamate	B-CHEBI
,	O
glutamine	B-CHEBI
,	O
alanine	B-CHEBI
,	O
and	O
other	O
similar	O
neuroactive	O
amino	B-CHEBI
acids	I-CHEBI
,	O
which	O
are	O
considered	O
the	O
culprit	O
for	O
MSUD	O
encephalopathies	O
in	O
patients	O
[	O
1	O
,	O
37	O
]	O
.	O

Finally	O
,	O
nearly	O
all	O
of	O
the	O
homozygous	O
pups	O
died	O
within	O
72	O
hours	O
of	O
birth	O
.	O

This	O
neonatal	O
lethality	O
is	O
likely	O
due	O
to	O
the	O
accumulation	O
of	O
BCAA	B-CHEBI
to	O
neurotoxic	O
levels	O
,	O
ketoacidosis	O
,	O
brain	O
edema	O
,	O
dehydration	O
,	O
and	O
malnutrition	O
as	O
observed	O
in	O
the	O
MSUD	O
calf	O
[	O
17	O
]	O
and	O
in	O
classic	O
MSUD	O
patients	O
[	O
1	O
]	O
.	O

Heterozygous	O
knockouts	O
were	O
normal	O
and	O
had	O
normal	O
levels	O
of	O
BCAA	B-CHEBI
despite	O
having	O
approximately	O
half	O
of	O
BCKDH	B-GO
enzymatic	B-SO
activity	O
.	O

From	O
the	O
characterization	O
studies	O
completed	O
thus	O
far	O
,	O
the	O
null	O
mutation	B-SO
mouse	B-Taxon
accurately	O
represents	O
a	O
model	O
of	O
classic	O
MSUD	O
and	O
appears	O
to	O
be	O
a	O
faithful	O
model	O
of	O
the	O
human	B-Taxon
disease	O
with	O
respect	O
to	O
several	O
biochemical	O
phenotypes	O
[	O
1	O
]	O
.	O

To	O
create	O
a	O
model	O
of	O
intermediate	O
MSUD	O
,	O
we	O
used	O
a	O
transgenic	B-SO
strategy	O
to	O
express	O
human	B-GGP
E2	I-GGP
in	O
the	O
liver	O
of	O
E2	B-GGP
knockout	O
mice	B-Taxon
.	O

As	O
mentioned	O
above	O
,	O
E2	B-GGP
knockouts	O
without	O
transgene	B-SO
derived	O
E2	B-GGP
die	O
during	O
the	O
early	O
neonatal	O
period	O
.	O

We	O
show	O
that	O
expression	O
of	O
a	O
human	B-GGP
E2	I-GGP
transgene	B-SO
in	O
the	O
liver	O
of	O
these	O
knockout	O
mice	B-Taxon
is	O
able	O
to	O
rescue	O
the	O
neonatal	O
lethality	O
.	O

Many	O
of	O
the	O
rescue	O
mice	B-Taxon
survived	O
to	O
adulthood	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
these	O
mouse	B-Taxon
lines	O
only	O
~	O
5	O
-	O
6	O
%	O
of	O
normal	O
BCKDH	B-GO
activity	O
in	O
the	O
liver	O
was	O
sufficient	O
to	O
allow	O
survival	O
.	O

We	O
also	O
demonstrated	O
that	O
BCAA	B-CHEBI
levels	O
in	O
blood	O
of	O
these	O
rescue	O
mice	B-Taxon
were	O
intermediate	O
between	O
controls	O
and	O
knockouts	O
.	O

The	O
hallmarks	O
of	O
intermediate	O
MSUD	O
human	B-Taxon
patients	O
are	O
persistently	O
increased	O
levels	O
of	O
BCAA	B-CHEBI
and	O
BCKDH	B-GO
activity	O
in	O
the	O
range	O
of	O
3	O
-	O
30	O
%	O
of	O
normal	O
[	O
1	O
]	O
.	O

Because	O
of	O
the	O
phenotypic	O
similarities	O
of	O
the	O
rescue	O
mice	B-Taxon
to	O
the	O
human	B-Taxon
patients	O
,	O
these	O
genetically	B-SO
engineered	O
mice	B-Taxon
represent	O
a	O
useful	O
small	O
animal	B-Taxon
model	O
of	O
the	O
intermediate	O
form	O
of	O
MSUD	O
.	O

The	O
transgenic	B-SO
approach	O
that	O
was	O
used	O
to	O
create	O
the	O
intermediate	O
MSUD	O
model	O
was	O
based	O
on	O
the	O
tetracycline	B-CHEBI
regulated	O
gene	B-SO
switch	O
system	O
that	O
has	O
been	O
used	O
with	O
great	O
success	O
in	O
other	O
studies	O
,	O
for	O
example	O
[	O
34	O
]	O
.	O

The	O
strategy	O
behind	O
our	O
approach	O
was	O
to	O
create	O
mice	B-Taxon
with	O
an	O
intermediate	O
MSUD	O
phenotype	O
that	O
could	O
be	O
converted	O
to	O
the	O
classic	O
phenotype	O
at	O
the	O
investigator	O
'	O
s	O
discretion	O
by	O
turning	O
off	O
the	O
rescuing	B-SO
transgene	B-SO
.	O

However	O
,	O
we	O
were	O
unable	O
to	O
consistently	O
turn	O
off	O
the	O
human	B-GGP
E2	I-GGP
expression	O
cassette	B-SO
by	O
the	O
potent	O
tetracycline	B-CHEBI
analogue	O
,	O
doxycycline	O
in	O
either	O
of	O
the	O
two	O
transgenic	B-SO
lines	O
tested	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
reason	O
these	O
two	O
lines	O
were	O
unresponsive	O
to	O
doxycycline	O
is	O
unknown	O
.	O

It	O
is	O
conceivable	O
that	O
the	O
integration	B-SO
site	I-SO
of	O
the	O
transgenes	B-SO
was	O
not	O
permissive	O
for	O
regulated	O
expression	O
.	O

Screening	O
of	O
additional	O
lines	O
may	O
be	O
needed	O
to	O
find	O
lines	O
that	O
allow	O
for	O
survival	O
and	O
can	O
also	O
be	O
regulated	O
.	O

The	O
models	O
described	O
in	O
this	O
communication	O
are	O
important	O
advances	O
over	O
the	O
previously	O
described	O
models	O
.	O

An	O
ENU	B-CHEBI
mouse	B-Taxon
resembling	O
human	B-Taxon
MSUD	O
was	O
previously	O
created	O
by	O
disrupting	O
the	O
mitochondrial	B-GGP
BCAT	I-GGP
gene	B-SO
[	O
20	O
]	O
.	O

The	O
BCKDH	B-GO
activity	O
in	O
the	O
liver	O
and	O
muscle	O
of	O
this	O
mouse	B-Taxon
was	O
normal	O
even	O
though	O
the	O
blood	O
BCAA	B-CHEBI
levels	O
were	O
markedly	O
elevated	O
.	O

While	O
this	O
is	O
an	O
interesting	O
model	O
,	O
it	O
is	O
not	O
a	O
true	O
model	O
of	O
MSUD	O
because	O
the	O
mutation	B-SO
is	O
not	O
in	O
BCKDH	B-GO
and	O
the	O
levels	O
of	O
BCKDH	B-GO
are	O
normal	O
.	O

Furthermore	O
,	O
no	O
case	O
of	O
MSUD	O
has	O
been	O
described	O
attributing	O
this	O
disease	O
to	O
BCAT	B-GGP
deficiency	O
.	O

In	O
addition	O
to	O
this	O
mouse	B-Taxon
model	O
,	O
a	O
cow	B-Taxon
model	O
of	O
MSUD	O
has	O
also	O
been	O
previously	O
described	O
[	O
17	O
-	O
19	O
]	O
.	O

However	O
,	O
due	O
to	O
practical	O
constraints	O
imposed	O
by	O
such	O
a	O
large	O
animal	B-Taxon
model	O
and	O
due	O
to	O
the	O
observation	O
of	O
differences	O
between	O
the	O
MSUD	O
cow	B-Taxon
model	O
and	O
MSUD	O
humans	B-Taxon
[	O
1	O
]	O
,	O
this	O
model	O
is	O
also	O
of	O
limited	O
utility	O
.	O

In	O
contrast	O
,	O
the	O
murine	B-Taxon
models	O
described	O
in	O
this	O
report	O
are	O
more	O
valid	O
and	O
appropriate	O
for	O
modeling	O
human	B-Taxon
MSUD	O
.	O

The	O
most	O
significant	O
opportunity	O
presented	O
by	O
the	O
MSUD	O
mouse	B-Taxon
models	O
is	O
to	O
test	O
novel	O
treatments	O
such	O
as	O
gene	B-SO
[	O
38	O
-	O
41	O
]	O
and	O
cell	B-CL
based	O
therapies	O
(	O
e	O
.	O
g	O
.	O
,	O
hepatocytes	B-CL
[	O
42	O
,	O
43	O
]	O
or	O
embryonic	O
stem	B-CL
cells	I-CL
[	O
44	O
]	O
)	O
.	O

Relevant	O
to	O
gene	B-SO
therapy	O
,	O
recent	O
problems	O
with	O
gene	B-SO
therapy	O
in	O
humans	B-Taxon
highlight	O
the	O
importance	O
and	O
critical	O
need	O
of	O
animal	B-Taxon
models	O
of	O
genetic	B-SO
diseases	O
for	O
preclinical	O
studies	O
.	O

The	O
testing	O
of	O
gene	B-SO
and	O
cell	B-CL
based	O
therapies	O
on	O
appropriate	O
animal	B-Taxon
model	O
systems	O
provides	O
a	O
preliminary	O
method	O
of	O
establishing	O
not	O
only	O
the	O
efficacy	O
,	O
but	O
also	O
short	O
-	O
and	O
long	O
-	O
term	O
safety	O
.	O

Success	O
with	O
animal	B-Taxon
studies	O
is	O
expected	O
to	O
advance	O
such	O
therapeutic	O
approaches	O
and	O
could	O
pave	O
the	O
way	O
for	O
studies	O
in	O
humans	B-Taxon
.	O

In	O
addition	O
to	O
testing	O
various	O
treatments	O
,	O
these	O
models	O
should	O
also	O
be	O
very	O
useful	O
for	O
investigating	O
the	O
underlying	O
pathophysiologic	O
consequences	O
of	O
the	O
disease	O
.	O

Such	O
studies	O
are	O
very	O
difficult	O
/	O
impossible	O
to	O
do	O
in	O
human	B-Taxon
patients	O
for	O
obvious	O
ethical	O
reasons	O
,	O
and	O
often	O
must	O
rely	O
on	O
autopsy	O
tissue	O
.	O

Additionally	O
,	O
the	O
intermediate	O
MSUD	O
model	O
may	O
also	O
be	O
useful	O
for	O
studies	O
to	O
test	O
the	O
effect	O
of	O
thiamin	B-CHEBI
.	O

A	O
thiamin	B-CHEBI
-	O
responsive	O
form	O
of	O
MSUD	O
has	O
been	O
described	O
[	O
1	O
]	O
.	O

The	O
phenotype	O
of	O
these	O
patients	O
is	O
heterogeneous	O
and	O
treatment	O
with	O
a	O
wide	O
range	O
of	O
thiamin	O
doses	O
has	O
produced	O
limited	O
success	O
[	O
1	O
]	O
.	O

Recent	O
cell	B-CL
culture	O
studies	O
with	O
MSUD	O
cells	B-CL
have	O
suggested	O
that	O
the	O
thiamin	B-CHEBI
-	O
responsive	O
phenotype	O
is	O
dependent	O
upon	O
the	O
presence	O
of	O
at	O
least	O
one	O
E2	B-GGP
expressing	O
allele	B-SO
[	O
45	O
,	O
46	O
]	O
.	O

In	O
light	O
of	O
these	O
newer	O
findings	O
,	O
our	O
intermediate	O
MSUD	O
mouse	B-Taxon
provides	O
a	O
model	O
to	O
test	O
the	O
effect	O
of	O
thiamin	B-CHEBI
with	O
respect	O
to	O
BCKDH	B-GO
activity	O
and	O
blood	O
amino	B-CHEBI
acid	I-CHEBI
levels	O
at	O
the	O
level	O
of	O
the	O
whole	O
animal	B-Taxon
.	O

Because	O
of	O
recent	O
interest	O
in	O
structural	O
analysis	O
of	O
multienzyme	O
complexes	B-GO
[	O
35	O
,	O
36	O
,	O
45	O
,	O
46	O
]	O
,	O
the	O
intermediate	O
MSUD	O
model	O
may	O
provide	O
a	O
valuable	O
resource	O
for	O
studies	O
of	O
structural	O
biology	O
.	O

Lastly	O
,	O
the	O
information	O
and	O
knowledge	O
gained	O
from	O
studies	O
with	O
the	O
MSUD	O
models	O
described	O
here	O
will	O
also	O
be	O
applicable	O
and	O
transferable	O
to	O
other	O
mitochondrial	B-GO
disorders	O
due	O
to	O
defects	O
in	O
multisubunit	O
enzymes	B-SO
.	O

Conclusion	O

In	O
summary	O
,	O
this	O
report	O
describes	O
the	O
development	O
and	O
characterization	O
of	O
genetically	B-SO
engineered	O
mouse	B-Taxon
models	O
of	O
classic	O
as	O
well	O
as	O
intermediate	O
MSUD	O
.	O

These	O
animals	B-Taxon
provide	O
useful	O
models	O
to	O
further	O
characterize	O
the	O
pathogenesis	O
of	O
MSUD	O
,	O
as	O
well	O
as	O
models	O
to	O
test	O
novel	O
therapeutic	O
strategies	O
,	O
such	O
as	O
gene	B-SO
and	O
cellular	B-CL
therapies	O
,	O
to	O
treat	O
this	O
devastating	O
metabolic	O
disease	O
.	O

Abbreviations	O

The	O
abbreviations	O
used	O
are	O
:	O
MSUD	O
,	O
Maple	B-Taxon
Syrup	O
Urine	O
Disease	O
;	O
BCKDH	B-GO
,	O
branched	B-GO
chain	I-GO
ketoacid	I-GO
dehydrogenase	I-GO
;	O
BCAA	B-CHEBI
,	O
branched	B-CHEBI
chain	I-CHEBI
amino	I-CHEBI
acids	I-CHEBI
;	O
ENU	B-CHEBI
,	O
N	B-CHEBI
-	I-CHEBI
ethyl	I-CHEBI
-	I-CHEBI
N	I-CHEBI
-	I-CHEBI
nitrosourea	I-CHEBI
;	O
BCAT	B-GGP
,	O
branched	B-GGP
chain	I-GGP
aminotransferase	I-GGP
;	O
ES	O
cell	B-CL
,	O
embryonic	O
stem	B-CL
cell	I-CL
;	O
TRE	O
,	O
tetracycline	B-CHEBI
responsive	O
element	B-SO
;	O
MEF	O
,	O
mouse	B-Taxon
embryonic	O
fibroblast	B-CL
.	O

Competing	O
interests	O

The	O
author	O
(	O
s	O
)	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Authors	O
'	O
contributions	O

GEH	O
designed	O
and	O
produced	O
the	O
mouse	B-Taxon
models	O
,	O
coordinated	O
experiments	O
,	O
interpreted	O
data	O
,	O
and	O
helped	O
draft	O
the	O
manuscript	O
.	O

KS	O
conducted	O
much	O
of	O
the	O
characterization	O
of	O
the	O
intermediate	O
MSUD	O
model	O
.	O

CF	O
assisted	O
with	O
production	O
of	O
the	O
mouse	B-Taxon
models	O
,	O
data	O
collection	O
,	O
analysis	O
,	O
and	O
interpretation	O
.	O

SW	O
directed	O
the	O
immunohistochemistry	O
experiments	O
.	O

HSP	O
conceived	O
of	O
the	O
knockout	O
model	O
,	O
interpreted	O
data	O
and	O
drafted	O
the	O
manuscript	O
.	O

All	O
authors	O
contributed	O
to	O
composing	O
and	O
editing	O
the	O
manuscript	O
and	O
have	O
read	O
and	O
approved	O
the	O
final	O
version	O
.	O

Pre	O
-	O
publication	O
history	O

The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O

Acknowledgements	O

The	O
authors	O
would	O
like	O
to	O
thank	O
Frank	O
Kist	O
,	O
Jodi	O
Dagget	O
,	O
Edward	O
Mallick	O
,	O
Brian	O
Sloat	O
,	O
and	O
Judith	O
Rodda	O
for	O
expert	O
technical	O
assistance	O
,	O
and	O
Dr	O
.	O
Susan	O
Hutson	O
for	O
the	O
gift	O
of	O
E2	B-GGP
antiserum	O
.	O

This	O
work	O
was	O
supported	O
by	O
National	O
Institutes	O
of	O
Health	O
Grants	O
DK51960	O
,	O
DK57386	O
,	O
DK57956	O
,	O
AA10422	O
,	O
the	O
Scott	O
C	O
.	O
Foster	O
Metabolic	O
Disease	O
Fund	O
,	O
and	O
the	O
MSUD	O
Family	O
Support	O
Group	O
.	O

Loss	O
of	O
Atrx	B-GGP
Affects	O
Trophoblast	O
Development	O
and	O
the	O
Pattern	O
of	O
X	B-GO
-	O
Inactivation	O
in	O
Extraembryonic	O
Tissues	O

Abstract	O

ATRX	B-GGP
is	O
an	O
X	B-GO
-	O
encoded	O
member	O
of	O
the	O
SNF2	O
family	O
of	O
ATPase	O
/	O
helicase	O
proteins	B-CHEBI
thought	O
to	O
regulate	O
gene	B-SO
expression	O
by	O
modifying	O
chromatin	B-GO
at	O
target	O
loci	B-SO
.	O

Mutations	B-SO
in	O
ATRX	B-GGP
provided	O
the	O
first	O
example	O
of	O
a	O
human	B-Taxon
genetic	B-SO
disease	O
associated	O
with	O
defects	O
in	O
such	O
proteins	B-CHEBI
.	O

To	O
better	O
understand	O
the	O
role	O
of	O
ATRX	B-GGP
in	O
development	O
and	O
the	O
associated	O
abnormalities	O
in	O
the	O
ATR	O
-	O
X	B-GO
(	O
alpha	O
thalassemia	O
mental	O
retardation	O
,	O
X	B-GO
-	O
linked	O
)	O
syndrome	O
,	O
we	O
conditionally	O
inactivated	O
the	O
homolog	B-SO
in	O
mice	B-Taxon
,	O
Atrx	B-GGP
,	O
at	O
the	O
8	O
-	O
to	O
16	O
-	O
cell	B-CL
stage	O
of	O
development	O
.	O

The	O
protein	B-CHEBI
,	O
Atrx	B-GGP
,	O
was	O
ubiquitously	O
expressed	O
,	O
and	O
male	O
embryos	O
null	O
for	O
Atrx	B-GGP
implanted	O
and	O
gastrulated	O
normally	O
but	O
did	O
not	O
survive	O
beyond	O
9	O
.	O
5	O
days	O
postcoitus	O
due	O
to	O
a	O
defect	O
in	O
formation	O
of	O
the	O
extraembryonic	O
trophoblast	O
,	O
one	O
of	O
the	O
first	O
terminally	O
differentiated	O
lineages	O
in	O
the	O
developing	O
embryo	O
.	O

Carrier	O
female	O
mice	B-Taxon
that	O
inherit	O
a	O
maternal	O
null	O
allele	B-SO
should	O
be	O
affected	O
,	O
since	O
the	O
paternal	O
X	B-GO
chromosome	I-GO
is	O
normally	O
inactivated	O
in	O
extraembryonic	O
tissues	O
.	O

Surprisingly	O
,	O
however	O
,	O
some	O
carrier	O
females	O
established	O
a	O
normal	O
placenta	O
and	O
appeared	O
to	O
escape	O
the	O
usual	O
pattern	O
of	O
imprinted	O
X	B-GO
-	O
inactivation	O
in	O
these	O
tissues	O
.	O

Together	O
these	O
findings	O
demonstrate	O
an	O
unexpected	O
,	O
specific	O
,	O
and	O
essential	O
role	O
for	O
Atrx	B-GGP
in	O
the	O
development	O
of	O
the	O
murine	B-Taxon
trophoblast	O
and	O
present	O
an	O
example	O
of	O
escape	O
from	O
imprinted	O
X	B-GO
chromosome	I-GO
inactivation	O
.	O

Synopsis	O

ATRX	B-GGP
belongs	O
to	O
a	O
class	O
of	O
proteins	B-CHEBI
that	O
may	O
modify	O
how	O
DNA	B-SO
is	O
packaged	O
into	O
chromatin	B-GO
,	O
altering	O
the	O
accessibility	O
of	O
other	O
proteins	B-CHEBI
in	O
the	O
nucleus	B-GO
to	O
DNA	B-SO
.	O

In	O
this	O
way	O
,	O
ATRX	B-GGP
is	O
thought	O
to	O
influence	O
gene	B-SO
expression	O
.	O

Mutations	B-SO
in	O
the	O
ATRX	B-GGP
gene	B-SO
,	O
which	O
is	O
located	O
on	O
the	O
female	B-GO
sex	I-GO
chromosome	I-GO
(	O
X	B-GO
)	O
,	O
provided	O
the	O
first	O
example	O
of	O
a	O
human	B-Taxon
disease	O
(	O
ATR	O
-	O
X	B-GO
syndrome	O
)	O
associated	O
with	O
defects	O
in	O
such	O
proteins	B-CHEBI
.	O

Affected	O
males	O
(	O
XMUTY	O
)	O
have	O
multiple	O
developmental	O
abnormalities	O
in	O
a	O
wide	O
variety	O
of	O
systems	O
.	O

Currently	O
,	O
it	O
is	O
not	O
understood	O
how	O
proteins	B-CHEBI
like	O
ATRX	B-GGP
influence	O
cell	B-CL
biology	O
.	O

To	O
address	O
this	O
question	O
,	O
the	O
authors	O
deleted	B-SO
the	O
version	B-SO
of	O
the	O
gene	B-SO
in	O
mice	B-Taxon
,	O
Atrx	B-GGP
.	O

Although	O
affected	O
male	O
mice	B-Taxon
(	O
XMUTY	O
)	O
started	O
to	O
develop	O
normally	O
,	O
they	O
died	O
early	O
in	O
development	O
because	O
they	O
failed	O
to	O
form	O
a	O
normal	O
placenta	O
.	O

In	O
the	O
placenta	O
,	O
female	O
mice	B-Taxon
normally	O
inactivate	O
the	O
X	B-GO
chromosome	I-GO
that	O
they	O
inherit	O
from	O
their	O
fathers	O
(	O
Xp	O
)	O
,	O
so	O
if	O
females	O
inherit	O
from	O
their	O
mother	O
an	O
X	B-GO
chromosome	I-GO
(	O
Xm	O
)	O
that	O
bears	O
the	O
abnormal	O
copy	O
of	O
Atrx	B-GGP
(	O
XmMUTXp	O
)	O
,	O
one	O
would	O
predict	O
that	O
,	O
like	O
affected	O
males	O
,	O
they	O
would	O
fail	O
to	O
form	O
a	O
normal	O
placenta	O
.	O

The	O
authors	O
unexpectedly	O
found	O
this	O
not	O
to	O
be	O
so	O
.	O

They	O
showed	O
,	O
instead	O
,	O
that	O
in	O
such	O
females	O
the	O
normal	O
,	O
paternally	O
derived	O
Atrx	B-GGP
gene	B-SO
is	O
active	O
.	O

This	O
study	O
has	O
therefore	O
demonstrated	O
an	O
important	O
facet	O
of	O
X	B-GO
-	I-GO
chromosome	I-GO
imprinting	O
.	O

Introduction	O

ATR	O
-	O
X	B-GO
syndrome	O
is	O
a	O
severe	O
,	O
nonprogressive	O
form	O
of	O
X	B-GO
-	O
linked	O
mental	O
retardation	O
that	O
is	O
frequently	O
associated	O
with	O
multiple	O
congenital	O
abnormalities	O
[	O
1	O
]	O
.	O

It	O
is	O
usually	O
associated	O
with	O
a	O
mild	O
form	O
of	O
alpha	O
-	O
thalassaemia	O
,	O
caused	O
by	O
reduced	O
expression	O
of	O
structurally	O
intact	O
alpha	O
-	O
globin	B-CHEBI
genes	B-SO
,	O
and	O
characterised	O
by	O
the	O
presence	O
of	O
beta	B-GGP
-	I-GGP
globin	I-GGP
tetramers	O
(	O
haemoglobin	B-GO
H	O
inclusion	B-GO
bodies	I-GO
)	O
in	O
peripheral	O
red	B-CL
blood	I-CL
cells	I-CL
.	O

Carrier	O
females	O
occasionally	O
manifest	O
haemoglobin	B-GO
H	O
inclusions	B-GO
,	O
but	O
are	O
otherwise	O
intellectually	O
and	O
physically	O
normal	O
.	O

Studies	O
of	O
X	B-GO
-	I-GO
chromosome	I-GO
inactivation	O
in	O
carrier	O
females	O
have	O
demonstrated	O
preferential	O
inactivation	O
of	O
the	O
chromosome	B-GO
bearing	O
the	O
abnormal	O
allele	B-SO
in	O
a	O
variety	O
of	O
tissues	O
[	O
2	O
]	O
,	O
and	O
this	O
skewing	O
of	O
X	B-GO
-	O
inactivation	O
is	O
thought	O
to	O
explain	O
the	O
mild	O
phenotype	O
observed	O
in	O
carriers	O
.	O

The	O
ATR	O
-	O
X	B-GO
syndrome	O
is	O
caused	O
by	O
mutations	B-SO
in	O
a	O
gene	B-SO
(	O
ATRX	B-GGP
)	O
that	O
comprises	O
36	O
exons	B-SO
spanning	O
300	O
kb	O
of	O
genomic	B-SO
DNA	I-SO
at	O
Chromosome	B-GO
Xq13	O
.	O
3	O
[	O
3	O
]	O
.	O

This	O
gene	B-SO
encodes	O
two	O
dominant	O
protein	B-CHEBI
isoforms	B-SO
(	O
Figure	O
1	O
)	O
.	O

As	O
well	O
as	O
the	O
full	O
-	O
length	O
ATRX	B-GGP
protein	B-CHEBI
of	O
~	O
280	O
kDa	O
,	O
which	O
is	O
encoded	O
by	O
a	O
transcript	B-SO
of	O
~	O
10	O
kb	O
,	O
we	O
recently	O
demonstrated	O
that	O
a	O
truncated	O
isoform	B-SO
called	O
ATRXt	O
(	O
~	O
200	O
kDa	O
)	O
is	O
produced	O
from	O
a	O
transcript	B-SO
of	O
around	O
7	O
kb	O
,	O
which	O
arises	O
when	O
intron	B-SO
11	O
fails	O
to	O
be	O
spliced	O
from	O
the	O
primary	B-SO
transcript	I-SO
and	O
an	O
alternative	O
intronic	B-SO
poly	B-SO
(	I-SO
A	I-SO
)	I-SO
signal	I-SO
is	O
used	O
[	O
4	O
]	O
.	O

The	O
mouse	B-Taxon
homolog	B-SO
of	O
the	O
ATRX	B-GGP
gene	B-SO
,	O
Atrx	B-GGP
,	O
is	O
also	O
situated	O
on	O
the	O
X	B-GO
chromosome	I-GO
,	O
and	O
also	O
gives	O
rise	O
to	O
full	O
-	O
length	O
(	O
Atrx	B-GGP
,	O
~	O
280	O
kDa	O
)	O
and	O
truncated	O
(	O
Atrxt	O
,	O
~	O
200	O
kDa	O
)	O
isoforms	B-SO
[	O
4	O
,	O
5	O
]	O
.	O

Disease	O
-	O
causing	O
missense	O
mutations	B-SO
are	O
clustered	O
in	O
two	O
regions	B-SO
of	I-SO
the	I-SO
gene	I-SO
:	O
a	O
PHD	O
-	O
like	O
zinc	B-CHEBI
finger	O
domain	B-SO
and	O
a	O
SNF2	O
-	O
like	O
ATPase	O
domain	B-SO
(	O
Figure	O
1	O
)	O
[	O
6	O
]	O
.	O

The	O
former	O
motif	O
is	O
thought	O
to	O
be	O
involved	O
in	O
protein	B-CHEBI
-	O
protein	B-CHEBI
interactions	O
in	O
chromatin	B-GO
[	O
7	O
]	O
,	O
and	O
the	O
latter	O
is	O
a	O
feature	B-SO
of	O
chromatin	B-GO
-	O
remodelling	O
proteins	B-CHEBI
,	O
and	O
the	O
presence	O
of	O
disease	O
-	O
causing	O
mutations	B-SO
indicates	O
the	O
functional	O
importance	O
of	O
these	O
domains	B-SO
.	O

ATRX	B-GGP
has	O
been	O
shown	O
to	O
remodel	O
chromatin	B-GO
[	O
8	O
]	O
.	O

It	O
also	O
interacts	O
with	O
HP1	O
at	O
heterochromatin	B-GO
[	O
9	O
]	O
and	O
is	O
recruited	O
to	O
promyelocytic	B-GO
leukemia	I-GO
nuclear	I-GO
bodies	I-GO
via	O
an	O
interaction	O
with	O
Daxx	B-GGP
[	O
10	O
]	O
.	O

Furthermore	O
,	O
disruption	O
of	O
ATRX	B-GGP
leads	O
to	O
diverse	O
changes	O
in	O
DNA	B-SO
methylation	O
[	O
11	O
]	O
.	O

Nevertheless	O
,	O
the	O
role	O
ATRX	B-GGP
plays	O
in	O
gene	B-SO
expression	O
remains	O
unclear	O
.	O

The	O
consistent	O
core	O
of	O
clinical	O
and	O
haematological	O
features	O
observed	O
in	O
ATR	O
-	O
X	B-GO
patients	O
suggests	O
that	O
,	O
like	O
the	O
SWI2	O
/	O
SNF2	O
chromatin	B-GO
-	O
remodelling	O
protein	B-CHEBI
,	O
ATRX	B-GGP
probably	O
regulates	O
transcription	O
of	O
a	O
discrete	O
set	O
of	O
target	O
genes	B-SO
.	O

However	O
,	O
although	O
there	O
are	O
clearly	O
others	O
to	O
be	O
found	O
,	O
at	O
present	O
the	O
alpha	O
-	O
globin	B-CHEBI
genes	B-SO
remain	O
the	O
only	O
confirmed	O
targets	O
for	O
transcriptional	O
regulation	O
by	O
ATRX	B-GGP
.	O

Little	O
is	O
currently	O
known	O
about	O
the	O
precise	O
role	O
of	O
the	O
ATRX	B-GGP
protein	B-CHEBI
during	O
mammalian	B-Taxon
development	O
.	O

To	O
investigate	O
the	O
role	O
of	O
this	O
protein	B-CHEBI
during	O
mouse	B-Taxon
development	O
,	O
we	O
generated	O
a	O
conditionally	O
deleted	B-SO
allele	B-SO
of	O
the	O
Atrx	B-GGP
gene	B-SO
in	O
mouse	B-Taxon
embryonic	O
stem	B-CL
(	I-CL
ES	I-CL
)	I-CL
cells	I-CL
,	O
and	O
used	O
these	O
cells	B-CL
to	O
examine	O
the	O
effect	O
of	O
ablating	O
expression	O
of	O
the	O
full	O
-	O
length	O
Atrx	B-GGP
protein	B-CHEBI
in	O
ES	O
cells	B-CL
and	O
in	O
mouse	B-Taxon
embryos	O
.	O

Results	O

Generation	O
of	O
ES	O
Cells	B-CL
Lacking	O
Full	O
-	O
Length	O
Atrx	B-GGP

Like	O
the	O
human	B-Taxon
gene	B-SO
,	O
the	O
mouse	B-GGP
Atrx	I-GGP
gene	B-SO
is	O
also	O
X	B-GO
-	O
linked	O
,	O
such	O
that	O
a	O
direct	O
disruption	O
of	O
the	O
single	O
Atrx	B-GGP
allele	B-SO
in	O
male	O
ES	O
cells	B-CL
would	O
immediately	O
give	O
rise	O
to	O
the	O
null	O
state	O
.	O

No	O
targeted	O
clones	B-SO
were	O
recovered	O
after	O
attempted	O
homologous	O
recombination	O
in	O
male	O
E14TG2a	O
ES	O
cells	B-CL
using	O
two	O
different	O
vectors	B-SO
that	O
removed	B-SO
exon	B-SO
18	O
of	O
the	O
Atrx	B-GGP
gene	B-SO
.	O

Exon	B-SO
18	O
encodes	O
the	O
first	O
of	O
the	O
seven	O
motifs	O
composing	O
the	O
conserved	B-SO
SNF2	O
-	O
like	O
domain	B-SO
of	O
Atrx	B-GGP
(	O
Figure	O
1	O
)	O
;	O
mutation	B-SO
of	O
the	O
corresponding	O
motif	O
of	O
the	O
yeast	B-GGP
SNF2	I-GGP
protein	B-CHEBI
has	O
been	O
shown	O
to	O
severely	O
impair	O
SWI	B-GO
/	I-GO
SNF	I-GO
-	O
dependent	O
gene	B-SO
expression	O
[	O
12	O
]	O
.	O

The	O
failure	O
to	O
recover	O
targeted	O
clones	B-SO
with	O
these	O
vectors	B-SO
suggested	O
that	O
Atrx	B-GGP
may	O
be	O
important	O
for	O
normal	O
ES	O
cell	B-CL
growth	O
and	O
expansion	O
and	O
that	O
direct	O
targeting	O
of	O
the	O
single	O
locus	B-SO
may	O
not	O
be	O
possible	O
.	O

We	O
therefore	O
adopted	O
a	O
conditional	O
strategy	O
for	O
targeting	O
exon	B-SO
18	O
(	O
Figure	O
2	O
)	O
and	O
recovered	O
two	O
clones	B-SO
in	O
which	O
exon	B-SO
18	O
has	O
been	O
flanked	B-SO
by	O
loxP	B-SO
recognition	I-SO
sites	I-SO
for	O
the	O
Cre	O
recombinase	O
(	O
Atrxflox	O
allele	B-SO
in	O
Figure	O
2A	O
)	O
(	O
Figure	O
2B	O
)	O
.	O

This	O
allele	B-SO
also	O
contains	O
a	O
loxP	B-SO
-	I-SO
flanked	I-SO
MC1	O
-	O
neor	O
cassette	B-SO
in	O
intron	B-SO
17	O
(	O
Figure	O
2A	O
)	O
.	O

Northern	O
and	O
Western	O
blot	O
analyses	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
confirmed	O
that	O
the	O
Atrxflox	O
clones	B-SO
continued	O
to	O
express	O
both	O
full	O
-	O
length	O
Atrx	B-GGP
protein	B-CHEBI
and	O
the	O
truncated	O
Atrxt	O
isoform	B-SO
.	O

To	O
generate	O
the	O
full	O
deletion	B-SO
in	O
ES	O
cells	B-CL
,	O
the	O
Atrxflox	O
clones	B-SO
(	O
1	O
/	O
F12	O
and	O
1	O
/	O
G11	O
)	O
were	O
transiently	O
transfected	O
with	O
a	O
Cre	O
-	O
recombinase	O
expression	O
plasmid	B-SO
(	O
pCAGGS	O
-	O
Cre	O
-	O
IRESpuro	O
)	O
,	O
and	O
subclones	O
were	O
recovered	O
bearing	O
an	O
allele	B-SO
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
in	O
Figure	O
2A	O
)	O
in	O
which	O
both	O
exon	B-SO
18	O
and	O
the	O
neor	O
cassette	B-SO
had	O
been	O
deleted	B-SO
by	O
the	O
Cre	O
recombinase	O
(	O
resulting	O
from	O
the	O
recombination	O
event	O
labelled	O
"	O
C	O
"	O
in	O
the	O
Atrxflox	O
allele	B-SO
shown	O
in	O
Figure	O
2A	O
)	O
(	O
Figure	O
2C	O
)	O
.	O

Northern	O
and	O
Western	O
blot	O
analyses	O
(	O
Figure	O
2D	O
and	O
2E	O
)	O
revealed	O
that	O
the	O
full	O
-	O
length	O
Atrx	B-GGP
transcript	B-SO
and	O
protein	B-CHEBI
is	O
completely	O
abolished	B-SO
in	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
recombinant	O
clones	B-SO
,	O
suggesting	O
that	O
deletion	B-SO
of	O
this	O
region	B-SO
has	O
a	O
highly	O
destabilising	O
effect	O
on	O
the	O
full	O
-	O
length	O
transcript	B-SO
.	O

As	O
expected	O
,	O
the	O
truncated	O
Atrxt	O
isoform	B-SO
,	O
the	O
transcript	B-SO
of	O
which	O
is	O
terminated	O
within	O
intron	B-SO
11	O
[	O
4	O
]	O
,	O
is	O
unaffected	O
by	O
the	O
deletion	B-SO
of	O
exon	B-SO
18	O
(	O
Figure	O
2E	O
)	O
.	O

While	O
the	O
function	O
of	O
Atrxt	O
is	O
not	O
yet	O
clear	O
,	O
this	O
isoform	B-SO
,	O
which	O
contains	O
the	O
PHD	O
-	O
like	O
domain	B-SO
but	O
not	O
the	O
SWI	O
/	O
SNF	O
motifs	O
(	O
Figure	O
1	O
)	O
,	O
is	O
unlikely	O
to	O
be	O
functionally	O
equivalent	O
to	O
the	O
full	O
-	O
length	O
protein	B-CHEBI
.	O

Thus	O
,	O
a	O
conditional	O
knockout	O
strategy	O
allowed	O
the	O
isolation	O
of	O
ES	O
cells	B-CL
that	O
are	O
null	O
for	O
full	O
-	O
length	O
Atrx	B-GGP
.	O

Perturbed	O
Growth	O
and	O
Methylation	O
Defects	O
in	O
Atrxnull	O
ES	O
Cells	B-CL

Atrxnull	O
ES	O
cells	B-CL
could	O
be	O
maintained	O
in	O
culture	O
but	O
were	O
generally	O
slower	O
growing	O
than	O
Atrx	B-GGP
+	O
ES	O
clones	O
,	O
and	O
appeared	O
to	O
undergo	O
higher	O
rates	O
of	O
spontaneous	O
differentiation	O
.	O

We	O
investigated	O
directly	O
the	O
effect	O
of	O
Atrx	B-GGP
on	O
ES	O
cell	B-CL
growth	O
by	O
comparing	O
Atrx	B-GGP
+	O
and	O
Atrxnull	O
ES	O
cell	B-CL
clones	O
in	O
competition	O
cultures	O
.	O

Equal	O
numbers	O
of	O
Atrx	B-GGP
+	O
(	O
bearing	O
either	O
an	O
AtrxWT	O
or	O
an	O
Atrxflox	O
allele	B-SO
)	O
and	O
Atrxnull	O
(	O
bearing	O
an	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	B-SO
)	O
ES	O
cells	B-CL
were	O
inoculated	O
into	O
cultures	O
and	O
the	O
mixed	O
cultures	O
were	O
passaged	O
(	O
1	O
:	O
3	O
split	O
)	O
every	O
2	O
d	O
for	O
8	O
-	O
10	O
d	O
.	O

The	O
relative	O
abundance	O
of	O
the	O
different	O
alleles	B-SO
in	O
the	O
culture	O
at	O
each	O
time	O
point	O
was	O
analysed	O
by	O
Southern	O
blotting	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
clone	O
containing	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	B-SO
was	O
rapidly	O
outgrown	O
by	O
both	O
AtrxWT	O
ES	O
cells	B-CL
and	O
cells	B-CL
bearing	O
the	O
Atrxflox	O
allele	B-SO
.	O

In	O
a	O
control	O
competition	O
experiment	O
between	O
different	O
clones	O
bearing	O
functional	O
Atrx	B-GGP
alleles	B-SO
(	O
AtrxWT	O
and	O
Atrxflox	O
)	O
,	O
both	O
clones	O
continued	O
to	O
be	O
equally	O
represented	O
after	O
8	O
d	O
of	O
cocultivation	O
.	O

Thus	O
,	O
although	O
Atrxnull	O
ES	O
cells	B-CL
could	O
be	O
recovered	O
and	O
maintained	O
in	O
culture	O
by	O
a	O
conditional	O
targeting	O
approach	O
,	O
these	O
cocultivation	O
experiments	O
suggested	O
that	O
the	O
absence	O
of	O
Atrx	B-GGP
does	O
negatively	O
impact	O
upon	O
normal	O
ES	O
cell	B-CL
growth	O
.	O

To	O
investigate	O
a	O
possible	O
cell	B-CL
-	O
cycle	O
defect	O
in	O
the	O
absence	O
of	O
Atrx	B-GGP
,	O
we	O
analysed	O
the	O
cell	B-CL
cycle	O
distribution	O
of	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
-	O
pulsed	O
ES	O
cells	B-CL
by	O
flow	O
cytometry	O
(	O
Figure	O
S1A	O
)	O
.	O

Surprisingly	O
,	O
both	O
Atrxnull	O
ES	O
cell	B-CL
clones	O
exhibited	O
a	O
cell	B-CL
cycle	O
profile	O
that	O
was	O
indistinguishable	O
from	O
ES	O
cells	B-CL
bearing	O
a	O
functional	O
Atrx	B-GGP
allele	B-SO
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
.	O

We	O
also	O
specifically	O
quantitated	O
the	O
mitotic	O
index	O
within	O
each	O
population	O
by	O
flow	O
cytometry	O
after	O
staining	O
ES	O
cells	B-CL
for	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	B-CHEBI
H3	O
,	O
a	O
specific	O
marker	O
of	O
mitosis	O
(	O
Figure	O
S1B	O
)	O
[	O
13	O
]	O
.	O

Consistent	O
with	O
the	O
normal	O
cell	B-CL
-	O
cycle	O
profile	O
observed	O
above	O
,	O
there	O
was	O
no	O
depletion	O
in	O
the	O
size	O
of	O
the	O
mitotic	O
population	O
in	O
the	O
Atrxnull	O
ES	O
clones	O
,	O
despite	O
their	O
slow	O
growth	O
.	O

Finally	O
,	O
we	O
investigated	O
whether	O
the	O
growth	O
defect	O
in	O
the	O
Atrxnull	O
ES	O
cells	B-CL
was	O
due	O
to	O
an	O
up	O
-	O
regulation	O
of	O
apoptosis	O
by	O
staining	O
cells	B-CL
with	O
Annexin	B-GGP
V	I-GGP
(	O
Figure	O
S2	O
)	O
and	O
found	O
that	O
the	O
proportion	O
of	O
apoptotic	B-CL
cells	I-CL
was	O
not	O
significantly	O
affected	O
by	O
the	O
absence	O
of	O
full	O
-	O
length	O
Atrx	B-GGP
.	O

Thus	O
,	O
the	O
growth	O
defect	O
observed	O
in	O
ES	O
cells	B-CL
lacking	O
Atrx	B-GGP
is	O
not	O
due	O
to	O
a	O
specific	O
cell	B-CL
cycle	O
block	O
or	O
significant	O
induction	O
of	O
cell	B-CL
death	O
.	O

While	O
the	O
cause	O
of	O
the	O
proliferative	O
delay	O
is	O
not	O
yet	O
clear	O
,	O
since	O
Atrxnull	O
ES	O
cells	B-CL
appear	O
to	O
undergo	O
higher	O
rates	O
of	O
spontaneous	O
differentiation	O
(	O
unpublished	O
data	O
)	O
,	O
it	O
seems	O
likely	O
that	O
the	O
observed	O
growth	O
defect	O
reflects	O
the	O
spontaneous	O
transition	O
from	O
fast	O
-	O
cycling	O
,	O
undifferentiated	O
ES	O
cells	B-CL
into	O
more	O
slowly	O
cycling	O
,	O
differentiated	O
cell	B-CL
types	O
in	O
these	O
cultures	O
.	O

It	O
has	O
been	O
shown	O
that	O
disease	O
-	O
causing	O
mutations	B-SO
in	O
the	O
human	B-GGP
ATRX	I-GGP
gene	B-SO
give	O
rise	O
to	O
changes	O
in	O
the	O
normal	O
pattern	O
of	O
DNA	B-SO
methylation	O
at	O
several	O
repetitive	B-SO
sequences	I-SO
within	O
the	O
human	B-Taxon
genome	B-SO
[	O
11	O
]	O
.	O

Notably	O
,	O
the	O
transcribed	O
region	O
of	O
the	O
ribosomal	B-GO
DNA	B-SO
(	O
rDNA	O
)	O
repeat	B-SO
was	O
found	O
to	O
be	O
significantly	O
hypomethylated	O
in	O
ATR	B-GGP
-	I-GGP
X	I-GGP
patients	O
relative	O
to	O
normal	O
individuals	B-Taxon
.	O

Using	O
methylation	O
-	O
sensitive	O
restriction	O
enzymes	B-SO
,	O
we	O
also	O
observed	O
significant	O
hypomethylation	O
at	O
several	O
sites	B-SO
tested	O
within	O
the	O
mouse	B-Taxon
rDNA	O
repeats	B-SO
in	O
Atrxnull	O
ES	O
cells	B-CL
and	O
12	O
-	O
d	O
embryoid	O
bodies	O
relative	O
to	O
ES	O
cells	B-CL
and	O
embryoid	O
bodies	O
bearing	O
a	O
functional	O
Atrx	B-GGP
allele	B-SO
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
(	O
Figure	O
3B	O
and	O
3C	O
)	O
.	O

The	O
observation	O
that	O
rDNA	O
is	O
hypomethylated	O
in	O
the	O
absence	O
of	O
Atrx	B-GGP
,	O
even	O
in	O
ES	O
cells	B-CL
,	O
is	O
consistent	O
with	O
the	O
finding	O
that	O
hypomethylation	O
of	O
the	O
human	B-Taxon
rDNA	O
repeats	B-SO
is	O
detectable	O
from	O
an	O
early	O
developmental	O
stage	O
in	O
ATR	O
-	O
X	B-GO
patients	O
.	O

Other	O
mouse	B-Taxon
repetitive	B-SO
sequence	I-SO
elements	I-SO
surveyed	O
in	O
ES	O
cell	B-CL
DNA	B-SO
include	O
the	O
heterochromatic	B-GO
major	O
satellite	B-SO
(	I-SO
assayed	I-SO
with	I-SO
MaeII	I-SO
)	I-SO
and	I-SO
minor	I-SO
satellite	I-SO
(	I-SO
assayed	I-SO
with	I-SO
HpaII	I-SO
)	I-SO
repeats	I-SO
,	O
as	O
well	O
as	O
interspersed	O
retroviral	B-Taxon
repeats	B-SO
of	O
the	O
intracisternal	O
A	O
particle	O
(	O
IAP	O
)	O
type	O
and	O
the	O
Line	O
1	O
and	O
Sine	O
B1	O
families	O
(	O
all	O
assayed	O
with	O
HpaII	O
)	O
.	O

These	O
repeats	B-SO
were	O
found	O
to	O
be	O
moderately	O
(	O
Line	O
1	O
and	O
Sine	O
B1	O
)	O
or	O
highly	O
(	O
IAP	O
,	O
major	O
satellite	B-SO
,	O
minor	O
satellite	B-SO
)	O
methylated	O
in	O
wild	B-SO
-	I-SO
type	I-SO
ES	O
cells	B-CL
,	O
and	O
this	O
methylation	O
was	O
not	O
detectably	O
perturbed	O
by	O
the	O
absence	O
of	O
Atrx	B-GGP
(	O
Figure	O
S3	O
and	O
unpublished	O
data	O
)	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
the	O
subtle	O
interplay	O
between	O
the	O
ATRX	B-GGP
protein	B-CHEBI
and	O
DNA	B-SO
methylation	O
observed	O
in	O
human	B-Taxon
patients	O
is	O
also	O
present	O
in	O
mouse	B-Taxon
cells	B-CL
.	O

Early	O
Embryonic	O
Lethality	O
in	O
Atrxnull	O
Male	O
Mice	B-Taxon

To	O
investigate	O
the	O
role	O
of	O
the	O
Atrx	B-GGP
protein	B-CHEBI
during	O
mouse	B-Taxon
development	O
,	O
we	O
initially	O
established	O
lines	O
of	O
mice	B-Taxon
bearing	O
the	O
Atrxflox	O
allele	B-SO
.	O

Two	O
independently	O
targeted	O
Atrxflox	O
ES	O
cell	B-CL
clones	O
with	O
normal	O
male	O
karyotype	O
were	O
injected	O
into	O
C57BL	O
/	O
6	O
blastocysts	O
to	O
produce	O
chimaeric	O
mice	B-Taxon
,	O
which	O
were	O
then	O
used	O
to	O
obtain	O
germline	O
transmission	O
.	O

Intercrosses	O
between	O
males	O
hemizygous	O
(	O
Atrxflox	O
/	O
Y	O
)	O
and	O
females	O
heterozygous	O
(	O
AtrxWT	O
/	O
flox	B-SO
)	O
for	O
the	O
floxed	B-SO
allele	B-SO
were	O
also	O
carried	O
out	O
to	O
generate	O
homozygous	O
females	O
(	O
Atrxflox	O
/	O
flox	B-SO
)	O
.	O

Males	O
hemizygous	O
and	O
females	O
heterozygous	O
or	O
homozygous	O
for	O
the	O
Atrxflox	O
allele	B-SO
were	O
viable	O
,	O
appeared	O
healthy	O
,	O
and	O
bred	O
normally	O
,	O
suggesting	O
that	O
,	O
as	O
expected	O
,	O
the	O
Atrxflox	O
allele	B-SO
was	O
functionally	O
normal	O
.	O

To	O
generate	O
Atrxnull	O
mice	B-Taxon
by	O
Cre	O
-	O
mediated	O
recombination	O
,	O
the	O
Atrxflox	O
mice	B-Taxon
were	O
crossed	O
with	O
mice	B-Taxon
harboring	O
a	O
transgene	B-SO
in	O
which	O
the	O
Cre	O
recombinase	O
is	O
expressed	O
under	O
the	O
control	O
of	O
the	O
regulatory	B-SO
elements	I-SO
of	O
the	O
mouse	B-GGP
GATA	I-GGP
-	I-GGP
1	I-GGP
gene	B-SO
(	O
GATA1	B-GGP
-	O
cre	O
)	O
[	O
14	O
]	O
.	O

Widespread	O
expression	O
of	O
the	O
GATA1	B-GGP
-	O
cre	O
transgene	B-SO
has	O
been	O
demonstrated	O
during	O
early	O
embryogenesis	O
[	O
14	O
]	O
.	O

We	O
more	O
accurately	O
defined	O
the	O
onset	O
of	O
GATA1	B-GGP
-	O
cre	O
expression	O
using	O
a	O
ROSA26	B-GGP
reporter	O
strain	O
,	O
in	O
which	O
a	O
beta	O
-	O
galactosidase	O
/	O
neor	O
fusion	B-SO
reporter	I-SO
gene	I-SO
is	O
expressed	O
only	O
after	O
Cre	O
-	O
mediated	O
excision	B-SO
of	O
loxP	B-SO
-	I-SO
flanked	I-SO
transcription	O
and	O
translation	B-SO
termination	I-SO
signals	I-SO
[	O
14	O
]	O
.	O

We	O
found	O
that	O
the	O
GATA1	B-GGP
-	O
cre	O
transgene	B-SO
was	O
already	O
active	O
at	O
the	O
16	O
-	O
cell	B-CL
morula	O
stage	O
of	O
development	O
(	O
0	O
.	O
5	O
days	O
postcoitus	O
[	O
dpc	O
]	O
)	O
(	O
Figure	O
4A	O
)	O
.	O

To	O
generate	O
Atrxnull	O
mice	B-Taxon
,	O
heterozygous	O
floxed	B-SO
females	O
(	O
AtrxWT	O
/	O
flox	B-SO
)	O
were	O
mated	O
with	O
homozygous	O
GATA1	B-GGP
-	O
cre	O
transgenic	B-SO
males	O
(	O
AtrxWT	O
/	O
Y	O
;	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
+	B-SO
)	O
.	O

No	O
Atrxnull	O
males	O
(	O
Atrxnull	O
/	O
Y	O
;	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
-	O
)	O
were	O
recovered	O
at	O
birth	O
,	O
indicating	O
that	O
the	O
absence	O
of	O
Atrx	B-GGP
results	O
in	O
embryonic	O
lethality	O
.	O

This	O
finding	O
was	O
unexpected	O
,	O
since	O
human	B-Taxon
ATR	O
-	O
X	B-GO
patients	O
clearly	O
survive	O
to	O
adulthood	O
(	O
see	O
Discussion	O
)	O
.	O

Embryos	O
were	O
dissected	O
at	O
7	O
.	O
5	O
,	O
8	O
.	O
5	O
,	O
and	O
9	O
.	O
5	O
dpc	O
and	O
genotyped	O
by	O
PCR	O
analysis	O
of	O
DNA	B-SO
extracted	O
from	O
yolk	O
sac	O
or	O
total	O
embryo	O
(	O
Figure	O
4B	O
and	O
Protocol	O
S1	O
)	O
.	O

Atrxnull	O
males	O
were	O
present	O
at	O
expected	O
mendelian	O
ratios	O
(	O
~	O
25	O
%	O
)	O
at	O
both	O
7	O
.	O
5	O
dpc	O
and	O
8	O
.	O
5	O
dpc	O
(	O
Table	O
1	O
)	O
.	O

However	O
,	O
by	O
9	O
.	O
5	O
dpc	O
,	O
depletion	O
was	O
observed	O
both	O
in	O
the	O
number	O
of	O
Atrxnull	O
males	O
(	O
7	O
%	O
)	O
and	O
in	O
the	O
total	O
number	O
of	O
males	O
recovered	O
(	O
31	O
%	O
)	O
.	O

No	O
Atrxnull	O
males	O
were	O
recovered	O
after	O
9	O
.	O
5	O
dpc	O
.	O

Thus	O
the	O
absence	O
of	O
Atrx	B-GGP
gives	O
rise	O
to	O
embryonic	O
lethality	O
in	O
mice	B-Taxon
before	O
9	O
.	O
5	O
dpc	O
.	O

To	O
investigate	O
the	O
morphology	O
of	O
Atrxnull	O
embryos	O
prior	O
to	O
death	O
,	O
embryos	O
from	O
the	O
above	O
crosses	O
were	O
initially	O
dissected	O
in	O
their	O
deciduas	O
at	O
7	O
.	O
5	O
dpc	O
,	O
and	O
paraffin	O
sections	O
were	O
stained	O
with	O
haematoxylin	O
(	O
Figure	O
5A	O
)	O
or	O
with	O
an	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
(	O
Figure	O
5B	O
-	O
5E	O
)	O
.	O

Immunohistochemical	O
staining	O
revealed	O
that	O
Atrx	B-GGP
was	O
widely	O
expressed	O
in	O
wild	B-SO
-	I-SO
type	I-SO
7	O
.	O
5	O
dpc	O
embryos	O
(	O
Figure	O
5B	O
)	O
.	O

Expression	O
was	O
highest	O
in	O
the	O
embryonic	O
region	O
(	O
Figure	O
5C	O
)	O
and	O
the	O
chorion	O
(	O
Figure	O
5D	O
)	O
.	O

Detectable	O
but	O
lower	O
levels	O
of	O
expression	O
were	O
observed	O
in	O
the	O
ectoplacental	O
cone	O
(	O
Figure	O
5D	O
)	O
and	O
surrounding	O
decidual	O
tissue	O
.	O

We	O
also	O
observed	O
very	O
high	O
levels	O
of	O
Atrx	B-GGP
expression	O
in	O
trophoblast	B-CL
giant	I-CL
cells	I-CL
(	O
TGCs	O
)	O
surrounding	O
the	O
Reichert	O
'	O
s	O
membrane	B-GO
(	O
Figure	O
5E	O
)	O
.	O

Within	O
the	O
large	O
nuclei	B-GO
of	O
these	O
TGCs	O
,	O
the	O
typical	O
nuclear	B-GO
association	O
of	O
Atrx	B-GGP
with	O
blocks	O
of	O
pericentromeric	B-GO
heterochromatin	I-GO
[	O
15	O
]	O
was	O
clearly	O
observable	O
.	O

Only	O
background	O
staining	O
was	O
seen	O
in	O
the	O
corresponding	O
Atrxnull	O
embryonic	O
tissues	O
(	O
Figure	O
5B	O
-	O
5D	O
)	O
,	O
while	O
expression	O
in	O
the	O
surrounding	O
decidual	O
tissue	O
(	O
of	O
maternal	O
origin	O
)	O
was	O
normal	O
and	O
served	O
as	O
an	O
antibody	B-GO
staining	O
control	O
(	O
unpublished	O
data	O
)	O
.	O

Morphologically	O
,	O
7	O
.	O
5	O
dpc	O
Atrxnull	O
embryos	O
were	O
dramatically	O
reduced	O
in	O
size	O
and	O
appeared	O
developmentally	O
retarded	O
relative	O
to	O
stage	O
-	O
matched	O
wild	B-SO
-	I-SO
type	I-SO
embryos	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

However	O
,	O
despite	O
their	O
reduced	O
size	O
,	O
the	O
general	O
morphology	O
and	O
organisation	O
of	O
embryonic	O
structures	O
in	O
Atrxnull	O
conceptuses	O
appeared	O
grossly	O
normal	O
.	O

The	O
amnion	O
and	O
chorion	O
were	O
clearly	O
present	O
and	O
the	O
amniotic	O
,	O
exocoelomic	O
,	O
and	O
ectoplacental	O
cavities	O
were	O
distinguishable	O
,	O
as	O
were	O
all	O
three	O
embryonic	O
germ	O
layers	O
(	O
Figure	O
5A	O
-	O
5C	O
)	O
.	O

At	O
8	O
.	O
5	O
dpc	O
,	O
embryos	O
were	O
dissected	O
free	O
of	O
deciduas	O
,	O
and	O
observed	O
in	O
whole	O
mount	O
.	O

Individual	O
conceptuses	O
were	O
genotyped	O
by	O
PCR	O
using	O
DNA	B-SO
isolated	O
from	O
yolk	O
sac	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

Consistent	O
with	O
observations	O
at	O
7	O
.	O
5	O
dpc	O
,	O
the	O
general	O
morphology	O
of	O
the	O
embryo	O
proper	O
of	O
Atrxnull	O
conceptuses	O
also	O
appeared	O
grossly	O
normal	O
at	O
8	O
.	O
5	O
dpc	O
.	O

The	O
head	O
fold	O
had	O
clearly	O
formed	O
,	O
and	O
expression	O
of	O
the	O
early	O
mesoderm	O
marker	O
brachyury	B-GGP
(	O
T	B-GGP
)	O
[	O
16	O
]	O
was	O
detected	O
in	O
the	O
primitive	O
streak	O
and	O
emerging	O
notochord	O
by	O
whole	O
-	O
mount	O
in	O
situ	O
hybridisation	O
(	O
WMISH	O
)	O
(	O
Figure	O
5F	O
)	O
,	O
indicating	O
that	O
Atrxnull	O
embryos	O
had	O
gastrulated	O
.	O

To	O
investigate	O
whether	O
the	O
reduced	O
size	O
of	O
the	O
Atrxnull	O
embryos	O
was	O
due	O
to	O
an	O
increase	O
in	O
apoptosis	O
,	O
we	O
analysed	O
sections	O
of	O
paraffin	O
-	O
embedded	O
7	O
.	O
5	O
dpc	O
embryos	O
by	O
TdT	B-GGP
-	O
mediated	O
dUTP	B-CHEBI
nick	O
end	O
labeling	O
(	O
TUNEL	O
)	O
assay	O
(	O
Figure	O
6A	O
)	O
.	O

Very	O
few	O
apoptotic	B-CL
cells	I-CL
were	O
detected	O
in	O
wild	B-SO
-	I-SO
type	I-SO
7	O
.	O
5	O
dpc	O
embryos	O
.	O

In	O
Atrxnull	O
embryos	O
,	O
a	O
slight	O
increase	O
in	O
the	O
apoptotic	O
population	O
was	O
evident	O
.	O

However	O
,	O
consistent	O
with	O
our	O
observation	O
of	O
a	O
grossly	O
normal	O
apoptotic	O
index	O
in	O
Atrxnull	O
ES	O
cells	B-CL
(	O
Figure	O
S2	O
)	O
,	O
the	O
apoptotic	O
response	O
observed	O
in	O
Atrxnull	O
embryos	O
was	O
also	O
not	O
uniform	O
,	O
but	O
was	O
restricted	O
to	O
a	O
low	O
number	O
of	O
scattered	O
TUNEL	O
-	O
positive	O
cells	B-CL
.	O

Since	O
this	O
small	O
apoptotic	O
response	O
is	O
unlikely	O
to	O
account	O
fully	O
for	O
the	O
dramatic	O
size	O
deficit	O
observed	O
in	O
Atrxnull	O
embryos	O
,	O
a	O
possible	O
proliferation	O
defect	O
was	O
also	O
investigated	O
by	O
immunohistochemical	O
staining	O
of	O
7	O
.	O
5	O
dpc	O
embryo	O
sections	O
for	O
the	O
mitosis	O
marker	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	B-CHEBI
H3	O
[	O
13	O
]	O
.	O

Relative	O
to	O
the	O
very	O
high	O
mitotic	O
index	O
observed	O
in	O
wild	B-SO
-	I-SO
type	I-SO
embryos	O
,	O
the	O
proportion	O
of	O
mitotic	O
cells	B-CL
observed	O
in	O
Atrxnull	O
embryos	O
at	O
7	O
.	O
5	O
dpc	O
was	O
dramatically	O
reduced	O
(	O
Figure	O
6B	O
)	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
the	O
size	O
deficit	O
observed	O
in	O
Atrxnull	O
embryos	O
prior	O
to	O
lethality	O
largely	O
reflects	O
a	O
proliferative	O
defect	O
,	O
with	O
a	O
minor	O
but	O
indirect	O
contribution	O
from	O
increased	O
apoptosis	O
.	O

Although	O
a	O
growth	O
defect	O
was	O
also	O
observed	O
in	O
Atrxnull	O
ES	O
cells	B-CL
(	O
Figure	O
3A	O
)	O
,	O
in	O
contrast	O
to	O
the	O
Atrxnull	O
embryos	O
,	O
the	O
mitotic	O
index	O
of	O
the	O
ES	O
cell	B-CL
population	O
(	O
as	O
measured	O
with	O
the	O
same	O
antibody	B-GO
)	O
was	O
not	O
depleted	O
(	O
Figure	O
S1B	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
mitotic	O
defect	O
observed	O
in	O
embryos	O
is	O
unlikely	O
to	O
be	O
a	O
direct	O
,	O
cell	B-CL
-	O
autonomous	O
effect	O
of	O
the	O
absence	O
of	O
Atrx	B-GGP
,	O
and	O
is	O
more	O
likely	O
to	O
be	O
a	O
secondary	O
effect	O
resulting	O
from	O
the	O
failure	O
to	O
develop	O
a	O
normal	O
trophoblast	O
(	O
see	O
below	O
)	O
.	O

Trophectoderm	O
Failure	O
in	O
Atrxnull	O
Embryos	O

Whole	O
-	O
mount	O
observation	O
of	O
8	O
.	O
5	O
dpc	O
embryos	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
the	O
basically	O
normal	O
although	O
delayed	O
morphology	O
of	O
the	O
embryo	O
itself	O
,	O
the	O
extraembryonic	O
tissues	O
of	O
Atrxnull	O
conceptuses	O
appeared	O
highly	O
disorganised	O
.	O

When	O
embryos	O
were	O
removed	O
from	O
deciduas	O
,	O
the	O
surrounding	O
trophectoderm	O
layer	O
appeared	O
dramatically	O
reduced	O
in	O
Atrxnull	O
embryos	O
relative	O
to	O
wild	B-SO
-	I-SO
type	I-SO
littermates	O
,	O
and	O
the	O
underlying	O
ectoplacental	O
cone	O
appeared	O
reduced	O
and	O
abnormally	O
shaped	O
(	O
Figure	O
7A	O
)	O
.	O

Vacated	O
deciduas	O
surrounding	O
8	O
.	O
5	O
dpc	O
wild	B-SO
-	I-SO
type	I-SO
and	O
Atrxnull	O
embryos	O
were	O
bisected	O
and	O
analysed	O
by	O
WMISH	O
for	O
expression	O
of	O
placental	B-GGP
lactogen	I-GGP
-	I-GGP
1	I-GGP
(	O
Pl	B-GGP
-	I-GGP
1	I-GGP
)	O
,	O
a	O
marker	O
of	O
terminally	O
differentiated	O
TGCs	O
.	O

The	O
number	O
of	O
Pl	B-GGP
-	I-GGP
1	I-GGP
-	O
expressing	O
cells	B-CL
attached	O
to	O
the	O
decidual	O
wall	O
after	O
removal	O
of	O
the	O
embryo	O
is	O
an	O
indication	O
of	O
the	O
density	O
of	O
trophoblast	B-CL
cells	I-CL
surrounding	O
each	O
implantation	O
site	O
[	O
17	O
]	O
.	O

We	O
found	O
that	O
the	O
population	O
of	O
Pl	B-GGP
-	I-GGP
1	I-GGP
-	O
expressing	O
cells	B-CL
was	O
depleted	O
in	O
the	O
decidual	O
implantation	O
sites	O
containing	O
Atrxnull	O
embryos	O
relative	O
to	O
those	O
containing	O
wild	B-SO
-	I-SO
type	I-SO
littermates	O
(	O
Figure	O
7B	O
)	O
;	O
this	O
was	O
also	O
apparent	O
at	O
7	O
.	O
5	O
dpc	O
,	O
as	O
determined	O
by	O
immunohistochemical	O
staining	O
of	O
paraffin	O
sections	O
of	O
embryos	O
in	O
deciduas	O
with	O
an	O
anti	O
-	O
Pl	B-GGP
-	I-GGP
1	I-GGP
antibody	B-GO
(	O
Figure	O
7C	O
)	O
.	O

A	O
TGC	O
deficiency	O
in	O
the	O
absence	O
of	O
Atrx	B-GGP
is	O
consistent	O
with	O
the	O
observation	O
that	O
Atrx	B-GGP
is	O
highly	O
expressed	O
in	O
giant	O
cells	B-CL
surrounding	O
wild	B-SO
-	I-SO
type	I-SO
7	O
.	O
5	O
dpc	O
embryos	O
(	O
Figure	O
5E	O
)	O
.	O

To	O
investigate	O
whether	O
the	O
trophoblast	O
defect	O
was	O
restricted	O
to	O
the	O
production	O
of	O
secondary	O
TGCs	O
(	O
produced	O
by	O
diploid	O
precursors	O
in	O
the	O
ectoplacental	O
cone	O
and	O
derived	O
originally	O
from	O
the	O
polar	O
trophectoderm	O
overlying	O
the	O
inner	O
cell	B-CL
mass	O
of	O
the	O
blastocyst	O
)	O
or	O
also	O
affected	O
the	O
production	O
of	O
primary	O
TGCs	O
(	O
resulting	O
from	O
differentiation	O
of	O
the	O
mural	O
trophectoderm	O
of	O
the	O
blastocyst	O
)	O
,	O
blastocysts	O
(	O
3	O
.	O
5	O
dpc	O
)	O
from	O
crosses	O
between	O
AtrxWT	O
/	O
flox	B-SO
females	O
and	O
GATA1	B-GGP
-	O
Cre	O
homozygous	O
transgenic	B-SO
males	O
(	O
AtrxWT	O
/	O
Y	O
;	O
GATA1	B-GGP
-	O
Cre	O
+	B-SO
/	O
+	B-SO
)	O
were	O
cultured	O
in	O
vitro	O
for	O
5	O
d	O
to	O
monitor	O
outgrowth	O
of	O
the	O
primary	O
trophoblast	O
.	O

After	O
5	O
d	O
,	O
individual	O
blastocyst	O
cultures	O
were	O
scored	O
for	O
the	O
extent	O
of	O
primary	O
trophoblast	O
outgrowth	O
,	O
and	O
the	O
Atrx	B-GGP
genotype	B-SO
and	O
sex	O
of	O
the	O
blastocyst	O
were	O
determined	O
by	O
PCR	O
.	O

Most	O
blastocysts	O
hatched	O
from	O
the	O
zona	O
pellucida	O
within	O
24	O
h	O
,	O
and	O
trophoblast	B-CL
cells	I-CL
spreading	O
out	O
from	O
the	O
inner	O
cell	B-CL
mass	O
could	O
usually	O
be	O
detected	O
within	O
48	O
h	O
of	O
culture	O
.	O

No	O
difference	O
was	O
observed	O
in	O
the	O
rate	O
or	O
extent	O
of	O
trophoblast	O
outgrowth	O
over	O
5	O
d	O
of	O
culture	O
between	O
Atrxnull	O
blastocysts	O
(	O
Atrxnull	O
/	O
Y	O
,	O
n	O
=	O
6	O
)	O
and	O
blastocysts	O
bearing	O
an	O
AtrxWT	O
allele	B-SO
(	O
AtrxWT	O
/	O
WT	B-SO
,	O
n	O
=	O
6	O
;	O
AtrxWT	O
/	O
null	O
,	O
n	O
=	O
6	O
;	O
AtrxWT	O
/	O
Y	O
,	O
n	O
=	O
6	O
)	O
(	O
examples	O
shown	O
in	O
Figure	O
7D	O
)	O
,	O
suggesting	O
that	O
the	O
defect	O
specifically	O
involves	O
the	O
secondary	O
giant	O
cell	B-CL
compartment	O
.	O

This	O
is	O
consistent	O
with	O
the	O
observation	O
that	O
Atrxnull	O
conceptuses	O
implant	O
successfully	O
and	O
survive	O
to	O
gastrulation	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
loss	O
of	O
Atrx	B-GGP
results	O
in	O
a	O
defect	O
in	O
formation	O
of	O
the	O
secondary	O
trophoblast	O
that	O
is	O
apparent	O
from	O
7	O
.	O
5	O
dpc	O
.	O

Despite	O
initiating	O
normal	O
organisation	O
in	O
the	O
embryo	O
proper	O
,	O
Atrxnull	O
conceptuses	O
exhibit	O
a	O
proliferative	O
defect	O
by	O
7	O
.	O
5	O
dpc	O
and	O
die	O
by	O
around	O
9	O
.	O
5	O
dpc	O
,	O
probably	O
due	O
to	O
a	O
nutritional	O
deficit	O
resulting	O
from	O
failure	O
to	O
develop	O
a	O
normal	O
trophoblast	O
.	O

Escape	O
from	O
Imprinted	O
Inactivation	O
of	O
the	O
Paternally	O
Inherited	O
AtrxWT	O
Allele	B-SO
in	O
Extraembryonic	O
Tissues	O
of	O
Carrier	O
Female	O
Mice	B-Taxon

Female	O
mice	B-Taxon
carrying	O
an	O
Atrxnull	O
allele	B-SO
(	O
AtrxWT	O
/	O
null	O
;	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
-	O
)	O
were	O
detected	O
at	O
9	O
.	O
5	O
dpc	O
(	O
Table	O
1	O
)	O
and	O
recovered	O
at	O
birth	O
(	O
unpublished	O
data	O
)	O
,	O
although	O
at	O
both	O
time	O
points	O
the	O
number	O
of	O
carrier	O
females	O
was	O
lower	O
than	O
that	O
of	O
wild	B-SO
-	I-SO
type	I-SO
(	O
AtrxWT	O
/	O
WT	B-SO
;	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
-	O
)	O
females	O
,	O
suggesting	O
that	O
a	O
proportion	O
of	O
carrier	O
female	O
embryos	O
died	O
in	O
utero	O
.	O

Surviving	O
adult	O
carrier	O
female	O
mice	B-Taxon
were	O
not	O
phenotypically	O
normal	O
and	O
exhibited	O
mild	O
behavioural	O
abnormalities	O
,	O
although	O
some	O
could	O
reproduce	O
.	O

For	O
all	O
AtrxWT	O
/	O
null	O
carrier	O
female	O
embryos	O
presented	O
in	O
Table	O
1	O
,	O
the	O
AtrxWT	O
allele	B-SO
was	O
paternally	O
derived	O
,	O
while	O
the	O
Atrxnull	O
allele	B-SO
was	O
maternally	O
derived	O
.	O

In	O
the	O
mouse	B-Taxon
,	O
X	B-GO
chromosome	I-GO
inactivation	O
is	O
subject	O
to	O
parental	O
imprinting	O
in	O
the	O
trophectoderm	O
and	O
primitive	O
endoderm	O
lineages	O
that	O
give	O
rise	O
to	O
the	O
extraembryonic	O
tissues	O
,	O
resulting	O
in	O
inactivation	O
of	O
the	O
paternal	O
X	B-GO
chromosome	I-GO
(	O
Xp	O
)	O
[	O
18	O
]	O
.	O

In	O
contrast	O
,	O
in	O
tissues	O
of	O
the	O
embryo	O
proper	O
(	O
derived	O
from	O
the	O
inner	O
cell	B-CL
mass	O
of	O
the	O
blastocyst	O
)	O
X	B-GO
-	O
inactivation	O
is	O
random	O
[	O
19	O
]	O
.	O

Thus	O
,	O
in	O
the	O
extraembryonic	O
compartment	O
of	O
AtrxWT	O
/	O
null	O
carrier	O
females	O
,	O
normal	O
imprinted	O
X	B-GO
-	O
inactivation	O
would	O
be	O
expected	O
to	O
result	O
in	O
silencing	O
of	O
the	O
paternally	O
derived	O
AtrxWT	O
allele	B-SO
,	O
leaving	O
only	O
the	O
Atrxnull	O
allele	B-SO
on	O
the	O
active	O
maternal	O
X	B-GO
(	O
Xm	O
)	O
and	O
thereby	O
render	O
the	O
extraembryonic	O
tissues	O
null	O
for	O
full	O
-	O
length	O
Atrx	B-GGP
protein	B-CHEBI
.	O

However	O
,	O
the	O
absence	O
of	O
Atrx	B-GGP
in	O
the	O
extraembryonic	O
compartment	O
is	O
lethal	O
in	O
Atrxnull	O
/	O
Y	O
males	O
.	O

This	O
suggested	O
the	O
possibility	O
of	O
an	O
escape	O
from	O
imprinted	O
inactivation	O
of	O
the	O
paternally	O
derived	O
AtrxWT	O
allele	B-SO
in	O
the	O
extraembryonic	O
compartment	O
of	O
a	O
proportion	O
of	O
carrier	O
female	O
embryos	O
.	O

To	O
investigate	O
further	O
,	O
we	O
crossed	O
homozygous	O
Atrxflox	O
/	O
flox	B-SO
females	O
and	O
homozygous	O
GATA1	B-GGP
-	O
cre	O
transgenic	B-SO
males	O
(	O
AtrxWT	O
/	O
Y	O
;	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
+	B-SO
)	O
,	O
which	O
would	O
be	O
expected	O
to	O
yield	O
only	O
Atrxnull	O
males	O
(	O
Atrxnull	O
/	O
Y	O
;	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
-	O
)	O
and	O
carrier	O
females	O
(	O
AtrxWT	O
/	O
null	O
;	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
-	O
)	O
.	O

In	O
these	O
carrier	O
females	O
,	O
the	O
AtrxWT	O
allele	B-SO
is	O
paternally	O
inherited	O
.	O

Embryos	O
were	O
dissected	O
in	O
their	O
deciduas	O
at	O
7	O
.	O
5	O
dpc	O
,	O
and	O
paraffin	O
sections	O
were	O
stained	O
with	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
,	O
along	O
with	O
sections	O
from	O
a	O
wild	B-SO
-	I-SO
type	I-SO
7	O
.	O
5	O
dpc	O
embryo	O
for	O
comparison	O
(	O
Figure	O
8	O
)	O
.	O

As	O
described	O
above	O
,	O
Atrx	B-GGP
expression	O
was	O
detected	O
in	O
every	O
cell	B-CL
in	I-CL
the	I-CL
epiblast	I-CL
(	I-CL
embryo	I-CL
proper	I-CL
)	I-CL
region	I-CL
of	O
wild	B-SO
-	I-SO
type	I-SO
7	O
.	O
5	O
dpc	O
embryos	O
(	O
Figure	O
8B	O
)	O
.	O

In	O
contrast	O
,	O
the	O
epiblast	O
region	O
of	O
carrier	O
female	O
embryos	O
was	O
composed	O
of	O
a	O
mosaic	O
of	O
small	O
clusters	O
of	O
Atrx	B-GGP
-	O
positive	O
cells	B-CL
(	O
in	O
which	O
the	O
Atrxnull	O
allele	B-SO
on	O
Xm	O
had	O
been	O
inactivated	O
)	O
and	O
Atrx	B-GGP
-	O
negative	O
cells	B-CL
(	O
in	O
which	O
the	O
AtrxWT	O
allele	B-SO
on	O
Xp	O
had	O
been	O
inactivated	O
)	O
,	O
indicating	O
that	O
the	O
Atrx	B-GGP
gene	B-SO
was	O
subject	O
to	O
normal	O
random	O
X	B-GO
-	O
inactivation	O
in	O
the	O
epiblast	O
.	O

Remarkably	O
,	O
clear	O
Atrx	B-GGP
expression	O
could	O
also	O
be	O
detected	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
carrier	O
females	O
,	O
as	O
shown	O
in	O
the	O
extraembryonic	O
-	O
derived	O
chorionic	O
ectoderm	O
(	O
Figure	O
8C	O
)	O
.	O

Atrx	B-GGP
expression	O
could	O
be	O
detected	O
in	O
almost	O
all	O
cells	B-CL
of	I-CL
the	I-CL
chorionic	I-CL
ectoderm	I-CL
.	O

Atrx	B-GGP
expression	O
was	O
also	O
clearly	O
detected	O
in	O
other	O
extraembryonic	O
structures	O
,	O
including	O
TGCs	O
(	O
unpublished	O
data	O
)	O
.	O

Escape	O
from	O
silencing	O
of	O
an	O
Xp	O
-	O
inherited	O
AtrxWT	O
allele	B-SO
was	O
also	O
observed	O
in	O
the	O
chorionic	O
ectoderm	O
of	O
carrier	O
females	O
at	O
8	O
.	O
5	O
dpc	O
(	O
Figure	O
S4	O
)	O
.	O

Thus	O
,	O
although	O
random	O
X	B-GO
-	O
inactivation	O
occurs	O
normally	O
within	O
the	O
epiblast	O
,	O
the	O
AtrxWT	O
allele	B-SO
(	O
inherited	O
on	O
the	O
Xp	O
chromosome	B-GO
)	O
escaped	O
the	O
normal	O
imprinted	O
X	B-GO
-	O
inactivation	O
in	O
the	O
extraembryonic	O
compartment	O
of	O
some	O
carrier	O
females	O
.	O

Discussion	O

We	O
investigated	O
the	O
role	O
of	O
the	O
Atrx	B-GGP
protein	B-CHEBI
in	O
mouse	B-Taxon
development	O
.	O

By	O
using	O
a	O
conditional	O
knockout	O
approach	O
,	O
we	O
ablated	O
the	O
full	O
-	O
length	O
Atrx	B-GGP
protein	B-CHEBI
first	O
in	O
ES	O
cells	B-CL
and	O
embryoid	O
bodies	O
,	O
and	O
then	O
in	O
developing	O
mouse	B-Taxon
embryos	O
.	O

Atrx	B-GGP
in	O
ES	O
Cells	B-CL

Atrxnull	O
ES	O
cells	B-CL
could	O
not	O
be	O
recovered	O
by	O
direct	O
targeting	O
and	O
were	O
eventually	O
generated	O
by	O
adopting	O
a	O
conditional	O
targeting	O
approach	O
.	O

This	O
is	O
consistent	O
with	O
our	O
observation	O
that	O
Atrx	B-GGP
is	O
highly	O
expressed	O
in	O
ES	O
cells	B-CL
,	O
and	O
that	O
the	O
absence	O
of	O
full	O
-	O
length	O
Atrx	B-GGP
imparts	O
a	O
growth	O
disadvantage	O
relative	O
to	O
cells	B-CL
bearing	O
a	O
functional	O
Atrx	B-GGP
allele	B-SO
.	O

At	O
present	O
,	O
the	O
cause	O
of	O
the	O
proliferative	O
delay	O
in	O
Atrxnull	O
ES	O
cells	B-CL
is	O
not	O
known	O
.	O

Interestingly	O
,	O
we	O
demonstrated	O
that	O
apoptosis	O
is	O
not	O
significantly	O
up	O
-	O
regulated	O
in	O
ES	O
cells	B-CL
lacking	O
Atrx	B-GGP
and	O
is	O
only	O
mildly	O
elevated	O
in	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
mouse	B-Taxon
embryos	O
.	O

In	O
contrast	O
,	O
it	O
was	O
recently	O
shown	O
that	O
the	O
loss	O
of	O
Atrx	B-GGP
markedly	O
increased	O
the	O
apoptotic	O
population	O
in	O
the	O
differentiating	O
cells	B-CL
of	O
the	O
embryonic	O
cortex	O
and	O
postnatal	O
hippocampus	O
,	O
when	O
Atrx	B-GGP
expression	O
was	O
ablated	O
in	O
the	O
developing	O
mouse	B-Taxon
forebrain	O
using	O
the	O
Atrxflox	O
allele	B-SO
described	O
here	O
[	O
20	O
]	O
.	O

The	O
human	B-GGP
ATRX	I-GGP
protein	B-CHEBI
has	O
been	O
shown	O
to	O
associate	O
in	O
a	O
complex	B-GO
with	O
Daxx	B-GGP
[	O
8	O
]	O
,	O
a	O
protein	B-CHEBI
that	O
has	O
been	O
implicated	O
in	O
multiple	O
pathways	O
for	O
the	O
regulation	O
of	O
apoptosis	O
[	O
21	O
]	O
.	O

It	O
is	O
possible	O
that	O
disruption	O
of	O
the	O
mouse	B-GGP
Atrx	I-GGP
-	I-GGP
Daxx	I-GGP
complex	B-GO
(	O
by	O
ablation	O
of	O
the	O
Atrx	B-GGP
protein	B-CHEBI
)	O
could	O
have	O
triggered	O
a	O
universal	O
proapoptotic	O
response	O
.	O

However	O
,	O
our	O
observations	O
in	O
ES	O
cells	B-CL
demonstrate	O
that	O
the	O
induction	O
of	O
apoptosis	O
is	O
not	O
an	O
automatic	O
response	O
triggered	O
by	O
the	O
removal	O
of	O
Atrx	B-GGP
in	O
all	O
cell	B-CL
types	O
,	O
and	O
suggest	O
that	O
the	O
inappropriate	O
apoptosis	O
observed	O
in	O
the	O
Atrx	B-GGP
-	O
mutant	B-SO
forebrain	O
may	O
reflect	O
a	O
requirement	O
for	O
Atrx	B-GGP
during	O
terminal	O
differentiation	O
.	O

An	O
Unexpected	O
Role	O
for	O
Atrx	B-GGP
in	O
Development	O
of	O
the	O
Mouse	B-Taxon
Trophoblast	O

We	O
show	O
that	O
Atrxnull	O
male	O
mice	B-Taxon
are	O
not	O
viable	O
and	O
embryos	O
die	O
by	O
around	O
9	O
.	O
5	O
dpc	O
.	O

Before	O
death	O
,	O
Atrxnull	O
embryos	O
exhibit	O
a	O
markedly	O
reduced	O
mitotic	O
index	O
,	O
suggesting	O
a	O
proliferative	O
defect	O
.	O

Although	O
the	O
embryonic	O
compartment	O
of	O
the	O
conceptus	O
appears	O
initially	O
normal	O
,	O
by	O
7	O
.	O
5	O
dpc	O
Atrxnull	O
embryos	O
display	O
abnormalities	O
in	O
development	O
of	O
the	O
trophoblast	O
,	O
including	O
a	O
depletion	O
in	O
the	O
population	O
of	O
TGCs	O
surrounding	O
the	O
conceptus	O
and	O
a	O
reduction	O
in	O
the	O
size	O
of	O
the	O
ectoplacental	O
cone	O
,	O
which	O
contains	O
the	O
diploid	B-CL
giant	I-CL
cell	I-CL
precursors	O
[	O
22	O
]	O
.	O

TGCs	O
are	O
highly	O
differentiated	O
,	O
postmitotic	O
cells	B-CL
that	O
ultimately	O
form	O
an	O
epithelial	O
layer	O
at	O
the	O
periphery	O
of	O
the	O
placenta	O
,	O
which	O
interfaces	O
with	O
the	O
maternal	O
cells	B-CL
of	O
the	O
decidua	O
[	O
23	O
]	O
.	O

These	O
highly	O
invasive	O
cells	B-CL
are	O
important	O
for	O
mediating	O
initial	O
invasion	O
of	O
the	O
uterine	O
tissue	O
,	O
but	O
are	O
also	O
involved	O
in	O
remodelling	O
the	O
maternal	O
decidua	O
after	O
implantation	O
and	O
in	O
secreting	O
hormones	O
that	O
regulate	O
fetal	O
and	O
maternal	O
growth	O
[	O
24	O
]	O
.	O

Since	O
Atrxnull	O
embryos	O
appear	O
to	O
implant	O
normally	O
,	O
lethality	O
is	O
likely	O
to	O
arise	O
due	O
to	O
a	O
failure	O
of	O
TGC	O
function	O
later	O
during	O
development	O
.	O

Embryonic	O
lethality	O
in	O
mice	B-Taxon
in	O
the	O
absence	O
of	O
Atrx	B-GGP
was	O
a	O
surprising	O
finding	O
,	O
as	O
there	O
had	O
been	O
no	O
suggestion	O
of	O
foetal	O
loss	O
in	O
the	O
human	B-Taxon
ATR	B-GGP
-	I-GGP
X	I-GGP
syndrome	O
.	O

It	O
is	O
possible	O
that	O
the	O
role	O
of	O
Atrx	B-GGP
in	O
the	O
trophoblast	O
is	O
specific	O
to	O
mice	B-Taxon
and	O
that	O
ATRX	B-GGP
has	O
no	O
role	O
or	O
is	O
redundant	O
in	O
the	O
human	B-Taxon
trophoblast	O
.	O

Indeed	O
,	O
the	O
birth	O
weight	O
of	O
babies	O
with	O
ATR	B-GGP
-	I-GGP
X	I-GGP
syndrome	O
is	O
usually	O
normal	O
.	O

An	O
alternative	O
explanation	O
for	O
the	O
unexpectedly	O
severe	O
phenotype	O
we	O
observed	O
in	O
mice	B-Taxon
is	O
that	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
deletion	B-SO
generated	O
by	O
Cre	O
recombination	O
completely	O
ablates	O
full	O
-	O
length	O
Atrx	B-GGP
protein	B-CHEBI
(	O
Figure	O
2E	O
)	O
.	O

In	O
contrast	O
,	O
all	O
disease	O
-	O
causing	O
mutations	B-SO
characterised	O
in	O
human	B-Taxon
ATR	O
-	O
X	B-GO
pedigrees	O
appear	O
to	O
give	O
rise	O
to	O
hypomorphic	O
alleles	B-SO
.	O

Some	O
full	O
-	O
length	O
ATRX	B-GGP
protein	B-CHEBI
is	O
detected	O
in	O
cases	O
predicted	O
to	O
have	O
truncating	O
mutations	B-SO
(	O
RJG	O
,	O
unpublished	O
data	O
)	O
,	O
and	O
residual	O
ATPase	O
activity	O
in	O
ATRX	B-GGP
immunoprecipitates	O
can	O
be	O
detected	O
in	O
Epstein	B-Taxon
-	I-Taxon
Barr	I-Taxon
virus	I-Taxon
-	O
transformed	O
lymphocytes	B-CL
of	O
all	O
human	B-Taxon
patients	O
analysed	O
to	O
date	O
(	O
A	O
.	O
Argentaro	O
and	O
M	O
.	O
Mitson	O
,	O
unpublished	O
data	O
)	O
.	O

The	O
failure	O
to	O
observe	O
a	O
truly	O
null	O
ATRX	B-GGP
allele	B-SO
among	O
human	B-Taxon
patients	O
strongly	O
suggests	O
that	O
,	O
as	O
in	O
the	O
mouse	B-Taxon
,	O
the	O
complete	O
absence	O
of	O
ATRX	B-GGP
protein	B-CHEBI
is	O
incompatible	O
with	O
human	B-Taxon
fetal	O
survival	O
.	O

While	O
this	O
study	O
has	O
revealed	O
an	O
unexpected	O
role	O
for	O
Atrx	B-GGP
in	O
the	O
murine	B-Taxon
trophectoderm	O
,	O
as	O
a	O
result	O
of	O
the	O
early	O
lethality	O
observed	O
in	O
Atrxnull	O
embryos	O
it	O
is	O
not	O
possible	O
to	O
rule	O
out	O
other	O
roles	O
for	O
Atrx	B-GGP
at	O
later	O
developmental	O
stages	O
in	O
tissues	O
of	O
the	O
embryo	O
proper	O
.	O

Indeed	O
,	O
we	O
show	O
that	O
Atrx	B-GGP
is	O
highly	O
expressed	O
throughout	O
the	O
entire	O
developing	O
embryo	O
at	O
7	O
.	O
5	O
dpc	O
(	O
Figure	O
5B	O
)	O
,	O
and	O
it	O
is	O
likely	O
that	O
Atrx	B-GGP
function	O
will	O
turn	O
out	O
to	O
be	O
important	O
for	O
other	O
differentiating	O
tissues	O
.	O

Tetraploid	O
aggregation	O
experiments	O
(	O
in	O
which	O
mutant	B-SO
embryos	O
are	O
rescued	O
with	O
wild	B-SO
-	I-SO
type	I-SO
extraembryonic	O
tissues	O
)	O
might	O
shed	O
more	O
light	O
on	O
the	O
role	O
of	O
Atrx	B-GGP
during	O
later	O
mouse	B-Taxon
development	O
,	O
but	O
these	O
issues	O
can	O
be	O
more	O
subtly	O
dissected	O
by	O
combining	O
the	O
conditional	O
Atrxflox	O
allele	B-SO
that	O
we	O
have	O
generated	O
with	O
different	O
tissue	O
-	O
specific	O
Cre	O
transgenes	B-SO
.	O

As	O
mentioned	O
above	O
,	O
this	O
approach	O
has	O
already	O
revealed	O
a	O
critical	O
role	O
for	O
Atrx	B-GGP
during	O
neuronal	B-CL
differentiation	O
in	O
adult	O
mice	B-Taxon
[	O
20	O
]	O
.	O

Further	O
evidence	O
that	O
Atrx	B-GGP
is	O
also	O
required	O
at	O
later	O
stages	O
of	O
mouse	B-Taxon
development	O
is	O
provided	O
by	O
the	O
observed	O
dramatic	O
skewing	O
against	O
Atrx	B-GGP
-	O
negative	O
cells	B-CL
in	O
some	O
somatic	O
tissues	O
of	O
carrier	O
female	O
mice	B-Taxon
,	O
whose	O
tissues	O
initially	O
comprise	O
a	O
mosaic	O
of	O
Atrx	B-GGP
-	O
positive	O
and	O
Atrx	B-GGP
-	O
negative	O
cells	B-CL
as	O
a	O
result	O
of	O
random	O
X	B-GO
-	O
inactivation	O
(	O
M	O
.	O
Muers	O
,	O
personal	O
communication	O
)	O
.	O

Atrx	B-GGP
joins	O
an	O
expanding	O
list	O
of	O
mouse	B-Taxon
genes	B-SO
for	O
which	O
targeted	O
disruption	O
results	O
in	O
peri	O
-	O
implantation	O
lethality	O
as	O
a	O
result	O
of	O
trophoblast	O
or	O
placental	O
abnormalities	O
(	O
reviewed	O
in	O
[	O
25	O
]	O
)	O
.	O

Comparison	O
with	O
other	O
phenotypes	O
might	O
provide	O
some	O
insight	O
into	O
the	O
role	O
of	O
Atrx	B-GGP
in	O
trophoblast	O
development	O
.	O

Atrx	B-GGP
-	O
mutant	B-SO
embryos	O
progress	O
further	O
than	O
embryos	O
nullizygous	O
for	O
factors	O
involved	O
in	O
the	O
initial	O
specification	O
of	O
trophoblast	B-CL
stem	I-CL
cells	I-CL
(	O
such	O
as	O
Cdx2	B-GGP
)	O
or	O
in	O
stem	B-CL
cell	I-CL
maintenance	O
and	O
proliferation	O
(	O
such	O
as	O
Eomes	B-GGP
)	O
.	O

Cdx2	B-GGP
-	O
mutant	B-SO
embryos	O
fail	O
to	O
implant	O
and	O
die	O
between	O
3	O
.	O
5	O
and	O
5	O
.	O
5	O
dpc	O
[	O
26	O
]	O
,	O
while	O
Eomes	B-GGP
-	O
mutant	B-SO
blastocysts	O
implant	O
into	O
the	O
uterus	O
,	O
but	O
arrest	O
soon	O
after	O
implantation	O
without	O
forming	O
organised	O
embryonic	O
or	O
extraembryonic	O
structures	O
[	O
27	O
]	O
.	O

In	O
contrast	O
,	O
Atrx	B-GGP
-	O
mutant	B-SO
embryos	O
implant	O
successfully	O
and	O
establish	O
organised	O
embryonic	O
structures	O
by	O
7	O
.	O
5	O
dpc	O
.	O

The	O
Atrx	B-GGP
-	O
mutant	B-SO
phenotype	O
closely	O
resembles	O
that	O
observed	O
in	O
mice	B-Taxon
nullizygous	O
for	O
the	O
basic	B-CHEBI
helix	B-SO
-	O
loop	O
-	O
helix	B-SO
transcription	O
factor	O
Hand1	B-GGP
.	O

Hand1	B-GGP
-	O
mutant	B-SO
conceptuses	O
arrest	O
at	O
around	O
7	O
.	O
5	O
dpc	O
and	O
display	O
a	O
normal	O
embryonic	O
compartment	O
,	O
but	O
,	O
like	O
Atrx	B-GGP
-	O
mutant	B-SO
embryos	O
,	O
ablation	O
of	O
Hand1	B-GGP
causes	O
a	O
reduction	O
in	O
the	O
size	O
of	O
the	O
ectoplacental	O
cone	O
and	O
density	O
of	O
TGCs	O
[	O
28	O
]	O
.	O

As	O
with	O
Atrx	B-GGP
mutants	B-SO
,	O
only	O
arrested	O
or	O
resorbed	O
Hand1	B-GGP
-	O
mutant	B-SO
conceptuses	O
were	O
recovered	O
after	O
8	O
.	O
5	O
dpc	O
.	O

Also	O
like	O
Atrx	B-GGP
,	O
disruption	O
of	O
Hand1	B-GGP
specifically	O
affects	O
secondary	O
giant	O
cell	B-CL
formation	O
,	O
and	O
primary	O
trophoblast	O
outgrowths	O
from	O
blastocysts	O
appeared	O
normal	O
.	O

Hand1	B-GGP
is	O
required	O
for	O
terminal	O
differentiation	O
of	O
secondary	O
TGCs	O
,	O
and	O
in	O
its	O
absence	O
trophoblast	B-CL
cells	I-CL
arrest	O
at	O
a	O
precursor	O
stage	O
in	O
the	O
ectoplacental	O
cone	O
[	O
17	O
,	O
28	O
]	O
.	O

Given	O
the	O
similarity	O
of	O
the	O
Atrx	B-GGP
-	O
and	O
Hand1	B-GGP
-	O
mutant	B-SO
phenotypes	O
and	O
the	O
likelihood	O
that	O
Atrx	B-GGP
acts	O
as	O
a	O
transcriptional	O
regulator	O
by	O
modifying	O
chromatin	B-GO
structure	O
,	O
it	O
will	O
be	O
of	O
interest	O
to	O
determine	O
whether	O
Atrx	B-GGP
is	O
itself	O
a	O
regulator	O
of	O
Hand1	B-GGP
expression	O
,	O
or	O
alternatively	O
whether	O
it	O
acts	O
as	O
a	O
co	O
-	O
regulator	O
of	O
one	O
or	O
more	O
of	O
the	O
downstream	O
transcriptional	O
targets	O
of	O
Hand1	B-GGP
.	O

It	O
is	O
noteworthy	O
that	O
,	O
in	O
the	O
brain	O
-	O
specific	O
Atrx	B-GGP
knockout	O
mice	B-Taxon
,	O
the	O
defect	O
was	O
observed	O
in	O
terminally	O
differentiating	O
neurons	B-CL
[	O
20	O
]	O
.	O

The	O
secondary	O
TGCs	O
affected	O
in	O
the	O
universal	O
Atrx	B-GGP
knockout	O
reported	O
here	O
represent	O
one	O
of	O
the	O
first	O
terminally	O
differentiated	O
tissues	O
in	O
the	O
developing	O
mouse	B-Taxon
,	O
and	O
this	O
may	O
point	O
to	O
the	O
requirement	O
for	O
Atrx	B-GGP
in	O
the	O
high	O
-	O
level	O
expression	O
of	O
some	O
tissue	O
-	O
specific	O
genes	B-SO
during	O
the	O
final	O
stages	O
of	O
differentiation	O
.	O

Interestingly	O
,	O
the	O
alpha	O
-	O
globin	B-CHEBI
genes	B-SO
,	O
the	O
only	O
confirmed	O
transcriptional	O
targets	O
of	O
regulation	O
by	O
human	B-GGP
ATRX	I-GGP
,	O
are	O
also	O
highly	O
expressed	O
specifically	O
during	O
terminal	O
differentiation	O
within	O
the	O
erythroid	O
lineage	O
.	O

Atrx	B-GGP
Escapes	O
Imprinted	O
X	B-GO
-	O
Inactivation	O
in	O
Extraembryonic	O
Tissues	O
of	O
Carrier	O
Female	O
Mice	B-Taxon

Another	O
surprising	O
finding	O
of	O
this	O
study	O
is	O
that	O
,	O
in	O
carrier	O
female	O
embryos	O
,	O
a	O
paternally	O
inherited	O
AtrxWT	O
allele	B-SO
appears	O
to	O
escape	O
the	O
process	O
of	O
imprinted	O
X	B-GO
-	O
inactivation	O
,	O
which	O
ordinarily	O
silences	O
the	O
Xp	O
chromosome	B-GO
in	O
the	O
extraembryonic	O
compartment	O
of	O
female	O
murine	B-Taxon
tissues	O
[	O
18	O
]	O
.	O

Silencing	O
of	O
the	O
AtrxWT	O
allele	B-SO
on	O
Xp	O
should	O
render	O
these	O
females	O
null	O
for	O
Atrx	B-GGP
in	O
the	O
extraembryonic	O
tissues	O
,	O
since	O
the	O
normally	O
active	O
Xm	O
chromosome	B-GO
carries	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	B-SO
.	O

Although	O
not	O
phenotypically	O
normal	O
,	O
some	O
Atrx	B-GGP
carrier	O
females	O
developed	O
to	O
term	O
and	O
went	O
on	O
to	O
reproduce	O
.	O

Thus	O
,	O
the	O
failure	O
to	O
correctly	O
silence	O
the	O
paternally	O
derived	O
AtrxWT	O
allele	B-SO
in	O
the	O
extraembryonic	O
tissues	O
of	O
carrier	O
females	O
is	O
consistent	O
with	O
our	O
observations	O
that	O
in	O
Atrxnull	O
males	O
,	O
the	O
Atrx	B-GGP
protein	B-CHEBI
plays	O
an	O
essential	O
role	O
in	O
the	O
development	O
of	O
the	O
trophoblast	O
and	O
is	O
necessary	O
for	O
survival	O
in	O
utero	O
in	O
the	O
mouse	B-Taxon
.	O

The	O
survival	O
of	O
Atrx	B-GGP
carrier	O
females	O
contrasts	O
with	O
the	O
phenotypes	O
seen	O
in	O
carriers	O
of	O
mutations	B-SO
of	O
other	O
murine	B-Taxon
X	B-GO
-	O
linked	O
genes	B-SO
known	O
to	O
be	O
essential	O
in	O
the	O
extraembryonic	O
compartment	O
.	O

For	O
example	O
,	O
targeted	O
disruption	O
of	O
the	O
dyskerin	B-GGP
(	O
Dkc1	B-GGP
)	O
,	O
glucose	B-GGP
6	I-GGP
-	I-GGP
phosphate	I-GGP
dehydrogenase	I-GGP
(	O
G6PD	B-GGP
)	O
,	O
and	O
choroideremia	B-GGP
(	O
Chm	B-GGP
)	O
genes	B-SO
cause	O
embryonic	O
lethality	O
in	O
null	O
male	O
embryos	O
through	O
defects	O
of	O
the	O
extraembryonic	O
-	O
derived	O
tissues	O
[	O
29	O
-	O
31	O
]	O
.	O

Female	O
mice	B-Taxon
carrying	O
mutations	B-SO
of	O
these	O
genes	B-SO
on	O
the	O
maternally	O
inherited	O
X	B-GO
chromosome	I-GO
also	O
die	O
in	O
utero	O
,	O
whereas	O
females	O
that	O
inherit	O
the	O
mutation	B-SO
on	O
the	O
Xp	O
chromosome	B-GO
survive	O
.	O

Thus	O
,	O
unlike	O
Atrx	B-GGP
,	O
these	O
genes	B-SO
and	O
/	O
or	O
their	O
effects	O
on	O
cell	B-CL
growth	O
are	O
unable	O
to	O
circumvent	O
the	O
processes	O
that	O
ultimately	O
cause	O
all	O
cells	B-CL
in	I-CL
the	I-CL
extraembryonic	I-CL
tissues	I-CL
to	O
express	O
only	O
the	O
maternally	O
derived	O
X	B-GO
chromosome	I-GO
.	O

How	O
might	O
expression	O
of	O
the	O
paternal	O
AtrxWT	O
allele	B-SO
be	O
maintained	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
the	O
Atrx	B-GGP
carrier	O
females	O
?	O

One	O
possibility	O
is	O
that	O
,	O
like	O
some	O
other	O
X	B-GO
-	O
linked	O
genes	B-SO
,	O
silencing	O
of	O
the	O
Atrx	B-GGP
gene	B-SO
on	O
Xp	O
is	O
incomplete	O
,	O
such	O
that	O
there	O
is	O
always	O
a	O
low	O
-	O
level	O
,	O
leaky	O
output	O
of	O
Atrx	B-GGP
from	O
a	O
normally	O
inactivated	O
Xp	O
chromosome	B-GO
in	O
extraembryonic	O
tissues	O
.	O

However	O
,	O
it	O
was	O
recently	O
demonstrated	O
that	O
the	O
paternal	O
Atrx	B-GGP
(	O
called	O
Xnp	O
)	O
allele	B-SO
is	O
completely	O
silenced	O
in	O
a	O
normal	O
mouse	B-Taxon
trophoblast	B-CL
stem	I-CL
cell	I-CL
line	O
[	O
32	O
]	O
,	O
suggesting	O
that	O
Atrx	B-GGP
does	O
not	O
normally	O
escape	O
imprinted	O
X	B-GO
-	O
inactivation	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
wild	B-SO
-	I-SO
type	I-SO
females	O
.	O

Thus	O
,	O
the	O
expression	O
of	O
the	O
Xp	O
-	O
linked	O
AtrxWT	O
allele	B-SO
that	O
we	O
observed	O
is	O
unique	O
to	O
female	O
carriers	O
of	O
the	O
Atrxnull	O
allele	B-SO
.	O

Perhaps	O
a	O
more	O
likely	O
explanation	O
for	O
this	O
phenomenon	O
stems	O
from	O
experimental	O
observations	O
suggesting	O
that	O
imprinted	O
X	B-GO
-	O
inactivation	O
is	O
not	O
imposed	O
on	O
all	O
precursors	O
of	O
the	O
mouse	B-Taxon
extraembryonic	O
tissues	O
:	O
A	O
subpopulation	O
of	O
cells	B-CL
may	O
escape	O
this	O
process	O
and	O
make	O
a	O
random	O
"	O
choice	O
"	O
of	O
which	O
X	B-GO
chromosome	I-GO
will	O
be	O
inactivated	O
.	O

On	O
average	O
,	O
50	O
%	O
of	O
the	O
cells	B-CL
in	O
this	O
randomly	O
inactivating	O
subpopulation	O
would	O
be	O
expected	O
to	O
maintain	O
an	O
active	O
Xp	O
chromosome	B-GO
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
expression	O
of	O
paternally	O
transmitted	O
X	B-GO
-	O
linked	O
lacZ	O
[	O
33	O
,	O
34	O
]	O
and	O
GFP	O
[	O
35	O
]	O
transgenes	B-SO
failed	O
to	O
be	O
silenced	O
in	O
a	O
small	O
subpopulation	O
of	O
extraembryonic	B-CL
cells	I-CL
.	O

Further	O
,	O
it	O
has	O
been	O
shown	O
that	O
in	O
a	O
subpopulation	O
of	O
extraembryonic	B-CL
cells	I-CL
,	O
it	O
is	O
the	O
Xm	O
rather	O
than	O
the	O
Xp	O
that	O
undergoes	O
late	O
replication	O
,	O
a	O
molecular	B-CHEBI
correlate	O
of	O
the	O
inactive	O
state	O
[	O
18	O
,	O
36	O
]	O
.	O

Although	O
initially	O
small	O
and	O
quickly	O
diluted	O
in	O
normal	O
embryos	O
,	O
the	O
cellular	B-CL
subpopulation	O
that	O
inactivates	O
the	O
Xm	O
chromosome	B-GO
could	O
rapidly	O
expand	O
to	O
replace	O
the	O
normally	O
imprinted	O
cells	B-CL
in	O
extraembryonic	O
lineages	O
if	O
the	O
normal	O
silencing	O
of	O
Xp	O
compromises	O
cell	B-CL
growth	O
or	O
differentiation	O
.	O

Interestingly	O
,	O
it	O
has	O
been	O
suggested	O
that	O
the	O
size	O
of	O
the	O
population	O
that	O
initially	O
escapes	O
imprinting	O
may	O
range	O
widely	O
(	O
from	O
0	O
%	O
to	O
30	O
%	O
)	O
,	O
even	O
between	O
genetically	B-SO
identical	O
embryos	O
[	O
37	O
]	O
,	O
and	O
this	O
may	O
account	O
for	O
the	O
variable	O
phenotype	O
observed	O
among	O
females	O
bearing	O
Xm	O
-	O
linked	O
mutant	B-SO
alleles	B-SO
of	O
genes	B-SO
essential	O
for	O
normal	O
extraembryonic	O
development	O
[	O
38	O
]	O
.	O

Put	O
simply	O
,	O
carrier	O
females	O
bearing	O
a	O
small	O
initial	O
population	O
of	O
escaping	O
cells	B-CL
would	O
be	O
more	O
severely	O
affected	O
than	O
those	O
bearing	O
a	O
larger	O
population	O
.	O

This	O
could	O
explain	O
why	O
we	O
have	O
observed	O
significant	O
phenotypic	O
variation	O
among	O
Atrx	B-GGP
carrier	O
females	O
,	O
with	O
some	O
carriers	O
dying	O
in	O
utero	O
by	O
9	O
.	O
5	O
dpc	O
(	O
Table	O
1	O
)	O
and	O
others	O
developing	O
to	O
term	O
.	O

Another	O
possible	O
mechanism	O
is	O
that	O
inactivation	O
of	O
the	O
paternal	O
X	B-GO
proceeds	O
normally	O
in	O
all	O
cells	B-CL
,	O
but	O
subsequently	O
the	O
Atrx	B-GGP
gene	B-SO
within	O
individual	O
cells	B-CL
is	O
reactivated	O
.	O

Alternatively	O
,	O
in	O
the	O
absence	O
of	O
Atrx	B-GGP
,	O
the	O
paternal	O
allele	B-SO
may	O
partially	O
escape	O
the	O
normal	O
process	O
of	O
silencing	O
.	O

In	O
both	O
of	O
these	O
cases	O
,	O
other	O
genes	B-SO
on	O
the	O
paternal	O
X	B-GO
chromosome	I-GO
must	O
be	O
inactivated	O
and	O
remain	O
so	O
,	O
since	O
blocking	O
inactivation	O
of	O
the	O
entire	O
Xp	O
chromosome	B-GO
causes	O
embryonic	O
lethality	O
due	O
to	O
biallelic	O
expression	O
of	O
X	B-GO
-	O
linked	O
genes	B-SO
in	O
the	O
trophoblast	O
[	O
39	O
]	O
.	O

Summary	O

ATR	O
-	O
X	B-GO
syndrome	O
is	O
the	O
first	O
human	B-Taxon
genetic	B-SO
disease	O
known	O
to	O
be	O
caused	O
by	O
mutations	B-SO
in	O
a	O
chromatin	B-GO
remodelling	O
factor	O
.	O

At	O
present	O
we	O
do	O
not	O
know	O
how	O
ATRX	B-GGP
influences	O
gene	B-SO
expression	O
or	O
what	O
effect	O
it	O
has	O
on	O
cell	B-CL
behaviour	O
.	O

Nevertheless	O
,	O
we	O
have	O
previously	O
noted	O
that	O
none	O
of	O
the	O
natural	B-SO
mutations	B-SO
causing	O
ATR	O
-	O
X	B-GO
syndrome	O
are	O
nulls	O
,	O
which	O
suggests	O
that	O
it	O
plays	O
a	O
critical	O
role	O
in	O
normal	O
development	O
.	O

Results	O
of	O
conditional	O
inactivation	O
of	O
Atrx	B-GGP
in	O
the	O
developing	O
mouse	B-Taxon
forebrain	O
,	O
based	O
on	O
the	O
Atrxflox	O
allele	B-SO
described	O
here	O
,	O
shows	O
that	O
Atrx	B-GGP
exerts	O
a	O
major	O
effect	O
on	O
terminally	O
differentiating	O
neurons	B-CL
.	O

Conditional	O
inactivation	O
of	O
Atrx	B-GGP
in	O
other	O
tissues	O
is	O
underway	O
.	O

Here	O
we	O
have	O
shown	O
that	O
animal	B-Taxon
-	O
wide	O
disruption	O
of	O
the	O
Atrx	B-GGP
gene	B-SO
causes	O
a	O
severe	O
embryonic	O
-	O
lethal	O
phenotype	O
,	O
revealing	O
an	O
essential	O
role	O
for	O
Atrx	B-GGP
in	O
the	O
formation	O
of	O
the	O
murine	B-Taxon
trophoblast	O
.	O

In	O
addition	O
,	O
Atrx	B-GGP
appears	O
to	O
escape	O
imprinted	O
X	B-GO
-	I-GO
chromosome	I-GO
inactivation	O
in	O
the	O
extraembryonic	O
tissues	O
of	O
some	O
carrier	O
female	O
mice	B-Taxon
.	O

Materials	O
and	O
Methods	O

Generation	O
of	O
ES	O
cells	B-CL
bearing	O
the	O
Atrxflox	O
allele	B-SO
.	O

Briefly	O
,	O
the	O
targeting	O
vector	B-SO
(	O
shown	O
in	O
Figure	O
2A	O
)	O
places	O
a	O
loxP	B-SO
site	I-SO
within	O
intron	B-SO
18	O
and	O
a	O
loxP	B-SO
-	I-SO
flanked	I-SO
MC1neopA	O
selection	O
cassette	B-SO
in	O
intron	B-SO
17	O
of	O
the	O
Atrx	B-GGP
gene	B-SO
.	O

A	O
detailed	O
description	O
of	O
the	O
targeting	O
construct	B-SO
is	O
provided	O
in	O
[	O
20	O
]	O
.	O

Linearised	O
plasmid	B-SO
(	O
150	O
mu	O
g	O
)	O
was	O
electroporated	O
into	O
1	O
x	O
108	O
E14Tg2a	O
ES	O
cells	B-CL
,	O
and	O
colonies	O
resistant	O
to	O
G418	O
and	O
ganciclovir	O
were	O
isolated	O
.	O

Homologous	O
targeting	O
events	O
were	O
identified	O
by	O
Southern	O
blot	O
of	O
EcoRI	O
-	O
digested	O
DNA	B-SO
and	O
hybridisation	O
with	O
a	O
5	O
'	O
probe	B-SO
(	O
generated	O
with	O
primers	B-SO
PPS1	O
.	O
20	O
and	O
PPS1	O
.	O
27	O
)	O
and	O
a	O
3	O
'	O
probe	B-SO
(	O
a	O
0	O
.	O
9	O
-	O
kb	O
HaeIII	O
fragment	B-SO
)	O
as	O
shown	O
in	O
Figure	O
2A	O
and	O
2B	O
.	O

DNA	B-SO
from	O
correctly	O
targeted	O
clones	O
was	O
also	O
digested	O
with	O
SacI	O
and	O
analysed	O
by	O
Southern	O
blot	O
and	O
hybridisation	O
with	O
a	O
probe	B-SO
from	O
within	O
intron	B-SO
17	O
(	O
a	O
PCR	B-SO
product	I-SO
generated	O
with	O
primers	B-SO
PPS1	O
.	O
15	O
and	O
Xnp46	O
)	O
to	O
confirm	O
that	O
the	O
loxP	B-SO
site	I-SO
within	O
intron	B-SO
18	O
had	O
been	O
included	O
within	O
the	O
crossed	O
-	O
over	O
region	B-SO
(	O
Figure	O
2A	O
and	O
2C	O
)	O
.	O

Sequences	B-SO
of	O
primers	B-SO
are	O
shown	O
in	O
Table	O
S1	O
.	O

Cre	O
-	O
recombination	O
and	O
characterisation	O
of	O
Atrxnull	O
ES	O
cells	B-CL
and	O
embryoid	O
bodies	O
.	O

ES	O
cell	B-CL
clones	O
bearing	O
the	O
Atrxflox	O
allele	B-SO
(	O
1	O
x	O
107	O
cells	B-CL
)	O
were	O
transiently	O
transfected	O
with	O
50	O
mu	O
g	O
of	O
uncut	O
Cre	O
expression	O
plasmid	B-SO
(	O
pCAGGS	O
-	O
Cre	O
-	O
IRESpuro	O
)	O
[	O
40	O
]	O
.	O

Following	O
transfection	O
,	O
cells	B-CL
were	O
plated	O
at	O
a	O
range	O
of	O
clonal	O
densities	O
in	O
complete	O
medium	O
without	O
G418	O
,	O
and	O
isolated	O
subclones	O
were	O
picked	O
after	O
7	O
d	O
.	O

Subclones	O
were	O
expanded	O
and	O
analysed	O
for	O
the	O
presence	O
of	O
a	O
recombinant	O
locus	B-SO
initially	O
by	O
PCR	O
,	O
to	O
detect	O
deletion	B-SO
of	O
the	O
MC1neopA	O
cassette	B-SO
,	O
and	O
then	O
by	O
Southern	O
blot	O
and	O
hybridisation	O
with	O
the	O
intron	B-SO
17	O
probe	B-SO
described	O
above	O
(	O
Figure	O
2A	O
and	O
2C	O
)	O
.	O

Northern	O
blots	O
were	O
carried	O
out	O
according	O
to	O
standard	O
techniques	O
using	O
20	O
mu	O
g	O
of	O
total	O
RNA	B-SO
isolated	O
using	O
TRI	O
Reagent	B-CHEBI
(	O
Sigma	O
-	O
Aldrich	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
.	O

The	O
blot	O
was	O
hybridised	O
with	O
a	O
probe	B-SO
from	O
within	O
exon	B-SO
10	O
of	O
the	O
Atrx	B-GGP
gene	B-SO
(	O
generated	O
with	O
primers	B-SO
Mxnp4	O
and	O
Mxnp28	O
[	O
Table	O
S1	O
]	O
)	O
.	O

After	O
it	O
was	O
stripped	O
,	O
the	O
membrane	O
was	O
hybridised	O
with	O
a	O
beta	B-GGP
-	I-GGP
actin	I-GGP
cDNA	B-SO
probe	B-SO
(	O
Clontech	O
,	O
Palo	O
Alto	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

Protein	B-CHEBI
extraction	O
and	O
detection	O
of	O
Atrx	B-GGP
by	O
Western	O
blotting	O
was	O
performed	O
as	O
described	O
previously	O
[	O
4	O
]	O
,	O
using	O
the	O
mouse	B-Taxon
monoclonal	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
23C	O
[	O
15	O
]	O
.	O

Analyses	O
of	O
cell	B-CL
cycle	O
and	O
apoptosis	O
are	O
described	O
in	O
Protocol	O
S1	O
.	O

Methylation	O
of	O
rDNA	O
was	O
analysed	O
in	O
DNA	B-SO
from	O
ES	O
cell	B-CL
clones	O
or	O
from	O
embryoid	O
bodies	O
recovered	O
after	O
7	O
d	O
of	O
in	O
vitro	O
differentiation	O
as	O
described	O
previously	O
[	O
41	O
]	O
.	O

Genomic	B-SO
DNA	I-SO
was	O
digested	O
with	O
methylation	O
-	O
sensitive	O
restriction	O
enzymes	B-SO
as	O
described	O
and	O
analysed	O
by	O
Southern	O
blotting	O
.	O

The	O
RIB3	O
and	O
RIB4	O
probes	B-SO
(	O
which	O
were	O
amplified	O
from	O
human	B-Taxon
DNA	B-SO
,	O
but	O
cross	O
-	O
react	O
with	O
the	O
mouse	B-Taxon
rDNA	O
repeat	B-SO
)	O
have	O
been	O
described	O
previously	O
[	O
11	O
]	O
.	O

Oligonucleotide	B-SO
probes	B-SO
to	O
detect	O
Line	O
1	O
and	O
Sine	O
B1	O
repeats	B-SO
have	O
been	O
described	O
previously	O
[	O
42	O
]	O
.	O

The	O
minor	O
satellite	B-SO
probe	B-SO
was	O
a	O
27	O
-	O
mer	O
oligonucleotide	B-SO
(	O
mCENT2	O
)	O
.	O

The	O
major	O
satellite	B-SO
probe	B-SO
was	O
a	O
27	O
-	O
mer	O
oligonucleotide	B-SO
(	O
DG27	O
)	O
.	O

The	O
IAP	O
probe	B-SO
was	O
an	O
~	O
400	O
bp	B-SO
PCR	B-SO
product	I-SO
(	O
primers	B-SO
14A	O
and	O
13K	O
)	O
amplified	O
from	O
an	O
IAP	O
inserted	B-SO
into	O
the	O
mouse	B-GGP
agouti	I-GGP
gene	B-SO
[	O
43	O
]	O
and	O
was	O
a	O
gift	O
from	O
Peter	O
Warnecke	O
and	O
Tim	O
Bestor	O
.	O

The	O
PCR	B-SO
product	I-SO
included	O
the	O
entire	O
5	B-SO
'	I-SO
LTR	I-SO
of	O
the	O
IAP	O
.	O

All	O
oligonucleotide	B-SO
sequences	I-SO
are	O
shown	O
in	O
Table	O
S1	O
.	O

Generation	O
of	O
chimeras	O
,	O
floxed	B-SO
mice	B-Taxon
,	O
and	O
mutant	B-SO
mice	B-Taxon
.	O

Targeted	O
Atrxflox	O
ES	O
cell	B-CL
clones	O
were	O
injected	O
into	O
C57BL	O
/	O
6	O
blastocysts	O
and	O
transferred	O
into	O
2	O
.	O
5	O
dpc	O
pseudopregnant	O
recipients	O
by	O
standard	O
techniques	O
.	O

Resulting	O
chimeras	O
were	O
mated	O
with	O
C57BL	O
/	O
6	O
to	O
establish	O
germline	O
transmission	O
.	O

Offspring	O
with	O
the	O
Atrxflox	O
allele	B-SO
were	O
identified	O
by	O
Southern	O
blotting	O
of	O
SacI	O
-	O
digested	O
tail	O
DNA	B-SO
using	O
the	O
intron	B-SO
17	O
probe	B-SO
as	O
shown	O
in	O
Figure	O
2A	O
and	O
2C	O
.	O

For	O
Cre	O
-	O
recombination	O
,	O
Atrxflox	O
mice	B-Taxon
were	O
crossed	O
with	O
GATA1	B-GGP
-	O
Cre	O
transgenic	B-SO
mice	B-Taxon
as	O
described	O
in	O
the	O
text	O
.	O

Recombinant	O
alleles	B-SO
were	O
detected	O
by	O
Southern	O
blotting	O
as	O
described	O
above	O
or	O
by	O
PCR	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

Immunohistochemistry	O
,	O
in	O
situ	O
hybridisation	O
,	O
and	O
TUNEL	O
assay	O
.	O

7	O
.	O
5	O
dpc	O
decidual	O
swellings	O
were	O
dissected	O
away	O
from	O
maternal	O
tissue	O
and	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
/	O
PBS	O
overnight	O
at	O
4	O
degrees	O
C	O
.	O

After	O
embryos	O
were	O
washed	O
thoroughly	O
in	O
PBS	O
,	O
they	O
were	O
dehydrated	O
through	O
an	O
ethanol	B-CHEBI
series	O
and	O
xylene	B-CHEBI
,	O
embedded	O
in	O
paraffin	O
,	O
and	O
sectioned	O
at	O
5	O
mu	O
m	O
.	O

Sections	O
were	O
processed	O
for	O
immunohistochemistry	O
using	O
the	O
ABC	O
Staining	O
System	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
California	O
,	O
United	O
States	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Sections	O
were	O
stained	O
with	O
rabbit	B-Taxon
polyclonal	O
antibodies	B-GO
against	O
ATRX	B-GGP
(	O
H	O
-	O
300	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
,	O
Placental	B-GGP
lactogen	I-GGP
-	I-GGP
I	I-GGP
(	O
AB1288	O
,	O
Chemicon	O
International	O
,	O
Temecula	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
phospho	B-CHEBI
(	O
Ser10	O
)	O
-	O
histone	B-CHEBI
H3	O
(	O
06	O
-	O
570	O
,	O
Upstate	O
Biotechnology	O
,	O
Waltham	O
,	O
Massachusetts	O
,	O
United	O
States	O
)	O
.	O

Where	O
appropriate	O
,	O
adjacent	O
sections	O
were	O
stained	O
with	O
haematoxylin	O
.	O

In	O
some	O
cases	O
,	O
adjacent	O
sections	O
were	O
also	O
analysed	O
to	O
detect	O
apoptotic	B-CL
cells	I-CL
by	O
TUNEL	O
using	O
the	O
in	O
situ	O
cell	B-CL
death	O
detection	O
kit	O
(	O
Roche	O
,	O
Basel	O
,	O
Switzerland	O
)	O
.	O

After	O
labelling	O
,	O
these	O
slides	O
were	O
mounted	O
in	O
Vectashield	O
containing	O
DAPI	O
(	O
Vector	B-SO
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
visualised	O
by	O
fluorescence	O
microscopy	O
.	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridisations	O
were	O
performed	O
on	O
8	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
away	O
from	O
maternal	O
and	O
extraembryonic	O
tissues	O
)	O
using	O
a	O
brachyury	B-GGP
(	O
T	B-GGP
)	O
riboprobe	O
[	O
16	O
]	O
and	O
on	O
bisected	O
decidual	O
implantation	O
sites	O
from	O
which	O
embryos	O
(	O
8	O
.	O
5	O
dpc	O
)	O
had	O
been	O
removed	O
using	O
a	O
placental	B-GGP
lactogen	I-GGP
-	I-GGP
1	I-GGP
(	O
Pl	B-GGP
-	I-GGP
1	I-GGP
)	O
riboprobe	O
(	O
see	O
Protocol	O
S1	O
for	O
details	O
)	O
.	O

Blastocyst	O
outgrowth	O
cultures	O
.	O

Superovulated	O
heterozygous	O
female	O
mice	B-Taxon
(	O
AtrxWT	O
/	O
flox	B-SO
)	O
were	O
mated	O
to	O
homozygous	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
+	B-SO
transgenic	B-SO
males	O
,	O
and	O
blastocysts	O
were	O
flushed	O
from	O
uterine	O
horns	O
with	O
M2	O
medium	O
(	O
Sigma	O
)	O
at	O
3	O
.	O
5	O
dpc	O
.	O

Individual	O
blastocysts	O
were	O
cultured	O
in	O
multiwell	O
tissue	O
cultures	O
plates	O
as	O
described	O
previously	O
[	O
44	O
]	O
.	O

Cultures	O
were	O
inspected	O
and	O
photographed	O
daily	O
and	O
the	O
extent	O
of	O
outgrowth	O
scored	O
.	O

After	O
7	O
d	O
,	O
cultures	O
were	O
harvested	O
and	O
DNA	B-SO
extracted	O
.	O

The	O
Atrx	B-GGP
genotype	B-SO
and	O
sex	O
of	O
each	O
culture	O
was	O
determined	O
by	O
PCR	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Cell	B-CL
Cycle	O
Analysis	O
of	O
Atrx	B-GGP
-	O
Positive	O
and	O
Atrxnull	O
ES	O
Cells	B-CL

(	O
A	O
)	O
Representative	O
FACS	O
profiles	O
of	O
BrdU	O
-	O
pulsed	O
ES	O
cells	B-CL
bearing	O
either	O
functional	O
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
or	O
null	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
Atrx	B-GGP
alleles	B-SO
showing	O
BrdU	O
-	O
FITC	B-CHEBI
(	O
y	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
against	O
propidium	O
iodide	B-CHEBI
(	O
x	O
-	O
axis	O
,	O
linear	O
scale	O
)	O
.	O

The	O
gated	O
populations	O
show	O
cells	B-CL
in	O
G1	O
(	O
PIlow	O
,	O
BrdU	O
-	O
negative	O
)	O
(	O
R1	O
)	O
,	O
S	O
(	O
BrdU	O
-	O
positive	O
)	O
(	O
R2	O
)	O
,	O
and	O
G2	O
/	O
M	O
(	O
PIhi	O
,	O
BrdU	O
-	O
negative	O
)	O
(	O
R3	O
)	O
phases	O
of	O
the	O
cell	B-CL
cycle	O
.	O

Below	O
is	O
shown	O
the	O
quantitation	O
of	O
gated	O
populations	O
,	O
indicating	O
the	O
percentage	O
of	O
cells	B-CL
in	O
G1	O
,	O
S	O
,	O
and	O
G2	O
/	O
M	O
cell	B-CL
-	O
cycle	O
phases	O
in	O
each	O
culture	O
.	O

(	O
B	O
)	O
FACS	O
profiles	O
of	O
ES	O
cells	B-CL
bearing	O
either	O
functional	O
(	O
AtrxWT	O
or	O
Atrxflox	O
)	O
or	O
null	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
Atrx	B-GGP
alleles	B-SO
stained	O
for	O
the	O
mitosis	O
marker	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	B-CHEBI
H3	O
(	O
FITC	B-CHEBI
,	O
y	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
against	O
propidium	O
iodide	B-CHEBI
(	O
x	O
-	O
axis	O
,	O
linear	O
scale	O
)	O
.	O

The	O
size	O
of	O
the	O
mitotic	O
population	O
(	O
phosphoH3S10	O
-	O
positive	O
,	O
PIhi	O
)	O
(	O
gate	O
R3	O
)	O
is	O
indicated	O
for	O
each	O
profile	O
.	O

The	O
ES	O
cell	B-CL
clone	O
analysed	O
in	O
each	O
trace	O
is	O
indicated	O
.	O

(	O
3	O
.	O
2	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Analysis	O
of	O
Apoptosis	O
in	O
Atrx	B-GGP
-	O
Positive	O
and	O
Atrxnull	O
ES	O
Cells	B-CL

FACS	O
analysis	O
of	O
ES	O
cells	B-CL
bearing	O
different	O
Atrx	B-GGP
alleles	B-SO
as	O
shown	O
,	O
after	O
costaining	O
for	O
Annexin	B-GGP
V	I-GGP
(	O
FITC	O
,	O
x	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
and	O
propidium	O
iodide	B-CHEBI
(	O
y	O
-	O
axis	O
,	O
logarithmic	O
scale	O
)	O
.	O

The	O
size	O
of	O
the	O
early	O
apoptotic	O
(	O
Annexin	B-GGP
-	O
positive	O
,	O
PIlow	O
)	O
and	O
late	O
apoptotic	O
or	O
necrotic	O
(	O
Annexin	B-GGP
-	O
positive	O
,	O
PIhi	O
)	O
populations	O
is	O
indicated	O
for	O
each	O
genotype	B-SO
.	O

(	O
223	O
KB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Normal	O
DNA	B-SO
Methylation	O
at	O
Mouse	B-Taxon
Repetitive	B-SO
Elements	I-SO
in	O
Atrxnull	O
ES	O
Cells	B-CL

DNA	B-SO
from	O
Atrx	B-GGP
-	O
positive	O
(	O
bearing	O
either	O
an	O
AtrxWT	O
or	O
Atrxflox	O
allele	B-SO
)	O
or	O
Atrxnull	O
(	O
bearing	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	B-SO
)	O
ES	O
cells	B-CL
was	O
digested	O
with	O
either	O
a	O
CpG	O
-	O
methylation	O
-	O
sensitive	O
enzyme	B-SO
HpaII	O
(	O
H	O
)	O
or	O
its	O
methylation	O
-	O
insensitive	O
isoschizomer	O
MspI	O
(	O
M	O
)	O
as	O
indicated	O
,	O
and	O
digested	O
DNA	B-SO
was	O
analysed	O
by	O
Southern	O
blotting	O
.	O

Membranes	O
were	O
hybridised	O
with	O
probes	B-SO
specific	O
for	O
the	O
mouse	B-Taxon
Line	O
1	O
(	O
A	O
)	O
,	O
Sine	O
B1	O
(	O
B	O
)	O
,	O
minor	O
satellite	B-SO
(	O
C	O
)	O
,	O
and	O
IAP	O
(	O
D	O
)	O
repeat	B-SO
elements	I-SO
.	O

No	O
significant	O
loss	O
of	O
CpG	O
-	O
methylation	O
was	O
observed	O
at	O
any	O
of	O
these	O
repetitive	B-SO
elements	I-SO
in	O
Atrxnull	O
ES	O
cells	B-CL
.	O

As	O
a	O
positive	O
control	O
for	O
loss	O
of	O
methylation	O
,	O
DNA	B-SO
from	O
ES	O
cells	B-CL
lacking	O
either	O
the	O
Dnmt1	B-GGP
(	I-GGP
Dnmt1	I-GGP
-	I-GGP
/	I-GGP
-	I-GGP
)	I-GGP
or	I-GGP
both	I-GGP
the	I-GGP
Dnmt3a	I-GGP
and	I-GGP
Dnmt3b	I-GGP
(	I-GGP
Dnmt3a3b	I-GGP
-	I-GGP
/	I-GGP
-	I-GGP
)	I-GGP
DNA	I-GGP
methyltransferases	I-GGP
was	O
included	O
in	O
the	O
analysis	O
of	O
Line	O
1	O
and	O
Sine	O
B1	O
repeats	B-SO
.	O

Loss	O
of	O
CpG	O
-	O
methylation	O
was	O
clearly	O
observed	O
at	O
these	O
repetitive	B-SO
elements	I-SO
in	O
these	O
cell	B-CL
lines	O
.	O

(	O
1	O
.	O
8	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Escape	O
from	O
Imprinted	O
Inactivation	O
in	O
8	O
.	O
5	O
dpc	O
Carrier	O
Female	O
Embryo	O

A	O
cross	O
was	O
carried	O
out	O
between	O
a	O
carrier	O
female	O
(	O
AtrxWT	O
/	O
null	O
)	O
and	O
wild	B-SO
-	I-SO
type	I-SO
male	O
(	O
AtrxWT	O
/	O
Y	O
)	O
,	O
and	O
embryos	O
were	O
dissected	O
in	O
their	O
deciduas	O
at	O
8	O
.	O
5	O
dpc	O
.	O

Any	O
carrier	O
female	O
progeny	O
of	O
this	O
cross	O
will	O
carry	O
an	O
AtrxWT	O
allele	B-SO
on	O
the	O
Xp	O
chromosome	B-GO
and	O
an	O
Atrxnull	O
allele	B-SO
on	O
the	O
Xm	O
chromosome	B-GO
.	O

Transverse	O
paraffin	O
sections	O
were	O
stained	O
with	O
the	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
(	O
H	O
-	O
300	O
)	O
.	O

(	O
A	O
)	O
High	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
of	O
the	O
neural	O
fold	O
region	O
(	O
nf	O
)	O
(	O
embryo	O
proper	O
)	O
of	O
a	O
carrier	O
female	O
(	O
AtrxWT	O
/	O
null	O
)	O
embryo	O
.	O

This	O
tissue	O
is	O
clearly	O
comprised	O
of	O
a	O
mosaic	O
of	O
Atrx	B-GGP
-	O
positive	O
and	O
Atrx	B-GGP
-	O
negative	O
cells	B-CL
due	O
to	O
random	O
X	B-GO
-	O
inactivation	O
.	O

This	O
section	O
was	O
counterstained	O
with	O
haematoxylin	O
.	O

(	O
B	O
)	O
High	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
of	O
the	O
same	O
embryo	O
depicted	O
in	O
(	O
A	O
)	O
,	O
showing	O
the	O
extraembryonic	O
derived	O
-	O
chorionic	O
ectoderm	O
(	O
ce	O
)	O
and	O
visceral	O
endoderm	O
(	O
ve	O
)	O
,	O
two	O
tissues	O
that	O
undergo	O
imprinted	O
X	B-GO
-	O
inactivation	O
.	O

Although	O
Atrx	B-GGP
is	O
poorly	O
expressed	O
in	O
the	O
visceral	O
endoderm	O
(	O
even	O
in	O
wild	B-SO
-	I-SO
type	I-SO
females	O
[	O
unpublished	O
data	O
]	O
)	O
,	O
strong	O
expression	O
of	O
Atrx	B-GGP
can	O
be	O
seen	O
in	O
the	O
chorionic	O
ectoderm	O
,	O
indicating	O
that	O
the	O
paternally	O
-	O
derived	O
AtrxWT	O
allele	B-SO
had	O
escaped	O
inactivation	O
in	O
this	O
tissue	O
.	O

(	O
1	O
.	O
7	O
MB	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Protocol	O
S1	O

Supplementary	O
Methods	O

(	O
42	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Table	O
S1	O

Primers	B-SO
Used	O
in	O
This	O
Study	O

(	O
20	O
KB	O
DOC	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
Online	O
Mendelian	O
Inheritance	O
in	O
Man	B-Taxon
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
OMIM	O
)	O
accession	O
number	O
for	O
ATR	O
-	O
X	B-GO
syndrome	O
is	O
301040	O
.	O

The	O
GeneID	O
(	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
gene	O
)	O
for	O
human	B-GGP
ATRX	I-GGP
is	O
546	O
and	O
for	O
mouse	B-GGP
Atrx	I-GGP
is	O
22589	O
.	O

The	O
GenBank	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
)	O
accession	O
number	O
for	O
the	O
minor	O
satellite	B-SO
probe	B-SO
mCENT2	O
is	O
X14470	O
(	O
nucleotides	B-CHEBI
75	O
-	O
101	O
)	O
,	O
for	O
the	O
major	O
satellite	B-SO
probe	B-SO
DG27	O
is	O
M25032	O
(	O
nucleotides	B-SO
146	O
-	O
172	O
)	O
,	O
and	O
for	O
the	O
IAP	O
probe	B-SO
is	O
L33247	O
.	O

Acknowledgements	O

We	O
would	O
like	O
to	O
thank	O
Stu	O
Orkin	O
for	O
providing	O
access	O
to	O
the	O
GATA1	B-GGP
-	O
Cre	O
transgenic	B-SO
mice	B-Taxon
,	O
Gillian	O
Morriss	O
-	O
Kay	O
for	O
advice	O
,	O
Peter	O
Warnecke	O
and	O
Tim	O
Bestor	O
for	O
the	O
IAP	O
probe	B-SO
,	O
En	O
Li	O
for	O
the	O
Dnmt	O
knockout	O
ES	O
cells	B-CL
,	O
Frank	O
Talamantes	O
for	O
the	O
pRSV	O
-	O
mPL	B-GGP
-	I-GGP
1	I-GGP
plasmid	B-SO
,	O
Ann	O
Atzberger	O
for	O
assistance	O
with	O
flow	O
cytometry	O
,	O
and	O
Deb	O
Bogani	O
and	O
Terry	O
Hacker	O
for	O
assistance	O
with	O
whole	O
-	O
mount	O
in	O
situ	O
hybridisation	O
analyses	O
and	O
embryo	O
sectioning	O
.	O

Abbreviations	O

BrdU	O
-	O
bromodeoxyuridine	O

dpc	O
-	O
days	O
postcoitus	O

ES	O
cells	B-CL
-	O
embryonic	O
stem	B-CL
cells	I-CL

IAP	O
-	O
intracisternal	O
A	O
particle	O

rDNA	O
-	O
ribosomal	B-GO
DNA	B-SO

TGC	O
-	O
trophoblast	B-CL
giant	I-CL
cell	I-CL

TUNEL	O
-	O
TdT	B-GGP
-	O
mediated	O
dUTP	B-CHEBI
nick	O
end	O
labeling	O

WMISH	O
-	O
whole	O
-	O
mount	O
in	O
situ	O
hybridisation	O

Figures	O
and	O
Tables	O

Figure	O
1	O

Schematic	O
Representation	O
of	O
the	O
ATRX	B-GGP
Isoforms	B-SO

Shown	O
at	O
the	O
top	O
is	O
the	O
human	B-GGP
ATRX	I-GGP
cDNA	B-SO
.	O

The	O
boxes	O
represent	O
the	O
36	O
exons	B-SO
.	O

The	O
introns	B-SO
are	O
not	O
to	O
scale	O
.	O

The	O
alternative	O
splicing	O
of	O
exons	B-SO
6	O
and	O
7	O
is	O
indicated	O
.	O

Shown	O
underneath	O
are	O
the	O
two	O
ATRX	B-GGP
protein	O
isoforms	B-SO
.	O

Full	O
-	O
length	O
ATRX	B-GGP
(	O
~	O
280	O
kDa	O
)	O
is	O
encoded	O
by	O
the	O
largest	O
open	B-SO
reading	I-SO
frame	I-SO
.	O

The	O
positions	B-SO
of	O
the	O
principal	O
features	B-SO
(	O
the	O
PHD	O
-	O
like	O
domain	B-SO
and	O
the	O
seven	O
SWI	O
/	O
SNF	O
-	O
like	O
motifs	O
)	O
are	O
indicated	O
.	O

Above	O
full	O
-	O
length	O
ATRX	B-GGP
is	O
shown	O
the	O
truncated	O
ATRXt	O
isoform	B-SO
(	O
apparent	O
molecular	B-CHEBI
weight	O
of	O
~	O
200	O
kDa	O
)	O
that	O
arises	O
through	O
the	O
failure	O
to	O
splice	O
intron	B-SO
11	O
and	O
the	O
use	O
of	O
an	O
intronic	B-SO
poly	B-SO
(	I-SO
A	I-SO
)	I-SO
signal	I-SO
.	O

The	O
intron	B-SO
-	O
encoded	O
region	B-SO
of	O
ATRXt	O
is	O
indicated	O
as	O
a	O
filled	O
grey	O
box	O
.	O

Locations	B-SO
of	O
recombinant	O
proteins	B-CHEBI
(	O
A2	O
,	O
FXNP5	O
,	O
and	O
H	O
-	O
300	O
)	O
used	O
to	O
generate	O
antibodies	B-GO
are	O
shown	O
.	O

The	O
scale	O
bar	O
represents	O
200	O
amino	B-CHEBI
acids	I-CHEBI
.	O

Figure	O
2	O

Cre	O
-	O
Mediated	O
Ablation	O
of	O
Full	O
-	O
Length	O
Atrx	B-GGP
Protein	B-CHEBI
in	O
ES	O
Cells	B-CL

(	O
A	O
)	O
Strategy	O
for	O
targeted	O
deletion	B-SO
of	O
exon	B-SO
18	O
of	O
the	O
Atrx	B-GGP
gene	B-SO
.	O

The	O
top	O
line	O
shows	O
the	O
wild	B-SO
-	I-SO
type	I-SO
allele	B-SO
(	O
AtrxWT	O
)	O
at	O
the	O
region	B-SO
surrounding	O
exon	B-SO
18	O
.	O

Below	O
is	O
shown	O
the	O
targeting	O
vector	B-SO
and	O
the	O
targeted	O
allele	B-SO
(	O
Atrxflox	O
)	O
resulting	O
from	O
homologous	O
recombination	O
.	O

The	O
loxP	B-SO
target	I-SO
sites	I-SO
of	O
the	O
Cre	O
recombinase	O
are	O
shown	O
as	O
black	O
triangles	O
,	O
and	O
the	O
three	O
possible	O
recombination	O
events	O
that	O
can	O
be	O
mediated	O
by	O
the	O
Cre	O
recombinase	O
are	O
indicated	O
(	O
labelled	O
A	O
,	O
B	O
,	O
and	O
C	O
in	O
the	O
Atrxflox	O
allele	B-SO
)	O
.	O

At	O
bottom	O
is	O
shown	O
the	O
Cre	O
-	O
recombined	O
allele	B-SO
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
(	O
resulting	O
from	O
recombination	O
event	O
C	O
)	O
in	O
which	O
both	O
exon	B-SO
18	O
and	O
the	O
MC1neopA	O
selection	O
cassette	B-SO
have	O
been	O
deleted	B-SO
.	O

EcoRI	O
(	O
labelled	O
E	O
)	O
and	O
SacI	O
(	O
labelled	O
S	O
)	O
sites	B-SO
present	O
on	O
the	O
targeted	O
129	O
strain	O
X	B-GO
chromosome	I-GO
are	O
indicated	O
.	O

Black	O
bars	O
indicate	O
the	O
positions	B-SO
of	O
the	O
probes	B-SO
used	O
in	O
Southern	O
blots	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
EcoRI	O
-	O
digested	O
DNA	B-SO
from	O
either	O
wild	B-SO
-	I-SO
type	I-SO
ES	O
cells	B-CL
(	O
E14	O
)	O
or	O
targeted	O
ES	O
cell	B-CL
clones	O
bearing	O
the	O
Atrxflox	O
allele	B-SO
(	O
1	O
/	O
F12	O
and	O
1	O
/	O
G11	O
)	O
hybridised	O
with	O
either	O
the	O
20	O
/	O
27	O
(	O
left	O
blot	O
)	O
or	O
Hae0	O
.	O
9	O
(	O
right	O
blot	O
)	O
probes	B-SO
.	O

The	O
EcoRI	O
fragment	B-SO
of	O
the	O
AtrxWT	O
allele	B-SO
(	O
18	O
.	O
5	O
kb	O
)	O
has	O
been	O
replaced	B-SO
with	O
the	O
expected	B-SO
fragments	B-SO
of	O
11	O
.	O
2	O
kb	O
(	O
20	O
/	O
27	O
probe	B-SO
)	O
or	O
8	O
.	O
5	O
kb	O
(	O
Hae0	O
.	O
9	O
probe	B-SO
)	O

(	O
C	O
)	O
Southern	O
blot	O
analysis	O
of	O
SacI	O
-	O
digested	O
DNA	B-SO
from	O
either	O
wild	B-SO
-	I-SO
type	I-SO
ES	O
cells	B-CL
(	O
E14	O
)	O
or	O
targeted	O
ES	O
cell	B-CL
clones	O
bearing	O
the	O
Atrxflox	O
allele	B-SO
(	O
1	O
/	O
F12	O
and	O
1	O
/	O
G11	O
)	O
or	O
Cre	O
-	O
recombinant	O
clones	B-SO
derived	O
from	O
these	O
(	O
1	O
/	O
F12B1F12	O
and	O
1	O
/	O
G11D5	O
)	O
.	O

The	O
membrane	O
was	O
hybridised	O
with	O
the	O
intron	B-SO
17	O
probe	B-SO
indicated	O
in	O
(	O
A	O
)	O
.	O

The	O
expected	O
bands	O
of	O
6	O
.	O
2	O
(	O
AtrxWT	O
)	O
,	O
5	O
.	O
0	O
(	O
Atrxflox	O
)	O
,	O
and	O
2	O
.	O
8	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
kb	O
were	O
observed	O
.	O

(	O
D	O
)	O
Northern	O
blot	O
analysis	O
of	O
RNA	B-SO
from	O
ES	O
cells	B-CL
shown	O
in	O
(	O
C	O
)	O
.	O

The	O
membrane	O
was	O
hybridised	O
first	O
to	O
a	O
probe	B-SO
from	O
exon	B-SO
10	O
of	O
the	O
Atrx	B-GGP
gene	B-SO
(	O
top	O
blot	O
)	O
and	O
subsequently	O
to	O
a	O
beta	B-GGP
-	I-GGP
actin	I-GGP
cDNA	B-SO
probe	B-SO
as	O
loading	O
control	O
(	O
bottom	O
blot	O
)	O
.	O

The	O
transcripts	B-SO
responsible	O
for	O
full	O
-	O
length	O
Atrx	B-GGP
(	O
~	O
10	O
kb	O
)	O
and	O
the	O
truncated	O
Atrxt	O
isoforms	B-SO
(	O
~	O
7	O
kb	O
)	O
are	O
indicated	O
.	O

(	O
E	O
)	O
Western	O
blot	O
analysis	O
of	O
whole	O
-	O
cell	B-CL
extracts	O
from	O
the	O
clones	B-SO
shown	O
in	O
(	O
C	O
)	O
using	O
an	O
anti	O
-	O
ATRX	B-GGP
monoclonal	O
antibody	B-GO
(	O
23C	O
,	O
raised	O
against	O
peptide	B-SO
A2	O
of	O
the	O
human	B-GGP
ATRX	I-GGP
protein	B-CHEBI
shown	O
in	O
Figure	O
1	O
)	O
.	O

The	O
full	O
-	O
length	O
and	O
truncated	O
Atrx	B-GGP
isoforms	B-SO
are	O
indicated	O
.	O

Figure	O
3	O

Growth	O
and	O
Methylation	O
Defects	O
in	O
Atrxnull	O
ES	O
Cells	B-CL

(	O
A	O
)	O
Cultures	O
were	O
inoculated	O
with	O
equivalent	O
numbers	O
of	O
ES	O
cells	B-CL
bearing	O
different	O
Atrx	B-GGP
alleles	B-SO
as	O
indicated	O
,	O
and	O
were	O
serially	O
passaged	O
.	O

After	O
the	O
indicated	O
days	O
of	O
coculture	O
,	O
DNA	B-SO
extracted	O
from	O
a	O
sample	O
of	O
cells	B-CL
was	O
analysed	O
by	O
Southern	O
blot	O
to	O
detect	O
the	O
Atrx	B-GGP
alleles	B-SO
.	O

DNA	B-SO
was	O
digested	O
with	O
SpeI	O
,	O
and	O
the	O
membrane	O
was	O
hybridised	O
with	O
the	O
20	O
/	O
27	O
probe	B-SO
shown	O
in	O
Figure	O
2A	O
.	O

The	O
expected	O
sizes	O
of	O
the	O
different	O
alleles	B-SO
are	O
indicated	O
.	O

(	O
B	O
)	O
Schematic	O
diagram	O
of	O
the	O
transcribed	O
portion	O
of	O
the	O
mouse	B-Taxon
rDNA	O
repeat	B-SO
with	O
the	O
18S	B-GGP
,	O
5	B-GGP
.	I-GGP
8S	I-GGP
,	O
and	O
28S	B-GGP
genes	B-SO
indicated	O
.	O

The	O
positions	B-SO
of	I-SO
the	I-SO
limit	I-SO
-	I-SO
digesting	I-SO
enzymes	I-SO
BamH	O
(	O
labelled	O
B	O
)	O
and	O
EcoRI	O
(	O
labelled	O
E	O
)	O
and	O
the	O
probes	B-SO
(	O
RIB3	O
and	O
RIB4	O
)	O
used	O
in	O
the	O
Southern	O
blots	O
shown	O
in	O
(	O
C	O
)	O
are	O
indicated	O
.	O

Below	O
are	O
shown	O
the	O
locations	B-SO
of	O
the	O
methylation	O
-	O
sensitive	O
enzymes	B-SO
(	O
SmaI	O
,	O
PvuI	O
,	O
and	O
MluI	O
)	O
whose	O
methylation	O
status	O
has	O
been	O
analysed	O
in	O
the	O
Southern	O
blots	O
shown	O
in	O
(	O
C	O
)	O
.	O

(	O
C	O
)	O
DNA	B-SO
from	O
Atrx	B-GGP
-	O
positive	O
(	O
Atrx	B-GGP
+	O
,	O
bearing	O
either	O
an	O
AtrxWT	O
or	O
Atrxflox	O
allele	B-SO
)	O
or	O
Atrxnull	O
(	O
bearing	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	B-SO
)	O
ES	O
cells	B-CL
and	O
7	O
-	O
d	O
embryoid	O
bodies	O
were	O
digested	O
with	O
the	O
enzymes	B-SO
shown	O
and	O
analysed	O
by	O
Southern	O
blotting	O
using	O
the	O
probes	B-SO
indicated	O
.	O

Arrows	O
indicate	O
the	O
fully	O
methylated	O
copies	O
(	O
cut	O
by	O
only	O
the	O
limit	O
-	O
digesting	O
enzyme	B-SO
)	O
.	O

Phosphorimager	O
quantitation	O
of	O
the	O
blots	O
are	O
shown	O
below	O
.	O

The	O
y	O
-	O
axis	O
shows	O
the	O
percentage	O
of	O
copies	O
that	O
are	O
undigested	O
by	O
the	O
methylation	O
-	O
sensitive	O
enzyme	B-SO
as	O
a	O
percentage	O
of	O
the	O
total	O
signal	O
from	O
cut	O
and	O
uncut	O
rDNA	O
.	O

Mean	O
values	O
are	O
indicated	O
by	O
horizontal	O
lines	O
,	O
and	O
the	O
significance	O
of	O
the	O
differences	O
between	O
the	O
Atrx	B-GGP
-	O
positive	O
and	O
Atrxnull	O
populations	O
are	O
shown	O
for	O
each	O
enzyme	B-SO
.	O

Figure	O
4	O

Timing	O
of	O
Onset	O
of	O
GATA1	B-GGP
-	O
Cre	O
Expression	O
and	O
PCR	O
Genotyping	O
of	O
Atrx	B-GGP
Alleles	B-SO

(	O
A	O
)	O
GATA1	B-GGP
-	O
cre	O
+	B-SO
/	O
+	B-SO
transgenic	B-SO
males	O
were	O
crossed	O
to	O
females	O
of	O
the	O
ROSA26	B-GGP
reporter	O
strain	O
(	O
ROSA26	B-GGP
+	B-SO
/	O
-	O
)	O
,	O
and	O
embryos	O
were	O
recovered	O
at	O
0	O
.	O
5	O
dpc	O
(	O
~	O
16	O
-	O
cell	B-CL
morula	O
stage	O
)	O
and	O
stained	O
with	O
X	O
-	O
gal	O
.	O

Cre	O
-	O
mediated	O
activation	O
of	O
the	O
ROSA26	B-GGP
beta	O
-	O
galactosidase	O
reporter	O
allele	B-SO
was	O
detected	O
in	O
all	O
cells	B-CL
in	O
embryos	O
in	O
which	O
both	O
alleles	B-SO
are	O
coinherited	O
.	O

(	O
B	O
)	O
Top	O
gel	O
:	O
PCR	O
genotyping	O
of	O
Atrx	B-GGP
alleles	B-SO
in	O
embryos	O
using	O
primers	B-SO
PPS1	O
.	O
15	O
(	O
exon	B-SO
17	O
)	O
and	O
Mxnp30	O
(	O
exon	B-SO
20	O
)	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

The	O
sizes	O
of	O
PCR	B-SO
products	I-SO
from	O
the	O
different	O
alleles	B-SO
are	O
indicated	O
.	O

Both	O
the	O
Atrx	O
Delta	O
18	O
(	O
resulting	O
from	O
recombination	O
event	O
B	O
in	O
Figure	O
2A	O
)	O
and	O
the	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
allele	B-SO
(	O
resulting	O
from	O
recombination	O
event	O
C	O
in	O
Figure	O
2A	O
)	O
are	O
null	O
for	O
full	O
-	O
length	O
Atrx	B-GGP
protein	B-CHEBI
.	O

The	O
bottom	O
gel	O
shows	O
products	B-SO
from	I-SO
a	I-SO
PCR	I-SO
reaction	I-SO
(	O
primers	B-SO
DG52	O
/	O
DG53	O
)	O
used	O
to	O
sex	O
embryos	O
as	O
described	O
in	O
Protocol	O
S1	O
.	O

A	O
450	O
-	O
bp	B-SO
PCR	B-SO
product	I-SO
is	O
amplified	O
from	O
a	O
mouse	B-Taxon
Y	B-GO
chromosome	I-GO
-	O
specific	O
satellite	B-SO
repeat	I-SO
.	O

Figure	O
5	O

Morphology	O
of	O
Atrxnull	O
Embryos	O
at	O
7	O
.	O
5	O
dpc	O
and	O
8	O
.	O
5	O
dpc	O

Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	I-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
stained	O
with	O
haematoxylin	O
(	O
A	O
)	O
or	O
with	O
an	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
(	O
H	O
-	O
300	O
,	O
Figure	O
1	O
)	O
(	O
B	O
-	O
E	O
)	O
.	O

Photomicrographs	O
C	O
-	O
E	O
show	O
higher	O
magnification	O
images	O
(	O
200	O
x	O
)	O
of	O
the	O
stained	O
sections	O
shown	O
in	O
(	O
B	O
)	O
(	O
40	O
x	O
)	O
.	O

Scale	O
bars	O
represent	O
200	O
mu	O
m	O
(	O
40	O
x	O
magnification	O
)	O
or	O
40	O
mu	O
m	O
(	O
200	O
x	O
magnification	O
)	O
.	O

a	O
,	O
amnion	O
;	O
ac	O
,	O
amniotic	O
cavity	O
;	O
c	O
,	O
chorion	O
;	O
e	O
,	O
epiblast	O
;	O
ec	O
,	O
ectoplacental	O
cavity	O
;	O
ecc	O
,	O
exocoelomic	O
cavity	O
;	O
ep	O
,	O
ectoplacental	O
cone	O
;	O
ne	O
,	O
neural	O
ectoderm	O
;	O
rm	O
,	O
Reichert	O
'	O
s	O
membrane	B-GO
;	O
tgc	O
,	O
trophoblast	B-CL
giant	I-CL
cell	I-CL
.	O

(	O
F	O
)	O
Detection	O
of	O
brachyury	B-GGP
(	O
T	B-GGP
)	O
expression	O
in	O
Atrxnull	O
8	O
.	O
5	O
dpc	O
embryo	O
(	O
head	O
fold	O
stage	O
)	O
by	O
WMISH	O
.	O

The	O
genotype	B-SO
was	O
determined	O
by	O
PCR	O
(	O
as	O
shown	O
in	O
Protocol	O
S1	O
)	O
using	O
DNA	B-SO
extracted	O
from	O
yolk	O
sac	O
.	O

hf	O
,	O
head	O
fold	O
;	O
n	O
,	O
emerging	O
notochord	O
;	O
ps	O
,	O
primitive	O
streak	O
.	O

Figure	O
6	O

Analysis	O
of	O
Apoptosis	O
and	O
Mitosis	O
in	O
Atrxnull	O
Embryos	O

(	O
A	O
)	O
Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	I-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
analysed	O
by	O
TUNEL	O
assay	O
and	O
apoptotic	B-CL
cells	I-CL
labelled	O
with	O
fluorescein	B-CHEBI
-	O
dUTP	B-CHEBI
.	O

Sections	O
were	O
counterstained	O
with	O
DAPI	O
.	O

(	O
B	O
)	O
Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	I-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
were	O
stained	O
with	O
an	O
antibody	B-GO
against	O
the	O
mitosis	O
marker	O
phosphorylated	O
(	O
Ser10	O
)	O
histone	B-CHEBI
H3	O
.	O

Sections	O
were	O
counterstained	O
with	O
haematoxylin	O
.	O

For	O
both	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
,	O
the	O
presence	O
or	O
absence	O
of	O
Atrx	B-GGP
in	O
each	O
embryo	O
was	O
determined	O
by	O
staining	O
adjacent	O
sections	O
with	O
the	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
(	O
H	O
-	O
300	O
)	O
as	O
in	O
Figure	O
5	O
(	O
unpublished	O
data	O
)	O
.	O

Figure	O
7	O

Trophectoderm	O
Defect	O
in	O
Atrxnull	O
Embryos	O

(	O
A	O
)	O
8	O
.	O
5	O
dpc	O
embryos	O
were	O
dissected	O
from	O
surrounding	O
decidual	O
tissue	O
and	O
observed	O
in	O
whole	O
mount	O
.	O

The	O
genotype	B-SO
of	O
each	O
(	O
indicated	O
above	O
)	O
was	O
determined	O
by	O
PCR	O
using	O
DNA	B-SO
extracted	O
from	O
whole	O
embryos	O
after	O
photography	O
.	O

In	O
the	O
left	O
image	O
,	O
the	O
wild	B-SO
-	I-SO
type	I-SO
female	O
(	O
three	O
-	O
somite	O
stage	O
,	O
left	O
)	O
is	O
surrounded	O
by	O
trophoblast	O
(	O
t	O
)	O
while	O
the	O
trophoblast	O
component	O
surrounding	O
the	O
Atrxnull	O
males	O
(	O
at	O
headfold	O
/	O
presomite	O
[	O
middle	O
]	O
and	O
two	O
-	O
somite	O
stages	O
[	O
right	O
]	O
,	O
respectively	O
)	O
is	O
severely	O
depleted	O
.	O

In	O
the	O
right	O
image	O
,	O
the	O
trophoblast	O
has	O
been	O
dissected	O
away	O
from	O
the	O
embryonic	O
region	O
of	O
the	O
wild	B-SO
-	I-SO
type	I-SO
embryo	O
,	O
to	O
reveal	O
the	O
small	O
,	O
abnormally	O
shaped	O
ectoplacental	O
cone	O
(	O
epc	O
)	O
of	O
the	O
mutant	B-SO
littermates	O
.	O

(	O
B	O
)	O
WMISH	O
to	O
detect	O
expression	O
of	O
Pl	B-GGP
-	I-GGP
1	I-GGP
(	O
a	O
marker	O
of	O
TGCs	O
)	O
at	O
the	O
implantation	O
sites	O
in	O
vacated	O
deciduas	O
that	O
had	O
contained	O
8	O
.	O
5	O
dpc	O
wild	B-SO
-	I-SO
type	I-SO
(	O
AtrxWT	O
/	O
WT	B-SO
)	O
or	O
Atrxnull	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
/	O
Y	O
)	O
embryos	O
.	O

The	O
genotype	B-SO
was	O
determined	O
by	O
PCR	O
using	O
DNA	B-SO
extracted	O
from	O
whole	O
embryos	O
.	O

TGCs	O
are	O
stained	O
with	O
Pl	B-GGP
-	I-GGP
1	I-GGP
.	O

(	O
C	O
)	O
Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	I-SO
or	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
stained	O
with	O
an	O
anti	O
-	O
Pl	B-GGP
-	I-GGP
1	I-GGP
antibody	B-GO
.	O

The	O
presence	O
or	O
absence	O
of	O
Atrx	B-GGP
in	O
each	O
embryo	O
was	O
determined	O
by	O
staining	O
adjacent	O
sections	O
with	O
the	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
(	O
H	O
-	O
300	O
)	O
as	O
in	O
Figure	O
5	O
(	O
unpublished	O
data	O
)	O
.	O

(	O
D	O
)	O
Examples	O
of	O
5	O
-	O
d	O
blastocyst	O
outgrowth	O
cultures	O
.	O

Extensive	O
trophoblast	O
outgrowing	O
from	O
the	O
inner	O
cell	B-CL
mass	O
(	O
icm	O
)	O
was	O
observed	O
in	O
all	O
genotypes	B-SO
.	O

The	O
Atrx	B-GGP
genotype	B-SO
and	O
sex	O
of	O
the	O
blastocyst	O
indicated	O
were	O
determined	O
by	O
PCR	O
.	O

Figure	O
8	O

Escape	O
from	O
Imprinted	O
Inactivation	O
of	O
the	O
Paternally	O
Inherited	O
AtrxWT	O
Allele	B-SO
in	O
Carrier	O
Females	O

Paraffin	O
sections	O
of	O
wild	B-SO
-	I-SO
type	I-SO
(	O
AtrxWT	O
/	O
Y	O
)	O
and	O
carrier	O
female	O
(	O
AtrxWT	O
/	O
null	O
)	O
7	O
.	O
5	O
dpc	O
embryos	O
(	O
dissected	O
in	O
their	O
deciduas	O
)	O
were	O
stained	O
with	O
the	O
anti	O
-	O
ATRX	B-GGP
antibody	B-GO
(	O
H	O
-	O
300	O
)	O
.	O

Scale	O
bars	O
represent	O
200	O
mu	O
m	O
(	O
40	O
x	O
magnification	O
)	O
or	O
20	O
mu	O
m	O
(	O
400	O
x	O
magnification	O
)	O
.	O

(	O
A	O
)	O
Stained	O
sections	O
showing	O
whole	O
embryos	O
at	O
40	O
x	O
magnification	O
.	O

a	O
,	O
amnion	O
;	O
c	O
,	O
chorion	O
;	O
e	O
,	O
epiblast	O
;	O
ep	O
,	O
ectoplacental	O
cone	O
.	O

(	O
B	O
)	O
Higher	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
of	O
the	O
epiblast	O
regions	O
of	O
the	O
stained	O
sections	O
shown	O
in	O
(	O
A	O
)	O
.	O

(	O
C	O
)	O
Higher	O
-	O
magnification	O
image	O
(	O
400	O
x	O
)	O
showing	O
the	O
extraembryonic	O
derived	O
-	O
chorionic	O
ectoderm	O
of	O
the	O
stained	O
sections	O
shown	O
in	O
(	O
A	O
)	O
.	O

ce	O
,	O
chorionic	O
ectoderm	O
;	O
cm	O
,	O
chorionic	O
mesoderm	O
.	O

Table	O
1	O

Distribution	O
of	O
Atrx	B-GGP
Genotypes	B-SO
in	O
Timed	O
Matings	O

Footnotes	O

Author	O
contributions	O
.	O

DG	O
,	O
AJHS	O
,	O
WGW	O
,	O
DRH	O
,	O
and	O
RJG	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

DG	O
,	O
JAS	O
,	O
RA	O
,	O
and	O
RJG	O
performed	O
the	O
experiments	O
.	O

DG	O
,	O
RA	O
,	O
WGW	O
,	O
DRH	O
,	O
and	O
RJG	O
analysed	O
the	O
data	O
.	O

LD	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

LD	O
provided	O
technical	O
assistance	O
.	O

DG	O
wrote	O
the	O
paper	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Medical	O
Research	O
Council	O
of	O
the	O
United	O
Kingdom	O
.	O

Citation	O
:	O
Garrick	O
D	O
,	O
Sharpe	O
JA	O
,	O
Arkell	O
R	O
,	O
Dobbie	O
L	O
,	O
Smith	O
AJH	O
,	O
et	O
al	O
.	O

(	O
2006	O
)	O
Loss	O
of	O
Atrx	B-GGP
affects	O
trophoblast	O
development	O
and	O
the	O
pattern	O
of	O
X	B-GO
-	O
inactivation	O
in	O
extraembryonic	O
tissues	O
.	O

PLoS	O
Genet	O
2	O
(	O
4	O
)	O
:	O
e58	O
.	O

DOI	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0020058	O

Adenomatous	B-GGP
Polyposis	I-GGP
Coli	I-GGP
(	O
APC	B-GGP
)	O
Is	O
Required	O
for	O
Normal	O
Development	O
of	O
Skin	O
and	O
Thymus	O

Abstract	O

The	O
tumor	O
suppressor	O
gene	B-SO
Apc	B-GGP
(	O
adenomatous	B-GGP
polyposis	I-GGP
coli	I-GGP
)	O
is	O
a	O
member	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
that	O
is	O
involved	O
in	O
development	O
and	O
tumorigenesis	O
.	O

Heterozygous	O
knockout	O
mice	B-Taxon
for	O
Apc	B-GGP
have	O
a	O
tumor	O
predisposition	O
phenotype	O
and	O
homozygosity	O
leads	O
to	O
embryonic	O
lethality	O
.	O

To	O
understand	O
the	O
role	O
of	O
Apc	B-GGP
in	O
development	O
we	O
generated	O
a	O
floxed	B-SO
allele	B-SO
.	O

These	O
mice	B-Taxon
were	O
mated	O
with	O
a	O
strain	O
carrying	O
Cre	O
recombinase	O
under	O
the	O
control	O
of	O
the	O
human	B-GGP
Keratin	I-GGP
14	I-GGP
(	I-GGP
K14	I-GGP
)	O
promoter	B-SO
,	O
which	O
is	O
active	O
in	O
basal	O
cells	B-CL
of	I-CL
epidermis	I-CL
and	I-CL
other	I-CL
stratified	I-CL
epithelia	I-CL
.	O

Mice	B-Taxon
homozygous	O
for	O
the	O
floxed	B-SO
allele	B-SO
that	O
also	O
carry	O
the	O
K14	B-GGP
-	O
cre	O
transgene	B-SO
were	O
viable	O
but	O
had	O
stunted	O
growth	O
and	O
died	O
before	O
weaning	O
.	O

Histological	O
and	O
immunochemical	O
examinations	O
revealed	O
that	O
K14	B-GGP
-	O
cre	O
-	O
mediated	O
Apc	B-GGP
loss	O
resulted	O
in	O
aberrant	O
growth	O
in	O
many	O
ectodermally	O
derived	O
squamous	O
epithelia	O
,	O
including	O
hair	O
follicles	O
,	O
teeth	O
,	O
and	O
oral	O
and	O
corneal	O
epithelia	O
.	O

In	O
addition	O
,	O
squamous	O
metaplasia	O
was	O
observed	O
in	O
various	O
epithelial	O
-	O
derived	O
tissues	O
,	O
including	O
the	O
thymus	O
.	O

The	O
aberrant	O
growth	O
of	O
hair	O
follicles	O
and	O
other	O
appendages	O
as	O
well	O
as	O
the	O
thymic	O
abnormalities	O
in	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
mice	B-Taxon
suggest	O
the	O
Apc	B-GGP
gene	B-SO
is	O
crucial	O
in	O
embryonic	O
cells	B-CL
to	O
specify	O
epithelial	B-CL
cell	I-CL
fates	O
in	O
organs	O
that	O
require	O
epithelial	O
-	O
mesenchymal	O
interactions	O
for	O
their	O
development	O
.	O

Synopsis	O

Patients	O
with	O
familial	O
adenomatous	O
polyposis	O
(	O
FAP	O
)	O
and	O
its	O
variant	O
,	O
Gardner	O
'	O
s	O
syndrome	O
,	O
will	O
develop	O
hundreds	O
of	O
colorectal	O
polyps	O
.	O

It	O
is	O
a	O
heritable	O
disease	O
that	O
is	O
linked	O
to	O
a	O
genetic	B-SO
mutation	B-SO
in	O
the	O
tumor	O
suppressor	O
gene	B-SO
APC	B-GGP
(	O
adenomatous	B-GGP
polyposis	I-GGP
coli	I-GGP
)	O
.	O

These	O
individuals	B-Taxon
also	O
develop	O
extracolonic	O
symptoms	O
,	O
among	O
which	O
are	O
congenital	O
hypertrophy	O
of	O
the	O
retinal	O
pigment	O
epithelium	O
,	O
desmoid	O
tumors	O
,	O
epidermoid	O
cysts	O
,	O
disorders	O
of	O
the	O
maxillary	O
and	O
skeletal	O
bones	O
,	O
and	O
dental	O
abnormalities	O
,	O
suggesting	O
the	O
importance	O
of	O
APC	B-GGP
functions	O
in	O
these	O
organs	O
.	O

To	O
understand	O
the	O
role	O
of	O
Apc	B-GGP
in	O
development	O
and	O
in	O
organs	O
other	O
than	O
intestine	O
,	O
we	O
generated	O
Apc	B-GGP
mutant	B-SO
mice	B-Taxon
that	O
can	O
conditionally	O
delete	B-SO
the	O
gene	B-SO
when	O
exposed	O
to	O
Cre	O
recombinase	O
.	O

These	O
mice	B-Taxon
were	O
mated	O
with	O
K14	B-GGP
(	O
Keratin	B-GGP
14	I-GGP
)	O
-	O
cre	O
mice	B-Taxon
that	O
express	O
Cre	O
recombinase	O
in	O
skin	O
and	O
its	O
appendages	O
.	O

The	O
authors	O
found	O
that	O
the	O
mutant	B-SO
mice	B-Taxon
that	O
have	O
lost	O
Apc	B-GGP
in	O
K14	B-GGP
-	O
cre	O
transgene	B-SO
-	O
expressing	O
tissues	O
were	O
viable	O
,	O
but	O
had	O
stunted	O
growth	O
and	O
died	O
before	O
weaning	O
.	O

These	O
mutant	B-SO
mice	B-Taxon
showed	O
developmental	O
abnormalities	O
not	O
only	O
in	O
skin	O
but	O
also	O
in	O
many	O
epithelial	O
-	O
derived	O
tissues	O
,	O
including	O
teeth	O
and	O
thymus	O
.	O

This	O
work	O
demonstrates	O
the	O
importance	O
of	O
Apc	B-GGP
in	O
development	O
of	O
many	O
organs	O
,	O
and	O
provides	O
new	O
insights	O
into	O
diagnosis	O
and	O
management	O
of	O
patients	O
with	O
APC	B-GGP
mutations	B-SO
.	O

Introduction	O

Adenomatous	B-GGP
polyposis	I-GGP
coli	I-GGP
(	O
APC	B-GGP
)	O
is	O
a	O
member	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
and	O
one	O
of	O
its	O
known	O
functions	O
is	O
to	O
regulate	O
the	O
levels	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
.	O

Alterations	O
in	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
regulation	O
are	O
very	O
common	O
in	O
human	B-Taxon
tumors	O
[	O
1	O
]	O
.	O

Loss	O
of	O
APC	B-GGP
is	O
associated	O
with	O
stabilization	O
of	O
the	O
cytosolic	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
that	O
ultimately	O
results	O
in	O
its	O
migration	O
to	O
the	O
nucleus	B-GO
and	O
activating	O
a	O
cascade	O
of	O
events	O
leading	O
to	O
tumorigenesis	O
.	O

APC	B-GGP
also	O
interacts	O
with	O
a	O
multitude	O
of	O
other	O
cellular	B-CL
proteins	B-CHEBI
,	O
including	O
axin	B-GGP
-	I-GGP
2	I-GGP
(	O
AXIN2	B-GGP
)	O
,	O
plakoglobin	B-GGP
(	O
JUP	B-GGP
)	O
,	O
Asef	B-GGP
(	O
ARHGEF4	B-GGP
)	O
,	O
kinesin	B-GGP
superfamily	I-GGP
-	I-GGP
associated	I-GGP
protein	I-GGP
3	I-GGP
(	O
KIFAP3	B-GGP
)	O
,	O
EB1	B-GGP
(	O
MAPRE1	B-GGP
)	O
,	O
microtubules	B-GO
,	O
and	O
the	O
human	B-GGP
homolog	I-GGP
of	I-GGP
Drosophila	I-GGP
discs	I-GGP
large	I-GGP
(	O
DLG1	B-GGP
)	O
.	O

These	O
interactions	O
suggest	O
that	O
APC	B-GGP
can	O
potentially	O
regulate	O
many	O
cellular	B-CL
functions	O
,	O
including	O
intercellular	O
adhesion	O
,	O
cytoskeletal	B-GO
organization	O
,	O
regulation	O
of	O
plakoglobin	B-GGP
levels	O
,	O
regulation	O
of	O
the	O
cell	B-CL
cycle	O
and	O
apoptosis	O
,	O
orientation	O
of	O
asymmetric	O
stem	B-CL
cell	I-CL
division	O
,	O
and	O
control	O
of	O
cell	B-CL
polarization	O
[	O
2	O
,	O
3	O
]	O
.	O

APC	B-GGP
is	O
a	O
tumor	O
suppressor	O
gene	B-SO
.	O

Somatic	O
mutations	B-SO
in	O
APC	B-GGP
are	O
frequently	O
found	O
in	O
many	O
sporadic	O
tumors	O
of	O
the	O
colon	O
and	O
rectum	O
.	O

Autosomal	B-GO
dominant	O
germline	O
mutations	B-SO
in	O
APC	B-GGP
cause	O
familial	O
adenomatous	O
polypois	O
(	O
FAP	O
)	O
and	O
its	O
variant	O
,	O
Gardner	O
syndrome	O
.	O

FAP	O
patients	O
are	O
characterized	O
by	O
hundreds	O
of	O
adenomatous	O
colorectal	O
polyps	O
,	O
with	O
an	O
almost	O
inevitable	O
progression	O
to	O
colorectal	O
cancer	O
in	O
the	O
third	O
and	O
fourth	O
decades	O
of	O
life	O
[	O
4	O
,	O
5	O
]	O
.	O

In	O
addition	O
to	O
colorectal	O
neoplams	O
,	O
these	O
individuals	B-Taxon
can	O
develop	O
extracolonic	O
symptoms	O
,	O
among	O
which	O
are	O
upper	O
gastrointestinal	O
tract	O
polyps	O
,	O
congenital	O
hypertrophy	O
of	O
the	O
retinal	O
pigment	O
epithelium	O
,	O
desmoid	O
tumors	O
,	O
disorders	O
of	O
the	O
maxillary	O
and	O
skeletal	O
bones	O
,	O
and	O
dental	O
abnormalities	O
[	O
6	O
]	O
,	O
suggesting	O
the	O
importance	O
of	O
APC	B-GGP
gene	B-SO
functions	O
in	O
these	O
organ	O
systems	O
.	O

Although	O
the	O
role	O
of	O
APC	B-GGP
in	O
the	O
initiation	O
of	O
human	B-Taxon
colorectal	O
cancer	O
is	O
well	O
established	O
,	O
its	O
role	O
in	O
other	O
tissue	O
and	O
developmental	O
processes	O
are	O
not	O
well	O
understood	O
.	O

Given	O
the	O
importance	O
of	O
regulation	O
of	O
Wnt	O
signaling	O
in	O
embryonic	O
pattern	O
formation	O
and	O
morphogenesis	O
of	O
many	O
organs	O
,	O
mechanistic	O
understanding	O
of	O
APC	B-GGP
in	O
development	O
and	O
in	O
extracolonic	O
tissues	O
becomes	O
critical	O
to	O
better	O
assess	O
potential	O
adverse	O
events	O
in	O
humans	B-Taxon
.	O

One	O
approach	O
to	O
understand	O
the	O
role	O
of	O
Apc	B-GGP
in	O
development	O
is	O
to	O
develop	O
mice	B-Taxon
with	O
an	O
inactivating	O
Apc	B-GGP
mutation	B-SO
.	O

Several	O
genetically	B-SO
modified	B-SO
mouse	B-Taxon
strains	O
for	O
Apc	B-GGP
have	O
been	O
described	O
[	O
7	O
-	O
10	O
]	O
.	O

Most	O
of	O
these	O
models	O
,	O
in	O
the	O
heterozygous	O
state	O
,	O
show	O
a	O
gastrointestinal	O
and	O
other	O
tumor	O
predisposition	O
phenotype	O
[	O
7	O
-	O
10	O
]	O
.	O

Mouse	B-Taxon
embryos	O
that	O
are	O
homozygous	O
for	O
the	O
genetic	B-SO
modification	B-SO
die	O
during	O
embryogenesis	O
,	O
and	O
some	O
of	O
the	O
models	O
do	O
not	O
survive	O
beyond	O
gastrulation	O
[	O
8	O
,	O
11	O
]	O
.	O

An	O
alternate	O
approach	O
to	O
understand	O
the	O
role	O
of	O
Apc	B-GGP
in	O
development	O
and	O
/	O
or	O
in	O
specific	O
tissues	O
is	O
to	O
generate	O
a	O
mouse	B-Taxon
strain	O
that	O
carries	O
a	O
conditionally	O
modified	B-SO
allele	B-SO
and	O
mate	O
it	O
with	O
a	O
mouse	B-Taxon
strain	O
that	O
facilitates	O
the	O
modification	B-SO
of	O
the	O
conditional	O
allele	B-SO
in	O
specific	O
cell	B-CL
lineages	O
.	O

To	O
assess	O
the	O
role	O
of	O
Apc	B-GGP
in	O
different	O
stages	O
of	O
life	O
systematically	O
,	O
we	O
generated	O
mice	B-Taxon
containing	O
a	O
conditional	O
knockout	O
(	O
CKO	O
)	O
mutant	B-SO
allele	B-SO
of	O
Apc	B-GGP
(	O
ApcCKO	O
)	O
.	O

These	O
mice	B-Taxon
were	O
mated	O
with	O
a	O
strain	O
carrying	O
Cre	O
recombinase	O
under	O
the	O
control	O
of	O
the	O
human	B-GGP
Keratin	I-GGP
14	I-GGP
(	I-GGP
K14	I-GGP
)	O
promoter	B-SO
,	O
which	O
is	O
active	O
in	O
basal	O
cells	B-CL
of	I-CL
epidermis	I-CL
and	I-CL
other	I-CL
stratified	I-CL
epithelia	I-CL
.	O

We	O
report	O
here	O
that	O
K14	B-GGP
promoter	B-SO
-	O
driven	O
loss	O
of	O
Apc	B-GGP
resulted	O
in	O
aberrant	O
development	O
of	O
several	O
organs	O
that	O
require	O
inductive	O
epithelial	O
-	O
mesenchymal	O
interactions	O
,	O
including	O
hair	O
follicle	O
,	O
teeth	O
,	O
and	O
thymus	O
,	O
and	O
resulted	O
in	O
neonatal	O
death	O
in	O
mice	B-Taxon
.	O

We	O
found	O
that	O
Apc	B-GGP
plays	O
a	O
crucial	O
role	O
in	O
determinations	O
of	O
cell	B-CL
fates	O
during	O
the	O
embryonic	O
development	O
,	O
possibly	O
via	O
temporal	O
and	O
tissue	O
-	O
specific	O
regulation	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
levels	O
in	O
the	O
skin	O
,	O
its	O
appendages	O
,	O
and	O
in	O
the	O
thymus	O
.	O

Results	O

Generation	O
of	O
the	O
ApcCKO	O
and	O
Apc	O
Delta	O
580	O
Mice	B-Taxon

To	O
investigate	O
the	O
role	O
of	O
Apc	B-GGP
in	O
development	O
of	O
skin	O
and	O
its	O
appendages	O
,	O
we	O
used	O
the	O
Cre	O
/	O
loxP	B-SO
technology	O
to	O
introduce	O
a	O
conditional	O
mutation	B-SO
of	O
the	O
Apc	B-GGP
gene	B-SO
in	O
mice	B-Taxon
.	O

We	O
constructed	O
embryonic	O
stem	B-CL
(	I-CL
ES	I-CL
)	I-CL
cells	I-CL
and	O
mice	B-Taxon
carrying	O
an	O
Apc	B-GGP
allele	B-SO
harboring	O
both	O
a	O
pair	O
of	O
loxP	B-SO
sites	I-SO
flanking	O
Apc	B-GGP
exon	B-SO
14	O
and	O
a	O
pair	O
of	O
FLP	B-SO
recognition	I-SO
target	I-SO
(	I-SO
FRT	I-SO
)	I-SO
sites	I-SO
flanking	O
PGK	O
-	O
neomycin	B-CHEBI
selection	O
cassette	B-SO
by	O
recombineering	O
[	O
12	O
,	O
13	O
]	O
(	O
Figure	O
1A	O
,	O
ApcCKON	O
allele	B-SO
,	O
N	O
for	O
neomycin	O
cassette	B-SO
)	O
.	O

A	O
PGK	O
-	O
neomycin	O
cassette	B-SO
was	O
inserted	B-SO
in	O
the	O
same	O
transcriptional	O
orientation	O
as	O
Apc	B-GGP
in	O
intron	B-SO
14	O
of	O
the	O
endogenous	O
gene	B-SO
.	O

The	O
loxP	B-SO
and	I-SO
FRT	I-SO
sites	I-SO
were	O
used	O
to	O
aid	O
unidirectional	O
recombination	O
[	O
12	O
,	O
13	O
]	O
.	O

Two	O
mouse	B-Taxon
lines	O
containing	O
the	O
same	O
modification	B-SO
were	O
generated	O
from	O
two	O
independent	O
ES	O
clones	O
to	O
ensure	O
that	O
these	O
two	O
lines	O
behave	O
in	O
the	O
same	O
way	O
.	O

These	O
ApcCKON	O
/	O
+	B-SO
mice	B-Taxon
were	O
crossed	O
with	O
FLPe	O
-	O
deleter	O
to	O
generate	O
ApcCKO	O
/	O
+	B-SO
mice	B-Taxon
that	O
were	O
heterozygous	O
for	O
the	O
final	O
Apc	B-GGP
conditional	O
(	O
ApcCKO	O
)	O
allele	B-SO
that	O
removed	B-SO
the	O
PGK	O
-	O
neomycin	O
cassette	B-SO
and	O
contains	O
only	O
the	O
loxP	B-SO
sites	I-SO
in	O
the	O
introns	B-SO
flanking	O
exon	B-SO
14	O
.	O

To	O
assess	O
the	O
effect	O
of	O
deleting	B-SO
exon	B-SO
14	O
in	O
mice	B-Taxon
,	O
both	O
lines	O
of	O
ApcCKO	O
/	O
+	B-SO
mice	B-Taxon
were	O
crossed	O
with	O
the	O
Cre	O
-	O
deleter	O
to	O
generate	O
the	O
germline	O
knockout	O
line	O
of	O
Apc	B-GGP
,	O
designated	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
.	O

The	O
mutant	B-SO
allele	B-SO
(	O
Apc	O
Delta	O
580	O
)	O
lacks	O
exon	B-SO
14	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
transcript	B-SO
from	O
loss	B-SO
of	O
exon	B-SO
14	O
results	O
in	O
a	O
shift	B-SO
in	I-SO
the	I-SO
normal	I-SO
reading	I-SO
frame	I-SO
,	O
resulting	O
in	O
a	O
premature	O
chain	B-SO
termination	B-SO
codon	I-SO
which	O
,	O
if	O
utilized	O
,	O
would	O
result	O
in	O
a	O
truncated	O
polypeptide	B-SO
that	O
is	O
605	O
aa	B-CHEBI
in	O
length	O
,	O
of	O
which	O
the	O
first	O
580	O
aa	B-CHEBI
correspond	O
to	O
the	O
normal	O
Apc	B-GGP
protein	B-CHEBI
.	O

Southern	O
blot	O
analysis	O
of	O
tail	O
DNA	B-SO
from	O
F1	O
offspring	O
of	O
both	O
ApcCKON	O
and	O
Apc	O
Delta	O
580	O
lines	O
confirmed	O
the	O
germline	O
transmission	O
of	O
modified	B-SO
Apc	B-GGP
allele	B-SO
(	O
Figure	O
1B	O
)	O
.	O

Mice	B-Taxon
that	O
are	O
heterozygous	O
for	O
Apc	O
Delta	O
580	O
mutation	B-SO
are	O
viable	O
but	O
have	O
a	O
significantly	O
reduced	O
lifespan	O
(	O
Figure	O
1C	O
)	O
.	O

These	O
results	O
suggested	O
that	O
deletion	B-SO
of	O
exon	B-SO
14	O
indeed	O
results	O
in	O
either	O
loss	O
or	O
abnormal	O
function	O
of	O
the	O
Apc	B-GGP
gene	B-SO
product	O
.	O

Apc	O
Delta	O
580	O
/	O
+	B-SO
mice	B-Taxon
have	O
median	O
survival	O
of	O
5	O
mo	O
of	O
age	O
(	O
Figure	O
1C	O
)	O
,	O
with	O
progressive	O
signs	O
of	O
rectal	O
bleeding	O
and	O
anemia	O
.	O

Similar	O
to	O
the	O
results	O
reported	O
with	O
an	O
independently	O
generated	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
conditional	O
mouse	B-Taxon
strain	O
[	O
14	O
]	O
,	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
mice	B-Taxon
had	O
more	O
than	O
100	O
(	O
120	O
+/-	O
37	O
,	O
n	O
=	O
11	O
)	O
intestinal	O
tumors	O
at	O
the	O
time	O
of	O
their	O
death	O
(	O
Figure	O
S1	O
)	O
.	O

Inactivation	O
of	O
wild	B-SO
-	I-SO
type	I-SO
Apc	B-GGP
is	O
an	O
important	O
prerequisite	O
for	O
tumor	O
development	O
.	O

We	O
analyzed	O
30	O
intestinal	O
tumors	O
from	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
mice	B-Taxon
by	O
in	O
vitro	O
transcription	O
and	O
translation	O
assay	O
,	O
but	O
none	O
of	O
them	O
showed	O
truncated	O
Apc	B-GGP
products	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
the	O
most	O
likely	O
mechanism	O
of	O
wild	B-SO
-	I-SO
type	I-SO
Apc	B-GGP
inactivation	O
is	O
by	O
allelic	B-SO
loss	B-SO
.	O

The	O
mutant	B-SO
allele	B-SO
had	O
to	O
be	O
maintained	O
and	O
transmitted	O
through	O
male	O
mice	B-Taxon
,	O
as	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
females	O
were	O
frequently	O
not	O
healthy	O
enough	O
to	O
successfully	O
nurse	O
their	O
own	O
pups	O
because	O
of	O
their	O
tumor	O
burden	O
.	O

ApcCKO	O
/	O
+	B-SO
mice	B-Taxon
were	O
intercrossed	O
to	O
generate	O
ApcCKO	O
/	O
CKO	O
offspring	O
.	O

Approximately	O
one	O
-	O
quarter	O
of	O
the	O
offspring	O
(	O
17	O
of	O
81	O
)	O
were	O
homozygous	O
for	O
the	O
ApcCKO	O
allele	B-SO
.	O

These	O
mice	B-Taxon
as	O
well	O
as	O
heterozygous	O
mice	B-Taxon
for	O
ApcCKO	O
allele	B-SO
are	O
normal	O
,	O
showing	O
no	O
differences	O
in	O
their	O
survival	O
to	O
the	O
wild	B-SO
-	I-SO
type	I-SO
littermates	O
(	O
Figure	O
1C	O
)	O
.	O

We	O
tested	O
whether	O
our	O
ApcCKO	O
allele	B-SO
can	O
compliment	O
the	O
wild	B-SO
-	I-SO
type	I-SO
allele	B-SO
by	O
crossing	O
the	O
ApcCKO	O
/	O
CKO	O
female	O
with	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
male	O
mouse	B-Taxon
.	O

The	O
resultant	O
ApcCKO	O
/	O
Delta	O
580	O
offspring	O
were	O
viable	O
and	O
born	O
in	O
the	O
Mendelian	O
ratio	O
,	O
suggesting	O
that	O
the	O
presence	O
of	O
loxP	B-SO
sites	I-SO
in	O
introns	B-SO
flanking	O
exon	B-SO
14	O
have	O
no	O
adverse	O
effect	O
on	O
the	O
function	O
of	O
the	O
Apc	B-GGP
gene	B-SO
.	O

K14	B-GGP
-	O
Driven	O
Loss	O
of	O
Apc	B-GGP
Results	O
in	O
Severe	O
Growth	O
Retardation	O
and	O
Early	O
Lethality	O

To	O
introduce	O
the	O
mutation	B-SO
of	O
Apc	B-GGP
into	O
cells	B-CL
expressing	O
K14	B-GGP
,	O
we	O
crossed	O
WW6	O
ES	O
cell	B-CL
-	O
derived	O
[	O
15	O
]	O
ApcCKO	O
/	O
+	B-SO
mice	B-Taxon
with	O
K14	B-GGP
-	O
cre	O
recombinase	O
mice	B-Taxon
in	O
FVB	O
background	O
[	O
16	O
]	O
.	O

The	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-SO
mice	B-Taxon
were	O
normal	O
in	O
appearance	O
and	O
were	O
fertile	O
.	O

K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-SO
males	O
were	O
crossed	O
to	O
ApcCKO	O
/	O
CKO	O
females	O
to	O
avoid	O
the	O
potential	O
deleter	O
effect	O
in	O
oocytes	B-CL
of	O
K14	B-GGP
-	O
cre	O
-	O
positive	O
females	O
[	O
17	O
]	O
.	O

The	O
mice	B-Taxon
were	O
intercrossed	O
thereafter	O
for	O
maintenance	O
;	O
hence	O
,	O
the	O
mice	B-Taxon
used	O
for	O
analysis	O
were	O
in	O
a	O
mixed	O
background	O
of	O
FVB	O
,	O
129	O
/	O
S	O
,	O
and	O
C57BL	O
/	O
6	O
in	O
similar	O
proportions	O
,	O
with	O
minimal	O
contribution	O
of	O
SJ	O
.	O

The	O
K14	B-GGP
promoter	B-SO
is	O
a	O
commonly	O
used	O
epidermal	B-CL
cell	I-CL
promoter	B-SO
because	O
of	O
its	O
expression	O
by	O
the	O
mitotically	O
active	O
cells	B-CL
of	I-CL
the	I-CL
epidermis	I-CL
and	O
its	O
appendages	O
in	O
mature	O
skin	O
[	O
18	O
]	O
,	O
but	O
most	O
notably	O
it	O
is	O
active	O
in	O
embryonic	O
ectoderm	O
as	O
early	O
as	O
the	O
single	O
layered	O
ectodermal	O
stage	O
of	O
embryonic	O
day	O
(	O
E	O
)	O
9	O
.	O
5	O
[	O
19	O
]	O
.	O

A	O
restricted	O
expression	O
of	O
K14	B-GGP
is	O
also	O
found	O
in	O
thymic	O
epithelial	B-CL
cells	I-CL
(	O
TECs	O
)	O
in	O
the	O
medulla	O
of	O
normal	O
thymus	O
[	O
20	O
]	O
.	O

We	O
genotyped	O
a	O
total	O
of	O
458	O
pups	O
(	O
8	O
-	O
10	O
d	O
old	O
)	O
from	O
67	O
litters	O
resulting	O
from	O
crosses	O
between	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-SO
and	O
ApcCKO	O
/	O
CKO	O
mice	B-Taxon
.	O

The	O
mutant	B-SO
mice	B-Taxon
of	O
the	O
genotype	B-SO
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
(	O
hereafter	O
,	O
KA	O
mutant	B-SO
)	O
were	O
born	O
,	O
but	O
the	O
observed	O
frequency	O
of	O
KA	O
mutants	B-SO
was	O
much	O
less	O
than	O
expected	O
(	O
78	O
of	O
458	O
[	O
17	O
.	O
0	O
%	O
]	O
;	O
p	O
<	O
0	O
.	O
0005	O
Chi	O
-	O
square	O
analysis	O
,	O
Table	O
1	O
)	O
.	O

To	O
assess	O
the	O
basis	O
for	O
the	O
neonatal	O
lethality	O
of	O
KA	O
mutants	B-SO
,	O
we	O
monitored	O
three	O
litters	O
from	O
birth	O
to	O
weaning	O
by	O
measuring	O
the	O
body	O
weight	O
of	O
each	O
pup	O
every	O
day	O
.	O

A	O
total	O
of	O
25	O
pups	O
were	O
born	O
from	O
three	O
litters	O
,	O
of	O
which	O
7	O
(	O
28	O
%	O
)	O
were	O
confirmed	O
to	O
be	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
by	O
genotyping	O
,	O
indicating	O
that	O
KA	O
mutants	B-SO
were	O
born	O
in	O
the	O
expected	O
Mendelian	O
ratio	O
.	O

The	O
KA	O
mutant	B-SO
pups	O
were	O
nursed	O
normally	O
,	O
and	O
there	O
was	O
milk	O
in	O
their	O
stomachs	O
during	O
the	O
first	O
2	O
or	O
3	O
d	O
after	O
birth	O
,	O
but	O
they	O
failed	O
to	O
thrive	O
(	O
Figure	O
2	O
)	O
.	O

By	O
postnatal	O
day	O
(	O
P	O
)	O
8	O
-	O
10	O
,	O
at	O
the	O
time	O
of	O
genotyping	O
,	O
many	O
KA	O
mutant	B-SO
pups	O
were	O
considerably	O
smaller	O
than	O
their	O
littermates	O
(	O
Figure	O
2B	O
-	O
2F	O
)	O
and	O
some	O
have	O
died	O
at	O
or	O
prior	O
to	O
this	O
age	O
.	O

None	O
of	O
KA	O
mutants	B-SO
survived	O
to	O
weaning	O
age	O
.	O

The	O
ability	O
of	O
whole	O
embryos	O
to	O
exclude	O
blue	O
dye	B-CHEBI
was	O
used	O
to	O
examine	O
the	O
epidermal	O
barrier	O
,	O
normally	O
acquired	O
beginning	O
at	O
E16	O
and	O
complete	O
by	O
E18	O
.	O
5	O
[	O
21	O
]	O
.	O

Analyses	O
of	O
E17	O
.	O
5	O
-	O
E18	O
.	O
5	O
KA	O
mutants	B-SO
showed	O
that	O
they	O
were	O
able	O
to	O
exclude	O
blue	O
dye	B-CHEBI
,	O
indicating	O
that	O
the	O
epidermal	O
barrier	O
was	O
intact	O
(	O
Figure	O
S2	O
)	O
.	O

At	O
these	O
embryonic	O
ages	O
,	O
there	O
were	O
no	O
differences	O
in	O
size	O
between	O
the	O
mutants	B-SO
and	O
their	O
littermates	O
,	O
but	O
the	O
mutants	B-SO
showed	O
a	O
patch	O
of	O
"	O
birthmark	O
"	O
or	O
dark	O
pigmentation	O
on	O
their	O
foreheads	O
and	O
a	O
dark	O
median	O
line	O
that	O
ran	O
caudally	O
from	O
head	O
to	O
tail	O
.	O

Their	O
external	O
ears	O
or	O
pinnae	O
were	O
shriveled	O
in	O
appearance	O
and	O
pigmented	O
compared	O
to	O
those	O
of	O
littermates	O
.	O

External	O
characteristics	O
of	O
KA	O
mutants	B-SO
that	O
were	O
evident	O
at	O
E18	O
.	O
5	O
persisted	O
after	O
birth	O
and	O
became	O
more	O
prominent	O
as	O
they	O
grew	O
(	O
Figure	O
2A	O
-	O
2F	O
)	O
.	O

Growth	O
of	O
pelage	O
hair	O
was	O
generally	O
delayed	O
in	O
the	O
mutants	B-SO
.	O

At	O
around	O
P8	O
,	O
the	O
KA	O
mutants	B-SO
were	O
hairless	O
and	O
had	O
wrinkled	O
skin	O
while	O
their	O
phenotypically	O
normal	O
littermates	O
had	O
a	O
smooth	O
thin	O
coat	O
of	O
hair	O
(	O
Figure	O
2B	O
)	O
.	O

At	O
this	O
age	O
,	O
two	O
lower	O
incisors	O
start	O
to	O
erupt	O
in	O
normal	O
littermates	O
and	O
these	O
were	O
absent	O
in	O
the	O
KA	O
mutants	B-SO
(	O
Figure	O
2C	O
and	O
2D	O
)	O
.	O

Animals	B-Taxon
also	O
tended	O
to	O
be	O
smaller	O
and	O
around	O
P10	O
-	O
P12	O
displayed	O
abnormally	O
short	O
and	O
misshapen	O
vibrissae	O
and	O
short	O
,	O
shaggy	O
pelage	O
hairs	O
(	O
Figure	O
2C	O
and	O
2D	O
)	O
.	O

Development	O
of	O
thick	O
ridges	O
in	O
their	O
skin	O
,	O
particularly	O
around	O
the	O
ears	O
,	O
eyelids	O
,	O
forehead	O
,	O
nose	O
,	O
and	O
paws	O
,	O
became	O
noticeable	O
(	O
Figure	O
2E	O
)	O
.	O

These	O
regions	O
looked	O
scaly	O
,	O
and	O
these	O
animals	B-Taxon
hardly	O
kept	O
their	O
eyes	O
open	O
.	O

In	O
contrast	O
to	O
the	O
normal	O
littermates	O
that	O
consistently	O
increased	O
their	O
body	O
weight	O
with	O
age	O
,	O
surviving	O
KA	O
mutants	B-SO
started	O
to	O
lose	O
weight	O
from	O
P10	O
onwards	O
;	O
by	O
P16	O
-	O
P17	O
they	O
were	O
all	O
lethargic	O
,	O
and	O
none	O
of	O
them	O
survived	O
to	O
weaning	O
(	O
Figure	O
2E	O
and	O
2F	O
)	O
.	O

At	O
the	O
time	O
of	O
autopsy	O
all	O
the	O
mutants	B-SO
were	O
toothless	O
,	O
without	O
incisors	O
or	O
molars	O
,	O
and	O
their	O
stomachs	O
were	O
consistently	O
small	O
and	O
had	O
no	O
solid	O
food	B-CHEBI
,	O
unlike	O
their	O
age	O
-	O
matched	O
littermates	O
,	O
suggesting	O
that	O
the	O
observed	O
weight	O
loss	O
could	O
be	O
the	O
result	O
of	O
failure	O
to	O
ingest	O
solid	O
food	B-CHEBI
(	O
Figure	O
2F	O
)	O
.	O

Interestingly	O
,	O
changes	O
in	O
body	O
weights	O
and	O
timing	O
of	O
hair	O
growth	O
varied	O
considerably	O
among	O
mutant	B-SO
pups	O
even	O
if	O
they	O
were	O
from	O
the	O
same	O
litter	O
,	O
whereas	O
those	O
of	O
phenotypically	O
normal	O
littermates	O
tended	O
to	O
be	O
similar	O
.	O

This	O
difference	O
was	O
also	O
reflected	O
in	O
the	O
variation	O
in	O
timing	O
of	O
death	O
in	O
mutants	B-SO
:	O
some	O
mutant	B-SO
pups	O
were	O
born	O
alive	O
but	O
died	O
within	O
a	O
day	O
or	O
two	O
,	O
some	O
survived	O
close	O
to	O
the	O
weaning	O
age	O
.	O

This	O
variability	O
of	O
the	O
mutant	B-SO
phenotypes	O
suggests	O
possible	O
variation	O
in	O
the	O
timing	O
and	O
efficiency	O
of	O
cre	O
-	O
mediated	O
Apc	B-GGP
deletion	B-SO
.	O

It	O
is	O
possible	O
that	O
the	O
genetic	B-SO
background	O
has	O
a	O
role	O
to	O
play	O
in	O
this	O
variability	O
.	O

Gross	O
examination	O
of	O
internal	O
organs	O
also	O
showed	O
that	O
the	O
mutants	B-SO
'	O
thymi	O
were	O
consistently	O
inconspicuous	O
and	O
were	O
very	O
small	O
for	O
their	O
age	O
,	O
whereas	O
those	O
of	O
their	O
littermates	O
were	O
very	O
prominent	O
in	O
size	O
(	O
Figure	O
2G	O
)	O
.	O

This	O
difference	O
was	O
evident	O
as	O
early	O
as	O
P3	O
.	O

Quite	O
frequently	O
mutant	B-SO
thymi	O
in	O
P12	O
-	O
P17	O
mutant	B-SO
mice	B-Taxon
also	O
contained	O
black	O
deposits	O
within	O
the	O
tissue	O
(	O
unpublished	O
data	O
)	O
.	O

Mutant	B-SO
mice	B-Taxon
were	O
also	O
examined	O
for	O
any	O
skeletal	O
abnormalities	O
by	O
preparing	O
skeletal	O
specimens	O
of	O
P16	O
-	O
P17	O
mice	B-Taxon
stained	O
with	O
Alizarin	B-CHEBI
red	I-CHEBI
.	O

No	O
differences	O
between	O
the	O
normal	O
and	O
KA	O
mutant	B-SO
mice	B-Taxon
in	O
the	O
mandibular	O
bone	O
can	O
be	O
detected	O
,	O
but	O
the	O
mutant	B-SO
mice	B-Taxon
lacked	O
or	O
had	O
underdeveloped	O
set	O
of	O
maxillary	O
incisors	O
and	O
molars	O
(	O
Figure	O
2H	O
)	O
.	O

We	O
detected	O
no	O
other	O
major	O
skeletal	O
abnormalities	O
.	O

Genotype	B-SO
-	O
and	O
Tissue	O
-	O
Specific	O
Expression	O
of	O
the	O
Truncated	O
Apc	B-GGP
Transcripts	B-SO

To	O
assess	O
the	O
molecular	B-CHEBI
effects	O
of	O
the	O
K14	B-GGP
-	O
cre	O
-	O
mediated	O
recombination	O
,	O
we	O
screened	O
for	O
the	O
presence	O
of	O
deleted	B-SO
Apc	B-GGP
(	O
Apc	O
Delta	O
580	O
)	O
alleles	B-SO
.	O

Genomic	B-SO
DNA	I-SO
was	O
extracted	O
from	O
liver	O
,	O
thymus	O
,	O
and	O
skin	O
from	O
all	O
4	O
possible	O
genotypes	B-SO
:	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
,	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-SO
,	O
ApcCKO	O
/	O
CKO	O
,	O
and	O
ApcCKO	O
/	O
+	B-SO
.	O

Genotyping	O
on	O
genomic	B-SO
DNA	I-SO
from	O
these	O
tissues	O
showed	O
that	O
the	O
Apc	O
Delta	O
580	O
allele	B-SO
(	O
500	O
-	O
bp	B-SO
product	O
)	O
was	O
detected	O
only	O
from	O
the	O
skin	O
and	O
thymus	O
of	O
the	O
K14	B-GGP
-	O
cre	O
-	O
positive	O
mice	B-Taxon
.	O

The	O
presence	O
of	O
mutant	B-SO
Apc	B-GGP
allele	B-SO
in	O
the	O
thymus	O
of	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-SO
mice	B-Taxon
was	O
consistently	O
much	O
less	O
than	O
the	O
DNA	B-SO
from	O
the	O
skin	O
of	O
the	O
same	O
animal	B-Taxon
or	O
other	O
tissues	O
from	O
the	O
KA	O
mutants	B-SO
.	O

In	O
addition	O
,	O
this	O
product	O
was	O
not	O
detected	O
at	O
all	O
in	O
either	O
the	O
liver	O
of	O
K14	B-GGP
-	O
cre	O
-	O
positive	O
or	O
in	O
any	O
of	O
the	O
K14	B-GGP
-	O
cre	O
-	O
negative	O
mouse	B-Taxon
tissues	O
samples	O
,	O
establishing	O
that	O
Cre	O
-	O
mediated	O
recombination	O
has	O
taken	O
place	O
in	O
the	O
tissue	O
-	O
specific	O
manner	O
in	O
the	O
mice	B-Taxon
that	O
inherited	O
K14	B-GGP
-	O
cre	O
(	O
Figure	O
3A	O
)	O
.	O

Apc	B-GGP
transcripts	B-SO
were	O
also	O
analyzed	O
by	O
RT	O
-	O
PCR	O
with	O
primers	B-SO
spanning	O
exon	B-SO
14	O
(	O
Figure	O
1A	O
)	O
using	O
total	O
RNA	B-SO
isolated	O
from	O
the	O
corresponding	O
tissue	O
samples	O
.	O

We	O
detected	O
the	O
expected	B-SO
RT	O
-	O
PCR	B-SO
product	I-SO
(	O
313	O
bp	B-SO
)	O
from	O
the	O
truncated	O
Apc	B-GGP
(	O
Apc	O
Delta	O
580	O
)	O
allele	B-SO
only	O
in	O
the	O
tissues	O
where	O
Cre	O
recombinase	O
is	O
known	O
to	O
be	O
expressed	O
in	O
the	O
K14	B-GGP
-	O
cre	O
-	O
positive	O
mice	B-Taxon
.	O

However	O
,	O
this	O
product	B-SO
was	O
not	O
detected	O
in	O
either	O
the	O
K14	B-GGP
-	O
cre	O
-	O
negative	O
mouse	B-Taxon
tissues	O
samples	O
or	O
the	O
liver	O
of	O
K14	B-GGP
-	O
cre	O
-	O
positive	O
mice	B-Taxon
,	O
and	O
only	O
the	O
product	B-SO
from	O
the	O
wild	B-SO
-	I-SO
type	I-SO
allele	B-SO
(	O
528	O
bp	B-SO
)	O
was	O
detected	O
from	O
these	O
RNA	B-SO
samples	O
,	O
further	O
confirming	O
that	O
Cre	O
-	O
mediated	O
recombination	O
has	O
taken	O
place	O
in	O
the	O
tissue	O
-	O
and	O
genotype	B-SO
-	O
specific	O
manner	O
(	O
Figure	O
3B	O
)	O
.	O

K14	B-GGP
-	O
cre	O
-	O
Driven	O
Apc	B-GGP
Loss	O
Induced	O
Aberrant	O
Hair	O
Follicles	O
throughout	O
the	O
Epidermis	O

To	O
understand	O
the	O
basis	O
for	O
delayed	O
and	O
abnormal	O
hair	O
development	O
in	O
the	O
KA	O
mutants	B-SO
,	O
we	O
conducted	O
a	O
histological	O
and	O
immunohistochemical	O
examination	O
(	O
Figure	O
4	O
)	O
.	O

The	O
hair	O
follicle	O
is	O
an	O
epidermal	O
appendage	O
that	O
consists	O
of	O
an	O
upper	O
permanent	O
portion	O
,	O
and	O
a	O
lower	O
cycling	O
portion	O
that	O
produces	O
the	O
hair	O
[	O
22	O
,	O
23	O
]	O
.	O

The	O
outer	O
root	O
sheath	O
(	O
ORS	O
)	O
is	O
contiguous	O
with	O
and	O
biochemically	O
similar	O
to	O
the	O
basal	O
layer	O
of	O
the	O
epidermis	O
.	O

The	O
inner	O
layers	O
of	O
the	O
hair	O
follicle	O
include	O
three	O
concentric	O
layers	O
of	O
inner	O
root	O
sheath	O
and	O
three	O
concentric	O
layers	O
of	O
hair	O
-	O
producing	O
cells	B-CL
.	O

At	O
the	O
base	O
of	O
the	O
hair	O
follicle	O
is	O
the	O
germinative	O
hair	O
follicle	O
bulb	O
,	O
which	O
contains	O
rapidly	O
proliferating	O
"	O
matrix	O
"	O
cells	B-CL
that	O
differentiate	O
to	O
populate	O
all	O
of	O
the	O
layers	O
of	O
the	O
inner	O
root	O
sheath	O
and	O
the	O
hair	O
shaft	O
itself	O
[	O
22	O
]	O
.	O

During	O
the	O
anagen	O
phase	O
of	O
the	O
hair	O
cycle	O
(	O
until	O
P15	O
)	O
,	O
hair	O
follicles	O
of	O
phenotypically	O
normal	O
mice	B-Taxon
grew	O
deeply	O
into	O
the	O
subcutaneous	O
fat	O
and	O
were	O
uniformly	O
spaced	O
and	O
aligned	O
in	O
parallel	O
arrays	O
at	O
a	O
specific	O
angle	O
relative	O
to	O
the	O
skin	O
surface	O
(	O
Figure	O
4A	O
)	O
.	O

In	O
contrast	O
,	O
KA	O
mutant	B-SO
follicles	O
were	O
irregularly	O
spaced	O
and	O
often	O
seen	O
as	O
disoriented	O
and	O
clamped	O
invaginations	O
at	O
P3	O
that	O
became	O
even	O
more	O
remarkable	O
at	O
P12	O
when	O
the	O
mutant	B-SO
mice	B-Taxon
were	O
covered	O
by	O
fur	O
coat	O
(	O
Figure	O
4F	O
)	O
.	O

Bulbs	O
were	O
often	O
bent	O
in	O
addition	O
to	O
being	O
irregularly	O
angled	O
to	O
one	O
another	O
and	O
their	O
sizes	O
and	O
locations	O
were	O
often	O
variable	O
.	O

Clusters	O
of	O
multiple	O
invaginations	O
or	O
dysplastic	O
follicular	O
structures	O
were	O
frequently	O
observed	O
throughout	O
the	O
epidermis	O
,	O
whereas	O
other	O
regions	O
showed	O
gaps	O
with	O
no	O
follicles	O
.	O

Serial	O
sectioning	O
indicated	O
that	O
some	O
of	O
the	O
hair	O
follicles	O
in	O
the	O
P12	O
mutant	B-SO
skin	O
were	O
not	O
properly	O
formed	O
or	O
shorter	O
than	O
normal	O
.	O

Taken	O
together	O
,	O
these	O
features	O
could	O
account	O
for	O
the	O
apparently	O
delayed	O
,	O
followed	O
by	O
outgrowth	O
,	O
of	O
the	O
short	O
and	O
shaggy	O
-	O
looking	O
fur	O
coat	O
of	O
these	O
mutant	B-SO
mice	B-Taxon
.	O

Apc	B-GGP
is	O
a	O
regulator	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
that	O
is	O
important	O
for	O
Wnt	O
signaling	O
.	O

We	O
examined	O
the	O
patterns	O
of	O
expression	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
the	O
affected	O
tissues	O
.	O

In	O
the	O
normal	O
skin	O
,	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
,	O
a	O
member	O
of	O
the	O
adherens	B-GO
junction	I-GO
complex	I-GO
,	O
was	O
found	O
in	O
the	O
ORS	O
of	O
hair	O
follicles	O
and	O
basal	O
layer	O
of	O
epidermis	O
,	O
where	O
K14	B-GGP
expression	O
is	O
also	O
observed	O
(	O
Figure	O
4C	O
and	O
4D	O
)	O
,	O
whereas	O
the	O
expression	O
of	O
K1	B-GGP
,	O
involucrin	B-GGP
,	O
and	O
loricrin	B-GGP
(	O
markers	O
for	O
spinous	O
and	O
granular	O
layers	O
of	O
epidermis	O
)	O
was	O
only	O
observed	O
in	O
the	O
nonbasal	O
epidermis	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
patterns	O
of	O
expression	O
of	O
K14	B-GGP
,	O
K1	B-GGP
,	O
involucrin	B-GGP
,	O
and	O
loricrin	B-GGP
,	O
in	O
skin	O
from	O
mutant	B-SO
and	O
normal	O
littermate	O
mice	B-Taxon
at	O
P3	O
-	O
P17	O
,	O
showed	O
no	O
significant	O
differences	O
in	O
the	O
terminal	O
differentiation	O
(	O
Figure	O
4A	O
-	O
4D	O
,	O
4F	O
-	O
4I	O
)	O
.	O

Similarly	O
,	O
the	O
pattern	O
of	O
expression	O
of	O
K6	B-GGP
,	O
which	O
is	O
normally	O
only	O
expressed	O
in	O
the	O
suprabasal	O
or	O
inner	O
layer	O
of	O
the	O
ORS	O
of	O
the	O
hair	O
follicle	O
but	O
not	O
in	O
the	O
epidermis	O
(	O
Figure	O
4E	O
)	O
,	O
did	O
not	O
change	O
.	O

Due	O
to	O
the	O
abnormal	O
and	O
disorganized	O
structure	O
of	O
hair	O
follicles	O
themselves	O
,	O
K6	B-GGP
localization	O
highlighted	O
the	O
histological	O
abnormality	O
(	O
Figure	O
4J	O
)	O
.	O

Yet	O
as	O
in	O
the	O
normal	O
skin	O
,	O
K6	B-GGP
was	O
principally	O
seen	O
only	O
in	O
the	O
suprabasal	O
layer	O
of	O
the	O
ORS	O
that	O
did	O
not	O
colocalize	O
with	O
the	O
basal	O
markers	O
,	O
K14	B-GGP
or	O
K5	B-GGP
(	O
Figure	O
4I	O
and	O
4J	O
)	O
.	O

In	O
normal	O
skin	O
,	O
proliferating	O
cells	B-CL
were	O
detected	O
in	O
either	O
the	O
basal	O
layer	O
of	O
epidermis	O
or	O
in	O
germinative	O
hair	O
follicle	O
bulbs	O
at	O
the	O
base	O
(	O
Figure	O
4B	O
)	O
.	O

In	O
the	O
mutant	B-SO
skin	O
,	O
either	O
BrdU	O
incorporation	B-SO
or	O
Ki67	B-GGP
expression	O
was	O
observed	O
not	O
only	O
in	O
cells	B-CL
in	O
bulbs	O
at	O
the	O
base	O
of	O
the	O
hair	O
follicle	O
but	O
also	O
in	O
bulb	O
-	O
like	O
structures	O
that	O
were	O
budding	O
out	O
from	O
the	O
ORS	O
of	O
the	O
existing	O
hair	O
follicles	O
(	O
Figure	O
4G	O
and	O
4G	O
'	O
)	O
.	O

Each	O
budding	O
tip	O
was	O
becoming	O
like	O
a	O
hair	O
follicle	O
bulb	O
containing	O
proliferating	O
cells	B-CL
.	O

Hence	O
,	O
despite	O
the	O
abnormal	O
histology	O
in	O
the	O
mutant	B-SO
skin	O
,	O
proliferation	O
seems	O
to	O
be	O
confined	O
to	O
bulb	O
-	O
like	O
structures	O
as	O
in	O
the	O
normal	O
skin	O
(	O
Figure	O
4G	O
and	O
4G	O
'	O
)	O
.	O

The	O
exact	O
locations	O
of	O
hair	O
follicle	O
bulbs	O
were	O
not	O
as	O
easy	O
to	O
define	O
for	O
some	O
mutant	B-SO
follicles	O
due	O
to	O
their	O
disorganized	O
structures	O
.	O

Interestingly	O
,	O
in	O
the	O
mutant	B-SO
skin	O
,	O
in	O
addition	O
to	O
diffuse	O
membrane	B-GO
-	O
bound	O
localization	O
as	O
in	O
the	O
normal	O
skin	O
,	O
cells	B-CL
with	O
strong	O
cytosolic	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
localization	O
were	O
also	O
observed	O
frequently	O
(	O
Figure	O
4H	O
and	O
4H	O
'	O
)	O
.	O

These	O
elevated	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
-	O
expressing	O
cells	B-CL
were	O
usually	O
surrounded	O
by	O
proliferating	O
cells	B-CL
,	O
forming	O
bulb	O
-	O
like	O
structures	O
.	O

Comparison	O
of	O
immunochemically	O
stained	O
serial	O
sections	O
showed	O
that	O
these	O
intense	O
cytosolic	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
stainings	O
were	O
usually	O
found	O
in	O
either	O
K14	B-GGP
-	O
positive	O
K1	B-GGP
-	O
negative	O
basal	O
epidermis	O
or	O
K14	B-GGP
-	O
positive	O
K6	B-GGP
-	O
negative	O
basal	O
ORS	O
cells	B-CL
,	O
and	O
are	O
surrounded	O
by	O
proliferating	O
cells	B-CL
.	O

To	O
determine	O
the	O
initiation	O
of	O
hair	O
follicle	O
morphogenesis	O
in	O
these	O
mutants	B-SO
,	O
we	O
examined	O
the	O
expression	O
pattern	O
of	O
Sonic	B-GGP
hedgehog	I-GGP
(	O
Shh	B-GGP
)	O
,	O
a	O
factor	O
expressed	O
in	O
hair	O
bulbs	O
in	O
embryonic	O
skin	O
(	O
Figure	O
5	O
)	O
.	O

The	O
aberrant	O
hair	O
follicle	O
morphogenesis	O
is	O
evident	O
as	O
early	O
as	O
E14	O
.	O
5	O
in	O
mutant	B-SO
embryonic	O
skin	O
,	O
by	O
multiple	O
apolarized	O
expression	O
of	O
Shh	B-GGP
throughout	O
the	O
epidermis	O
(	O
Figure	O
5B	O
)	O
,	O
whereas	O
that	O
of	O
control	O
embryos	O
was	O
well	O
polarized	O
and	O
regularly	O
spaced	O
(	O
Figure	O
5A	O
)	O
.	O

With	O
development	O
,	O
control	O
mouse	B-Taxon
hair	O
follicles	O
invaginate	O
downward	O
in	O
a	O
polarized	O
manner	O
(	O
Figure	O
5C	O
)	O
,	O
whereas	O
those	O
of	O
mutant	B-SO
embryos	O
were	O
completely	O
irregular	O
and	O
apolarized	O
(	O
Figure	O
5D	O
)	O
.	O

It	O
was	O
also	O
noted	O
that	O
the	O
size	O
of	O
each	O
"	O
budding	O
"	O
follicle	O
,	O
as	O
detected	O
by	O
Shh	B-GGP
expression	O
,	O
was	O
variable	O
(	O
Figure	O
5D	O
)	O
.	O

The	O
intensity	O
of	O
Shh	B-GGP
staining	O
was	O
generally	O
stronger	O
in	O
mutant	B-SO
skin	O
than	O
in	O
the	O
normal	O
skin	O
.	O

The	O
aberrant	O
initiation	O
of	O
multiple	O
hair	O
placodes	O
during	O
early	O
hair	O
follicle	O
morphogenesis	O
was	O
also	O
evident	O
by	O
the	O
whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
(	O
ISH	O
)	O
of	O
E15	O
.	O
5	O
mutant	B-SO
embryos	O
for	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
(	O
Figure	O
5F	O
and	O
5F	O
'	O
)	O
.	O

The	O
expression	O
pattern	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
embryos	O
clearly	O
demonstrated	O
the	O
formation	O
of	O
regular	O
arrays	O
of	O
hair	O
placodes	O
in	O
the	O
normal	O
embryonic	O
skin	O
(	O
Figure	O
5E	O
and	O
5E	O
'	O
)	O
,	O
but	O
such	O
regular	O
patterning	O
was	O
lost	O
,	O
and	O
often	O
tightly	O
clustered	O
abnormal	O
hair	O
placodes	O
were	O
initiated	O
in	O
mutant	B-SO
embryonic	O
skin	O
(	O
Figure	O
5F	O
'	O
)	O
.	O

Aberrant	O
hair	O
placodes	O
were	O
also	O
evident	O
throughout	O
the	O
skin	O
surface	O
of	O
limbs	O
in	O
E15	O
.	O
5	O
mutants	B-SO
(	O
Figure	O
5F	O
)	O
,	O
whereas	O
those	O
of	O
the	O
control	O
embryos	O
had	O
not	O
yet	O
formed	O
(	O
Figure	O
5E	O
)	O
.	O

Most	O
interestingly	O
,	O
in	O
the	O
mutant	B-SO
footpads	O
,	O
where	O
hair	O
placodes	O
do	O
not	O
normally	O
form	O
(	O
Figure	O
5G	O
)	O
,	O
we	O
also	O
found	O
ectopic	O
irregularly	O
sized	O
and	O
spaced	O
hair	O
placodes	O
,	O
indicating	O
that	O
the	O
footpads	O
still	O
have	O
the	O
potential	O
to	O
form	O
hair	O
placodes	O
in	O
the	O
absence	O
of	O
the	O
Apc	B-GGP
gene	B-SO
(	O
Figure	O
5H	O
)	O
.	O

These	O
results	O
collectively	O
suggest	O
that	O
the	O
terminal	O
differentiation	O
does	O
take	O
place	O
normally	O
in	O
the	O
mutant	B-SO
skin	O
,	O
but	O
initiation	O
of	O
embryonic	O
hair	O
follicle	O
morphogenesis	O
is	O
severely	O
disrupted	O
,	O
accompanied	O
by	O
a	O
continuous	O
ectopic	O
hair	O
follicle	O
morphogenesis	O
in	O
postnatal	O
mutant	B-SO
skin	O
.	O

Effects	O
of	O
K14	B-GGP
-	O
cre	O
-	O
Driven	O
Loss	O
of	O
Apc	B-GGP
in	O
Other	O
Epidermal	O
Appendages	O

Similar	O
to	O
the	O
biology	O
of	O
hair	O
follicles	O
,	O
K14	B-GGP
-	O
cre	O
-	O
driven	O
loss	O
of	O
Apc	B-GGP
also	O
affected	O
the	O
development	O
of	O
other	O
epidermal	O
appendages	O
that	O
depend	O
on	O
epithelial	O
-	O
mesenchymal	O
interactions	O
for	O
their	O
formation	O
.	O

The	O
most	O
striking	O
of	O
these	O
was	O
dental	O
dysplasia	O
(	O
Figure	O
4K	O
-	O
4R	O
)	O
.	O

Tooth	O
development	O
is	O
normally	O
initiated	O
between	O
E11	O
and	O
E12	O
by	O
invagination	O
of	O
ectodermally	O
derived	O
oral	O
epithelium	O
into	O
the	O
underlying	O
cranial	O
neural	O
crest	O
-	O
derived	O
mesenchyme	O
,	O
generating	O
a	O
tooth	O
germ	O
.	O

Despite	O
the	O
grossly	O
toothless	O
phenotype	O
of	O
KA	O
mutants	B-SO
,	O
histological	O
analysis	O
of	O
their	O
oral	O
cavities	O
revealed	O
the	O
formation	O
of	O
multiple	O
tooth	O
buds	O
at	O
each	O
location	O
.	O

These	O
aberrant	O
teeth	O
obviously	O
failed	O
to	O
grow	O
out	O
during	O
the	O
dietary	O
transition	O
from	O
milk	O
to	O
solid	O
food	B-CHEBI
.	O

Analogous	O
to	O
the	O
expression	O
patterns	O
of	O
K14	B-GGP
and	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
the	O
normal	O
skin	O
,	O
diffuse	O
membrane	B-GO
-	O
bound	O
expression	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
was	O
detected	O
in	O
K14	B-GGP
-	O
expressing	O
oral	O
epithelium	O
and	O
ameloblasts	B-CL
of	O
normal	O
mice	B-Taxon
.	O

In	O
mutants	B-SO
,	O
some	O
of	O
the	O
K14	B-GGP
-	O
expressing	O
cells	B-CL
also	O
showed	O
strong	O
cytosolic	B-GO
/	O
nuclear	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
staining	O
,	O
as	O
observed	O
in	O
the	O
mutant	B-SO
skin	O
(	O
Figure	O
4Q	O
,	O
4Q	O
'	O
,	O
and	O
4R	O
)	O
.	O

Initiation	O
of	O
ectopic	O
tooth	O
buds	O
in	O
the	O
mutant	B-SO
mice	B-Taxon
was	O
evident	O
at	O
E15	O
.	O
5	O
by	O
extra	O
dots	O
of	O
Shh	B-GGP
expression	O
adjacent	O
to	O
the	O
primary	O
teeth	O
(	O
data	O
not	O
shown	O
)	O
.	O

Loss	O
of	O
Apc	B-GGP
also	O
leads	O
to	O
hyperplasia	O
in	O
squamous	O
epithelia	O
of	O
cornea	O
,	O
oral	O
,	O
salivary	O
,	O
and	O
Hardarian	O
glands	O
(	O
unpublished	O
data	O
)	O
.	O

Squamous	O
metaplasia	O
to	O
hair	O
follicle	O
-	O
like	O
structures	O
,	O
ectopic	O
hair	O
follicle	O
morphogenesis	O
was	O
also	O
observed	O
in	O
these	O
epithelia	O
.	O

K14	B-GGP
-	O
cre	O
-	O
Driven	O
Apc	B-GGP
Loss	O
Results	O
in	O
Hypoplastic	O
/	O
Athymic	O
Mice	B-Taxon

Thymus	O
is	O
an	O
organ	O
that	O
is	O
also	O
known	O
to	O
have	O
K14	B-GGP
expression	O
[	O
16	O
]	O
.	O

It	O
represents	O
the	O
primary	O
lymphoid	O
organ	O
for	O
thymocyte	O
development	O
and	O
selection	O
.	O

Distinct	O
population	O
of	O
TECs	O
of	O
cortex	O
and	O
medulla	O
mediates	O
both	O
of	O
these	O
critical	O
functions	O
.	O

Cortical	O
and	O
medullary	O
TEC	O
subsets	O
are	O
characterized	O
by	O
differential	O
expression	O
of	O
four	O
keratin	O
species	O
:	O
K8	B-GGP
,	O
K18	B-GGP
,	O
K5	B-GGP
,	O
and	O
K14	B-GGP
.	O

The	O
normal	O
thymus	O
is	O
a	O
lobulated	O
lymphoid	O
organ	O
,	O
each	O
lobule	O
clearly	O
showing	O
the	O
two	O
distinct	O
TEC	O
compartments	O
,	O
an	O
outer	O
cortex	O
and	O
an	O
inner	O
medulla	O
(	O
Figure	O
6	O
)	O
.	O

There	O
were	O
no	O
major	O
differences	O
in	O
the	O
histology	O
of	O
thymus	O
between	O
the	O
ages	O
P3	O
to	O
P17	O
in	O
phenotypically	O
normal	O
littermates	O
.	O

As	O
shown	O
in	O
the	O
H	O
&	O
E	O
staining	O
of	O
thymus	O
,	O
the	O
cortex	O
was	O
formed	O
of	O
dense	O
lymphoid	O
tissue	O
that	O
lacks	O
nodules	O
(	O
Figure	O
6A	O
)	O
.	O

Since	O
the	O
stroma	O
of	O
the	O
medulla	O
is	O
less	O
heavily	O
infiltrated	O
with	O
lymphocytes	B-CL
than	O
the	O
cortex	O
,	O
the	O
medulla	O
stained	O
more	O
lightly	O
than	O
the	O
cortex	O
.	O

In	O
normal	O
mice	B-Taxon
,	O
the	O
thymus	O
retains	O
its	O
size	O
until	O
the	O
young	O
adult	O
age	O
and	O
regresses	O
thereafter	O
by	O
atrophy	O
.	O

In	O
the	O
normal	O
young	O
mice	B-Taxon
we	O
examined	O
(	O
P3	O
-	O
P17	O
)	O
,	O
it	O
is	O
evident	O
that	O
thymocytes	O
were	O
mitotically	O
active	O
in	O
the	O
cortex	O
as	O
determined	O
by	O
BrdU	O
immunostaining	O
(	O
Figure	O
6B	O
)	O
.	O

Immunohistochemistry	O
of	O
normal	O
thymus	O
from	O
P3	O
to	O
P17	O
mice	B-Taxon
showed	O
a	O
similar	O
staining	O
pattern	O
for	O
K14	B-GGP
in	O
that	O
its	O
expression	O
was	O
restricted	O
to	O
a	O
small	O
population	O
of	O
TECs	O
in	O
the	O
inner	O
medullary	O
region	O
and	O
in	O
the	O
keratinocytes	B-CL
in	O
Hassall	O
'	O
s	O
corpuscles	O
(	O
Figure	O
6D	O
)	O
.	O

Diffuse	O
cytoplasmic	B-GO
staining	O
for	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
was	O
also	O
detected	O
in	O
the	O
medullary	O
epithelial	B-CL
cells	I-CL
(	O
Figure	O
6C	O
)	O
.	O

In	O
contrast	O
to	O
K14	B-GGP
expression	O
,	O
diffuse	O
staining	O
for	O
K8	B-GGP
was	O
observed	O
in	O
epithelial	B-CL
cells	I-CL
both	O
in	O
the	O
medulla	O
and	O
cortex	O
(	O
Figure	O
S3	O
)	O
.	O

K1	B-GGP
staining	O
was	O
not	O
detected	O
in	O
young	O
mice	B-Taxon
at	O
P3	O
but	O
in	O
older	O
mice	B-Taxon
it	O
was	O
detected	O
in	O
differentiated	O
keratinocytes	B-CL
in	O
some	O
of	O
Hassall	O
'	O
s	O
corpuscles	O
(	O
Figure	O
S3	O
)	O
.	O

The	O
histological	O
abnormalities	O
of	O
thymus	O
were	O
evident	O
as	O
early	O
as	O
P3	O
in	O
KA	O
mutants	B-SO
(	O
Figure	O
6E	O
and	O
6H	O
)	O
.	O

The	O
thymus	O
was	O
made	O
of	O
two	O
lobules	O
as	O
in	O
the	O
normal	O
mice	B-Taxon
but	O
the	O
mutant	B-SO
thymus	O
was	O
significantly	O
smaller	O
in	O
size	O
than	O
that	O
of	O
the	O
age	O
-	O
matched	O
controls	O
(	O
Figure	O
2G	O
)	O
.	O

Interestingly	O
,	O
variations	O
in	O
the	O
phenotypic	O
severity	O
of	O
the	O
mutant	B-SO
pups	O
at	O
P3	O
were	O
prominently	O
reflected	O
in	O
the	O
extent	O
of	O
histological	O
abnormalities	O
of	O
thymus	O
.	O

A	O
P3	O
KA	O
mutant	B-SO
pup	O
that	O
showed	O
milder	O
phenotype	O
with	O
a	O
comparable	O
body	O
weight	O
to	O
its	O
normal	O
littermates	O
(	O
Figure	O
2A	O
,	O
M2	O
)	O
showed	O
milder	O
thymus	O
abnormalities	O
(	O
Figure	O
6E	O
)	O
compared	O
to	O
its	O
more	O
severe	O
mutant	B-SO
littermate	O
(	O
Figure	O
2A	O
,	O
M1	O
;	O
Figure	O
6H	O
)	O
.	O

The	O
milder	O
P3	O
mutant	B-SO
thymus	O
was	O
already	O
much	O
smaller	O
in	O
size	O
compared	O
to	O
those	O
of	O
normal	O
littermates	O
(	O
data	O
not	O
shown	O
)	O
but	O
two	O
epithelial	O
compartments	O
of	O
thymus	O
were	O
histologically	O
still	O
distinguishable	O
,	O
with	O
colonization	O
of	O
thymocytes	O
evident	O
in	O
the	O
cortex	O
.	O

However	O
,	O
there	O
were	O
small	O
populations	O
of	O
lightly	O
stained	O
cells	B-CL
by	O
H	O
&	O
E	O
extending	O
from	O
the	O
edge	O
of	O
the	O
outer	O
cortex	O
towards	O
inner	O
medulla	O
(	O
Figure	O
6E	O
)	O
,	O
and	O
these	O
cells	B-CL
showed	O
intense	O
nuclear	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
staining	O
whereas	O
the	O
rest	O
of	O
the	O
medullary	O
cells	B-CL
showed	O
diffuse	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
staining	O
pattern	O
similar	O
to	O
that	O
of	O
the	O
control	O
(	O
Figure	O
6F	O
)	O
.	O

Localization	O
of	O
K14	B-GGP
was	O
limited	O
to	O
a	O
few	O
cells	B-CL
in	O
the	O
medulla	O
and	O
some	O
overlapped	O
with	O
K8	B-GGP
localization	O
(	O
Figure	O
6G	O
)	O
.	O

In	O
the	O
other	O
P3	O
mutant	B-SO
thymus	O
the	O
distinct	O
thymic	O
epithelial	O
compartments	O
have	O
been	O
lost	O
completely	O
,	O
and	O
only	O
a	O
few	O
lymphocytes	B-CL
were	O
remaining	O
at	O
the	O
edges	O
and	O
some	O
in	O
the	O
middle	O
(	O
Figure	O
6H	O
)	O
.	O

Proliferative	O
activities	O
were	O
no	O
longer	O
observed	O
in	O
thymocytes	O
as	O
prominently	O
as	O
in	O
the	O
normal	O
thymus	O
,	O
but	O
the	O
epithelial	B-CL
cells	I-CL
seemed	O
to	O
be	O
forming	O
concentric	O
structures	O
(	O
Figure	O
6I	O
)	O
.	O

Unlike	O
in	O
the	O
normal	O
or	O
mild	O
mutant	B-SO
thymi	O
,	O
the	O
severe	O
P3	O
mutant	B-SO
thymus	O
showed	O
extensive	O
K14	B-GGP
expression	O
that	O
overlapped	O
with	O
K8	B-GGP
expression	O
(	O
Figure	O
6K	O
)	O
.	O

These	O
cells	B-CL
were	O
more	O
like	O
basal	B-CL
cells	I-CL
of	O
the	O
skin	O
than	O
TECs	O
and	O
were	O
adjacent	O
to	O
the	O
most	O
immature	O
looking	O
cells	B-CL
that	O
were	O
showing	O
strong	O
nuclear	B-GO
and	O
cytoplasmic	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
staining	O
(	O
Figure	O
6J	O
)	O
.	O

The	O
nuclear	B-GO
staining	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
was	O
not	O
observed	O
in	O
the	O
normal	O
age	O
-	O
matched	O
thymus	O
(	O
Figure	O
6C	O
)	O
.	O

Most	O
notably	O
,	O
the	O
K14	B-GGP
and	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
staining	O
patterns	O
were	O
mutually	O
exclusive	O
(	O
Figure	O
6J	O
and	O
6K	O
)	O
.	O

At	O
P10	O
-	O
P13	O
,	O
the	O
mutant	B-SO
thymus	O
consisted	O
of	O
numerous	O
enlarged	O
Hassall	O
'	O
s	O
corpuscle	O
-	O
like	O
structures	O
,	O
made	O
of	O
arrays	O
of	O
K14	B-GGP
-	O
and	O
K8	B-GGP
-	O
expressing	O
keratinizing	O
epithelial	B-CL
cells	I-CL
surrounding	O
large	O
keratin	O
deposits	O
(	O
Figure	O
6L	O
and	O
6O	O
)	O
.	O

There	O
were	O
numerous	O
neutrophils	B-CL
and	O
macrophages	B-CL
infiltrating	O
the	O
thymus	O
in	O
response	O
to	O
these	O
keratins	O
;	O
hence	O
,	O
these	O
structures	O
could	O
be	O
called	O
pyogranuloma	O
.	O

Varying	O
degrees	O
of	O
differentiation	O
-	O
specific	O
markers	O
depending	O
on	O
the	O
age	O
of	O
mice	B-Taxon
,	O
in	O
this	O
case	O
K1	B-GGP
and	O
involucrin	B-GGP
that	O
are	O
normally	O
present	O
only	O
in	O
Hassall	O
'	O
s	O
corpuscles	O
,	O
were	O
also	O
detected	O
in	O
mutant	B-SO
thymi	O
(	O
Figure	O
S3	O
)	O
.	O

In	O
these	O
mice	B-Taxon
no	O
thymocytes	O
were	O
detectable	O
.	O

BrdU	O
incorporation	B-SO
was	O
only	O
observed	O
in	O
very	O
few	O
keratinizing	O
epithelial	B-CL
cells	I-CL
,	O
looking	O
somewhat	O
similar	O
to	O
the	O
pattern	O
of	O
mature	O
skin	O
(	O
Figure	O
6M	O
)	O
.	O

The	O
diffuse	O
expression	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
was	O
also	O
present	O
in	O
these	O
epithelial	B-CL
cells	I-CL
,	O
and	O
at	O
this	O
age	O
fewer	O
cells	B-CL
were	O
positive	O
for	O
nuclear	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
staining	O
(	O
Figure	O
6N	O
)	O
.	O

As	O
in	O
the	O
younger	O
mutant	B-SO
mice	B-Taxon
,	O
however	O
,	O
nuclear	B-GO
localization	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
was	O
only	O
observed	O
in	O
K14	B-GGP
-	O
negative	O
cells	B-CL
that	O
looked	O
like	O
undifferentiated	O
basal	B-CL
cells	I-CL
.	O

In	O
older	O
P17	O
mice	B-Taxon
,	O
the	O
histopathology	O
and	O
keratin	O
expression	O
pattern	O
of	O
the	O
mutant	B-SO
thymus	O
was	O
similar	O
to	O
that	O
of	O
P13	O
except	O
for	O
the	O
fact	O
that	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
expression	O
became	O
increasingly	O
diffuse	O
and	O
appeared	O
to	O
colocalize	O
with	O
K8	B-GGP
/	O
K14	B-GGP
expression	O
(	O
data	O
not	O
shown	O
)	O
.	O

This	O
coincided	O
with	O
fewer	O
immature	O
cells	B-CL
in	O
the	O
older	O
mutant	B-SO
thymus	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
loss	O
of	O
Apc	B-GGP
and	O
consequent	O
stabilization	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
K14	B-GGP
-	O
expressing	O
TECs	O
lead	O
to	O
their	O
aberrant	O
proliferation	O
and	O
differentiation	O
to	O
keratinocytes	B-CL
,	O
causing	O
massive	O
squamous	O
metaplasia	O
,	O
rather	O
than	O
to	O
form	O
either	O
medullary	O
or	O
cortical	O
TECs	O
.	O

Loss	O
of	O
proper	O
TEC	O
compartments	O
consequently	O
resulted	O
in	O
loss	O
of	O
thymocytes	O
for	O
maturation	O
and	O
the	O
mice	B-Taxon
to	O
be	O
"	O
athymic	O
.	O
"	O

Discussion	O

Apc	B-GGP
is	O
implicated	O
in	O
the	O
Wnt	O
signaling	O
pathway	O
that	O
is	O
involved	O
both	O
in	O
development	O
and	O
tumorigenesis	O
.	O

Human	B-Taxon
germline	O
mutations	B-SO
in	O
APC	B-GGP
cause	O
FAP	O
[	O
4	O
,	O
5	O
]	O
,	O
which	O
is	O
characterized	O
by	O
hundreds	O
of	O
adenomatous	O
colorectal	O
polyps	O
,	O
with	O
an	O
almost	O
inevitable	O
progression	O
to	O
colorectal	O
cancer	O
in	O
the	O
third	O
and	O
fourth	O
decades	O
of	O
life	O
.	O

The	O
phenotypical	O
features	O
of	O
FAP	O
and	O
its	O
variant	O
,	O
Gardner	O
'	O
s	O
syndrome	O
,	O
can	O
be	O
very	O
variable	O
.	O

As	O
well	O
as	O
colorectal	O
polyps	O
,	O
these	O
individuals	B-Taxon
can	O
develop	O
extracolonic	O
symptoms	O
,	O
among	O
which	O
are	O
upper	O
gastrointestinal	O
tract	O
polyps	O
,	O
congenital	O
hypertrophy	O
of	O
the	O
retinal	O
pigment	B-CHEBI
epithelium	O
,	O
desmoid	O
tumors	O
,	O
disorders	O
of	O
the	O
maxillary	O
and	O
skeletal	O
bones	O
,	O
and	O
dental	O
abnormalities	O
[	O
6	O
]	O
.	O

While	O
the	O
heterozygous	O
knockout	O
mice	B-Taxon
for	O
Apc	B-GGP
develop	O
adenomatous	O
polyps	O
predominantly	O
in	O
small	O
intestine	O
,	O
the	O
homozygous	O
embryos	O
die	O
before	O
gastrulation	O
.	O

To	O
gain	O
more	O
insights	O
into	O
the	O
effects	O
of	O
Apc	B-GGP
loss	O
in	O
tissues	O
other	O
than	O
gastrointestinal	O
tract	O
during	O
life	O
of	O
animals	B-Taxon
and	O
to	O
circumvent	O
the	O
embryonic	O
lethality	O
associated	O
with	O
Apc	B-GGP
nullizygosity	O
,	O
we	O
created	O
a	O
mouse	B-Taxon
strain	O
carrying	O
a	O
conditional	O
allele	B-SO
of	O
Apc	B-GGP
(	O
ApcCKO	O
)	O
in	O
which	O
exon	B-SO
14	O
of	O
the	O
Apc	B-GGP
is	O
flanked	B-SO
by	O
loxP	B-SO
sequences	I-SO
.	O

The	O
homozygous	O
mice	B-Taxon
for	O
the	O
conditional	O
allele	B-SO
are	O
viable	O
and	O
indistinguishable	O
to	O
the	O
normal	O
mice	B-Taxon
,	O
allowing	O
us	O
to	O
study	O
the	O
roles	O
of	O
Apc	B-GGP
in	O
a	O
tissue	O
-	O
and	O
temporal	O
-	O
specific	O
manner	O
.	O

To	O
assess	O
the	O
phenotypic	O
consequences	O
of	O
inactivation	O
of	O
the	O
Apc	B-GGP
gene	B-SO
in	O
cells	B-CL
that	O
express	O
K14	B-GGP
,	O
we	O
created	O
mice	B-Taxon
that	O
are	O
homozygous	O
for	O
the	O
ApcCKO	O
allele	B-SO
and	O
contain	O
a	O
K14	B-GGP
-	O
cre	O
transgene	B-SO
.	O

These	O
mice	B-Taxon
failed	O
to	O
thrive	O
and	O
died	O
before	O
weaning	O
.	O

They	O
also	O
exhibited	O
hair	O
,	O
tooth	O
,	O
and	O
thymus	O
phenotypes	O
.	O

Apc	B-GGP
and	O
Hair	O
Follicle	O
Morphogenesis	O

Current	O
models	O
of	O
hair	O
follicle	O
development	O
suggest	O
that	O
the	O
establishment	O
of	O
a	O
regular	O
array	O
of	O
placodes	O
in	O
the	O
surface	O
epithelium	O
in	O
response	O
to	O
the	O
first	O
dermal	O
message	O
is	O
achieved	O
through	O
the	O
competing	O
activities	O
of	O
molecules	B-CHEBI
that	O
promote	O
or	O
repress	O
placode	O
fate	O
[	O
24	O
]	O
.	O

There	O
is	O
accumulating	O
evidence	O
that	O
activation	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
in	O
the	O
dermis	O
may	O
be	O
involved	O
in	O
establishing	O
the	O
first	O
dermal	O
signal	O
.	O

Experimental	O
activation	O
of	O
epithelial	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
signaling	O
(	O
by	O
expression	O
of	O
N	B-SO
-	I-SO
terminal	I-SO
-	O
truncated	O
,	O
constitutively	O
stabilized	O
forms	B-SO
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
or	O
ectopic	O
expression	O
of	O
Lef1	B-GGP
)	O
induces	O
ectopic	O
follicles	O
in	O
both	O
mouse	B-Taxon
and	O
chick	O
skin	O
[	O
25	O
-	O
27	O
]	O
.	O

Conversely	O
,	O
down	O
-	O
regulation	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
signaling	O
(	O
through	O
Lef1	B-GGP
knock	O
-	O
out	O
,	O
ectopic	O
expression	O
of	O
Wnt	O
inhibitor	O
Dkk1	B-GGP
or	O
conditional	O
deletion	B-SO
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
epidermis	O
)	O
results	O
in	O
loss	O
of	O
vibrissae	O
and	O
some	O
pelage	O
follicles	O
in	O
mice	B-Taxon
[	O
28	O
-	O
30	O
]	O
.	O

Our	O
finding	O
that	O
K14	B-GGP
-	O
driven	O
Apc	B-GGP
loss	O
in	O
embryonic	O
ectoderm	O
resulted	O
in	O
irregularly	O
spaced	O
and	O
often	O
tightly	O
clustered	O
abnormal	O
hair	O
placode	O
initiation	O
and	O
follicle	O
morphogenesis	O
(	O
Figures	O
4F	O
,	O
5B	O
,	O
5D	O
,	O
and	O
5F	O
)	O
as	O
well	O
as	O
in	O
the	O
development	O
of	O
multiple	O
tooth	O
buds	O
(	O
Figure	O
4O	O
and	O
4P	O
)	O
,	O
is	O
in	O
line	O
with	O
the	O
effects	O
seen	O
in	O
activation	O
of	O
epithelial	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
signaling	O
during	O
placode	O
formation	O
,	O
indicating	O
the	O
role	O
of	O
Apc	B-GGP
in	O
specification	O
of	O
embryonic	O
ectodermal	B-CL
stem	I-CL
cells	I-CL
to	O
produce	O
a	O
hair	O
follicle	O
.	O

Given	O
the	O
role	O
of	O
Apc	B-GGP
in	O
down	O
-	O
regulation	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
,	O
loss	O
of	O
Apc	B-GGP
would	O
inevitably	O
lead	O
to	O
altered	O
expression	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
ectodermal	B-CL
cells	I-CL
during	O
the	O
hair	O
placode	O
formation	O
,	O
giving	O
rise	O
to	O
aberrant	O
follicular	O
growth	O
throughout	O
the	O
embryonic	O
epidermis	O
,	O
including	O
the	O
footpads	O
,	O
where	O
normally	O
hairless	O
(	O
Figure	O
5B	O
,	O
5D	O
,	O
5F	O
,	O
and	O
5H	O
)	O
.	O

Of	O
interest	O
are	O
the	O
phenotypic	O
similarities	O
and	O
differences	O
between	O
our	O
KA	O
mutant	B-SO
mice	B-Taxon
and	O
the	O
previously	O
described	O
K14	B-GGP
-	O
Delta	O
N87	O
beta	O
cat	O
transgenic	B-SO
mice	B-Taxon
expressing	O
stable	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
under	O
the	O
control	O
of	O
K14	B-GGP
promoter	B-SO
[	O
25	O
]	O
and	O
K14	B-GGP
-	O
Lef1	B-GGP
transgenic	B-SO
mice	B-Taxon
[	O
27	O
]	O
.	O

Surprisingly	O
,	O
our	O
mutant	B-SO
mice	B-Taxon
shared	O
more	O
similarities	O
with	O
the	O
K14	B-GGP
-	O
Lef1	B-GGP
mice	B-Taxon
than	O
the	O
K14	B-GGP
-	O
Delta	O
N87	O
beta	O
cat	O
transgenic	B-SO
mice	B-Taxon
.	O

For	O
example	O
,	O
the	O
KA	O
mutant	B-SO
mice	B-Taxon
displayed	O
the	O
disoriented	O
and	O
short	O
,	O
curly	O
whiskers	O
seen	O
in	O
K14	B-GGP
-	O
Lef1but	O
not	O
in	O
K14	B-GGP
-	O
Delta	O
N87	O
beta	O
cat	O
transgenic	B-SO
mice	B-Taxon
.	O

In	O
addition	O
,	O
KA	O
mutant	B-SO
mice	B-Taxon
displayed	O
a	O
disorganized	O
hair	O
coat	O
beginning	O
with	O
the	O
emergence	O
of	O
neonatal	O
hairs	O
,	O
similar	O
to	O
that	O
observed	O
in	O
K14	B-GGP
-	O
Lef1	B-GGP
mice	B-Taxon
,	O
whereas	O
in	O
K14	B-GGP
-	O
Delta	O
N87	O
beta	O
cat	O
mice	B-Taxon
,	O
embryonic	O
hair	O
follicle	O
morphogenesis	O
was	O
unaffected	O
and	O
other	O
skin	O
changes	O
only	O
emerged	O
postnatally	O
.	O

The	O
reason	O
for	O
this	O
difference	O
could	O
be	O
attributed	O
to	O
one	O
or	O
all	O
of	O
three	O
possible	O
contributing	O
factors	O
.	O

(	O
1	O
)	O
Although	O
the	O
K14	B-GGP
promoter	B-SO
itself	O
is	O
known	O
to	O
initiate	O
the	O
expression	O
at	O
E9	O
.	O
5	O
and	O
elevated	O
dramatically	O
by	O
E13	O
.	O
5	O
-	O
E14	O
.	O
5	O
[	O
19	O
,	O
31	O
]	O
,	O
many	O
factors	O
could	O
influence	O
the	O
expression	O
of	O
promoter	B-SO
/	O
transgene	B-SO
construct	B-SO
in	O
transgenic	B-SO
mice	B-Taxon
.	O

One	O
of	O
the	O
most	O
important	O
considerations	O
has	O
to	O
do	O
with	O
the	O
integration	B-SO
site	I-SO
of	O
the	O
transgene	B-SO
in	O
the	O
mouse	B-Taxon
genome	B-SO
.	O

Depending	O
on	O
the	O
location	B-SO
of	I-SO
integration	I-SO
,	O
the	O
transcriptional	O
activity	O
of	O
even	O
the	O
same	O
transgene	B-SO
could	O
vary	O
considerably	O
.	O

It	O
is	O
possible	O
that	O
the	O
apparent	O
lack	O
of	O
Delta	O
N87	O
beta	O
cat	O
function	O
in	O
embryogenesis	O
could	O
be	O
due	O
to	O
the	O
delayed	O
or	O
weak	O
expression	O
of	O
the	O
K14	B-GGP
-	O
Delta	O
N87	O
beta	O
cat	O
transgene	B-SO
compared	O
to	O
the	O
intrinsic	O
promoter	B-SO
.	O

In	O
contrast	O
,	O
Cre	O
-	O
mediated	O
recombination	O
is	O
seen	O
in	O
E13	O
.	O
5	O
skin	O
of	O
K14	B-GGP
-	O
cre	O
transgenic	B-SO
mice	B-Taxon
used	O
in	O
this	O
study	O
[	O
16	O
]	O
and	O
K14	B-GGP
-	O
cre	O
-	O
mediated	O
truncation	O
of	O
the	O
Apc	B-GGP
gene	B-SO
is	O
likely	O
to	O
have	O
occurred	O
by	O
then	O
,	O
in	O
time	O
for	O
the	O
second	O
wave	O
of	O
hair	O
follicle	O
morphgenesis	O
.	O

(	O
2	O
)	O
Another	O
important	O
fact	O
is	O
that	O
in	O
the	O
aforementioned	O
transgenic	B-SO
model	O
the	O
overexpression	O
of	O
transgene	B-SO
is	O
confined	O
to	O
the	O
basal	O
cells	B-CL
of	I-CL
the	I-CL
epidermis	I-CL
and	O
the	O
ORS	O
of	O
hair	O
follicles	O
,	O
where	O
the	O
K14	B-GGP
promoter	B-SO
is	O
active	O
.	O

The	O
expression	O
of	O
transgene	B-SO
is	O
hence	O
transient	O
and	O
stops	O
once	O
K14	B-GGP
-	O
expressing	O
cells	B-CL
terminally	O
differentiate	O
.	O

In	O
contrast	O
,	O
in	O
our	O
model	O
,	O
K14	B-GGP
-	O
cre	O
-	O
mediated	O
deletion	B-SO
of	O
Apc	B-GGP
would	O
result	O
in	O
Apc	B-GGP
mutation	B-SO
not	O
only	O
in	O
K14	B-GGP
promoter	B-SO
active	O
cells	B-CL
,	O
but	O
remain	O
so	O
in	O
all	O
cell	B-CL
layers	O
that	O
derived	O
from	O
the	O
K14	B-GGP
promoter	B-SO
active	O
progenitors	O
.	O

These	O
derivatives	O
include	O
the	O
suprabasal	O
epidermis	O
and	O
the	O
entire	O
epithelium	O
of	O
the	O
hair	O
follicle	O
.	O

Stabilization	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
a	O
broader	O
population	O
of	O
cells	B-CL
could	O
account	O
for	O
some	O
of	O
the	O
phenotypic	O
differences	O
.	O

However	O
,	O
we	O
did	O
not	O
detect	O
any	O
elevated	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
expression	O
in	O
either	O
K1	B-GGP
-	O
or	O
K6	B-GGP
-	O
positive	O
differentiated	O
cells	B-CL
in	O
postnatal	O
mutant	B-SO
skin	O
.	O

This	O
indicates	O
that	O
despite	O
the	O
absence	O
of	O
Apc	B-GGP
and	O
potential	O
stabilization	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
derivatives	O
of	O
K14	B-GGP
-	O
expressing	O
progenitors	O
,	O
elevated	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
expression	O
,	O
and	O
subsequent	O
cell	B-CL
fate	O
determination	O
may	O
only	O
take	O
place	O
in	O
basal	B-CL
cells	I-CL
.	O

(	O
3	O
)	O
We	O
cannot	O
exclude	O
the	O
possibility	O
that	O
given	O
the	O
multifunctional	O
properties	O
of	O
Apc	B-GGP
,	O
disruption	O
of	O
its	O
functions	O
other	O
than	O
down	O
-	O
regulation	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
may	O
also	O
have	O
contributed	O
to	O
the	O
observed	O
overt	O
phenotype	O
.	O

While	O
some	O
features	O
of	O
our	O
mutant	B-SO
mice	B-Taxon
were	O
similar	O
to	O
these	O
transgenic	B-SO
mice	B-Taxon
,	O
other	O
phenotypic	O
aspects	O
were	O
largely	O
distinct	O
.	O

In	O
addition	O
to	O
aberrant	O
hair	O
follicle	O
morphogenesis	O
,	O
K14	B-GGP
-	O
driven	O
loss	O
of	O
Apc	B-GGP
caused	O
formation	O
of	O
multiple	O
tooth	O
buds	O
that	O
,	O
like	O
hair	O
follicles	O
,	O
were	O
known	O
to	O
develop	O
through	O
inductive	O
interactions	O
between	O
the	O
epithelium	O
and	O
mesenchyme	O
.	O

This	O
observation	O
was	O
similar	O
to	O
the	O
ectopic	O
tooth	O
buds	O
found	O
in	O
animals	B-Taxon
misexpressing	O
Lef1	B-GGP
[	O
27	O
]	O
,	O
but	O
more	O
severe	O
and	O
was	O
also	O
present	O
at	O
birth	O
,	O
indicating	O
the	O
effect	O
of	O
Apc	B-GGP
loss	O
during	O
the	O
initiation	O
of	O
embryonic	O
tooth	O
development	O
,	O
which	O
was	O
evident	O
by	O
aberrant	O
Shh	B-GGP
expression	O
in	O
E15	O
.	O
5	O
embryonic	O
oral	O
epithelium	O
(	O
unpublished	O
data	O
)	O
.	O

It	O
should	O
be	O
noted	O
that	O
although	O
multiple	O
tooth	O
buds	O
were	O
histologically	O
visible	O
(	O
Figure	O
4O	O
and	O
4P	O
)	O
,	O
these	O
teeth	O
never	O
broke	O
out	O
and	O
the	O
KA	O
mutant	B-SO
mice	B-Taxon
appeared	O
toothless	O
.	O

This	O
unusual	O
severe	O
tooth	O
defect	O
is	O
unique	O
to	O
these	O
mutant	B-SO
mice	B-Taxon
.	O

In	O
addition	O
,	O
neither	O
of	O
the	O
two	O
transgenic	B-SO
mice	B-Taxon
was	O
postnatally	O
lethal	O
as	O
in	O
the	O
KA	O
mutant	B-SO
mice	B-Taxon
.	O

We	O
did	O
not	O
find	O
any	O
obvious	O
histopathological	O
abnormalities	O
in	O
the	O
internal	O
organs	O
of	O
KA	O
mice	B-Taxon
that	O
could	O
contribute	O
to	O
the	O
lethality	O
.	O

However	O
,	O
the	O
fact	O
that	O
all	O
the	O
mutants	B-SO
had	O
lower	O
weight	O
(	O
Figure	O
2F	O
)	O
with	O
hardly	O
any	O
evidence	O
of	O
solid	O
food	B-CHEBI
in	O
their	O
stomach	O
indicates	O
that	O
the	O
mutants	B-SO
might	O
have	O
died	O
of	O
starvation	O
.	O

Dermal	O
fat	O
was	O
reduced	O
in	O
the	O
mutant	B-SO
skin	O
,	O
possibly	O
as	O
a	O
consequence	O
of	O
poor	O
nutrition	O
caused	O
by	O
the	O
absence	O
of	O
teeth	O
.	O

Since	O
the	O
weight	O
loss	O
in	O
KA	O
mutants	B-SO
started	O
from	O
P8	O
-	O
P10	O
while	O
pups	O
were	O
still	O
nursed	O
by	O
their	O
mothers	O
,	O
starvation	O
due	O
to	O
lack	O
of	O
teeth	O
cannot	O
be	O
the	O
sole	O
cause	O
of	O
death	O
,	O
but	O
is	O
likely	O
to	O
be	O
a	O
contributing	O
factor	O
.	O

Absence	O
of	O
teeth	O
and	O
mammary	O
glands	O
have	O
been	O
observed	O
in	O
mice	B-Taxon
deficient	O
in	O
Lef1	B-GGP
and	O
ectopically	O
expressing	O
Dkk1	B-GGP
[	O
29	O
,	O
30	O
]	O
but	O
their	O
absence	O
was	O
due	O
to	O
the	O
block	O
in	O
development	O
before	O
the	O
bud	O
stage	O
.	O

Hence	O
,	O
neither	O
loss	O
nor	O
excess	O
of	O
tooth	O
bud	O
formation	O
allows	O
proper	O
development	O
of	O
teeth	O
for	O
mice	B-Taxon
to	O
have	O
a	O
healthy	O
diet	O
and	O
normal	O
life	O
.	O

Mechanistic	O
studies	O
to	O
understand	O
how	O
increased	O
levels	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
leads	O
to	O
altered	O
skin	O
and	O
tooth	O
phenotypes	O
are	O
under	O
way	O
.	O

Apc	B-GGP
and	O
Thymus	O
Organogenesis	O

In	O
this	O
study	O
,	O
we	O
observed	O
that	O
K14	B-GGP
-	O
driven	O
loss	O
of	O
Apc	B-GGP
resulted	O
in	O
a	O
small	O
thymus	O
with	O
severe	O
squamous	O
metaplasia	O
leading	O
to	O
the	O
formation	O
of	O
numerous	O
pyogranuloma	O
and	O
loss	O
of	O
proper	O
meshwork	O
structure	O
for	O
thymocyte	O
maturation	O
,	O
rendering	O
the	O
mice	B-Taxon
athymic	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
in	O
normal	O
adult	O
thymus	O
K14	B-GGP
expression	O
is	O
found	O
together	O
with	O
K5	B-GGP
in	O
the	O
stellate	O
medullary	O
TECs	O
,	O
but	O
not	O
in	O
association	O
with	O
K5	B-GGP
+	O
TECs	O
in	O
the	O
cortex	O
or	O
at	O
the	O
cortico	O
-	O
medullary	O
junction	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
demonstrated	O
that	O
K14	B-GGP
+	O
TECs	O
do	O
not	O
coexpress	O
K8	B-GGP
;	O
hence	O
,	O
there	O
are	O
two	O
distinct	O
medullary	O
subsets	O
,	O
namely	O
a	O
K8	B-GGP
-	O
K14	B-GGP
+	O
stellate	O
subset	O
and	O
a	O
K8	B-GGP
+	O
K14	B-GGP
-	O
globular	O
subset	O
[	O
32	O
]	O
.	O

In	O
agreement	O
with	O
the	O
previous	O
results	O
,	O
in	O
P3	O
normal	O
thymus	O
K14	B-GGP
expression	O
was	O
restricted	O
to	O
stellate	O
medullary	O
TECs	O
(	O
Figure	O
6D	O
)	O
,	O
whereas	O
K8	B-GGP
expression	O
was	O
found	O
throughout	O
the	O
TECs	O
(	O
unpublished	O
data	O
)	O
.	O

We	O
could	O
not	O
clarify	O
whether	O
these	O
two	O
keratins	O
were	O
coexpressed	O
in	O
the	O
same	O
TECs	O
without	O
double	O
-	O
staining	O
.	O

There	O
were	O
individual	O
differences	O
among	O
mutants	B-SO
and	O
these	O
were	O
prominently	O
reflected	O
in	O
the	O
histological	O
abnormalities	O
of	O
the	O
thymus	O
at	O
P3	O
,	O
but	O
as	O
the	O
older	O
surviving	O
mutants	B-SO
all	O
showed	O
the	O
same	O
histopathologies	O
of	O
the	O
thymus	O
,	O
the	O
mutant	B-SO
thymi	O
eventually	O
seem	O
to	O
result	O
in	O
the	O
same	O
fate	O
.	O

It	O
is	O
unclear	O
when	O
K14	B-GGP
-	O
cre	O
induction	O
actually	O
takes	O
place	O
in	O
the	O
mutant	B-SO
thymus	O
,	O
but	O
as	O
the	O
population	O
of	O
cells	B-CL
showing	O
a	O
strong	O
nuclear	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
staining	O
as	O
well	O
as	O
the	O
cells	B-CL
expressing	O
K14	B-GGP
were	O
small	O
and	O
thymic	O
epithelial	O
compartments	O
still	O
existed	O
in	O
a	O
mild	O
P3	O
mutant	B-SO
thymus	O
(	O
Figure	O
6E	O
and	O
6F	O
)	O
,	O
it	O
seems	O
that	O
initial	O
differentiation	O
to	O
medullary	O
and	O
cortical	O
TECs	O
and	O
thymocyte	O
colonization	O
have	O
already	O
taken	O
place	O
prior	O
to	O
the	O
major	O
effects	O
of	O
K14	B-GGP
-	O
driven	O
Apc	B-GGP
loss	O
.	O

However	O
,	O
cells	B-CL
with	O
nuclear	B-GO
beta	B-GGP
-	I-GGP
catenin	I-GGP
and	O
K8	B-GGP
+	O
K14	B-GGP
+	O
double	O
-	O
positive	O
epithelial	B-CL
cells	I-CL
increased	O
subsequently	O
,	O
associated	O
with	O
active	O
proliferation	O
in	O
the	O
latter	O
group	O
of	O
cells	B-CL
and	O
loss	O
of	O
TEC	O
compartments	O
.	O

With	O
age	O
,	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
expression	O
pattern	O
became	O
more	O
diffuse	O
and	O
fewer	O
epithelial	B-CL
cells	I-CL
showed	O
nuclear	B-GO
localization	O
but	O
K8	B-GGP
+	O
K14	B-GGP
+	O
cells	B-CL
remained	O
,	O
forming	O
concentric	O
structures	O
of	O
epithelial	B-CL
cells	I-CL
filled	O
with	O
hard	O
keratin	O
deposits	O
and	O
infiltrated	O
with	O
vast	O
number	O
of	O
neutrophils	B-CL
and	O
macrophages	B-CL
.	O

Only	O
a	O
few	O
epithelial	B-CL
cells	I-CL
were	O
dividing	O
and	O
hardly	O
any	O
thymocytes	O
were	O
present	O
by	O
this	O
time	O
.	O

These	O
results	O
suggest	O
that	O
with	O
the	O
deletion	B-SO
of	O
Apc	B-GGP
in	O
TECs	O
,	O
stabililization	O
and	O
nuclear	B-GO
localization	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
took	O
place	O
and	O
subsequently	O
these	O
cells	B-CL
differentiated	O
into	O
keratinocytes	B-CL
that	O
expressed	O
both	O
K14	B-GGP
and	O
K8	B-GGP
,	O
similar	O
to	O
the	O
basal	B-CL
cells	I-CL
of	O
the	O
skin	O
,	O
instead	O
of	O
TEC	O
subsets	O
.	O

The	O
expansion	O
and	O
differentiation	O
of	O
these	O
keratinocytes	B-CL
lead	O
to	O
loss	O
of	O
proper	O
thymic	O
epithelial	O
compartments	O
and	O
in	O
turn	O
produced	O
and	O
deposited	O
the	O
hard	O
keratins	O
that	O
consequently	O
caused	O
vast	O
amount	O
of	O
neutrophils	B-CL
and	O
macrophages	B-CL
to	O
infiltrate	O
the	O
thymus	O
.	O

These	O
aberrant	O
epithelial	O
structures	O
eventually	O
have	O
overtaken	O
the	O
whole	O
of	O
the	O
thymus	O
and	O
driven	O
out	O
the	O
colonized	O
thymocytes	O
.	O

K14	B-GGP
-	O
driven	O
loss	O
of	O
Apc	B-GGP
and	O
subsequent	O
constitutive	O
expression	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
TECs	O
have	O
therefore	O
misdirected	O
them	O
to	O
wrong	O
epithelial	B-CL
cell	I-CL
fate	O
,	O
not	O
allowing	O
proper	O
differentiation	O
to	O
either	O
cortical	O
or	O
medullary	O
TECs	O
,	O
which	O
is	O
essential	O
for	O
normal	O
thymocyte	O
development	O
.	O

This	O
is	O
not	O
only	O
evident	O
from	O
the	O
lack	O
of	O
dividing	O
thymocytes	O
in	O
the	O
mutant	B-SO
thymus	O
by	O
P13	O
,	O
but	O
also	O
by	O
the	O
differential	O
expression	O
pattern	O
of	O
keratins	O
,	O
which	O
were	O
more	O
skin	O
-	O
like	O
than	O
TEC	O
-	O
like	O
.	O

The	O
importance	O
of	O
Apc	B-GGP
function	O
in	O
thymic	O
development	O
has	O
been	O
demonstrated	O
by	O
thymocyte	O
-	O
specific	O
loss	O
of	O
Apc	B-GGP
by	O
crossing	O
a	O
different	O
strain	O
of	O
Apc	B-GGP
conditional	O
mice	B-Taxon
and	O
LckCre	O
transgenic	B-SO
mice	B-Taxon
[	O
33	O
]	O
.	O

Here	O
,	O
by	O
K14	B-GGP
-	O
driven	O
TEC	O
-	O
specific	O
loss	O
of	O
Apc	B-GGP
,	O
we	O
have	O
demonstrated	O
its	O
importance	O
in	O
thymus	O
development	O
not	O
only	O
in	O
thymocytes	O
but	O
also	O
in	O
TECs	O
.	O

It	O
is	O
of	O
interest	O
that	O
dental	O
abnormalities	O
,	O
such	O
as	O
supernumerary	O
and	O
impacted	O
teeth	O
similar	O
to	O
those	O
observed	O
in	O
our	O
mutant	B-SO
mice	B-Taxon
,	O
are	O
frequently	O
seen	O
in	O
patients	O
with	O
Gardner	O
'	O
s	O
syndrome	O
,	O
carriers	O
of	O
APC	B-GGP
germline	O
mutation	B-SO
[	O
6	O
]	O
.	O

The	O
importance	O
of	O
odonto	O
-	O
stomatological	O
examinations	O
should	O
hence	O
be	O
pointed	O
out	O
as	O
a	O
means	O
of	O
reaching	O
a	O
presumptive	O
diagnosis	O
,	O
whose	O
confirmation	O
is	O
vital	O
to	O
the	O
patient	O
.	O

Further	O
characterization	O
of	O
the	O
mechanism	O
of	O
such	O
developmental	O
defects	O
using	O
our	O
mouse	B-Taxon
model	O
should	O
provide	O
important	O
insights	O
into	O
Apc	B-GGP
function	O
in	O
multiple	O
organ	O
systems	O
and	O
to	O
give	O
better	O
insights	O
into	O
potential	O
adverse	O
events	O
in	O
human	B-Taxon
subjects	O
.	O

In	O
conclusion	O
,	O
we	O
have	O
shown	O
that	O
loss	O
of	O
Apc	B-GGP
in	O
K14	B-GGP
-	O
expressing	O
embryonic	O
cells	B-CL
causes	O
aberrant	O
morphogenesis	O
in	O
various	O
skin	O
appendages	O
,	O
including	O
hair	O
follicles	O
and	O
teeth	O
,	O
and	O
abnormal	O
thymus	O
organogensis	O
.	O

Our	O
results	O
provide	O
genetic	B-SO
evidence	O
that	O
expression	O
of	O
Apc	B-GGP
is	O
essential	O
for	O
regulation	O
of	O
proper	O
cell	B-CL
fates	O
in	O
these	O
organs	O
that	O
require	O
epithelial	O
-	O
mesenchymal	O
interactions	O
.	O

Materials	O
and	O
Methods	O

Construction	O
of	O
targeting	O
vectors	B-SO
.	O

To	O
target	O
the	O
Apc	B-GGP
locus	B-SO
,	O
we	O
obtained	O
BAC	B-SO
clone	B-SO
RP23	O
-	O
233F17	O
that	O
contains	O
all	O
the	O
sequence	B-SO
of	O
Apc	B-GGP
except	O
for	O
the	O
5	B-SO
'	I-SO
UTR	I-SO
and	O
exon	B-SO
1	O
.	O

Using	O
a	O
recombineering	O
-	O
based	O
method	O
for	O
generating	O
conditional	O
mutations	B-SO
[	O
12	O
,	O
13	O
]	O
,	O
subcloning	O
of	O
BAC	B-SO
and	O
further	O
modifications	B-SO
were	O
conducted	O
.	O

The	O
genomic	B-SO
sequence	I-SO
encompassing	O
Apc	B-GGP
exons	B-SO
11	O
to	O
15	O
was	O
first	O
subcloned	O
into	O
pBR322	O
vector	B-SO
,	O
and	O
then	O
a	O
loxP	B-SO
site	I-SO
was	O
introduced	B-SO
into	O
intron	B-SO
13	O
followed	O
by	O
loxP	B-SO
-	O
FRT	B-SO
-	O
PGKneor	O
-	O
FRT	B-SO
selection	O
cassette	B-SO
into	O
intron14	O
of	O
the	O
Apc	B-GGP
gene	B-SO
(	O
Figure	O
1A	O
)	O
.	O

Generation	O
of	O
ApcCKO	O
ES	O
cells	B-CL
and	O
mice	B-Taxon
.	O

The	O
linearized	O
targeting	O
vectors	B-SO
were	O
electroporated	O
into	O
129	O
/	O
S	O
-	O
derived	O
ES	O
cells	B-CL
,	O
WW6	O
cells	B-CL
[	O
15	O
]	O
.	O

All	O
candidate	O
G418	O
-	O
resistant	O
ES	O
clones	O
were	O
screened	O
by	O
long	O
-	O
range	O
gene	B-SO
-	O
specific	O
PCR	O
using	O
Expand	O
Long	O
Template	O
PCR	O
System	O
(	O
Roche	O
,	O
Indianapolis	O
,	O
Indiana	O
,	O
United	O
States	O
)	O
,	O
followed	O
by	O
sequencing	O
to	O
validate	O
the	O
correct	O
insertion	B-SO
of	O
the	O
single	O
loxP	B-SO
site	I-SO
and	O
the	O
selection	O
cassette	B-SO
.	O

Two	O
ES	O
clones	O
with	O
correct	O
ApcCKON	O
/	O
+	B-SO
modification	B-SO
were	O
injected	O
into	O
C57BL	O
/	O
6J	O
blastocysts	O
,	O
after	O
which	O
chimeric	O
mice	B-Taxon
with	O
high	O
levels	O
of	O
ES	O
cell	B-CL
contribution	O
were	O
backcrossed	O
to	O
C57BL	O
/	O
6J	O
females	O
to	O
produce	O
heterozygous	O
F1	O
offspring	O
.	O

The	O
genomic	B-SO
DNA	I-SO
samples	O
obtained	O
from	O
the	O
tail	O
of	O
F1	O
offspring	O
were	O
subsequently	O
analyzed	O
by	O
Southern	O
blot	O
analysis	O
to	O
further	O
confirm	O
the	O
correct	O
homologous	O
recombination	O
.	O

By	O
crossing	O
the	O
heterozygous	O
mice	B-Taxon
to	O
FLPe	O
deleter	O
mice	B-Taxon
[	O
34	O
]	O
,	O
PGKneor	O
cassette	B-SO
was	O
deleted	B-SO
in	O
the	O
germline	O
by	O
FRT	B-SO
-	O
mediated	O
recombination	O
to	O
generate	O
mice	B-Taxon
with	O
the	O
final	O
ApcCKO	O
allele	B-SO
.	O

ApcCKO	O
heterozygous	O
mice	B-Taxon
were	O
crossed	O
together	O
to	O
generate	O
homozygous	O
mice	B-Taxon
,	O
and	O
the	O
homozygous	O
offspring	O
were	O
interbred	O
for	O
maintenance	O
.	O

Generation	O
of	O
Apc	O
Delta	O
580	O
mice	B-Taxon
.	O

ApcCKO	O
heterozygote	O
mice	B-Taxon
were	O
crossed	O
with	O
Cre	O
deleter	O
mice	B-Taxon
,	O
EIIA	O
-	O
cre	O
transgenic	B-SO
mice	B-Taxon
that	O
express	O
Cre	O
in	O
early	O
embryo	O
[	O
35	O
]	O
,	O
to	O
knockout	O
the	O
Apc	B-GGP
allele	B-SO
in	O
the	O
germline	O
,	O
consequently	O
creating	O
a	O
knockout	O
strain	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
resultant	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
mice	B-Taxon
were	O
maintained	O
by	O
backcrossing	O
to	O
C57BL	O
/	O
6J	O
females	O
.	O

Generation	O
of	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
mice	B-Taxon
.	O

The	O
mice	B-Taxon
analyzed	O
in	O
this	O
study	O
were	O
generated	O
by	O
crossing	O
ApcCKO	O
heterozygote	O
mice	B-Taxon
of	O
the	O
F1	O
generation	O
(	O
C57BL	O
/	O
6J	O
x	O
129	O
/	O
S	O
background	O
)	O
with	O
K14	B-GGP
-	O
cre	O
transgenic	B-SO
mice	B-Taxon
(	O
FVB	O
background	O
)	O
.	O

K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-SO
male	O
mice	B-Taxon
thus	O
generated	O
were	O
then	O
crossed	O
with	O
ApcCKO	O
/	O
CKO	O
females	O
to	O
generate	O
homozygous	O
and	O
heterozygous	O
ApcCKO	O
offspring	O
either	O
with	O
or	O
without	O
K14	B-GGP
-	O
cre	O
.	O

The	O
mice	B-Taxon
were	O
intercrossed	O
thereafter	O
for	O
maintenance	O
.	O

Genotyping	O
of	O
mice	B-Taxon
.	O

Genomic	B-SO
DNA	I-SO
from	O
tips	O
of	O
mouse	B-Taxon
tails	O
obtained	O
at	O
~	O
10	O
d	O
of	O
age	O
was	O
genotyped	O
in	O
a	O
single	O
PCR	O
reaction	O
with	O
the	O
following	O
primers	B-SO
:	O
Apc	B-GGP
-	O
Int13F2	O
(	O
GAGAAACCCTGTCTCGAAAAAA	O
)	O
and	O
Apc	B-GGP
-	O
Int13R2	O
(	O
AGTGCTGTTTCTATGAGTCAAC	O
)	O
,	O
resulting	O
in	O
320	O
-	O
bp	B-SO
and	O
430	O
-	O
bp	B-SO
products	B-SO
from	O
the	O
wild	B-SO
-	I-SO
type	I-SO
and	O
conditional	O
ApcCKO	O
allele	B-SO
,	O
respectively	O
.	O

For	O
the	O
detection	O
of	O
Cre	O
-	O
mediated	O
deleted	B-SO
Apc	B-GGP
allele	B-SO
,	O
Apc	O
Delta	O
580	O
,	O
the	O
primer	B-SO
Apc	B-GGP
-	O
Int14R4	O
(	O
TTGGCAGACTGTGTATATAAGC	O
)	O
in	O
combination	O
with	O
Apc	B-GGP
-	O
Int13F2	O
resulted	O
in	O
500	O
-	O
bp	B-SO
product	B-SO
.	O

Primers	B-SO
Cre	O
-	O
F1	O
(	O
TCCAATTTACTGACCGTACACC	O
)	O
and	O
Cre	O
-	O
R1	O
(	O
CCGACGATGAAGCATGTTTAG	O
)	O
were	O
used	O
for	O
detection	O
of	O
cre	O
transgene	B-SO
in	O
the	O
germline	O
,	O
resulting	O
in	O
300	O
-	O
bp	B-SO
products	B-SO
.	O

Amplification	O
was	O
performed	O
in	O
a	O
25	O
-	O
mu	O
l	O
volume	O
containing	O
15	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
(	O
pH	O
8	O
.	O
3	O
)	O
,	O
50	O
mM	O
KCl	B-CHEBI
,	O
2	O
.	O
5	O
mM	O
MgCl2	B-CHEBI
,	O
0	O
.	O
2	O
mM	O
dNTP	B-CHEBI
,	O
0	O
.	O
2	O
mu	O
M	O
of	O
each	O
primer	B-SO
,	O
and	O
1	O
.	O
25	O
U	O
of	O
AmpliTaq	O
Gold	B-CHEBI
(	O
Applied	O
Biosystems	O
,	O
Foster	O
City	O
,	O
California	O
,	O
United	O
States	O
)	O
.	O

The	O
reactions	O
were	O
heated	O
for	O
10	O
min	O
at	O
94	O
degrees	O
C	O
to	O
heat	O
-	O
activate	O
the	O
enzyme	B-SO
followed	O
by	O
30	O
PCR	O
cycles	O
at	O
94	O
degrees	O
C	O
for	O
30	O
s	O
,	O
58	O
degrees	O
C	O
for	O
30	O
s	O
,	O
and	O
72	O
degrees	O
C	O
for	O
45	O
s	O
,	O
followed	O
by	O
the	O
final	O
extension	O
for	O
5	O
min	O
at	O
72	O
degrees	O
C	O
.	O

Skin	O
permeability	O
assay	O
.	O

Unfixed	O
and	O
freshly	O
isolated	O
E18	O
.	O
5	O
embryos	O
were	O
rinsed	O
in	O
PBS	O
and	O
then	O
submerged	O
in	O
X	O
-	O
gal	O
reaction	O
mix	O
at	O
pH	O
4	O
.	O
5	O
(	O
100	O
mM	O
NaPO4	B-CHEBI
,	O
1	O
.	O
3	O
mM	O
MgCl2	B-CHEBI
,	O
3	O
mM	O
K3Fe	B-CHEBI
(	I-CHEBI
CN	I-CHEBI
)	I-CHEBI
6	I-CHEBI
,	O
3	O
mM	O
K4Fe	B-CHEBI
(	I-CHEBI
CN	I-CHEBI
)	I-CHEBI
6	I-CHEBI
,	O
and	O
1	O
mg	O
/	O
ml	O
X	O
-	O
gal	O
)	O
at	O
room	O
temperature	O
overnight	O
[	O
36	O
]	O
.	O

At	O
this	O
pH	O
in	O
the	O
absence	O
of	O
epidermal	O
barrier	O
,	O
the	O
solution	O
penetrates	O
epidermis	O
and	O
an	O
endogenous	O
beta	O
-	O
galactosidase	O
-	O
like	O
activity	O
catalyzes	O
production	O
of	O
a	O
blue	O
precipitate	O
.	O

After	O
staining	O
,	O
embryos	O
were	O
washed	O
twice	O
in	O
PBS	O
,	O
fixed	O
overnight	O
at	O
4	O
degrees	O
C	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
and	O
were	O
photographed	O
using	O
a	O
35	O
mm	O
Nikon	O
digital	O
camera	O
.	O

Skeletal	O
preparations	O
.	O

The	O
skinned	O
and	O
eviscerated	O
bodies	O
of	O
the	O
oldest	O
surviving	O
KA	O
mutants	B-SO
(	O
P16	O
-	O
P17	O
)	O
and	O
their	O
age	O
-	O
matched	O
littermates	O
were	O
placed	O
into	O
1	O
%	O
potassium	B-CHEBI
hydroxide	I-CHEBI
(	O
KOH	B-CHEBI
)	O
for	O
5	O
d	O
.	O

The	O
bodies	O
were	O
transferred	O
into	O
a	O
fresh	O
solution	O
of	O
1	O
%	O
KOH	B-CHEBI
containing	O
a	O
few	O
drops	O
of	O
0	O
.	O
5	O
%	O
alizarin	B-CHEBI
red	I-CHEBI
S	O
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Missouri	O
,	O
United	O
States	O
)	O
and	O
left	O
for	O
another	O
5	O
d	O
.	O

The	O
stained	O
bodies	O
were	O
stored	O
in	O
glycerin	O
and	O
viewed	O
under	O
a	O
dissection	O
microscope	O
.	O

Analysis	O
for	O
tissue	O
-	O
specific	O
recombination	O
.	O

Genotype	B-SO
/	O
tissue	O
-	O
specific	O
recombination	O
of	O
the	O
conditional	O
allele	B-SO
was	O
examined	O
by	O
both	O
PCR	O
and	O
RT	O
-	O
PCR	O
.	O

DNA	B-SO
samples	O
extracted	O
from	O
various	O
tissues	O
collected	O
at	O
the	O
time	O
of	O
autopsy	O
were	O
examined	O
by	O
genotyping	O
PCR	O
as	O
described	O
.	O

RNA	B-SO
extracted	O
from	O
various	O
tissue	O
homogenates	O
in	O
Trizol	O
reagent	B-CHEBI
were	O
examined	O
for	O
expression	O
of	O
wild	B-SO
-	I-SO
type	I-SO
and	O
truncated	O
Apc	B-GGP
alleles	B-SO
by	O
SuperScript	O
One	O
-	O
Step	O
RT	O
-	O
PCR	O
with	O
Platinum	B-CHEBI
Taq	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
following	O
manufacturer	O
'	O
s	O
protocol	O
.	O

Approximately	O
200	O
ng	O
of	O
total	O
RNA	B-SO
from	O
either	O
skin	O
,	O
liver	O
,	O
or	O
thymus	O
from	O
each	O
genotype	B-SO
was	O
reverse	O
-	O
transcribed	O
using	O
primers	B-SO
Apc	B-GGP
-	O
F546	O
(	O
TGAGGAATTTGTCTTGGCGAG	O
)	O
and	O
Apc	B-GGP
-	O
R721	O
(	O
GCACTTCCCATGGCAATCATT	O
)	O
,	O
resulting	O
in	O
528	O
-	O
bp	B-SO
and	O
313	O
-	O
bp	B-SO
products	B-SO
from	O
the	O
wild	B-SO
-	I-SO
type	I-SO
/	O
ApcCKO	O
alleles	B-SO
and	O
Apc	O
Delta	O
580	O
allele	B-SO
,	O
respectively	O
.	O

BrdU	O
labeling	O
.	O

Mice	B-Taxon
were	O
injected	O
intraperitoneally	O
with	O
approximately	O
50	O
mu	O
g	O
/	O
g	O
body	O
weight	O
of	O
BrdU	O
(	O
Sigma	O
)	O
dissolved	O
in	O
PBS	O
2	O
h	O
before	O
their	O
death	O
.	O

Tissue	O
samples	O
were	O
fixed	O
in	O
Bouin	O
'	O
s	O
and	O
processed	O
as	O
described	O
below	O
.	O

Histological	O
and	O
immunochemical	O
analysis	O
.	O

Mutant	B-SO
mice	B-Taxon
and	O
age	O
-	O
matching	O
littermates	O
were	O
humanely	O
killed	O
at	O
various	O
ages	O
by	O
CO2	B-CHEBI
inhalation	O
.	O

Mice	B-Taxon
were	O
skinned	O
and	O
pieces	O
of	O
skin	O
were	O
either	O
snap	O
-	O
frozen	O
in	O
liquid	O
nitrogen	B-CHEBI
or	O
immediately	O
homogenized	O
in	O
Trizol	O
reagent	B-CHEBI
and	O
stored	O
at	O
-	O
80	O
degrees	O
C	O
until	O
molecular	B-CHEBI
analysis	O
,	O
or	O
fixed	O
flat	O
on	O
a	O
piece	O
of	O
paper	O
towel	O
in	O
Bouin	O
'	O
s	O
solution	O
for	O
histological	O
and	O
immunohistochemical	O
examinations	O
.	O

The	O
mice	B-Taxon
were	O
then	O
dissected	O
for	O
gross	O
examination	O
,	O
various	O
tissues	O
were	O
similarly	O
collected	O
for	O
future	O
molecular	B-CHEBI
analyses	O
,	O
and	O
then	O
the	O
whole	O
body	O
was	O
fixed	O
in	O
Bouin	O
'	O
s	O
solution	O
.	O

The	O
samples	O
were	O
then	O
submitted	O
to	O
Rodent	B-Taxon
Histopathological	O
Core	O
for	O
processing	O
and	O
histopathological	O
examinations	O
.	O

For	O
immunohistochemistry	O
,	O
5	O
-	O
mu	O
m	O
paraffin	O
-	O
embedded	O
tissue	O
sections	O
were	O
deparafinized	O
in	O
xylene	B-CHEBI
,	O
followed	O
by	O
alcohol	B-CHEBI
rehydration	O
.	O

After	O
quenching	O
endogenous	O
peroxidases	O
in	O
3	O
%	O
H2O2	B-CHEBI
in	O
methanol	B-CHEBI
,	O
the	O
slides	O
were	O
rinsed	O
in	O
distilled	O
water	B-CHEBI
,	O
and	O
an	O
antigen	O
retrieval	O
step	O
was	O
carried	O
out	O
in	O
a	O
microwave	O
oven	O
for	O
a	O
total	O
of	O
10	O
min	O
in	O
preheated	O
citrate	B-CHEBI
buffer	O
(	O
pH	O
6	O
.	O
0	O
)	O
.	O

The	O
slides	O
were	O
then	O
incubated	O
with	O
primary	O
antibodies	B-GO
at	O
room	O
temperature	O
overnight	O
.	O

Antibodies	B-GO
used	O
were	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
(	O
BD	O
Transduction	O
Lab	O
,	O
San	O
Diego	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
keratins	B-GGP
1	I-GGP
,	I-GGP
5	I-GGP
,	I-GGP
6	I-GGP
,	I-GGP
14	I-GGP
,	O
involucrin	B-GGP
,	O
loricrin	B-GGP
(	O
Covance	O
,	O
Berkeley	O
,	O
California	O
,	O
United	O
States	O
)	O
,	O
keratin	B-GGP
8	I-GGP
(	O
Abcam	O
,	O
Cambridge	O
,	O
United	O
Kingdom	O
)	O
,	O
Ki67	B-GGP
(	O
Vector	O
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
United	O
States	O
)	O
and	O
BrdU	O
(	O
Roche	O
)	O
.	O

Biotinylated	O
secondary	O
antibodies	B-GO
(	O
donkey	B-Taxon
anti	O
-	O
rabbit	B-Taxon
and	O
goat	B-Taxon
anti	O
-	O
mouse	B-Taxon
IgG	O
,	O
1	O
:	O
250	O
;	O
Jackson	O
ImmunoResearch	O
,	O
West	O
Grove	O
,	O
Pennsylvania	O
,	O
United	O
States	O
)	O
,	O
followed	O
by	O
the	O
Vectastain	O
Elite	O
ABC	O
kit	O
(	O
Vector	O
Laboratories	O
)	O
were	O
used	O
for	O
detection	O
.	O

The	O
slides	O
were	O
stained	O
with	O
DAB	O
and	O
counterstained	O
with	O
Mayer	O
'	O
s	O
hematoxylin	O
.	O

In	O
situ	O
hybridization	O
.	O

Section	O
ISH	O
using	O
rat	B-GGP
Shh	I-GGP
probe	B-SO
[	O
37	O
]	O
and	O
whole	O
-	O
mount	O
ISH	O
using	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
probe	B-SO
[	O
38	O
]	O
were	O
performed	O
as	O
previously	O
described	O
[	O
39	O
,	O
40	O
]	O
.	O

Riboprobes	O
labeled	O
with	O
DIG	O
were	O
detected	O
with	O
BM	O
purple	O
AP	O
substrate	O
precipitation	O
solution	O
(	O
Roche	O
)	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Multiple	O
Intestinal	O
Neoplasia	O
in	O
Apc	O
Delta	O
580	O
Mice	B-Taxon

(	O
A	O
)	O
A	O
representative	O
appearance	O
of	O
small	O
intestine	O
of	O
4	O
-	O
month	O
-	O
old	O
mouse	B-Taxon
.	O

Scale	O
bar	O
,	O
1	O
.	O
5	O
mm	O
.	O

(	O
B	O
)	O
Histological	O
analysis	O
of	O
longitudinal	O
section	O
of	O
small	O
intestine	O
shown	O
in	O
(	O
A	O
)	O
by	O
H	O
&	O
E	O
staining	O
.	O

Scale	O
bar	O
,	O
100	O
mu	O
m	O
.	O

(	O
C	O
)	O
The	O
typical	O
histopathological	O
appearance	O
of	O
an	O
adenoma	O
shown	O
in	O
(	O
B	O
)	O
.	O

Scale	O
bar	O
,	O
20	O
mu	O
m	O
.	O

(	O
621	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Skin	O
Permeability	O
Assay	O
and	O
Neonatal	O
Mice	B-Taxon

(	O
A	O
)	O
Skin	O
permeability	O
assay	O
of	O
E18	O
.	O
5	O
embryos	O
.	O

Both	O
normal	O
(	O
N	O
)	O
and	O
KA	O
mutant	B-SO
(	O
M	B-SO
)	O
embryos	O
can	O
exclude	O
the	O
blue	O
dye	B-CHEBI
at	O
this	O
age	O
,	O
showing	O
no	O
defects	O
in	O
skin	O
barrier	O
function	O
.	O

Note	O
slight	O
pigmentations	O
in	O
pinnnae	O
and	O
"	O
birthmark	O
"	O
in	O
the	O
forehead	O
of	O
mutant	B-SO
embryo	O
(	O
B	O
)	O
,	O
which	O
are	O
present	O
at	O
P1	O
(	O
C	O
)	O
,	O
and	O
become	O
prominent	O
as	O
they	O
grow	O
.	O

(	O
749	O
KB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Immunochemical	O
Examination	O
of	O
P13	O
Normal	O
and	O
Mutant	B-SO
Thymi	O

(	O
A	O
-	O
E	O
)	O
P13	O
normal	O
thymus	O
.	O

(	O
F	O
-	O
K	O
)	O
P13	O
mutant	B-SO
thymus	O
.	O

Stained	O
with	O
K8	B-GGP
(	O
A	O
)	O
,	O
(	O
D	O
)	O
,	O
(	O
F	O
)	O
,	O
(	O
I	O
)	O
,	O
K1	B-GGP
(	O
B	O
)	O
,	O
(	O
E	O
)	O
,	O
(	O
G	O
)	O
,	O
(	O
J	O
)	O
,	O
and	O
involucrin	B-GGP
(	O
C	O
)	O
,	O
(	O
H	O
)	O
,	O
(	O
K	O
)	O
.	O

Scale	O
bars	O
,	O
100	O
mu	O
m	O
for	O
(	O
A	O
-	O
C	O
)	O
,	O
(	O
F	O
-	O
H	O
)	O
,	O
(	O
J	O
-	O
K	O
)	O
and	O
20	O
mu	O
m	O
for	O
(	O
D	O
-	O
E	O
)	O
,	O
(	O
I	O
)	O
.	O

Note	O
the	O
lack	O
of	O
involucrin	B-GGP
staining	O
in	O
normal	O
thymus	O
but	O
varying	O
degree	O
of	O
positive	O
cells	B-CL
in	O
mutant	B-SO
thymus	O
.	O

(	O
6	O
.	O
4	O
MB	O
PPT	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
GenBank	O
(	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
)	O
accession	O
numbers	O
for	O
the	O
genes	B-SO
and	O
gene	B-SO
products	O
discussed	O
in	O
this	O
paper	O
are	O
Apc	B-GGP
(	O
NM	O
_	O
007462	O
)	O
,	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
(	O
NM	O
_	O
007614	O
)	O
,	O
AXIN	B-GGP
2	I-GGP
(	O
NM	O
_	O
004655	O
)	O
,	O
plakoglobin	B-GGP
(	O
NM	O
_	O
002230	O
)	O
,	O
Asef	B-GGP
(	O
NM	O
_	O
015320	O
)	O
,	O
kinesin	B-GGP
superfamily	I-GGP
-	I-GGP
associated	I-GGP
protein	I-GGP
3	I-GGP
(	O
NM	O
_	O
014970	O
)	O
,	O
EB1	B-GGP
(	O
NM	O
_	O
012325	O
)	O
,	O
human	B-GGP
homolog	I-GGP
of	I-GGP
Drosophila	I-GGP
Discs	I-GGP
large	I-GGP
(	O
U13897	O
)	O
,	O
Lef1	B-GGP
(	O
NM	O
_	O
010703	O
)	O
,	O
Dkk1	B-GGP
(	O
NM	O
_	O
010051	O
)	O
,	O
K1	B-GGP
(	O
NM	O
_	O
008473	O
)	O
,	O
K5	B-GGP
(	O
NM	O
_	O
027011	O
)	O
,	O
K6	B-GGP
(	O
NM	O
_	O
008476	O
)	O
,	O
K8	B-GGP
(	O
NM	O
_	O
031170	O
)	O
,	O
K14	B-GGP
(	O
NM	O
_	O
016958	O
)	O
,	O
involucrin	B-GGP
(	O
NM	O
_	O
008412	O
)	O
,	O
loricrin	B-GGP
(	O
NM	O
_	O
008508	O
)	O
,	O
and	O
Shh	B-GGP
(	O
NM	O
_	O
009170	O
)	O
.	O

Abbreviations	O

APC	B-GGP
-	O
adenomatous	B-GGP
polyposis	I-GGP
coli	I-GGP

CKO	O
-	O
conditional	O
knockout	O

E	O
-	O
embryonic	O
day	O

ES	O
-	O
embryonic	O
stem	O

FAP	O
-	O
familial	O
adenomatous	O
polyposis	O

FRT	B-SO
-	O
FLP	B-SO
recognition	I-SO
target	I-SO

ISH	O
-	O
in	O
situ	O
hybridization	O

K14	B-GGP
-	O
keratin	B-GGP
14	I-GGP

ORS	O
-	O
outer	O
root	O
sheath	O

P	O
-	O
postnatal	O
day	O

TEC	O
-	O
thymic	O
epithelial	B-CL
cell	I-CL

Figures	O
and	O
Tables	O

Figure	O
1	O

Generation	O
of	O
the	O
Conditional	O
Apc	B-GGP
Allele	B-SO

(	O
A	O
)	O
Schematic	O
diagram	O
of	O
exons	B-SO
14	O
and	O
15	O
of	O
the	O
mouse	B-GGP
Apc	I-GGP
gene	B-SO
,	O
the	O
targeting	O
vector	B-SO
,	O
and	O
the	O
resulting	O
conditional	O
allele	B-SO
with	O
2	O
LoxP	B-SO
sites	I-SO
sandwiching	O
the	O
exon	B-SO
14	O
.	O

The	O
PGK	O
-	O
neomycin	O
cassette	B-SO
was	O
inserted	B-SO
within	O
intron	B-SO
14	O
by	O
recombineering	O
technique	O
.	O

This	O
cassette	B-SO
is	O
sandwiched	B-SO
by	O
2	O
FRT	B-SO
sites	I-SO
that	O
could	O
be	O
removed	B-SO
by	O
crossing	O
to	O
FLPe	O
-	O
expressing	O
mice	B-Taxon
.	O

Positions	B-SO
of	O
PCR	O
primers	B-SO
used	O
for	O
genotyping	O
PCR	O
(	O
F2	O
,	O
R2	O
,	O
R4	O
)	O
and	O
RT	O
-	O
PCR	O
(	O
F546	O
and	O
R721	O
)	O
are	O
indicated	O
.	O

Positions	B-SO
of	O
probe	B-SO
used	O
for	O
Southern	O
blot	O
analysis	O
with	O
NdeI	O
sites	B-SO
are	O
also	O
shown	O
.	O

Upon	O
Cre	O
-	O
mediated	O
recombination	O
,	O
exon	B-SO
14	O
is	O
removed	B-SO
and	O
leads	O
to	O
truncated	O
Apc	B-GGP
protein	B-CHEBI
,	O
of	O
which	O
the	O
first	O
580	O
aa	B-CHEBI
correspond	O
to	O
the	O
normal	O
.	O

(	O
B	O
)	O
Southern	O
blot	O
analysis	O
of	O
NdeI	O
-	O
digested	O
genomic	B-SO
tail	I-SO
DNA	I-SO
isolated	O
from	O
F1	O
mice	B-Taxon
of	O
various	O
Apc	B-GGP
mouse	B-Taxon
lines	O
(	O
ApcCKON	O
,	O
Apc	O
Delta	O
580	O
)	O
,	O
hybridized	O
to	O
a	O
600	O
-	O
bp	B-SO
probe	B-SO
.	O

Tail	O
genomic	B-SO
DNA	I-SO
from	O
ApcCKON	O
F1	O
mice	B-Taxon
derived	O
from	O
a	O
modified	B-SO
ES	O
clone	O
showed	O
a	O
12	O
-	O
kb	O
band	O
for	O
the	O
ApcCKON	O
allele	B-SO
and	O
a	O
10	O
-	O
kb	O
band	O
for	O
the	O
wild	B-SO
-	I-SO
type	I-SO
allele	B-SO
,	O
whereas	O
genomic	B-SO
DNA	I-SO
from	O
the	O
Apc	O
Delta	O
580	O
mouse	B-Taxon
was	O
heterozygous	O
for	O
the	O
Apc	O
Delta	O
580	O
allele	B-SO
(	O
9	O
.	O
2	O
-	O
kb	O
band	O
)	O
.	O

(	O
C	O
)	O
Kaplan	O
-	O
Meier	O
survival	O
plot	O
of	O
ApcCKO	O
/	O
+	B-SO
mice	B-Taxon
(	O
thin	O
solid	O
line	O
,	O
n	O
=	O
39	O
)	O
,	O
ApcCKO	O
/	O
CKO	O
mice	B-Taxon
(	O
thin	O
dotted	O
line	O
,	O
n	O
=	O
57	O
)	O
,	O
Apc	O
Delta	O
580	O
/	O
+	B-SO
mice	B-Taxon
(	O
solid	O
line	O
,	O
n	O
=	O
51	O
)	O
,	O
and	O
wild	B-SO
-	I-SO
type	I-SO
littermates	O
(	O
broken	O
line	O
,	O
n	O
=	O
21	O
)	O
.	O

Heterozygosity	O
of	O
the	O
Apc	O
Delta	O
580	O
allele	B-SO
led	O
to	O
a	O
significantly	O
shortened	O
survival	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
whereas	O
those	O
of	O
heterozygous	O
and	O
homozygous	O
ApcCKO	O
mice	B-Taxon
had	O
no	O
significant	O
difference	O
to	O
that	O
of	O
wild	B-SO
-	I-SO
type	I-SO
littermates	O
.	O

Figure	O
2	O

Postnatal	O
Mortality	O
and	O
Stunted	O
Growth	O
in	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
Mutant	B-SO
Mice	B-Taxon

Animals	B-Taxon
whose	O
genotype	B-SO
is	O
either	O
heterozygous	O
or	O
homozygous	O
for	O
the	O
wild	B-SO
-	I-SO
type	I-SO
Apc	B-GGP
allele	B-SO
are	O
referred	O
to	O
as	O
normal	O
(	O
N	O
)	O
;	O
those	O
whose	O
genotype	B-SO
are	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
and	O
show	O
the	O
presence	O
of	O
K14	B-GGP
-	O
cre	O
-	O
recombined	O
mutant	B-SO
Apc	B-GGP
allele	B-SO
are	O
called	O
mutant	B-SO
(	O
M	B-SO
)	O
.	O

(	O
A	O
)	O
Two	O
P3	O
mutant	B-SO
mice	B-Taxon
,	O
M1	O
and	O
M2	O
,	O
and	O
their	O
normal	O
littermates	O
,	O
showing	O
size	O
variation	O
among	O
mutants	B-SO
.	O

(	O
B	O
)	O
P8	O
mutant	B-SO
mouse	B-Taxon
(	O
right	O
)	O
and	O
a	O
normal	O
littermate	O
.	O

Note	O
sparseness	O
of	O
hair	O
coat	O
and	O
abnormal	O
ears	O
.	O

(	O
C	O
-	O
D	O
)	O
Vibrissae	O
of	O
whisker	O
pads	O
are	O
short	O
and	O
oddly	O
angled	O
in	O
a	O
P12	O
mutant	B-SO
mouse	B-Taxon
(	O
C	O
)	O
,	O
relative	O
to	O
control	O
(	O
D	O
)	O
.	O

Note	O
the	O
lack	O
of	O
incisors	O
in	O
the	O
mutant	B-SO
.	O

(	O
E	O
)	O
A	O
P17	O
mutant	B-SO
mouse	B-Taxon
(	O
right	O
)	O
with	O
its	O
littermate	O
.	O

Its	O
bare	O
forehead	O
,	O
dorsal	O
median	O
line	O
,	O
and	O
abnormal	O
ears	O
are	O
evident	O
.	O

(	O
F	O
)	O
Growth	O
curve	O
of	O
mutants	B-SO
and	O
normal	O
littermates	O
.	O

Mutants	B-SO
exhibit	O
stunted	O
growth	O
,	O
which	O
became	O
more	O
prominent	O
as	O
they	O
aged	O
,	O
and	O
weigh	O
significantly	O
less	O
than	O
littermates	O
from	O
P8	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

(	O
G	O
)	O
Comparison	O
of	O
mutant	B-SO
and	O
normal	O
thymus	O
from	O
P3	O
mice	B-Taxon
.	O

The	O
mutant	B-SO
thymus	O
(	O
left	O
)	O
is	O
dramatically	O
smaller	O
for	O
its	O
age	O
compared	O
to	O
the	O
normal	O
littermate	O
(	O
right	O
)	O
.	O

The	O
scale	O
bar	O
equals	O
1	O
mm	O
.	O

(	O
H	O
)	O
Skeletal	O
preparations	O
of	O
normal	O
(	O
left	O
)	O
and	O
mutant	B-SO
(	O
right	O
)	O
,	O
showing	O
differences	O
in	O
development	O
of	O
both	O
incisor	O
(	O
I	O
)	O
and	O
molar	O
(	O
M	O
)	O
teeth	O
.	O

Figure	O
3	O

Tissue	O
-	O
Specific	O
Detection	O
and	O
Expression	O
of	O
Deleted	B-SO
Apc	B-GGP
Alleles	B-SO

(	O
A	O
)	O
Tissue	O
-	O
specific	O
genotyping	O
PCR	O
.	O

Only	O
genomic	B-SO
DNA	I-SO
samples	O
from	O
the	O
skin	O
(	O
S	O
)	O
and	O
thymus	O
(	O
T	O
)	O
,	O
but	O
not	O
liver	O
(	O
L	O
)	O
of	O
mice	B-Taxon
positive	O
for	O
K14	B-GGP
-	O
cre	O
show	O
the	O
presence	O
of	O
deleted	B-SO
Apc	O
Delta	O
580	O
allele	B-SO
.	O

(	O
B	O
)	O
Genotype	B-SO
-	O
and	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
truncated	O
Apc	B-GGP
transcripts	B-SO
.	O

A	O
representative	O
gel	O
of	O
RT	O
-	O
PCR	O
using	O
primers	B-SO
F546	O
and	O
R721	O
,	O
showing	O
that	O
only	O
RNA	B-SO
from	O
the	O
skin	O
and	O
thymus	O
but	O
not	O
liver	O
of	O
mice	B-Taxon
positive	O
for	O
K14	B-GGP
-	O
cre	O
have	O
transcripts	B-SO
from	O
both	O
wild	B-SO
-	I-SO
type	I-SO
(	O
528	O
bp	B-SO
)	O
and	O
deleted	B-SO
(	O
313	O
bp	B-SO
)	O
Apc	B-GGP
alleles	B-SO
.	O

Figure	O
4	O

Histological	O
and	O
Immunochemical	O
Examination	O
of	O
P12	O
Skin	O
and	O
Teeth	O

(	O
A	O
-	O
E	O
)	O
P12	O
normal	O
skin	O
.	O

(	O
F	O
-	O
J	O
)	O
P12	O
mutant	B-SO
skin	O
.	O

(	O
K	O
-	O
N	O
)	O
P12	O
normal	O
oral	O
cavity	O
.	O

(	O
O	O
-	O
R	O
)	O
P12	O
mutant	B-SO
oral	O
cavity	O
.	O

Stained	O
with	O
H	O
&	O
E	O
for	O
histology	O
(	O
A	O
,	O
F	O
,	O
K	O
-	O
L	O
,	O
O	O
-	O
P	O
)	O
,	O
Ki67	B-GGP
(	O
B	O
,	O
G	O
)	O
,	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
(	O
C	O
,	O
H	O
,	O
M	O
,	O
Q	O
)	O
,	O
K14	B-GGP
(	O
D	O
,	O
I	O
,	O
N	O
,	O
R	O
)	O
,	O
and	O
K6	B-GGP
(	O
E	O
,	O
J	O
)	O
.	O

Aberrant	O
follicular	O
morphogenesis	O
,	O
characterized	O
by	O
formation	O
of	O
irregularly	O
spaced	O
,	O
nonpolarized	O
hair	O
follicles	O
,	O
in	O
mutant	B-SO
skin	O
is	O
evident	O
.	O

Despite	O
the	O
abnormal	O
histology	O
,	O
proliferation	O
seems	O
to	O
be	O
confined	O
to	O
hair	O
bulb	O
-	O
like	O
structures	O
(	O
arrows	O
in	O
[	O
G	O
]	O
,	O
inset	O
[	O
G	O
'	O
]	O
at	O
higher	O
magnification	O
)	O
,	O
but	O
in	O
mutant	B-SO
skin	O
(	O
arrows	O
in	O
[	O
H	O
]	O
,	O
inset	O
[	O
H	O
'	O
]	O
at	O
higher	O
magnification	O
)	O
and	O
oral	O
cavity	O
(	O
arrows	O
in	O
insets	O
[	O
Q	O
'	O
]	O
at	O
higher	O
magnification	O
)	O
elevated	O
cytosolic	B-GO
localization	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
is	O
detected	O
in	O
some	O
cells	B-CL
.	O

Scale	O
bars	O
:	O
50	O
mu	O
m	O
for	O
(	O
A	O
-	O
F	O
)	O
,	O
(	O
H	O
-	O
J	O
)	O
;	O
250	O
mu	O
m	O
for	O
(	O
K	O
)	O
and	O
(	O
O	O
)	O
;	O
100	O
mu	O
m	O
for	O
(	O
G	O
)	O
,	O
(	O
L	O
-	O
N	O
)	O
,	O
(	O
P	O
-	O
R	O
)	O
;	O
20	O
mu	O
m	O
for	O
(	O
Q	O
'	O
)	O
.	O

Figure	O
5	O

Expression	O
of	O
Shh	B-GGP
and	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
Transcripts	B-SO
in	O
Normal	O
(	O
ApcCKO	O
/	O
CKO	O
)	O
and	O
Mutant	B-SO
(	O
K14	B-GGP
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
)	O
Embryonic	O
Skin	O

(	O
A	O
-	O
D	O
)	O
Section	O
ISH	O
with	O
Shh	B-GGP
probe	B-SO
in	O
E14	O
.	O
5	O
normal	O
(	O
A	O
)	O
,	O
E14	O
.	O
5	O
mutant	B-SO
(	O
B	O
)	O
,	O
E16	O
.	O
5	O
normal	O
(	O
C	O
)	O
,	O
and	O
E16	O
.	O
5	O
mutant	B-SO
(	O
D	O
)	O
skin	O
.	O

Broken	O
lines	O
indicate	O
the	O
interface	O
between	O
epithelium	O
and	O
mesenchyme	O
.	O

Scale	O
bars	O
:	O
50	O
mu	O
m	O
.	O

Whole	O
mount	O
in	O
situ	O
detection	O
of	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
in	O
E15	O
.	O
5	O
normal	O
(	O
E	O
,	O
G	O
)	O
,	O
mutant	B-SO
(	O
F	O
,	O
H	O
)	O
embryos	O
.	O

Aberrant	O
initiation	O
of	O
multiple	O
hair	O
placodes	O
is	O
evident	O
at	O
E14	O
.	O
5	O
.	O

Loss	O
of	O
K14	B-GGP
-	O
driven	O
Apc	B-GGP
loss	O
caused	O
aberrant	O
pattern	O
formation	O
(	O
F	O
'	O
)	O
and	O
formed	O
ectopic	O
hair	O
placodes	O
in	O
normally	O
hairless	O
foot	O
pads	O
(	O
H	O
,	O
arrows	O
)	O
which	O
are	O
absent	O
in	O
normal	O
(	O
G	O
)	O
.	O

Figure	O
6	O

Histological	O
and	O
Immunochemical	O
Examination	O
of	O
Thymus	O

(	O
A	O
-	O
D	O
)	O
P3	O
normal	O
thymus	O
.	O

(	O
E	O
-	O
G	O
)	O
Mild	O
P3	O
mutant	B-SO
thymus	O
.	O

(	O
H	O
-	O
K	O
)	O
Severe	O
P3	O
mutant	B-SO
thymus	O
.	O

(	O
L	O
-	O
O	O
)	O
P13	O
mutant	B-SO
thymus	O
.	O

Stained	O
with	O
H	O
&	O
E	O
for	O
histology	O
(	O
A	O
,	O
E	O
,	O
H	O
,	O
L	O
)	O
,	O
BrdU	O
(	O
B	O
,	O
I	O
,	O
M	O
)	O
,	O
beta	B-GGP
-	I-GGP
catenin	I-GGP
(	O
C	O
,	O
F	O
,	O
J	O
,	O
N	O
)	O
,	O
and	O
K14	B-GGP
(	O
D	O
,	O
G	O
,	O
K	O
,	O
O	O
)	O
.	O

(	O
B	O
)	O
Actively	O
dividing	O
thymocytes	O
are	O
visible	O
at	O
the	O
superficial	O
edge	O
of	O
cortex	O
of	O
normal	O
P3	O
thymus	O
.	O

Note	O
the	O
progression	O
of	O
histological	O
abnormalities	O
in	O
the	O
mutant	B-SO
thymus	O
from	O
mild	O
P3	O
,	O
severe	O
P3	O
to	O
P13	O
(	O
A	O
,	O
E	O
,	O
H	O
,	O
L	O
)	O
.	O

Scale	O
bars	O
,	O
20	O
mu	O
m	O
.	O

Table	O
1	O

Genotype	B-SO
Distribution	O
of	O
Progeny	O
from	O
the	O
Matings	O

Footnotes	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
July	O
28	O
,	O
2006	O
(	O
DOI	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0020146	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

M	O
.	O

Kuraguchi	O
and	O
R	O
.	O

Kucherlapati	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

M	O
.	O

Kuraguchi	O
,	O
X	O
.	O

Wang	O
,	O
R	O
.	O

Bronson	O
,	O
R	O
.	O

Rothenberg	O
,	O
N	O
.	O

Ohene	O
-	O
Baah	O
,	O
J	O
.	O

Lund	O
,	O
and	O
M	O
.	O

Kucherlapati	O
performed	O
the	O
experiments	O
.	O

M	O
.	O

Kuraguchi	O
analyzed	O
the	O
data	O
.	O

R	O
.	O

Maas	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

M	O
.	O

Kuraguchi	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
work	O
was	O
supported	O
by	O
grants	O
from	O
the	O
National	O
Cancer	O
Institute	O
(	O
CA	O
-	O
084301	O
)	O
,	O
the	O
National	O
Institute	O
of	O
Environmental	O
Health	O
Sciences	O
(	O
ES	O
-	O
11040	O
)	O
,	O
and	O
the	O
National	O
Institute	O
of	O
Dental	O
and	O
Craniofacial	O
Research	O
(	O
DE	O
-	O
11697	O
,	O
DE	O
-	O
16140	O
)	O
.	O

Deletion	B-SO
at	O
ITPR1	B-GGP
Underlies	O
Ataxia	O
in	O
Mice	B-Taxon
and	O
Spinocerebellar	O
Ataxia	O
15	O
in	O
Humans	B-Taxon

Abstract	O

We	O
observed	O
a	O
severe	O
autosomal	B-GO
recessive	O
movement	O
disorder	O
in	O
mice	B-Taxon
used	O
within	O
our	O
laboratory	O
.	O

We	O
pursued	O
a	O
series	O
of	O
experiments	O
to	O
define	O
the	O
genetic	B-SO
lesion	O
underlying	O
this	O
disorder	O
and	O
to	O
identify	O
a	O
cognate	O
disease	O
in	O
humans	B-Taxon
with	O
mutation	B-SO
at	O
the	O
same	O
locus	B-SO
.	O

Through	O
linkage	O
and	O
sequence	B-SO
analysis	O
we	O
show	O
here	O
that	O
this	O
disorder	O
is	O
caused	O
by	O
a	O
homozygous	O
in	O
-	O
frame	B-SO
18	O
-	O
bp	B-SO
deletion	B-SO
in	O
Itpr1	B-GGP
(	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
)	O
,	O
encoding	O
inositol	B-GGP
1	I-GGP
,	I-GGP
4	I-GGP
,	I-GGP
5	I-GGP
-	I-GGP
triphosphate	I-GGP
receptor	I-GGP
1	I-GGP
.	O

A	O
previously	O
reported	O
spontaneous	O
Itpr1	B-GGP
mutation	B-SO
in	O
mice	B-Taxon
causes	O
a	O
phenotype	O
identical	O
to	O
that	O
observed	O
here	O
.	O

In	O
both	O
models	O
in	O
-	O
frame	B-SO
deletion	B-SO
within	O
Itpr1	B-GGP
leads	O
to	O
a	O
decrease	O
in	O
the	O
normally	O
high	O
level	O
of	O
Itpr1	B-GGP
expression	O
in	O
cerebellar	O
Purkinje	B-CL
cells	I-CL
.	O

Spinocerebellar	O
ataxia	O
15	O
(	O
SCA15	O
)	O
,	O
a	O
human	B-Taxon
autosomal	B-GO
dominant	O
disorder	O
,	O
maps	O
to	O
the	O
genomic	B-SO
region	I-SO
containing	O
ITPR1	B-GGP
;	O
however	O
,	O
to	O
date	O
no	O
causal	O
mutations	B-SO
had	O
been	O
identified	O
.	O

Because	O
ataxia	O
is	O
a	O
prominent	O
feature	O
in	O
Itpr1	B-GGP
mutant	B-SO
mice	B-Taxon
,	O
we	O
performed	O
a	O
series	O
of	O
experiments	O
to	O
test	O
the	O
hypothesis	O
that	O
mutation	B-SO
at	O
ITPR1	B-GGP
may	O
be	O
the	O
cause	O
of	O
SCA15	O
.	O

We	O
show	O
here	O
that	O
heterozygous	O
deletion	B-SO
of	O
the	O
5	O
'	O
part	B-SO
of	I-SO
the	I-SO
ITPR1	I-SO
gene	I-SO
,	O
encompassing	O
exons	B-SO
1	O
-	O
10	O
,	O
1	O
-	O
40	O
,	O
and	O
1	O
-	O
44	O
in	O
three	O
studied	O
families	O
,	O
underlies	O
SCA15	O
in	O
humans	B-Taxon
.	O

Author	O
Summary	O

We	O
have	O
identified	O
a	O
spontaneous	O
in	O
-	O
frame	B-SO
deletion	B-SO
mutation	I-SO
in	O
the	O
gene	B-SO
Itpr1	B-GGP
that	O
causes	O
a	O
recessive	O
movement	O
disorder	O
in	O
mice	B-Taxon
.	O

In	O
an	O
attempt	O
to	O
define	O
whether	O
any	O
similar	O
disease	O
occurs	O
in	O
humans	B-Taxon
we	O
performed	O
a	O
literature	O
search	O
for	O
diseases	O
linked	O
to	O
the	O
human	B-Taxon
chromosomal	B-SO
region	I-SO
containing	O
ITPR1	B-GGP
.	O

We	O
identified	O
the	O
disease	O
spinocerebellar	O
ataxia	O
15	O
as	O
linked	O
to	O
this	O
region	B-SO
.	O

High	O
-	O
density	O
genomic	B-SO
analysis	O
of	O
affected	O
members	O
from	O
three	O
families	O
revealed	O
that	O
disease	O
in	O
these	O
patients	O
was	O
caused	O
by	O
deletion	B-SO
of	O
a	O
large	O
portion	B-SO
of	O
the	O
region	B-SO
containing	O
ITPR1	B-GGP
.	O

We	O
show	O
here	O
that	O
this	O
mutation	B-SO
results	O
in	O
a	O
dramatic	O
reduction	O
in	O
ITPR1	B-GGP
in	O
cells	B-CL
from	O
these	O
patients	O
.	O

These	O
data	O
show	O
convincingly	O
that	O
ITPR1	B-GGP
deletion	B-SO
underlies	O
spinocerebellar	O
ataxia	O
15	O
in	O
humans	B-Taxon
.	O

Introduction	O

The	O
use	O
of	O
forward	O
genetics	O
to	O
define	O
novel	O
loci	B-SO
of	O
interest	O
in	O
human	B-Taxon
disease	O
has	O
become	O
increasingly	O
viable	O
with	O
the	O
implementation	O
of	O
large	O
-	O
scale	O
mutagenesis	B-SO
programs	O
.	O

Prior	O
to	O
these	O
initiatives	O
this	O
work	O
was	O
carried	O
out	O
in	O
part	O
by	O
the	O
investigation	O
of	O
spontaneous	O
mutations	B-SO
that	O
cause	O
disorders	O
in	O
mouse	B-Taxon
breeding	O
colonies	O
.	O

Careful	O
observation	O
of	O
these	O
serendipitous	O
events	O
has	O
led	O
to	O
the	O
establishment	O
and	O
study	O
of	O
many	O
in	O
vivo	O
disease	O
models	O
[	O
3	O
]	O
.	O

During	O
the	O
generation	O
of	O
a	O
knockout	O
line	O
of	O
mice	B-Taxon
we	O
noted	O
an	O
early	O
movement	O
disorder	O
that	O
was	O
inherited	O
independently	O
of	O
targeting	O
vector	B-SO
transmission	O
.	O

We	O
embarked	O
on	O
a	O
series	O
of	O
experiments	O
to	O
identify	O
the	O
genetic	B-SO
lesion	O
underlying	O
this	O
movement	O
disorder	O
and	O
to	O
identify	O
a	O
cognate	O
disease	O
and	O
corresponding	O
mutation	B-SO
in	O
humans	B-Taxon
.	O

Here	O
we	O
describe	O
this	O
effort	O
and	O
the	O
discovery	O
of	O
deletion	B-SO
at	O
the	O
ITPR1	B-GGP
locus	B-SO
as	O
a	O
cause	O
of	O
this	O
disorder	O
in	O
mice	B-Taxon
and	O
of	O
spinocerebellar	O
ataxia	O
15	O
(	O
SCA15	O
)	O
in	O
humans	B-Taxon
.	O

Results	O
/	O
Discussion	O

During	O
the	O
generation	O
of	O
a	O
line	O
of	O
mice	B-Taxon
with	O
knockout	O
of	O
the	O
gene	B-SO
Park7	B-GGP
we	O
noted	O
an	O
early	O
movement	O
disorder	O
that	O
was	O
inherited	O
independently	O
of	O
targeting	O
vector	B-SO
transmission	O
.	O

Our	O
initial	O
observations	O
suggested	O
the	O
affected	O
mice	B-Taxon
suffered	O
from	O
an	O
apparently	O
paroxysmal	O
movement	O
disorder	O
,	O
often	O
induced	O
by	O
touch	O
.	O

The	O
abnormal	O
movements	O
occurred	O
predominantly	O
below	O
the	O
cervical	O
level	O
,	O
and	O
the	O
disorder	O
appeared	O
progressive	O
.	O

At	O
initial	O
examination	O
,	O
a	O
human	B-Taxon
movement	O
disorder	O
specialist	O
(	O
K	O
.	O
G	O
.	O
-	O
H	O
.	O
)	O
likened	O
the	O
disorder	O
to	O
episodic	O
intermittent	O
ataxia	O
or	O
kinesiogenic	O
paroxysmal	O
dystonia	O
and	O
predicted	O
the	O
involvement	O
of	O
an	O
ion	B-CHEBI
channel	O
mutation	B-SO
in	O
the	O
etiology	O
.	O

Affected	O
mice	B-Taxon
presented	O
at	O
approximately	O
postnatal	O
day	O
14	O
,	O
and	O
survival	O
time	O
without	O
weaning	O
was	O
on	O
average	O
4	O
wk	O
after	O
onset	O
.	O

Breeding	O
experiments	O
suggested	O
that	O
the	O
observed	O
disorder	O
was	O
inherited	O
in	O
an	O
autosomal	B-GO
recessive	O
manner	O
.	O

To	O
map	O
the	O
location	B-SO
of	O
the	O
disease	O
-	O
causing	O
lesion	O
,	O
we	O
performed	O
genome	B-SO
-	O
wide	O
linkage	O
analysis	O
using	O
strain	O
-	O
specific	O
single	B-SO
nucleotide	I-SO
polymorphisms	I-SO
(	O
SNPs	B-SO
)	O
at	O
120	O
loci	B-SO
across	O
the	O
mouse	B-Taxon
genome	B-SO
.	O

Analysis	O
of	O
these	O
data	O
showed	O
a	O
single	O
genomic	B-SO
region	I-SO
with	O
significant	O
linkage	O
to	O
disease	O
,	O
providing	O
a	O
two	O
-	O
point	O
LOD	O
score	O
of	O
5	O
.	O
13	O
at	O
marker	O
20	O
.	O
MMHAP85FLG2	O
on	O
Chromosome	B-GO
6qE1	O
.	O

The	O
linked	O
haplotype	B-SO
suggested	O
the	O
mutation	B-SO
had	O
occurred	O
on	O
the	O
129x1	O
/	O
SvJ	O
background	O
(	O
Figure	O
S1	O
)	O
.	O

Literature	O
searches	O
revealed	O
that	O
among	O
disease	O
lines	O
mapped	O
to	O
6qE1	O
,	O
the	O
spontaneous	O
mutant	B-SO
opt	O
mouse	B-Taxon
displays	O
a	O
strikingly	O
similar	O
presentation	O
to	O
that	O
described	O
here	O
[	O
1	O
]	O
.	O

The	O
underlying	O
genetic	B-SO
lesion	O
causing	O
the	O
opt	O
phenotype	O
is	O
a	O
homozygous	O
in	O
-	O
frame	B-SO
deletion	B-SO
of	O
exons	B-SO
43	O
and	O
44	O
of	O
the	O
gene	B-SO
Itpr1	B-GGP
(	O
Itpr1opt	O
/	O
opt	O
)	O
,	O
encoding	O
inositol	B-GGP
1	I-GGP
,	I-GGP
4	I-GGP
,	I-GGP
5	I-GGP
-	I-GGP
triphosphate	I-GGP
receptor	I-GGP
1	I-GGP
(	O
Itpr1	B-GGP
)	O
.	O

Sequencing	O
of	O
all	O
exons	B-SO
and	O
intron	B-SO
-	I-SO
exon	I-SO
boundaries	I-SO
of	O
Itpr1	B-GGP
in	O
affected	O
mice	B-Taxon
from	O
the	O
current	O
study	O
revealed	O
a	O
single	O
mutation	B-SO
within	O
Itpr1	B-GGP
:	O
a	O
novel	O
in	O
-	O
frame	B-SO
deletion	B-SO
of	O
18	O
bp	B-SO
within	O
exon	B-SO
36	O
(	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
)	O
.	O

To	O
confirm	O
the	O
pathogenicity	O
of	O
this	O
mutation	B-SO
we	O
crossed	O
heterozygous	O
mice	B-Taxon
from	O
the	O
current	O
study	O
(	O
Itpr1wt	O
/	O
Delta	O
18	O
)	O
with	O
mice	B-Taxon
heterozygous	O
for	O
the	O
opt	O
mutation	B-SO
(	O
Itpr1wt	O
/	O
opt	O
)	O
.	O

This	O
resulted	O
in	O
two	O
litters	O
of	O
mice	B-Taxon
with	O
a	O
total	O
of	O
four	O
affected	O
Itpr1opt	O
/	O
Delta	O
18	O
pups	O
(	O
from	O
a	O
total	O
of	O
15	O
)	O
with	O
a	O
phenotype	O
indistinguishable	O
from	O
that	O
of	O
the	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
and	O
Itpr1opt	O
/	O
opt	O
mice	B-Taxon
[	O
1	O
]	O
.	O

Furthermore	O
,	O
this	O
phenotype	O
was	O
similar	O
,	O
although	O
less	O
severe	O
,	O
to	O
that	O
described	O
in	O
a	O
mouse	B-Taxon
line	O
with	O
targeted	O
deletion	B-SO
of	O
Itpr1	B-GGP
,	O
where	O
ataxia	O
was	O
described	O
as	O
a	O
prominent	O
feature	O
[	O
4	O
]	O
.	O

As	O
with	O
the	O
Itpr1opt	O
/	O
opt	O
mice	B-Taxon
,	O
where	O
the	O
deletion	B-SO
of	O
exons	B-SO
43	O
and	O
44	O
is	O
also	O
predicted	O
to	O
leave	O
the	O
translational	O
reading	B-SO
frame	I-SO
unaffected	O
,	O
the	O
in	O
-	O
frame	B-SO
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
deletion	B-SO
mutation	I-SO
results	O
in	O
markedly	O
decreased	O
levels	O
of	O
Itpr1	B-GGP
in	O
cerebellar	O
Purkinje	B-CL
cells	I-CL
.	O

In	O
these	O
two	O
spontaneous	O
mutants	B-SO
[	O
1	O
]	O
and	O
in	O
the	O
Itpr1	B-GGP
-	O
deficient	O
mouse	B-Taxon
[	O
4	O
]	O
generated	O
by	O
gene	B-SO
targeting	O
,	O
decreased	O
Itpr1	B-GGP
expression	O
is	O
associated	O
with	O
the	O
same	O
autosomal	B-GO
recessive	O
movement	O
disorder	O
(	O
Figure	O
1	O
)	O
.	O

Given	O
our	O
interest	O
in	O
human	B-Taxon
neurological	O
disease	O
we	O
sought	O
to	O
identify	O
any	O
cognate	O
human	B-Taxon
disorders	O
where	O
linkage	O
had	O
been	O
established	O
to	O
the	O
syntenic	B-SO
region	I-SO
of	O
the	O
human	B-Taxon
genome	B-SO
,	O
but	O
where	O
no	O
causal	O
mutation	B-SO
had	O
been	O
identified	O
.	O

SCA15	O
,	O
an	O
adult	O
-	O
onset	O
autosomal	B-GO
dominant	O
progressive	O
ataxia	O
is	O
linked	O
to	O
this	O
locus	B-SO
[	O
5	O
]	O
.	O

Although	O
missense	O
mutation	B-SO
of	O
ITPR1	B-GGP
had	O
previously	O
been	O
ruled	O
out	O
[	O
2	O
]	O
and	O
the	O
mode	O
of	O
inheritance	O
was	O
inconsistent	O
with	O
that	O
seen	O
in	O
the	O
Itpr1	O
Delta	O
18	O
and	O
Itpr1opt	O
mice	B-Taxon
,	O
the	O
phenotypic	O
presence	O
of	O
ataxia	O
in	O
the	O
mice	B-Taxon
led	O
us	O
to	O
reexamine	O
this	O
candidate	O
gene	B-SO
as	O
a	O
possible	O
cause	O
of	O
SCA15	O
.	O

We	O
obtained	O
genomic	B-SO
DNA	I-SO
from	O
three	O
affected	O
family	O
members	O
and	O
one	O
family	O
member	O
with	O
unknown	O
disease	O
status	O
from	O
the	O
kindred	O
originally	O
used	O
to	O
define	O
and	O
map	O
SCA15	O
(	O
family	O
AUS1	O
,	O
of	O
Australian	O
Anglo	O
-	O
Celtic	O
origin	O
)	O
[	O
2	O
]	O
.	O

We	O
performed	O
two	O
experiments	O
concurrently	O
in	O
three	O
affected	O
members	O
of	O
this	O
family	O
:	O
sequence	B-SO
analysis	O
of	O
the	O
coding	B-SO
exons	I-SO
of	O
ITPR1	B-GGP
and	O
high	O
-	O
density	O
genome	B-SO
-	O
wide	O
SNP	B-SO
genotyping	O
.	O

Sequence	B-SO
analysis	O
failed	O
to	O
show	O
any	O
coding	B-SO
alterations	B-SO
segregating	O
with	O
disease	O
or	O
any	O
alterations	B-SO
that	O
were	O
inconsistent	O
with	O
Mendelian	O
patterns	O
of	O
inheritance	O
within	O
the	O
family	O
.	O

However	O
,	O
visualization	O
of	O
log	O
R	O
ratio	O
and	O
B	O
allele	B-SO
frequency	O
metrics	O
from	O
the	O
genome	B-SO
-	O
wide	O
SNP	B-SO
genotyping	O
experiments	O
clearly	O
showed	O
data	O
consistent	O
with	O
a	O
heterozygous	O
genomic	B-SO
deletion	B-SO
across	O
the	O
first	O
one	O
-	O
third	O
of	O
ITPR1	B-GGP
and	O
across	O
the	O
first	O
half	O
of	O
a	O
neighboring	O
gene	B-SO
,	O
SUMF1	B-GGP
(	O
Figure	O
2	O
)	O
.	O

This	O
deletion	B-SO
was	O
apparent	O
in	O
all	O
three	O
affected	O
family	O
members	O
studied	O
and	O
absent	O
from	O
the	O
family	O
member	O
with	O
unknown	O
affection	O
status	O
(	O
Figure	O
3	O
)	O
.	O

The	O
SNP	B-SO
data	O
showed	O
a	O
deletion	B-SO
of	O
between	O
188	O
kb	O
and	O
210	O
kb	O
in	O
size	O
;	O
examination	O
of	O
SNPs	B-SO
at	O
the	O
flanking	B-SO
unknown	I-SO
regions	I-SO
of	O
this	O
deletion	B-SO
allowed	O
us	O
to	O
delimit	O
the	O
borders	B-SO
of	I-SO
the	I-SO
deletion	I-SO
to	O
7	O
.	O
5	O
kb	O
on	O
the	O
telomeric	B-SO
side	O
of	O
the	O
deletion	B-SO
(	O
between	O
rs12634249	O
and	O
rs793396	O
)	O
and	O
~	O
14	O
.	O
4	O
kb	O
on	O
the	O
centromeric	B-SO
side	O
of	O
the	O
deletion	B-SO
(	O
between	O
rs4073665	O
and	O
rs17709863	O
)	O
.	O

In	O
an	O
attempt	O
to	O
define	O
whether	O
this	O
variation	B-SO
was	O
a	O
benign	O
polymorphism	B-SO
we	O
analyzed	O
genome	B-SO
-	O
wide	O
SNP	B-SO
data	O
at	O
this	O
locus	B-SO
,	O
produced	O
using	O
the	O
same	O
genotyping	O
chip	O
,	O
from	O
577	O
individuals	B-Taxon
of	O
European	O
descent	O
who	O
were	O
either	O
controls	O
or	O
individuals	B-Taxon
with	O
an	O
unrelated	O
neurological	O
disorder	O
.	O

We	O
failed	O
to	O
find	O
any	O
deletions	B-SO
affecting	O
the	O
coding	B-SO
sequence	I-SO
of	O
either	O
gene	B-SO
,	O
ITPR1	B-GGP
or	O
SUMF1	B-GGP
;	O
we	O
did	O
,	O
however	O
,	O
identify	O
a	O
single	O
individual	B-Taxon
with	O
a	O
possible	O
heterozygous	O
deletion	B-SO
approximately	O
6	O
kb	O
in	O
size	O
within	O
intron	B-SO
40	O
-	O
41	O
of	O
ITPR1	B-GGP
,	O
at	O
least	O
5	O
kb	O
away	O
from	O
exon	B-SO
40	O
.	O

Given	O
the	O
location	B-SO
of	O
this	O
alteration	B-SO
it	O
is	O
unlikely	O
to	O
effect	O
the	O
expression	O
or	O
splicing	O
of	O
ITPR1	B-GGP
.	O

In	O
an	O
attempt	O
to	O
fine	O
-	O
map	O
the	O
breakpoints	B-SO
of	I-SO
the	I-SO
disease	I-SO
-	I-SO
causing	I-SO
deletion	I-SO
we	O
performed	O
a	O
series	O
of	O
experiments	O
designed	O
to	O
refine	O
the	O
unknown	O
intervals	B-SO
at	O
the	O
edges	B-SO
between	O
definite	O
deleted	B-SO
and	O
definite	O
diploid	O
sequences	B-SO
.	O

These	O
data	O
narrowed	O
the	O
unknown	O
borders	B-SO
to	O
~	O
4	O
kb	O
on	O
the	O
telomeric	B-SO
side	O
and	O
~	O
7	O
kb	O
on	O
the	O
centromeric	B-SO
side	O
.	O

We	O
used	O
all	O
possible	O
combinations	O
of	O
forward	B-SO
orientation	I-SO
primers	I-SO
designed	B-SO
within	O
the	O
newly	O
defined	O
telomeric	B-SO
boundary	B-SO
and	O
of	O
reverse	B-SO
orientation	I-SO
primers	I-SO
designed	B-SO
within	O
the	O
newly	O
defined	O
centromeric	B-SO
boundary	B-SO
in	O
PCR	O
assays	O
in	O
an	O
attempt	O
to	O
amplify	O
across	O
the	O
deletion	B-SO
in	O
affected	O
family	O
members	O
.	O

Using	O
PCR	O
primers	B-SO
T3F	O
and	O
C11R	O
,	O
which	O
should	O
be	O
more	O
than	O
200	O
kb	O
apart	O
,	O
we	O
were	O
able	O
to	O
amplify	O
a	O
fragment	B-SO
953	O
bp	B-SO
in	O
size	O
using	O
DNA	B-SO
from	O
each	O
of	O
the	O
three	O
affected	O
family	O
members	O
as	O
template	O
.	O

Sequencing	O
of	O
this	O
fragment	B-SO
revealed	O
a	O
deletion	B-SO
of	O
201	O
,	O
509	O
bp	B-SO
(	O
Figure	O
S3	O
)	O
,	O
removing	B-SO
the	O
first	O
three	O
of	O
the	O
nine	O
exons	B-SO
of	O
SUMF1	B-GGP
and	O
the	O
first	O
ten	O
of	O
the	O
58	O
exons	B-SO
of	O
ITPR1	B-GGP
.	O

We	O
were	O
unable	O
to	O
amplify	O
the	O
deletion	B-SO
-	O
specific	O
fragment	B-SO
in	O
the	O
family	O
member	O
of	O
unknown	O
affection	O
status	O
,	O
or	O
in	O
275	O
neurologically	O
normal	O
controls	O
.	O

To	O
further	O
establish	O
genetic	B-SO
deletion	B-SO
at	O
ITPR1	B-GGP
as	O
the	O
cause	O
of	O
SCA15	O
we	O
analyzed	O
two	O
additional	O
families	O
with	O
an	O
inherited	O
cerebellar	O
ataxia	O
similar	O
to	O
that	O
described	O
in	O
the	O
AUS1	O
family	O
,	O
ascertained	O
through	O
neurology	O
clinics	O
in	O
London	O
,	O
United	O
Kingdom	O
.	O

DNA	B-SO
extracted	O
from	O
probands	O
from	O
these	O
two	O
families	O
(	O
family	O
H33	O
and	O
family	O
H27	O
)	O
were	O
also	O
analyzed	O
using	O
Illumina	O
Infinium	O
HumanHap550	O
genotyping	O
chips	O
.	O

These	O
experiments	O
showed	O
deletion	B-SO
at	O
the	O
SCA15	O
locus	B-SO
in	O
all	O
affected	O
members	O
assayed	O
,	O
from	O
SUMF1	B-GGP
through	O
ITPR1	B-GGP
.	O

These	O
mutations	B-SO
segregated	O
with	O
disease	O
in	O
these	O
two	O
families	O
(	O
Figure	O
S3	O
)	O
.	O

A	O
strategy	O
similar	O
to	O
the	O
one	O
outlined	O
above	O
enabled	O
us	O
to	O
sequence	O
over	O
the	O
breakpoint	B-SO
in	O
family	O
H27	O
but	O
not	O
family	O
H33	O
.	O

In	O
the	O
former	O
,	O
the	O
deletion	B-SO
spans	O
344	O
,	O
408	O
bp	B-SO
,	O
removing	B-SO
exons	B-SO
1	O
-	O
3	O
of	O
SUMF1	B-GGP
and	O
1	O
-	O
44	O
of	O
ITPR1	B-GGP
;	O
in	O
the	O
latter	O
,	O
we	O
estimate	O
that	O
the	O
deletion	B-SO
is	O
310	O
kb	O
in	O
length	O
and	O
that	O
it	O
removes	B-SO
exons	B-SO
1	O
-	O
3	O
of	O
SUMF1	B-GGP
and	O
exons	B-SO
1	O
-	O
40	O
of	O
ITPR1	B-GGP
.	O

The	O
site	B-SO
of	O
mutation	B-SO
is	O
of	O
interest	O
,	O
particularly	O
the	O
fact	O
that	O
in	O
each	O
of	O
the	O
three	O
families	O
the	O
telomeric	B-SO
end	O
of	O
the	O
deletion	B-SO
is	O
anchored	O
between	O
exons	B-SO
3	O
and	O
4	O
of	O
SUMF1	B-GGP
;	O
sequence	B-SO
searches	O
failed	O
to	O
identify	O
any	O
repeat	B-SO
sequences	I-SO
that	O
might	O
explain	O
this	O
phenomenon	O
.	O

With	O
three	O
cerebellar	O
ataxia	O
families	O
segregating	O
a	O
SUMF1	B-GGP
-	O
ITPR1	B-GGP
deletion	B-SO
,	O
and	O
this	O
deletion	B-SO
not	O
observed	O
in	O
a	O
control	O
population	O
,	O
we	O
may	O
reasonably	O
conclude	O
that	O
the	O
association	O
is	O
causal	O
,	O
and	O
that	O
the	O
deletion	B-SO
is	O
indeed	O
the	O
genetic	B-SO
basis	O
of	O
the	O
disease	O
,	O
with	O
SCA15	O
the	O
diagnosis	O
in	O
the	O
two	O
British	O
families	O
as	O
well	O
as	O
the	O
original	O
Australian	O
family	O
.	O

It	O
is	O
improbable	O
that	O
heterozygosity	O
for	O
the	O
deletion	B-SO
of	O
SUMF1	B-GGP
,	O
encoding	O
sulfatase	B-GGP
modifying	I-GGP
factor	I-GGP
1	I-GGP
,	O
of	O
itself	O
causes	O
or	O
contributes	O
to	O
SCA15	O
.	O

Homozygous	O
mutation	B-SO
of	O
SUMF1	B-GGP
results	O
in	O
autosomal	B-GO
recessive	O
multiple	O
sulfatase	O
deficiency	O
,	O
a	O
metabolic	O
disorder	O
characterized	O
by	O
hepatosplenomegaly	O
,	O
deafness	O
,	O
and	O
developmental	O
delay	O
[	O
6	O
,	O
7	O
]	O
.	O

No	O
co	O
-	O
occurrence	O
of	O
ataxia	O
has	O
been	O
described	O
in	O
(	O
heterozygous	O
)	O
parents	O
of	O
patients	O
with	O
multiple	O
sulfatase	O
deficiency	O
.	O

Conversely	O
,	O
mutation	B-SO
of	O
ITPR1	B-GGP
is	O
biologically	O
plausible	O
as	O
a	O
cause	O
of	O
ataxia	O
:	O
the	O
protein	B-CHEBI
is	O
highly	O
expressed	O
in	O
Purkinje	B-CL
cells	I-CL
;	O
as	O
we	O
have	O
shown	O
here	O
,	O
mice	B-Taxon
with	O
mutation	B-SO
at	O
this	O
locus	B-SO
present	O
with	O
ataxia	O
;	O
and	O
perturbed	O
Ca2	B-CHEBI
+	I-CHEBI
signaling	O
has	O
previously	O
been	O
implicated	O
in	O
the	O
etiology	O
of	O
ataxia	O
,	O
notably	O
in	O
episodic	O
ataxia	O
type	O
2	O
and	O
SCA6	O
[	O
8	O
]	O
.	O

In	O
further	O
support	O
of	O
this	O
conclusion	O
,	O
analysis	O
of	O
protein	B-CHEBI
levels	O
of	O
ITPR1	B-GGP
in	O
Epstein	B-Taxon
-	I-Taxon
Barr	I-Taxon
virus	I-Taxon
(	O
EBV	B-Taxon
)	O
immortalized	O
lymphocytes	B-CL
from	O
affected	O
and	O
unaffected	O
AUS1	O
family	O
members	O
revealed	O
that	O
all	O
affected	O
members	O
showed	O
a	O
dramatic	O
decrease	O
in	O
ITPR1	B-GGP
levels	O
when	O
compared	O
with	O
the	O
family	O
member	O
without	O
the	O
deletion	B-SO
(	O
Figure	O
4	O
)	O
.	O

Itpr1	B-GGP
contains	O
three	O
domains	B-SO
,	O
an	O
N	B-SO
-	I-SO
terminal	I-SO
inositol	I-SO
triphosphate	I-SO
binding	I-SO
domain	I-SO
,	O
a	O
coupling	O
domain	B-SO
,	O
and	O
a	O
C	B-SO
-	I-SO
terminal	I-SO
transmembrane	I-SO
domain	I-SO
;	O
it	O
also	O
contains	O
two	O
protein	B-CHEBI
kinase	O
A	O
phosphorylation	O
sites	B-SO
and	O
an	O
ATP	B-CHEBI
-	O
binding	B-SO
site	I-SO
.	O

Itpr1	B-GGP
is	O
coupled	O
to	O
Ca2	B-CHEBI
+	I-CHEBI
channels	O
and	O
facilitates	O
Ca2	B-CHEBI
+	I-CHEBI
release	O
from	O
the	O
endoplasmic	B-GO
reticulum	I-GO
after	O
binding	O
by	O
the	O
intracellular	B-GO
second	O
messenger	O
inositol	B-CHEBI
1	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
[	O
9	O
]	O
.	O

Itpr1	B-GGP
is	O
enriched	O
in	O
the	O
Purkinje	B-CL
cells	I-CL
of	O
the	O
cerebellum	O
[	O
4	O
]	O
.	O

ITPR1	B-GGP
mutations	B-SO
have	O
more	O
than	O
one	O
potential	O
pathogenic	O
mechanism	O
.	O

First	O
,	O
the	O
disease	O
may	O
be	O
a	O
result	O
of	O
haploinsufficiency	O
at	O
ITPR1	B-GGP
;	O
this	O
concept	O
is	O
consistent	O
with	O
the	O
observation	O
that	O
heterozygous	O
deletion	B-SO
leads	O
to	O
a	O
later	O
onset	O
disorder	O
in	O
humans	B-Taxon
,	O
whereas	O
homozygous	O
deletion	B-SO
in	O
mice	B-Taxon
leads	O
to	O
an	O
early	O
onset	O
disorder	O
,	O
able	O
to	O
be	O
expressed	O
within	O
the	O
much	O
shorter	O
life	O
span	O
of	O
the	O
mouse	B-Taxon
.	O

Second	O
,	O
we	O
cannot	O
rule	O
out	O
the	O
existence	O
of	O
an	O
alternate	O
start	B-SO
site	I-SO
for	O
ITPR1	B-GGP
that	O
may	O
result	O
in	O
a	O
product	O
that	O
confers	O
a	O
pathogenic	O
gain	O
of	O
function	O
to	O
the	O
protein	B-CHEBI
;	O
however	O
,	O
Western	O
blot	O
analysis	O
of	O
cells	B-CL
derived	O
from	O
affected	O
AUS1	O
family	O
members	O
,	O
which	O
was	O
performed	O
using	O
an	O
antibody	B-GO
raised	O
against	O
the	O
C	B-SO
-	I-SO
terminal	I-SO
portion	I-SO
of	O
ITPR1	B-GGP
,	O
failed	O
to	O
identify	O
any	O
disease	O
-	O
specific	O
truncated	O
protein	B-CHEBI
products	I-CHEBI
.	O

Clearly	O
,	O
the	O
identification	O
of	O
distinct	O
ITPR1	B-GGP
mutations	B-SO
underlying	O
SCA15	O
will	O
help	O
elucidate	O
the	O
pathogenic	O
mechanism	O
of	O
this	O
disorder	O
.	O

We	O
show	O
here	O
the	O
utility	O
of	O
investigating	O
spontaneous	O
mouse	B-Taxon
mutations	B-SO
in	O
understanding	O
human	B-Taxon
disease	O
.	O

Currently	O
,	O
the	O
small	O
number	O
of	O
aged	O
Itpr1wt	O
/	O
Delta	O
18	O
animals	B-Taxon
precludes	O
us	O
from	O
examining	O
these	O
mice	B-Taxon
for	O
subtle	O
signs	O
and	O
symptoms	O
similar	O
to	O
those	O
seen	O
in	O
SCA15	O
patients	O
;	O
however	O
,	O
these	O
mice	B-Taxon
are	O
clearly	O
of	O
interest	O
to	O
us	O
as	O
a	O
potential	O
model	O
of	O
SCA15	O
.	O

These	O
data	O
also	O
demonstrate	O
that	O
genome	B-SO
-	O
wide	O
SNP	B-SO
assay	O
can	O
facilitate	O
rapid	O
detection	O
of	O
structural	O
genomic	B-SO
mutations	B-SO
that	O
may	O
underlie	O
disease	O
.	O

The	O
data	O
provided	O
by	O
these	O
approaches	O
provide	O
compelling	O
evidence	O
that	O
heterozygous	O
deletion	B-SO
of	O
ITPR1	B-GGP
causes	O
SCA15	O
.	O

Clearly	O
,	O
sequence	B-SO
analysis	O
of	O
ITPR1	B-GGP
in	O
potential	O
SCA15	O
cases	O
may	O
provide	O
additional	O
insight	O
into	O
the	O
disease	O
,	O
particularly	O
if	O
a	O
stop	O
mutation	B-SO
were	O
to	O
be	O
identified	O
;	O
however	O
,	O
the	O
mutational	B-SO
mechanism	O
noted	O
here	O
means	O
that	O
standard	O
sequencing	O
approaches	O
alone	O
are	O
insufficient	O
to	O
confidently	O
rule	O
out	O
ITPR1	B-GGP
mutation	B-SO
as	O
a	O
cause	O
of	O
disease	O
:	O
a	O
comprehensive	O
gene	B-SO
dosage	O
approach	O
is	O
also	O
required	O
.	O

Given	O
that	O
SCA16	O
and	O
autosomal	B-GO
dominant	O
congenital	O
nonprogressive	O
ataxia	O
have	O
both	O
recently	O
been	O
mapped	O
to	O
regions	B-SO
overlapping	B-SO
with	O
the	O
SCA15	O
locus	B-SO
[	O
10	O
,	O
11	O
]	O
,	O
ITPR1	B-GGP
is	O
a	O
gene	B-SO
of	O
importance	O
for	O
screening	O
in	O
these	O
families	O
.	O

These	O
data	O
add	O
weight	O
to	O
a	O
role	O
for	O
aberrant	O
intracellular	B-GO
Ca2	B-CHEBI
+	I-CHEBI
signaling	O
in	O
Purkinje	B-CL
cells	I-CL
in	O
the	O
pathogenesis	O
of	O
spinocerebellar	O
ataxia	O
.	O

Materials	O
and	O
Methods	O

Genome	B-SO
-	O
wide	O
linkage	O
in	O
mice	B-Taxon
.	O

One	O
hundred	O
and	O
twenty	O
DNA	B-SO
fragments	B-SO
were	O
amplified	O
across	O
the	O
genome	B-SO
,	O
each	O
selected	O
to	O
contain	O
one	O
or	O
more	O
strain	O
-	O
specific	O
SNPs	B-SO
that	O
would	O
differentiate	O
between	O
C57BL	O
/	O
6J	O
and	O
129x1	O
/	O
SvJ	O
inbred	O
strains	O
[	O
12	O
]	O
.	O

Each	O
fragment	B-SO
was	O
initially	O
amplified	O
in	O
11	O
affected	O
mice	B-Taxon
and	O
nine	O
unaffected	O
mice	B-Taxon
;	O
genotype	B-SO
calling	O
was	O
performed	O
by	O
dye	B-CHEBI
-	O
terminator	B-SO
sequencing	O
of	O
these	O
fragments	B-SO
.	O

Linkage	O
analysis	O
using	O
these	O
data	O
was	O
performed	O
using	O
mlink	O
[	O
13	O
]	O
,	O
which	O
revealed	O
a	O
positive	O
linkage	O
at	O
Chromosome	B-GO
6qE1	O
,	O
on	O
the	O
129x1	O
/	O
SvJ	O
background	O
(	O
two	O
-	O
point	O
LOD	O
score	O
5	O
.	O
13	O
at	O
marker	O
20	O
.	O
MMHAP85FLG2	O
)	O
.	O

In	O
an	O
attempt	O
to	O
narrow	O
the	O
disease	O
interval	B-SO
we	O
performed	O
backcross	O
experiments	O
that	O
resulted	O
in	O
the	O
generation	O
of	O
three	O
additional	O
affected	O
mice	B-Taxon
.	O

Genotyping	O
of	O
all	O
affected	O
mice	B-Taxon
across	O
the	O
disease	O
-	O
segregating	O
interval	B-SO
revealed	O
flanking	O
recombinants	O
and	O
a	O
candidate	O
region	B-SO
of	O
~	O
5	O
Mb	O
,	O
between	O
markers	O
D6Mit37	O
and	O
44	O
.	O
MMHAP85FLG5	O
(	O
Figure	O
S1	O
)	O
.	O

This	O
region	B-SO
contains	O
16	O
genes	B-SO
and	O
predicted	B-SO
transcripts	B-SO
.	O

Identification	O
of	O
the	O
underlying	O
genetic	B-SO
lesion	O
in	O
mice	B-Taxon
.	O

Identification	O
of	O
similar	O
phenotypes	O
in	O
mice	B-Taxon
linked	O
to	O
the	O
6qE1	O
interval	B-SO
was	O
performed	O
by	O
literature	O
searches	O
.	O

This	O
revealed	O
the	O
Itpr1opt	O
/	O
opt	O
mouse	B-Taxon
,	O
in	O
which	O
disease	O
is	O
caused	O
by	O
homozygous	O
deletion	B-SO
mutation	I-SO
of	O
exons	B-SO
43	O
and	O
44	O
of	O
Itpr1	B-GGP
.	O

Primer	B-SO
pairs	O
were	O
designed	O
to	O
sequence	O
each	O
of	O
the	O
coding	B-SO
exons	I-SO
and	O
at	O
least	O
50	O
bp	B-SO
of	O
each	O
flanking	B-SO
intronic	I-SO
sequence	I-SO
of	O
Itpr1	B-GGP
.	O

PCR	O
amplification	O
of	O
each	O
exon	B-SO
was	O
performed	O
using	O
DNA	B-SO
from	O
two	O
affected	O
mice	B-Taxon
as	O
templates	O
.	O

The	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mutation	B-SO
was	O
confirmed	O
by	O
sequencing	O
in	O
all	O
affected	O
mice	B-Taxon
(	O
Figure	O
S2	O
)	O
.	O

Breeding	O
experiments	O
were	O
performed	O
between	O
two	O
female	O
mice	B-Taxon
heterozygous	O
for	O
the	O
current	O
mutation	B-SO
(	O
Itpr1wt	O
/	O
Delta	O
18	O
)	O
and	O
a	O
male	O
mouse	B-Taxon
heterozygous	O
for	O
the	O
Itpr1opt	O
mutation	B-SO
(	O
Itpr1wt	O
/	O
opt	O
)	O
.	O

This	O
resulted	O
in	O
two	O
litters	O
of	O
mice	B-Taxon
with	O
a	O
total	O
of	O
four	O
affected	O
Itpr1opt	O
/	O
Delta	O
18	O
pups	O
(	O
from	O
a	O
total	O
of	O
15	O
;	O
two	O
of	O
seven	O
from	O
first	O
mating	O
;	O
two	O
of	O
eight	O
from	O
the	O
second	O
mating	O
)	O
with	O
a	O
phenotype	O
indistinguishable	O
from	O
that	O
of	O
the	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
and	O
Itpr1opt	O
/	O
opt	O
mice	B-Taxon
.	O

Analysis	O
of	O
Itpr1	B-GGP
protein	B-CHEBI
in	O
mice	B-Taxon
.	O

We	O
performed	O
Western	O
blot	O
analyses	O
using	O
standard	O
techniques	O
with	O
ECL	O
detection	O
kits	O
(	O
Amersham	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
amersham	O
.	O
com	O
)	O
.	O

Briefly	O
,	O
dissected	O
whole	O
brains	O
from	O
postnatal	O
day	O
21	O
littermates	O
were	O
homogenized	O
in	O
a	O
buffer	O
containing	O
50	O
mM	O
Tris	B-CHEBI
-	O
HCl	B-CHEBI
,	O
150	O
mM	O
NaCl	B-CHEBI
,	O
1	O
mM	O
EDTA	B-CHEBI
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
1	O
%	O
sodium	B-CHEBI
deoxycholate	I-CHEBI
,	O
0	O
.	O
1	O
%	O
SDS	B-CHEBI
,	O
and	O
a	O
cocktail	O
of	O
protease	B-CHEBI
inhibitors	I-CHEBI
(	O
Roche	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
roche	O
.	O
com	O
)	O
.	O

Homogenates	O
were	O
diluted	O
appropriately	O
,	O
mixed	O
with	O
4	O
x	O
reducing	O
sample	O
buffer	O
,	O
and	O
loaded	O
onto	O
4	O
%	O
-	O
12	O
%	O
precast	O
gradient	O
gels	O
(	O
Novex	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
invitrogen	O
.	O
com	O
)	O
for	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
immunoblotting	O
.	O

The	O
antibodies	B-GO
to	O
Itpr1	B-GGP
(	O
1	O
:	O
2	O
,	O
000	O
)	O
and	O
Actb	B-GGP
(	O
1	O
:	O
5	O
,	O
000	O
)	O
were	O
used	O
as	O
recommended	O
by	O
manufacturers	O
.	O

Immunohistochemistry	O
.	O

Brains	O
were	O
isolated	O
from	O
21	O
-	O
d	O
-	O
old	O
mice	B-Taxon
,	O
perfused	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
,	O
and	O
post	O
-	O
fixed	O
overnight	O
in	O
the	O
same	O
fixative	O
.	O

Brains	O
were	O
embedded	O
in	O
gelatin	O
,	O
and	O
35	O
-	O
mu	O
m	O
sagittal	O
sections	O
were	O
cut	O
using	O
a	O
sliding	O
microtome	O
(	O
NeuroScience	O
Associates	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
neuroscienceassociates	O
.	O
com	O
)	O
.	O

Sections	O
from	O
wild	B-SO
-	I-SO
type	I-SO
,	O
heterozygote	O
,	O
and	O
homozygous	O
brains	O
were	O
placed	O
in	O
the	O
MultiBrain	O
template	O
.	O

Sections	O
were	O
washed	O
in	O
1	O
x	O
PBS	O
prior	O
to	O
1	O
h	O
of	O
incubation	O
in	O
block	O
solution	O
containing	O
1	O
x	O
PBS	O
with	O
20	O
%	O
normal	O
goat	B-Taxon
serum	O
and	O
0	O
.	O
3	O
%	O
Triton	O
X	O
-	O
100	O
(	O
pH	O
7	O
.	O
4	O
)	O
.	O

Sections	O
were	O
incubated	O
overnight	O
at	O
4	O
degrees	O
C	O
in	O
primary	O
antibodies	B-GO
:	O
affinity	O
purified	O
polyclonal	O
Itpr1	B-GGP
antibody	B-GO
(	O
1	O
:	O
2	O
,	O
000	O
,	O
Chemicon	O
International	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
chemicon	O
.	O
com	O
)	O
and	O
monoclonal	O
anti	O
-	O
Calb1	B-GGP
antibody	B-GO
(	O
1	O
:	O
6	O
,	O
000	O
,	O
Sigma	O
-	O
Aldrich	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
)	O
diluted	O
in	O
carrier	O
solution	O
.	O

Following	O
extensive	O
washes	O
(	O
in	O
6	O
.	O
0	O
ml	O
of	O
PBS	O
,	O
three	O
times	O
)	O
,	O
sections	O
were	O
incubated	O
with	O
appropriate	O
secondary	O
antibodies	B-GO
(	O
Alexa	O
Fluor	O
555	O
goat	B-Taxon
anti	O
-	O
rabbit	B-Taxon
IgG	O
and	O
Alexa	O
Fluor	O
488	O
goat	B-Taxon
anti	O
-	O
mouse	B-Taxon
IgG	O
[	O
Invitrogen	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
invitrogen	O
.	O
com	O
]	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Sections	O
were	O
washed	O
and	O
mounted	O
on	O
glass	O
slides	O
in	O
a	O
buffered	B-CHEBI
medium	O
containing	O
Mowiol	O
(	O
Calbiochem	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
emdbiosciences	O
.	O
com	O
)	O
as	O
described	O
earlier	O
[	O
14	O
]	O
.	O

Sections	O
were	O
imaged	O
using	O
a	O
laser	O
scanning	O
confocal	O
microscope	O
(	O
LSM	O
510	O
;	O
Zeiss	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
zeiss	O
.	O
com	O
)	O
.	O

Imaging	O
parameters	O
(	O
pinhole	O
,	O
detector	O
gain	O
,	O
laser	O
power	O
)	O
were	O
optimized	O
,	O
and	O
were	O
kept	O
constant	O
for	O
the	O
wild	B-SO
-	I-SO
type	I-SO
,	O
heterozygous	O
,	O
and	O
homozygous	O
mutant	B-SO
brains	O
.	O

Specificity	O
of	O
the	O
Itpr1	B-GGP
antibodies	B-GO
was	O
verified	O
by	O
preabsorption	O
control	O
experiments	O
.	O

Antibody	B-GO
dilutions	O
were	O
incubated	O
for	O
24	O
h	O
at	O
4	O
degrees	O
C	O
with	O
the	O
immunizing	O
peptide	B-SO
.	O

Tissue	O
sections	O
were	O
incubated	O
with	O
the	O
preabsorbed	O
antibodies	B-GO
and	O
processed	O
as	O
described	O
above	O
.	O

Under	O
these	O
conditions	O
,	O
no	O
staining	O
above	O
autofluorescence	O
was	O
detected	O
.	O

Analysis	O
of	O
ITPR1	B-GGP
in	O
SCA15	O
patients	O
.	O

DNA	B-SO
was	O
extracted	O
from	O
EBV	B-Taxon
immortalized	O
lymphocytes	B-CL
,	O
derived	O
from	O
family	O
members	O
.	O

The	O
coding	B-SO
exons	I-SO
and	O
at	O
least	O
50	O
bp	B-SO
of	O
flanking	O
introns	B-SO
of	O
ITPR1	B-GGP
were	O
PCR	O
amplified	O
and	O
sequenced	O
using	O
dye	B-CHEBI
-	O
terminator	B-SO
sequencing	O
(	O
BigDye	O
version	O
3	O
.	O
1	O
;	O
Applied	O
Biosystems	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
appliedbiosystems	O
.	O
com	O
)	O
.	O

Sequence	B-SO
reactions	O
were	O
run	O
on	O
an	O
ABI3730XP	O
automated	O
sequencer	O
as	O
per	O
the	O
manufacturer	O
'	O
s	O
instructions	O
(	O
Applied	O
Biosystems	O
)	O
.	O

This	O
analysis	O
was	O
performed	O
in	O
all	O
three	O
affected	O
family	O
members	O
for	O
whom	O
genomic	B-SO
DNA	I-SO
was	O
available	O
(	O
members	O
6	O
,	O
7	O
,	O
and	O
19	O
)	O
.	O

Primer	B-SO
sequences	I-SO
and	O
conditions	O
are	O
available	O
upon	O
request	O
.	O

Sequence	B-SO
data	O
were	O
analyzed	O
using	O
Sequencher	O
(	O
Gene	B-SO
Codes	O
Corporation	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
genecodes	O
.	O
com	O
)	O
.	O

Genome	B-SO
-	O
wide	O
SNP	B-SO
genotyping	O
was	O
performed	O
using	O
Infinium	O
HumanHap550	O
SNP	B-SO
genotyping	O
chips	O
as	O
per	O
the	O
manufacturer	O
'	O
s	O
protocol	O
(	O
Illumina	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
illumina	O
.	O
com	O
)	O
.	O

This	O
product	O
assays	O
555	O
,	O
352	O
unique	O
SNPs	B-SO
.	O

Data	O
were	O
collected	O
using	O
the	O
Illumina	O
BeadStation	O
scanner	O
and	O
data	O
collection	O
software	O
.	O

Genotypes	B-SO
were	O
produced	O
using	O
the	O
genotyping	O
module	O
of	O
BeadStudio	O
(	O
version	O
2	O
.	O
3	O
.	O
25	O
;	O
Illumina	O
)	O
,	O
and	O
log	O
R	O
ratio	O
and	O
B	O
allele	B-SO
frequency	O
were	O
visualized	O
using	O
the	O
genome	B-SO
viewer	O
tool	O
within	O
this	O
package	O
.	O

In	O
order	O
to	O
rule	O
out	O
the	O
possibility	O
that	O
the	O
observed	O
deletion	B-SO
within	O
ITPR1	B-GGP
was	O
a	O
benign	O
copy	O
number	O
variant	O
we	O
examined	O
log	O
R	O
ratio	O
and	O
B	O
allele	B-SO
frequency	O
metrics	O
of	O
HumanHap550	O
genotyping	O
data	O
at	O
this	O
locus	B-SO
from	O
577	O
individuals	B-Taxon
of	O
Northern	O
European	O
descent	O
from	O
North	O
America	O
and	O
Europe	O
,	O
produced	O
by	O
us	O
as	O
a	O
part	O
of	O
an	O
ongoing	O
study	O
.	O

In	O
an	O
attempt	O
to	O
narrow	O
the	O
unknown	O
intervals	B-SO
flanking	O
the	O
deletion	B-SO
observed	O
in	O
family	O
AUS1	O
,	O
we	O
designed	O
primers	B-SO
for	O
30	O
PCR	O
amplifications	O
that	O
would	O
generate	O
overlapping	B-SO
fragments	B-SO
across	O
the	O
two	O
bordering	B-SO
regions	I-SO
(	O
primer	B-SO
sequence	I-SO
and	O
conditions	O
available	O
upon	O
request	O
)	O
.	O

There	O
were	O
ten	O
primer	B-SO
pairs	O
in	O
the	O
telomeric	B-SO
flanking	B-SO
region	I-SO
and	O
20	O
pairs	O
in	O
the	O
centromeric	B-SO
flanking	B-SO
region	I-SO
(	O
Figure	O
S3	O
)	O
.	O

On	O
average	O
each	O
product	O
was	O
~	O
750	O
bp	B-SO
in	O
size	O
,	O
and	O
amplifications	O
were	O
performed	O
using	O
genomic	B-SO
DNA	I-SO
from	O
each	O
of	O
the	O
three	O
affected	O
individuals	B-Taxon
(	O
family	O
members	O
6	O
,	O
7	O
,	O
and	O
19	O
)	O
.	O

Dye	B-CHEBI
-	O
terminator	B-SO
sequencing	O
of	O
each	O
product	O
was	O
performed	O
using	O
the	O
forward	B-SO
and	I-SO
reverse	I-SO
primers	I-SO
designed	B-SO
for	O
amplification	O
;	O
running	O
and	O
analysis	O
of	O
each	O
fragment	B-SO
was	O
performed	O
as	O
described	O
above	O
.	O

Amplification	O
of	O
a	O
fragment	B-SO
from	O
a	O
normal	O
diploid	O
genome	B-SO
was	O
denoted	O
by	O
the	O
presence	O
of	O
a	O
heterozygous	O
polymorphism	B-SO
;	O
amplification	O
of	O
a	O
fragment	B-SO
from	O
a	O
region	B-SO
of	O
the	O
genome	B-SO
harboring	O
a	O
heterozygous	O
genomic	B-SO
deletion	B-SO
was	O
inferred	O
when	O
homozygosity	O
for	O
the	O
major	O
allele	B-SO
and	O
the	O
minor	O
allele	B-SO
were	O
noted	O
among	O
the	O
three	O
affected	O
family	O
members	O
(	O
i	O
.	O
e	O
.	O
,	O
this	O
is	O
inconsistent	O
with	O
Mendelian	O
inheritance	O
in	O
related	O
individuals	B-Taxon
known	O
to	O
share	O
a	O
common	O
haplotype	B-SO
)	O
.	O

Using	O
the	O
data	O
from	O
the	O
experiments	O
described	O
above	O
we	O
were	O
able	O
to	O
limit	O
the	O
size	O
of	O
unknown	O
regions	B-SO
flanking	O
the	O
deletion	B-SO
to	O
~	O
4	O
kb	O
on	O
the	O
telomeric	B-SO
side	O
and	O
7	O
kb	O
on	O
the	O
centromeric	B-SO
side	O
.	O

All	O
combinations	O
of	O
forward	B-SO
primers	I-SO
from	O
the	O
newly	O
defined	O
region	B-SO
flanking	O
the	O
deletion	B-SO
on	O
the	O
telomeric	B-SO
side	O
with	O
reverse	B-SO
primers	I-SO
from	O
the	O
newly	O
defined	O
region	B-SO
flanking	O
the	O
deletion	B-SO
on	O
the	O
centromeric	B-SO
side	O
were	O
used	O
in	O
PCR	O
amplification	O
reactions	O
performed	O
with	O
DNA	B-SO
from	O
the	O
three	O
affected	O
family	O
members	O
and	O
single	O
unaffected	O
family	O
members	O
.	O

This	O
experiment	O
was	O
performed	O
in	O
an	O
attempt	O
to	O
amplify	O
across	O
the	O
deleted	B-SO
fragment	B-SO
and	O
define	O
the	O
exact	O
breakpoint	B-SO
.	O

A	O
single	O
fragment	B-SO
was	O
obtained	O
from	O
the	O
third	O
forward	B-SO
primer	I-SO
from	O
the	O
telomeric	B-SO
side	O
(	O
T3f	O
5	O
'	O
-	O
TGAATGCTCAATTTTCCAGC	O
-	O
3	O
'	O
)	O
with	O
the	O
11th	O
reverse	B-SO
primer	I-SO
from	O
the	O
centromeric	B-SO
side	O
(	O
C11r	O
5	O
'	O
-	O
GGGAAAATGGATAGAGGGTG	O
-	O
3	O
'	O
)	O
.	O

The	O
fragment	B-SO
,	O
which	O
is	O
953	O
bp	B-SO
in	O
size	O
,	O
was	O
sequenced	O
as	O
described	O
above	O
and	O
compared	O
to	O
the	O
current	O
build	B-SO
of	O
the	O
human	B-Taxon
genome	B-SO
.	O

A	O
similar	O
series	O
of	O
experiments	O
was	O
performed	O
to	O
identify	O
the	O
deletion	B-SO
breakpoints	I-SO
in	O
families	O
H27	O
and	O
H33	O
;	O
we	O
were	O
able	O
to	O
amplify	O
a	O
369	O
-	O
bp	B-SO
PCR	B-SO
product	I-SO
across	O
the	O
breakpoint	B-SO
found	O
in	O
affected	O
members	O
of	O
family	O
H27	O
using	O
primer	B-SO
pair	O
H27	O
-	O
11F	O
5	O
'	O
-	O
GACCTCAAGAAGGCATGAATAC	O
-	O
3	O
'	O
and	O
H27	O
-	O
3R	O
5	O
'	O
-	O
ATGGTGGCCAGGTACACAAG	O
-	O
3	O
'	O
(	O
Figure	O
S4	O
)	O
,	O
but	O
to	O
date	O
we	O
have	O
been	O
unable	O
to	O
identify	O
the	O
breakpoint	B-SO
in	O
family	O
H33	O
.	O

Western	O
blot	O
analysis	O
in	O
SCA15	O
patients	O
.	O

EBV	B-Taxon
immortalized	O
lymphoblasts	O
from	O
three	O
affected	O
family	O
members	O
who	O
carry	O
the	O
deletion	B-SO
and	O
one	O
family	O
member	O
without	O
the	O
mutation	B-SO
were	O
used	O
as	O
a	O
readily	O
accessible	O
source	O
of	O
protein	B-CHEBI
;	O
all	O
samples	O
came	O
from	O
members	O
of	O
family	O
AUS1	O
.	O

Protein	B-CHEBI
extraction	O
was	O
performed	O
using	O
lysis	O
buffer	O
containing	O
1	O
x	O
TBS	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
,	O
and	O
a	O
cocktail	O
of	O
protease	B-CHEBI
inhibitors	I-CHEBI
(	O
Roche	O
)	O
with	O
overnight	O
lysis	O
at	O
-	O
80	O
degrees	O
C	O
.	O

Homogenates	O
were	O
diluted	O
appropriately	O
,	O
mixed	O
with	O
4	O
x	O
reducing	O
sample	O
buffer	O
,	O
and	O
loaded	O
onto	O
4	O
%	O
-	O
12	O
%	O
precast	O
gradient	O
gels	O
(	O
NuPAGE	O
,	O
Invitrogen	O
)	O
for	O
SDS	B-CHEBI
-	O
PAGE	O
and	O
immunoblotting	O
.	O

The	O
antibodies	B-GO
to	O
ITPR1	B-GGP
(	O
1	O
:	O
1	O
,	O
000	O
)	O
and	O
ACTB	B-GGP
(	O
1	O
:	O
5	O
,	O
000	O
)	O
were	O
used	O
as	O
recommended	O
by	O
manufacturers	O
.	O

Supporting	O
Information	O

Figure	O
S1	O

Schematic	O
of	O
Genotyping	O
Results	O
across	O
Mouse	B-Taxon
Chromosome	B-GO
6	O
in	O
Affected	O
Mice	B-Taxon

Black	O
squares	O
are	O
indicative	O
of	O
a	O
C57BL	O
/	O
6J	O
homozygous	O
genotype	B-SO
;	O
light	O
grey	O
squares	O
,	O
a	O
129x1	O
/	O
SvJ	O
homozygous	O
genotype	B-SO
;	O
grey	O
squares	O
,	O
a	O
C57BL	O
/	O
6J	O
129x1	O
/	O
SvJ	O
heterozygous	O
genotype	B-SO
;	O
white	O
squares	O
,	O
undetermined	O
genotype	B-SO
.	O

The	O
black	O
box	O
bounds	O
a	O
region	B-SO
of	O
homozygous	O
129x1	O
/	O
SvJ	O
genotypes	B-SO
that	O
segregate	O
with	O
disease	O
;	O
thus	O
,	O
the	O
critical	O
region	B-SO
was	O
determined	O
to	O
be	O
between	O
markers	O
D6Mit37	O
and	O
44	O
.	O
MMHAP85FLG5	O
.	O

(	O
10	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S2	O

Sequence	B-SO
of	O
Exon	B-SO
36	O
of	O
Itpr1	B-GGP
from	O
Four	O
Mice	B-Taxon

A	O
wild	B-SO
-	I-SO
type	I-SO
homozygous	O
C57BL	O
/	O
6J	O
mouse	B-Taxon
(	O
A	O
)	O
,	O
a	O
wild	B-SO
-	I-SO
type	I-SO
homozygous	O
129x1	O
/	O
SvJ	O
mouse	B-Taxon
(	O
B	O
)	O
,	O
an	O
affected	O
129x1B6	O
mice	B-Taxon
homozygous	O
for	O
the	O
18	O
-	O
bp	B-SO
deletion	B-SO
mutation	I-SO
(	O
C	O
)	O
,	O
and	O
an	O
unaffected	O
mouse	B-Taxon
heterozygous	O
for	O
the	O
18	O
-	O
bp	B-SO
deletion	B-SO
mutation	I-SO
(	O
D	O
)	O
.	O

The	O
deleted	B-SO
nucleotides	B-CHEBI
are	O
bounded	O
by	O
a	O
green	O
box	O
.	O

(	O
5	O
.	O
1	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S3	O

Additional	O
Families	O
Harboring	O
Deletion	B-SO
at	O
the	O
SCA15	O
Locus	B-SO

(	O
A	O
)	O
Family	O
H33	O
;	O
(	O
B	O
)	O
family	O
H27	O
.	O

Upper	O
panel	O
shows	O
log	O
R	O
ratio	O
and	O
B	O
allele	B-SO
frequency	O
metrics	O
generated	O
from	O
Infinium	O
HumanHap550	O
arrays	O
for	O
an	O
affected	O
family	O
member	O
from	O
each	O
family	O
.	O

Log	O
R	O
ratio	O
is	O
the	O
ratio	O
of	O
normalized	O
,	O
observed	O
R	O
to	O
expected	O
R	O
for	O
each	O
SNP	B-SO
(	O
each	O
SNP	B-SO
is	O
a	O
blue	O
dot	O
)	O
and	O
thus	O
serves	O
as	O
a	O
surrogate	O
of	O
copy	O
number	O
at	O
each	O
locus	B-SO
.	O

B	O
allele	B-SO
frequency	O
is	O
a	O
measure	O
of	O
the	O
number	O
of	O
times	O
the	O
A	O
or	O
B	O
alleles	B-SO
are	O
detected	O
at	O
each	O
locus	B-SO
(	O
each	O
SNP	B-SO
is	O
denoted	O
by	O
a	O
blue	O
dot	O
)	O
.	O

Thus	O
,	O
SNPs	B-SO
with	O
a	O
B	O
allele	B-SO
frequency	O
of	O
one	O
are	O
apparent	O
B	O
/	O
B	O
homozygotes	O
,	O
SNPs	B-SO
with	O
a	O
B	O
allele	B-SO
frequency	O
of	O
0	O
.	O
5	O
are	O
apparent	O
A	O
/	O
B	O
heterozygotes	O
,	O
and	O
those	O
with	O
a	O
B	O
allele	B-SO
frequency	O
of	O
zero	O
are	O
apparent	O
A	O
/	O
A	O
homozygotes	O
.	O

These	O
plots	O
show	O
a	O
contiguous	O
region	B-SO
~	O
310	O
kb	O
long	O
(	O
family	O
H33	O
)	O
and	O
~	O
350	O
kb	O
long	O
(	O
family	O
H27	O
)	O
with	O
decreased	O
copy	O
number	O
and	O
apparent	O
homozygosity	O
indicative	O
of	O
a	O
genomic	B-SO
deletion	B-SO
(	O
shaded	O
grey	O
)	O
.	O

The	O
pedigrees	O
below	O
show	O
the	O
available	O
family	O
members	O
assayed	O
for	O
these	O
deletions	B-SO
,	O
all	O
of	O
whom	O
were	O
affected	O
and	O
all	O
of	O
whom	O
carried	O
a	O
deletion	B-SO
at	O
this	O
locus	B-SO
.	O

(	O
6	O
.	O
8	O
MB	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Figure	O
S4	O

Deleted	B-SO
Regions	B-SO
Identified	O
in	O
Families	O
AUS1	O
and	O
H27	O

(	O
Top	O
)	O
Family	O
AUS1	O
;	O
sequence	B-SO
from	O
the	O
PCR	B-SO
product	I-SO
generated	O
using	O
primers	B-SO
T3f	O
and	O
C11r	O
from	O
genomic	B-SO
DNA	I-SO
from	O
an	O
affected	O
family	O
member	O
.	O

Red	O
arrowhead	O
denotes	O
the	O
deletion	B-SO
breakpoint	I-SO
;	O
the	O
deletion	B-SO
is	O
201	O
,	O
510	O
bp	B-SO
in	O
length	O
.	O

(	O
Bottom	O
)	O
Family	O
H27	O
;	O
sequence	B-SO
flanking	O
deleted	B-SO
region	B-SO
.	O

Green	O
font	O
indicates	O
nucleotides	B-CHEBI
telomeric	B-SO
to	O
the	O
deletion	B-SO
;	O
blue	O
font	O
indicates	O
nucleotides	B-CHEBI
centromeric	B-SO
to	O
the	O
deletion	B-SO
.	O

The	O
deletion	B-SO
is	O
344	O
,	O
408	O
bp	B-SO
in	O
length	O
.	O

Basepair	B-SO
positions	I-SO
are	O
based	O
on	O
NCBI	O
genome	B-SO
build	B-SO
36	O
reference	O
assembly	B-SO
.	O

(	O
876	O
KB	O
MB	O
TIF	O
)	O
.	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Accession	O
Numbers	O

The	O
OMIM	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
OMIM	O
)	O
accession	O
number	O
for	O
SUMF1	B-GGP
is	O
607939	B-GGP
.	O

Acknowledgements	O

We	O
thank	O
the	O
SCA15	O
family	O
members	O
for	O
participating	O
in	O
this	O
study	O
.	O

Abbreviations	O

EBV	B-Taxon
-	O
Epstein	B-Taxon
-	I-Taxon
Barr	I-Taxon
virus	I-Taxon

SCA	O
[	O
number	O
]	O
-	O
spinocerebellar	O
ataxia	O
[	O
number	O
]	O

SNP	B-SO
-	O
single	B-SO
nucleotide	I-SO
polymorphism	I-SO

Figures	O
and	O
Tables	O

Figure	O
1	O

Immunohistochemistry	O
and	O
Western	O
Blot	O
Analysis	O
of	O
ITPR1	B-GGP
Protein	B-CHEBI
Levels	O
in	O
Mouse	B-Taxon
Cerebellum	O

(	O
A	O
-	O
F	O
)	O
Immunohistochemistry	O
of	O
cerebellum	O
from	O
a	O
wild	B-SO
-	I-SO
type	I-SO
mouse	B-Taxon
(	O
A	O
and	O
D	O
)	O
,	O
a	O
mouse	B-Taxon
heterozygous	O
for	O
the	O
Itpr1	B-GGP
18	O
-	O
bp	B-SO
deletion	B-SO
(	O
B	O
and	O
E	O
)	O
,	O
and	O
a	O
mouse	B-Taxon
homozygous	O
for	O
the	O
18	O
-	O
bp	B-SO
Itpr1	B-GGP
deletion	B-SO
(	O
C	O
and	O
F	O
)	O
.	O

(	O
A	O
-	O
C	O
)	O
Immunohistochemistry	O
using	O
polyclonal	O
Itpr1	B-GGP
anti	O
-	O
rabbit	B-Taxon
antibody	B-GO
(	O
1	O
:	O
2	O
,	O
000	O
;	O
Alexa	O
Fluor	O
555	O
)	O
;	O
(	O
D	O
-	O
F	O
)	O
immunohistochemistry	O
using	O
monoclonal	O
Calb1	B-GGP
anti	O
-	O
mouse	B-Taxon
antibody	B-GO
(	O
1	O
:	O
6	O
,	O
000	O
;	O
Alexa	O
Fluor	O
488	O
)	O
.	O

Scale	O
bars	O
denote	O
100	O
mu	O
m	O
.	O

As	O
previously	O
described	O
,	O
Iptr1	B-GGP
is	O
highly	O
expressed	O
in	O
the	O
Purkinje	B-CL
cells	I-CL
.	O

Notably	O
,	O
there	O
appears	O
to	O
be	O
decreased	O
immunoreactivity	O
to	O
Itpr1	B-GGP
in	O
the	O
heterozygous	O
and	O
homozygous	O
mutant	B-SO
mice	B-Taxon
.	O

(	O
G	O
)	O
Western	O
blot	O
performed	O
to	O
examine	O
Itpr1	B-GGP
levels	O
in	O
whole	O
brain	O
from	O
wild	B-SO
-	I-SO
type	I-SO
,	O
Itpr1wt	O
/	O
Delta	O
18	O
,	O
and	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mice	B-Taxon
;	O
this	O
clearly	O
shows	O
a	O
reduction	O
of	O
Itpr1	B-GGP
in	O
brain	O
tissue	O
from	O
Itpr1wt	O
/	O
Delta	O
18	O
mice	B-Taxon
and	O
a	O
greater	O
reduction	O
of	O
Itpr1	B-GGP
in	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mice	B-Taxon
.	O

Figure	O
2	O

Metrics	O
Derived	O
from	O
Analysis	O
of	O
DNA	B-SO
from	O
Affected	O
Family	O
Member	O
7	O
Using	O
Illumina	O
Infinium	O
HumanHap550	O
Genotyping	O
Chips	O

The	O
upper	O
and	O
lower	O
plots	O
are	O
log	O
R	O
ratio	O
and	O
B	O
allele	B-SO
frequency	O
,	O
respectively	O
,	O
at	O
an	O
~	O
800	O
-	O
kb	O
segment	B-SO
on	O
the	O
p	O
arm	B-SO
of	I-SO
Chromosome	I-SO
3	O
.	O

Log	O
R	O
ratio	O
is	O
the	O
ratio	O
of	O
normalized	O
,	O
observed	O
R	O
to	O
expected	O
R	O
for	O
each	O
SNP	B-SO
(	O
each	O
SNP	B-SO
is	O
a	O
blue	O
dot	O
)	O
and	O
thus	O
serves	O
as	O
a	O
surrogate	O
of	O
copy	O
number	O
at	O
each	O
locus	B-SO
.	O

B	O
allele	B-SO
frequency	O
is	O
a	O
measure	O
of	O
the	O
number	O
of	O
times	O
the	O
A	O
or	O
B	O
alleles	B-SO
are	O
detected	O
at	O
each	O
locus	B-SO
(	O
each	O
SNP	B-SO
is	O
denoted	O
by	O
a	O
blue	O
dot	O
)	O
.	O

Thus	O
,	O
SNPs	B-SO
with	O
a	O
B	O
allele	B-SO
frequency	O
of	O
one	O
are	O
apparent	O
B	O
/	O
B	O
homozygotes	O
,	O
SNPs	B-SO
with	O
a	O
B	O
allele	B-SO
frequency	O
of	O
0	O
.	O
5	O
are	O
apparent	O
A	O
/	O
B	O
heterozygotes	O
,	O
and	O
those	O
with	O
a	O
B	O
allele	B-SO
frequency	O
of	O
zero	O
are	O
apparent	O
A	O
/	O
A	O
homozygotes	O
.	O

Clearly	O
,	O
these	O
plots	O
show	O
a	O
contiguous	O
region	B-SO
~	O
200	O
kb	O
long	O
with	O
decreased	O
copy	O
number	O
and	O
apparent	O
homozygosity	O
(	O
bounded	O
by	O
a	O
red	O
box	O
)	O
.	O

As	O
we	O
have	O
demonstrated	O
previously	O
,	O
this	O
is	O
indicative	O
of	O
a	O
heterozygous	O
genomic	B-SO
deletion	B-SO
[	O
15	O
]	O
.	O

Below	O
these	O
plots	O
is	O
a	O
schematic	O
of	O
the	O
two	O
known	B-SO
genes	B-SO
affected	O
by	O
this	O
deletion	B-SO
,	O
ITPR1	B-GGP
and	O
SUMF1	B-GGP
.	O

Figure	O
3	O

Mutation	B-SO
Analysis	O
in	O
the	O
Australian	O
SCA15	O
Family	O

(	O
Top	O
)	O
Pedigree	O
of	O
kindred	O
.	O

Filled	O
symbols	O
denote	O
affected	O
individuals	B-Taxon
;	O
open	O
symbols	O
,	O
unaffected	O
individuals	B-Taxon
;	O
grey	O
symbol	O
denotes	O
unknown	O
disease	O
status	O
;	O
bulls	O
-	O
eye	O
symbol	O
denotes	O
obligate	O
carrier	O
.	O

w	B-SO
/	O
w	B-SO
,	O
wild	B-SO
-	I-SO
type	I-SO
at	O
ITPR1	B-GGP
;	O
w	B-SO
/	O
m	B-SO
,	O
heterozygous	O
carrier	O
of	O
the	O
ITPR1	B-GGP
deletion	B-SO
.	O

(	O
Middle	O
)	O
Schematic	O
of	O
primer	B-SO
pairs	O
used	O
to	O
narrow	O
the	O
unknown	O
regions	B-SO
between	O
known	B-SO
deleted	B-SO
sequence	B-SO
and	O
known	B-SO
diploid	O
sequence	B-SO
at	O
the	O
SCA15	O
locus	B-SO
.	O

Nine	O
primer	B-SO
pairs	O
(	O
T1	O
-	O
T9	O
)	O
were	O
used	O
to	O
amplify	O
across	O
the	O
unknown	O
region	B-SO
telomeric	B-SO
to	O
the	O
known	B-SO
deleted	B-SO
region	B-SO
;	O
19	O
primer	B-SO
pairs	O
(	O
C1	O
-	O
C19	O
)	O
were	O
used	O
to	O
amplify	O
across	O
the	O
unknown	O
region	B-SO
centromeric	B-SO
to	O
the	O
known	B-SO
deleted	B-SO
region	B-SO
.	O

All	O
PCRs	O
were	O
carried	O
out	O
in	O
the	O
three	O
affected	O
family	O
members	O
.	O

Analysis	O
of	O
these	O
data	O
narrowed	O
the	O
unknown	O
region	B-SO
,	O
and	O
ultimately	O
we	O
were	O
able	O
to	O
use	O
primer	B-SO
T3f	O
and	O
C11r	O
to	O
amplify	O
across	O
the	O
deletion	B-SO
breakpoint	I-SO
in	O
the	O
three	O
affected	O
family	O
members	O
,	O
producing	O
a	O
fragment	B-SO
of	O
953	O
bp	B-SO
in	O
affected	O
individuals	B-Taxon
.	O

(	O
Bottom	O
)	O
Gel	O
showing	O
amplification	O
product	B-SO
using	O
primer	B-SO
pair	O
T3f	O
and	O
C11r	O
from	O
affected	O
pedigree	O
members	O
6	O
,	O
7	O
,	O
and	O
19	O
;	O
in	O
pedigree	O
member	O
23	O
,	O
with	O
unknown	O
disease	O
affection	O
status	O
;	O
in	O
a	O
neurologically	O
normal	O
control	O
(	O
C	O
)	O
;	O
and	O
in	O
a	O
no	O
template	O
control	O
(	O
NC	O
)	O
.	O

Figure	O
4	O

Western	O
Blot	O
Analysis	O
of	O
ITPR1	B-GGP
Protein	B-CHEBI
Levels	O
in	O
EBV	B-Taxon
Immortalized	O
Lymphoblasts	O
from	O
AUS1	O
Family	O
Members	O

Western	O
blot	O
performed	O
to	O
examine	O
ITPR1	B-GGP
levels	O
in	O
EBV	B-Taxon
immortalized	O
lymphocytes	B-CL
from	O
AUS1	O
affected	O
family	O
members	O
carrying	O
the	O
ITPR1	B-GGP
deletion	B-SO
and	O
from	O
an	O
AUS1	O
family	O
member	O
of	O
unknown	O
disease	O
status	O
who	O
does	O
not	O
carry	O
the	O
deletion	B-SO
.	O

Notably	O
the	O
samples	O
from	O
patients	O
with	O
ITPR1	B-GGP
deletion	B-SO
show	O
a	O
dramatic	O
decrease	O
in	O
ITPR1	B-GGP
levels	O
.	O

To	O
demonstrate	O
equal	O
loading	O
,	O
these	O
samples	O
were	O
diluted	O
one	O
in	O
five	O
,	O
and	O
the	O
Western	O
blot	O
was	O
repeated	O
using	O
an	O
antibody	B-GO
against	O
ACTB	B-GGP
.	O

Footnotes	O

A	O
previous	O
version	O
of	O
this	O
article	O
appeared	O
as	O
an	O
Early	O
Online	O
Release	O
on	O
May	O
16	O
,	O
2007	O
(	O
doi	O
:	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pgen	O
.	O
0030108	O
.	O
eor	O
)	O
.	O

Author	O
contributions	O
.	O

EMCF	O
,	O
JTR	O
,	O
and	O
ABS	O
conceived	O
and	O
designed	O
the	O
experiments	O
.	O

JvdL	O
,	O
JC	O
,	O
MAK	O
,	O
LAH	O
,	O
SS	O
,	O
MRC	O
,	O
HCF	O
,	O
XL	O
,	O
DH	O
,	O
JSS	O
,	O
IR	O
,	O
and	O
HC	O
performed	O
the	O
experiments	O
.	O

JvdL	O
,	O
JC	O
,	O
MAK	O
,	O
SS	O
,	O
MRC	O
,	O
KGH	O
,	O
HCF	O
,	O
JSS	O
,	O
JTR	O
,	O
and	O
ABS	O
analyzed	O
the	O
data	O
.	O

HH	O
,	O
NWW	O
,	O
PG	O
,	O
JH	O
,	O
ES	O
,	O
RJMG	O
,	O
SMF	O
,	O
HC	O
,	O
and	O
ABS	O
contributed	O
reagents	B-CHEBI
/	O
materials	O
/	O
analysis	O
tools	O
.	O

RJMG	O
,	O
EMCF	O
,	O
and	O
ABS	O
wrote	O
the	O
paper	O
.	O

Funding	O
.	O

This	O
research	O
was	O
funded	O
in	O
part	O
by	O
the	O
intramural	O
programs	O
of	O
the	O
National	O
Institute	O
on	O
Aging	O
and	O
the	O
National	O
Institute	O
on	O
Neurological	O
Disorders	O
and	O
Stroke	O
(	O
NINDS	O
)	O
,	O
both	O
of	O
the	O
National	O
Institutes	O
of	O
Health	O
,	O
Department	O
of	O
Health	O
and	O
Human	B-Taxon
Services	O
,	O
United	O
States	O
of	O
America	O
.	O

MAK	O
was	O
supported	O
by	O
a	O
NINDS	O
Competitive	O
Postdoctoral	O
Fellowship	O
.	O

HH	O
is	O
supported	O
by	O
the	O
Medical	O
Research	O
Council	O
,	O
United	O
Kingdom	O
.	O

Competing	O
interests	O
.	O

The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Clonación	O
y	O
caracterización	O
de	O
los	O
ratón	B-Protein
Mcoln1	I-Protein
gene	B-Sequence
revela	O
un	O
transcripción	B-Sequence
empalmada	I-Sequence
alternativamente	I-Sequence
no	O
visto	O
en	O
humanos	B-Taxon

Resumen	O

Antecedentes	O

La	O
mucolipidosis	O
tipo	O
IV	O
(	O
MLIV	O
)	O
es	O
una	O
autosómico	B-GENE
recesivo	O
lisosomal	B-GENE
Trastorno	O
de	O
almacenamiento	O
caracterizado	O
por	O
anomalías	O
neurológicas	O
y	O
oftalmológicas	O
graves	O
.	O

Recientemente	O
el	O
MLIV	B-Protein
gene	B-Sequence
,	O
MCOLN1	B-Protein
,	O
ha	O
sido	O
identificado	O
como	O
un	O
nuevo	O
miembro	O
del	O
receptor	O
de	O
potencial	O
transitorio	O
(	O
TRP	O
)	O
catión	B-Chemical
superfamilia	O
de	O
canales	O
.	O

Aquí	O
reportamos	O
la	O
clonación	O
y	O
caracterización	O
de	O
los	O
ratón	B-Taxon
homólogo	B-Sequence
,	O
mcoln1	B-Protein
,	O
y	O
reportar	O
una	O
novela	O
variante	B-Sequence
de	I-Sequence
empalme	I-Sequence
eso	O
no	O
se	O
ve	O
en	O
humanos	B-Taxon
.	O

Resultados	O

los	O
humano	B-Taxon
y	O
ratón	B-Taxon
genes	B-Sequence
mostrar	O
un	O
alto	O
grado	B-Sequence
de	I-Sequence
sintenia	I-Sequence
.	O

mcoln1	B-Protein
muestra	O
91	O
%	O
aminoácidos	B-Chemical
y	O
86	O
%	O
nucleótido	B-Chemical
identidad	O
a	O
MCOLN1	B-Protein
.	O

También	O
,	O
mcoln1	B-Protein
mapas	O
a	O
cromosoma	B-GENE
8	O
y	O
contiene	O
un	O
marco	B-Sequence
de	I-Sequence
lectura	I-Sequence
abierto	I-Sequence
de	O
580	O
aminoácidos	B-Chemical
,	O
con	O
un	O
transcripción	B-Sequence
longitud	O
de	O
aproximadamente	O
2	O
kb	O
codificada	O
por	O
14	O
exones	B-Sequence
,	O
similar	O
a	O
su	O
humano	B-Taxon
contrapartida	B-Sequence
.	O

los	O
transcripción	B-Sequence
que	O
resulta	O
de	O
murino	B-Taxon
empalme	O
alternativo	O
específico	O
codifica	O
un	O
611	O
proteína	B-Chemical
de	I-Chemical
aminoácidos	I-Chemical
que	O
difiere	O
en	O
el	O
c	B-Sequence
-	I-Sequence
terminal	I-Sequence
.	O

Conclusiones	O

mcoln1	B-Protein
es	O
muy	O
similar	O
a	O
MCOLN1	B-Protein
,	O
especialmente	O
en	O
el	O
transmembrana	B-GENE
dominios	B-Sequence
y	O
ion	B-Chemical
poro	O
región	B-Sequence
.	O

También	O
el	O
endosomal	B-GENE
tardío	I-GENE
/	O
lisosomal	B-GENE
apuntando	O
señal	B-Sequence
es	O
conservado	B-Sequence
,	O
apoyando	O
la	O
hipótesis	O
de	O
que	O
la	O
proteína	B-Chemical
se	O
localiza	O
en	O
estos	O
membranas	B-GENE
vesiculares	I-GENE
.	O

Hasta	O
la	O
fecha	O
,	O
hay	O
muy	O
pocos	O
informes	O
que	O
describan	O
especies	O
específicas	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
.	O

Mientras	O
que	O
la	O
identificación	O
de	O
mcoln1	B-Protein
es	O
fundamental	O
para	O
el	O
desarrollo	O
de	O
ratón	B-Taxon
modelos	O
para	O
MLIV	O
,	O
el	O
hecho	O
de	O
que	O
hay	O
dos	O
transcripciones	B-Sequence
en	O
ratones	B-Taxon
sugiere	O
una	O
función	O
adicional	O
o	O
alternativa	O
del	O
gene	B-Sequence
eso	O
puede	O
complicar	O
la	O
evaluación	O
fenotípica	O
.	O

Antecedentes	O

La	O
mucolipidosis	O
tipo	O
IV	O
(	O
MLIV	O
;	O
MIM	O
252650	O
)	O
es	O
una	O
autosómico	B-GENE
recesivo	O
lisosomal	B-GENE
trastorno	O
de	O
almacenamiento	O
que	O
se	O
caracteriza	O
por	O
opacidad	O
de	O
la	O
córnea	O
,	O
retraso	O
en	O
el	O
desarrollo	O
psicomotor	O
y	O
retraso	O
mental	O
que	O
suele	O
presentarse	O
durante	O
el	O
primer	O
año	O
de	O
vida	O
[	O
1	O
]	O
.	O

Otra	O
característica	O
clínica	O
interesante	O
es	O
que	O
los	O
pacientes	O
son	O
constitutivamente	O
aclorhídricos	O
con	O
hipergastremia	O
asociada	O
[	O
2	O
]	O
.	O

Los	O
pacientes	O
con	O
MLIV	O
no	O
muestran	O
mucopolisacárido	B-Chemical
excreción	O
,	O
cambios	O
esqueléticos	O
u	O
organomegalia	O
como	O
las	O
otras	O
mucolipidosis	O
.	O

Anormal	O
lisosomal	B-GENE
cuerpos	O
de	O
almacenamiento	O
y	O
grandes	O
vacuolas	B-GENE
se	O
han	O
encontrado	O
en	O
biopsias	O
de	O
piel	O
y	O
conjuntiva	O
usando	O
microscopía	O
electrónica	O
y	O
,	O
antes	O
de	O
gene	B-Sequence
la	O
identificación	O
,	O
servía	O
como	O
único	O
medio	O
de	O
diagnóstico	O
[	O
3-5	O
]	O
.	O

Un	O
informe	O
reciente	O
estima	O
que	O
la	O
frecuencia	O
de	O
portadores	O
de	O
MLIV	O
en	O
la	O
población	O
judía	O
Ashkenazi	O
es	O
de	O
1	O
en	O
100	O
,	O
y	O
mutaciones	B-Sequence
se	O
han	O
informado	O
en	O
familias	O
judías	O
y	O
no	O
judías	O
[	O
6	O
-	O
9	O
]	O
.	O

los	O
humano	B-Taxon
gene	B-Sequence
MCOLN1	B-Protein
GenBank	O
#	O
AF287270	O
)	O
se	O
asigna	O
a	O
cromosoma	B-GENE
19p13	O
.	O
2	O
-	O
13	O
.	O
3	O
y	O
codifica	O
una	O
novela	O
proteína	B-Chemical
que	O
es	O
un	O
miembro	O
del	O
potencial	O
receptor	O
transitorio	O
(	O
TRP	O
)	O
catión	B-Chemical
canal	O
gene	B-Sequence
superfamilia	O
[	O
7	O
-	O
10	O
]	O
.	O

Proteína	B-Chemical
Los	O
estudios	O
de	O
tráfico	O
sugieren	O
que	O
la	O
MLIV	O
es	O
el	O
resultado	O
de	O
un	O
defecto	O
en	O
la	O
vía	O
endocítica	O
tardía	O
,	O
a	O
diferencia	O
de	O
otras	O
mucolipidosis	O
que	O
generalmente	O
son	O
causadas	O
por	O
defectos	O
lisosomal	B-GENE
hidrolasas	O
[	O
11	O
,	O
12	O
]	O
.	O

trabajo	O
reciente	O
en	O
Caenorhabditis	B-Taxon
elegans	I-Taxon
apoya	O
esta	O
hipótesis	O
.	O

Pérdida	O
de	O
función	O
mutantes	B-Sequence
de	O
El	O
MCOLN1	B-Protein
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
homólogo	B-Sequence
,	O
taza	B-Protein
-	I-Protein
5	I-Protein
,	O
resultan	O
en	O
un	O
aumento	O
de	O
la	O
tasa	O
de	O
endocitosis	O
,	O
acumulación	O
de	O
grandes	O
vacuolas	B-GENE
,	O
y	O
una	O
disminución	O
de	O
la	O
tasa	O
de	O
endocitosis	O
proteína	B-Chemical
desglose	O
;	O
mientras	O
que	O
sobre	O
-	O
expresión	O
de	O
este	O
gene	B-Sequence
invierte	O
el	O
fenotipo	O
[	O
13	O
]	O
.	O

Clonación	O
y	O
caracterización	O
de	O
los	O
ratón	B-Taxon
homólogo	B-Sequence
de	O
MCOLN1	B-Protein
es	O
fundamental	O
para	O
el	O
desarrollo	O
de	O
ratón	B-Taxon
modelos	O
de	O
MLIV	O
para	O
seguir	O
estudiando	O
este	O
trastorno	O
.	O

Resultados	O
y	O
discusión	O

Clonación	O
y	O
mapeo	O
de	O
la	O
ratón	B-Taxon
homólogo	B-Sequence
mcoln1	B-Protein

Para	O
clonar	O
el	O
ratón	B-Taxon
homólogo	B-Sequence
de	O
MCOLN1	B-Protein
,	O
los	O
humano	B-Taxon
secuencia	B-Sequence
de	I-Sequence
aminoácidos	I-Sequence
se	O
comparó	O
con	O
el	O
alto	O
rendimiento	O
secuencia	B-Sequence
genómica	I-Sequence
(	O
HTGS	O
)	O
usando	O
TBLASTN	O
,	O
que	O
identificó	O
la	O
ratón	B-Taxon
clon	B-Sequence
BAC	I-Sequence
RPCI	O
-	O
23	O
_	O
387H4	O
(	O
GB	O
n	O
.	O
AC079544	O
.	O
1	O
)	O
.	O

Correspondencia	O
con	O
la	O
Junta	O
genoma	B-Sequence
Instituto	O
y	O
el	O
Laboratorio	O
Nacional	O
Lawrence	O
Livermore	O
(	O
LLNL	O
)	O
Humano	B-Taxon
genoma	B-Sequence
Centro	O
confirmó	O
la	O
ubicación	B-Sequence
de	O
esta	O
BAC	B-Sequence
para	O
ratón	B-Taxon
cromosoma	B-GENE
8	O
y	O
nos	O
permitió	O
construir	O
un	O
mapa	B-Sequence
físico	I-Sequence
de	O
esta	O
región	B-Sequence
[	O
14	O
]	O
(	O
Figura	O
1A	O
)	O
.	O

los	O
secuencia	B-Sequence
BAC	I-Sequence
luego	O
se	O
comparó	O
con	O
el	O
ratón	B-Taxon
est	B-Sequence
base	O
de	O
datos	O
usando	O
BLASTN	O
,	O
y	O
múltiples	O
EST	B-Sequence
y	O
su	O
I	O
correspondiente	O
.	O
m	O
UN	O
.	O
g	O
mi	O
clones	B-Sequence
fueron	O
identificados	O
.	O

Figura	O
1	O

Mapa	B-Sequence
físico	I-Sequence
y	I-Sequence
de	I-Sequence
transcripción	I-Sequence
de	O
El	O
mcoln1	B-Protein
región	B-Sequence
del	I-Sequence
gen	I-Sequence
.	O

(	O
A	O
)	O
Mapa	B-Sequence
físico	I-Sequence
mostrando	O
un	O
590	O
kb	O
segmento	B-Sequence
de	I-Sequence
cromosoma	I-Sequence
de	I-Sequence
ratón	I-Sequence
8	O
sinteno	B-Sequence
para	O
humano	B-Taxon
cromosoma	B-GENE
19	O
,	O
anclado	O
por	O
el	O
genes	B-Sequence
Insr	B-Protein
y	O
No	B-Protein
.	I-Protein
.	O

los	O
región	B-Sequence
está	O
cubierto	O
por	O
tres	O
BAC	B-Sequence
RPCI	O
-	O
23	O
_	O
334D24	O
(	O
AC087153	O
)	O
,	O
RPCI	O
-	O
23	O
_	O
312B8	O
(	O
AC087150	O
)	O
y	O
RPCI	O
-	O
23	O
_	O
387H4	O
(	O
AC079544	O
)	O
.	O

(	O
B	O
)	O
El	O
transcripción	B-Sequence
mapa	O
de	O
mcoln1	B-Protein
espectáculos	O
14	O
exones	B-Sequence
,	O
y	O
el	O
ubicaciones	B-Sequence
de	O
El	O
sondas	B-Sequence
utilizados	O
en	O
este	O
estudio	O
se	O
ilustran	O
.	O

El	O
mapa	O
también	O
muestra	O
la	O
expansión	O
exón	B-Sequence
13	O
en	O
el	O
transcripción	B-Sequence
empalmada	I-Sequence
alternativamente	I-Sequence
(	O
cuadro	O
hash	O
)	O
.	O

Grupo	O
UniGene	O
Mm	O
.	O
39099	O
es	O
el	O
homólogo	B-Sequence
de	O
El	O
humano	B-Taxon
zinc	B-Chemical
dedo	O
gene	B-Sequence
(	O
AC001252	O
)	O
.	O

Cabe	O
señalar	O
que	O
la	O
escala	O
de	O
la	O
transcripción	B-Sequence
mapa	O
es	O
en	O
referencia	O
a	O
la	O
escala	O
de	O
201	O
kb	O
de	O
BAC	B-Sequence
RPCI-23_387H4	O
.	O

Tres	O
clones	B-Sequence
(	O
ID	O
Nos	O
.	O
604971	O
,	O
1228665	O
,	O
1247566	O
)	O
del	O
grupo	O
UniGene	O
Mm	O
.	O

8356	O
fueron	O
obtenidos	O
,	O
secuenciados	O
y	O
ensamblados	O
en	O
un	O
2	O
kb	O
transcripción	B-Sequence
con	O
un	O
marco	B-Sequence
de	I-Sequence
lectura	I-Sequence
abierto	I-Sequence
de	O
580	O
aminoácidos	B-Chemical
designado	O
mcoln1	B-Protein
(	O
GB	O
No	O
.	O
AF302010	O
)	O
.	O

Comparación	O
de	O
los	O
secuencia	B-Sequence
de	I-Sequence
ADNc	I-Sequence
al	O
clon	B-Sequence
BAC	I-Sequence
mostró	O
que	O
el	O
gene	B-Sequence
consta	O
de	O
14	O
exones	B-Sequence
.	O

Entonces	O
creamos	O
un	O
transcripción	B-Sequence
mapa	O
de	O
la	O
mcoln1	B-Protein
región	B-Sequence
del	I-Sequence
cromosoma	I-Sequence
de	I-Sequence
ratón	I-Sequence
8	O
(	O
Fig	O
.	O
1B	O
)	O
,	O
observando	O
la	O
presencia	O
del	O
UniGene	O
Cluster	O
Mm	O
.	O

39099	O
,	O
un	O
homólogo	B-Sequence
de	O
El	O
humano	B-Taxon
zinc	B-Chemical
dedo	O
gene	B-Sequence
GB	O
No	O
.	O
AC001252	O
)	O
que	O
termina	O
aproximadamente	O
en	O
1	O
.	O
8	O
kb	O
antes	O
del	O
comienzo	O
de	O
mcoln1	B-Protein
;	O
y	O
No	B-Protein
.	I-Protein
,	O
los	O
ratón	B-Taxon
homólogo	B-Sequence
de	O
El	O
gen	B-Protein
de	I-Protein
la	I-Protein
esterasa	I-Protein
diana	I-Protein
de	I-Protein
la	I-Protein
neuropatía	I-Protein
humana	I-Protein
(	I-Protein
NTE	I-Protein
)	I-Protein
)	O
a	O
partir	O
de	O
130	O
pares	B-Sequence
de	I-Sequence
bases	I-Sequence
después	O
de	O
la	O
señal	B-Sequence
de	I-Sequence
poliadenilación	I-Sequence
por	O
mcoln1	B-Protein
.	O

los	O
transcripción	B-Sequence
mapa	O
de	O
la	O
región	B-Sequence
rodeando	O
mcoln1	B-Protein
es	O
similar	O
al	O
correspondiente	O
región	B-Sequence
de	O
El	O
región	B-Sequence
homóloga	I-Sequence
humana	I-Sequence
MCOLN1	I-Sequence
[	O
15	O
]	O
,	O
y	O
la	O
presencia	O
del	O
zinc	B-Chemical
dedo	O
gene	B-Sequence
y	O
No	B-Protein
.	I-Protein
confirma	O
y	O
amplía	O
la	O
región	B-Sequence
de	I-Sequence
synteny	I-Sequence
Entre	O
humano	B-Taxon
cromosoma	B-GENE
19	O
y	O
ratón	B-Taxon
cromosoma	B-GENE
8	O

Caracterización	O
de	O
mcoln1	B-Protein

Comparación	O
de	O
los	O
ratón	B-Taxon
y	O
humano	B-Taxon
secuencias	B-Sequence
peptídicas	I-Sequence
mostró	O
un	O
91	O
%	O
de	O
identidad	O
(	O
Fig	O
.	O
2	O
)	O
.	O

los	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
homólogo	B-Sequence
taza	B-Protein
-	I-Protein
5	I-Protein
muestra	O
un	O
34	O
%	O
de	O
identidad	O
con	O
mcoln1	B-Protein
y	O
análisis	O
BLASTP	O
de	O
mcoln1	B-Protein
identificó	O
un	O
supuesto	O
Drosophila	B-Taxon
melanogaster	I-Taxon
homólogo	B-Sequence
que	O
muestra	O
un	O
38	O
%	O
de	O
identidad	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Curiosamente	O
,	O
dos	O
MCOLN1	B-Protein
aminoácidos	B-Chemical
sustituciones	B-Sequence
que	O
resultan	O
en	O
MLIV	O
ocurren	O
en	O
conservado	B-Sequence
aminoácidos	B-Chemical
.	O

El	O
análisis	O
de	O
TMPred	O
predice	O
una	O
proteína	B-Chemical
estructura	O
que	O
es	O
casi	O
idéntica	O
a	O
MCOLN1	B-Protein
,	O
que	O
contiene	O
6	O
transmembrana	B-GENE
dominios	B-Sequence
con	O
el	O
N	B-Sequence
-	I-Sequence
y	I-Sequence
C	I-Sequence
-	I-Sequence
terminales	I-Sequence
residiendo	O
en	O
el	O
citoplasma	B-GENE
(	O
Fig	O
.	O
2	O
)	O
[	O
9	O
]	O
.	O

Figura	O
2	O

Secuencia	B-Sequence
peptídica	I-Sequence
comparación	O
de	O
mcoln1	B-Protein
para	O
humano	B-Taxon
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
,	O
y	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
(	O
taza	B-Protein
-	I-Protein
5	I-Protein
)	O
homólogos	B-Sequence
.	O

Las	O
líneas	O
azules	O
indican	O
transmembrana	B-GENE
dominios	B-Sequence
,	O
el	O
cuadro	O
rojo	O
rodea	O
el	O
poro	O
del	O
canal	O
putativo	O
,	O
el	O
cuadro	O
naranja	O
rodea	O
el	O
poro	O
del	O
canal	O
putativo	O
endosomal	B-GENE
tardío	I-GENE
/	O
lisosomal	B-GENE
apuntando	O
señal	B-Sequence
.	O

Análisis	O
de	O
expresión	O
de	O
mcoln1	B-Protein

Ratón	B-Taxon
Se	O
hibridaron	O
transferencias	O
de	O
Northern	O
de	O
embriones	O
y	O
tejidos	O
múltiples	O
adultos	O
usando	O
un	O
Investigacion	B-Sequence
generada	O
a	O
partir	O
de	O
ratón	B-Taxon
exón	B-Sequence
2	O
(	O
Investigacion	B-Sequence
1	O
,	O
figura	O
.	O
1B	O
)	O
,	O
dando	O
una	O
banda	O
de	O
aproximadamente	O
2	O
.	O
4	O
kb	O
(	O
isoforma	B-Sequence
1	O
)	O
,	O
como	O
era	O
de	O
esperar	O
,	O
y	O
un	O
4	O
menos	O
abundante	O
e	O
inesperado	O
.	O
banda	O
de	O
4	O
kb	O
(	O
isoforma	B-Sequence
2	O
)	O
(	O
Figs	O
.	O
3A	O
y	O
3B	O
)	O
.	O

El	O
2	O
.	O
La	O
banda	O
de	O
4	O
kb	O
muestra	O
una	O
expresión	O
ubicua	O
pero	O
variable	O
,	O
con	O
la	O
máxima	O
expresión	O
en	O
cerebro	O
,	O
hígado	O
y	O
riñón	O
.	O

La	O
transferencia	O
de	O
tejido	O
fetal	O
muestra	O
niveles	O
decrecientes	O
de	O
2	O
.	O
4	O
kb	O
mensaje	B-Sequence
con	O
el	O
aumento	O
de	O
la	O
edad	O
gestacional	O
.	O

Desde	O
el	O
humano	B-Protein
MCOLN1	I-Protein
gene	B-Sequence
codifica	O
un	O
solo	O
transcripción	B-Sequence
[	O
7	O
-	O
9	O
]	O
,	O
llevamos	O
a	O
cabo	O
hibridaciones	O
adicionales	O
con	O
sondas	B-Sequence
generado	O
a	O
partir	O
de	O
varios	O
regiones	B-Sequence
de	I-Sequence
la	I-Sequence
secuencia	I-Sequence
codificante	I-Sequence
y	I-Sequence
3	I-Sequence
'	I-Sequence
UTR	I-Sequence
,	O
y	O
todo	O
sondas	B-Sequence
identificado	O
los	O
mismos	O
dos	O
transcripciones	B-Sequence
en	O
el	O
ratón	B-Taxon
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Para	O
verificar	O
la	O
presencia	O
de	O
un	O
solo	O
ratón	B-Taxon
lugar	B-Sequence
,	O
hibridamos	O
un	O
ratón	B-Taxon
mancha	O
sureña	O
con	O
el	O
exón	B-Sequence
2	O
Investigacion	B-Sequence
.	O

Cuatro	O
restricciones	O
diferentes	O
enzimas	B-Sequence
se	O
usaron	O
,	O
y	O
solo	O
las	O
bandas	O
de	O
tamaño	O
esperadas	O
para	O
el	O
locus	B-Sequence
del	I-Sequence
cromosoma	I-Sequence
8	I-Sequence
fueron	O
detectados	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

figura	O
3	O

Análisis	O
del	O
norte	O
de	O
mcoln1	B-Protein
.	O

(	O
A	O
)	O
Ratón	B-Taxon
tejido	O
fetal	O
Northern	O
y	O
(	O
B	O
)	O
ratón	B-Taxon
Northern	O
blot	O
de	O
tejidos	O
múltiples	O
(	O
Clontech	O
)	O
hibridados	O
con	O
un	O
Investigacion	B-Sequence
generada	O
a	O
partir	O
de	O
exón	B-Sequence
2	O
(	O
Investigacion	B-Sequence
1	O
,	O
figura	O
.	O
1B	O
)	O
.	O

(	O
C	O
)	O
Hibridación	O
de	O
la	O
transferencia	O
tisular	O
múltiple	O
con	O
un	O
Investigacion	B-Sequence
del	O
empalme	O
alternativo	O
segmento	B-Sequence
de	I-Sequence
exón	I-Sequence
13	O
(	O
Investigacion	B-Sequence
2	O
,	O
figura	O
.	O
1B	O
)	O
.	O

beta	B-Protein
-	I-Protein
actina	I-Protein
la	O
hibridación	O
de	O
control	O
se	O
muestra	O
debajo	O
de	O
cada	O
transferencia	O
.	O

Caracterización	O
de	O
la	O
mcoln1	B-Protein
variante	B-Sequence
de	I-Sequence
empalme	I-Sequence
alternativa	I-Sequence

Para	O
determinar	O
la	O
secuencia	B-Sequence
de	I-Sequence
codificación	I-Sequence
para	O
el	O
más	O
grande	O
transcripción	B-Sequence
,	O
buscamos	O
en	O
ratón	B-Taxon
est	B-Sequence
base	O
de	O
datos	O
usando	O
cada	O
intrón	B-Sequence
así	O
como	O
el	O
secuencia	B-Sequence
genómica	I-Sequence
flanqueando	O
el	O
mcoln1	B-Protein
gene	B-Sequence
.	O

Dos	O
EST	B-Sequence
fueron	O
identificados	O
que	O
contenían	O
secuencia	B-Sequence
desde	O
intrón	B-Sequence
12	O
(	O
GB	O
No	O
.	O
AI430291	O
y	O
AA874645	O
)	O
,	O
y	O
el	O
correspondiente	O
clones	B-Sequence
fueron	O
secuenciados	O
.	O

Clon	B-Sequence
408619	O
(	O
EST	B-Sequence
:	O
GB	O
No	O
.	O
AI430291	O
,	O
AI429558	O
)	O
comienza	O
aproximadamente	O
el	O
1	O
.	O
1	O
kb	O
antes	O
exón	B-Sequence
13	O
y	O
continúa	O
por	O
el	O
exón	B-Sequence
y	O
empalmes	O
correctamente	O
para	O
exón	B-Sequence
14	O

Clon	B-Sequence
1281641	O
(	O
est	B-Sequence
:	O
GB	O
No	O
.	O
AA874645	O
)	O
comienza	O
175	O
pb	B-Sequence
antes	O
de	O
exón	B-Sequence
13	O
y	O
también	O
empalma	O
correctamente	O
a	O
exón	B-Sequence
14	O

A	O
ratón	B-Taxon
múltiples	O
tejidos	O
Northern	O
se	O
hibridaron	O
usando	O
un	O
Investigacion	B-Sequence
generado	O
a	O
partir	O
del	O
supuesto	O
secuencia	B-Sequence
de	I-Sequence
intrones	I-Sequence
en	O
clon	B-Sequence
408619	O
(	O
Investigacion	B-Sequence
2	O
,	O
figura	O
.	O
1B	O
)	O
,	O
que	O
detectó	O
sólo	O
el	O
4	O
.	O
Banda	O
de	O
4	O
kb	O
(	O
Fig	O
.	O
3C	O
)	O
.	O

Para	O
determinar	O
la	O
secuencia	B-Sequence
del	O
todo	O
transcripción	B-Sequence
,	O
RT-PCR	O
utilizando	O
cebadores	B-Sequence
en	O
exones	B-Sequence
10	O
y	O
11	O
emparejados	O
con	O
un	O
cebador	B-Sequence
en	O
intrón	B-Sequence
12	O
se	O
realizó	O
utilizando	O
BALB/c	O
ratón	B-Taxon
cerebro	O
total	O
ARN	B-Sequence
y	O
el	O
resultado	O
productos	B-Sequence
secuenciado	O

Estas	O
productos	B-Sequence
demostrar	O
que	O
cuanto	O
más	O
grande	O
transcripción	B-Sequence
se	O
debe	O
a	O
un	O
evento	O
de	O
empalme	O
alternativo	O
que	O
da	O
como	O
resultado	O
una	O
expansión	O
exón	B-Sequence
13	O

Específicamente	O
,	O
exón	B-Sequence
12	O
empalmes	O
en	O
pb	B-Sequence
436	O
de	O
intrón	B-Sequence
12	O
,	O
creando	O
un	O
gran	O
1614	O
pb	B-Sequence
exón	I-Sequence
13	O
que	O
empalme	O
correctamente	O
a	O
exón	B-Sequence
14	O

los	O
marco	B-Sequence
de	I-Sequence
lectura	I-Sequence
abierto	I-Sequence
de	O
esta	O
transcripción	B-Sequence
empalmada	I-Sequence
alternativamente	I-Sequence
es	O
611	O
aminoácidos	B-Chemical
,	O
28	O
aminoácidos	B-Chemical
más	O
largo	O
que	O
el	O
mensaje	B-Sequence
codificado	O
por	O
el	O
2	O
.	O
4	O
kb	O
transcripción	B-Sequence
.	O

El	O
análisis	O
TMPred	O
predice	O
que	O
isoforma	B-Sequence
2	O
codifica	O
un	O
proteína	B-Chemical
idéntico	O
en	O
estructura	O
a	O
mcoln1	B-Protein
,	O
poseyendo	O
6	O
transmembrana	B-GENE
dominios	B-Sequence
y	O
un	O
poro	O
de	O
canal	O
,	O
sin	O
embargo	O
el	O
proteína	B-Chemical
secuencias	B-Sequence
divergir	O
en	O
aminoácidos	B-Chemical
526	O
.	O

el	O
55	O
aminoácidos	B-Chemical
C	B-Sequence
-	I-Sequence
cola	I-Sequence
citoplasmática	I-Sequence
terminal	I-Sequence
codificado	O
por	O
el	O
2	O
.	O
4	O
kb	O
transcripción	B-Sequence
es	O
completamente	O
diferente	O
del	O
86	O
cola	B-Sequence
de	I-Sequence
aminoácido	I-Sequence
codificado	O
por	O
el	O
murino	B-Taxon
específico	O
4	O
.	O
4	O
kb	O
transcripción	B-Sequence
(	O
Fig	O
.	O
4	O
)	O
.	O

Clontech	O
Ratón	B-Taxon
ARN	B-Sequence
Los	O
Master	O
Blot	O
se	O
hibridaron	O
con	O
el	O
exón	B-Sequence
2	O
y	O
intrón	B-Sequence
12	O
sondas	B-Sequence
mencionado	O
anteriormente	O
en	O
un	O
intento	O
de	O
determinar	O
si	O
estos	O
dos	O
transcripciones	B-Sequence
mostró	O
diferencias	O
en	O
los	O
patrones	O
de	O
expresión	O
,	O
sin	O
embargo	O
,	O
no	O
hubo	O
diferencia	O
significativa	O
en	O
los	O
22	O
tejidos	O
representados	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Figura	O
4	O

Secuencia	B-Sequence
peptídica	I-Sequence
comparación	O
de	O
los	O
dos	O
isoformas	B-Sequence
Mcoln1	I-Sequence
empalmadas	I-Sequence
alternativamente	I-Sequence
.	O

El	O
cuadro	O
verde	O
rodea	O
la	O
divergente	O
.	O
c	B-Sequence
-	I-Sequence
colas	I-Sequence
citoplasmáticas	I-Sequence
terminales	I-Sequence
.	O

Las	O
líneas	O
azules	O
indican	O
el	O
transmembrana	B-GENE
dominios	B-Sequence
.	O

A	O
continuación	O
,	O
comparamos	O
directamente	O
el	O
secuencia	B-Sequence
de	I-Sequence
nucleótidos	I-Sequence
y	I-Sequence
aminoácidos	I-Sequence
de	O
El	O
transcripción	B-Sequence
de	I-Sequence
ratón	I-Sequence
empalmada	I-Sequence
alternativamente	I-Sequence
a	O
la	O
totalidad	O
humano	B-Protein
MCOLN1	I-Protein
secuencia	B-Sequence
genómica	I-Sequence
y	O
no	O
encontró	O
ninguna	O
similitud	O
significativa	O
.	O

Como	O
se	O
mencionó	O
anteriormente	O
,	O
las	O
transferencias	O
Northern	O
realizadas	O
con	O
humano	B-Protein
MCOLN1	I-Protein
sondas	B-Sequence
mostrar	O
solo	O
uno	O
2	O
.	O
4	O
kb	O
transcripción	B-Sequence
.	O

Además	O
,	O
hibridamos	O
un	O
humano	B-Taxon
múltiples	O
tejidos	O
del	O
Norte	O
y	O
humano	B-Taxon
Sur	O
con	O
un	O
Investigacion	B-Sequence
en	O
humano	B-Taxon
intrón	B-Sequence
12	O
eso	O
es	O
adyacente	B-Sequence
para	O
exón	B-Sequence
13	O

los	O
Investigacion	B-Sequence
estaba	O
ubicado	O
en	O
el	O
región	B-Sequence
sintética	I-Sequence
al	O
que	O
codifica	O
el	O
transcripción	B-Sequence
alternativa	I-Sequence
de	I-Sequence
ratón	I-Sequence
.	O

Solo	O
se	O
detectaron	O
las	O
bandas	O
esperadas	O
en	O
el	O
sur	O
y	O
no	O
se	O
detectaron	O
bandas	O
en	O
el	O
norte	O
,	O
lo	O
que	O
confirma	O
que	O
este	O
transcripción	B-Sequence
alternativa	I-Sequence
es	O
específico	O
para	O
Mcoln1	B-Protein
murino	I-Protein
.	O

Análisis	O
reciente	O
de	O
BLASTP	O
de	O
la	O
transcripción	B-Sequence
alternativa	I-Sequence
de	I-Sequence
Mcoln1	I-Sequence
produce	O
un	O
partido	B-Sequence
a	O
un	O
putativo	O
145	O
aminoácidos	B-Chemical
anónimo	O
proteína	B-Chemical
(	O
GB	O
No	O
.	O
BAB25862	O
)	O
predicho	B-Sequence
de	O
un	O
RIKEN	O
clon	B-Sequence
.	O

Es	O
obvio	O
de	O
nuestros	O
resultados	O
,	O
sin	O
embargo	O
,	O
que	O
la	O
identificación	O
de	O
este	O
secuencia	B-Sequence
como	O
una	O
longitud	O
completa	O
proteína	B-Chemical
es	O
incorrecto	O
ya	O
que	O
sondas	B-Sequence
exclusivo	O
de	O
la	O
clon	B-Sequence
,	O
así	O
como	O
también	O
sondas	B-Sequence
que	O
contiene	O
el	O
mcoln1	B-Protein
secuencia	B-Sequence
de	I-Sequence
codificación	I-Sequence
,	O
identificar	O
el	O
mismo	O
transcripciones	B-Sequence
.	O

Conclusiones	O

Comparación	O
de	O
mcoln1	B-Protein
isoforma	B-Sequence
1	O
a	O
su	O
humano	B-Taxon
homólogo	B-Sequence
muestra	O
una	O
sorprendente	O
similitud	O
tanto	O
en	O
el	O
aminoácidos	B-Chemical
y	O
nucleótido	B-Chemical
nivel	O
.	O

Los	O
seis	O
de	O
los	O
transmembrana	B-GENE
dominios	B-Sequence
,	O
así	O
como	O
el	O
supuesto	O
catión	B-Chemical
canal	O
son	O
altamente	O
conservado	B-Sequence
.	O

El	O
putativo	O
di	O
-	O
leucina	B-Chemical
(	O
L	B-Chemical
-	O
L	B-Chemical
-	O
X	B-Chemical
-	O
X	B-Chemical
)	O
motivo	O
en	O
el	O
C	B-Sequence
-	I-Sequence
terminal	I-Sequence
,	O
que	O
puede	O
actuar	O
como	O
endosomal	B-GENE
tardío	I-GENE
/	O
lisosomal	B-GENE
apuntando	O
señal	B-Sequence
,	O
es	O
también	O
conservado	B-Sequence
[	O
9	O
]	O
.	O

Esta	O
especulación	O
está	O
respaldada	O
por	O
el	O
trabajo	O
con	O
taza	B-Protein
-	I-Protein
5	I-Protein
[	O
13	O
]	O
,	O
el	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
homólogo	B-Sequence
de	O
MCOLN1	B-Protein
,	O
ya	O
que	O
celular	B-Cell
Los	O
estudios	O
de	O
localización	O
sugieren	O
que	O
la	O
proteína	B-Chemical
se	O
encuentra	O
en	O
el	O
endosomas	B-GENE
tardíos	I-GENE
y/o	O
lisosomas	B-GENE
.	O

los	O
ratón	B-Protein
Mcoln1	I-Protein
gene	B-Sequence
tiene	O
dos	O
isoformas	B-Sequence
empalmadas	I-Sequence
alternativamente	I-Sequence
,	O
con	O
isoforma	B-Sequence
2	O
teniendo	O
una	O
diferente	O
c	B-Sequence
-	I-Sequence
cola	I-Sequence
citoplasmática	I-Sequence
terminal	I-Sequence
.	O

el	O
único	O
86	O
aminoácidos	B-Chemical
c	B-Sequence
-	I-Sequence
cola	I-Sequence
terminal	I-Sequence
le	O
falta	O
el	O
lisosomal	B-GENE
apuntando	O
señal	B-Sequence
no	O
contiene	O
nada	O
dominios	B-Sequence
conservados	I-Sequence
cuando	O
se	O
compara	O
con	O
las	O
bases	O
de	O
datos	O
de	O
perfiles	O
actuales	O
.	O

Especulamos	O
que	O
esto	O
proteína	B-Chemical
puede	O
tener	O
una	O
función	O
de	O
canal	O
similar	O
pero	O
una	O
localización	O
subcelular	O
alternativa	O
,	O
pero	O
esto	O
debe	O
probarse	O
una	O
vez	O
isoforma	B-Sequence
#	O
¿NOMBRE	O
?	O
anticuerpos	B-GENE
están	O
alzadas	O
.	O

Sin	O
embargo	O
,	O
nuestros	O
resultados	O
sugieren	O
que	O
la	O
evaluación	O
fenotípica	O
de	O
mcoln1	B-Protein
knockear	O
ratones	B-Taxon
puede	O
ser	O
complicado	O
y	O
que	O
se	O
debe	O
tener	O
cuidado	O
al	O
interpretar	O
los	O
datos	O
en	O
ratón	B-Taxon
gene	B-Sequence
expresión	O
y	O
fenotipo	O
.	O

Curiosamente	O
,	O
el	O
segundo	O
mcoln1	B-Protein
isoforma	B-Sequence
no	O
se	O
ve	O
en	O
humanos	B-Taxon
y	O
el	O
secuencia	B-Sequence
del	O
empalme	O
alternativo	O
región	B-Sequence
no	O
es	O
conservado	B-Sequence
Entre	O
hombre	B-Taxon
y	O
ratón	B-Taxon
.	O

Hasta	O
la	O
fecha	O
,	O
muy	O
pocos	O
genes	B-Sequence
han	O
sido	O
reportados	O
que	O
muestran	O
especies	O
específicas	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
alternativas	I-Sequence
.	O

GATITO	B-Protein
,	O
glicoproteína	B-Protein
de	I-Protein
mielina/oligodendrocitos	I-Protein
,	O
tiene	O
muchas	O
diferentes	B-Sequence
variantes	I-Sequence
de	I-Sequence
empalme	I-Sequence
en	O
humanos	B-Taxon
que	O
no	O
se	O
encuentran	O
en	O
ratones	B-Taxon
[	O
17	O
]	O
.	O

ATP11B	B-Protein
,	O
una	O
ATPasa	O
de	O
tipo	O
P	O
,	O
tiene	O
un	O
Conejo	B-Taxon
#	O
¿NOMBRE	O
?	O
variante	B-Sequence
de	I-Sequence
empalme	I-Sequence
que	O
elimina	B-Sequence
a	O
transmembrana	B-GENE
dominio	B-Sequence
por	O
lo	O
tanto	O
probablemente	O
altera	O
la	O
supuesta	O
función	O
de	O
la	O
proteína	B-Chemical
[	O
18	O
]	O
.	O

Secuenciación	O
de	O
la	O
humano	B-Taxon
genoma	B-Sequence
ha	O
llevado	O
a	O
estimaciones	O
de	O
aproximadamente	O
32	O
000	O
genes	B-Sequence
,	O
una	O
sorpresa	O
total	O
dadas	O
las	O
estimaciones	O
anteriores	O
significativamente	O
más	O
altas	O
que	O
se	O
basaron	O
en	O
el	O
número	O
de	O
etiquetas	B-Sequence
de	I-Sequence
secuencia	I-Sequence
expresada	I-Sequence
(	O
EST	B-Sequence
)	O
en	O
las	O
bases	O
de	O
datos	O
públicas	O
.	O

Esta	O
aparente	O
disparidad	O
sugiere	O
un	O
papel	O
importante	O
para	O
el	O
empalme	O
alternativo	O
en	O
la	O
creación	O
genético	B-Sequence
complejidad	O
,	O
y	O
ha	O
llevado	O
el	O
estudio	O
de	O
la	O
regulación	O
de	O
empalme	O
a	O
la	O
vanguardia	O
de	O
la	O
genética	O
molecular	O
.	O

Es	O
probable	O
que	O
una	O
gran	O
cantidad	O
de	O
especies	O
-específicas	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
se	O
identificará	O
como	O
la	O
caracterización	O
de	O
transcripciones	B-Sequence
empalmadas	I-Sequence
alternativamente	I-Sequence
progresa	O

Materiales	O
y	O
métodos	O

Bioinformática	O

Realizamos	O
búsquedas	O
en	O
bases	O
de	O
datos	O
usando	O
BLAST	O
y	O
Draft	O
Humano	B-Taxon
genoma	B-Sequence
Navegador	O
.	O

Secuencias	B-Sequence
de	O
UniGene	O
se	O
utilizaron	O
para	O
confirmar	O
la	O
mcoln1	B-Protein
secuencia	B-Sequence
.	O

Realizamos	O
búsquedas	O
de	O
motivos	O
utilizando	O
ProfileScan	O
y	O
TMPred	O
y	O
la	O
alineación	O
de	O
proteína	B-Chemical
secuencias	B-Sequence
utilizando	O
Pileup	O
(	O
GCG	O
)	O
y	O
Boxshade	O
.	O

ADN	B-Sequence
Secuenciación	O

I	O
.	O
m	O
UN	O
.	O
g	O
mi	O

Clones	B-Sequence
se	O
adquirieron	O
de	O
Research	O
Genetics	O
(	O
Huntsville	O
,	O
AL	O
)	O
.	O

La	O
secuenciación	O
se	O
realizó	O
con	O
el	O
kit	O
de	O
secuenciación	O
AmpliCycle	O
de	O
Applied	O
Biosystems	O
(	O
Foster	O
City	O
,	O
CA	O
)	O
en	O
un	O
equipo	O
programable	O
Genomyx	O
LR	O
.	O
ADN	B-Sequence
secuenciador	O

RT	O
-	O
Reacción	O
PCR	O

BALB	O
/	O
c	O
ratón	B-Taxon
cerebro	O
total	O
ARN	B-Sequence
se	O
adquirió	O
de	O
Clontech	O
Laboratories	O
(	O
Palo	O
Alto	O
,	O
CA	O
)	O
y	O
se	O
preparó	O
a	O
una	O
concentración	O
de	O
1	O
µg/ml	O
.	O

Esta	O
ARN	B-Sequence
se	O
usó	O
como	O
plantilla	O
para	O
crear	O
ADNc	B-Sequence
a	O
través	O
de	O
RT	O
-	O
PCR	O
usando	O
aleatorio	B-Sequence
hexámeros	O
y	O
oligo	B-Sequence
dT	O
cebador	B-Sequence
.	O

El	O
RT	O
producto	B-Sequence
se	O
usó	O
para	O
confirmar	O
la	O
forma	B-Sequence
alternativamente	I-Sequence
empalmada	I-Sequence
utilizando	O
cebadores	B-Sequence
:	O
5	O
'	O
-	O
CATCTACCTGGGCTATTGC	O
-	O
3	O
'	O
(	O
hacia	B-Sequence
adelante	I-Sequence
)	O
y	O
5	O
'	O
-	O
GCTCTCAGGTGGTGGACAC	O
-	O
3	O
'	O
(	O
contrarrestar	B-Sequence
)	O
en	O
una	O
reacción	O
de	O
PCR	O
con	O
una	O
temperatura	O
de	O
hibridación	O
de	O
61	O
grados	O
C	O
.	O

Análisis	O
de	O
transferencia	O
Southern	O

Total	O
ratón	B-Taxon
ADN	B-Sequence
genómico	I-Sequence
se	O
digirió	O
utilizando	O
EcoRI	O
,	O
BamHI	O
,	O
PstI	O
y	O
XbaI	O
.	O

Los	O
digestos	O
se	O
sometieron	O
a	O
electroforesis	O
al	O
1	O
%	O
.	O
agarosa	B-Chemical
gel	O
a	O
60	O
V	O
durante	O
la	O
noche	O
y	O
se	O
transfirieron	O
a	O
una	O
membrana	O
Hybond	O
N+	O
de	O
Amersham	O
Pharmacia	O
Biotech	O
(	O
Piscataway	O
,	O
NJ	O
)	O
.	O

A	O
32P	B-Chemical
-	O
dATP	B-Chemical
PCR	O
etiquetado	O
fragmento	B-Sequence
de	I-Sequence
la	I-Sequence
región	I-Sequence
codificante	I-Sequence
de	I-Sequence
Mcoln1	I-Sequence
correspondiente	O
a	O
exón	B-Sequence
2	O
fue	O
utilizado	O
como	O
Investigacion	B-Sequence
(	O
cebadores	B-Sequence
5	O
'	O
-	O
CCCCACAGAAGAGGAAGAC	O
-	O
3	O
'	O
(	O
hacia	B-Sequence
adelante	I-Sequence
)	O
y	O
5	O
'	O
-	O
AGATCTTGACCACCTGCAG	O
-	O
3	O
'	O
(	O
contrarrestar	B-Sequence
)	O
con	O
una	O
temperatura	O
de	O
recocido	O
de	O
59	O
grados	O
C	O
)	O
.	O

Hibridación	O
y	O
lavados	O
se	O
llevaron	O
a	O
cabo	O
en	O
condiciones	O
estándar	O
[	O
16	O
]	O
.	O

Análisis	O
de	O
transferencia	O
Northern	O

Ratón	B-Taxon
embrión	O
múltiple	O
-	O
tejido	O
Northern	O
blot	O
y	O
ratón	B-Taxon
Los	O
filtros	O
de	O
transferencia	O
Northern	O
de	O
tejido	O
múltiple	O
para	O
adultos	O
se	O
adquirieron	O
de	O
Clontech	O
Laboratories	O
(	O
Palo	O
Alto	O
,	O
CA	O
)	O
.	O

Los	O
filtros	O
se	O
hibridaron	O
con	O
el	O
32P	B-Chemical
-	O
dATP	B-Chemical
etiquetado	O
Fragmento	B-Sequence
de	I-Sequence
ADN	I-Sequence
de	I-Sequence
la	I-Sequence
región	I-Sequence
codificante	I-Sequence
de	I-Sequence
Mcoln1	I-Sequence
correspondiente	O
a	O
exón	B-Sequence
2	O
(	O
ver	O
arriba	O
)	O
.	O

por	O
la	O
alternativa	O
transcripción	B-Sequence
,	O
a	O
Investigacion	B-Sequence
se	O
generó	O
en	O
el	O
región	B-Sequence
Entre	O
exones	B-Sequence
12	O
y	O
13	O
con	O
cebadores	B-Sequence
5	O
'	O
-	O
GTGTCCACCACCTGAGAG	O
-	O
3	O
'	O
(	O
hacia	B-Sequence
adelante	I-Sequence
y	O
5	O
'	O
-	O
GAAGTAGCATTCCTGCAGGC	O
-	O
3	O
'	O
(	O
contrarrestar	B-Sequence
)	O
con	O
una	O
temperatura	O
de	O
recocido	O
de	O
62	O
grados	O
C	O
.	O

A	O
continuación	O
,	O
los	O
filtros	O
se	O
hibridaron	O
con	O
beta	B-Protein
-	I-Protein
actina	I-Protein
sondas	B-Sequence
.	O

Las	O
hibridaciones	O
y	O
lavados	O
se	O
realizaron	O
en	O
condiciones	O
estándar	O
,	O
con	O
decapado	O
de	O
los	O
previamente	O
ligados	O
sondas	B-Sequence
en	O
el	O
medio	O
[	O
16	O
]	O
.	O

Agradecimientos	O

Este	O
trabajo	O
fue	O
apoyado	O
por	O
la	O
subvención	O
NS39995	O
.	O

Patrón	O
dorsoventral	O
del	O
Ratón	B-Taxon
Abrigo	O
por	O
Tbx15	B-Protein

Resumen	O

muchos	O
miembros	O
de	O
la	O
animal	B-Taxon
El	O
reino	O
muestra	O
diferencias	O
en	O
el	O
color	O
de	O
la	O
piel	O
o	O
del	O
pelaje	O
a	O
lo	O
largo	O
de	O
su	O
eje	O
dorsoventral	O
.	O

Para	O
determinar	O
los	O
mecanismos	O
que	O
controlan	O
las	O
diferencias	O
regionales	O
en	O
la	O
pigmentación	O
,	O
hemos	O
estudiado	O
cómo	O
un	O
clásico	O
ratón	B-Taxon
mutación	B-Sequence
,	O
oreja	O
caída	O
(	O
deH	O
)	O
,	O
afecta	O
las	O
características	O
de	O
la	O
piel	O
dorsoventral	O
,	O
especialmente	O
aquellas	O
bajo	O
el	O
control	O
del	O
Agutí	B-Protein
gene	B-Sequence
.	O

Ratones	B-Taxon
llevando	O
el	O
Agutí	B-Protein
alelo	B-Sequence
black-and-tan	O
(	O
at	O
)	O
normalmente	O
tienen	O
un	O
límite	O
definido	O
entre	O
el	O
pelo	O
negro	O
dorsal	O
y	O
el	O
pelo	O
ventral	O
amarillo	O
;	O
el	O
deH	O
mutación	B-Sequence
eleva	O
el	O
límite	O
de	O
pigmentación	O
,	O
produciendo	O
una	O
aparente	O
transformación	O
de	O
dorsal	O
a	O
ventral	O
.	O

Identificamos	O
un	O
216	O
kb	O
supresión	B-Sequence
en	O
deH	O
que	O
elimina	B-Sequence
todos	O
menos	O
el	O
primer	O
exón	O
del	O
Tbx15	B-Protein
gene	B-Sequence
,	O
cuya	O
expresión	O
embrionaria	O
en	O
el	O
mesénquima	O
en	O
desarrollo	O
se	O
correlaciona	O
con	O
pigmentario	B-Chemical
y	O
malformaciones	O
esqueléticas	O
observadas	O
en	O
deH	O
/	O
deH	O
animales	B-Taxon
.	O

Construcción	O
de	O
un	O
objetivo	O
alelo	B-Sequence
de	O
Tbx15	B-Protein
confirmó	O
que	O
el	O
fenotipo	O
deH	O
fue	O
causado	O
por	O
Tbx15	B-Protein
pérdida	O
de	O
función	O
.	O

Expresión	O
embrionaria	O
temprana	O
de	O
Tbx15	B-Protein
en	O
el	O
mesénquima	O
dorsal	O
es	O
complementario	O
a	O
Agutí	B-Protein
expresión	O
en	O
mesénquima	O
ventral	O
;	O
en	O
ausencia	O
de	O
Tbx15	B-Protein
,	O
expresión	O
de	O
Agutí	B-Protein
tanto	O
en	O
embriones	O
como	O
en	O
postnatal	O
animales	B-Taxon
se	O
desplaza	O
dorsalmente	O
.	O

Los	O
experimentos	O
de	O
trasplante	O
demuestran	O
que	O
E12	O
adquiere	O
la	O
identidad	O
posicional	O
de	O
la	O
piel	O
con	O
respecto	O
a	O
las	O
diferencias	O
de	O
pigmentación	O
dorsoventral	O
.	O
5	O
,	O
que	O
es	O
poco	O
después	O
de	O
la	O
expresión	O
embrionaria	O
temprana	O
de	O
Tbx15	B-Protein
.	O

Destino	O
:	O
los	O
estudios	O
de	O
mapeo	O
muestran	O
que	O
el	O
límite	O
de	O
pigmentación	O
dorsoventral	O
no	O
está	O
en	O
registro	O
con	O
una	O
dermis	O
previamente	O
identificada	O
.	O
célula	B-Cell
límite	O
del	O
linaje	O
,	O
sino	O
más	O
bien	O
con	O
el	O
límite	O
dorsoventral	O
del	O
miembro	O
.	O

expresión	O
embrionaria	O
de	O
Tbx15	B-Protein
en	O
el	O
mesénquima	O
dorsolateral	O
proporciona	O
una	O
clave	O
de	O
instrucción	O
necesaria	O
para	O
establecer	O
la	O
futura	O
identidad	O
posicional	O
de	O
la	O
dermis	O
dorsal	O
.	O

Estos	O
hallazgos	O
representan	O
un	O
papel	O
novedoso	O
para	O
T	O
-	O
box	O
gene	B-Sequence
acción	O
en	O
el	O
desarrollo	O
embrionario	O
,	O
identifique	O
un	O
aspecto	O
previamente	O
no	O
apreciado	O
del	O
patrón	O
dorsoventral	O
que	O
está	O
ampliamente	O
representado	O
en	O
la	O
piel	O
mamíferos	B-Taxon
y	O
brindar	O
información	O
sobre	O
los	O
mecanismos	O
que	O
subyacen	O
a	O
las	O
diferencias	O
específicas	O
de	O
la	O
región	O
en	O
la	O
morfología	O
corporal	O
.	O

Introducción	O

Una	O
pregunta	O
fundamental	O
en	O
biología	O
del	O
desarrollo	O
es	O
cómo	O
las	O
regiones	O
adyacentes	O
del	O
vertebrado	B-Taxon
cuerpo	O
adquieren	O
diferencias	O
en	O
su	O
apariencia	O
o	O
morfología	O
.	O

Los	O
mecanismos	O
que	O
establecen	O
el	O
plan	O
corporal	O
general	O
hacen	O
uso	O
de	O
un	O
número	O
relativamente	O
pequeño	O
de	O
vías	O
de	O
señalización	O
compartidas	O
entre	O
todos	O
.	O
animales	B-Taxon
(	O
revisado	O
en	O
Pires-daSilva	O
y	O
Sommer	O
2003	O
)	O
,	O
pero	O
no	O
está	O
claro	O
hasta	O
qué	O
punto	O
estas	O
vías	O
controlan	O
las	O
diferencias	O
más	O
finas	O
entre	O
las	O
regiones	O
del	O
cuerpo	O
.	O

Entre	O
vertebrados	B-Taxon
,	O
diferencias	O
en	O
la	O
forma	O
o	O
número	O
de	O
elementos	O
esqueléticos	O
,	O
morfología	O
alterada	O
de	O
apéndices	O
epidérmicos	O
y	O
variación	O
en	O
pigmento	B-Chemical
la	O
distribución	O
se	O
combinan	O
para	O
producir	O
la	O
mayoría	O
de	O
lo	O
que	O
distingue	O
a	O
uno	O
animal	B-Taxon
de	O
otro	O
.	O

Entre	O
estos	O
,	O
pigmento	B-Chemical
Los	O
patrones	O
son	O
un	O
excelente	O
sistema	O
para	O
investigar	O
cómo	O
surgen	O
las	O
diferencias	O
morfológicas	O
,	O
tanto	O
para	O
diferentes	O
regiones	O
del	O
cuerpo	O
dentro	O
de	O
una	O
especie	O
como	O
para	O
diferentes	O
animales	B-Taxon
de	O
especies	O
estrechamente	O
relacionadas	O
.	O

En	O
entornos	O
naturales	O
,	O
la	O
variación	O
de	O
color	O
es	O
un	O
mecanismo	O
casi	O
universal	O
para	O
el	O
reconocimiento	O
,	O
el	O
camuflaje	O
o	O
ambos	O
;	O
en	O
consecuencia	O
,	O
un	O
gran	O
número	O
de	O
pigmento	B-Chemical
los	O
patrones	O
se	O
han	O
caracterizado	O
desde	O
una	O
perspectiva	O
evolutiva	O
y	O
ecológica	O
(	O
Boughman	O
2001	O
;	O
Jiggins	O
et	O
al	O
.	O
2001	O
)	O
.	O

En	O
el	O
laboratorio	O
,	O
la	O
variación	O
de	O
color	O
ha	O
sido	O
objeto	O
de	O
vertebrado	B-Taxon
genética	O
durante	O
más	O
de	O
un	O
siglo	O
(	O
Searle	O
1968	O
;	O
Silvers	O
1979	O
)	O
,	O
y	O
muchos	O
pigmentario	B-Chemical
se	O
han	O
identificado	O
componentes	O
cuyas	O
acciones	O
se	O
entienden	O
en	O
un	O
celular	B-Cell
o	O
contexto	O
basado	O
en	O
órganos	O
(	O
revisado	O
en	O
Bennett	O
y	O
Lamoreux	O
2003	O
)	O
.	O

Varios	O
mecanismos	O
pueden	O
contribuir	O
a	O
las	O
diferencias	O
regionales	O
en	O
vertebrado	B-Taxon
pigmentación	O

En	O
el	O
embrión	O
,	O
alteraciones	O
en	O
la	O
determinación	O
o	O
migración	O
de	O
melanoblastos	B-Cell
de	O
la	O
cresta	O
neural	O
afectan	O
el	O
número	O
o	O
la	O
distribución	O
de	O
células	B-Cell
pigmentarias	I-Cell
en	O
la	O
piel	O
(	O
revisado	O
en	O
Reedy	O
et	O
al	O
.	O
1998	O
)	O
.	O

Dentro	O
de	O
los	O
folículos	O
pilosos	O
,	O
las	O
señales	O
paracrinas	O
controlan	O
el	O
tipo	O
de	O
pigmento	B-Chemical
hecho	O
en	O
regiones	O
específicas	O
del	O
cuerpo	O
o	O
en	O
momentos	O
específicos	O
durante	O
el	O
ciclo	O
del	O
cabello	O
(	O
revisado	O
en	O
Furumura	O
et	O
al	O
.	O
1996	O
;	O
Barsh	O
et	O
al	O
.	O
2000	O
)	O
.	O

Finalmente	O
,	O
el	O
movimiento	O
de	O
gránulos	B-GENE
de	I-GENE
pigmento	I-GENE
dentro	O
de	O
melanocitos	B-Cell
o	O
de	O
melanocitos	B-Cell
para	O
queratinocitos	B-Cell
hace	O
uso	O
de	O
celular	B-Cell
maquinaria	O
que	O
es	O
compartida	O
por	O
una	O
variedad	O
de	O
célula	B-Cell
tipos	O
,	O
pero	O
que	O
pueden	O
variar	O
en	O
diferentes	O
regiones	O
del	O
cuerpo	O
(	O
revisado	O
en	O
Marks	O
y	O
Seabra	O
2001	O
)	O
.	O

Sin	O
embargo	O
,	O
para	O
todos	O
estos	O
mecanismos	O
(	O
manchas	O
blancas	O
,	O
pigmento	B-Chemical
-	O
cambio	O
de	O
tipo	O
,	O
y	O
melanosoma	B-GENE
biogénesis	O
:	O
se	O
sabe	O
más	O
sobre	O
la	O
identidad	O
de	O
los	O
molecular	B-Chemical
componentes	O
que	O
su	O
control	O
espacial	O
y	O
temporal	O
.	O

Uno	O
de	O
los	O
aspectos	O
más	O
obvios	O
de	O
la	O
variación	O
de	O
color	O
regional	O
en	O
vertebrados	B-Taxon
es	O
una	O
superficie	O
dorsal	O
oscura	O
yuxtapuesta	O
a	O
una	O
superficie	O
ventral	O
clara	O
,	O
evidente	O
en	O
el	O
color	O
de	O
la	O
piel	O
,	O
las	O
escamas	O
,	O
las	O
plumas	O
o	O
el	O
pelo	O
,	O
en	O
la	O
que	O
el	O
límite	O
entre	O
los	O
compartimentos	O
dorsal	O
y	O
ventral	O
suele	O
ser	O
nítido	O
y	O
coincide	O
con	O
las	O
extremidades	O
.	O

En	O
roedores	B-Taxon
y	O
probablemente	O
otros	O
mamíferos	B-Taxon
,	O
esta	O
diferencia	O
dorsoventral	O
en	O
el	O
color	O
del	O
cabello	O
es	O
provocada	O
por	O
diferencias	O
en	O
pigmento	B-Chemical
tipo	O
determinado	O
por	O
alelo	B-Sequence
variación	O
de	O
la	O
Agutí	B-Protein
gene	B-Sequence
(	O
Bultman	O
y	O
col.	O
1992	O
;	O
Miller	O
y	O
col.	O
1993	O
)	O
.	O

secretado	O
por	O
células	B-Cell
de	I-Cell
la	I-Cell
papila	I-Cell
dérmica	I-Cell
dentro	O
de	O
cada	O
folículo	O
piloso	O
(	O
Millar	O
et	O
al	O
.	O
1995	O
)	O
,	O
Agutí	B-Protein
proteína	B-Chemical
causas	O
melanocitos	B-Cell
en	O
ese	O
folículo	O
para	O
cambiar	O
de	O
la	O
producción	O
de	O
marrón	O
/	O
negro	O
eumelanina	B-Chemical
a	O
la	O
feomelanina	O
roja/amarilla	O
.	O

Agutí	B-Protein
proteína	B-Chemical
tiene	O
un	O
radio	O
de	O
acción	O
corto	O
(	O
Silvers	O
y	O
Russel	O
1955	O
)	O
y	O
puede	O
encenderse	O
y	O
apagarse	O
durante	O
un	O
solo	O
ciclo	O
capilar	O
(	O
Bultman	O
et	O
al	O
.	O
1992	O
,	O
1994	O
;	O
Miller	O
et	O
al	O
.	O
1993	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
;	O
por	O
lo	O
tanto	O
,	O
se	O
cree	O
que	O
su	O
expresión	O
regulada	O
es	O
responsable	O
de	O
la	O
superficie	O
ventral	O
de	O
color	O
crema	O
o	O
amarillo	O
de	O
ratones	B-Taxon
llevando	O
el	O
negro	O
-	O
y	O
-	O
bronceado	O
(	O
at	O
)	O
alelo	B-Sequence
y	O
para	O
las	O
marcas	O
amarillas	O
alrededor	O
de	O
los	O
pies	O
,	O
las	O
orejas	O
o	O
la	O
cabeza	O
,	O
i.	O
mi	O
.	O
,	O
puntos	O
bronceados	O
o	O
manchas	O
en	O
la	O
cabeza	O
,	O
de	O
ciertos	O
perro	B-Taxon
razas	O

en	O
laboratorio	O
ratones	B-Taxon
,	O
estudios	O
previos	O
de	O
nuestro	O
grupo	O
y	O
otros	O
identificaron	O
dos	O
predominantes	O
Agutí	B-Protein
ARNm	B-Chemical
isoformas	B-Sequence
que	O
se	O
diferencian	O
en	O
virtud	O
de	O
su	O
sitio	B-Sequence
de	I-Sequence
iniciación	I-Sequence
transcripcional	I-Sequence
y	O
5	B-Sequence
'exones	I-Sequence
no	I-Sequence
traducidos	I-Sequence
.	O

``	O
Un	O
``	O
''	O
ciclo	O
del	O
cabello	O
-	O
específico	O
''	O
''	O
''	O
transcripción	B-Sequence
``	O
se	O
expresa	O
tanto	O
en	O
la	O
piel	O
dorsal	O
como	O
ventral	O
durante	O
2	O
o	O
3	O
días	O
durante	O
el	O
crecimiento	O
temprano	O
del	O
cabello	O
,	O
mientras	O
que	O
un	O
``	O
''	O
específico	O
ventral	O
''	O
''	O
''	O
transcripción	B-Sequence
se	O
expresa	O
a	O
lo	O
largo	O
de	O
todo	O
el	O
período	O
de	O
crecimiento	O
activo	O
del	O
cabello	O
,	O
pero	O
sólo	O
en	O
la	O
piel	O
ventral	O
(	O
Bultman	O
et	O
al	O
.	O
1994	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
.	O

animales	B-Taxon
llevando	O
el	O
en	O
alelo	B-Sequence
expresar	O
sólo	O
el	O
ventral	O
-	O
específico	O
Agutí	B-Protein
transcripción	B-Sequence
(	O
Bultman	O
et	O
al	O
.	O
1994	O
;	O
Vrieling	O
et	O
al	O
.	O
1994	O
)	O
y	O
tienen	O
pelos	O
dorsales	O
negros	O
y	O
pelos	O
ventrales	O
de	O
color	O
crema	O
a	O
amarillo	O
,	O
con	O
un	O
límite	O
nítido	O
al	O
nivel	O
de	O
las	O
articulaciones	O
de	O
la	O
pared	O
de	O
las	O
extremidades	O
y	O
el	O
cuerpo	O
y	O
en	O
el	O
medio	O
de	O
la	O
almohadilla	O
del	O
bigote	O
.	O

Ventral	O
-	O
específico	O
Agutí	B-Protein
isoformas	B-Sequence
también	O
se	O
expresan	O
en	O
la	O
piel	O
en	O
desarrollo	O
a	O
partir	O
del	O
día	O
10	O
embrionario	O
.	O
5	O
(	O
E10	O
.	O
5	O
)	O
y	O
más	O
allá	O
y	O
puede	O
jugar	O
un	O
papel	O
en	O
célula	B-Cell
de	I-Cell
pigmento	I-Cell
diferenciación	O
(	O
Millar	O
et	O
al	O
.	O
1995	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
elementos	B-Sequence
regulatorios	I-Sequence
para	O
ventral	O
-	O
específico	O
Agutí	B-Protein
isoformas	B-Sequence
responden	O
a	O
señales	O
posicionales	O
dorsoventrales	O
establecidas	O
en	O
el	O
embrión	O
y	O
cuyos	O
efectos	O
persisten	O
después	O
del	O
nacimiento	O
.	O

El	O
límite	O
entre	O
los	O
compartimentos	O
de	O
color	O
dorsal	O
y	O
ventral	O
en	O
at	O
/	O
at	O
ratones	B-Taxon
tiene	O
un	O
parecido	O
superficial	O
con	O
los	O
límites	O
dorsoventrales	O
aparentes	O
para	O
muchos	O
otros	O
mamíferos	B-Taxon
,	O
pero	O
las	O
diferencias	O
morfogenéticas	O
entre	O
la	O
piel	O
dorsal	O
y	O
ventral	O
parecen	O
incluir	O
más	O
elementos	O
que	O
el	O
tipo	O
de	O
pigmento	B-Chemical
hecho	O
por	O
el	O
folículo	O
piloso	O
melanocitos	B-Cell
.	O

En	O
particular	O
,	O
la	O
dermis	O
del	O
flanco	O
tiene	O
al	O
menos	O
dos	O
orígenes	O
distintos	O
:	O
derivados	O
dermatomales	O
de	O
los	O
somitas	O
y	O
mesénquima	O
laxo	O
derivado	O
del	O
mesodermo	O
de	O
la	O
placa	O
lateral	O
(	O
Mauger	O
1972	O
;	O
Christ	O
et	O
al	O
.	O
1983	O
;	O
Olivera-Martinez	O
et	O
al	O
.	O
2000	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
.	O
)	O
;	O
estos	O
linajes	O
se	O
establecen	O
temprano	O
en	O
el	O
desarrollo	O
y	O
podrían	O
,	O
en	O
principio	O
,	O
establecer	O
compartimentos	O
cuya	O
identidad	O
contribuye	O
a	O
las	O
diferencias	O
dorsoventrales	O
en	O
la	O
piel	O
adulta	O
.	O

Para	O
comprender	O
mejor	O
los	O
mecanismos	O
que	O
dan	O
lugar	O
a	O
las	O
diferencias	O
entre	O
la	O
piel	O
dorsal	O
y	O
ventral	O
y	O
al	O
límite	O
entre	O
ellas	O
,	O
hemos	O
determinado	O
cómo	O
varían	O
varias	O
características	O
morfológicas	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
de	O
la	O
piel	O
.	O
ratón	B-Taxon
y	O
cómo	O
estas	O
características	O
corresponden	O
a	O
ventral	O
-	O
específico	O
Agutí	B-Protein
expresión	O
y	O
el	O
límite	O
de	O
linaje	O
que	O
distingue	O
a	O
los	O
somitas	O
de	O
los	O
derivados	O
de	O
la	O
placa	O
lateral	O
.	O

Nuestros	O
resultados	O
indican	O
que	O
la	O
aparente	O
uniformidad	O
del	O
límite	O
dorsoventral	O
representa	O
la	O
suma	O
de	O
mecanismos	O
independientes	O
que	O
afectan	O
melanocito	B-Cell
densidad	O
y/o	O
diferenciación	O
,	O
pigmento	B-Chemical
-	O
tipo	O
de	O
síntesis	O
y	O
longitud	O
del	O
cabello	O
;	O
sorprendentemente	O
,	O
ninguno	O
de	O
estos	O
coincide	O
con	O
el	O
límite	O
del	O
linaje	O
de	O
la	O
placa	O
lateral	O
del	O
somita	O
.	O

También	O
hacemos	O
uso	O
de	O
un	O
clásico	O
ratón	B-Taxon
mutación	B-Sequence
,	O
oreja	O
caída	O
(	O
Curry	O
1959	O
)	O
,	O
que	O
produce	O
una	O
transformación	O
de	O
dorsal	O
a	O
ventral	O
del	O
color	O
del	O
pelaje	O
del	O
flanco	O
al	O
permitir	O
la	O
expansión	O
de	O
la	O
ventral	O
específica	O
Agutí	B-Protein
transcripción	B-Sequence
.	O

Por	O
posicional	B-Sequence
clonación	O
y	O
gene	B-Sequence
focalización	O
,	O
identificamos	O
un	O
alelo	B-Sequence
de	O
oreja	B-Protein
caída	I-Protein
deH	O
,	O
como	O
una	O
pérdida	O
de	O
función	O
para	O
Tbx15	B-Protein
,	O
que	O
codifica	O
un	O
factor	O
de	O
transcripción	O
T	O
-	O
box	O
expresado	O
de	O
manera	O
dinámica	O
y	O
espacialmente	O
restringida	O
en	O
la	O
piel	O
y	O
el	O
sistema	O
musculoesquelético	O
en	O
desarrollo	O
.	O

Los	O
estudios	O
de	O
trasplante	O
y	O
expresión	O
embrionaria	O
sugieren	O
que	O
Tbx15	B-Protein
se	O
requiere	O
para	O
establecer	O
ciertas	O
características	O
del	O
patrón	O
dorsal	O
en	O
células	B-Cell
mesenquimales	I-Cell
del	O
flanco	O
en	O
desarrollo	O
.	O

Estos	O
resultados	O
identifican	O
un	O
aspecto	O
previamente	O
no	O
apreciado	O
del	O
patrón	O
dorsoventral	O
que	O
está	O
ampliamente	O
representado	O
en	O
la	O
piel	O
peluda	O
.	O
mamíferos	B-Taxon
y	O
proporcionar	O
información	O
sobre	O
los	O
mecanismos	O
que	O
subyacen	O
a	O
las	O
diferencias	O
específicas	O
de	O
la	O
región	O
en	O
la	O
morfología	O
corporal	O
.	O

Resultados	O

Componentes	O
morfológicos	O
de	O
las	O
diferencias	O
de	O
la	O
piel	O
dorsoventral	O

Además	O
del	O
cambio	O
obvio	O
en	O
el	O
color	O
del	O
cabello	O
que	O
con	O
frecuencia	O
distingue	O
la	O
piel	O
dorsal	O
de	O
la	O
ventral	O
,	O
la	O
observación	O
casual	O
sugiere	O
que	O
existen	O
diferencias	O
adicionales	O
en	O
la	O
longitud	O
del	O
cabello	O
,	O
la	O
distribución	O
del	O
tipo	O
de	O
cabello	O
y	O
el	O
grosor	O
de	O
la	O
piel	O
.	O

Además	O
,	O
las	O
diferencias	O
dorsoventrales	O
en	O
la	O
pigmentación	O
pueden	O
representar	O
diferencias	O
en	O
el	O
número	O
y	O
/	O
o	O
estado	O
diferenciado	O
de	O
células	B-Cell
pigmentarias	I-Cell
,	O
así	O
como	O
el	O
tipo	O
de	O
pigmento	B-Chemical
sintetizado	O
en	O
respuesta	O
a	O
la	O
expresión	O
de	O
Agutí	B-Protein
.	O

En	O
particular	O
,	O
pelo	O
ventral	O
de	O
at	O
/	O
at	O
animales	B-Taxon
puede	O
variar	O
de	O
un	O
color	O
crema	O
a	O
un	O
amarillo	O
rojizo	O
dependiendo	O
de	O
la	O
edad	O
,	O
el	O
antecedente	O
de	O
la	O
cepa	O
y	O
la	O
posición	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
.	O

Para	O
evaluar	O
la	O
relación	O
entre	O
estos	O
componentes	O
,	O
comparamos	O
sus	O
características	O
entre	O
ratones	B-Taxon
de	O
diferente	O
Agutí	B-Protein
genotipos	B-Sequence
.	O

Las	O
mediciones	O
semicuantitativas	O
de	O
la	O
longitud	O
del	O
cabello	O
representadas	O
en	O
función	O
de	O
la	O
posición	O
dorsoventral	O
revelan	O
que	O
el	O
límite	O
definido	O
aparente	O
entre	O
el	O
dorso	O
y	O
el	O
ventral	O
pigmento	B-Chemical
compartimentos	O
en	O
en	O
/	O
en	O
ratones	B-Taxon
coincide	O
con	O
un	O
cambio	O
más	O
gradual	O
tanto	O
en	O
el	O
color	O
como	O
en	O
la	O
longitud	O
del	O
cabello	O
(	O
Figura	O
1A-1D	O
)	O
.	O

Dentro	O
de	O
la	O
región	O
de	O
transición	O
del	O
dorso	O
al	O
vientre	O
(	O
Figura	O
1B	O
)	O
,	O
los	O
pelos	O
de	O
los	O
flancos	O
de	O
at	O
/	O
at	O
ratones	B-Taxon
se	O
vuelven	O
progresivamente	O
más	O
cortos	O
y	O
exhiben	O
cantidades	O
crecientes	O
de	O
depósito	O
de	O
feomelanina	O
que	O
progresa	O
desde	O
la	O
punta	O
hasta	O
la	O
base	O
del	O
cabello	O
.	O

Sin	O
embargo	O
,	O
la	O
región	O
de	O
transición	O
para	O
la	O
longitud	O
del	O
cabello	O
es	O
considerablemente	O
más	O
amplia	O
que	O
la	O
de	O
la	O
pigmentación	O
e	O
independiente	O
de	O
Agutí	B-Protein
genotipo	B-Sequence
.	O

Aunque	O
el	O
tiempo	O
del	O
ciclo	O
del	O
cabello	O
varía	O
a	O
lo	O
largo	O
del	O
eje	O
rostrocaudal	O
,	O
las	O
mediciones	O
de	O
la	O
longitud	O
absoluta	O
del	O
cabello	O
para	O
ratones	B-Taxon
emparejados	O
por	O
edad	O
y	O
nivel	O
rostrocaudal	O
son	O
notablemente	O
similares	O
(	O
Figura	O
1D	O
)	O
.	O

Además	O
,	O
las	O
mediciones	O
de	O
la	O
longitud	O
relativa	O
del	O
cabello	O
para	O
animales	B-Taxon
de	O
diferente	O
edad	O
,	O
tamaño	O
y	O
Agutí	B-Protein
genotipo	B-Sequence
también	O
son	O
muy	O
similares	O
cuando	O
se	O
normalizan	O
a	O
la	O
circunferencia	O
del	O
cuerpo	O
(	O
Figura	O
1C	O
)	O
.	O

Tomadas	O
en	O
conjunto	O
,	O
estas	O
observaciones	O
indican	O
que	O
la	O
variación	O
de	O
la	O
longitud	O
del	O
cabello	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
es	O
estereotipada	O
y	O
se	O
mantiene	O
a	O
través	O
de	O
múltiples	O
ciclos	O
pilosos	O
,	O
con	O
una	O
transición	O
en	O
la	O
longitud	O
del	O
cabello	O
que	O
es	O
gradual	O
y	O
abarca	O
el	O
pigmento	B-Chemical
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
.	O

La	O
piel	O
dorsal	O
y	O
ventral	O
se	O
desarrollan	O
a	O
ritmos	O
diferentes	O
.	O

Cortes	O
transversales	O
de	O
piel	O
en	O
el	O
día	O
postnatal	O
4	O
.	O
5	O
(	O
P4.5	O
)	O
exhiben	O
folículos	O
pilosos	O
dorsales	O
que	O
están	O
notablemente	O
más	O
desarrollados	O
que	O
los	O
folículos	O
pilosos	O
ventrales	O
,	O
junto	O
con	O
una	O
disminución	O
dorsoventral	O
gradual	O
del	O
espesor	O
dérmico	O
(	O
Figura	O
1F	O
)	O
.	O

Sin	O
embargo	O
,	O
las	O
diferencias	O
en	O
el	O
grosor	O
de	O
la	O
piel	O
desaparecen	O
entre	O
las	O
3	O
y	O
4	O
semanas	O
de	O
edad	O
(	O
Forsthoefel	O
et	O
al	O
.	O
1966	O
)	O
y	O
,	O
en	O
general	O
,	O
la	O
proporción	O
de	O
diferentes	O
tipos	O
de	O
cabello	O
también	O
es	O
similar	O
en	O
el	O
dorso	O
y	O
ventra	O
de	O
los	O
adultos	O
.	O
ratones	B-Taxon
.	O

En	O
edad	O
-	O
consanguíneo	O
emparejado	O
ratones	B-Taxon
,	O
observamos	O
una	O
pequeña	O
disminución	O
en	O
la	O
proporción	O
de	O
pelos	O
de	O
la	O
capa	O
inferior	O
(	O
zigzags	O
)	O
y	O
pelos	O
de	O
la	O
capa	O
superior	O
(	O
auchenes	O
,	O
punzones	O
y	O
pelos	O
protectores	O
)	O
en	O
el	O
dorso	O
en	O
comparación	O
con	O
el	O
vientre	O
(	O
Figura	O
1E	O
)	O
,	O
pero	O
no	O
hubo	O
una	O
diferencia	O
constante	O
en	O
la	O
distribución	O
del	O
tipo	O
de	O
pelo	O
para	O
los	O
consanguíneos	O
ratones	B-Taxon
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Diferencias	O
entre	O
pigmentación	O
dorsal	O
y	O
ventral	O
de	O
at/at	O
ratones	B-Taxon
se	O
suelen	O
atribuir	O
a	O
pigmento	B-Chemical
#	O
¿NOMBRE	O
?	O
Agutí	B-Protein
,	O
pero	O
animales	B-Taxon
homocigoto	O
para	O
un	O
nulo	O
alelo	B-Sequence
de	O
Agutí	B-Protein
,	O
extremo	O
nonagouti	O
(	O
ae	O
)	O
,	O
tienen	O
pelos	O
ventrales	O
que	O
contienen	O
menos	O
melanina	B-Chemical
que	O
los	O
pelos	O
dorsales	O
,	O
dando	O
una	O
apariencia	O
ligeramente	O
más	O
pálida	O
a	O
la	O
capa	O
ventral	O
(	O
Figura	O
1G	O
)	O
.	O

Utilizando	O
DOPA	B-Chemical
tinción	O
como	O
indicador	O
de	O
tirosinasa	B-Protein
actividad	O
,	O
observamos	O
una	O
transición	O
dorsoventral	O
gradual	O
en	O
preparaciones	O
de	O
dermis	O
aisladas	O
de	O
P4	O
.	O
5	O
ae	O
/	O
ae	O
ratones	B-Taxon
(	O
Figura	O
1G	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
la	O
piel	O
de	O
at	O
/	O
at	O
ratones	B-Taxon
revelan	O
una	O
abrupta	O
transición	O
dorsoventral	O
de	O
DOPA	B-Chemical
tinción	O
,	O
que	O
probablemente	O
refleja	O
los	O
efectos	O
aditivos	O
de	O
la	O
reducción	O
melanina	B-Chemical
contenido	O
(	O
como	O
en	O
ae	O
/	O
ae	O
ratones	B-Taxon
)	O
y	O
regulación	O
a	O
la	O
baja	O
de	O
tirosinasa	B-Protein
actividad	O
inducida	O
por	O
Agutí	B-Protein
.	O

Melanina	B-Chemical
Es	O
probable	O
que	O
el	O
contenido	O
de	O
cabellos	O
individuales	O
esté	O
influenciado	O
tanto	O
por	O
el	O
número	O
de	O
células	B-Cell
pigmentarias	I-Cell
y	O
su	O
entorno	O
folicular	O
.	O

Independientemente	O
,	O
las	O
diferencias	O
dorsoventrales	O
en	O
el	O
cabello	O
pigmento	B-Chemical
contenido	O
de	O
ae/ae	O
ratones	B-Taxon
persisten	O
a	O
lo	O
largo	O
de	O
múltiples	O
ciclos	O
del	O
cabello	O
hasta	O
la	O
edad	O
adulta	O
,	O
de	O
forma	O
similar	O
a	O
la	O
longitud	O
del	O
cabello	O
(	O
pero	O
a	O
diferencia	O
del	O
grosor	O
de	O
la	O
piel	O
)	O
.	O

Así	O
,	O
al	O
menos	O
tres	O
características	O
distinguen	O
la	O
piel	O
dorsal	O
de	O
la	O
ventral	O
:	O
diferencias	O
en	O
pigmento	B-Chemical
-	O
tipo	O
síntesis	O
(	O
dependiendo	O
de	O
Agutí	B-Protein
genotipo	B-Sequence
,	O
diferencias	O
en	O
la	O
longitud	O
del	O
cabello	O
y	O
diferencias	O
en	O
melanina	B-Chemical
contenido	O
.	O

Ventralización	O
de	O
la	O
Morfología	O
de	O
la	O
Piel	O
por	O
el	O
oreja	B-Protein
caída	I-Protein
Mutación	B-Sequence

Llamado	O
así	O
por	O
sus	O
efectos	O
sobre	O
la	O
morfología	O
craneofacial	O
,	O
el	O
oído	O
caído	O
es	O
un	O
recesivo	O
mutación	B-Sequence
en	O
ratón	B-Taxon
Cromosoma	B-GENE
3	O
;	O
el	O
original	O
alelo	B-Sequence
descrita	O
hace	O
más	O
de	O
40	O
años	O
por	O
Curry	O
(	O
1959	O
)	O
está	O
extinta	O
,	O
pero	O
una	O
mutación	O
espontánea	O
que	O
ocurrió	O
en	O
Harwell	O
,	O
deH	O
,	O
está	O
disponible	O
a	O
través	O
de	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
Estados	O
Unidos	O
)	O
.	O

Las	O
malformaciones	O
craneofaciales	O
externas	O
son	O
la	O
característica	O
más	O
evidente	O
de	O
la	O
deH/deH	O
animales	B-Taxon
,	O
incluyendo	O
ojos	O
muy	O
separados	O
,	O
fisuras	O
palpebrales	O
pequeñas	O
,	O
área	O
nasal	O
ancha	O
y	O
un	O
cráneo	O
acortado	O
sostenido	O
en	O
una	O
posición	O
elevada	O
,	O
lo	O
que	O
presumiblemente	O
causa	O
o	O
contribuye	O
a	O
la	O
posición	O
anormal	O
de	O
las	O
orejas	O
.	O

Nos	O
interesamos	O
por	O
oreja	B-Protein
caída	I-Protein
porque	O
el	O
original	O
alelo	B-Sequence
fue	O
descrito	O
para	O
afectar	O
pigmento	B-Chemical
``	O
patrón	O
de	O
una	O
manera	O
que	O
sugiere	O
una	O
posible	O
transformación	O
de	O
dorsal	O
a	O
ventral	O
:	O
``	O
''	O
En	O
un	O
''	O
genético	B-Sequence
fondo	O
(	O
at	O
y	O
AW	O
)	O
que	O
hace	O
que	O
el	O
vello	O
del	O
vientre	O
sea	O
más	O
claro	O
que	O
el	O
de	O
la	O
espalda	O
,	O
el	O
vello	O
del	O
vientre	O
se	O
eleva	O
más	O
alrededor	O
de	O
los	O
lados	O
del	O
cuerpo	O
y	O
la	O
cara	O
(	O
Curry	O
1959	O
)	O
.	O

Un	O
dorsoventral	O
anormal	O
pigmento	B-Chemical
el	O
patrón	O
es	O
evidente	O
en	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
ratones	B-Taxon
,	O
pero	O
la	O
comparación	O
con	O
no	O
mutante	O
animales	B-Taxon
se	O
describe	O
con	O
mayor	O
precisión	O
en	O
términos	O
de	O
regiones	O
ventral	O
,	O
lateral	O
y	O
dorsal	O
(	O
Figuras	O
1G	O
y	O
2A	O
)	O
.	O

La	O
región	O
ventral	O
presenta	O
pelos	O
cortos	O
de	O
base	O
gris	O
y	O
punta	O
color	O
crema	O
cuyo	O
límite	O
coincide	O
con	O
la	O
unión	O
de	O
la	O
pared	O
del	O
cuerpo	O
con	O
la	O
extremidad	O
;	O
tanto	O
la	O
apariencia	O
de	O
esta	O
región	O
como	O
la	O
posición	O
del	O
límite	O
son	O
aproximadamente	O
similares	O
en	O
at/at	O
en	O
comparación	O
con	O
at/at	O
;	O
deH	O
/	O
deH	O
ratones	B-Taxon
.	O

La	O
región	O
lateral	O
contiene	O
pelos	O
amarillos	O
de	O
longitud	O
progresivamente	O
creciente	O
;	O
en	O
en	O
/	O
en	O
ratones	B-Taxon
,	O
la	O
región	O
lateral	O
aparece	O
como	O
una	O
delgada	O
franja	O
amarilla	O
a	O
lo	O
largo	O
del	O
flanco	O
,	O
pero	O
en	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
ratones	B-Taxon
,	O
la	O
región	O
lateral	O
se	O
expande	O
considerablemente	O
con	O
un	O
límite	O
difuso	O
a	O
lo	O
largo	O
del	O
flanco	O
dorsal	O
,	O
y	O
un	O
dorsal	O
eumelanica	B-Chemical
región	O
cuyo	O
tamaño	O
se	O
reduce	O
correspondientemente	O
(	O
Figura	O
2A	O
y	O
2B	O
)	O
.	O

El	O
tamaño	O
total	O
del	O
cuerpo	O
es	O
más	O
pequeño	O
en	O
mutante	B-Sequence
en	O
comparación	O
con	O
no	O
mutante	O
animales	B-Taxon
,	O
pero	O
la	O
proporción	O
de	O
la	O
circunferencia	O
corporal	O
ocupada	O
por	O
la	O
región	O
lateral	O
en	O
mutante	B-Sequence
animales	B-Taxon
se	O
incrementa	O
alrededor	O
de	O
2	O
veces	O
,	O
de	O
11	O
.	O
9	O
%	O
a	O
22	O
.	O
2	O
%	O
(	O
Figura	O
2C	O
)	O
.	O

La	O
proporción	O
de	O
la	O
región	O
color	O
crema	O
ventral	O
también	O
se	O
expande	O
un	O
poco	O
,	O
47	O
.	O
9	O
%	O
en	O
mutante	B-Sequence
en	O
comparación	O
con	O
37	O
.	O
8	O
%	O
en	O
no	O
mutantes	O
animales	B-Taxon
,	O
pero	O
la	O
expansión	O
de	O
la	O
región	O
lateral	O
,	O
que	O
ocurre	O
en	O
todos	O
los	O
niveles	O
del	O
cuerpo	O
,	O
incluidos	O
los	O
miembros	O
y	O
el	O
cráneo	O
(	O
pero	O
no	O
la	O
almohadilla	O
del	O
bigote	O
)	O
,	O
es	O
la	O
principal	O
característica	O
responsable	O
de	O
la	O
apariencia	O
ventralizada	O
causada	O
por	O
deH	O
.	O

Para	O
investigar	O
si	O
la	O
deH	O
afecta	O
otras	O
características	O
de	O
la	O
piel	O
dorsoventral	O
además	O
de	O
pigmento	B-Chemical
cambio	O
de	O
tipo	O
,	O
examinamos	O
sus	O
efectos	O
sobre	O
la	O
longitud	O
del	O
cabello	O
y	O
la	O
pigmentación	O
en	O
un	O
fondo	O
ae/ae	O
.	O

En	O
general	O
,	O
la	O
deH	O
causa	O
una	O
reducción	O
pequeña	O
pero	O
consistente	O
en	O
la	O
longitud	O
del	O
cabello	O
tanto	O
en	O
el	O
dorso	O
como	O
en	O
el	O
vientre	O
;	O
Cuándo	O
mutante	B-Sequence
y	O
no	O
mutante	O
animales	B-Taxon
están	O
normalizados	O
para	O
la	O
circunferencia	O
del	O
cuerpo	O
,	O
la	O
reducción	O
de	O
la	O
longitud	O
del	O
cabello	O
es	O
más	O
evidente	O
en	O
la	O
región	O
lateral	O
(	O
Figura	O
2E	O
)	O
.	O

Adulto	O
ae	O
/	O
ae	O
;	O
deH	O
/	O
deH	O
animales	B-Taxon
muestran	O
reducción	O
del	O
tamaño	O
corporal	O
y	O
anomalías	O
esqueléticas	O
,	O
pero	O
no	O
muestran	O
fenotipo	O
del	O
color	O
del	O
pelaje	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Sin	O
embargo	O
,	O
ae/ae	O
y	O
ae/ae	O
;	O
Los	O
neonatos	O
deH/deH	O
son	O
claramente	O
distinguibles	O
en	O
los	O
primeros	O
días	O
después	O
del	O
nacimiento	O
,	O
cuando	O
un	O
gradiente	O
dorsoventral	O
de	O
actividad	O
melanogénica	O
es	O
evidente	O
debajo	O
de	O
la	O
piel	O
(	O
Figura	O
2D	O
)	O
.	O

En	O
este	O
punto	O
,	O
melanoblasto	B-Cell
la	O
migración	O
desde	O
la	O
cresta	O
neural	O
es	O
casi	O
completa	O
,	O
pero	O
hay	O
un	O
gradiente	O
dorsoventral	O
en	O
melanocito	B-Cell
diferenciación	O
y	O
pigmento	B-Chemical
síntesis	O

La	O
piel	O
de	O
los	O
neonatos	O
ae/ae	O
aparece	O
uniformemente	O
oscura	O
en	O
todo	O
el	O
dorso	O
,	O
pero	O
en	O
ae/ae	O
;	O
deH/deH	O
neonatos	O
,	O
el	O
área	O
de	O
piel	O
oscura	O
es	O
más	O
restringida	O
,	O
particularmente	O
por	O
encima	O
de	O
las	O
extremidades	O
,	O
y	O
se	O
asemeja	O
al	O
patrón	O
de	O
dorsal	O
eumelanina	B-Chemical
en	O
en	O
/	O
en	O
;	O
deH	O
/	O
deH	O
adulto	O
animales	B-Taxon
.	O

Tomadas	O
en	O
conjunto	O
,	O
estas	O
observaciones	O
sugieren	O
que	O
deH	O
interfiere	O
con	O
el	O
establecimiento	O
del	O
patrón	O
dorsoventral	O
durante	O
el	O
desarrollo	O
de	O
la	O
piel	O
al	O
causar	O
la	O
expansión	O
dorsal	O
de	O
una	O
región	O
lateral	O
que	O
normalmente	O
tiene	O
entre	O
3	O
y	O
5	O
mm	O
de	O
ancho	O
.	O

Esta	O
misma	O
región	O
puede	O
servir	O
como	O
límite	O
entre	O
la	O
piel	O
dorsal	O
y	O
ventral	O
al	O
inhibir	O
melanocito	B-Cell
diferenciación	O
,	O
promoviendo	O
la	O
síntesis	O
de	O
feomelanina	O
y	O
apoyando	O
un	O
aumento	O
progresivo	O
en	O
el	O
crecimiento	O
del	O
cabello	O
desde	O
el	O
vientre	O
hasta	O
el	O
dorso	O
.	O

Como	O
se	O
describe	O
a	O
continuación	O
,	O
el	O
gene	B-Sequence
defectuoso	O
en	O
deH	O
,	O
Tbx15	B-Protein
,	O
normalmente	O
se	O
expresa	O
en	O
la	O
región	O
dorsal	O
y	O
,	O
por	O
lo	O
tanto	O
,	O
es	O
probable	O
que	O
desempeñe	O
un	O
papel	O
en	O
el	O
establecimiento	O
del	O
tamaño	O
y	O
la	O
extensión	O
dorsal	O
de	O
la	O
región	O
lateral	O
.	O

posicional	B-Sequence
Clonación	O
de	O
deH	O

Como	O
marcador	O
visible	O
,	O
los	O
primeros	O
estudios	O
de	O
vinculación	O
con	O
el	O
original	O
oreja	B-Protein
caída	I-Protein
alelo	B-Sequence
o	O
el	O
deH	O
alelo	B-Sequence
identificado	O
un	O
posición	B-Sequence
del	I-Sequence
mapa	I-Sequence
en	O
el	O
medio	O
de	O
Cromosoma	B-GENE
3	O
,	O
distal	O
a	O
enmarañado	B-Protein
y	O
proximal	O
a	O
Varitint	B-Protein
-	I-Protein
anadeón	I-Protein
(	O
Carter	O
y	O
Falconer	O
1951	O
;	O
Curry	O
1959	O
;	O
Lane	O
y	O
Eicher	O
1979	O
;	O
Holmes	O
et	O
al	O
.	O
1981	O
)	O
.	O

Usamos	O
un	O
cruce	O
F2	O
con	O
CAST/Ei	O
ratones	B-Taxon
para	O
localizar	O
deH	O
a	O
un	O
0	O
.	O
1cm	O
intervalo	B-Sequence
entre	O
D3Mit213	O
y	O
16	O
.	O
MMHAP32FLF1	O
,	O
que	O
fue	O
perfeccionado	O
mediante	O
el	O
desarrollo	O
de	O
un	O
cromosoma	B-Sequence
artificial	I-Sequence
bacteriano	I-Sequence
(	O
BAC	B-Sequence
)	O
contiguo	B-Sequence
y	O
marcadores	O
adicionales	O
a	O
un	O
1	O
.	O
4	O
MB	O
región	B-Sequence
que	O
contenía	O
ocho	O
genes	B-Sequence
,	O
incluyendo	O
Tbx15	B-Protein
(	O
Figura	O
3A	O
)	O
.	O

Nosotros	O
consideramos	O
Tbx15	B-Protein
como	O
un	O
excelente	O
candidato	O
para	O
las	O
anomalías	O
esqueléticas	O
causadas	O
por	O
deH	O
,	O
según	O
los	O
estudios	O
de	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
,	O
quienes	O
describieron	O
su	O
expresión	O
embrionaria	O
en	O
la	O
región	O
craneofacial	O
y	O
extremidades	O
en	O
desarrollo	O
.	O

Utilizando	O
secuencia	B-Sequence
información	O
de	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
y	O
el	O
parcialmente	B-Sequence
completado	I-Sequence
ratón	B-Taxon
secuencia	B-Sequence
del	I-Sequence
genoma	I-Sequence
,	O
Encontramos	O
eso	O
porciones	B-Sequence
de	I-Sequence
varios	I-Sequence
exones	I-Sequence
Tbx15	I-Sequence
no	O
se	O
pudo	O
amplificar	O
de	O
deH	O
/	O
deH	O
ADN	B-Sequence
genómico	I-Sequence
.	O

Lo	O
mismo	O
gene	B-Sequence
se	O
denominó	O
inicialmente	O
como	O
Tbx8	B-Protein
(	O
Wattler	O
et	O
al	O
.	O
1998	O
)	O
y	O
luego	O
renombrado	O
Tbx14	B-Protein
pero	O
actualmente	O
se	O
menciona	O
en	O
varios	O
vertebrado	B-Taxon
genomas	B-Sequence
como	O
Tbx15	B-Protein
(	O
Agulnik	O
et	O
al	O
.	O
1998	O
;	O
Begemann	O
et	O
al	O
.	O
2002	O
)	O
.	O

Al	O
comparar	O
el	O
secuencia	B-Sequence
de	O
un	O
1	O
3	O
KB	O
fragmento	B-Sequence
de	I-Sequence
unión	I-Sequence
amplificado	O
de	O
deH	O
/	O
deH	O
ADN	B-Sequence
genómico	I-Sequence
disponible	O
públicamente	O
ratón	B-Taxon
secuencia	B-Sequence
del	I-Sequence
genoma	I-Sequence
,	O
identificamos	O
un	O
216	O
kb	O
supresión	B-Sequence
que	O
se	O
extiende	O
desde	O
Tbx15	B-Protein
intrón	B-Sequence
1	O
a	O
148	O
kb	O
aguas	O
abajo	O
del	O
secuencia	B-Sequence
de	I-Sequence
poliadenilación	I-Sequence
en	O
un	O
región	B-Sequence
anotado	O
como	O
un	O
manosa	B-Protein
-	I-Protein
6	I-Protein
-	I-Protein
receptor	I-Protein
de	I-Protein
fosfato	I-Protein
pseudogen	B-Sequence
,	O
M6pr	B-Protein
-	O
PD	B-Sequence
(	O
Figura	O
3B	O
y	O
3C	O
)	O
.	O

(	O
Ludwig	O
y	O
col.	O
1992	O
)	O
.	O

Por	O
análisis	O
de	O
transferencia	O
de	O
Northern	O
,	O
identificamos	O
un	O
transcripción	B-Sequence
de	I-Sequence
fusión	I-Sequence
producido	O
a	O
partir	O
de	O
la	O
deH	O
cromosoma	B-GENE
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Sin	O
embargo	O
,	O
el	O
eliminación	B-Sequence
elimina	I-Sequence
534	O
de	O
los	O
602	O
aminoácidos	B-Chemical
codificado	O
por	O
Tbx15	B-Protein
(	O
incluida	O
la	O
caja	O
T	O
ADN	B-Sequence
#	O
¿NOMBRE	O
?	O
dominio	B-Sequence
)	O
,	O
deH	O
/	O
+	B-Sequence
animales	B-Taxon
son	O
macroscópicamente	O
normales	O
y	O
el	O
fenotipo	O
de	O
deH	O
/	O
deH	O
animales	B-Taxon
es	O
idéntico	O
al	O
descrito	O
para	O
el	O
original	O
alelo	B-Sequence
.	O

Además	O
,	O
aparte	O
de	O
M6pr	B-Protein
-	O
PD	B-Sequence
,	O
ninguna	O
otra	O
genes	B-Sequence
o	O
transcripciones	B-Sequence
se	O
han	O
anotado	O
a	O
los	O
216	O
kb	O
supresión	B-Sequence
.	O

Mientras	O
que	O
la	O
posicional	B-Sequence
el	O
trabajo	O
de	O
clonación	O
estaba	O
en	O
marcha	O
,	O
uno	O
de	O
nosotros	O
(	O
A.	O
Russ	O
)	O
generó	O
un	O
mutación	B-Sequence
de	O
Tbx15	B-Protein
por	O
gene	B-Sequence
focalización	O
en	O
embrionario	O
Células	B-Cell
madre	I-Cell
.	O

el	O
objetivo	O
alelo	B-Sequence
,	O
Tbx15LacZ	O
,	O
lleva	O
un	O
ires	B-Sequence
#	O
¿NOMBRE	O
?	O
casete	B-Sequence
de	I-Sequence
ADNc	I-Sequence
que	O
interrumpe	O
el	O
marco	B-Sequence
de	I-Sequence
lectura	I-Sequence
abierto	I-Sequence
en	O
codón	B-Sequence
154	O
temprano	O
en	O
el	O
T	O
-	O
box	O
dominio	B-Sequence
(	O
Figura	O
3D	O
)	O
.	O

animales	B-Taxon
heterocigoto	O
para	O
el	O
objetivo	O
alelo	B-Sequence
son	O
completamente	O
normales	O
con	O
respecto	O
al	O
tamaño	O
,	O
la	O
morfología	O
esquelética	O
y	O
la	O
distribución	O
del	O
color	O
del	O
cabello	O
,	O
pero	O
se	O
observó	O
que	O
los	O
homocigotos	O
Tbx15LacZ/Tbx15LacZ	O
exhibían	O
un	O
tamaño	O
corporal	O
reducido	O
y	O
una	O
apariencia	O
craneofacial	O
anormal	O
idéntica	O
a	O
la	O
causada	O
por	O
deH	O
.	O

Generamos	O
heterocigotos	O
compuestos	O
Tbx15LacZ/deH	O
;	O
sobre	O
un	O
fondo	O
Aw/at	O
,	O
estos	O
animales	B-Taxon
exhibió	O
la	O
misma	O
restricción	O
anormal	O
de	O
la	O
pigmentación	O
dorsal	O
en	O
P3	O
.	O
5	O
y	O
área	O
de	O
flanco	O
amarilla	O
expandida	O
como	O
se	O
describe	O
arriba	O
para	O
deH	O
/	O
deH	O
animales	B-Taxon
(	O
ver	O
Figura	O
2	O
)	O
.	O

Estas	O
observaciones	O
demuestran	O
que	O
la	O
pigmentario	B-Chemical
y	O
las	O
características	O
craneofaciales	O
de	O
deH	O
son	O
causadas	O
por	O
la	O
pérdida	O
de	O
función	O
para	O
Tbx15	B-Protein
.	O

Expresión	O
de	O
Tbx15	B-Protein
y	O
Agutí	B-Protein

Estudios	O
previos	O
de	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
usando	O
hibridación	O
in	O
situ	O
de	O
montaje	O
completo	O
describió	O
la	O
expresión	O
de	O
Tbx15	B-Protein
como	O
detectable	O
por	O
primera	O
vez	O
en	O
E9	O
.	O
5	O
en	O
los	O
esbozos	O
de	O
las	O
extremidades	O
,	O
progresando	O
a	O
los	O
arcos	O
branquiales	O
,	O
flancos	O
y	O
regiones	O
craneofaciales	O
a	O
través	O
de	O
E12	O
.	O
5	O
.	O

Para	O
investigar	O
este	O
patrón	O
con	O
más	O
detalle	O
,	O
hibridamos	O
un	O
Tbx15	B-Protein
ARNm	B-Chemical
Investigacion	B-Sequence
a	O
una	O
serie	O
de	O
secciones	O
transversales	O
en	O
E12	O
.	O
5	O
y	O
la	O
expresión	O
observada	O
en	O
múltiples	O
tejidos	O
mesenquimales	O
de	O
la	O
cabeza	O
,	O
el	O
tronco	O
y	O
las	O
extremidades	O
en	O
desarrollo	O
(	O
Figura	O
4A	O
)	O
,	O
gran	O
parte	O
de	O
la	O
cual	O
es	O
compatible	O
con	O
las	O
malformaciones	O
del	O
cráneo	O
,	O
las	O
vértebras	O
cervicales	O
y	O
las	O
extremidades	O
notificadas	O
para	O
ratones	B-Taxon
llevando	O
el	O
original	O
oreja	B-Protein
caída	I-Protein
alelo	B-Sequence
.	O

Estábamos	O
particularmente	O
interesados	O
en	O
determinar	O
la	O
naturaleza	O
exacta	O
de	O
la	O
expresión	O
del	O
flanco	O
embrionario	O
en	O
relación	O
con	O
el	O
fenotipo	O
ventralizado	O
de	O
adultos	O
deH	O
/	O
deH	O
ratones	B-Taxon
.	O

Las	O
secciones	O
abdominales	O
transversales	O
de	O
diferentes	O
momentos	O
durante	O
el	O
desarrollo	O
revelan	O
una	O
banda	O
de	O
expresión	O
dorsolateral	O
en	O
el	O
mesénquima	O
superficial	O
en	O
E11	O
.	O
5	O
que	O
se	O
ensancha	O
tanto	O
dorsal	O
como	O
ventralmente	O
durante	O
los	O
próximos	O
días	O
(	O
Figura	O
4B	O
)	O
.	O

Por	O
E13	O
.	O
5	O
,	O
la	O
dermis	O
en	O
desarrollo	O
se	O
ha	O
separado	O
del	O
mesénquima	O
suelto	O
por	O
una	O
capa	O
de	O
músculo	O
subcutáneo	O
;	O
Tbx15	B-Protein
se	O
expresa	O
en	O
todas	O
estas	O
capas	O
,	O
así	O
como	O
en	O
los	O
músculos	O
abdominales	O
subyacentes	O
.	O

En	O
P3	O
.	O
5	O
piel	O
,	O
Tbx15	B-Protein
se	O
expresa	O
tanto	O
en	O
la	O
piel	O
dorsal	O
como	O
en	O
la	O
ventral	O
,	O
más	O
fuertemente	O
en	O
la	O
dermis	O
superior	O
condensada	O
y	O
en	O
las	O
vainas	O
dérmicas	O
en	O
desarrollo	O
de	O
los	O
folículos	O
pilosos	O
;	O
expresión	O
débil	O
también	O
se	O
puede	O
detectar	O
en	O
casos	O
raros	O
células	B-Cell
de	I-Cell
las	I-Cell
papilas	I-Cell
dérmicas	I-Cell
(	O
Figura	O
4B	O
)	O
.	O

Aunque	O
los	O
efectos	O
de	O
Agutí	B-Protein
en	O
pigmento	B-Chemical
-	O
el	O
cambio	O
de	O
tipo	O
ocurre	O
durante	O
el	O
crecimiento	O
postnatal	O
del	O
cabello	O
,	O
el	O
ventral	O
-	O
específico	O
isoforma	B-Sequence
de	O
Agutí	B-Protein
se	O
expresa	O
en	O
la	O
piel	O
en	O
desarrollo	O
a	O
partir	O
de	O
E11	O
.	O
5	O
.	O

Comparamos	O
secciones	O
adyacentes	O
hibridadas	O
con	O
sondas	B-Sequence
por	O
Tbx15	B-Protein
y	O
Agutí	B-Protein
y	O
observó	O
patrones	O
complementarios	O
en	O
E12	O
.	O
5	O
,	O
con	O
expresión	O
de	O
Agutí	B-Protein
en	O
piel	O
ventral	O
y	O
expresión	O
de	O
Tbx15	B-Protein
en	O
piel	O
dorsal	O
(	O
Figura	O
5A	O
y	O
5B	O
)	O
.	O

La	O
unión	O
entre	O
los	O
dominios	O
de	O
expresión	O
es	O
indistinta	O
y	O
por	O
E14	O
.	O
5	O
,	O
Tbx15	B-Protein
expresión	O
se	O
extiende	O
ventralmente	O
y	O
se	O
superpone	O
ampliamente	O
con	O
Agutí	B-Protein
expresión	O
(	O
Figura	O
5C	O
y	O
5D	O
)	O
.	O

También	O
examinamos	O
el	O
efecto	O
de	O
deH	O
en	O
la	O
expresión	O
de	O
Agutí	B-Protein
y	O
no	O
encontró	O
diferencia	O
entre	O
mutante	B-Sequence
y	O
no	O
mutante	O
en	O
E12	O
.	O
5	O
o	O
E13	O
.	O
5	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Sin	O
embargo	O
,	O
en	O
E14	O
.	O
5	O
,	O
el	O
gradiente	O
ventral	O
a	O
dorsal	O
normal	O
de	O
Agutí	B-Protein
la	O
expresión	O
pareció	O
extenderse	O
más	O
dorsalmente	O
en	O
los	O
embriones	O
deH/deH	O
(	O
Figura	O
6A	O
)	O
.	O

En	O
P4	O
.	O
5	O
piel	O
,	O
expresión	O
de	O
Agutí	B-Protein
también	O
se	O
extiende	O
dorsalmente	O
en	O
deH	O
/	O
deH	O
animales	B-Taxon
y	O
es	O
más	O
evidente	O
en	O
la	O
región	O
del	O
flanco	O
medio	O
dentro	O
de	O
la	O
dermis	O
superior	O
y	O
células	B-Cell
de	I-Cell
las	I-Cell
papilas	I-Cell
dérmicas	I-Cell
(	O
Figura	O
6B	O
)	O
.	O

Así	O
,	O
mientras	O
que	O
el	O
fenotipo	O
de	O
pigmentación	O
de	O
deH	O
/	O
deH	O
ratones	B-Taxon
puede	O
explicarse	O
,	O
como	O
era	O
de	O
esperar	O
,	O
por	O
la	O
extensión	O
dorsal	O
de	O
Agutí	B-Protein
expresión	O
después	O
del	O
nacimiento	O
,	O
expresión	O
modelada	O
de	O
Tbx15	B-Protein
y	O
Agutí	B-Protein
son	O
evidentes	O
unos	O
10	O
días	O
antes	O
,	O
entre	O
E12	O
.	O
5	O
y	O
E13	O
.	O
5	O
,	O
y	O
los	O
efectos	O
de	O
Tbx15	B-Protein
deficiencia	O
en	O
la	O
expresión	O
de	O
Agutí	B-Protein
puede	O
ser	O
detectado	O
por	O
E14	O
.	O
5	O
.	O

Relación	O
de	O
Embrionario	O
Tbx15	B-Protein
Expresión	O
a	O
Dominios	O
de	O
Pigmentación	O
Dorsal	O
y	O
Ventral	O

Las	O
observaciones	O
descritas	O
anteriormente	O
son	O
consistentes	O
con	O
un	O
modelo	O
en	O
el	O
que	O
la	O
expresión	O
transitoria	O
de	O
Tbx15	B-Protein
en	O
el	O
flanco	O
dorsal	O
embrionario	O
se	O
requiere	O
para	O
establecer	O
la	O
identidad	O
posicional	O
de	O
la	O
futura	O
dermis	O
,	O
al	O
menos	O
con	O
respecto	O
a	O
pigmento	B-Chemical
#	O
¿NOMBRE	O
?	O
Agutí	B-Protein
isoforma	B-Sequence
.	O

Para	O
investigar	O
más	O
a	O
fondo	O
esta	O
hipótesis	O
,	O
llevamos	O
a	O
cabo	O
experimentos	O
de	O
trasplante	O
en	O
los	O
que	O
se	O
aislaron	O
trozos	O
de	O
piel	O
embrionaria	O
de	O
diferentes	O
posiciones	O
dorsoventrales	O
.	O

Evaluamos	O
los	O
fragmentos	O
de	O
piel	O
embrionaria	O
por	O
su	O
potencial	O
para	O
dar	O
lugar	O
a	O
diferentes	O
colores	O
de	O
cabello	O
y	O
por	O
su	O
expresión	O
de	O
Tbx15	B-Protein
y	O
Agutí	B-Protein
.	O

Estudios	O
previos	O
de	O
Silvers	O
y	O
colegas	O
(	O
Poole	O
y	O
Silvers	O
1976	O
)	O
mostraron	O
que	O
la	O
piel	O
dorsal	O
y	O
ventral	O
aislada	O
de	O
embriones	O
at/at	O
da	O
lugar	O
a	O
pelo	O
negro	O
y	O
amarillo	O
,	O
respectivamente	O
,	O
cuando	O
se	O
trasplantan	O
a	O
los	O
testículos	O
y	O
se	O
les	O
permite	O
desarrollarse	O
durante	O
varias	O
semanas	O
.	O

Además	O
,	O
los	O
experimentos	O
de	O
recombinación	O
dérmica-epidérmica	O
llevados	O
a	O
cabo	O
en	O
E14	O
.	O
5	O
demostraron	O
que	O
la	O
identidad	O
posicional	O
la	O
lleva	O
la	O
dermis	O
embrionaria	O
.	O

En	O
una	O
variación	O
de	O
este	O
experimento	O
,	O
dividimos	O
la	O
piel	O
embrionaria	O
de	O
embriones	O
at	O
/	O
a	O
en	O
piezas	O
dorsales	O
,	O
laterales	O
y	O
ventrales	O
y	O
analizamos	O
las	O
diferentes	O
piezas	O
en	O
cuanto	O
a	O
su	O
capacidad	O
para	O
dar	O
lugar	O
a	O
pelo	O
negro	O
o	O
amarillo	O
después	O
del	O
trasplante	O
de	O
testículos	O
y	O
,	O
en	O
paralelo	O
,	O
para	O
gene	B-Sequence
expresión	O
usando	O
hibridación	O
in	O
situ	O
.	O

Con	O
el	O
fin	O
de	O
establecer	O
un	O
límite	O
morfológico	O
reproducible	O
,	O
dividimos	O
la	O
piel	O
del	O
flanco	O
de	O
la	O
ventral	O
en	O
función	O
de	O
un	O
cambio	O
en	O
el	O
grosor	O
de	O
la	O
piel	O
y	O
dividimos	O
la	O
piel	O
del	O
flanco	O
y	O
la	O
dorsal	O
al	O
nivel	O
de	O
una	O
muesca	O
ectodérmica	O
que	O
se	O
encuentra	O
al	O
mismo	O
nivel	O
que	O
la	O
extensión	O
ventral	O
del	O
miotoma	O
(	O
Figura	O
7	O
)	O
(	O
Huang	O
y	O
Christ	O
2000	O
;	O
Olivera-Martinez	O
et	O
al	O
.	O
2000	O
;	O
Sudo	O
et	O
al	O
.	O
2001	O
;	O
Burke	O
y	O
Nowicki	O
2003	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
.	O

Encontramos	O
que	O
E12	O
.	O
5	O
es	O
el	O
momento	O
más	O
temprano	O
en	O
el	O
que	O
la	O
piel	O
ventral	O
embrionaria	O
es	O
capaz	O
de	O
producir	O
cabello	O
cuando	O
se	O
trasplanta	O
a	O
los	O
testículos	O
.	O

De	O
los	O
injertos	O
que	O
produjeron	O
pelo	O
,	O
la	O
piel	O
ventral	O
dio	O
lugar	O
a	O
pelo	O
amarillo	O
(	O
n=3	O
)	O
,	O
y	O
la	O
piel	O
dorsal	O
dio	O
lugar	O
a	O
pelo	O
negro	O
(	O
n=4	O
)	O
.	O

El	O
trasplante	O
de	O
la	O
piel	O
del	O
flanco	O
dio	O
lugar	O
a	O
un	O
parche	O
de	O
cabello	O
amarillo	O
yuxtapuesto	O
contra	O
un	O
parche	O
de	O
cabello	O
negro	O
en	O
el	O
85	O
%	O
de	O
los	O
injertos	O
exitosos	O
(	O
n	O
=	O
13	O
)	O
;	O
los	O
dos	O
injertos	O
de	O
flanco	O
restantes	O
produjeron	O
únicamente	O
pelo	O
negro	O
o	O
amarillo	O
.	O

En	O
ningún	O
caso	O
observamos	O
mezcla	O
de	O
pelos	O
negros	O
y	O
amarillos	O
.	O

Como	O
se	O
predijo	O
a	O
partir	O
de	O
los	O
experimentos	O
usando	O
secciones	O
de	O
tejido	O
(	O
ver	O
Figuras	O
5	O
y	O
6	O
)	O
,	O
las	O
piezas	O
dorsales	O
expresaron	O
Tbx15	B-Protein
pero	O
no	O
Agutí	B-Protein
,	O
mientras	O
que	O
las	O
piezas	O
de	O
flanco	O
expresaron	O
tanto	O
genes	B-Sequence
(	O
ver	O
Figura	O
7	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
la	O
identidad	O
dorsoventral	O
para	O
la	O
pigmentación	O
adulta	O
se	O
establece	O
en	O
el	O
momento	O
en	O
que	O
la	O
expresión	O
patrón	O
se	O
hace	O
evidente	O
para	O
Tbx15	B-Protein
y	O
Agutí	B-Protein
(	O
E11	O
.	O
5	O
-	O
E12	O
.	O
5	O
)	O
;	O
además	O
,	O
la	O
identidad	O
posicional	O
se	O
mantiene	O
a	O
lo	O
largo	O
de	O
las	O
etapas	O
posteriores	O
del	O
desarrollo	O
de	O
la	O
piel	O
,	O
aunque	O
la	O
expresión	O
de	O
Tbx15	B-Protein
se	O
ensancha	O
para	O
incluir	O
piel	O
ventral	O
y	O
dorsal	O
.	O

Relación	O
de	O
la	O
Dorsoventral	O
Pigmento	B-Chemical
Límite	O
a	O
los	O
compartimentos	O
de	O
linaje	O
y	O
la	O
frontera	O
somítica	O
lateral	O

La	O
muesca	O
ectodérmica	O
que	O
usamos	O
para	O
marcar	O
el	O
límite	O
entre	O
el	O
dorso	O
embrionario	O
y	O
el	O
flanco	O
embrionario	O
es	O
un	O
rasgo	O
característico	O
en	O
vertebrado	B-Taxon
embriones	O

En	O
célula	B-Cell
``	O
En	O
estudios	O
de	O
linaje	O
llevados	O
a	O
cabo	O
en	O
el	O
sistema	O
de	O
los	O
pollitos	O
,	O
la	O
muesca	O
sirve	O
como	O
punto	O
de	O
referencia	O
para	O
el	O
límite	O
entre	O
la	O
dermis	O
derivada	O
del	O
mesodermo	O
somítico	O
y	O
la	O
dermis	O
derivada	O
del	O
mesodermo	O
de	O
la	O
placa	O
lateral	O
y	O
se	O
ha	O
denominado	O
``	O
''	O
frontera	O
somítica	O
lateral	O
''	O
''	O
(	O
Olivera-Martinez	O
et	O
al	O
.	O
2000	O
;	O
Sudo	O
y	O
otros	O
2001	O
,	O
Burke	O
y	O
Nowicki	O
2003	O
,	O
Nowicki	O
y	O
otros	O
2003	O
)	O
.	O
''	O

Aunque	O
no	O
se	O
han	O
realizado	O
estudios	O
de	O
cartografía	O
del	O
destino	O
en	O
mamífero	B-Taxon
embriones	O
,	O
somita	O
y	O
mesodermo	O
derivado	O
de	O
la	O
placa	O
lateral	O
podría	O
dar	O
lugar	O
a	O
precursores	O
de	O
la	O
dermis	O
dorsal	O
y	O
ventral	O
a	O
la	O
unión	O
de	O
la	O
pared	O
del	O
cuerpo	O
con	O
la	O
extremidad	O
,	O
respectivamente	O
.	O

Sin	O
embargo	O
,	O
esta	O
noción	O
entra	O
en	O
conflicto	O
con	O
nuestra	O
observación	O
de	O
que	O
el	O
futuro	O
límite	O
de	O
pigmentación	O
se	O
encuentra	O
ventral	O
a	O
la	O
muesca	O
ectodérmica	O
(	O
ver	O
Figura	O
7	O
)	O
.	O

Para	O
examinar	O
directamente	O
la	O
relación	O
entre	O
el	O
límite	O
de	O
pigmentación	O
y	O
la	O
dermis	O
derivada	O
del	O
mesodermo	O
de	O
la	O
placa	O
lateral	O
,	O
utilizamos	O
un	O
Cre	O
transgén	B-Sequence
impulsado	O
por	O
el	O
Hoxb6	B-Protein
promotor	B-Sequence
que	O
fue	O
desarrollado	O
por	O
Kuehn	O
y	O
colegas	O
(	O
Lowe	O
et	O
al	O
.	O
2000	O
)	O
.	O

Como	O
se	O
describe	O
por	O
Lowe	O
et	O
al	O
.	O

(	O
2000	O
)	O
,	O
embriones	O
de	O
mediana	O
gestación	O
que	O
portan	O
tanto	O
el	O
Hoxb6	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
y	O
el	O
reportero	O
R26R	O
lacZ	O
gene	B-Sequence
(	O
Soriano	O
1999	O
)	O
muestran	O
tinción	O
con	O
X-Gal	O
en	O
el	O
mesodermo	O
de	O
la	O
placa	O
lateral	O
pero	O
no	O
en	O
el	O
mesodermo	O
del	O
tronco	O
derivado	O
de	O
somita	O
.	O

En	O
preparados	O
para	O
la	O
piel	O
enteros	O
a	O
partir	O
de	O
P1	O
.	O
5	O
o	O
P4	O
.	O
5	O
neonatal	O
animales	B-Taxon
,	O
observamos	O
una	O
banda	O
ventral	O
de	O
tinción	O
oscura	O
de	O
X	O
-	O
Gal	O
correspondiente	O
a	O
la	O
dermis	O
derivada	O
de	O
placa	O
lateral	O
,	O
que	O
representa	O
el	O
63	O
%	O
de	O
la	O
circunferencia	O
total	O
(	O
Figura	O
8A	O
)	O
.	O

Sin	O
embargo	O
,	O
en	O
preparaciones	O
paralelas	O
desde	O
at	O
/	O
at	O
ratones	B-Taxon
,	O
el	O
dominio	O
de	O
feomelanina	O
ventral	O
representa	O
el	O
47	O
%	O
de	O
la	O
circunferencia	O
total	O
de	O
la	O
piel	O
;	O
por	O
lo	O
tanto	O
,	O
las	O
proporciones	O
de	O
la	O
circunferencia	O
total	O
de	O
la	O
piel	O
ocupada	O
por	O
dorsal	O
eumelanina	B-Chemical
y	O
la	O
dermis	O
derivada	O
de	O
somita	O
son	O
53	O
%	O
y	O
37	O
%	O
,	O
respectivamente	O
(	O
Figura	O
8B	O
)	O
.	O

Estos	O
resultados	O
indican	O
que	O
el	O
límite	O
de	O
pigmentación	O
es	O
claramente	O
distinto	O
y	O
más	O
ventral	O
al	O
límite	O
entre	O
la	O
placa	O
lateral	O
y	O
la	O
dermis	O
derivada	O
de	O
somita	O
.	O

Debido	O
a	O
que	O
el	O
límite	O
de	O
pigmentación	O
se	O
encuentra	O
en	O
registro	O
con	O
la	O
unión	O
de	O
la	O
pared	O
del	O
cuerpo	O
y	O
la	O
extremidad	O
(	O
consulte	O
la	O
Figura	O
2	O
)	O
,	O
nos	O
preguntamos	O
si	O
los	O
mecanismos	O
utilizados	O
para	O
el	O
patrón	O
dorsoventral	O
de	O
las	O
extremidades	O
podrían	O
estar	O
relacionados	O
con	O
los	O
utilizados	O
para	O
establecer	O
el	O
límite	O
de	O
pigmentación	O
.	O

En	O
el	O
miembro	O
en	O
desarrollo	O
,	O
grabado1	B-Protein
(	O
En1	B-Protein
)	O
,	O
Wnt7a	B-Protein
,	O
y	O
Lmx1b	B-Protein
son	O
parte	O
de	O
una	O
red	O
cuyos	O
dominios	O
de	O
expresión	O
restringidos	O
ayudan	O
a	O
establecer	O
la	O
identidad	O
dorsoventral	O
(	O
revisado	O
en	O
Niswander	O
2003	O
)	O
.	O

En1	B-Protein
se	O
expresa	O
transitoriamente	O
en	O
el	O
flanco	O
en	O
desarrollo	O
;	O
en	O
E11	O
.	O
5	O
,	O
las	O
secciones	O
abdominales	O
transversales	O
revelan	O
dominios	O
en	O
el	O
tubo	O
neural	O
,	O
mesénquima	O
derivado	O
de	O
somita	O
y	O
la	O
pared	O
corporal	O
ventral	O
(	O
Figura	O
8C	O
)	O
.	O

Una	O
sección	O
adyacente	O
hibridó	O
con	O
Tbx15	B-Protein
revela	O
un	O
patrón	O
complementario	O
en	O
el	O
flanco	O
,	O
que	O
proporciona	O
evidencia	O
adicional	O
de	O
los	O
mecanismos	O
de	O
desarrollo	O
que	O
establecen	O
un	O
límite	O
de	O
pigmentación	O
completamente	O
dentro	O
del	O
mesodermo	O
de	O
la	O
placa	O
lateral	O
e	O
independiente	O
de	O
las	O
restricciones	O
de	O
linaje	O
impuestas	O
por	O
la	O
frontera	O
somítica	O
lateral	O
.	O

Discusión	O

Varios	O
mutaciones	B-Sequence
y	O
genes	B-Sequence
han	O
identificado	O
que	O
afectan	O
el	O
patrón	O
de	O
desarrollo	O
del	O
folículo	O
piloso	O
,	O
pero	O
Tbx15	B-Protein
es	O
el	O
único	O
gene	B-Sequence
del	O
cual	O
somos	O
conscientes	O
que	O
afecta	O
el	O
patrón	O
de	O
pigmentación	O
del	O
cabello	O
en	O
diferentes	O
regiones	O
del	O
cuerpo	O
.	O

Las	O
áreas	O
ventrales	O
que	O
normalmente	O
producen	O
vello	O
amarillo	O
en	O
el	O
tronco	O
,	O
las	O
extremidades	O
y	O
las	O
regiones	O
craneofaciales	O
se	O
expanden	O
en	O
deH/deH	O
ratones	B-Taxon
y	O
,	O
al	O
menos	O
en	O
el	O
tronco	O
,	O
representan	O
una	O
expresión	O
dorsal	O
inapropiada	O
de	O
una	O
Agutí	B-Protein
ARNm	B-Chemical
isoforma	B-Sequence
que	O
normalmente	O
se	O
restringe	O
a	O
la	O
piel	O
ventral	O
.	O

El	O
deH	O
alelo	B-Sequence
es	O
causado	O
por	O
una	O
gran	O
supresión	B-Sequence
que	O
elimina	B-Sequence
la	O
mayoría	O
de	O
Tbx15	B-Protein
secuencia	B-Sequence
de	I-Sequence
codificación	I-Sequence
,	O
pero	O
el	O
fenotipo	O
pleiotrópico	O
es	O
causado	O
por	O
una	O
simple	O
pérdida	O
de	O
función	O
para	O
Tbx15	B-Protein
en	O
lugar	O
de	O
un	O
dominante	O
-	O
negativo	O
o	O
contiguo	O
gene	B-Sequence
efecto	O

En	O
particular	O
,	O
no	O
existe	O
un	O
fenotipo	O
heterocigoto	O
,	O
ningún	O
otro	O
genes	B-Sequence
se	O
encuentran	O
dentro	O
o	O
cerca	O
de	O
la	O
puntos	B-Sequence
de	I-Sequence
interrupción	I-Sequence
de	I-Sequence
eliminación	I-Sequence
,	O
y	O
el	O
patrón	O
de	O
expresión	O
de	O
Tbx15	B-Protein
es	O
consistente	O
con	O
el	O
espectro	O
de	O
anomalías	O
fenotípicas	O
tanto	O
en	O
el	O
original	O
Delaware	B-Protein
alelo	B-Sequence
y	O
el	O
deH	O
alelo	B-Sequence
.	O

Finalmente	O
,	O
un	O
Tbx15	B-Protein
dirigido	O
alelo	B-Sequence
tiene	O
el	O
mismo	O
fenotipo	O
que	O
deH	O
.	O

Nuestros	O
resultados	O
sugieren	O
que	O
la	O
expresión	O
modelada	O
de	O
Tbx15	B-Protein
proporciona	O
una	O
pista	O
de	O
instrucción	O
requerida	O
para	O
establecer	O
la	O
futura	O
identidad	O
de	O
la	O
dermis	O
dorsal	O
con	O
respecto	O
a	O
pigmentario	B-Chemical
y	O
patrones	O
de	O
longitud	O
del	O
cabello	O
.	O

El	O
borde	O
ventral	O
de	O
Tbx15	B-Protein
la	O
expresión	O
en	O
el	O
flanco	O
en	O
desarrollo	O
no	O
corresponde	O
a	O
un	O
compartimiento	O
de	O
linaje	O
conocido	O
,	O
sino	O
que	O
,	O
al	O
igual	O
que	O
el	O
desarrollo	O
de	O
las	O
extremidades	O
,	O
ocurre	O
dentro	O
del	O
mesodermo	O
de	O
la	O
placa	O
lateral	O
.	O

Estos	O
hallazgos	O
representan	O
un	O
papel	O
novedoso	O
para	O
T	O
-	O
box	O
gene	B-Sequence
acción	O
en	O
el	O
desarrollo	O
embrionario	O
y	O
proporcionar	O
evidencia	O
de	O
una	O
complejidad	O
previamente	O
no	O
apreciada	O
para	O
la	O
adquisición	O
de	O
la	O
identidad	O
posicional	O
dorsoventral	O
en	O
mamífero	B-Taxon
piel	O
.	O

Distintas	O
regiones	O
morfológicas	O
representan	O
la	O
suma	O
de	O
diferentes	O
gradientes	O

El	O
límite	O
visual	O
entre	O
la	O
piel	O
dorsal	O
y	O
ventral	O
en	O
at	O
/	O
at	O
ratones	B-Taxon
recuerda	O
a	O
otros	O
sistemas	O
en	O
los	O
que	O
los	O
compartimentos	O
adyacentes	O
imponen	O
una	O
elección	O
binaria	O
entre	O
patrones	O
alternativos	O
de	O
gene	B-Sequence
expresión	O
y	O
célula	B-Cell
destino	O
(	O
revisado	O
en	O
Dahmann	O
y	O
Basler	O
1999	O
)	O
.	O

Sin	O
embargo	O
,	O
Agutí	B-Protein
ARNm	B-Chemical
tanto	O
en	O
la	O
piel	O
embrionaria	O
como	O
posnatal	O
se	O
distribuye	O
a	O
lo	O
largo	O
de	O
un	O
gradiente	O
cuyo	O
límite	O
dorsal	O
es	O
indistinto	O
y	O
se	O
superpone	O
con	O
dos	O
gradientes	O
adicionales	O
reconocidos	O
por	O
sus	O
efectos	O
sobre	O
la	O
longitud	O
del	O
cabello	O
y	O
la	O
tinción	O
histoquímica	O
para	O
melanocitos	B-Cell
.	O

Los	O
tres	O
gradientes	O
son	O
cercanos	O
pero	O
no	O
congruentes	O
,	O
y	O
es	O
su	O
proximidad	O
lo	O
que	O
da	O
lugar	O
a	O
la	O
distinción	O
superficial	O
entre	O
la	O
piel	O
dorsal	O
y	O
ventral	O
de	O
at	O
/	O
at	O
ratones	B-Taxon
.	O

De	O
hecho	O
,	O
ligeras	O
diferencias	O
entre	O
las	O
regiones	O
de	O
transición	O
para	O
pigmento	B-Chemical
#	O
¿NOMBRE	O
?	O
pigmento	B-Chemical
contenido	O
dan	O
lugar	O
a	O
una	O
sutil	O
franja	O
amarilla	O
a	O
lo	O
largo	O
del	O
flanco	O
(	O
ver	O
Figuras	O
1	O
,	O
2	O
y	O
9A	O
)	O
.	O

Niveles	O
de	O
Agutí	B-Protein
ARNm	B-Chemical
permanecen	O
altos	O
a	O
lo	O
largo	O
de	O
todo	O
el	O
vientre	O
,	O
pero	O
el	O
cabello	O
pigmento	B-Chemical
el	O
contenido	O
se	O
reduce	O
,	O
dando	O
lugar	O
a	O
una	O
región	O
de	O
color	O
crema	O
en	O
el	O
vientre	O
que	O
,	O
dependiendo	O
de	O
la	O
edad	O
y	O
genético	B-Sequence
fondos	O
,	O
pueden	O
aparecer	O
más	O
o	O
menos	O
distintos	O
de	O
la	O
franja	O
amarilla	O
del	O
flanco	O
.	O

Pérdida	O
de	O
Tbx15	B-Protein
afecta	O
las	O
transiciones	O
dorsoventrales	O
de	O
la	O
longitud	O
del	O
cabello	O
,	O
pigmento	B-Chemical
contenido	O
y	O
expresión	O
de	O
la	O
ventral-específica	O
Agutí	B-Protein
isoforma	B-Sequence
;	O
sin	O
embargo	O
,	O
los	O
dos	O
primeros	O
efectos	O
son	O
sutiles	O
y	O
contribuyen	O
poco	O
o	O
nada	O
a	O
la	O
pigmentación	O
anormal	O
de	O
los	O
adultos	O
deH/deH	O
.	O
ratones	B-Taxon
.	O

Por	O
lo	O
tanto	O
,	O
a	O
pesar	O
del	O
patrón	O
anormal	O
de	O
piel	O
oscura	O
en	O
la	O
deH	O
/	O
deH	O
neonatal	O
ratones	B-Taxon
``	O
(	O
p	O
.	O
ej.	O
,	O
Figura	O
2D	O
)	O
,	O
la	O
característica	O
más	O
obvia	O
en	O
adultos	O
es	O
el	O
desplazamiento	O
dorsal	O
del	O
``	O
''	O
límite	O
''	O
''	O
entre	O
el	O
cabello	O
negro	O
y	O
amarillo	O
(	O
Figura	O
9A	O
)	O
.	O
''	O

Genética	O
de	O
Tbx15	B-Protein

Llamado	O
así	O
por	O
la	O
presencia	O
de	O
un	O
ADN	B-Sequence
#	O
¿NOMBRE	O
?	O
dominio	B-Sequence
identificado	O
por	O
primera	O
vez	O
en	O
el	O
braquiuria	B-Protein
de	I-Protein
ratón	I-Protein
gene	B-Sequence
(	O
la	O
haploinsuficiencia	O
causa	O
una	O
cola	O
corta	O
)	O
,	O
que	O
contiene	O
la	O
caja	O
T	O
genes	B-Sequence
han	O
sido	O
identificados	O
como	O
reguladores	O
del	O
desarrollo	O
en	O
un	O
amplio	O
espectro	O
de	O
tejidos	O
y	O
multicelulares	O
organismos	B-Taxon
(	O
revisado	O
en	O
Papaioannou	O
2001	O
)	O
.	O

los	O
Tbx15	B-Protein
subfamilia	O
,	O
que	O
también	O
incluye	O
tbx18	B-Protein
y	O
Tbx22	B-Protein
,	O
es	O
probable	O
que	O
haya	O
surgido	O
durante	O
los	O
primeros	O
cordado	B-Taxon
evolución	O
ya	O
que	O
hay	O
una	O
sola	O
gene	B-Sequence
en	O
anfioxo	B-Taxon
pero	O
no	O
obvio	O
homólogo	B-Sequence
en	O
el	O
mosca	B-Taxon
genoma	B-Sequence
(	O
Ruvinsky	O
et	O
al	O
.	O
2000	O
)	O
.	O

De	O
acuerdo	O
con	O
esta	O
relación	O
,	O
los	O
tres	O
genes	B-Sequence
se	O
expresan	O
en	O
patrones	O
parcialmente	O
superpuestos	O
que	O
incluyen	O
somitas	O
anteriores	O
(	O
tbx18	B-Protein
y	O
Tbx22	B-Protein
)	O
,	O
mesénquima	O
de	O
las	O
extremidades	O
(	O
Tbx15	B-Protein
y	O
tbx18	B-Protein
)	O
y	O
mesénquima	O
craneofacial	O
(	O
los	O
tres	O
genes	B-Sequence
,	O
Tbx15	B-Protein
más	O
ampliamente	O
que	O
tbx18	B-Protein
o	O
Tbx22	B-Protein
)	O
(	O
Agulnik	O
et	O
al	O
.	O
1998	O
;	O
Kraus	O
et	O
al	O
.	O
2001	O
;	O
Braybrook	O
et	O
al	O
.	O
2002	O
;	O
Bush	O
et	O
al	O
.	O
2002	O
;	O
Herr	O
et	O
al	O
.	O
2003	O
)	O
.	O

Estas	O
observaciones	O
sugieren	O
que	O
un	O
antepasado	O
gene	B-Sequence
por	O
Tbx15	B-Protein
,	O
tbx18	B-Protein
,	O
y	O
Tbx22	B-Protein
puede	O
haber	O
sido	O
importante	O
para	O
el	O
desarrollo	O
craneofacial	O
en	O
cefalocordados	B-Taxon
,	O
con	O
la	O
adquisición	O
de	O
patrones	O
de	O
expresión	O
adicionales	O
y	O
funciones	O
de	O
desarrollo	O
en	O
la	O
extremidad	O
y	O
el	O
tronco	O
durante	O
los	O
primeros	O
vertebrado	B-Taxon
evolución	O
.	O

Expresión	O
de	O
tbx18	B-Protein
y	O
Tbx22	B-Protein
no	O
se	O
ha	O
informado	O
en	O
el	O
mesénquima	O
del	O
flanco	O
embrionario	O
,	O
lo	O
que	O
sugiere	O
que	O
Tbx15	B-Protein
es	O
el	O
único	O
miembro	O
de	O
la	O
familia	O
involucrado	O
en	O
el	O
establecimiento	O
de	O
la	O
identidad	O
dorsoventral	O
del	O
tronco	O
.	O

Sin	O
embargo	O
,	O
no	O
sería	O
sorprendente	O
encontrar	O
algún	O
grado	O
de	O
redundancia	O
funcional	O
en	O
animales	B-Taxon
mutado	B-Sequence
para	O
dos	O
o	O
tres	O
de	O
los	O
miembros	O
de	O
la	O
subfamilia	O
en	O
otras	O
regiones	O
del	O
cuerpo	O
,	O
particularmente	O
las	O
extremidades	O
y	O
la	O
cabeza	O
.	O

Por	O
ejemplo	O
,	O
mutaciones	B-Sequence
en	O
Tbx22	B-Protein
causar	O
el	O
humano	B-Taxon
síndrome	O
X	B-GENE
paladar	O
hendido	O
vinculado	O
y	O
anquiloglosia	O
(	O
Braybrook	O
et	O
al	O
.	O
2001	O
)	O
.	O

A	O
pesar	O
de	O
los	O
altos	O
niveles	O
de	O
Tbx22	B-Protein
expresión	O
en	O
el	O
mesénquima	O
embrionario	O
periocular	O
(	O
Braybrook	O
et	O
al	O
.	O
2002	O
;	O
Bush	O
et	O
al	O
.	O
2002	O
;	O
Herr	O
et	O
al	O
.	O
2003	O
)	O
,	O
la	O
condición	O
no	O
afecta	O
al	O
ojo	O
,	O
quizás	O
porque	O
la	O
actividad	O
residual	O
es	O
proporcionada	O
por	O
Tbx15	B-Protein
en	O
la	O
misma	O
región	O
.	O

En	O
una	O
descripción	O
inicial	O
de	O
la	O
expresión	O
y	O
ubicación	B-Sequence
del	I-Sequence
mapa	I-Sequence
de	O
ratón	B-Protein
Tbx15	I-Protein
,	O
Agulnik	O
et	O
al	O
.	O

(	O
1998	O
)	O
sugirió	O
humano	B-Protein
tbx15	I-Protein
que	O
se	O
encuentra	O
en	O
Cromosoma	B-GENE
1p11	O
.	O
1	O
como	O
candidato	O
para	O
el	O
síndrome	O
de	O
apariencia	O
facial	O
acromegaloide	O
(	O
AFA	O
)	O
,	O
para	O
el	O
cual	O
hay	O
una	O
puntuación	O
LOD	O
positiva	O
débil	O
para	O
Cromosoma	B-GENE
1p	O
(	O
Hughes	O
et	O
al	O
.	O
1985	O
)	O
.	O

Originalmente	O
descrito	O
como	O
un	O
raro	O
autosómico	B-GENE
-	O
síndrome	O
dominante	O
con	O
engrosamiento	O
facial	O
progresivo	O
,	O
crecimiento	O
excesivo	O
de	O
la	O
mucosa	O
intraoral	O
y	O
manos	O
grandes	O
y	O
pastosas	O
,	O
los	O
informes	O
de	O
casos	O
más	O
recientes	O
describen	O
macrosomía	O
,	O
macrocefalia	O
o	O
ambas	O
e	O
hipertricosis	O
generalizada	O
con	O
engrosamiento	O
progresivo	O
(	O
Dal	O

El	O
fenotipo	O
deH	O
exhibe	O
poca	O
superposición	O
con	O
estas	O
características	O
;	O
en	O
su	O
lugar	O
,	O
sugerimos	O
un	O
candidato	O
más	O
probable	O
para	O
mutaciones	B-Sequence
de	O
humano	B-Protein
TBX15	I-Protein
sería	O
el	O
síndrome	O
frontofacionasal	O
,	O
un	O
sin	O
mapear	O
autosómico	B-GENE
condición	O
recesiva	O
caracterizada	O
por	O
braquicefalia	O
,	O
blefarofimosis	O
e	O
hipoplasia	O
del	O
tercio	O
medio	O
facial	O
(	O
Reardon	O
et	O
al	O
.	O
1994	O
)	O
.	O

Dos	O
de	O
nosotros	O
(	O
S	O
.	O
Kuijper	O
y	O
F	O
.	O
Meijlink	O
)	O
nos	O
interesamos	O
en	O
el	O
deH	O
mutación	B-Sequence
debido	O
a	O
sus	O
efectos	O
sobre	O
el	O
desarrollo	O
del	O
esqueleto	O
(	O
Curry	O
1959	O
)	O
y	O
la	O
posibilidad	O
de	O
que	O
los	O
gene	B-Sequence
Alx3	B-Protein
puede	O
ser	O
alelo	B-Sequence
con	O
oreja	B-Protein
caída	I-Protein
(	O
ten	O
Berge	O
et	O
al	O
.	O
1998	O
)	O
.	O

A	O
pesar	O
de	O
las	O
similitudes	O
entre	O
los	O
fenotipos	O
esqueléticos	O
de	O
deH	O
y	O
Alx3	B-Protein
o	O
Alx4	B-Protein
mutantes	B-Sequence
experimentos	O
posteriores	O
(	O
datos	O
no	O
publicados	O
)	O
excluyeron	O
el	O
alelismo	O
de	O
Alx3	B-Protein
y	O
deH	O
,	O
y	O
una	O
descripción	O
completa	O
del	O
Tbx15	B-Protein
El	O
fenotipo	O
esquelético	O
se	O
publicará	O
en	O
otro	O
lugar	O
.	O

Mecanismo	O
de	O
desarrollo	O
de	O
Tbx15	B-Protein
Expresión	O
y	O
Acción	O
en	O
la	O
Piel	O

Nuestra	O
atención	O
al	O
papel	O
de	O
Tbx15	B-Protein
en	O
pigmento	B-Chemical
patrón	O
fue	O
motivado	O
por	O
los	O
efectos	O
de	O
Agutí	B-Protein
en	O
posparto	O
animales	B-Taxon
.	O

Sin	O
embargo	O
,	O
Agutí	B-Protein
también	O
se	O
expresa	O
en	O
el	O
embrión	O
,	O
donde	O
proporciona	O
un	O
marcador	O
conveniente	O
de	O
identidad	O
de	O
la	O
dermis	O
ventral	O
.	O

Debido	O
a	O
que	O
un	O
dominio	O
expandido	O
de	O
embriones	O
Agutí	B-Protein
expresión	O
en	O
deH	O
/	O
deH	O
animales	B-Taxon
es	O
detectable	O
por	O
E14	O
.	O
5	O
,	O
los	O
efectos	O
de	O
Tbx15	B-Protein
en	O
el	O
patrón	O
dorsoventral	O
debe	O
ocurrir	O
antes	O
de	O
este	O
momento	O
.	O

Entre	O
otros	O
T-box	O
genes	B-Sequence
cuyas	O
acciones	O
de	O
desarrollo	O
se	O
entienden	O
al	O
menos	O
parcialmente	O
,	O
han	O
surgido	O
dos	O
temas	O
generales	O
,	O
uno	O
centrado	O
en	O
la	O
capacidad	O
de	O
especificar	O
destinos	O
alternativos	O
para	O
un	O
grupo	O
indiferenciado	O
de	O
precursores	O
células	B-Cell
y	O
otro	O
centrado	O
en	O
la	O
capacidad	O
de	O
soportar	O
la	O
expansión	O
proliferativa	O
de	O
un	O
célula	B-Cell
población	O
cuyo	O
destino	O
ya	O
está	O
determinado	O
(	O
revisado	O
en	O
Tada	O
y	O
Smith	O
2001	O
)	O
.	O

Cualquier	O
mecanismo	O
puede	O
aplicarse	O
a	O
la	O
aparente	O
transformación	O
de	O
dorsal	O
a	O
ventral	O
en	O
deH	O
/	O
deH	O
ratones	B-Taxon
.	O

Por	O
ejemplo	O
,	O
mientras	O
que	O
el	O
dominio	O
expandido	O
de	O
Agutí	B-Protein
expresión	O
en	O
postnatal	O
deH/deH	O
animales	B-Taxon
se	O
puede	O
atribuir	O
a	O
eventos	O
que	O
ocurren	O
entre	O
E11	O
.	O
5	O
y	O
E13	O
.	O
5	O
,	O
la	O
causa	O
subyacente	O
puede	O
ser	O
que	O
el	O
embrión	O
células	B-Cell
en	O
el	O
mesénquima	O
dorsolateral	O
adquieren	O
una	O
identidad	O
ventral	O
en	O
lugar	O
de	O
dorsal	O
o	O
que	O
aquellos	O
células	B-Cell
no	O
proliferan	O
normalmente	O
,	O
seguido	O
de	O
una	O
expansión	O
compensatoria	O
de	O
ventral	O
células	B-Cell
.	O

Célula	B-Cell
los	O
estudios	O
de	O
linaje	O
deberían	O
proporcionar	O
una	O
respuesta	O
definitiva	O
,	O
pero	O
estamos	O
a	O
favor	O
de	O
la	O
última	O
hipótesis	O
,	O
porque	O
las	O
mediciones	O
de	O
las	O
regiones	O
dorsoventrales	O
según	O
el	O
color	O
del	O
cabello	O
en	O
deH/deH	O
ratones	B-Taxon
reveló	O
un	O
pequeño	O
aumento	O
de	O
la	O
región	O
ventral	O
de	O
color	O
crema	O
además	O
de	O
la	O
duplicación	O
aproximada	O
de	O
la	O
región	O
amarilla	O
del	O
flanco	O
(	O
ver	O
Figura	O
2	O
)	O
.	O

En	O
el	O
mesénquima	O
embrionario	O
,	O
la	O
expresión	O
de	O
Tbx15	B-Protein
y	O
Agutí	B-Protein
son	O
complementarios	O
,	O
y	O
es	O
posible	O
que	O
Tbx15	B-Protein
actúa	O
directamente	O
para	O
inhibir	O
Agutí	B-Protein
transcripción	O
en	O
el	O
mesénquima	O
dorsolateral	O
.	O

Sin	O
embargo	O
,	O
la	O
habilidad	O
de	O
Tbx15	B-Protein
para	O
suprimir	O
la	O
expresión	O
de	O
la	O
ventral	O
-	O
específica	O
Agutí	B-Protein
isoforma	B-Sequence
en	O
posparto	O
ratones	B-Taxon
es	O
probable	O
que	O
sea	O
indirecta	O
,	O
ya	O
que	O
la	O
expresión	O
posnatal	O
de	O
Tbx15	B-Protein
ocurre	O
ampliamente	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
y	O
se	O
superpone	O
ampliamente	O
con	O
el	O
de	O
Agutí	B-Protein
.	O

En	O
cualquier	O
caso	O
,	O
los	O
objetivos	O
de	O
Tbx15	B-Protein
acción	O
en	O
la	O
piel	O
incluyen	O
genes	B-Sequence
además	O
de	O
Agutí	B-Protein
,	O
desde	O
la	O
longitud	O
del	O
cabello	O
y	O
melanocito	B-Cell
distribución	O
exhiben	O
una	O
alteración	O
demostrable	O
,	O
aunque	O
sutil	O
,	O
en	O
animales	B-Taxon
que	O
llevan	O
un	O
nulo	O
Agutí	B-Protein
alelo	B-Sequence
.	O

Un	O
objetivo	O
potencial	O
es	O
Alx4	B-Protein
,	O
que	O
,	O
como	O
Agutí	B-Protein
,	O
se	O
expresa	O
en	O
el	O
mesénquima	O
embrionario	O
ventral	O
,	O
y	O
,	O
cuando	O
mutado	B-Sequence
,	O
afecta	O
el	O
folículo	O
piloso	O
así	O
como	O
el	O
desarrollo	O
craneofacial	O
y	O
de	O
las	O
extremidades	O
(	O
Qu	O
et	O
al	O
.	O
1997	O
,	O
1998	O
;	O
Wu	O
et	O
al	O
.	O
2000	O
;	O
Wuyts	O
et	O
al	O
.	O
2000	O
;	O
Mavrogiannis	O
et	O
al	O
.	O
2001	O
)	O
.	O

Sin	O
embargo	O
,	O
la	O
expresión	O
de	O
marcadores	O
ventrales	O
como	O
Alx4	B-Protein
,	O
así	O
como	O
también	O
Alx3	B-Protein
y	O
msx2	B-Protein
,	O
parece	O
no	O
verse	O
afectado	O
en	O
E11	O
.	O
5	O
en	O
embriones	O
deH/deH	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Diferencias	O
y	O
similitudes	O
con	O
el	O
patrón	O
de	O
las	O
extremidades	O
dorsoventrales	O

Pérdida	O
de	O
Tbx15	B-Protein
también	O
afecta	O
la	O
distribución	O
regional	O
del	O
color	O
del	O
cabello	O
en	O
las	O
extremidades	O
,	O
con	O
áreas	O
que	O
normalmente	O
producirían	O
cabello	O
negro	O
dando	O
lugar	O
a	O
cabello	O
amarillo	O
en	O
su	O
lugar	O
.	O

Sin	O
embargo	O
,	O
ni	O
los	O
patrones	O
normales	O
de	O
pigmento	B-Chemical
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
corresponden	O
a	O
compartimentos	O
de	O
desarrollo	O
obvios	O
.	O

Además	O
,	O
las	O
pérdidas	O
de	O
función	O
para	O
En1	B-Protein
o	O
Wnt7a	B-Protein
,	O
que	O
causan	O
una	O
transformación	O
parcial	O
del	O
miembro	O
distal	O
de	O
dorso	O
a	O
ventrum	O
(	O
Loomis	O
et	O
al	O
.	O
1996	O
)	O
o	O
de	O
ventrum	O
a	O
dorso	O
(	O
Parr	O
y	O
McMahon	O
1995	O
)	O
,	O
respectivamente	O
,	O
no	O
tienen	O
efecto	O
sobre	O
los	O
patrones	O
regionales	O
de	O
Agutí	B-Protein
expresión	O
o	O
distribución	O
de	O
regiones	O
de	O
color	O
de	O
cabello	O
(	O
Y.	O
Chen	O
,	O
datos	O
no	O
publicados	O
)	O
.	O

(	O
Pigmentación	O
ectópica	O
de	O
las	O
almohadillas	O
de	O
las	O
patas	O
ventrales	O
que	O
se	O
desarrolla	O
en	O
En1	B-Protein
mutante	B-Sequence
ratones	B-Taxon
no	O
está	O
relacionado	O
con	O
pigmento	B-Chemical
#	O
¿NOMBRE	O
?	O
En1	B-Protein
,	O
independiente	O
de	O
Wnt7a	B-Protein
,	O
para	O
reprimir	O
la	O
migración	O
o	O
la	O
proliferación	O
(	O
o	O
ambas	O
)	O
de	O
células	B-Cell
pigmentarias	I-Cell
en	O
la	O
epidermis	O
ventral	O
[	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
]	O
.	O
)	O

A	O
pesar	O
de	O
estas	O
consideraciones	O
,	O
el	O
control	O
del	O
patrón	O
del	O
tronco	O
dorsoventral	O
por	O
Tbx15	B-Protein
comparte	O
ciertas	O
características	O
con	O
el	O
control	O
del	O
patrón	O
de	O
las	O
extremidades	O
dorsoventrales	O
por	O
Lmx1b	B-Protein
,	O
un	O
LIM	O
dominio	B-Sequence
factor	O
de	O
transcripción	O
que	O
actúa	O
aguas	O
abajo	O
de	O
Wnt7a	B-Protein
y	O
En1	B-Protein
(	O
Riddle	O
et	O
al	O
.	O
1995	O
;	O
Vogel	O
et	O
al	O
.	O
1995	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Logan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
;	O
Chen	O
y	O
Johnson	O
2002	O
)	O
.	O

Ambas	O
cosas	O
Tbx15	B-Protein
y	O
Lmx1b	B-Protein
actuar	O
de	O
forma	O
autónoma	O
en	O
células	B-Cell
mesenquimales	I-Cell
para	O
promover	O
una	O
identidad	O
dorsal	O
,	O
pero	O
tienen	O
dominios	O
de	O
expresión	O
que	O
no	O
corresponden	O
a	O
célula	B-Cell
compartimentos	O
de	O
linaje	O
en	O
el	O
flanco	O
(	O
Tbx15	B-Protein
)	O
o	O
la	O
extremidad	O
(	O
Lmx1b	B-Protein
)	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
)	O
.	O

En	O
el	O
caso	O
de	O
Lmx1b	B-Protein
,	O
su	O
expresión	O
en	O
el	O
miembro	O
distal	O
depende	O
de	O
Wnt7a	B-Protein
producido	O
en	O
el	O
ectodermo	O
dorsal	O
suprayacente	O
(	O
Riddle	O
et	O
al	O
.	O
1995	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Loomis	O
et	O
al	O
.	O
1998	O
)	O
.	O

Wnt7a	B-Protein
,	O
a	O
su	O
vez	O
,	O
está	O
restringida	O
al	O
ectodermo	O
dorsal	O
por	O
En1	B-Protein
en	O
el	O
ectodermo	O
ventral	O
(	O
Loomis	O
et	O
al	O
.	O
1996	O
;	O
Cygan	O
et	O
al	O
.	O
1997	O
;	O
Logan	O
et	O
al	O
.	O
1997	O
)	O
,	O
cuya	O
expresión	O
marca	O
un	O
límite	O
de	O
linaje	O
coincidente	O
con	O
la	O
línea	O
media	O
dorsoventral	O
de	O
la	O
cresta	O
ectodérmica	O
apical	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
.	O
1997	O
;	O
Kimmel	O
et	O
al	O
.	O
2000	O
)	O
.	O

Como	O
se	O
describió	O
anteriormente	O
,	O
En1	B-Protein
o	O
Wnt7a	B-Protein
mutaciones	B-Sequence
no	O
se	O
ha	O
informado	O
que	O
afecte	O
los	O
patrones	O
de	O
distribución	O
del	O
color	O
del	O
cabello	O
(	O
C.	O
Loomis	O
,	O
comunicación	O
personal	O
;	O
Parr	O
y	O
McMahon	O
1995	O
;	O
Loomis	O
et	O
al	O
.	O
1996	O
)	O
.	O

Sin	O
embargo	O
,	O
el	O
tema	O
esencial	O
de	O
que	O
los	O
compartimentos	O
del	O
linaje	O
ectodérmico	O
controlan	O
el	O
destino	O
del	O
mesénquima	O
subyacente	O
en	O
las	O
extremidades	O
en	O
desarrollo	O
puede	O
aplicarse	O
tanto	O
al	O
tronco	O
como	O
a	O
la	O
extremidad	O
.	O

Las	O
glándulas	O
mamarias	O
también	O
se	O
desarrollan	O
en	O
una	O
posición	O
dorsoventral	O
estereotipada	O
y	O
dependen	O
de	O
interacciones	O
epiteliales-mesenquimatosas	O
.	O

Sin	O
embargo	O
,	O
el	O
número	O
y	O
la	O
posición	O
aparente	O
de	O
las	O
glándulas	O
mamarias	O
son	O
normales	O
en	O
deH	O
/	O
deH	O
animales	B-Taxon
,	O
indicando	O
la	O
existencia	O
de	O
mecanismos	O
adicionales	O
que	O
controlan	O
el	O
patrón	O
dorsoventral	O
tanto	O
en	O
el	O
tronco	O
como	O
en	O
las	O
extremidades	O
.	O

Estas	O
ideas	O
se	O
resumen	O
en	O
el	O
modelo	O
que	O
se	O
muestra	O
en	O
la	O
Figura	O
9B	O
.	O

Especulamos	O
que	O
una	O
señal	O
difusible	O
del	O
ectodermo	O
del	O
tronco	O
dorsal	O
,	O
en	O
o	O
antes	O
de	O
E11	O
.	O
5	O
,	O
promueve	O
la	O
expresión	O
de	O
Tbx15	B-Protein
en	O
el	O
mesénquima	O
del	O
tronco	O
dorsal	O
,	O
que	O
luego	O
establece	O
la	O
identidad	O
posicional	O
dorsal	O
de	O
esos	O
células	B-Cell
como	O
se	O
manifiesta	O
en	O
las	O
diferencias	O
de	O
Agutí	B-Protein
expresión	O
,	O
pigmento	B-Cell
-	I-Cell
célula	I-Cell
desarrollo	O
y	O
crecimiento	O
del	O
cabello	O
.	O

Debido	O
a	O
que	O
el	O
límite	O
ventral	O
de	O
Tbx15	B-Protein
expresión	O
corresponde	O
al	O
límite	O
dorsal	O
de	O
En1	B-Protein
expresión	O
y	O
debido	O
a	O
que	O
la	O
posición	O
normal	O
del	O
límite	O
de	O
pigmentación	O
se	O
encuentra	O
aproximadamente	O
en	O
registro	O
con	O
las	O
excrecencias	O
de	O
yemas	O
de	O
las	O
extremidades	O
,	O
representamos	O
la	O
posición	O
de	O
un	O
límite	O
dorsoventral	O
putativo	O
en	O
el	O
ectodermo	O
del	O
tronco	O
como	O
coincidente	O
con	O
el	O
límite	O
dorsoventral	O
de	O
las	O
extremidades	O
.	O

Este	O
modelo	O
es	O
consistente	O
con	O
los	O
estudios	O
en	O
pollos	O
,	O
donde	O
existen	O
distintos	O
compartimentos	O
de	O
linaje	O
dorsal	O
y	O
ventral	O
para	O
el	O
ectodermo	O
tanto	O
en	O
la	O
extremidad	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
;	O
Kimmel	O
et	O
al	O
.	O
2000	O
)	O
como	O
en	O
las	O
regiones	O
entre	O
las	O
extremidades	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
,	O
2000	O
)	O
.	O
et	O
al	O
.	O
1997	O
,	O
2000	O
)	O
,	O
pero	O
no	O
para	O
el	O
mesodermo	O
de	O
las	O
extremidades	O
(	O
Altabef	O
et	O
al	O
.	O
1997	O
;	O
Michaud	O
et	O
al	O
.	O
1997	O
)	O
.	O

De	O
hecho	O
,	O
el	O
mismo	O
mecanismo	O
que	O
determina	O
la	O
posición	O
dorsoventral	O
de	O
las	O
extremidades	O
y	O
la	O
cresta	O
ectodérmica	O
apical	O
también	O
puede	O
actuar	O
sobre	O
la	O
expresión	O
de	O
Tbx15	B-Protein
en	O
el	O
tronco	O
,	O
ya	O
que	O
las	O
extremidades	O
ectópicas	O
inducidas	O
en	O
la	O
región	O
entre	O
las	O
extremidades	O
mediante	O
la	O
aplicación	O
de	O
microesferas	O
de	O
FGF	O
se	O
desarrollan	O
a	O
lo	O
largo	O
de	O
una	O
sola	O
línea	O
que	O
coincide	O
con	O
los	O
brotes	O
normales	O
de	O
las	O
extremidades	O
(	O
y	O
el	O
futuro	O
límite	O
de	O
pigmentación	O
)	O
(	O
Cohn	O
et	O
al	O
.	O
1995	O
;	O
Crossley	O
et	O
al	O
.	O
1996	O
;	O
Vogel	O
y	O
otros	O
1996	O
,	O
Altabef	O
y	O
otros	O
1997	O
,	O
2000	O
)	O
.	O

Nuestro	O
modelo	O
predice	O
que	O
la	O
expresión	O
ectópica	O
de	O
Tbx15	B-Protein
en	O
el	O
mesénquima	O
ventral	O
debería	O
dar	O
lugar	O
a	O
un	O
fenotipo	O
de	O
pigmentación	O
dorsalizada	O
y	O
podría	O
probarse	O
con	O
enfoques	O
de	O
ganancia	O
de	O
función	O
.	O

Sin	O
embargo	O
,	O
Tbx15	B-Protein
la	O
expresión	O
es	O
muy	O
dinámica	O
y	O
está	O
restringida	O
al	O
mesodermo	O
dorsal	O
solo	O
de	O
E11	O
.	O
5	O
a	O
E13	O
.	O
5	O
.	O

Es	O
posible	O
que	O
Tbx15	B-Protein
influye	O
en	O
el	O
patrón	O
de	O
la	O
piel	O
en	O
una	O
ventana	O
de	O
desarrollo	O
muy	O
estrecha	O
;	O
alternativamente	O
,	O
el	O
establecimiento	O
de	O
la	O
identidad	O
dorsal	O
por	O
Tbx15	B-Protein
puede	O
requerir	O
otro	O
factor	O
aún	O
no	O
identificado	O
que	O
sólo	O
está	O
presente	O
en	O
el	O
mesénquima	O
subyacente	O
al	O
ectodermo	O
dorsal	O
.	O

Patrones	O
de	O
pigmentación	O
y	O
Tbx15	B-Protein
en	O
otra	O
Mamíferos	B-Taxon

La	O
frontera	O
somítica	O
lateral	O
,	O
definida	O
como	O
el	O
límite	O
del	O
linaje	O
entre	O
el	O
mesodermo	O
derivado	O
de	O
la	O
placa	O
lateral	O
y	O
el	O
derivado	O
del	O
somita	O
,	O
se	O
establece	O
durante	O
la	O
somitogénesis	O
en	O
las	O
primeras	O
etapas	O
del	O
desarrollo	O
(	O
Mauger	O
1972	O
;	O
Christ	O
et	O
al	O
.	O
1983	O
;	O
Olivera-Martinez	O
et	O
al	O
.	O
2000	O
;	O
Nowicki	O
et	O
al	O
.	O
2003	O
)	O
,	O
pero	O
sigue	O
siendo	O
distinta	O
en	O
posnatal	O
animales	B-Taxon
a	O
pesar	O
del	O
potencial	O
de	O
amplia	O
célula	B-Cell
mezclando	O
(	O
ver	O
Figura	O
8	O
)	O
.	O

Sin	O
embargo	O
,	O
nuestros	O
estudios	O
de	O
trasplante	O
y	O
mapeo	O
del	O
destino	O
demuestran	O
que	O
la	O
frontera	O
somítica	O
lateral	O
se	O
encuentra	O
dorsal	O
al	O
límite	O
de	O
pigmentación	O
y	O
obviamente	O
no	O
se	O
correlaciona	O
con	O
una	O
diferencia	O
en	O
la	O
morfología	O
de	O
la	O
piel	O
.	O

Un	O
dominio	O
dorsoventral	O
adicional	O
que	O
no	O
es	O
aparente	O
externamente	O
ha	O
surgido	O
de	O
estudios	O
de	O
msx1	B-Protein
,	O
cuya	O
expresión	O
marca	O
un	O
subgrupo	O
de	O
somita	O
-	O
derivado	O
células	B-Cell
mesenquimales	I-Cell
que	O
contribuyen	O
a	O
la	O
dermis	O
en	O
una	O
franja	O
estrecha	O
a	O
lo	O
largo	O
de	O
la	O
región	O
paraespinal	O
(	O
Houzelstein	O
et	O
al	O
.	O
2000	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
existen	O
al	O
menos	O
tres	O
límites	O
distintos	O
en	O
el	O
postnatal	O
mamífero	B-Taxon
piel	O
que	O
son	O
paralelas	O
al	O
plano	O
sagital	O
,	O
marcadas	O
por	O
diferencias	O
en	O
pigmento	B-Chemical
-	O
tipo	O
de	O
síntesis	O
,	O
diferencias	O
en	O
célula	B-Cell
linaje	O
y	O
diferencias	O
en	O
la	O
expresión	O
de	O
msx1	B-Protein
.	O

En	O
roedores	B-Taxon
,	O
solo	O
el	O
límite	O
de	O
pigmentación	O
es	O
evidente	O
externamente	O
,	O
pero	O
muchos	O
mamíferos	B-Taxon
tienen	O
patrones	O
más	O
complicados	O
de	O
tipo	O
de	O
cabello	O
,	O
longitud	O
y/o	O
color	O
que	O
varían	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
.	O

mapaches	B-Taxon
,	O
ardillas	O
,	O
mofetas	B-Taxon
y	O
muchos	O
ungulados	O
diferentes	O
exhiben	O
franjas	O
laterales	O
cuyos	O
orígenes	O
de	O
desarrollo	O
no	O
han	O
sido	O
investigados	O
,	O
pero	O
pueden	O
corresponder	O
a	O
la	O
frontera	O
somítica	O
lateral	O
,	O
la	O
paraespinal	O
msx1	B-Protein
compartimiento	O
,	O
o	O
una	O
interacción	O
entre	O
estos	O
dominios	O
.	O

El	O
efecto	O
de	O
Tbx15	B-Protein
sobre	O
pigmentación	O
en	O
laboratorio	O
ratones	B-Taxon
recuerda	O
a	O
los	O
patrones	O
de	O
color	O
del	O
pelaje	O
en	O
poblaciones	O
seleccionadas	O
y	O
naturales	O
de	O
otros	O
mamíferos	B-Taxon
.	O

Las	O
marcas	O
del	O
sillín	O
son	O
comunes	O
en	O
algunos	O
perro	B-Taxon
razas	O
,	O
como	O
los	O
pastores	O
alemanes	O
,	O
y	O
en	O
ciertas	O
poblaciones	O
de	O
Peromyscus	B-Taxon
polionotus	I-Taxon
,	O
en	O
el	O
que	O
una	O
extensión	O
dorsal	O
de	O
despigmentación	O
ventral	O
proporciona	O
una	O
ventaja	O
adaptativa	O
a	O
las	O
subespecies	O
que	O
viven	O
en	O
arrecifes	O
de	O
arena	O
blanca	O
(	O
Blair	O
1951	O
;	O
Kaufman	O
1974	O
;	O
Belk	O
y	O
Smith	O
1996	O
)	O
.	O

Ni	O
pastores	O
alemanes	O
ni	O
ratones	B-Taxon
ciervos	I-Taxon
tienen	O
características	O
craneofaciales	O
similares	O
a	O
las	O
deH	O
mutación	B-Sequence
,	O
pero	O
los	O
patrones	O
de	O
pigmentación	O
en	O
estos	O
animales	B-Taxon
podría	O
representar	O
alteraciones	O
en	O
la	O
regulación	O
o	O
acción	O
de	O
Tbx15	B-Protein
actividad	O
.	O

Desde	O
la	O
perspectiva	O
opuesta	O
,	O
los	O
efectos	O
de	O
Tbx15	B-Protein
en	O
el	O
color	O
del	O
pelaje	O
solo	O
son	O
aparentes	O
en	O
ciertos	O
genético	B-Sequence
antecedentes	O
y	O
puede	O
no	O
ser	O
evidente	O
en	O
absoluto	O
en	O
mamíferos	B-Taxon
que	O
carecen	O
de	O
patrones	O
de	O
pigmentación	O
dorsoventral	O
.	O

estudiando	O
el	O
secuencia	B-Sequence
y	O
expresión	O
de	O
Tbx15	B-Protein
en	O
otra	O
vertebrados	B-Taxon
puede	O
proporcionar	O
información	O
adicional	O
sobre	O
los	O
patrones	O
que	O
afectan	O
el	O
esqueleto	O
,	O
así	O
como	O
el	O
pigmentario	B-Chemical
sistema	O
.	O

Materiales	O
y	O
métodos	O

Ratones	B-Taxon

Todos	O
ratones	B-Taxon
se	O
obtuvieron	O
originalmente	O
de	O
The	O
Jackson	O
Laboratory	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
Estados	O
Unidos	O
)	O
,	O
excepto	O
la	O
cepa	O
BA	O
(	O
Stanford	O
Veterinary	O
Services	O
Center	O
,	O
Stanford	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
,	O
Hoxb6	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
(	O
amablemente	O
proporcionado	O
por	O
M	O
.	O
Kuehn	O
de	O
los	O
Institutos	O
Nacionales	O
de	O
Salud	O
,	O
Bethesda	O
,	O
Maryland	O
,	O
Estados	O
Unidos	O
)	O
,	O
ratones	B-Taxon
llevando	O
el	O
reportero	O
R26R	O
lacZ	O
alelo	B-Sequence
(	O
amablemente	O
proporcionado	O
por	O
P.	O
Soriano	O
,	O
Fred	O
Hutchinson	O
Cancer	O
Research	O
Center	O
,	O
Seattle	O
,	O
Washington	O
,	O
Estados	O
Unidos	O
)	O
,	O
y	O
C57BL	O
/	O
6J	O
(	O
B6	O
)	O
ae	O
/	O
ae	O
ratones	B-Taxon
(	O
amablemente	O
proporcionado	O
por	O
L.	O
Siracusa	O
,	O
Jefferson	O
Medical	O
College	O
,	O
Filadelfia	O
,	O
Pensilvania	O
,	O
Estados	O
Unidos	O
)	O
.	O

El	O
deH	O
mutación	B-Sequence
surgió	O
en	O
la	O
década	O
de	O
1960	O
en	O
Harwell	O
,	O
probablemente	O
con	O
antecedentes	O
de	O
la	O
cepa	O
BN	O
(	O
C.	O
Beechey	O
,	O
comunicación	O
personal	O
)	O
.	O

Obtuvimos	O
deH	O
sobre	O
un	O
fondo	O
B6	O
/	O
EiC3H	O
,	O
introducido	B-Sequence
el	O
en	O
alelo	B-Sequence
de	O
la	O
cepa	O
BTBR	O
,	O
y	O
han	O
mantenido	O
la	O
línea	O
como	O
una	O
mezcla	O
deH	O
/	O
+	B-Sequence
x	O
de	O
H	O
/	O
+	B-Sequence
entrecruzar	O
stock	O
con	O
cruzamiento	O
periódico	O
a	O
BTBR	O
o	O
B6	O
.	O

Para	O
apareamientos	O
cronometrados	O
,	O
se	O
consideró	O
E0	O
la	O
mañana	O
del	O
cebado	O
.	O
5	O
.	O

Después	O
del	O
nacimiento	O
,	O
el	O
día	O
de	O
nacimiento	O
se	O
consideró	O
como	O
P0	O
.	O
5	O
.	O

Análisis	O
fenotípico	O

Para	O
medir	O
la	O
longitud	O
y	O
el	O
color	O
del	O
cabello	O
,	O
primero	O
se	O
diseccionó	O
toda	O
la	O
región	O
entre	O
las	O
extremidades	O
de	O
la	O
piel	O
con	O
una	O
sola	O
incisión	O
en	O
la	O
línea	O
media	O
dorsal	O
y	O
se	O
conservó	O
con	O
polvo	O
bicarbonato	B-Chemical
de	I-Chemical
sodio	I-Chemical
.	O

Rebanadas	O
2	O
-	O
2	O
.	O
Luego	O
se	O
prepararon	O
5	O
mm	O
de	O
ancho	O
paralelos	O
al	O
eje	O
dorsoventral	O
,	O
se	O
determinaron	O
los	O
límites	O
de	O
la	O
longitud	O
del	O
cabello	O
a	O
partir	O
de	O
imágenes	O
electrónicas	O
con	O
Adobe	O
Photoshop	O
(	O
San	O
José	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
y	O
se	O
obtuvieron	O
las	O
medidas	O
con	O
ImageJ	O
(	O
Institutos	O
Nacionales	O
de	O
Salud	O
)	O
.	O

Este	O
enfoque	O
muestra	O
punzones	O
y	O
auchenes	O
,	O
porque	O
son	O
mucho	O
más	O
gruesos	O
y	O
,	O
por	O
lo	O
tanto	O
,	O
visualmente	O
más	O
predominantes	O
que	O
los	O
vellos	O
en	O
zigzag	O
.	O

Para	O
evaluar	O
la	O
variación	O
dorsoventral	O
en	O
la	O
distribución	O
del	O
tipo	O
de	O
cabello	O
,	O
se	O
arrancaron	O
varios	O
cientos	O
de	O
cabellos	O
del	O
dorso	O
medio	O
o	O
del	O
vientre	O
medio	O
de	O
machos	O
de	O
8	O
semanas	O
de	O
edad	O
de	O
la	O
cepa	O
BA	O
.	O
animales	B-Taxon
,	O
luego	O
ordenados	O
y	O
categorizados	O
usando	O
un	O
microscopio	O
de	O
disección	O
.	O

No	O
se	O
intentó	O
distinguir	O
entre	O
punzones	O
y	O
auchenes	O
.	O

Para	O
la	O
histología	O
de	O
la	O
piel	O
,	O
se	O
tiñeron	O
con	O
hematoxilina	O
y	O
eosina	O
secciones	O
de	O
12	O
µm	O
de	O
tejido	O
embebido	O
en	O
parafina	O
.	O

Para	O
DOPA	B-Chemical
tinción	O
,	O
la	O
dermis	O
y	O
la	O
epidermis	O
se	O
dividieron	O
después	O
de	O
3	O
h	O
de	O
incubación	O
en	O
2	O
M	O
bromuro	B-Chemical
de	I-Chemical
sodio	I-Chemical
a	O
37	O
grados	O
C	O
(	O
esta	O
preparación	O
hace	O
que	O
la	O
mayoría	O
de	O
los	O
folículos	O
pilosos	O
permanezcan	O
con	O
la	O
dermis	O
)	O
,	O
fijados	O
individualmente	O
durante	O
1	O
h	O
,	O
luego	O
aclarados	O
y	O
teñidos	O
con	O
0	O
.	O
1	O
%	O
L-DOPA	B-Chemical
(	O
Sigma	O
,	O
St	O
.	O
Louis	O
,	O
Misuri	O
,	O
Estados	O
Unidos	O
)	O
,	O
0	O
.	O
1M	O
fosfato	B-Chemical
de	I-Chemical
sodio	I-Chemical
tampón	O
(	O
pH	O
6,8	O
)	O
durante	O
5	O
horas	O
a	O
37	O
grados	O
C	O
en	O
la	O
oscuridad	O
,	O
cambiando	O
la	O
solución	O
de	O
tinción	O
después	O
de	O
1	O
hora	O
.	O

A	O
continuación	O
,	O
las	O
muestras	O
se	O
fijaron	O
durante	O
la	O
noche	O
,	O
se	O
deshidrataron	O
y	O
se	O
montaron	O
.	O

Este	O
método	O
es	O
suficiente	O
para	O
teñir	O
interfolicular	O
melanocitos	B-Cell
sin	O
crear	O
un	O
fondo	O
alto	O
.	O

El	O
fijador	O
utilizado	O
fue	O
siempre	O
paraformaldehído	O
al	O
4	O
%	O
.	O

posicional	B-Sequence
clonación	O

Una	O
alta	O
resolución	O
mapa	B-Sequence
para	O
deH	O
se	O
generó	O
a	O
partir	O
de	O
un	O
cruce	O
intersubespecífico	O
entre	O
deH	O
/	O
deH	O
y	O
CAST	O
/	O
Ei	O
ratones	B-Taxon
.	O

Inicialmente	O
localizamos	O
deH	O
a	O
1	O
cm	O
intervalo	B-Sequence
entre	O
D3Mit233	O
y	O
D3Mit11	O
.	O

F2	O
animales	B-Taxon
portador	O
recombinante	O
cromosomas	B-GENE
entre	O
estos	O
marcadores	O
cuyo	O
genotipo	B-Sequence
en	O
Delaware	B-Protein
era	O
indeterminado	O
(	O
deH/	O
+	B-Sequence
o	O
+	B-Sequence
/	O
+	B-Sequence
)	O
fueron	O
descendientes	O
-	O
probados	O
cruzando	O
a	O
deH	O
/	O
deH	O
animales	B-Taxon
.	O

Más	O
genético	B-Sequence
el	O
mapeo	O
estableció	O
un	O
mínimo	O
región	B-Sequence
de	O
0	O
1	O
cm	O
entre	O
D3Mit213	O
y	O
16	O
.	O
MMHAP32FLF1	O
;	O
estos	O
marcadores	O
se	O
utilizaron	O
para	O
iniciar	O
la	O
construcción	O
de	O
un	O
mapa	B-Sequence
físico	I-Sequence
con	O
Clones	B-Sequence
genómicos	I-Sequence
BAC	I-Sequence
(	O
Research	O
Genetics	O
,	O
Huntsville	O
,	O
Alabama	O
,	O
Estados	O
Unidos	O
,	O
y	O
genoma	B-Sequence
Sistemas	O
,	O
St.	O
Louis	O
,	O
Misuri	O
,	O
Estados	O
Unidos	O
)	O
.	O

Terminar	B-Sequence
la	I-Sequence
secuencia	I-Sequence
de	I-Sequence
esos	I-Sequence
BAC	I-Sequence
se	O
utilizó	O
para	O
desarrollar	O
los	O
marcadores	O
SSCP	O
M1	O
a	O
M3	O
,	O
como	O
se	O
muestra	O
en	O
la	O
Figura	O
3	O
,	O
y	O
para	O
establecer	O
un	O
mínimo	O
físico	O
intervalo	B-Sequence
de	O
1	O
.	O
4	O
MB	O

Cebador	B-Sequence
los	O
pares	O
utilizados	O
fueron	O
TTCCCTCCAATAAGTTCTGGGTACC	O
y	O
AAGCTTGCTGCTCTGGATTCCATTTGTAG	O
para	O
M1	O
,	O
CCTTCATTTTTTTTTCAAGTAAAA	O
y	O
AAGCTTGGCTTAGTCCCAGTGGC	O
para	O
M2	O
,	O
CCTCCAGGAAGATCTACTAGGCAC	O
y	O
ATGGAAAAAAAAAAGTAAGATTGAAAG	O
para	O
M3	O
,	O
y	O
TGGTTATCGATCTGTGGACCATTC	O
y	O
AAGTGAGAGAGCAGGATGGACCAC	O
para	O
M3	O
,	O
y	O
TGGTTATCGATCTGTGGACCATTC	O
y	O
AAGTGAGAGAGCAGGATGGACCAC	O
para	O
M2	O
STS	B-Sequence
dieciséis	O
.	O
MMHAP32FLF1	O
)	O
.	O

Secuencia	B-Sequence
genómica	I-Sequence
y	O
las	O
anotaciones	O
se	O
obtuvieron	O
de	O
la	O
UCSC	O
genoma	B-Sequence
Navegador	O
febrero	O
de	O
2003	O
versión	B-Sequence
de	I-Sequence
montaje	I-Sequence
mm3	O
(	O
http	O
:	O
/	O
/	O
genoma	B-Sequence
.	O
ucsc	O
.	O
edu	O
)	O
;	O
el	O
1	O
4	O
MB	O
intervalo	B-Sequence
entre	O
M1	O
y	O
M4	O
contiene	O
ocho	O
genes	B-Sequence
:	O
cuatro	O
hidroxiesteroide	B-Chemical
isomerasas	O
deshidrogenasa	O
,	O
Hsd3b3	B-Protein
,	O
Hsd3b2	B-Protein
,	O
Hsd3b6	B-Protein
,	O
y	O
Hsd3b1	B-Protein
;	O
un	O
hidroácido	B-Chemical
oxidasa	O
,	O
Hao3	B-Protein
;	O
a	O
triptofanilo	B-Chemical
-	I-Chemical
ARNt	I-Chemical
sintetasa	O
,	O
guerras2	B-Protein
;	O
una	O
caja	O
en	O
T	O
gene	B-Sequence
,	O
Tbx15	B-Protein
;	O
y	O
una	O
novela	O
gene	B-Sequence
,	O
4931427F14Rik	B-Protein
.	O

En	O
el	O
secuencia	B-Sequence
del	I-Sequence
genoma	I-Sequence
,	O
M1	O
cebadores	B-Sequence
corresponden	O
a	O
AGGCCTCCAATAAGTTCTGGGTACC	O
y	O
AAGCTTGCTCTCTGGATTCCATTTGTAG	O
,	O
el	O
M2	O
imprimación	B-Sequence
inversa	I-Sequence
corresponde	O
a	O
AAGCTTGGCTTTAGTCCCAGTGGGC	O
,	O
y	O
el	O
M3	O
cebadores	B-Sequence
corresponden	O
a	O
CCTCCAGGAAGAATCTACTAGGCAC	O
y	O
AATGAAAAAAAAAAAAGTAAGATTGAAAG	O
.	O

Pequeñas	O
diferencias	O
entre	O
los	O
secuencias	B-Sequence
de	O
El	O
cebadores	B-Sequence
obtuvimos	O
de	O
la	O
BAC	B-Sequence
termina	I-Sequence
y	O
el	O
publico	O
secuencia	B-Sequence
del	I-Sequence
genoma	I-Sequence
pueden	O
representar	O
diferencias	O
de	O
tensión	O
o	O
errores	O
de	O
secuencia	O
en	O
el	O
ADN	B-Sequence
BAC	I-Sequence
.	O

Se	O
desarrolló	O
un	O
ensayo	O
de	O
genotipado	O
multiplex	O
para	O
genotipar	O
el	O
deH	O
supresión	B-Sequence
utilizando	O
cebadores	B-Sequence
GGAGCAGATCCAATTGCTTT	O
,	O
TCCATAGCCCATCTTCACAA	O
y	O
CATGTCCACTTCTGCTTCCA	O
.	O

Este	O
ensayo	O
de	O
PCR	O
produce	O
un	O
392	O
producto	B-Sequence
pb	I-Sequence
de	O
la	O
deH	O
cromosoma	B-GENE
y	O
un	O
595	O
producto	B-Sequence
pb	I-Sequence
de	O
lo	O
no	O
mutante	O
cromosoma	B-GENE
.	O

Gene	B-Sequence
apuntando	O

un	O
objetivo	O
alelo	B-Sequence
de	O
Tbx15	B-Protein
se	O
construyó	O
usando	O
el	O
mismo	O
enfoque	O
descrito	O
en	O
Russ	O
et	O
al	O
.	O

(	O
2000	O
)	O
.	O

En	O
resumen	O
,	O
un	O
ires	B-Sequence
#	O
¿NOMBRE	O
?	O
casete	B-Sequence
con	O
homología	O
de	O
5	O
'	O
y	O
3	O
'	O
brazos	O
de	O
3	O
.	O
5kb	O
y	O
1	O
.	O
8kb	O
era	O
insertado	B-Sequence
en	O
un	O
BamHI	O
único	O
sitio	B-Sequence
eso	O
miente	O
479	O
nucleótidos	B-Chemical
aguas	O
abajo	O
de	O
la	O
iniciación	O
transcripcional	O
sitio	B-Sequence
(	O
relativo	O
a	O
la	O
secuencia	B-Chemical
de	I-Chemical
ARNm	I-Chemical
)	O
en	O
exón	B-Sequence
3	O
.	O

ES	O
positivo	O
clones	B-Sequence
se	O
inyectaron	O
en	O
blastocistos	O
B6	O
y	O
los	O
fundadores	O
quiméricos	O
se	O
cruzaron	O
con	O
B6	O
ratones	B-Taxon
o	O
a	O
deH	O
/	O
+	B-Sequence
animales	B-Taxon
.	O

Hibridación	O
in	O
situ	O

La	O
hibridación	O
in	O
situ	O
se	O
llevó	O
a	O
cabo	O
en	O
secciones	O
de	O
parafina	O
de	O
12	O
µm	O
usando	O
digoxigenina	B-Chemical
#	O
¿NOMBRE	O
?	O
sondas	B-Sequence
de	I-Sequence
ARN	I-Sequence
(	O
Roche	O
Diagnostics	O
,	O
Indianápolis	O
,	O
Indiana	O
,	O
Estados	O
Unidos	O
)	O
según	O
protocolos	O
estándar	O
(	O
Wilkinson	O
y	O
Nieto	O
1993	O
)	O
.	O

Embriones	O
y	O
muestras	O
de	O
piel	O
posnatal	O
se	O
obtuvieron	O
de	O
cruces	O
de	O
deH/	O
+	B-Sequence
ratones	B-Taxon
.	O

Embriones	O
E13	O
.	O
5	O
o	O
menos	O
se	O
fijaron	O
durante	O
24	O
h	O
;	O
los	O
mayores	O
de	O
E13	O
.	O
5	O
y	O
la	O
piel	O
posnatal	O
se	O
fijaron	O
durante	O
36	O
a	O
48	O
h	O
antes	O
de	O
la	O
inclusión	O
.	O

los	O
Tbx15	B-Protein
Investigacion	B-Sequence
fue	O
generado	O
por	O
RT	O
-	O
PCR	O
utilizando	O
cebadores	B-Sequence
GGCGGCTAAAATGAGTGAAC	O
y	O
TGCCTGCTTTGGTGATGAT	O
(	O
corresponde	O
a	O
exones	B-Sequence
y	O
2	O
)	O
,	O
y	O
el	O
En1	B-Protein
Investigacion	B-Sequence
fue	O
generado	O
por	O
PCR	O
a	O
partir	O
de	O
ADN	B-Sequence
genómico	I-Sequence
utilizando	O
cebadores	B-Sequence
ACGCACCAGGAAGCTAAAGA	O
y	O
AGCAACGAAAACGAAACTGG	O
(	O
ubicados	O
en	O
el	O
último	O
exón	B-Sequence
)	O
.	O

los	O
Agutí	B-Protein
Investigacion	B-Sequence
corresponde	O
a	O
la	O
proteína	B-Chemical
-	O
secuencia	B-Sequence
de	I-Sequence
codificación	I-Sequence
.	O

Trasplante	O
de	O
piel	O
embrionaria	O

(	O
BTBR	O
-	O
en	O
/	O
en	O
x	O
B6	O
-	O
a	O
/	O
a	O
)	O
Embriones	O
F1	O
en	O
E12	O
.	O
5	O
se	O
disecaron	O
en	O
solución	O
estéril	O
de	O
Tyrode	O
y	O
la	O
piel	O
embrionaria	O
se	O
dividió	O
en	O
piezas	O
dorsales	O
,	O
laterales	O
y	O
ventrales	O
,	O
cada	O
una	O
de	O
1	O
-	O
2	O
mm2	O
de	O
tamaño	O
,	O
como	O
se	O
muestra	O
en	O
la	O
Figura	O
7	O
.	O

Se	O
injertaron	O
fragmentos	O
de	O
piel	O
en	O
los	O
testículos	O
de	O
pacientes	O
congénitos	O
animales	B-Taxon
como	O
sigue	O
.	O

Después	O
de	O
la	O
anestesia	O
con	O
2	O
.	O
5	O
%	O
Avertin	O
,	O
un	O
1	O
.	O
Se	O
realizó	O
una	O
incisión	O
de	O
5	O
cm	O
en	O
la	O
piel	O
y	O
la	O
pared	O
del	O
cuerpo	O
en	O
un	O
punto	O
al	O
nivel	O
de	O
la	O
parte	O
superior	O
de	O
las	O
extremidades	O
.	O

Se	O
extrajeron	O
las	O
bolsas	O
de	O
grasa	O
y	O
se	O
colocaron	O
en	O
la	O
parte	O
exterior	O
del	O
cuerpo	O
,	O
dejando	O
al	O
descubierto	O
los	O
testículos	O
.	O

Se	O
utilizaron	O
fórceps	O
para	O
introducir	O
un	O
pequeño	O
orificio	O
en	O
la	O
cápsula	O
testicular	O
a	O
través	O
del	O
cual	O
se	O
insertó	O
un	O
trozo	O
de	O
piel	O
embrionaria	O
diseccionada	O
,	O
luego	O
se	O
colocaron	O
los	O
testículos	O
en	O
la	O
cavidad	O
abdominal	O
y	O
se	O
cerró	O
la	O
herida	O
tanto	O
en	O
la	O
pared	O
corporal	O
como	O
en	O
la	O
piel	O
.	O

Después	O
de	O
21	O
días	O
,	O
ratones	B-Taxon
que	O
recibieron	O
los	O
injertos	O
se	O
sacrificaron	O
y	O
el	O
cabello	O
resultante	O
se	O
diseccionó	O
de	O
los	O
testículos	O
y	O
se	O
examinó	O
.	O

Destino	O
:	O
mapeo	O
de	O
la	O
frontera	O
somítica	O
lateral	O

los	O
Hoxb6	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
descrito	O
por	O
Kuehn	O
y	O
colegas	O
(	O
Lowe	O
et	O
al	O
.	O
2000	O
)	O
se	O
expresa	O
en	O
la	O
placa	O
lateral	O
pero	O
no	O
en	O
el	O
mesodermo	O
somítico	O
del	O
tronco	O
,	O
comenzando	O
en	O
E9	O
.	O
5	O
.	O

animales	B-Taxon
doblemente	O
heterocigoto	O
para	O
esto	O
transgén	B-Sequence
y	O
el	O
reportero	O
R26R	O
gene	B-Sequence
se	O
utilizaron	O
como	O
fuente	O
de	O
piel	O
entera	O
en	O
P1	O
.	O
5	O
o	O
P4	O
.	O
5	O
.	O

Se	O
prepararon	O
secciones	O
de	O
piel	O
paralelas	O
al	O
eje	O
dorsoventral	O
con	O
una	O
única	O
incisión	O
a	O
lo	O
largo	O
de	O
la	O
línea	O
media	O
ventral	O
y	O
se	O
tiñeron	O
para	O
actividad	O
beta-galactosidasa	O
utilizando	O
protocolos	O
estándar	O
a	O
temperatura	O
ambiente	O
.	O

El	O
P1	O
.	O
5	O
la	O
muestra	O
se	O
tiñó	O
durante	O
la	O
noche	O
y	O
el	O
P4	O
.	O
Se	O
tiñeron	O
5	O
muestras	O
durante	O
5	O
.	O
5	O
horas	O

Se	O
prepararon	O
secciones	O
de	O
piel	O
no	O
teñidas	O
similares	O
a	O
partir	O
de	O
animales	B-Taxon
llevando	O
el	O
en	O
alelo	B-Sequence
.	O

Las	O
imágenes	O
de	O
los	O
diferentes	O
fragmentos	O
de	O
piel	O
se	O
alinearon	O
y	O
escalaron	O
,	O
y	O
la	O
posición	O
relativa	O
de	O
la	O
placa	O
lateral	O
del	O
somita	O
y	O
los	O
límites	O
de	O
pigmentación	O
se	O
midieron	O
usando	O
ImageJ	O
.	O

información	O
de	O
soporte	O

Los	O
números	O
de	O
acceso	O
de	O
GenBank	O
(	O
http	O
:	O
//	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
/	O
index	O
.	O
html	O
)	O
discutidos	O
en	O
este	O
documento	O
son	O
para	O
4931427F14Rik	B-Protein
(	O
AK016477	O
)	O
,	O
Agutí	B-Protein
gene	B-Sequence
(	O
L06451	O
)	O
,	O
Alx3	B-Protein
(	O
U96109	O
)	O
,	O
Alx4	B-Protein
(	O
AF001465	O
)	O
,	O
En1	B-Protein
(	O
L12703	O
)	O
,	O
M6pr	B-Protein
-	O
pd	O
(	O
X64069	O
)	O
,	O
Tbx14	B-Protein
(	O
AF013282	O
)	O
,	O
Tbx15	B-Protein
(	O
AF041822	O
)	O
,	O
tbx18	B-Protein
(	O
AF306666	O
)	O
,	O
y	O
Tbx22	B-Protein
(	O
NM_145224	O
)	O
.	O

Los	O
números	O
de	O
acceso	O
de	O
OMIM	O
(	O
http	O
:	O
//www.ncbi.nlm.nih.gov/omim/	O
)	O
discutidos	O
en	O
este	O
documento	O
son	O
para	O
apariencia	O
facial	O
acromegaloide	O
(	O
MIM	O
102150	O
)	O
,	O
síndrome	O
frontofacionasal	O
(	O
MIM	O
229400	O
)	O
y	O
humano	B-Taxon
síndrome	O
X	B-GENE
paladar	O
hendido	O
vinculado	O
y	O
anquiloglosia	O
(	O
MIM	O
303400	O
)	O
.	O

Agradecimientos	O

Agradecemos	O
a	O
Colin	O
Beechey	O
y	O
Bruce	O
Cattanach	O
por	O
brindar	O
información	O
sobre	O
el	O
origen	O
de	O
deH	O
,	O
a	O
Cindy	O
Loomis	O
por	O
comunicar	O
resultados	O
no	O
publicados	O
y	O
a	O
Michael	O
Kuehn	O
por	O
proporcionar	O
Hoxb6	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
.	O

Estamos	O
especialmente	O
agradecidos	O
con	O
Hirotake	O
Ono	O
por	O
la	O
discusión	O
,	O
con	O
Hermie	O
Manuel	O
y	O
Carla	O
Kroon-Veenboer	O
por	O
la	O
ayuda	O
técnica	O
,	O
y	O
con	O
David	O
Kingsley	O
por	O
llamar	O
nuestra	O
atención	O
primero	O
sobre	O
los	O
efectos	O
de	O
oreja	B-Protein
caída	I-Protein
sobre	O
la	O
pigmentación	O
.	O

SIC	O
cuenta	O
con	O
el	O
apoyo	O
de	O
una	O
subvención	O
de	O
The	O
Donald	O
E	O
.	O
y	O
Delia	O
B.	O
Fundación	O
Baxter	O
.	O

GSB	O
es	O
investigador	O
asociado	O
del	O
Instituto	O
Médico	O
Howard	O
Hughes	O
.	O

abreviaturas	O

ae	O
-	O
nonagouti	O
extremo	O
alelo	B-Sequence

AFA	O
-	O
apariencia	O
facial	O
acromegaloide	O

en	O
-	O
negro	O
-	O
y	O
-	O
bronceado	O
alelo	B-Sequence

AW	O
-	O
blanco	O
-	O
vientre	O
Agutí	B-Protein
alelo	B-Sequence

B6-C57BL/6J	O
ratones	B-Taxon

BAC	B-Sequence
-	O
cromosoma	B-Sequence
artificial	I-Sequence
bacteriano	I-Sequence

deH-	O
oreja	B-Protein
caída	I-Protein
alelo	B-Sequence
que	O
surgió	O
en	O
Harwell	O

E10	O
.	O
5	O
-	O
día	O
embrionario	O
10	O
.	O
5	O

En1	B-Protein
-	O
grabado1	B-Protein

M6pr	B-Protein
-	O
PD	B-Sequence
-	O
manosa	B-Protein
-	I-Protein
6	I-Protein
-	I-Protein
receptor	I-Protein
de	I-Protein
fosfato	I-Protein
pseudogen	B-Sequence

P4	O
.	O
5	O
-	O
día	O
postnatal	O
4	O
.	O
5	O

Tbx15	B-Protein
-	O
T	B-Protein
-	I-Protein
caja	I-Protein
gen	I-Protein
15	I-Protein

Figuras	O
y	O
Tablas	O

Figura	O
1	O

Características	O
de	O
la	O
piel	O
dorsoventral	O

(	O
A	O
)	O
Rebanadas	O
de	O
piel	O
de	O
animales	B-Taxon
de	O
diferente	O
edad	O
y	O
genotipo	B-Sequence
demostrar	O
patrones	O
similares	O
de	O
variación	O
de	O
la	O
longitud	O
del	O
cabello	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
(	O
barra	O
de	O
escala	O
=	O
1	O
cm	O
)	O
.	O

B	O
)	O
Área	O
ampliada	O
de	O
(	O
A	O
)	O
,	O
que	O
demuestra	O
la	O
transición	O
en	O
la	O
longitud	O
y	O
el	O
color	O
del	O
cabello	O
en	O
/	O
en	O
ratones	B-Taxon
(	O
barra	O
de	O
escala	O
=	O
0,375	O
cm	O
)	O
.	O

(	O
C	O
)	O
Longitud	O
proporcional	O
del	O
cabello	O
para	O
(	O
A	O
)	O
representada	O
en	O
función	O
de	O
la	O
posición	O
relativa	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
.	O

(	O
D	O
)	O
Longitud	O
del	O
cabello	O
representada	O
en	O
función	O
de	O
la	O
posición	O
absoluta	O
a	O
lo	O
largo	O
del	O
eje	O
dorsoventral	O
para	O
la	O
cepa	O
BA	O
de	O
8	O
semanas	O
de	O
edad	O
ratones	B-Taxon
.	O

(	O
E	O
)	O
La	O
proporción	O
de	O
pelos	O
en	O
zigzag	O
(	O
+/-	O
SEM	O
)	O
difiere	O
ligeramente	O
entre	O
el	O
dorso	O
y	O
el	O
vientre	O
de	O
los	O
endogámicos	O
ratones	B-Taxon
(	O
p	O
<	O
0	O
.	O
0001	O
,	O
prueba	O
chi	O
2	O
,	O
n	O
=	O
1	O
,	O
958	O
,	O
1	O
,	O
477	O
,	O
1	O
,	O
579	O
,	O
1	O
,	O
502	O
)	O
.	O

(	O
F	O
)	O
Diferencias	O
en	O
el	O
desarrollo	O
de	O
la	O
piel	O
dorsal	O
y	O
ventral	O
en	O
P4	O
.	O
5	O
(	O
barra	O
de	O
escala	O
=	O
1	O
mm	O
,	O
superior	O
;	O
200	O
mu	O
m	O
,	O
inferior	O
)	O
.	O

(	O
G	O
)	O
Diferencias	O
en	O
el	O
cabello	O
melanina	B-Chemical
contenido	O
y	O
DOPA	B-Chemical
tinción	O
para	O
dorso	O
(	O
d	O
)	O
,	O
flanco	O
(	O
f	O
)	O
y	O
vientre	O
(	O
v	O
)	O
en	O
ae	O
/	O
ae	O
y	O
en	O
/	O
en	O
ratones	B-Taxon
.	O

El	O
panel	O
superior	O
también	O
muestra	O
una	O
apariencia	O
de	O
color	O
crema	O
del	O
t/at	O
ventrum	O
.	O

El	O
panel	O
central	O
muestra	O
leznas	O
representativas	O
(	O
barra	O
de	O
escala	O
=	O
100	O
mu	O
m	O
)	O
.	O

El	O
panel	O
inferior	O
muestra	O
DOPA	B-Chemical
-	O
dermis	O
teñida	O
(	O
barra	O
de	O
escala	O
=	O
200	O
mu	O
m	O
)	O
.	O

Figura	O
2	O

El	O
fenotipo	O
de	O
pigmentación	O
deH	O

(	O
A	O
)	O
10	O
-	O
wk	O
-	O
viejo	O
deH	O
/	O
deH	O
y	O
no	O
mutante	O
animales	B-Taxon
en	O
un	O
fondo	O
.	O

Una	O
fina	O
franja	O
de	O
pelo	O
amarillo	O
normalmente	O
separa	O
los	O
pelos	O
negros	O
dorsales	O
de	O
los	O
pelos	O
crema	O
ventrales	O
.	O

En	O
deH	O
,	O
la	O
franja	O
amarilla	O
se	O
extiende	O
dorsalmente	O
,	O
y	O
el	O
límite	O
entre	O
los	O
pelos	O
amarillo	O
y	O
negro	O
es	O
más	O
borroso	O
.	O

(	O
B	O
)	O
Cortes	O
de	O
piel	O
tomados	O
de	O
1	O
.	O
deH/deH	O
de	O
5	O
meses	O
de	O
edad	O
y	O
compañeros	O
de	O
camada	O
no	O
mutantes	O
(	O
barra	O
de	O
escala	O
=	O
0,5	O
cm	O
)	O
.	O

(	O
C	O
)	O
Proporción	O
del	O
área	O
total	O
de	O
la	O
piel	O
determinada	O
por	O
la	O
observación	O
de	O
pieles	O
tomadas	O
de	O
la	O
región	O
entre	O
las	O
extremidades	O
.	O

La	O
proporción	O
ocupada	O
por	O
el	O
compartimiento	O
lateral	O
amarillo	O
(	O
+/-	O
SEM	O
)	O
difiere	O
entre	O
mutante	B-Sequence
y	O
flancos	O
de	O
compañeros	O
de	O
camada	O
no	O
mutantes	O
(	O
p	O
<	O
0,0005	O
,	O
prueba	O
t	O
pareada	O
,	O
n	O
=	O
6	O
pares	O
)	O
.	O

También	O
hay	O
(	O
datos	O
no	O
mostrados	O
)	O
un	O
pequeño	O
aumento	O
en	O
la	O
proporción	O
del	O
área	O
total	O
de	O
la	O
piel	O
ocupada	O
por	O
el	O
compartimiento	O
ventral	O
de	O
color	O
crema	O
,	O
47	O
.	O
9	O
%	O
en	O
mutante	B-Sequence
en	O
comparación	O
con	O
37	O
.	O
8	O
%	O
en	O
no	O
mutantes	O
(	O
p	O
<	O
0,005	O
,	O
prueba	O
t	O
pareada	O
,	O
n	O
=	O
6	O
pares	O
)	O
.	O

(	O
D	O
)	O
En	O
un	O
fondo	O
ae/ae	O
,	O
la	O
extensión	O
de	O
la	O
pigmentación	O
de	O
la	O
piel	O
dorsal	O
se	O
reduce	O
en	O
los	O
recién	O
nacidos	O
deH/deH	O
(	O
P3.5	O
)	O
.	O

(	O
E	O
)	O
Longitud	O
del	O
cabello	O
en	O
un	O
par	O
representativo	O
de	O
1	O
.	O
DeH/deH	O
de	O
5	O
meses	O
de	O
edad	O
y	O
compañeros	O
de	O
camada	O
no	O
mutantes	O
,	O
promediados	O
sobre	O
tres	O
cortes	O
de	O
piel	O
a	O
diferentes	O
niveles	O
rostrocaudales	O
,	O
y	O
trazados	O
como	O
una	O
función	O
de	O
la	O
distancia	O
absoluta	O
desde	O
el	O
dorso	O
medio	O
o	O
el	O
porcentaje	O
de	O
la	O
longitud	O
total	O
del	O
corte	O
.	O

figura	O
3	O

Molecular	B-Chemical
Genética	O
de	O
deH	O
y	O
Tbx15	B-Protein

(	O
A	O
)	O
Genético	B-Sequence
y	O
mapa	B-Sequence
físico	I-Sequence
,	O
como	O
se	O
describe	O
en	O
el	O
texto	O
.	O

Los	O
marcadores	O
M1	O
a	O
M3	O
son	O
marcadores	O
SSCP	O
generados	O
a	O
partir	O
de	O
un	O
BAC	B-Sequence
contig	I-Sequence
de	O
El	O
región	B-Sequence
;	O
el	O
marcador	O
M4	O
es	O
STS	B-Sequence
dieciséis	O
.	O
MMHAP32FLF1	O
y	O
también	O
se	O
utilizó	O
como	O
marcador	O
SSCP	O
.	O

M2	O
y	O
M3	O
,	O
que	O
flanco	B-Sequence
los	O
Tbx15	B-Protein
y	O
M6pr	B-Protein
-	O
PD	B-Sequence
en	O
la	O
UCSC	O
genoma	B-Sequence
navegador	O
mapa	B-Sequence
y	O
se	O
encuentran	O
a	O
634	O
kb	O
de	O
distancia	O
,	O
fueron	O
no	O
recombinantes	O
con	O
deH	O
en	O
2340	O
meiosis	O
.	O

(	O
B	O
)	O
El	O
deH	O
mutación	B-Sequence
es	O
un	O
supresión	B-Sequence
que	O
comienza	O
en	O
Tbx15	B-Protein
intrón	B-Sequence
1	O
y	O
termina	O
en	O
el	O
M6pr	B-Protein
-	O
PD	B-Sequence
.	O

(	O
C	O
)	O
Secuencia	B-Sequence
de	O
puntos	B-Sequence
de	I-Sequence
interrupción	I-Sequence
de	I-Sequence
eliminación	I-Sequence
.	O

D	O
)	O
Diagrama	O
de	O
Tbx15LacZ	O
alelo	B-Sequence
construido	O
por	O
gene	B-Sequence
apuntando	O

Como	O
se	O
describe	O
en	O
el	O
texto	O
,	O
este	O
alelo	B-Sequence
se	O
prevé	O
que	O
dará	O
lugar	O
a	O
una	O
proteína	B-Chemical
truncado	O
después	O
de	O
aproximadamente	O
154	O
codones	B-Sequence
y	O
le	O
falta	O
critica	O
residuos	B-Chemical
de	O
la	O
caja	O
T	O
.	O

Heterocigotos	O
para	O
el	O
objetivo	O
alelo	B-Sequence
muestran	O
un	O
tamaño	O
,	O
morfología	O
y	O
patrones	O
de	O
color	O
de	O
cabello	O
normales	O
,	O
pero	O
los	O
homocigotos	O
y	O
los	O
heterocigotos	O
compuestos	O
Tbx15LacZ/deH	O
son	O
idénticos	O
a	O
los	O
homocigotos	O
deH	O
.	O

Figura	O
4	O

Expresión	O
del	O
desarrollo	O
de	O
Tbx15	B-Protein

(	O
A	O
)	O
En	O
E12	O
.	O
5	O
,	O
cortes	O
transversales	O
a	O
diferentes	O
niveles	O
muestran	O
expresión	O
en	O
el	O
mesénquima	O
de	O
la	O
cabeza	O
(	O
ayb	O
)	O
;	O
miotomo	O
,	O
mesénquima	O
occipital	O
y	O
periocular	O
(	O
b	O
)	O
;	O
plataforma	O
palatina	O
,	O
esclerotomo	O
cervical	O
y	O
cartílago	O
nasal	O
(	O
c	O
)	O
;	O
procesos	O
maxilares	O
y	O
mandibulares	O
(	O
d	O
)	O
;	O
extremidades	O
(	O
e	O
)	O
;	O
y	O
miotomo	O
y	O
mesénquima	O
lateral	O
(	O
eyf	O
)	O
(	O
barras	O
de	O
escala	O
=	O
500	O
mu	O
m	O
)	O
.	O

B	O
)	O
Las	O
secciones	O
transversales	O
a	O
través	O
del	O
flanco	O
en	O
diferentes	O
momentos	O
muestran	O
expresión	O
en	O
el	O
mesénquima	O
lateral	O
(	O
E11	O
.	O
5	O
)	O
,	O
expandiéndose	O
dorsalmente	O
en	O
E12	O
.	O
5	O
,	O
y	O
tanto	O
ventral	O
como	O
dorsalmente	O
en	O
E13	O
.	O
5	O
,	O
detectable	O
en	O
el	O
mesénquima	O
suelto	O
subyacente	O
a	O
la	O
dermis	O
y	O
los	O
músculos	O
abdominales	O
y	O
subcutáneos	O
(	O
barra	O
de	O
escala	O
=	O
500	O
mu	O
m	O
)	O
.	O

En	O
P3	O
.	O
5	O
,	O
Tbx15	B-Protein
se	O
expresa	O
en	O
toda	O
la	O
dermis	O
y	O
se	O
expresa	O
más	O
fuertemente	O
en	O
las	O
vainas	O
dérmicas	O
(	O
barra	O
de	O
escala	O
=	O
200	O
mu	O
m	O
)	O
.	O

Figura	O
5	O

Expresión	O
embrionaria	O
de	O
Tbx15	B-Protein
Comparado	O
con	O
Agutí	B-Protein
en	O
en	O
/	O
en	O
Ratones	B-Taxon

(	O
A	O
y	O
C	O
)	O
Tbx15	B-Protein
.	O

(	O
B	O
y	O
D	O
)	O
Agutí	B-Protein
.	O

En	O
E12	O
.	O
5	O
,	O
expresión	O
de	O
Tbx15	B-Protein
en	O
la	O
piel	O
dorsal	O
es	O
aproximadamente	O
complementaria	O
a	O
la	O
de	O
Agutí	B-Protein
en	O
piel	O
ventral	O
.	O

En	O
E14	O
.	O
5	O
,	O
los	O
niveles	O
de	O
expresión	O
para	O
ambos	O
genes	B-Sequence
son	O
inferiores	O
,	O
pero	O
Tbx15	B-Protein
expresión	O
se	O
ha	O
expandido	O
ventralmente	O
y	O
se	O
superpone	O
ampliamente	O
con	O
la	O
de	O
Agutí	B-Protein
.	O

En	O
los	O
cuatro	O
paneles	O
,	O
las	O
flechas	O
marcan	O
el	O
límite	O
ventral	O
aproximado	O
de	O
Tbx15	B-Protein
y	O
el	O
límite	O
dorsal	O
aproximado	O
de	O
Agutí	B-Protein
(	O
barras	O
de	O
escala	O
=	O
500	O
mu	O
m	O
)	O
.	O

Figura	O
6	O

Efecto	O
de	O
deH	O
sobre	O
Agutí	B-Protein
Expresión	O

Secciones	O
comparables	O
de	O
at	O
/	O
at	O
;	O
deH	O
/	O
deH	O
y	O
en	O
/	O
en	O
;	O
+	B-Sequence
/	O
+	B-Sequence
compañeros	O
de	O
camada	O

(	O
A	O
)	O
En	O
E14	O
.	O
5	O
,	O
los	O
embriones	O
deH	O
/	O
deH	O
tienen	O
una	O
cavidad	O
corporal	O
más	O
pequeña	O
y	O
piel	O
suelta	O
dentro	O
de	O
la	O
cual	O
Agutí	B-Protein
la	O
expresión	O
parece	O
estar	O
desplazada	O
dorsalmente	O
,	O
como	O
lo	O
marcan	O
las	O
flechas	O
(	O
barras	O
de	O
escala	O
=	O
500	O
mu	O
m	O
)	O
.	O

(	O
B	O
)	O
En	O
P4	O
.	O
5	O
,	O
Agutí	B-Protein
la	O
expresión	O
tanto	O
en	O
la	O
piel	O
dorsal	O
como	O
en	O
la	O
ventral	O
es	O
similar	O
en	O
deH/deH	O
en	O
comparación	O
con	O
los	O
no	O
mutantes	O
,	O
pero	O
en	O
la	O
región	O
del	O
flanco	O
medio	O
,	O
hay	O
un	O
aumento	O
Agutí	B-Protein
expresión	O
en	O
deH/deH	O
,	O
especialmente	O
en	O
la	O
dermis	O
superior	O
(	O
barras	O
de	O
escala	O
=	O
200	O
mu	O
m	O
)	O
.	O

Las	O
secciones	O
mostradas	O
son	O
representativas	O
de	O
dos	O
mutante	B-Sequence
y	O
dos	O
muestras	O
no	O
mutantes	O
examinadas	O
en	O
cada	O
momento	O
.	O

Figura	O
7	O

Establecimiento	O
embrionario	O
del	O
patrón	O
de	O
piel	O
dorsoventral	O

Trozos	O
de	O
piel	O
de	O
las	O
regiones	O
dorsal	O
,	O
lateral	O
y	O
ventral	O
de	O
at/a	O
E12	O
.	O
Se	O
trasplantaron	O
5	O
embriones	O
en	O
los	O
testículos	O
de	O
congénitas	O
.	O
animales	B-Taxon
como	O
se	O
describe	O
en	O
el	O
texto	O
.	O

El	O
color	O
del	O
pelo	O
de	O
los	O
injertos	O
se	O
examinó	O
3	O
semanas	O
más	O
tarde	O
.	O

Los	O
injertos	O
de	O
piel	O
embrionaria	O
ventral	O
(	O
n	O
=	O
3	O
)	O
produjeron	O
pelos	O
amarillos	O
,	O
la	O
piel	O
embrionaria	O
dorsal	O
(	O
n	O
=	O
4	O
)	O
produjo	O
pelos	O
negros	O
y	O
la	O
piel	O
embrionaria	O
lateral	O
produjo	O
principalmente	O
(	O
13	O
de	O
15	O
)	O
pelos	O
negros	O
y	O
amarillos	O
en	O
distintas	O
regiones	O
,	O
como	O
se	O
muestra	O
.	O

Paralelamente	O
,	O
los	O
estudios	O
de	O
hibridación	O
in	O
situ	O
revelaron	O
que	O
el	O
flanco	O
embrionario	O
contiene	O
el	O
límite	O
de	O
expresión	O
entre	O
Agutí	B-Protein
y	O
Tbx15	B-Protein
(	O
barras	O
de	O
escala	O
=	O
1	O
mm	O
para	O
pelos	O
y	O
200	O
mu	O
m	O
para	O
resultados	O
de	O
hibridación	O
in	O
situ	O
)	O
.	O

Figura	O
8	O

Comparación	O
del	O
dorsoventral	O
en/en	O
el	O
límite	O
de	O
pigmentación	O
con	O
la	O
frontera	O
somítica	O
lateral	O

(	O
A	O
)	O
Cortes	O
dorsoventrales	O
de	O
piel	O
de	O
la	O
región	O
media	O
del	O
tronco	O
preparados	O
de	O
manera	O
que	O
la	O
línea	O
media	O
dorsal	O
quede	O
en	O
el	O
centro	O
del	O
corte	O
.	O

Se	O
tomaron	O
secciones	O
en	O
P1	O
.	O
5	O
(	O
a	O
)	O
o	O
P4	O
.	O
5	O
(	O
b	O
-	O
e	O
)	O
desde	O
en	O
/	O
en	O
o	O
R26R	O
/	O
+	B-Sequence
;	O
Tg	B-Sequence
.	O
Hoxb6	B-Protein
-	O
Cre	O
/	O
+	B-Sequence
ratones	B-Taxon
(	O
estas	O
últimas	O
se	O
tiñeron	O
con	O
X-Gal	O
)	O
,	O
como	O
se	O
describe	O
en	O
Materiales	O
y	O
Métodos	O
.	O

Para	O
fines	O
de	O
comparación	O
,	O
las	O
imágenes	O
se	O
escalaron	O
proporcionalmente	O
.	O

El	O
límite	O
de	O
la	O
tinción	O
con	O
X-Gal	O
marca	O
la	O
dermis	O
derivada	O
de	O
la	O
placa	O
lateral	O
frente	O
a	O
la	O
dermis	O
derivada	O
del	O
mesodermo	O
(	O
la	O
frontera	O
somítica	O
lateral	O
)	O
y	O
se	O
encuentra	O
más	O
dorsal	O
que	O
el	O
límite	O
de	O
pigmentación	O
at/at	O
.	O

(	O
B	O
)	O
La	O
cuantificación	O
del	O
área	O
de	O
pigmentación	O
dorsal	O
media	O
(	O
+/-	O
SEM	O
)	O
(	O
n	O
=	O
5	O
)	O
y	O
el	O
área	O
de	O
la	O
dermis	O
derivada	O
de	O
somita	O
(	O
n	O
=	O
3	O
)	O
muestra	O
una	O
diferencia	O
significativa	O
(	O
p	O
<	O
0,005	O
,	O
prueba	O
t	O
)	O
.	O

(	O
C	O
)	O
ARN	B-Sequence
hibridación	O
in	O
situ	O
que	O
muestra	O
que	O
Tbx15	B-Protein
expresión	O
en	O
E11	O
.	O
5	O
es	O
complementario	O
a	O
En1	B-Protein
expresión	O
en	O
el	O
flanco	O
(	O
barras	O
de	O
escala	O
=	O
200	O
mu	O
m	O
)	O
.	O

La	O
flecha	O
indica	O
el	O
límite	O
entre	O
los	O
dominios	O
de	O
expresión	O
de	O
los	O
dos	O
genes	B-Sequence
.	O

Figura	O
9	O

Modelo	O
para	O
la	O
Adquisición	O
del	O
Patrón	O
Dorsoventral	O
en	O
el	O
Tronco	O
y	O
el	O
Rol	O
de	O
Tbx15	B-Protein

(	O
A	O
)	O
Un	O
patrón	O
de	O
pigmentación	O
tricolor	O
es	O
generado	O
por	O
la	O
combinación	O
de	O
distintos	O
mecanismos	O
que	O
afectan	O
la	O
distribución	O
de	O
Agutí	B-Protein
ARNm	B-Chemical
y	O
tinción	O
histoquímica	O
para	O
melanocitos	B-Cell
;	O
efectos	O
de	O
este	O
último	O
mecanismo	O
por	O
sí	O
mismo	O
son	O
evidentes	O
en	O
ae/ae	O
ratones	B-Taxon
(	O
ver	O
Figura	O
1	O
)	O
.	O

en	O
en	O
/	O
en	O
ratones	B-Taxon
,	O
pelo	O
reducido	O
melanocito	B-Cell
actividad	O
y	O
altos	O
niveles	O
de	O
Agutí	B-Protein
ARNm	B-Chemical
en	O
el	O
vientre	O
lleva	O
a	O
un	O
color	O
crema	O
;	O
como	O
melanocito	B-Cell
la	O
actividad	O
aumenta	O
gradualmente	O
hacia	O
el	O
dorso	O
,	O
una	O
franja	O
lateral	O
es	O
aparente	O
en	O
el	O
flanco	O
.	O

Las	O
distribuciones	O
de	O
Agutí	B-Protein
ARNm	B-Chemical
y	O
tinción	O
histoquímica	O
para	O
melanocitos	B-Cell
Ambos	O
están	O
afectados	O
por	O
Tbx15	B-Protein
y	O
son	O
evidentes	O
externamente	O
por	O
un	O
ensanchamiento	O
de	O
la	O
franja	O
lateral	O
y	O
una	O
mayor	O
proporción	O
de	O
piel	O
total	O
ocupada	O
por	O
el	O
área	O
de	O
color	O
crema	O
.	O

(	O
B	O
)	O
La	O
franja	O
amarilla	O
lateral	O
en	O
at/at	O
ratones	B-Taxon
se	O
encuentra	O
al	O
mismo	O
nivel	O
que	O
el	O
límite	O
dorsoventral	O
del	O
miembro	O
.	O

Como	O
se	O
describe	O
en	O
el	O
texto	O
,	O
proponemos	O
que	O
los	O
distintos	O
compartimentos	O
dorsoventrales	O
en	O
el	O
ectodermo	O
del	O
tronco	O
proporcionan	O
una	O
señal	O
de	O
instrucción	O
para	O
el	O
mesodermo	O
,	O
lo	O
que	O
lleva	O
a	O
la	O
expresión	O
de	O
Tbx15	B-Protein
en	O
el	O
mesénquima	O
del	O
tronco	O
dorsal	O
y	O
adquisición	O
del	O
carácter	O
de	O
la	O
dermis	O
dorsal	O
.	O

En	O
ausencia	O
de	O
Tbx15	B-Protein
,	O
el	O
mesénquima	O
dorsal	O
asume	O
características	O
ventrales	O
en	O
su	O
lugar	O
.	O

notas	O
al	O
pie	O

Conflictos	O
de	O
interés	O
.	O

Los	O
autores	O
han	O
declarado	O
que	O
no	O
existen	O
conflictos	O
de	O
interés	O
.	O

Contribuciones	O
de	O
autor	O
.	O

SIC	O
y	O
GSB	O
concibieron	O
y	O
diseñaron	O
los	O
experimentos	O
.	O

SIC	O
,	O
CDVR	O
,	O
CC	O
,	O
AR	O
y	O
SK	O
realizaron	O
los	O
experimentos	O
.	O

SIC	O
,	O
CDVR	O
,	O
CC	O
,	O
SK	O
y	O
FM	O
analizaron	O
los	O
datos	O
.	O

YC	O
y	O
AR	O
contribuyeron	O
reactivos	B-Chemical
/	O
materiales	O
/	O
herramientas	O
de	O
análisis	O
.	O

SIC	O
y	O
GSB	O
escribieron	O
el	O
artículo	O
.	O

Editora	O
académica	O
:	O
Brigid	O
L	O
.	O

m	O

Hogan	O
,	O
Centro	O
Médico	O
de	O
la	O
Universidad	O
de	O
Duke	O

Hipoplasia	O
pulmonar	O
gestacional	O
tardía	O
en	O
un	O
ratón	B-Taxon
modelo	O
del	O
síndrome	O
de	O
Smith	O
-	O
Lemli	O
-	O
Opitz	O

Resumen	O

Antecedentes	O

publicación	O
normal	O
-	O
colesterol	B-Chemical
escualeno	I-Chemical
La	O
biosíntesis	O
es	O
importante	O
para	O
mamífero	B-Taxon
desarrollo	O
embriónico	O
.	O

Neonatal	O
ratones	B-Taxon
carente	O
de	O
funcionalidad	O
dehidrocolesterol	B-Protein
Delta	I-Protein
7	I-Protein
-	I-Protein
reductasa	I-Protein
(	O
Dhcr7	B-Protein
)	O
,	O
un	O
modelo	O
para	O
la	O
humano	B-Taxon
enfermedad	O
del	O
síndrome	O
de	O
Smith-Lemli-Opitz	O
,	O
muere	O
dentro	O
de	O
las	O
24	O
horas	O
posteriores	O
al	O
nacimiento	O
.	O

Aunque	O
tienen	O
una	O
serie	O
de	O
anomalías	O
bioquímicas	O
y	O
estructurales	O
,	O
una	O
causa	O
de	O
muerte	O
es	O
la	O
aparente	O
insuficiencia	O
respiratoria	O
debida	O
a	O
anomalías	O
pulmonares	O
del	O
desarrollo	O
.	O

Resultados	O

En	O
este	O
estudio	O
,	O
caracterizamos	O
aún	O
más	O
el	O
papel	O
de	O
colesterol	B-Chemical
deficiencia	O
en	O
el	O
desarrollo	O
pulmonar	O
de	O
estos	O
ratones	B-Taxon
.	O

Retraso	O
significativo	O
del	O
crecimiento	O
,	O
comenzando	O
en	O
E14	O
.	O
5~E16	O
.	O
5	O
,	O
se	O
observó	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

Se	O
observó	O
una	O
lobulación	O
normal	O
pero	O
pulmones	O
más	O
pequeños	O
con	O
una	O
disminución	O
significativa	O
en	O
la	O
relación	O
entre	O
el	O
peso	O
de	O
los	O
pulmones	O
y	O
el	O
cuerpo	O
en	O
Dhcr7	B-Protein
-/-	O
embriones	O
,	O
en	O
comparación	O
con	O
los	O
controles	O
.	O

La	O
morfogénesis	O
de	O
ramificación	O
pulmonar	O
fue	O
comparable	O
entre	O
Dhcr7	B-Protein
-	O
/	O
-	O
y	O
controles	O
en	O
etapas	O
tempranas	O
,	O
pero	O
el	O
retraso	O
en	O
el	O
desarrollo	O
sacular	O
fue	O
visible	O
en	O
todos	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
de	O
E17	O
.	O
5	O
en	O
adelante	O
.	O

Deterioro	O
del	O
desarrollo	O
prealveolar	O
de	O
gravedad	O
variable	O
,	O
inhibido	O
célula	B-Cell
proliferación	O
,	O
diferenciación	O
retardada	O
de	O
alveolar	O
tipo	O
I	O
células	B-Cell
epiteliales	I-Cell
(	O
AEC	O
)	O
y	O
el	O
retraso	O
en	O
el	O
desarrollo	O
vascular	O
fueron	O
evidentes	O
en	O
los	O
pulmones	O
inactivados	O
.	O

Aparentemente	O
,	O
la	O
diferenciación	O
de	O
las	O
AEC	O
de	O
tipo	O
II	O
era	O
normal	O
a	O
juzgar	O
por	O
proteína	B-Chemical
tensioactiva	I-Chemical
(	O
SP	O
)	O
ARNm	B-Chemical
y	O
SP-C	B-Protein
inmunotinción	O
.	O

una	O
cantidad	O
significativa	O
de	O
colesterol	B-Chemical
fue	O
detectable	O
en	O
pulmones	O
knockout	O
,	O
lo	O
que	O
implica	O
alguna	O
transferencia	O
materna	O
de	O
colesterol	B-Chemical
.	O

No	O
hay	O
diferencias	O
significativas	O
de	O
la	O
localización	O
espacio	O
-	O
temporal	O
de	O
erizo	B-Protein
Sonic	I-Protein
(	O
Shh	B-Protein
)	O
o	O
sus	O
objetivos	O
aguas	O
abajo	O
por	O
inmunohistoquímica	O
se	O
detectaron	O
entre	O
knockout	O
y	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
y	O
Shh	B-Protein
el	O
autoprocesamiento	O
ocurrió	O
normalmente	O
en	O
tejidos	O
de	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

Conclusión	O

Nuestros	O
datos	O
indicaron	O
que	O
colesterol	B-Chemical
deficiencia	O
causada	O
por	O
Dhcr7	B-Protein
null	O
se	O
asoció	O
con	O
una	O
hipoplasia	O
sacular	O
pulmonar	O
distinta	O
,	O
caracterizada	O
por	O
la	O
falta	O
de	O
diferenciación	O
terminal	O
de	O
los	O
sacos	O
alveolares	O
,	O
una	O
diferenciación	O
tardía	O
de	O
las	O
AEC	O
de	O
tipo	O
I	O
y	O
una	O
red	O
vascular	O
inmadura	O
en	O
etapas	O
gestacionales	O
tardías	O
.	O

los	O
molecular	B-Chemical
mecanismo	O
de	O
deterioro	O
del	O
desarrollo	O
pulmonar	O
asociado	O
con	O
esterol	B-Chemical
deficiencia	O
por	O
Dhcr7	B-Protein
Todavía	O
se	O
desconoce	O
la	O
pérdida	O
,	O
pero	O
estos	O
resultados	O
no	O
respaldan	O
la	O
participación	O
de	O
desregulados	O
Shh	B-Protein
#	O
¿NOMBRE	O
?	O

Antecedentes	O

Colesterol	B-Chemical
es	O
necesario	O
membrana	B-GENE
constituyente	O
de	O
todos	O
mamífero	B-Taxon
,	O
reptil	B-Taxon
y	O
aviar	B-Taxon
células	B-Cell
,	O
así	O
como	O
algunos	O
otros	O
organismos	B-Taxon
,	O
pero	O
no	O
todos	O
organismos	B-Taxon
eucariotas	I-Taxon
.	O

En	O
estos	O
últimos	O
casos	O
,	O
como	O
plantas	B-Taxon
y	O
hongos	B-Taxon
,	O
colesterol	B-Chemical
#	O
¿NOMBRE	O
?	O
esteroles	B-Chemical
(	O
fitoesteroles	B-Chemical
,	O
ergosterol	B-Chemical
etc	O
.	O
)	O
parecen	O
sustituir	O
a	O
colesterol	B-Chemical
.	O

La	O
necesidad	O
precisa	O
de	O
esteroles	B-Chemical
en	O
membranas	B-GENE
biológicas	I-GENE
sigue	O
estando	O
pobremente	O
definido	O
,	O
aunque	O
su	O
vínculo	O
con	O
los	O
microdominios	O
(	O
variamente	O
denominados	O
rafts	O
,	O
caveoli	B-GENE
etc	O
.	O
)	O
puede	O
ser	O
parte	O
de	O
la	O
respuesta	O
[	O
1	O
]	O
.	O

Aunque	O
la	O
acumulación	O
de	O
colesterol	B-Chemical
en	O
placas	O
ateroscleróticas	O
ha	O
llevado	O
al	O
concepto	O
de	O
que	O
'demasiado	O
'	O
colesterol	B-Chemical
puede	O
ser	O
perjudicial	O
,	O
muy	O
poco	O
colesterol	B-Chemical
Ahora	O
se	O
ha	O
demostrado	O
que	O
es	O
fisiopatológico	O
del	O
desarrollo	O
embrionario	O
anormal	O
.	O

El	O
síndrome	O
de	O
Smith-Lemli-Opitz	O
(	O
SLOS	O
,	O
MIM	O
270400	O
)	O
,	O
un	O
trastorno	O
dismorfológico	O
relativamente	O
común	O
,	O
es	O
causado	O
por	O
mutaciones	B-Sequence
en	O
DHCR7	B-Protein
[	O
2	O
-	O
5	O
]	O
,	O
que	O
codifica	O
para	O
7	B-Protein
-	I-Protein
dehidrocolesterol	I-Protein
Delta	I-Protein
7	I-Protein
-	I-Protein
reductasa	I-Protein
y	O
cataliza	O
un	O
paso	O
final	O
de	O
colesterol	B-Chemical
biosíntesis	O

Reconocimiento	O
de	O
otros	O
síndromes	O
dismorfológicos	O
causados	O
por	O
defectos	O
en	O
el	O
post	O
-	O
colesterol	B-Chemical
escualeno	I-Chemical
vía	O
de	O
biosíntesis	O
,	O
como	O
desmosterolosis	O
,	O
latosterolosis	O
,	O
X	B-GENE
la	O
condrodisplasia	O
punctanta	O
y	O
el	O
síndrome	O
CHILD	O
[	O
6	O
-	O
15	O
]	O
,	O
ha	O
fortalecido	O
este	O
concepto	O
.	O

Genético	B-Sequence
interrupción	O
de	O
la	O
Dhcr7	B-Protein
resulta	O
en	O
letalidad	O
neonatal	O
[	O
16	O
]	O
.	O

Neonatal	O
ratones	B-Taxon
homocigoto	O
para	O
el	O
Dhcr7	B-Protein
gene	B-Sequence
la	O
disrupción	O
es	O
deficiente	O
en	O
colesterol	B-Chemical
y	O
han	O
aumentado	O
la	O
acumulación	O
de	O
colesterol	B-Chemical
precursor	O
7-dehidrocolesterol	O
(	O
7DHC	O
)	O
.	O

Aunque	O
no	O
se	O
observó	O
letalidad	O
embrionaria	O
,	O
estos	O
cachorros	O
knockout	O
exhibieron	O
una	O
serie	O
de	O
anomalías	O
en	O
el	O
desarrollo	O
y	O
murieron	O
dentro	O
de	O
las	O
24	O
horas	O
posteriores	O
al	O
nacimiento	O
.	O

Un	O
similar	O
ratón	B-Taxon
Modelo	O
SLOS	O
,	O
generado	O
por	O
reemplazando	B-Sequence
exones	I-Sequence
3	O
,	O
4	O
y	O
parte	B-Sequence
del	I-Sequence
exón	I-Sequence
5	O
de	O
los	O
murino	B-Protein
Dhcr7	I-Protein
gene	B-Sequence
,	O
con	O
defectos	O
bioquímicos	O
y	O
estructurales	O
similares	O
y	O
una	O
letalidad	O
neonatal	O
del	O
100	O
%	O
,	O
también	O
se	O
ha	O
informado	O
[	O
17	O
]	O
.	O

El	O
desarrollo	O
pulmonar	O
deficiente	O
o	O
la	O
atelectasia	O
alveolar	O
pulmonar	O
difusa	O
con	O
respiración	O
cianótica	O
y	O
letárgica	O
son	O
consistentes	O
entre	O
ambos	O
.	O
Dhcr7	B-Protein
modelos	O
nulos	O
[	O
16	O
,	O
17	O
]	O
,	O
y	O
por	O
lo	O
tanto	O
es	O
la	O
razón	O
probable	O
de	O
la	O
insuficiencia	O
respiratoria	O
y	O
posterior	O
muerte	O
de	O
Dhcr7	B-Protein
-	O
/	O
-	O
cachorros	O
.	O

Estas	O
Dhcr7	B-Protein
knockear	O
ratones	B-Taxon
son	O
modelos	O
para	O
humano	B-Taxon
SLOS	O
,	O
especialmente	O
en	O
los	O
pacientes	O
más	O
gravemente	O
afectados	O
,	O
ya	O
que	O
se	O
ha	O
notificado	O
letalidad	O
posnatal	O
temprana	O
con	O
insuficiencia	O
respiratoria	O
en	O
casos	O
graves	O
de	O
SLOS	O
[	O
4	O
,	O
5	O
]	O
.	O

Las	O
anomalías	O
del	O
desarrollo	O
pulmonar	O
también	O
son	O
relativamente	O
comunes	O
en	O
los	O
pacientes	O
con	O
SLOS	O
,	O
incluida	O
la	O
hipoplasia	O
pulmonar	O
,	O
la	O
lobulación	O
pulmonar	O
anormal	O
y	O
las	O
arterias	O
pulmonares	O
,	O
anomalías	O
del	O
desarrollo	O
laríngeo	O
y	O
traqueal	O
[	O
18	O
]	O
.	O

Mamífero	B-Taxon
el	O
pulmón	O
es	O
único	O
porque	O
está	O
completamente	O
desarrollado	O
,	O
pero	O
no	O
funciona	O
para	O
el	O
intercambio	O
de	O
gases	O
hasta	O
el	O
momento	O
del	O
nacimiento	O
;	O
la	O
mayor	O
parte	O
del	O
desarrollo	O
estructural	O
y	O
la	O
maduración	O
tiene	O
lugar	O
en	O
el	O
útero	O
.	O

El	O
desarrollo	O
pulmonar	O
es	O
un	O
proceso	O
complejo	O
que	O
implica	O
la	O
morfogénesis	O
ramificada	O
del	O
epitelio	O
,	O
el	O
desarrollo	O
intersticial	O
,	O
incluida	O
la	O
vasculogénesis	O
,	O
celular	B-Cell
diferenciación	O
,	O
maduración	O
bioquímica	O
y	O
crecimiento	O
físico	O
.	O

Cuatro	O
etapas	O
de	O
ratón	B-Taxon
se	O
ha	O
descrito	O
el	O
desarrollo	O
pulmonar	O
,	O
basado	O
en	O
las	O
apariencias	O
histológicas	O
del	O
pulmón	O
;	O
estadios	O
pseudoglandular	O
,	O
canalicular	O
,	O
sacular	O
terminal	O
y	O
alveolar	O
[	O
19	O
]	O
.	O

Se	O
ha	O
propuesto	O
el	O
deterioro	O
de	O
la	O
función	O
hedgehog	O
como	O
un	O
mecanismo	O
subyacente	O
a	O
las	O
malformaciones	O
encontradas	O
en	O
SLOS	O
.	O

Los	O
miembros	O
de	O
la	O
familia	O
Hedgehog	O
juegan	O
diversos	O
roles	O
en	O
el	O
desarrollo	O
embrionario	O
y	O
colesterol	B-Chemical
es	O
necesario	O
para	O
la	O
maduración	O
de	O
estos	O
morfógenos	O
[	O
20	O
-	O
23	O
]	O
.	O

los	O
erizo	B-Protein
Sonic	I-Protein
(	O
Shh	B-Protein
)	O
se	O
ha	O
demostrado	O
que	O
la	O
cascada	O
de	O
señalización	O
desempeña	O
un	O
papel	O
central	O
en	O
el	O
desarrollo	O
pulmonar	O
[	O
24	O
-	O
26	O
]	O
.	O

Pérdida	O
de	O
Shh	B-Protein
la	O
función	O
resultó	O
en	O
defectos	O
pulmonares	O
severos	O
asociados	O
con	O
la	O
pérdida	O
de	O
la	O
morfogénesis	O
de	O
ramificación	O
,	O
pero	O
conservó	O
la	O
diferenciación	O
de	O
proximal	O
a	O
distal	O
del	O
epitelio	O
pulmonar	O
[	O
24	O
]	O
.	O

Sobreexpresión	O
de	O
Shh	B-Protein
en	O
el	O
epitelio	O
pulmonar	O
distal	O
resultó	O
en	O
la	O
ausencia	O
de	O
alvéolos	O
funcionales	O
y	O
un	O
aumento	O
en	O
el	O
tejido	O
intersticial	O
causado	O
por	O
una	O
mayor	O
proliferación	O
de	O
ambos	O
células	B-Cell
epiteliales	I-Cell
y	I-Cell
mesénquimas	I-Cell
[	O
26	O
]	O
.	O

Ratones	B-Taxon
con	O
Shh	B-Protein
sobreexpresión	O
murió	O
menos	O
de	O
24	O
h	O
después	O
del	O
nacimiento	O
,	O
probablemente	O
debido	O
a	O
insuficiencia	O
respiratoria	O
.	O

Se	O
ha	O
informado	O
que	O
la	O
inhibición	O
de	O
colesterol	B-Chemical
biosíntesis	O
por	O
inhibidores	B-Chemical
químicos	I-Chemical
de	O
Dhcr7	B-Protein
también	O
condujo	O
a	O
una	O
perturbación	O
de	O
la	O
Shh	B-Protein
señalización	O
con	O
embriogénesis	O
anormal	O
[	O
27	O
,	O
28	O
]	O
y	O
graves	O
esterol	B-Chemical
la	O
privación	O
de	O
hecho	O
puede	O
inhibir	O
el	O
procesamiento	O
de	O
transfected	O
Shh	B-Protein
en	O
culto	O
mamífero	B-Taxon
células	B-Cell
[	O
29	O
]	O
.	O

En	O
los	O
presentes	O
estudios	O
,	O
caracterizamos	O
el	O
desarrollo	O
pulmonar	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
de	O
E10	O
.	O
5	O
al	O
nacimiento	O
.	O

Nuestros	O
resultados	O
mostraron	O
que	O
colesterol	B-Chemical
deficiencia	O
,	O
causada	O
por	O
la	O
pérdida	O
de	O
Dhcr7	B-Protein
actividad	O
,	O
no	O
alteró	O
la	O
morfogénesis	O
de	O
ramificación	O
pulmonar	O
(	O
etapas	O
gestacionales	O
tempranas	O
,	O
E9	O
.	O
5	O
a	O
E14	O
.	O
5	O
)	O
.	O

Sin	O
embargo	O
,	O
el	O
desarrollo	O
sacular	O
pulmonar	O
estaba	O
deteriorado	O
,	O
con	O
túbulos	O
epiteliales	O
detenidos	O
o	O
parcialmente	O
desarrollados	O
y	O
desarrollo	O
vascular	O
retrasado	O
.	O

Diferenciación	O
de	O
alveolar	O
tipo	O
II	O
células	B-Cell
epiteliales	I-Cell
(	O
AEC	O
)	O
parecían	O
normales	O
pero	O
la	O
diferenciación	O
de	O
AEC	O
tipo	O
I	O
estaba	O
gravemente	O
afectada	O
.	O

Por	O
lo	O
tanto	O
,	O
colesterol	B-Chemical
la	O
deficiencia	O
resultó	O
en	O
una	O
clara	O
hipoplasia	O
pulmonar	O
gestacional	O
tardía	O
,	O
caracterizada	O
por	O
alteración	O
de	O
la	O
saculación	O
con	O
retraso	O
en	O
la	O
diferenciación	O
de	O
AEC	O
de	O
tipo	O
I	O
y	O
desarrollo	O
vascular	O
inmaduro	O
.	O

Sin	O
embargo	O
,	O
este	O
estudio	O
no	O
apoya	O
el	O
concepto	O
de	O
que	O
la	O
perturbación	O
de	O
Shh	B-Protein
#	O
¿NOMBRE	O
?	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

Patrones	O
de	O
expresión	O
de	O
Shh	B-Protein
los	O
miembros	O
de	O
la	O
cascada	O
de	O
señalización	O
no	O
fueron	O
alterados	O
,	O
y	O
el	O
procesamiento	O
de	O
Shh	B-Protein
parecía	O
normal	O
.	O

Resultados	O

Retraso	O
en	O
el	O
crecimiento	O
corporal	O
al	O
final	O
de	O
la	O
gestación	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O

Dhcr7	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
nacieron	O
en	O
las	O
proporciones	O
mendelianas	O
esperadas	O
de	O
padres	O
heterocigotos	O
,	O
pero	O
todos	O
estos	O
cachorros	O
murieron	O
dentro	O
de	O
las	O
24	O
hy	O
la	O
mayoría	O
dentro	O
de	O
las	O
14	O
h	O
posteriores	O
al	O
nacimiento	O
[	O
16	O
]	O
.	O

Al	O
nacer	O
,	O
eran	O
claramente	O
más	O
pequeños	O
que	O
tipo	B-Sequence
salvaje	I-Sequence
o	O
compañeros	O
de	O
camada	O
heterocigotos	O
.	O

Un	O
investigador	O
experimentado	O
puede	O
seleccionar	O
cachorros	O
noqueados	O
basándose	O
en	O
esto	O
junto	O
con	O
la	O
presencia	O
de	O
hipoxia	O
y	O
su	O
falta	O
de	O
movimiento	O
espontáneo	O
.	O

La	O
frecuencia	O
respiratoria	O
en	O
P0	O
Dhcr7	B-Protein
-	O
/	O
-	O
cachorros	O
fue	O
notablemente	O
más	O
lento	O
que	O
los	O
compañeros	O
de	O
camada	O
de	O
control	O
(	O
34	O
+/-	O
7	O
respiraciones	O
/	O
min	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
,	O
n	O
=	O
10	O
frente	O
a	O
.	O
92	O
+/-	O
16	O
respiraciones	O
/	O
min	O
en	O
controles	O
,	O
n	O
=	O
32	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
y	O
se	O
observó	O
que	O
la	O
respiración	O
era	O
más	O
irregular	O
y	O
superficial	O
,	O
con	O
largos	O
periodos	O
de	O
apnea	O
.	O

Para	O
determinar	O
la	O
etapa	O
de	O
gestación	O
en	O
la	O
que	O
se	O
vio	O
afectado	O
el	O
crecimiento	O
de	O
los	O
embriones	O
knockout	O
,	O
se	O
recolectaron	O
embriones	O
en	O
varias	O
etapas	O
de	O
gestación	O
y	O
se	O
compararon	O
las	O
longitudes	O
de	O
sus	O
cuerpos	O
entre	O
Dhcr7	B-Protein
-/-	O
y	O
controles	O
.	O

Un	O
aumento	O
lineal	O
en	O
la	O
longitud	O
del	O
cuerpo	O
de	O
E9	O
.	O
5	O
a	O
E19	O
.	O
5	O
en	O
los	O
embriones	O
de	O
control	O
(	O
Fig	O
.	O
1	O
)	O
.	O

No	O
hay	O
diferencias	O
significativas	O
en	O
la	O
longitud	O
del	O
cuerpo	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
se	O
observaron	O
embriones	O
heterocigóticos	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
los	O
embriones	O
knockout	O
mostraron	O
un	O
crecimiento	O
de	O
longitud	O
corporal	O
comparable	O
hasta	O
E14	O
.	O
5~E16	O
.	O
5	O
,	O
luego	O
comenzó	O
a	O
mostrar	O
un	O
aumento	O
más	O
lento	O
en	O
longitud	O
,	O
tal	O
que	O
en	O
E17	O
.	O
5	O
,	O
esto	O
fue	O
estadísticamente	O
significativo	O
(	O
18	O
,	O
87	O
+/-	O
1	O
,	O
29	O
mm	O
en	O
controles	O
,	O
n	O
=	O
15	O
en	O
comparación	O
con	O
16	O
,	O
69	O
+/-	O
1	O
,	O
05	O
mm	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
,	O
norte	O
=	O
7	O
,	O
pags	O
<	O
0	O
.	O
05	O
,	O
figura	O
.	O
1	O
)	O
.	O

Figura	O
1	O

Curvas	O
de	O
crecimiento	O
de	O
la	O
longitud	O
del	O
cuerpo	O
.	O

Crecimiento	O
de	O
la	O
longitud	O
corporal	O
vs.	O
días	O
de	O
gestación	O
es	O
como	O
se	O
muestra	O
.	O

Embriones	O
de	O
control	O
(	O
triángulos	O
rellenos	O
,	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
los	O
embriones	O
heterocigotos	O
se	O
agruparon	O
ya	O
que	O
no	O
hubo	O
diferencias	O
entre	O
estos	O
dos	O
grupos	O
)	O
y	O
los	O
embriones	O
knockout	O
(	O
círculos	O
rellenos	O
)	O
fueron	O
como	O
se	O
muestra	O
.	O

La	O
curva	O
de	O
crecimiento	O
mostró	O
un	O
aumento	O
lineal	O
desde	O
E9	O
.	O
5	O
a	O
E19	O
.	O
5	O
en	O
controles	O
,	O
pero	O
desviado	O
en	O
~E14	O
.	O
5	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

Longitudes	O
de	O
cuerpo	O
en	O
E17	O
.	O
5	O
(	O
18	O
.	O
87	O
+/-	O
1	O
.	O
29	O
mm	O
en	O
controles	O
,	O
n	O
=	O
15	O
vs	O
.	O
16	O
.	O
69	O
+/-	O
1	O
.	O
05	O
mm	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
,	O
norte	O
=	O
7	O
,	O
pags	O
<	O
0	O
.	O
05	O
)	O
,	O
E18	O
.	O
5	O
(	O
21	O
.	O
35	O
+/-	O
1	O
.	O
05	O
mm	O
en	O
controles	O
,	O
n	O
=	O
15	O
vs	O
.	O
19	O
.	O
38	O
+/-	O
0	O
.	O
9	O
mm	O
en	O
Dhcr7	B-Protein
/	O
-	O
,	O
n	O
=	O
5	O
,	O
pags	O
<	O
0	O
.	O
05	O
)	O
y	O
E19	O
.	O
5	O
(	O
23	O
.	O
4	O
+/-	O
0	O
.	O
97	O
mm	O
en	O
controles	O
,	O
n	O
=	O
13	O
vs	O
.	O
20	O
.	O
3	O
+/-	O
0	O
.	O
44	O
mm	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
,	O
norte	O
=	O
4	O
,	O
pags	O
<	O
0	O
.	O
05	O
)	O
se	O
redujeron	O
significativamente	O
,	O
en	O
comparación	O
con	O
los	O
de	O
los	O
controles	O
.	O

Los	O
resultados	O
se	O
expresan	O
como	O
media	O
+/-	O
s.	O
D	O
.	O

Dhcr7	B-Protein
-	O
/	O
-	O
los	O
embriones	O
en	O
etapas	O
tardías	O
mostraron	O
hipoplasia	O
pulmonar	O
con	O
retraso	O
en	O
el	O
desarrollo	O
sacular	O

El	O
peso	O
de	O
los	O
pulmones	O
húmedos	O
,	O
así	O
como	O
la	O
proporción	O
entre	O
el	O
peso	O
de	O
los	O
pulmones	O
y	O
el	O
cuerpo	O
,	O
fueron	O
significativamente	O
más	O
bajos	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
en	O
E18	O
.	O
5	O
en	O
comparación	O
con	O
los	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
pero	O
no	O
en	O
E13	O
.	O
5	O
(	O
Tabla	O
1	O
)	O
.	O

Tanto	O
el	O
peso	O
corporal	O
como	O
el	O
de	O
los	O
pulmones	O
se	O
redujeron	O
,	O
pero	O
los	O
pulmones	O
parecían	O
estar	O
más	O
afectados	O
.	O

Una	O
figura	O
representativa	O
de	O
embriones	O
en	O
E10	O
.	O
5	O
y	O
de	O
las	O
crías	O
al	O
nacer	O
se	O
muestra	O
en	O
la	O
Fig	O
.	O
.	O

2A	O
y	O
2B	O
.	O

tabla	O
1	O

Pesos	O
de	O
todo	O
el	O
cuerpo	O
y	O
de	O
los	O
pulmones	O
de	O
ratón	B-Taxon
embriones	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
en	O
comparación	O
con	O
Dhcr7	B-Protein
+	B-Sequence
/	O
+	B-Sequence
.	O

PC	O
,	O
peso	O
corporal	O
;	O
PV	O
,	O
peso	O
pulmonar	O
.	O

Figura	O
2	O

Tamaño	O
embrionario	O
,	O
morfología	O
pulmonar	O
e	O
histología	O
en	O
diversas	O
etapas	O
de	O
desarrollo	O
.	O

El	O
panel	O
A	O
muestra	O
el	O
tamaño	O
y	O
la	O
morfología	O
general	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
Dhcr7	B-Protein
-/-	O
(	O
-/-	O
)	O
embriones	O
en	O
E10	O
.	O
5	O
,	O
sin	O
diferencia	O
significativa	O
.	O

En	O
P0	O
,	O
las	O
crías	O
knockout	O
eran	O
significativamente	O
más	O
pequeñas	O
y	O
parecían	O
hipóxicas	O
(	O
panel	O
B	O
)	O
.	O

El	O
panel	O
C	O
muestra	O
vistas	O
dorsales	O
de	O
los	O
pulmones	O
desde	O
el	O
knockout	O
y	O
tipo	B-Sequence
salvaje	I-Sequence
en	O
E13	O
.	O
5	O
y	O
panel	O
D	O
los	O
de	O
P0	O
.	O

Examen	O
transversal	O
a	O
nivel	O
cardiopulmonar	O
en	O
E	O
20	O
.	O
5	O
(	O
antes	O
del	O
nacimiento	O
)	O
mostraron	O
una	O
tabicación	O
lobar	O
normal	O
,	O
pero	O
los	O
pulmones	O
no	O
estaban	O
animales	B-Taxon
eran	O
de	O
menor	O
tamaño	O
y	O
tenían	O
menos	O
espacio	O
en	O
el	O
saco	O
distal	O
(	O
cf	O
.	O
paneles	O
E	O
y	O
F	O
)	O
.	O

Ampliación	O
original	O
:	O
Paneles	O
A	O
y	O
C	O
,	O
2X	O
;	O
paneles	O
B	O
y	O
D	O
,	O
0	O
.	O
7X	O
;	O
E	O
y	O
F	O
,	O
2X	O
.	O

Etiquetas	O
:	O
r	O
,	O
derecha	O
;	O
l	O
,	O
izquierda	O
;	O
b	O
,	O
bronquial	O
;	O
bronquiolo	O
;	O
e	O
,	O
esófago	O
;	O
pa	O
,	O
arteria	O
pulmonar	O
;	O
ra	O
,	O
aurícula	O
derecha	O
;	O
la	O
,	O
aurícula	O
izquierda	O
;	O
rv	O
,	O
ventrículo	O
derecho	O
;	O
lv	O
,	O
ventrículo	O
izquierdo	O
.	O

Examinamos	O
los	O
pulmones	O
en	O
busca	O
de	O
anomalías	O
morfológicas	O
graves	O
.	O

La	O
organogénesis	O
general	O
de	O
los	O
pulmones	O
se	O
conservó	O
en	O
Dhcr7	B-Protein
/	O
-	O
cachorros	O
;	O
cuatro	O
lóbulos	O
del	O
pulmón	O
derecho	O
y	O
un	O
solo	O
lóbulo	O
izquierdo	O
que	O
flanqueaba	O
el	O
corazón	O
se	O
vieron	O
fácilmente	O
en	O
el	O
examen	O
externo	O
al	O
nacer	O
(	O
Fig	O
.	O
2D	O
)	O
.	O

Examen	O
de	O
lobación	O
en	O
E13	O
.	O
5	O
también	O
mostró	O
una	O
anatomía	O
macroscópica	O
comparable	O
(	O
Fig	O
.	O
2C	O
)	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
embriones	O
knockout	O
.	O

Análisis	O
histológicos	O
de	O
las	O
estructuras	O
cardiopulmonares	O
en	O
E20	O
.	O
5	O
,	O
tomada	O
justo	O
antes	O
del	O
nacimiento	O
para	O
evitar	O
artefactos	O
por	O
falta	O
de	O
inflación	O
pulmonar	O
,	O
también	O
confirmó	O
un	O
desarrollo	O
anatómico	O
macroscópico	O
normal	O
(	O
Fig	O
.	O
2E	O
y	O
2F	O
)	O
.	O

Además	O
,	O
no	O
se	O
identificaron	O
defectos	O
cardíacos	O
y	O
esto	O
se	O
confirmó	O
mediante	O
análisis	O
histológicos	O
más	O
detallados	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
a	O
pesar	O
de	O
la	O
hipoxia	O
evidente	O
que	O
se	O
observa	O
con	O
frecuencia	O
en	O
el	O
nacimiento	O
de	O
las	O
crías	O
knockout	O
,	O
no	O
se	O
observaron	O
anomalías	O
estructurales	O
cardíacas	O
importantes	O
que	O
explicaran	O
este	O
fenotipo	O
.	O

No	O
se	O
observaron	O
diferencias	O
morfológicas	O
distinguibles	O
entre	O
Dhcr7	B-Protein
-	O
/	O
-	O
y	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
en	O
E10	O
.	O
5	O
,	O
E13	O
.	O
5	O
,	O
E14	O
.	O
5	O
y	O
E16	O
.	O
5	O
con	O
aumentos	O
bajos	O
(	O
10X	O
)	O
o	O
altos	O
(	O
40X	O
)	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
a-h	O
,	O
datos	O
para	O
E10.5	O
y	O
E13.5	O
no	O
mostrados	O
)	O
.	O

Sin	O
embargo	O
,	O
a	O
partir	O
de	O
E17	O
.	O
5	O
en	O
adelante	O
,	O
los	O
pulmones	O
de	O
embriones	O
knockout	O
parecían	O
tener	O
menos	O
espacio	O
sacular	O
y	O
relativamente	O
más	O
mesénquima	O
en	O
comparación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
I-x	O
)	O
.	O

Pulmones	O
de	O
control	O
animales	B-Taxon
mostró	O
una	O
progresión	O
normal	O
con	O
formación	O
de	O
estructuras	O
en	O
forma	O
de	O
saco	O
,	O
los	O
precursores	O
de	O
los	O
alvéolos	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
A	O
:	O
i	O
,	O
m	O
,	O
q	O
y	O
u	O
)	O
.	O

En	O
pulmones	O
de	O
embriones	O
knockout	O
,	O
se	O
produjo	O
la	O
expansión	O
de	O
los	O
túbulos	O
epiteliales	O
pero	O
se	O
retrasó	O
significativamente	O
(	O
Fig	O
.	O
3	O
,	O
cf	O
.	O
panel	O
A	O
:	O
j	O
,	O
n	O
,	O
r	O
,	O
v	O
con	O
i	O
,	O
m	O
,	O
q	O
y	O
u	O
)	O
.	O

Mediciones	O
morfométricas	O
de	O
secciones	O
de	O
pulmón	O
en	O
E17	O
.	O
5	O
,	O
E18	O
.	O
5	O
,	O
E20	O
.	O
5	O
y	O
en	O
los	O
pulmones	O
de	O
los	O
recién	O
nacidos	O
mostró	O
que	O
la	O
proporción	O
del	O
área	O
del	O
espacio	O
del	O
saco	O
terminal	O
se	O
redujo	O
significativamente	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
pulmones	O
,	O
comparados	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
(	O
Fig	O
.	O
3	O
,	O
panel	O
B	O
)	O
.	O

El	O
mesénquima	O
intersticial	O
parecía	O
más	O
grueso	O
y	O
los	O
pulmones	O
tenían	O
menos	O
tabiques	O
en	O
comparación	O
con	O
los	O
pulmones	O
de	O
control	O
.	O

``	O
Este	O
``	O
''	O
engrosamiento	O
''	O
''	O
de	O
los	O
alvéolos	O
puede	O
explicar	O
la	O
hipoxia	O
que	O
se	O
observa	O
con	O
frecuencia	O
en	O
''	O
Dhcr7	B-Protein
-	O
/	O
-	O
crías	O
al	O
nacer	O
.	O

figura	O
3	O

Análisis	O
histológicos	O
de	O
pulmones	O
en	O
varias	O
etapas	O
embrionarias	O
.	O

El	O
panel	O
A	O
indica	O
secciones	O
de	O
pulmón	O
teñidas	O
con	O
H	O
y	O
E	O
,	O
y	O
tomadas	O
en	O
varias	O
etapas	O
gestacionales	O
como	O
se	O
indica	O
.	O

Las	O
dos	O
primeras	O
columnas	O
tienen	O
un	O
aumento	O
menor	O
(	O
10X	O
)	O
y	O
las	O
dos	O
últimas	O
columnas	O
tienen	O
un	O
aumento	O
mayor	O
(	O
40X	O
)	O
.	O

Las	O
columnas	O
primera	O
y	O
tercera	O
son	O
secciones	O
representativas	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
embriones	O
y	O
la	O
segunda	O
y	O
cuarta	O
columnas	O
de	O
embriones	O
knockout	O
(	O
-	O
/	O
-	O
)	O
.	O

No	O
se	O
observaron	O
diferencias	O
en	O
E14	O
.	O
5	O
o	O
E16	O
.	O
5	O
(	O
panel	O
A	O
,	O
a-h	O
)	O
.	O

Se	O
observaron	O
diferencias	O
significativas	O
a	O
partir	O
de	O
E17	O
.	O
5	O
en	O
adelante	O
(	O
panel	O
A	O
,	O
i-x	O
)	O
.	O

Los	O
túbulos	O
distales	O
mostraron	O
dilatación	O
y	O
adelgazamiento	O
del	O
mesénquima	O
,	O
con	O
progresión	O
de	O
tabicación	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
(	O
panel	O
A	O
,	O
i	O
,	O
myq	O
)	O
,	O
mientras	O
que	O
los	O
pulmones	O
knockout	O
mostraron	O
menos	O
estructuras	O
saculares	O
y	O
más	O
mesénquima	O
(	O
panel	O
A	O
,	O
j	O
,	O
nyr	O
)	O
.	O

A	O
mayores	O
aumentos	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
Se	O
observaron	O
pulmones	O
(	O
panel	O
A	O
,	O
k	O
,	O
o	O
y	O
s	O
)	O
,	O
prealvéolos	O
en	O
desarrollo	O
y	O
mesénquima	O
adelgazado	O
(	O
puntas	O
de	O
flecha	O
)	O
,	O
pero	O
las	O
secciones	O
de	O
embriones	O
knockout	O
mostraron	O
un	O
retraso	O
en	O
esta	O
secuencia	O
de	O
desarrollo	O
(	O
panel	O
A	O
,	O
l	O
,	O
p	O
y	O
t	O
)	O
.	O

Al	O
nacer	O
,	O
los	O
pulmones	O
de	O
las	O
crías	O
knockout	O
mostraron	O
una	O
tabicación	O
deficiente	O
y	O
un	O
mesénquima	O
de	O
paredes	O
gruesas	O
(	O
panel	O
A	O
,	O
x	O
,	O
puntas	O
de	O
flecha	O
)	O
.	O

Etiquetas	O
:	O
de	O
,	O
epitelio	O
distal	O
;	O
m	O
,	O
mesénquima	O
;	O
PA	O
,	O
arteria	O
pulmonar	O
;	O
a	O
,	O
pre	O
-	O
alvéolos	O
;	O
b	O
,	O
bronquios	O
.	O

El	O
panel	O
B	O
muestra	O
los	O
análisis	O
morfométricos	O
de	O
los	O
espacios	O
del	O
saco	O
terminal	O
pulmonar	O
en	O
los	O
pulmones	O
en	O
varias	O
etapas	O
gestacionales	O
.	O

Se	O
observó	O
una	O
reducción	O
significativa	O
en	O
el	O
espacio	O
del	O
saco	O
terminal	O
de	O
E17	O
.	O
5	O
en	O
adelante	O
.	O

Los	O
resultados	O
se	O
expresan	O
como	O
media	O
+/-	O
s.	O
D	O
.	O

atenuado	O
célula	B-Cell
proliferación	O
al	O
final	O
de	O
la	O
gestación	O
Dhcr7	B-Protein
-	O
/	O
-	O
pulmones	O

¿La	O
pérdida	O
de	O
la	O
normalidad	O
colesterol	B-Chemical
biosíntesis	O
conducen	O
a	O
anomalías	O
de	O
célula	B-Cell
proliferación	O
/	O
división	O
o	O
célula	B-Cell
muerte	O
?	O

Célula	B-Cell
la	O
proliferación	O
fue	O
examinada	O
por	O
inmunotinción	O
para	O
PCNA	B-Protein
y	O
también	O
por	O
BrdU	O
incorporación	B-Sequence
.	O

Ambas	O
cosas	O
PCNA	B-Protein
y	O
tinción	O
con	O
BrdU	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
los	O
pulmones	O
inactivados	O
en	O
etapas	O
gestacionales	O
tempranas	O
(	O
E13.5	O
y	O
E14.5	O
)	O
mostraron	O
patrones	O
comparables	O
(	O
Fig	O
.	O
4	O
,	O
paneles	O
A-D	O
)	O
.	O

Sin	O
embargo	O
,	O
una	O
clara	O
reducción	O
de	O
PCNA	B-Protein
y	O
el	O
marcaje	O
de	O
BrdU	O
se	O
visualizó	O
en	O
pulmones	O
distales	O
de	O
embriones	O
knockout	O
en	O
etapas	O
gestacionales	O
tardías	O
(	O
E18.5	O
y	O
E20.5	O
,	O
Fig	O
.	O
4	O
,	O
paneles	O
E-H	O
)	O
.	O

atenuado	O
PCNA	B-Protein
También	O
se	O
observó	O
marcaje	O
en	O
corazones	O
knockout	O
a	O
término	O
(	O
Fig	O
.	O
4	O
,	O
cf	O
.	O
Paneles	O
I	O
y	O
J	O
)	O
.	O

Cuando	O
los	O
pulmones	O
se	O
tiñeron	O
para	O
pHH3	O
,	O
un	O
marcador	O
de	O
actividad	O
célula	B-Cell
división	O
,	O
se	O
observó	O
una	O
clara	O
reducción	O
de	O
la	O
expresión	O
de	O
pHH3	O
en	O
el	O
epitelio	O
del	O
pulmón	O
inactivado	O
en	O
E20	O
.	O
5	O
pero	O
no	O
en	O
E14	O
.	O
5	O
(	O
Fig	O
.	O
4	O
,	O
paneles	O
K	O
,	O
L	O
,	O
O	O
y	O
P	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
utilizando	O
el	O
ensayo	O
TUNEL	O
,	O
no	O
se	O
observaron	O
diferencias	O
aparentes	O
en	O
célula	B-Cell
Se	O
observaron	O
tasas	O
de	O
apoptosis	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
pulmones	O
knockout	O
en	O
E18	O
.	O
5	O
(	O
Fig	O
.	O
4	O
,	O
cf	O
.	O
paneles	O
M	O
y	O
N	O
)	O
.	O

Así	O
,	O
en	O
las	O
últimas	O
etapas	O
de	O
la	O
gestación	O
,	O
célula	B-Cell
la	O
proliferación	O
/	O
división	O
se	O
vio	O
afectada	O
en	O
embriones	O
knockout	O
sin	O
aumento	O
en	O
célula	B-Cell
tasas	O
de	O
mortalidad	O

Figura	O
4	O

Análisis	O
de	O
célula	B-Cell
proliferación	O
,	O
célula	B-Cell
división	O
y	O
célula	B-Cell
muerte	O
.	O

Célula	B-Cell
proliferación	O
(	O
PCNA	B-Protein
:	O
paneles	O
A	O
,	O
B	O
,	O
E	O
y	O
F	O
;	O
BrdU	O
:	O
paneles	O
C	O
,	O
D	O
,	O
G	O
y	O
H	O
)	O
,	O
célula	B-Cell
división	O
(	O
pHH3	O
:	O
paneles	O
K	O
,	O
L	O
,	O
O	O
y	O
P	O
)	O
y	O
célula	B-Cell
muerte	O
(	O
TUNEL	O
:	O
paneles	O
M	O
y	O
N	O
)	O
se	O
analizaron	O
mediante	O
inmunotinción	O
en	O
secciones	O
de	O
pulmón	O
en	O
etapas	O
gestacionales	O
tempranas	O
y	O
tardías	O
.	O

Ambas	O
cosas	O
PCNA	B-Protein
y	O
BrdU	O
etiquetados	O
células	B-Cell
en	I-Cell
las	I-Cell
regiones	I-Cell
epiteliales	I-Cell
y	I-Cell
mesenquimales	I-Cell
eran	O
comparables	O
en	O
las	O
primeras	O
etapas	O
(	O
E14	O
.	O
5	O
para	O
PCNA	B-Protein
y	O
E13	O
.	O
5	O
para	O
BrdU	O
)	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
pulmones	O
knockout	O
(	O
-	O
/	O
-	O
)	O
.	O

Positivamente	O
teñido	O
células	B-Cell
en	O
pulmones	O
distales	O
en	O
etapa	O
tardía	O
(	O
E20	O
.	O
5	O
para	O
PCNA	B-Protein
y	O
E18	O
.	O
5	O
para	O
BrdU	O
)	O
de	O
pulmones	O
knockout	O
se	O
redujeron	O
notablemente	O
,	O
en	O
comparación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
.	O

PCNA	B-Protein
el	O
marcaje	O
del	O
músculo	O
cardíaco	O
también	O
se	O
atenuó	O
en	O
embriones	O
knockout	O
en	O
E20	O
.	O
5	O
(	O
cf	O
.	O
paneles	O
I	O
y	O
J	O
)	O
.	O

No	O
se	O
observaron	O
diferencias	O
aparentes	O
en	O
la	O
inmunotinción	O
de	O
TUNEL	O
en	O
secciones	O
de	O
pulmón	O
en	O
E18	O
.	O
5	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
nocaut	O
.	O

La	O
inmunotinción	O
de	O
pHH3	O
fue	O
comparable	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
pulmones	O
knockout	O
en	O
E14	O
.	O
5	O
,	O
y	O
los	O
pulmones	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
en	O
E20	O
.	O
5	O
mostró	O
un	O
alto	O
índice	O
de	O
positividad	O
células	B-Cell
,	O
mientras	O
que	O
los	O
pulmones	O
del	O
knockout	O
mostraron	O
un	O
patrón	O
de	O
tinción	O
aparentemente	O
reducido	O
.	O

Tenga	O
en	O
cuenta	O
la	O
división	O
células	B-Cell
son	O
principalmente	O
epiteliales	O
.	O

Ampliación	O
original	O
:	O
A-D	O
y	O
G-N	O
son	O
20X	O
;	O
E	O
,	O
F	O
,	O
O	O
y	O
P	O
son	O
40X	O
.	O

esterol	B-Chemical
contenido	O
de	O
los	O
pulmones	O
en	O
desarrollo	O
en	O
Dhcr7	B-Protein
ratones	O
deficientes	O

Niveles	O
marcadamente	O
elevados	O
de	O
7	O
-	O
DHC	O
/	O
8	O
-	O
DHC	O
y	O
cuerpo	O
reducido	O
colesterol	B-Chemical
niveles	O
han	O
sido	O
reportados	O
previamente	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
P0	O
ratones	B-Taxon
[	O
16	O
,	O
17	O
]	O
.	O

una	O
cantidad	O
significativa	O
de	O
colesterol	B-Chemical
fue	O
detectable	O
en	O
los	O
pulmones	O
de	O
Dhcr7	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
,	O
que	O
comprende	O
~	O
60	O
%	O
y	O
~	O
30	O
%	O
del	O
tejido	O
total	O
esteroles	B-Chemical
en	O
E13	O
.	O
5	O
y	O
neonato	O
,	O
respectivamente	O
.	O

A	O
diferencia	O
de	O
la	O
duplicación	O
de	O
colesterol	B-Chemical
en	O
los	O
pulmones	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
embriones	O
(	O
1	O
,	O
82	O
mg	O
/	O
g	O
de	O
tejido	O
en	O
E13	O
,	O
5	O
a	O
3	O
,	O
55	O
mg	O
/	O
g	O
de	O
tejido	O
en	O
P0	O
)	O
,	O
colesterol	B-Chemical
contenido	O
en	O
los	O
pulmones	O
de	O
Dhcr7	B-Protein
los	O
embriones	O
nulos	O
permanecieron	O
en	O
niveles	O
bajos	O
casi	O
constantes	O
entre	O
E13	O
.	O
5	O
y	O
P0	O
etapas	O
gestacionales	O
(	O
Fig	O
.	O
5	O
)	O
.	O

Hubo	O
un	O
aumento	O
progresivo	O
de	O
7-DHC	O
y	O
8-DHC	O
;	O
el	O
último	O
se	O
genera	O
como	O
una	O
isomerización	O
espontánea	O
del	O
primero	O
.	O

Total	O
esteroles	B-Chemical
al	O
nacer	O
se	O
redujeron	O
en	O
los	O
pulmones	O
de	O
los	O
Dhcr7	B-Protein
nulo	O
ratones	B-Taxon
,	O
pero	O
solo	O
fueron	O
inferiores	O
en	O
~	O
30	O
%	O
(	O
Fig	O
.	O
5	O
,	O
ver	O
valores	O
para	O
P0	O
ratones	B-Taxon
)	O
.	O

Figura	O
5	O

esterol	B-Chemical
Análisis	O
de	O
pulmones	O
embrionarios	O
.	O

esterol	B-Chemical
contenidos	O
,	O
incluyendo	O
colesterol	B-Chemical
(	O
barras	O
negras	O
)	O
y	O
7DHC/8DHC	O
(	O
barras	O
blancas	O
)	O
,	O
fueron	O
cuantificados	O
por	O
GC-MS	O
en	O
los	O
pulmones	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
embriones	O
knockout	O
(	O
-	O
/	O
-	O
)	O
.	O

Los	O
resultados	O
se	O
expresan	O
como	O
media	O
+/-	O
s.	O
d	O
y	O
el	O
número	O
de	O
pulmones	O
analizados	O
es	O
el	O
indicado	O
.	O

Total	O
esteroles	B-Chemical
fueron	O
más	O
bajos	O
en	O
todas	O
las	O
etapas	O
en	O
los	O
pulmones	O
knockout	O
,	O
casi	O
sin	O
aumento	O
en	O
colesterol	B-Chemical
contenido	O
con	O
el	O
tiempo	O
(	O
barras	O
negras	O
)	O
,	O
pero	O
hubo	O
un	O
incremento	O
progresivo	O
en	O
el	O
precursor	O
esteroles	B-Chemical
,	O
7DHC	O
/	O
8DHC	O
(	O
barras	O
abiertas	O
)	O
,	O
con	O
gestación	O
creciente	O
.	O

Colesterol	B-Chemical
es	O
absolutamente	O
necesario	O
para	O
hormona	B-Chemical
esteroide	I-Chemical
síntesis	O
por	O
las	O
glándulas	O
suprarrenales	O
.	O

La	O
insuficiencia	O
suprarrenal	O
,	O
como	O
se	O
ha	O
informado	O
en	O
algunos	O
casos	O
graves	O
de	O
pacientes	O
con	O
SLOS	O
,	O
podría	O
ser	O
responsable	O
de	O
la	O
hipoplasia	O
pulmonar	O
y	O
la	O
letalidad	O
perinatal	O
[	O
30	O
]	O
.	O

esteroides	B-Chemical
,	O
pero	O
particularmente	O
corticosteroides	B-Chemical
,	O
son	O
necesarios	O
para	O
la	O
maduración	O
pulmonar	O
,	O
especialmente	O
la	O
síntesis	O
y	O
secreción	O
de	O
surfactante	B-Chemical
componentes	O
[	O
31	O
]	O
.	O

Determinamos	O
el	O
plasma	O
corticosterona	B-Chemical
niveles	O
en	O
P0	O
ratones	B-Taxon
dentro	O
de	O
las	O
12	O
horas	O
del	O
nacimiento	O
.	O

Tipo	B-Sequence
salvaje	I-Sequence
P0	O
ratones	B-Taxon
tenido	O
corticosterona	B-Chemical
niveles	O
de	O
158	O
+/-	O
50	O
ng	O
/	O
ml	O
(	O
n	O
=	O
11	O
)	O
,	O
en	O
comparación	O
con	O
225	O
+/-	O
50	O
ng	O
/	O
ml	O
(	O
n	O
=	O
7	O
,	O
p	O
<	O
0,01	O
)	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
P0	O
ratones	B-Taxon
.	O

Por	O
lo	O
tanto	O
,	O
la	O
corticosterona	B-Chemical
niveles	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
no	O
disminuyeron	O
,	O
sino	O
que	O
aumentaron	O
en	O
~40	O
%	O
.	O

Sin	O
embargo	O
,	O
dado	O
que	O
estos	O
P0	O
ratones	B-Taxon
estaban	O
muriendo	O
,	O
tal	O
vez	O
este	O
aumento	O
fue	O
subóptimo	O
dado	O
el	O
estrés	O
.	O

Sin	O
embargo	O
,	O
una	O
falta	O
absoluta	O
de	O
corticosterona	B-Chemical
no	O
estaba	O
presente	O
en	O
estos	O
cachorros	O
knockout	O
.	O

Para	O
descartar	O
aún	O
más	O
cualquier	O
efecto	O
de	O
corticosterona	B-Chemical
deficiencia	O
en	O
la	O
inmadurez	O
pulmonar	O
,	O
examinamos	O
los	O
pulmones	O
para	O
proteína	B-Chemical
tensioactiva	I-Chemical
expresión	O
.	O

Proteína	B-Protein
C	I-Protein
tensioactiva	I-Protein
,	O
según	O
lo	O
determinado	O
por	O
IHC	O
,	O
fue	O
comparable	O
en	O
secciones	O
de	O
pulmón	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
o	O
Dhcr7	B-Protein
embriones	O
nulos	O
en	O
E18	O
.	O
5	O
o	O
en	O
E20	O
.	O
5	O
edades	O
gestacionales	O
(	O
Fig	O
.	O
6	O
,	O
panel	O
A	O
)	O
.	O

Análisis	O
del	O
norte	O
para	O
SP-A	B-Protein
,	O
SP-B	B-Protein
,	O
SP-C	B-Protein
o	O
SP-D	B-Protein
no	O
mostró	O
diferencias	O
significativas	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
Dhcr7	B-Protein
nulo	O
ratones	B-Taxon
a	O
término	O
(	O
Fig	O
.	O
6	O
,	O
panel	O
B	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
proteína	B-Chemical
tensioactiva	I-Chemical
expresión	O
no	O
fue	O
alterada	O
por	O
Dhcr7	B-Protein
deficiencia	O

Figura	O
6	O

Proteína	B-Chemical
surfactante	I-Chemical
expresión	O
en	O
los	O
pulmones	O
.	O

El	O
panel	O
A	O
muestra	O
los	O
patrones	O
de	O
inmunotinción	O
para	O
SP-C	B-Protein
en	O
pulmones	O
en	O
E18	O
.	O
5	O
y	O
E20	O
.	O
5	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
embriones	O
knockout	O
(	O
-	O
/	O
-	O
)	O
.	O

No	O
hay	O
diferencias	O
significativas	O
en	O
los	O
patrones	O
de	O
SP-C	B-Protein
las	O
tinciones	O
eran	O
evidentes	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
pulmones	O
ciegos	O
(	O
panel	O
A	O
,	O
a	O
-	O
d	O
)	O
.	O

Tenga	O
en	O
cuenta	O
que	O
los	O
túbulos	O
epiteliales	O
subdesarrollados	O
en	O
los	O
pulmones	O
knockout	O
también	O
expresaron	O
SP-C	B-Protein
(	O
panel	O
A	O
,	O
b	O
y	O
d	O
,	O
puntas	O
de	O
flecha	O
)	O
,	O
lo	O
que	O
indica	O
una	O
diferenciación	O
normal	O
de	O
AEC	O
de	O
tipo	O
II	O
.	O

Ampliación	O
original	O
:	O
10X	O
.	O

El	O
panel	O
B	O
,	O
panel	O
de	O
la	O
izquierda	O
,	O
muestra	O
un	O
resultado	O
representativo	O
de	O
los	O
análisis	O
Northern	O
del	O
total	O
ARN	B-Sequence
desde	O
tipo	B-Sequence
salvaje	I-Sequence
heterocigotos	O
y	O
pulmones	O
knockout	O
P0	O
para	O
SP-A	B-Protein
,	O
SP-B	B-Protein
,	O
SP-C	B-Protein
y	O
SP-D	B-Protein
expresión	O
.	O

Los	O
análisis	O
de	O
densitometría	O
mostraron	O
la	O
expresión	O
relativa	O
(	O
n	O
=	O
3	O
,	O
media	O
+/-	O
s	O
.	O
d	O
.	O
)	O
de	O
estos	O
ARNm	B-Chemical
de	I-Chemical
proteína	I-Chemical
tensioactiva	I-Chemical
no	O
fueron	O
significativamente	O
diferentes	O
entre	O
estos	O
tres	O
genotipos	B-Sequence
.	O

Dhcr7	B-Protein
-	O
/	O
-	O
los	O
pulmones	O
mostraron	O
una	O
diferenciación	O
anormal	O
de	O
tipo	O
I	O
alveolar	O
células	B-Cell
epiteliales	I-Cell
(	O
AEC	O
)	O

En	O
E20	O
.	O
5	O
,	O
el	O
pulmón	O
distal	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
Los	O
embriones	O
consistían	O
en	O
estructuras	O
saculares	O
revestidas	O
por	O
AEC	O
planas	O
de	O
tipo	O
I	O
y	O
por	O
cuboides	O
.	O
surfactante	B-Chemical
-	O
que	O
producen	O
AEC	O
de	O
tipo	O
II	O
(	O
Fig	O
.	O
7A	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
la	O
formación	O
de	O
estos	O
sáculos	O
típicos	O
se	O
vio	O
afectada	O
en	O
Dhcr7	B-Protein
pulmones	O
deficientes	O
.	O

En	O
cambio	O
,	O
estas	O
estructuras	O
saculares	O
estaban	O
revestidas	O
por	O
un	O
epitelio	O
cilíndrico	O
bajo	O
que	O
carecía	O
de	O
epitelio	O
tipo	O
I	O
aplanado	O
.	O
células	B-Cell
con	O
la	O
presencia	O
de	O
muchos	O
túbulos	O
epiteliales	O
no	O
desarrollados	O
o	O
detenidos	O
(	O
Fig	O
.	O
7B	O
)	O
.	O

En	O
consonancia	O
con	O
la	O
alteración	O
de	O
la	O
diferenciación	O
de	O
las	O
AEC	O
de	O
tipo	O
I	O
,	O
se	O
produjo	O
una	O
drástica	O
reducción	O
de	O
la	O
expresión	O
de	O
T1	B-Protein
alfa	I-Protein
,	O
un	O
membrana	B-GENE
apical	I-GENE
proteína	B-Chemical
marcador	O
de	O
AEC	O
de	O
pulmón	O
tipo	O
I	O
(	O
Fig	O
.	O
7	O
,	O
cf	O
.	O
paneles	O
C	O
y	O
D	O
)	O
.	O

Disminución	O
de	O
la	O
inmunotinción	O
para	O
AQP5	B-Protein
,	O
otro	O
marcador	O
AEC	O
de	O
tipo	O
I	O
,	O
también	O
se	O
observó	O
en	O
Dhcr7	B-Protein
pulmones	O
deficientes	O
en	O
E20	O
.	O
5	O
,	O
en	O
comparación	O
con	O
los	O
pulmones	O
de	O
control	O
(	O
Fig	O
.	O
7	O
,	O
cf	O
.	O
paneles	O
E	O
y	O
F	O
)	O
.	O

Megalín	B-Protein
,	O
a	O
receptor	B-Protein
de	I-Protein
lipoproteínas	I-Protein
de	I-Protein
baja	I-Protein
densidad	I-Protein
(	O
LDLR	B-Protein
)	O
gene	B-Sequence
miembro	O
de	O
la	O
familia	O
,	O
se	O
expresa	O
por	O
embrión	O
células	B-Cell
epiteliales	I-Cell
y	O
puede	O
funcionar	O
como	O
endocítica	O
Shh	B-Protein
receptor	O
[	O
32	O
]	O
.	O

Megalín	B-Protein
fue	O
altamente	O
expresada	O
en	O
el	O
epitelio	O
distal	O
en	O
E20	O
.	O
5	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
,	O
así	O
como	O
AEC	O
tipo	O
I	O
que	O
recubren	O
los	O
sáculos	O
desarrollados	O
(	O
Fig	O
.	O
7G	O
)	O
.	O

En	O
cambio	O
,	O
aunque	O
megalín	B-Protein
La	O
tinción	O
se	O
detectó	O
en	O
sáculos	O
en	O
desarrollo	O
en	O
pulmones	O
embrionarios	O
knockout	O
,	O
su	O
expresión	O
se	O
limitó	O
a	O
cuboides	O
indiferenciados	O
.	O
células	B-Cell
(	O
Fig	O
.	O
7H	O
)	O
,	O
lo	O
que	O
indica	O
además	O
un	O
retraso	O
en	O
la	O
diferenciación	O
de	O
las	O
AEC	O
de	O
tipo	O
I	O
en	O
los	O
pulmones	O
inactivados	O
.	O

Figura	O
7	O

Caracterización	O
de	O
la	O
diferenciación	O
de	O
las	O
AECs	O
tipo	O
I	O
.	O

Los	O
sáculos	O
distales	O
normales	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
a	O
corto	O
plazo	O
(	O
E20	O
.	O
5	O
)	O
mostró	O
típico	O
tipo	O
I	O
(	O
t1	O
)	O
y	O
tipo	O
II	O
(	O
t2	O
)	O
células	B-Cell
epiteliales	I-Cell
panel	O
A	O
,	O
puntas	O
de	O
flecha	O
)	O
,	O
pero	O
los	O
pulmones	O
eliminados	O
(	O
-	O
/	O
-	O
)	O
de	O
los	O
compañeros	O
de	O
camada	O
mostraron	O
sáculos	O
menos	O
desarrollados	O
revestidos	O
por	O
columnas	O
células	B-Cell
epiteliales	I-Cell
(	O
panel	O
B	O
,	O
puntas	O
de	O
flecha	O
negras	O
)	O
,	O
con	O
túbulos	O
parcialmente	O
detenidos	O
en	O
el	O
pulmón	O
distal	O
(	O
panel	O
B	O
,	O
puntas	O
de	O
flecha	O
verdes	O
)	O
.	O

Inmunotinción	O
para	O
tipo	O
I	O
célula	B-Cell
marcadores	O
T1	B-Protein
alfa	I-Protein
y	O
AQP5	B-Protein
demostró	O
una	O
tinción	O
intensa	O
en	O
plano	O
células	B-Cell
epiteliales	I-Cell
en	I-Cell
pulmones	I-Cell
de	I-Cell
tipo	I-Cell
salvaje	I-Cell
en	O
E20	O
.	O
5	O
(	O
paneles	O
C	O
y	O
E	O
,	O
puntas	O
de	O
flecha	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
en	O
los	O
pulmones	O
de	O
compañeros	O
de	O
camada	O
noqueados	O
,	O
T1	B-Protein
alfa	I-Protein
y	O
AQP5	B-Protein
la	O
tinción	O
disminuyó	O
drásticamente	O
(	O
paneles	O
D	O
y	O
F	O
,	O
puntas	O
de	O
flecha	O
)	O
.	O

Megalín	B-Protein
expresión	O
(	O
Mega	B-Protein
)	O
fue	O
detectado	O
en	O
la	O
vía	O
aérea	O
células	B-Cell
epiteliales	I-Cell
,	O
pero	O
no	O
en	O
el	O
bronquiolo	O
proximal	O
células	B-Cell
epiteliales	I-Cell
(	I-Cell
datos	I-Cell
no	I-Cell
mostrados	I-Cell
)	I-Cell
en	I-Cell
los	I-Cell
pulmones	I-Cell
de	O
ambos	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
nocaut	O
en	O
E20	O
.	O
5	O
.	O

el	O
alargado	O
megalín	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
epiteliales	I-Cell
,	O
que	O
recubren	O
los	O
sacculi	O
normalmente	O
desarrollados	O
,	O
eran	O
fácilmente	O
evidentes	O
en	O
muchas	O
áreas	O
de	O
la	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
.	O

En	O
cambio	O
,	O
la	O
terminal	O
células	B-Cell
epiteliales	I-Cell
teñido	O
positivamente	O
por	O
megalín	B-Protein
anticuerpos	B-GENE
en	O
los	O
pulmones	O
knockout	O
estaban	O
compuestos	O
principalmente	O
de	O
cuboides	O
indiferenciados	O
células	B-Cell
(	O
compare	O
las	O
puntas	O
de	O
flecha	O
en	O
G	O
y	O
H	O
)	O
.	O

Aumento	O
original	O
:	O
A	O
,	O
B	O
,	O
G	O
y	O
H	O
son	O
60X	O
,	O
C-F	O
son	O
40X	O
.	O

Retraso	O
en	O
el	O
desarrollo	O
vascular	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
pulmones	O

Existe	O
una	O
estrecha	O
relación	O
entre	O
el	O
desarrollo	O
de	O
los	O
vasos	O
sanguíneos	O
y	O
el	O
desarrollo	O
estructural	O
de	O
los	O
pulmones	O
.	O

En	O
etapas	O
posteriores	O
del	O
desarrollo	O
pulmonar	O
,	O
el	O
desarrollo	O
cronometrado	O
del	O
lecho	O
capilar	O
es	O
esencial	O
para	O
la	O
formación	O
de	O
intercambio	O
gaseoso	O
alveolar	O
maduro	O
,	O
con	O
una	O
pérdida	O
de	O
mesénquima	O
que	O
separa	O
los	O
lechos	O
capilares	O
y	O
las	O
AEC	O
[	O
19	O
]	O
.	O

En	O
Dhcr7	B-Protein
-	O
/	O
-	O
pulmones	O
en	O
etapas	O
gestacionales	O
tardías	O
,	O
la	O
abundancia	O
relativa	O
de	O
mesénquima	O
fue	O
consistente	O
con	O
la	O
detención	O
general	O
en	O
la	O
saculación	O
.	O

Para	O
investigar	O
si	O
la	O
saculación	O
pulmonar	O
retrasada	O
también	O
implicó	O
el	O
desarrollo	O
anormal	O
de	O
vasos	O
sanguíneos	O
,	O
la	O
inmunotinción	O
para	O
alfa	O
-	O
isoforma	B-Sequence
de	O
caveolina	B-Protein
-	I-Protein
1	I-Protein
(	O
cav	O
-	O
1	O
alfa	O
)	O
y	O
molecular	B-Protein
de	I-Protein
adhesión	I-Protein
de	I-Protein
células	I-Protein
endoteliales	I-Protein
de	I-Protein
plaquetas	I-Protein
(	O
PECAM	B-Protein
-	I-Protein
1	I-Protein
)	O
se	O
realizaron	O
en	O
secciones	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
Dhcr7	B-Protein
-	O
/	O
-	O
pulmones	O
.	O

En	O
el	O
pulmón	O
en	O
desarrollo	O
,	O
cav-1	O
alfa	O
se	O
expresa	O
estrictamente	O
en	O
el	O
endotelio	O
de	O
los	O
vasos	O
sanguíneos	O
y	O
capilares	O
en	O
desarrollo	O
.	O

Cav-1	O
alfa	O
está	O
presente	O
en	O
las	O
AEC	O
de	O
tipo	O
I	O
diferenciadas	O
terminalmente	O
,	O
pero	O
no	O
es	O
detectable	O
en	O
sus	O
progenitores	O
ni	O
en	O
las	O
AEC	O
de	O
tipo	O
II	O
[	O
33	O
]	O
.	O

En	O
E14	O
.	O
5	O
,	O
tanto	O
el	O
epitelio	O
como	O
el	O
mesénquima	O
fueron	O
negativos	O
para	O
la	O
tinción	O
de	O
cav-1	O
alfa	O
,	O
y	O
se	O
detectó	O
cav-1	O
alfa	O
en	O
los	O
vasos	O
sanguíneos	O
y	O
capilares	O
en	O
desarrollo	O
,	O
sin	O
que	O
se	O
observaran	O
diferencias	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
Dhcr7	B-Protein
-	O
/	O
-	O
pulmones	O
(	O
Fig	O
.	O
8	O
,	O
paneles	O
A	O
y	O
B	O
)	O
.	O

La	O
inmunotinción	O
de	O
Cav-1	O
alfa	O
demostró	O
que	O
el	O
desarrollo	O
vascular	O
procedía	O
rápidamente	O
durante	O
las	O
etapas	O
saculares	O
en	O
pulmones	O
normales	O
(	O
E17.5	O
y	O
E20.5	O
)	O
.	O

En	O
pulmones	O
normales	O
a	O
corto	O
plazo	O
(	O
E20.5	O
)	O
,	O
se	O
observó	O
una	O
extensa	O
red	O
vascular	O
,	O
asociada	O
con	O
tabiques	O
marcadamente	O
adelgazados	O
de	O
alvéolos	O
bien	O
desarrollados	O
y	O
estrecha	O
aposición	O
con	O
AEC	O
planas	O
de	O
tipo	O
I	O
(	O
Fig	O
.	O
8	O
,	O
paneles	O
C	O
y	O
E	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
los	O
patrones	O
cav	O
-	O
1	O
alfa	O
en	O
los	O
pulmones	O
de	O
Dhcr7	B-Protein
Los	O
embriones	O
-	O
/	O
-	O
revelaron	O
un	O
lecho	O
capilar	O
pulmonar	O
relativamente	O
poco	O
desarrollado	O
(	O
Fig	O
.	O
8	O
,	O
paneles	O
D	O
y	O
F	O
)	O
.	O

En	O
E20	O
.	O
5	O
,	O
cav	O
-	O
1	O
teñido	O
alfa	O
células	B-Cell
en	O
los	O
pulmones	O
knockout	O
estaban	O
incrustados	O
en	O
un	O
mesénquima	O
relativamente	O
grueso	O
que	O
rodea	O
los	O
túbulos	O
epiteliales	O
no	O
desarrollados	O
,	O
y	O
estos	O
células	B-Cell
epiteliales	I-Cell
permaneció	O
cuboidal	O
,	O
en	O
lugar	O
de	O
aplanarse	O
(	O
Fig	O
.	O
8	O
,	O
panel	O
F	O
)	O
.	O

PECAM	B-Protein
-	I-Protein
1	I-Protein
tinción	O
en	O
E20	O
.	O
5	O
confirmaron	O
el	O
retraso	O
en	O
el	O
desarrollo	O
vascular	O
pulmonar	O
en	O
estas	O
últimas	O
etapas	O
gestacionales	O
en	O
Dhcr7	B-Protein
embriones	O
deficientes	O
(	O
Fig	O
.	O
8	O
,	O
cf	O
.	O
paneles	O
G	O
y	O
H	O
)	O
.	O

Figura	O
8	O

Patrones	O
de	O
inmunotinción	O
para	O
caveolina	O
-	O
1	O
alfa	O
y	O
PECAM	B-Protein
-	I-Protein
1	I-Protein
en	O
secciones	O
de	O
pulmón	O
.	O

La	O
tinción	O
de	O
Cav-1	O
alfa	O
se	O
comparó	O
en	O
E14	O
.	O
5	O
,	O
E17	O
.	O
5	O
y	O
E20	O
.	O
5	O
etapas	O
de	O
desarrollo	O
.	O

Tanto	O
el	O
epitelio	O
como	O
el	O
mesénquima	O
fueron	O
negativos	O
para	O
cav-1	O
alfa	O
en	O
E14	O
.	O
5	O
.	O

Los	O
vasos	O
sanguíneos	O
en	O
desarrollo	O
(	O
puntas	O
de	O
flecha	O
rojas	O
)	O
y	O
los	O
capilares	O
(	O
flechas	O
)	O
(	O
paneles	O
A	O
y	O
B	O
)	O
se	O
tiñeron	O
positivamente	O
para	O
cav	O
-	O
1	O
alfa	O
,	O
pero	O
los	O
patrones	O
de	O
tinción	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
los	O
pulmones	O
knockout	O
(	O
-	O
/	O
-	O
)	O
no	O
se	O
alteraron	O
.	O

También	O
se	O
detectó	O
Cav-1	O
alfa	O
en	O
las	O
matrices	O
subepiteliales	O
del	O
bronquiolo	O
proximal	O
(	O
paneles	O
A-D	O
,	O
puntas	O
de	O
flecha	O
negras	O
)	O
.	O

En	O
E17	O
.	O
5	O
,	O
el	O
epitelio	O
de	O
las	O
vías	O
respiratorias	O
,	O
negativo	O
para	O
la	O
tinción	O
de	O
cav-1	O
alfa	O
,	O
estaba	O
rodeado	O
por	O
anillos	O
de	O
redes	O
capilares	O
teñidas	O
positivamente	O
para	O
cav-1	O
alfa	O
(	O
paneles	O
C	O
y	O
D	O
,	O
flechas	O
)	O
.	O

Patrones	O
de	O
expresión	O
de	O
Cav-1	O
alfa	O
en	O
pulmones	O
de	O
embriones	O
knockout	O
en	O
E17	O
.	O
5	O
eran	O
similares	O
a	O
tipo	B-Sequence
salvaje	I-Sequence
embriones	O
,	O
pero	O
se	O
notó	O
un	O
lecho	O
capilar	O
relativamente	O
menor	O
en	O
los	O
pulmones	O
knockout	O
(	O
cf	O
.	O
paneles	O
C	O
y	O
D	O
)	O
.	O

En	O
E20	O
.	O
5	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
,	O
tanto	O
cav	O
-	O
1	O
alfa	O
como	O
PECAM	B-Protein
-	I-Protein
1	I-Protein
La	O
tinción	O
demostró	O
una	O
extensa	O
red	O
vascular	O
en	O
los	O
sáculos	O
bien	O
desarrollados	O
,	O
observándose	O
la	O
tinción	O
muy	O
cerca	O
de	O
los	O
sáculos	O
planos	O
.	O
células	B-Cell
epiteliales	I-Cell
recubriendo	O
los	O
espacios	O
de	O
aire	O
(	O
paneles	O
E	O
y	O
G	O
,	O
flechas	O
)	O
.	O

Sin	O
embargo	O
,	O
se	O
observó	O
un	O
retraso	O
en	O
el	O
desarrollo	O
vascular	O
en	O
los	O
pulmones	O
knockout	O
,	O
mostrando	O
capilares	O
(	O
paneles	O
F	O
y	O
H	O
,	O
flechas	O
)	O
de	O
los	O
pulmones	O
knockout	O
en	O
E20	O
.	O
5	O
estaban	O
incrustados	O
en	O
un	O
mesénquima	O
relativamente	O
grueso	O
alrededor	O
de	O
los	O
túbulos	O
epiteliales	O
no	O
desarrollados	O
en	O
los	O
que	O
el	O
células	B-Cell
epiteliales	I-Cell
se	O
mantuvieron	O
cúbicas	O
(	O
puntas	O
de	O
flecha	O
)	O
.	O

Ampliación	O
original	O
:	O
A-D	O
son	O
20X	O
;	O
E-H	O
son	O
40X	O
.	O

es	O
el	O
patrón	O
de	O
erizo	B-Protein
Sonic	I-Protein
expresión	O
o	O
señalización	O
alterada	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
?	O

Shh	B-Protein
es	O
fundamental	O
para	O
el	O
desarrollo	O
embrionario	O
normal	O
y	O
su	O
autoprocesamiento	O
,	O
lo	O
que	O
resulta	O
en	O
una	O
molécula	B-Chemical
de	I-Chemical
colesterol	I-Chemical
unido	O
covalentemente	O
en	O
su	O
C	B-Sequence
-	I-Sequence
terminal	I-Sequence
,	O
es	O
un	O
paso	O
necesario	O
para	O
su	O
función	O
de	O
señalización	O
regulada	O
[	O
23	O
,	O
34	O
]	O
.	O

Así	O
,	O
la	O
interrupción	O
de	O
colesterol	B-Chemical
la	O
biosíntesis	O
posiblemente	O
podría	O
alterar	O
su	O
patrón	O
de	O
distribución	O
y	O
,	O
por	O
lo	O
tanto	O
,	O
afectar	O
el	O
desarrollo	O
normal	O
.	O

Para	O
determinar	O
si	O
la	O
expresión	O
aberrante	O
de	O
Shh	B-Protein
contribuido	O
a	O
la	O
Dhcr7	B-Protein
-	O
/	O
-	O
fenotipo	O
pulmonar	O
,	O
distribución	O
de	O
Shh	B-Protein
en	O
el	O
Dhcr7	B-Protein
-	O
/	O
-	O
y	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
se	O
evaluó	O
a	O
partir	O
de	O
E10	O
.	O
5	O
a	O
P0	O
por	O
IHC	O
usando	O
Shh	B-Protein
-	O
norte	B-Chemical
péptido	B-Sequence
anticuerpo	B-GENE
.	O

En	O
E10	O
.	O
5	O
,	O
la	O
distribución	O
de	O
Shh	B-Protein
fue	O
detectado	O
en	O
el	O
células	B-Cell
epiteliales	I-Cell
de	O
yemas	O
pulmonares	O
(	O
Fig	O
.	O
9	O
,	O
panel	O
izquierdo	O
:	O
C	O
y	O
D	O
)	O
,	O
así	O
como	O
en	O
el	O
más	O
típico	O
Shh	B-Protein
-	O
lugares	O
de	O
expresión	O
,	O
como	O
la	O
placa	O
del	O
suelo	O
,	O
la	O
notocorda	O
y	O
el	O
intestino	O
medio	O
(	O
Fig	O
.	O
9	O
,	O
panel	O
izquierdo	O
:	O
A-D	O
)	O
.	O

Es	O
importante	O
destacar	O
que	O
no	O
hay	O
diferencias	O
entre	O
Dhcr7	B-Protein
-/-	O
y	O
se	O
observaron	O
embriones	O
de	O
control	O
.	O

Asimismo	O
,	O
el	O
examen	O
de	O
secciones	O
pulmonares	O
desde	O
edades	O
gestacionales	O
crecientes	O
hasta	O
el	O
nacimiento	O
no	O
mostró	O
diferencias	O
significativas	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
Dhcr7	B-Protein
tejidos	O
deficientes	O
.	O

Los	O
patrones	O
de	O
tinción	O
observados	O
fueron	O
comparables	O
a	O
los	O
informados	O
previamente	O
para	O
Shh	B-Protein
en	O
ratón	B-Taxon
pulmones	O
[	O
25	O
]	O
.	O

Figura	O
9	O

Shh	B-Protein
y	O
patrones	O
de	O
expresión	O
de	O
Ptch	O
en	O
diferentes	O
etapas	O
gestacionales	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
y	O
tipo	B-Sequence
salvaje	I-Sequence
ratones	B-Taxon
.	O

El	O
panel	O
izquierdo	O
muestra	O
el	O
Shh	B-Protein
patrones	O
de	O
inmunotinción	O
usando	O
un	O
anticuerpo	B-GENE
para	O
Shh	B-Protein
norte	B-Chemical
-	O
péptido	B-Sequence
en	O
varias	O
etapas	O
gestacionales	O
como	O
lo	O
indica	O
la	O
leyenda	O
en	O
el	O
eje	O
y	O
.	O

No	O
se	O
observaron	O
diferencias	O
significativas	O
en	O
ninguna	O
de	O
las	O
etapas	O
examinadas	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
embriones	O
knockout	O
(	O
-	O
/	O
-	O
)	O
.	O

En	O
E10	O
.	O
5	O
,	O
Shh	B-Protein
se	O
detectó	O
en	O
la	O
placa	O
del	O
suelo	O
(	O
fp	O
)	O
,	O
notocorda	O
(	O
nc	O
)	O
(	O
A	O
y	O
B	O
)	O
,	O
intestino	O
medio	O
(	O
mg	O
)	O
y	O
las	O
yemas	O
epiteliales	O
de	O
los	O
pulmones	O
(	O
lb	O
)	O
(	O
C	O
y	O
D	O
)	O
.	O

Shh	B-Protein
La	O
tinción	O
se	O
restringió	O
a	O
células	B-Cell
epiteliales	I-Cell
en	O
la	O
región	O
distal	O
de	O
los	O
tubos	O
primordiales	O
de	O
los	O
pulmones	O
en	O
E13	O
.	O
5	O
y	O
E15	O
.	O
5	O
.	O

Tenga	O
en	O
cuenta	O
que	O
proximal	O
células	B-Cell
epiteliales	I-Cell
de	O
los	O
tubos	O
primordiales	O
no	O
fueron	O
inmunoteñidos	O
para	O
Shh	B-Protein
(	O
E	O
y	O
F	O
,	O
flechas	O
)	O
.	O

Shh	B-Protein
fue	O
detectado	O
en	O
el	O
células	B-Cell
epiteliales	I-Cell
de	I-Cell
pulmón	I-Cell
en	O
E18	O
.	O
5	O
,	O
y	O
principalmente	O
en	O
las	O
vías	O
aéreas	O
de	O
conducción	O
en	O
los	O
neonatos	O
.	O

Aumentos	O
originales	O
:	O
A~H	O
,	O
K	O
y	O
L	O
son	O
10X	O
,	O
I	O
y	O
J	O
son	O
20X	O
.	O

El	O
panel	O
derecho	O
muestra	O
los	O
patrones	O
de	O
Ptch	O
IHC	O
en	O
varias	O
etapas	O
gestacionales	O
.	O

Inmunotinción	O
de	O
Ptch	O
de	O
E13	O
.	O
5	O
a	O
P	O
0	O
concordancia	O
confirmada	O
con	O
Shh	B-Protein
expresión	O
y	O
no	O
fue	O
significativamente	O
diferente	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
embriones	O
knockout	O
.	O

Tenga	O
en	O
cuenta	O
que	O
la	O
parte	O
proximal	O
células	B-Cell
epiteliales	I-Cell
de	O
los	O
tubos	O
primordiales	O
tampoco	O
fueron	O
inmunoteñidos	O
para	O
Ptch	O
en	O
E13	O
.	O
5	O
pulmones	O
(	O
flechas	O
)	O
.	O

Los	O
aumentos	O
originales	O
:	O
A~F	O
,	O
I	O
y	O
J	O
son	O
10X	O
.	O

G	O
y	O
H	O
son	O
20X	O
.	O

Para	O
investigar	O
más	O
a	O
fondo	O
Shh	B-Protein
señalización	O
en	O
estos	O
embriones	O
,	O
examinamos	O
los	O
patrones	O
de	O
expresión	O
de	O
Patched	O
(	O
Ptch	O
)	O
,	O
un	O
receptor	O
afín	O
para	O
Shh	B-Protein
y	O
uno	O
cuya	O
expresión	O
también	O
está	O
regulada	O
por	O
Shh	B-Protein
señalización	O

Los	O
patrones	O
de	O
Ptch	O
en	O
secciones	O
de	O
pulmón	O
de	O
varias	O
etapas	O
gestacionales	O
también	O
fueron	O
indistinguibles	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
embriones	O
knockout	O
(	O
Fig	O
.	O
9	O
,	O
paneles	O
de	O
la	O
derecha	O
)	O
.	O

La	O
expresión	O
de	O
Ptch	O
estaba	O
en	O
concordancia	O
con	O
la	O
de	O
Shh	B-Protein
(	O
Fig	O
.	O
9	O
,	O
paneles	O
izquierdo	O
y	O
derecho	O
)	O
,	O
mostrando	O
célula	B-Cell
epitelial	I-Cell
pulmonar	I-Cell
expresión	O
.	O

aguas	O
abajo	O
de	O
la	O
Shh	B-Protein
#	O
¿NOMBRE	O
?	O
proteinas	B-Chemical
tal	O
como	O
alisado	B-Protein
(	O
humo	B-Protein
)	O
,	O
y	O
Gli	O
proteinas	B-Chemical
,	O
reguladores	O
clave	O
del	O
objetivo	O
-	O
gene	B-Sequence
expresión	O
en	O
respuesta	O
a	O
Shh	B-Protein
señalización	O

No	O
hay	O
diferencias	O
en	O
los	O
patrones	O
de	O
expresión	O
para	O
humo	B-Protein
(	O
Fig	O
.	O
10	O
,	O
paneles	O
superiores	O
)	O
,	O
Gli1	B-Protein
(	O
Fig	O
.	O
10	O
,	O
paneles	O
intermedios	O
)	O
o	O
Gli3	B-Protein
(	O
Fig	O
.	O
10	O
,	O
paneles	O
inferiores	O
)	O
se	O
observaron	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
pulmones	O
knockout	O
en	O
E13	O
.	O
5	O
,	O
E15	O
.	O
5	O
y	O
E17	O
.	O
5	O
días	O
de	O
gestación	O
.	O

Figura	O
10	O

comparaciones	O
de	O
humo	B-Protein
,	O
Gli1	B-Protein
y	O
Gli3	B-Protein
expresión	O
en	O
secciones	O
de	O
pulmón	O
.	O

alisado	B-Protein
(	O
humo	B-Protein
Panel	O
superior	O
)	O
,	O
Gli1	B-Protein
(	O
panel	O
central	O
)	O
y	O
Gli3	B-Protein
(	O
panel	O
inferior	O
)	O
mostró	O
un	O
patrón	O
de	O
distribución	O
similar	O
al	O
visto	O
con	O
Shh	B-Protein
y	O
Ptch	O
(	O
comparar	O
con	O
la	O
Fig	O
.	O
7	O
)	O
.	O

Sin	O
diferencias	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
embriones	O
knockout	O
(	O
-	O
/	O
-	O
)	O
fueron	O
evidentes	O
.	O

Ampliaciones	O
originales	O
:	O
20X	O
.	O

Shh	B-Protein
proteína	B-Chemical
procesamiento	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O

Ya	O
que	O
Shh	B-Protein
expresión	O
,	O
así	O
como	O
algunas	O
de	O
las	O
Shh	B-Protein
componentes	O
de	O
señalización	O
parecían	O
ser	O
normales	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
,	O
autoprocesamiento	O
endógeno	O
de	O
Shh	B-Protein
para	O
generar	O
un	O
colesterol	B-Chemical
#	O
¿NOMBRE	O
?	O
N	B-Sequence
-	I-Sequence
fragmento	I-Sequence
terminal	I-Sequence
de	O
Shh	B-Protein
(	O
Shh	B-Protein
-Np	O
)	O
fue	O
evaluado	O
.	O

porque	O
-	O
1	O
células	B-Cell
,	O
transfectado	O
con	O
longitud	O
completa	O
Shh	B-Protein
ADNc	B-Sequence
(	O
capaz	O
de	O
autoescisión	O
endógena	O
)	O
o	O
un	O
truncado	O
Shh	B-Protein
ADNc	B-Sequence
(	O
Shh	B-Protein
-	O
norte	B-Chemical
,	O
expresión	O
del	O
más	O
corto	O
formulario	B-Sequence
constitutivamente	O
)	O
se	O
usaron	O
como	O
controles	O
(	O
Fig	O
.	O
11	O
,	O
pistas	O
1	O
y	O
2	O
)	O
.	O

Transfección	O
de	O
la	O
longitud	O
completa	O
ADNc	B-Sequence
por	O
Shh	B-Protein
condujo	O
a	O
la	O
detección	O
de	O
un	O
~	O
20	O
kD	O
proteína	B-Chemical
que	O
se	O
corresponde	O
con	O
el	O
hendido	O
y	O
con	O
cola	O
Shh	B-Protein
(	O
Fig	O
.	O
11	O
,	O
pista	O
1	O
)	O
,	O
como	O
se	O
describió	O
anteriormente	O
[	O
35	O
]	O
.	O

Transfección	O
de	O
COS	O
células	B-Cell
con	O
el	O
constitutivo	O
truncado	O
Shh	B-Protein
-	O
norte	B-Chemical
ADNc	B-Sequence
condujo	O
a	O
dos	O
bandas	O
de	O
migración	O
más	O
lentas	O
que	O
corresponden	O
a	O
truncadas	O
Shh	B-Protein
,	O
pero	O
que	O
se	O
piensa	O
que	O
son	O
generados	O
por	O
diferencias	O
en	O
lípido	B-Chemical
modificaciones	O
,	O
como	O
se	O
demostró	O
anteriormente	O
[	O
35	O
]	O
.	O

En	O
lisados	O
de	O
tejidos	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
,	O
Dhcr7	B-Protein
+	B-Sequence
/	O
-	O
y	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
en	O
E11	O
.	O
5	O
,	O
una	O
banda	O
que	O
corre	O
en	O
la	O
misma	O
posición	O
que	O
Shh	B-Protein
#	O
¿NOMBRE	O
?	O

No	O
hubo	O
diferencias	O
distinguibles	O
entre	O
Dhcr7	B-Protein
-	O
/	O
-	O
y	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
muestras	O
,	O
lo	O
que	O
sugiere	O
que	O
Shh	B-Protein
el	O
autoprocesamiento	O
ocurrió	O
normalmente	O
,	O
a	O
pesar	O
de	O
una	O
deficiencia	O
absoluta	O
de	O
colesterol	B-Chemical
en	O
embriones	O
knockout	O
.	O

Más	O
importante	O
aún	O
,	O
ninguna	O
banda	O
correspondiente	O
a	O
un	O
Shh	B-Protein
de	I-Protein
cuerpo	I-Protein
entero	I-Protein
(	O
~	O
45	O
kD	O
)	O
estaba	O
presente	O
en	O
los	O
lisados	O
de	O
pulmón	O
de	O
los	O
embriones	O
knockout	O
,	O
lo	O
que	O
sugiere	O
que	O
el	O
procesamiento	O
de	O
Shh	B-Protein
no	O
estaba	O
deteriorado	O
.	O

Figura	O
11	O

Shh	B-Protein
proteína	B-Chemical
autoprocesamiento	O
en	O
ratón	B-Taxon
embriones	O

Western	O
blotting	O
de	O
lisados	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
pista	O
3	O
)	O
,	O
heterocigotos	O
(	O
pista	O
4	O
)	O
y	O
embriones	O
knockout	O
(	O
pista	O
5	O
)	O
en	O
E11	O
.	O
5	O
o	O
COS1	O
células	B-Cell
transfectado	O
con	O
Shh	B-Protein
(	O
pista	O
1	O
)	O
o	O
Shh	B-Protein
-	O
norte	B-Chemical
(	O
pista	O
2	O
)	O
fueron	O
probados	O
con	O
anti	O
-	O
Shh	B-Protein
0	O
anticuerpos	B-GENE
.	O

20	O
ug	O
de	O
lisado	O
proteinas	B-Chemical
desde	O
Shh	B-Protein
COS1	O
transfectado	O
células	B-Cell
y	O
se	O
cargaron	O
75	O
µg	O
de	O
embriones	O
.	O

Ambos	O
sin	O
procesar	O
(	O
Shh	B-Protein
,	O
flecha	O
superior	O
~	O
45	O
kDa	O
,	O
señal	O
débil	O
)	O
y	O
procesado	O
(	O
Shh	B-Protein
-	O
Np	O
,	O
flecha	O
más	O
baja	O
,	O
señal	O
fuerte	O
,	O
pista	O
1	O
)	O
formularios	B-Sequence
de	O
Shh	B-Protein
fueron	O
detectados	O
de	O
Shh	B-Protein
COS1	O
transfectado	O
células	B-Cell
.	O

Las	O
dos	O
bandas	O
migratorias	O
más	O
lentas	O
en	O
Shh	B-Protein
-	O
norte	B-Chemical
COS1	O
transfectado	O
células	B-Cell
(	O
pista	O
2	O
)	O
representada	O
Shh	B-Protein
-	O
N	B-Chemical
proteínas	I-Chemical
con	O
diferente	O
lípido	B-Chemical
modificaciones	O
en	O
su	O
terminal	B-Sequence
N	I-Sequence
.	O

Una	O
banda	O
principal	O
que	O
se	O
ejecuta	O
en	O
la	O
misma	O
posición	O
que	O
procesada	O
Shh	B-Protein
se	O
detectó	O
en	O
los	O
lisados	O
de	O
todos	O
los	O
embriones	O
(	O
pistas	O
3-5	O
)	O
.	O

Es	O
importante	O
destacar	O
que	O
no	O
hay	O
cantidades	O
significativas	O
de	O
datos	O
sin	O
procesar	O
o	O
que	O
migren	O
de	O
forma	O
anómala	O
.	O
Shh	B-Protein
proteinas	B-Chemical
se	O
detectaron	O
en	O
lisados	O
de	O
embriones	O
knockout	O
en	O
esta	O
etapa	O
.	O

Discusión	O

La	O
aclaración	O
de	O
que	O
SLOS	O
es	O
causado	O
por	O
un	O
defecto	O
en	O
un	O
enzima	B-Sequence
necesario	O
para	O
colesterol	B-Chemical
la	O
biosíntesis	O
ha	O
mejorado	O
nuestra	O
comprensión	O
del	O
desarrollo	O
embrionario	O
.	O

Este	O
descubrimiento	O
ha	O
llevado	O
a	O
la	O
identificación	O
de	O
otros	O
trastornos	O
del	O
desarrollo	O
embrionario	O
causados	O
por	O
mutaciones	B-Sequence
en	O
genes	B-Sequence
codificando	O
otros	O
enzimas	B-Sequence
en	O
el	O
post	O
-	O
escualeno	B-Chemical
pasos	O
de	O
colesterol	B-Chemical
biosíntesis	O

Aunque	O
estos	O
genético	B-Sequence
estudios	O
ahora	O
implican	O
la	O
necesidad	O
de	O
normal	O
colesterol	B-Chemical
síntesis	O
,	O
el	O
rol	O
(	O
s	O
)	O
mecanicista	O
(	O
s	O
)	O
de	O
colesterol	B-Chemical
en	O
el	O
desarrollo	O
embrionario	O
normal	O
queda	O
por	O
aclarar	O
.	O

En	O
el	O
presente	O
estudio	O
,	O
reportamos	O
la	O
caracterización	O
del	O
desarrollo	O
pulmonar	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

Aunque	O
las	O
anomalías	O
cardíacas	O
son	O
comunes	O
en	O
humano	B-Taxon
SLOS	O
[	O
36	O
]	O
,	O
no	O
se	O
observaron	O
anormalidades	O
estructurales	O
del	O
corazón	O
o	O
de	O
los	O
grandes	O
vasos	O
en	O
el	O
Dhcr7	B-Protein
-	O
/	O
-	O
cachorros	O
.	O

desarrollo	O
pulmonar	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
en	O
las	O
primeras	O
etapas	O
,	O
desde	O
la	O
formación	O
de	O
yemas	O
pulmonares	O
hasta	O
la	O
etapa	O
canalicular	O
,	O
fue	O
morfológicamente	O
similar	O
a	O
los	O
controles	O
.	O

En	O
cambio	O
,	O
una	O
hipoplasia	O
pulmonar	O
distinta	O
en	O
la	O
etapa	O
sacular	O
,	O
caracterizada	O
por	O
túbulos	O
epiteliales	O
distales	O
detenidos	O
o	O
parcialmente	O
desarrollados	O
,	O
espacio	O
reducido	O
del	O
saco	O
terminal	O
,	O
diferenciación	O
retrasada	O
de	O
AEC	O
tipo	O
I	O
y	O
desarrollo	O
vascular	O
retrasado	O
,	O
se	O
observó	O
consistentemente	O
en	O
etapas	O
gestacionales	O
tardías	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

En	O
las	O
últimas	O
etapas	O
del	O
desarrollo	O
fetal	O
normal	O
,	O
el	O
mamífero	B-Taxon
el	O
epitelio	O
alveolar	O
sufre	O
una	O
diferenciación	O
abrupta	O
como	O
parte	O
de	O
la	O
preparación	O
de	O
los	O
pulmones	O
para	O
las	O
demandas	O
posnatales	O
de	O
intercambio	O
gaseoso	O
[	O
37	O
]	O
.	O

Ambos	O
AEC	O
de	O
tipo	O
II	O
,	O
que	O
producen	O
tensioactivos	B-Chemical
y	O
las	O
AEC	O
de	O
tipo	O
I	O
,	O
que	O
recubren	O
los	O
alvéolos	O
expandidos	O
,	O
son	O
importantes	O
para	O
la	O
maduración	O
alveolar	O
.	O

Además	O
,	O
el	O
desarrollo	O
vascular	O
de	O
los	O
alvéolos	O
también	O
es	O
esencial	O
para	O
la	O
morfogénesis	O
pulmonar	O
normal	O
en	O
las	O
etapas	O
gestacionales	O
tardías	O
[	O
19	O
]	O
.	O

Mostramos	O
aquí	O
que	O
la	O
diferenciación	O
de	O
AEC	O
tipo	O
I	O
pero	O
no	O
AEC	O
tipo	O
II	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
los	O
pulmones	O
estaban	O
bloqueados	O
o	O
retrasados	O
,	O
según	O
lo	O
indicado	O
por	O
menos	O
tipo	O
I	O
aplanado	O
células	B-Cell
por	O
expresión	O
reducida	O
de	O
marcadores	O
de	O
AEC	O
tipo	O
I	O
,	O
T1	B-Protein
alfa	I-Protein
y	O
AQP5	B-Protein
.	O

El	O
desarrollo	O
vascular	O
retrasado	O
también	O
estuvo	O
involucrado	O
en	O
la	O
saculación	O
tardía	O
de	O
Dhcr7	B-Protein
-	O
/	O
-	O
pulmones	O
.	O

Además	O
,	O
el	O
mesénquima	O
que	O
separa	O
las	O
AEC	O
de	O
los	O
lechos	O
vasculares	O
permaneció	O
engrosado	O
.	O

En	O
apoyo	O
de	O
la	O
diferenciación	O
normal	O
de	O
las	O
AEC	O
tipo	O
II	O
,	O
no	O
hay	O
alteración	O
en	O
el	O
gene	B-Sequence
patrones	O
de	O
expresión	O
para	O
proteínas	B-Protein
tensioactivas	I-Protein
A	I-Protein
,	I-Protein
B	I-Protein
,	I-Protein
C	I-Protein
o	I-Protein
D	I-Protein
se	O
observó	O
,	O
ni	O
el	O
patrón	O
de	O
distribución	O
de	O
SP-C	B-Protein
alterado	O
en	O
los	O
pulmones	O
de	O
embriones	O
knockout	O
.	O

Por	O
lo	O
tanto	O
,	O
el	O
deterioro	O
del	O
intercambio	O
de	O
gases	O
,	O
a	O
diferencia	O
de	O
la	O
mala	O
inflación	O
y	O
la	O
tensión	O
alveolar	O
,	O
puede	O
ser	O
la	O
causa	O
de	O
la	O
insuficiencia	O
respiratoria	O
en	O
estos	O
cachorros	O
.	O

Pérdida	O
de	O
funcional	O
Dhcr7	B-Protein
condujo	O
a	O
un	O
retraso	O
del	O
crecimiento	O
embrionario	O
de	O
E14	O
.	O
5~E16	O
.	O
5	O
en	O
adelante	O
.	O

En	O
esta	O
etapa	O
,	O
colesterol	B-Chemical
los	O
niveles	O
ya	O
eran	O
más	O
bajos	O
y	O
su	O
precursor	O
inmediato	O
,	O
el	O
7-DHC	O
,	O
estaba	O
elevado	O
en	O
los	O
pulmones	O
(	O
este	O
estudio	O
)	O
,	O
así	O
como	O
en	O
todo	O
el	O
cuerpo	O
[	O
16	O
,	O
17	O
]	O
.	O

El	O
retraso	O
del	O
crecimiento	O
intrauterino	O
(	O
RCIU	O
)	O
seguido	O
de	O
retraso	O
del	O
crecimiento	O
posnatal	O
es	O
un	O
fenotipo	O
observado	O
universalmente	O
en	O
pacientes	O
con	O
SLOS	O
[	O
2	O
,	O
18	O
]	O
.	O

Mostramos	O
aquí	O
que	O
la	O
longitud	O
del	O
cuerpo	O
se	O
redujo	O
significativamente	O
en	O
las	O
últimas	O
etapas	O
de	O
la	O
gestación	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
animales	B-Taxon
,	O
en	O
comparación	O
con	O
los	O
controles	O
.	O

Los	O
pesos	O
de	O
todo	O
el	O
cuerpo	O
y	O
los	O
pesos	O
de	O
los	O
pulmones	O
frescos	O
(	O
así	O
como	O
el	O
cerebro	O
,	O
el	O
corazón	O
y	O
los	O
riñones	O
,	O
datos	O
no	O
mostrados	O
)	O
en	O
las	O
etapas	O
gestacionales	O
tardías	O
también	O
fueron	O
más	O
bajos	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

Curiosamente	O
,	O
las	O
proporciones	O
más	O
bajas	O
de	O
pulmón/cuerpo	O
en	O
E18	O
.	O
5	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
en	O
comparación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
sugirió	O
una	O
inhibición	O
desproporcionada	O
del	O
crecimiento	O
pulmonar	O
en	O
comparación	O
con	O
otros	O
órganos	O
.	O

Célula	B-Cell
proliferación	O
y	O
división	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
los	O
pulmones	O
se	O
detuvieron	O
notablemente	O
sin	O
aumento	O
aparente	O
en	O
célula	B-Cell
apoptosis	O

Por	O
lo	O
tanto	O
,	O
parece	O
que	O
el	O
retraso	O
del	O
crecimiento	O
causado	O
por	O
colesterol	B-Chemical
deficiencia	O
se	O
debió	O
principalmente	O
a	O
una	O
inhibición	O
de	O
célula	B-Cell
el	O
crecimiento	O
y	O
la	O
proliferación	O
,	O
en	O
lugar	O
de	O
un	O
aumento	O
en	O
célula	B-Cell
muerte	O
.	O

Colesterol	B-Chemical
está	O
presente	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
,	O
tal	O
como	O
está	O
en	O
Sc5d	B-Protein
-	O
/	O
-	O
(	O
latosterolosis	O
)	O
y	O
Dhcr24	B-Protein
-/-	O
(	O
desmosterolosis	O
)	O
embriones	O
[	O
15	O
,	O
38	O
]	O
.	O

Total	O
esteroles	B-Chemical
y	O
colesterol	B-Chemical
en	O
Dhcr7	B-Protein
-/-	O
los	O
pulmones	O
embrionarios	O
(	O
así	O
como	O
en	O
el	O
cerebro	O
y	O
el	O
hígado	O
,	O
datos	O
no	O
mostrados	O
)	O
se	O
redujeron	O
y	O
el	O
7DHC/8DHC	O
aumentó	O
,	O
pero	O
una	O
cantidad	O
significativa	O
de	O
colesterol	B-Chemical
fue	O
detectable	O
,	O
comprendiendo	O
~	O
60	O
%	O
y	O
~	O
30	O
%	O
del	O
tejido	O
total	O
esteroles	B-Chemical
en	O
E13	O
.	O
5	O
y	O
neonato	O
,	O
respectivamente	O
.	O

Fetal	O
colesterol	B-Chemical
puede	O
sintetizarse	O
endógenamente	O
en	O
tejidos	O
fetales	O
o	O
acumularse	O
a	O
partir	O
de	O
tejidos	O
extraembrionarios	O
como	O
el	O
suero	O
materno	O
,	O
la	O
placenta	O
y	O
el	O
saco	O
vitelino	O
[	O
39	O
]	O
.	O

Dado	O
que	O
estos	O
ratones	B-Taxon
teóricamente	O
no	O
se	O
puede	O
sintetizar	O
colesterol	B-Chemical
,	O
cualquier	O
acumulación	O
de	O
colesterol	B-Chemical
debe	O
derivarse	O
de	O
las	O
fuentes	O
maternas	O
.	O

Curiosamente	O
,	O
Dhcr24	B-Protein
nulo	O
ratones	B-Taxon
son	O
viables	O
pero	O
casi	O
no	O
contienen	O
colesterol	B-Chemical
en	O
plasma	O
y	O
tejidos	O
a	O
los	O
3	O
meses	O
,	O
mientras	O
que	O
colesterol	B-Chemical
contenido	O
en	O
Dhcr24	B-Protein
los	O
tejidos	O
embrionarios	O
nulos	O
representan	O
~	O
60	O
%	O
en	O
E11	O
.	O
5	O
y	O
~	O
30	O
%	O
en	O
E17	O
.	O
5	O
,	O
del	O
tejido	O
total	O
esteroles	B-Chemical
[	O
38	O
]	O
.	O

Estos	O
resultados	O
,	O
así	O
como	O
este	O
estudio	O
,	O
sugieren	O
que	O
una	O
cantidad	O
considerable	O
de	O
colesterol	B-Chemical
puede	O
ser	O
transferido	O
a	O
la	O
murino	B-Taxon
feto	O

Una	O
explicación	O
de	O
por	O
qué	O
la	O
Dhcr24	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
son	O
normales	O
desde	O
el	O
punto	O
de	O
vista	O
del	O
desarrollo	O
,	O
pero	O
Dhcr7	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
se	O
ven	O
afectados	O
puede	O
deberse	O
a	O
desmosterol	B-Chemical
puede	O
sustituir	O
funcionalmente	O
a	O
colesterol	B-Chemical
,	O
mientras	O
que	O
el	O
otro	O
colesterol	B-Chemical
los	O
precursores	O
no	O
pueden	O
.	O

Aunque	O
una	O
comprensión	O
mecanicista	O
de	O
por	O
qué	O
una	O
deficiencia	O
en	O
colesterol	B-Chemical
falta	O
la	O
biosíntesis	O
conduce	O
a	O
un	O
desarrollo	O
embrionario	O
anormal	O
,	O
una	O
explicación	O
frecuentemente	O
avanzada	O
ha	O
sido	O
que	O
Shh	B-Protein
la	O
señalización	O
,	O
involucrada	O
en	O
el	O
patrón	O
de	O
desarrollo	O
temprano	O
,	O
puede	O
verse	O
interrumpida	O
.	O

En	O
el	O
primordio	O
pulmonar	O
en	O
desarrollo	O
,	O
Shh	B-Protein
se	O
expresa	O
inicialmente	O
en	O
E9	O
y	O
promueve	O
la	O
morfogénesis	O
de	O
ramificación	O
,	O
que	O
está	O
alterada	O
en	O
Shh	B-Protein
knockear	O
ratones	B-Taxon
[	O
24	O
]	O
,	O
sugiriendo	O
que	O
Shh	B-Protein
,	O
secretada	O
por	O
el	O
epitelio	O
,	O
es	O
fundamental	O
para	O
la	O
morfogénesis	O
de	O
ramificación	O
.	O

En	O
este	O
estudio	O
,	O
la	O
falta	O
de	O
evidencia	O
de	O
morfogénesis	O
de	O
ramificación	O
pulmonar	O
anormal	O
en	O
las	O
primeras	O
etapas	O
,	O
pero	O
una	O
maduración	O
retrasada	O
constante	O
de	O
la	O
región	O
de	O
intercambio	O
de	O
gases	O
del	O
pulmón	O
en	O
el	O
período	O
sacular	O
de	O
desarrollo	O
de	O
Dhcr7	B-Protein
-	O
/	O
-	O
se	O
observaron	O
embriones	O
,	O
lo	O
que	O
sugiere	O
una	O
temprana	O
Shh	B-Protein
la	O
señalización	O
era	O
normal	O
.	O

Shh	B-Protein
proteína	B-Chemical
expresión	O
y	O
autoprocesamiento	O
en	O
E11	O
.	O
5	O
era	O
indistinguible	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
.	O

Además	O
,	O
aunque	O
estos	O
experimentos	O
no	O
fueron	O
cuantitativos	O
,	O
la	O
abundancia	O
de	O
Shh	B-Protein
apareció	O
sin	O
cambios	O
entre	O
estos	O
genotipos	B-Sequence
.	O

Así	O
,	O
es	O
posible	O
que	O
el	O
colesterol	B-Chemical
(	O
aproximadamente	O
el	O
50	O
%	O
de	O
los	O
niveles	O
normales	O
)	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
los	O
embriones	O
fueron	O
suficientes	O
para	O
completar	O
Shh	B-Protein
autoprocesamiento	O
o	O
7DHC	O
acumulados	O
en	O
Dhcr7	B-Protein
-/-	O
los	O
tejidos	O
embrionarios	O
también	O
pueden	O
participar	O
eficientemente	O
como	O
esterol	B-Chemical
aducir	O
en	O
el	O
Shh	B-Protein
reacción	O
de	O
procesamiento	O
[	O
20	O
]	O
.	O

En	O
este	O
estudio	O
,	O
también	O
examinamos	O
la	O
Shh	B-Protein
vía	O
de	O
señalización	O
por	O
inmunohistoquímica	O
de	O
componentes	O
clave	O
conocidos	O
de	O
esta	O
vía	O
,	O
como	O
patched	O
,	O
alisado	B-Protein
y	O
gli	O
proteinas	B-Chemical
.	O

Shh	B-Protein
señalización	O
conduce	O
a	O
la	O
activación	O
de	O
la	O
transcripción	O
y	O
aumento	O
proteína	B-Chemical
niveles	O
de	O
estos	O
componentes	O
[	O
40	O
-	O
42	O
]	O
.	O

Si	O
Shh	B-Protein
la	O
señalización	O
era	O
defectuosa	O
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
,	O
estos	O
podrían	O
haber	O
resultado	O
en	O
anormalidades	O
de	O
los	O
patrones	O
de	O
tinción	O
de	O
estos	O
componentes	O
,	O
pero	O
no	O
se	O
detectó	O
tal	O
alteración	O
.	O

De	O
hecho	O
,	O
los	O
patrones	O
de	O
proteína	B-Chemical
expresión	O
parecía	O
comparable	O
e	O
indistinguible	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
embriones	O
en	O
todas	O
las	O
etapas	O
de	O
desarrollo	O
pulmonar	O
examinados	O
.	O

En	O
un	O
reciente	O
estudio	O
in	O
vitro	O
[	O
43	O
]	O
,	O
ratón	B-Taxon
embrionario	O
fibroblastos	B-Cell
(	O
MEF	O
)	O
de	O
Dhcr7	B-Protein
-	O
/	O
-	O
embriones	O
,	O
cultivados	O
en	O
cultivo	O
deplecionado	O
en	O
lípidos	O
y	O
tratados	O
transitoriamente	O
con	O
ciclodextrina	B-Chemical
,	O
no	O
mostró	O
ningún	O
efecto	O
sobre	O
Shh	B-Protein
Procesando	O
.	O

Sin	O
embargo	O
,	O
una	O
deficiencia	O
en	O
su	O
capacidad	O
para	O
responder	O
a	O
Shh	B-Protein
activación	O
,	O
a	O
juicio	O
del	O
reportero	O
gene	B-Sequence
expresión	O
,	O
era	O
demostrable	O
.	O

Por	O
el	O
contrario	O
,	O
cuando	O
CHO	O
células	B-Cell
,	O
que	O
expresó	O
de	O
manera	O
estable	O
Shh	B-Protein
,	O
fueron	O
sometidos	O
a	O
esterol	B-Chemical
privación	O
,	O
arresto	O
de	O
Shh	B-Protein
el	O
autoprocesamiento	O
era	O
claramente	O
demostrable	O
[	O
29	O
]	O
.	O

En	O
el	O
presente	O
estudio	O
,	O
no	O
detectamos	O
sin	O
procesar	O
Shh	B-Protein
en	O
Dhcr7	B-Protein
-	O
/	O
-	O
tejidos	O
embrionarios	O
en	O
E11	O
.	O
5	O
.	O

Sutiles	O
diferencias	O
en	O
Shh	B-Protein
la	O
transducción	O
de	O
señales	O
no	O
puede	O
ser	O
excluida	O
por	O
el	O
presente	O
estudio	O
.	O

Sin	O
embargo	O
,	O
estamos	O
a	O
favor	O
de	O
un	O
modelo	O
en	O
el	O
que	O
la	O
pérdida	O
de	O
la	O
normalidad	O
colesterol	B-Chemical
la	O
biosíntesis	O
es	O
importante	O
,	O
no	O
tanto	O
para	O
Shh	B-Protein
autoescisión	O
,	O
en	O
cuanto	O
a	O
la	O
pérdida	O
de	O
la	O
correcta	O
membrana	B-GENE
de	I-GENE
plasma	I-GENE
medio	O

Desde	O
la	O
pérdida	O
de	O
colesterol	B-Chemical
contenido	O
en	O
el	O
membrana	B-GENE
de	I-GENE
plasma	I-GENE
(	O
y	O
tal	O
vez	O
alguna	O
membrana	B-GENE
)	O
es	O
probable	O
que	O
altere	O
la	O
función	O
de	O
los	O
receptores	O
más	O
sensibles	O
a	O
esto	O
,	O
pérdida	O
de	O
normal	O
colesterol	B-Chemical
la	O
síntesis	O
puede	O
causar	O
una	O
pérdida	O
de	O
transducción	O
de	O
señales	O
de	O
una	O
gran	O
cantidad	O
de	O
tales	O
vías	O
.	O

Por	O
lo	O
tanto	O
,	O
este	O
efecto	O
no	O
puede	O
limitarse	O
a	O
la	O
Shh	B-Protein
la	O
ruta	O
y	O
otros	O
objetivos	O
pueden	O
ser	O
más	O
importantes	O
.	O

Esta	O
hipótesis	O
es	O
susceptible	O
de	O
ser	O
probada	O
en	O
el	O
Dhcr7	B-Protein
nulo	O
ratones	B-Taxon
.	O

Conclusión	O

Colesterol	B-Chemical
deficiencia	O
causada	O
por	O
Dhcr7	B-Protein
deficiencia	O
en	O
ratones	B-Taxon
dio	O
lugar	O
,	O
junto	O
con	O
RCIU	O
,	O
a	O
una	O
hipoplasia	O
sacular	O
pulmonar	O
distintiva	O
con	O
una	O
diferenciación	O
alterada	O
de	O
las	O
AEC	O
de	O
tipo	O
I	O
pero	O
no	O
de	O
las	O
de	O
tipo	O
II	O
y	O
un	O
retraso	O
en	O
el	O
desarrollo	O
vascular	O
asociado	O
.	O

Pérdida	O
de	O
las	O
cantidades	O
correctas	O
de	O
colesterol	B-Chemical
en	O
el	O
membranas	B-GENE
puede	O
perturbar	O
los	O
receptores	O
que	O
dependen	O
de	O
colesterol	B-Chemical
para	O
una	O
transducción	O
de	O
señal	O
eficiente	O
.	O

La	O
investigación	O
adicional	O
de	O
qué	O
vías	O
transcripcionales	O
y	O
de	O
transducción	O
de	O
señales	O
se	O
ven	O
más	O
afectadas	O
por	O
la	O
pérdida	O
de	O
Dhcr7	B-Protein
será	O
fundamental	O
para	O
dilucidar	O
el	O
mecanismo	O
de	O
hipoplasia	O
pulmonar	O
de	O
este	O
modelo	O
,	O
así	O
como	O
el	O
papel	O
de	O
colesterol	B-Chemical
en	O
el	O
desarrollo	O
embrionario	O
.	O

Métodos	O

animales	B-Taxon

Todos	O
ratones	B-Taxon
estaban	O
alojados	O
en	O
un	O
animal	B-Taxon
instalación	O
a	O
22	O
grados	O
C	O
con	O
un	O
ciclo	O
de	O
12	O
h	O
luz	O
~	O
12	O
h	O
oscuridad	O
y	O
todos	O
los	O
protocolos	O
fueron	O
aprobados	O
por	O
el	O
Institucional	O
Animal	B-Taxon
Comité	O
de	O
Bienestar	O
.	O

Dhcr7	B-Protein
heterocigoto	O
animales	B-Taxon
utilizados	O
en	O
este	O
estudio	O
han	O
sido	O
retrocruzados	O
con	O
un	O
fondo	O
C57BL/6J	O
durante	O
11	O
generaciones	O
sucesivas	O
.	O

La	O
presencia	O
de	O
tapones	O
vaginales	O
se	O
consideró	O
como	O
día	O
embrionario	O
(	O
E	O
)	O
0	O
.	O
5	O
.	O

Se	O
sacrificaron	O
hembras	O
preñadas	O
cronometradas	O
,	O
se	O
diseccionaron	O
los	O
embriones	O
de	O
los	O
úteros	O
y	O
se	O
colocaron	O
en	O
PBS	O
1X	O
.	O

Se	O
midieron	O
las	O
longitudes	O
corona-rabadilla	O
de	O
los	O
embriones	O
mediante	O
el	O
uso	O
de	O
un	O
calibrador	O
digital	O
electrónico	O
y	O
se	O
pesaron	O
los	O
embriones	O
,	O
después	O
de	O
eliminar	O
el	O
exceso	O
de	O
líquido	O
.	O

Cada	O
pulmón	O
se	O
extrajo	O
intacto	O
de	O
la	O
cavidad	O
torácica	O
,	O
se	O
secó	O
para	O
eliminar	O
el	O
exceso	O
de	O
líquido	O
y	O
se	O
pesó	O
.	O

Ratones	B-Taxon
se	O
clasificaron	O
como	O
P0	O
cuando	O
se	O
presenció	O
el	O
nacimiento	O
y	O
se	O
visualizaron	O
sus	O
actividades	O
respiratorias	O
bajo	O
un	O
microscopio	O
de	O
disección	O
.	O

Se	O
capturaron	O
imágenes	O
digitales	O
de	O
embriones	O
o	O
pulmones	O
usando	O
un	O
microscopio	O
de	O
disección	O
Zeiss-1000	O
.	O

Genotipado	O
se	O
realizó	O
por	O
PCR	O
,	O
como	O
se	O
describe	O
anteriormente	O
[	O
16	O
]	O
.	O

Y	O
en	O
casos	O
selectivos	O
,	O
se	O
realizó	O
transferencia	O
de	O
Southern	O
para	O
la	O
confirmación	O
de	O
Dhcr7	B-Protein
genotipo	B-Sequence
.	O

Mediciones	O
bioquímicas	O

Tejido	O
esterol	B-Chemical
las	O
composiciones	O
se	O
analizaron	O
mediante	O
cromatografía	O
de	O
gases-espectrometría	O
de	O
masas	O
(	O
GC-MS	O
)	O
como	O
se	O
describió	O
anteriormente	O
[	O
2	O
,	O
44	O
]	O
.	O

Suero	O
corticosterona	B-Chemical
los	O
niveles	O
se	O
midieron	O
mediante	O
radioinmunoensayo	O
(	O
RIA	O
)	O
en	O
la	O
sangre	O
obtenida	O
de	O
neonatos	O
decapitados	O
por	O
una	O
fuente	O
comercial	O
(	O
DRTC	O
hormona	B-Chemical
Ensayo	O
Core	O
Lab	O
,	O
Universidad	O
de	O
Vanderbilt	O
,	O
TN	O
)	O
.	O

Histología	O
e	O
Inmunohistoquímica	O

Partes	O
torácicas	O
de	O
embriones	O
o	O
P0	O
ratones	B-Taxon
se	O
fijaron	O
en	O
el	O
fijador	O
de	O
Amsterdam	O
(	O
metanol	B-Chemical
:	O
acetona	B-Chemical
:	O
ácido	B-Chemical
acético	I-Chemical
:	O
agua	B-Chemical
35	O
:	O
35	O
:	O
5	O
:	O
25	O
v	O
/	O
v	O
)	O
o	O
paraformaldehído	O
al	O
4	O
%	O
en	O
PBS	O
.	O

Los	O
tejidos	O
se	O
fijaron	O
durante	O
la	O
noche	O
a	O
temperatura	O
ambiente	O
(	O
TA	O
)	O
,	O
se	O
enjuagaron	O
en	O
PBS	O
,	O
se	O
deshidrataron	O
en	O
un	O
recipiente	O
graduado	O
etanol	B-Chemical
serie	O
,	O
liquidada	O
en	O
tolueno	B-Chemical
e	O
incrustado	O
en	O
parafina	O
.	O

Se	O
montaron	O
cinco	O
secciones	O
mu	O
m	O
en	O
portaobjetos	O
Superfrost-Plus	O
(	O
VWR	O
,	O
West	O
Chester	O
,	O
PA	O
)	O
para	O
análisis	O
histológicos	O
o	O
inmunohistoquímicos	O
(	O
IHC	O
)	O
.	O

La	O
IHC	O
se	O
realizó	O
mediante	O
un	O
método	O
indirecto	O
.	O

Después	O
de	O
la	O
desparafinación	O
en	O
xileno	B-Chemical
y	O
rehidratación	O
a	O
través	O
de	O
una	O
serie	O
graduada	O
de	O
etanol	B-Chemical
,	O
las	O
secciones	O
se	O
calentaron	O
a	O
95	O
grados	O
C	O
en	O
10	O
mM	O
citrato	B-Chemical
de	I-Chemical
sodio	I-Chemical
(	O
pH	O
6,0	O
)	O
durante	O
15	O
min	O
iniciales	O
y	O
durante	O
tres	O
períodos	O
sucesivos	O
de	O
5	O
min	O
[	O
25	O
]	O
.	O

Una	O
vez	O
enfriados	O
,	O
los	O
cortes	O
se	O
trataron	O
con	O
peróxido	B-Chemical
de	I-Chemical
hidrógeno	I-Chemical
(	O
3	O
%	O
v	O
/	O
v	O
en	O
PBS	O
,	O
pH	O
7	O
,	O
4	O
)	O
durante	O
10	O
min	O
y	O
se	O
aclara	O
en	O
PBS	O
.	O

Las	O
secciones	O
se	O
bloquearon	O
con	O
suero	O
normal	O
al	O
5	O
%	O
durante	O
2	O
h	O
,	O
se	O
lavaron	O
en	O
PBS	O
y	O
se	O
incubaron	O
con	O
anticuerpos	B-GENE
en	O
contra	O
Shh	B-Protein
-N19	O
(	O
1	O
:	O
100	O
)	O
,	O
parcheado	O
(	O
1	O
:	O
100	O
)	O
,	O
humo	B-Protein
-N19	O
(	O
1	O
:	O
100	O
)	O
,	O
Gli1	B-Protein
(	O
1	O
:	O
100	O
)	O
,	O
Gli3	B-Protein
-N19	O
(	O
1	O
:	O
100	O
)	O
,	O
SP-C	B-Protein
C19	O
(	O
1	O
:	O
200	O
)	O
,	O
caveolina	O
1	O
alfa	O
-	O
N20	O
(	O
1	O
:	O
200	O
)	O
,	O
acuaporina	B-Protein
5	I-Protein
(	O
AQP5	B-Protein
,	O
1	O
:	O
200	O
)	O
,	O
megalín	B-Protein
(	O
1	O
:	O
200	O
)	O
,	O
PECAM	B-Protein
-	I-Protein
1	I-Protein
(	O
1	O
:	O
200	O
)	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
CA	O
)	O
o	O
T1	B-Protein
alfa	I-Protein
(	O
mAB	O
8.1.1	O
,	O
dilución	O
1:1000	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
Iowa	O
City	O
,	O
IA	O
)	O
durante	O
la	O
noche	O
a	O
4	O
grados	O
C	O
en	O
una	O
cámara	O
humidificada	O
.	O

Las	O
secciones	O
se	O
lavaron	O
en	O
PBS	O
,	O
se	O
incubaron	O
con	O
biotina	O
secundaria	O
anticuerpos	B-GENE
(	O
1	O
:	O
1000	O
~	O
1	O
:	O
5000	O
,	O
Santa	O
Cruz	O
Biotechnology	O
)	O
en	O
PBS	O
durante	O
2	O
h	O
a	O
temperatura	O
ambiente	O
,	O
incubado	O
con	O
complejo	O
HRP	O
-	O
estreptavidina	O
durante	O
30	O
min	O
,	O
enjuagado	O
en	O
PBS	O
y	O
visualizado	O
usando	O
un	O
Metal	B-Chemical
Kit	O
de	O
sustrato	O
de	O
diaminobencidina	O
mejorada	O
(	O
DAB	O
)	O
(	O
Pierce	O
,	O
Rockford	O
,	O
IL	O
)	O
.	O

Las	O
imágenes	O
digitales	O
se	O
recogieron	O
usando	O
una	O
cámara	O
de	O
microscopio	O
digital	O
Polaroid	O
montada	O
en	O
un	O
microscopio	O
Olympus	O
BX40	O
.	O

Morfometría	O
pulmonar	O

Las	O
áreas	O
del	O
espacio	O
sacular	O
terminal	O
se	O
midieron	O
utilizando	O
el	O
software	O
NIH	O
Image	O
(	O
NIH	O
,	O
Bethesda	O
,	O
MD	O
)	O
como	O
se	O
describió	O
anteriormente	O
[	O
45	O
]	O
.	O

Se	O
realizaron	O
múltiples	O
mediciones	O
en	O
0	O
seleccionados	O
al	O
azar	O
.	O
Campos	O
de	O
04	O
mm2	O
ubicados	O
en	O
la	O
parte	O
distal	O
de	O
las	O
secciones	O
pulmonares	O
.	O

La	O
proporción	O
de	O
pulmón	O
que	O
comprende	O
espacios	O
saculares	O
terminales	O
se	O
calculó	O
como	O
un	O
porcentaje	O
del	O
área	O
total	O
examinada	O
de	O
la	O
sección	O
de	O
pulmón	O
.	O

Tres	O
animales	B-Taxon
por	O
genotipo	B-Sequence
fueron	O
examinados	O
.	O

Evaluación	O
de	O
célula	B-Cell
proliferación	O
/	O
división	O
/	O
muerte	O

Cambios	O
en	O
célula	B-Cell
la	O
proliferación	O
y	O
la	O
división	O
fueron	O
evaluadas	O
por	O
antígeno	B-Protein
nuclear	I-Protein
de	I-Protein
células	I-Protein
en	I-Protein
proliferación	I-Protein
(	O
PCNA	B-Protein
)	O
IHC	O
,	O
bromodesoxiuridina	O
(	O
BrdU	O
)	O
incorporación	B-Sequence
y	O
fosforilado	O
histona	B-Chemical
H3	O
(	O
pH3	O
)	O
IHC	O
.	O

los	O
PCNA	B-Protein
(	O
1	O
:	O
2000	O
)	O
y	O
pHH3	O
-	O
Ser28	O
(	O
1	O
:	O
200	O
)	O
anticuerpos	B-GENE
se	O
obtuvieron	O
de	O
Santa	O
Cruz	O
Biotechnology	O
.	O

Para	O
BrdU	O
incorporación	B-Sequence
,	O
cronometrada	O
embarazada	O
ratones	B-Taxon
en	O
E18	O
.	O
A	O
5	O
se	O
les	O
inyectó	O
por	O
vía	O
intraperitoneal	O
100	O
µg/g	O
de	O
peso	O
corporal	O
de	O
BrdU	O
(	O
Sigma	O
,	O
St	O
Louis	O
,	O
MO	O
)	O
2	O
h	O
antes	O
del	O
sacrificio	O
,	O
los	O
embriones	O
se	O
diseccionaron	O
del	O
útero	O
y	O
se	O
procesaron	O
como	O
se	O
describe	O
anteriormente	O
.	O

Las	O
secciones	O
se	O
tiñeron	O
con	O
un	O
anti-BrdU	O
monoclonal	O
anticuerpo	B-GENE
1	O
:	O
100	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
Iowa	O
City	O
,	O
IA	O
)	O
y	O
se	O
visualiza	O
con	O
un	O
Cy2	O
conjugado	O
Conejo	B-Taxon
anti	O
-	O
ratón	B-Taxon
anticuerpo	B-GENE
utilizando	O
un	O
microscopio	O
confocal	O
de	O
barrido	O
láser	O
.	O

Célula	B-Cell
La	O
muerte	O
fue	O
investigada	O
por	O
desoxinucleotidiltransferasa	B-Protein
terminal	I-Protein
#	O
¿NOMBRE	O
?	O
dUTP	B-Chemical
marcaje	O
de	O
muescas	O
(	O
TUNEL	O
)	O
usando	O
Fluorescein	O
In	O
Situ	O
Célula	B-Cell
Death	O
Detection	O
Kit	O
(	O
Roche	O
,	O
Indianapolis	O
,	O
IN	O
)	O
según	O
protocolo	O
del	O
fabricante	O
.	O

transferencia	O
occidental	O

La	O
preparación	O
de	O
muestras	O
y	O
el	O
Western	O
Blot	O
se	O
realizaron	O
de	O
acuerdo	O
con	O
Kawakami	O
et	O
al	O
con	O
algunas	O
modificaciones	O
menores	O
[	O
35	O
]	O
.	O

Brevemente	O
,	O
3	O
embriones	O
de	O
cada	O
genotipo	B-Sequence
se	O
agruparon	O
,	O
se	O
homogeneizaron	O
en	O
tampón	O
de	O
lisis	O
enfriado	O
con	O
hielo	O
(	O
50	O
mM	O
tris	B-Chemical
-	O
pH8	O
.	O
0	O
,	O
150	O
mM	O
NaCl	B-Chemical
,	O
2	O
mm	O
EDTA	B-Chemical
,	O
1	O
%	O
Tritón	O
X	O
-	O
100	O
,	O
0	O
.	O
5	O
mm	O
TDT	B-Chemical
,	O
1	O
mm	O
PMSF	B-Chemical
2	O
µg/ml	O
cada	O
uno	O
de	O
aprotinina	O
,	O
leupeptina	O
y	O
pepstatina	O
A	O
)	O
con	O
un	O
homogeneizador	O
de	O
tejidos	O
(	O
PRO	O
Scientific	O
Inc.	O
,	O
Oxford	O
,	O
CT	O
)	O
usando	O
tres	O
pulsos	O
de	O
10	O
segundos	O
cada	O
uno	O
y	O
luego	O
sometido	O
al	O
homogeneizador	O
Dounce	O
por	O
10	O
golpes	O
.	O

Los	O
homogeneizados	O
se	O
centrifugaron	O
a	O
10	O
000	O
g	O
durante	O
30	O
minutos	O
a	O
4	O
grados	O
C	O
,	O
se	O
recogieron	O
los	O
sobrenadantes	O
,	O
proteína	B-Chemical
concentración	O
determinada	O
y	O
utilizada	O
para	O
transferencia	O
Western	O
.	O

COS1	O
células	B-Cell
se	O
transfectaron	O
utilizando	O
la	O
transfección	O
Superfect	O
reactivo	B-Chemical
(	O
Qiagen	O
,	O
Valencia	O
,	O
CA	O
)	O
con	O
expresión	O
construcciones	B-Sequence
codificando	O
el	O
Shh	B-Protein
de	I-Protein
cuerpo	I-Protein
entero	I-Protein
o	O
la	O
N	B-Sequence
-	I-Sequence
fragmento	I-Sequence
terminal	I-Sequence
de	O
Shh	B-Protein
sin	O
post	O
-	O
traduccional	O
modificaciones	B-Sequence
(	O
construcciones	B-Sequence
proporcionado	O
amablemente	O
por	O
el	O
Dr.	O
Pao-Tien	O
Chuang	O
,	O
Instituto	O
de	O
Investigación	O
Cardiovascular	O
,	O
Universidad	O
de	O
California	O
,	O
San	O
Francisco	O
,	O
CA	O
)	O
,	O
recolectado	O
3	O
días	O
después	O
de	O
la	O
transfección	O
y	O
proteína	B-Chemical
extractos	O
preparados	O
como	O
se	O
ha	O
descrito	O
anteriormente	O
.	O

Proteína	B-Chemical
la	O
concentración	O
se	O
determinó	O
usando	O
Bio	O
-	O
Rad	O
proteína	B-Chemical
kit	O
de	O
ensayo	O
(	O
BioRad	O
,	O
Hercules	O
,	O
CA	O
)	O
y	O
20	O
mu	O
g	O
(	O
COS1	O
células	B-Cell
y	O
75	O
mu	O
g	O
(	O
embriones	O
)	O
de	O
lisados	O
separados	O
al	O
15	O
%	O
SDS	B-Chemical
-	O
PÁGINA	O
,	O
transferida	O
a	O
membrana	O
de	O
nitrocelulosa	O
,	O
incubada	O
con	O
primario	O
anticuerpo	B-GENE
(	O
Shh	B-Protein
-	O
N19	O
,	O
1	O
:	O
100	O
)	O
durante	O
2	O
horas	O
,	O
seguido	O
de	O
Burro	B-Taxon
anti	O
-	O
cabra	O
HRP	O
segundo	O
anticuerpo	B-GENE
(	O
1:1000	O
)	O
y	O
visualizado	O
por	O
detección	O
quimioluminiscente	O
de	O
acuerdo	O
con	O
los	O
protocolos	O
del	O
fabricante	O
(	O
Perkin-Elmer	O
Life	O
Sciences	O
,	O
Boston	O
MA	O
)	O
.	O

transferencia	O
del	O
norte	O

Northern	O
blotting	O
se	O
realizó	O
como	O
se	O
describió	O
anteriormente	O
[	O
46	O
]	O
,	O
usando	O
total	O
ARN	B-Sequence
(	O
20	O
tazas	O
)	O
desde	O
P0	O
ratones	B-Taxon
pulmones	O
.	O

los	O
sondas	B-Sequence
de	I-Sequence
ADNc	I-Sequence
por	O
SP-A	B-Protein
,	O
SP-B	B-Protein
y	O
SP-C	B-Protein
fueron	O
amablemente	O
proporcionados	O
por	O
el	O
Dr.	O
Jeffery	O
Whitsett	O
(	O
División	O
de	O
Biología	O
Pulmonar	O
,	O
Centro	O
Médico	O
del	O
Hospital	O
Infantil	O
de	O
Cincinnati	O
,	O
Cincinnati	O
,	O
Ohio	O
)	O
.	O

A	O
sonda	B-Sequence
de	I-Sequence
ADNc	I-Sequence
por	O
SP-D	B-Protein
fue	O
amplificado	O
por	O
RT	O
-	O
PCR	O
,	O
usando	O
murino	B-Taxon
SP-D	B-Protein
ADNc	B-Sequence
específico	O
cebadores	B-Sequence
(	O
sentido	O
5	O
'	O
-	O
TGCCTGGTCGTGATGGACG	O
-	O
3	O
'	O
,	O
y	O
antisentido	B-Sequence
5'-AGCACTGTCTGGAAGCCCGC-3	O
'	O
)	O
y	O
confirmado	O
por	O
secuenciación	O
.	O

Contribuciones	O
del	O
autor	O

HY	O
diseñó	O
los	O
experimentos	O
.	O

HY	O
,	O
ALP	O
y	O
JLC	O
realizaron	O
experimentos	O
.	O

Tejido	O
analizado	O
GST	O
esteroles	B-Chemical
por	O
GC-MS	O
y	O
JO	O
realizó	O
análisis	O
morfométricos	O
de	O
pulmón	O
.	O

HY	O
,	O
AW	O
y	O
SBP	O
analizaron	O
los	O
datos	O
.	O

HY	O
y	O
SBP	O
prepararon	O
el	O
manuscrito	O
.	O

Todos	O
los	O
autores	O
leyeron	O
y	O
aprobaron	O
el	O
manuscrito	O
final	O
.	O

Agradecimientos	O

Agradecemos	O
a	O
Jeffery	O
Whitsett	O
por	O
brindarnos	O
sondas	B-Sequence
de	I-Sequence
ADNc	I-Sequence
por	O
SP-A	B-Protein
,	O
SP-B	B-Protein
y	O
SP-C	B-Protein
y	O
Pao	O
-	O
Tien	O
Chuang	O
por	O
la	O
Shh	B-Protein
y	O
Shh	B-Protein
-	O
norte	B-Chemical
plásmidos	B-Sequence
.	O

Esta	O
investigación	O
fue	O
apoyada	O
por	O
una	O
subvención	O
inicial	O
0160349U	O
de	O
la	O
American	O
Heart	O
Association	O
,	O
Mid-Atlantic	O
Consortium	O
(	O
HY	O
)	O
;	O
NIH	O
PO1	O
HL52813	O
y	O
NIH	O
PO1	O
HD39946	O
(	O
AW	O
)	O
y	O
NIH	O
HL68660	O
(	O
SBP	O
)	O
.	O

Receptores	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
mediar	O
la	O
discriminación	O
de	O
dos	O
olores	O
y	O
el	O
aprendizaje	O
inverso	O
en	O
C57BL	O
/	O
6	O
ratones	B-Taxon

Resumen	O

Antecedentes	O

dopamina	B-Chemical
modulación	O
de	O
neuronales	B-Cell
la	O
señalización	O
en	O
la	O
corteza	O
frontal	O
,	O
el	O
mesencéfalo	O
y	O
el	O
cuerpo	O
estriado	O
es	O
esencial	O
para	O
procesar	O
e	O
integrar	O
diversos	O
estímulos	O
sensoriales	O
externos	O
y	O
otorgar	O
prominencia	O
a	O
las	O
señales	O
ambientales	O
que	O
señalan	O
relaciones	O
causales	O
,	O
guiando	O
así	O
conductas	O
adaptables	O
dirigidas	O
a	O
objetivos	O
.	O

En	O
el	O
celular	B-Cell
nivel	O
,	O
dopamina	B-Chemical
La	O
señalización	O
está	O
mediada	O
por	O
Receptores	B-Protein
similares	I-Protein
a	I-Protein
D1	I-Protein
o	I-Protein
D2	I-Protein
.	O

Aunque	O
un	O
papel	O
para	O
D1	B-Protein
-	I-Protein
como	I-Protein
receptores	I-Protein
en	O
una	O
variedad	O
de	O
comportamientos	O
dirigidos	O
a	O
un	O
objetivo	O
ha	O
sido	O
identificado	O
,	O
una	O
participación	O
explícita	O
de	O
receptores	B-Protein
D2	I-Protein
no	O
se	O
ha	O
establecido	O
claramente	O
.	O

Para	O
determinar	O
si	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
-	O
la	O
señalización	O
mediada	O
contribuye	O
al	O
aprendizaje	O
asociativo	O
y	O
reverso	O
,	O
comparamos	O
C57Bl	O
/	O
6J	O
ratones	B-Taxon
que	O
carecen	O
por	O
completo	O
de	O
funcionalidad	O
receptores	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
para	O
tipo	B-Sequence
salvaje	I-Sequence
ratones	B-Taxon
con	O
respecto	O
a	O
su	O
capacidad	O
para	O
otorgar	O
prominencia	O
adecuada	O
a	O
los	O
estímulos	O
externos	O
(	O
discriminación	O
de	O
estímulos	O
)	O
y	O
desvincularse	O
de	O
estrategias	O
conductuales	O
inapropiadas	O
cuando	O
cambian	O
las	O
contingencias	O
de	O
refuerzo	O
(	O
p	O
.	O
ej	O
.	O
,	O
aprendizaje	O
inverso	O
)	O
.	O

Resultados	O

Levemente	O
comida	B-Chemical
#	O
¿NOMBRE	O
?	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
deficiente	O
ratones	B-Taxon
aprendió	O
rápidamente	O
a	O
recuperar	O
y	O
consumir	O
visible	O
comida	B-Chemical
refuerzos	O
de	O
un	O
pequeño	O
plato	O
de	O
plástico	O
.	O

Además	O
,	O
ambos	O
genotipos	B-Sequence
aprendió	O
fácilmente	O
a	O
cavar	O
a	O
través	O
del	O
mismo	O
plato	O
lleno	O
de	O
arena	O
estéril	O
para	O
localizar	O
un	O
enterrado	O
comida	B-Chemical
bolita	O

Sin	O
embargo	O
,	O
el	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
deficiente	O
ratones	B-Taxon
requirió	O
significativamente	O
más	O
ensayos	O
que	O
tipo	B-Sequence
salvaje	I-Sequence
ratones	B-Taxon
discriminar	O
entre	O
dos	O
platos	O
,	O
cada	O
uno	O
lleno	O
de	O
una	O
arena	O
perfumada	O
diferente	O
,	O
y	O
asociar	O
uno	O
de	O
los	O
dos	O
olores	O
con	O
la	O
presencia	O
de	O
un	O
reforzador	O
(	O
comida	B-Chemical
)	O
.	O

Además	O
,	O
el	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
deficiente	O
ratones	B-Taxon
fallan	O
repetidamente	O
en	O
alterar	O
sus	O
patrones	O
de	O
respuesta	O
durante	O
los	O
ensayos	O
de	O
reversión	O
donde	O
se	O
invirtieron	O
las	O
reglas	O
de	O
refuerzo	O
.	O

Conclusiones	O

C57Bl	O
/	O
6J	O
endogámico	O
ratones	B-Taxon
que	O
se	O
desarrollan	O
en	O
ausencia	O
total	O
de	O
funcionamiento	O
receptores	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
son	O
capaces	O
de	O
olfato	O
pero	O
muestran	O
una	O
capacidad	O
disminuida	O
para	O
adquirir	O
contingencias	O
de	O
refuerzo	O
impulsadas	O
por	O
el	O
olor	O
.	O

Además	O
,	O
la	O
capacidad	O
de	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
deficiente	O
ratones	B-Taxon
para	O
ajustar	O
su	O
respuesta	O
a	O
un	O
estímulo	O
previamente	O
reforzado	O
cuando	O
se	O
encuentran	O
resultados	O
inesperados	O
se	O
ve	O
significativamente	O
afectada	O
.	O

Estos	O
hallazgos	O
sugieren	O
que	O
la	O
señalización	O
mediada	O
por	O
el	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
es	O
importante	O
para	O
regular	O
el	O
aprendizaje	O
asociativo	O
e	O
inverso	O
y	O
puede	O
tener	O
implicaciones	O
para	O
el	O
tratamiento	O
de	O
humano	B-Taxon
trastornos	O
de	O
atención	O
.	O

Antecedentes	O

Aprendizaje	O
asociativo	O
mediado	O
por	O
refuerzo	O
,	O
o	O
la	O
capacidad	O
de	O
atribuir	O
relaciones	O
deterministas	O
entre	O
estímulos	O
ambientales	O
que	O
señalan	O
la	O
probabilidad	O
de	O
recibir	O
un	O
reforzador	O
primario	O
(	O
p	O
.	O
comida	B-Chemical
)	O
,	O
se	O
ha	O
dividido	O
en	O
3	O
componentes	O
o	O
etapas	O
[	O
1	O
]	O
.	O

La	O
primera	O
etapa	O
,	O
no	O
aprendida	O
,	O
es	O
la	O
organismo	B-Taxon
experiencia	O
con	O
un	O
reforzador	O
primario	O
que	O
provoca	O
alguna	O
respuesta	O
fisiológica	O
no	O
aprendida/innata	O
(	O
por	O
ejemplo	O
,	O
la	O
palatabilidad	O
de	O
un	O
comida	B-Chemical
o	O
saciedad	O
)	O
.	O

La	O
segunda	O
fase	O
implica	O
el	O
apego	O
de	O
la	O
prominencia	O
a	O
los	O
estímulos	O
externos	O
(	O
estímulos	O
discriminativos	O
)	O
que	O
señalan	O
si	O
la	O
entrega	O
de	O
un	O
reforzador	O
primario	O
ocurrirá	O
o	O
no	O
en	O
función	O
de	O
algún	O
comportamiento	O
emitido	O
(	O
p	O
.	O
ej.	O
,	O
un	O
roedor	B-Taxon
prensas	O
de	O
palanca	O
para	O
comida	B-Chemical
gránulos	O
sólo	O
cuando	O
se	O
ilumina	O
una	O
luz	O
de	O
estímulo	O
en	O
una	O
cámara	O
operante	O
)	O
.	O

Finalmente	O
,	O
está	O
el	O
mantenimiento	O
de	O
las	O
relaciones	O
de	O
aprendizaje	O
asociativo	O
a	O
lo	O
largo	O
del	O
tiempo	O
(	O
una	O
luz	O
de	O
estímulo	O
siempre	O
significa	O
un	O
comida	B-Chemical
pellet	O
está	O
disponible	O
después	O
de	O
una	O
presión	O
de	O
palanca	O
)	O
[	O
ver	O
refs	O
.	O
[	O
1	O
,	O
2	O
]	O
para	O
revisión	O
]	O
.	O

Berridge	O
y	O
Robinson	O
[	O
1	O
]	O
han	O
propuesto	O
que	O
dopamina	B-Chemical
``	O
juega	O
un	O
papel	O
fundamental	O
en	O
la	O
segunda	O
fase	O
del	O
aprendizaje	O
asociativo	O
mediado	O
por	O
refuerzo	O
al	O
moldear	O
la	O
``	O
''	O
prominencia	O
del	O
incentivo	O
''	O
''	O
o	O
las	O
propiedades	O
motivacionales	O
aprendidas	O
de	O
los	O
estímulos	O
condicionados	O
.	O
''	O

En	O
apoyo	O
de	O
este	O
punto	O
de	O
vista	O
hay	O
varios	O
estudios	O
que	O
demuestran	O
que	O
la	O
interrupción	O
de	O
dopamina	B-Chemical
señalización	O
a	O
través	O
del	O
bloqueo	O
agudo	O
de	O
dopamina	B-Chemical
receptores	O
con	O
antagonistas	B-Chemical
de	I-Chemical
los	I-Chemical
receptores	I-Chemical
de	I-Chemical
dopamina	I-Chemical
3	O
-	O
9	O
]	O
o	O
lesiones	O
6	O
-	O
OHDA	O
[	O
1	O
,	O
10	O
,	O
11	O
]	O
no	O
interrumpen	O
la	O
fase	O
1	O
,	O
la	O
palatabilidad	O
o	O
las	O
características	O
de	O
refuerzo	O
primarias	O
de	O
un	O
reforzador	O
natural	O
(	O
p	O
.	O
ej	O
.	O
palatabilidad	O
)	O
pero	O
interrumpen	O
la	O
fase	O
2	O
,	O
la	O
formación	O
de	O
prominencia	O
de	O
incentivo	O
.	O

dopamina	B-Chemical
la	O
señalización	O
está	O
mediada	O
en	O
el	O
celular	B-Cell
nivel	O
por	O
dos	O
subclases	O
principales	O
de	O
receptores	O
acoplados	O
a	O
proteína	O
G	O
que	O
se	O
denominan	O
D	B-Protein
-	I-Protein
1	I-Protein
me	I-Protein
gusta	I-Protein
(	O
D1aR	B-Protein
,	O
D1b	B-Protein
/	O
5R	O
)	O
o	O
D	B-Protein
-	I-Protein
2	I-Protein
me	I-Protein
gusta	I-Protein
(	O
D2R	B-Protein
,	O
D3R	B-Protein
,	O
D4R	B-Protein
)	O
[	O
12	O
,	O
13	O
]	O
.	O

Aunque	O
individual	O
genes	B-Sequence
código	O
para	O
cada	O
dopamina	B-Chemical
subtipo	O
de	O
receptor	O
,	O
existe	O
una	O
considerable	O
superposición	O
farmacológica	O
entre	O
Receptores	B-Protein
tipo	I-Protein
D1	I-Protein
y	I-Protein
tipo	I-Protein
D2	I-Protein
.	O

Varios	O
estudios	O
han	O
utilizado	O
manipulaciones	O
farmacológicas	O
para	O
investigar	O
la	O
contribución	O
de	O
dopamina	B-Chemical
subtipos	O
de	O
receptores	O
en	O
varias	O
etapas	O
de	O
aprendizaje	O
asociativo	O
[	O
1	O
,	O
2	O
,	O
14	O
]	O
.	O

Actualmente	O
se	O
sostiene	O
que	O
excitatorio	O
dopamina	B-Protein
D1R	I-Protein
mediar	O
en	O
la	O
adquisición	O
y	O
expresión	O
de	O
varios	O
comportamientos	O
condicionados	O
que	O
implican	O
comida	B-Chemical
reforzadores	O
[	O
e	O
.	O
g.	O
[	O
6	O
,	O
7	O
]	O
]	O
así	O
como	O
responder	O
a	O
señales	O
condicionadas	O
predictivas	O
de	O
cocaína	B-Chemical
entrega	O
[	O
9	O
]	O
-	O
consistente	O
con	O
la	O
interpretación	O
de	O
que	O
D1R	B-Protein
la	O
señalización	O
mediada	O
podría	O
modular	O
el	O
mantenimiento	O
de	O
los	O
resultados	O
de	O
estímulo-respuesta	O
.	O

A	O
pesar	O
de	O
una	O
creciente	O
literatura	O
que	O
demuestra	O
aprendizaje	O
asociativo	O
interrumpido	O
después	O
de	O
manipulaciones	O
agudas	O
de	O
dopamina	B-Protein
D1R	I-Protein
señalización	O
durante	O
la	O
adquisición	O
de	O
tareas	O
de	O
aprendizaje	O
asociativo	O
con	O
comida	B-Chemical
[	O
mi	O
.	O
g.	O
[	O
6	O
,	O
7	O
]	O
]	O
,	O
la	O
contribución	O
real	O
de	O
D2R	B-Protein
#	O
¿NOMBRE	O
?	O
roedores	B-Taxon
está	O
sin	O
resolver	O
.	O

Tiempo	O
D2R	B-Protein
antagonistas	B-Chemical
han	O
sido	O
utilizados	O
en	O
el	O
contexto	O
de	O
roedor	B-Taxon
Los	O
paradigmas	O
de	O
aprendizaje	O
asociativo	O
,	O
su	O
falta	O
de	O
especificidad	O
de	O
subtipo	O
de	O
receptor	O
[	O
13	O
]	O
y	O
los	O
efectos	O
de	O
alteración	O
motora	O
[	O
6	O
,	O
8	O
]	O
han	O
impedido	O
un	O
examen	O
riguroso	O
del	O
papel	O
real	O
de	O
este	O
dopamina	B-Chemical
El	O
subtipo	O
de	O
receptor	O
juega	O
en	O
el	O
aprendizaje	O
asociativo	O
y	O
de	O
inversión	O
en	O
el	O
contexto	O
de	O
un	O
comportamiento	O
operante	O
.	O

Experimentos	O
anteriores	O
que	O
buscaban	O
explorar	O
la	O
posible	O
participación	O
de	O
dopamina	B-Protein
D2R	I-Protein
en	O
el	O
aprendizaje	O
asociativo	O
han	O
utilizado	O
dosis	O
bajas	O
a	O
moderadas	O
de	O
drogas	B-Chemical
[	O
2	O
,	O
5	O
,	O
6	O
]	O
y	O
la	O
administración	O
en	O
un	O
sitio	O
específico	O
[	O
7	O
,	O
9	O
]	O
para	O
evitar	O
el	O
efecto	O
de	O
confusión	O
de	O
que	O
la	O
interrupción	O
del	O
aparato	O
locomotor	O
asociada	O
con	O
la	O
D2R	B-Protein
bloqueo	O
puede	O
tener	O
sobre	O
el	O
rendimiento	O
del	O
aprendizaje	O
en	O
roedores	B-Taxon
.	O

Además	O
de	O
su	O
falta	O
de	O
especificidad	O
de	O
subtipo	O
de	O
receptor	O
,	O
una	O
exposición	O
aguda	O
a	O
los	O
disponibles	O
comercialmente	O
receptor	B-Protein
D2	I-Protein
antagonistas	B-Chemical
no	O
bloquea	O
completamente	O
la	O
señalización	O
mediada	O
únicamente	O
por	O
D2R	B-Protein
.	O

Además	O
,	O
la	O
dosificación	O
aguda	O
no	O
recapitula	O
los	O
marcados	O
déficits	O
de	O
aprendizaje	O
producidos	O
en	O
roedores	B-Taxon
[	O
15	O
,	O
16	O
]	O
por	O
exposición	O
crónica	O
a	O
antagonistas	B-Chemical
de	I-Chemical
dopamina	I-Chemical
D2R	I-Chemical
[	O
6	O
,	O
7	O
]	O
.	O

La	O
influencia	O
de	O
dopamina	B-Protein
D2R	I-Protein
La	O
señalización	O
mediada	O
por	O
el	O
aprendizaje	O
inverso	O
también	O
es	O
poco	O
conocida	O
.	O

El	O
aprendizaje	O
inverso	O
se	O
puede	O
conceptualizar	O
como	O
la	O
capacidad	O
de	O
reconocer	O
una	O
consecuencia	O
inesperada	O
de	O
una	O
regla	O
de	O
aprendizaje	O
asociativo	O
previamente	O
establecida	O
y	O
luego	O
modificar	O
las	O
estrategias	O
de	O
respuesta	O
en	O
consecuencia	O
[	O
17	O
,	O
18	O
]	O
.	O

Aprendizaje	O
inverso	O
en	O
roedores	B-Taxon
puede	O
servir	O
como	O
un	O
índice	O
de	O
adaptabilidad	O
al	O
aprendizaje	O
y	O
estado	O
de	O
alerta	O
que	O
se	O
correlaciona	O
con	O
humano	B-Taxon
paradigmas	O
de	O
cambio	O
de	O
atención	O
[	O
17	O
,	O
18	O
]	O
.	O

Además	O
,	O
un	O
informe	O
anterior	O
demostró	O
que	O
las	O
lesiones	O
excitotóxicas	O
de	O
Terminal	B-GENE
objetivos	O
de	O
campo	O
de	O
mesocortical	O
dopamina	B-Chemical
se	O
ha	O
demostrado	O
que	O
interrumpe	O
el	O
aprendizaje	O
inverso	O
[	O
19	O
]	O
.	O

administración	O
de	O
la	O
D2R	B-Protein
/	O
D3R	B-Protein
antagonista	B-Chemical
,	O
sulpirida	O
,	O
perjudica	O
la	O
inversión	O
espacial	O
apoyándose	O
ratones	B-Taxon
[	O
20	O
]	O
y	O
también	O
se	O
ha	O
demostrado	O
que	O
afecta	O
la	O
atención	O
y	O
el	O
rendimiento	O
cognitivo	O
de	O
personas	O
sanas	O
.	O
humano	B-Taxon
voluntarios	O
[	O
21	O
]	O
.	O

Además	O
,	O
una	O
relación	O
inversa	O
entre	O
la	O
baja	O
dopamina	B-Protein
D2R	I-Protein
niveles	O
y	O
conducta	O
compulsiva	O
en	O
humano	B-Taxon
temas	O
ha	O
sido	O
informado	O
[	O
22	O
]	O
.	O

En	O
conjunto	O
,	O
estos	O
hallazgos	O
sugieren	O
que	O
D2R	B-Protein
La	O
señalización	O
mediada	O
por	O
señales	O
podría	O
desempeñar	O
un	O
papel	O
fundamental	O
en	O
el	O
aprendizaje	O
inverso	O
,	O
pero	O
es	O
insuficiente	O
para	O
demostrarlo	O
.	O

En	O
un	O
esfuerzo	O
por	O
establecer	O
la	O
contribución	O
de	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
,	O
comparamos	O
ratones	B-Taxon
[	O
23	O
]	O
que	O
se	O
había	O
desarrollado	O
en	O
ausencia	O
total	O
de	O
toda	O
funcionalidad	O
receptores	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
(	O
D2R	B-Protein
-	O
/	O
-	O
)	O
para	O
tipo	B-Sequence
salvaje	I-Sequence
compañeros	O
de	O
camada	O
(	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
)	O
en	O
un	O
procedimiento	O
de	O
aprendizaje	O
operante	O
pasa	O
/	O
no	O
pasa	O
que	O
mide	O
el	O
refuerzo	O
primario	O
,	O
el	O
procesamiento	O
sensorial	O
y	O
el	O
aprendizaje	O
inverso	O
[	O
17	O
-	O
19	O
]	O
.	O

Aquí	O
informamos	O
que	O
dopamina	B-Protein
D2R	I-Protein
#	O
¿NOMBRE	O
?	O
ratón	B-Taxon
es	O
aprender	O
eficientemente	O
a	O
asociar	O
un	O
comida	B-Chemical
reforzador	O
con	O
un	O
olor	O
específico	O
y	O
luego	O
desvincularse	O
adaptativamente	O
de	O
estrategias	O
conductuales	O
inapropiadas	O
siguiendo	O
la	O
reversión	O
de	O
las	O
contingencias	O
de	O
refuerzo	O
.	O

Resultados	O

Ambas	O
cosas	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
D2R	B-Protein
deficiente	O
ratones	B-Taxon
aprender	O
comportamientos	O
operantes	O
igualmente	O
bien	O

Levemente	O
comida	B-Chemical
#	O
¿NOMBRE	O
?	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
y	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
fácilmente	O
aprendido	O
a	O
localizar	O
y	O
consumir	O
comida	B-Chemical
balines	O
durante	O
ambas	O
sesiones	O
de	O
entrenamiento	O
.	O

La	O
Figura	O
1	O
muestra	O
la	O
latencia	O
para	O
ambos	O
genotipos	B-Sequence
para	O
deambular	O
a	O
un	O
plato	O
para	O
recuperar	O
un	O
oculto	O
comida	B-Chemical
bolita	O

No	O
hubo	O
diferencias	O
entre	O
genotipos	B-Sequence
para	O
recuperar	O
los	O
reforzadores	O
(	O
F1	O
,	O
59	O
=	O
0	O
.	O
2	O
,	O
p	O
>	O
0	O
.	O
65	O
)	O
,	O
y	O
ambos	O
grupos	O
redujeron	O
significativamente	O
la	O
cantidad	O
de	O
tiempo	O
necesario	O
para	O
realizar	O
esta	O
tarea	O
a	O
lo	O
largo	O
de	O
ensayos	O
sucesivos	O
(	O
F4	O
,	O
59	O
=	O
5	O
.	O
74	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

La	O
figura	O
2	O
muestra	O
la	O
latencia	O
para	O
excavar	O
en	O
busca	O
del	O
comida	B-Chemical
gránulo	O
enterrado	O
en	O
un	O
solo	O
plato	O
lleno	O
de	O
arena	O
sin	O
perfume	O
.	O

No	O
genotipo	B-Sequence
se	O
encontraron	O
diferencias	O
en	O
la	O
capacidad	O
de	O
cavar	O
a	O
través	O
de	O
la	O
arena	O
sin	O
olor	O
para	O
un	O
oculto	O
comida	B-Chemical
pastilla	O
(	O
F1	O
,	O
128	O
=	O
1	O
,	O
26	O
,	O
p	O
>	O
0	O
,	O
27	O
)	O
.	O

Tipo	B-Sequence
salvaje	I-Sequence
ratones	B-Taxon
superar	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
en	O
una	O
tarea	O
operante	O
impulsada	O
por	O
olores	O
,	O
discriminación	O
de	O
estímulos	O
.	O

Para	O
dominar	O
la	O
tarea	O
de	O
discriminación	O
de	O
estímulos	O
impulsada	O
por	O
olores	O
,	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
requirió	O
significativamente	O
más	O
ensayos	O
(	O
Fig	O
.	O
3A	O
:	O
t	O
(	O
14	O
)	O
=	O
2	O
.	O
20	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
y	O
cometió	O
más	O
errores	O
(	O
Fig	O
.	O
3B	O
:	O
t	O
(	O
14	O
)	O
=	O
2	O
.	O
92	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
que	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
aprender	O
a	O
asociar	O
un	O
olor	O
específico	O
con	O
la	O
presencia	O
o	O
ausencia	O
del	O
comida	B-Chemical
reforzador	O

Sin	O
embargo	O
,	O
ambos	O
genotipos	B-Sequence
Aprendió	O
la	O
tarea	O
y	O
eventualmente	O
mantuvo	O
una	O
discriminación	O
precisa	O
para	O
un	O
mínimo	O
de	O
8	O
respuestas	O
correctas	O
de	O
10	O
intentos	O
.	O

Ratones	B-Taxon
carente	O
receptores	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
participar	O
en	O
un	O
comportamiento	O
no	O
reforzado	O
de	O
manera	O
perseverante	O
después	O
de	O
la	O
reversión	O
de	O
las	O
contingencias	O
de	O
refuerzo	O

D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
fallaron	O
repetidamente	O
en	O
inhibir	O
las	O
contingencias	O
de	O
aprendizaje	O
previamente	O
establecidas	O
durante	O
los	O
ensayos	O
de	O
reversión	O
(	O
Fig	O
.	O
4A	O
:	O
t	O
(	O
14	O
)	O
=	O
3.54	O
;	O
p	O
<	O
0.01	O
)	O
y	O
cometieron	O
significativamente	O
más	O
errores	O
de	O
reversión	O
que	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
Fig	O
.	O
4B	O
:	O
t	O
(	O
14	O
)	O
=	O
3,18	O
;	O
p	O
<	O
0,01	O
)	O
.	O

División	O
categórica	O
de	O
los	O
errores	O
de	O
reversión	O
(	O
Ferry	O
et	O
al	O
.	O
,	O
2000	O
)	O
-	O
cavar	O
en	O
el	O
plato	O
que	O
no	O
contenía	O
el	O
comida	B-Chemical
gránulo	O
(	O
S-	O
)	O
(	O
error	O
de	O
comisión	O
;	O
Fig	O
.	O
5A	O
)	O
versus	O
no	O
responder	O
dentro	O
de	O
los	O
3	O
minutos	O
de	O
la	O
presentación	O
(	O
error	O
de	O
omisión	O
;	O
Fig	O
.	O
5B	O
)	O
reveló	O
que	O
ambos	O
genotipos	B-Sequence
cometió	O
principalmente	O
errores	O
de	O
comisión	O
frente	O
a	O
errores	O
de	O
omisión	O
(	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
,	O
U	O
=	O
0	O
.	O
00	O
;	O
pag	O
<	O
0	O
.	O
01	O
;	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
tu	O
=	O
9	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
cometió	O
más	O
errores	O
de	O
comisión	O
que	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
U	O
=	O
5	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
y	O
no	O
hubo	O
diferencias	O
entre	O
D2R	B-Protein
-	O
/	O
-	O
y	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
en	O
errores	O
de	O
omisión	O
(	O
U	O
=	O
27	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
65	O
)	O
.	O

Además	O
,	O
el	O
número	O
de	O
errores	O
de	O
comisión	O
cometidos	O
durante	O
la	O
primera	O
sesión	O
de	O
reversión	O
(	O
un	O
índice	O
de	O
perseverancia	O
del	O
límite	O
de	O
estímulo	O
,	O
donde	O
todos	O
animales	B-Taxon
están	O
respondiendo	O
a	O
las	O
contingencias	O
invertidas	O
por	O
primera	O
vez	O
;	O
Higo	O
.	O
6	O
)	O
indicó	O
un	O
déficit	O
en	O
el	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
en	O
comparación	O
con	O
el	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
U	O
=	O
8	O
.	O
5	O
,	O
pags	O
<	O
0	O
.	O
01	O
)	O
.	O

Finalmente	O
,	O
en	O
un	O
intento	O
de	O
evaluar	O
si	O
la	O
perseveración	O
ocurrió	O
a	O
través	O
de	O
múltiples	O
sesiones	O
de	O
inversión	O
(	O
Fig	O
.	O
7	O
)	O
,	O
analizamos	O
el	O
número	O
de	O
errores	O
de	O
comisión	O
emitidos	O
antes	O
de	O
volver	O
a	O
aprender	O
las	O
contingencias	O
de	O
refuerzo	O
durante	O
las	O
sesiones	O
de	O
inversión	O
.	O

Los	O
datos	O
representados	O
se	O
recopilaron	O
de	O
sujetos	O
que	O
no	O
habían	O
alcanzado	O
el	O
criterio	O
de	O
desempeño	O
del	O
80	O
%	O
.	O

Por	O
lo	O
tanto	O
,	O
el	O
número	O
de	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
representado	O
en	O
la	O
sesión	O
#	O
1	O
es	O
8	O
,	O
en	O
la	O
sesión	O
#	O
2	O
n	O
=	O
8	O
,	O
en	O
la	O
sesión	O
#	O
3	O
n	O
=	O
6	O
(	O
2	O
ratones	B-Taxon
cumplieron	O
con	O
nuestro	O
criterio	O
)	O
,	O
en	O
la	O
sesión	O
#	O
4	O
n=5	O
(	O
tres	O
cumplieron	O
con	O
el	O
criterio	O
)	O
.	O

Después	O
de	O
la	O
sesión	O
5	O
,	O
las	O
5	O
restantes	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
había	O
cumplido	O
con	O
los	O
criterios	O
.	O

Para	O
el	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
,	O
cada	O
punto	O
del	O
gráfico	O
representa	O
8	O
sujetos	O
.	O

Ninguno	O
de	O
los	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
alcanzó	O
el	O
criterio	O
del	O
80	O
%	O
de	O
precisión	O
en	O
la	O
sesión	O
5	O
.	O

Para	O
el	O
ANOVA	O
general	O
de	O
2	O
vías	O
,	O
hubo	O
una	O
diferencia	O
significativa	O
entre	O
genotipos	B-Sequence
para	O
el	O
número	O
de	O
errores	O
perseverantes	O
(	O
F1	O
,	O
51	O
=	O
16	O
.	O
61	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Discusión	O

En	O
este	O
estudio	O
se	O
buscó	O
determinar	O
la	O
contribución	O
de	O
receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
#	O
¿NOMBRE	O
?	O

D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
demostraron	O
que	O
eran	O
capaces	O
de	O
aprender	O
a	O
localizar	O
y	O
consumir	O
comida	B-Chemical
gránulos	O
,	O
lo	O
que	O
indica	O
que	O
su	O
comportamiento	O
locomotor	O
no	O
se	O
interrumpió	O
de	O
manera	O
detectable	O
y	O
su	O
principal	O
motivación	O
para	O
obtener	O
un	O
reforzador	O
natural	O
(	O
comida	B-Chemical
gránulo	O
)	O
no	O
se	O
alteró	O
.	O

Más	O
bien	O
,	O
la	O
capacidad	O
disminuida	O
de	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
para	O
asignar	O
relaciones	O
de	O
estímulo	O
discriminativo	O
apropiadas	O
en	O
una	O
tarea	O
de	O
discriminación	O
operante	O
argumenta	O
que	O
D2R	B-Protein
#	O
¿NOMBRE	O
?	O
neuronales	B-Cell
Procesos	O
involucrados	O
en	O
atribuir	O
prominencia	O
a	O
los	O
estímulos	O
ambientales	O
.	O

La	O
deficiente	O
capacidad	O
de	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
para	O
desconectar	O
estrategias	O
de	O
decisión	O
inapropiadas	O
argumenta	O
fuertemente	O
que	O
mesolímbico	O
dopamina	B-Chemical
señalización	O
,	O
mediada	O
por	O
dopamina	B-Protein
D2R	I-Protein
es	O
esencial	O
para	O
que	O
ocurra	O
un	O
aprendizaje	O
inverso	O
eficiente	O
.	O

Ratones	B-Taxon
con	O
o	O
sin	O
intacto	O
dopamina	B-Protein
D2R	I-Protein
#	O
¿NOMBRE	O
?	O
comida	B-Chemical
gránulos	O
(	O
Fig	O
.	O
1	O
)	O
y	O
aprendió	O
a	O
cavar	O
para	O
comida	B-Chemical
enterrado	O
en	O
arena	O
sin	O
perfume	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Estos	O
resultados	O
están	O
en	O
completo	O
acuerdo	O
con	O
estudios	O
anteriores	O
que	O
utilizaron	O
ratas	B-Taxon
y	O
bastante	O
selectivo	O
D2R	B-Protein
antagonistas	B-Chemical
[	O
3	O
-	O
8	O
]	O
,	O
así	O
como	O
incluso	O
lesiones	O
muy	O
extensas	O
de	O
6	O
-	O
OHDA	O
[	O
1	O
,	O
10	O
,	O
11	O
]	O
en	O
paradigmas	O
de	O
aprendizaje	O
asociativo	O
y	O
operante	O
.	O

Nuestros	O
resultados	O
se	O
suman	O
a	O
una	O
creciente	O
literatura	O
que	O
demuestra	O
un	O
papel	O
insignificante	O
de	O
dopamina	B-Chemical
,	O
y	O
ahora	O
,	O
concretamente	O
,	O
D2R	B-Protein
en	O
el	O
valor	O
incondicionado	O
o	O
hedónico	O
de	O
lo	O
natural	O
(	O
comida	B-Chemical
)	O
reforzadores	O
[	O
1	O
,	O
2	O
]	O
.	O

La	O
habilidad	O
comparativamente	O
pobre	O
de	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
durante	O
los	O
juicios	O
por	O
discriminación	O
sugiere	O
un	O
papel	O
para	O
D2R	B-Protein
en	O
la	O
adquisición	O
de	O
relaciones	O
S+/S-	O
apropiadas	O
en	O
el	O
aprendizaje	O
asociativo	O
operante	O
.	O

Varios	O
estudios	O
han	O
demostrado	O
que	O
tanto	O
la	O
adquisición	O
[	O
6	O
,	O
7	O
]	O
como	O
la	O
expresión	O
[	O
9	O
]	O
del	O
aprendizaje	O
asociativo	O
están	O
mediadas	O
por	O
dopamina	B-Protein
D1R	I-Protein
.	O

La	O
mayoría	O
de	O
las	O
revisiones	O
de	O
la	O
literatura	O
identifican	O
dopamina	B-Protein
D1R	I-Protein
con	O
dopamina	B-Chemical
#	O
¿NOMBRE	O
?	O
D2R	B-Protein
con	O
comportamientos	O
relacionados	O
con	O
el	O
motor	O
[	O
p	O
.	O
g.	O
[	O
24	O
]	O
]	O
.	O

Además	O
,	O
se	O
ha	O
informado	O
que	O
la	O
administración	O
aguda	O
del	O
antagonista	B-Chemical
de	I-Chemical
la	I-Chemical
dopamina	I-Chemical
D2/3	I-Chemical
racloprida	O
,	O
en	O
realidad	O
mejora	O
la	O
adquisición	O
de	O
comida	B-Chemical
-	O
aprendizaje	O
asociativo	O
motivado	O
[	O
6	O
]	O
.	O

Sin	O
embargo	O
,	O
sólo	O
las	O
administraciones	O
agudas	O
de	O
antagonistas	B-Chemical
se	O
les	O
dio	O
,	O
y	O
el	O
aprendizaje	O
no	O
se	O
midió	O
durante	O
la	O
completa	O
D1R	B-Protein
o	O
D2R	B-Protein
bloqueo	O
[	O
6	O
]	O
.	O

Significativamente	O
,	O
los	O
informes	O
citados	O
anteriormente	O
no	O
abordaron	O
las	O
limitaciones	O
técnicas	O
del	O
enfoque	O
:	O
i	O
.	O
mi	O
.	O
que	O
el	O
antagonistas	B-Chemical
utilizados	O
carecen	O
de	O
especificidad	O
de	O
subtipo	O
adecuada	O
y	O
solo	O
se	O
bloquean	O
parcialmente	O
D2R	B-Protein
#	O
¿NOMBRE	O
?	O
D2R	B-Protein
#	O
¿NOMBRE	O
?	O

Además	O
,	O
ninguno	O
de	O
estos	O
estudios	O
abordó	O
la	O
observación	O
de	O
que	O
los	O
efectos	O
de	O
D2R	B-Protein
antagonistas	B-Chemical
en	O
la	O
locomoción	O
y	O
el	O
aprendizaje	O
dependen	O
de	O
si	O
la	O
exposición	O
es	O
crónica	O
o	O
aguda	O
[	O
p	O
.	O
g.	O
[	O
15	O
,	O
16	O
]	O
]	O
.	O

Que	O
D2R	B-Protein
#	O
¿NOMBRE	O
?	O
drogas	B-Chemical
que	O
inducen	O
catalepsia	O
(	O
y	O
,	O
por	O
lo	O
tanto	O
,	O
miden	O
solo	O
un	O
bloqueo	O
parcial	O
de	O
dopamina	B-Protein
D2R	I-Protein
)	O
y	O
administraciones	O
únicas	O
[	O
e	O
.	O
g.	O
[	O
3	O
]	O
]	O
.	O

Muy	O
posiblemente	O
,	O
el	O
papel	O
funcional	O
de	O
D2R	B-Protein
en	O
el	O
aprendizaje	O
asociativo	O
podría	O
estar	O
enmascarado	O
debido	O
a	O
esta	O
preocupación	O
por	O
la	O
interrupción	O
del	O
aparato	O
locomotor	O
[	O
2	O
,	O
6	O
,	O
8	O
]	O
.	O

Dosis	O
de	O
racloprida	O
tan	O
bajas	O
como	O
0	O
.	O
5	O
mg/kg	O
interrumpen	O
significativamente	O
el	O
comportamiento	O
motor	O
[	O
25	O
]	O
,	O
aunque	O
esta	O
dosis	O
periférica	O
se	O
usa	O
consistentemente	O
en	O
paradigmas	O
de	O
aprendizaje	O
[	O
p.	O
g.	O
[	O
6	O
]	O
]	O
.	O

``	O
Uno	O
podría	O
entonces	O
preguntarse	O
:	O
``	O
''	O
¿Cómo	O
podría	O
entonces	O
el	O
papel	O
de	O
''	O
D2R	B-Protein
``	O
en	O
el	O
aprendizaje	O
asociativo	O
se	O
disociará	O
de	O
la	O
conducta	O
motora	O
?	O
``	O
''	O
Experimentos	O
seminales	O
[	O
26	O
-	O
28	O
]	O
han	O
demostrado	O
claramente	O
que	O
la	O
administración	O
repetida	O
de	O
dosis	O
inductoras	O
de	O
catalepsia	O
de	O
''	O
D2R	B-Protein
antagonistas	B-Chemical
en	O
roedores	B-Taxon
en	O
realidad	O
conduce	O
a	O
una	O
notable	O
tolerancia	O
conductual	O
a	O
la	O
catalepsia	O
.	O

Se	O
ha	O
demostrado	O
que	O
estas	O
dosis	O
ocupan	O
bastante	O
más	O
del	O
80	O
%	O
de	O
los	O
D2R	B-Protein
[	O
29	O
]	O
.	O

Futuros	O
experimentos	O
que	O
miden	O
la	O
adquisición	O
de	O
aprendizaje	O
asociativo	O
en	O
roedores	B-Taxon
que	O
recibió	O
administración	O
crónica	O
de	O
D2R	B-Protein
antagonistas	B-Chemical
y	O
la	O
tolerancia	O
conductual	O
demostrada	O
a	O
sus	O
efectos	O
disruptivos	O
motores	O
sería	O
una	O
prueba	O
lógica	O
de	O
esta	O
hipótesis	O
.	O

Sin	O
embargo	O
,	O
la	O
comprensión	O
de	O
que	O
múltiples	O
dopamina	B-Chemical
los	O
subtipos	O
de	O
receptores	O
serían	O
dirigidos	O
simultáneamente	O
con	O
los	O
actualmente	O
disponibles	O
comercialmente	O
antagonistas	B-Chemical
,	O
tal	O
como	O
D2R	B-Protein
,	O
D3R	B-Protein
,	O
y	O
D4R	B-Protein
habría	O
que	O
rectificar	O
.	O

Argumentaríamos	O
que	O
el	O
enfoque	O
más	O
parsimonioso	O
en	O
este	O
momento	O
es	O
utilizar	O
ratones	B-Taxon
eso	O
ha	O
sido	O
genéticamente	B-Sequence
alterado	I-Sequence
tal	O
que	O
carecen	O
de	O
uno	O
o	O
ambos	O
funcionales	O
alelos	B-Sequence
del	O
receptor	O
específico	O
de	O
interés	O
.	O

Si	O
bien	O
tienen	O
sus	O
limitaciones	O
(	O
p	O
.	O
ej	O
.	O
,	O
compensación	O
del	O
desarrollo	O
y	O
efectos	O
de	O
tensión	O
en	O
ratón	B-Taxon
líneas	O
no	O
retrocruzadas	O
adecuadamente	O
con	O
una	O
cepa	O
parental	O
durante	O
un	O
mínimo	O
de	O
10	O
generaciones	O
)	O
,	O
uso	O
de	O
nuestra	O
línea	O
endogámica	O
(	O
generación	O
N20	O
)	O
animales	B-Taxon
en	O
el	O
presente	O
estudio	O
(	O
donde	O
no	O
se	O
detectaron	O
diferencias	O
en	O
el	O
comportamiento	O
locomotor	O
entre	O
D2R	B-Protein
-	O
/	O
-	O
y	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
;	O
higos	O
1	O
y	O
2	O
)	O
reveló	O
un	O
papel	O
previamente	O
no	O
apreciado	O
de	O
D2R	B-Protein
-	O
Señalización	O
mediada	O
en	O
el	O
aprendizaje	O
asociativo	O
y	O
la	O
atención	O
que	O
no	O
se	O
pudo	O
medir	O
con	O
los	O
actualmente	O
disponibles	O
,	O
administrados	O
de	O
forma	O
aguda	O
.	O
D2R	B-Protein
antagonistas	B-Chemical
.	O

Un	O
análisis	O
superficial	O
de	O
nuestros	O
datos	O
podría	O
sugerir	O
a	O
algunos	O
que	O
el	O
genético	B-Sequence
manipulación	O
de	O
la	O
drd2	B-Protein
lugar	B-Sequence
confirió	O
una	O
grave	O
deficiencia	O
olfativa	O
a	O
la	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
.	O

Más	O
bien	O
,	O
argumentamos	O
que	O
esto	O
no	O
es	O
probable	O
porque	O
el	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
aprendió	O
a	O
recuperar	O
el	O
comida	B-Chemical
gránulos	O
de	O
los	O
platos	O
y	O
finalmente	O
aprendió	O
a	O
discriminar	O
con	O
precisión	O
los	O
olores	O
.	O

Datos	O
electrofisiológicos	O
recientes	O
demuestran	O
que	O
dopamina	B-Protein
D2R	I-Protein
's	I-Protein
están	O
ubicados	O
en	O
glutamatérgico	B-Chemical
Terminal	O
axones	B-GENE
de	O
los	O
nervios	O
olfatorios	O
y	O
deprimir	O
la	O
entrada	O
excitatoria	O
del	O
nervio	O
olfatorio	O
a	O
la	O
mitral	O
células	B-Cell
del	O
bulbo	O
olfatorio	O
[	O
30	O
,	O
31	O
]	O
.	O

En	O
consecuencia	O
,	O
nuestros	O
datos	O
y	O
los	O
datos	O
de	O
otros	O
estudios	O
sugieren	O
que	O
la	O
falta	O
total	O
de	O
D2R	B-Protein
en	O
el	O
bulbo	O
olfatorio	O
no	O
impide	O
la	O
transducción	O
de	O
estímulos	O
olfativos	O
;	O
más	O
bien	O
afecta	O
la	O
capacidad	O
de	O
habituarse	O
o	O
afinar	O
la	O
actividad	O
del	O
nervio	O
olfativo	O
asociada	O
con	O
concentraciones	O
repetidas	O
de	O
químico	B-Chemical
estímulos	O
[	O
32	O
]	O
.	O

El	O
rendimiento	O
de	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
durante	O
el	O
aprendizaje	O
inverso	O
es	O
deficiente	O
,	O
lo	O
que	O
revela	O
un	O
papel	O
para	O
dopamina	B-Protein
D2R	I-Protein
#	O
¿NOMBRE	O
?	O

Los	O
patrones	O
de	O
conducta	O
perseverantes	O
caracterizaron	O
a	O
los	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
relativo	O
a	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
durante	O
las	O
sesiones	O
de	O
aprendizaje	O
de	O
reversión	O
(	O
Figura	O
4	O
)	O
,	O
se	O
manifestó	O
durante	O
los	O
primeros	O
ensayos	O
de	O
reversión	O
(	O
Figura	O
6	O
)	O
y	O
persistió	O
a	O
lo	O
largo	O
de	O
varias	O
sesiones	O
(	O
Figura	O
7	O
)	O
.	O

Estos	O
hallazgos	O
son	O
significativos	O
porque	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
responder	O
a	O
comida	B-Chemical
reforzadores	O
y	O
,	O
en	O
última	O
instancia	O
,	O
forman	O
y	O
mantienen	O
relaciones	O
S	O
+	O
/	O
S	O
-	O
impulsadas	O
por	O
olores	O
(	O
un	O
supuesto	O
D1R	B-Protein
-	O
comportamiento	O
mediado	O
[	O
6	O
]	O
)	O
al	O
igual	O
que	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
ambos	O
grupos	O
lograron	O
>	O
=	O
80	O
%	O
de	O
precisión	O
de	O
discriminación	O
,	O
el	O
dopamina	B-Protein
D1R	I-Protein
en	O
nuestro	O
ratones	B-Taxon
no	O
fueron	O
atacados	O
)	O
.	O

Una	O
extensión	O
futura	O
de	O
este	O
estudio	O
sería	O
evaluar	O
el	O
rendimiento	O
en	O
un	O
número	O
fijo	O
de	O
intentos	O
y	O
determinar	O
los	O
patrones	O
de	O
las	O
tasas	O
de	O
error	O
durante	O
la	O
adquisición	O
de	O
las	O
tareas	O
de	O
discriminación	O
y	O
aprendizaje	O
inverso	O
.	O

Esta	O
manipulación	O
controlaría	O
la	O
cantidad	O
de	O
errores	O
en	O
función	O
de	O
los	O
ensayos	O
realizados	O
para	O
determinar	O
si	O
la	O
diferencia	O
aparente	O
en	O
la	O
cantidad	O
absoluta	O
de	O
errores	O
demostrada	O
por	O
el	O
mutante	B-Sequence
ratones	B-Taxon
(	O
el	O
supuesto	O
déficit	O
de	O
rendimiento	O
)	O
es	O
simplemente	O
un	O
reflejo	O
de	O
ensayos	O
adicionales	O
.	O

No	O
obstante	O
,	O
la	O
incapacidad	O
de	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
para	O
desconectarse	O
de	O
las	O
contingencias	O
S	O
+	O
/	O
S	O
-	O
previamente	O
establecidas	O
(	O
respondiendo	O
a	O
un	O
estímulo	O
discriminativo	O
;	O
Fig	O
.	O
4	O
)	O
argumenta	O
fuertemente	O
que	O
mesolímbico	O
dopamina	B-Chemical
,	O
y	O
en	O
particular	O
dopamina	B-Protein
D2R	I-Protein
-	O
La	O
señalización	O
mediada	O
,	O
modula	O
el	O
proceso	O
de	O
alertar	O
al	O
sujeto	O
de	O
que	O
las	O
contingencias	O
familiares	O
tienen	O
ahora	O
asociadas	O
consecuencias	O
inesperadas	O
.	O

Schultz	O
y	O
sus	O
colegas	O
han	O
demostrado	O
que	O
células	B-Cell
de	I-Cell
dopamina	I-Cell
Mostrar	O
patrones	O
de	O
disparo	O
tónico	O
consistentes	O
durante	O
el	O
mantenimiento	O
de	O
tareas	O
de	O
aprendizaje	O
asociativo	O
[	O
33	O
]	O
.	O

Sin	O
embargo	O
,	O
la	O
actividad	O
de	O
estallido	O
fásico	O
de	O
células	B-Cell
dopaminérgicas	I-Cell
se	O
produce	O
cuando	O
se	O
producen	O
discrepancias	O
entre	O
las	O
contingencias	O
de	O
refuerzo	O
previstas	O
y	O
reales	O
[	O
14	O
]	O
.	O

Este	O
fuerte	O
aumento	O
de	O
célula	B-Cell
dopaminérgica	I-Cell
``	O
la	O
activación	O
en	O
respuesta	O
a	O
resultados	O
imprevistos	O
ha	O
sido	O
referida	O
como	O
una	O
señal	O
de	O
``	O
''	O
error	O
''	O
''	O
[	O
14	O
]	O
.	O
''	O

Hasta	O
la	O
fecha	O
,	O
el	O
molecular	B-Chemical
No	O
se	O
ha	O
identificado	O
la	O
base	O
de	O
esta	O
señal	O
de	O
error	O
.	O

La	O
incapacidad	O
del	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
desistir	O
de	O
responder	O
a	O
un	O
estímulo	O
previamente	O
reforzado	O
sugiere	O
que	O
el	O
dopamina	B-Protein
D2R	I-Protein
podría	O
ser	O
,	O
de	O
hecho	O
,	O
el	O
punto	O
focal	O
de	O
esta	O
cascada	O
de	O
señales	O
de	O
error	O
.	O

Los	O
datos	O
electrofisiológicos	O
apoyan	O
aún	O
más	O
la	O
hipótesis	O
de	O
que	O
la	O
señalización	O
mediada	O
por	O
dopamina	B-Protein
D2R	I-Protein
melodías	O
D1R	B-Protein
#	O
¿NOMBRE	O
?	O

Calabresi	O
et	O
al	O
.	O

[	O
34	O
]	O
demostró	O
que	O
la	O
estimulación	O
tetánica	O
de	O
cortes	O
del	O
cuerpo	O
estriado	O
dorsal	O
preparados	O
a	O
partir	O
de	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
se	O
asocia	O
con	O
un	O
EPSP	O
mejorado	O
y	O
,	O
como	O
resultado	O
,	O
un	O
aumento	O
del	O
cuerpo	O
estriado	O
sináptico	B-GENE
eficacia	O
.	O

Por	O
el	O
contrario	O
,	O
la	O
estimulación	O
de	O
cortes	O
del	O
cuerpo	O
estriado	O
dorsal	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
ratones	B-Taxon
resultó	O
en	O
actividad	O
IPSP	O
,	O
depresión	O
a	O
largo	O
plazo	O
y	O
disminución	O
neuronales	B-Cell
actividad	O
de	O
los	O
eferentes	O
estriatales	O
[	O
34	O
]	O
.	O

Carlsson	O
y	O
sus	O
colegas	O
[	O
35	O
]	O
han	O
especulado	O
que	O
dopamina	B-Protein
D2R	I-Protein
``	O
la	O
estimulación	O
en	O
el	O
cuerpo	O
estriado	O
sirve	O
para	O
``	O
''	O
frenar	O
''	O
''	O
o	O
disminuir	O
la	O
plasticidad	O
y	O
la	O
señalización	O
corticostriatal	O
excitatoria	O
.	O
''	O

De	O
hecho	O
,	O
el	O
comportamiento	O
perseverante	O
está	O
asociado	O
con	O
una	O
actividad	O
excesiva	O
del	O
cuerpo	O
estriado	O
dorsal	O
en	O
roedores	B-Taxon
36	O
]	O
y	O
sobre	O
la	O
actividad	O
del	O
caudado	O
en	O
pacientes	O
con	O
TDAH	O
[	O
37	O
]	O
y	O
una	O
fuerte	O
correlación	O
inversa	O
de	O
D2R	B-Protein
vinculante	O
con	O
el	O
comportamiento	O
compulsivo	O
se	O
ha	O
informado	O
[	O
22	O
]	O
.	O

Es	O
importante	O
destacar	O
que	O
nuestros	O
datos	O
indican	O
que	O
los	O
malos	O
resultados	O
mostrados	O
por	O
el	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
son	O
manifestaciones	O
de	O
déficits	O
de	O
aprendizaje	O
invertidos	O
y	O
no	O
deficiencias	O
motivacionales	O
o	O
sensoriales	O
graves	O
.	O

Argumentamos	O
,	O
por	O
tanto	O
,	O
que	O
D2R	B-Protein
participar	O
en	O
la	O
señalización	O
o	O
alerta	O
del	O
organismo	B-Taxon
de	O
cambios	O
de	O
contingencia	O
de	O
aprendizaje	O
durante	O
el	O
aprendizaje	O
inverso	O
y	O
esculpir	O
un	O
comportamiento	O
continuo	O
dirigido	O
a	O
objetivos	O
.	O

Conclusiones	O

Este	O
estudio	O
demuestra	O
que	O
la	O
señalización	O
por	O
dopamina	B-Protein
D2R	I-Protein
no	O
media	O
el	O
valor	O
hedónico	O
de	O
los	O
reforzadores	O
,	O
apoyando	O
y	O
refinando	O
hallazgos	O
anteriores	O
[	O
1	O
,	O
2	O
]	O
.	O

Sin	O
embargo	O
,	O
ratones	B-Taxon
completamente	O
deficiente	O
en	O
D2R	B-Protein
demostró	O
una	O
adquisición	O
interrumpida	O
de	O
relaciones	O
de	O
estímulo	O
discriminativo	O
y	O
una	O
capacidad	O
deteriorada	O
para	O
reconocer	O
cambios	O
en	O
los	O
determinantes	O
del	O
comportamiento	O
.	O

Por	O
lo	O
tanto	O
,	O
sugerimos	O
que	O
durante	O
el	O
aprendizaje	O
asociativo	O
o	O
cuando	O
se	O
modifican	O
resultados	O
de	O
refuerzo	O
inesperados	O
(	O
aprendizaje	O
inverso	O
)	O
dopamina	B-Chemical
#	O
¿NOMBRE	O
?	O
dopamina	B-Protein
D2R	I-Protein
.	O

En	O
el	O
curso	O
del	O
aprendizaje	O
asociativo	O
,	O
el	O
estriado	O
sinapsis	B-GENE
[	O
38	O
]	O
reciben	O
una	O
ganancia	O
impulsada	O
por	O
la	O
experiencia	O
[	O
7	O
]	O
,	O
lo	O
que	O
permite	O
que	O
las	O
señales	O
mediadas	O
por	O
refuerzo	O
recién	O
establecidas	O
atraviesen	O
eferentes	O
ascendentes	O
en	O
el	O
camino	O
hacia	O
la	O
corteza	O
frontal	O
,	O
completando	O
un	O
circuito	O
límbico	O
/	O
motor	O
funcional	O
[	O
39	O
-	O
41	O
]	O
.	O

Posiblemente	O
,	O
la	O
falta	O
de	O
dopamina	B-Protein
D2R	I-Protein
#	O
¿NOMBRE	O
?	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
,	O
perjudicando	O
así	O
su	O
capacidad	O
para	O
formar	O
contingencias	O
S	O
+	O
/	O
S	O
-	O
y	O
desvincularse	O
dopamina	B-Protein
D1R	I-Protein
#	O
¿NOMBRE	O
?	O

En	O
consecuencia	O
,	O
nos	O
vemos	O
obligados	O
a	O
concluir	O
que	O
los	O
perseverantes	O
déficits	O
de	O
desempeño	O
demostrados	O
por	O
el	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
en	O
las	O
tareas	O
utilizadas	O
en	O
el	O
presente	O
estudio	O
revelan	O
un	O
papel	O
previamente	O
no	O
informado	O
para	O
D2R	B-Protein
en	O
el	O
aprendizaje	O
asociativo	O
e	O
inverso	O
.	O

Métodos	O

Asignaturas	O

Los	O
dieciséis	O
,	O
8	O
-	O
10	O
semanas	O
,	O
25	O
-	O
30	O
g	O
ratones	B-Taxon
(	O
8	O
por	O
genotipo	B-Sequence
usados	O
en	O
este	O
estudio	O
fueron	O
descendientes	O
congénicos	O
de	O
reproductores	O
que	O
eran	O
descendientes	O
del	O
híbrido	O
F2	O
original	O
(	O
129/Sv	O
x	O
C57BL/6J	O
;	O
Kelly	O
et	O
al.	O
,	O
1997	O
)	O
que	O
fue	O
retrocruzado	O
con	O
cepas	O
endogámicas	O
C57Bl/6J	O
(	O
Jackson	O
Laboratories	O
,	O
ME	O
)	O
.	O

Esta	O
estrategia	O
de	O
reproducción	O
se	O
repitió	O
durante	O
20	O
generaciones	O
sucesivas	O
con	O
el	O
género	O
del	O
donante/	O
mutante	B-Sequence
alternando	O
con	O
cada	O
generación	O
.	O

Todos	O
los	O
sujetos	O
experimentales	O
fueron	O
genotipados	O
por	O
PCR	O
como	O
se	O
describió	O
anteriormente	O
[	O
23	O
]	O
.	O

Todas	O
las	O
pruebas	O
se	O
realizaron	O
al	O
azar	O
a	O
lo	O
largo	O
de	O
los	O
ciclos	O
estrales	O
.	O

El	O
Departamento	O
de	O
Medicina	O
Comparada	O
de	O
la	O
Universidad	O
de	O
Ciencias	O
y	O
Salud	O
de	O
Oregón	O
aprobó	O
todos	O
los	O
protocolos	O
y	O
todos	O
animales	B-Taxon
se	O
mantuvieron	O
de	O
acuerdo	O
con	O
la	O
Guía	O
para	O
el	O
cuidado	O
y	O
uso	O
de	O
laboratorio	O
de	O
los	O
Institutos	O
Nacionales	O
de	O
Salud	O
animales	B-Taxon
.	O

Procedimientos	O
experimentales	O

Capacitación	O
y	O
pruebas	O
de	O
discriminación	O
de	O
olores	O

Se	O
eligió	O
un	O
paradigma	O
de	O
discriminación	O
de	O
2	O
olores	O
porque	O
permite	O
una	O
medida	O
del	O
enfoque	O
atencional	O
en	O
el	O
comportamiento	O
dirigido	O
a	O
un	O
objetivo	O
.	O

La	O
discriminación	O
de	O
olores	O
se	O
eligió	O
como	O
la	O
tarea	O
particular	O
porque	O
es	O
un	O
comportamiento	O
muy	O
robusto	O
en	O
roedores	B-Taxon
[	O
18	O
]	O
.	O

Para	O
minimizar	O
el	O
error	O
experimental	O
,	O
el	O
experimentador	O
estaba	O
ciego	O
a	O
genotipo	B-Sequence
durante	O
la	O
prueba	O
.	O

Ratones	B-Taxon
fueron	O
levemente	O
comida	B-Chemical
privados	O
hasta	O
aproximadamente	O
el	O
85	O
%	O
del	O
peso	O
ad	O
libitum	O
.	O

Dopamina	B-Protein
D2R	I-Protein
-	I-Protein
/	I-Protein
-	I-Protein
y	I-Protein
D2R	I-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
n	O
=	O
8	O
por	O
grupo	O
)	O
fueron	O
entrenados	O
inicialmente	O
para	O
deambular	O
a	O
lo	O
largo	O
de	O
un	O
polivinilo	O
ratón	B-Taxon
jaula	O
(	O
30	O
-	O
cm	O
)	O
para	O
recuperar	O
~	O
30	O
-	O
mg	O
de	O
grasa	O
Pico	O
(	O
R	O
)	O
suplementada	O
roedor	B-Taxon
comida	B-Chemical
ubicado	O
en	O
un	O
pequeño	O
vaso	O
de	O
plástico	O
(	O
3	O
cm	O
)	O
sujeto	O
al	O
piso	O
del	O
aparato	O
de	O
prueba	O
con	O
velcro	O
.	O

Cada	O
sujeto	O
recibió	O
cinco	O
intentos	O
,	O
y	O
la	O
latencia	O
para	O
localizar	O
y	O
comenzar	O
a	O
consumir	O
el	O
comida	B-Chemical
el	O
sedimento	O
se	O
registró	O
manualmente	O
con	O
un	O
cronómetro	O
manual	O
estándar	O
.	O

Veinticuatro	O
horas	O
más	O
tarde	O
,	O
los	O
sujetos	O
fueron	O
entrenados	O
para	O
deambular	O
y	O
cavar	O
a	O
través	O
del	O
mismo	O
plato	O
de	O
3	O
cm	O
lleno	O
de	O
arena	O
estéril	O
para	O
localizar	O
un	O
comida	B-Chemical
pellet	O
enterrado	O
debajo	O
de	O
la	O
arena	O
.	O

Los	O
sujetos	O
recibieron	O
10	O
intentos	O
.	O

si	O
un	O
ratón	B-Taxon
no	O
pudo	O
localizar	O
un	O
comida	B-Chemical
gránulo	O
dentro	O
de	O
los	O
10	O
minutos	O
de	O
la	O
primera	O
prueba	O
,	O
un	O
adicional	O
comida	B-Chemical
se	O
dejó	O
caer	O
la	O
bolita	O
encima	O
del	O
plato	O
.	O

Esta	O
manipulación	O
generalmente	O
aseguraba	O
que	O
un	O
sujeto	O
excavaría	O
en	O
la	O
arena	O
para	O
localizar	O
la	O
bolita	O
original	O
y	O
aprender	O
esta	O
tarea	O
.	O

El	O
día	O
siguiente	O
,	O
ratones	B-Taxon
fueron	O
presentados	O
al	O
aparato	O
de	O
prueba	O
que	O
ahora	O
contenía	O
2	O
platos	O
,	O
cada	O
uno	O
lleno	O
de	O
arena	O
perfumada	O
diferente	O
.	O

Un	O
olor	O
indicaba	O
que	O
un	O
comida	B-Chemical
el	O
reforzador	O
estaba	O
enterrado	O
en	O
ese	O
plato	O
en	O
particular	O
(	O
S+	O
)	O
,	O
mientras	O
que	O
el	O
otro	O
olor	O
indicaba	O
que	O
no	O
había	O
reforzador	O
contenido	O
dentro	O
de	O
ese	O
plato	O
en	O
particular	O
(	O
S-	O
)	O
.	O

La	O
arena	O
se	O
perfumó	O
añadiendo	O
0	O
.	O
80	O
gramos	O
de	O
canela	O
o	O
eneldo	B-Taxon
hierba	O
a	O
98	O
.	O
8	O
gramos	O
de	O
arena	O
para	O
juegos	O
autoclavada	O
comprada	O
en	O
una	O
tienda	O
local	O
de	O
productos	O
agrícolas	O
y	O
de	O
jardinería	O
.	O

Finalmente	O
,	O
0	O
.	O
40	O
gramos	O
de	O
molido	O
fino	O
comida	B-Chemical
se	O
mezcló	O
con	O
la	O
arena	O
perfumada	O
para	O
enmascarar	O
cualquier	O
olor	O
emitido	O
por	O
el	O
comida	B-Chemical
reforzador	O
en	O
el	O
plato	O
S+	O
.	O

Esta	O
mezcla	O
final	O
no	O
parecía	O
ser	O
del	O
agrado	O
de	O
los	O
sujetos	O
.	O

Un	O
juicio	O
termina	O
cuando	O
el	O
ratón	B-Taxon
cavó	O
en	O
el	O
plato	O
correcto	O
y	O
consumió	O
la	O
bolita	O
escondida	O
,	O
o	O
comenzó	O
a	O
cavar	O
en	O
el	O
plato	O
incorrecto	O
.	O

Se	O
consideró	O
excavación	O
el	O
desplazamiento	O
físico	O
real	O
de	O
la	O
arena	O
con	O
las	O
patas	O
delanteras	O
y/o	O
el	O
hocico	O
.	O

Colocar	O
las	O
extremidades	O
anteriores	O
en	O
cualquiera	O
de	O
los	O
platos	O
y	O
olfatear	O
no	O
se	O
consideraba	O
excavar	O
y	O
no	O
se	O
penalizaba	O
ni	O
puntuaba	O
.	O

Cada	O
ensayo	O
completado	O
estuvo	O
separado	O
por	O
un	O
intervalo	O
entre	O
ensayos	O
(	O
ITI	O
)	O
de	O
20	O
segundos	O
.	O

Los	O
experimentos	O
preliminares	O
demostraron	O
que	O
no	O
se	O
requería	O
un	O
tiempo	O
de	O
espera	O
prolongado	O
después	O
de	O
una	O
respuesta	O
incorrecta	O
para	O
garantizar	O
un	O
comportamiento	O
dirigido	O
a	O
un	O
objetivo	O
en	O
el	O
grupo	O
.	O
tipo	B-Sequence
salvaje	I-Sequence
o	O
mutante	B-Sequence
ratones	B-Taxon
para	O
esta	O
tarea	O
en	O
particular	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
se	O
usó	O
el	O
ITI	O
de	O
20	O
segundos	O
para	O
separar	O
todas	O
las	O
pruebas	O
(	O
con	O
éxito	O
y	O
sin	O
éxito	O
)	O
.	O

Los	O
aromas	O
S+	O
y	O
S-se	O
equilibraron	O
entre	O
los	O
sujetos	O
para	O
controlar	O
el	O
posible	O
sesgo	O
de	O
olores	O
(	O
los	O
datos	O
piloto	O
sugieren	O
que	O
no	O
hay	O
sesgos	O
,	O
los	O
datos	O
no	O
se	O
muestran	O
)	O
.	O

Después	O
de	O
una	O
discriminación	O
precisa	O
,	O
definida	O
como	O
8	O
recuperaciones	O
correctas	O
en	O
10	O
ensayos	O
consecutivos	O
,	O
comenzaron	O
los	O
ensayos	O
de	O
reversión	O
.	O

Medición	O
del	O
aprendizaje	O
inverso	O

A	O
continuación	O
investigamos	O
la	O
contribución	O
de	O
dopamina	B-Protein
D2R	I-Protein
a	O
la	O
inversión	O
de	O
la	O
conducta	O
de	O
aprendizaje	O
invirtiendo	O
las	O
contingencias	O
de	O
reforzamiento	O
-ahora	O
el	O
S+	O
anterior	O
indicaba	O
que	O
no	O
había	O
reforzamiento	O
y	O
el	O
S-ahora	O
indicaba	O
disponibilidad	O
de	O
reforzamiento	O
.	O

Esta	O
manipulación	O
permite	O
una	O
evaluación	O
de	O
la	O
capacidad	O
de	O
inhibir	O
las	O
respuestas	O
a	O
estímulos	O
discriminativos	O
previamente	O
reforzados	O
[	O
18	O
]	O
.	O

El	O
número	O
de	O
intentos	O
necesarios	O
para	O
establecer	O
8	O
de	O
10	O
respuestas	O
precisas	O
fue	O
nuestra	O
definición	O
de	O
aprendizaje	O
inverso	O
exitoso	O
.	O

Análisis	O
de	O
los	O
datos	O

La	O
latencia	O
para	O
recuperar	O
una	O
bolita	O
de	O
un	O
plato	O
vacío	O
,	O
la	O
latencia	O
para	O
cavar	O
a	O
través	O
de	O
un	O
plato	O
lleno	O
de	O
arena	O
sin	O
olor	O
y	O
el	O
número	O
de	O
errores	O
de	O
comisión	O
cometidos	O
en	O
las	O
sesiones	O
de	O
reversión	O
se	O
analizaron	O
con	O
análisis	O
de	O
varianza	O
de	O
2	O
vías	O
(	O
genotipo	B-Sequence
x	O
ensayos	O
)	O
.	O

El	O
número	O
de	O
intentos	O
necesarios	O
para	O
lograr	O
el	O
desempeño	O
del	O
criterio	O
en	O
la	O
discriminación	O
de	O
olores	O
(	O
8	O
respuestas	O
correctas	O
en	O
10	O
intentos	O
consecutivos	O
)	O
y	O
los	O
errores	O
cometidos	O
durante	O
el	O
aprendizaje	O
de	O
las	O
tareas	O
de	O
discriminación	O
se	O
separaron	O
como	O
fases	O
de	O
prueba	O
individuales	O
(	O
p	O
.	O
ej	O
.	O
,	O
discriminación	O
de	O
olores	O
y	O
aprendizaje	O
inverso	O
)	O
y	O
se	O
analizaron	O
por	O
separado	O
con	O
Pruebas	O
t	O
de	O
2	O
colas	O
no	O
apareadas	O
.	O

La	O
significancia	O
se	O
estableció	O
en	O
p	O
<	O
0	O
.	O
05	O
.	O

Los	O
errores	O
cometidos	O
durante	O
los	O
ensayos	O
de	O
reversión	O
se	O
separaron	O
categóricamente	O
como	O
errores	O
de	O
comisión	O
(	O
no	O
retener	O
la	O
respuesta	O
a	O
S-	O
)	O
y	O
errores	O
de	O
omisión	O
(	O
no	O
cavar	O
en	O
ninguno	O
de	O
los	O
platos	O
después	O
de	O
que	O
habían	O
expirado	O
los	O
3	O
minutos	O
)	O
.	O

Los	O
errores	O
categóricos	O
y	O
el	O
número	O
de	O
errores	O
de	O
comisión	O
cometidos	O
durante	O
la	O
primera	O
sesión	O
de	O
aprendizaje	O
inverso	O
se	O
analizaron	O
entre	O
grupos	O
con	O
pruebas	O
U	O
de	O
Mann-Whitney	O
no	O
paramétricas	O
.	O

Contribuciones	O
de	O
los	O
autores	O

PJK	O
diseñó	O
y	O
ejecutó	O
todos	O
los	O
experimentos	O
,	O
analizó	O
los	O
datos	O
y	O
coescribió	O
el	O
manuscrito	O
.	O

DKG	O
supervisó	O
y	O
facilitó	O
los	O
experimentos	O
y	O
co-escribió	O
el	O
manuscrito	O
.	O

Agradecimientos	O

Este	O
estudio	O
fue	O
apoyado	O
por	O
subvenciones	O
DA07262	O
(	O
PJK	O
)	O
,	O
DA12062	O
(	O
DKG	O
)	O
,	O
y	O
MH067497	O
(	O
DKG	O
)	O
.	O

Agradecemos	O
a	O
Katherine	O
M.	O
Suchland	O
por	O
su	O
excelente	O
asistencia	O
técnica	O
.	O

Figuras	O
y	O
Tablas	O

Figura	O
1	O

Ratones	B-Taxon
carente	O
receptores	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
adquirir	O
una	O
meta	O
-	O
comportamiento	O
dirigido	O
similar	O
a	O
tipo	B-Sequence
salvaje	I-Sequence
ratones	B-Taxon
.	O

Ambas	O
cosas	O
genotipos	B-Sequence
fácilmente	O
aprendió	O
a	O
recuperar	O
comida	B-Chemical
gránulos	O
de	O
un	O
plato	O
pequeño	O
y	O
redujeron	O
significativamente	O
sus	O
latencias	O
para	O
realizar	O
esta	O
tarea	O
a	O
través	O
de	O
los	O
ensayos	O
(	O
*	O
p	O
<	O
0,001	O
)	O
.	O

Figura	O
2	O

Tipo	B-Sequence
salvaje	I-Sequence
y	O
D2R	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
realizar	O
la	O
tarea	O
de	O
excavación	O
igualmente	O
bien	O
.	O

No	O
hay	O
diferencias	O
en	O
la	O
respuesta	O
en	O
función	O
de	O
genotipo	B-Sequence
se	O
encontraron	O
,	O
y	O
se	O
observaron	O
latencias	O
similares	O
para	O
recuperar	O
el	O
reforzador	O
.	O

Estos	O
patrones	O
de	O
respuesta	O
sugieren	O
que	O
el	O
entrenamiento	O
del	O
día	O
anterior	O
influyó	O
en	O
el	O
comportamiento	O
,	O
demostrando	O
que	O
tanto	O
genotipos	B-Sequence
son	O
capaces	O
de	O
aprender	O
y	O
retener	O
comportamientos	O
dirigidos	O
a	O
objetivos	O
.	O

figura	O
3	O

Receptor	B-Protein
de	I-Protein
dopamina	I-Protein
D2	I-Protein
#	O
¿NOMBRE	O
?	O

Tipo	B-Sequence
salvaje	I-Sequence
(	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
)	O
ratones	B-Taxon
superó	O
(	O
media	O
+	O
error	O
estándar	O
)	O
al	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
durante	O
la	O
adquisición	O
de	O
(	O
A	O
)	O
discriminación	O
de	O
olores	O
(	O
*	O
p	O
<	O
0,05	O
)	O
,	O
y	O
(	O
B	O
)	O
cometieron	O
significativamente	O
menos	O
errores	O
de	O
discriminación	O
(	O
*	O
p	O
<	O
0,01	O
)	O
durante	O
la	O
tarea	O
de	O
discriminación	O
.	O

Figura	O
4	O

D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
perseverar	O
en	O
el	O
comportamiento	O
no	O
reforzado	O
durante	O
las	O
pruebas	O
de	O
aprendizaje	O
inverso	O
.	O

El	O
número	O
de	O
intentos	O
necesarios	O
(	O
media	O
+	O
error	O
estándar	O
)	O
para	O
(	O
A	O
)	O
demostrar	O
el	O
aprendizaje	O
inverso	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
y	O
(	O
B	O
)	O
los	O
errores	O
inversos	O
cometidos	O
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
por	O
D2R	B-Protein
-	O
/	O
-	O
y	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
.	O

Figura	O
5	O

Las	O
medidas	O
de	O
aprendizaje	O
inverso	O
revelan	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
emiten	O
significativamente	O
más	O
errores	O
de	O
comisión	O
pero	O
no	O
errores	O
de	O
omisión	O
que	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
.	O

Patrones	O
de	O
respuesta	O
(	O
media	O
+	O
error	O
estándar	O
)	O
por	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
son	O
más	O
sugestivos	O
de	O
perseveración	O
ligada	O
al	O
estímulo	O
y	O
no	O
de	O
extinción	O
.	O

D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
cometió	O
significativamente	O
más	O
errores	O
de	O
comisión	O
(	O
A	O
)	O
que	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
*	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
pero	O
no	O
se	O
observaron	O
diferencias	O
en	O
los	O
errores	O
de	O
omisión	O
(	O
B	O
)	O
entre	O
genotipos	B-Sequence
(	O
p	O
>	O
0	O
.	O
6	O
)	O
.	O

Figura	O
6	O

Ratones	B-Taxon
carente	O
de	O
funcionalidad	O
D2R	B-Protein
mostrar	O
una	O
incapacidad	O
para	O
retener	O
respuestas	O
inapropiadas	O
.	O

Los	O
patrones	O
de	O
respuesta	O
durante	O
los	O
primeros	O
10	O
ensayos	O
de	O
reversión	O
revelan	O
déficits	O
en	O
ratones	B-Taxon
carente	O
D2R	B-Protein
.	O

Cuando	O
el	O
ratones	B-Taxon
encontró	O
las	O
contingencias	O
de	O
refuerzo	O
invertido	O
durante	O
la	O
primera	O
sesión	O
de	O
aprendizaje	O
inverso	O
,	O
el	O
D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
demostró	O
una	O
incapacidad	O
casi	O
completa	O
para	O
inhibir	O
la	O
respuesta	O
a	O
estímulos	O
previamente	O
reforzados	O
en	O
comparación	O
con	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Figura	O
7	O

D2R	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
cometer	O
significativamente	O
más	O
errores	O
perseverantes	O
en	O
las	O
sesiones	O
de	O
reversión	O
que	O
tipo	B-Sequence
salvaje	I-Sequence
ratones	B-Taxon
.	O

Un	O
análisis	O
del	O
curso	O
temporal	O
de	O
la	O
respuesta	O
por	O
errores	O
de	O
comisión	O
en	O
las	O
primeras	O
cuatro	O
sesiones	O
de	O
revocación	O
reveló	O
que	O
el	O
D2R	B-Protein
-	O
/	O
-	O
cometió	O
varios	O
errores	O
de	O
comisión	O
más	O
que	O
el	O
D2R	B-Protein
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
*	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Estructura	O
-	O
función	O
evolución	O
del	O
Transformador	O
ácido	B-Chemical
genes	B-Sequence
de	I-Sequence
bobina	I-Sequence
enrollada	I-Sequence
revelado	O
por	O
el	O
análisis	O
de	O
filogenéticamente	O
diversos	O
organismos	B-Taxon

Resumen	O

Antecedentes	O

examen	O
de	O
los	O
antiguos	O
gene	B-Sequence
familias	O
pueden	O
proporcionar	O
una	O
idea	O
de	O
cómo	O
la	O
evolución	O
de	O
gene	B-Sequence
la	O
estructura	O
puede	O
relacionarse	O
con	O
la	O
función	O
.	O

Funcional	O
homólogos	B-Sequence
de	O
El	O
conservado	B-Sequence
evolutivamente	I-Sequence
transformando	O
ácido	B-Chemical
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
(	O
TACC	O
)	O
gene	B-Sequence
la	O
familia	O
está	O
presente	O
en	O
organismos	B-Taxon
desde	O
levadura	B-Taxon
para	O
hombre	B-Taxon
.	O

Sin	O
embargo	O
,	O
las	O
correlaciones	O
entre	O
las	O
interacciones	O
funcionales	O
y	O
la	O
evolución	O
de	O
estas	O
proteinas	B-Chemical
aún	O
no	O
se	O
han	O
determinado	O
.	O

Resultados	O

Hemos	O
realizado	O
un	O
extenso	O
análisis	O
de	O
la	O
base	O
de	O
datos	O
para	O
determinar	O
la	O
secuencias	B-Sequence
genómicas	I-Sequence
y	I-Sequence
de	I-Sequence
ADNc	I-Sequence
de	O
los	O
TACC	O
de	O
filogenéticamente	O
diversos	O
organismos	B-Taxon
.	O

Este	O
análisis	O
ha	O
determinado	O
la	O
relación	O
filogenética	O
de	O
la	O
TACC	O
proteinas	B-Chemical
para	O
otro	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
proteinas	B-Chemical
,	O
la	O
resolución	O
de	O
la	O
colocación	O
del	O
Conejo	B-Taxon
TACC4	O
como	O
el	O
ortólogo	B-Sequence
de	O
humano	B-Protein
TACC3	I-Protein
,	O
y	O
RHAMM	B-Protein
como	O
una	O
familia	O
distinta	O
de	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
proteinas	B-Chemical
.	O

También	O
hemos	O
extendido	O
el	O
análisis	O
de	O
los	O
TACCs	O
a	O
las	O
bases	O
de	O
datos	O
de	O
interacción	O
de	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
y	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
para	O
identificar	O
interacciones	O
TACC	O
potencialmente	O
novedosas	O
.	O

La	O
validez	O
de	O
este	O
modelo	O
fue	O
confirmada	O
de	O
forma	O
independiente	O
por	O
la	O
demostración	O
de	O
unión	O
directa	O
de	O
humano	B-Protein
TACC2	I-Protein
al	O
nuclear	B-GENE
hormona	B-Chemical
receptor	O
RXR	B-Protein
beta	I-Protein
.	O

Conclusión	O

Los	O
datos	O
hasta	O
ahora	O
sugieren	O
que	O
el	O
TACC	O
ancestral	O
proteína	B-Chemical
jugó	O
un	O
papel	O
en	O
centrosomales	B-GENE
/	O
mitótico	O
huso	B-GENE
dinámica	O

TACC	O
proteinas	B-Chemical
luego	O
fueron	O
reclutados	O
para	O
complejos	B-GENE
envuelto	O
en	O
proteína	B-Chemical
traducción	O
,	O
ARN	B-Sequence
procesamiento	O
y	O
transcripción	O
por	O
interacciones	O
con	O
puentes	O
específicos	O
proteinas	B-Chemical
.	O

Sin	O
embargo	O
,	O
durante	O
la	O
evolución	O
,	O
la	O
TACC	O
proteinas	B-Chemical
ahora	O
han	O
adquirido	O
la	O
capacidad	O
de	O
interactuar	O
directamente	O
con	O
los	O
componentes	O
de	O
estos	O
complejos	B-GENE
(	O
como	O
el	O
LSm	O
proteinas	B-Chemical
,	O
nuclear	B-GENE
hormona	B-Chemical
receptores	O
,	O
GAS41	B-Protein
y	O
factores	O
de	O
transcripción	O
)	O
.	O

Esto	O
sugiere	O
que	O
la	O
función	O
del	O
TACC	O
proteinas	B-Chemical
puede	O
haber	O
evolucionado	O
desde	O
el	O
desempeño	O
de	O
funciones	O
de	O
asamblea	O
o	O
coordinación	O
en	O
el	O
centrosoma	B-GENE
para	O
incluir	O
un	O
papel	O
más	O
íntimo	O
en	O
la	O
evolución	O
funcional	O
de	O
cromatina	B-GENE
remodelación	O
,	O
transcripcional	O
y	O
postranscripcional	O
complejos	B-GENE
en	O
el	O
célula	B-Cell
.	O

Antecedentes	O

La	O
evolución	O
de	O
los	O
complejos	O
.	O
organismos	B-Taxon
se	O
ha	O
relacionado	O
con	O
la	O
generación	O
de	O
gene	B-Sequence
familias	O
por	O
el	O
continuo	O
duplicación	B-Sequence
de	O
un	O
conjunto	O
inicial	O
relativamente	O
pequeño	O
de	O
ancestrales	O
genes	B-Sequence
.	O

A	O
través	O
de	O
este	O
proceso	O
,	O
seguido	O
de	O
posteriores	O
mutación	B-Sequence
,	O
reduplicación	O
y	O
exón	B-Sequence
barajando	O
entre	O
gene	B-Sequence
familias	O
,	O
genes	B-Sequence
han	O
desarrollado	O
funciones	O
discretas	O
y	O
parcialmente	O
redundantes	O
con	O
sus	O
familiares	O
relacionados	O
.	O

Con	O
la	O
finalización	O
de	O
la	O
genoma	B-Sequence
proyectos	O
de	O
secuenciación	O
de	O
humano	B-Taxon
,	O
ratón	B-Taxon
,	O
rata	B-Taxon
,	O
mosca	B-Taxon
de	I-Taxon
la	I-Taxon
fruta	I-Taxon
y	O
nematodos	B-Taxon
,	O
ahora	O
estamos	O
en	O
posición	O
de	O
hacer	O
preguntas	O
fundamentales	O
con	O
respecto	O
a	O
cómo	O
genes	B-Sequence
interactuar	O
en	O
el	O
contexto	O
del	O
todo	O
.	O
organismo	B-Taxon
.	O

Por	O
lo	O
tanto	O
,	O
con	O
la	O
aplicación	O
adecuada	O
de	O
la	O
bioinformática	O
,	O
ahora	O
es	O
posible	O
rastrear	O
el	O
linaje	O
de	O
determinados	O
genes	B-Sequence
y	O
gene	B-Sequence
familias	O
,	O
con	O
parentesco	O
gene	B-Sequence
familias	O
en	O
otros	O
organismos	B-Taxon
.	O

Además	O
,	O
con	O
la	O
creciente	O
cantidad	O
de	O
estudios	O
proteómicos	O
y	O
genómico	B-Sequence
los	O
datos	O
estén	O
disponibles	O
públicamente	O
,	O
este	O
análisis	O
ahora	O
puede	O
extenderse	O
para	O
revelar	O
la	O
compleja	O
interacción	O
entre	O
la	O
evolución	O
de	O
gene	B-Sequence
estructura	O
y	O
proteína	B-Chemical
función	O

La	O
primera	O
transformación	O
ácido	B-Chemical
gen	B-Sequence
de	I-Sequence
bobina	I-Sequence
enrollada	I-Sequence
,	O
TACC1	B-Protein
,	O
fue	O
identificado	O
durante	O
el	O
desarrollo	O
de	O
un	O
mapa	O
de	O
expresión	O
del	O
corto	O
proximal	O
brazo	B-Sequence
del	I-Sequence
cromosoma	I-Sequence
humano	I-Sequence
8	O
[	O
1	O
]	O
.	O

Posteriormente	O
,	O
se	O
identificaron	O
y	O
mapearon	O
dos	O
miembros	O
adicionales	O
de	O
la	O
familia	O
TACC	O
para	O
regiones	B-Sequence
cromosómicas	I-Sequence
parálogas	I-Sequence
en	O
humano	B-Taxon
cromosomas	B-GENE
4p16	O
y	O
10q26	O
,	O
físicamente	O
cerca	O
de	O
los	O
miembros	O
de	O
la	O
FGFR	B-Protein
gene	B-Sequence
familia	O
[	O
1	O
-	O
3	O
]	O
.	O

Estos	O
datos	O
de	O
mapeo	O
,	O
junto	O
con	O
la	O
identificación	O
de	O
un	O
solo	O
TACC	O
gene	B-Sequence
en	O
el	O
protostomas	B-Taxon
Caenorhabitis	I-Taxon
elegans	I-Taxon
,	O
y	O
Drosophila	B-Taxon
melanogaster	I-Taxon
[	O
4	O
-	O
6	O
]	O
,	O
condujo	O
a	O
la	O
especulación	O
de	O
que	O
los	O
antepasados	O
FGFR	B-Protein
y	O
TACC	O
genes	B-Sequence
estaban	O
ubicados	O
físicamente	O
cerca	O
uno	O
del	O
otro	O
.	O

Así	O
,	O
durante	O
la	O
evolución	O
de	O
vertebrados	B-Taxon
,	O
sucesivos	O
sucesivos	O
duplicaciones	B-Sequence
de	O
los	O
ancestrales	O
grupo	B-Sequence
de	I-Sequence
genes	I-Sequence
han	O
dado	O
lugar	O
a	O
tres	O
miembros	O
de	O
la	O
familia	O
TACC	O
ubicados	O
cerca	O
de	O
FGFR	B-Protein
genes	B-Sequence
en	O
humanos	B-Taxon
.	O

De	O
acuerdo	O
con	O
la	O
propuesta	O
de	O
cuadriplicación	O
de	O
los	O
vertebrado	B-Taxon
genoma	B-Sequence
durante	O
la	O
evolución	O
,	O
hay	O
un	O
cuarto	O
FGFR	B-Protein
miembro	O
de	O
la	O
familia	O
en	O
vertebrados	B-Taxon
,	O
lo	O
que	O
plantea	O
la	O
cuestión	O
de	O
si	O
un	O
cuarto	O
TACC	O
gene	B-Sequence
está	O
asociado	O
con	O
FGFR4	B-Protein
en	O
vertebrado	B-Taxon
genomas	B-Sequence
.	O

Hasta	O
la	O
fecha	O
,	O
solo	O
tres	O
TACC	O
activos	O
genes	B-Sequence
han	O
sido	O
clonados	O
en	O
humanos	B-Taxon
[	O
1	O
-	O
3	O
]	O
,	O
uno	O
en	O
cada	O
uno	O
de	O
ratón	B-Taxon
[	O
7	O
]	O
,	O
Xenopus	B-Taxon
laevis	I-Taxon
[	O
8	O
]	O
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
4	O
]	O
,	O
y	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
[	O
5	O
,	O
6	O
]	O
.	O

Aunque	O
dos	O
nuevos	O
miembros	O
candidatos	O
adicionales	O
de	O
la	O
familia	O
TACC	O
,	O
Oryctolagus	B-Taxon
cuniculus	I-Taxon
TACC4	O
[	O
9	O
]	O
y	O
RHAMM	B-Protein
humano	I-Protein
[	O
10	O
]	O
han	O
sido	O
propuestos	O
,	O
su	O
verdadera	O
identidad	O
y	O
ubicación	O
en	O
la	O
evolución	O
de	O
la	O
familia	O
TACC	O
está	O
bajo	O
debate	O
.	O

Así	O
,	O
la	O
identificación	O
y	O
caracterización	O
funcional	O
de	O
nuevos	O
miembros	O
de	O
la	O
familia	O
TACC	O
en	O
otros	O
organismos	B-Taxon
,	O
isoformas	B-Sequence
empalmadas	I-Sequence
alternativamente	I-Sequence
de	O
cada	O
TACC	O
y	O
comparación	O
de	O
la	O
relación	O
filogenética	O
de	O
estos	O
genes	B-Sequence
en	O
relación	O
con	O
otros	O
miembros	O
de	O
la	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
superfamilia	O
resolverá	O
este	O
problema	O
y	O
proporcionará	O
pistas	O
sobre	O
la	O
evolución	O
de	O
la	O
función	O
TACC	O
.	O

Resultados	O
y	O
discusión	O

Identificación	O
in	O
silico	O
de	O
miembros	O
de	O
la	O
familia	O
TACC	O
de	O
vertebrado	B-Taxon
y	O
linajes	O
de	O
invertebrados	O

Secuencia	B-Sequence
búsquedas	O
de	O
similitud	O
de	O
los	O
disponibles	O
públicamente	O
genoma	B-Sequence
bases	O
de	O
datos	O
con	O
los	O
programas	O
BLAST	O
y	O
TBLAST	O
para	O
identificar	O
TACC	O
y	O
RHAMM	B-Protein
ortólogos	B-Sequence
,	O
y	O
otros	O
miembros	O
de	O
la	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
superfamilia	O
en	O
un	O
conjunto	O
diverso	O
de	O
especies	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Esto	O
identificó	O
el	O
completo	O
secuencia	B-Sequence
del	O
TAC	O
genes	B-Sequence
en	O
representantes	O
de	O
cinco	O
grandes	O
clados	O
filogenéticamente	O
distintos	O
.	O

Siempre	O
que	O
sea	O
posible	O
,	O
la	O
construcción	O
del	O
TACC	O
secuencias	B-Sequence
a	O
partir	O
de	O
estos	O
organismos	B-Taxon
también	O
fue	O
confirmada	O
por	O
el	O
análisis	O
de	O
la	O
ADNc	B-Sequence
bases	O
de	O
datos	O

Varios	O
secuencias	B-Sequence
parciales	I-Sequence
en	O
otra	O
vertebrado	B-Taxon
especie	O
,	O
la	O
equinodermato	B-Taxon
Strongylocentrotus	I-Taxon
purpuratus	I-Taxon
y	O
el	O
insecto	B-Taxon
protostoma	I-Taxon
Anopheles	I-Taxon
gambiae	I-Taxon
también	O
fueron	O
identificados	O
,	O
lo	O
que	O
sugiere	O
una	O
antigua	O
conservación	B-Sequence
del	O
TAC	O
genes	B-Sequence
en	O
metazoario	B-Taxon
linajes	O

Sin	O
embargo	O
,	O
debido	O
a	O
la	O
relativa	O
infancia	O
de	O
la	O
ADNc	B-Sequence
/	O
genoma	B-Sequence
proyectos	O
para	O
estos	O
últimos	O
organismos	B-Taxon
,	O
caracterización	O
completa	O
de	O
estos	O
TACC	O
genes	B-Sequence
no	O
se	O
pudo	O
emprender	O
.	O

No	O
se	O
pudo	O
sacar	O
ninguna	O
conclusión	O
sobre	O
la	O
existencia	O
de	O
TACC	O
,	O
como	O
secuencia	B-Sequence
en	O
no	O
-	O
metazoos	B-Taxon
bilaterales	I-Taxon
,	O
tal	O
como	O
cnidarios	B-Taxon
o	O
Porifera	B-Taxon
,	O
debido	O
a	O
la	O
escasez	O
de	O
secuencia	B-Sequence
información	O
para	O
estos	O
organismos	B-Taxon
,	O
y	O
definitiva	O
adicional	O
secuencias	B-Sequence
con	O
un	O
TACC	O
definido	O
dominio	B-Sequence
no	O
se	O
pudo	O
encontrar	O
en	O
otros	O
no	O
-	O
organismos	B-Taxon
metazoarios	I-Taxon
.	O

Figura	O
1	O

Análisis	O
filogenético	O
de	O
los	O
miembros	O
de	O
la	O
familia	O
TACC	O
en	O
comparación	O
con	O
otros	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
proteinas	B-Chemical
.	O

El	O
árbol	O
filogenético	O
se	O
construyó	O
como	O
se	O
describe	O
en	O
la	O
sección	O
Métodos	O
.	O

La	O
familia	O
TACC	O
define	O
una	O
subfamilia	O
separada	O
de	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
que	O
contiene	O
proteinas	B-Chemical
,	O
distinto	O
de	O
otros	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
familias	O
como	O
las	O
queratinas	O
,	O
RHAMM	B-Protein
y	O
tropomiosinas	O
.	O

Tenga	O
en	O
cuenta	O
que	O
el	O
RHAMM	B-Protein
proteinas	B-Chemical
forman	O
una	O
rama	O
separada	O
más	O
estrechamente	O
relacionada	O
con	O
las	O
tropomiosinas	O
y	O
la	O
kinesina	O
como	O
proteinas	B-Chemical
(	O
KLP	O
)	O
,	O
que	O
el	O
TACC	O
proteinas	B-Chemical
.	O

En	O
la	O
base	O
de	O
la	O
cordado	B-Taxon
rama	O
de	O
la	O
vida	O
,	O
un	O
solo	O
TACC	O
gene	B-Sequence
fue	O
identificado	O
en	O
el	O
genoma	B-Sequence
de	O
El	O
urocordato	B-Taxon
Ciona	I-Taxon
intestinalis	I-Taxon
[	O
11	O
]	O
,	O
y	O
un	O
parcial	B-Sequence
TACC	O
secuencia	B-Sequence
de	O
un	O
análisis	O
de	O
la	O
Halocynthia	B-Taxon
rortezi	I-Taxon
est	B-Sequence
base	O
de	O
datos	O
[	O
12	O
]	O
.	O

Esto	O
confirma	O
la	O
suposición	O
original	O
de	O
que	O
un	O
solo	O
TACC	O
gene	B-Sequence
estuvo	O
presente	O
en	O
el	O
cordado	B-Taxon
antepasado	O

El	O
próximo	O
gran	O
evento	O
en	O
la	O
evolución	O
de	O
la	O
cordado	B-Taxon
genoma	B-Sequence
se	O
ha	O
sugerido	O
que	O
ocurrió	O
687	O
+/-	O
155	O
.	O
hace	O
7	O
millones	O
de	O
años	O
(	O
MAA	O
)	O
,	O
con	O
la	O
primera	O
duplicación	B-Sequence
de	O
El	O
cordado	B-Taxon
genoma	B-Sequence
,	O
y	O
un	O
segundo	O
duplicación	B-Sequence
ocurriendo	O
poco	O
tiempo	O
después	O
.	O

Por	O
lo	O
tanto	O
,	O
si	O
el	O
TACC	O
genes	B-Sequence
se	O
duplicaron	O
en	O
ambos	O
eventos	O
,	O
esperaríamos	O
identificar	O
cuatro	O
TACC	O
genes	B-Sequence
``	O
en	O
el	O
compacto	O
más	O
``	O
''	O
primitivo	O
''	O
''	O
''	O
vertebrado	B-Taxon
genoma	B-Sequence
secuenciado	O
hasta	O
la	O
fecha	O
,	O
el	O
pez	B-Taxon
globo	I-Taxon
Takifugu	I-Taxon
rubripes	I-Taxon
,	O
con	O
tres	O
genes	B-Sequence
correspondiente	O
a	O
la	O
humano	B-Protein
TACC1	I-Protein
-	O
3	O
,	O
y	O
,	O
de	O
acuerdo	O
con	O
el	O
modelo	O
propuesto	O
para	O
duplicación	B-Sequence
genómica	I-Sequence
de	O
El	O
locus	B-Sequence
cromosómicos	I-Sequence
para	O
el	O
TACC	O
genes	B-Sequence
(	O
discutido	O
abajo	O
)	O
,	O
un	O
posible	O
cuarto	O
gene	B-Sequence
derivado	O
de	O
la	O
TACC3	B-Protein
antepasado	O

De	O
hecho	O
,	O
cuatro	O
TACC	O
genes	B-Sequence
fueron	O
identificados	O
en	O
t	B-Taxon
rubíes	I-Taxon
.	O

De	O
estos	O
,	O
dos	O
genes	B-Sequence
correspondía	O
a	O
la	O
t	B-Taxon
rubíes	I-Taxon
ortólogos	B-Sequence
de	O
humanos	B-Protein
TACC2	I-Protein
y	I-Protein
TACC3	I-Protein
.	O

Sin	O
embargo	O
,	O
los	O
otros	O
dos	O
genes	B-Sequence
,	O
trTACC1A	B-Protein
y	O
trTACC1B	B-Protein
están	O
claramente	O
más	O
relacionados	O
con	O
TACC1	B-Protein
(	O
Figura	O
1	O
)	O
.	O

Aunque	O
trTACC1A	B-Protein
es	O
altamente	O
homólogo	B-Sequence
para	O
trTACC1B	B-Protein
,	O
este	O
último	O
codifica	O
una	O
cantidad	O
significativamente	O
más	O
pequeña	O
predicho	B-Sequence
proteína	B-Chemical
.	O

los	O
trTACC1B	B-Protein
gene	B-Sequence
está	O
codificado	O
por	O
15	O
exones	B-Sequence
más	O
de	O
aproximadamente	O
7	O
kb	O
de	O
la	O
Takifugu	B-Taxon
Andamio	B-Sequence
191	O
(	O
ver	O
más	O
abajo	O
)	O
.	O

Una	O
busqueda	O
de	O
esto	O
región	B-Sequence
utilizando	O
el	O
trTACC1A	B-Protein
secuencia	B-Sequence
y	O
gene	B-Sequence
el	O
software	O
de	O
predicción	O
hasta	O
ahora	O
no	O
ha	O
podido	O
identificar	O
exones	B-Sequence
de	O
trTACC1B	B-Protein
.	O

Sin	O
embargo	O
,	O
dada	O
la	O
intrón	B-Sequence
/	O
exón	B-Sequence
estructura	O
de	O
este	O
aparentemente	O
completo	O
gene	B-Sequence
,	O
parece	O
probable	O
que	O
trTACC1B	B-Protein
está	O
activo	O
en	O
el	O
pez	B-Taxon
globo	I-Taxon
,	O
y	O
presumiblemente	O
cumple	O
una	O
función	O
temporal-espacial	O
específica	O
dentro	O
de	O
la	O
organismo	B-Taxon
,	O
o	O
una	O
función	O
distinta	O
de	O
la	O
más	O
grande	O
trTACC1A	B-Protein
producto	O
dentro	O
del	O
célula	B-Cell
.	O

Por	O
lo	O
tanto	O
,	O
con	O
base	O
en	O
el	O
entorno	O
locus	B-Sequence
cromosómicos	I-Sequence
(	O
ver	O
más	O
abajo	O
)	O
,	O
el	O
trTACC1A	B-Protein
y	O
trTACC1B	B-Protein
genes	B-Sequence
parece	O
haber	O
surgido	O
de	O
la	O
duplicación	B-Sequence
de	O
El	O
segmento	B-Sequence
cromosómico	I-Sequence
que	O
contiene	O
el	O
teleósteo	B-Taxon
TACC1	B-Protein
ascendiente	O
,	O
durante	O
el	O
parcial	O
adicional	O
duplicación	B-Sequence
genómica	I-Sequence
que	O
ocurrió	O
en	O
el	O
teleósteo	B-Taxon
linaje	O

Por	O
lo	O
tanto	O
,	O
este	O
análisis	O
de	O
t	B-Taxon
rubíes	I-Taxon
no	O
apoya	O
la	O
hipótesis	O
de	O
que	O
la	O
región	B-Sequence
rodeando	O
el	O
TACC3	B-Protein
antepasado	O
fue	O
incluido	O
en	O
la	O
segunda	O
ronda	O
de	O
vertebrado	B-Taxon
duplicación	B-Sequence
genómica	I-Sequence
.	O

examen	O
de	O
mayor	O
vertebrados	B-Taxon
llevó	O
a	O
la	O
identificación	O
de	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
de	O
TACC1	B-Protein
y	O
TACC2	B-Protein
en	O
Mus	B-Taxon
musculus	I-Taxon
,	O
y	O
el	O
montaje	O
de	O
los	O
previamente	O
no	O
identificados	O
ortólogos	B-Sequence
de	O
TACC1	B-Protein
-	O
3	O
de	O
rattus	B-Taxon
norvegus	I-Taxon
.	O

Además	O
,	O
el	O
TACC1X	O
secuencia	B-Sequence
fue	O
encontrado	O
en	O
ratón	B-Taxon
cromosoma	B-GENE
X	I-GENE
.	O

Esta	O
gene	B-Sequence
está	O
claramente	O
relacionado	O
con	O
la	O
ratón	B-Protein
TACC1	I-Protein
,	O
sin	O
embargo	O
,	O
un	O
examen	O
más	O
detenido	O
reveló	O
una	O
ratón	B-Taxon
B1	O
repetir	B-Sequence
distribuidos	O
a	O
lo	O
largo	O
de	O
la	O
propuesta	O
intrón	B-Sequence
.	O

Además	O
,	O
no	O
se	O
detectó	O
expresión	O
de	O
TACC1X	O
en	O
ratón	B-Taxon
ARN	B-Sequence
por	O
análisis	O
de	O
rt	O
-	O
PCR	O
(	O
datos	O
no	O
mostrados	O
)	O
,	O
lo	O
que	O
sugiere	O
que	O
este	O
secuencia	B-Sequence
es	O
un	O
pseudogen	B-Sequence
procesado	I-Sequence
.	O

Similar	O
,	O
TACC1	B-Protein
pseudogenes	B-Sequence
también	O
existen	O
repartidos	O
en	O
22	O
kb	O
de	O
la	O
región	B-GENE
centromérica	I-GENE
del	I-GENE
cromosoma	I-GENE
humano	I-GENE
10	O
y	O
,	O
en	O
8q21	O
,	O
una	O
más	O
corta	O
región	B-Sequence
86	O
%	O
idéntico	O
al	O
359	O
final	O
pb	B-Sequence
de	O
El	O
TACC1	B-Protein
3	B-Sequence
'región	I-Sequence
no	I-Sequence
traducida	I-Sequence
.	O

No	O
pseudogenes	B-Sequence
correspondiente	O
a	O
TACC2	B-Protein
o	O
TACC3	B-Protein
fueron	O
identificados	O
en	O
cualquier	O
mamífero	B-Taxon
especies	O

Caracterización	O
de	O
vertebrado	B-Taxon
TACC3	B-Protein
ortólogos	B-Sequence

Con	O
base	O
en	O
el	O
análisis	O
funcional	O
actual	O
,	O
la	O
caracterización	O
de	O
TACC3	B-Protein
ortólogos	B-Sequence
es	O
probable	O
que	O
sea	O
fundamental	O
para	O
comprender	O
la	O
secuencia	B-Sequence
y	O
evolución	O
funcional	O
del	O
TACC	O
gene	B-Sequence
familia	O
.	O

Como	O
se	O
indica	O
a	O
continuación	O
,	O
la	O
región	B-Sequence
cromosómica	I-Sequence
que	O
contiene	O
el	O
TACC	O
gene	B-Sequence
precursores	O
se	O
duplicó	O
dos	O
veces	O
durante	O
vertebrado	B-Taxon
evolución	O
.	O

Aunque	O
el	O
análisis	O
de	O
t	B-Taxon
rubíes	I-Taxon
,	O
roedores	B-Taxon
y	O
humanos	B-Taxon
hasta	O
ahora	O
sugiere	O
que	O
el	O
vertebrado	B-Taxon
TACC3	B-Protein
precursor	O
no	O
fue	O
incluido	O
en	O
la	O
segunda	O
ronda	O
de	O
duplicación	B-Sequence
genómica	I-Sequence
no	O
se	O
puede	O
excluir	O
que	O
un	O
TACC4	O
gene	B-Sequence
podría	O
haber	O
sido	O
perdió	B-Sequence
durante	O
la	O
evolución	O
de	O
estos	O
linajes	O
.	O

La	O
clonación	O
de	O
un	O
nuevo	O
miembro	O
de	O
la	O
familia	O
TACC	O
en	O
Oryctolagus	B-Taxon
cuniculus	I-Taxon
ha	O
añadido	O
a	O
esta	O
controversia	O
[	O
9	O
]	O
.	O

Designado	O
TACC4	O
,	O
el	O
1	O
.	O
5kb	O
ADNc	B-Sequence
estaba	O
muy	O
relacionado	O
,	O
pero	O
propuesto	O
para	O
ser	O
distinto	O
de	O
TACC3	B-Protein
.	O

Sin	O
embargo	O
,	O
los	O
datos	O
de	O
Northern	O
blot	O
sugirieron	O
que	O
este	O
gene	B-Sequence
produce	O
un	O
solo	O
2	O
.	O
3	O
KB	O
transcripción	B-Sequence
[	O
9	O
]	O
,	O
indicando	O
que	O
el	O
clonado	O
ADNc	B-Sequence
era	O
incompleto	B-Sequence
.	O

El	O
grado	O
de	O
similitud	O
con	O
lo	O
publicado	O
.	O
secuencia	B-Sequence
de	O
humana	B-Protein
y	I-Protein
de	I-Protein
ratón	I-Protein
TACC3	I-Protein
nos	O
sugirió	O
que	O
TACC4	O
en	O
realidad	O
representa	O
un	O
parcial	B-Sequence
conejo	B-Protein
TACC3	I-Protein
ADNc	B-Sequence
.	O

Para	O
probar	O
esta	O
hipótesis	O
,	O
nos	O
propusimos	O
clonar	O
el	O
conejo	B-Protein
TACC3	I-Protein
secuencia	B-Sequence
,	O
basado	O
en	O
el	O
caracteristicas	B-Sequence
conocidas	I-Sequence
de	O
humana	B-Protein
y	I-Protein
de	I-Protein
ratón	I-Protein
TACC3	I-Protein
.	O

Anteriormente	O
hemos	O
señalado	O
que	O
la	O
N	B-Sequence
-	I-Sequence
terminal	I-Sequence
y	I-Sequence
C	I-Sequence
-	I-Sequence
regiones	I-Sequence
terminales	I-Sequence
de	O
El	O
humana	B-Protein
y	I-Protein
de	I-Protein
ratón	I-Protein
TACC3	I-Protein
proteinas	B-Chemical
son	O
altamente	O
conservado	B-Sequence
(	O
[	O
2	O
]	O
,	O
ver	O
más	O
abajo	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
en	O
base	O
a	O
la	O
secuencia	B-Sequence
identidad	O
entre	O
estos	O
genes	B-Sequence
,	O
diseñamos	O
un	O
cebador	B-Sequence
de	I-Sequence
oligonucleótido	I-Sequence
consenso	I-Sequence
T3con2	O
,	O
que	O
sería	O
adecuado	O
para	O
la	O
identificación	O
del	O
región	B-Sequence
que	O
contiene	O
el	O
iniciador	O
metionina	B-Chemical
de	O
El	O
TACC3	B-Protein
ADNc	B-Sequence
desde	O
primates	B-Taxon
y	O
roedores	B-Taxon
.	O

Usando	O
esto	O
cebador	B-Sequence
,	O
en	O
combinación	O
con	O
el	O
TACC4	O
-	O
RACE	O
específico	O
cebador	B-Sequence
(	O
RACE2	O
)	O
,	O
utilizado	O
inicialmente	O
por	O
Steadman	O
et	O
al	O
[	O
9	O
]	O
,	O
aislamos	O
un	O
1	O
.	O
5kb	O
producto	B-Sequence
PCR	I-Sequence
desde	O
Conejo	B-Taxon
cerebro	O
ADNc	B-Sequence
por	O
rt-PCR	O
.	O

En	O
combinación	O
con	O
3	O
'	O
RACE	O
,	O
esto	O
generó	O
una	O
ADNc	B-Sequence
de	I-Sequence
consenso	I-Sequence
de	O
2283	O
pb	B-Sequence
que	O
corresponde	O
a	O
la	O
transcripción	B-Sequence
``	O
tamaño	O
de	O
2	O
.	O
3	O
kb	O
detectados	O
por	O
el	O
``	O
''	O
TACC4	O
``	O
''	O
''	O
secuencia	B-Sequence
informado	O
en	O
la	O
Figura	O
4	O
de	O
Steadman	O
et	O
al	O
[	O
9	O
]	O
.	O

``	O
Por	O
lo	O
tanto	O
,	O
aunque	O
es	O
posible	O
que	O
el	O
``	O
''	O
TACC4	O
''	O
''	O
''	O
secuencia	B-Sequence
es	O
un	O
producto	B-Sequence
de	I-Sequence
empalme	I-Sequence
alternativo	I-Sequence
,	O
o	O
es	O
el	O
producto	O
de	O
la	O
reduplicación	O
de	O
la	O
TACC3	B-Protein
gene	B-Sequence
(	O
eventos	O
que	O
serían	O
específicos	O
de	O
la	O
Conejo	B-Taxon
)	O
,	O
lo	O
único	O
transcripción	B-Sequence
detectado	O
en	O
Conejo	B-Taxon
ARN	B-Sequence
corresponde	O
a	O
la	O
transcripción	B-Sequence
predicha	I-Sequence
tamaño	O
de	O
la	O
TACC3	B-Protein
secuencia	B-Sequence
que	O
hemos	O
identificado	O
aquí	O
.	O

Además	O
,	O
el	O
cadena	B-Sequence
de	I-Sequence
nucleótidos	I-Sequence
``	O
se	O
encuentra	O
en	O
el	O
extremo	O
5	O
'	O
del	O
``	O
''	O
TACC4	O
``	O
''	O
''	O
secuencia	B-Sequence
también	O
se	O
encuentra	O
en	O
los	O
extremos	O
5	O
'de	O
una	O
serie	O
de	O
secuencias	B-Sequence
de	I-Sequence
ADNc	I-Sequence
(	O
p	O
.	O
ej	O
.	O
U82468	O
,	O
NM_	O
023500	O
)	O
,	O
que	O
fueron	O
aislados	O
por	O
5	O
'	O
RACE	O
,	O
lo	O
que	O
sugiere	O
que	O
pueden	O
corresponder	O
a	O
un	O
artefacto	O
de	O
la	O
metodología	O
5	O
'	O
RACE	O
utilizada	O
en	O
su	O
construcción	O
.	O

los	O
Conejo	B-Taxon
TACC4	O
y	O
el	O
conejo	B-Protein
TACC3	I-Protein
secuencia	B-Sequence
que	O
hemos	O
aislado	O
también	O
se	O
encuentran	O
en	O
la	O
misma	O
rama	O
del	O
árbol	O
filogenético	O
TACC	O
con	O
los	O
otros	O
TACC3	B-Protein
ortólogos	B-Sequence
,	O
incluyendo	O
máscara	B-Protein
(	I-Protein
Xenopus	I-Protein
laevis	I-Protein
)	I-Protein
,	O
y	O
los	O
recién	O
identificados	O
TACC3	B-Protein
secuencias	B-Sequence
en	O
rattus	B-Taxon
norvegus	I-Taxon
,	O
gallo	B-Taxon
gallo	I-Taxon
,	O
Silurana	B-Taxon
tropicalis	I-Taxon
,	O
danio	B-Taxon
rerio	I-Taxon
y	O
t	B-Taxon
rubíes	I-Taxon
,	O
informado	O
en	O
este	O
manuscrito	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
no	O
está	O
en	O
una	O
rama	O
separada	O
que	O
se	O
puede	O
esperar	O
si	O
el	O
secuencia	B-Sequence
era	O
un	O
miembro	O
distinto	O
de	O
la	O
familia	O
TACC	O
.	O

Colocación	O
de	O
la	O
RHAMM	B-Protein
gene	B-Sequence
en	O
la	O
filogenia	O
de	O
los	O
gen	B-Sequence
de	I-Sequence
bobina	I-Sequence
enrollada	I-Sequence
familia	O

RHAMM	B-Protein
humano	I-Protein
también	O
se	O
ha	O
propuesto	O
que	O
sea	O
el	O
cuarto	O
miembro	O
desaparecido	O
de	O
la	O
familia	O
TACC	O
[	O
10	O
]	O
.	O

Las	O
pruebas	O
utilizadas	O
en	O
apoyo	O
de	O
esta	O
afirmación	O
incluyeron	O
su	O
ubicación	B-Sequence
cromosómica	I-Sequence
en	O
5q32	O
en	O
humanos	B-Taxon
(	O
discutido	O
abajo	O
)	O
,	O
su	O
secuencia	B-Sequence
similitud	O
en	O
su	O
dominio	B-Sequence
de	I-Sequence
bobina	I-Sequence
enrollada	I-Sequence
al	O
TACC	O
dominio	B-Sequence
y	O
la	O
localización	O
subcelular	O
del	O
RHAMM	B-Protein
proteína	B-Chemical
en	O
el	O
centrosoma	B-GENE
.	O

Sin	O
embargo	O
,	O
si	O
RHAMM	B-Protein
fuera	O
un	O
miembro	O
de	O
la	O
familia	O
TACC	O
de	O
buena	O
fe	O
,	O
entonces	O
predeciríamos	O
que	O
su	O
evolución	O
sería	O
similar	O
a	O
la	O
de	O
otros	O
miembros	O
de	O
la	O
familia	O
TACC	O
,	O
y	O
encajaría	O
con	O
la	O
evolución	O
propuesta	O
del	O
vertebrado	B-Taxon
genoma	B-Sequence
.	O

Así	O
,	O
nos	O
propusimos	O
identificar	O
RHAMM	B-Protein
ortólogos	B-Sequence
y	O
relacionado	O
genes	B-Sequence
en	O
metazoos	B-Taxon
,	O
por	O
lo	O
que	O
una	O
filogenia	O
más	O
completa	O
de	O
la	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
Se	O
podría	O
generar	O
una	O
súper	O
familia	O
.	O

Identificamos	O
un	O
solo	O
RHAMM	B-Protein
gene	B-Sequence
en	O
todo	O
deuterostomas	B-Taxon
para	O
cual	O
ADNc	B-Sequence
y/o	I-Sequence
secuencia	I-Sequence
genómica	I-Sequence
estaba	O
disponible	O
,	O
incluyendo	O
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
.	O

No	O
RHAMM	B-Protein
gene	B-Sequence
fue	O
identificado	O
en	O
insectos	B-Taxon
o	O
nematodos	B-Taxon
.	O

Esto	O
indica	O
que	O
el	O
RHAMM	B-Protein
/	O
TACC	O
genes	B-Sequence
divergió	O
después	O
de	O
la	O
protostoma	B-Taxon
/	O
deuterostomo	B-Taxon
dividido	O
833	O
-	O
933	O
MYA	O
,	O
pero	O
antes	O
de	O
la	O
equinodermos	B-Taxon
/	O
urocordato	B-Taxon
divergencia	O
(	O
>	O
750	O
MYA	O
)	O
.	O

Significativamente	O
,	O
secuencia	B-Sequence
y	O
análisis	O
filogenético	O
de	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
proteinas	B-Chemical
(	O
Fig	O
.	O
1	O
)	O
muestra	O
claramente	O
que	O
RHAMM	B-Protein
no	O
contiene	O
un	O
TACC	O
dominio	B-Sequence
en	O
su	O
lugar	O
forma	O
una	O
familia	O
distinta	O
de	O
proteinas	B-Chemical
en	O
el	O
espiral	B-Sequence
de	I-Sequence
la	I-Sequence
bobina	I-Sequence
superfamilia	O
,	O
y	O
no	O
es	O
un	O
descendiente	O
directo	O
del	O
TACC	O
ancestral	O
gene	B-Sequence
.	O

Evolución	O
de	O
la	O
segmentos	B-Sequence
cromosómicos	I-Sequence
que	O
contiene	O
el	O
TACC	O
genes	B-Sequence

El	O
árbol	O
filogenético	O
de	O
la	O
FGFR	B-Protein
genes	B-Sequence
se	O
parece	O
mucho	O
a	O
la	O
del	O
vertebrado	B-Taxon
TACC1	B-Protein
-3	O
genes	B-Sequence
.	O

Recientemente	O
,	O
análisis	O
detallados	O
de	O
la	O
regiones	B-Sequence
cromosómicas	I-Sequence
que	O
contiene	O
el	O
FGFR	B-Protein
gene	B-Sequence
familia	O
en	O
humanos	B-Taxon
,	O
ratón	B-Taxon
y	O
el	O
artrópodo	B-Taxon
D.	I-Taxon
melanogaster	I-Taxon
haber	O
revelado	O
el	O
conservación	B-Sequence
de	O
segmentos	B-Sequence
cromosómicos	I-Sequence
parálogos	I-Sequence
entre	O
estos	O
organismos	B-Taxon
(	O
Fig	O
.	O
2	O
,	O
[	O
13	O
]	O
,	O
Tabla	O
1	O
[	O
ver	O
archivo	O
adicional	O
1	O
]	O
)	O
.	O

Esto	O
ha	O
proporcionado	O
más	O
apoyo	O
de	O
que	O
un	O
antiguo	O
segmento	B-Sequence
cromosómico	I-Sequence
se	O
duplicó	O
dos	O
veces	O
durante	O
vertebrado	B-Taxon
evolución	O
,	O
con	O
la	O
primera	O
duplicación	B-Sequence
que	O
dio	O
origen	O
a	O
la	O
humano	B-Taxon
cromosoma	B-GENE
4p16/5q32	O
-	O
ter	O
y	O
humano	B-Taxon
cromosoma	B-GENE
8p/10q23-ter	O
antepasados	O
que	O
ocurren	O
en	O
las	O
primeras	O
etapas	O
después	O
de	O
la	O
divergencia	O
de	O
los	O
invertebrados	O
.	O

Esto	O
sugiere	O
que	O
los	O
antepasados	O
FGFR	B-Protein
#	O
¿NOMBRE	O
?	O
gene	B-Sequence
par	O
probablemente	O
surgió	O
antes	O
de	O
la	O
inicial	O
duplicación	B-Sequence
y	O
la	O
subsiguiente	O
divergencia	O
de	O
estos	O
segmentos	B-Sequence
cromosómicos	I-Sequence
parálogos	I-Sequence
,	O
estimado	O
que	O
ocurrió	O
687	O
+/-	O
155	O
.	O
7	O
millones	O
de	O
años	O
.	O

Esto	O
ha	O
planteado	O
la	O
sugerencia	O
de	O
que	O
un	O
cuarto	O
TACC	O
gene	B-Sequence
en	O
vertebrados	B-Taxon
residiría	O
en	O
el	O
mismo	O
región	B-Sequence
cromosómica	I-Sequence
como	O
FGFR4	B-Protein
.	O

De	O
hecho	O
,	O
esta	O
hipótesis	O
se	O
ha	O
utilizado	O
en	O
apoyo	O
de	O
la	O
RHAMM	B-Protein
gene	B-Sequence
como	O
miembro	O
de	O
la	O
familia	O
TACC	O
[	O
10	O
]	O
.	O

RHAMM	B-Protein
humano	I-Protein
mapas	O
a	O
cromosoma	B-GENE
5q32	O
en	O
un	O
región	B-Sequence
delimitada	O
por	O
GPX3	B-Protein
y	O
NKX2E	B-Protein
.	O

Estas	O
lugares	B-Sequence
separar	O
dos	O
grupos	B-Sequence
de	I-Sequence
genes	I-Sequence
en	O
humano	B-Taxon
cromosoma	B-GENE
5	O
que	O
son	O
parálogo	B-Sequence
con	O
4p16	O
.	O

Curiosamente	O
,	O
estos	O
tres	O
racimos	B-Sequence
están	O
ubicados	O
en	O
diferentes	O
cromosomas	B-GENE
en	O
ratón	B-Taxon
y	O
rata	B-Taxon
(	O
Fig	O
.	O
2	O
)	O
,	O
lo	O
que	O
sugiere	O
además	O
que	O
este	O
grupo	B-Sequence
de	I-Sequence
genes	I-Sequence
se	O
transpuso	O
a	O
este	O
región	B-Sequence
después	O
de	O
la	O
primate	B-Taxon
/	O
roedor	B-Taxon
divergencia	O

Figura	O
2	O

Organización	O
lineal	O
de	O
grupos	B-Sequence
de	I-Sequence
genes	I-Sequence
centrado	O
en	O
el	O
locus	B-Sequence
cromosómicos	I-Sequence
de	O
El	O
FGFR	B-Protein
genes	B-Sequence
en	O
humanos	B-Taxon
.	O

genes	B-Sequence
parálogos	I-Sequence
presente	O
en	O
al	O
menos	O
dos	O
de	O
los	O
cuatro	O
lugares	B-Sequence
se	O
muestran	O
,	O
con	O
la	O
excepción	O
de	O
la	O
región	B-Sequence
Entre	O
GPX3	B-Protein
y	O
NKX2E	B-Protein
en	O
cromosoma	B-GENE
5	O
,	O
que	O
parece	O
representar	O
una	O
serie	O
de	O
intervenciones	O
genes	B-Sequence
insertados	I-Sequence
después	O
duplicación	B-Sequence
del	O
4p16/5q32	O
-	O
35	O
racimos	B-Sequence
,	O
y	O
genes	B-Sequence
mencionado	O
en	O
la	O
Fig	O
.	O

3	O
.	O

Correspondiente	O
regiones	B-Sequence
cromosómicas	I-Sequence
sintéticas	I-Sequence
de	I-Sequence
ratón	I-Sequence
(	O
mm	O
*	O
)	O
se	O
indican	O
.	O

rubíes	B-Taxon
takifugu	I-Taxon
andamios	B-Sequence
se	O
muestran	O
(	O
TR	O
*	O
)	O
que	O
contienen	O
más	O
de	O
una	O
gen	B-Sequence
homólogo	I-Sequence
a	O
partir	O
de	O
estos	O
racimos	B-Sequence
.	O

Más	O
detalles	O
sobre	O
el	O
ubicación	B-Sequence
de	O
genes	B-Sequence
parálogos	I-Sequence
se	O
puede	O
encontrar	O
en	O
[	O
ver	O
archivo	O
adicional	O
1	O
]	O
.	O

Porque	O
el	O
conservación	B-Sequence
de	O
gene	B-Sequence
El	O
orden	O
también	O
puede	O
proporcionar	O
pistas	O
sobre	O
la	O
evolución	O
de	O
gene	B-Sequence
regulación	O
,	O
a	O
continuación	O
intentamos	O
rastrear	O
la	O
evolución	O
de	O
estos	O
segmentos	B-Sequence
parálogos	I-Sequence
al	O
examinar	O
el	O
genoma	B-Sequence
de	O
El	O
tunicado	B-Taxon
C.	I-Taxon
intestinalis	I-Taxon
``	O
[	O
11	O
]	O
y	O
el	O
compacto	O
más	O
``	O
''	O
primitivo	O
``	O
''	O
''	O
vertebrado	B-Taxon
genoma	B-Sequence
secuenciado	O
hasta	O
la	O
fecha	O
,	O
t	B-Taxon
rubíes	I-Taxon
[	O
14	O
]	O
.	O

Aunque	O
no	O
está	O
completamente	O
ensamblado	O
,	O
el	O
examen	O
del	O
genoma	B-Sequence
de	O
t	B-Taxon
rubíes	I-Taxon
confirmó	O
la	O
presencia	O
de	O
segmentos	B-Sequence
cromosómicos	I-Sequence
parálogos	I-Sequence
a	O
los	O
que	O
se	O
encuentran	O
en	O
la	O
parte	O
superior	O
vertebrados	B-Taxon
(	O
Figura	O
2	O
)	O
.	O

Por	O
ejemplo	O
,	O
el	O
ortólogos	B-Sequence
de	O
GPRK2L	B-Protein
y	O
RGS12	B-Protein
se	O
encuentran	O
en	O
t	B-Taxon
rubíes	I-Taxon
andamio	B-Sequence
290	O
(	O
emb	O
|	O
CAAB01000290	O
.	O
1	O
)	O
,	O
y	O
dentro	O
de	O
300	O
kb	O
entre	O
sí	O
en	O
humano	B-Taxon
4p16	O
.	O

los	O
t	B-Taxon
rubíes	I-Taxon
ortólogos	B-Sequence
de	O
FGFR3	B-Protein
,	O
LETM1	O
y	O
WHSC1	O
están	O
ubicados	O
en	O
el	O
mismo	O
166	O
kb	O
andamio	B-Sequence
genómico	I-Sequence
251	O
(	O
emb	O
|	O
CAAB01000166	O
.	O
1	O
)	O
.	O

Significativamente	O
,	O
los	O
tres	O
humano	B-Taxon
ortólogos	B-Sequence
de	O
estos	O
genes	B-Sequence
también	O
se	O
encuentran	O
dentro	O
de	O
los	O
300	O
kb	O
entre	O
sí	O
en	O
4p16	O
.	O

Es	O
más	O
,	O
TACC3	B-Protein
y	O
FGFRL	B-Protein
mapa	O
a	O
la	O
andamios	B-Sequence
superpuestos	I-Sequence
1184/4669	O
(	O
en	O
|	O
CAAB01004668	O
)	O
.	O

Del	O
mismo	O
modo	O
,	O
elementos	O
de	O
estos	O
grupos	B-Sequence
de	I-Sequence
genes	I-Sequence
,	O
que	O
se	O
extiende	O
desde	O
HMP19	B-Protein
para	O
GPRK6	B-Protein
en	O
humano	B-Taxon
cromosoma	B-GENE
5q34	O
-	O
ter	O
también	O
se	O
encuentran	O
en	O
el	O
pez	B-Taxon
globo	I-Taxon
,	O
con	O
el	O
t	B-Taxon
rubíes	I-Taxon
ortólogos	B-Sequence
de	O
NSD1	B-Protein
,	O
FGFR4	B-Protein
y	O
un	O
RAB	O
-	O
como	O
gene	B-Sequence
mapeo	O
en	O
andamio	B-Sequence
407	O
(	O
en	O
|	O
CAAB01000407	O
)	O
.	O

Sin	O
embargo	O
,	O
no	O
hay	O
evidencia	O
de	O
una	O
gene	B-Sequence
correspondiente	O
a	O
un	O
TACC4	O
gene	B-Sequence
en	O
cualquiera	O
de	O
estos	O
racimos	B-Sequence
.	O

Como	O
se	O
señaló	O
anteriormente	O
,	O
el	O
análisis	O
filogenético	O
de	O
la	O
TACC	O
secuencias	B-Sequence
indicar	O
que	O
hay	O
dos	O
TACC1	B-Protein
relacionados	O
genes	B-Sequence
en	O
el	O
pez	B-Taxon
globo	I-Taxon
.	O

trTACC1B	B-Protein
se	O
encuentra	O
en	O
los	O
180	O
kb	O
andamio	B-Sequence
191	O
(	O
emb	O
|	O
CAAB01000191	O
.	O
1	O
)	O
,	O
que	O
también	O
contiene	O
la	O
ortólogos	B-Sequence
de	O
varios	O
genes	B-Sequence
situado	O
en	O
humano	B-Taxon
cromosoma	B-GENE
8p21	O
-	O
11	O
.	O

Así	O
,	O
este	O
andamio	B-Sequence
``	O
representa	O
a	O
los	O
más	O
``	O
''	O
desarrollados	O
''	O
''	O
''	O
TACC1	B-Protein
segmento	B-Sequence
cromosómico	I-Sequence
eso	O
es	O
evidente	O
en	O
mayor	O
vertebrados	B-Taxon
.	O

Por	O
otro	O
lado	O
,	O
el	O
trTACC1A	B-Protein
gene	B-Sequence
se	O
encuentra	O
en	O
el	O
396	O
kb	O
andamio	B-Sequence
12	O
(	O
embr	O
|	O
CAAB010012	O
.	O
1	O
)	O
.	O

Esta	O
andamio	B-Sequence
también	O
contiene	O
el	O
t	B-Taxon
rubíes	I-Taxon
ortólogos	B-Sequence
de	O
MSX1	B-Protein
,	O
STX18	B-Protein
,	O
D4S234E	B-Protein
y	O
el	O
gen	B-Sequence
predicho	I-Sequence
LOC118711	B-Protein
,	O
además	O
de	O
secuencias	B-Sequence
con	I-Sequence
homología	I-Sequence
para	O
LOXL	B-Protein
,	O
EVC	B-Protein
,	O
LOC159291	B-Protein
y	O
la	O
familia	O
LDB	O
.	O

Por	O
lo	O
tanto	O
,	O
andamio	B-Sequence
12	O
contiene	O
genes	B-Sequence
encontrado	O
en	O
el	O
regiones	B-Sequence
del	I-Sequence
cromosoma	I-Sequence
humano	I-Sequence
4	O
y	O
10	O
que	O
también	O
contienen	O
el	O
lugares	B-Sequence
por	O
TACC3	B-Protein
y	O
TACC2	B-Protein
,	O
respectivamente	O
,	O
y	O
por	O
lo	O
tanto	O
puede	O
parecerse	O
más	O
a	O
la	O
genómico	B-Sequence
organización	O
resultante	O
de	O
la	O
primera	O
duplicación	B-Sequence
de	O
los	O
ancestrales	O
segmento	B-Sequence
cromosómico	I-Sequence
parálogo	I-Sequence
.	O

Clústeres	B-Sequence
parálogos	I-Sequence
conservados	I-Sequence
puede	O
resultar	O
de	O
la	O
inicial	O
agrupamiento	B-Sequence
de	I-Sequence
los	I-Sequence
genes	I-Sequence
en	O
un	O
ancestral	O
relativamente	O
pequeño	O
cóntigo	B-Sequence
genómico	I-Sequence
.	O

``	O
Algunas	O
evidencias	O
de	O
la	O
existencia	O
de	O
``	O
''	O
protocúmulos	O
''	O
''	O
que	O
podrían	O
corresponder	O
al	O
''	O
segmentos	B-Sequence
cromosómicos	I-Sequence
parálogos	I-Sequence
anotado	O
en	O
mayor	O
vertebrados	B-Taxon
está	O
presente	O
en	O
el	O
genoma	B-Sequence
de	O
El	O
urocordato	B-Taxon
C.	I-Taxon
intestinalis	I-Taxon
[	O
11	O
]	O
.	O

Por	O
ejemplo	O
,	O
el	O
ortólogos	B-Sequence
de	O
FGFR	B-Protein
,	O
y	O
WHSC1	O
,	O
carboxipeptidasa	B-Protein
Z	I-Protein
y	O
FLJ25359	O
grupo	B-Sequence
dentro	O
de	O
un	O
85	O
kb	O
región	B-Sequence
de	O
El	O
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
genoma	B-Sequence
y	O
el	O
humano	B-Taxon
ortólogos	B-Sequence
todavía	O
se	O
mantienen	O
en	O
segmentos	B-Sequence
parálogos	I-Sequence
de	O
4p16	O
,	O
8p	O
y	O
10q	O
(	O
Fig	O
.	O
3	O
,	O
[	O
ver	O
archivo	O
adicional	O
1	O
]	O
)	O
.	O

Sin	O
embargo	O
,	O
cabe	O
señalar	O
que	O
no	O
grupos	B-Sequence
de	I-Sequence
genes	I-Sequence
desde	O
el	O
vertebrado	B-Taxon
segmentos	B-Sequence
parálogos	I-Sequence
están	O
ubicados	O
cerca	O
del	O
TACC	O
o	O
Los	B-Protein
genes	I-Protein
RHAMM	I-Protein
de	I-Protein
C.	I-Protein
intestinalis	I-Protein
,	O
lo	O
que	O
indica	O
que	O
la	O
formación	O
de	O
la	O
mucho	O
más	O
grande	O
segmentos	B-Sequence
parálogos	I-Sequence
abarcando	O
el	O
FGFR	B-Protein
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
formado	O
más	O
tarde	O
en	O
el	O
tiempo	O
evolutivo	O
,	O
o	O
por	O
el	O
contrario	O
han	O
estado	O
sujetos	O
a	O
una	O
amplia	O
reorganización	O
en	O
tunicados	B-Taxon
.	O

En	O
combinación	O
con	O
el	O
examen	O
de	O
la	O
t	B-Taxon
rubíes	I-Taxon
genoma	B-Sequence
,	O
esto	O
también	O
proporciona	O
evidencia	O
adicional	O
de	O
que	O
la	O
segunda	O
ronda	O
de	O
duplicación	B-Sequence
de	O
El	O
segmento	B-Sequence
cromosómico	I-Sequence
que	O
contenía	O
el	O
FGFR3	B-Protein
/	O
4	O
antepasado	O
no	O
incluía	O
un	O
TACC	O
gene	B-Sequence
,	O
o	O
que	O
tal	O
gene	B-Sequence
se	O
perdió	O
muy	O
temprano	O
en	O
vertebrado	B-Taxon
evolución	O
,	O
antes	O
de	O
la	O
divergencia	O
de	O
los	O
Gnantóstomo	B-Taxon
linajes	O

Sin	O
embargo	O
,	O
la	O
resolución	O
final	O
de	O
la	O
evolución	O
inicial	O
de	O
estos	O
segmento	B-Sequence
parálogo	I-Sequence
esperará	O
la	O
secuenciación	O
del	O
anfioxo	B-Taxon
y	O
lamprea	B-Taxon
genomas	B-Sequence
,	O
que	O
solo	O
tienen	O
uno	O
FGFR	B-Protein
gene	B-Sequence
,	O
y	O
por	O
lo	O
tanto	O
sólo	O
debe	O
contener	O
una	O
copia	O
de	O
la	O
otra	O
correspondiente	O
genes	B-Sequence
en	O
esto	O
segmento	B-Sequence
conservado	I-Sequence
.	O

figura	O
3	O

Formación	O
de	O
protocúmulos	O
en	O
rubíes	B-Taxon
takifugu	I-Taxon
y	O
Ciona	B-Taxon
intestinalis	I-Taxon
:	O
(	O
A	O
)	O
:	O
Estructura	O
de	O
la	O
andamios	B-Sequence
genómicos	I-Sequence
que	O
contiene	O
el	O
Takifugu	B-Protein
rubripes	I-Protein
trTACC1A	I-Protein
y	I-Protein
trTACC1B	I-Protein
genes	B-Sequence
.	O

Andamio	B-Sequence
12	O
,	O
el	O
sitio	B-Sequence
Para	O
el	O
trTACC1A	B-Protein
gene	B-Sequence
contiene	O
genes	B-Sequence
encontrado	O
con	O
cualquiera	O
homólogos	B-Sequence
o	O
ortólogos	B-Sequence
en	O
el	O
distal	O
largo	O
brazo	B-Sequence
del	I-Sequence
cromosoma	I-Sequence
humano	I-Sequence
10	O
y	O
4p16	O
.	O

Esta	O
andamio	B-Sequence
,	O
por	O
lo	O
tanto	O
,	O
tiene	O
algunas	O
de	O
las	O
características	O
del	O
predicho	B-Sequence
antepasado	O
inmediato	O
del	O
TACC1	B-Protein
/	O
TACC2	B-Protein
segmento	B-Sequence
cromosómico	I-Sequence
.	O

trTACC1B	B-Protein
se	O
encuentra	O
en	O
andamio	B-Sequence
191	O
,	O
que	O
contiene	O
ortólogos	B-Sequence
de	O
genes	B-Sequence
se	O
encuentra	O
en	O
el	O
corto	O
proximal	O
brazo	B-Sequence
del	I-Sequence
cromosoma	I-Sequence
humano	I-Sequence
8	O

(	O
B	O
)	O
:	O
Ciona	B-Taxon
intestinalis	I-Taxon
racimos	B-Sequence
que	O
contiene	O
genes	B-Sequence
encontrado	O
en	O
segmentos	B-Sequence
parálogos	I-Sequence
en	O
humano	B-Taxon
8	O
,	O
4p16	O
,	O
10q	O
y	O
5q	O
.	O

Figura	O
4	O

genómico	B-Sequence
estructura	O
del	O
TACC	O
genes	B-Sequence
.	O

Regiones	B-Sequence
conservadas	I-Sequence
conocido	O
por	O
unirse	O
proteína	B-Chemical
factores	O
en	O
todos	O
humano	B-Taxon
TACC	O
proteinas	B-Chemical
son	O
exhibidos	O
.	O

El	O
SDP	O
repetir	B-Sequence
de	O
humano	B-Protein
TACC1	I-Protein
-	O
3	O
se	O
sabe	O
que	O
se	O
une	O
GAS41	B-Protein
(	O
[	O
3	O
,	O
15	O
]	O
y	O
datos	O
no	O
mostrados	O
)	O
.	O

El	O
TACC	O
dominio	B-Sequence
une	O
ch	B-Protein
-	I-Protein
TOG	I-Protein
y	O
miembros	O
de	O
las	O
Aurora	O
quinasas	O
en	O
todas	O
las	O
especies	O
examinadas	O
hasta	O
la	O
fecha	O
.	O

Este	O
motivo	O
está	O
codificado	O
característicamente	O
por	O
el	O
3	O
'	O
exones	B-Sequence
del	O
TAC	O
genes	B-Sequence
.	O

El	O
tamaño	O
del	O
más	O
grande	O
isoforma	B-Sequence
para	O
cada	O
gene	B-Sequence
se	O
muestra	O
.	O

Comparativo	O
genómico	B-Sequence
estructura	O
de	O
la	O
familia	O
TACC	O

los	O
secuencias	B-Sequence
de	I-Sequence
ADN	I-Sequence
genómico	I-Sequence
correspondiente	O
a	O
la	O
ortólogo	B-Sequence
TACC	O
genes	B-Sequence
de	O
humano	B-Taxon
,	O
ratón	B-Taxon
,	O
rata	B-Taxon
,	O
pez	B-Taxon
globo	I-Taxon
,	O
C	B-Taxon
.	I-Taxon
intestinalis	I-Taxon
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
y	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
fueron	O
extraídos	O
y	O
analizados	O
por	O
Genescan	O
y	O
BLAST	O
para	O
determinar	O
la	O
genómico	B-Sequence
estructura	O
de	O
cada	O
TACC	O
gene	B-Sequence
.	O

En	O
algunos	O
casos	O
,	O
por	O
rata	B-Taxon
y	O
pez	B-Taxon
globo	I-Taxon
,	O
exones	B-Sequence
fueron	O
agregado	B-Sequence
o	O
modificado	B-Sequence
basado	O
en	O
la	O
mejor	O
similitud	O
de	O
los	O
traducidos	O
péptidos	B-Sequence
a	O
la	O
correspondiente	O
ratón	B-Taxon
y	O
humano	B-Taxon
proteinas	B-Chemical
.	O

Para	O
regiones	B-Sequence
con	O
bajo	O
secuencia	B-Sequence
similitud	O
en	O
t	B-Taxon
rubíes	I-Taxon
,	O
secuencias	B-Sequence
genómicas	I-Sequence
del	O
agua	O
dulce	O
pez	B-Taxon
globo	I-Taxon
,	O
Tetraodon	B-Taxon
nigroviridis	I-Taxon
se	O
utilizaron	O
como	O
medios	O
adicionales	O
para	O
verificar	O
la	O
exones	B-Sequence
predichos	I-Sequence
.	O

La	O
estructura	O
general	O
del	O
TACC	O
genes	B-Sequence
y	O
proteinas	B-Chemical
se	O
representa	O
en	O
la	O
Fig	O
.	O

4	O
.	O

El	O
principal	O
rasgo	B-Sequence
conservado	I-Sequence
de	O
la	O
familia	O
TACC	O
,	O
el	O
TACC	O
dominio	B-Sequence
,	O
se	O
encuentra	O
en	O
el	O
terminal	B-Sequence
carboxi	I-Sequence
de	O
El	O
proteína	B-Chemical
.	O

en	O
el	O
caso	O
de	O
la	O
C	B-Protein
.	I-Protein
elegante	I-Protein
TAC	I-Protein
proteína	B-Chemical
,	O
esta	O
estructura	O
comprende	O
la	O
mayoría	O
de	O
los	O
proteína	B-Chemical
y	O
está	O
codificado	O
por	O
dos	O
de	O
los	O
tres	O
exones	B-Sequence
de	O
El	O
gene	B-Sequence
.	O

en	O
lo	O
alto	O
organismos	B-Taxon
,	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
,	O
y	O
el	O
deuterostomas	B-Taxon
C.	I-Taxon
intestinalis	I-Taxon
para	O
humano	B-Taxon
,	O
esta	O
rasgo	B-Sequence
también	O
está	O
codificado	O
por	O
el	O
final	O
exones	B-Sequence
de	O
El	O
gene	B-Sequence
(	O
cinco	O
en	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
,	O
siete	O
en	O
el	O
deuterostomo	B-Taxon
genes	B-Sequence
)	O
.	O

Fuera	O
del	O
TACC	O
dominio	B-Sequence
,	O
sin	O
embargo	O
,	O
los	O
miembros	O
de	O
la	O
familia	O
TACC	O
muestran	O
relativamente	O
poco	O
homología	B-Sequence
.	O

Es	O
interesante	O
que	O
cada	O
TACC	O
gene	B-Sequence
contiene	O
uno	O
grande	O
exón	B-Sequence
,	O
que	O
muestra	O
una	O
variabilidad	O
considerable	O
entre	O
TACC	O
ortólogos	B-Sequence
,	O
y	O
constituye	O
la	O
principal	O
diferencia	O
entre	O
el	O
TACC3	B-Protein
genes	B-Sequence
en	O
el	O
vertebrados	B-Taxon
(	O
vea	O
abajo	O
)	O
.	O

En	O
deuterostomas	B-Taxon
,	O
esta	O
exón	B-Sequence
contiene	O
el	O
SDP	O
repetir	B-Sequence
(	O
o	O
en	O
el	O
caso	O
de	O
la	O
murino	B-Taxon
TACC3	B-Protein
's	I-Protein
,	O
a	O
roedor	B-Taxon
-	O
específico	O
24	O
aminoácidos	B-Chemical
repetir	B-Sequence
)	O
,	O
que	O
es	O
responsable	O
de	O
la	O
vinculación	O
de	O
los	O
Complejo	B-GENE
remodelador	I-GENE
de	I-GENE
cromatina	I-GENE
SWI/SNF	I-GENE
componente	O
GAS41	B-Protein
[	O
15	O
,	O
16	O
]	O
.	O

De	O
El	O
vertebrado	B-Taxon
TACC	O
proteinas	B-Chemical
,	O
los	O
TACC3	B-Protein
ortólogos	B-Sequence
muestran	O
la	O
mayor	O
variabilidad	O
en	O
tamaño	O
y	O
secuencia	B-Sequence
,	O
que	O
varían	O
en	O
tamaño	O
desde	O
599	O
aminoácidos	B-Chemical
Para	O
el	O
rata	B-Protein
TACC3	I-Protein
proteína	B-Chemical
,	O
al	O
942	O
aminoácidos	B-Chemical
en	O
el	O
danio	B-Taxon
rerio	I-Taxon
proteína	B-Chemical
.	O

Las	O
razones	O
de	O
estas	O
diferencias	O
se	O
desprenden	O
de	O
la	O
genómico	B-Sequence
estructura	O
de	O
la	O
TACC3	B-Protein
ortólogos	B-Sequence
.	O

TACC3	B-Protein
puede	O
dividirse	O
en	O
tres	O
secciones	O
:	O
una	O
conservada	B-Sequence
N	I-Sequence
-	I-Sequence
región	I-Sequence
terminal	I-Sequence
(	O
CNTR	O
)	O
de	O
108	O
aminoácidos	B-Chemical
,	O
codificado	O
por	O
exones	B-Sequence
2	O
y	O
3	O
en	O
cada	O
vertebrado	B-Taxon
TACC3	B-Protein
gene	B-Sequence
,	O
los	O
conservado	B-Sequence
TACC	O
dominio	B-Sequence
repartidos	O
entre	O
los	O
siete	O
finalistas	O
exones	B-Sequence
,	O
y	O
un	O
centro	O
muy	O
variable	O
región	B-Sequence
.	O

La	O
falta	O
de	O
conservación	B-Sequence
tanto	O
en	O
tamaño	O
como	O
secuencia	B-Sequence
del	O
central	O
parte	B-Sequence
de	O
El	O
TACC3	B-Protein
proteinas	B-Chemical
de	O
humano	B-Taxon
y	O
ratón	B-Taxon
se	O
ha	O
señalado	O
anteriormente	O
,	O
y	O
explica	O
la	O
principal	O
diferencia	O
entre	O
estos	O
dos	O
ortólogos	B-Sequence
[	O
2	O
]	O
.	O

La	O
mayor	O
parte	O
de	O
este	O
centro	O
parte	B-Sequence
,	O
que	O
contiene	O
el	O
SDP	O
repetir	B-Sequence
motivos	I-Sequence
,	O
está	O
codificado	O
por	O
uno	O
exón	B-Sequence
en	O
humano	B-Taxon
y	O
el	O
pez	B-Taxon
globo	I-Taxon
(	O
emb	O
|	O
CAAB01001184	O
)	O
.	O

En	O
roedores	B-Taxon
,	O
sin	O
embargo	O
,	O
este	O
región	B-Sequence
se	O
compone	O
casi	O
en	O
su	O
totalidad	O
de	O
siete	O
24	O
aminoácidos	B-Chemical
repite	B-Sequence
,	O
que	O
se	O
encuentran	O
en	O
un	O
solo	O
exón	B-Sequence
de	O
El	O
ratón	B-Protein
y	I-Protein
rata	I-Protein
TACC3	I-Protein
genes	B-Sequence
.	O

Anteriormente	O
se	O
informó	O
que	O
hay	O
cuatro	O
ratón	B-Protein
TACC3	I-Protein
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
que	O
difieren	O
en	O
el	O
número	O
de	O
estos	O
repite	B-Sequence
[	O
2	O
,	O
7	O
,	O
17	O
]	O
.	O

Como	O
estos	O
repite	B-Sequence
están	O
presentes	O
en	O
un	O
solo	O
exón	B-Sequence
,	O
parece	O
probable	O
que	O
estos	O
diferentes	O
secuencias	B-Sequence
puede	O
ser	O
el	O
resultado	O
de	O
la	O
ADN	B-Sequence
polimerasas	O
utilizadas	O
en	O
la	O
ADNc	B-Sequence
síntesis	O
y/o	O
reacción	O
de	O
PCR	O
tartamudeando	O
a	O
través	O
de	O
la	O
repetir	B-Sequence
motivo	I-Sequence
.	O

Lo	O
correcto	O
secuencia	B-Sequence
,	O
informado	O
por	O
Sadek	O
et	O
al	O
[	O
7	O
]	O
,	O
es	O
el	O
que	O
se	O
utiliza	O
en	O
la	O
totalidad	O
de	O
este	O
manuscrito	O
.	O

Estas	O
repite	B-Sequence
no	O
son	O
evidentes	O
en	O
el	O
Conejo	B-Taxon
proteína	B-Chemical
,	O
o	O
cualquier	O
otro	O
TACC	O
proteína	B-Chemical
,	O
y	O
puede	O
indicar	O
que	O
el	O
roedor	B-Taxon
TACC3	B-Protein
ha	O
desarrollado	O
distintas	O
funciones	O
,	O
como	O
ya	O
se	O
ha	O
señalado	O
para	O
el	O
anfibio	B-Taxon
xenopus	I-Taxon
TACC3	B-Protein
,	O
enmascarar	B-Protein
[	O
8	O
]	O
.	O

Empalme	O
alternativo	O
en	O
vertebrado	B-Taxon
TACC	O
genes	B-Sequence

Mientras	O
que	O
exón	B-Sequence
barajar	O
puede	O
impulsar	O
la	O
diversificación	O
funcional	O
de	O
gene	B-Sequence
familias	O
a	O
lo	O
largo	O
del	O
tiempo	O
evolutivo	O
,	O
el	O
empalme	O
alternativo	O
temporal	O
y	O
/	O
o	O
tejido	O
específico	O
de	O
un	O
gene	B-Sequence
puede	O
dar	O
lugar	O
a	O
la	O
diversificación	O
funcional	O
de	O
un	O
solo	O
gene	B-Sequence
durante	O
el	O
desarrollo	O
de	O
un	O
organismo	B-Taxon
.	O

Aunque	O
no	O
hay	O
empalme	O
alternativo	O
de	O
TACC3	B-Protein
ha	O
sido	O
claramente	O
documentado	O
,	O
tanto	O
el	O
empalme	O
temporal	O
como	O
el	O
específico	O
del	O
tejido	O
se	O
observan	O
en	O
el	O
TACC1	B-Protein
y	O
TACC2	B-Protein
genes	B-Sequence
.	O

En	O
el	O
caso	O
de	O
TACC2	B-Protein
,	O
un	O
grande	O
adicional	O
(	O
5	O
kb	O
)	O
exón	B-Sequence
representa	O
la	O
principal	O
diferencia	O
entre	O
los	O
principales	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
de	O
El	O
vertebrado	B-Taxon
TACC2	B-Protein
genes	B-Sequence
[	O
3	O
]	O
.	O

El	O
empalme	O
alternativo	O
de	O
este	O
exón	B-Sequence
sugiere	O
una	O
gran	O
diferencia	O
funcional	O
entre	O
los	O
dos	O
TACC2	B-Protein
isoformas	B-Sequence
,	O
TACC2s	O
y	O
TACC2l	O
[	O
3	O
]	O
,	O
así	O
como	O
una	O
diferencia	O
significativa	O
entre	O
TACC2	B-Protein
y	O
su	O
pariente	O
más	O
cercano	O
de	O
la	O
familia	O
TACC	O
,	O
TACC1	B-Protein
.	O

Sin	O
embargo	O
,	O
la	O
función	O
de	O
este	O
región	B-Sequence
del	O
TACC2l	O
isoforma	B-Sequence
es	O
actual	O
desconocido	O
.	O

Empalme	O
alternativo	O
,	O
junto	O
con	O
diferencial	O
promotor	B-Sequence
El	O
uso	O
ya	O
se	O
ha	O
señalado	O
para	O
el	O
humano	B-Protein
TACC1	I-Protein
gene	B-Sequence
[	O
18	O
,	O
19	O
]	O
.	O

Además	O
,	O
como	O
se	O
muestra	O
en	O
la	O
Fig	O
.	O

5	O
,	O
hemos	O
identificado	O
más	O
TACC1	B-Protein
isoformas	B-Sequence
que	O
resultan	O
del	O
empalme	O
alternativo	O
de	O
exones	B-Sequence
1b-4a	O
.	O

Las	O
funciones	O
de	O
estos	O
diferentes	B-Sequence
isoformas	I-Sequence
son	O
desconocidos	O
,	O
sin	O
embargo	O
el	O
región	B-Sequence
eliminada	I-Sequence
del	O
mas	O
corto	O
variantes	B-Sequence
puede	O
incluir	O
el	O
sitio	B-Sequence
de	I-Sequence
unión	I-Sequence
por	O
LSm7	B-Protein
[	O
20	O
]	O
(	O
variantes	B-Sequence
C	O
,	O
D	O
,	O
F	O
-	O
I	O
)	O
,	O
y	O
/	O
o	O
el	O
nuclear	B-GENE
localización	O
señales	B-Sequence
y	O
sitio	B-Sequence
de	I-Sequence
unión	I-Sequence
por	O
GAS41	B-Protein
[	O
15	O
]	O
y	O
PCTAIRE2BP	B-Protein
[	O
20	O
]	O
(	O
isoformas	B-Sequence
B-D	O
,	O
S	O
)	O
.	O

Uno	O
de	O
estos	O
isoformas	B-Sequence
,	O
TACC1S	O
está	O
localizado	O
exclusivamente	O
en	O
el	O
citoplasma	B-GENE
[	O
19	O
]	O
,	O
sugiriendo	O
que	O
cuanto	O
más	O
corto	O
isoformas	B-Sequence
no	O
sería	O
capaz	O
de	O
interactuar	O
con	O
los	O
elementos	O
de	O
la	O
chomatina	B-GENE
remodelación	O
y/o	O
ARN	B-Sequence
maquinaria	O
de	O
procesamiento	O
en	O
la	O
núcleo	B-GENE
.	O

Así	O
,	O
los	O
cambios	O
en	O
el	O
complemento	O
de	O
TACC1	B-Protein
isoformas	B-Sequence
en	O
el	O
célula	B-Cell
puede	O
resultar	O
en	O
alteraciones	O
en	O
celular	B-Cell
ARN	B-Sequence
metabolismo	O
en	O
múltiples	O
niveles	O
,	O
y	O
puede	O
explicar	O
la	O
observación	O
de	O
que	O
TACC1D	O
y	O
TACC1F	O
isoformas	B-Sequence
se	O
asocian	O
con	O
cambios	O
tumorigénicos	O
en	O
la	O
mucosa	O
gástrica	O
[	O
18	O
]	O
.	O

Figura	O
5	O

Empalme	O
alternativo	O
del	O
humano	B-Protein
TACC1	I-Protein
gene	B-Sequence
.	O

(	O
A	O
)	O
:	O
Siete	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
han	O
sido	O
identificados	O
por	O
humano	B-Protein
TACC1	I-Protein
(	O
A-F	O
y	O
S	O
)	O
.	O

También	O
hemos	O
identificado	O
más	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
(	O
G	O
-	O
I	O
)	O
del	O
análisis	O
de	O
la	O
base	O
de	O
datos	O
y	O
del	O
análisis	O
rt	O
-	O
PCR	O
de	O
humano	B-Taxon
cerebro	O
ARN	B-Sequence
.	O

(	O
B	O
)	O
:	O
Empalme	O
alternativo	O
de	O
TACC1	B-Protein
en	O
el	O
humano	B-Taxon
cerebro	O
.	O

rt	O
-	O
El	O
análisis	O
PCR	O
confirma	O
el	O
empalme	O
del	O
exón	B-Sequence
no	I-Sequence
traducido	I-Sequence
1a	O
a	O
exón	B-Sequence
1	O
,	O
con	O
retención	O
del	O
inicio	O
definido	O
originalmente	O
metionina	B-Chemical
(	O
GB	O
:	O
NP	O
_	O
006274	O
)	O
(	O
Variante	B-Sequence
A	O
*	O
,	O
carriles	O
1	O
y	O
3	O
)	O
.	O

exón	B-Sequence
1a	O
también	O
empalma	O
a	O
exón	B-Sequence
2	O
,	O
quitando	B-Sequence
los	O
L-Sm7	B-Protein
motivo	O
vinculante	O
(	O
variante	B-Sequence
I	O
,	O
carriles	O
3	O
,	O
12	O
y	O
13	O
)	O
.	O

variantes	B-Sequence
que	O
funcionalmente	O
eliminar	B-Sequence
exones	I-Sequence
2	O
y/o	O
3	O
,	O
como	O
variante	B-Sequence
C	O
(	O
carril	O
15	O
)	O
también	O
retirar	B-Sequence
los	O
predicho	B-Sequence
nuclear	B-GENE
localización	O
señales	B-Sequence
,	O
y	O
la	O
unión	O
dominios	B-Sequence
por	O
GAS41	B-Protein
y	O
PCTAIRE2BP	B-Protein
.	O

Estas	O
variantes	B-Sequence
mantendría	O
el	O
TACC	O
dominio	B-Sequence
,	O
y	O
por	O
lo	O
tanto	O
el	O
potencial	O
para	O
unirse	O
a	O
ch	B-Protein
-	I-Protein
TOG	I-Protein
y	O
Aurora	B-Protein
A	I-Protein
quinasa	I-Protein
en	O
el	O
centrosoma	B-GENE
.	O

Carril	O
1	O
:	O
EF	O
/	O
X1R	O
,	O
Carril	O
2	O
:	O
EF	O
/	O
BX647R	O
,	O
Carril	O
3	O
:	O
EF	O
/	O
6SPR	O
,	O
Carril	O
4	O
:	O
EF	O
/	O
1DR	O
,	O
Carril	O
5	O
,	O
EF	O
/	O
128R	O
,	O
Carril	O
6	O
X3F	O
/	O
X1R	O
,	O
Carril	O
7	O
:	O
X3F	O
/	O
BX647R	O
,	O
Carril	O
8	O
:	O
X3F	O
/	O
6SPR	O
,	O
Carril	O
9	O
:	O
X3F	O
/	O
1DR	O
,	O
Carril	O
10	O
,	O
X3F	O
/	O
128R	O
,	O
Carril	O
11	O
:	O
1DF	O
/	O
X1R	O
,	O
Carril	O
12	O
:	O
1DF	O
/	O
BX647R	O
,	O
Carril	O
13	O
:	O
1DF	O
/	O
6SPR	O
,	O
Carril	O
14	O
:	O
1DF	O
/	O
1DR	O
,	O
Carril	O
15	O
:	O
1DF/128R	O
,	O
Carril	O
16	O
:	O
Biorad	O
1	O
kb	O
+	O
Escala	O
de	O
tamaño	O
.	O

Modelado	O
in	O
silico	O
de	O
la	O
evolución	O
de	O
TACC	O
proteína	B-Chemical
función	O

los	O
proteína	B-Chemical
y	O
genómico	B-Sequence
estructura	O
de	O
los	O
miembros	O
actuales	O
de	O
la	O
familia	O
TACC	O
sugiere	O
que	O
la	O
función	O
del	O
TACC	O
ancestral	O
proteína	B-Chemical
fue	O
mediada	O
únicamente	O
a	O
través	O
de	O
las	O
interacciones	O
de	O
los	O
conservado	B-Sequence
TACC	O
dominio	B-Sequence
.	O

Usando	O
un	O
in	O
silico	O
proteína	B-Chemical
-	O
proteína	B-Chemical
modelo	O
de	O
interacción	O
basado	O
en	O
mitótica	O
conocida	O
huso	B-GENE
y	O
centrosomales	B-GENE
componentes	O
,	O
hemos	O
predicho	O
previamente	O
una	O
serie	O
de	O
interacciones	O
adicionales	O
que	O
podrían	O
conservarse	O
entre	O
un	O
TACC	O
funcional	O
homólogo	B-Sequence
en	O
levadura	B-Taxon
,	O
spc	B-Protein
-	I-Protein
72	I-Protein
,	O
y	O
uno	O
o	O
más	O
humano	B-Taxon
TACC	O
proteinas	B-Chemical
[	O
21	O
]	O
.	O

Así	O
,	O
se	O
sabe	O
que	O
todos	O
los	O
TACC	O
proteinas	B-Chemical
examinados	O
hasta	O
la	O
fecha	O
interactúan	O
,	O
a	O
través	O
del	O
TACC	O
dominio	B-Sequence
,	O
con	O
el	O
microtúbulo	B-GENE
/	O
centrosomales	B-GENE
proteinas	B-Chemical
de	O
El	O
stu2	B-Protein
/	O
msps	B-Protein
/	O
ch	B-Protein
-	I-Protein
TOG	I-Protein
familia	O
[	O
5	O
,	O
6	O
,	O
22	O
-	O
24	O
]	O
,	O
y	O
con	O
las	O
Aurora	O
quinasas	O
[	O
20	O
,	O
21	O
,	O
25	O
]	O
.	O

Estas	O
interacciones	O
son	O
necesarias	O
para	O
la	O
acumulación	O
de	O
D-TACC	O
,	O
spc72	O
,	O
ceTAC1	O
y	O
TACC3	B-Protein
proteinas	B-Chemical
al	O
centrosoma	B-GENE
[	O
5	O
,	O
6	O
,	O
22	O
-	O
24	O
]	O
.	O

Por	O
lo	O
tanto	O
,	O
esta	O
interacción	O
funcional	O
con	O
el	O
centrosoma	B-GENE
y	O
mitótico	O
huso	B-GENE
es	O
probable	O
que	O
represente	O
la	O
antigua	O
función	O
conservada	O
de	O
la	O
familia	O
TACC	O
.	O

Sin	O
embargo	O
,	O
es	O
evidente	O
que	O
la	O
humano	B-Taxon
TACC	O
proteinas	B-Chemical
también	O
difieren	O
en	O
su	O
capacidad	O
para	O
interactuar	O
con	O
las	O
Aurora	O
quinasas	O
.	O

Por	O
ejemplo	O
,	O
TACC1	B-Protein
y	O
TACC3	B-Protein
interactuar	O
con	O
Aurora	B-Protein
A	I-Protein
quinasa	I-Protein
,	O
mientras	O
que	O
TACC2	B-Protein
interactúa	O
con	O
Aurora	B-Protein
C	I-Protein
quinasa	I-Protein
[	O
21	O
]	O
,	O
sugiriendo	O
un	O
grado	O
de	O
especialización	O
funcional	O
en	O
los	O
derivados	O
del	O
ancestral	O
cordado	B-Taxon
TACC	O
,	O
después	O
de	O
la	O
radiación	O
del	O
vertebrado	B-Taxon
TACC	O
genes	B-Sequence
.	O

La	O
localización	O
de	O
la	O
vertebrado	B-Taxon
TACC	O
proteinas	B-Chemical
en	O
la	O
interfase	O
núcleo	B-GENE
[	O
15	O
,	O
26	O
,	O
27	O
]	O
sugiere	O
que	O
tienen	O
funciones	O
adicionales	O
fuera	O
de	O
su	O
papel	O
antiguo	O
en	O
el	O
centrosoma	B-GENE
y	O
microtúbulo	B-GENE
dinámica	O

Por	O
lo	O
tanto	O
,	O
parece	O
probable	O
que	O
los	O
miembros	O
de	O
la	O
familia	O
TACC	O
en	O
protostomas	B-Taxon
y	O
deuterostomas	B-Taxon
han	O
integrado	O
nuevas	O
funciones	O
únicas	O
como	O
el	O
TACC	O
en	O
evolución	O
genes	B-Sequence
adquirido	O
adicional	O
exones	B-Sequence
.	O

Los	O
resultados	O
del	O
análisis	O
proteómico	O
piloto	O
a	O
gran	O
escala	O
en	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
y	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
proporcionar	O
más	O
evidencia	O
sugestiva	O
de	O
esta	O
evolución	O
funcional	O
.	O

Levadura	B-Taxon
El	O
análisis	O
de	O
dos	O
híbridos	O
indica	O
que	O
ceTAC	B-Protein
se	O
une	O
directamente	O
a	O
C	B-Protein
.	I-Protein
elegante	I-Protein
lin15A	I-Protein
,	I-Protein
lin36	I-Protein
y	I-Protein
lin37	I-Protein
[	O
28	O
]	O
.	O

Estas	O
proteinas	B-Chemical
puente	O
ceTAC	B-Protein
a	O
otros	O
elementos	O
de	O
la	O
citoesqueleto	B-GENE
y	O
microtúbulo	B-GENE
red	O
,	O
así	O
como	O
a	O
los	O
componentes	O
de	O
la	O
ribosoma	B-GENE
,	O
los	O
histona	B-Chemical
desacetilasa	O
cromatina	B-GENE
remodelación	O
de	O
maquinaria	O
como	O
egr	B-Protein
-	I-Protein
1	I-Protein
y	O
lin-53	B-Protein
(	O
los	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
homólogos	B-Sequence
de	O
El	O
MTA	B-Protein
humano	I-Protein
-	I-Protein
1	I-Protein
y	I-Protein
RbAP48	I-Protein
)	O
,	O
y	O
a	O
factores	O
de	O
transcripción	O
como	O
el	O
PAL1	B-Protein
homeobox	O
y	O
el	O
nuclear	B-GENE
hormona	B-Chemical
receptor	O
nhr	B-Protein
-	I-Protein
86	I-Protein
[	O
28	O
]	O
(	O
Figura	O
6A	O
)	O
.	O

Del	O
mismo	O
modo	O
,	O
la	O
proteómica	O
a	O
gran	O
escala	O
[	O
29	O
]	O
ha	O
demostrado	O
que	O
Drosophila	B-Protein
TACC	I-Protein
interactúa	O
con	O
dos	O
proteinas	B-Chemical
,	O
los	O
ARN	B-Sequence
Unión	O
proteína	B-Chemical
TBPH	B-Protein
y	O
CG14540	B-Protein
(	O
Fig	O
.	O
6B	O
)	O
,	O
y	O
por	O
lo	O
tanto	O
indirectamente	O
con	O
el	O
drosófila	B-Taxon
Complejo	B-GENE
remodelador	I-GENE
de	I-GENE
cromatina	I-GENE
SWI/SNF	I-GENE
y	O
ADN	B-Sequence
Maquinaria	O
de	O
reparación	O
de	O
daños	O
.	O

Significativamente	O
,	O
el	O
ceTAC	B-Protein
proteína	B-Chemical
recientemente	O
también	O
ha	O
sido	O
implicado	O
en	O
ADN	B-Sequence
reparación	O
a	O
través	O
de	O
su	O
interacción	O
directa	O
con	O
el	O
C	B-Protein
.	I-Protein
elegante	I-Protein
BARD1	I-Protein
ortólogo	B-Sequence
[	O
30	O
]	O
.	O

Cabe	O
señalar	O
que	O
una	O
serie	O
de	O
interacciones	O
con	O
el	O
TACC	O
proteinas	B-Chemical
a	O
partir	O
de	O
estos	O
organismos	B-Taxon
probablemente	O
han	O
sido	O
pasados	O
por	O
alto	O
por	O
estos	O
métodos	O
a	O
gran	O
escala	O
,	O
incluidas	O
las	O
interacciones	O
directas	O
bien	O
documentadas	O
con	O
las	O
aurora	O
quinasas	O
y	O
la	O
stu2	B-Protein
/	O
msps	B-Protein
/	O
ch	B-Protein
-	I-Protein
TOG	I-Protein
familia	O
.	O

Figura	O
6	O

Evolución	O
funcional	O
del	O
TACC	O
proteinas	B-Chemical
modelado	O
en	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
y	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
.	O

(	O
A	O
)	O
.	O

C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
El	O
mapa	O
de	O
interacción	O
muestra	O
interacciones	O
definidas	O
empíricamente	O
de	O
ceTAC	B-Protein
,	O
y	O
las	O
interacciones	O
extrapoladas	O
definidas	O
por	O
[	O
28	O
]	O
.	O

(	O
B	O
)	O
:	O
Utilizando	O
la	O
base	O
de	O
datos	O
BIND	O
[	O
29	O
]	O
,	O
DTACC	B-Protein
se	O
une	O
directamente	O
a	O
TBPH	B-Protein
y	O
CG14540	B-Protein
,	O
y	O
por	O
lo	O
tanto	O
indirectamente	O
a	O
complejos	B-GENE
remodeladores	I-GENE
de	I-GENE
cromatina	I-GENE
(	O
SWI/SNF	B-GENE
y	O
histona	B-Chemical
acetiltransferasas	O
)	O
,	O
ADN	B-Sequence
maquinaria	O
de	O
reparación	O
de	O
daños	O
(	O
vía	O
RAD23	B-Protein
)	O
,	O
y	O
ARN	B-Sequence
Maquinaria	O
de	O
empalme	O
,	O
transporte	O
y	O
traslación	O
.	O

(	O
C	O
)	O
:	O
Mapa	O
de	O
interacción	O
pronosticado	O
para	O
vertebrado	B-Taxon
TACC	O
,	O
basado	O
en	O
ceTAC	B-Protein
,	O
sugiere	O
una	O
interacción	O
indirecta	O
con	O
el	O
nuclear	B-GENE
hormona	B-Chemical
receptor	O
RXR	B-Protein
beta	I-Protein
.	O

También	O
es	O
interesante	O
que	O
esto	O
prediga	O
una	O
interacción	O
funcional	O
con	O
la	O
familia	O
LDB	O
,	O
cuyos	O
miembros	O
también	O
se	O
encuentran	O
en	O
TACC	O
que	O
contienen	O
segmentos	B-Sequence
parálogos	I-Sequence
señalado	O
en	O
las	O
figuras	O
2	O
,	O
3	O
y	O
archivo	O
adicional	O
1	O
.	O

(	O
D	O
)	O
:	O
Mapa	O
de	O
interacción	O
TACC	O
pronosticado	O
basado	O
en	O
DTACC	B-Protein
.	O

(	O
E	O
)	O
:	O
Vertebrado	B-Taxon
Interacciones	O
TACC	O
identificadas	O
hasta	O
la	O
fecha	O
.	O

?	O
denota	O
incertidumbre	O
sobre	O
la	O
identidad	O
de	O
un	O
funcional	O
vertebrado	B-Taxon
homólogo	B-Sequence
.	O

En	O
C	O
,	O
D	O
y	O
E	O
,	O
'	O
*	O
'	O
indica	O
uno	O
o	O
más	O
miembros	O
de	O
la	O
familia	O
de	O
quinasas	O
TACC	O
o	O
Aurora	O
.	O

debido	O
a	O
la	O
conservación	B-Sequence
evolutiva	I-Sequence
del	O
TAC	O
dominio	B-Sequence
,	O
predeciríamos	O
que	O
algunas	O
de	O
las	O
interacciones	O
funcionales	O
vistas	O
en	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
y	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
se	O
observaría	O
en	O
mayor	O
animales	B-Taxon
.	O

El	O
perfil	O
filogenético	O
de	O
estos	O
mapas	O
de	O
interacción	O
sugiere	O
dos	O
conjuntos	O
similares	O
de	O
interacciones	O
predichas	O
para	O
vertebrado	B-Taxon
TACC	O
(	O
Fig	O
.	O
6C	O
y	O
6D	O
)	O
.	O

Sorprendentemente	O
,	O
sin	O
embargo	O
,	O
la	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
específico	O
proteinas	B-Chemical
lin15A	B-Protein
,	O
lin36	B-Protein
y	O
lin37	B-Protein
no	O
tiene	O
fácilmente	O
discernible	O
homólogos	B-Sequence
en	O
vertebrados	B-Taxon
o	O
drosófila	B-Taxon
,	O
aunque	O
la	O
presencia	O
de	O
un	O
zinc	B-Chemical
dedo	O
dominio	B-Sequence
en	O
lin36	B-Protein
puede	O
sugerir	O
que	O
esto	O
proteína	B-Chemical
está	O
involucrado	O
directamente	O
en	O
la	O
transcripción	O
o	O
realiza	O
un	O
papel	O
de	O
adaptador	O
similar	O
al	O
LIM	O
que	O
contiene	O
proteinas	B-Chemical
.	O

Para	O
el	O
DTACC	B-Protein
interactuando	O
proteinas	B-Chemical
,	O
TBPH	B-Protein
corresponde	O
a	O
TDP43	B-Protein
,	O
a	O
proteína	B-Chemical
implicado	O
en	O
la	O
regulación	O
transcripcional	O
y	O
empalme	O
[	O
31	O
,	O
32	O
]	O
.	O

Sin	O
embargo	O
,	O
la	O
asignación	O
de	O
la	O
humano	B-Taxon
homólogo	B-Sequence
de	O
CG14540	B-Protein
es	O
menos	O
claro	O
,	O
con	O
el	O
más	O
cercano	O
partidos	B-Sequence
en	O
el	O
humano	B-Taxon
bases	O
de	O
datos	O
correspondientes	O
a	O
glutamina	B-Chemical
ricos	O
factores	O
de	O
transcripción	O
como	O
CREB	B-Protein
y	O
el	O
GRAMO	B-Chemical
#	O
¿NOMBRE	O
?	O

Comparación	O
de	O
interacciones	O
modeladas	O
con	O
definidas	O
experimentalmente	O
del	O
vertebrado	B-Taxon
TACC	O
proteinas	B-Chemical

Los	O
datos	O
de	O
interacción	O
para	O
el	O
vertebrado	B-Taxon
TACC	O
es	O
relativamente	O
limitado	O
;	O
sin	O
embargo	O
,	O
ahora	O
comienzan	O
a	O
surgir	O
redes	O
de	O
interacción	O
.	O

Los	O
resultados	O
de	O
nuestro	O
análisis	O
funcional	O
,	O
así	O
como	O
otros	O
datos	O
publicados	O
,	O
indican	O
claramente	O
que	O
el	O
vertebrado	B-Taxon
Los	O
TACC	O
interactúan	O
con	O
proteinas	B-Chemical
que	O
se	O
pueden	O
dividir	O
en	O
dos	O
grandes	O
categorías	O
:	O
1	O
)	O
proteinas	B-Chemical
con	O
papeles	O
en	O
centrosoma	B-GENE
/	O
mitótico	O
huso	B-GENE
dinámica	O
,	O
y	O
2	O
)	O
proteinas	B-Chemical
envuelto	O
en	O
gene	B-Sequence
regulación	O
,	O
ya	O
sea	O
a	O
nivel	O
de	O
transcripción	O
,	O
o	O
posterior	O
ARN	B-Sequence
procesamiento	O
y	O
traducción	O
[	O
3	O
,	O
5	O
-	O
7	O
,	O
15	O
,	O
19	O
-	O
21	O
,	O
24	O
,	O
25	O
,	O
33	O
,	O
34	O
]	O
.	O

Muchos	O
de	O
estos	O
proteinas	B-Chemical
no	O
parecen	O
interactuar	O
directamente	O
con	O
los	O
TACC	O
de	O
protostoma	O
,	O
pero	O
se	O
esperaría	O
que	O
estuvieran	O
en	O
el	O
mismo	O
complejo	B-GENE
proteico	I-GENE
(	O
Fig	O
.	O
6C	O
,	O
6D	O
)	O
.	O

Análisis	O
significativo	O
de	O
la	O
asociación	O
de	O
los	O
TACC	O
con	O
el	O
centrosoma	B-GENE
y	O
la	O
dinámica	O
de	O
la	O
mitosis	O
huso	B-GENE
asamblea	O
de	O
levadura	B-Taxon
a	O
los	O
humanos	O
ha	O
sido	O
publicado	O
[	O
5	O
,	O
6	O
,	O
21-24	O
]	O
.	O

A	O
partir	O
de	O
este	O
análisis	O
,	O
parece	O
probable	O
que	O
la	O
vertebrado	B-Taxon
TACC3	B-Protein
proteína	B-Chemical
ha	O
conservado	O
esta	O
función	O
ancestral	O
directa	O
,	O
basada	O
en	O
su	O
ubicación	O
en	O
estas	O
estructuras	O
durante	O
la	O
mitosis	O
[	O
27	O
]	O
,	O
su	O
fuerte	O
interacción	O
con	O
Aurora	B-Protein
quinasa	I-Protein
A	I-Protein
,	O
y	O
la	O
observación	O
de	O
que	O
es	O
el	O
único	O
humano	B-Taxon
TACC	O
proteína	B-Chemical
fosforilado	O
por	O
este	O
enzima	B-Sequence
[	O
21	O
]	O
.	O

Sin	O
embargo	O
,	O
la	O
variabilidad	O
del	O
centro	O
dominio	B-Sequence
de	O
El	O
vertebrado	B-Taxon
ortólogos	B-Sequence
,	O
sugiere	O
que	O
TACC3	B-Protein
también	O
puede	O
haber	O
adquirido	O
funciones	O
adicionales	O
y	O
,	O
en	O
algunos	O
casos	O
,	O
específicas	O
de	O
la	O
especie	O
.	O

Por	O
ejemplo	O
,	O
en	O
X	B-Taxon
.	I-Taxon
laevis	I-Taxon
,	O
los	O
enmascarar	B-Protein
proteína	B-Chemical
ha	O
adquirido	O
un	O
sitio	B-Sequence
de	I-Sequence
unión	I-Sequence
para	I-Sequence
la	I-Sequence
proteína	I-Sequence
eIF4E	I-Sequence
y	O
por	O
lo	O
tanto	O
una	O
función	O
en	O
el	O
control	O
coordinado	O
de	O
poliadenilación	O
y	O
traducción	O
en	O
el	O
Xenopo	B-Taxon
ovocito	B-Cell
[	O
8	O
,	O
35	O
]	O
.	O

Un	O
estudio	O
reciente	O
ha	O
sugerido	O
que	O
esta	O
función	O
puede	O
ser	O
exclusiva	O
de	O
enmascarar	B-Protein
:	O
aunque	O
no	O
está	O
claro	O
si	O
el	O
otro	O
vertebrado	B-Taxon
TACC3	B-Protein
proteinas	B-Chemical
interactuar	O
con	O
el	O
eIF4E	B-Protein
/	O
CPEB	O
complejo	B-GENE
,	O
los	O
humano	B-Taxon
TACC1A	O
isoforma	B-Sequence
es	O
incapaz	O
de	O
interactuar	O
con	O
el	O
eIF4E	B-Protein
/	O
CPEB	B-Protein
complejo	B-GENE
.	O

En	O
cambio	O
,	O
algunos	O
TACC1	B-Protein
isoformas	B-Sequence
han	O
desarrollado	O
una	O
función	O
relacionada	O
,	O
pero	O
distinta	O
,	O
al	O
interactuar	O
directamente	O
con	O
elementos	O
del	O
ARN	B-Sequence
maquinaria	O
de	O
empalme	O
y	O
transporte	O
[	O
19	O
]	O
.	O

Caracterizar	O
aún	O
más	O
las	O
funciones	O
en	O
evolución	O
del	O
TACC	O
proteinas	B-Chemical
,	O
hemos	O
utilizado	O
un	O
enfoque	O
imparcial	O
levadura	B-Taxon
dos	O
métodos	O
híbridos	O
de	O
cribado	O
para	O
identificar	O
proteinas	B-Chemical
que	O
se	O
unen	O
a	O
la	O
humano	B-Taxon
TACC	O
proteinas	B-Chemical
[	O
3	O
,	O
34	O
]	O
.	O

En	O
una	O
pantalla	O
de	O
una	O
biblioteca	O
de	O
cerebro	O
fetal	O
MATCHMAKER	O
(	O
BD	O
Biosciences	O
Clontech	O
)	O
,	O
además	O
de	O
aislar	O
el	O
histona	B-Chemical
acetiltransferasa	O
hGCN5L2	B-Protein
[	O
34	O
]	O
,	O
también	O
identificamos	O
la	O
beta	O
3	O
isoforma	B-Sequence
de	O
retinoide	B-Protein
-	I-Protein
receptor	I-Protein
X	I-Protein
beta	I-Protein
como	O
un	O
proteína	B-Chemical
que	O
interactúa	O
con	O
el	O
TACC	O
dominio	B-Sequence
de	O
TACC2	B-Protein
.	O

Como	O
se	O
muestra	O
en	O
la	O
figura	O
.	O

7	O
,	O
esta	O
interacción	O
se	O
confirma	O
in	O
vitro	O
por	O
GST	B-Protein
#	O
¿NOMBRE	O
?	O

Significativamente	O
,	O
RXR	B-Protein
beta	I-Protein
es	O
pariente	O
cercano	O
de	O
la	O
nuclear	B-GENE
hormona	B-Chemical
receptor	O
,	O
nhr	B-Protein
-	I-Protein
86	I-Protein
,	O
desde	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
,	O
que	O
interactúa	O
con	O
el	O
ceTAC	B-Protein
Unión	O
proteína	B-Chemical
lin36	B-Protein
(	O
Fig	O
.	O
6A	O
)	O
.	O

Esto	O
sugiere	O
que	O
mientras	O
protostoma	B-Taxon
Los	O
TACC	O
pueden	O
requerir	O
proteína	B-Chemical
factores	O
para	O
interactuar	O
con	O
dichos	O
componentes	O
,	O
los	O
TACC	O
en	O
mayor	O
organismos	B-Taxon
puede	O
haber	O
desarrollado	O
la	O
capacidad	O
de	O
interactuar	O
directamente	O
con	O
algunos	O
de	O
los	O
proteinas	B-Chemical
en	O
el	O
mapa	O
de	O
interacción	O
previsto	O
(	O
Fig	O
.	O
6E	O
)	O
.	O

De	O
hecho	O
,	O
esto	O
parece	O
estar	O
directamente	O
relacionado	O
con	O
la	O
adquisición	O
de	O
nuevos	O
dominios	B-Sequence
y	O
duplicación	B-Sequence
de	O
El	O
cordado	B-Taxon
Precursor	O
de	O
TACC	O
.	O

De	O
hecho	O
,	O
la	O
primera	O
función	O
identificada	O
de	O
un	O
vertebrado	B-Taxon
TACC	O
proteína	B-Chemical
actuaba	O
como	O
un	O
coactivador	O
transcripcional	O
a	O
través	O
de	O
una	O
interacción	O
directa	O
con	O
el	O
factor	B-Protein
de	I-Protein
transcripción	I-Protein
ARNT	I-Protein
[	O
7	O
]	O
.	O

También	O
es	O
intrigante	O
que	O
el	O
deuterostomo	B-Taxon
SDP	O
específico	O
repetir	B-Sequence
interactúa	O
con	O
GAS41	B-Protein
,	O
un	O
factor	O
componente/accesorio	O
de	O
la	O
humano	B-Taxon
Complejo	B-GENE
remodelador	I-GENE
de	I-GENE
cromatina	I-GENE
SWI/SNF	I-GENE
[	O
3	O
,	O
15	O
]	O
.	O

Aunque	O
hay	O
un	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
homólogo	B-Sequence
de	O
GAS41	B-Protein
,	O
dmGAS41	B-Protein
la	O
base	O
de	O
datos	O
de	O
interacción	O
proteómica	O
a	O
gran	O
escala	O
no	O
indica	O
una	O
interacción	O
directa	O
de	O
dmGAS41	B-Protein
con	O
DTACC	B-Protein
.	O

Esto	O
puede	O
ser	O
debido	O
a	O
la	O
falta	O
de	O
la	O
SDP	O
repetir	B-Sequence
región	I-Sequence
en	O
el	O
Drosophila	B-Protein
TACC	I-Protein
proteína	B-Chemical
.	O

Esto	O
sugiere	O
además	O
que	O
el	O
vertebrado	B-Taxon
Los	O
TACC	O
han	O
adquirido	O
la	O
capacidad	O
específica	O
de	O
interactuar	O
directamente	O
con	O
complejos	B-GENE
reguladores	I-GENE
transcripcionales	I-GENE
,	O
y	O
ese	O
puente	O
proteina	B-Chemical
(	I-Chemical
s	I-Chemical
)	I-Chemical
ya	O
no	O
son	O
necesarios	O
.	O

Así	O
,	O
donde	O
el	O
ceTAC	B-Protein
proteína	B-Chemical
solo	O
está	O
compuesto	O
por	O
el	O
TACC	O
dominio	B-Sequence
,	O
los	O
miembros	O
de	O
la	O
familia	O
TACC	O
significativamente	O
más	O
grandes	O
en	O
mayor	O
protostomas	B-Taxon
y	O
deuterostomas	B-Taxon
puede	O
haber	O
integrado	O
una	O
o	O
más	O
funciones	O
del	O
puente	O
proteína	B-Chemical
(	O
en	O
este	O
caso	O
lin15A	B-Protein
,	O
lin36	B-Protein
o	O
lin37	B-Protein
)	O
.	O

Esto	O
también	O
puede	O
explicar	O
la	O
ausencia	O
de	O
lin15A	B-Protein
,	O
lin36	B-Protein
y	O
lin37	B-Protein
homólogos	B-Sequence
en	O
alto	O
organismos	B-Taxon
,	O
ya	O
que	O
ya	O
no	O
estaban	O
bajo	O
presión	O
evolutiva	O
selectiva	O
para	O
permanecer	O
dentro	O
del	O
complejo	B-GENE
,	O
y	O
por	O
lo	O
tanto	O
perdido	O
en	O
la	O
evolución	O
genoma	B-Sequence
.	O

Figura	O
7	O

Interacción	O
in	O
vitro	O
de	O
RXR	O
beta	O
3	O
y	O
TACC2s	B-Protein
.	O

Panel	O
superior	O
:	O
Autorradiografía	O
del	O
12	O
%	O
SDS	B-Chemical
gel	O
de	O
poliacrilamida	O
con	O
RXR	O
beta	O
3	O
traducido	O
in	O
vitro	O
construir	B-Sequence
derribado	O
con	O
GST	B-Protein
-	O
TACC2	B-Protein
(	O
Carril	O
1	O
)	O
o	O
GST	B-Protein
Carril	O
2	O
)	O
;	O
Carril	O
3	O
:	O
5	O
%	O
de	O
entrada	O
de	O
in	O
vitro	O
traducida	O
RXR-beta	B-Protein
proteína	B-Chemical
.	O

Los	O
dos	O
paneles	O
inferiores	O
representan	O
geles	O
teñidos	O
con	O
azul	O
de	O
Coomassie	O
del	O
experimento	O
desplegable	O
que	O
muestra	O
la	O
carga	O
de	O
GST	B-Protein
-	O
TACC2	B-Protein
y	O
GST	B-Protein
.	O

Conclusión	O

Propuesta	O
de	O
evolución	O
funcional	O
de	O
la	O
familia	O
TACC	O

Examen	O
de	O
la	O
evolución	O
de	O
la	O
antigüedad	O
gene	B-Sequence
familias	O
proporciona	O
una	O
idea	O
de	O
cómo	O
gene	B-Sequence
la	O
estructura	O
se	O
relaciona	O
con	O
la	O
función	O
.	O

Hemos	O
presentado	O
arriba	O
,	O
un	O
examen	O
detallado	O
de	O
uno	O
de	O
esos	O
gene	B-Sequence
familia	O
.	O

Los	O
datos	O
hasta	O
ahora	O
sugieren	O
que	O
el	O
TACC	O
funcional	O
homólogo	B-Sequence
en	O
levadura	B-Taxon
(	O
spc72	B-Protein
)	O
tiene	O
un	O
papel	O
específico	O
en	O
centrosomales	B-GENE
/	O
mitótico	O
huso	B-GENE
dinámica	O
[	O
21	O
,	O
22	O
]	O
.	O

Esta	O
antigua	O
función	O
TACC	O
se	O
conserva	O
a	O
lo	O
largo	O
de	O
la	O
evolución	O
tanto	O
en	O
protostomas	B-Taxon
y	O
deuterostomas	B-Taxon
.	O

Además	O
,	O
el	O
TAC	O
proteinas	B-Chemical
de	O
menor	O
organismos	B-Taxon
parecen	O
interactuar	O
con	O
el	O
puente	O
proteinas	B-Chemical
que	O
son	O
componentes	O
de	O
varios	O
complejos	B-GENE
proteicos	I-GENE
envuelto	O
en	O
ADN	B-Sequence
reparación	O
de	O
daños	O
,	O
proteína	B-Chemical
traducción	O
,	O
ARN	B-Sequence
procesamiento	O
y	O
transcripción	O
.	O

Sin	O
embargo	O
,	O
a	O
lo	O
largo	O
del	O
proceso	O
del	O
tiempo	O
evolutivo	O
,	O
con	O
la	O
adquisición	O
de	O
nuevos	O
dominios	B-Sequence
y	O
duplicación	B-Sequence
de	O
El	O
cordado	B-Taxon
precursor	O
de	O
TACC	O
,	O
el	O
cordado	B-Taxon
TACC	O
proteinas	B-Chemical
han	O
adquirido	O
la	O
capacidad	O
de	O
interactuar	O
directamente	O
con	O
algunos	O
de	O
los	O
otros	O
componentes	O
de	O
estos	O
complejos	B-GENE
(	O
como	O
el	O
LSm	O
proteinas	B-Chemical
,	O
nuclear	B-GENE
hormona	B-Chemical
receptores	O
,	O
GAS41	B-Protein
,	O
accesorio	O
proteinas	B-Chemical
y	O
factores	O
de	O
transcripción	O
)	O
,	O
y	O
por	O
lo	O
tanto	O
desarrollaron	O
funciones	O
adicionales	O
dentro	O
de	O
estos	O
complejos	B-GENE
.	O

De	O
hecho	O
,	O
la	O
primera	O
función	O
asignada	O
de	O
un	O
vertebrado	B-Taxon
TACC	O
proteína	B-Chemical
,	O
ratón	B-Protein
TACC3	I-Protein
,	O
fue	O
como	O
un	O
coactivador	O
transcripcional	O
de	O
la	O
ARNT	B-Protein
respuesta	O
transcripcional	O
mediada	O
por	O
hipoxia	O
y	O
hidrocarburos	B-Chemical
poliaromáticos	I-Chemical
[	O
7	O
]	O
.	O

Ratón	B-Protein
TACC3	I-Protein
También	O
se	O
ha	O
informado	O
que	O
interactúa	O
con	O
el	O
factor	O
de	O
transcripción	O
STAT5	B-Protein
[	O
33	O
]	O
.	O

Recientemente	O
,	O
hemos	O
demostrado	O
que	O
TACC2	B-Protein
y	O
TACC3	B-Protein
puede	O
unirse	O
a	O
nuclear	B-GENE
histona	B-Chemical
acetiltransferasas	O
[	O
34	O
]	O
,	O
lo	O
que	O
confirma	O
aún	O
más	O
un	O
papel	O
más	O
directo	O
para	O
el	O
TACC	O
proteinas	B-Chemical
en	O
transcripcional	O
y	O
cromatina	B-GENE
eventos	O
de	O
remodelación	O
.	O

Curiosamente	O
,	O
aunque	O
todos	O
humano	B-Taxon
TACC	O
proteinas	B-Chemical
puede	O
interactuar	O
directamente	O
con	O
el	O
histona	B-Chemical
acetiltransferasa	O
pCAF	B-Protein
in	O
vitro	O
,	O
la	O
TACC1	B-Protein
isoformas	B-Sequence
Expresado	O
en	O
humano	B-Taxon
cáncer	O
de	O
mama	O
células	B-Cell
no	O
interactúes	O
con	O
esto	O
histona	B-Chemical
acetilasa	O
[	O
34	O
]	O
.	O

Esto	O
puede	O
atribuirse	O
a	O
la	O
función	O
propuesta	O
del	O
exón	B-Sequence
1	O
que	O
contiene	O
TACC1	B-Protein
variantes	B-Sequence
en	O
ARN	B-Sequence
procesamiento	O
,	O
a	O
través	O
de	O
la	O
interacción	O
con	O
LSm	B-Protein
-	I-Protein
7	I-Protein
y	O
SmG	B-Protein
[	O
19	O
]	O
.	O

Por	O
lo	O
tanto	O
,	O
el	O
empalme	O
alternativo	O
de	O
la	O
TACC1	B-Protein
gene	B-Sequence
añade	O
más	O
diversidad	O
a	O
TACC1	B-Protein
función	O
,	O
como	O
la	O
supresión	B-Sequence
de	O
específico	O
exones	B-Sequence
y	O
su	O
unión	O
asociada	O
dominios	B-Sequence
cambiará	O
el	O
potencial	O
complejos	B-GENE
proteicos	I-GENE
con	O
los	O
que	O
pueden	O
asociarse	O
,	O
ya	O
sea	O
directamente	O
,	O
o	O
redirigiendo	O
el	O
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
a	O
diferentes	O
compartimentos	O
subcelulares	O
.	O

Con	O
el	O
duplicación	B-Sequence
de	O
El	O
TACC1	B-Protein
/	O
TACC2	B-Protein
antepasado	O
,	O
es	O
evidente	O
que	O
se	O
puede	O
haber	O
introducido	O
una	O
diversidad	O
funcional	O
aún	O
mayor	O
en	O
la	O
familia	O
TACC	O
.	O

los	O
TACC2	B-Protein
proteína	B-Chemical
conserva	O
la	O
capacidad	O
de	O
TACC3	B-Protein
interactuar	O
con	O
GAS41	B-Protein
,	O
INI1	B-Protein
,	O
histona	B-Chemical
acetiltransferasas	O
y	O
factores	O
de	O
transcripción	O
(	O
en	O
este	O
caso	O
,	O
RXR	B-Protein
beta	I-Protein
)	O
(	O
figura	O
7	O
)	O
[	O
3	O
,	O
34	O
]	O
.	O

Sin	O
embargo	O
,	O
el	O
empalme	O
específico	O
de	O
tejido	O
de	O
los	O
5	O
kb	O
exón	B-Sequence
en	O
el	O
TACC2l	O
isoforma	B-Sequence
[	O
3	O
]	O
indica	O
que	O
este	O
proteína	B-Chemical
tiene	O
varias	O
funciones	O
específicas	O
temporales	O
y	O
tisulares	O
aún	O
por	O
identificar	O
.	O

Métodos	O

Compilación	O
y	O
ensamblaje	O
de	O
TACC	O
previamente	O
no	O
caracterizados	O
ADNc	B-Sequence
y	O
genes	B-Sequence

Correspondiente	O
secuencias	B-Sequence
ortólogas	I-Sequence
para	O
TACC	O
,	O
RHAMM	B-Protein
KLP	O
,	O
KIF	O
,	O
TPM	O
y	O
familias	O
de	O
queratinas	O
se	O
identificaron	O
inicialmente	O
usando	O
el	O
programa	O
TBLASTN	O
[	O
36	O
]	O
para	O
buscar	O
en	O
las	O
publicaciones	O
genómico	B-Sequence
y	O
ADNc	B-Sequence
bases	O
de	O
datos	O

Para	O
rubíes	B-Taxon
takifugu	I-Taxon
,	O
gene	B-Sequence
las	O
predicciones	O
fueron	O
producidas	O
por	O
la	O
canalización	O
automatizada	O
de	O
Ensembl	O
[	O
37	O
]	O
y	O
el	O
servidor	O
JGI	O
blast	O
.	O

secuencias	B-Sequence
de	I-Sequence
ADN	I-Sequence
cubriendo	O
el	O
regiones	B-Sequence
de	I-Sequence
homología	I-Sequence
fueron	O
extraídos	O
y	O
analizados	O
por	O
Genscan	O
para	O
obtener	O
potenciales	O
exones	B-Sequence
.	O

En	O
algunos	O
casos	O
,	O
exones	B-Sequence
fueron	O
agregado	B-Sequence
o	O
modificado	B-Sequence
basado	O
en	O
la	O
mejor	O
similitud	O
de	O
los	O
traducidos	O
péptidos	B-Sequence
a	O
la	O
correspondiente	O
ratón	B-Taxon
y	O
humano	B-Taxon
proteinas	B-Chemical
.	O

Para	O
regiones	B-Sequence
con	O
bajo	O
secuencia	B-Sequence
similitud	O
,	O
secuencias	B-Sequence
genómicas	I-Sequence
del	O
agua	O
dulce	O
pez	B-Taxon
globo	I-Taxon
,	O
Tetraodon	B-Taxon
nigroviridis	I-Taxon
se	O
utilizaron	O
como	O
medios	O
adicionales	O
para	O
verificar	O
la	O
exones	B-Sequence
predichos	I-Sequence
.	O

Debido	O
a	O
la	O
variabilidad	O
del	O
centro	O
región	B-Sequence
de	O
vertebrado	B-Taxon
TACC3	B-Protein
ADNc	B-Sequence
(	O
ver	O
texto	O
)	O
,	O
para	O
confirmar	O
aún	O
más	O
la	O
predicción	O
de	O
la	O
Takifugu	B-Protein
rubíes	I-Protein
TACC3	I-Protein
,	O
longitud	O
total	O
ADNc	B-Sequence
correspondiente	O
a	O
la	O
danio	B-Protein
rerio	I-Protein
tac3	I-Protein
(	O
IMAGEN	O
clones	B-Sequence
2639991	O
,	O
2640369	O
y	O
3724452	O
)	O
también	O
se	O
obtuvieron	O
de	O
A.	O
t	O
C	O
.	O
C	O
.	O
y	O
totalmente	O
secuenciado	O
.	O

Potencial	O
segmentos	B-Sequence
cromosómicos	I-Sequence
parálogos	I-Sequence
y	O
andamio	B-Sequence
fueron	O
identificados	O
al	O
buscar	O
en	O
las	O
bases	O
de	O
datos	O
públicas	O
depositadas	O
en	O
el	O
NCBI	O
y	O
en	O
el	O
Humano	B-Taxon
genoma	B-Sequence
Proyecto	O
de	O
Mapeo	O
,	O
Cambridge	O
Reino	O
Unido	O
.	O

Clonación	O
de	O
vertebrado	B-Taxon
TACC	O
ADNc	B-Sequence

los	O
conejo	B-Protein
TACC3	I-Protein
``	O
fue	O
clonado	O
por	O
rt	O
-	O
PCR	O
usando	O
el	O
``	O
''	O
TACC4	O
``	O
''	O
específico	O
''	O
cebador	B-Sequence
T4RACE2	O
[	O
9	O
]	O
(	O
5	O
'	O
-	O
cccgaactgctccaggtaatcgatctc	O
-	O
3	O
'	O
)	O
y	O
un	O
cartilla	B-Sequence
de	I-Sequence
consenso	I-Sequence
,	O
T3con2	O
,	O
diseñado	B-Sequence
al	O
región	B-Sequence
abarcando	O
el	O
vertebrado	B-Taxon
TACC3	B-Protein
iniciador	O
metionina	B-Chemical
(	O
5	O
'	O
-	O
tatgagtctgcaggtcttaaacgac	O
-	O
3	O
'	O
)	O
.	O

Para	O
clonar	O
el	O
ratón	B-Taxon
Tacc1X	O
ADNc	B-Sequence
,	O
los	O
cebadores	B-Sequence
utilizados	O
se	O
basaron	O
en	O
la	O
secuencia	B-Sequence
genómica	I-Sequence
reportado	O
,	O
y	O
el	O
secuencia	B-Sequence
de	O
la	O
IMAGEN	O
clon	B-Sequence
de	I-Sequence
ADNc	I-Sequence
4933429k08	O
:	O
t1xf	O
(	O
5	O
'-	O
ccatgttcagtttgggcaggTC	O
-	O
3	O
'	O
)	O
,	O
T1XF2	O
(	O
5	O
'-	O
CTGCAGAACCAACAGTTCAAG	O
-	O
3	O
'	O
)	O
,	O
T1XR1	O
(	O
5	O
'-	O
AgatctgtgAcatcacagCTC	O
-	O
3	O
'	O
)	O
,	O
T1XR2	O
(	O
5	O
'-	O
CTCGAGTCAGTTTAGTTTTTATCCAPCTTT	O
-	O
3	O
'	O
)	O
,	O
BB617F	O
(	O
5	O
'	O
-accaccaacttgagtacctg-3	O
'	O
)	O
y	O
BB617R	O
(	O
5'-gtatcttgaactgttggttctg-3	O
'	O
)	O
.	O

para	O
el	O
análisis	O
de	O
TACC1	B-Protein
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
,	O
los	O
cebadores	B-Sequence
directos	I-Sequence
utilizados	O
estaban	O
ubicados	O
en	O
exón	B-Sequence
1b	O
:	O
EF	O
(	O
5	O
'	O
-	O
gagagatgcgaaatcagcg	O
-	O
3	O
'	O
)	O
,	O
exón	B-Sequence
1d	O
:	O
X3F	O
(	O
5	O
'	O
-	O
agtcaaagaaggcatctgcag	O
-	O
3	O
'	O
)	O
,	O
exón	B-Sequence
1a	O
:	O
1DF	O
(	O
5	O
'	O
-	O
ccaagttctgcgccatggg	O
-	O
3	O
'	O
)	O
.	O

los	O
cebadores	B-Sequence
inversos	I-Sequence
utilizados	O
fueron	O
:	O
exón	B-Sequence
1	O
:	O
X1R	O
(	O
5'-ggatttggtctcggcttgcgaatc-3	O
'	O
)	O
,	O
exón	B-Sequence
2	O
:	O
BX647R	O
(	O
5'-cttgtgattcttggcttttgg-3	O
'	O
)	O
,	O
exón	B-Sequence
:	O
6SPR	O
(	O
5	O
'	O
-	O
gtcatcgcctcgtcctggagggc	O
-	O
3	O
'	O
)	O
,	O
exón	B-Sequence
4a	O
:	O
1DR	O
(	O
5	O
'	O
-	O
aatttcacttgttcagtagtc	O
-	O
3	O
'	O
)	O
,	O
exón	B-Sequence
5	O
:	O
128R	O
(	O
5	O
'	O
-	O
cctgcttctgaggatgaaaacgc	O
-	O
3	O
'	O
)	O
.	O

Conejo	B-Taxon
cerebro	O
poli	B-Sequence
A	I-Sequence
+	I-Sequence
ARNm	B-Chemical
,	O
ratón	B-Taxon
testículos	O
y	O
humano	B-Taxon
cerebro	O
total	O
ARN	B-Sequence
se	O
obtuvieron	O
de	O
BD	O
Bioscience	O
Clontech	O
(	O
Palo	O
Alto	O
,	O
CA	O
,	O
EE	O
.	O
UU	O
.	O
)	O
.	O

La	O
transcripción	O
inversa	O
y	O
la	O
PCR	O
se	O
realizaron	O
como	O
se	O
describió	O
anteriormente	O
,	O
usando	O
1	O
µg	O
de	O
total	O
ARN	B-Sequence
o	O
50	O
ng	O
de	O
poli	B-Sequence
A	I-Sequence
+	I-Sequence
ARNm	B-Chemical
como	O
plantilla	O
para	O
la	O
primera	O
cadena	B-Sequence
de	I-Sequence
ADNc	I-Sequence
síntesis	O

productos	B-Sequence
PCR	I-Sequence
fueron	O
clonados	O
en	O
pCR2	O
.	O
1	O
(	O
Invitrogen	O
,	O
Carlsbad	O
CA	O
,	O
U	O
.	O
S	O
.	O
A	O
.	O
)	O
y	O
se	O
transformó	O
en	O
Inv	O
alpha	O
F	O
'	O
competente	O
células	B-Cell
.	O

Insertos	B-Sequence
de	I-Sequence
plásmidos	I-Sequence
fueron	O
secuenciados	O
por	O
el	O
Centro	O
de	O
Biopolímeros	O
del	O
Instituto	O
del	O
Cáncer	O
de	O
Roswell	O
Park	O
.	O

Deposición	O
de	O
secuencias	B-Sequence
de	I-Sequence
nucleótidos	I-Sequence

Secuencias	B-Sequence
de	O
este	O
artículo	O
se	O
han	O
depositado	O
en	O
la	O
base	O
de	O
datos	O
GenBank	O
con	O
los	O
siguientes	O
números	O
de	O
acceso	O
:	O
Homo	B-Protein
sapiens	I-Protein
TACC1	I-Protein
pequeño	O
isoforma	B-Sequence
S	O
(	O
AY177411	O
)	O
,	O
Mus	B-Protein
musculus	I-Protein
TACC1	I-Protein
pequeño	O
isoforma	B-Sequence
S	O
(	O
AY177412	O
)	O
,	O
Mus	B-Protein
musculus	I-Protein
TACC1	I-Protein
largo	O
isoforma	B-Sequence
Un	O
(	O
AY177413	O
)	O
,	O
Mus	B-Taxon
musculus	I-Taxon
TACC2	O
(	O
AY177410	O
)	O
,	O
Oryctolagus	B-Protein
cuniculus	I-Protein
TACC3	I-Protein
(	O
AY161270	O
)	O
,	O
danio	B-Protein
rerio	I-Protein
tac3	I-Protein
(	O
AY170618	O
)	O
.	O

Las	O
anotaciones	O
enviadas	O
a	O
la	O
base	O
de	O
datos	O
de	O
anotaciones	O
de	O
terceros	O
en	O
NCBI	O
son	O
las	O
siguientes	O
:	O
Rattus	B-Protein
norvegus	I-Protein
TACC1	I-Protein
largo	O
isoforma	B-Sequence
Un	O
(	O
BK001653	O
)	O
,	O
Takifugu	B-Protein
rubíes	I-Protein
TACC1A	I-Protein
(	O
BK000666	O
/	O
BK000667	O
)	O
,	O
Takifugu	B-Protein
rubíes	I-Protein
TACC1B	I-Protein
(	O
BK000664	O
)	O
,	O
Mus	B-Taxon
musculus	I-Taxon
TACC2l	O
(	O
BK001495	O
)	O
,	O
rattus	B-Taxon
norvegus	I-Taxon
TACC2l	O
(	O
BK001658	O
)	O
,	O
rattus	B-Taxon
norvegus	I-Taxon
TACC2	O
(	O
BK001657	O
)	O
,	O
rubíes	B-Taxon
takifugu	I-Taxon
TACC2l	O
(	O
BK000690	O
)	O
,	O
Rattus	B-Protein
norvegus	I-Protein
TACC3	I-Protein
(	O
BK001491	O
)	O
,	O
Gallus	B-Protein
gallus	I-Protein
TACC3	I-Protein
(	O
BK001482	O
)	O
,	O
Silurana	B-Protein
tropicalis	I-Protein
TACC3	I-Protein
(	O
BK001481	O
)	O
,	O
Takifugu	B-Protein
rubíes	I-Protein
TACC3	I-Protein
(	O
BK000649	O
)	O
,	O
Takifugu	B-Protein
rubíes	I-Protein
RHAMM	I-Protein
(	O
BK000676	O
)	O
,	O
Ciona	B-Protein
intestinalis	I-Protein
RHAMM	I-Protein
(	O
BK001479	O
)	O
,	O
Takifugu	B-Protein
rubripes	I-Protein
Queratina	I-Protein
(	O
BK000677	O
)	O
,	O
Takifugu	B-Protein
rubíes	I-Protein
TPM1	I-Protein
(	O
BAC10576	O
)	O
,	O
Ciona	B-Protein
intestinalis	I-Protein
Kif3b	I-Protein
(	O
BK001492	O
)	O
,	O
Ciona	B-Protein
intestinalis	I-Protein
klp2	I-Protein
(	O
BK001493	O
)	O
.	O

Análisis	O
filogenético	O

Para	O
examinar	O
las	O
relaciones	O
evolutivas	O
de	O
proteinas	B-Chemical
que	O
contiene	O
dominios	B-Sequence
de	I-Sequence
bobina	I-Sequence
enrollada	I-Sequence
,	O
proteína	B-Chemical
secuencias	B-Sequence
representando	O
a	O
los	O
principales	O
miembros	O
de	O
esta	O
súper	O
familia	O
,	O
incluyendo	O
TACC	O
,	O
RHAMM	B-Protein
,	O
KLP	O
,	O
queratina	O
y	O
tropomiosina	O
de	O
disponibles	O
vertebrados	B-Taxon
y	O
sus	O
reconocibles	O
ortólogos	B-Sequence
desde	O
el	O
urocordato	B-Taxon
Ciona	I-Taxon
intestinalis	I-Taxon
,	O
Drosophila	B-Taxon
melanogaster	I-Taxon
,	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
y	O
Saccharomyces	B-Taxon
cerevisiae	I-Taxon
se	O
recuperaron	O
directamente	O
de	O
NCBI	O
secuencia	B-Sequence
bases	O
de	O
datos	O
,	O
recién	O
predichas	O
o	O
aisladas	O
(	O
ver	O
arriba	O
)	O
.	O

Las	O
abreviaturas	O
de	O
las	O
especies	O
son	O
las	O
siguientes	O
:	O
hora	B-Taxon
(	O
Homo	B-Taxon
sapiens	I-Taxon
)	O
,	O
milímetro	B-Taxon
(	O
Mus	B-Taxon
musculus	I-Taxon
)	O
,	O
rn	B-Taxon
(	O
rattus	B-Taxon
norvegus	I-Taxon
)	O
,	O
jefe	B-Taxon
(	O
Oryctolagus	B-Taxon
cuniculus	I-Taxon
)	O
,	O
g	B-Taxon
(	O
gallo	B-Taxon
gallo	I-Taxon
)	O
,	O
SG	B-Taxon
(	O
Xenopus	B-Taxon
laevis	I-Taxon
)	O
,	O
S	B-Taxon
t	I-Taxon
(	O
Silurana	B-Taxon
tropicalis	I-Taxon
)	O
,	O
tr	B-Taxon
(	O
rubíes	B-Taxon
takifugu	I-Taxon
)	O
,	O
Dr	B-Taxon
(	O
danio	B-Taxon
rerio	I-Taxon
)	O
,	O
ci	B-Taxon
(	O
Ciona	B-Taxon
intestinalis	I-Taxon
)	O
,	O
mensaje	B-Taxon
directo	I-Taxon
(	O
D	B-Taxon
.	I-Taxon
melanogaster	I-Taxon
)	O
,	O
ce	B-Taxon
(	O
C	B-Taxon
.	I-Taxon
elegantes	I-Taxon
)	O
,	O
Carolina	B-Taxon
del	I-Taxon
Sur	I-Taxon
(	O
Saccharomyces	B-Taxon
cerevisiae	I-Taxon
)	O
.	O

los	O
secuencias	B-Sequence
identificado	O
anteriormente	O
y	O
los	O
siguientes	O
proteína	B-Chemical
o	O
predicho	B-Sequence
se	O
usaron	O
traducciones	O
para	O
el	O
análisis	O
filogenético	O
:	O
hsTACC1A	O
(	O
NP	O
_	O
006274	O
)	O
,	O
hsTACC2l	O
(	O
AAO62630	O
)	O
hsTACC2s	O
(	O
AAO62629	O
)	O
,	O
hsTACC3	B-Protein
(	O
NP_006333	O
)	O
,	O
mmTACC3	B-Protein
(	O
Q9JJ11	O
)	O
,	O
xlMáscara	B-Protein
(	O
Q9PTG8	O
)	O
,	O
dmTACC	B-Protein
(	O
AAF52099	O
)	O
,	O
ceTAC1	B-Protein
(	O
NP_497059	O
)	O
,	O
scSPC72	B-Protein
(	O
NP_009352	O
)	O
,	O
hsRHAMM	B-Protein
(	O
NP_036616	O
)	O
,	O
mmRHAMM	B-Protein
(	O
NP_038580	O
)	O
,	O
rnRHAMM	B-Protein
(	O
NP_037096	O
)	O
,	O
DrRHAMM	B-Protein
(	O
AAQ97980	O
)	O
,	O
hskeratina	B-Protein
(	O
CAB76828	O
)	O
,	O
mm	O
queratina	O
(	O
A61368	O
)	O
,	O
rn	O
queratina	O
(	O
XP	O
_	O
235679	O
)	O
,	O
hsTPM1	B-Protein
(	O
NP_000357	O
)	O
,	O
mmTPM1	B-Protein
(	O
NP_077745	O
)	O
,	O
rnTPM1	B-Protein
(	O
NP_62004	O
,	O
drTPM1	B-Protein
(	O
NP_571180	O
)	O
dmTPM1	B-Protein
(	O
P06754	O
)	O
,	O
ceTPM	B-Protein
(	O
NP_493540	O
)	O
scTPM1	B-Protein
(	O
P17536	O
)	O
,	O
hsKLP2	B-Protein
(	O
BAB03309	O
)	O
,	O
rnKIF15	B-Protein
(	O
AAP44513	O
)	O
,	O
xlKLP2	B-Protein
(	O
CAA08879	O
)	O
,	O
dmKLP2	B-Protein
(	O
NP_476818	O
)	O
,	O
ceKLP18	B-Protein
(	O
AA034669	O
)	O
,	O
hsKIF3A	B-Protein
(	O
Q9Y496	O
)	O
,	O
mmKIF3A	B-Protein
(	O
NP_032469	O
)	O
,	O
rnKIF3A	B-Protein
(	O
XP	O
_	O
340797	O
)	O
,	O
xlKIF3A	B-Protein
(	O
CAA08879	O
)	O
,	O
ceKLP11	B-Protein
(	O
NP_741473	O
)	O
,	O
ciKIF3	O
(	O
ci0100148992	O
)	O
,	O
hsKIF3B	B-Protein
(	O
NP_004789	O
)	O
,	O
mmKIF3B	B-Protein
(	O
NP_004789	O
)	O
,	O
rnKIF3B	B-Protein
(	O
XP	O
_	O
215883	O
)	O
,	O
dmKIF3B	B-Protein
(	O
NP_524029	O
)	O
,	O
hsKIF3C	B-Protein
(	O
NP_002245	O
)	O
,	O
mmKIF3C	B-Protein
(	O
NP_032471	O
)	O
,	O
rnKIF3C	B-Protein
(	O
NP_445938	O
)	O
,	O
dmKIF3C	B-Protein
(	O
NP_651939	O
)	O
.	O

Estas	O
proteína	B-Chemical
secuencias	B-Sequence
se	O
alinearon	O
inicialmente	O
con	O
CLUSTAL	O
X	O
[	O
38	O
]	O
.	O

Ajustes	O
menores	O
a	O
ciertos	O
regiones	B-Sequence
de	O
la	O
alineación	O
con	O
fines	O
de	O
optimización	O
se	O
realizaron	O
en	O
base	O
a	O
alineaciones	O
por	O
pares	O
,	O
la	O
salida	O
se	O
guardó	O
en	O
formato	O
PHYLIP	O
,	O
después	O
de	O
lo	O
cual	O
,	O
las	O
distancias	O
entre	O
proteinas	B-Chemical
se	O
calcularon	O
utilizando	O
la	O
corrección	O
de	O
Poisson	O
y	O
los	O
árboles	O
sin	O
raíz	O
se	O
infirieron	O
con	O
el	O
método	O
NJ	O
y	O
luego	O
se	O
mostraron	O
utilizando	O
TreeView	O
[	O
39	O
]	O
.	O

Los	O
valores	O
de	O
Bootstrap	O
por	O
encima	O
de	O
700	O
para	O
1000	O
ensayos	O
se	O
muestran	O
en	O
el	O
nodo	O
.	O

Para	O
validar	O
el	O
árbol	O
,	O
lo	O
mismo	O
secuencia	B-Sequence
El	O
conjunto	O
fue	O
analizado	O
con	O
herramientas	O
en	O
el	O
paquete	O
PHYLIP	O
[	O
40	O
]	O
,	O
usando	O
PRODIST	O
seguido	O
de	O
FITCH	O
o	O
NEIGNBOR	O
y	O
visualización	O
de	O
árboles	O
usando	O
TreeView	O
.	O

Este	O
método	O
adicional	O
produjo	O
árboles	O
con	O
esencialmente	O
la	O
misma	O
topología	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Interacción	O
in	O
vitro	O
de	O
TACC2	B-Protein
y	O
RXR	O
beta	O
3	O

los	O
TACC2	B-Protein
ADNc	B-Sequence
fue	O
clonado	O
en	O
GST	B-Protein
vectores	B-Sequence
de	I-Sequence
fusión	I-Sequence
pGEX5X2	O
(	O
Amersham	O
Biosciences	O
,	O
Piscataway	O
,	O
NJ	O
,	O
EE	O
.	O
UU	O
.	O
)	O
.	O

GST	B-Protein
y	O
GST	B-Protein
-	O
TACC2	B-Protein
proteinas	B-Chemical
se	O
expresaron	O
en	O
mi	B-Taxon
coli	I-Taxon
``	O
BL21	O
(	O
DE3	O
)	O
capas	O
``	O
''	O
S	O
''	O
''	O
con	O
IPTG	O
1	O
mM	O
a	O
37	O
grados	O
C	O
en	O
agitación	O
durante	O
2	O
horas	O
.	O
''	O

Células	B-Cell
(	O
50	O
ml	O
)	O
se	O
recogieron	O
y	O
se	O
resuspendieron	O
en	O
5	O
ml	O
de	O
solución	O
20	O
mM	O
tris	B-Chemical
-	O
HCl	B-Chemical
pH	O
8	O
0	O
,	O
200	O
mM	O
NaCl	B-Chemical
,	O
1	O
mm	O
EDTA	B-Chemical
pH8	O
.	O
0	O
,	O
inhibidor	B-Chemical
de	I-Chemical
la	I-Chemical
proteasa	I-Chemical
serie	O
III	O
(	O
Calbiochem	O
)	O
.	O

los	O
células	B-Cell
se	O
lisaron	O
por	O
sonicación	O
y	O
el	O
lisado	O
se	O
aclaró	O
por	O
centrifugación	O
a	O
7500	O
rpm	O
a	O
4	O
grados	O
C	O
durante	O
15	O
min	O
.	O

El	O
lisado	O
aclarado	O
se	O
inmovilizó	O
en	O
glutatión	B-Chemical
perlas	O
de	O
sefarosa	O
en	O
3	O
ml	O
de	O
20	O
mM	O
tris	B-Chemical
-	O
HCl	B-Chemical
pH	O
8	O
0	O
,	O
200	O
mM	O
NaCl	B-Chemical
,	O
1	O
mm	O
EDTA	B-Chemical
pH8	O
.	O
0	O
)	O
.	O

RXR	O
beta	O
3	O
ADNc	B-Sequence
fue	O
clonado	O
en	O
pET	O
28C	O
(	O
+	O
)	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
,	O
EE	O
.	O
UU	O
.	O
)	O
y	O
proteína	B-Chemical
sintetizado	O
por	O
el	O
kit	O
del	O
sistema	O
de	O
traducción	O
/	O
transcripción	O
de	O
acoplamiento	O
rápido	O
TNT	O
(	O
Promega	O
)	O
y	O
radiomarcado	O
con	O
35S	B-Chemical
metionina	I-Chemical
según	O
las	O
instrucciones	O
del	O
fabricante	O
.	O

100	O
mu	O
l	O
de	O
RXR	O
beta	O
3	O
traducido	O
in	O
vitro	O
proteína	B-Chemical
en	O
1	O
ml	O
de	O
20	O
mM	O
tris	B-Chemical
-	O
HCl	B-Chemical
pH	O
8	O
0	O
,	O
200	O
mM	O
NaCl	B-Chemical
,	O
1	O
mm	O
EDTA	B-Chemical
pH8	O
.	O
0	O
se	O
incubó	O
a	O
4	O
grados	O
C	O
con	O
inmovilizado	O
GST	B-Protein
-	O
TACC2	B-Protein
o	O
GST	B-Protein
durante	O
90	O
min	O
.	O

El	O
RXR	O
beta	O
3	O
no	O
unido	O
se	O
eliminó	O
lavando	O
tres	O
veces	O
con	O
20	O
mM	O
tris	B-Chemical
-	O
HCl	B-Chemical
pH	O
8	O
0	O
,	O
200	O
mM	O
NaCl	B-Chemical
,	O
1	O
mm	O
EDTA	B-Chemical
pH8	O
.	O
0	O

Ligado	O
proteinas	B-Chemical
se	O
eluyeron	O
de	O
las	O
perlas	O
a	O
temperatura	O
ambiente	O
durante	O
10	O
min	O
en	O
tampón	O
de	O
elución	O
(	O
100	O
mM	O
clorhidrato	B-Chemical
de	I-Chemical
tris	I-Chemical
,	O
pH8	O
.	O
0	O
,	O
20	O
mM	O
reducido	O
glutatión	B-Chemical
)	O
.	O

los	O
proteinas	B-Chemical
se	O
analizaron	O
el	O
12	O
%	O
SDS	B-Chemical
geles	O
de	O
poliacrilamida	O
.	O

La	O
tinción	O
con	O
azul	O
de	O
Coomassie	O
verificó	O
una	O
carga	O
igual	O
de	O
GST	B-Protein
fusión	B-Sequence
proteína	B-Chemical
.	O

Los	O
geles	O
secos	O
se	O
autorradiografiaron	O
.	O

Contribuciones	O
de	O
los	O
autores	O

I	O
.	O
H.	O
S	O
realizó	O
la	O
mayoría	O
de	O
las	O
secuencia	B-Sequence
análisis	O
y	O
redactó	O
el	O
ensamblaje	B-Sequence
de	I-Sequence
las	I-Sequence
secuencias	I-Sequence
TACC	I-Sequence
,	I-Sequence
KLP	I-Sequence
,	I-Sequence
KIF	I-Sequence
y	I-Sequence
RHAMM	I-Sequence
.	O

I	O
.	O
H.	O
S	O
.	O
realizó	O
el	O
ADNc	B-Sequence
aislamiento	O
de	O
la	O
conejo	B-Protein
TACC3	I-Protein
ADNc	B-Sequence
.	O

AK	O
identificado	O
potencial	O
TACC1	B-Protein
variantes	B-Sequence
de	I-Sequence
empalme	I-Sequence
,	O
y	O
la	O
interacción	O
entre	O
RXR	O
beta	O
3	O
y	O
TACC2	B-Protein
.	O

UN	O
.	O
m	O
caracterizado	O
ratón	B-Taxon
TACC	O
ortólogos	B-Sequence
.	O

PAGS	O
.	O
l	O
realizó	O
la	O
identificación	O
y	O
montaje	O
de	O
t	B-Taxon
rubíes	I-Taxon
secuencias	B-Sequence
de	I-Sequence
genes	I-Sequence
,	O
y	O
el	O
análisis	O
filogenético	O
.	O

I	O
.	O
H.	O
S	O
.	O
concibió	O
y	O
diseñó	O
el	O
proyecto	O
y	O
redactó	O
el	O
manuscrito	O
completo	O
.	O

Material	O
suplementario	O

Archivo	O
adicional	O
1	O

Ubicación	O
de	O
genes	B-Sequence
parálogos	I-Sequence
encontrado	O
en	O
humano	B-Taxon
4p16	O
,	O
5q31-ter	O
,	O
10q23-ter	O
,	O
8p	O
y	O
cromosoma	B-GENE
2	O
.	O

Posiciones	B-Sequence
de	O
genes	B-Sequence
se	O
dan	O
en	O
Mb	O
de	O
la	O
telómero	B-Sequence
del	O
corto	O
brazo	B-Sequence
del	I-Sequence
cromosoma	I-Sequence
.	O

Resaltado	O
en	O
azul	O
genes	B-Sequence
(	O
cinco	O
copias	O
)	O
se	O
encuentran	O
en	O
los	O
cuatro	O
segmentos	B-Sequence
parálogos	I-Sequence
,	O
y	O
el	O
parcialmente	O
duplicado	O
segmento	B-Sequence
en	I-Sequence
el	I-Sequence
cromosoma	I-Sequence
2	O
.	O

Resaltado	O
en	O
verde	O
genes	B-Sequence
se	O
encuentran	O
en	O
los	O
cuatro	O
segmentos	B-Sequence
parálogos	I-Sequence
,	O
o	O
tres	O
de	O
los	O
segmentos	B-Sequence
y	O
el	O
parcialmente	O
duplicado	O
región	B-Sequence
en	I-Sequence
el	I-Sequence
cromosoma	I-Sequence
2	O
.	O

rosa	O
resaltado	O
genes	B-Sequence
tener	O
parálogos	B-Sequence
en	O
tres	O
de	O
los	O
segmentos	B-Sequence
,	O
sugiriendo	O
ya	O
sea	O
pérdida	B-Sequence
del	O
cuarto	O
ejemplar	O
o	O
exclusión	O
de	O
uno	O
parálogo	B-Sequence
de	O
la	O
segunda	O
ronda	O
de	O
duplicación	B-Sequence
.	O

Resaltado	O
en	O
negro	O
genes	B-Sequence
(	O
dos	O
parálogos	B-Sequence
)	O
se	O
encuentran	O
en	O
solo	O
uno	O
de	O
los	O
derivados	O
de	O
la	O
segunda	O
ronda	O
de	O
duplicación	B-Sequence
del	I-Sequence
genoma	I-Sequence
,	O
lo	O
que	O
sugiere	O
la	O
exclusión	O
completa	O
de	O
ambas	O
copias	O
de	O
la	O
segunda	O
ronda	O
de	O
duplicación	B-Sequence
.	O

Púrpura	O
resaltado	O
genes	B-Sequence
(	O
dos	O
parálogos	B-Sequence
)	O
se	O
duplicaron	O
en	O
la	O
segunda	O
ronda	O
de	O
duplicación	B-Sequence
del	I-Sequence
genoma	I-Sequence
,	O
o	O
de	O
la	O
recombinación	O
intercromosómica	O
entre	O
grupos	B-Sequence
parálogos	I-Sequence
.	O

Haga	O
clic	O
aquí	O
para	O
el	O
archivo	O

Agradecimientos	O

Deseamos	O
agradecer	O
al	O
Dr.	O
Sei-ichi	O
Matsui	O
por	O
su	O
ayuda	O
y	O
aportes	O
en	O
la	O
preparación	O
de	O
este	O
manuscrito	O
.	O

Este	O
trabajo	O
fue	O
apoyado	O
en	O
parte	O
por	O
fondos	O
de	O
desarrollo	O
del	O
Instituto	O
del	O
Cáncer	O
de	O
Roswell	O
Park	O
y	O
la	O
subvención	O
básica	O
2P30CA016056-27	O
del	O
Instituto	O
Nacional	O
del	O
Cáncer	O
.	O

niebla2	B-Protein
es	O
necesario	O
para	O
el	O
desarrollo	O
normal	O
del	O
diafragma	O
y	O
los	O
pulmones	O
en	O
Ratones	B-Taxon
y	O
humanos	B-Taxon

Resumen	O

La	O
hernia	O
diafragmática	O
congénita	O
y	O
otros	O
defectos	O
diafragmáticos	O
congénitos	O
están	O
asociados	O
con	O
una	O
mortalidad	O
y	O
morbilidad	O
significativas	O
en	O
los	O
recién	O
nacidos	O
;	O
sin	O
embargo	O
,	O
el	O
molecular	B-Chemical
Se	O
desconoce	O
la	O
base	O
de	O
estas	O
anomalías	O
del	O
desarrollo	O
.	O

En	O
un	O
análisis	O
de	O
E18	O
.	O
5	O
embriones	O
derivados	O
de	O
ratones	B-Taxon
tratado	O
con	O
N	B-Chemical
-	I-Chemical
etil	I-Chemical
-	I-Chemical
N	I-Chemical
-	I-Chemical
nitrosourea	I-Chemical
,	O
identificamos	O
un	O
mutación	B-Sequence
que	O
causa	O
hipoplasia	O
pulmonar	O
y	O
desarrollo	O
diafragmático	O
anormal	O
.	O

niebla2	B-Protein
(	O
Zfpm2	B-Protein
)	O
mapas	O
dentro	O
del	O
recombinante	O
intervalo	B-Sequence
llevando	O
el	O
N	B-Chemical
-	I-Chemical
etil	I-Chemical
-	I-Chemical
N	I-Chemical
-	I-Chemical
nitrosourea	I-Chemical
#	O
¿NOMBRE	O
?	O
mutación	B-Sequence
,	O
y	O
ADN	B-Sequence
secuenciación	O
de	O
niebla2	B-Protein
identificado	O
un	O
mutación	B-Sequence
en	O
un	O
sitio	B-Sequence
donante	I-Sequence
de	I-Sequence
empalme	I-Sequence
que	O
genera	O
una	O
anomalía	O
transcripción	B-Sequence
codificando	O
un	O
truncado	O
proteína	B-Chemical
.	O

Humano	B-Taxon
Se	O
evaluaron	O
casos	O
de	O
autopsia	O
con	O
defecto	O
diafragmático	O
e	O
hipoplasia	O
pulmonar	O
para	O
mutaciones	B-Sequence
en	O
FOG2	B-Protein
.	O

Secuencia	B-Sequence
análisis	O
reveló	O
un	O
mutación	B-Sequence
de	I-Sequence
novo	I-Sequence
resultando	O
en	O
un	O
prematuro	O
codón	B-Sequence
de	I-Sequence
parada	I-Sequence
en	O
un	O
niño	O
que	O
falleció	O
el	O
primer	O
día	O
de	O
vida	O
secundario	O
a	O
una	O
hipoplasia	O
pulmonar	O
bilateral	O
severa	O
y	O
un	O
diafragma	O
anormalmente	O
muscularizado	O
.	O

Utilizando	O
un	O
enfoque	O
basado	O
en	O
el	O
fenotipo	O
,	O
hemos	O
establecido	O
que	O
niebla2	B-Protein
es	O
necesaria	O
para	O
el	O
desarrollo	O
normal	O
del	O
diafragma	O
y	O
los	O
pulmones	O
,	O
una	O
función	O
que	O
no	O
se	O
había	O
apreciado	O
anteriormente	O
.	O

FOG2	B-Protein
es	O
el	O
primero	O
gene	B-Sequence
implicado	O
en	O
la	O
patogénesis	O
de	O
la	O
enfermedad	O
no	O
sindrómica	O
humano	B-Taxon
defectos	O
diafragmáticos	O
congénitos	O
y	O
su	O
necesidad	O
para	O
el	O
desarrollo	O
pulmonar	O
valida	O
la	O
hipótesis	O
de	O
que	O
los	O
recién	O
nacidos	O
con	O
hernia	O
diafragmática	O
congénita	O
también	O
pueden	O
tener	O
anomalías	O
primarias	O
del	O
desarrollo	O
pulmonar	O
.	O

Sinopsis	O

Los	O
defectos	O
de	O
nacimiento	O
que	O
afectan	O
al	O
diafragma	O
son	O
tan	O
comunes	O
y	O
graves	O
como	O
genético	B-Sequence
trastornos	O
como	O
la	O
fibrosis	O
quística	O
,	O
aunque	O
se	O
desconocen	O
las	O
causas	O
subyacentes	O
de	O
estos	O
defectos	O
.	O

La	O
mayoría	O
de	O
los	O
bebés	O
que	O
nacen	O
con	O
defectos	O
diafragmáticos	O
tienen	O
pulmones	O
muy	O
pequeños	O
y	O
muchos	O
mueren	O
en	O
el	O
período	O
neonatal	O
con	O
graves	O
dificultades	O
para	O
respirar	O
.	O

Se	O
desconoce	O
si	O
los	O
pulmones	O
pequeños	O
se	O
deben	O
a	O
que	O
estos	O
niños	O
tienen	O
un	O
defecto	O
diafragmático	O
o	O
si	O
algunos	O
pacientes	O
pueden	O
tener	O
un	O
defecto	O
diafragmático	O
.	O
genético	B-Sequence
anormalidad	O
que	O
afecta	O
el	O
desarrollo	O
tanto	O
del	O
pulmón	O
como	O
del	O
diafragma	O
simultáneamente	O
.	O

En	O
una	O
pantalla	O
de	O
fetal	O
ratones	B-Taxon
que	O
lleva	O
químicamente	B-Chemical
inducido	O
mutaciones	B-Sequence
geneticas	I-Sequence
,	O
los	O
autores	O
encontraron	O
que	O
un	O
mutación	B-Sequence
en	O
el	O
gene	B-Sequence
niebla2	B-Protein
(	O
amigo	B-Protein
de	I-Protein
gata	I-Protein
2	I-Protein
)	O
,	O
provoca	O
un	O
desarrollo	O
anormal	O
del	O
diafragma	O
y	O
pequeños	O
pulmones	O
.	O

Los	O
pulmones	O
tienen	O
una	O
anomalía	O
primaria	O
del	O
desarrollo	O
que	O
incluye	O
la	O
pérdida	O
específica	O
de	O
un	O
lóbulo	O
pulmonar	O
.	O

Con	O
base	O
en	O
este	O
resultado	O
,	O
los	O
autores	O
estudiaron	O
a	O
niños	O
afectados	O
con	O
anomalías	O
diafragmáticas	O
e	O
identificaron	O
una	O
humano	B-Taxon
bebé	O
con	O
un	O
serio	O
mutación	B-Sequence
en	O
el	O
humano	B-Taxon
gene	B-Sequence
FOG2	B-Protein
quien	O
falleció	O
a	O
las	O
cinco	O
horas	O
de	O
vida	O
con	O
severas	O
dificultades	O
respiratorias	O
,	O
defecto	O
diafragmático	O
y	O
pulmones	O
pequeños	O
.	O

Los	O
autores	O
han	O
establecido	O
que	O
niebla2	B-Protein
es	O
necesaria	O
tanto	O
para	O
el	O
desarrollo	O
del	O
diafragma	O
como	O
del	O
pulmón	O
en	O
ratones	B-Taxon
y	O
en	O
humanos	B-Taxon
.	O

Esta	O
es	O
la	O
primera	O
causa	O
conocida	O
de	O
un	O
defecto	O
diafragmático	O
congénito	O
no	O
sindrómico	O
y	O
establece	O
que	O
algunos	O
pacientes	O
pueden	O
tener	O
una	O
anomalía	O
primaria	O
del	O
desarrollo	O
tanto	O
del	O
pulmón	O
como	O
del	O
diafragma	O
.	O

Introducción	O

Los	O
defectos	O
diafragmáticos	O
congénitos	O
son	O
un	O
espectro	O
de	O
defectos	O
de	O
nacimiento	O
relativamente	O
comunes	O
.	O

Las	O
hernias	O
posterolaterales	O
o	O
de	O
Bochdalek	O
(	O
a	O
menudo	O
denominadas	O
hernia	O
diafragmática	O
congénita	O
[	O
HDC	O
]	O
)	O
ocurren	O
en	O
1/3	O
000	O
nacidos	O
vivos	O
[	O
1	O
]	O
,	O
y	O
aunque	O
estos	O
son	O
el	O
tipo	O
más	O
común	O
de	O
defecto	O
diafragmático	O
que	O
se	O
presenta	O
al	O
nacer	O
,	O
la	O
aplasia	O
diafragmática	O
y	O
la	O
muscularización	O
diafragmática	O
los	O
defectos	O
(	O
eventaciones	O
)	O
pueden	O
tener	O
una	O
presentación	O
clínica	O
similar	O
.	O

Hacer	O
distinciones	O
anatómicas	O
específicas	O
entre	O
estos	O
tipos	O
de	O
defectos	O
puede	O
ser	O
difícil	O
sin	O
un	O
examen	O
macroscópico	O
directo	O
(	O
intraoperatorio	O
o	O
post-mortem	O
)	O
.	O

La	O
hipoplasia	O
pulmonar	O
asociada	O
con	O
estos	O
defectos	O
diafragmáticos	O
causa	O
morbilidad	O
y	O
mortalidad	O
severas	O
.	O

La	O
patogenia	O
y	O
la	O
relación	O
de	O
desarrollo	O
entre	O
los	O
defectos	O
diafragmáticos	O
y	O
la	O
hipoplasia	O
pulmonar	O
no	O
se	O
conocen	O
.	O

Aunque	O
los	O
avances	O
en	O
el	O
tratamiento	O
médico	O
de	O
la	O
hipoplasia	O
pulmonar	O
pueden	O
haber	O
disminuido	O
la	O
mortalidad	O
asociada	O
con	O
los	O
pacientes	O
con	O
HDC	O
que	O
sobreviven	O
para	O
recibir	O
atención	O
en	O
centros	O
de	O
alto	O
volumen	O
[	O
2	O
,	O
3	O
]	O
,	O
se	O
ha	O
informado	O
que	O
la	O
mortalidad	O
basada	O
en	O
la	O
población	O
llega	O
al	O
62	O
%	O
,	O
y	O
hay	O
un	O
gran	O
número	O
de	O
muertes	O
antes	O
del	O
nacimiento	O
o	O
de	O
la	O
transferencia	O
a	O
un	O
centro	O
de	O
atención	O
terciaria	O
[	O
4	O
]	O
.	O

Como	O
estos	O
pacientes	O
suelen	O
presentar	O
una	O
insuficiencia	O
respiratoria	O
grave	O
al	O
nacer	O
,	O
la	O
terapia	O
se	O
ha	O
centrado	O
en	O
desarrollar	O
mejores	O
métodos	O
para	O
proporcionar	O
apoyo	O
ventilatorio	O
sin	O
producir	O
más	O
lesiones	O
pulmonares	O
.	O

La	O
oxigenación	O
por	O
membrana	O
extracorpórea	O
(	O
ECMO	O
)	O
se	O
utiliza	O
en	O
algunos	O
centros	O
para	O
proporcionar	O
un	O
período	O
prolongado	O
de	O
derivación	O
cardiopulmonar	O
[	O
5	O
,	O
6	O
]	O
,	O
mientras	O
que	O
otros	O
centros	O
tienen	O
éxito	O
utilizando	O
otras	O
técnicas	O
de	O
soporte	O
ventilatorio	O
[	O
7	O
]	O
.	O

La	O
morbilidad	O
en	O
los	O
que	O
sobreviven	O
es	O
alta	O
,	O
y	O
muchos	O
pacientes	O
sobreviven	O
con	O
insuficiencia	O
respiratoria	O
crónica	O
,	O
déficits	O
cognitivos	O
y	O
neuromotores	O
,	O
y	O
pérdida	O
de	O
la	O
audición	O
como	O
resultado	O
de	O
las	O
intervenciones	O
intensivas	O
necesarias	O
y	O
anormalidades	O
del	O
desarrollo	O
estructurales	O
e	O
irreversibles	O
asociadas	O
[	O
8-11	O
]	O
.	O

Hasta	O
la	O
fecha	O
,	O
no	O
ha	O
habido	O
ninguna	O
mutaciones	B-Sequence
asociado	O
con	O
defectos	O
diafragmáticos	O
no	O
sindrómicos	O
e	O
hipoplasia	O
pulmonar	O
en	O
humanos	B-Taxon
.	O

La	O
heredabilidad	O
de	O
estos	O
defectos	O
no	O
está	O
clara	O
,	O
ya	O
que	O
la	O
alta	O
morbilidad	O
y	O
mortalidad	O
limitan	O
la	O
recolección	O
de	O
familias	O
multigeneracionales	O
para	O
el	O
análisis	O
.	O

los	O
genético	B-Sequence
Es	O
probable	O
que	O
las	O
etiologías	O
sean	O
complejas	O
y	O
probablemente	O
surjan	O
de	O
diferentes	O
mutaciones	B-Sequence
en	O
varias	O
partes	O
del	O
molecular	B-Chemical
vías	O
de	O
desarrollo	O
requeridas	O
para	O
el	O
desarrollo	O
diafragmático	O
.	O

De	O
hecho	O
,	O
existen	O
numerosos	O
informes	O
que	O
implican	O
a	O
diferentes	O
cromosómico	B-GENE
anomalías	O
en	O
la	O
patogenia	O
de	O
la	O
CDH	O
[	O
12	O
,	O
13	O
]	O
.	O

Dada	O
la	O
dificultad	O
de	O
estudiar	O
anomalías	O
letales	O
del	O
desarrollo	O
en	O
humanos	B-Taxon
es	O
de	O
gran	O
utilidad	O
potencial	O
para	O
desarrollar	O
animal	B-Taxon
modelos	O
de	O
humano	B-Taxon
defectos	O
de	O
nacimiento	O
,	O
como	O
el	O
específico	O
genético	B-Sequence
anormalidades	O
encontradas	O
en	O
animal	B-Taxon
Los	O
modelos	O
pueden	O
entonces	O
ser	O
investigados	O
en	O
humano	B-Taxon
poblaciones	O

Proyectamos	O
ratones	B-Taxon
tratado	O
con	O
el	O
mutágeno	B-Chemical
químico	I-Chemical
N	I-Chemical
-	I-Chemical
etil	I-Chemical
-	I-Chemical
N	I-Chemical
-	I-Chemical
nitrosourea	I-Chemical
(	O
ENU	B-Chemical
)	O
para	O
líneas	O
con	O
defectos	O
de	O
desarrollo	O
que	O
se	O
presentan	O
en	O
el	O
período	O
perinatal	O
[	O
14	O
]	O
.	O

Desde	O
esta	O
pantalla	O
,	O
identificamos	O
una	O
línea	O
de	O
ratones	B-Taxon
llevando	O
un	O
recesivo	O
mutación	B-Sequence
que	O
resulta	O
en	O
hipoplasia	O
pulmonar	O
primaria	O
y	O
desarrollo	O
diafragmático	O
y	O
cardíaco	O
anormal	O
.	O

posicional	B-Sequence
análisis	O
de	O
clonación	O
identificado	O
niebla2	B-Protein
(	O
Zfpm2	B-Protein
)	O
como	O
probable	O
candidato	O
,	O
y	O
ADN	B-Sequence
secuenciación	O
reveló	O
un	O
mutación	B-Sequence
en	O
un	O
sitio	B-Sequence
donante	I-Sequence
de	I-Sequence
empalme	I-Sequence
que	O
genera	O
una	O
anomalía	O
transcripción	B-Sequence
codificando	O
un	O
truncado	O
proteína	B-Chemical
.	O

Este	O
resultado	O
sugirió	O
que	O
examináramos	O
la	O
gen	B-Sequence
ortólogo	I-Sequence
en	O
humanos	B-Taxon
con	O
defectos	O
de	O
desarrollo	O
similares	O
,	O
y	O
reportamos	O
el	O
hallazgo	O
de	O
un	O
de	B-Sequence
novo	I-Sequence
disparates	O
mutación	B-Sequence
en	O
FOG2	B-Protein
en	O
un	O
paciente	O
que	O
murió	O
al	O
nacer	O
con	O
un	O
defecto	O
diafragmático	O
e	O
hipoplasia	O
pulmonar	O
severa	O
.	O

Este	O
es	O
el	O
primero	O
reportado	O
mutación	B-Sequence
asociado	O
con	O
estas	O
anomalías	O
en	O
un	O
humano	B-Taxon
.	O

Presentamos	O
datos	O
adicionales	O
que	O
proporcionan	O
evidencia	O
directa	O
de	O
que	O
la	O
hipoplasia	O
pulmonar	O
puede	O
ser	O
un	O
componente	O
principal	O
de	O
este	O
espectro	O
de	O
trastornos	O
.	O

Resultados	O

Identificación	O
del	O
pequeño	O
pulmón	O
Mutación	B-Sequence
en	O
niebla2	B-Protein

Examinamos	O
progenie	O
de	O
tercera	O
generación	O
de	O
ENU	B-Chemical
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
en	O
el	O
día	O
embrionario	O
18	O
.	O
5	O
(	O
E18	O
.	O
5	O
)	O
para	O
fenotipos	O
de	O
desarrollo	O
anormales	O
[	O
14	O
]	O
.	O

una	O
linea	O
de	O
ratones	B-Taxon
se	O
encontró	O
que	O
tenía	O
múltiples	O
embriones	O
en	O
camadas	O
independientes	O
que	O
mostraban	O
hipoplasia	O
pulmonar	O
y	O
un	O
diafragma	O
delgado	O
.	O

los	O
mutación	B-Sequence
,	O
que	O
llamamos	O
pequeño	O
pulmón	O
(	O
lil	O
)	O
,	O
fue	O
asignado	O
a	O
Cromosoma	B-GENE
15	O
utilizando	O
una	O
estrategia	O
de	O
haplotipo	B-Sequence
de	I-Sequence
intervalo	I-Sequence
análisis	O
(	O
datos	O
no	O
mostrados	O
)	O
[	O
15	O
]	O
.	O

Para	O
el	O
mapeo	O
de	O
alta	O
resolución	O
,	O
se	O
analizó	O
la	O
progenie	O
F2	O
de	O
dos	O
cruces	O
.	O

En	O
450	O
descendencia	O
de	O
un	O
cruce	O
de	O
F1	O
(	O
A/J	O
x	O
FVB/N	O
)	O
lil/+	O
ratones	B-Taxon
,	O
los	O
intervalo	B-Sequence
que	O
contiene	O
el	O
mutación	B-Sequence
fue	O
definido	O
por	O
19	O
recombinantes	O
entre	O
D15Mit220	O
y	O
D15Mit154	O
.	O

Debido	O
a	O
la	O
falta	O
de	O
marcadores	O
informativos	O
dentro	O
de	O
este	O
intervalo	B-Sequence
,	O
se	O
analizó	O
una	O
progenie	O
adicional	O
de	O
39	O
F2	O
de	O
un	O
cruce	O
A	O
/	O
J	O
x	O
C57BL	O
/	O
6J	O
.	O

La	O
identificación	O
de	O
dos	O
recombinantes	O
estableció	O
D15Mit85	O
como	O
marcador	O
proximal	O
y	O
D15Mit5	O
como	O
marcador	O
flanqueante	O
distal	O
.	O

El	O
fenotipo	O
lil	O
se	O
identificó	O
en	O
E18	O
.	O
5	O
tener	O
hipoplasia	O
pulmonar	O
bilateral	O
y	O
un	O
diafragma	O
anormal	O
.	O

La	O
hipoplasia	O
pulmonar	O
fue	O
evidente	O
en	O
todos	O
mutante	B-Sequence
ratones	B-Taxon
que	O
sobrevivió	O
al	O
nacimiento	O
.	O

En	O
una	O
comparación	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
mutante	B-Sequence
ratones	B-Taxon
encontrado	O
muerto	O
el	O
primer	O
día	O
de	O
vida	O
,	O
los	O
pesos	O
corporales	O
no	O
eran	O
diferentes	O
;	O
sin	O
embargo	O
,	O
los	O
pesos	O
de	O
los	O
pulmones	O
fueron	O
significativamente	O
más	O
bajos	O
en	O
los	O
mutante	B-Sequence
ratones	B-Taxon
.	O

La	O
media	O
mutante	B-Sequence
peso	O
pulmonar	O
fue	O
de	O
9	O
.	O
6	O
+/-	O
2	O
.	O
5	O
mg	O
mientras	O
que	O
el	O
promedio	O
tipo	B-Sequence
salvaje	I-Sequence
el	O
peso	O
pulmonar	O
fue	O
de	O
26	O
.	O
4	O
+/-	O
4	O
.	O
6	O
mg	O
(	O
p	O
<	O
0	O
,	O
001	O
)	O
.	O

Todos	O
los	O
pulmones	O
de	O
mutante	B-Sequence
ratones	B-Taxon
carecían	O
de	O
un	O
lóbulo	O
accesorio	O
en	O
el	O
lado	O
derecho	O
y	O
tenían	O
subdesarrollo	O
del	O
lóbulo	O
medio	O
anterior	O
derecho	O
(	O
Figura	O
1A	O
)	O
.	O

Diafragmas	O
de	O
mutante	B-Sequence
pequeño	O
ratones	B-Taxon
estaban	O
intactos	O
,	O
pero	O
la	O
musculatura	O
estaba	O
ausente	O
en	O
las	O
regiones	O
dorsales	O
.	O

Los	O
miotúbulos	O
estaban	O
presentes	O
en	O
una	O
distribución	O
limitada	O
y	O
anormal	O
.	O

Más	O
específicamente	O
,	O
los	O
miotúbulos	O
normalmente	O
se	O
irradian	O
en	O
forma	O
mediolateral	O
para	O
encontrarse	O
con	O
las	O
paredes	O
laterales	O
del	O
cuerpo	O
,	O
con	O
una	O
escasez	O
normal	O
de	O
fibras	O
musculares	O
en	O
la	O
región	O
tendinosa	O
central	O
.	O

En	O
el	O
mutante	B-Sequence
diafragma	O
,	O
los	O
miotúbulos	O
irradiaban	O
en	O
una	O
orientación	O
dorsal-ventral	O
,	O
y	O
el	O
tejido	O
muscular	O
no	O
alcanzaba	O
toda	O
la	O
superficie	O
de	O
las	O
paredes	O
del	O
cuerpo	O
(	O
Figura	O
1B	O
)	O
.	O

el	O
numero	O
de	O
lil	O
mutante	B-Sequence
ratones	B-Taxon
que	O
sobrevivió	O
al	O
nacimiento	O
fue	O
menos	O
del	O
5	O
%	O
de	O
la	O
progenie	O
total	O
,	O
en	O
lugar	O
del	O
25	O
%	O
esperado	O
para	O
un	O
recesivo	O
mutación	B-Sequence
.	O

Evaluamos	O
las	O
camadas	O
en	O
diferentes	O
momentos	O
embrionarios	O
para	O
determinar	O
si	O
el	O
número	O
reducido	O
se	O
debió	O
a	O
una	O
muerte	O
intrauterina	O
.	O

Las	O
camadas	O
se	O
recogieron	O
en	O
E12	O
.	O
5	O
,	O
13	O
.	O
5	O
,	O
15	O
.	O
5	O
,	O
17	O
.	O
5	O
y	O
18	O
.	O
5	O
,	O
y	O
los	O
embriones	O
fueron	O
genotipados	O
y	O
evaluados	O
en	O
busca	O
de	O
evidencia	O
de	O
muerte	O
intrauterina	O
,	O
incluyendo	O
retraso	O
en	O
el	O
crecimiento	O
,	O
palidez	O
y	O
friabilidad	O
del	O
tejido	O
.	O
los	O
embriones	O
pequeños	O
tuvieron	O
una	O
tasa	O
de	O
muerte	O
progresivamente	O
más	O
alta	O
entre	O
E13	O
.	O
5	O
y	O
E15	O
.	O
5	O
.	O

En	O
E12	O
.	O
5	O
,	O
20	O
de	O
87	O
(	O
23	O
%	O
)	O
eran	O
homocigotos	O
para	O
el	O
mutación	B-Sequence
y	O
todos	O
estos	O
parecían	O
viables	O
.	O

En	O
E13	O
.	O
5	O
,	O
13	O
de	O
49	O
(	O
27	O
%	O
)	O
fueron	O
mutante	B-Sequence
y	O
dos	O
habían	O
muerto	O
.	O

En	O
E15	O
.	O
5	O
,	O
22	O
de	O
91	O
(	O
24	O
%	O
)	O
fueron	O
mutante	B-Sequence
y	O
la	O
mayoria	O
de	O
mutante	B-Sequence
los	O
embriones	O
(	O
17	O
de	O
los	O
22	O
)	O
habían	O
muerto	O
.	O

Por	O
E18	O
.	O
5	O
,	O
nueve	O
de	O
29	O
embriones	O
(	O
31	O
%	O
)	O
fueron	O
homocigotos	O
para	O
el	O
mutación	B-Sequence
,	O
de	O
los	O
cuales	O
sólo	O
un	O
embrión	O
era	O
viable	O
.	O

La	O
muscularización	O
diafragmática	O
fue	O
anormal	O
en	O
todos	O
mutante	B-Sequence
ratones	B-Taxon
examinados	O
(	O
n	O
>	O
25	O
)	O
.	O

Se	O
observó	O
hipoplasia	O
pulmonar	O
en	O
el	O
100	O
%	O
de	O
mutantes	B-Sequence
evaluado	O
para	O
ese	O
fenotipo	O
entre	O
E11	O
.	O
5	O
y	O
nacimiento	O
(	O
n	O
>	O
50	O
)	O
.	O

El	O
examen	O
de	O
la	O
morfología	O
cardíaca	O
mostró	O
que	O
los	O
corazones	O
de	O
E15	O
.	O
5	O
pequeños	O
mutante	B-Sequence
ratones	B-Taxon
tenía	O
una	O
variedad	O
de	O
defectos	O
de	O
desarrollo	O
,	O
incluyendo	O
almohadillas	O
endocárdicas	O
agrandadas	O
y	O
anormalmente	O
desarrolladas	O
,	O
un	O
ventrículo	O
derecho	O
de	O
doble	O
salida	O
y	O
un	O
canal	O
auriculoventricular	O
completo	O
.	O

El	O
miocardio	O
también	O
estaba	O
poco	O
desarrollado	O
,	O
con	O
adelgazamiento	O
de	O
la	O
capa	O
externa	O
compacta	O
y	O
disminución	O
de	O
la	O
vascularización	O
.	O

la	O
cohorte	O
de	O
mutante	B-Sequence
ratones	B-Taxon
que	O
sobrevivieron	O
al	O
nacimiento	O
también	O
tenían	O
malformaciones	O
cardíacas	O
,	O
incluidos	O
defectos	O
del	O
tabique	O
ventricular	O
del	O
tipo	O
del	O
canal	O
auriculoventricular	O
,	O
defectos	O
del	O
tabique	O
auricular	O
tipo	O
ostium	O
primum	O
y	O
aurículas	O
agrandadas	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Todos	O
mutantes	B-Sequence
evaluados	O
específicamente	O
para	O
un	O
fenotipo	O
cardíaco	O
(	O
n	O
=	O
10	O
)	O
tenían	O
un	O
desarrollo	O
cardíaco	O
anormal	O
.	O

Examen	O
de	O
los	O
3	O
-	O
Mb	O
región	B-Sequence
entre	O
D15Mit85	O
y	O
D15Mit5	O
en	O
secuencia	B-Sequence
de	I-Sequence
ADN	I-Sequence
bases	O
de	O
datos	O
revelaron	O
tres	O
genes	B-Sequence
predichos	I-Sequence
y	O
cuatro	O
genes	B-Sequence
conocidos	I-Sequence
,	O
incluyendo	O
niebla2	B-Protein
.	O

apuntado	O
mutaciones	B-Sequence
de	O
niebla2	B-Protein
tienen	O
defectos	O
cardíacos	O
sorprendentemente	O
similares	O
a	O
los	O
que	O
identificamos	O
en	O
lil	O
mutante	B-Sequence
ratones	B-Taxon
,	O
incluidos	O
los	O
defectos	O
del	O
canal	O
auriculoventricular	O
,	O
el	O
miocardio	O
adelgazado	O
y	O
la	O
ausencia	O
de	O
vasculatura	O
coronaria	O
[	O
16	O
]	O
.	O

RT	O
-	O
Amplificación	O
por	O
PCR	O
del	O
proximal	O
parte	B-Sequence
de	O
niebla2	B-Protein
revelado	O
por	O
más	O
tiempo	O
transcripciones	B-Sequence
en	O
el	O
pequeño	O
mutante	B-Sequence
que	O
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
embriones	O
(	O
Figura	O
2A	O
)	O
.	O

Secuenciación	O
de	O
la	O
transcripción	B-Sequence
mutante	I-Sequence
reveló	O
un	O
mutación	B-Sequence
puntual	I-Sequence
(	I-Sequence
de	I-Sequence
timina	I-Sequence
a	I-Sequence
citosina	I-Sequence
)	I-Sequence
)	O
2	O
pb	B-Sequence
después	O
posición	B-Sequence
301	O
,	O
que	O
está	O
en	O
el	O
sitio	B-Sequence
donante	I-Sequence
de	I-Sequence
empalme	I-Sequence
al	O
final	O
de	O
la	O
tercera	O
exón	B-Sequence
.	O

Esta	O
mutación	B-Sequence
causa	O
un	O
defecto	O
de	O
empalme	O
que	O
resulta	O
en	O
la	O
inserción	B-Sequence
de	O
85	O
pb	B-Sequence
de	O
secuencia	B-Sequence
intrónica	I-Sequence
en	O
el	O
transcripción	B-Sequence
mutante	I-Sequence
,	O
e	O
introduce	O
un	O
codón	B-Sequence
de	I-Sequence
parada	I-Sequence
que	O
genera	O
un	O
severamente	O
truncado	O
producto	B-Chemical
proteico	I-Chemical
(	O
Figura	O
2B	O
)	O
.	O

pequeño	O
heterocigoto	O
mutante	B-Sequence
ratones	B-Taxon
se	O
cruzaron	O
con	O
un	O
niebla2	B-Protein
+	O
/	O
-	O
(	O
nulo	O
alelo	B-Sequence
)	O
mutante	B-Sequence
generado	O
por	O
gene	B-Sequence
focalización	O
[	O
16	O
]	O
.	O

Doblemente	O
heterocigoto	O
ratones	B-Taxon
tenía	O
un	O
fenotipo	O
letal	O
embrionario	O
;	O
esta	O
falta	O
de	O
complemento	O
demuestra	O
que	O
lil	O
es	O
un	O
mutación	B-Sequence
en	O
niebla2	B-Protein
.	O

El	O
fenotipo	O
variable	O
de	O
lil	O
ratones	B-Taxon
(	O
relativa	O
a	O
la	O
encontrada	O
para	O
el	O
niebla2	B-Protein
nulo	O
mutante	B-Sequence
)	O
es	O
probablemente	O
debido	O
a	O
la	O
generación	O
de	O
un	O
nivel	O
bajo	O
de	O
normal	O
transcripción	B-Sequence
a	O
pesar	O
de	O
la	O
presencia	O
del	O
mutación	B-Sequence
del	I-Sequence
sitio	I-Sequence
de	I-Sequence
empalme	I-Sequence
.	O

Desarrollo	O
de	O
pulmón	O
y	O
diafragma	O
en	O
el	O
niebla2	B-Protein
mutante	B-Sequence
Ratón	B-Taxon

Se	O
realizaron	O
experimentos	O
para	O
evaluar	O
el	O
papel	O
de	O
niebla2	B-Protein
en	O
el	O
desarrollo	O
pulmonar	O
y	O
diafragmático	O
.	O

El	O
fenotipo	O
pulmonar	O
se	O
caracteriza	O
por	O
hipoplasia	O
difusa	O
y	O
pérdida	O
específica	O
del	O
lóbulo	O
accesorio	O
y	O
una	O
porción	O
del	O
lóbulo	O
medio	O
derecho	O
.	O

Está	O
bien	O
establecido	O
que	O
las	O
anomalías	O
en	O
el	O
desarrollo	O
diafragmático	O
o	O
en	O
la	O
respiración	O
fetal	O
pueden	O
dar	O
lugar	O
a	O
una	O
hipoplasia	O
pulmonar	O
secundaria	O
,	O
aunque	O
nunca	O
se	O
ha	O
documentado	O
la	O
pérdida	O
de	O
la	O
estructura	O
normal	O
en	O
este	O
contexto	O
[	O
17	O
,	O
18	O
]	O
.	O

niebla2	B-Protein
se	O
expresa	O
de	O
forma	O
difusa	O
en	O
el	O
mesénquima	O
pulmonar	O
durante	O
el	O
período	O
de	O
morfogénesis	O
de	O
ramificación	O
,	O
mientras	O
que	O
la	O
expresión	O
posterior	O
se	O
restringe	O
a	O
los	O
músculos	O
lisos	O
de	O
las	O
vías	O
respiratorias	O
y	O
los	O
vasos	O
pulmonares	O
(	O
Figura	O
3	O
)	O
.	O

Esto	O
,	O
y	O
la	O
observación	O
de	O
que	O
los	O
pulmones	O
parecían	O
pequeños	O
en	O
secciones	O
transversales	O
evaluadas	O
antes	O
de	O
la	O
muscularización	O
o	O
función	O
diafragmática	O
,	O
sugiere	O
que	O
la	O
hipoplasia	O
pulmonar	O
ocurre	O
independientemente	O
del	O
defecto	O
diafragmático	O
.	O

Para	O
probar	O
esta	O
hipótesis	O
,	O
los	O
pulmones	O
fueron	O
disecados	O
de	O
niebla2	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
y	O
controles	O
de	O
compañeros	O
de	O
camada	O
antes	O
del	O
inicio	O
del	O
movimiento	O
diafragmático	O
fetal	O
.	O

niebla2	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
se	O
utilizaron	O
para	O
este	O
experimento	O
,	O
ya	O
que	O
queríamos	O
evitar	O
la	O
posible	O
variación	O
fenotípica	O
del	O
lil	O
hipomórfico	O
mutación	B-Sequence
.	O

Pulmones	O
disecados	O
en	O
E12	O
de	O
niebla2	B-Protein
-/-	O
los	O
embriones	O
eran	O
de	O
menor	O
tamaño	O
y	O
carecían	O
del	O
desarrollo	O
de	O
un	O
lóbulo	O
accesorio	O
.	O

En	O
11	O
viables	O
niebla2	B-Protein
-	O
/	O
-	O
explantes	O
de	O
cultivo	O
de	O
pulmón	O
,	O
nunca	O
hubo	O
desarrollo	O
de	O
un	O
lóbulo	O
accesorio	O
,	O
y	O
los	O
pesos	O
de	O
mutante	B-Sequence
los	O
pulmones	O
cultivados	O
durante	O
5	O
días	O
fueron	O
significativamente	O
más	O
bajos	O
que	O
los	O
de	O
los	O
controles	O
de	O
compañeros	O
de	O
camada	O
(	O
Figura	O
4	O
)	O
.	O

Estos	O
datos	O
demuestran	O
que	O
la	O
hipoplasia	O
pulmonar	O
en	O
niebla2	B-Protein
mutante	B-Sequence
ratones	B-Taxon
es	O
un	O
defecto	O
primario	O
.	O

La	O
ramificación	O
en	O
los	O
lóbulos	O
no	O
afectados	O
pareció	O
retrasarse	O
entre	O
6	O
y	O
12	O
h	O
,	O
pero	O
todos	O
mutantes	B-Sequence
desarrolló	O
un	O
patrón	O
de	O
ramificación	O
intrincado	O
en	O
los	O
lóbulos	O
no	O
afectados	O
después	O
del	O
cultivo	O
durante	O
5	O
días	O
.	O

Porque	O
el	O
niebla2	B-Protein
fenotipo	O
es	O
sorprendente	O
para	O
la	O
pérdida	O
lobular	O
específica	O
,	O
el	O
patrón	O
espacial	O
de	O
niebla2	B-Protein
expresión	O
se	O
evaluó	O
en	O
embriones	O
normales	O
durante	O
el	O
período	O
de	O
establecimiento	O
lobular	O
temprano	O
para	O
determinar	O
si	O
niebla2	B-Protein
la	O
expresión	O
es	O
específicamente	O
diferente	O
en	O
estas	O
yemas	O
lobulares	O
.	O

La	O
expresión	O
se	O
evaluó	O
en	O
ratones	B-Taxon
llevando	O
un	O
lacZ	O
gen	B-Sequence
incorporado	I-Sequence
en	O
el	O
niebla2	B-Protein
lugar	B-Sequence
(	O
S.	O
Tevosian	O
,	O
datos	O
no	O
publicados	O
)	O
.	O

en	O
nueve	O
ratones	B-Taxon
examinado	O
en	O
E11	O
.	O
5	O
,	O
todos	O
los	O
pulmones	O
mostraron	O
una	O
mejora	O
específica	O
de	O
niebla2	B-Protein
expresión	O
en	O
el	O
mesénquima	O
que	O
rodea	O
la	O
yema	O
accesoria	O
y	O
la	O
yema	O
del	O
lóbulo	O
medio	O
derecho	O
,	O
que	O
son	O
los	O
lóbulos	O
que	O
no	O
se	O
desarrollan	O
normalmente	O
en	O
niebla2	B-Protein
mutante	B-Sequence
ratones	B-Taxon
(	O
Figura	O
5	O
)	O
.	O

Por	O
E12	O
.	O
5	O
,	O
la	O
expresión	O
fue	O
difusa	O
en	O
el	O
mesénquima	O
pulmonar	O
,	O
como	O
se	O
vio	O
previamente	O
con	O
hibridación	O
in	O
situ	O
en	O
secciones	O
de	O
tejido	O
.	O

Diafragmas	O
de	O
niebla2	B-Protein
pequeño	O
ratones	B-Taxon
muestran	O
una	O
membrana	O
intacta	O
con	O
un	O
defecto	O
en	O
el	O
patrón	O
muscular	O
(	O
ver	O
Figura	O
1B	O
)	O
.	O

La	O
porción	O
membranosa	O
del	O
diafragma	O
está	O
poblada	O
por	O
una	O
población	O
migratoria	O
de	O
células	B-Cell
precursoras	I-Cell
musculares	I-Cell
,	O
al	O
igual	O
que	O
las	O
extremidades	O
[	O
19	O
,	O
20	O
]	O
.	O

Ratones	B-Taxon
con	O
defectos	O
en	O
genes	B-Sequence
Se	O
sabe	O
que	O
son	O
importantes	O
para	O
el	O
control	O
de	O
este	O
proceso	O
.	O
Tienen	O
diafragmas	O
intactos	O
pero	O
amusculares	O
[	O
17	O
,	O
21	O
,	O
22	O
]	O
.	O

factor	B-Protein
de	I-Protein
crecimiento	I-Protein
de	I-Protein
hepatocitos	I-Protein
/	O
factor	B-Protein
de	I-Protein
dispersión	I-Protein
(	O
HGF	B-Protein
)	O
es	O
un	O
candidato	O
potencial	O
responsable	O
de	O
la	O
orientación	O
de	O
precursores	B-Cell
musculares	I-Cell
al	O
diafragma	O
membranoso	O
.	O

Se	O
ha	O
demostrado	O
que	O
HGF	B-Protein
se	O
expresa	O
a	O
lo	O
largo	O
de	O
esta	O
vía	O
anatómica	O
[	O
23	O
]	O
,	O
y	O
ratones	B-Taxon
con	O
ausencia	O
del	O
Receptor	B-Protein
c	I-Protein
de	I-Protein
HGF	I-Protein
-	I-Protein
Met	I-Protein
no	O
logran	O
formar	O
pliegues	O
pleuroperitoneales	O
muscularizados	O
(	O
PPF	O
)	O
y	O
,	O
por	O
lo	O
tanto	O
,	O
tienen	O
diafragmas	O
amusculares	O
[	O
24	O
,	O
25	O
]	O
.	O

niebla2	B-Protein
se	O
expresa	O
de	O
forma	O
difusa	O
en	O
el	O
diafragma	O
amuscular	O
temprano	O
en	O
E11	O
.	O
5	O
así	O
como	O
en	O
el	O
diafragma	O
muscularizado	O
posterior	O
(	O
ver	O
Figura	O
3C	O
y	O
3D	O
)	O
.	O

Pax3	B-Protein
y	O
MyoD	B-Protein
,	O
factores	O
de	O
transcripción	O
necesarios	O
para	O
la	O
migración	O
adecuada	O
y	O
determinación	O
de	O
precursores	B-Cell
miogénicos	I-Cell
,	O
se	O
detectaron	O
en	O
las	O
FPP	O
de	O
niebla2	B-Protein
pequeño	O
ratones	B-Taxon
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Sin	O
embargo	O
,	O
el	O
análisis	O
de	O
expresión	O
in	O
situ	O
demostró	O
que	O
la	O
expresión	O
de	O
HGF	B-Protein
en	O
la	O
región	O
donde	O
esta	O
estructura	O
se	O
encuentra	O
con	O
el	O
diafragma	O
membranoso	O
se	O
redujo	O
notablemente	O
en	O
niebla2	B-Protein
mutante	B-Sequence
ratones	B-Taxon
(	O
Figura	O
6	O
)	O
.	O

Tenemos	O
la	O
hipótesis	O
de	O
que	O
niebla2	B-Protein
se	O
requiere	O
(	O
ya	O
sea	O
directa	O
o	O
indirectamente	O
)	O
para	O
la	O
inducción	O
de	O
HGF	B-Protein
en	O
el	O
diafragma	O
en	O
desarrollo	O
y	O
desregulación	O
de	O
HGF	B-Protein
modelando	O
a	O
lo	O
largo	O
del	O
camino	O
de	O
célula	B-Cell
precursora	I-Cell
muscular	I-Cell
la	O
migración	O
entre	O
la	O
FPP	O
y	O
el	O
diafragma	O
explica	O
el	O
fenotipo	O
anormal	O
en	O
estos	O
ratones	B-Taxon
.	O

FOG2	B-Protein
Mutación	B-Sequence
en	O
un	O
paciente	O
con	O
anomalías	O
diafragmáticas	O
y	O
pulmonares	O

FOG2	B-Protein
secuencia	B-Sequence
El	O
análisis	O
se	O
realizó	O
en	O
tejido	O
de	O
autopsia	O
de	O
30	O
de	O
32	O
niños	O
fallecidos	O
con	O
diagnóstico	O
anatómico	O
de	O
defecto	O
diafragmático	O
evaluados	O
en	O
el	O
Children	O
's	O
Hospital	O
de	O
Boston	O
,	O
Massachusetts	O
,	O
entre	O
1993	O
y	O
2003	O
.	O

Se	O
revisaron	O
los	O
informes	O
de	O
autopsia	O
para	O
determinar	O
los	O
diagnósticos	O
específicos	O
.	O

De	O
estos	O
30	O
casos	O
,	O
17	O
(	O
57	O
%	O
)	O
tenían	O
HDC	O
de	O
Bochdalek	O
,	O
dos	O
(	O
7	O
%	O
)	O
tenían	O
agenesia	O
diafragmática	O
,	O
siete	O
(	O
23	O
%	O
)	O
tenían	O
defectos	O
de	O
eventración	O
/	O
muscularización	O
diafragmática	O
(	O
sin	O
HDC	O
de	O
Bochdalek	O
)	O
,	O
y	O
cuatro	O
(	O
13	O
%	O
)	O
tenían	O
hernia	O
de	O
Bochdalek	O
de	O
un	O
hemidiafragma	O
y	O
eventración	O
del	O
otro	O
.	O

La	O
hipoplasia	O
pulmonar	O
se	O
evaluó	O
mediante	O
la	O
relación	O
peso	O
pulmonar/cuerpo	O
y	O
recuentos	O
alveolares	O
radiales	O
[	O
26	O
]	O
.	O

El	O
material	O
disponible	O
para	O
la	O
revisión	O
incluía	O
informes	O
escritos	O
y	O
láminas	O
histológicas	O
en	O
todos	O
los	O
casos	O
y	O
kodacromos	O
macroscópicos	O
en	O
un	O
subconjunto	O
de	O
casos	O
.	O

Un	O
niño	O
llevaba	O
un	O
muy	O
significativo	O
FOG2	B-Protein
cambio	B-Sequence
de	I-Sequence
secuencia	I-Sequence
.	O

La	O
paciente	O
era	O
una	O
niña	O
de	O
3.500	O
g	O
nacida	O
a	O
término	O
que	O
desarrolló	O
insuficiencia	O
respiratoria	O
grave	O
al	O
nacer	O
y	O
murió	O
después	O
de	O
5	O
h	O
de	O
reanimación	O
.	O

Las	O
radiografías	O
antemortem	O
mostraron	O
campos	O
pulmonares	O
opacificados	O
y	O
posible	O
intestino	O
en	O
el	O
tórax	O
.	O

El	O
diagnóstico	O
clínico	O
del	O
paciente	O
fue	O
HDC	O
.	O

La	O
revisión	O
del	O
material	O
de	O
la	O
autopsia	O
reveló	O
hipoplasia	O
pulmonar	O
bilateral	O
grave	O
(	O
peso	O
pulmonar	O
combinado	O
,	O
11,1	O
g	O
;	O
esperado	O
para	O
la	O
longitud/peso	O
corporal	O
,	O
46,8	O
+/-	O
26,2	O
g	O
;	O
[	O
27	O
]	O
)	O
,	O
que	O
afectaba	O
de	O
manera	O
más	O
marcada	O
al	O
pulmón	O
izquierdo	O
.	O

La	O
relación	O
peso	O
pulmonar	O
/	O
corporal	O
fue	O
0	O
.	O
0037	O
(	O
esperado	O
>	O
0	O
.	O
010	O
)	O
[	O
28	O
]	O
.	O

Hubo	O
un	O
número	O
reducido	O
de	O
generaciones	O
bronquiales	O
,	O
y	O
el	O
conteo	O
alveolar	O
radial	O
fue	O
de	O
2-3	O
(	O
esperado	O
=	O
5	O
)	O
[	O
29	O
]	O
.	O

Había	O
fisuras	O
pulmonares	O
incompletas	O
bilateralmente	O
.	O

Una	O
eventración	O
diafragmática	O
posterior	O
profunda	O
estaba	O
presente	O
en	O
el	O
lado	O
izquierdo	O
.	O

Además	O
,	O
dos	O
bandas	O
de	O
ligamentos	O
musculosos	O
que	O
se	O
asemejan	O
a	O
restos	O
diafragmáticos	O
rodeaban	O
el	O
lóbulo	O
izquierdo	O
del	O
hígado	O
,	O
creando	O
un	O
contorno	O
hepático	O
fisurado	O
anormal	O
.	O

Lejos	O
de	O
la	O
eventración	O
,	O
el	O
diafragma	O
se	O
presentaba	O
bien	O
musculado	O
,	O
midiendo	O
0	O
.	O
3cm	O
de	O
espesor	O
.	O

Una	O
autopsia	O
completa	O
no	O
reveló	O
otras	O
malformaciones	O
;	O
se	O
determinó	O
que	O
el	O
corazón	O
era	O
muy	O
normal	O
y	O
se	O
donó	O
para	O
la	O
recolección	O
de	O
válvulas	O
.	O

Secuencia	B-Sequence
análisis	O
reveló	O
un	O
citosina	B-Chemical
para	O
timina	B-Chemical
heterocigoto	O
cambiar	B-Sequence
en	O
exón	B-Sequence
4	O
que	O
cambios	B-Sequence
el	O
112	O
aminoácidos	B-Chemical
desde	O
arginina	B-Chemical
a	O
un	O
codón	B-Sequence
de	I-Sequence
parada	I-Sequence
.	O

Esta	O
mutación	B-Sequence
produce	O
un	O
severamente	O
truncado	O
péptido	B-Sequence
que	O
no	O
contiene	O
zinc	B-Chemical
dedo	O
dominios	B-Sequence
(	O
Figura	O
7	O
)	O
.	O

Esta	O
cambio	B-Sequence
de	I-Sequence
base	I-Sequence
no	O
estuvo	O
presente	O
en	O
el	O
análisis	O
de	O
ADN	B-Sequence
de	O
400	O
adultos	O
normales	O
.	O

Para	O
evaluar	O
la	O
probabilidad	O
de	O
que	O
el	O
mutación	B-Sequence
fue	O
causal	O
para	O
el	O
fenotipo	O
de	O
desarrollo	O
,	O
examinamos	O
a	O
ambos	O
padres	O
.	O

Se	O
confirmó	O
la	O
paternidad	O
y	O
secuencia	B-Sequence
El	O
análisis	O
reveló	O
que	O
ninguno	O
de	O
los	O
padres	O
llevaba	O
este	O
mutación	B-Sequence
,	O
demostrando	O
que	O
el	O
paciente	O
tenía	O
una	O
mutación	B-Sequence
de	I-Sequence
novo	I-Sequence
en	O
FOG2	B-Protein
(	O
Figura	O
7	O
)	O
.	O

Discusión	O

Los	O
defectos	O
diafragmáticos	O
congénitos	O
son	O
un	O
grupo	O
heterogéneo	O
de	O
trastornos	O
de	O
etiología	O
desconocida	O
.	O

Los	O
defectos	O
que	O
se	O
presentan	O
en	O
el	O
período	O
pre	O
o	O
perinatal	O
incluyen	O
la	O
hernia	O
de	O
Bochdalek	O
,	O
la	O
aplasia	O
diafragmática	O
y	O
varios	O
grados	O
de	O
defectos	O
de	O
muscularización	O
o	O
eventraciones	O
.	O

Se	O
producen	O
diferentes	O
tipos	O
de	O
defectos	O
en	O
los	O
mismos	O
pacientes	O
o	O
en	O
hermanos	O
,	O
lo	O
que	O
sugiere	O
que	O
representan	O
una	O
expresión	O
variable	O
de	O
la	O
misma	O
patogenia	O
subyacente	O
[	O
30	O
,	O
31	O
]	O
.	O

La	O
diferenciación	O
clínica	O
entre	O
estos	O
defectos	O
puede	O
ser	O
muy	O
difícil	O
,	O
ya	O
que	O
el	O
diafragma	O
membranoso	O
residual	O
de	O
un	O
defecto	O
de	O
muscularización	O
es	O
delgado	O
y	O
puede	O
no	O
ser	O
fácilmente	O
visible	O
en	O
la	O
ecografía	O
prenatal	O
o	O
en	O
las	O
radiografías	O
de	O
tórax	O
posnatales	O
[	O
32	O
]	O
.	O

Aunque	O
los	O
defectos	O
de	O
muscularización	O
diafragmática	O
históricamente	O
se	O
consideraban	O
predictivos	O
de	O
un	O
buen	O
resultado	O
,	O
ha	O
habido	O
estudios	O
poblacionales	O
inadecuados	O
que	O
incluyen	O
casos	O
fetales	O
o	O
neonatales	O
y	O
diagnósticos	O
de	O
autopsias	O
para	O
hacer	O
que	O
esta	O
conclusión	O
sea	O
definitiva	O
.	O

De	O
hecho	O
,	O
la	O
serie	O
de	O
pacientes	O
que	O
reportamos	O
aquí	O
y	O
la	O
literatura	O
publicada	O
indican	O
que	O
un	O
defecto	O
de	O
eventración	O
puede	O
estar	O
asociado	O
con	O
el	O
desplazamiento	O
del	O
contenido	O
abdominal	O
y	O
también	O
con	O
hipoplasia	O
pulmonar	O
severa	O
e	O
insuficiencia	O
respiratoria	O
[	O
33	O
,	O
34	O
]	O
.	O

Numeroso	O
cromosoma	B-GENE
se	O
han	O
encontrado	O
anomalías	O
en	O
asociación	O
con	O
anomalías	O
congénitas	O
del	O
diafragma	O
[	O
12	O
,	O
35	O
]	O
.	O

FOG2	B-Protein
humano	I-Protein
mapas	O
a	O
Cromosoma	B-GENE
8q23	O
.	O
1	O
y	O
,	O
lo	O
que	O
es	O
más	O
importante	O
,	O
varios	O
pacientes	O
con	O
defectos	O
del	O
diafragma	O
y	O
reordenamientos	O
relacionados	O
con	O
este	O
lugar	B-Sequence
ha	O
sido	O
reportado	O
.	O

Específicamente	O
,	O
hay	O
tres	O
pacientes	O
con	O
HDC	O
no	O
relacionados	O
con	O
citogenéticamente	O
balanceada	O
.	O
translocaciones	B-Sequence
en	O
o	O
cerca	O
del	O
FOG2	B-Protein
lugar	B-Sequence
[	O
36	O
,	O
37	O
]	O
.	O

Además	O
,	O
dos	O
pacientes	O
con	O
eliminaciones	B-Sequence
aparentemente	O
abarcando	O
el	O
FOG2	B-Protein
lugar	B-Sequence
han	O
muerto	O
a	O
causa	O
de	O
múltiples	O
anomalías	O
congénitas	O
,	O
incluida	O
la	O
HDC	O
[	O
38-40	O
]	O
.	O

Inactivación	O
de	O
este	O
gene	B-Sequence
debido	O
a	O
cromosómico	B-GENE
reordenamiento	O
o	O
supresión	B-Sequence
resultaría	O
en	O
un	O
heterocigoto	O
nulo	O
mutación	B-Sequence
similar	O
a	O
la	O
encontrada	O
en	O
el	O
paciente	O
que	O
reportamos	O
.	O

Porque	O
el	O
FOG2	B-Protein
mutación	B-Sequence
informamos	O
es	O
de	B-Sequence
novo	I-Sequence
y	O
los	O
fenotipos	O
de	O
los	O
defectos	O
pulmonares	O
y	O
diafragmáticos	O
son	O
similares	O
entre	O
ratón	B-Taxon
y	O
humano	B-Taxon
,	O
sugerimos	O
que	O
este	O
mutación	B-Sequence
en	O
FOG2	B-Protein
es	O
la	O
primera	O
causa	O
reportada	O
de	O
una	O
humano	B-Taxon
Defecto	O
diafragmático	O
y	O
pulmonar	O
del	O
desarrollo	O
.	O

A	O
diferencia	O
del	O
niño	O
afectado	O
,	O
ratones	B-Taxon
heterocigoto	O
para	O
un	O
nulo	O
mutación	B-Sequence
de	O
niebla2	B-Protein
parecer	O
normales	O
.	O

Sin	O
embargo	O
,	O
existe	O
un	O
amplio	O
precedente	O
para	O
la	O
observación	O
de	O
que	O
la	O
haploinsuficiencia	O
de	O
un	O
gene	B-Sequence
con	O
funciones	O
de	O
desarrollo	O
es	O
mucho	O
menos	O
bien	O
tolerado	O
en	O
humanos	B-Taxon
que	O
ratones	B-Taxon
[	O
41	O
]	O
.	O

No	O
está	O
claro	O
cómo	O
el	O
niebla2	B-Protein
el	O
defecto	O
diafragmático	O
se	O
relaciona	O
con	O
la	O
CDH	O
de	O
Bochdalek	O
más	O
común	O
,	O
ya	O
que	O
los	O
mecanismos	O
patogénicos	O
para	O
ambos	O
son	O
en	O
gran	O
parte	O
desconocidos	O
.	O

precursores	B-Cell
musculares	I-Cell
destinados	O
a	O
poblar	O
el	O
diafragma	O
migran	O
desde	O
el	O
dermomiotomo	O
lateral	O
de	O
los	O
somitas	O
cervicales	O
.	O

Antes	O
de	O
migrar	O
al	O
diafragma	O
,	O
pueblan	O
el	O
FPP	O
,	O
un	O
tejido	O
en	O
forma	O
de	O
cuña	O
que	O
se	O
estrecha	O
medialmente	O
desde	O
la	O
pared	O
lateral	O
del	O
cuerpo	O
hasta	O
el	O
mesenterio	O
esofágico	O
y	O
se	O
fusiona	O
ventralmente	O
con	O
el	O
tabique	O
transverso	O
[	O
42	O
]	O
.	O

precursores	B-Cell
musculares	I-Cell
alcanzan	O
la	O
FPP	O
en	O
E11	O
,	O
donde	O
proliferan	O
,	O
se	O
diferencian	O
y	O
luego	O
migran	O
hacia	O
las	O
regiones	O
costal	O
dorsolateral	O
,	O
costal	O
esternal	O
y	O
crural	O
del	O
diafragma	O
en	O
desarrollo	O
.	O

Por	O
lo	O
tanto	O
,	O
un	O
defecto	O
en	O
la	O
formación	O
de	O
la	O
FPP	O
da	O
como	O
resultado	O
la	O
formación	O
anormal	O
del	O
diafragma	O
[	O
43	O
]	O
.	O

Hemos	O
demostrado	O
que	O
el	O
niebla2	B-Protein
mutante	B-Sequence
tiene	O
un	O
patrón	O
anormal	O
de	O
HGF	B-Protein
expresión	O
en	O
la	O
región	O
a	O
través	O
de	O
la	O
cual	O
células	B-Cell
precursoras	I-Cell
musculares	I-Cell
migrar	O
al	O
diafragma	O
en	O
desarrollo	O
.	O

Este	O
hallazgo	O
puede	O
explicar	O
el	O
patrón	O
muscular	O
anormal	O
que	O
se	O
desarrolla	O
en	O
la	O
niebla2	B-Protein
mutante	B-Sequence
diafragma	O

Aunque	O
Pax3	B-Protein
y	O
MyoD	B-Protein
expresión	O
se	O
detecta	O
en	O
el	O
PPF	O
,	O
un	O
análisis	O
detallado	O
de	O
los	O
factores	O
de	O
transcripción	O
responsables	O
de	O
célula	B-Cell
precursora	I-Cell
muscular	I-Cell
la	O
migración	O
y	O
la	O
diferenciación	O
deberán	O
completarse	O
tanto	O
en	O
el	O
PPF	O
como	O
a	O
lo	O
largo	O
del	O
camino	O
de	O
célula	B-Cell
precursora	I-Cell
muscular	I-Cell
migración	O
entre	O
la	O
FPP	O
y	O
el	O
diafragma	O
membranoso	O
.	O

niebla2	B-Protein
puede	O
interactuar	O
con	O
cualquiera	O
de	O
los	O
factores	O
de	O
Gata	O
,	O
Gatas	B-Protein
1	I-Protein
-	I-Protein
6	I-Protein
,	O
así	O
como	O
otros	O
factores	O
de	O
transcripción	O
como	O
GolpeTFII	B-Protein
[	O
44	O
,	O
45	O
]	O
.	O

Se	O
sabe	O
que	O
un	O
niebla2	B-Protein
-	O
gata4	B-Protein
la	O
interacción	O
es	O
crítica	O
para	O
el	O
desarrollo	O
cardíaco	O
y	O
gonadal	O
normal	O
,	O
pero	O
aún	O
no	O
se	O
han	O
determinado	O
los	O
factores	O
que	O
interactúan	O
en	O
el	O
pulmón	O
y	O
el	O
diafragma	O
.	O

La	O
severidad	O
de	O
la	O
hipoplasia	O
pulmonar	O
en	O
el	O
paciente	O
que	O
reportamos	O
fue	O
desproporcionada	O
con	O
la	O
del	O
defecto	O
del	O
diafragma	O
.	O

La	O
hipoplasia	O
pulmonar	O
se	O
asocia	O
con	O
una	O
anatomía	O
o	O
función	O
diafragmática	O
anormal	O
,	O
y	O
se	O
sabe	O
que	O
ocurre	O
como	O
un	O
defecto	O
de	O
desarrollo	O
secundario	O
en	O
modelos	O
de	O
disfunción	O
diafragmática	O
como	O
la	O
amuscularización	O
completa	O
[	O
17	O
]	O
o	O
la	O
interrupción	O
del	O
nervio	O
frénico	O
[	O
46	O
]	O
.	O

Ocurre	O
en	O
un	O
modelo	O
quirúrgico	O
de	O
CDH	O
en	O
el	O
que	O
se	O
crea	O
físicamente	O
una	O
hernia	O
en	O
un	O
útero	O
.	O
Cordero	B-Taxon
[	O
47	O
,	O
48	O
]	O
.	O

Sin	O
embargo	O
,	O
la	O
posibilidad	O
de	O
que	O
las	O
anomalías	O
primarias	O
del	O
desarrollo	O
pulmonar	O
se	O
produzcan	O
con	O
defectos	O
diafragmáticos	O
,	O
en	O
lugar	O
de	O
ser	O
secundarias	O
a	O
ellos	O
,	O
ha	O
sido	O
sugerida	O
por	O
otros	O
basados	O
en	O
un	O
modelo	O
teratogénico	O
de	O
HDC	O
[	O
49-51	O
]	O
y	O
ha	O
sido	O
sospechada	O
durante	O
mucho	O
tiempo	O
por	O
los	O
médicos	O
que	O
atienden	O
a	O
estos	O
pacientes	O
.	O

Además	O
,	O
la	O
alta	O
incidencia	O
de	O
anomalías	O
lobares	O
asociadas	O
con	O
la	O
HDC	O
[	O
52	O
]	O
apoya	O
la	O
posibilidad	O
de	O
que	O
este	O
trastorno	O
pueda	O
estar	O
asociado	O
con	O
una	O
anomalía	O
pulmonar	O
primaria	O
del	O
desarrollo	O
.	O

Nuestro	O
análisis	O
de	O
ratones	B-Taxon
que	O
lleva	O
mutaciones	B-Sequence
de	O
niebla2	B-Protein
demuestra	O
que	O
existe	O
un	O
defecto	O
primario	O
en	O
el	O
desarrollo	O
pulmonar	O
que	O
resulta	O
en	O
la	O
pérdida	O
específica	O
del	O
lóbulo	O
accesorio	O
y	O
la	O
pérdida	O
parcial	O
del	O
lóbulo	O
medio	O
derecho	O
.	O

Los	O
defectos	O
lobares	O
específicos	O
nos	O
llevaron	O
a	O
evaluar	O
niebla2	B-Protein
expresión	O
en	O
el	O
momento	O
de	O
la	O
brotación	O
lobular	O
temprana	O
.	O

Tiempo	O
niebla2	B-Protein
la	O
expresión	O
es	O
difusa	O
en	O
el	O
mesénquima	O
pulmonar	O
después	O
de	O
que	O
la	O
estructura	O
lobar	O
está	O
bien	O
establecida	O
(	O
E12.5	O
)	O
,	O
se	O
expresa	O
más	O
focalmente	O
en	O
el	O
mesénquima	O
que	O
rodea	O
el	O
lóbulo	O
medio	O
derecho	O
y	O
las	O
yemas	O
accesorias	O
a	O
medida	O
que	O
se	O
forman	O
estos	O
lóbulos	O
.	O

Esto	O
coincide	O
con	O
el	O
fenotipo	O
de	O
pérdida	O
del	O
lóbulo	O
medio	O
derecho	O
y	O
del	O
lóbulo	O
accesorio	O
,	O
y	O
sugiere	O
que	O
niebla2	B-Protein
tiene	O
un	O
papel	O
patrón	O
específico	O
en	O
el	O
establecimiento	O
de	O
estos	O
lóbulos	O
.	O

Está	O
menos	O
claro	O
si	O
la	O
pérdida	O
de	O
niebla2	B-Protein
resulta	O
en	O
un	O
defecto	O
de	O
ramificación	O
global	O
,	O
como	O
niebla2	B-Protein
Los	O
pulmones	O
parecen	O
tener	O
un	O
ligero	O
retraso	O
en	O
el	O
desarrollo	O
,	O
lo	O
que	O
podría	O
deberse	O
a	O
muchas	O
causas	O
.	O

Culto	O
niebla2	B-Protein
Los	O
pulmones	O
desarrollan	O
un	O
patrón	O
de	O
ramificación	O
intrincado	O
en	O
los	O
lóbulos	O
no	O
afectados	O
que	O
parece	O
similar	O
en	O
el	O
patrón	O
a	O
tipo	B-Sequence
salvaje	I-Sequence
pulmones	O
después	O
de	O
5	O
d	O
en	O
cultivo	O
.	O

En	O
este	O
informe	O
,	O
mostramos	O
que	O
un	O
mutación	B-Sequence
de	O
niebla2	B-Protein
en	O
el	O
ratón	B-Taxon
causa	O
el	O
fenotipo	O
de	O
muscularización	O
diafragmática	O
anormal	O
e	O
hipoplasia	O
pulmonar	O
primaria	O
.	O

Además	O
demostramos	O
que	O
un	O
mutación	B-Sequence
en	O
esto	O
gene	B-Sequence
está	O
asociado	O
con	O
un	O
defecto	O
letal	O
en	O
el	O
desarrollo	O
de	O
los	O
pulmones	O
y	O
el	O
diafragma	O
en	O
un	O
niño	O
.	O

Es	O
notable	O
que	O
,	O
a	O
pesar	O
de	O
un	O
extenso	O
análisis	O
de	O
niebla2	B-Protein
biología	O
y	O
la	O
generación	O
de	O
un	O
niebla2	B-Protein
knockear	O
ratón	B-Taxon
,	O
su	O
papel	O
en	O
el	O
desarrollo	O
del	O
diafragma	O
y	O
los	O
pulmones	O
no	O
se	O
reconocía	O
previamente	O
.	O

Es	O
solo	O
como	O
consecuencia	O
de	O
los	O
análisis	O
basados	O
en	O
el	O
fenotipo	O
como	O
los	O
que	O
estamos	O
realizando	O
que	O
uno	O
tiene	O
la	O
oportunidad	O
de	O
ensayar	O
todo	O
el	O
potencial	O
molecular	B-Chemical
trastornos	O
que	O
pueden	O
resultar	O
en	O
humano	B-Taxon
enfermedad	O
.	O

Materiales	O
y	O
métodos	O

Estas	O
investigaciones	O
se	O
realizaron	O
con	O
la	O
aprobación	O
de	O
la	O
junta	O
de	O
revisión	O
institucional	O
del	O
Children	O
's	O
Hospital	O
,	O
Boston	O
,	O
y	O
el	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
,	O
Boston	O
.	O

Animal	B-Taxon
El	O
uso	O
fue	O
aprobado	O
por	O
el	O
Centro	O
de	O
Animal	B-Taxon
Recursos	O
y	O
Medicina	O
Comparada	O
(	O
Harvard	O
Medical	O
School	O
)	O
.	O

Genético	B-Sequence
mapeo	O
de	O
la	O
ratón	B-Taxon
mutación	B-Sequence
pequeño	O
.	O

el	O
pequeño	O
mutación	B-Sequence
se	O
identificó	O
como	O
se	O
describe	O
en	O
los	O
resultados	O
.	O

Tipo	B-Sequence
salvaje	I-Sequence
FVB/N	O
y	O
C57BL/6J	O
ratones	B-Taxon
usado	O
para	O
genético	B-Sequence
los	O
cruces	O
se	O
obtuvieron	O
del	O
Laboratorio	O
Jackson	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
Estados	O
Unidos	O
)	O
.	O

Ratones	B-Taxon
llevando	O
un	O
nulo	O
mutación	B-Sequence
de	O
niebla2	B-Protein
generado	O
por	O
gene	B-Sequence
targeting	O
[	O
16	O
]	O
fueron	O
el	O
generoso	O
regalo	O
del	O
Dr	O
.	O
Stuart	O
Orkin	O
.	O

Análisis	O
del	O
desarrollo	O
de	O
ratones	B-Taxon
.	O

Se	O
establecieron	O
embarazos	O
cronometrados	O
para	O
la	O
recolección	O
de	O
E11	O
.	O
5	O
-	O
E17	O
.	O
5	O
embriones	O
.	O

Los	O
embriones	O
se	O
fijaron	O
,	O
deshidrataron	O
e	O
incluyeron	O
en	O
parafina	O
antes	O
del	O
corte	O
.	O

En	O
embriones	O
más	O
viejos	O
,	O
se	O
realizó	O
una	O
esternotomía	O
media	O
bajo	O
guía	O
microscópica	O
y	O
se	O
examinaron	O
el	O
diafragma	O
,	O
los	O
pulmones	O
y	O
el	O
corazón	O
.	O

Se	O
extrajeron	O
y	O
pesaron	O
los	O
pulmones	O
y	O
el	O
árbol	O
traqueobronquial	O
.	O

Se	O
aislaron	O
diafragmas	O
completos	O
a	O
partir	O
de	O
tejido	O
torácico	O
fijado	O
de	O
E15	O
.	O
5	O
y	O
E17	O
.	O
5	O
embriones	O
.	O

Para	O
el	O
cultivo	O
de	O
explantes	O
de	O
pulmón	O
,	O
se	O
diseccionaron	O
pulmones	O
de	O
embriones	O
frescos	O
en	O
E11	O
.	O
5	O
y	O
E12	O
.	O
5	O
y	O
colocado	O
sobre	O
poroso	O
de	O
24	O
-	O
mm	O
(	O
0	O
.	O
4	O
-	O
mu	O
)	O
poliéster	B-Chemical
las	O
membranas	O
flotaron	O
en	O
pocillos	O
que	O
contenían	O
2	O
ml	O
de	O
medio	O
de	O
Eagle	O
modificado	O
por	O
Dulbecco	O
,	O
nutritivo	B-Chemical
mezcla	O
F	O
-	O
12	O
(	O
11039	O
-	O
021	O
,	O
Gibco	O
,	O
San	O
Diego	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
,	O
suplementada	O
con	O
10	O
%	O
fetal	O
bovino	B-Taxon
suero	O
,	O
0	O
.	O
3	O
mg/ml	O
L	B-Chemical
-	I-Chemical
glutamina	I-Chemical
,	O
100	O
unidades	O
/	O
ml	O
penicilina	B-Chemical
,	O
100	O
mcg/ml	O
estreptomicina	B-Chemical
,	O
y	O
0	O
.	O
25	O
mcg/ml	O
de	O
anfotericina	O
B	O
.	O

Los	O
explantes	O
de	O
pulmón	O
se	O
cultivaron	O
a	O
37	O
grados	O
C	O
en	O
95	O
%	O
de	O
aire	O
/	O
5	O
%	O
CO2	B-Chemical
por	O
hasta	O
5	O
días	O
.	O

Fueron	O
fotografiados	O
diariamente	O
con	O
un	O
microscopio	O
de	O
disección	O
(	O
MZ12.5	O
,	O
Leica	O
,	O
Wetzlar	O
,	O
Alemania	O
)	O
equipado	O
con	O
una	O
cámara	O
digital	O
Leica	O
DC500	O
.	O

transgénico	B-Sequence
ratones	B-Taxon
llevando	O
el	O
lacZ	O
gene	B-Sequence
impulsado	O
por	O
el	O
niebla2	B-Protein
promotor	B-Sequence
han	O
sido	O
desarrollados	O
por	O
S	O
.	O

tevosiano	O
.	O

En	O
estos	O
animales	B-Taxon
la	O
lacZ	O
gene	B-Sequence
es	O
incorporado	B-Sequence
``	O
(	O
``	O
''	O
golpeado	O
''	O
''	O
)	O
en	O
el	O
''	O
niebla2	B-Protein
lugar	B-Sequence
para	O
permitir	O
la	O
expresión	O
de	O
beta	O
-	O
galactosidasa	O
como	O
fusión	B-Sequence
proteína	B-Chemical
en	O
marco	B-Sequence
con	O
los	O
primeros	O
235	O
aminoácidos	B-Chemical
de	O
El	O
FOG2	B-Protein
proteína	B-Chemical
.	O

los	O
niebla2	B-Protein
#	O
¿NOMBRE	O
?	O
ires	B-Sequence
#	O
¿NOMBRE	O
?	O
casete	B-Sequence
.	O

Esto	O
crea	O
un	O
nulo	O
alelo	B-Sequence
de	O
niebla2	B-Protein
gene	B-Sequence
.	O

los	O
niebla2	B-Protein
#	O
¿NOMBRE	O
?	O
construir	B-Sequence
se	O
linealizó	O
con	O
KspI	O
y	O
se	O
sometió	O
a	O
electroporación	O
en	O
el	O
CJ7	O
ES	O
células	B-Cell
.	O

El	O
clon	O
dirigido	O
correctamente	O
se	O
seleccionó	O
mediante	O
análisis	O
de	O
transferencia	O
Southern	O
y	O
se	O
inyectó	O
en	O
blastocistos	O
C57BL/6J	O
.	O

niebla2	B-Protein
#	O
¿NOMBRE	O
?	O
animales	B-Taxon
se	O
mantuvieron	O
en	O
el	O
fondo	O
mixto	O
C57BL/6J/129	O
.	O

La	O
expresión	O
de	O
lacZ	O
en	O
pulmones	O
embrionarios	O
disecados	O
completos	O
se	O
analizó	O
mediante	O
tinción	O
para	O
la	O
actividad	O
de	O
beta-galactosidasa	O
con	O
X-gal	O
después	O
de	O
la	O
fijación	O
durante	O
30	O
min	O
.	O

RT	O
-	O
PCR	O
y	O
secuencia	B-Sequence
análisis	O
en	O
el	O
ratón	B-Taxon
.	O

ARN	B-Sequence
fue	O
extraído	O
por	O
técnicas	O
estándar	O
de	O
tejido	O
embrionario	O
torácico	O
.	O

RT	O
-	O
PCR	O
se	O
realizó	O
utilizando	O
seis	O
cebador	B-Sequence
conjuntos	O
diseñado	B-Sequence
para	O
cubrir	O
el	O
niebla2	B-Protein
gene	B-Sequence
.	O

RT	O
-	O
PCR	O
se	O
repitió	O
con	O
radiomarcado	B-Chemical
cebadores	B-Sequence
para	O
amplificar	O
un	O
empalme	O
anormal	O
región	B-Sequence
del	I-Sequence
gen	I-Sequence
(	O
Tabla	O
S1	O
)	O
,	O
y	O
el	O
producto	B-Sequence
se	O
ejecutó	O
en	O
un	O
gel	O
de	O
secuenciación	O
desnaturalizante	O
de	O
acuerdo	O
con	O
técnicas	O
estándar	O
.	O

El	O
RT	O
-	O
producto	B-Sequence
PCR	I-Sequence
fue	O
clonado	O
en	O
pCR2	O
.	O
1	O
vector	B-Sequence
usando	O
TOPO	O
TA	O
Cloning	O
Kit	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
y	O
secuenciado	O
usando	O
gene	B-Sequence
#	O
¿NOMBRE	O
?	O
cebadores	B-Sequence
.	O

Secuencia	B-Sequence
El	O
análisis	O
se	O
realizó	O
utilizando	O
Sequencher	O
4	O
.	O
1	O
(	O
Gene	B-Sequence
Codes	O
,	O
Ann	O
Arbor	O
,	O
Michigan	O
,	O
Estados	O
Unidos	O
)	O
.	O

Hibridación	O
in	O
situ	O
.	O

Después	O
de	O
la	O
deshidratación	O
y	O
la	O
inclusión	O
en	O
cera	O
de	O
parafina	O
,	O
las	O
secciones	O
de	O
10	O
mu	O
se	O
sometieron	O
a	O
hibridación	O
in	O
situ	O
radiactiva	O
como	O
se	O
describe	O
[	O
53	O
]	O
.	O

Sondas	B-Sequence
etiquetado	O
con	O
35S	B-Chemical
fueron	O
preparados	O
por	O
run	O
-	O
off	O
transcripción	O
de	O
linearized	O
plásmido	B-Sequence
moldes	O
e	O
hibridados	O
a	O
secciones	O
de	O
tejido	O
.	O

Núcleos	B-GENE
se	O
contratiñeron	O
con	O
Hoescht	O
33258	O
,	O
y	O
se	O
obtuvieron	O
imágenes	O
de	O
la	O
señal	O
usando	O
microscopía	O
fluorescente	O
y	O
de	O
campo	O
oscuro	O
.	O

Humano	B-Taxon
Extracción	B-Sequence
y	I-Sequence
secuenciación	I-Sequence
de	I-Sequence
ADN	I-Sequence
análisis	O

ADN	B-Sequence
fue	O
aislado	O
de	O
bloques	O
de	O
parafina	O
por	O
fenol	B-Chemical
-	O
cloroformo	B-Chemical
extracción	O
[	O
54	O
,	O
55	O
]	O
,	O
y	O
de	O
tejidos	O
congelados	O
mediante	O
técnicas	O
estándar	O
.	O

imprimaciones	B-Sequence
fueron	O
diseñados	O
para	O
amplificar	O
FOG2	B-Protein
codificando	B-Sequence
exones	I-Sequence
más	O
50	O
pb	B-Sequence
de	O
flanqueando	B-Sequence
secuencia	I-Sequence
aguas	I-Sequence
arriba	I-Sequence
y	I-Sequence
aguas	I-Sequence
abajo	I-Sequence
.	O

La	O
amplificación	O
por	O
PCR	O
y	O
la	O
secuenciación	O
se	O
realizaron	O
mediante	O
métodos	O
estándar	O
.	O

Secuencias	B-Sequence
de	I-Sequence
cebadores	I-Sequence
utilizados	O
se	O
enumeran	O
en	O
la	O
Tabla	O
S2	O
.	O

Secuencia	B-Sequence
El	O
análisis	O
se	O
realizó	O
con	O
Sequencher	O
4	O
.	O
1	O
(	O
Gene	B-Sequence
códigos	O
)	O
.	O

ADN	B-Sequence
de	O
los	O
padres	O
de	O
un	O
paciente	O
de	O
autopsia	O
se	O
extrajo	O
de	O
muestras	O
de	O
sangre	O
fresca	O
.	O

Se	O
envió	O
un	O
segundo	O
conjunto	O
de	O
muestras	O
de	O
sangre	O
a	O
un	O
laboratorio	O
externo	O
certificado	O
por	O
CLIA	O
para	O
ADN	B-Sequence
extracción	O
,	O
PCR	O
,	O
secuenciación	O
y	O
análisis	O
.	O

La	O
prueba	O
de	O
paternidad	O
fue	O
realizada	O
por	O
un	O
laboratorio	O
externo	O
utilizando	O
un	O
panel	O
estándar	O
de	O
marcadores	O
.	O

SNP	B-Sequence
el	O
genotipado	O
se	O
realizó	O
utilizando	O
las	O
instalaciones	O
centrales	O
de	O
genotipado	O
del	O
Harvard	O
Partners	O
Center	O
for	O
Genetics	O
and	O
Genomics	O
(	O
Cambridge	O
,	O
Massachusetts	O
,	O
Estados	O
Unidos	O
)	O
.	O

información	O
de	O
soporte	O

Tabla	O
S1	O

imprimaciones	B-Sequence
para	O
RT	O
-	O
PCR	O
(	O
Ratón	B-Taxon
)	O
:	O
Amplificación	O
de	O
Anormal	O
Transcripción	B-Sequence
en	O
niebla2	B-Protein
mutante	B-Sequence
(	O
pequeño	O
)	O
Ratones	B-Taxon

(	O
26	O
KB	O
DOCUMENTO	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S2	O

Humano	B-Taxon
imprimaciones	B-Sequence
para	O
amplificación	O
de	O
FOG2	B-Protein
Secuencia	B-Sequence
de	I-Sequence
codificación	I-Sequence
desde	O
ADN	B-Sequence
genómico	I-Sequence

(	O
46	O
KB	O
DOC	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Agradecimientos	O

Este	O
manuscrito	O
está	O
dedicado	O
a	O
Baby	O
Lucy	O
ya	O
sus	O
padres	O
por	O
la	O
contribución	O
que	O
han	O
hecho	O
para	O
ayudarnos	O
a	O
comprender	O
los	O
defectos	O
pulmonares	O
y	O
diafragmáticos	O
del	O
desarrollo	O
.	O

Este	O
trabajo	O
fue	O
financiado	O
por	O
el	O
Instituto	O
Nacional	O
de	O
Salud	O
Infantil	O
y	O
Humano	B-Taxon
Desarrollo	O
(	O
NIHCD	O
)	O
subvención	O
HD36404	O
(	O
DRB	O
)	O
y	O
la	O
Fundación	O
Hearst	O
(	O
KGA	O
)	O
.	O

KGA	O
también	O
recibió	O
apoyo	O
salarial	O
de	O
la	O
subvención	O
T32HD040129-02	O
del	O
NICHD	O
.	O

Nos	O
gustaría	O
agradecer	O
a	O
Stuart	O
Orkin	O
,	O
M	O
.	O

D	O
.	O
,	O
por	O
el	O
generoso	O
regalo	O
de	O
su	O
niebla2	B-Protein
-	O
/	O
-	O
ratones	B-Taxon
.	O

También	O
nos	O
gustaría	O
agradecer	O
a	O
Raju	O
Kucherlapati	O
,	O
Ph	O
.	O

D	O
.	O
y	O
Birgit	O
Funke	O
,	O
Ph	O
.	O

D	O
.	O
,	O
para	O
proporcionar	O
control	O
ADN	B-Sequence
muestras	O

abreviaturas	O

CDH	O
-	O
hernia	O
diafragmática	O
congénita	O

E	O
[	O
número	O
]	O
-	O
día	O
embrionario	O
[	O
número	O
]	O

ENU	B-Chemical
-	O
N	B-Chemical
-	I-Chemical
etil	I-Chemical
-	I-Chemical
N	I-Chemical
-	I-Chemical
nitrosourea	I-Chemical

HGF	B-Protein
-	O
factor	B-Protein
de	I-Protein
crecimiento	I-Protein
de	I-Protein
hepatocitos	I-Protein
/	O
factor	B-Protein
de	I-Protein
dispersión	I-Protein

lil	O
-	O
pequeño	O
pulmón	O

PPF	O
-	O
pliegue	O
pleuroperitoneal	O

Cifras	O

Figura	O
1	O

Desarrollo	O
pulmonar	O
y	O
diafragmático	O
anormal	O
en	O
el	O
pequeño	O
Ratón	B-Taxon

(	O
A	O
)	O
El	O
mutante	B-Sequence
pulmón	O
hipoplásico	O
(	O
derecho	O
)	O
carece	O
del	O
desarrollo	O
del	O
lóbulo	O
accesorio	O
y	O
la	O
porción	O
anterior	O
del	O
lóbulo	O
medio	O
derecho	O
(	O
marcado	O
con	O
flechas	O
en	O
la	O
muestra	O
de	O
control	O
a	O
la	O
izquierda	O
)	O
.	O

(	O
B	O
)	O
Los	O
diafragmas	O
completos	O
muestran	O
una	O
falta	O
de	O
muscularización	O
normal	O
en	O
las	O
regiones	O
posterolaterales	O
y	O
las	O
regiones	O
periféricas	O
de	O
la	O
mutante	B-Sequence
diafragma	O
(	O
control	O
a	O
la	O
izquierda	O
y	O
pequeño	O
diafragma	O
a	O
la	O
derecha	O
)	O
.	O

Figura	O
2	O

los	O
ENU	B-Chemical
#	O
¿NOMBRE	O
?	O
Mutación	B-Sequence
en	O
niebla2	B-Protein
es	O
un	O
Mutación	B-Sequence
del	I-Sequence
sitio	I-Sequence
de	I-Sequence
empalme	I-Sequence

(	O
A	O
)	O
RT	O
-	O
PCR	O
reveló	O
un	O
alargamiento	O
transcripción	B-Sequence
en	O
ratones	B-Taxon
con	O
el	O
fenotipo	O
lil	O
:	O
la	O
primera	O
banda	O
es	O
un	O
lil	O
ratón	B-Taxon
,	O
y	O
la	O
segunda	O
banda	O
es	O
un	O
control	O
ratón	B-Taxon
.	O

(	O
B	O
)	O
Secuenciación	O
niebla2	B-Protein
reveló	O
un	O
mutación	B-Sequence
del	I-Sequence
sitio	I-Sequence
de	I-Sequence
empalme	I-Sequence
que	O
causa	O
la	O
inserción	B-Sequence
de	O
85	O
pb	B-Sequence
de	O
secuencia	B-Sequence
intrónica	I-Sequence
en	O
el	O
mutante	B-Sequence
ratón	B-Taxon
.	O

Esto	O
resulta	O
en	O
un	O
prematuro	O
codón	B-Sequence
de	I-Sequence
parada	I-Sequence
Antes	O
de	O
zinc	B-Chemical
transcripción	O
de	O
dedos	O
.	O

figura	O
3	O

niebla2	B-Protein
Se	O
expresa	O
en	O
el	O
pulmón	O
y	O
el	O
diafragma	O
en	O
desarrollo	O

niebla2	B-Protein
se	O
expresa	O
en	O
el	O
mesénquima	O
pulmonar	O
difuso	O
en	O
E13	O
.	O
5	O
(	O
A	O
)	O
(	O
la	O
flecha	O
muestra	O
el	O
mesénquima	O
)	O
y	O
está	O
restringida	O
al	O
músculo	O
liso	O
bronquial	O
y	O
vascular	O
(	O
sm	O
)	O
en	O
E16	O
.	O
5	O
(	O
B	O
)	O
.	O

niebla2	B-Protein
se	O
expresa	O
de	O
forma	O
difusa	O
en	O
el	O
diafragma	O
en	O
desarrollo	O
(	O
Di	O
)	O
tanto	O
antes	O
de	O
(	O
E11.5	O
)	O
(	O
C	O
)	O
como	O
después	O
de	O
la	O
muscularización	O
(	O
E13.5	O
)	O
(	O
D	O
)	O
.	O

Figura	O
4	O

niebla2	B-Protein
es	O
necesario	O
para	O
el	O
desarrollo	O
pulmonar	O
primario	O

niebla2	B-Protein
los	O
pulmones	O
nulos	O
extirpados	O
antes	O
de	O
la	O
muscularización	O
diafragmática	O
y	O
cultivados	O
in	O
vitro	O
no	O
muestran	O
desarrollo	O
de	O
lóbulos	O
accesorios	O
.	O

El	O
lóbulo	O
accesorio	O
está	O
marcado	O
con	O
una	O
flecha	O
negra	O
en	O
los	O
pulmones	O
de	O
compañeros	O
de	O
camada	O
de	O
control	O
.	O

Figura	O
5	O

niebla2	B-Protein
Expresión	O
en	O
Embrionario	O
No	O
-	O
mutante	B-Sequence
Pulmones	O

En	O
embrionario	O
no	O
-	O
mutante	B-Sequence
pulmones	O
,	O
niebla2	B-Protein
se	O
expresa	O
más	O
en	O
las	O
puntas	O
del	O
accesorio	O
(	O
flechas	O
simples	O
)	O
y	O
en	O
los	O
lóbulos	O
medios	O
derechos	O
(	O
flechas	O
dobles	O
)	O
en	O
E11	O
.	O
25	O
(	O
A	O
)	O
y	O
E11	O
.	O
75	O
(	O
B	O
)	O
,	O
mientras	O
que	O
la	O
expresión	O
es	O
difusa	O
por	O
E12	O
.	O
75	O
(	O
C	O
)	O
.	O

Figura	O
6	O

HGF	B-Protein
El	O
patrón	O
es	O
anormal	O
en	O
niebla2	B-Protein
Nulo	O
Ratones	B-Taxon

Hibridación	O
in	O
situ	O
de	O
HGF	B-Protein
en	O
E12	O
.	O
5	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
A	O
)	O
y	O
niebla2	B-Protein
-/-	O
(	O
B	O
)	O
los	O
embriones	O
muestran	O
una	O
expresión	O
disminuida	O
en	O
la	O
región	O
donde	O
el	O
PPF	O
se	O
encuentra	O
con	O
el	O
diafragma	O
membranoso	O
.	O

Li	O
,	O
hígado	O
;	O
Lu	O
,	O
pulmón	O
.	O

Figura	O
7	O

FOG2	B-Protein
Mutación	B-Sequence
en	O
un	O
paciente	O
con	O
anomalías	O
diafragmáticas	O
y	O
pulmonares	O

La	O
secuenciación	O
reveló	O
una	O
de	B-Sequence
novo	I-Sequence
tonterías	O
heterocigotas	O
mutación	B-Sequence
en	O
un	O
paciente	O
que	O
murió	O
al	O
nacer	O
con	O
hipoplasia	O
pulmonar	O
severa	O
y	O
una	O
eventración	O
diafragmática	O
profunda	O
posterior	O
.	O

Ella	O
fue	O
clínicamente	O
diagnosticada	O
con	O
CDH	O
.	O

esta	O
tontería	O
mutación	B-Sequence
se	O
produce	O
antes	O
de	O
la	O
funcional	O
zinc	B-Chemical
dedo	O
dominios	B-Sequence
.	O

notas	O
al	O
pie	O

Conflicto	O
de	O
intereses	O
.	O

Los	O
autores	O
han	O
declarado	O
que	O
no	O
existen	O
intereses	O
contrapuestos	O
.	O

Contribuciones	O
de	O
autor	O
.	O

KGA	O
,	O
JJG	O
y	O
DRB	O
concibieron	O
y	O
diseñaron	O
los	O
experimentos	O
.	O

KGA	O
,	O
BJH	O
,	O
HH	O
,	O
SGT	O
,	O
LK	O
,	O
CR	O
,	O
RPB	O
y	O
JAE	O
realizaron	O
los	O
experimentos	O
.	O

KGA	O
,	O
BJH	O
,	O
HH	O
,	O
LK	O
,	O
CR	O
,	O
JAE	O
,	O
JJG	O
y	O
DRB	O
analizaron	O
los	O
datos	O
.	O

KGA	O
,	O
SOV	O
,	O
SGT	O
,	O
BRP	O
,	O
JAE	O
,	O
JJG	O
y	O
DRB	O
contribuyeron	O
reactivos	B-Chemical
/	O
materiales	O
/	O
herramientas	O
de	O
análisis	O
.	O

KGA	O
y	O
DRB	O
escribieron	O
el	O
documento	O
.	O

Cita	O
:	O
Ackerman	O
KG	O
,	O
Herron	O
BJ	O
,	O
Vargas	O
SO	O
,	O
Huang	O
H	O
,	O
Tevosian	O
SG	O
,	O
et	O
al	O
.	O

-2005	O
niebla2	B-Protein
se	O
requiere	O
para	O
el	O
desarrollo	O
normal	O
del	O
diafragma	O
y	O
los	O
pulmones	O
en	O
ratones	B-Taxon
y	O
humanos	B-Taxon
.	O

PLoS	O
Genet	O
1	O
(	O
1	O
)	O
:	O
e10	O
.	O

Un	O
híbrido	O
fotorreceptor	B-Cell
expresando	O
ambos	O
vara	B-Cell
y	O
Cono	B-Cell
genes	B-Sequence
en	O
un	O
Ratón	B-Taxon
Modelo	O
de	O
Mejorado	O
S	O
-	O
Cono	B-Cell
Síndrome	O

Resumen	O

Fotorreceptores	B-Cell
de	I-Cell
bastones	I-Cell
y	I-Cell
conos	I-Cell
subserve	O
la	O
visión	O
en	O
condiciones	O
de	O
luz	O
tenue	O
y	O
brillante	O
,	O
respectivamente	O
.	O

Se	O
cree	O
que	O
las	O
diferencias	O
en	O
su	O
función	O
se	O
derivan	O
de	O
sus	O
diferentes	O
gene	B-Sequence
patrones	O
de	O
expresión	O
,	O
morfologías	O
y	O
sináptico	B-GENE
conectividades	O

En	O
este	O
estudio	O
,	O
hemos	O
examinado	O
la	O
células	B-Cell
fotorreceptoras	I-Cell
de	O
la	O
degeneración	O
retiniana	O
7	O
(	O
rd7	O
)	O
mutante	B-Sequence
ratón	B-Taxon
,	O
un	O
modelo	O
para	O
el	O
humano	B-Taxon
mejorado	O
S-	O
cono	B-Cell
síndrome	O
(	O
CESS	O
)	O
.	O

Esta	O
mutante	B-Sequence
lleva	O
un	O
espontáneo	O
supresión	B-Sequence
en	O
el	O
ratón	B-Taxon
ortólogo	B-Sequence
de	O
NR2E3	B-Protein
,	O
Un	O
huérfano	O
nuclear	B-GENE
factor	O
de	O
transcripción	O
del	O
receptor	O
mutado	B-Sequence
en	O
CES	O
.	O

Empleando	O
micromatrices	O
y	O
análisis	O
de	O
hibridación	O
in	O
situ	O
,	O
hemos	O
encontrado	O
que	O
la	O
retina	O
rd7	O
contiene	O
un	O
número	O
ligeramente	O
mayor	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
que	O
ultraestructuralmente	O
parecen	O
ser	O
normales	O
conos	B-Cell
.	O

Sorprendentemente	O
,	O
la	O
mayoría	O
de	O
los	O
fotorreceptores	B-Cell
en	I-Cell
la	I-Cell
retina	I-Cell
rd7	I-Cell
representan	O
un	O
híbrido	O
morfológicamente	O
célula	B-Cell
tipo	O
que	O
expresa	O
ambos	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
.	O

Además	O
,	O
la	O
selección	O
de	O
hibridación	O
in	O
situ	O
de	O
genes	B-Sequence
se	O
muestra	O
que	O
está	O
regulado	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
por	O
microarray	O
identificó	O
diez	O
nuevos	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
con	O
una	O
amplia	O
gama	O
de	O
funciones	O
bioquímicas	O
,	O
incluidas	O
dos	O
genes	B-Sequence
involucrado	O
específicamente	O
en	O
glucosa	B-Chemical
/	O
glucógeno	B-Chemical
metabolismo	O
.	O

Sugerimos	O
que	O
los	O
electrorretinogramas	O
anormales	O
,	O
la	O
degeneración	O
retiniana	O
lenta	O
y	O
la	O
dismorfología	O
retiniana	O
que	O
se	O
observan	O
en	O
humanos	B-Taxon
con	O
ESCS	O
puede	O
,	O
en	O
parte	O
,	O
atribuirse	O
a	O
la	O
función	O
aberrante	O
de	O
un	O
híbrido	O
célula	B-Cell
fotorreceptora	I-Cell
tipo	O
similar	O
al	O
identificado	O
en	O
este	O
estudio	O
.	O

La	O
diversidad	O
funcional	O
de	O
la	O
novela	O
.	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
identificado	O
aquí	O
indica	O
molecular	B-Chemical
diferencias	O
entre	O
varillas	B-Cell
y	O
conos	B-Cell
extendiéndose	O
mucho	O
más	O
allá	O
de	O
los	O
descubiertos	O
previamente	O
.	O

Sinopsis	O

La	O
visión	O
comienza	O
con	O
la	O
luz	O
que	O
entra	O
en	O
el	O
ojo	O
.	O

Esta	O
luz	O
se	O
proyecta	O
sobre	O
la	O
retina	O
,	O
una	O
estructura	O
nerviosa	O
delgada	O
que	O
recubre	O
el	O
interior	O
del	O
ojo	O
.	O

Fotorreceptores	B-Cell
,	O
entre	O
los	O
más	O
importantes	O
célula	B-Cell
tipos	O
en	O
la	O
retina	O
,	O
son	O
los	O
primeros	O
en	O
recibir	O
los	O
rayos	O
de	O
luz	O
entrantes	O
.	O

En	O
mamíferos	B-Taxon
,	O
hay	O
dos	O
tipos	O
de	O
fotorreceptores	B-Cell
:	O
varillas	B-Cell
y	O
conos	B-Cell
.	O

Varillas	B-Cell
están	O
especializados	O
para	O
la	O
visión	O
nocturna	O
,	O
y	O
conos	B-Cell
para	O
la	O
visión	O
diurna	O
y	O
en	O
color	O
.	O

En	O
este	O
estudio	O
,	O
los	O
autores	O
examinaron	O
la	O
fotorreceptores	B-Cell
de	O
un	O
ratón	B-Taxon
con	O
un	O
mutación	B-Sequence
genética	I-Sequence
que	O
causa	O
fotorreceptores	B-Cell
desarrollarse	O
anormalmente	O
.	O

humanos	B-Taxon
con	O
un	O
parecido	O
mutación	B-Sequence
tienen	O
una	O
forma	O
de	O
ceguera	O
llamada	O
S	O
mejorada	O
-	O
cono	B-Cell
síndrome	O
(	O
CESS	O
)	O
.	O

Sorprendentemente	O
,	O
la	O
mayoría	O
de	O
fotorreceptores	B-Cell
en	O
esto	O
mutante	B-Sequence
ratón	B-Taxon
se	O
encontró	O
que	O
tenían	O
características	O
tanto	O
normales	O
varillas	B-Cell
y	O
conos	B-Cell
.	O

Es	O
posible	O
que	O
las	O
características	O
anormales	O
de	O
estos	O
fotorreceptores	B-Cell
predisponerlos	O
a	O
sufrir	O
una	O
muerte	O
prematura	O
.	O

Si	O
este	O
modelo	O
refleja	O
fielmente	O
la	O
situación	O
en	O
humano	B-Taxon
pacientes	O
con	O
ESCS	O
,	O
puede	O
proporcionar	O
una	O
explicación	O
para	O
la	O
pérdida	O
de	O
visión	O
que	O
se	O
observa	O
en	O
esta	O
enfermedad	O
.	O

Este	O
estudio	O
también	O
esclareció	O
previamente	O
desconocido	O
molecular	B-Chemical
diferencias	O
entre	O
normales	O
varillas	B-Cell
y	O
conos	B-Cell
.	O

Este	O
nuevo	O
conocimiento	O
puede	O
contribuir	O
a	O
una	O
mejor	O
comprensión	O
general	O
de	O
los	O
mecanismos	O
subyacentes	O
a	O
la	O
visión	O
nocturna	O
,	O
diurna	O
y	O
cromática	O
.	O

Introducción	O

S	O
mejorada	O
-	O
cono	B-Cell
(	O
ESCS	O
)	O
es	O
una	O
enfermedad	O
inusual	O
de	O
fotorreceptores	B-Cell
que	O
incluye	O
ceguera	O
nocturna	O
(	O
que	O
sugiere	O
vara	B-Cell
disfunción	O
)	O
,	O
un	O
electrorretinograma	O
(	O
ERG	O
)	O
anormal	O
con	O
una	O
forma	O
de	O
onda	O
que	O
es	O
casi	O
idéntica	O
bajo	O
la	O
adaptación	O
tanto	O
a	O
la	O
luz	O
como	O
a	O
la	O
oscuridad	O
,	O
y	O
una	O
mayor	O
sensibilidad	O
del	O
ERG	O
a	O
la	O
luz	O
de	O
longitud	O
de	O
onda	O
corta	O
[	O
1	O
,	O
2	O
]	O
.	O

La	O
enfermedad	O
es	O
causada	O
por	O
mutaciones	B-Sequence
en	O
el	O
huérfano	O
nuclear	B-GENE
factor	O
de	O
transcripción	O
del	O
receptor	O
NR2E3	B-Protein
(	O
también	O
conocido	O
como	O
receptor	B-Protein
nuclear	I-Protein
fotorreceptor	I-Protein
)	O
,	O
que	O
se	O
expresa	O
exclusivamente	O
en	O
varillas	B-Cell
[	O
3	O
,	O
4	O
]	O
.	O

Reciente	O
humano	B-Taxon
genético	B-Sequence
estudios	O
también	O
han	O
demostrado	O
mutaciones	B-Sequence
en	O
esto	O
gene	B-Sequence
en	O
el	O
síndrome	O
de	O
Goldmann-Favre	O
y	O
muchos	O
casos	O
de	O
degeneración	O
retiniana	O
pigmentaria	O
agrupada	O
[	O
5	O
]	O
.	O

Los	O
informes	O
iniciales	O
de	O
pacientes	O
con	O
ESCS	O
atribuyeron	O
el	O
ERG	O
inusual	O
a	O
un	O
funcionamiento	O
anormal	O
fotorreceptor	B-Cell
de	I-Cell
varilla	I-Cell
sistema	O
con	O
actividad	O
persistente	O
bajo	O
adaptación	O
a	O
la	O
luz	O
[	O
6	O
-	O
8	O
]	O
.	O

``	O
Sin	O
embargo	O
,	O
estudios	O
posteriores	O
concluyeron	O
que	O
el	O
ERG	O
se	O
debía	O
a	O
supernumerarios	O
de	O
longitud	O
de	O
onda	O
corta	O
(	O
``	O
''	O
azul	O
''	O
''	O
)	O
.	O
''	O
fotorreceptores	B-Cell
de	I-Cell
cono	I-Cell
(	O
S	O
-	O
conos	B-Cell
)	O
en	O
estos	O
pacientes	O
[	O
1	O
,	O
2	O
,	O
9	O
-	O
11	O
]	O
.	O

Análisis	O
histopatológico	O
de	O
una	O
retina	O
de	O
un	O
humano	B-Taxon
paciente	O
con	O
ESCS	O
y	O
degeneración	O
retiniana	O
extensa	O
demostró	O
una	O
ausencia	O
de	O
rodopsina	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
y	O
un	O
aumento	O
en	O
el	O
número	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
.	O

No	O
obstante	O
,	O
la	O
densidad	O
global	O
de	O
conos	B-Cell
solo	O
aumentó	O
modestamente	O
en	O
este	O
paciente	O
(	O
aproximadamente	O
2	O
veces	O
)	O
,	O
lo	O
que	O
sugiere	O
que	O
podría	O
haber	O
factores	O
adicionales	O
que	O
contribuyan	O
al	O
ERG	O
muy	O
grande	O
y	O
adaptado	O
a	O
la	O
luz	O
que	O
se	O
observa	O
en	O
esta	O
enfermedad	O
.	O

Además	O
de	O
los	O
hallazgos	O
del	O
ERG	O
,	O
los	O
pacientes	O
con	O
ESCS	O
tienen	O
retinas	O
dismórficas	O
con	O
formación	O
de	O
rosetas	O
en	O
la	O
capa	O
nuclear	O
externa	O
(	O
ONL	O
)	O
donde	O
célula	B-Cell
fotorreceptora	I-Cell
residen	O
los	O
cuerpos	O
,	O
y	O
una	O
lenta	O
degeneración	O
de	O
la	O
retina	O
que	O
finalmente	O
puede	O
conducir	O
a	O
la	O
ceguera	O
total	O
[	O
12-14	O
]	O
.	O

Mutaciones	B-Sequence
en	O
el	O
ratón	B-Taxon
ortólogo	B-Sequence
de	O
NR2E3	B-Protein
han	O
sido	O
identificados	O
en	O
el	O
espontáneo	O
mutante	B-Sequence
degeneración	O
retiniana	O
7	O
(	O
rd7	O
)	O
[	O
15	O
]	O
.	O

Esta	O
mutante	B-Sequence
demuestra	O
una	O
degeneración	O
retiniana	O
lenta	O
y	O
una	O
laminación	O
anormal	O
de	O
la	O
ONL	O
con	O
formación	O
de	O
rosetas	O
[	O
15	O
,	O
16	O
]	O
.	O

Curiosamente	O
,	O
el	O
ERG	O
del	O
ratón	B-Taxon
Se	O
ha	O
informado	O
que	O
la	O
adaptación	O
tanto	O
a	O
la	O
luz	O
como	O
a	O
la	O
oscuridad	O
es	O
normal	O
,	O
mostrando	O
una	O
atenuación	O
progresiva	O
con	O
el	O
tiempo	O
,	O
presumiblemente	O
debido	O
a	O
procesos	O
degenerativos	O
célula	B-Cell
pérdida	O
[	O
15	O
]	O
.	O

Un	O
estudio	O
anterior	O
mostró	O
un	O
aumento	O
de	O
2	O
a	O
3	O
veces	O
en	O
el	O
número	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
la	O
retina	O
rd7	O
en	O
comparación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
[	O
17	O
]	O
.	O

Además	O
,	O
dos	O
grupos	O
informaron	O
recientemente	O
desrepresión	O
de	O
más	O
cono	B-Cell
genes	B-Sequence
en	O
el	O
rd7	O
mutante	B-Sequence
[	O
18	O
,	O
19	O
]	O
.	O

Con	O
el	O
fin	O
de	O
comprender	O
mejor	O
la	O
base	O
mecanicista	O
de	O
ESCS	O
,	O
llevamos	O
a	O
cabo	O
un	O
molecular	B-Chemical
y	O
análisis	O
ultraestructural	O
de	O
la	O
fotorreceptores	B-Cell
de	O
la	O
rd7	O
mutante	B-Sequence
ratón	B-Taxon
.	O

Los	O
análisis	O
de	O
micromatrices	O
e	O
hibridación	O
in	O
situ	O
revelaron	O
un	O
modesto	O
aumento	O
en	O
el	O
número	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
y	O
la	O
desrepresión	O
generalizada	O
de	O
muchos	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
dentro	O
de	O
células	B-Cell
fotorreceptoras	I-Cell
de	I-Cell
varilla	I-Cell
.	O

Los	O
estudios	O
ultraestructurales	O
demostraron	O
que	O
la	O
células	B-Cell
que	O
coexpresan	O
vara	B-Cell
y	O
cono	B-Cell
genes	B-Sequence
en	O
la	O
retina	O
rd7	O
representan	O
un	O
híbrido	O
morfológicamente	O
célula	B-Cell
tipo	O
,	O
intermedio	O
entre	O
lo	O
normal	O
varillas	B-Cell
y	O
conos	B-Cell
.	O

Resultados	O

Generalizado	O
Arriba	O
-	O
Regulación	O
de	O
Cono	B-Cell
genes	B-Sequence
en	O
el	O
rd7	O
mutante	B-Sequence
Retina	O

En	O
un	O
análisis	O
inicial	O
del	O
rd7	O
mutante	B-Sequence
,	O
homocigoto	O
mutante	B-Sequence
Las	O
retinas	O
se	O
compararon	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
controles	O
en	O
múltiples	O
puntos	O
de	O
tiempo	O
postnatal	O
usando	O
ambos	O
ADNc	B-Sequence
y	O
micromatrices	O
Affymetrix	O
.	O

los	O
ADNc	B-Sequence
microarreglo	O
utilizado	O
en	O
este	O
estudio	O
contiene	O
aproximadamente	O
12	O
000	O
diferentes	O
ADNc	B-Sequence
derivado	O
en	O
gran	O
medida	O
de	O
la	O
retina	O
y	O
el	O
sistema	O
nervioso	O
,	O
y	O
el	O
microarreglo	O
Affymetrix	O
contiene	O
más	O
de	O
34.000	O
genes	B-Sequence
.	O

Los	O
experimentos	O
en	O
todos	O
los	O
puntos	O
de	O
tiempo	O
se	O
llevaron	O
a	O
cabo	O
por	O
triplicado	O
y	O
se	O
aplicaron	O
criterios	O
estrictos	O
para	O
decidir	O
si	O
un	O
determinado	O
gene	B-Sequence
estaba	O
regulado	O
hacia	O
arriba	O
o	O
hacia	O
abajo	O
en	O
el	O
mutante	B-Sequence
(	O
ver	O
Materiales	O
y	O
Métodos	O
para	O
más	O
detalles	O
)	O
.	O

Estos	O
experimentos	O
demostraron	O
una	O
regulación	O
ascendente	O
generalizada	O
de	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
la	O
retina	O
rd7	O
,	O
especialmente	O
en	O
el	O
día	O
postnatal	O
14	O
(	O
P14	O
)	O
y	O
P21	O
(	O
Figura	O
1	O
)	O
.	O

Más	O
conocido	B-Sequence
cono	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
se	O
encontró	O
que	O
estaban	O
regulados	O
al	O
alza	O
en	O
el	O
mutante	B-Sequence
(	O
Figura	O
1	O
,	O
genes	B-Sequence
G1-G15	O
)	O
.	O

La	O
mayoría	O
de	O
estos	O
genes	B-Sequence
representan	O
componentes	O
de	O
la	O
cascada	O
de	O
fototransducción	O
(	O
p	O
.	O
ej	O
.	O
,	O
opsinas	B-Protein
,	O
transducinas	O
y	O
fosfodiesterasa	B-GENE
subunidades	O
)	O
.	O

Además	O
de	O
estos	O
genes	B-Sequence
,	O
varias	O
novelas	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
de	O
funciones	O
desconocidas	O
recientemente	O
identificadas	O
en	O
nuestro	O
laboratorio	O
también	O
fueron	O
reguladas	O
al	O
alza	O
(	O
Figura	O
1	O
,	O
genes	B-Sequence
G16	O
,	O
G17	O
,	O
G21	O
y	O
G24	O
;	O
datos	O
no	O
publicados	O
)	O
.	O

Por	O
último	O
,	O
una	O
amplia	O
gama	O
de	O
otros	O
genes	B-Sequence
,	O
la	O
mayoría	O
sin	O
un	O
papel	O
previamente	O
reconocido	O
en	O
la	O
retina	O
,	O
se	O
encontró	O
que	O
estaban	O
regulados	O
al	O
alza	O
en	O
el	O
rd7	O
mutante	B-Sequence
(	O
Figura	O
1	O
,	O
G26-G53	O
;	O
Tablas	O
S1	O
y	O
S2	O
;	O
Figuras	O
S1-S7	O
)	O
.	O

nr2e3	B-Protein
la	O
expresión	O
es	O
detectable	O
primero	O
por	O
hibridación	O
in	O
situ	O
alrededor	O
del	O
día	O
embrionario	O
18	O
(	O
E18	O
)	O
;	O
luego	O
alcanza	O
su	O
punto	O
máximo	O
alrededor	O
de	O
P6	O
y	O
posteriormente	O
disminuye	O
a	O
niveles	O
adultos	O
en	O
P21	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

De	O
acuerdo	O
con	O
este	O
curso	O
de	O
tiempo	O
de	O
expresión	O
,	O
casi	O
ninguna	O
gene	B-Sequence
se	O
encontraron	O
cambios	O
de	O
expresión	O
en	O
P0	O
,	O
con	O
más	O
cambios	O
progresivamente	O
en	O
puntos	O
de	O
tiempo	O
posteriores	O
(	O
Figura	O
1	O
)	O
.	O

Una	O
excepción	O
a	O
esta	O
afirmación	O
es	O
la	O
gene	B-Sequence
ADNc	B-Protein
de	I-Protein
RIKEN	I-Protein
4933409K07	I-Protein
(	O
Figura	O
1	O
,	O
gene	B-Sequence
G47	O
)	O
,	O
que	O
fue	O
el	O
único	O
gene	B-Sequence
mostró	O
estar	O
regulado	O
al	O
alza	O
en	O
todos	O
los	O
puntos	O
de	O
tiempo	O
examinados	O
.	O

Discusión	O
adicional	O
de	O
este	O
gene	B-Sequence
y	O
su	O
patrón	O
de	O
expresión	O
inusual	O
se	O
presentará	O
a	O
continuación	O
.	O

Dos	O
patrones	O
distintos	O
de	O
Cono	B-Cell
Gene	B-Sequence
Desrepresión	O
en	O
rd7	O

Para	O
confirmar	O
estos	O
resultados	O
de	O
micromatrices	O
,	O
se	O
realizó	O
un	O
análisis	O
de	O
hibridación	O
in	O
situ	O
de	O
la	O
supuesta	O
regulación	O
ascendente	O
cono	B-Cell
genes	B-Sequence
se	O
llevó	O
a	O
cabo	O
en	O
el	O
que	O
el	O
rd7	O
mutante	B-Sequence
retina	O
se	O
comparó	O
con	O
la	O
misma	O
edad	O
,	O
tipo	B-Sequence
salvaje	I-Sequence
control	O
S	O
.	O

Encontramos	O
que	O
la	O
mayoría	O
de	O
los	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
que	O
estaban	O
regulados	O
al	O
alza	O
en	O
los	O
experimentos	O
de	O
micromatrices	O
se	O
desreprimieron	O
cuando	O
se	O
evaluaron	O
mediante	O
hibridación	O
in	O
situ	O
(	O
Figura	O
2	O
)	O
.	O

Había	O
dos	O
patrones	O
principales	O
de	O
cono	B-Cell
gene	B-Sequence
desrepresión	O

El	O
patrón	O
más	O
común	O
(	O
tipo	O
I	O
)	O
se	O
manifestó	O
como	O
ectópico	O
gene	B-Sequence
expresión	O
a	O
lo	O
largo	O
de	O
la	O
ONL	O
,	O
en	O
consonancia	O
con	O
gene	B-Sequence
expresión	O
en	O
todo	O
fotorreceptores	B-Cell
(	O
Figura	O
2	O
;	O
fotomicrografías	O
arriba	O
a	O
la	O
izquierda	O
)	O
.	O

Los	O
ejemplos	O
típicos	O
de	O
este	O
patrón	O
de	O
desrepresión	O
se	O
muestran	O
en	O
la	O
Figura	O
2	O
,	O
y	O
muchos	O
más	O
están	O
disponibles	O
en	O
la	O
Tabla	O
S1	O
.	O

Este	O
patrón	O
de	O
expresión	O
contrasta	O
marcadamente	O
con	O
el	O
patrón	O
habitual	O
de	O
cono	B-Cell
gene	B-Sequence
expresión	O
,	O
que	O
consiste	O
en	O
dispersos	O
células	B-Cell
localizado	O
en	O
el	O
borde	O
escleral	O
de	O
la	O
ONL	O
(	O
Figura	O
2	O
)	O
.	O

La	O
segunda	O
categoría	O
de	O
cono	B-Cell
gene	B-Sequence
La	O
desrepresión	O
(	O
tipo	O
II	O
)	O
consistía	O
en	O
un	O
patrón	O
irregular	O
de	O
expresión	O
ectópica	O
en	O
el	O
que	O
los	O
individuos	O
positivos	O
células	B-Cell
estaban	O
dispersos	O
a	O
lo	O
largo	O
de	O
la	O
ONL	O
(	O
Figura	O
2	O
,	O
microfotografías	O
arriba	O
a	O
la	O
derecha	O
;	O
Tabla	O
S1	O
)	O
.	O

Aunque	O
numerosos	O
positivos	O
células	B-Cell
estaban	O
presentes	O
en	O
la	O
retina	O
rd7	O
(	O
particularmente	O
en	O
la	O
porción	O
ventral	O
)	O
,	O
había	O
claramente	O
muchos	O
intercalados	O
células	B-Cell
que	O
mostraba	O
una	O
completa	O
ausencia	O
de	O
expresión	O
.	O

Para	O
descartar	O
la	O
posibilidad	O
de	O
que	O
estos	O
positivos	O
dispersos	O
células	B-Cell
eran	O
simplemente	O
el	O
complemento	O
normal	O
de	O
conos	B-Cell
que	O
no	O
había	O
podido	O
localizar	O
su	O
cuerpos	B-GENE
celulares	I-GENE
hasta	O
el	O
borde	O
escleral	O
de	O
la	O
ONL	O
,	O
el	O
número	O
de	O
positivos	O
células	B-Cell
en	O
la	O
retina	O
rd7	O
fue	O
cuantificada	O
por	O
disociado	O
célula	B-Cell
hibridación	O
in	O
situ	O
.	O

disociado	O
célula	B-Cell
La	O
hibridación	O
in	O
situ	O
se	O
realizó	O
con	O
un	O
Investigacion	B-Sequence
Para	O
el	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
gene	B-Sequence
(	O
Opn1sw	B-Protein
)	O
,	O
que	O
muestra	O
desrepresión	O
tipo	O
II	O
(	O
Figuras	O
2	O
y	O
3A	O
-	O
3C	O
)	O
.	O

S	B-Protein
-	I-Protein
opsina	I-Protein
se	O
expresó	O
en	O
3	O
.	O
2	O
%	O
de	O
retina	O
células	B-Cell
en	O
el	O
rd7	O
mutante	B-Sequence
(	O
66	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
de	O
2	O
,	O
056	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
fenilindol	B-Chemical
[	O
DAPI	O
]	O
-	O
positivo	O
células	B-Cell
)	O
.	O

Este	O
valor	O
es	O
aproximadamente	O
2	O
veces	O
mayor	O
que	O
el	O
porcentaje	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
identificado	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
controlar	O
las	O
retinas	O
,	O
1	O
.	O
65	O
%	O
(	O
54	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
de	O
3	O
,	O
271	O
DAPI	O
-	O
positivo	O
células	B-Cell
)	O
,	O
y	O
concuerda	O
bien	O
con	O
el	O
valor	O
informado	O
previamente	O
de	O
2	O
a	O
3	O
veces	O
más	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
rd7	O
en	O
comparación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
llegado	O
por	O
anticuerpo	B-GENE
tinción	O
de	O
secciones	O
de	O
tejido	O
[	O
17	O
]	O
.	O

Estudios	O
previos	O
han	O
estimado	O
que	O
el	O
número	O
total	O
de	O
conos	B-Cell
en	O
el	O
ratón	B-Taxon
la	O
retina	O
es	O
el	O
2	O
%	O
de	O
todo	O
el	O
retinal	O
células	B-Cell
[	O
20	O
]	O
,	O
y	O
que	O
S	B-Protein
-	I-Protein
opsina	I-Protein
está	O
en	O
gran	O
parte	O
reprimida	O
en	O
conos	B-Cell
en	O
el	O
tercio	O
dorsal	O
de	O
la	O
retina	O
[	O
21	O
]	O
.	O

La	O
estimación	O
de	O
1	O
.	O
sesenta	O
y	O
cinco	O
%	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O
está	O
de	O
acuerdo	O
con	O
estos	O
datos	O
.	O

El	O
hecho	O
de	O
que	O
sólo	O
3	O
.	O
2	O
%	O
de	O
todos	O
los	O
retinales	O
células	B-Cell
están	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
mutante	B-Sequence
también	O
confirma	O
que	O
la	O
mayoría	O
de	O
los	O
fotorreceptores	B-Cell
(	O
que	O
constituyen	O
algo	O
más	O
del	O
70	O
%	O
de	O
la	O
células	B-Cell
en	O
el	O
adulto	O
ratón	B-Taxon
retina	O
)	O
no	O
expresan	O
esto	O
gene	B-Sequence
.	O

Para	O
evaluar	O
si	O
estos	O
supernumerarios	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
coexpresado	O
vara	B-Cell
-	O
marcadores	O
específicos	O
,	O
un	O
doble	O
anticuerpo	B-GENE
tinción	O
para	O
S	B-Protein
-	I-Protein
opsina	I-Protein
y	O
rodopsina	B-Protein
fue	O
realizado	O
.	O

Este	O
estudio	O
mostró	O
dominios	O
mutuamente	O
excluyentes	O
de	O
expresión	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
y	O
rodopsina	B-Protein
en	O
el	O
segmentos	B-GENE
externos	I-GENE
de	I-GENE
los	I-GENE
fotorreceptores	I-GENE
(	O
Figura	O
3D-3F	O
)	O
.	O

Este	O
hallazgo	O
sugiere	O
que	O
el	O
supernumerario	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
``	O
en	O
la	O
retina	O
rd7	O
puede	O
representar	O
un	O
``	O
''	O
azul	O
''	O
''	O
normal	O
''	O
conos	B-Cell
.	O

Novela	O
Cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
Están	O
desreprimidos	O
en	O
rd7	O

Dado	O
que	O
la	O
mayoría	O
de	O
conocido	B-Sequence
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
mostró	O
marcada	O
desrepresión	O
en	O
el	O
rd7	O
mutante	B-Sequence
,	O
candidato	O
adicional	O
genes	B-Sequence
up	O
-	O
regulado	O
en	O
el	O
análisis	O
de	O
microarrays	O
fueron	O
evaluados	O
para	O
cono	B-Cell
-	O
expresión	O
específica	O
.	O

La	O
hibridación	O
in	O
situ	O
se	O
realizó	O
en	O
45	O
adicionales	O
regulados	O
hacia	O
arriba	O
.	O
genes	B-Sequence
,	O
confirmando	O
que	O
21	O
de	O
ellos	O
estaban	O
desreprimidos	O
.	O

De	O
estos	O
,	O
al	O
menos	O
diez	O
mostraron	O
una	O
clara	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O
(	O
Figura	O
1	O
,	O
genes	B-Sequence
G26-G35	O
)	O
.	O

En	O
la	O
Figura	O
4	O
se	O
dan	O
varios	O
ejemplos	O
.	O

Tenga	O
en	O
cuenta	O
que	O
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O
,	O
hay	O
un	O
patrón	O
relativamente	O
débil	O
de	O
positivo	O
disperso	O
células	B-Cell
en	O
el	O
borde	O
escleral	O
de	O
la	O
ONL	O
,	O
en	O
consonancia	O
con	O
una	O
cono	B-Cell
-	O
patrón	O
específico	O
de	O
expresión	O
.	O

Todos	O
estos	O
genes	B-Sequence
muestran	O
marcada	O
desrepresión	O
en	O
la	O
retina	O
rd7	O
.	O

Algunas	O
de	O
estas	O
novelas	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
mostró	O
una	O
sorprendente	O
localización	O
de	O
sus	O
transcripciones	B-Sequence
al	O
segmento	B-GENE
interno	I-GENE
del	I-GENE
fotorreceptor	I-GENE
(	O
p.ej	O
.	O
,	O
bub1b	B-Protein
y	O
Tcta	B-Protein
)	O
.	O

Esta	O
localización	O
se	O
manifiesta	O
en	O
una	O
sección	O
de	O
hibridación	O
in	O
situ	O
como	O
una	O
banda	O
oscura	O
de	O
tinción	O
justo	O
más	O
allá	O
del	O
borde	O
exterior	O
de	O
la	O
ONL	O
inmediatamente	O
subyacente	O
a	O
la	O
segmento	B-GENE
exterior	I-GENE
capa	O
.	O

Aunque	O
tal	O
patrón	O
de	O
transcripción	B-Sequence
la	O
localización	O
se	O
ve	O
comúnmente	O
en	O
muchos	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
(	O
p.ej	O
.	O
,	O
Rho	B-Protein
en	O
la	O
figura	O
2	O
;	O
pcdh21	B-Protein
,	O
Rbp3	B-Protein
,	O
y	O
cnga1	B-Protein
en	O
la	O
Tabla	O
S2	O
)	O
,	O
no	O
se	O
aprecia	O
fácilmente	O
en	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
,	O
posiblemente	O
debido	O
a	O
la	O
relativa	O
escasez	O
de	O
conos	B-Cell
en	O
el	O
ratón	B-Taxon
.	O

en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
en	O
la	O
que	O
tal	O
genes	B-Sequence
están	O
ampliamente	O
deprimidos	O
,	O
tal	O
patrón	O
de	O
transcripción	B-Sequence
la	O
localización	O
a	O
menudo	O
se	O
hace	O
evidente	O
.	O

Además	O
de	O
los	O
diez	O
genes	B-Sequence
que	O
mostró	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O
,	O
otra	O
novela	O
de	O
11	O
genes	B-Sequence
fueron	O
desreprimidos	O
en	O
la	O
retina	O
rd7	O
por	O
hibridación	O
in	O
situ	O
(	O
Figura	O
1	O
,	O
genes	B-Sequence
G36-G46	O
)	O
.	O

Algunos	O
de	O
estos	O
genes	B-Sequence
mostró	O
una	O
expresión	O
débil	O
en	O
un	O
cono	B-Cell
-	O
distribución	O
similar	O
(	O
ver	O
Tabla	O
S1	O
,	O
genes	B-Sequence
G36	O
,	O
G40	O
y	O
G44	O
)	O
,	O
y	O
uno	O
parecía	O
expresarse	O
en	O
todo	O
el	O
ONL	O
pero	O
en	O
mayores	O
niveles	O
en	O
conos	B-Cell
que	O
en	O
varillas	B-Cell
(	O
Tabla	O
S1	O
,	O
gene	B-Sequence
G37	O
)	O
.	O

El	O
resto	O
del	O
up-regulated	O
genes	B-Sequence
no	O
tenia	O
detectable	O
cono	B-Cell
tinción	O
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O

A	O
pesar	O
de	O
esta	O
aparente	O
ausencia	O
de	O
cono	B-Cell
tinción	O
,	O
el	O
patrón	O
de	O
desrepresión	O
en	O
rd7	O
sugiere	O
que	O
estos	O
genes	B-Sequence
tambien	O
puede	O
ser	O
novela	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
,	O
aunque	O
expresado	O
a	O
niveles	O
por	O
debajo	O
del	O
umbral	O
de	O
sensibilidad	O
de	O
nuestro	O
ensayo	O
de	O
hibridación	O
in	O
situ	O
.	O

En	O
la	O
mayoría	O
de	O
los	O
casos	O
,	O
la	O
novela	O
cono	B-Cell
genes	B-Sequence
identificados	O
en	O
este	O
estudio	O
parecen	O
tener	O
un	O
patrón	O
tipo	O
I	O
de	O
desrepresión	O
.	O

Sin	O
embargo	O
,	O
debido	O
a	O
la	O
debilidad	O
de	O
la	O
señal	O
en	O
algunos	O
casos	O
,	O
o	O
transcripción	B-Sequence
localización	O
a	O
la	O
segmento	B-GENE
interior	I-GENE
en	O
otros	O
,	O
no	O
siempre	O
fue	O
posible	O
determinar	O
con	O
confianza	O
cuál	O
de	O
los	O
dos	O
patrones	O
de	O
desrepresión	O
(	O
si	O
alguno	O
)	O
cada	O
uno	O
de	O
estos	O
genes	B-Sequence
exhibido	O

En	O
términos	O
de	O
categorización	O
funcional	O
,	O
la	O
novela	O
cono	B-Cell
genes	B-Sequence
cubrir	O
una	O
amplia	O
gama	O
que	O
incluye	O
glucosa	B-Chemical
metabolismo	O
(	O
pigmeo	B-Protein
y	O
Glo1	B-Protein
)	O
,	O
ácido	B-Chemical
graso	I-Chemical
metabolismo	O
(	O
elovl2	B-Protein
)	O
,	O
ADN	B-Sequence
reparar	O
(	O
presumido1	B-Protein
)	O
,	O
célula	B-Cell
ciclo	O
/	O
cromosoma	B-GENE
segregación	O
(	O
bub1b	B-Protein
)	O
,	O
carcinogénesis	O
(	O
Tcta	B-Protein
)	O
,	O
biología	O
endotelial	O
(	O
Ece1	B-Protein
)	O
,	O
citoesquelético	B-GENE
(	O
Ebp4	O
.	O
1l1	O
)	O
,	O
e	O
incluso	O
formación	O
de	O
otolitos	O
(	O
Otop3	B-Protein
)	O
.	O

Un	O
hallazgo	O
relativamente	O
frecuente	O
entre	O
los	O
dos	O
previamente	O
identificados	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
,	O
así	O
como	O
en	O
algunos	O
de	O
los	O
identificados	O
en	O
el	O
presente	O
estudio	O
,	O
es	O
la	O
ocurrencia	O
de	O
gene	B-Sequence
expresión	O
en	O
un	O
principio	O
fotorreceptor	B-Cell
patrón	O
precursor	O
(	O
Figura	O
5	O
)	O
.	O

Este	O
patrón	O
de	O
expresión	O
consiste	O
en	O
tinción	O
positiva	O
por	O
hibridación	O
in	O
situ	O
específicamente	O
en	O
el	O
borde	O
escleral	O
de	O
la	O
retina	O
durante	O
puntos	O
de	O
tiempo	O
prenatales	O
(	O
en	O
el	O
rango	O
de	O
E13-E18	O
)	O
.	O

Gnb3	B-Protein
y	O
Thrb2	B-Protein
son	O
dos	O
ejemplos	O
de	O
conocido	B-Sequence
cono	B-Cell
genes	B-Sequence
con	O
este	O
patrón	O
temprano	O
de	O
expresión	O
(	O
Figura	O
5	O
)	O
.	O

Dos	O
de	O
la	O
novela	O
11	O
cono	B-Cell
genes	B-Sequence
identificados	O
en	O
este	O
estudio	O
también	O
tienen	O
esta	O
temprana	O
fotorreceptor	B-Cell
patrón	O
de	O
expresión	O
(	O
Ece1	B-Protein
y	O
Otop3	B-Protein
)	O
.	O

Curiosamente	O
,	O
tres	O
genes	B-Sequence
mostró	O
estar	O
regulado	O
al	O
alza	O
en	O
rd7	O
en	O
microarray	O
,	O
pero	O
que	O
no	O
tenía	O
una	O
señal	O
detectable	O
por	O
hibridación	O
in	O
situ	O
en	O
etapas	O
adultas	O
o	O
ningún	O
cambio	O
aparente	O
en	O
la	O
expresión	O
por	O
hibridación	O
in	O
situ	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
rd7	O
,	O
también	O
mostró	O
esto	O
temprano	O
fotorreceptor	B-Cell
patrón	O
(	O
Figura	O
1	O
,	O
genes	B-Sequence
G48-G50	O
)	O
.	O

El	O
patrón	O
de	O
expresión	O
embrionario	O
de	O
dos	O
de	O
estos	O
genes	B-Sequence
se	O
muestra	O
en	O
la	O
Figura	O
5	O
(	O
la	O
hibridación	O
embrionaria	O
in	O
situ	O
para	O
el	O
tercero	O
,	O
G50	O
,	O
se	O
puede	O
encontrar	O
en	O
la	O
Tabla	O
S1	O
)	O
.	O

Aunque	O
la	O
importancia	O
de	O
tan	O
temprano	O
fotorreceptor	B-Cell
expresión	O
no	O
se	O
conoce	O
,	O
es	O
posible	O
que	O
estos	O
genes	B-Sequence
tambien	O
puede	O
ser	O
cono	B-Cell
-	O
específicos	O
pero	O
se	O
expresan	O
en	O
niveles	O
indetectablemente	O
bajos	O
en	O
el	O
adulto	O
.	O

M	B-Protein
-	I-Protein
Opsina	I-Protein
y	O
Receptor	B-Protein
de	I-Protein
hormona	I-Protein
tiroidea	I-Protein
beta	I-Protein
2	I-Protein
No	O
han	O
cambiado	O
en	O
el	O
rd7	O
mutante	B-Sequence

Sólo	O
dos	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
no	O
pudo	O
mostrar	O
ningún	O
cambio	O
en	O
la	O
expresión	O
por	O
microarray	O
o	O
hibridación	O
in	O
situ	O
en	O
el	O
rd7	O
mutante	B-Sequence
:	O
M	B-Protein
-	I-Protein
opsina	I-Protein
(	O
Op.1mw	B-Protein
)	O
y	O
receptor	B-Protein
beta	I-Protein
2	I-Protein
de	I-Protein
la	I-Protein
hormona	I-Protein
tiroidea	I-Protein
(	O
Thrb2	B-Protein
)	O
(	O
Figura	O
S8	O
)	O
.	O

Este	O
resultado	O
es	O
particularmente	O
notable	O
porque	O
Thrb2	B-Protein
es	O
absolutamente	O
necesaria	O
para	O
la	O
expresión	O
de	O
M	B-Protein
-	I-Protein
opsina	I-Protein
[	O
22	O
]	O
.	O

Además	O
,	O
la	O
represión	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
expresión	O
en	O
el	O
tercio	O
dorsal	O
del	O
ratón	B-Taxon
Se	O
cree	O
que	O
la	O
retina	O
depende	O
,	O
al	O
menos	O
en	O
parte	O
,	O
de	O
Thrb2	B-Protein
ya	O
que	O
S	B-Protein
-	I-Protein
opsina	I-Protein
muestra	O
desrepresión	O
dorsal	O
en	O
el	O
Thrb2	B-Protein
mutante	B-Sequence
[	O
22	O
]	O
.	O

A	O
pesar	O
de	O
la	O
desrepresión	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
visto	O
en	O
la	O
porción	O
ventral	O
de	O
la	O
retina	O
rd7	O
,	O
la	O
represión	O
dorsal	O
normal	O
de	O
este	O
gene	B-Sequence
sigue	O
presente	O
en	O
este	O
mutante	B-Sequence
(	O
datos	O
no	O
publicados	O
)	O
.	O

Este	O
hallazgo	O
es	O
consistente	O
con	O
el	O
patrón	O
de	O
expresión	O
normal	O
y	O
la	O
función	O
de	O
Thrb2	B-Protein
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Otro	O
hallazgo	O
a	O
tener	O
en	O
cuenta	O
es	O
que	O
el	O
cuerpos	B-GENE
celulares	I-GENE
de	O
El	O
M	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
parecen	O
estar	O
dispersos	O
por	O
todo	O
el	O
ONL	O
en	O
el	O
rd7	O
mutante	B-Sequence
en	O
P14	O
(	O
Figura	O
S8	O
)	O
.	O

A	O
pesar	O
de	O
este	O
hecho	O
,	O
su	O
número	O
total	O
no	O
parece	O
haber	O
aumentado	O
en	O
relación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
.	O

Además	O
,	O
por	O
P28	O
,	O
el	O
M	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
cuerpos	B-GENE
celulares	I-GENE
en	O
rd7	O
parecen	O
haberse	O
reubicado	O
en	O
su	O
posición	O
normal	O
en	O
el	O
borde	O
escleral	O
de	O
la	O
ONL	O
(	O
Figura	O
S8	O
)	O
.	O

Se	O
sabe	O
que	O
hasta	O
P11	O
,	O
el	O
cuerpos	B-GENE
celulares	I-GENE
de	O
fotorreceptores	B-Cell
de	I-Cell
cono	I-Cell
en	O
el	O
ratón	B-Taxon
normalmente	O
están	O
dispersos	O
por	O
todo	O
el	O
ONL	O
,	O
sólo	O
para	O
reubicarse	O
posteriormente	O
en	O
el	O
borde	O
escleral	O
del	O
ONL	O
alrededor	O
de	O
P12	O
[	O
23	O
]	O
.	O

Es	O
posible	O
que	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
,	O
hay	O
un	O
breve	O
retraso	O
en	O
la	O
reubicación	O
de	O
la	O
M	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
cuerpos	B-GENE
celulares	I-GENE
hasta	O
el	O
borde	O
escleral	O
de	O
la	O
ONL	O
.	O

vara	B-Cell
genes	B-Sequence
Solo	O
se	O
ven	O
afectados	O
de	O
manera	O
modesta	O
y	O
temporal	O
en	O
rd7	O

En	O
marcado	O
contraste	O
con	O
los	O
cambios	O
en	O
cono	B-Cell
gene	B-Sequence
expresión	O
,	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
se	O
vieron	O
mucho	O
menos	O
afectados	O
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Microarray	O
y	O
análisis	O
de	O
hibridación	O
in	O
situ	O
de	O
numerosos	O
vara	B-Cell
genes	B-Sequence
no	O
pudo	O
revelar	O
cambios	O
marcados	O
en	O
los	O
niveles	O
de	O
expresión	O
en	O
P14	O
y	O
P21	O
(	O
ver	O
Figura	O
2	O
,	O
fotomicrografías	O
en	O
la	O
parte	O
inferior	O
izquierda	O
;	O
Tabla	O
S2	O
)	O
.	O

Además	O
de	O
los	O
tres	O
vara	B-Cell
genes	B-Sequence
representado	O
en	O
la	O
Figura	O
2	O
,	O
análisis	O
de	O
hibridación	O
in	O
situ	O
en	O
19	O
vara	B-Cell
-	O
especifico	O
y	O
pan	O
-	O
fotorreceptor	B-Cell
genes	B-Sequence
demostró	O
sólo	O
una	O
disminución	O
muy	O
leve	O
de	O
la	O
expresión	O
en	O
dos	O
de	O
estos	O
genes	B-Sequence
,	O
gucy2e	B-Protein
y	O
Rgs9	B-Protein
,	O
en	O
P14	O
,	O
y	O
un	O
aumento	O
en	O
la	O
expresión	O
en	O
dos	O
,	O
nr2e3	B-Protein
,	O
y	O
cnga1	B-Protein
(	O
Cuadro	O
S2	O
)	O
.	O

A	O
pesar	O
de	O
los	O
cambios	O
mínimos	O
en	O
vara	B-Cell
gene	B-Sequence
expresión	O
en	O
puntos	O
de	O
tiempo	O
posnatales	O
posteriores	O
,	O
hubo	O
evidencia	O
de	O
un	O
retraso	O
significativo	O
en	O
el	O
inicio	O
de	O
rodopsina	B-Protein
(	O
Rho	B-Protein
)	O
expresión	O
en	O
rd7	O
mutantes	B-Sequence
relativo	O
a	O
tipo	B-Sequence
salvaje	I-Sequence
.	O

El	O
análisis	O
de	O
micromatrices	O
en	O
P6	O
demostró	O
cinco	O
ADNc	B-Sequence
puntos	O
que	O
fueron	O
regulados	O
a	O
la	O
baja	O
en	O
tres	O
de	O
los	O
tres	O
experimentos	O
.	O

De	O
estos	O
spots	O
,	O
tres	O
correspondieron	O
a	O
rodopsina	B-Protein
(	O
Cuadro	O
S3	O
)	O
.	O

Análisis	O
de	O
hibridación	O
in	O
situ	O
de	O
varios	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
P6	O
reveló	O
que	O
rodopsina	B-Protein
solo	O
mostró	O
un	O
nivel	O
de	O
expresión	O
notablemente	O
más	O
bajo	O
en	O
comparación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
Figura	O
6	O
;	O
datos	O
no	O
publicados	O
)	O
.	O

A	O
pesar	O
de	O
este	O
modesto	O
retraso	O
en	O
el	O
inicio	O
de	O
rodopsina	B-Protein
expresión	O
,	O
por	O
P14	O
la	O
gene	B-Sequence
había	O
alcanzado	O
niveles	O
casi	O
normales	O
en	O
el	O
rd7	O
mutante	B-Sequence
(	O
ver	O
Figura	O
2	O
,	O
fotomicrografías	O
abajo	O
a	O
la	O
izquierda	O
)	O
.	O

Este	O
último	O
hallazgo	O
sugiere	O
que	O
todos	O
los	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
se	O
coexpresan	O
en	O
la	O
mayoría	O
de	O
fotorreceptores	B-Cell
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Cambios	O
en	O
el	O
factor	O
de	O
transcripción	O
retinal	O
y	O
M	O
u	O
ller	O
Glial	O
Gene	B-Sequence
Expresión	O
en	O
rd7	O

análisis	O
de	O
varios	O
fotorreceptor	B-Cell
factores	O
de	O
transcripción	O
en	O
el	O
rd7	O
mutante	B-Sequence
indicó	O
que	O
los	O
niveles	O
de	O
crx	B-Protein
y	O
NRL	B-Protein
no	O
se	O
ven	O
afectados	O
en	O
el	O
mutante	B-Sequence
en	O
P14	O
(	O
ver	O
Figura	O
2	O
,	O
fotomicrografías	O
abajo	O
a	O
la	O
derecha	O
)	O
.	O

NRL	B-Protein
es	O
un	O
vara	B-Cell
-	O
específico	O
,	O
leucina	B-Chemical
básica	I-Chemical
factor	O
de	O
transcripción	O
zip	O
requerido	O
para	O
la	O
activación	O
de	O
muchos	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
y	O
la	O
represión	O
de	O
la	O
mayoría	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
varillas	B-Cell
[	O
24	O
]	O
.	O

NRL	B-Protein
se	O
sabe	O
que	O
es	O
genéticamente	B-Sequence
aguas	O
arriba	O
de	O
nr2e3	B-Protein
y	O
se	O
requiere	O
para	O
su	O
expresión	O
[	O
24	O
]	O
.	O

crx	B-Protein
es	O
un	O
factor	O
de	O
transcripción	O
homeobox	O
expresado	O
en	O
ambos	O
varillas	B-Cell
y	O
conos	B-Cell
y	O
se	O
requiere	O
para	O
la	O
expresión	O
de	O
una	O
variedad	O
de	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
[	O
25	O
]	O
.	O

A	O
diferencia	O
de	O
lo	O
que	O
se	O
ve	O
en	O
el	O
NRL	B-Protein
mutante	B-Sequence
,	O
nr2e3	B-Protein
la	O
expresión	O
no	O
cambia	O
en	O
crx	B-Protein
mutante	B-Sequence
homocigotos	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Sorprendentemente	O
,	O
nr2e3	B-Protein
en	O
sí	O
mismo	O
estaba	O
marcadamente	O
arriba	O
-	O
regulado	O
en	O
el	O
rd7	O
mutante	B-Sequence
tanto	O
por	O
micromatriz	O
como	O
por	O
hibridación	O
in	O
situ	O
(	O
ver	O
Figura	O
2	O
,	O
fotomicrografías	O
en	O
la	O
parte	O
inferior	O
derecha	O
;	O
Tabla	O
S2	O
)	O
.	O

el	O
rd7	O
mutante	B-Sequence
lleva	O
un	O
supresión	B-Sequence
en	O
nr2e3	B-Protein
que	O
quita	B-Sequence
porciones	I-Sequence
de	O
los	O
dos	O
ADN	B-Sequence
#	O
¿NOMBRE	O
?	O
dominios	B-Sequence
[	O
15	O
]	O
.	O

Aunque	O
esto	O
supresión	B-Sequence
lo	O
más	O
probable	O
es	O
que	O
cree	O
un	O
valor	O
nulo	O
alelo	B-Sequence
,	O
un	O
residual	O
transcripción	B-Sequence
está	O
claramente	O
presente	O
y	O
regulado	O
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Este	O
hallazgo	O
sugiere	O
que	O
nr2e3	B-Protein
se	O
requiere	O
para	O
la	O
represión	O
de	O
su	O
propia	O
transcripción	O
.	O

Una	O
gene	B-Sequence
,	O
ADNc	B-Protein
de	I-Protein
RIKEN	I-Protein
4933409K07	I-Protein
(	O
Figura	O
1	O
,	O
gene	B-Sequence
G47	O
)	O
,	O
se	O
encontró	O
que	O
estaba	O
regulado	O
al	O
alza	O
en	O
la	O
micromatriz	O
en	O
los	O
cuatro	O
puntos	O
de	O
tiempo	O
examinados	O
.	O

Esta	O
gene	B-Sequence
mostró	O
un	O
patrón	O
único	O
de	O
expresión	O
en	O
el	O
adulto	O
rd7	O
mutante	B-Sequence
retina	O

Mientras	O
que	O
sólo	O
había	O
un	O
indicio	O
apenas	O
detectable	O
de	O
expresión	O
en	O
la	O
capa	O
nuclear	O
interna	O
(	O
INL	O
)	O
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O
,	O
esto	O
gene	B-Sequence
mostró	O
una	O
fuerte	O
expresión	O
en	O
los	O
tercios	O
medio	O
y	O
vítreo	O
del	O
INL	O
,	O
así	O
como	O
una	O
expresión	O
irregular	O
en	O
el	O
ganglio	O
célula	B-Cell
capa	O
(	O
GCL	O
)	O
y	O
en	O
el	O
borde	O
escleral	O
de	O
la	O
ONL	O
en	O
rd7	O
(	O
ver	O
Tabla	O
S1	O
)	O
.	O

Este	O
patrón	O
de	O
hibridación	O
in	O
situ	O
es	O
consistente	O
con	O
la	O
tinción	O
en	O
Müller	B-Cell
glia	I-Cell
,	O
el	O
director	O
células	B-Cell
gliales	I-Cell
tipo	O
de	O
la	O
ratón	B-Taxon
retina	O

Una	O
posible	O
interpretación	O
de	O
este	O
patrón	O
de	O
expresión	O
inusual	O
es	O
que	O
representa	O
una	O
reacción	O
temprana	O
de	O
la	O
glía	O
de	O
Muller	O
a	O
la	O
lesión	O
en	O
este	O
mutante	B-Sequence
.	O

La	O
mayoría	O
de	O
los	O
Fotorreceptores	B-Cell
en	O
la	O
retina	O
rd7	O
representan	O
un	O
híbrido	O
morfológicamente	O
Célula	B-Cell
Escribe	O

Con	O
el	O
fin	O
de	O
evaluar	O
los	O
efectos	O
morfológicos	O
de	O
lo	O
anterior	O
gene	B-Sequence
cambios	O
de	O
expresión	O
,	O
la	O
ultraestructura	O
de	O
la	O
célula	B-Cell
fotorreceptora	I-Cell
cuerpos	O
en	O
el	O
rd7	O
mutante	B-Sequence
fue	O
examinado	O
.	O

los	O
cuerpos	B-GENE
celulares	I-GENE
fueron	O
elegidos	O
para	O
la	O
evaluación	O
en	O
lugar	O
de	O
los	O
segmentos	B-GENE
exteriores	I-GENE
,	O
ya	O
que	O
en	O
el	O
ratón	B-Taxon
,	O
las	O
diferencias	O
ultraestructurales	O
entre	O
vara	B-Cell
y	O
cono	B-Cell
somata	O
son	O
mucho	O
mayores	O
que	O
las	O
diferencias	O
entre	O
los	O
segmentos	B-GENE
exteriores	I-GENE
[	O
26	O
]	O
.	O

En	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
ratón	B-Taxon
,	O
cono	O
cuerpos	B-GENE
celulares	I-GENE
están	O
alineados	O
a	O
lo	O
largo	O
del	O
borde	O
escleral	O
de	O
la	O
ONL	O
,	O
y	O
son	O
más	O
grandes	O
que	O
los	O
de	O
varillas	B-Cell
.	O

Tienen	O
una	O
masa	O
más	O
pequeña	O
e	O
irregular	O
de	O
heterocromatina	B-GENE
nuclear	I-GENE
que	O
a	O
menudo	O
se	O
divide	O
en	O
múltiples	O
grupos	O
discretos	O
conectados	O
por	O
hilos	O
delgados	O
.	O

También	O
tienen	O
más	O
abundante	O
electrón	B-Chemical
#	O
¿NOMBRE	O
?	O
eucromatina	B-GENE
que	O
varillas	B-Cell
.	O

Por	O
último	O
,	O
frecuentemente	O
tienen	O
un	O
parche	O
de	O
orgánulo	B-GENE
#	O
¿NOMBRE	O
?	O
citoplasma	B-GENE
al	O
lado	O
de	O
su	O
núcleos	B-GENE
,	O
que	O
por	O
lo	O
general	O
contiene	O
grandes	O
mitocondrias	B-GENE
[	O
26	O
]	O
.	O

El	O
análisis	O
de	O
secciones	O
semidelgadas	O
teñidas	O
con	O
azul	O
de	O
toluidina	O
reveló	O
que	O
tales	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
células	B-Cell
estaban	O
presentes	O
en	O
mayor	O
abundancia	O
en	O
la	O
retina	O
rd7	O
que	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
,	O
y	O
que	O
su	O
somata	B-GENE
estaban	O
dispersos	O
a	O
lo	O
largo	O
de	O
la	O
ONL	O
(	O
Figura	O
7	O
)	O
.	O

Una	O
comparación	O
entre	O
la	O
distribución	O
de	O
estos	O
células	B-Cell
y	O
los	O
que	O
expresan	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
sugiere	O
fuertemente	O
que	O
representan	O
lo	O
mismo	O
célula	B-Cell
población	O
(	O
comparar	O
la	O
Figura	O
7D	O
y	O
7F	O
)	O
.	O

Análisis	O
de	O
la	O
nuclear	B-GENE
morfología	O
de	O
la	O
retina	O
disociada	O
células	B-Cell
manchado	O
por	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
por	O
disociado	O
célula	B-Cell
la	O
hibridación	O
in	O
situ	O
confirmó	O
que	O
este	O
es	O
el	O
caso	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Estos	O
hallazgos	O
,	O
junto	O
con	O
la	O
ausencia	O
de	O
rodopsina	B-Protein
tinción	O
en	O
estos	O
células	B-Cell
``	O
(	O
ver	O
Figura	O
3D-3F	O
)	O
,	O
sugieren	O
que	O
estos	O
``	O
''	O
''	O
cono	B-Cell
``	O
-	O
me	O
gusta	O
``	O
''	O
''	O
células	B-Cell
en	O
el	O
rd7	O
mutante	B-Sequence
la	O
retina	O
puede	O
representar	O
normal	O
supernumerario	O
conos	B-Cell
con	O
una	O
localización	O
anormal	O
de	O
sus	O
cuerpos	B-GENE
celulares	I-GENE
.	O

A	O
diferencia	O
del	O
cono	O
cuerpo	B-GENE
de	I-GENE
la	I-GENE
célula	I-GENE
,	O
los	O
tipo	B-Sequence
salvaje	I-Sequence
vara	B-Cell
soma	B-GENE
es	O
pequeño	O
y	O
casi	O
redondo	O
.	O

Tiene	O
un	O
solo	O
grupo	O
grande	O
de	O
denso	O
heterocromatina	B-GENE
,	O
un	O
borde	O
delgado	O
de	O
moderadamente	O
electrón	B-Chemical
#	O
¿NOMBRE	O
?	O
eucromatina	B-GENE
,	O
y	O
muy	O
escaso	O
citoplasma	B-GENE
yuxtanuclear	I-GENE
sin	O
orgánulos	B-GENE
[	O
26	O
,	O
27	O
]	O
.	O

El	O
segundo	O
célula	B-Cell
población	O
en	O
el	O
ONL	O
de	O
la	O
retina	O
rd7	O
tiene	O
algunos	O
de	O
los	O
nuclear	B-GENE
caracteristicas	O
de	O
la	O
normalidad	O
varillas	B-Cell
,	O
como	O
una	O
sola	O
masa	O
densa	O
de	O
heterocromatina	B-GENE
y	O
moderadamente	O
electrón	B-Chemical
#	O
¿NOMBRE	O
?	O
eucromatina	B-GENE
(	O
Figura	O
7H	O
)	O
;	O
sin	O
embargo	O
,	O
estos	O
células	B-Cell
también	O
muestran	O
las	O
características	O
de	O
conos	B-Cell
.	O

Primero	O
el	O
eucromatina	B-GENE
es	O
,	O
en	O
promedio	O
,	O
más	O
abundante	O
en	O
estos	O
células	B-Cell
que	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
varillas	B-Cell
(	O
comparar	O
la	O
figura	O
7G	O
y	O
7H	O
)	O
.	O

Además	O
,	O
la	O
comparación	O
de	O
la	O
representación	O
esquemática	O
de	O
los	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
rd7	O
ONLs	O
sugiere	O
que	O
el	O
área	O
promedio	O
de	O
la	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
rd7	O
es	O
mayor	O
que	O
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
Figura	O
7C	O
y	O
7D	O
)	O
.	O

Para	O
confirmar	O
esta	O
impresión	O
,	O
cuantificamos	O
el	O
área	O
de	O
50	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
50	O
mutante	B-Sequence
vara	B-Cell
#	O
¿NOMBRE	O
?	O
cuerpos	B-GENE
celulares	I-GENE
(	O
ver	O
Materiales	O
y	O
Métodos	O
para	O
más	O
detalles	O
)	O
.	O

Este	O
experimento	O
confirmó	O
que	O
el	O
área	O
promedio	O
de	O
la	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
somata	B-GENE
en	O
rd7	O
es	O
aproximadamente	O
un	O
30	O
%	O
mayor	O
que	O
la	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
vara	B-Cell
somata	B-GENE
(	O
el	O
área	O
media	O
en	O
rd7	O
fue	O
9	O
.	O
75	O
+/-	O
1	O
.	O
36	O
(	O
desviación	O
estándar	O
)	O
mu	O
m2	O
,	O
en	O
comparación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
varillas	B-Cell
,	O
con	O
7	O
.	O
53	O
+/-	O
0	O
.	O
72	O
mu	O
m2	O
;	O
n	O
=	O
50	O
;	O
pags	O
=	O
7	O
.	O
6	O
x	O
10-16	O
,	O
prueba	O
t	O
de	O
Student	O
)	O
.	O

También	O
es	O
notable	O
que	O
la	O
desviación	O
estándar	O
de	O
la	O
somal	B-GENE
el	O
área	O
es	O
casi	O
el	O
doble	O
en	O
rd7	O
que	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
lo	O
que	O
confirma	O
la	O
impresión	O
subjetiva	O
de	O
una	O
mayor	O
variabilidad	O
en	O
el	O
tamaño	O
y	O
la	O
forma	O
somal	O
en	O
el	O
mutante	B-Sequence
en	O
comparación	O
con	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
comparar	O
la	O
figura	O
7C	O
y	O
7D	O
)	O
.	O

Por	O
último	O
,	O
el	O
38	O
%	O
(	O
19	O
/	O
50	O
)	O
del	O
rd7	O
fotorreceptores	B-Cell
seleccionado	O
para	O
somal	B-GENE
la	O
cuantificación	O
del	O
área	O
tuvo	O
mitocondrias	B-GENE
yuxtanucleares	I-GENE
(	O
flecha	O
roja	O
en	O
la	O
Figura	O
7H	O
;	O
datos	O
no	O
publicados	O
)	O
.	O

Tal	O
orgánulos	B-GENE
yuxtanucleares	I-GENE
se	O
ven	O
muy	O
raramente	O
en	O
condiciones	O
normales	O
varillas	B-Cell
(	O
1	O
.	O
5	O
%	O
;	O
seis	O
de	O
399	O
células	B-Cell
contados	O
)	O
,	O
pero	O
son	O
comunes	O
en	O
conos	B-Cell
(	O
flecha	O
amarilla	O
en	O
la	O
Figura	O
7H	O
)	O
.	O

En	O
conclusión	O
,	O
es	O
claro	O
que	O
este	O
segundo	O
célula	B-Cell
población	O
en	O
la	O
retina	O
rd7	O
tiene	O
características	O
morfológicas	O
tanto	O
normales	O
varillas	B-Cell
y	O
conos	B-Cell
consistente	O
con	O
la	O
coexpresión	O
de	O
muchos	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
estos	O
células	B-Cell
.	O

Discusión	O

En	O
este	O
trabajo	O
hemos	O
determinado	O
que	O
el	O
papel	O
principal	O
de	O
la	O
vara	B-Cell
-	O
factor	O
de	O
transcripción	O
específico	O
,	O
nr2e3	B-Protein
,	O
es	O
mantener	O
cono	B-Cell
genes	B-Sequence
transcripcionalmente	O
silencioso	O
dentro	O
varillas	B-Cell
.	O

Hemos	O
identificado	O
dos	O
patrones	O
de	O
cono	B-Cell
gene	B-Sequence
desrepresión	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
,	O
de	O
acuerdo	O
con	O
un	O
informe	O
anterior	O
de	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
.	O

El	O
primer	O
patrón	O
de	O
desrepresión	O
identificado	O
(	O
tipo	O
I	O
)	O
consiste	O
en	O
la	O
expresión	O
ectópica	O
de	O
cono	B-Cell
genes	B-Sequence
en	O
la	O
gran	O
mayoría	O
de	O
células	B-Cell
en	O
la	O
ONL	O
.	O

Estas	O
células	B-Cell
también	O
se	O
demostró	O
que	O
coexpresan	O
todos	O
vara	B-Cell
genes	B-Sequence
probado	O

De	O
acuerdo	O
con	O
el	O
patrón	O
híbrido	O
de	O
gene	B-Sequence
expresión	O
en	O
estos	O
células	B-Cell
,	O
electrón	B-Chemical
el	O
análisis	O
microscópico	O
reveló	O
que	O
eran	O
morfológicamente	O
intermedios	O
entre	O
lo	O
normal	O
varillas	B-Cell
y	O
conos	B-Cell
.	O

Aunque	O
genes	B-Sequence
que	O
muestra	O
desrepresión	O
tipo	O
I	O
mostró	O
tinción	O
en	O
la	O
mayoría	O
de	O
los	O
células	B-Cell
en	O
la	O
ONL	O
,	O
dos	O
líneas	O
de	O
evidencia	O
sugieren	O
que	O
estos	O
genes	B-Sequence
no	O
están	O
completamente	O
deprimidos	O
en	O
estos	O
células	B-Cell
en	O
comparación	O
con	O
su	O
expresión	O
en	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
conos	B-Cell
.	O

En	O
primer	O
lugar	O
,	O
una	O
evaluación	O
minuciosa	O
del	O
patrón	O
de	O
tinción	O
de	O
una	O
serie	O
de	O
tipos	O
I	O
genes	B-Sequence
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
(	O
p	O
.	O
ej	O
.	O
,	O
consulte	O
la	O
Tabla	O
S1	O
,	O
genes	B-Sequence
G9	O
,	O
G19	O
y	O
G24	O
)	O
,	O
revela	O
que	O
,	O
además	O
de	O
la	O
tinción	O
de	O
fondo	O
en	O
todo	O
el	O
ONL	O
,	O
hay	O
una	O
subpoblación	O
de	O
tinción	O
más	O
oscura	O
de	O
células	B-Cell
dispersos	O
a	O
lo	O
largo	O
de	O
esta	O
capa	O
en	O
una	O
distribución	O
correspondiente	O
a	O
la	O
del	O
supernumerario	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
.	O

Este	O
patrón	O
de	O
tinción	O
sugiere	O
que	O
estos	O
genes	B-Sequence
se	O
expresan	O
más	O
en	O
S	B-Protein
-	I-Protein
opsina	I-Protein
expresando	O
células	B-Cell
que	O
en	O
el	O
hibrido	O
células	B-Cell
de	O
la	O
retina	O
rd7	O
.	O

La	O
segunda	O
línea	O
de	O
evidencia	O
se	O
deriva	O
de	O
una	O
comparación	O
del	O
patrón	O
de	O
expresión	O
de	O
muchos	O
tipos	O
I	O
genes	B-Sequence
en	O
rd7	O
y	O
NRL	B-Protein
-	O
/	O
-	O
mutante	B-Sequence
antecedentes	O
.	O

Como	O
se	O
ha	O
mencionado	O
más	O
arriba	O
,	O
NRL	B-Protein
es	O
un	O
factor	O
de	O
transcripción	O
retinal	O
que	O
,	O
cuando	O
mutado	B-Sequence
,	O
resulta	O
en	O
una	O
conversión	O
masiva	O
de	O
varillas	B-Cell
dentro	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
conos	B-Cell
[	O
24	O
]	O
.	O

Se	O
puede	O
inferir	O
de	O
este	O
hecho	O
que	O
NRL	B-Protein
es	O
absolutamente	O
necesario	O
para	O
el	O
silenciamiento	O
normal	O
de	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
varillas	B-Cell
.	O

En	O
el	O
NRL	B-Protein
homocigoto	O
mutante	B-Sequence
,	O
hay	O
una	O
desrepresión	O
más	O
fuerte	O
y	O
más	O
uniforme	O
de	O
muchos	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
a	O
lo	O
largo	O
de	O
la	O
ONL	O
de	O
lo	O
que	O
se	O
ve	O
en	O
la	O
retina	O
rd7	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Este	O
hallazgo	O
sugiere	O
además	O
que	O
,	O
además	O
de	O
su	O
represión	O
de	O
cono	B-Cell
gene	B-Sequence
expresión	O
por	O
inducción	O
de	O
nr2e3	B-Protein
expresión	O
,	O
NRL	B-Protein
ejerce	O
un	O
nivel	O
adicional	O
de	O
control	O
negativo	O
sobre	O
cono	B-Cell
genes	B-Sequence
ya	O
sea	O
directamente	O
oa	O
través	O
de	O
un	O
segundo	O
represor	O
,	O
aún	O
no	O
caracterizado	O
.	O

El	O
segundo	O
patrón	O
de	O
desrepresión	O
visto	O
en	O
la	O
retina	O
rd7	O
(	O
tipo	O
II	O
)	O
,	O
está	O
representado	O
por	O
una	O
población	O
dispersa	O
de	O
células	B-Cell
en	O
toda	O
la	O
ONL	O
que	O
muestra	O
desrepresión	O
de	O
varios	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
,	O
incluyendo	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
.	O

Por	O
criterios	O
ultraestructurales	O
,	O
estos	O
células	B-Cell
parece	O
ser	O
normal	O
conos	B-Cell
,	O
aunque	O
con	O
desplazados	O
cuerpos	B-GENE
celulares	I-GENE
.	O

Cuantificación	O
de	O
estos	O
supernumerarios	O
.	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
indica	O
que	O
son	O
aproximadamente	O
2	O
veces	O
más	O
abundantes	O
que	O
en	O
la	O
retina	O
normal	O
,	O
en	O
consonancia	O
con	O
las	O
observaciones	O
anteriores	O
anticuerpo	B-GENE
estudios	O
[	O
17	O
]	O
.	O

Dos	O
estudios	O
recientes	O
han	O
presentado	O
datos	O
que	O
son	O
consistentes	O
con	O
muchos	O
de	O
los	O
hallazgos	O
de	O
nuestro	O
estudio	O
[	O
18	O
,	O
19	O
]	O
.	O

Ambos	O
estudios	O
demostraron	O
que	O
cono	B-Cell
genes	B-Sequence
además	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
están	O
desreprimidos	O
en	O
el	O
ratón	B-Taxon
rd7	O
mutante	B-Sequence
.	O

Además	O
,	O
Peng	O
et	O
al	O
.	O

[	O
19	O
]	O
encontró	O
por	O
RT	O
-	O
PCR	O
que	O
los	O
niveles	O
de	O
varios	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
,	O
incluyendo	O
rodopsina	B-Protein
,	O
se	O
redujeron	O
modestamente	O
en	O
rd7	O
en	O
P28	O
.	O

Nuestros	O
datos	O
de	O
hibridación	O
in	O
situ	O
sugieren	O
que	O
rodopsina	B-Protein
expresión	O
se	O
reduce	O
notablemente	O
en	O
P6	O
,	O
pero	O
que	O
alcanza	O
niveles	O
indistinguibles	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
por	O
P14	O
.	O

Desde	O
el	O
cambio	O
de	O
rodopsina	B-Protein
los	O
niveles	O
identificados	O
por	O
Peng	O
et	O
al	O
.	O
eran	O
relativamente	O
pequeños	O
(	O
una	O
reducción	O
de	O
aproximadamente	O
el	O
15	O
%	O
)	O
,	O
no	O
es	O
sorprendente	O
que	O
tal	O
diferencia	O
no	O
fuera	O
detectada	O
por	O
hibridación	O
in	O
situ	O
.	O

El	O
hallazgo	O
general	O
de	O
modestas	O
reducciones	O
en	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
gene	B-Sequence
expresión	O
está	O
totalmente	O
de	O
acuerdo	O
con	O
los	O
resultados	O
del	O
presente	O
estudio	O
.	O

Además	O
de	O
demostrar	O
desrepresión	O
de	O
una	O
gama	O
de	O
conocido	B-Sequence
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
rd7	O
mutantes	B-Sequence
,	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
apareció	O
-	O
regulación	O
por	O
Northern	O
blot	O
de	O
dos	O
genes	B-Sequence
en	O
el	O
rd7	O
mutante	B-Sequence
,	O
elovl2	B-Protein
y	O
Fabp7	B-Protein
.	O

Estos	O
dos	O
genes	B-Sequence
también	O
se	O
encontró	O
que	O
estaban	O
regulados	O
al	O
alza	O
en	O
rd7	O
en	O
el	O
presente	O
estudio	O
(	O
ver	O
Figura	O
1	O
;	O
Tabla	O
S1	O
)	O
.	O

Aunque	O
encontramos	O
elovl2	B-Protein
tener	O
un	O
cono	B-Cell
-	O
patrón	O
de	O
expresión	O
enriquecido	O
(	O
ver	O
Figura	O
1	O
)	O
,	O
análisis	O
de	O
hibridación	O
in	O
situ	O
de	O
Fabp7	B-Protein
no	O
pudo	O
mostrar	O
una	O
señal	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
o	O
mutante	B-Sequence
retina	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Sin	O
embargo	O
,	O
estudios	O
previos	O
han	O
sugerido	O
que	O
Fabp7	B-Protein
se	O
expresa	O
en	O
glía	B-Cell
radial	I-Cell
e	O
inmaduro	O
astrocitos	B-Cell
en	O
el	O
cerebro	O
[	O
28	O
-	O
30	O
]	O
.	O

Dado	O
el	O
patrón	O
de	O
expresión	O
en	O
otras	O
partes	O
del	O
sistema	O
nervioso	O
,	O
es	O
posible	O
que	O
Fabp7	B-Protein
está	O
arriba	O
-	O
regulado	O
en	O
Müller	B-Cell
glia	I-Cell
en	O
la	O
retina	O
rd7	O
en	O
respuesta	O
a	O
una	O
lesión	O
de	O
una	O
manera	O
similar	O
a	O
la	O
novela	O
M	B-Cell
u	I-Cell
ller	I-Cell
glial	I-Cell
gene	B-Sequence
identificado	O
en	O
este	O
estudio	O
,	O
ADNc	B-Protein
de	I-Protein
RIKEN	I-Protein
4933409K07	I-Protein
(	O
Figura	O
1	O
,	O
gene	B-Sequence
G47	O
)	O
.	O

El	O
apoyo	O
indirecto	O
a	O
esta	O
idea	O
lo	O
proporciona	O
la	O
observación	O
de	O
que	O
Fabp7	B-Protein
está	O
regulada	O
por	O
análisis	O
de	O
microarrays	O
en	O
NRL	B-Protein
y	O
crx	B-Protein
mutante	B-Sequence
retinas	O
también	O
(	O
datos	O
no	O
publicados	O
)	O
,	O
lo	O
que	O
sugiere	O
que	O
este	O
cambio	O
puede	O
representar	O
una	O
respuesta	O
generalizada	O
a	O
la	O
lesión	O
en	O
la	O
retina	O
en	O
lugar	O
de	O
la	O
desrepresión	O
de	O
un	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
gene	B-Sequence
.	O

El	O
estudio	O
de	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
hizo	O
otras	O
dos	O
observaciones	O
dignas	O
de	O
mención	O
.	O

Primero	O
,	O
identificaron	O
un	O
pez	B-Taxon
cebra	I-Taxon
homólogo	B-Sequence
de	O
nr2e3	B-Protein
y	O
mostró	O
que	O
se	O
expresa	O
en	O
fotorreceptores	B-Cell
.	O

Curiosamente	O
,	O
demostraron	O
que	O
este	O
homólogo	B-Sequence
parece	O
tener	O
una	O
cacerola	O
-	O
fotorreceptor	B-Cell
patrón	O
de	O
expresión	O
temprano	O
en	O
el	O
desarrollo	O
que	O
más	O
tarde	O
se	O
resuelve	O
en	O
un	O
vara	B-Cell
-	O
patrón	O
específico	O
de	O
expresión	O
.	O

Esta	O
primera	O
expresión	O
en	O
conos	B-Cell
puede	O
representar	O
un	O
mecanismo	O
por	O
el	O
cual	O
la	O
expresión	O
de	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
gene	B-Sequence
productos	O
se	O
reprime	O
temporalmente	O
.	O

Será	O
importante	O
determinar	O
en	O
qué	O
medida	O
la	O
función	O
de	O
nr2e3	B-Protein
se	O
ha	O
conservado	O
en	O
la	O
retina	O
de	O
un	O
pariente	O
tan	O
distante	O
organismo	B-Taxon
.	O

En	O
segundo	O
lugar	O
,	O
Chen	O
et	O
al	O
.	O

[	O
18	O
]	O
usó	O
un	O
in	O
vitro	O
oligonucleótido	B-Sequence
protocolo	O
de	O
selección	O
para	O
determinar	O
el	O
preferido	O
sitio	B-Sequence
de	I-Sequence
unión	I-Sequence
por	O
nr2e3	B-Protein
.	O

Esta	O
información	O
será	O
de	O
gran	O
utilidad	O
para	O
futuros	O
análisis	O
bioinformáticos	O
de	O
nr2e3	B-Protein
objetivo	O
genes	B-Sequence
.	O

los	O
gene	B-Sequence
cambios	O
de	O
expresión	O
identificados	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
en	O
el	O
presente	O
estudio	O
sugieren	O
el	O
esquema	O
de	O
gene	B-Sequence
regulación	O
en	O
ratón	B-Taxon
varillas	B-Cell
representado	O
en	O
la	O
figura	O
8	O
.	O

Como	O
implica	O
este	O
diagrama	O
,	O
parece	O
haber	O
al	O
menos	O
dos	O
represores	O
diferentes	O
de	O
cono	B-Cell
genes	B-Sequence
dentro	O
de	O
varillas	B-Cell
,	O
nr2e3	B-Protein
y	O
también	O
NRL	B-Protein
sí	O
mismo	O
o	O
un	O
factor	O
de	O
transcripción	O
adicional	O
desconocido	O
aguas	O
abajo	O
de	O
NRL	B-Protein
``	O
,	O
aquí	O
denominado	O
``	O
''	O
factor	O
de	O
transcripción	O
X	O
``	O
''	O
.	O
De	O
hecho	O
,	O
parece	O
que	O
las	O
diferencias	O
entre	O
el	O
tipo	O
I	O
y	O
el	O
tipo	O
II	O
''	O
cono	B-Cell
genes	B-Sequence
puede	O
simplemente	O
depender	O
de	O
qué	O
represor	O
--	O
nr2e3	B-Protein
o	O
factor	O
de	O
transcripción	O
X	O
,	O
es	O
el	O
principal	O
responsable	O
de	O
la	O
regulación	O
de	O
la	O
gene	B-Sequence
en	O
cuestión	O
.	O

En	O
el	O
caso	O
del	O
tipo	O
I	O
genes	B-Sequence
,	O
nr2e3	B-Protein
es	O
el	O
principal	O
represor	O
y	O
el	O
factor	O
de	O
transcripción	O
X	O
tiene	O
una	O
importancia	O
secundaria	O
.	O

En	O
el	O
caso	O
del	O
tipo	O
II	O
genes	B-Sequence
,	O
el	O
factor	O
de	O
transcripción	O
X	O
ejerce	O
el	O
mayor	O
efecto	O
represivo	O
sobre	O
la	O
transcripción	O
,	O
y	O
nr2e3	B-Protein
juega	O
un	O
papel	O
menor	O
,	O
pero	O
aún	O
importante	O
.	O

En	O
contraste	O
con	O
la	O
marcada	O
desrepresión	O
de	O
la	O
gran	O
mayoría	O
de	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
el	O
rd7	O
mutante	B-Sequence
,	O
dos	O
genes	B-Sequence
destacan	O
por	O
no	O
verse	O
afectados	O
por	O
la	O
mutación	B-Sequence
:	O
los	O
gene	B-Sequence
codificación	O
M	B-Protein
-	I-Protein
opsina	I-Protein
y	O
Thrb2	B-Protein
.	O

Como	O
Thrb2	B-Protein
se	O
sabe	O
que	O
es	O
necesario	O
para	O
la	O
expresión	O
de	O
M	B-Protein
-	I-Protein
opsina	I-Protein
[	O
22	O
]	O
,	O
la	O
ausencia	O
de	O
supernumerario	O
M	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
puede	O
ser	O
simplemente	O
una	O
consecuencia	O
del	O
hecho	O
de	O
que	O
Thrb2	B-Protein
la	O
expresión	O
no	O
cambia	O
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Un	O
trabajo	O
reciente	O
en	O
nuestro	O
laboratorio	O
que	O
muestra	O
una	O
desrepresión	O
generalizada	O
de	O
cono	B-Cell
genes	B-Sequence
en	O
el	O
Muesca1	B-Protein
-/-retina	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

En	O
contraste	O
con	O
el	O
rd7	O
mutante	B-Sequence
,	O
Muesca1	B-Protein
-	O
/	O
-	O
las	O
retinas	O
muestran	O
marcada	O
desrepresión	O
de	O
Thrb2	B-Protein
y	O
una	O
correspondiente	O
desrepresión	O
del	O
gene	B-Sequence
que	O
codifica	O
M	B-Protein
-	I-Protein
opsina	I-Protein
.	O

Una	O
observación	O
adicional	O
que	O
sugiere	O
que	O
M	B-Protein
-	I-Protein
opsina	I-Protein
y	O
S	B-Protein
-	I-Protein
opsina	I-Protein
son	O
controlados	O
por	O
diferentes	O
mecanismos	O
proviene	O
de	O
experimentos	O
in	O
vitro	O
[	O
31	O
,	O
32	O
]	O
.	O

Mientras	O
que	O
las	O
retinas	O
P3	O
explantadas	O
expresan	O
S	B-Protein
-	I-Protein
opsina	I-Protein
y	O
M	B-Protein
-	I-Protein
opsina	I-Protein
con	O
cinética	O
normal	O
,	O
las	O
retinas	O
P0	O
explantadas	O
expresan	O
solo	O
S	B-Protein
-	I-Protein
opsina	I-Protein
[	O
32	O
]	O
.	O

Se	O
desconocen	O
los	O
factores	O
que	O
controlan	O
estas	O
diferencias	O
,	O
pero	O
pueden	O
ser	O
intrínsecos	O
,	O
como	O
cocultivos	O
de	O
retinas	O
más	O
viejas	O
y	O
más	O
jóvenes	O
,	O
medios	O
condicionados	O
de	O
retinas	O
más	O
viejas	O
y	O
adición	O
de	O
una	O
variedad	O
de	O
retinas	O
pequeñas	O
moléculas	B-Chemical
fueron	O
incapaces	O
de	O
promover	O
la	O
expresión	O
de	O
M	B-Protein
-	I-Protein
opsina	I-Protein
en	O
las	O
culturas	O
iniciadas	O
por	O
P0	O
[	O
32	O
]	O
.	O

En	O
contraste	O
con	O
nuestros	O
hallazgos	O
,	O
Peng	O
et	O
al	O
.	O

[	O
19	O
]	O
informó	O
que	O
M	B-Protein
-	I-Protein
opsina	I-Protein
la	O
expresión	O
está	O
ligeramente	O
aumentada	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O

Es	O
posible	O
que	O
un	O
aumento	O
sutil	O
en	O
M	B-Protein
-	I-Protein
opsina	I-Protein
transcripción	B-Sequence
los	O
niveles	O
sí	O
ocurren	O
en	O
la	O
retina	O
rd7	O
,	O
y	O
que	O
esta	O
diferencia	O
no	O
pudo	O
ser	O
detectada	O
por	O
hibridación	O
in	O
situ	O
.	O

Dado	O
que	O
prácticamente	O
todos	O
M	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
se	O
localizan	O
en	O
el	O
borde	O
exterior	O
de	O
la	O
ONL	O
por	O
P28	O
en	O
el	O
rd7	O
mutante	B-Sequence
(	O
Figura	O
S8	O
)	O
,	O
cualquier	O
aumento	O
en	O
M	B-Protein
-	I-Protein
opsina	I-Protein
transcripción	B-Sequence
en	O
el	O
mutante	B-Sequence
debe	O
haber	O
ocurrido	O
en	O
células	B-Cell
en	O
ese	O
lugar	O
.	O

Variedad	O
de	O
novela	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
se	O
caracterizaron	O
en	O
este	O
estudio	O
.	O

Uno	O
de	O
estos	O
genes	B-Sequence
,	O
pigmeo	B-Protein
,	O
está	O
involucrado	O
en	O
glucógeno	B-Chemical
/	O
glucosa	B-Chemical
metabolismo	O
,	O
y	O
un	O
segundo	O
,	O
Glo1	B-Protein
,	O
es	O
necesario	O
para	O
la	O
desintoxicación	O
de	O
metilglioxal	B-Chemical
,	O
a	O
subproducto	B-Chemical
de	O
la	O
glucólisis	O
[	O
33	O
]	O
.	O

Un	O
tercio	O
gene	B-Sequence
envuelto	O
en	O
glucosa	B-Chemical
metabolismo	O
,	O
hexoquinasa	B-Protein
2	I-Protein
(	O
Hk2	B-Protein
)	O
,	O
también	O
está	O
desreprimido	O
en	O
el	O
rd7	O
mutante	B-Sequence
y	O
muestra	O
un	O
patrón	O
de	O
expresión	O
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O
,	O
lo	O
que	O
sugiere	O
una	O
mayor	O
expresión	O
en	O
conos	B-Cell
que	O
en	O
varillas	B-Cell
(	O
ver	O
Figura	O
1	O
;	O
Tabla	O
S1	O
)	O
.	O

Un	O
cuarto	O
gene	B-Sequence
envuelto	O
en	O
glucosa	B-Chemical
metabolismo	O
,	O
proteína	B-Protein
reguladora	I-Protein
de	I-Protein
la	I-Protein
glucoquinasa	I-Protein
(	O
Gckr	B-Protein
)	O
,	O
se	O
encontró	O
que	O
aumentaba	O
en	O
tres	O
de	O
los	O
tres	O
microarrays	O
en	O
P21	O
pero	O
no	O
se	O
analizó	O
mediante	O
hibridación	O
in	O
situ	O
(	O
Tabla	O
S4	O
)	O
.	O

La	O
mayor	O
expresión	O
de	O
Gckr	B-Protein
en	O
rd7	O
mutante	B-Sequence
retina	O
sugiere	O
que	O
también	O
puede	O
ser	O
un	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
gene	B-Sequence
.	O

Un	O
estudio	O
anterior	O
encontró	O
que	O
dos	O
de	O
estos	O
genes	B-Sequence
,	O
pigmeo	B-Protein
y	O
Hk2	B-Protein
,	O
tienen	O
niveles	O
de	O
etiqueta	O
marcadamente	O
elevados	O
en	O
un	O
análisis	O
en	O
serie	O
específico	O
de	O
ONL	O
de	O
gene	B-Sequence
biblioteca	O
de	O
expresión	O
consistente	O
con	O
su	O
alto	O
enriquecimiento	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
fotorreceptores	B-Cell
[	O
34	O
]	O
.	O

Además	O
,	O
estudios	O
previos	O
han	O
sugerido	O
diferencias	O
en	O
glucógeno	B-Chemical
y	O
glucosa	B-Chemical
metabolismo	O
entre	O
primate	B-Taxon
varillas	B-Cell
y	O
conos	B-Cell
35	O
]	O
.	O

Nuestros	O
resultados	O
prestan	O
más	O
apoyo	O
a	O
este	O
concepto	O
.	O

Curiosamente	O
,	O
pigmeo	B-Protein
ha	O
sido	O
implicado	O
en	O
humano	B-Taxon
enfermedad	O
.	O

Mutaciones	B-Sequence
en	O
esto	O
gene	B-Sequence
subyacen	O
a	O
la	O
enfermedad	O
de	O
McArdle	O
(	O
glucógeno	B-Chemical
enfermedad	O
de	O
almacenamiento	O
tipo	O
V	O
)	O
,	O
cuyos	O
síntomas	O
incluyen	O
intolerancia	O
al	O
ejercicio	O
,	O
calambres	O
musculares	O
y	O
mioglobinuria	O
[	O
36	O
]	O
.	O

Hasta	O
donde	O
sabemos	O
,	O
no	O
se	O
han	O
informado	O
anormalidades	O
de	O
la	O
función	O
retiniana	O
.	O

Uno	O
de	O
los	O
hallazgos	O
más	O
curiosos	O
en	O
el	O
rd7	O
.	O
mutante	B-Sequence
retina	O
fue	O
la	O
ocurrencia	O
de	O
dos	O
tipos	O
diferentes	O
de	O
cambios	O
:	O
un	O
aumento	O
en	O
el	O
número	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
conos	B-Cell
y	O
una	O
transformación	O
de	O
varillas	B-Cell
en	O
híbrido	O
fotorreceptores	B-Cell
.	O

Se	O
sabe	O
que	O
nr2e3	B-Protein
se	O
expresa	O
solo	O
en	O
varillas	B-Cell
,	O
y	O
el	O
transcripción	B-Sequence
es	O
primero	O
detectable	O
en	O
postmitotic	O
células	B-Cell
(	O
J.	O
Trimarchi	O
y	O
CLC	O
,	O
datos	O
no	O
publicados	O
)	O
.	O

Asumiendo	O
que	O
nr2e3	B-Protein
hechos	O
célula	B-Cell
autónomamente	O
,	O
podemos	O
concluir	O
que	O
el	O
supernumerario	O
S	B-Protein
-	I-Protein
cono	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
y	O
el	O
hibrido	O
fotorreceptores	B-Cell
identificados	O
en	O
la	O
retina	O
rd7	O
fueron	O
redirigidos	O
a	O
estos	O
destinos	O
desde	O
posmitóticos	O
células	B-Cell
que	O
estaban	O
destinados	O
a	O
convertirse	O
varillas	B-Cell
.	O

Esta	O
conclusión	O
plantea	O
esta	O
pregunta	O
:	O
¿Por	O
qué	O
la	O
pérdida	O
de	O
un	O
solo	O
factor	O
de	O
transcripción	O
dentro	O
vara	B-Cell
precursores	O
conducen	O
a	O
dos	O
destinos	O
alternativos	O
:	O
un	O
híbrido	O
célula	B-Cell
escriba	O
por	O
un	O
lado	O
y	O
aparentemente	O
normal	O
S	O
-	O
conos	B-Cell
en	O
el	O
otro	O
?	O

Existen	O
al	O
menos	O
dos	O
posibles	O
explicaciones	O
para	O
estas	O
diferencias	O
.	O

En	O
primer	O
lugar	O
,	O
es	O
posible	O
que	O
haya	O
dos	O
tipos	O
distintos	O
de	O
vara	B-Cell
precursor	O
;	O
pérdida	O
de	O
nr2e3	B-Protein
en	O
uno	O
lleva	O
a	O
S	O
-	O
cono	B-Cell
el	O
destino	O
y	O
en	O
el	O
otro	O
resulta	O
un	O
hibrido	O
célula	B-Cell
escribe	O
.	O

De	O
hecho	O
,	O
hay	O
evidencia	O
experimental	O
de	O
la	O
rata	B-Taxon
para	O
apoyar	O
la	O
conclusión	O
de	O
que	O
los	O
nacidos	O
tempranos	O
y	O
tardíos	O
varillas	B-Cell
son	O
intrínsecamente	O
diferentes	O
[	O
37	O
]	O
.	O

Una	O
prueba	O
de	O
la	O
hipótesis	O
de	O
que	O
hay	O
dos	O
temporalmente	O
distintos	O
vara	B-Cell
poblaciones	O
precursoras	O
sería	O
llevar	O
a	O
cabo	O
experimentos	O
de	O
datación	O
para	O
determinar	O
si	O
el	O
supernumerario	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
la	O
retina	O
rd7	O
derivada	O
exclusivamente	O
de	O
una	O
población	O
temprana	O
o	O
tardía	O
.	O

Por	O
supuesto	O
,	O
si	O
este	O
no	O
fuera	O
el	O
caso	O
,	O
este	O
experimento	O
no	O
podría	O
descartar	O
la	O
posibilidad	O
de	O
que	O
molecularmente	B-Chemical
distintas	O
poblaciones	O
de	O
vara	B-Cell
los	O
precursores	O
están	O
presentes	O
simultáneamente	O
en	O
la	O
retina	O
en	O
desarrollo	O
.	O

Una	O
explicación	O
alternativa	O
sería	O
que	O
solo	O
hay	O
una	O
única	O
población	O
homogénea	O
de	O
pacientes	O
posmitóticos	O
.	O
vara	B-Cell
precursores	O
en	O
el	O
ratón	B-Taxon
,	O
y	O
un	O
evento	O
estocástico	O
desencadena	O
la	O
suposición	O
de	O
S	O
-	O
cono	B-Cell
destino	O
en	O
una	O
pequeña	O
subpoblación	O
de	O
estos	O
células	B-Cell
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Estudios	O
recientes	O
en	O
una	O
variedad	O
de	O
sistemas	O
de	O
experimentos	O
sugieren	O
que	O
tal	O
mecanismo	O
estocástico	O
de	O
todo	O
o	O
nada	O
de	O
gene	B-Sequence
la	O
activación	O
es	O
un	O
lugar	O
común	O
[	O
38	O
-	O
44	O
]	O
.	O

En	O
este	O
escenario	O
,	O
la	O
ausencia	O
de	O
nr2e3	B-Protein
alteraría	O
la	O
probabilidad	O
de	O
que	O
un	O
maestro	O
desconocido	O
controle	O
gene	B-Sequence
se	O
expresa	O
en	O
vara	B-Cell
precursores	O

Una	O
vez	O
que	O
este	O
evento	O
ocurra	O
,	O
iniciaría	O
un	O
programa	O
irreversible	O
de	O
diferenciación	O
hacia	O
S-	O
cono	B-Cell
destino	O
,	O
aunque	O
a	O
una	O
frecuencia	O
relativamente	O
baja	O
.	O

De	O
esta	O
forma	O
,	O
un	O
subconjunto	O
de	O
células	B-Cell
de	O
una	O
población	O
inicialmente	O
homogénea	O
seleccionaría	O
la	O
S	O
-	O
cono	B-Cell
destino	O
de	O
una	O
manera	O
totalmente	O
probabilística	O
.	O

Humano	B-Taxon
Los	O
pacientes	O
con	O
ESCS	O
muestran	O
tres	O
tipos	O
de	O
anomalías	O
atribuibles	O
a	O
la	O
retina	O
:	O
(	O
1	O
)	O
una	O
forma	O
de	O
onda	O
ERG	O
atípica	O
que	O
es	O
preferentemente	O
sensible	O
a	O
la	O
luz	O
de	O
longitud	O
de	O
onda	O
corta	O
,	O
(	O
2	O
)	O
degeneración	O
retiniana	O
lentamente	O
progresiva	O
y	O
(	O
3	O
)	O
laminación	O
retiniana	O
anormal	O
con	O
formación	O
de	O
rosetas	O
[	O
1	O
,	O
12	O
,	O
13	O
]	O
.	O

el	O
rd7	O
mutante	B-Sequence
ratones	B-Taxon
también	O
demuestran	O
los	O
dos	O
últimos	O
defectos	O
,	O
pero	O
tienen	O
un	O
ERG	O
normal	O
[	O
15	O
,	O
45	O
]	O
.	O

Estas	O
similitudes	O
y	O
diferencias	O
entre	O
las	O
dos	O
especies	O
ayudan	O
a	O
explicar	O
la	O
posible	O
base	O
mecanicista	O
del	O
ESCS	O
.	O

El	O
hecho	O
de	O
que	O
el	O
rd7	O
ratón	B-Taxon
tiene	O
un	O
ERG	O
normal	O
sugiere	O
fuertemente	O
que	O
el	O
ERG	O
aberrante	O
en	O
ESCS	O
no	O
es	O
atribuible	O
a	O
la	O
actividad	O
de	O
un	O
híbrido	O
fotorreceptor	B-Cell
idéntico	O
al	O
encontrado	O
en	O
este	O
estudio	O
.	O

Es	O
decir	O
,	O
es	O
poco	O
probable	O
que	O
la	O
señal	O
se	O
derive	O
de	O
una	O
población	O
de	O
células	B-Cell
coexpresando	O
ambos	O
vara	B-Cell
y	O
cono	B-Cell
genes	B-Sequence
pero	O
cuyo	O
fotopigmento	O
es	O
rodopsina	B-Protein
y	O
no	O
S	B-Protein
-	I-Protein
opsina	I-Protein
de	I-Protein
cono	I-Protein
.	O

Esta	O
conclusión	O
es	O
consistente	O
con	O
la	O
evidencia	O
de	O
humano	B-Taxon
Los	O
pacientes	O
con	O
ESCS	O
que	O
indican	O
una	O
marcada	O
reducción	O
vara	B-Cell
sistema	O
y	O
la	O
falta	O
de	O
medibles	O
rodopsina	B-Protein
por	O
densitometría	O
de	O
reflexión	O
[	O
1	O
,	O
2	O
,	O
10	O
,	O
11	O
]	O
.	O

También	O
es	O
poco	O
probable	O
que	O
fallemos	O
en	O
detectar	O
una	O
señal	O
ESCS	O
-	O
como	O
ERG	O
en	O
ratones	B-Taxon
si	O
estuviera	O
presente	O
,	O
como	O
tal	O
señal	O
se	O
ha	O
demostrado	O
en	O
el	O
NRL	B-Protein
mutante	B-Sequence
ratón	B-Taxon
,	O
que	O
tiene	O
una	O
transformación	O
casi	O
total	O
de	O
todos	O
sus	O
varillas	B-Cell
en	O
azul	O
conos	B-Cell
[	O
24	O
]	O
.	O

Estos	O
hallazgos	O
,	O
sin	O
embargo	O
,	O
no	O
descartan	O
la	O
posibilidad	O
de	O
que	O
la	O
anomalía	O
humano	B-Taxon
ERG	O
deriva	O
de	O
un	O
híbrido	O
célula	B-Cell
fotorreceptora	I-Cell
tipo	O
que	O
también	O
expresa	O
S	B-Protein
-	I-Protein
opsina	I-Protein
.	O

Es	O
posible	O
que	O
haya	O
gene	B-Sequence
diferencias	O
normativas	O
entre	O
ratones	B-Taxon
y	O
humanos	B-Taxon
tal	O
que	O
en	O
humano	B-Protein
NR2E3	I-Protein
mutantes	B-Sequence
,	O
S	B-Protein
-	I-Protein
opsina	I-Protein
muestra	O
un	O
patrón	O
de	O
desrepresión	O
tipo	O
I	O
en	O
lugar	O
de	O
un	O
tipo	O
II	O
como	O
se	O
ve	O
en	O
el	O
rd7	O
ratón	B-Taxon
,	O
y	O
por	O
lo	O
tanto	O
se	O
expresa	O
en	O
todos	O
los	O
híbridos	O
células	B-Cell
fotorreceptoras	I-Cell
.	O

Alternativamente	O
,	O
la	O
proporción	O
de	O
supernumerarios	O
S	O
-	O
conos	B-Cell
a	O
hibrido	O
fotorreceptores	B-Cell
producido	O
en	O
la	O
retina	O
de	O
los	O
pacientes	O
con	O
ESCS	O
podría	O
ser	O
tal	O
que	O
un	O
mayor	O
porcentaje	O
de	O
los	O
presuntos	O
varillas	B-Cell
en	O
pacientes	O
ESCS	O
se	O
convierten	O
en	O
S	O
-	O
conos	B-Cell
en	O
lugar	O
de	O
híbrido	O
fotorreceptores	B-Cell
.	O

Como	O
se	O
discutió	O
anteriormente	O
,	O
esta	O
relación	O
podría	O
depender	O
de	O
los	O
porcentajes	O
relativos	O
de	O
dos	O
vara	B-Cell
poblaciones	O
precursoras	O
o	O
sobre	O
efectos	O
estocásticos	O
en	O
la	O
regulación	O
gene	B-Sequence
expresión	O
.	O

A	O
diferencia	O
de	O
las	O
diferencias	O
ERG	O
entre	O
ratón	B-Taxon
rd7	O
y	O
humano	B-Protein
NR2E3	I-Protein
mutantes	B-Sequence
,	O
ambas	O
especies	O
muestran	O
una	O
degeneración	O
retiniana	O
lenta	O
.	O

Es	O
posible	O
que	O
esta	O
degeneración	O
sea	O
atribuible	O
a	O
la	O
función	O
anormal	O
del	O
híbrido	O
.	O
célula	B-Cell
fotorreceptora	I-Cell
tipo	O
caracterizado	O
en	O
el	O
presente	O
estudio	O
.	O

La	O
coexpresión	O
de	O
ambos	O
vara	B-Cell
y	O
cono	B-Cell
genes	B-Sequence
en	O
el	O
mismo	O
célula	B-Cell
podría	O
predisponer	O
a	O
la	O
célula	B-Cell
a	O
la	O
apoptosis	O
.	O

El	O
último	O
rasgo	O
común	O
entre	O
ratón	B-Taxon
rd7	O
y	O
humano	B-Protein
NR2E3	I-Protein
mutantes	B-Sequence
es	O
la	O
presencia	O
de	O
una	O
retina	O
anormalmente	O
laminada	O
con	O
ondulación	O
y	O
formación	O
de	O
rosetas	O
en	O
la	O
ONL	O
[	O
12	O
-	O
15	O
]	O
.	O

Se	O
desconoce	O
la	O
causa	O
de	O
esta	O
anormalidad	O
,	O
pero	O
posiblemente	O
esté	O
relacionada	O
con	O
defectos	O
en	O
célula	B-Cell
fotorreceptora	I-Cell
polaridad	O
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

La	O
formación	O
de	O
rosetas	O
y	O
el	O
epitelio	O
anormalmente	O
ondulado	O
son	O
secuelas	O
comunes	O
de	O
defectos	O
en	O
las	O
vías	O
que	O
controlan	O
célula	B-Cell
polaridad	O
[	O
46	O
,	O
47	O
]	O
.	O

En	O
particular	O
,	O
pérdida	O
de	O
función	O
mutaciones	B-Sequence
en	O
la	O
polaridad	O
gene	B-Sequence
migas	B-Protein
(	O
CRB1	B-Protein
)	O
han	O
demostrado	O
causar	O
anomalías	O
morfológicas	O
de	O
la	O
ONL	O
en	O
ambos	O
humanos	B-Taxon
y	O
ratones	B-Taxon
incluida	O
la	O
formación	O
de	O
rosetas	O
en	O
ratones	B-Taxon
muy	O
similar	O
a	O
la	O
que	O
se	O
ve	O
en	O
la	O
rd7	O
mutante	B-Sequence
[	O
48	O
,	O
49	O
]	O
.	O

Curiosamente	O
,	O
Sharon	O
et	O
al	O
.	O

[	O
5	O
]	O
recientemente	O
han	O
señalado	O
características	O
adicionales	O
compartidas	O
por	O
pacientes	O
con	O
CRB1	B-Protein
mutaciones	B-Sequence
y	O
mutaciones	B-Sequence
en	O
NR2E3	B-Protein
,	O
incluidos	O
errores	O
refractivos	O
hipermétropes	O
y	O
un	O
patrón	O
distintivo	O
de	O
pigmentación	O
agrupada	O
en	O
la	O
retina	O
.	O

En	O
el	O
presente	O
estudio	O
encontramos	O
la	O
ratón	B-Taxon
migas	B-Protein
ortólogo	B-Sequence
estar	O
arriba	O
-	O
regulado	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
por	O
microarray	O
,	O
consistente	O
con	O
su	O
mayor	O
nivel	O
de	O
expresión	O
en	O
conos	B-Cell
que	O
en	O
varillas	B-Cell
[	O
50	O
]	O
.	O

Aunque	O
no	O
pudimos	O
confirmar	O
este	O
hallazgo	O
por	O
hibridación	O
in	O
situ	O
debido	O
a	O
la	O
debilidad	O
de	O
la	O
señal	O
,	O
es	O
posible	O
que	O
la	O
sobrerregulación	O
de	O
migas	B-Protein
en	O
la	O
retina	O
es	O
la	O
causa	O
de	O
los	O
defectos	O
de	O
laminación	O
vistos	O
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Sobreexpresión	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
migas	B-Protein
en	O
drosófila	B-Taxon
Se	O
ha	O
demostrado	O
que	O
causa	O
defectos	O
de	O
polaridad	O
que	O
conducen	O
a	O
la	O
ondulación	O
de	O
los	O
epitelios	O
e	O
incluso	O
a	O
la	O
desalineación	O
de	O
núcleos	B-GENE
dentro	O
de	O
fotorreceptores	B-Cell
análogo	O
a	O
lo	O
que	O
se	O
ve	O
en	O
la	O
retina	O
rd7	O
[	O
47	O
,	O
51	O
]	O
.	O

Los	O
experimentos	O
futuros	O
abordarán	O
esta	O
pregunta	O
al	O
sobreexpresar	O
la	O
longitud	O
completa	O
Crb1	B-Protein
en	O
un	O
tipo	B-Sequence
salvaje	I-Sequence
antecedentes	O
.	O

Otro	O
punto	O
digno	O
de	O
mención	O
es	O
la	O
sorprendente	O
similitud	O
entre	O
el	O
híbrido	O
fotorreceptor	B-Cell
identificados	O
en	O
este	O
estudio	O
y	O
de	O
origen	O
natural	O
fotorreceptor	B-Cell
encontrado	O
en	O
ardillas	B-Taxon
de	I-Taxon
tierra	I-Taxon
.	O

``	O
Los	O
``	O
''	O
''	O
varillas	B-Cell
de	O
esta	O
especie	O
tienen	O
electrofisiológicos	O
,	O
molecular	B-Chemical
,	O
y	O
las	O
características	O
ultraestructurales	O
de	O
ambos	O
varillas	B-Cell
y	O
conos	B-Cell
[	O
52	O
-	O
58	O
]	O
.	O

``	O
Aunque	O
estos	O
hallazgos	O
inusuales	O
han	O
sido	O
difíciles	O
de	O
interpretar	O
bajo	O
los	O
supuestos	O
habituales	O
de	O
la	O
``	O
''	O
teoría	O
de	O
la	O
duplicidad	O
''	O
''	O
[	O
56	O
]	O
,	O
nos	O
gustaría	O
sugerir	O
que	O
''	O
ardillas	B-Taxon
de	I-Taxon
tierra	I-Taxon
puede	O
haber	O
experimentado	O
una	O
disminución	O
natural	O
o	O
pérdida	O
de	O
nr2e3	B-Protein
``	O
expresión	O
en	O
su	O
``	O
''	O
''	O
varillas	B-Cell
que	O
los	O
transformó	O
en	O
un	O
híbrido	O
célula	B-Cell
fotorreceptora	I-Cell
escribe	O
.	O

Se	O
desconoce	O
el	O
significado	O
adaptativo	O
de	O
tal	O
cambio	O
,	O
si	O
lo	O
hay	O
,	O
y	O
puede	O
deberse	O
simplemente	O
a	O
la	O
relajación	O
de	O
la	O
presión	O
selectiva	O
para	O
la	O
visión	O
nocturna	O
en	O
esta	O
especie	O
estrictamente	O
diurna	O
.	O

Materiales	O
y	O
métodos	O

mutante	B-Sequence
ratones	B-Taxon
.	O

Nr2e3rd7	O
mutante	B-Sequence
ratones	B-Taxon
se	O
obtuvieron	O
de	O
Jackson	O
Laboratories	O
(	O
Bar	O
Harbor	O
,	O
Maine	O
,	O
Estados	O
Unidos	O
;	O
código	O
RS	O
004643	O
)	O
y	O
se	O
mantuvieron	O
en	O
un	O
fondo	O
C57BL/6	O
.	O

Todo	O
controlado	O
ratones	B-Taxon
eran	O
C57BL/6	O
.	O

Análisis	O
de	O
micromatrices	O
.	O

retina	O
total	O
ARN	B-Sequence
las	O
muestras	O
se	O
aislaron	O
de	O
P0	O
,	O
P6	O
,	O
P14	O
y	O
P21	O
nr2e3	B-Protein
mutante	B-Sequence
ratones	B-Taxon
usando	O
el	O
Trizol	O
reactivo	B-Chemical
(	O
Gibco	O
,	O
San	O
Diego	O
,	O
California	O
.	O
Estados	O
Unidos	O
)	O
.	O

retina	O
total	O
ARN	B-Sequence
muestras	O
de	O
edad	O
-	O
emparejadas	O
tipo	B-Sequence
salvaje	I-Sequence
C57BL	O
/	O
6	O
ratones	B-Taxon
se	O
usaron	O
como	O
controles	O
.	O

totales	O
individuales	O
ARN	B-Sequence
Las	O
muestras	O
se	O
derivaron	O
de	O
cuatro	O
retinas	O
(	O
agrupadas	O
de	O
dos	O
animales	B-Taxon
)	O
.	O

Todos	O
los	O
experimentos	O
de	O
microarrays	O
se	O
realizaron	O
por	O
triplicado	O
,	O
en	O
cada	O
caso	O
con	O
ARN	B-Sequence
preparaciones	O

Experimentos	O
de	O
micromatrices	O
con	O
ADNc	B-Sequence
se	O
realizaron	O
con	O
las	O
muestras	O
derivadas	O
de	O
P0	O
,	O
P6	O
y	O
P14	O
.	O

Sondas	B-Sequence
fueron	O
etiquetados	O
con	O
Cy3	O
o	O
Cy5	O
usando	O
el	O
kit	O
Array	O
900	O
de	O
Genisphere	O
(	O
Hatfield	O
,	O
Pensilvania	O
,	O
Estados	O
Unidos	O
)	O
comenzando	O
con	O
5	O
ug	O
de	O
total	O
ARN	B-Sequence
según	O
las	O
instrucciones	O
del	O
fabricante	O
.	O

Tipo	B-Sequence
salvaje	I-Sequence
control	O
sondas	B-Sequence
fueron	O
comparados	O
con	O
mutante	B-Sequence
en	O
el	O
mismo	O
microarreglo	O
.	O

En	O
dos	O
de	O
las	O
tres	O
repeticiones	O
,	O
el	O
sonda	B-Sequence
mutante	I-Sequence
fue	O
etiquetado	O
con	O
Cy3	O
y	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
con	O
Cy5	O
,	O
y	O
en	O
la	O
tercera	O
réplica	O
se	O
intercambiaron	O
los	O
colorantes	O
.	O

Etiquetado	O
Investigacion	B-Sequence
se	O
hibridó	O
con	O
portaobjetos	O
de	O
microarray	O
manchados	O
con	O
aproximadamente	O
11	O
500	O
clones	B-Sequence
de	I-Sequence
ADNc	I-Sequence
del	O
cerebro	O
molecular	B-Chemical
biblioteca	O
del	O
proyecto	O
de	O
anatomía	O
(	O
obsequio	O
amable	O
de	O
B.	O
Soares	O
,	O
Universidad	O
de	O
Iowa	O
;	O
consulte	O
http	O
:	O
//trans.nih.gov/bmap/index.htm	O
para	O
obtener	O
más	O
detalles	O
)	O
y	O
500	O
clones	B-Sequence
de	I-Sequence
ADNc	I-Sequence
de	O
nuestra	O
colección	O
de	O
laboratorio	O
.	O

Los	O
portaobjetos	O
se	O
imprimieron	O
e	O
hibridaron	O
como	O
se	O
describe	O
[	O
59	O
,	O
60	O
]	O
.	O

Después	O
de	O
la	O
hibridación	O
y	O
el	O
lavado	O
de	O
los	O
portaobjetos	O
según	O
las	O
instrucciones	O
del	O
fabricante	O
(	O
Genisphere	O
)	O
,	O
los	O
portaobjetos	O
se	O
escanearon	O
en	O
un	O
escáner	O
GenePix	O
4000	O
de	O
Axon	O
Instruments	O
(	O
Union	O
City	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
y	O
las	O
imágenes	O
se	O
analizaron	O
con	O
el	O
paquete	O
de	O
software	O
GenePix	O
Pro	O
adjunto	O
.	O

El	O
crudo	O
completo	O
ADNc	B-Sequence
El	O
conjunto	O
de	O
datos	O
de	O
micromatrices	O
está	O
disponible	O
en	O
las	O
Tablas	O
S6-S14	O
.	O

Se	O
realizaron	O
dos	O
tipos	O
de	O
normalización	O
en	O
las	O
puntuaciones	O
de	O
intensidad	O
sin	O
procesar	O
derivadas	O
del	O
análisis	O
GenePix	O
Pro	O
.	O

Primero	O
,	O
para	O
un	O
experimento	O
dado	O
,	O
la	O
intensidad	O
promedio	O
de	O
todos	O
los	O
puntos	O
en	O
el	O
más	O
débil	O
de	O
los	O
dos	O
canales	O
(	O
Cy3	O
o	O
Cy5	O
)	O
se	O
normalizó	O
a	O
aquellos	O
en	O
el	O
canal	O
más	O
fuerte	O
.	O

En	O
segundo	O
lugar	O
,	O
en	O
un	O
conjunto	O
dado	O
de	O
experimentos	O
realizados	O
por	O
triplicado	O
en	O
un	O
punto	O
de	O
tiempo	O
particular	O
,	O
los	O
dos	O
experimentos	O
con	O
la	O
intensidad	O
de	O
señal	O
promedio	O
más	O
débil	O
sobre	O
todos	O
los	O
puntos	O
se	O
normalizaron	O
a	O
aquellos	O
en	O
el	O
tercer	O
microarreglo	O
con	O
la	O
intensidad	O
de	O
señal	O
promedio	O
más	O
fuerte	O
.	O

Todos	O
los	O
puntos	O
con	O
niveles	O
de	O
señal	O
iguales	O
o	O
inferiores	O
al	O
fondo	O
se	O
eliminaron	O
del	O
análisis	O
.	O

Los	O
archivos	O
resultantes	O
contenían	O
una	O
media	O
de	O
6.000	O
anuncios	O
.	O

Luego	O
,	O
estos	O
archivos	O
se	O
clasificaron	O
de	O
acuerdo	O
con	O
la	O
intensidad	O
de	O
la	O
señal	O
Cy3/Cy5	O
,	O
y	O
los	O
puntos	O
con	O
el	O
10	O
%	O
más	O
alto	O
y	O
el	O
10	O
%	O
más	O
bajo	O
de	O
intensidad	O
(	O
aproximadamente	O
600	O
puntos/experimento	O
)	O
se	O
compararon	O
entre	O
los	O
tres	O
experimentos	O
en	O
un	O
punto	O
de	O
tiempo	O
dado	O
usando	O
secuencias	O
de	O
comandos	O
Perl	O
personalizadas	O
(	O
disponible	O
a	O
pedido	O
de	O
JCC	O
)	O
.	O

Todos	O
los	O
lugares	O
que	O
estaban	O
presentes	O
en	O
el	O
10	O
%	O
superior	O
más	O
regulados	O
hacia	O
arriba	O
o	O
hacia	O
abajo	O
genes	B-Sequence
en	O
dos	O
de	O
tres	O
o	O
tres	O
de	O
tres	O
experimentos	O
se	O
registraron	O
(	O
estos	O
últimos	O
se	O
enumeran	O
en	O
la	O
Tabla	O
S3	O
)	O
.	O

El	O
análisis	O
de	O
micromatrices	O
de	O
las	O
retinas	O
P21	O
se	O
realizó	O
en	O
Affymetrix	O
ratón	B-Taxon
genoma	B-Sequence
430	O
2	O
.	O
0	O
Array	O
GeneChip	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
.	O

Se	O
realizaron	O
un	O
total	O
de	O
seis	O
hibridaciones	O
de	O
micromatrices	O
:	O
tres	O
con	O
sondas	B-Sequence
derivado	O
de	O
ARN	B-Sequence
mutante	I-Sequence
y	O
tres	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
.	O

Sondas	B-Sequence
fueron	O
sintetizados	O
a	O
partir	O
de	O
10	O
µg	O
de	O
total	O
ARN	B-Sequence
para	O
cada	O
muestra	O
según	O
las	O
instrucciones	O
del	O
fabricante	O
(	O
Affymetrix	O
)	O
.	O

La	O
hibridación	O
,	O
el	O
lavado	O
y	O
la	O
exploración	O
de	O
las	O
micromatrices	O
se	O
realizaron	O
en	O
el	O
Centro	O
Bauer	O
para	O
la	O
Investigación	O
Genómica	O
de	O
la	O
Universidad	O
de	O
Harvard	O
de	O
acuerdo	O
con	O
las	O
instrucciones	O
del	O
fabricante	O
(	O
Affymetrix	O
)	O
.	O

El	O
análisis	O
de	O
datos	O
inicial	O
se	O
llevó	O
a	O
cabo	O
usando	O
el	O
software	O
GeneChip	O
Operating	O
System	O
(	O
GCOS	O
)	O
de	O
Affymetrix	O
.	O

Se	O
realizaron	O
comparaciones	O
por	O
pares	O
entre	O
individuos	O
mutante	B-Sequence
resultados	O
y	O
controles	O
de	O
microarrays	O
.	O

Todos	O
genes	B-Sequence
``	O
fueron	O
eliminados	O
del	O
análisis	O
para	O
los	O
cuales	O
el	O
software	O
hizo	O
llamadas	O
``	O
''	O
ausentes	O
''	O
''	O
tanto	O
para	O
el	O
''	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
mutante	B-Sequence
muestras	O
que	O
se	O
comparan	O
.	O

El	O
restante	O
gene	B-Sequence
las	O
listas	O
contenían	O
aproximadamente	O
26	O
000	O
transcripciones	B-Sequence
.	O

A	O
continuación	O
,	O
estas	O
listas	O
se	O
ordenaron	O
según	O
el	O
mutante	B-Sequence
-	O
para	O
-	O
tipo	B-Sequence
salvaje	I-Sequence
relación	O
de	O
registro	O
de	O
señal	O
para	O
identificar	O
las	O
más	O
marcadamente	O
reguladas	O
hacia	O
arriba	O
y	O
hacia	O
abajo	O
genes	B-Sequence
.	O

Los	O
500	O
más	O
regulados	O
hacia	O
arriba	O
y	O
hacia	O
abajo	O
transcripciones	B-Sequence
(	O
aproximadamente	O
el	O
2	O
%	O
de	O
todos	O
genes	B-Sequence
en	O
cada	O
caso	O
)	O
de	O
cada	O
una	O
de	O
las	O
tres	O
comparaciones	O
por	O
pares	O
entre	O
mutante	B-Sequence
y	O
tipo	B-Sequence
salvaje	I-Sequence
se	O
compararon	O
utilizando	O
secuencias	O
de	O
comandos	O
Perl	O
personalizadas	O
(	O
disponibles	O
a	O
pedido	O
de	O
JCC	O
)	O
para	O
identificar	O
aquellos	O
genes	B-Sequence
que	O
estaban	O
presentes	O
en	O
dos	O
o	O
tres	O
de	O
las	O
tres	O
listas	O
.	O

Esos	O
genes	B-Sequence
que	O
fueron	O
regulados	O
hacia	O
arriba	O
o	O
hacia	O
abajo	O
en	O
tres	O
de	O
los	O
tres	O
experimentos	O
se	O
registraron	O
(	O
Tablas	O
S4	O
y	O
S5	O
)	O
.	O

Los	O
conjuntos	O
completos	O
de	O
datos	O
de	O
microarreglos	O
de	O
Affymetrix	O
por	O
pares	O
están	O
disponibles	O
en	O
las	O
Tablas	O
S15-S17	O
.	O

Hibridación	O
in	O
situ	O
.	O

La	O
hibridación	O
in	O
situ	O
de	O
la	O
sección	O
se	O
realizó	O
como	O
se	O
describió	O
anteriormente	O
[	O
61	O
]	O
usando	O
criosecciones	O
de	O
20	O
mu	O
m	O
de	O
tejido	O
embebido	O
en	O
OCT	O
o	O
secciones	O
de	O
parafina	O
de	O
4	O
mu	O
m	O
.	O

Todas	O
las	O
hibridaciones	O
in	O
situ	O
se	O
realizaron	O
con	O
el	O
mutante	B-Sequence
y	O
tipo	B-Sequence
salvaje	I-Sequence
secciones	O
de	O
control	O
en	O
el	O
mismo	O
portaobjetos	O
de	O
vidrio	O
.	O

Ribosondas	O
marcadas	O
con	O
digoxigenina	B-Chemical
#	O
¿NOMBRE	O
?	O
UTP	B-Chemical
(	O
Roche	O
,	O
Basilea	O
,	O
Suiza	O
)	O
fueron	O
detectados	O
con	O
NBT/BCIP	O
(	O
Sigma	O
,	O
St.	O
Louis	O
,	O
Missouri	O
,	O
Estados	O
Unidos	O
)	O
.	O

Las	O
fuentes	O
de	O
las	O
ribosondas	O
individuales	O
utilizadas	O
en	O
este	O
estudio	O
se	O
describen	O
en	O
las	O
tablas	O
S1	O
y	O
S2	O
.	O

disociado	O
célula	B-Cell
hibridación	O
in	O
situ	O
se	O
realizó	O
como	O
se	O
describe	O
anteriormente	O
[	O
62	O
]	O
utilizando	O
el	O
mismo	O
S	B-Protein
-	I-Protein
opsina	I-Protein
digoxigenina	B-Chemical
#	O
¿NOMBRE	O
?	O
Investigacion	B-Sequence
utilizado	O
para	O
la	O
sección	O
de	O
hibridación	O
in	O
situ	O
.	O

Todas	O
las	O
imágenes	O
fueron	O
capturadas	O
en	O
un	O
microscopio	O
compuesto	O
(	O
Eclipse	O
e1000	O
;	O
Nikon	O
,	O
Tokio	O
,	O
Japón	O
)	O
utilizando	O
una	O
cámara	O
CCD	O
(	O
DXM1200F	O
,	O
Nikon	O
)	O
.	O

S	B-Protein
-	I-Protein
opsina	I-Protein
positivo	O
células	B-Cell
fueron	O
cuantificados	O
en	O
disociados	O
célula	B-Cell
hibridación	O
in	O
situ	O
como	O
se	O
ha	O
descrito	O
anteriormente	O
[	O
62	O
]	O
.	O

Se	O
cuantificaron	O
veinte	O
campos	O
de	O
esta	O
manera	O
con	O
un	O
aumento	O
de	O
200	O
x	O
tanto	O
para	O
rd7	O
como	O
para	O
tipo	B-Sequence
salvaje	I-Sequence
retinas	O

Inmunohistoquímica	O
.	O

Para	O
anticuerpo	B-GENE
tinción	O
,	O
se	O
prepararon	O
criosecciones	O
y	O
se	O
tiñeron	O
como	O
se	O
describió	O
anteriormente	O
[	O
63	O
]	O
.	O

Primario	O
anticuerpos	B-GENE
utilizados	O
fueron	O
un	O
anti	O
policlonal	O
-	O
opsina	B-Protein
azul	I-Protein
criado	O
en	O
Conejo	B-Taxon
(	O
1	O
:	O
300	O
;	O
Chemicon	O
International	O
,	O
Temecula	O
,	O
California	O
,	O
Estados	O
Unidos	O
;	O
AB5407	O
)	O
y	O
un	O
ratón	B-Taxon
anti	O
monoclonal	O
-	O
rodopsina	B-Protein
(	O
1	O
:	O
200	O
;	O
rho4D2	O
)	O
.	O

Secundario	O
anticuerpos	B-GENE
utilizados	O
fueron	O
Cy2	O
-	O
o	O
Cy3	O
-	O
conjugados	O
cabra	B-Taxon
anti	O
-	O
Conejo	B-Taxon
y	O
anti-	O
ratón	B-Taxon
(	O
1	O
:	O
500	O
;	O
Jackson	O
Immunologicals	O
,	O
West	O
Grove	O
,	O
Pensilvania	O
,	O
Estados	O
Unidos	O
)	O
.	O

Siguiente	O
anticuerpo	B-GENE
tinción	O
,	O
se	O
aplicó	O
4	O
'	O
-	O
DAPI	O
para	O
teñir	O
núcleos	B-GENE
(	O
Sigma	O
)	O
,	O
y	O
las	O
secciones	O
fueron	O
cubiertas	O
y	O
montadas	O
en	O
Gel/Mount	O
(	O
Biomeda	O
,	O
Foster	O
City	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
.	O

Electrón	B-Chemical
microscopía	O

Este	O
protocolo	O
fue	O
adaptado	O
del	O
utilizado	O
por	O
Raviola	O
[	O
64	O
]	O
con	O
algunas	O
modificaciones	O
derivadas	O
de	O
Carter-Dawson	O
y	O
Lavail	O
[	O
26	O
]	O
.	O

cuatro	O
adultos	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
cuatro	O
mutante	B-Sequence
animales	B-Taxon
fueron	O
profundamente	O
anestesiados	O
mediante	O
una	O
inyección	O
intraperitoneal	O
de	O
Avertin	O
y	O
luego	O
se	O
extrajeron	O
los	O
ojos	O
.	O

La	O
córnea	O
se	O
punzó	O
suavemente	O
con	O
pinzas	O
afiladas	O
y	O
se	O
extirpó	O
con	O
tijeras	O
de	O
iridectomía	O
.	O

Luego	O
se	O
transfirió	O
el	O
ojo	O
a	O
una	O
solución	O
de	O
paraformaldehído	O
al	O
2	O
%	O
/	O
glutaraldehído	O
al	O
2	O
%	O
en	O
cacodilato	B-Chemical
tampón	O
(	O
0	O
.	O
1	O
M	O
ácido	B-Chemical
cacodílico	I-Chemical
;	O
0	O
1	O
%	O
cloruro	B-Chemical
de	I-Chemical
calcio	I-Chemical
)	O
.	O

La	O
lente	O
se	O
retiró	O
suavemente	O
y	O
la	O
copa	O
ocular	O
se	O
dejó	O
fijar	O
durante	O
2	O
horas	O
a	O
temperatura	O
ambiente	O
.	O

A	O
continuación	O
,	O
el	O
ojo	O
fijo	O
se	O
colocó	O
sobre	O
cera	O
dental	O
y	O
se	O
seccionó	O
en	O
la	O
línea	O
media	O
con	O
una	O
hoja	O
de	O
afeitar	O
nueva	O
(	O
la	O
mitad	O
de	O
las	O
retinas	O
se	O
seccionaron	O
a	O
lo	O
largo	O
del	O
eje	O
D-V	O
y	O
la	O
otra	O
mitad	O
a	O
lo	O
largo	O
del	O
eje	O
nasal-temporal	O
)	O
.	O

Las	O
retinas	O
(	O
y	O
el	O
retinal	O
adherido	O
pigmento	B-Chemical
epitelio	O
)	O
se	O
disecaron	O
cuidadosamente	O
de	O
la	O
esclerótica	O
,	O
que	O
se	O
descartó	O
.	O

A	O
continuación	O
,	O
las	O
retinas	O
se	O
enjuagaron	O
cuatro	O
veces	O
durante	O
15	O
min	O
cada	O
una	O
con	O
tampón	O
de	O
Sorenson	O
(	O
pH	O
7,4	O
)	O
.	O

Luego	O
se	O
tiñeron	O
durante	O
2	O
horas	O
a	O
4	O
grados	O
C	O
con	O
1	O
%	O
osmio	B-Chemical
tetróxido	O
en	O
1	O
.	O
5	O
%	O
ferrocianuro	B-Chemical
de	I-Chemical
potasio	I-Chemical
.	O

A	O
continuación	O
,	O
las	O
retinas	O
se	O
enjuagaron	O
cuatro	O
veces	O
durante	O
15	O
min	O
en	O
maleato	B-Chemical
tampón	O
(	O
pH	O
5	O
.	O
1	O
)	O
y	O
luego	O
teñido	O
durante	O
2	O
h	O
a	O
temperatura	O
ambiente	O
con	O
1	O
%	O
acetato	B-Chemical
de	I-Chemical
uranilo	I-Chemical
en	O
maleato	B-Chemical
tampón	O
(	O
pH	O
6,2	O
)	O
.	O

Luego	O
se	O
lavaron	O
cuatro	O
veces	O
durante	O
15	O
min	O
con	O
maleato	B-Chemical
tampón	O
(	O
pH	O
5,1	O
)	O
;	O
una	O
vez	O
durante	O
10	O
min	O
con	O
70	O
%	O
etanol	B-Chemical
;	O
una	O
vez	O
durante	O
10	O
min	O
con	O
95	O
%	O
etanol	B-Chemical
;	O
y	O
cuatro	O
veces	O
por	O
30	O
min	O
con	O
100	O
%	O
etanol	B-Chemical
.	O

A	O
continuación	O
,	O
las	O
retinas	O
se	O
lavaron	O
tres	O
veces	O
durante	O
una	O
hora	O
con	O
óxido	B-Chemical
de	I-Chemical
propileno	I-Chemical
y	O
luego	O
incrustado	O
en	O
resina	O
TAAB	O
812	O
(	O
Marivac	O
,	O
Quebec	O
,	O
Canadá	O
)	O
durante	O
1-2	O
días	O
en	O
un	O
horno	O
a	O
60	O
grados	O
C	O
.	O

Se	O
cortaron	O
secciones	O
semidelgadas	O
a	O
un	O
espesor	O
de	O
0	O
.	O
5	O
mu	O
m	O
y	O
teñido	O
con	O
azul	O
de	O
toluidina	O
al	O
1	O
%	O
en	O
1	O
%	O
Borato	B-Chemical
de	I-Chemical
sodio	I-Chemical
buffer	O
.	O

Imágenes	O
de	O
secciones	O
semi	O
-	O
delgadas	O
de	O
la	O
mutante	B-Sequence
retina	O
se	O
tomaron	O
dentro	O
de	O
los	O
dos	O
tercios	O
ventrales	O
de	O
la	O
retina	O
donde	O
la	O
mayoría	O
de	O
los	O
supernumerarios	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
residir	O

Tipo	B-Sequence
salvaje	I-Sequence
las	O
imágenes	O
fueron	O
tomadas	O
en	O
regiones	O
comparables	O
.	O

Secciones	O
para	O
electrón	B-Chemical
microscopía	O
se	O
cortaron	O
a	O
un	O
espesor	O
de	O
95	O
nm	O
,	O
se	O
colocaron	O
en	O
rejillas	O
y	O
se	O
posteñeron	O
con	O
2	O
%	O
acetato	B-Chemical
de	I-Chemical
uranilo	I-Chemical
seguido	O
de	O
0	O
.	O
2	O
%	O
citrato	B-Chemical
de	I-Chemical
plomo	I-Chemical
.	O

Todas	O
las	O
secciones	O
se	O
cortaron	O
en	O
un	O
plano	O
perpendicular	O
al	O
plano	O
de	O
la	O
fotorreceptor	B-Cell
capa	O
.	O

Luego	O
se	O
visualizaron	O
en	O
un	O
Jeol	O
1200EX	O
electrón	B-Chemical
microscopio	O
(	O
Jeol	O
,	O
Tokio	O
,	O
Japón	O
)	O
.	O

los	O
electrón	B-Chemical
Las	O
imágenes	O
microscópicas	O
de	O
la	O
Figura	O
7	O
se	O
derivan	O
de	O
los	O
dos	O
tercios	O
ventrales	O
del	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
mutante	B-Sequence
retinas	O

El	O
área	O
de	O
la	O
cuerpos	B-GENE
celulares	I-GENE
de	O
El	O
varillas	B-Cell
``	O
y	O
``	O
''	O
''	O
vara	B-Cell
``	O
-	O
me	O
gusta	O
``	O
''	O
''	O
células	B-Cell
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
mutante	B-Sequence
Los	O
ONL	O
,	O
respectivamente	O
,	O
se	O
cuantificaron	O
de	O
la	O
siguiente	O
manera	O
.	O

Primero	O
,	O
diez	O
campos	O
dentro	O
de	O
la	O
ONL	O
se	O
eligieron	O
al	O
azar	O
con	O
un	O
aumento	O
de	O
1	O
000	O
x	O
y	O
luego	O
se	O
fotografiaron	O
con	O
un	O
aumento	O
de	O
4	O
000	O
x	O
para	O
cada	O
uno	O
de	O
los	O
dos	O
genotipos	B-Sequence
.	O

Estas	O
imágenes	O
normalmente	O
contenían	O
35	O
-	O
45	O
cuerpos	B-GENE
celulares	I-GENE
.	O

Para	O
cuantificar	O
sólo	O
el	O
área	O
de	O
esos	O
cuerpos	B-GENE
celulares	I-GENE
que	O
fueron	O
cortados	O
tan	O
cerca	O
de	O
la	O
línea	O
media	O
de	O
la	O
célula	B-Cell
como	O
sea	O
posible	O
(	O
es	O
decir	O
,	O
con	O
el	O
fin	O
de	O
obtener	O
el	O
área	O
transversal	O
máxima	O
)	O
los	O
cinco	O
células	B-Cell
con	O
el	O
área	O
aparente	O
más	O
grande	O
en	O
cada	O
fotografía	O
fueron	O
elegidos	O
a	O
simple	O
vista	O
y	O
el	O
contorno	O
de	O
la	O
membranas	B-GENE
celulares	I-GENE
fueron	O
calcados	O
en	O
papel	O
blanco	O
.	O

Estos	O
trazados	O
se	O
escanearon	O
junto	O
con	O
la	O
barra	O
de	O
tamaño	O
de	O
la	O
electrón	B-Chemical
micrografías	O
,	O
y	O
las	O
áreas	O
de	O
las	O
imágenes	O
digitales	O
resultantes	O
se	O
cuantificaron	O
usando	O
el	O
software	O
Scion	O
Image	O
(	O
NIH	O
Image	O
,	O
http	O
:	O
//rsb.info.nih.gov/nih-image	O
)	O
.	O

Un	O
total	O
de	O
50	O
células	B-Cell
de	O
cada	O
genotipo	B-Sequence
fueron	O
cuantificados	O
de	O
esta	O
manera	O
.	O

Además	O
,	O
para	O
evaluar	O
el	O
porcentaje	O
de	O
varillas	B-Cell
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
retina	O
que	O
tenía	O
alguna	O
mitocondrias	B-GENE
yuxtanucleares	I-GENE
,	O
todos	O
varillas	B-Cell
dentro	O
de	O
las	O
diez	O
imágenes	O
se	O
contaron	O
al	O
igual	O
que	O
el	O
número	O
de	O
células	B-Cell
demostración	O
orgánulos	B-GENE
yuxtanucleares	I-GENE
.	O

Un	O
total	O
de	O
seis	O
de	O
399	O
tipo	B-Sequence
salvaje	I-Sequence
varillas	B-Cell
(	O
1	O
.	O
5	O
%	O
)	O
poseía	O
un	O
orgánulo	B-GENE
yuxtanuclear	I-GENE
.	O

Este	O
análisis	O
nos	O
permitió	O
evaluar	O
la	O
tipo	B-Sequence
salvaje	I-Sequence
varillas	B-Cell
por	O
mitocondrias	B-GENE
yuxtanucleares	I-GENE
en	O
múltiples	O
planos	O
de	O
sección	O
;	O
sin	O
embargo	O
,	O
secciones	O
seriadas	O
de	O
individuos	O
cuerpos	B-GENE
celulares	I-GENE
no	O
se	O
realizaron	O
.	O

información	O
de	O
soporte	O

Las	O
figuras	O
S1	O
-	O
S7	O
muestran	O
las	O
imágenes	O
de	O
hibridación	O
in	O
situ	O
de	O
todos	O
genes	B-Sequence
discutido	O
en	O
el	O
documento	O
(	O
ver	O
Tablas	O
S1	O
y	O
S2	O
)	O
.	O

Todas	O
las	O
imágenes	O
emparejadas	O
(	O
que	O
muestran	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
control	O
a	O
la	O
izquierda	O
y	O
el	O
rd7	O
mutante	B-Sequence
retina	O
a	O
la	O
derecha	O
)	O
están	O
etiquetados	O
en	O
la	O
esquina	O
inferior	O
izquierda	O
con	O
el	O
gene	B-Sequence
símbolo	O
seguido	O
de	O
la	O
edad	O
de	O
las	O
retinas	O
en	O
cuestión	O
(	O
P6	O
,	O
P14	O
,	O
P28	O
o	O
adulto	O
)	O
.	O

Las	O
imágenes	O
no	O
emparejadas	O
representan	O
puntos	O
de	O
tiempo	O
prenatales	O
y	O
están	O
etiquetadas	O
con	O
el	O
gene	B-Sequence
símbolo	O
de	O
la	O
gene	B-Sequence
``	O
en	O
cuestión	O
(	O
``	O
''	O
''	O
peso	B-Sequence
indica	O
que	O
la	O
retina	O
es	O
de	O
un	O
tipo	B-Sequence
salvaje	I-Sequence
animal	B-Taxon
)	O
y	O
una	O
designación	O
del	O
día	O
embrionario	O
del	O
que	O
deriva	O
la	O
retina	O
(	O
p	O
.	O
ej	O
.	O
,	O
e17	O
.	O
5	O
=	O
día	O
embrionario	O
17	O
.	O
5	O
)	O
.	O

Figura	O
S1	O

Imágenes	O
de	O
hibridación	O
in	O
situ	O
para	O
G1	O
-	O
G13	O
en	O
la	O
Tabla	O
S1	O

(	O
3	O
.	O
JPG	O
de	O
1	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S2	O

Imágenes	O
de	O
hibridación	O
in	O
situ	O
para	O
G14	O
-	O
G25	O
en	O
la	O
Tabla	O
S1	O

(	O
2	O
.	O
JPG	O
de	O
4	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S3	O

Imágenes	O
de	O
hibridación	O
in	O
situ	O
para	O
G26	O
-	O
G35	O
en	O
la	O
Tabla	O
S1	O

(	O
2	O
.	O
JPG	O
de	O
1	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S4	O

Imágenes	O
de	O
hibridación	O
in	O
situ	O
para	O
G36	O
-	O
G46	O
en	O
la	O
Tabla	O
S1	O

(	O
2	O
.	O
0	O
MB	O
JPG	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S5	O

Imágenes	O
de	O
hibridación	O
in	O
situ	O
para	O
G47	O
-	O
G53	O
en	O
la	O
Tabla	O
S1	O

(	O
1	O
.	O
JPG	O
de	O
7	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S6	O

Hibridación	O
in	O
situ	O
Imágenes	O
para	O
genes	B-Sequence
-	O
11	O
en	O
la	O
Tabla	O
S2	O

(	O
2	O
.	O
JPG	O
de	O
9	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S7	O

Hibridación	O
in	O
situ	O
Imágenes	O
para	O
genes	B-Sequence
12	O
-	O
22	O
en	O
la	O
Tabla	O
S2	O

(	O
3	O
.	O
JPG	O
de	O
2	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S8	O

Resultados	O
de	O
hibridación	O
in	O
situ	O
para	O
M	B-Protein
-	I-Protein
Opsina	I-Protein
y	O
Thrb2	B-Protein

Tenga	O
en	O
cuenta	O
que	O
el	O
M	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
están	O
dispersos	O
por	O
todo	O
el	O
ONL	O
en	O
P14	O
,	O
pero	O
parecen	O
haber	O
migrado	O
al	O
borde	O
escleral	O
del	O
ONL	O
en	O
P28	O
.	O

No	O
hay	O
cambio	O
en	O
el	O
número	O
de	O
M	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
Thrb2	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

(	O
2	O
.	O
PDF	O
de	O
1	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S1	O

Cono	B-Cell
#	O
¿NOMBRE	O
?	O
Cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
Evaluado	O
en	O
el	O
rd7	O
mutante	B-Sequence
por	O
Microarray	O
e	O
Hibridación	O
In	O
Situ	O

Esta	O
tabla	O
es	O
una	O
versión	O
complementaria	O
de	O
la	O
Figura	O
1	O
.	O

El	O
número	O
de	O
figura	O
indica	O
qué	O
figura	O
(	O
Figura	O
S1-S5	O
)	O
contiene	O
las	O
imágenes	O
de	O
hibridación	O
in	O
situ	O
correspondientes	O
a	O
la	O
gene	B-Sequence
en	O
cuestión	O
.	O

Laboratorio	O
Clon	B-Sequence
``	O
Información	O
``	O
''	O
indica	O
el	O
''	O
región	B-Sequence
del	I-Sequence
gen	I-Sequence
en	O
cuestión	O
de	O
donde	O
el	O
Investigacion	B-Sequence
utilizado	O
para	O
la	O
hibridación	O
in	O
situ	O
se	O
derivó	O
.	O

Todas	O
las	O
abreviaturas	O
son	O
como	O
se	O
indica	O
en	O
la	O
Figura	O
1	O
.	O

(	O
26	O
KB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S2	O

vara	B-Cell
genes	B-Sequence
Evaluado	O
en	O
el	O
rd7	O
mutante	B-Sequence
por	O
hibridación	O
in	O
situ	O

Esta	O
tabla	O
contiene	O
detalles	O
sobre	O
los	O
patrones	O
de	O
hibridación	O
in	O
situ	O
de	O
22	O
genes	B-Sequence
(	O
muchos	O
de	O
los	O
cuales	O
son	O
vara	B-Cell
-	O
específico	O
)	O
evaluado	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O

El	O
número	O
de	O
figura	O
indica	O
qué	O
figura	O
(	O
Figura	O
S6	O
o	O
S7	O
)	O
contiene	O
las	O
imágenes	O
de	O
hibridación	O
in	O
situ	O
correspondientes	O
a	O
la	O
gene	B-Sequence
en	O
cuestión	O
.	O

Laboratorio	O
Clon	B-Sequence
``	O
Información	O
``	O
''	O
indica	O
el	O
''	O
región	B-Sequence
del	I-Sequence
gen	I-Sequence
en	O
cuestión	O
de	O
donde	O
el	O
Investigacion	B-Sequence
utilizado	O
para	O
la	O
hibridación	O
in	O
situ	O
se	O
derivó	O
.	O

``	O
El	O
código	O
de	O
colores	O
de	O
los	O
resultados	O
de	O
la	O
hibridación	O
in	O
situ	O
bajo	O
``	O
''	O
Patrón	O
in	O
situ	O
''	O
''	O
es	O
el	O
siguiente	O
:	O
verde	O
oscuro	O
,	O
marcadamente	O
regulado	O
a	O
la	O
baja	O
;	O
verde	O
claro	O
,	O
levemente	O
regulado	O
a	O
la	O
baja	O
;	O
rojo	O
,	O
marcadamente	O
regulado	O
al	O
alza	O
;	O
anaranjado	O
,	O
levemente	O
regulado	O
al	O
alza	O
.	O
''	O

(	O
20KB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S3	O

Resumen	O
de	O
ADNc	B-Sequence
Resultados	O
de	O
micromatrices	O
de	O
P0	O
,	O
P6	O
y	O
P14	O

Los	O
puntos	O
enumerados	O
en	O
esta	O
tabla	O
representan	O
aquellos	O
que	O
fueron	O
regulados	O
hacia	O
arriba	O
o	O
hacia	O
abajo	O
en	O
tres	O
de	O
los	O
tres	O
experimentos	O
de	O
microarrays	O
como	O
se	O
describe	O
en	O
Materiales	O
y	O
Métodos	O
.	O

Las	O
relaciones	O
de	O
señal	O
Cy3/Cy5	O
se	O
indican	O
para	O
los	O
tres	O
experimentos	O
de	O
microarrays	O
en	O
cada	O
punto	O
de	O
tiempo	O
.	O

``	O
Tenga	O
en	O
cuenta	O
que	O
las	O
relaciones	O
Cy3/Cy5	O
para	O
el	O
``	O
''	O
Microarray	O
#	O
3	O
''	O
''	O
están	O
invertidas	O
en	O
relación	O
con	O
los	O
otros	O
dos	O
,	O
ya	O
que	O
el	O
''	O
etiqueta	B-Chemical
fluorescente	I-Chemical
solía	O
etiquetar	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
ARN	B-Sequence
mutante	I-Sequence
se	O
intercambió	O
como	O
se	O
describe	O
en	O
Materiales	O
y	O
Métodos	O
.	O

(	O
22	O
KB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S4	O

Resumen	O
de	O
genes	B-Sequence
Arriba	O
-	O
Regulado	O
en	O
rd7	O
mutante	B-Sequence
Retina	O
en	O
P21	O
por	O
Affymetrix	O
Microarray	O

Solamente	O
genes	B-Sequence
que	O
se	O
encontró	O
que	O
estaban	O
regulados	O
al	O
alza	O
en	O
tres	O
de	O
los	O
tres	O
experimentos	O
de	O
micromatrices	O
(	O
como	O
se	O
describe	O
en	O
Materiales	O
y	O
métodos	O
)	O
se	O
enumeran	O
.	O

nr2e3	B-Protein
``	O
señal	O
``	O
''	O
y	O
``	O
''	O
C57BL	O
/	O
6	O
señal	O
``	O
''	O
representan	O
la	O
señal	O
promedio	O
para	O
ese	O
''	O
transcripción	B-Sequence
en	O
los	O
tres	O
experimentos	O
de	O
microarrays	O
.	O

(	O
92	O
KB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S5	O

Resumen	O
de	O
genes	B-Sequence
Abajo	O
-	O
Regulado	O
en	O
rd7	O
mutante	B-Sequence
Retina	O
en	O
P21	O
por	O
Affymetrix	O
Microarray	O

Solamente	O
genes	B-Sequence
que	O
se	O
encontró	O
que	O
estaban	O
regulados	O
a	O
la	O
baja	O
en	O
tres	O
de	O
los	O
tres	O
experimentos	O
de	O
microarreglos	O
(	O
como	O
se	O
describe	O
en	O
Materiales	O
y	O
métodos	O
)	O
se	O
enumeran	O
.	O

nr2e3	B-Protein
``	O
señal	O
``	O
''	O
y	O
``	O
''	O
C57BL	O
/	O
6	O
señal	O
``	O
''	O
representan	O
la	O
señal	O
promedio	O
para	O
ese	O
''	O
transcripción	B-Sequence
en	O
los	O
tres	O
experimentos	O
de	O
microarrays	O
.	O

(	O
58	O
KB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S6	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P0	O
(	O
I	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S7	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P0	O
(	O
II	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Mesa	O
S8	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P0	O
(	O
III	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S9	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P6	O
(	O
I	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S10	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P6	O
(	O
II	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S11	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P6	O
(	O
III	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S12	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P14	O
(	O
I	O
)	O

(	O
5	O
.	O
5	O
MB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S13	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P14	O
(	O
II	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S14	O

Crudo	O
ADNc	B-Sequence
Datos	O
de	O
micromatrices	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P14	O
(	O
III	O
)	O

(	O
5	O
.	O
XLS	O
de	O
6	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S15	O

Datos	O
sin	O
procesar	O
de	O
microarrays	O
Affymetrix	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P21	O
(	O
I	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S16	O

Datos	O
sin	O
procesar	O
de	O
microarrays	O
Affymetrix	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P21	O
(	O
II	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S17	O

Datos	O
sin	O
procesar	O
de	O
microarrays	O
Affymetrix	O
para	O
rd7	O
versus	O
Tipo	B-Sequence
salvaje	I-Sequence
Comparación	O
en	O
P21	O
(	O
III	O
)	O

(	O
18	O
MB	O
XLS	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Agradecimientos	O

Agradecemos	O
a	O
E	O
.	O

Raviola	O
y	O
T	O
.	O

Reese	O
para	O
ayudar	O
con	O
electrón	B-Chemical
microscopía	O
y	O
a	O
A	O
.	O

Jadhav	O
y	O
J	O
.	O

Trimarchi	O
para	O
el	O
acceso	O
a	O
datos	O
no	O
publicados	O
y	O
reactivos	B-Chemical
.	O

Gracias	O
a	O
A	O
.	O

Jadhav	O
,	O
J	O
.	O

Trimarchi	O
,	O
D	O
.	O

Kim	O
y	O
T	O
.	O

Cherry	O
por	O
sus	O
útiles	O
comentarios	O
sobre	O
el	O
manuscrito	O
.	O

Este	O
trabajo	O
fue	O
apoyado	O
por	O
el	O
Instituto	O
Médico	O
Howard	O
Hughes	O
y	O
subvenciones	O
de	O
los	O
Institutos	O
Nacionales	O
de	O
Salud	O
(	O
EY014822	O
a	O
JCC	O
y	O
EY009676	O
a	O
CLC	O
)	O
.	O

Gracias	O
a	O
A	O
.	O

Swaroop	O
por	O
proporcionarnos	O
NRL	B-Protein
mutante	B-Sequence
ratones	B-Taxon
.	O

abreviaturas	O

DAPI	O
-	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
fenilindol	B-Chemical

E	O
[	O
número	O
]	O
-	O
día	O
embrionario	O
[	O
número	O
]	O

ERG	O
-	O
electrorretinograma	O

ESCS	O
-	O
mejorado	O
S	O
-	O
cono	B-Cell
síndrome	O

GCL	O
-	O
ganglio	O
célula	B-Cell
capa	O

INL	O
-	O
capa	O
nuclear	O
interna	O

ONL	O
-	O
capa	O
nuclear	O
externa	O

[	O
número	O
]	O
-	O
día	O
postnatal	O
[	O
número	O
]	O

Cifras	O

Figura	O
1	O

Cono	B-Cell
#	O
¿NOMBRE	O
?	O
Cono	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
Evaluado	O
en	O
el	O
rd7	O
mutante	B-Sequence
por	O
Microarray	O
e	O
Hibridación	O
In	O
Situ	O

``	O
El	O
código	O
de	O
colores	O
del	O
texto	O
en	O
la	O
columna	O
``	O
''	O
Nombre	O
del	O
gen	O
``	O
''	O
es	O
el	O
siguiente	O
:	O
azul	O
claro	O
(	O
G1	O
-	O
G15	O
)	O
,	O
''	O
genes	B-Sequence
reportado	O
previamente	O
en	O
la	O
literatura	O
que	O
tiene	O
cono	B-Cell
#	O
¿NOMBRE	O
?	O
cono	B-Cell
-	O
patrones	O
de	O
expresión	O
enriquecidos	O
;	O
amarillo	O
(	O
G16	O
-	O
G25	O
)	O
,	O
novela	O
cono	B-Cell
genes	B-Sequence
identificado	O
en	O
un	O
estudio	O
no	O
relacionado	O
(	O
datos	O
no	O
publicados	O
)	O
;	O
verde	O
oscuro	O
(	O
G26	O
-	O
G36	O
)	O
,	O
novela	O
cono	B-Cell
genes	B-Sequence
identificados	O
en	O
el	O
presente	O
estudio	O
que	O
fueron	O
regulados	O
al	O
alza	O
en	O
rd7	O
;	O
verde	O
claro	O
(	O
G37	O
-	O
G46	O
)	O
,	O
adicional	O
genes	B-Sequence
se	O
encontró	O
que	O
estaba	O
regulado	O
al	O
alza	O
en	O
rd7	O
por	O
microarray	O
en	O
el	O
presente	O
estudio	O
,	O
pero	O
que	O
tenía	O
un	O
efecto	O
débil	O
o	O
inaparente	O
cono	B-Cell
-	O
señal	O
específica	O
sobre	O
hibridación	O
in	O
situ	O
;	O
blanco	O
(	O
G47	O
-	O
G53	O
)	O
,	O
adicional	O
genes	B-Sequence
regulado	O
al	O
alza	O
por	O
micromatriz	O
en	O
dos	O
momentos	O
diferentes	O
pero	O
con	O
patrones	O
de	O
expresión	O
inusuales	O
o	O
hibridaciones	O
in	O
situ	O
no	O
confirmatorias	O
.	O

``	O
La	O
columna	O
``	O
''	O
ID	O
``	O
''	O
contiene	O
identificadores	O
utilizados	O
en	O
el	O
presente	O
documento	O
para	O
referirse	O
a	O
''	O
genes	B-Sequence
.	O

GenBank	O
ID	O
contiene	O
el	O
número	O
de	O
acceso	O
de	O
GenBank	O
del	O
clon	B-Sequence
usado	O
para	O
hacer	O
el	O
Investigacion	B-Sequence
para	O
hibridación	O
in	O
situ	O
.	O

``	O
Dentro	O
de	O
esta	O
columna	O
,	O
``	O
''	O
laboratorio	O
''	O
clon	B-Sequence
indica	O
que	O
el	O
Investigacion	B-Sequence
utilizado	O
para	O
la	O
hibridación	O
in	O
situ	O
derivada	O
de	O
un	O
clon	B-Sequence
en	O
nuestro	O
laboratorio	O
.	O

los	O
región	B-Sequence
del	I-Sequence
gen	I-Sequence
al	O
que	O
corresponde	O
se	O
indica	O
en	O
la	O
Tabla	O
S1	O
.	O

``	O
Las	O
columnas	O
``	O
''	O
P0	O
''	O
''	O
a	O
``	O
''	O
P21	O
''	O
''	O
contienen	O
los	O
resultados	O
de	O
los	O
experimentos	O
de	O
micromatrices	O
en	O
las	O
fechas	O
posnatales	O
dadas	O
.	O
''	O

Los	O
puntos	O
de	O
tiempo	O
P0	O
,	O
P6	O
y	O
P14	O
representan	O
análisis	O
en	O
ADNc	B-Sequence
micromatrices	O
;	O
el	O
punto	O
de	O
tiempo	O
P21	O
representa	O
datos	O
de	O
un	O
microarreglo	O
Affymetrix	O
(	O
ratón	B-Taxon
genoma	B-Sequence
432	O
2	O
.	O
0	O
)	O
.	O

Un	O
rojo	O
célula	B-Cell
con	O
una	O
sola	O
flecha	O
hacia	O
arriba	O
indica	O
que	O
el	O
gene	B-Sequence
en	O
cuestión	O
estaba	O
regulado	O
al	O
alza	O
en	O
tres	O
de	O
los	O
tres	O
microarrays	O
en	O
ese	O
momento	O
(	O
como	O
se	O
describe	O
en	O
Materiales	O
y	O
Métodos	O
)	O
.	O

Esos	O
células	B-Cell
etiquetados	O
de	O
color	O
naranja	O
con	O
una	O
sola	O
flecha	O
hacia	O
arriba	O
y	O
un	O
asterisco	O
indican	O
que	O
el	O
gene	B-Sequence
en	O
cuestión	O
estaba	O
regulado	O
al	O
alza	O
en	O
dos	O
de	O
los	O
tres	O
microarrays	O
en	O
ese	O
momento	O
.	O

``	O
La	O
columna	O
``	O
''	O
In	O
Situ	O
''	O
''	O
enumera	O
el	O
tipo	O
de	O
desrepresión	O
visto	O
para	O
el	O
''	O
gene	B-Sequence
en	O
cuestion	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
(	O
el	O
tipo	O
I	O
y	O
el	O
tipo	O
II	O
se	O
describen	O
en	O
el	O
texto	O
principal	O
)	O
.	O

genes	B-Sequence
``	O
designados	O
como	O
``	O
''	O
no	O
clasificados	O
''	O
''	O
representan	O
patrones	O
de	O
desrepresión	O
que	O
fueron	O
difíciles	O
de	O
clasificar	O
como	O
tipo	O
I	O
o	O
tipo	O
II	O
(	O
consulte	O
el	O
texto	O
principal	O
para	O
obtener	O
más	O
detalles	O
)	O
.	O
''	O

Tipo	B-Sequence
salvaje	I-Sequence
en	O
esta	O
columna	O
indica	O
que	O
el	O
patrón	O
de	O
hibridación	O
in	O
situ	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
no	O
era	O
diferente	O
de	O
la	O
tipo	B-Sequence
salvaje	I-Sequence
``	O
patrón	O
;	O
y	O
``	O
''	O
especial	O
''	O
''	O
indica	O
un	O
patrón	O
especial	O
de	O
expresión	O
discutido	O
con	O
más	O
detalle	O
en	O
el	O
texto	O
principal	O
.	O
''	O

``	O
La	O
columna	O
``	O
''	O
Patrón	O
de	O
expresión	O
''	O
''	O
contiene	O
una	O
descripción	O
concisa	O
del	O
''	O
tipo	B-Sequence
salvaje	I-Sequence
patrón	O
de	O
expresión	O
de	O
la	O
gene	B-Sequence
en	O
cuestión	O
.	O

En	O
el	O
caso	O
de	O
genes	B-Sequence
para	O
los	O
cuales	O
no	O
se	O
obtuvo	O
señal	O
en	O
la	O
hibridación	O
in	O
situ	O
en	O
el	O
presente	O
estudio	O
,	O
el	O
patrón	O
de	O
expresión	O
especificado	O
se	O
deriva	O
de	O
informes	O
en	O
la	O
literatura	O
.	O

``	O
Dentro	O
de	O
esta	O
columna	O
,	O
``	O
''	O
''	O
cono	B-Cell
>	O
vara	B-Cell
indica	O
que	O
el	O
gene	B-Sequence
se	O
expresa	O
en	O
todos	O
fotorreceptores	B-Cell
,	O
pero	O
en	O
niveles	O
más	O
altos	O
conos	B-Cell
que	O
varillas	B-Cell
``	O
;	O
``	O
''	O
''	O
cono	B-Cell
``	O
?	O
``	O
''	O
indica	O
una	O
tinción	O
muy	O
débil	O
en	O
un	O
''	O
cono	B-Cell
-	O
como	O
distribución	O
.	O

PA	B-Cell
,	O
células	B-Cell
bipolares	I-Cell
;	O
EP	O
,	O
temprano	O
fotorreceptor	B-Cell
patrón	O
de	O
expresión	O
;	O
ES	B-GENE
,	O
segmento	B-GENE
del	I-GENE
núcleo	I-GENE
interno	I-GENE
localización	O
;	O
mg	B-Cell
,	O
Müller	B-Cell
glia	I-Cell
;	O
N/A	O
,	O
no	O
disponible	O
en	O
el	O
microarreglo	O
;	O
NS	O
,	O
no	O
se	O
detecta	O
señal	O
en	O
la	O
hibridación	O
in	O
situ	O
;	O
RPE	O
,	O
retina	O
pigmento	B-Chemical
epitelio	O

Figura	O
2	O

Cono	B-Cell
y	O
vara	B-Cell
Gene	B-Sequence
Expresión	O
en	O
el	O
rd7	O
mutante	B-Sequence
en	O
P14	O

Los	O
conjuntos	O
superiores	O
de	O
fotomicrografías	O
muestran	O
ejemplos	O
de	O
tipo	O
I	O
y	O
tipo	O
II	O
.	O
cono	B-Cell
gene	B-Sequence
desrepresión	O
en	O
el	O
rd7	O
mutante	B-Sequence
retina	O
como	O
se	O
explica	O
en	O
el	O
texto	O
principal	O
.	O

Las	O
imágenes	O
de	O
abajo	O
a	O
la	O
izquierda	O
muestran	O
varios	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
que	O
esencialmente	O
no	O
han	O
cambiado	O
en	O
el	O
fondo	O
rd7	O
en	O
P14	O
.	O

Las	O
imágenes	O
de	O
abajo	O
a	O
la	O
derecha	O
muestran	O
el	O
patrón	O
de	O
expresión	O
de	O
tres	O
fotorreceptor	B-Cell
factores	O
de	O
transcripción	O
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

Las	O
abreviaturas	O
en	O
la	O
esquina	O
inferior	O
izquierda	O
de	O
cada	O
par	O
de	O
paneles	O
representan	O
el	O
gene	B-Sequence
símbolos	O
resumidos	O
en	O
la	O
figura	O
1	O
.	O

figura	O
3	O

S	B-Protein
-	I-Protein
Opsina	I-Protein
disociado	O
Célula	B-Cell
Hibridación	O
in	O
situ	O
y	O
S	B-Protein
-	I-Protein
Opsina	I-Protein
/	O
rodopsina	B-Protein
Anticuerpo	B-GENE
Tinción	O
en	O
rd7	O
mutante	B-Sequence
Retina	O

(	O
A	O
-	O
C	O
)	O
A	O
disociado	O
célula	B-Cell
hibridación	O
in	O
situ	O
con	O
un	O
S	B-Protein
-	I-Protein
opsina	I-Protein
Investigacion	B-Sequence
(	O
rojo	O
)	O
en	O
disociado	O
rd7	O
mutante	B-Sequence
de	O
retina	O
células	B-Cell
teñido	O
con	O
DAPI	O
(	O
azul	O
)	O
.	O

(	O
C	O
)	O
muestra	O
las	O
imágenes	O
combinadas	O
.	O

D	O
-	O
F	O
)	O
La	O
capa	O
nuclear	O
exterior	O
de	O
un	O
rd7	O
mutante	B-Sequence
retina	O
manchada	O
por	O
anticuerpo	B-GENE
por	O
S	B-Protein
-	I-Protein
opsina	I-Protein
(	O
rojo	O
y	O
rodopsina	B-Protein
(	O
verde	O
)	O
.	O

El	O
borde	O
escleral	O
de	O
la	O
capa	O
nuclear	O
externa	O
está	O
hacia	O
arriba	O
.	O

La	O
tinción	O
DAPI	O
está	O
en	O
azul	O
.	O

(	O
F	O
)	O
muestra	O
las	O
imágenes	O
combinadas	O
.	O

Los	O
recuadros	O
son	O
más	O
altos	O
:	O
imágenes	O
de	O
potencia	O
del	O
segmentos	B-GENE
exteriores	I-GENE
mostrando	O
la	O
no	O
superposición	O
de	O
S	B-Protein
-	I-Protein
opsina	I-Protein
y	O
rodopsina	B-Protein
tinción	O
en	O
el	O
mutante	B-Sequence
.	O

Figura	O
4	O

Patrones	O
de	O
expresión	O
de	O
varias	O
novelas	O
Cono	B-Cell
genes	B-Sequence
Arriba	O
-	O
Regulado	O
en	O
rd7	O

En	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
imágenes	O
(	O
peso	B-Sequence
)	O
,	O
nótese	O
el	O
disperso	O
,	O
débilmente	O
positivo	O
células	B-Cell
en	O
el	O
borde	O
escleral	O
de	O
la	O
capa	O
nuclear	O
externa	O
en	O
un	O
cono	B-Cell
distribucion	O

Toda	O
la	O
genes	B-Sequence
mostrar	O
marcado	O
-	O
regulación	O
en	O
el	O
rd7	O
mutante	B-Sequence
.	O

bub1b	B-Protein
y	O
Tcta	B-Protein
show	O
transcripción	B-Sequence
localización	O
predominantemente	O
en	O
el	O
segmento	B-GENE
interno	I-GENE
de	I-GENE
los	I-GENE
fotorreceptores	I-GENE
.	O

Las	O
retinas	O
están	O
orientadas	O
de	O
manera	O
que	O
el	O
borde	O
escleral	O
está	O
hacia	O
arriba	O
.	O

Figura	O
5	O

Algunos	O
de	O
los	O
genes	B-Sequence
Up	O
-	O
Regulado	O
en	O
rd7	O
Show	O
an	O
Early	O
fotorreceptor	B-Cell
patrón	O
de	O
expresión	O

Gnb3	B-Protein
y	O
Thrb2	B-Protein
ambos	O
están	O
previamente	O
caracterizados	O
cono	B-Cell
genes	B-Sequence
que	O
muestran	O
tinción	O
en	O
el	O
borde	O
escleral	O
del	O
embrión	O
ratón	B-Taxon
retina	O
en	O
células	B-Cell
que	O
se	O
diferenciará	O
en	O
fotorreceptores	B-Cell
.	O

Ece1	B-Protein
y	O
Otop3	B-Protein
son	O
dos	O
novela	O
cono	B-Cell
genes	B-Sequence
identificados	O
en	O
este	O
estudio	O
que	O
fueron	O
regulados	O
al	O
alza	O
en	O
rd7	O
y	O
también	O
mostraron	O
una	O
temprana	O
fotorreceptor	B-Cell
patrón	O
de	O
expresión	O
.	O

prdm1	B-Protein
y	O
RIKEN	O
ADNc	B-Sequence
1300018I05	O
(	O
Figura	O
1	O
,	O
genes	B-Sequence
G48	O
y	O
G49	O
,	O
respectivamente	O
)	O
son	O
otros	O
dos	O
genes	B-Sequence
que	O
tenía	O
una	O
señal	O
indetectable	O
(	O
prdm1	B-Protein
)	O
o	O
ningún	O
cambio	O
aparente	O
en	O
el	O
patrón	O
de	O
expresión	O
en	O
el	O
adulto	O
rd7	O
mutantes	B-Sequence
(	O
RIKEN	O
ADNc	B-Sequence
1300018I05	O
)	O
,	O
pero	O
que	O
también	O
mostró	O
tinción	O
en	O
la	O
retina	O
embrionaria	O
en	O
un	O
presunto	O
fotorreceptor	B-Cell
patrón	O
.	O

Todas	O
las	O
imágenes	O
son	O
de	O
E17	O
.	O
5	O
retina	O
excepto	O
Gnb3	B-Protein
,	O
que	O
era	O
de	O
E16	O
.	O

Figura	O
6	O

El	O
comienzo	O
de	O
rodopsina	B-Protein
La	O
expresión	O
se	O
retrasa	O
en	O
el	O
rd7	O
mutante	B-Sequence
Retina	O

Tenga	O
en	O
cuenta	O
la	O
tinción	O
casi	O
indetectable	O
para	O
rodopsina	B-Protein
en	O
este	O
P6	O
mutante	B-Sequence
retina	O
(	O
arriba	O
a	O
la	O
derecha	O
)	O
.	O

La	O
mayoría	O
de	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
no	O
mostró	O
este	O
retraso	O
en	O
el	O
inicio	O
de	O
la	O
expresión	O
,	O
como	O
lo	O
indica	O
la	O
cantidad	O
normal	O
de	O
tinción	O
para	O
Pde6a	B-Protein
en	O
el	O
mutante	B-Sequence
en	O
P6	O
(	O
imágenes	O
inferiores	O
)	O
.	O

Figura	O
7	O

el	O
rd7	O
mutante	B-Sequence
Retina	O
contiene	O
un	O
híbrido	O
morfológicamente	O
Célula	B-Cell
fotorreceptora	I-Cell
Escriba	O
además	O
de	O
supernumerario	O
S	B-Protein
-	I-Protein
Opsina	I-Protein
#	O
¿NOMBRE	O
?	O
Conos	B-Cell

(	O
A	O
y	O
B	O
)	O
Secciones	O
semidelgadas	O
teñidas	O
con	O
azul	O
de	O
toluidina	O
de	O
la	O
capa	O
nuclear	O
externa	O
(	O
borde	O
escleral	O
orientado	O
hacia	O
arriba	O
)	O
.	O

(	O
C	O
y	O
D	O
)	O
Diagramas	O
dibujados	O
a	O
mano	O
de	O
los	O
células	B-Cell
en	O
(	O
A	O
)	O
y	O
(	O
B	O
)	O
,	O
respectivamente	O
.	O

Células	B-Cell
con	O
el	O
nuclear	B-GENE
caracteristicas	O
de	O
conos	B-Cell
se	O
resaltan	O
en	O
azul	O
.	O

Tenga	O
en	O
cuenta	O
que	O
el	O
número	O
de	O
tales	O
células	B-Cell
es	O
mayor	O
en	O
el	O
mutante	B-Sequence
,	O
y	O
ellos	O
cuerpos	B-GENE
celulares	I-GENE
están	O
dispersos	O
por	O
toda	O
la	O
capa	O
nuclear	O
exterior	O
.	O

Además	O
,	O
la	O
arquitectura	O
columnar	O
general	O
de	O
la	O
capa	O
nuclear	O
exterior	O
vista	O
en	O
la	O
tipo	B-Sequence
salvaje	I-Sequence
se	O
interrumpe	O
en	O
esta	O
parte	O
del	O
mutante	B-Sequence
retina	O

Otras	O
porciones	O
de	O
la	O
mutante	B-Sequence
retina	O
con	O
menos	O
supernumerario	O
células	B-Cell
cónicas	I-Cell
,	O
sin	O
embargo	O
,	O
retiene	O
la	O
apariencia	O
columnar	O
normal	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

(	O
E	O
y	O
F	O
)	O
Imágenes	O
de	O
la	O
capa	O
nuclear	O
externa	O
(	O
borde	O
escleral	O
hacia	O
arriba	O
)	O
teñidas	O
por	O
hibridación	O
in	O
situ	O
para	O
S	B-Protein
-	I-Protein
opsina	I-Protein
.	O

Tenga	O
en	O
cuenta	O
el	O
patrón	O
típico	O
de	O
tinción	O
en	O
el	O
borde	O
escleral	O
de	O
la	O
capa	O
nuclear	O
externa	O
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
.	O

el	O
rd7	O
mutante	B-Sequence
retina	O
muestra	O
supernumerario	O
S	B-Protein
-	I-Protein
opsina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
dispersos	O
por	O
toda	O
la	O
capa	O
nuclear	O
externa	O
en	O
una	O
distribución	O
muy	O
similar	O
a	O
la	O
supernumeraria	O
células	B-Cell
cónicas	I-Cell
visto	O
en	O
(	O
B	O
)	O
.	O

Dado	O
que	O
las	O
imágenes	O
(	O
E	O
)	O
y	O
(	O
F	O
)	O
se	O
derivan	O
de	O
retinas	O
diferentes	O
a	O
las	O
representadas	O
en	O
(	O
A	O
)	O
y	O
(	O
B	O
)	O
,	O
la	O
ubicación	O
del	O
individuo	O
células	B-Cell
no	O
corresponden	O

(	O
G	O
y	O
H	O
)	O
Electrón	B-Chemical
micrografías	O
de	O
la	O
capa	O
nuclear	O
externa	O
(	O
aumento	O
de	O
10	O
000	O
x	O
)	O
.	O

Tenga	O
en	O
cuenta	O
la	O
distribución	O
uniforme	O
de	O
varilla	O
cuerpos	B-GENE
celulares	I-GENE
en	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
G	O
)	O
.	O

los	O
cuerpos	B-GENE
celulares	I-GENE
son	O
casi	O
redondas	O
y	O
consisten	O
casi	O
exclusivamente	O
en	O
un	O
núcleo	B-GENE
con	O
una	O
sola	O
masa	O
densa	O
de	O
heterocromatina	B-GENE
.	O

en	O
el	O
rd7	O
mutante	B-Sequence
(	O
H	O
)	O
,	O
dos	O
tipos	O
de	O
célula	B-Cell
son	O
exhibidos	O
.	O

El	O
ovoide	O
con	O
menor	O
cantidad	O
de	O
heterocromatina	B-GENE
,	O
más	O
pálido	O
eucromatina	B-GENE
,	O
y	O
dos	O
mitocondrias	B-GENE
yuxtanucleares	I-GENE
(	O
flecha	O
amarilla	O
)	O
representa	O
un	O
cono	O
típico	O
cuerpo	B-GENE
de	I-GENE
la	I-GENE
célula	I-GENE
.	O

El	O
adyacente	O
célula	B-Cell
``	O
con	O
un	O
mas	O
''	O
''	O
''	O
vara	B-Cell
``	O
-	O
como	O
``	O
''	O
masa	O
de	O
''	O
heterocromatina	B-GENE
y	O
un	O
solo	O
mitocondria	B-GENE
yuxtanuclear	I-GENE
(	O
flecha	O
roja	O
)	O
representa	O
uno	O
de	O
los	O
híbridos	O
fotorreceptores	B-Cell
discutido	O
más	O
completamente	O
en	O
el	O
texto	O
principal	O
.	O

Figura	O
8	O

Una	O
vista	O
parcial	O
de	O
la	O
Fotorreceptor	B-Cell
de	I-Cell
varilla	I-Cell
Red	O
de	O
Regulación	O
Transcripcional	O

Tenga	O
en	O
cuenta	O
que	O
las	O
líneas	O
verdes	O
indican	O
activación	O
,	O
y	O
las	O
líneas	O
amarillas	O
y	O
rojas	O
indican	O
represión	O
débil	O
y	O
fuerte	O
,	O
respectivamente	O
.	O

Las	O
líneas	O
punteadas	O
asociadas	O
con	O
un	O
signo	O
de	O
interrogación	O
indican	O
que	O
no	O
se	O
sabe	O
si	O
NRL	B-Protein
reprime	O
directamente	O
al	O
objetivo	O
genes	B-Sequence
``	O
en	O
cuestión	O
o	O
si	O
su	O
represión	O
está	O
mediada	O
por	O
un	O
factor	O
de	O
transcripción	O
aguas	O
abajo	O
(	O
``	O
''	O
X	O
''	O
''	O
)	O
.	O
''	O

Tenga	O
en	O
cuenta	O
que	O
nr2e3	B-Protein
parece	O
regular	O
negativamente	O
su	O
propia	O
transcripción	O
.	O

Los	O
vínculos	O
regulatorios	O
representados	O
en	O
este	O
diagrama	O
no	O
son	O
necesariamente	O
directos	O
.	O

La	O
débil	O
activación	O
de	O
algunos	O
vara	B-Cell
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
por	O
nr2e3	B-Protein
se	O
omite	O
de	O
este	O
diagrama	O
para	O
mayor	O
claridad	O
.	O

Tampoco	O
se	O
muestra	O
el	O
papel	O
de	O
otros	O
fotorreceptor	B-Cell
factores	O
de	O
transcripción	O
,	O
como	O
crx	B-Protein
.	O

notas	O
al	O
pie	O

Conflicto	O
de	O
intereses	O
.	O

Los	O
autores	O
han	O
declarado	O
que	O
no	O
existen	O
intereses	O
contrapuestos	O
.	O

Contribuciones	O
de	O
autor	O
.	O

JCC	O
y	O
CLC	O
concibieron	O
y	O
diseñaron	O
los	O
experimentos	O
.	O

JCC	O
realizó	O
los	O
experimentos	O
.	O

JCC	O
y	O
CLC	O
analizaron	O
los	O
datos	O
.	O

JCC	O
contribuyó	O
reactivos	B-Chemical
/	O
materiales	O
/	O
herramientas	O
de	O
análisis	O
.	O

JCC	O
y	O
CLC	O
escribieron	O
el	O
artículo	O
.	O

Cita	O
:	O
Corbo	O
JC	O
,	O
Cepko	O
CL	O
(	O
2005	O
)	O
Un	O
híbrido	O
fotorreceptor	B-Cell
expresando	O
ambos	O
vara	B-Cell
y	O
cono	B-Cell
genes	B-Sequence
en	O
un	O
ratón	B-Taxon
modelo	O
de	O
s	O
mejorado	O
-	O
cono	B-Cell
síndrome	O

PLoS	O
Genet	O
1	O
(	O
2	O
)	O
:	O
e11	O
.	O

Producción	O
y	O
caracterización	O
de	O
murino	B-Taxon
modelos	O
de	O
clasica	O
e	O
intermedia	O
arce	B-Taxon
enfermedad	O
de	O
la	O
orina	O
en	O
jarabe	O

Resumen	O

Antecedentes	O

Arce	B-Taxon
La	O
enfermedad	O
de	O
la	O
orina	O
en	O
jarabe	O
(	O
MSUD	O
)	O
es	O
un	O
error	O
innato	O
del	O
metabolismo	O
causado	O
por	O
una	O
deficiencia	O
de	O
cetoácido	B-GENE
deshidrogenasa	I-GENE
de	I-GENE
cadena	I-GENE
ramificada	I-GENE
.	O

MSUD	O
tiene	O
varios	O
fenotipos	O
clínicos	O
dependiendo	O
del	O
grado	O
de	O
enzima	B-Sequence
deficiencia	O

Los	O
tratamientos	O
actuales	O
no	O
son	O
satisfactorios	O
y	O
requieren	O
nuevos	O
enfoques	O
para	O
combatir	O
esta	O
enfermedad	O
.	O

Un	O
obstáculo	O
importante	O
en	O
el	O
desarrollo	O
de	O
nuevos	O
tratamientos	O
ha	O
sido	O
la	O
falta	O
de	O
un	O
animal	B-Taxon
modelo	O

Métodos	O

Para	O
crear	O
un	O
murino	B-Taxon
modelo	O
de	O
MSUD	O
clásico	O
,	O
usamos	O
gene	B-Sequence
focalización	O
y	O
embrionario	O
célula	B-Cell
madre	I-Cell
tecnologías	O
para	O
crear	O
un	O
ratón	B-Taxon
línea	O
que	O
carecía	O
de	O
un	O
funcional	O
subunidad	B-Protein
E2	I-Protein
gene	B-Sequence
de	O
cetoácido	B-GENE
deshidrogenasa	I-GENE
de	I-GENE
cadena	I-GENE
ramificada	I-GENE
.	O

Para	O
crear	O
un	O
murino	B-Taxon
modelo	O
de	O
MSUD	O
intermedio	O
,	O
usamos	O
transgénico	B-Sequence
tecnología	O
para	O
expresar	O
humano	B-Protein
E2	I-Protein
ADNc	B-Sequence
en	O
el	O
fondo	O
del	O
nocaut	O
.	O

Ratones	B-Taxon
de	O
ambos	O
modelos	O
se	O
caracterizaron	O
al	O
molecular	B-Chemical
,	O
bioquímicos	O
y	O
completos	O
animal	B-Taxon
niveles	O

Resultados	O

Al	O
interrumpir	O
el	O
subunidad	B-Protein
E2	I-Protein
gene	B-Sequence
de	O
cetoácido	B-GENE
deshidrogenasa	I-GENE
de	I-GENE
cadena	I-GENE
ramificada	I-GENE
,	O
creamos	O
un	O
gene	B-Sequence
knockear	O
ratón	B-Taxon
modelo	O
de	O
MSUD	O
clásico	O
.	O

El	O
nocaut	O
homocigoto	O
ratones	B-Taxon
faltaba	O
cetoácido	B-GENE
deshidrogenasa	I-GENE
de	I-GENE
cadena	I-GENE
ramificada	I-GENE
actividad	O
,	O
E2	B-Protein
inmunoreactividad	O
,	O
y	O
tuvo	O
un	O
aumento	O
de	O
3	O
veces	O
en	O
la	O
circulación	O
aminoácidos	B-Chemical
de	I-Chemical
cadena	I-Chemical
ramificada	I-Chemical
.	O

Estos	O
trastornos	O
metabólicos	O
resultaron	O
en	O
letalidad	O
neonatal	O
.	O

transgénico	B-Sequence
expresión	O
de	O
un	O
humano	B-Protein
E2	I-Protein
ADNc	B-Sequence
en	O
el	O
hígado	O
del	O
E2	B-Protein
knockear	O
animales	B-Taxon
produjo	O
un	O
modelo	O
de	O
MSUD	O
intermedio	O
.	O

Deshidrogenasa	B-GENE
de	I-GENE
cetoácidos	I-GENE
de	I-GENE
cadena	I-GENE
ramificada	I-GENE
actividad	O
fue	O
del	O
5	O
al	O
6	O
%	O
de	O
lo	O
normal	O
y	O
fue	O
suficiente	O
para	O
permitir	O
la	O
supervivencia	O
,	O
pero	O
fue	O
insuficiente	O
para	O
normalizar	O
la	O
circulación	O
aminoácidos	B-Chemical
de	I-Chemical
cadena	I-Chemical
ramificada	I-Chemical
niveles	O
intermedios	O
entre	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
el	O
clásico	O
MSUD	O
ratón	B-Taxon
modelo	O

Conclusión	O

Estas	O
ratones	B-Taxon
representar	O
importante	O
animal	B-Taxon
modelos	O
que	O
se	O
aproximan	O
mucho	O
al	O
fenotipo	O
de	O
humanos	B-Taxon
con	O
las	O
formas	O
clásica	O
e	O
intermedia	O
de	O
MSUD	O
.	O

Estas	O
animales	B-Taxon
proporcionar	O
modelos	O
útiles	O
para	O
caracterizar	O
aún	O
más	O
la	O
patogenia	O
de	O
la	O
MSUD	O
,	O
así	O
como	O
modelos	O
para	O
probar	O
nuevas	O
estrategias	O
terapéuticas	O
,	O
como	O
gene	B-Sequence
y	O
celular	B-Cell
terapias	O
,	O
para	O
tratar	O
esta	O
devastadora	O
enfermedad	O
metabólica	O
.	O

Antecedentes	O

Arce	B-Taxon
La	O
enfermedad	O
de	O
la	O
orina	O
con	O
jarabe	O
(	O
MSUD	O
)	O
es	O
una	O
genético	B-Sequence
trastorno	O
causado	O
por	O
una	O
deficiencia	O
de	O
cetoácido	B-GENE
deshidrogenasa	I-GENE
de	I-GENE
cadena	I-GENE
ramificada	I-GENE
(	O
BCKDH	B-GENE
)	O
,	O
a	O
mitocondrial	B-GENE
multienzima	O
complejo	B-GENE
responsable	O
de	O
la	O
descarboxilación	O
oxidativa	O
de	O
cadenas	O
ramificadas	O
cetoácidos	B-Chemical
derivado	O
de	O
aminoácidos	B-Chemical
de	I-Chemical
cadena	I-Chemical
ramificada	I-Chemical
(	O
BCAA	B-Chemical
)	O
,	O
leucina	B-Chemical
,	O
isoleucina	B-Chemical
y	O
valina	B-Chemical
(	O
para	O
revisión	O
,	O
ver	O
:	O
[	O
1	O
]	O
)	O
.	O

Pacientes	O
con	O
MSUD	O
,	O
dependiendo	O
de	O
la	O
mutación	B-Sequence
,	O
muestran	O
grados	O
variables	O
de	O
enzima	B-Sequence
deficiencia	O
que	O
conduce	O
a	O
varios	O
fenotipos	O
clínicos	O
diferentes	O
[	O
1	O
]	O
.	O

Aproximadamente	O
el	O
75	O
%	O
de	O
los	O
pacientes	O
con	O
MSUD	O
tienen	O
la	O
forma	O
clásica	O
de	O
la	O
enfermedad	O
con	O
BCKDH	B-GENE
actividad	O
en	O
el	O
rango	O
de	O
0-2	O
%	O
de	O
lo	O
normal	O
[	O
1	O
]	O
.	O

Estos	O
pacientes	O
muestran	O
niveles	O
marcadamente	O
elevados	O
de	O
BCAA	B-Chemical
en	O
sangre	O
y	O
otros	O
fluidos	O
corporales	O
[	O
1	O
]	O
.	O

Además	O
de	O
la	O
forma	O
clásica	O
,	O
existen	O
otras	O
variantes	O
de	O
la	O
enfermedad	O
.	O

Los	O
pacientes	O
con	O
la	O
forma	O
intermedia	O
de	O
la	O
enfermedad	O
muestran	O
BCKDH	B-GENE
actividad	O
en	O
el	O
rango	O
de	O
3-30	O
%	O
de	O
lo	O
normal	O
.	O

En	O
tales	O
pacientes	O
,	O
el	O
inicio	O
de	O
la	O
enfermedad	O
se	O
retrasa	O
,	O
pero	O
hay	O
niveles	O
persistentemente	O
elevados	O
de	O
BCAA	B-Chemical
[	O
1	O
]	O
.	O

Los	O
pacientes	O
con	O
la	O
forma	O
intermitente	O
de	O
MSUD	O
muestran	O
BCKDH	B-GENE
actividad	O
en	O
el	O
rango	O
de	O
5	O
-	O
20	O
%	O
y	O
durante	O
la	O
fase	O
asintomática	O
la	O
sangre	O
BCAA	B-Chemical
los	O
niveles	O
son	O
normales	O
[	O
1	O
]	O
.	O

La	O
incidencia	O
global	O
de	O
MSUD	O
en	O
la	O
población	O
general	O
es	O
de	O
1:185.000	O
[	O
1	O
]	O
,	O
y	O
en	O
ciertos	O
grupos	O
de	O
población	O
,	O
como	O
los	O
menonitas	O
de	O
Pensilvania	O
,	O
se	O
estima	O
que	O
la	O
incidencia	O
es	O
tan	O
alta	O
como	O
1:176	O
[	O
2	O
]	O
.	O

los	O
complejo	B-GENE
BCKDH	I-GENE
,	O
el	O
deficiente	O
enzima	B-Sequence
en	O
MSUD	O
,	O
consta	O
de	O
tres	O
catalizadores	O
proteinas	B-Chemical
,	O
una	O
descarboxilasa	O
(	O
E1	O
)	O
,	O
una	O
dihidrolipoil	B-Protein
transacilasa	I-Protein
(	O
E2	B-Protein
)	O
,	O
y	O
un	O
dihidrolipoil	B-Protein
deshidrogenasa	I-Protein
(	O
E3	B-Protein
)	O
.	O

El	O
componente	O
E1	O
es	O
un	O
heterotetrámero	O
compuesto	O
por	O
dos	O
subunidades	B-Protein
alfa	I-Protein
y	I-Protein
dos	I-Protein
beta	I-Protein
[	O
3	O
]	O
.	O

El	O
E1	O
y	O
E2	B-Protein
Los	O
componentes	O
son	O
específicos	O
para	O
BCKDH	B-GENE
,	O
mientras	O
que	O
E3	B-Protein
también	O
es	O
usado	O
por	O
complejos	B-GENE
de	I-GENE
piruvato	I-GENE
y	I-GENE
alfa	I-GENE
-	I-GENE
cetoglutarato	I-GENE
deshidrogenasa	I-GENE
[	O
3	O
]	O
y	O
el	O
sistema	B-GENE
de	I-GENE
escisión	I-GENE
de	I-GENE
glicina	I-GENE
[	O
4	O
]	O
.	O

BCKDH	B-GENE
también	O
está	O
asociado	O
con	O
dos	O
reguladores	O
proteinas	B-Chemical
,	O
una	O
quinasa	O
específica	O
y	O
una	O
fosfatasa	O
que	O
regulan	O
la	O
actividad	O
de	O
este	O
enzima	B-Sequence
través	O
de	O
un	O
ciclo	O
de	O
fosforilación	O
(	O
inactivación	O
)	O
y	O
desfosforilación	O
(	O
activación	O
)	O
del	O
subunidad	B-Protein
alfa	I-Protein
E1	I-Protein
[	O
5	O
,	O
6	O
]	O
.	O

Mutaciones	B-Sequence
en	O
el	O
genes	B-Sequence
de	O
la	O
E1	O
y	O
Subunidades	B-Protein
E2	I-Protein
de	I-Protein
BCKDH	I-Protein
han	O
sido	O
descritos	O
,	O
sin	O
embargo	O
,	O
la	O
mayoría	O
de	O
MSUD	O
mutaciones	B-Sequence
identificados	O
hasta	O
ahora	O
están	O
en	O
el	O
subunidad	B-Protein
E2	I-Protein
[	O
1	O
,	O
7	O
]	O
.	O

Hasta	O
la	O
fecha	O
,	O
los	O
casos	O
de	O
MSUD	O
no	O
se	O
han	O
asociado	O
con	O
defectos	O
en	O
la	O
cinasa	O
y	O
la	O
fosfatasa	O
reguladoras	O
[	O
1	O
]	O
.	O

El	O
tratamiento	O
actual	O
de	O
los	O
pacientes	O
con	O
MSUD	O
se	O
basa	O
en	O
una	O
estricta	O
restricción	O
dietética	O
de	O
por	O
vida	O
de	O
proteína	B-Chemical
o	O
BCAA	B-Chemical
[	O
1	O
,	O
8	O
]	O
.	O

Este	O
manejo	O
dietético	O
de	O
la	O
enfermedad	O
,	O
sin	O
embargo	O
,	O
no	O
es	O
del	O
todo	O
satisfactorio	O
,	O
especialmente	O
en	O
tiempos	O
de	O
descompensación	O
metabólica	O
debido	O
a	O
infecciones	O
,	O
lesiones	O
y	O
otros	O
factores	O
estresantes	O
.	O

A	O
pesar	O
de	O
la	O
intervención	O
dietética	O
,	O
hay	O
una	O
mortalidad	O
significativa	O
asociada	O
con	O
la	O
MSUD	O
y	O
hay	O
una	O
alta	O
incidencia	O
de	O
retraso	O
mental	O
en	O
los	O
sobrevivientes	O
[	O
9	O
]	O
.	O

Debido	O
al	O
papel	O
central	O
del	O
hígado	O
en	O
aminoácidos	B-Chemical
metabolismo	O
y	O
niveles	O
moderados/altos	O
de	O
BCKDH	B-GENE
actividad	O
en	O
humano	B-Taxon
hígado	O
[	O
10	O
-	O
12	O
]	O
,	O
algunos	O
casos	O
de	O
MSUD	O
han	O
sido	O
tratados	O
recientemente	O
mediante	O
trasplante	O
de	O
hígado	O
[	O
13	O
-	O
16	O
]	O
.	O

Si	O
bien	O
el	O
resultado	O
a	O
corto	O
plazo	O
del	O
trasplante	O
de	O
hígado	O
es	O
alentador	O
,	O
se	O
desconocen	O
los	O
efectos	O
a	O
largo	O
plazo	O
de	O
este	O
enfoque	O
.	O

Sin	O
embargo	O
,	O
estos	O
pacientes	O
ahora	O
están	O
obligados	O
a	O
tomar	O
medicamentos	B-Chemical
inmunosupresores	I-Chemical
por	O
el	O
resto	O
de	O
sus	O
vidas	O
,	O
a	O
menudo	O
con	O
efectos	O
secundarios	O
indeseables	O
.	O

Además	O
,	O
el	O
costo	O
asociado	O
con	O
el	O
trasplante	O
de	O
hígado	O
y	O
la	O
disponibilidad	O
de	O
hígados	O
de	O
donantes	O
son	O
factores	O
limitantes	O
adicionales	O
para	O
la	O
practicidad	O
del	O
tratamiento	O
de	O
esta	O
enfermedad	O
.	O

Debido	O
a	O
las	O
opciones	O
insatisfactorias	O
actuales	O
para	O
el	O
tratamiento	O
de	O
la	O
MSUD	O
,	O
existe	O
la	O
necesidad	O
de	O
mejorar	O
las	O
terapias	O
para	O
combatir	O
esta	O
enfermedad	O
.	O

Un	O
obstáculo	O
para	O
el	O
desarrollo	O
de	O
tratamientos	O
novedosos	O
para	O
la	O
MSUD	O
ha	O
sido	O
la	O
falta	O
de	O
un	O
animal	B-Taxon
modelo	O
para	O
realizar	O
los	O
estudios	O
preclínicos	O
necesarios	O
.	O

Aunque	O
se	O
ha	O
descrito	O
un	O
modelo	O
de	O
ternero	O
Hereford	O
con	O
MSUD	O
[	O
17-19	O
]	O
,	O
este	O
modelo	O
no	O
está	O
fácilmente	O
disponible	O
ni	O
es	O
práctico	O
para	O
realizar	O
estudios	O
preclínicos	O
.	O

Además	O
,	O
la	O
comparación	O
de	O
este	O
animal	B-Taxon
modelo	O
con	O
humano	B-Taxon
MSUD	O
ha	O
mostrado	O
algunas	O
diferencias	O
en	O
la	O
patología	O
de	O
la	O
enfermedad	O
[	O
1	O
]	O
,	O
por	O
lo	O
que	O
esta	O
animal	B-Taxon
un	O
modelo	O
menos	O
deseable	O
para	O
el	O
humano	B-Taxon
enfermedad	O
.	O

Recientemente	O
,	O
un	O
N	B-Chemical
-	I-Chemical
etil	I-Chemical
-	I-Chemical
N	I-Chemical
-	I-Chemical
nitrosourea	I-Chemical
(	O
ENU	B-Chemical
)	O
-	O
inducido	O
mutante	B-Sequence
ratón	B-Taxon
que	O
se	O
asemeja	O
fenotípicamente	O
humano	B-Taxon
MSUD	O
ha	O
sido	O
descrito	O
[	O
20	O
]	O
.	O

Sin	O
embargo	O
,	O
el	O
mutación	B-Sequence
en	O
este	O
modelo	O
interrumpe	O
un	O
sitio	B-Sequence
de	I-Sequence
empalme	I-Sequence
en	O
el	O
aminotransferasa	B-Protein
de	I-Protein
cadena	I-Protein
ramificada	I-Protein
mitocondrial	I-Protein
(	I-Protein
BCAT	I-Protein
)	I-Protein
)	O
gene	B-Sequence
,	O
no	O
en	O
BCKDH	B-GENE
,	O
el	O
deficiente	O
enzima	B-Sequence
en	O
MSUD	O
.	O

Porque	O
el	O
mutación	B-Sequence
no	O
está	O
dentro	O
BCKDH	B-GENE
,	O
la	O
validez	O
de	O
este	O
mutante	B-Sequence
ratón	B-Taxon
línea	O
para	O
modelar	O
humano	B-Taxon
MSUD	O
es	O
cuestionable	O
.	O

El	O
objetivo	O
del	O
presente	O
estudio	O
fue	O
crear	O
genéticamente	B-Sequence
diseñado	O
murino	B-Taxon
modelos	O
de	O
MSUD	O
que	O
imitan	O
la	O
patología	O
de	O
las	O
variantes	O
clásica	O
e	O
intermedia	O
de	O
la	O
humano	B-Taxon
enfermedad	O
.	O

El	O
modelo	O
clásico	O
fue	O
creado	O
por	O
la	O
inactivación	O
dirigida	O
de	O
la	O
Subunidad	B-Protein
E2	I-Protein
de	I-Protein
BCKDH	I-Protein
por	O
recombinación	O
homóloga	O
en	O
embriones	O
células	B-Cell
madre	I-Cell
(	I-Cell
ES	I-Cell
)	I-Cell
.	O

El	O
modelo	O
de	O
MSUD	O
intermedio	O
fue	O
creado	O
por	O
parcial	O
transgénico	B-Sequence
rescate	O
de	O
la	O
E2	B-Protein
gene	B-Sequence
knockear	O
.	O

Este	O
informe	O
describe	O
la	O
generación	O
y	O
caracterización	O
de	O
estos	O
murino	B-Taxon
modelos	O
de	O
MSUD	O
.	O

Estos	O
modelos	O
permitirán	O
el	O
desarrollo	O
de	O
nuevos	O
enfoques	O
de	O
tratamiento	O
,	O
como	O
gene	B-Sequence
o	O
célula	B-Cell
madre	I-Cell
terapias	O
,	O
para	O
finalmente	O
curar	O
la	O
MSUD	O
.	O

Métodos	O

Todos	O
los	O
estudios	O
que	O
involucran	O
animales	B-Taxon
fueron	O
revisados	O
y	O
aprobados	O
por	O
el	O
Instituto	O
Institucional	O
de	O
la	O
Universidad	O
de	O
Pittsburgh	O
.	O
Animal	B-Taxon
Comité	O
de	O
Cuidado	O
y	O
Uso	O
.	O

Gene	B-Sequence
producción	O
de	O
knockout	O

A	O
ADN	B-Sequence
genómico	I-Sequence
subclón	O
de	O
la	O
Cepa	O
129	O
/	O
SvJ	O
ADN	B-Sequence
que	O
contenía	O
un	O
porción	B-Sequence
de	I-Sequence
exones	I-Sequence
4	O
y	O
5	O
de	O
la	O
E2	B-Protein
gene	B-Sequence
y	O
flanqueando	O
ADN	B-Sequence
se	O
obtuvo	O
de	O
una	O
biblioteca	O
de	O
fagos	O
P1	O
de	O
genoma	B-Sequence
Sistemas	O
,	O
Inc.	O
,	O
(	O
St	O
.	O
Louis	O
,	O
MO	O
;	O
'	O
3	O
-	O
Hit	O
Ratón	B-Taxon
ES	O
Biblioteca	O
'	O
)	O
.	O

Un	O
positivo/negativo	O
reemplazo	B-Sequence
escribe	O
gene	B-Sequence
apuntando	O
vector	B-Sequence
[	O
21	O
]	O
fue	O
creado	O
por	O
reemplazando	B-Sequence
un	O
1	O
67	O
kb	O
EcoRV	O
-	O
Pequeño	O
fragmento	B-Sequence
que	O
incluía	O
un	O
porción	B-Sequence
de	I-Sequence
exón	I-Sequence
4	O
y	O
todo	O
exón	B-Sequence
5	O
con	O
el	O
marcador	O
PGKneo	O
gene	B-Sequence
(	O
Ver	O
Fig	O
.	O
1A	O
)	O
del	O
pPNT	O
vector	B-Sequence
[	O
22	O
]	O
.	O

la	O
focalización	O
construir	B-Sequence
fue	O
linealizado	O
con	O
NotI	O
y	O
electroporado	O
en	O
R1	O
ES	O
células	B-Cell
[	O
23	O
]	O
en	O
las	O
condiciones	O
descritas	O
anteriormente	O
[	O
24	O
]	O
.	O

ES	O
células	B-Cell
fueron	O
seleccionados	O
con	O
G418	O
(	O
300	O
µg/ml	O
;	O
Life	O
Technologies	O
Inc.	O
,	O
Gaithersburg	O
,	O
MD	O
)	O
y	O
ganciclovir	O
(	O
2	O
µM	O
;	O
obsequio	O
de	O
Syntex	O
,	O
Palo	O
Alto	O
,	O
CA	O
)	O
.	O

Los	O
clones	O
doblemente	O
resistentes	O
fueron	O
examinados	O
para	O
gene	B-Sequence
direccionamiento	O
por	O
análisis	O
de	O
transferencia	O
Southern	O
de	O
BglI	O
digerido	O
ADN	B-Sequence
genómico	I-Sequence
.	O

Las	O
transferencias	O
se	O
hibridaron	O
con	O
un	O
exón	B-Sequence
6	O
específicos	O
Investigacion	B-Sequence
que	O
era	O
externo	O
a	O
la	O
gene	B-Sequence
apuntando	O
construir	B-Sequence
.	O

ES	O
correctamente	O
orientado	O
células	B-Cell
se	O
inyectaron	O
en	O
blastocistos	O
C57BL/6J	O
para	O
producir	O
quiméricos	O
ratones	B-Taxon
utilizando	O
procedimientos	O
estándar	O
.	O

La	O
descendencia	O
heterocigota	O
de	O
quimeras	O
competentes	O
de	O
la	O
línea	O
germinal	O
se	O
entrecruzó	O
para	O
producir	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
,	O
heterocigoto	O
(	O
+	B-Sequence
/	O
-	O
)	O
y	O
knockout	O
homocigoto	O
(	O
-	O
/	O
-	O
)	O
ratones	B-Taxon
.	O

En	O
todas	O
las	O
generaciones	O
,	O
+	B-Sequence
/-	O
se	O
utilizaron	O
parejas	O
reproductoras	O
.	O

Los	O
resultados	O
presentados	O
aquí	O
son	O
de	O
ratones	B-Taxon
derivados	O
de	O
las	O
generaciones	O
F2+	O
.	O

Todos	O
animales	B-Taxon
eran	O
de	O
una	O
mezcla	O
C57BL	O
/	O
6J	O
x	O
Strain	O
129Sv	O
/	O
SvJ	O
genético	B-Sequence
antecedentes	O
.	O

Figura	O
1	O

E2	B-Protein
gene	B-Sequence
knockear	O
ratón	B-Taxon
producción	O

A	O
,	O
Gene	B-Sequence
estrategia	O
de	O
segmentación	O
utilizada	O
para	O
segmentar	O
E2	B-Protein
lugar	B-Sequence
en	O
ratón	B-Taxon
ES	O
células	B-Cell
.	O

la	O
focalización	O
construir	B-Sequence
fue	O
diseñado	O
para	O
Eliminar	B-Sequence
1	O
.	O
67	O
kb	O
de	O
secuencia	B-Sequence
entre	O
un	O
EcoRV	O
sitio	B-Sequence
en	I-Sequence
exón	I-Sequence
4	O
y	O
un	O
pequeño	O
sitio	B-Sequence
en	O
intrón	B-Sequence
5	O
.	O

los	O
tipo	B-Sequence
salvaje	I-Sequence
E2	B-Protein
gene	B-Sequence
contiene	O
un	O
BglI	O
de	O
~	O
16	O
kb	O
fragmento	B-Sequence
de	I-Sequence
restricción	I-Sequence
que	O
hibrida	O
a	O
la	O
exón	B-Sequence
6	O
específicos	O
Investigacion	B-Sequence
.	O

Un	O
apuntado	O
correctamente	O
E2	B-Protein
lugar	B-Sequence
alberga	O
un	O
BglI	O
de	O
~	O
11	O
kb	O
fragmento	B-Sequence
de	I-Sequence
restricción	I-Sequence
que	O
hibrida	O
al	O
mismo	O
Investigacion	B-Sequence
.	O

Tenga	O
en	O
cuenta	O
que	O
el	O
Investigacion	B-Sequence
no	O
detectará	O
al	O
azar	O
integración	B-Sequence
de	O
la	O
focalización	O
vector	B-Sequence
porque	O
es	O
externo	O
a	O
la	O
segmentación	O
vector	B-Sequence
.	O

B	O
,	O
análisis	O
de	O
transferencia	O
Southern	O
de	O
Bgll	O
digerido	O
ADN	B-Sequence
genómico	I-Sequence
derivado	O
de	O
los	O
padres	O
tipo	B-Sequence
salvaje	I-Sequence
ES	O
célula	B-Cell
línea	O
(	O
R1	O
)	O
,	O
un	O
ES	O
objetivo	O
heterocigoto	O
célula	B-Cell
línea	O
(	O
362	O
)	O
,	O
y	O
desde	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
,	O
heterocigoto	O
(	O
+	B-Sequence
/	O
-	O
)	O
y	O
knockout	O
homocigoto	O
(	O
-	O
/	O
-	O
)	O
ratones	B-Taxon
.	O

El	O
blot	O
se	O
hibridó	O
con	O
un	O
exón	B-Sequence
6	O
específicos	O
Investigacion	B-Sequence
.	O

C	O
,	O
Análisis	O
inmunohistoquímico	O
de	O
secciones	O
de	O
hígado	O
fresco	O
congelado	O
del	O
control	O
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
y	O
E2	B-Protein
knockout	O
(	O
-	O
/	O
-	O
)	O
día	O
postnatal	O
1	O
ratón	B-Taxon
cachorros	O

Las	O
secciones	O
se	O
tiñeron	O
para	O
E2	B-Protein
usando	O
un	O
E2	B-Protein
específico	O
anticuerpo	B-GENE
(	O
verde	O
)	O
y	O
un	O
nuclear	B-GENE
mancha	O
(	O
azul	O
)	O
.	O

Nótese	O
la	O
ausencia	O
total	O
de	O
E2	B-Protein
inmunoreactividad	O
en	O
la	O
sección	O
del	O
knockout	O
ratón	B-Taxon
.	O

,	O
Se	O
observaron	O
resultados	O
similares	O
en	O
el	O
análisis	O
inmunohistoquímico	O
de	O
primaria	O
ratón	B-Taxon
embrionario	O
fibroblastos	B-Cell
(	O
MEF	O
)	O
.	O

Tenga	O
en	O
cuenta	O
que	O
la	O
señal	O
fácilmente	O
detectable	O
para	O
E2	B-Protein
en	O
el	O
mando	O
células	B-Cell
estaba	O
presente	O
en	O
un	O
patrón	O
característico	O
de	O
mitocondrias	B-GENE
,	O
la	O
ubicación	O
subcelular	O
de	O
BCKDH	B-GENE
.	O

Produccion	O
de	O
transgénico	B-Sequence
ratones	B-Taxon

Estándar	O
molecular	B-Chemical
Se	O
utilizaron	O
técnicas	O
para	O
ensamblar	O
construcción	B-Sequence
transgénica	I-Sequence
,	O
pTRE	O
-	O
E2	B-Protein
.	O

Esta	O
transgén	B-Sequence
contiene	O
la	O
tetraciclina	B-Chemical
sensible	O
CMVh	B-Taxon
*	O
-	O
1	O
promotor	B-Sequence
[	O
consistente	O
en	O
el	O
tetraciclina	B-Chemical
sensible	O
elemento	B-Sequence
(	O
TRE	O
)	O
y	O
un	O
mínimo	O
CMVh	B-Taxon
promotor	B-Sequence
]	O
[	O
25	O
]	O
de	O
pTRE2	O
(	O
Clontech	O
Inc	O
.	O
,	O
Mt	O
.	O
View	O
,	O
CA	O
)	O
,	O
un	O
quimérico	O
intrón	B-Sequence
de	O
pCI	O
(	O
Promega	O
)	O
para	O
aumentar	O
mensaje	B-Sequence
estabilidad	O
y	O
expresión	O
[	O
26	O
,	O
27	O
]	O
,	O
un	O
Kozak	O
secuencia	B-Sequence
de	I-Sequence
consenso	I-Sequence
en	O
el	O
codón	B-Sequence
de	I-Sequence
iniciación	I-Sequence
para	O
optimizar	O
la	O
traducción	O
[	O
28	O
]	O
,	O
el	O
humano	B-Protein
E2	I-Protein
ADNc	B-Sequence
que	O
ha	O
sido	O
modificado	B-Sequence
para	O
contener	O
un	O
4	O
x	O
alanina	B-Chemical
enlazador	O
seguido	O
de	O
un	O
c-myc	B-Protein
epítopo	B-Sequence
etiqueta	O
en	O
el	O
terminal	B-Sequence
carboxi	I-Sequence
para	O
facilitar	O
la	O
detección	O
,	O
y	O
una	O
SV40	B-Taxon
tarde	O
secuencia	B-Sequence
de	I-Sequence
poliadenilación	I-Sequence
de	O
pCI	O
para	O
mejorar	O
ARNm	B-Chemical
estabilidad	O
y	O
traducción	O
.	O

El	O
2	O
.	O
48	O
kb	O
TRE	O
-	O
E2	B-Protein
transgén	B-Sequence
fue	O
purificado	O
de	O
secuencias	B-Sequence
vectoriales	I-Sequence
después	O
de	O
la	O
digestión	O
con	O
XhoI	O
y	O
BamHI	O
e	O
inyectado	O
en	O
C57BL	O
/	O
6J	O
o	O
C57BL	O
/	O
6J	O
x	O
Strain	O
129SvEv	O
ratón	B-Taxon
embriones	O
en	O
el	O
transgénico	B-Sequence
instalaciones	O
centrales	O
de	O
la	O
Universidad	O
de	O
Pittsburgh	O
y	O
la	O
Universidad	O
de	O
Cincinnati	O
,	O
respectivamente	O
.	O

ADN	B-Sequence
genómico	I-Sequence
de	O
la	O
cola	O
de	O
ratones	B-Taxon
se	O
examinó	O
mediante	O
análisis	O
de	O
transferencia	O
Southern	O
después	O
de	O
la	O
digestión	O
con	O
EcoRI	O
y	O
la	O
hibridación	O
a	O
~	O
400	O
sonda	B-Sequence
de	I-Sequence
pb	I-Sequence
derivado	O
de	O
la	O
SV40	B-Taxon
parte	B-Sequence
de	O
la	O
TRE	O
-	O
E2	B-Protein
transgén	B-Sequence
.	O

Producción	O
de	O
MSUD	O
intermedio	O
murino	B-Taxon
modelo	O

Los	O
diversos	O
TRE	O
-	O
E2	B-Protein
transgénico	B-Sequence
las	O
líneas	O
producidas	O
se	O
aparearon	O
de	O
forma	O
independiente	O
con	O
ratones	B-Taxon
que	O
eran	O
heterocigotos	O
tanto	O
para	O
el	O
E2	B-Protein
nocaut	O
y	O
el	O
VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
[	O
Tg	B-Sequence
(	O
tTALap	O
)	O
Bjd/J	O
;	O
Existencia	O
3272	O
;	O
El	O
Laboratorio	O
Jackson	O
,	O
Bar	O
Harbor	O
,	O
ME	O
;	O
Fondo	O
NMRI	O
x	O
FVB	O
x	O
C57BL/6J	O
]	O
.	O

mestizaje	O
de	O
animales	B-Taxon
que	O
eran	O
heterocigotos	O
para	O
ambos	O
transgenes	B-Sequence
y	O
el	O
golpe	O
de	O
gracia	O
resultó	O
en	O
la	O
producción	O
de	O
ratones	B-Taxon
con	O
una	O
variedad	O
de	O
genotipos	B-Sequence
incluyendo	O
algunos	O
animales	B-Taxon
que	O
eran	O
homocigotos	O
para	O
el	O
golpe	O
de	O
gracia	O
y	O
fueron	O
positivos	O
para	O
ambos	O
transgenes	B-Sequence
(	O
nos	O
referimos	O
a	O
esto	O
genotipo	B-Sequence
``	O
como	O
el	O
``	O
''	O
''	O
rescate	B-Sequence
genotipo	B-Sequence
)	O
.	O

Si	O
nuestra	O
estrategia	O
para	O
rescatar	O
el	O
fenotipo	O
letal	O
neonatal	O
del	O
knockout	O
fuera	O
exitosa	O
,	O
entonces	O
esos	O
knockout	O
homocigotos	O
animales	B-Taxon
que	O
tenia	O
los	O
dos	O
transgenes	B-Sequence
sobreviviría	O
más	O
allá	O
del	O
período	O
neonatal	O
.	O

genotipado	O

Todos	O
ratones	B-Taxon
fueron	O
genotipados	O
por	O
análisis	O
de	O
transferencia	O
Southern	O
.	O

ADN	B-Sequence
genómico	I-Sequence
preparados	O
a	O
partir	O
de	O
cortes	O
de	O
cola	O
fueron	O
digeridos	O
con	O
una	O
restricción	O
adecuada	O
enzima	B-Sequence
,	O
tamaño	O
fraccionado	O
por	O
agarosa	B-Chemical
electroforesis	O
en	O
gel	O
,	O
transferida	O
a	O
nylon	B-Chemical
,	O
y	O
probado	O
usando	O
procedimientos	O
estándar	O
.	O

inmunohistoquímica	O

Primario	O
ratón	B-Taxon
embrionario	O
fibroblastos	B-Cell
se	O
prepararon	O
a	O
partir	O
del	O
día	O
embrionario	O
~	O
16	O
.	O
5	O
-	O
18	O
.	O
5	O
fetos	O
como	O
se	O
describe	O
[	O
29	O
]	O
.	O

fibroblastos	B-Cell
se	O
pasaron	O
sobre	O
vidrio	O
,	O
se	O
fijaron	O
en	O
paraformaldehído	O
al	O
2	O
%	O
en	O
PBS	O
durante	O
10	O
minutos	O
,	O
se	O
permeabilizaron	O
en	O
paraformaldehído	O
al	O
2	O
%	O
que	O
contenía	O
0	O
.	O
Triton	O
X100	O
al	O
1	O
%	O
durante	O
10	O
minutos	O
y	O
se	O
lavó	O
tres	O
veces	O
en	O
PBS	O
que	O
contenía	O
0	O
.	O
5	O
%	O
BSA	B-Protein
y	O
0	O
15	O
%	O
glicina	B-Chemical
pH	O
7	O
.	O
4	O
(	O
tampón	O
A	O
)	O
.	O

Después	O
de	O
una	O
incubación	O
de	O
30	O
min	O
con	O
agua	O
purificada	O
cabra	B-Taxon
IgG	O
(	O
50	O
(	O
mu	O
g	O
/	O
ml	O
)	O
a	O
25	O
grados	O
C	O
y	O
tres	O
lavados	O
adicionales	O
con	O
Buffer	O
A	O
,	O
células	B-Cell
se	O
incubaron	O
durante	O
60	O
min	O
con	O
E2	B-Protein
-	O
antisuero	O
específico	O
[	O
30	O
]	O
a	O
1	O
µg/ml	O
seguido	O
de	O
tres	O
lavados	O
en	O
tampón	O
A	O
e	O
incubación	O
de	O
60	O
minutos	O
en	O
marcado	B-Chemical
fluorescentemente	I-Chemical
segundo	O
anticuerpo	B-GENE
(	O
1	O
-	O
2	O
ug	O
/	O
ml	O
)	O
.	O

los	O
células	B-Cell
luego	O
se	O
lavaron	O
seis	O
veces	O
(	O
5	O
min/lavado	O
)	O
en	O
tampón	O
A	O
y	O
luego	O
se	O
montaron	O
en	O
gelvatol	B-Chemical
(	O
Monsanto	O
,	O
San	O
Luis	O
)	O
.	O

Cuando	O
se	O
examinaron	O
hígados	O
de	O
cachorros	O
recién	O
nacidos	O
,	O
la	O
fijación	O
se	O
realizó	O
mediante	O
inmersión	O
en	O
paraformaldehído	O
al	O
2	O
%	O
,	O
seguido	O
de	O
crioprotección	O
y	O
congelación	O
rápida	O
en	O
líquido	O
.	O
nitrógeno	B-Chemical
enfriado	O
isopentano	B-Chemical
y	O
seccionamiento	O
(	O
5	O
micras	O
)	O
.	O

De	O
lo	O
contrario	O
,	O
el	O
procesamiento	O
fue	O
como	O
para	O
el	O
células	B-Cell
arriba	O
(	O
sin	O
los	O
pasos	O
de	O
fijación	O
y	O
permabilización	O
)	O
.	O

Aminoácidos	B-Chemical
análisis	O

Se	O
recolectó	O
sangre	O
del	O
seno	O
retroorbitario	O
o	O
de	O
la	O
vena	O
de	O
la	O
cola	O
de	O
ratones	B-Taxon
y	O
manchado	O
en	O
un	O
papel	O
de	O
filtro	O
que	O
se	O
usa	O
habitualmente	O
para	O
la	O
sangre	O
aminoácidos	B-Chemical
análisis	O
para	O
el	O
tamizaje	O
prenatal	O
.	O

Concentraciones	O
de	O
BCAA	B-Chemical
y	O
otra	O
aminoácidos	B-Chemical
en	O
sangre	O
se	O
determinaron	O
mediante	O
espectrometría	O
de	O
masas	O
en	O
tándem	O
(	O
Pediatrix	O
Screening	O
,	O
Bridgeville	O
,	O
PA	O
)	O
.	O

ensayo	O
de	O
BCKDH	B-GENE
actividad	O

Se	O
extrajeron	O
los	O
hígados	O
,	O
se	O
congelaron	O
en	O
líquido	O
nitrógeno	B-Chemical
,	O
y	O
almacenado	O
a	O
-80	O
grados	O
C	O
.	O

En	O
el	O
momento	O
de	O
enzima	B-Sequence
ensayo	O
,	O
los	O
hígados	O
se	O
descongelaron	O
y	O
homogeneizaron	O
(	O
1	O
:	O
9	O
,	O
p	O
/	O
v	O
)	O
en	O
0	O
.	O
25M	O
sacarosa	B-Chemical
,	O
10	O
mm	O
tris	B-Chemical
-	O
HC1	B-Chemical
,	O
pH	O
7	O
.	O
4	O
.	O

Los	O
homogeneizados	O
de	O
hígado	O
se	O
centrifugaron	O
a	O
600	O
xg	O
durante	O
10	O
min	O
a	O
4	O
grados	O
C	O
y	O
el	O
sobrenadante	O
fracción	B-GENE
se	O
guardó	O
para	O
determinar	O
la	O
BCKDH	B-GENE
actividad	O
.	O

El	O
uso	O
de	O
homogeneizados	O
de	O
tejido	O
fue	O
necesario	O
debido	O
a	O
la	O
limitada	O
disponibilidad	O
de	O
tejido	O
hepático	O
,	O
particularmente	O
de	O
cachorros	O
recién	O
nacidos	O
.	O

BCKDH	B-GENE
actividad	O
se	O
determinó	O
midiendo	O
la	O
liberación	O
de	O
14CO2	O
de	O
alfa	B-Chemical
-	I-Chemical
ceto	I-Chemical
[	I-Chemical
1	I-Chemical
-	I-Chemical
14C	I-Chemical
]	I-Chemical
isocaproato	I-Chemical
como	O
se	O
ha	O
descrito	O
anteriormente	O
[	O
31	O
]	O
.	O

La	O
mezcla	O
de	O
reacción	O
completa	O
contenía	O
(	O
volumen	O
final	O
1	O
ml	O
)	O
30	O
mM	O
fosfato	B-Chemical
de	I-Chemical
potasio	I-Chemical
tampón	O
,	O
pH	O
7	O
.	O
4	O
,	O
0	O
.	O
20	O
mm	O
alfa	B-Chemical
-	I-Chemical
cetoisocaproato	I-Chemical
,	O
0	O
.	O
40	O
mm	O
CoASH	B-Chemical
,	O
0	O
.	O
40	O
mm	O
pirofosfato	B-Chemical
de	I-Chemical
tiamina	I-Chemical
,	O
2	O
mm	O
NAD	B-Chemical
+	I-Chemical
,	O
2	O
mm	O
ditiotreitol	B-Chemical
,	O
5	O
mm	O
mg2	B-Chemical
+	I-Chemical
,	O
aproximadamente	O
250	O
000	O
DPM	O
de	O
alfa	B-Chemical
-	I-Chemical
ceto	I-Chemical
[	I-Chemical
1	I-Chemical
-	I-Chemical
14C	I-Chemical
]	I-Chemical
isocaproato	I-Chemical
,	O
y	O
0	O
.	O
10	O
ml	O
de	O
homogeneizado	O
de	O
hígado	O
(	O
2	O
-	O
3	O
mg	O
proteína	B-Chemical
)	O
.	O

Los	O
ensayos	O
se	O
llevaron	O
a	O
cabo	O
durante	O
15	O
min	O
a	O
37	O
grados	O
C	O
,	O
el	O
14CO2	O
quedó	O
atrapado	O
en	O
hidróxido	B-Chemical
de	O
hiamina	O
,	O
y	O
la	O
radiactividad	O
se	O
determinó	O
mediante	O
espectrometría	O
de	O
centelleo	O
líquido	O
.	O

Análisis	O
de	O
Western	O
Blot	O

Proteína	B-Chemical
Los	O
extractos	O
se	O
aislaron	O
de	O
hígado	O
homogeneizado	O
(	O
recién	O
cosechado	O
y	O
ultracongelado	O
)	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
,	O
Línea	O
525A	O
y	O
Línea	O
A	O
transgénico	B-Sequence
ratones	B-Taxon
.	O

Proteína	B-Chemical
(	O
25	O
ug	O
por	O
muestra	O
)	O
fue	O
analizado	O
por	O
electroforesis	O
en	O
un	O
10	O
%	O
SDS	B-Chemical
-PAGE	O
Ready	O
Gel	O
(	O
Bio-Rad	O
,	O
Hercules	O
,	O
CA	O
)	O
y	O
se	O
transfirió	O
a	O
una	O
membrana	O
de	O
PVDF	O
(	O
Sequi-Blot	O
;	O
Bio-Rad	O
)	O
mediante	O
electrotransferencia	O
.	O

Todos	O
los	O
blots	O
fueron	O
probados	O
para	O
E2	B-Protein
proteína	B-Chemical
usando	O
policlonal	O
Conejo	B-Taxon
E2	B-Protein
antisueros	O
(	O
1	O
:	O
5	O
,	O
000	O
)	O
,	O
que	O
detecta	O
ambos	O
ratón	B-Protein
(	I-Protein
~	I-Protein
47	I-Protein
kD	I-Protein
)	I-Protein
y	I-Protein
humanos	I-Protein
(	I-Protein
~	I-Protein
54	I-Protein
kD	I-Protein
)	I-Protein
subunidades	I-Protein
E2	I-Protein
(	O
[	O
30	O
]	O
;	O
obsequio	O
de	O
la	O
Dra	O
.	O
Susan	O
Hutson	O
,	O
Wake	O
Forest	O
University	O
)	O
.	O

Las	O
transferencias	O
se	O
volvieron	O
a	O
probar	O
con	O
un	O
Conejo	B-Taxon
anti	O
-	O
c-myc	B-Protein
etiqueta	O
anticuerpo	B-GENE
(	O
1	O
:	O
10	O
000	O
;	O
abCam	O
,	O
Cambridge	O
,	O
MA	O
;	O
cat	O
.	O
#	O
ab9106	O
-	O
100	O
)	O
.	O

Las	O
transferencias	O
también	O
se	O
volvieron	O
a	O
probar	O
con	O
un	O
anticuerpo	B-GENE
por	O
beta	B-Protein
-	I-Protein
actina	I-Protein
(	O
43	O
kD	O
;	O
1	O
:	O
10	O
000	O
;	O
abCam	O
;	O
cat	O
.	O
#	O
ab8227	O
-	O
50	O
)	O
para	O
permitir	O
comparaciones	O
de	O
carga	O
.	O

A	O
cabra	B-Taxon
anti	O
-	O
Conejo	B-Taxon
secundario	O
anticuerpo	B-GENE
conjugado	O
a	O
Rábano	B-Taxon
picante	I-Taxon
peroxidasa	O
(	O
1	O
:	O
10	O
000	O
;	O
Novus	O
,	O
Littleton	O
,	O
CO	O
;	O
cat	O
.	O
#	O
NB730	O
-	O
H	O
)	O
se	O
usó	O
para	O
la	O
detección	O
usando	O
la	O
quimioluminiscencia	O
Western	O
Lightning	O
reactivo	B-Chemical
(	O
Perkin	O
Elmer	O
,	O
Boston	O
,	O
MA	O
)	O
y	O
expuesto	O
a	O
una	O
película	O
de	O
rayos	O
X	O
.	O

Análisis	O
estadístico	O

Todos	O
BCAA	B-Chemical
y	O
BCKDH	B-GENE
enzima	B-Sequence
los	O
datos	O
de	O
actividad	O
se	O
presentan	O
como	O
la	O
media	O
+/-	O
el	O
error	O
estándar	O
de	O
la	O
media	O
(	O
S.E.M	O
.	O
)	O
.	O

Diferencias	O
entre	O
genotipos	B-Sequence
se	O
compararon	O
mediante	O
la	O
prueba	O
de	O
la	O
t	O
de	O
Student	O
[	O
32	O
]	O
.	O

Resultados	O

Produccion	O
de	O
E2	B-Protein
gene	B-Sequence
knockear	O
ratones	B-Taxon

Crear	O
E2	B-Protein
knockear	O
ratones	B-Taxon
,	O
nosotros	O
usamos	O
gene	B-Sequence
apuntando	O
en	O
ratón	B-Taxon
ES	O
células	B-Cell
interrumpir	O
el	O
E2	B-Protein
gene	B-Sequence
.	O

La	O
estrategia	O
general	O
para	O
interrumpir	O
el	O
E2	B-Protein
gene	B-Sequence
se	O
ilustra	O
en	O
la	O
figura	O
.	O

1A	O
.	O

los	O
gene	B-Sequence
apuntando	O
construir	B-Sequence
fue	O
diseñado	O
para	O
reemplazar	B-Sequence
un	O
1	O
67	O
kb	O
EcoRV	O
/	O
Pequeño	O
fragmento	B-Sequence
de	I-Sequence
ADN	I-Sequence
genómico	I-Sequence
abarcando	O
parte	B-Sequence
de	I-Sequence
exón	I-Sequence
4	O
y	O
todo	O
exón	B-Sequence
con	O
el	O
marcador	O
seleccionable	O
PGKneo	O
casete	B-Sequence
.	O

de	O
522	O
ES	O
célula	B-Cell
clones	O
examinados	O
para	O
la	O
orientación	O
por	O
análisis	O
de	O
transferencia	O
de	O
Southern	O
,	O
29	O
(	O
5	O
%	O
)	O
mostraron	O
la	O
polimorfismos	B-Sequence
de	I-Sequence
longitud	I-Sequence
de	I-Sequence
fragmentos	I-Sequence
de	I-Sequence
restricción	I-Sequence
predichos	I-Sequence
indicativo	O
de	O
gene	B-Sequence
apuntando	O
a	O
la	O
E2	B-Protein
lugar	B-Sequence
.	O

Como	O
se	O
ilustra	O
en	O
la	O
figura	O
.	O

1A	O
y	O
1B	O
,	O
un	O
E2	B-Protein
exón	B-Sequence
6	O
específicos	O
Investigacion	B-Sequence
,	O
que	O
es	O
externo	O
a	O
la	O
segmentación	O
construir	B-Sequence
,	O
se	O
hibrida	O
a	O
solo	O
un	O
BglI	O
de	O
~	O
16	O
kb	O
fragmento	B-Sequence
de	I-Sequence
restricción	I-Sequence
desde	O
el	O
alelo	B-Sequence
de	I-Sequence
tipo	I-Sequence
salvaje	I-Sequence
en	O
el	O
R1	O
ES	O
parental	O
célula	B-Cell
línea	O
.	O

En	O
ES	O
correctamente	O
dirigido	O
células	B-Cell
,	O
esta	O
Investigacion	B-Sequence
también	O
se	O
hibrida	O
a	O
un	O
BglI	O
de	O
~	O
11	O
kb	O
fragmento	B-Sequence
de	I-Sequence
restricción	I-Sequence
.	O

La	O
segmentación	O
se	O
confirmó	O
con	O
varias	O
restricciones	O
adicionales	O
enzimas	B-Sequence
y	O
sondas	B-Sequence
(	O
datos	O
no	O
mostrados	O
)	O
.	O

ES	O
correctamente	O
orientado	O
células	B-Cell
fueron	O
microinyectados	O
en	O
blastocistos	O
para	O
producir	O
quiméricos	O
ratones	B-Taxon
.	O

Los	O
quiméricos	O
se	O
cruzaron	O
con	O
C57BL	O
/	O
6J	O
ratones	B-Taxon
.	O

Después	O
de	O
la	O
transmisión	O
de	O
la	O
línea	O
germinal	O
del	O
objetivo	O
alelo	B-Sequence
,	O
heterocigoto	O
ratones	B-Taxon
se	O
cruzaron	O
para	O
producir	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
,	O
heterocigoto	O
(	O
+	B-Sequence
/	O
-	O
)	O
y	O
homocigotos	O
(	O
-	O
/	O
-	O
)	O
animales	B-Taxon
.	O

Ratones	B-Taxon
fueron	O
genotipados	O
por	O
análisis	O
de	O
transferencia	O
Southern	O
.	O

los	O
exón	B-Sequence
6	O
específicos	O
Investigacion	B-Sequence
hibridado	O
a	O
solo	O
un	O
BglI	O
de	O
~	O
16	O
kb	O
fragmento	B-Sequence
de	I-Sequence
restricción	I-Sequence
en	O
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
,	O
a	O
~	O
11	O
kb	O
BglI	O
fragmento	B-Sequence
en	O
-	O
/	O
-	O
ratones	B-Taxon
,	O
y	O
a	O
ambos	O
fragmentos	B-Sequence
en	O
+	B-Sequence
/	O
-	O
ratones	B-Taxon
(	O
Figura	O
1B	O
)	O
.	O

Ratones	B-Taxon
homocigoto	O
para	O
el	O
E2	B-Protein
mutación	B-Sequence
nacieron	O
con	O
la	O
frecuencia	O
esperada	O
.	O

Genotipo	B-Sequence
análisis	O
de	O
crías	O
derivadas	O
de	O
+	B-Sequence
/	O
-	O
por	O
+	B-Sequence
/	O
-	O
los	O
apareamientos	O
revelaron	O
que	O
+	B-Sequence
/	O
+	B-Sequence
,	O
+	B-Sequence
/	O
-	O
,	O
y	O
-	O
/	O
-	O
ratones	B-Taxon
estuvieron	O
presentes	O
en	O
casi	O
la	O
frecuencia	O
esperada	O
de	O
1:2:1	O
.	O

De	O
los	O
60	O
iniciales	O
animales	B-Taxon
genotipados	O
,	O
19	O
(	O
32	O
%	O
)	O
fueron	O
+	B-Sequence
/	O
+	B-Sequence
,	O
27	O
(	O
45	O
%	O
)	O
fueron	O
+	B-Sequence
/	O
-	O
,	O
y	O
14	O
(	O
23	O
%	O
)	O
fueron	O
-	O
/	O
-	O
.	O

Por	O
lo	O
tanto	O
,	O
la	O
E2	B-Protein
gene	B-Sequence
era	O
prescindible	O
para	O
el	O
desarrollo	O
embrionario	O
normal	O
.	O

Sin	O
embargo	O
,	O
como	O
era	O
de	O
esperar	O
,	O
casi	O
todos	O
los	O
homocigotos	O
ratones	B-Taxon
murió	O
en	O
el	O
período	O
perinatal	O
.	O

Inmediatamente	O
después	O
del	O
nacimiento	O
,	O
los	O
cachorros	O
homocigóticos	O
eran	O
indistinguibles	O
de	O
sus	O
+	B-Sequence
/	O
+	B-Sequence
y	O
+	B-Sequence
/	O
-	O
compañeros	O
de	O
camada	O
;	O
eran	O
vigorosos	O
,	O
activos	O
y	O
capaces	O
de	O
amamantar	O
.	O

Hacia	O
la	O
mitad	O
o	O
hacia	O
el	O
final	O
del	O
primer	O
día	O
posnatal	O
,	O
la	O
mayoría	O
de	O
los	O
cachorros	O
estaban	O
moribundos	O
y	O
eran	O
fácilmente	O
identificables	O
,	O
ya	O
que	O
estaban	O
letárgicos	O
,	O
pálidos	O
y	O
exhibían	O
movimientos	O
respiratorios	O
entrecortados	O
.	O

Con	O
pocas	O
excepciones	O
,	O
los	O
cachorros	O
-/-	O
murieron	O
dentro	O
de	O
las	O
72	O
horas	O
posteriores	O
al	O
nacimiento	O
.	O

Hemos	O
observado	O
un	O
raro	O
-	O
/	O
-	O
cachorro	O
que	O
sobrevivió	O
hasta	O
el	O
día	O
13	O
postnatal	O
.	O

Se	O
desconoce	O
el	O
motivo	O
de	O
la	O
supervivencia	O
prolongada	O
de	O
este	O
cachorro	O
.	O

E2	B-Protein
deficiente	O
ratones	B-Taxon
modelar	O
con	O
precisión	O
MSUD	O
clásico	O

Para	O
demostrar	O
que	O
el	O
gene	B-Sequence
evento	O
de	O
orientación	O
creó	O
un	O
verdadero	O
E2	B-Protein
nulo	O
alelo	B-Sequence
,	O
determinamos	O
BCKDH	B-GENE
actividad	O
en	O
homogeneizados	O
de	O
hígado	O
del	O
día	O
postnatal	O
1	O
ratón	B-Taxon
cachorros	O
derivados	O
de	O
+	B-Sequence
/	O
-	O
por	O
+	B-Sequence
/	O
-	O
parejas	O
de	O
apareamiento	O
.	O

Como	O
se	O
muestra	O
en	O
la	O
Figura	O
2A	O
,	O
el	O
BCKDH	B-GENE
actividad	O
en	O
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
era	O
fácilmente	O
detectable	O
.	O

En	O
marcado	O
contraste	O
,	O
BCKDH	B-GENE
la	O
actividad	O
estuvo	O
completamente	O
ausente	O
en	O
-	O
/	O
-	O
ratón	B-Taxon
hígados	O

Como	O
era	O
de	O
esperar	O
,	O
los	O
homogeneizados	O
de	O
+	B-Sequence
/	O
-	O
ratones	B-Taxon
tenían	O
aproximadamente	O
la	O
mitad	O
de	O
la	O
actividad	O
de	O
sus	O
+	B-Sequence
/	O
+	B-Sequence
compañeros	O
de	O
camada	O
(	O
Figura	O
2A	O
)	O
.	O

Los	O
resultados	O
de	O
-	O
/	O
-	O
ratones	B-Taxon
son	O
similares	O
a	O
las	O
observadas	O
en	O
humanos	B-Taxon
con	O
MSUD	O
clásico	O
[	O
1	O
]	O
.	O

Figura	O
2	O

Caracterización	O
bioquímica	O
de	O
la	O
MSUD	O
clásica	O
murino	B-Taxon
modelo	O

A	O
,	O
BCKDH	B-GENE
enzima	B-Sequence
actividad	O
en	O
el	O
hígado	O
del	O
recién	O
nacido	O
tipo	B-Sequence
salvaje	I-Sequence
control	O
(	O
+	B-Sequence
/	O
+	B-Sequence
)	O
,	O
heterocigoto	O
(	O
+	B-Sequence
/	O
-	O
)	O
y	O
homocigotos	O
(	O
-	O
/	O
-	O
)	O
knockout	O
ratones	B-Taxon
.	O

Enzima	B-Sequence
la	O
actividad	O
se	O
redujo	O
significativamente	O
en	O
+	B-Sequence
/	O
-	O
hígado	O
en	O
comparación	O
con	O
+	B-Sequence
/	O
+	B-Sequence
,	O
y	O
estuvo	O
por	O
debajo	O
del	O
nivel	O
de	O
detección	O
en	O
-	O
/	O
-	O
hígado	O
.	O

B	O
,	O
total	O
BCAA	B-Chemical
concentraciones	O
en	O
sangre	O
de	O
ratones	B-Taxon
.	O

Total	O
BCAA	B-Chemical
representan	O
la	O
suma	O
de	O
leucina	B-Chemical
,	O
isoleucina	B-Chemical
,	O
y	O
valina	B-Chemical
.	O

Total	O
BCAA	B-Chemical
concentraciones	O
en	O
sangre	O
de	O
-	O
/	O
-	O
ratones	B-Taxon
fueron	O
significativamente	O
elevados	O
en	O
comparación	O
con	O
+	B-Sequence
/	O
+	B-Sequence
y	O
+	B-Sequence
/	O
-	O
.	O

C	O
,	O
Relación	O
del	O
total	O
BCAA	B-Chemical
para	O
alanina	B-Chemical
en	O
sangre	O
de	O
ratones	B-Taxon
.	O

Esta	O
relación	O
fue	O
significativamente	O
elevada	O
en	O
-	O
/	O
-	O
ratones	B-Taxon
comparado	O
con	O
+	B-Sequence
/	O
+	B-Sequence
y	O
+	B-Sequence
/	O
-	O
ratones	B-Taxon
.	O

Los	O
números	O
en	O
las	O
barras	O
indican	O
el	O
número	O
de	O
ratones	B-Taxon
analizado	O

*	O
,	O
Significativamente	O
diferente	O
de	O
+	B-Sequence
/	O
+	B-Sequence
(	O
P	O
<	O
0,001	O
)	O
;	O
*	O
*	O
,	O
significativamente	O
diferente	O
de	O
+	B-Sequence
/	O
+	B-Sequence
y	O
+	B-Sequence
/	O
-	O
(	O
PAG	O
<	O
0	O
.	O
001	O
)	O
.	O

Inmunohistoquímica	O
con	O
un	O
E2	B-Protein
específico	O
anticuerpo	B-GENE
se	O
utilizó	O
para	O
examinar	O
E2	B-Protein
proteína	B-Chemical
en	O
el	O
ratones	B-Taxon
.	O

Como	O
se	O
muestra	O
en	O
la	O
Figura	O
1C	O
y	O
1D	O
,	O
inmunorreactivo	O
E2	B-Protein
proteína	B-Chemical
fue	O
abundante	O
en	O
hígado	O
y	O
embriones	O
fibroblastos	B-Cell
de	O
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
.	O

En	O
marcado	O
contraste	O
,	O
inmunorreactivo	O
E2	B-Protein
proteína	B-Chemical
estaba	O
ausente	O
en	O
estos	O
mismos	O
tejidos	O
de	O
-	O
/	O
-	O
ratones	B-Taxon
.	O

Homocigoto	O
E2	B-Protein
knockear	O
ratones	B-Taxon
tuvo	O
un	O
aumento	O
de	O
casi	O
3	O
veces	O
en	O
los	O
niveles	O
de	O
sangre	O
(	O
Figura	O
2B	O
)	O
y	O
orina	O
(	O
datos	O
no	O
mostrados	O
)	O
de	O
BCAA	B-Chemical
(	O
la	O
suma	O
de	O
leucina	B-Chemical
,	O
isoleucina	B-Chemical
,	O
y	O
valina	B-Chemical
)	O
en	O
comparación	O
con	O
sus	O
+	B-Sequence
/	O
+	B-Sequence
compañeros	O
de	O
camada	O

Porque	O
aminoácidos	B-Chemical
fueron	O
analizados	O
por	O
espectrometría	O
de	O
masas	O
en	O
tándem	O
,	O
la	O
suma	O
de	O
BCAA	B-Chemical
que	O
se	O
muestra	O
en	O
la	O
Figura	O
2B	O
también	O
puede	O
incluir	O
aloisoleucina	B-Chemical
que	O
puede	O
haber	O
sido	O
producido	O
en	O
-	O
/	O
-	O
MSUD	O
ratones	B-Taxon
.	O

El	O
metabolismo	O
de	O
BCAA	B-Chemical
está	O
relacionado	O
con	O
la	O
síntesis	O
de	O
alanina	B-Chemical
,	O
glutamato	B-Chemical
,	O
y	O
glutamina	B-Chemical
[	O
33	O
]	O
.	O

Debido	O
al	O
metabolismo	O
alterado	O
de	O
BCAA	B-Chemical
en	O
MSUD	O
ratones	B-Taxon
,	O
y	O
para	O
caracterizar	O
aún	O
más	O
la	O
bioquímica	O
anormal	O
en	O
este	O
modelo	O
,	O
analizamos	O
los	O
niveles	O
en	O
sangre	O
de	O
los	O
alanina	B-Chemical
,	O
glutamato	B-Chemical
,	O
y	O
glutamina	B-Chemical
.	O

Como	O
se	O
muestra	O
en	O
la	O
Tabla	O
1	O
,	O
los	O
niveles	O
de	O
los	O
tres	O
aminoácidos	B-Chemical
en	O
homocigoto	O
ratones	B-Taxon
fueron	O
marcadamente	O
inferiores	O
a	O
los	O
niveles	O
de	O
+	B-Sequence
/	O
+	B-Sequence
o	O
+	B-Sequence
/	O
-	O
ratones	B-Taxon
.	O

Los	O
niveles	O
de	O
estos	O
aminoácidos	B-Chemical
en	O
el	O
+	B-Sequence
/	O
-	O
ratones	B-Taxon
eran	O
comparables	O
a	O
los	O
de	O
+	B-Sequence
/	O
+	B-Sequence
ratones	B-Taxon
(	O
Tabla	O
1	O
)	O
.	O

Debido	O
a	O
la	O
disminución	O
anormal	O
en	O
la	O
sangre	O
.	O
alanina	B-Chemical
nivel	O
y	O
marcado	O
aumento	O
en	O
la	O
sangre	O
BCAA	B-Chemical
niveles	O
que	O
son	O
característicos	O
de	O
MSUD	O
,	O
un	O
informe	O
reciente	O
sobre	O
pacientes	O
con	O
MSUD	O
ha	O
sugerido	O
que	O
la	O
proporción	O
de	O
BCAA	B-Chemical
/	O
alanina	B-Chemical
proporciona	O
una	O
medida	O
más	O
sensible	O
de	O
la	O
bioquímica	O
anormal	O
de	O
MSUD	O
que	O
BCAA	B-Chemical
nivel	O
solo	O
[	O
8	O
]	O
.	O

Por	O
lo	O
tanto	O
,	O
también	O
expresamos	O
la	O
aminoácidos	B-Chemical
resultados	O
como	O
BCAA	B-Chemical
/	O
alanina	B-Chemical
proporción	O

Como	O
se	O
muestra	O
en	O
la	O
Figura	O
2C	O
,	O
esta	O
proporción	O
en	O
-	O
/	O
-	O
cachorros	O
fue	O
más	O
de	O
6	O
veces	O
mayor	O
que	O
+	B-Sequence
/	O
+	B-Sequence
o	O
+	B-Sequence
/	O
-	O
compañeros	O
de	O
camada	O
.	O

esta	O
sangre	O
aminoácidos	B-Chemical
los	O
resultados	O
son	O
consistentes	O
con	O
las	O
concentraciones	O
observadas	O
en	O
pacientes	O
con	O
MSUD	O
[	O
1	O
,	O
8	O
,	O
15	O
]	O
.	O

tabla	O
1	O

Resumen	O
de	O
sangre	O
adicional	O
aminoácidos	B-Chemical
niveles	O
en	O
el	O
modelo	O
MSUD	O
clásico	O
y	O
compañeros	O
de	O
camada	O
de	O
control	O
determinados	O
por	O
espectrometría	O
de	O
masas	O
en	O
tándem	O
.	O

Todas	O
las	O
muestras	O
se	O
recogieron	O
el	O
día	O
del	O
nacimiento	O
.	O

Todos	O
los	O
valores	O
son	O
medios	O
+/-	O
SEM	O
.	O

*	O
:	O
Significativamente	O
diferente	O
de	O
+	B-Sequence
/	O
+	B-Sequence
y	O
+	B-Sequence
/	O
-	O
(	O
PAG	O
<	O
0	O
.	O
001	O
)	O
.	O

En	O
resumen	O
,	O
E2	B-Protein
knockear	O
ratones	B-Taxon
carecer	O
BCKDH	B-GENE
enzimático	B-Sequence
actividad	O
,	O
E2	B-Protein
inmunorreactividad	O
y	O
tienen	O
niveles	O
marcadamente	O
elevados	O
de	O
BCAA	B-Chemical
en	O
la	O
sangre	O
y	O
la	O
orina	O
.	O

Estos	O
trastornos	O
metabólicos	O
finalmente	O
resultan	O
en	O
letalidad	O
neonatal	O
.	O

Estos	O
fenotipos	O
son	O
notablemente	O
similares	O
a	O
los	O
observados	O
en	O
humanos	B-Taxon
con	O
la	O
forma	O
clásica	O
de	O
MSUD	O
.	O

Por	O
lo	O
tanto	O
,	O
E2	B-Protein
knockear	O
ratones	B-Taxon
modelo	O
de	O
cerca	O
MSUD	O
clásico	O
.	O

Knockear	O
ratones	B-Taxon
expresando	O
un	O
humano	B-Protein
E2	I-Protein
transgén	B-Sequence
modelar	O
una	O
forma	O
variante	O
de	O
MSUD	O
que	O
imita	O
el	O
MSUD	O
intermedio	O

Para	O
crear	O
un	O
murino	B-Taxon
modelo	O
de	O
la	O
variante	O
intermedia	O
de	O
MSUD	O
,	O
usamos	O
un	O
transgénico	B-Sequence
estrategia	O
para	O
rescatar	O
la	O
elevación	O
severa	O
de	O
BCAA	B-Chemical
y	O
letalidad	O
neonatal	O
que	O
ocurre	O
en	O
la	O
MSUD	O
clásica	O
ratón	B-Taxon
modelo	O

Nuestra	O
estrategia	O
se	O
componía	O
de	O
dos	O
partes	O
transgénico	B-Sequence
sistema	O
para	O
expresar	O
humano	B-Protein
E2	I-Protein
en	O
hígado	O
en	O
el	O
E2	B-Protein
fondo	O
de	O
nocaut	O
.	O

Esta	O
bi-	O
transgénico	B-Sequence
sistema	O
consistía	O
en	O
un	O
VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
y	O
un	O
TRE	O
-	O
E2	B-Protein
transgén	B-Sequence
(	O
Fig	O
.	O
3A	O
)	O
.	O

los	O
VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
[	O
34	O
]	O
dirige	O
altos	O
niveles	O
de	O
expresión	O
específica	O
del	O
hígado	O
de	O
la	O
tetraciclina	B-Chemical
-	O
transactivador	O
controlado	O
(	O
tTA	O
)	O
,	O
un	O
factor	O
de	O
transcripción	O
que	O
estimula	O
la	O
expresión	O
de	O
promotores	B-Sequence
que	O
albergan	O
una	O
respuesta	O
transactivadora	O
elemento	B-Sequence
(	O
TRE	O
)	O
.	O

El	O
TRE	O
-	O
E2	B-Protein
transgén	B-Sequence
fue	O
diseñado	O
para	O
expresar	O
una	O
humano	B-Protein
E2	I-Protein
ADNc	B-Sequence
de	O
un	O
TRE	O
que	O
contiene	O
un	O
mínimo	O
promotor	B-Sequence
tras	O
la	O
estimulación	O
por	O
tTA	O
.	O

figura	O
3	O

transgénico	B-Sequence
ratón	B-Taxon
producción	O
y	O
caracterización	O
.	O

A	O
,	O
transgénico	B-Sequence
estrategia	O
utilizada	O
para	O
producir	O
ratones	B-Taxon
que	O
expresan	O
humano	B-Protein
E2	I-Protein
.	O

VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
se	O
han	O
descrito	O
previamente	O
[	O
34	O
]	O
.	O

Estas	O
ratones	B-Taxon
expresar	O
el	O
tetraciclina	B-Chemical
#	O
¿NOMBRE	O
?	O
VUELTA	B-Protein
promotor	B-Sequence
.	O

El	O
TRE	O
-	O
E2	B-Protein
transgén	B-Sequence
contiene	O
la	O
tetraciclina	B-Chemical
respuesta	O
elemento	B-Sequence
(	O
TRE	O
)	O
como	O
parte	O
del	O
promotor	B-Sequence
,	O
a	O
intrón	B-Sequence
sintético	I-Sequence
(	O
línea	O
delgada	O
)	O
,	O
la	O
humano	B-Protein
E2	I-Protein
ADNc	B-Sequence
,	O
un	O
alanina	B-Chemical
espaciador	O
,	O
un	O
c-myc	B-Protein
epítopo	B-Sequence
etiqueta	O
,	O
y	O
SV40	B-Taxon
derivado	O
secuencia	B-Sequence
de	I-Sequence
poliadenilación	I-Sequence
.	O

Esta	O
construir	B-Sequence
se	O
utilizó	O
para	O
crear	O
varias	O
líneas	O
de	O
transgénico	B-Sequence
ratones	B-Taxon
.	O

B	O
,	O
análisis	O
de	O
transferencia	O
Western	O
de	O
E2	B-Protein
proteína	B-Chemical
en	O
hígado	O
de	O
control	O
e	O
intermedio	O
MSUD	O
ratones	B-Taxon
.	O

Tenga	O
en	O
cuenta	O
que	O
la	O
cantidad	O
de	O
humano	B-Protein
E2	I-Protein
proteína	B-Chemical
(	O
MW	O
previsto	O
~	O
54	O
Kd	O
)	O
en	O
ratones	B-Taxon
de	O
las	O
Líneas	O
A	O
y	O
525	O
A	O
era	O
variable	O
pero	O
en	O
muchas	O
de	O
las	O
animales	B-Taxon
la	O
cantidad	O
era	O
similar	O
a	O
la	O
cantidad	O
de	O
ratón	B-Protein
E2	I-Protein
MW	O
=	O
~	O
47	O
Kd	O
)	O
en	O
control	O
animales	B-Taxon
.	O

Volver	O
a	O
sondear	O
con	O
un	O
c-myc	B-Protein
etiqueta	O
anticuerpo	B-GENE
confirmó	O
la	O
presencia	O
del	O
transgén	B-Sequence
derivado	O
,	O
c-myc	B-Protein
etiquetado	O
,	O
humano	B-Protein
E2	I-Protein
en	O
transgénico	B-Sequence
ratones	B-Taxon
pero	O
no	O
en	O
los	O
controles	O
.	O

El	O
análisis	O
de	O
transferencia	O
Western	O
de	O
cerebro	O
(	O
C	O
)	O
,	O
riñón	O
(	O
D	O
)	O
y	O
músculo	O
(	O
E	O
)	O
reveló	O
cantidades	O
insignificantes	O
de	O
transgén	B-Sequence
derivado	O
E2	B-Protein
en	O
esos	O
tejidos	O
.	O

Todos	O
los	O
blots	O
se	O
volvieron	O
a	O
probar	O
con	O
un	O
actina	B-Protein
anticuerpo	B-GENE
para	O
permitir	O
la	O
cantidad	O
de	O
proteína	B-Chemical
cargado	O
en	O
cada	O
carril	O
para	O
ser	O
comparado	O
.	O

VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
fueron	O
previamente	O
producidos	O
y	O
caracterizados	O
por	O
el	O
laboratorio	O
Bujard	O
[	O
34	O
]	O
.	O

pronuclear	B-GENE
Se	O
utilizó	O
microinyección	O
para	O
producir	O
transgénico	B-Sequence
ratones	B-Taxon
que	O
albergaba	O
la	O
TRE	O
-	O
E2	B-Protein
transgén	B-Sequence
.	O

De	O
inyecciones	O
en	O
la	O
Universidad	O
de	O
Pittsburgh	O
,	O
2	O
transgén	B-Sequence
se	O
identificaron	O
fundadores	O
positivos	O
que	O
llevaron	O
a	O
la	O
generación	O
de	O
3	O
diferentes	O
transgénico	B-Sequence
líneas	O
(	O
líneas	O
A	O
,	O
B	O
y	O
D	O
)	O
.	O

De	O
las	O
inyecciones	O
en	O
la	O
Universidad	O
de	O
Cincinnati	O
,	O
obtuvimos	O
8	O
transgén	B-Sequence
fundadores	O
positivos	O
.	O

La	O
reproducción	O
posterior	O
de	O
estos	O
fundadores	O
reveló	O
que	O
muchos	O
de	O
los	O
animales	B-Taxon
tenía	O
múltiples	O
sitios	B-Sequence
de	I-Sequence
inserción	I-Sequence
de	I-Sequence
transgenes	I-Sequence
que	O
segregaba	O
.	O

Establecimos	O
un	O
total	O
de	O
15	O
diferentes	O
transgénico	B-Sequence
líneas	O
de	O
estos	O
fundadores	O
.	O

Los	O
recursos	O
limitados	O
nos	O
permitieron	O
concentrarnos	O
únicamente	O
en	O
un	O
total	O
de	O
9	O
de	O
estas	O
líneas	O
.	O

Estas	O
líneas	O
diferían	O
sustancialmente	O
en	O
transgén	B-Sequence
número	O
de	O
copias	O
en	O
comparación	O
con	O
el	O
análisis	O
de	O
transferencia	O
de	O
Southern	O
de	O
la	O
cola	O
ADN	B-Sequence
(	O
datos	O
no	O
mostrados	O
)	O
.	O

transgénico	B-Sequence
TRE	O
-	O
E2	B-Protein
ratones	B-Taxon
de	O
cada	O
línea	O
(	O
ya	O
sea	O
fundadores	O
o	O
descendientes	O
de	O
F1	O
)	O
se	O
cruzaron	O
para	O
ratones	B-Taxon
que	O
fueron	O
positivos	O
para	O
el	O
VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
y	O
eran	O
heterocigotos	O
para	O
el	O
E2	B-Protein
knockear	O
.	O

En	O
definitiva	O
,	O
se	O
utilizaron	O
parejas	O
reproductoras	O
en	O
las	O
que	O
el	O
ratones	B-Taxon
eran	O
heterocigotos	O
para	O
el	O
VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
,	O
el	O
TRE	O
-	O
E2	B-Protein
transgén	B-Sequence
,	O
y	O
el	O
E2	B-Protein
knockear	O
.	O

Para	O
evaluar	O
de	O
manera	O
eficiente	O
la	O
capacidad	O
del	O
transgenes	B-Sequence
para	O
rescatar	O
el	O
knockout	O
de	O
la	O
letalidad	O
neonatal	O
,	O
genotipificamos	O
las	O
camadas	O
al	O
destete	O
.	O

Se	O
espera	O
que	O
esta	O
estrategia	O
de	O
mejoramiento	O
resulte	O
en	O
un	O
máximo	O
teórico	O
de	O
animales	B-Taxon
con	O
el	O
genotipo	B-Sequence
de	I-Sequence
rescate	I-Sequence
(	O
es	O
decir	O
,	O
homocigoto	O
E2	B-Protein
nocaut	O
y	O
positivo	O
para	O
ambos	O
transgenes	B-Sequence
)	O
del	O
14	O
%	O
.	O

Higo	O
.	O

4A	O
muestra	O
el	O
porcentaje	O
de	O
ratones	B-Taxon
vivo	O
al	O
destete	O
con	O
el	O
genotipo	B-Sequence
de	I-Sequence
rescate	I-Sequence
de	O
cada	O
transgénico	B-Sequence
línea	O
probada	O
.	O

Se	O
observó	O
una	O
variabilidad	O
considerable	O
entre	O
líneas	O
.	O

La	O
línea	O
con	O
mayor	O
porcentaje	O
de	O
rescate	O
ratones	B-Taxon
al	O
destete	O
era	O
la	O
línea	O
525	O
A	O
.	O

Aproximadamente	O
el	O
10	O
%	O
de	O
los	O
cachorros	O
destetados	O
y	O
supervivientes	O
de	O
esta	O
línea	O
tenían	O
la	O
genotipo	B-Sequence
de	I-Sequence
rescate	I-Sequence
.	O

Así	O
,	O
el	O
525A	O
transgén	B-Sequence
parece	O
ser	O
muy	O
eficaz	O
para	O
rescatar	O
el	O
fenotipo	O
letal	O
neonatal	O
del	O
E2	B-Protein
knockear	O
.	O

Por	O
el	O
contrario	O
,	O
la	O
línea	O
520B	O
fracasó	O
por	O
completo	O
en	O
el	O
rescate	O
del	O
fenotipo	O
letal	O
neonatal	O
.	O

Todas	O
las	O
demás	O
líneas	O
probadas	O
produjeron	O
rescate	O
sobreviviente	O
animales	B-Taxon
con	O
una	O
frecuencia	O
entre	O
el	O
1	O
y	O
el	O
5	O
%	O
de	O
las	O
crías	O
destetadas	O
.	O

Figura	O
4	O

Caracterización	O
de	O
la	O
MSUD	O
intermedia	O
murino	B-Taxon
modelo	O

A	O
,	O
Análisis	O
de	O
supervivencia	O
de	O
transgénico	B-Sequence
líneas	O
de	O
rescate	O
.	O

Se	O
presentan	O
porcentajes	O
de	O
ratones	B-Taxon
vivos	O
al	O
destete	O
de	O
cada	O
transgénico	B-Sequence
línea	O
probada	O
que	O
tenía	O
la	O
genotipo	B-Sequence
de	I-Sequence
rescate	I-Sequence
(	O
es	O
decir	O
,	O
homocigoto	O
para	O
nocaut	O
de	O
endógeno	O
E2	B-Protein
y	O
positivo	O
para	O
ambos	O
VUELTA	B-Protein
-	O
tTA	O
y	O
TRE	O
-	O
E2	B-Protein
transgenes	B-Sequence
)	O
.	O

También	O
se	O
representa	O
la	O
frecuencia	O
máxima	O
teórica	O
a	O
la	O
que	O
genotipo	B-Sequence
se	O
espera	O
en	O
esta	O
población	O
de	O
animales	B-Taxon
.	O

Los	O
números	O
en	O
las	O
barras	O
indican	O
el	O
número	O
de	O
observaciones	O
para	O
cada	O
línea	O
.	O

B	O
,	O
Relación	O
del	O
total	O
BCAA	B-Chemical
para	O
alanina	B-Chemical
en	O
sangre	O
de	O
ratones	B-Taxon
de	O
controles	O
y	O
Líneas	O
A	O
y	O
525A	O
.	O

Total	O
BCAA	B-Chemical
representan	O
la	O
suma	O
de	O
leucina	B-Chemical
,	O
isoleucina	B-Chemical
,	O
y	O
valina	B-Chemical
.	O

BCAA	B-Chemical
/	O
alanina	B-Chemical
los	O
valores	O
fueron	O
significativamente	O
mayores	O
para	O
las	O
Líneas	O
A	O
y	O
525A	O
en	O
comparación	O
con	O
los	O
controles	O
de	O
todas	O
las	O
edades	O
evaluadas	O
.	O

Los	O
números	O
en	O
las	O
barras	O
indican	O
el	O
número	O
de	O
muestras	O
analizadas	O
.	O

*	O
,	O
PAGS	O
<	O
=	O
0	O
.	O
01	O
;	O
*	O
*	O
,	O
PAG	O
<	O
0	O
.	O
005	O
.	O

C	O
,	O
BCKDH	B-GENE
enzima	B-Sequence
actividad	O
en	O
hígado	O
de	O
control	O
y	O
Líneas	O
A	O
y	O
525A	O
ratones	B-Taxon
.	O

*	O
,	O
PAGS	O
<	O
=	O
0	O
.	O
001	O
;	O
*	O
*	O
,	O
PAG	O
<	O
=	O
0	O
.	O
0001	O
.	O

D	O
,	O
Curvas	O
de	O
supervivencia	O
para	O
ratones	B-Taxon
de	O
las	O
Líneas	O
A	O
y	O
525A	O
.	O

Rescate	B-Sequence
ratones	B-Taxon
vivos	O
al	O
destete	O
fueron	O
monitoreados	O
hasta	O
que	O
estaban	O
moribundos	O
y	O
posteriormente	O
fueron	O
sacrificados	O
o	O
encontrados	O
muertos	O
en	O
sus	O
jaulas	O
.	O

Las	O
líneas	O
A	O
y	O
525A	O
fueron	O
seleccionadas	O
para	O
una	O
caracterización	O
detallada	O
.	O

Higo	O
.	O

4B	O
muestra	O
los	O
resultados	O
de	O
la	O
sangre	O
aminoácidos	B-Chemical
análisis	O
presentado	O
como	O
una	O
proporción	O
del	O
total	O
BCAA	B-Chemical
para	O
alanina	B-Chemical
.	O

los	O
BCAA	B-Chemical
/	O
alanina	B-Chemical
valores	O
para	O
ratones	B-Taxon
de	O
ambas	O
líneas	O
fueron	O
significativamente	O
elevados	O
en	O
comparación	O
con	O
los	O
controles	O
para	O
todos	O
los	O
puntos	O
de	O
tiempo	O
analizados	O
.	O

Tenga	O
en	O
cuenta	O
que	O
el	O
BCAA	B-Chemical
/	O
alanina	B-Chemical
valores	O
para	O
el	O
transgénico	B-Sequence
ratones	B-Taxon
son	O
intermedios	O
entre	O
los	O
controles	O
y	O
los	O
knockouts	O
(	O
ver	O
Figura	O
2C	O
)	O
.	O

niveles	O
en	O
sangre	O
de	O
alanina	B-Chemical
,	O
glutamato	B-Chemical
,	O
y	O
glutamina	B-Chemical
se	O
redujeron	O
en	O
la	O
Línea	O
A	O
ratones	B-Taxon
,	O
como	O
era	O
glutamato	B-Chemical
en	O
la	O
Línea	O
525A	O
ratones	B-Taxon
,	O
en	O
comparación	O
con	O
los	O
controles	O
(	O
Tabla	O
2	O
)	O
.	O

Tabla	O
2	O

Resumen	O
de	O
sangre	O
adicional	O
aminoácidos	B-Chemical
niveles	O
en	O
el	O
modelo	O
MSUD	O
intermedio	O
y	O
controles	O
de	O
compañeros	O
de	O
camada	O
determinados	O
por	O
espectrometría	O
de	O
masas	O
en	O
tándem	O
.	O

Se	O
recogieron	O
muestras	O
de	O
ratones	B-Taxon
que	O
tenían	O
entre	O
4	O
y	O
6	O
semanas	O
de	O
edad	O
.	O

Todos	O
los	O
valores	O
son	O
medios	O
+/-	O
SEM	O
.	O

*	O
:	O
Significativamente	O
diferente	O
del	O
control	O
(	O
P	O
<	O
0,05	O
)	O
.	O

*	O
*	O
:	O
Significativamente	O
diferente	O
del	O
control	O
(	O
P	O
<	O
0	O
,	O
01	O
)	O
.	O

*	O
*	O
*	O
:	O
Significativamente	O
diferente	O
de	O
la	O
Línea	O
525A	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Porque	O
el	O
VUELTA	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
que	O
se	O
utilizaron	O
para	O
impulsar	O
la	O
expresión	O
de	O
transgénico	B-Sequence
humano	B-Protein
E2	I-Protein
se	O
ha	O
demostrado	O
que	O
producen	O
expresión	O
específica	O
en	O
el	O
hígado	O
[	O
34	O
]	O
,	O
BCKDH	B-GENE
enzima	B-Sequence
actividad	O
y	O
producción	O
de	O
humano	B-Protein
E2	I-Protein
proteína	B-Chemical
en	O
hígado	O
de	O
las	O
Líneas	O
A	O
y	O
525A	O
.	O

BCKDH	B-GENE
enzimático	B-Sequence
la	O
actividad	O
en	O
el	O
hígado	O
de	O
las	O
Líneas	O
A	O
y	O
525A	O
fue	O
~	O
6	O
y	O
5	O
%	O
,	O
respectivamente	O
,	O
de	O
la	O
enzimático	B-Sequence
actividad	O
presente	O
en	O
el	O
hígado	O
de	O
control	O
(	O
Fig	O
.	O
4C	O
)	O
.	O

Como	O
se	O
muestra	O
en	O
la	O
figura	O
.	O

3B	O
,	O
la	O
cantidad	O
de	O
humano	B-Protein
E2	I-Protein
(	O
MW	O
previsto	O
~	O
54	O
Kd	O
)	O
en	O
estos	O
transgénico	B-Sequence
ratones	B-Taxon
era	O
bastante	O
variable	O
entre	O
ratones	B-Taxon
.	O

en	O
algunos	O
de	O
estos	O
transgénico	B-Sequence
ratones	B-Taxon
,	O
el	O
nivel	O
de	O
humano	B-Protein
E2	I-Protein
era	O
aproximadamente	O
igual	O
a	O
la	O
cantidad	O
de	O
ratón	B-Protein
E2	I-Protein
~	O
47	O
Kd	O
)	O
producido	O
en	O
hígado	O
de	O
control	O
no	O
transgénico	O
ratones	B-Taxon
.	O

Las	O
observaciones	O
de	O
que	O
estas	O
cantidades	O
casi	O
normales	O
de	O
E2	B-Protein
proteína	B-Chemical
dan	O
como	O
resultado	O
solo	O
~	O
5	O
-	O
6	O
%	O
de	O
lo	O
normal	O
BCKDH	B-GENE
enzima	B-Sequence
actividad	O
sugiere	O
que	O
transgén	B-Sequence
derivado	O
E2	B-Protein
está	O
funcionando	O
a	O
un	O
nivel	O
subóptimo	O
.	O

Es	O
probable	O
que	O
el	O
c-myc	B-Protein
etiqueta	O
en	O
el	O
terminal	B-Sequence
carboxi	I-Sequence
de	O
El	O
transgén	B-Sequence
derivado	O
humano	B-Protein
E2	I-Protein
interferido	O
con	O
enzimático	B-Sequence
actividad	O
.	O

Esta	O
interpretación	O
es	O
consistente	O
con	O
estudios	O
previos	O
que	O
han	O
revelado	O
que	O
la	O
terminal	B-Sequence
carboxi	I-Sequence
de	O
una	O
subunidad	O
análoga	O
de	O
la	O
complejo	B-GENE
piruvato	I-GENE
deshidrogenasa	I-GENE
es	O
esencial	O
para	O
las	O
interacciones	O
de	O
subunidades	O
[	O
35	O
]	O
y	O
inserción	B-Sequence
de	O
una	O
etiqueta	O
Hisx6	O
en	O
el	O
terminal	B-Sequence
carboxi	I-Sequence
de	O
un	O
análogo	O
mi	B-Taxon
coli	I-Taxon
la	O
subunidad	O
interfirió	O
con	O
el	O
ensamblaje	O
normal	O
de	O
la	O
subunidad	O
[	O
36	O
]	O
.	O

También	O
es	O
posible	O
que	O
humano	B-Protein
E2	I-Protein
no	O
era	O
completamente	O
funcional	O
cuando	O
se	O
acomplejó	O
con	O
subunidades	B-Protein
E1	I-Protein
y	I-Protein
E3	I-Protein
de	I-Protein
ratón	I-Protein
.	O

E2	B-Protein
humano	I-Protein
comparte	O
~	O
88	O
%	O
de	O
identidad	O
con	O
ratón	B-Protein
E2	I-Protein
en	O
el	O
aminoácidos	B-Chemical
nivel	O
.	O

También	O
utilizamos	O
el	O
análisis	O
de	O
transferencia	O
Western	O
para	O
analizar	O
la	O
expresión	O
de	O
la	O
E2	B-Protein
transgén	B-Sequence
en	O
cerebro	O
,	O
riñón	O
y	O
músculo	O
.	O

Como	O
se	O
muestra	O
en	O
la	O
Figura	O
3C	O
,	O
D	O
y	O
3E	O
respectivamente	O
,	O
la	O
expresión	O
de	O
E2	B-Protein
es	O
insignificante	O
en	O
esos	O
tejidos	O
.	O

Supervivencia	O
a	O
largo	O
plazo	O
de	O
la	O
ratones	B-Taxon
de	O
estos	O
dos	O
transgénico	B-Sequence
las	O
líneas	O
que	O
sobrevivieron	O
más	O
allá	O
del	O
destete	O
se	O
trazan	O
en	O
la	O
Fig	O
.	O
.	O

4D	O

Aunque	O
los	O
datos	O
de	O
supervivencia	O
para	O
el	O
control	O
animales	B-Taxon
no	O
fue	O
recolectado	O
,	O
es	O
evidente	O
que	O
la	O
supervivencia	O
del	O
rescate	O
ratones	B-Taxon
estaba	O
comprometido	O
.	O

A	O
las	O
16	O
semanas	O
,	O
todos	O
ratones	B-Taxon
de	O
la	O
Línea	O
A	O
estaban	O
moribundos	O
y	O
sacrificados	O
humanamente	O
,	O
o	O
fueron	O
encontrados	O
muertos	O
en	O
su	O
jaula	O
.	O

La	O
supervivencia	O
de	O
la	O
Línea	O
525A	O
parecía	O
ser	O
algo	O
mejor	O
.	O

A	O
las	O
20	O
semanas	O
de	O
edad	O
,	O
~	O
12	O
%	O
de	O
ratones	B-Taxon
(	O
2	O
de	O
16	O
)	O
todavía	O
estaban	O
vivos	O
.	O

Estos	O
dos	O
sobrevivientes	O
raros	O
murieron	O
a	O
las	O
40	O
y	O
60	O
semanas	O
de	O
edad	O
.	O

En	O
resumen	O
,	O
estos	O
supervivientes	O
ratones	B-Taxon
tenido	O
BCAA	B-Chemical
/	O
alanina	B-Chemical
proporciones	O
que	O
fueron	O
intermedias	O
entre	O
controles	O
y	O
knockouts	O
y	O
expresaron	O
~	O
5	O
-	O
6	O
%	O
de	O
lo	O
normal	O
BCKDH	B-GENE
enzima	B-Sequence
actividad	O
en	O
el	O
hígado	O
.	O

Estas	O
observaciones	O
fenotípicas	O
son	O
notablemente	O
similares	O
al	O
fenotipo	O
clínico	O
observado	O
en	O
pacientes	O
con	O
MSUD	O
con	O
la	O
forma	O
intermedia	O
de	O
la	O
enfermedad	O
[	O
1	O
]	O
.	O

Así	O
,	O
estos	O
rescates	O
ratones	B-Taxon
representan	O
un	O
modelo	O
muy	O
útil	O
del	O
fenotipo	O
MSUD	O
intermedio	O
.	O

Discusión	O

Un	O
obstáculo	O
importante	O
en	O
el	O
desarrollo	O
de	O
nuevos	O
tratamientos	O
para	O
la	O
MSUD	O
ha	O
sido	O
la	O
falta	O
de	O
un	O
método	O
práctico	O
y	O
preciso	O
animal	B-Taxon
modelo	O
de	O
la	O
enfermedad	O
.	O

Este	O
obstáculo	O
ya	O
ha	O
sido	O
superado	O
.	O

En	O
este	O
informe	O
,	O
describimos	O
el	O
desarrollo	O
y	O
la	O
caracterización	O
de	O
dos	O
genéticamente	B-Sequence
diseñado	O
ratón	B-Taxon
modelos	O
que	O
son	O
fenotípicamente	O
muy	O
similares	O
a	O
los	O
pacientes	O
con	O
MSUD	O
con	O
las	O
formas	O
clásica	O
e	O
intermedia	O
de	O
la	O
enfermedad	O
.	O

Nuestro	O
modelo	O
de	O
MSUD	O
clásico	O
fue	O
creado	O
por	O
gene	B-Sequence
nocaut	O
de	O
la	O
Subunidad	B-Protein
E2	I-Protein
de	I-Protein
BCKDH	I-Protein
.	O

El	O
fenotipo	O
de	O
estos	O
knockout	O
animales	B-Taxon
es	O
sorprendentemente	O
similar	O
a	O
humanos	B-Taxon
con	O
MSUD	O
clásico	O
.	O

Knockear	O
ratones	B-Taxon
nacieron	O
con	O
la	O
frecuencia	O
esperada	O
y	O
parecían	O
normales	O
al	O
nacer	O
.	O

Dentro	O
de	O
un	O
día	O
de	O
nacimiento	O
y	O
después	O
de	O
la	O
lactancia	O
,	O
los	O
niveles	O
en	O
sangre	O
de	O
BCAA	B-Chemical
fueron	O
marcadamente	O
elevados	O
.	O

Al	O
mismo	O
tiempo	O
,	O
los	O
niveles	O
de	O
aminoácidos	B-Chemical
alanina	I-Chemical
,	O
glutamato	B-Chemical
,	O
y	O
glutamina	B-Chemical
,	O
cuya	O
síntesis	O
está	O
ligada	O
al	O
metabolismo	O
normal	O
de	O
BCAA	B-Chemical
,	O
se	O
redujeron	O
(	O
Tabla	O
1	O
)	O
.	O

la	O
actividad	O
de	O
BCKDH	B-GENE
en	O
hígados	O
de	O
homocigotos	O
knockout	O
ratón	B-Taxon
cachorros	O
era	O
indetectable	O
,	O
lo	O
que	O
explica	O
la	O
acumulación	O
de	O
no	O
metabolizado	O
BCAA	B-Chemical
.	O

inmunorreactivo	O
E2	B-Protein
proteína	B-Chemical
estuvo	O
ausente	O
en	O
hígado	O
y	O
fibroblastos	B-Cell
de	O
cachorros	O
homocigotos	O
.	O

El	O
comportamiento	O
fenotípico	O
de	O
los	O
homocigotos	O
.	O
ratón	B-Taxon
cachorros	O
se	O
asemeja	O
a	O
los	O
síntomas	O
observados	O
en	O
pacientes	O
recién	O
nacidos	O
con	O
MSUD	O
clásica	O
.	O

Estos	O
incluyen	O
signos	O
de	O
disfunción	O
neurológica	O
,	O
como	O
convulsiones	O
,	O
estupor	O
,	O
letargo	O
,	O
pérdida	O
de	O
la	O
actividad	O
motora	O
y	O
dificultades	O
respiratorias	O
[	O
1	O
]	O
.	O

Estos	O
síntomas	O
neurológicos	O
pueden	O
resultar	O
de	O
niveles	O
reducidos	O
de	O
glutamato	B-Chemical
,	O
glutamina	B-Chemical
,	O
alanina	B-Chemical
,	O
y	O
otros	O
neuroactivos	O
similares	O
aminoácidos	B-Chemical
,	O
que	O
se	O
consideran	O
los	O
culpables	O
de	O
las	O
encefalopatías	O
MSUD	O
en	O
los	O
pacientes	O
[	O
1	O
,	O
37	O
]	O
.	O

Finalmente	O
,	O
casi	O
todos	O
los	O
cachorros	O
homocigóticos	O
murieron	O
dentro	O
de	O
las	O
72	O
horas	O
posteriores	O
al	O
nacimiento	O
.	O

Esta	O
letalidad	O
neonatal	O
probablemente	O
se	O
deba	O
a	O
la	O
acumulación	O
de	O
BCAA	B-Chemical
a	O
niveles	O
neurotóxicos	O
,	O
cetoacidosis	O
,	O
edema	O
cerebral	O
,	O
deshidratación	O
y	O
desnutrición	O
,	O
como	O
se	O
observó	O
en	O
terneros	O
con	O
MSUD	O
[	O
17	O
]	O
y	O
en	O
pacientes	O
clásicos	O
con	O
MSUD	O
[	O
1	O
]	O
.	O

Los	O
knockouts	O
heterocigóticos	O
eran	O
normales	O
y	O
tenían	O
niveles	O
normales	O
de	O
BCAA	B-Chemical
a	O
pesar	O
de	O
tener	O
aproximadamente	O
la	O
mitad	O
de	O
BCKDH	B-GENE
enzimático	B-Sequence
actividad	O
.	O

De	O
los	O
estudios	O
de	O
caracterización	O
realizados	O
hasta	O
el	O
momento	O
,	O
la	O
nula	O
mutación	B-Sequence
ratón	B-Taxon
representa	O
con	O
precisión	O
un	O
modelo	O
de	O
MSUD	O
clásico	O
y	O
parece	O
ser	O
un	O
modelo	O
fiel	O
del	O
humano	B-Taxon
enfermedad	O
con	O
respecto	O
a	O
varios	O
fenotipos	O
bioquímicos	O
[	O
1	O
]	O
.	O

Para	O
crear	O
un	O
modelo	O
de	O
MSUD	O
intermedio	O
,	O
usamos	O
un	O
transgénico	B-Sequence
estrategia	O
para	O
expresar	O
humano	B-Protein
E2	I-Protein
en	O
el	O
hígado	O
de	O
E2	B-Protein
knockear	O
ratones	B-Taxon
.	O

Como	O
se	O
ha	O
mencionado	O
más	O
arriba	O
,	O
E2	B-Protein
nocauts	O
sin	O
transgén	B-Sequence
derivado	O
E2	B-Protein
mueren	O
durante	O
el	O
período	O
neonatal	O
temprano	O
.	O

Demostramos	O
que	O
la	O
expresión	O
de	O
un	O
humano	B-Protein
E2	I-Protein
transgén	B-Sequence
en	O
el	O
higado	O
de	O
estos	O
knockout	O
ratones	B-Taxon
es	O
capaz	O
de	O
rescatar	O
la	O
letalidad	O
neonatal	O
.	O

muchos	O
de	O
los	O
rescatados	O
ratones	B-Taxon
sobrevivió	O
hasta	O
la	O
edad	O
adulta	O
.	O

Es	O
interesante	O
notar	O
que	O
en	O
estos	O
ratón	B-Taxon
líneas	O
solamente	O
~	O
5	O
-	O
6	O
%	O
de	O
lo	O
normal	O
BCKDH	B-GENE
la	O
actividad	O
en	O
el	O
hígado	O
fue	O
suficiente	O
para	O
permitir	O
la	O
supervivencia	O
.	O

También	O
demostramos	O
que	O
BCAA	B-Chemical
niveles	O
en	O
sangre	O
de	O
estos	O
rescates	O
ratones	B-Taxon
fueron	O
intermedios	O
entre	O
los	O
controles	O
y	O
los	O
knockouts	O
.	O

Las	O
características	O
de	O
la	O
MSUD	O
intermedia	O
humano	B-Taxon
los	O
pacientes	O
presentan	O
niveles	O
persistentemente	O
elevados	O
de	O
BCAA	B-Chemical
y	O
BCKDH	B-GENE
actividad	O
en	O
el	O
rango	O
de	O
3	O
a	O
30	O
%	O
de	O
lo	O
normal	O
[	O
1	O
]	O
.	O

Por	O
las	O
similitudes	O
fenotípicas	O
del	O
rescate	O
ratones	B-Taxon
al	O
humano	B-Taxon
pacientes	O
,	O
estos	O
genéticamente	B-Sequence
diseñado	O
ratones	B-Taxon
representan	O
un	O
pequeño	O
útil	O
animal	B-Taxon
modelo	O
de	O
la	O
forma	O
intermedia	O
de	O
MSUD	O
.	O

los	O
transgénico	B-Sequence
El	O
enfoque	O
que	O
se	O
usó	O
para	O
crear	O
el	O
modelo	O
MSUD	O
intermedio	O
se	O
basó	O
en	O
el	O
tetraciclina	B-Chemical
regulado	O
gene	B-Sequence
sistema	O
de	O
conmutación	O
que	O
ha	O
sido	O
utilizado	O
con	O
gran	O
éxito	O
en	O
otros	O
estudios	O
,	O
por	O
ejemplo	O
[	O
34	O
]	O
.	O

La	O
estrategia	O
detrás	O
de	O
nuestro	O
enfoque	O
fue	O
crear	O
ratones	B-Taxon
con	O
un	O
fenotipo	O
MSUD	O
intermedio	O
que	O
podría	O
convertirse	O
al	O
fenotipo	O
clásico	O
a	O
discreción	O
del	O
investigador	O
apagando	O
el	O
rescatando	B-Sequence
transgén	I-Sequence
.	O

Sin	O
embargo	O
,	O
no	O
pudimos	O
apagar	O
constantemente	O
el	O
humano	B-Protein
E2	I-Protein
expresión	O
casete	B-Sequence
por	O
el	O
potente	O
tetraciclina	B-Chemical
análogo	O
,	O
doxiciclina	O
en	O
cualquiera	O
de	O
los	O
dos	O
transgénico	B-Sequence
líneas	O
probadas	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Se	O
desconoce	O
la	O
razón	O
por	O
la	O
que	O
estas	O
dos	O
líneas	O
no	O
respondieron	O
a	O
la	O
doxiciclina	O
.	O

Es	O
concebible	O
que	O
el	O
sitio	B-Sequence
de	I-Sequence
integración	I-Sequence
de	O
El	O
transgenes	B-Sequence
no	O
era	O
permisivo	O
para	O
la	O
expresión	O
regulada	O
.	O

Es	O
posible	O
que	O
se	O
necesite	O
la	O
detección	O
de	O
líneas	O
adicionales	O
para	O
encontrar	O
líneas	O
que	O
permitan	O
la	O
supervivencia	O
y	O
que	O
también	O
puedan	O
regularse	O
.	O

Los	O
modelos	O
descritos	O
en	O
esta	O
comunicación	O
son	O
avances	O
importantes	O
sobre	O
los	O
modelos	O
descritos	O
anteriormente	O
.	O

Un	O
ENU	B-Chemical
ratón	B-Taxon
parecido	O
a	O
humano	B-Taxon
MSUD	O
se	O
creó	O
previamente	O
interrumpiendo	O
el	O
BCAT	B-Protein
mitocondrial	I-Protein
gene	B-Sequence
[	O
20	O
]	O
.	O

los	O
BCKDH	B-GENE
actividad	O
en	O
el	O
hígado	O
y	O
el	O
músculo	O
de	O
este	O
ratón	B-Taxon
era	O
normal	O
a	O
pesar	O
de	O
que	O
la	O
sangre	O
BCAA	B-Chemical
los	O
niveles	O
estaban	O
marcadamente	O
elevados	O
.	O

Si	O
bien	O
este	O
es	O
un	O
modelo	O
interesante	O
,	O
no	O
es	O
un	O
verdadero	O
modelo	O
de	O
MSUD	O
porque	O
el	O
mutación	B-Sequence
no	O
está	O
dentro	O
BCKDH	B-GENE
y	O
los	O
niveles	O
de	O
BCKDH	B-GENE
son	O
normales	O

Además	O
,	O
no	O
se	O
ha	O
descrito	O
ningún	O
caso	O
de	O
MSUD	O
que	O
atribuya	O
esta	O
enfermedad	O
a	O
BCAT	B-Protein
deficiencia	O

Además	O
de	O
esto	O
ratón	B-Taxon
modelo	O
,	O
un	O
vaca	B-Taxon
modelo	O
de	O
MSUD	O
también	O
se	O
ha	O
descrito	O
previamente	O
[	O
17	O
-	O
19	O
]	O
.	O

Sin	O
embargo	O
,	O
debido	O
a	O
las	O
limitaciones	O
prácticas	O
impuestas	O
por	O
un	O
número	O
tan	O
grande	O
animal	B-Taxon
modelo	O
y	O
debido	O
a	O
la	O
observación	O
de	O
diferencias	O
entre	O
el	O
MSUD	O
vaca	B-Taxon
modelo	O
y	O
MSUD	O
humanos	B-Taxon
[	O
1	O
]	O
,	O
este	O
modelo	O
también	O
tiene	O
una	O
utilidad	O
limitada	O
.	O

En	O
contraste	O
,	O
el	O
murino	B-Taxon
Los	O
modelos	O
descritos	O
en	O
este	O
informe	O
son	O
más	O
válidos	O
y	O
apropiados	O
para	O
modelar	O
humano	B-Taxon
MSUD	O
.	O

La	O
oportunidad	O
más	O
importante	O
que	O
presenta	O
la	O
MSUD	O
ratón	B-Taxon
modelos	O
es	O
probar	O
nuevos	O
tratamientos	O
como	O
gene	B-Sequence
[	O
38	O
-	O
41	O
]	O
y	O
célula	B-Cell
terapias	O
basadas	O
(	O
por	O
ejemplo	O
,	O
hepatocitos	B-Cell
[	O
42	O
,	O
43	O
]	O
o	O
embrionario	O
Células	B-Cell
madre	I-Cell
[	O
44	O
]	O
)	O
.	O

Relevante	O
para	O
gene	B-Sequence
terapia	O
,	O
problemas	O
recientes	O
con	O
gene	B-Sequence
terapia	O
en	O
humanos	B-Taxon
resaltar	O
la	O
importancia	O
y	O
la	O
necesidad	O
crítica	O
de	O
animal	B-Taxon
modelos	O
de	O
genético	B-Sequence
enfermedades	O
para	O
estudios	O
preclínicos	O
.	O

la	O
prueba	O
de	O
gene	B-Sequence
y	O
célula	B-Cell
terapias	O
basadas	O
en	O
animal	B-Taxon
Los	O
sistemas	O
modelo	O
proporcionan	O
un	O
método	O
preliminar	O
para	O
establecer	O
no	O
sólo	O
la	O
eficacia	O
,	O
sino	O
también	O
la	O
seguridad	O
a	O
corto	O
y	O
largo	O
plazo	O
.	O

Éxito	O
con	O
animal	B-Taxon
Se	O
espera	O
que	O
los	O
estudios	O
avancen	O
tales	O
enfoques	O
terapéuticos	O
y	O
podrían	O
allanar	O
el	O
camino	O
para	O
estudios	O
en	O
humanos	B-Taxon
.	O

Además	O
de	O
probar	O
varios	O
tratamientos	O
,	O
estos	O
modelos	O
también	O
deberían	O
ser	O
muy	O
útiles	O
para	O
investigar	O
las	O
consecuencias	O
fisiopatológicas	O
subyacentes	O
de	O
la	O
enfermedad	O
.	O

Tales	O
estudios	O
son	O
muy	O
difíciles/imposibles	O
de	O
hacer	O
en	O
humano	B-Taxon
pacientes	O
por	O
obvias	O
razones	O
éticas	O
,	O
y	O
con	O
frecuencia	O
deben	O
confiar	O
en	O
el	O
tejido	O
de	O
la	O
autopsia	O
.	O

Además	O
,	O
el	O
modelo	O
MSUD	O
intermedio	O
también	O
puede	O
ser	O
útil	O
para	O
estudios	O
para	O
probar	O
el	O
efecto	O
de	O
tiamina	B-Chemical
.	O

A	O
tiamina	B-Chemical
-	O
Se	O
ha	O
descrito	O
una	O
forma	O
sensible	O
de	O
MSUD	O
[	O
1	O
]	O
.	O

El	O
fenotipo	O
de	O
estos	O
pacientes	O
es	O
heterogéneo	O
y	O
el	O
tratamiento	O
con	O
una	O
amplia	O
gama	O
de	O
dosis	O
de	O
tiamina	O
ha	O
tenido	O
un	O
éxito	O
limitado	O
[	O
1	O
]	O
.	O

Reciente	O
célula	B-Cell
estudios	O
culturales	O
con	O
MSUD	O
células	B-Cell
han	O
sugerido	O
que	O
el	O
tiamina	B-Chemical
#	O
¿NOMBRE	O
?	O
E2	B-Protein
expresando	O
alelo	B-Sequence
[	O
45	O
,	O
46	O
]	O
.	O

A	O
la	O
luz	O
de	O
estos	O
hallazgos	O
más	O
recientes	O
,	O
nuestro	O
MSUD	O
intermedio	O
ratón	B-Taxon
proporciona	O
un	O
modelo	O
para	O
probar	O
el	O
efecto	O
de	O
tiamina	B-Chemical
con	O
respecto	O
a	O
BCKDH	B-GENE
actividad	O
y	O
sangre	O
aminoácidos	B-Chemical
niveles	O
a	O
nivel	O
del	O
todo	O
animal	B-Taxon
.	O

Debido	O
al	O
reciente	O
interés	O
en	O
el	O
análisis	O
estructural	O
de	O
multienzimas	O
complejos	B-GENE
[	O
35	O
,	O
36	O
,	O
45	O
,	O
46	O
]	O
,	O
el	O
modelo	O
MSUD	O
intermedio	O
puede	O
proporcionar	O
un	O
recurso	O
valioso	O
para	O
los	O
estudios	O
de	O
biología	O
estructural	O
.	O

Por	O
último	O
,	O
la	O
información	O
y	O
los	O
conocimientos	O
obtenidos	O
de	O
los	O
estudios	O
con	O
los	O
modelos	O
MSUD	O
descritos	O
aquí	O
también	O
serán	O
aplicables	O
y	O
transferibles	O
a	O
otros	O
mitocondrial	B-GENE
trastornos	O
debido	O
a	O
defectos	O
en	O
multisubunidad	O
enzimas	B-Sequence
.	O

Conclusión	O

En	O
resumen	O
,	O
este	O
informe	O
describe	O
el	O
desarrollo	O
y	O
caracterización	O
de	O
genéticamente	B-Sequence
diseñado	O
ratón	B-Taxon
modelos	O
de	O
MSUD	O
clásicos	O
e	O
intermedios	O
.	O

Estas	O
animales	B-Taxon
proporcionar	O
modelos	O
útiles	O
para	O
caracterizar	O
aún	O
más	O
la	O
patogenia	O
de	O
la	O
MSUD	O
,	O
así	O
como	O
modelos	O
para	O
probar	O
nuevas	O
estrategias	O
terapéuticas	O
,	O
como	O
gene	B-Sequence
y	O
celular	B-Cell
terapias	O
,	O
para	O
tratar	O
esta	O
devastadora	O
enfermedad	O
metabólica	O
.	O

abreviaturas	O

Las	O
abreviaturas	O
utilizadas	O
son	O
:	O
MSUD	O
,	O
Arce	B-Taxon
Enfermedad	O
de	O
la	O
orina	O
en	O
jarabe	O
;	O
BCKDH	B-GENE
,	O
cetoácido	B-GENE
deshidrogenasa	I-GENE
de	I-GENE
cadena	I-GENE
ramificada	I-GENE
;	O
BCAA	B-Chemical
,	O
aminoácidos	B-Chemical
de	I-Chemical
cadena	I-Chemical
ramificada	I-Chemical
;	O
ENU	B-Chemical
,	O
N	B-Chemical
-	I-Chemical
etil	I-Chemical
-	I-Chemical
N	I-Chemical
-	I-Chemical
nitrosourea	I-Chemical
;	O
BCAT	B-Protein
,	O
aminotransferasa	B-Protein
de	I-Protein
cadena	I-Protein
ramificada	I-Protein
;	O
ES	O
célula	B-Cell
,	O
embrionario	O
célula	B-Cell
madre	I-Cell
;	O
TRE	O
,	O
tetraciclina	B-Chemical
sensible	O
elemento	B-Sequence
;	O
MEF	O
,	O
ratón	B-Taxon
embrionario	O
fibroblasto	B-Cell
.	O

Conflicto	O
de	O
intereses	O

El	O
autor	O
(	O
s	O
)	O
declara	O
que	O
no	O
tienen	O
intereses	O
en	O
competencia	O
.	O

Contribuciones	O
de	O
los	O
autores	O

GEH	O
diseñó	O
y	O
produjo	O
el	O
ratón	B-Taxon
modelos	O
,	O
experimentos	O
coordinados	O
,	O
datos	O
interpretados	O
,	O
y	O
ayudó	O
a	O
redactar	O
el	O
manuscrito	O
.	O

KS	O
llevó	O
a	O
cabo	O
gran	O
parte	O
de	O
la	O
caracterización	O
del	O
modelo	O
MSUD	O
intermedio	O
.	O

CF	O
ayudó	O
con	O
la	O
producción	O
del	O
ratón	B-Taxon
modelos	O
,	O
recopilación	O
de	O
datos	O
,	O
análisis	O
e	O
interpretación	O
.	O

SW	O
dirigió	O
los	O
experimentos	O
de	O
inmunohistoquímica	O
.	O

HSP	O
concibió	O
el	O
modelo	O
knockout	O
,	O
interpretó	O
los	O
datos	O
y	O
redactó	O
el	O
manuscrito	O
.	O

Todos	O
los	O
autores	O
contribuyeron	O
a	O
redactar	O
y	O
editar	O
el	O
manuscrito	O
y	O
leyeron	O
y	O
aprobaron	O
la	O
versión	O
final	O
.	O

Historial	O
previo	O
a	O
la	O
publicación	O

Se	O
puede	O
acceder	O
al	O
historial	O
previo	O
a	O
la	O
publicación	O
de	O
este	O
artículo	O
aquí	O
:	O

Agradecimientos	O

Los	O
autores	O
desean	O
agradecer	O
a	O
Frank	O
Kist	O
,	O
Jodi	O
Dagget	O
,	O
Edward	O
Mallick	O
,	O
Brian	O
Sloat	O
y	O
Judith	O
Rodda	O
por	O
su	O
asistencia	O
técnica	O
experta	O
,	O
y	O
al	O
Dr.	O
Susan	O
Hutson	O
por	O
el	O
regalo	O
de	O
E2	B-Protein
antisuero	O

Este	O
trabajo	O
fue	O
apoyado	O
por	O
los	O
Institutos	O
Nacionales	O
de	O
Salud	O
Subvenciones	O
DK51960	O
,	O
DK57386	O
,	O
DK57956	O
,	O
AA10422	O
,	O
Scott	O
C	O
.	O
Foster	O
Metabolic	O
Disease	O
Fund	O
y	O
MSUD	O
Family	O
Support	O
Group	O
.	O

Pérdida	O
de	O
Atrx	B-Protein
Afecta	O
el	O
desarrollo	O
del	O
trofoblasto	O
y	O
el	O
patrón	O
de	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

Resumen	O

ATRX	B-Protein
es	O
un	O
X	B-GENE
#	O
¿NOMBRE	O
?	O
proteinas	B-Chemical
pensado	O
para	O
regular	O
gene	B-Sequence
expresión	O
modificando	O
cromatina	B-GENE
en	O
el	O
objetivo	O
lugares	B-Sequence
.	O

Mutaciones	B-Sequence
en	O
ATRX	B-Protein
proporcionó	O
el	O
primer	O
ejemplo	O
de	O
un	O
humano	B-Taxon
genético	B-Sequence
enfermedad	O
asociada	O
con	O
defectos	O
en	O
tales	O
proteinas	B-Chemical
.	O

Para	O
entender	O
mejor	O
el	O
papel	O
de	O
ATRX	B-Protein
en	O
el	O
desarrollo	O
y	O
las	O
anormalidades	O
asociadas	O
en	O
el	O
ATR	O
-	O
X	B-GENE
(	O
alfa	O
talasemia	O
retraso	O
mental	O
,	O
X	B-GENE
-	O
vinculado	O
)	O
síndrome	O
,	O
condicionalmente	O
inactivamos	O
el	O
homólogo	B-Sequence
en	O
ratones	B-Taxon
,	O
Atrx	B-Protein
,	O
a	O
las	O
8	O
-	O
a	O
las	O
16	O
-	O
célula	B-Cell
etapa	O
de	O
desarrollo	O
.	O

los	O
proteína	B-Chemical
,	O
Atrx	B-Protein
,	O
se	O
expresaba	O
de	O
manera	O
ubicua	O
y	O
los	O
embriones	O
masculinos	O
eran	O
nulos	O
para	O
Atrx	B-Protein
implantado	O
y	O
gastrulado	O
normalmente	O
pero	O
no	O
sobrevivió	O
más	O
allá	O
de	O
9	O
.	O
5	O
días	O
poscoito	O
debido	O
a	O
un	O
defecto	O
en	O
la	O
formación	O
del	O
trofoblasto	O
extraembrionario	O
,	O
uno	O
de	O
los	O
primeros	O
linajes	O
terminalmente	O
diferenciados	O
en	O
el	O
embrión	O
en	O
desarrollo	O
.	O

mujer	O
portadora	O
ratones	B-Taxon
que	O
heredan	O
una	O
nula	O
materna	O
alelo	B-Sequence
debe	O
ser	O
afectado	O
,	O
ya	O
que	O
el	O
paterno	O
cromosoma	B-GENE
X	I-GENE
normalmente	O
está	O
inactivado	O
en	O
los	O
tejidos	O
extraembrionarios	O
.	O

Sorprendentemente	O
,	O
sin	O
embargo	O
,	O
algunas	O
hembras	O
portadoras	O
establecieron	O
una	O
placenta	O
normal	O
y	O
parecían	O
escapar	O
del	O
patrón	O
habitual	O
de	O
impronta	O
.	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

Juntos	O
,	O
estos	O
hallazgos	O
demuestran	O
un	O
papel	O
inesperado	O
,	O
específico	O
y	O
esencial	O
para	O
Atrx	B-Protein
en	O
el	O
desarrollo	O
de	O
la	O
murino	B-Taxon
trofoblasto	O
y	O
presentar	O
un	O
ejemplo	O
de	O
escape	O
de	O
impronta	O
cromosoma	B-GENE
X	I-GENE
inactivación	O

Sinopsis	O

ATRX	B-Protein
pertenece	O
a	O
una	O
clase	O
de	O
proteinas	B-Chemical
que	O
puede	O
modificar	O
cómo	O
ADN	B-Sequence
está	O
empaquetado	O
en	O
cromatina	B-GENE
,	O
alterando	O
la	O
accesibilidad	O
de	O
otros	O
proteinas	B-Chemical
en	O
el	O
núcleo	B-GENE
para	O
ADN	B-Sequence
.	O

De	O
este	O
modo	O
,	O
ATRX	B-Protein
se	O
cree	O
que	O
influye	O
gene	B-Sequence
expresión	O
.	O

Mutaciones	B-Sequence
en	O
el	O
ATRX	B-Protein
gene	B-Sequence
,	O
que	O
se	O
encuentra	O
en	O
la	O
cromosoma	B-GENE
sexual	I-GENE
femenino	I-GENE
(	O
X	B-GENE
)	O
,	O
proporcionó	O
el	O
primer	O
ejemplo	O
de	O
un	O
humano	B-Taxon
enfermedad	O
(	O
ATR	O
-	O
X	B-GENE
síndrome	O
)	O
asociado	O
con	O
defectos	O
en	O
tales	O
proteinas	B-Chemical
.	O

Los	O
varones	O
afectados	O
(	O
XMUTY	O
)	O
tienen	O
múltiples	O
anomalías	O
del	O
desarrollo	O
en	O
una	O
amplia	O
variedad	O
de	O
sistemas	O
.	O

Actualmente	O
,	O
no	O
se	O
entiende	O
cómo	O
proteinas	B-Chemical
me	O
gusta	O
ATRX	B-Protein
influencia	O
célula	B-Cell
biología	O

Para	O
abordar	O
esta	O
cuestión	O
,	O
los	O
autores	O
eliminado	B-Sequence
los	O
versión	B-Sequence
de	O
El	O
gene	B-Sequence
en	O
ratones	B-Taxon
,	O
Atrx	B-Protein
.	O

Aunque	O
varón	O
afectado	O
ratones	B-Taxon
(	O
XMUTY	O
)	O
comenzaron	O
a	O
desarrollarse	O
normalmente	O
,	O
murieron	O
temprano	O
en	O
el	O
desarrollo	O
porque	O
no	O
lograron	O
formar	O
una	O
placenta	O
normal	O
.	O

En	O
la	O
placenta	O
,	O
hembra	O
ratones	B-Taxon
normalmente	O
inactiva	O
el	O
cromosoma	B-GENE
X	I-GENE
que	O
heredan	O
de	O
sus	O
padres	O
(	O
Xp	O
)	O
,	O
por	O
lo	O
que	O
si	O
las	O
mujeres	O
heredan	O
de	O
su	O
madre	O
un	O
cromosoma	B-GENE
X	I-GENE
(	O
Xm	O
)	O
que	O
lleva	O
la	O
copia	O
anormal	O
de	O
Atrx	B-Protein
(	O
XmMUTXp	O
)	O
,	O
se	O
podría	O
predecir	O
que	O
,	O
al	O
igual	O
que	O
los	O
varones	O
afectados	O
,	O
no	O
lograrían	O
formar	O
una	O
placenta	O
normal	O
.	O

Los	O
autores	O
encontraron	O
inesperadamente	O
que	O
esto	O
no	O
era	O
así	O
.	O

Demostraron	O
,	O
en	O
cambio	O
,	O
que	O
en	O
tales	O
hembras	O
el	O
normal	O
,	O
derivado	O
del	O
padre	O
Atrx	B-Protein
gene	B-Sequence
está	O
activo	O
.	O

Por	O
lo	O
tanto	O
,	O
este	O
estudio	O
ha	O
demostrado	O
una	O
faceta	O
importante	O
de	O
X	B-GENE
-	I-GENE
cromosoma	I-GENE
impronta	O

Introducción	O

ATR-	O
X	B-GENE
El	O
síndrome	O
es	O
una	O
forma	O
grave	O
y	O
no	O
progresiva	O
de	O
X	B-GENE
relacionado	O
con	O
el	O
retraso	O
mental	O
que	O
se	O
asocia	O
con	O
frecuencia	O
a	O
múltiples	O
anomalías	O
congénitas	O
[	O
1	O
]	O
.	O

Por	O
lo	O
general	O
,	O
se	O
asocia	O
con	O
una	O
forma	O
leve	O
de	O
alfa-talasemia	O
,	O
causada	O
por	O
una	O
expresión	O
reducida	O
de	O
alfa-talasemia	O
estructuralmente	O
intacta	O
.	O
globina	B-Chemical
genes	B-Sequence
y	O
se	O
caracteriza	O
por	O
la	O
presencia	O
de	O
beta	B-Protein
-	I-Protein
globina	I-Protein
tetrámeros	O
(	O
hemoglobina	B-GENE
H	O
cuerpos	B-GENE
de	I-GENE
inclusión	I-GENE
)	O
en	O
periférico	O
las	B-Cell
células	I-Cell
rojas	I-Cell
de	I-Cell
la	I-Cell
sangre	I-Cell
.	O

Las	O
hembras	O
portadoras	O
ocasionalmente	O
se	O
manifiestan	O
hemoglobina	B-GENE
H	O
inclusiones	B-GENE
,	O
pero	O
por	O
lo	O
demás	O
son	O
intelectual	O
y	O
físicamente	O
normales	O
.	O

Estudios	O
de	O
X	B-GENE
-	I-GENE
cromosoma	I-GENE
inactivación	O
en	O
hembras	O
portadoras	O
han	O
demostrado	O
inactivación	O
preferencial	O
de	O
la	O
cromosoma	B-GENE
teniendo	O
lo	O
anormal	O
alelo	B-Sequence
en	O
una	O
variedad	O
de	O
tejidos	O
[	O
2	O
]	O
,	O
y	O
este	O
sesgo	O
de	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

El	O
ATR-	O
X	B-GENE
síndrome	O
es	O
causado	O
por	O
mutaciones	B-Sequence
en	O
un	O
gene	B-Sequence
(	O
ATRX	B-Protein
)	O
que	O
comprende	O
36	O
exones	B-Sequence
que	O
abarca	O
300	O
kb	O
de	O
ADN	B-Sequence
genómico	I-Sequence
en	O
Cromosoma	B-GENE
Xq13	O
.	O
3	O
[	O
3	O
]	O
.	O

Esta	O
gene	B-Sequence
codifica	O
dos	O
dominantes	O
proteína	B-Chemical
isoformas	B-Sequence
(	O
Figura	O
1	O
)	O
.	O

Así	O
como	O
la	O
longitud	O
completa	O
ATRX	B-Protein
proteína	B-Chemical
de	O
~	O
280	O
kDa	O
,	O
que	O
está	O
codificado	O
por	O
un	O
transcripción	B-Sequence
de	O
~	O
10	O
kb	O
,	O
demostramos	O
recientemente	O
que	O
un	O
truncado	O
isoforma	B-Sequence
llamado	O
ATRXt	O
(	O
~	O
200	O
kDa	O
)	O
se	O
produce	O
a	O
partir	O
de	O
un	O
transcripción	B-Sequence
de	O
alrededor	O
de	O
7	O
kb	O
,	O
que	O
surge	O
cuando	O
intrón	B-Sequence
11	O
no	O
se	O
empalma	O
desde	O
el	O
transcripción	B-Sequence
primaria	I-Sequence
y	O
una	O
alternativa	O
señal	B-Sequence
intronic	I-Sequence
poli	I-Sequence
(	I-Sequence
A	I-Sequence
)	I-Sequence
se	O
utiliza	O
[	O
4	O
]	O
.	O

los	O
ratón	B-Taxon
homólogo	B-Sequence
de	O
El	O
ATRX	B-Protein
gene	B-Sequence
,	O
Atrx	B-Protein
,	O
también	O
está	O
situado	O
en	O
la	O
cromosoma	B-GENE
X	I-GENE
,	O
y	O
también	O
da	O
lugar	O
a	O
de	O
longitud	O
completa	O
(	O
Atrx	B-Protein
~	O
280	O
kDa	O
)	O
y	O
truncado	O
(	O
Atrxt	O
,	O
~	O
200	O
kDa	O
)	O
isoformas	B-Sequence
[	O
4	O
,	O
5	O
]	O
.	O

Enfermedad	O
-	O
causando	O
missense	O
mutaciones	B-Sequence
se	O
agrupan	O
en	O
dos	O
regiones	B-Sequence
del	I-Sequence
gen	I-Sequence
:	O
un	O
doctorado	O
-	O
como	O
zinc	B-Chemical
dedo	O
dominio	B-Sequence
y	O
un	O
SNF2	O
-	O
como	O
ATPasa	O
dominio	B-Sequence
(	O
Figura	O
1	O
)	O
[	O
6	O
]	O
.	O

Se	O
cree	O
que	O
el	O
primer	O
motivo	O
está	O
involucrado	O
en	O
proteína	B-Chemical
-	O
proteína	B-Chemical
interacciones	O
en	O
cromatina	B-GENE
[	O
7	O
]	O
,	O
y	O
este	O
último	O
es	O
un	O
rasgo	B-Sequence
de	O
cromatina	B-GENE
#	O
¿NOMBRE	O
?	O
proteinas	B-Chemical
,	O
y	O
la	O
presencia	O
de	O
enfermedades	O
que	O
causan	O
mutaciones	B-Sequence
indica	O
la	O
importancia	O
funcional	O
de	O
estos	O
dominios	B-Sequence
.	O

ATRX	B-Protein
se	O
ha	O
demostrado	O
que	O
remodela	O
cromatina	B-GENE
[	O
8	O
]	O
.	O

También	O
interactúa	O
con	O
HP1	O
en	O
heterocromatina	B-GENE
[	O
9	O
]	O
y	O
es	O
reclutado	O
para	O
cuerpos	B-GENE
nucleares	I-GENE
de	I-GENE
la	I-GENE
leucemia	I-GENE
promielocítica	I-GENE
a	O
través	O
de	O
una	O
interacción	O
con	O
Daxx	B-Protein
[	O
10	O
]	O
.	O

Además	O
,	O
la	O
interrupción	O
de	O
ATRX	B-Protein
conduce	O
a	O
diversos	O
cambios	O
en	O
ADN	B-Sequence
metilación	O
[	O
11	O
]	O
.	O

No	O
obstante	O
,	O
el	O
papel	O
ATRX	B-Protein
juega	O
en	O
gene	B-Sequence
la	O
expresión	O
sigue	O
sin	O
estar	O
clara	O
.	O

El	O
núcleo	O
consistente	O
de	O
características	O
clínicas	O
y	O
hematológicas	O
observadas	O
en	O
ATR	O
-	O
X	B-GENE
pacientes	O
sugiere	O
que	O
,	O
al	O
igual	O
que	O
el	O
SWI2/SNF2	O
cromatina	B-GENE
#	O
¿NOMBRE	O
?	O
proteína	B-Chemical
,	O
ATRX	B-Protein
probablemente	O
regula	O
la	O
transcripción	O
de	O
un	O
conjunto	O
discreto	O
de	O
objetivos	O
genes	B-Sequence
.	O

Sin	O
embargo	O
,	O
aunque	O
es	O
evidente	O
que	O
se	O
pueden	O
encontrar	O
otros	O
,	O
en	O
la	O
actualidad	O
el	O
alfa	O
-	O
globina	B-Chemical
genes	B-Sequence
siguen	O
siendo	O
los	O
únicos	O
objetivos	O
confirmados	O
para	O
la	O
regulación	O
transcripcional	O
por	O
ATRX	B-Protein
.	O

Poco	O
se	O
sabe	O
actualmente	O
sobre	O
el	O
papel	O
preciso	O
de	O
la	O
ATRX	B-Protein
proteína	B-Chemical
durante	O
mamífero	B-Taxon
desarrollo	O
.	O

Para	O
investigar	O
el	O
papel	O
de	O
este	O
proteína	B-Chemical
durante	O
ratón	B-Taxon
desarrollo	O
,	O
generamos	O
un	O
condicionalmente	O
alelo	B-Sequence
eliminado	I-Sequence
de	O
El	O
Atrx	B-Protein
gene	B-Sequence
en	O
ratón	B-Taxon
embrionario	O
células	B-Cell
madre	I-Cell
(	I-Cell
ES	I-Cell
)	I-Cell
,	O
y	O
usó	O
estos	O
células	B-Cell
para	O
examinar	O
el	O
efecto	O
de	O
la	O
ablación	O
de	O
la	O
expresión	O
de	O
la	O
longitud	O
completa	O
Atrx	B-Protein
proteína	B-Chemical
en	O
ES	O
células	B-Cell
y	O
en	O
ratón	B-Taxon
embriones	O

Resultados	O

Generación	O
de	O
ES	O
Células	B-Cell
Falta	O
de	O
longitud	O
completa	O
Atrx	B-Protein

Como	O
el	O
humano	B-Taxon
gene	B-Sequence
,	O
los	O
ratón	B-Protein
atrx	I-Protein
gene	B-Sequence
es	O
también	O
X	B-GENE
-	O
vinculado	O
,	O
tal	O
que	O
una	O
interrupción	O
directa	O
del	O
único	O
Atrx	B-Protein
alelo	B-Sequence
en	O
ES	O
masculino	O
células	B-Cell
inmediatamente	O
daría	O
lugar	O
al	O
estado	O
nulo	O
.	O

sin	O
objetivo	O
clones	B-Sequence
se	O
recuperaron	O
después	O
de	O
un	O
intento	O
de	O
recombinación	O
homóloga	O
en	O
macho	O
E14TG2a	O
ES	O
células	B-Cell
usando	O
dos	O
diferentes	O
vectores	B-Sequence
que	O
exón	B-Sequence
eliminado	I-Sequence
18	O
de	O
los	O
Atrx	B-Protein
gene	B-Sequence
.	O

exón	B-Sequence
18	O
codifica	O
el	O
primero	O
de	O
los	O
siete	O
motivos	O
que	O
componen	O
el	O
conservado	B-Sequence
SNF2	O
-	O
como	O
dominio	B-Sequence
de	O
Atrx	B-Protein
(	O
Figura	O
1	O
)	O
;	O
mutación	B-Sequence
del	O
motivo	O
correspondiente	O
de	O
la	O
levadura	B-Protein
SNF2	I-Protein
proteína	B-Chemical
se	O
ha	O
demostrado	O
que	O
afecta	O
gravemente	O
SWI/SNF	B-GENE
#	O
¿NOMBRE	O
?	O
gene	B-Sequence
expresión	O
[	O
12	O
]	O
.	O

El	O
fracaso	O
en	O
la	O
recuperación	O
de	O
objetivos	O
clones	B-Sequence
con	O
estos	O
vectores	B-Sequence
sugerido	O
que	O
Atrx	B-Protein
puede	O
ser	O
importante	O
para	O
ES	O
normal	O
célula	B-Cell
crecimiento	O
y	O
expansión	O
y	O
que	O
la	O
focalización	O
directa	O
en	O
el	O
único	O
lugar	B-Sequence
puede	O
que	O
no	O
sea	O
posible	O
.	O

Por	O
lo	O
tanto	O
,	O
adoptamos	O
una	O
estrategia	O
condicional	O
para	O
focalizar	O
exón	B-Sequence
18	O
(	O
Figura	O
2	O
)	O
y	O
recuperó	O
dos	O
clones	B-Sequence
en	O
el	O
cual	O
exón	B-Sequence
18	O
ha	O
sido	O
flanqueado	B-Sequence
por	O
sitios	B-Sequence
de	I-Sequence
reconocimiento	I-Sequence
loxP	I-Sequence
para	O
la	O
recombinasa	O
Cre	O
(	O
Atrxflox	O
alelo	B-Sequence
en	O
la	O
Figura	O
2A	O
)	O
(	O
Figura	O
2B	O
)	O
.	O

Esta	O
alelo	B-Sequence
también	O
contiene	O
un	O
loxP	B-Sequence
-	I-Sequence
flanqueado	I-Sequence
MC1	O
-	O
nuevo	O
casete	B-Sequence
en	O
intrón	B-Sequence
17	O
(	O
Figura	O
2A	O
)	O
.	O

Los	O
análisis	O
de	O
transferencia	O
Northern	O
y	O
Western	O
(	O
Figura	O
2D	O
y	O
2E	O
)	O
confirmaron	O
que	O
Atrxflox	O
clones	B-Sequence
continuó	O
expresando	O
tanto	O
de	O
cuerpo	O
entero	O
Atrx	B-Protein
proteína	B-Chemical
y	O
el	O
Atrxt	O
truncado	O
isoforma	B-Sequence
.	O

Para	O
generar	O
el	O
pleno	O
supresión	B-Sequence
en	O
ES	O
células	B-Cell
,	O
el	O
Atrxflox	O
clones	B-Sequence
(	O
1	O
/	O
F12	O
y	O
1	O
/	O
G11	O
)	O
se	O
transfectaron	O
transitoriamente	O
con	O
una	O
expresión	O
de	O
Cre	O
-	O
recombinasa	O
plásmido	B-Sequence
(	O
pCAGGS	O
-	O
Cre	O
-	O
IRESpuro	O
)	O
,	O
y	O
se	O
recuperaron	O
subclones	O
con	O
una	O
alelo	B-Sequence
Atrx	O
Delta	O
18	O
Delta	O
neo	O
en	O
la	O
Figura	O
2A	O
)	O
en	O
el	O
que	O
ambos	O
exón	B-Sequence
18	O
y	O
el	O
neor	O
casete	B-Sequence
había	O
sido	O
eliminado	B-Sequence
``	O
por	O
la	O
recombinasa	O
Cre	O
(	O
resultante	O
del	O
evento	O
de	O
recombinación	O
etiquetado	O
como	O
``	O
''	O
C	O
''	O
''	O
en	O
el	O
Atrxflox	O
''	O
alelo	B-Sequence
se	O
muestra	O
en	O
la	O
Figura	O
2A	O
)	O
(	O
Figura	O
2C	O
)	O
.	O

Los	O
análisis	O
de	O
transferencia	O
Northern	O
y	O
Western	O
(	O
Figura	O
2D	O
y	O
2E	O
)	O
revelaron	O
que	O
la	O
longitud	O
completa	O
Atrx	B-Protein
transcripción	B-Sequence
y	O
proteína	B-Chemical
es	O
completamente	O
abolido	B-Sequence
en	O
el	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
recombinante	O
clones	B-Sequence
,	O
sugiriendo	O
que	O
supresión	B-Sequence
de	O
esta	O
región	B-Sequence
tiene	O
un	O
efecto	O
altamente	O
desestabilizador	O
en	O
toda	O
la	O
longitud	O
transcripción	B-Sequence
.	O

Como	O
era	O
de	O
esperar	O
,	O
el	O
Atrxt	O
truncado	O
isoforma	B-Sequence
,	O
los	O
transcripción	B-Sequence
del	O
cual	O
se	O
termina	O
dentro	O
de	O
intrón	B-Sequence
11	O
[	O
4	O
]	O
,	O
no	O
se	O
ve	O
afectado	O
por	O
la	O
supresión	B-Sequence
de	O
exón	B-Sequence
18	O
(	O
Figura	O
2E	O
)	O
.	O

Si	O
bien	O
la	O
función	O
de	O
Atrxt	O
aún	O
no	O
está	O
clara	O
,	O
este	O
isoforma	B-Sequence
,	O
que	O
contiene	O
el	O
PHD	O
-	O
como	O
dominio	B-Sequence
pero	O
no	O
los	O
motivos	O
SWI	O
/	O
SNF	O
(	O
Figura	O
1	O
)	O
,	O
es	O
poco	O
probable	O
que	O
sea	O
funcionalmente	O
equivalente	O
al	O
de	O
longitud	O
completa	O
proteína	B-Chemical
.	O

Así	O
,	O
una	O
estrategia	O
de	O
nocaut	O
condicional	O
permitió	O
el	O
aislamiento	O
de	O
ES	O
células	B-Cell
que	O
son	O
nulos	O
para	O
longitud	O
completa	O
Atrx	B-Protein
.	O

Crecimiento	O
perturbado	O
y	O
defectos	O
de	O
metilación	O
en	O
Atrxnull	O
ES	O
Células	B-Cell

Atrxnull	O
ES	O
células	B-Cell
podían	O
mantenerse	O
en	O
cultivo	O
,	O
pero	O
generalmente	O
eran	O
de	O
crecimiento	O
más	O
lento	O
que	O
Atrx	B-Protein
+	O
ES	O
clones	O
,	O
y	O
parecía	O
experimentar	O
mayores	O
tasas	O
de	O
diferenciación	O
espontánea	O
.	O

Investigamos	O
directamente	O
el	O
efecto	O
de	O
Atrx	B-Protein
unos	O
célula	B-Cell
crecimiento	O
comparando	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
célula	B-Cell
clones	O
en	O
cultivos	O
de	O
competición	O
.	O

Números	O
iguales	O
de	O
Atrx	B-Protein
+	O
(	O
con	O
un	O
AtrxWT	O
o	O
un	O
Atrxflox	O
alelo	B-Sequence
)	O
y	O
Atrxnull	O
(	O
con	O
un	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
alelo	B-Sequence
)	O
ES	O
células	B-Cell
se	O
inocularon	O
en	O
cultivos	O
y	O
los	O
cultivos	O
mixtos	O
se	O
pasaron	O
(	O
división	O
1:3	O
)	O
cada	O
2	O
días	O
durante	O
8-10	O
días	O
.	O

La	O
abundancia	O
relativa	O
de	O
los	O
diferentes	O
alelos	B-Sequence
en	O
el	O
cultivo	O
en	O
cada	O
punto	O
de	O
tiempo	O
se	O
analizó	O
mediante	O
transferencia	O
de	O
Southern	O
(	O
Figura	O
3A	O
)	O
.	O

El	O
clon	O
que	O
contiene	O
el	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
alelo	B-Sequence
fue	O
rápidamente	O
superado	O
por	O
ambos	O
AtrxWT	O
ES	O
células	B-Cell
y	O
células	B-Cell
teniendo	O
el	O
Atrxflox	O
alelo	B-Sequence
.	O

En	O
un	O
experimento	O
de	O
competencia	O
de	O
control	O
entre	O
diferentes	O
clones	O
portadores	O
de	O
Atrx	B-Protein
alelos	B-Sequence
(	O
AtrxWT	O
y	O
Atrxflox	O
)	O
,	O
ambos	O
clones	O
continuaron	O
estando	O
igualmente	O
representados	O
después	O
de	O
8	O
d	O
de	O
cocultivo	O
.	O

Así	O
,	O
aunque	O
Atrxnull	O
ES	O
células	B-Cell
podría	O
recuperarse	O
y	O
mantenerse	O
en	O
cultivo	O
mediante	O
un	O
enfoque	O
de	O
focalización	O
condicional	O
,	O
estos	O
experimentos	O
de	O
cocultivo	O
sugirieron	O
que	O
la	O
ausencia	O
de	O
Atrx	B-Protein
tiene	O
un	O
impacto	O
negativo	O
en	O
el	O
ES	O
normal	O
célula	B-Cell
crecimiento	O
.	O

Para	O
investigar	O
una	O
posible	O
célula	B-Cell
#	O
¿NOMBRE	O
?	O
Atrx	B-Protein
,	O
analizamos	O
la	O
célula	B-Cell
distribución	O
del	O
ciclo	O
de	O
bromodesoxiuridina	O
(	O
BrdU	O
)	O
-	O
ES	O
pulsado	O
células	B-Cell
por	O
citometría	O
de	O
flujo	O
(	O
Figura	O
S1A	O
)	O
.	O

Sorprendentemente	O
,	O
tanto	O
Atrxnull	O
ES	O
célula	B-Cell
los	O
clones	O
exhibieron	O
una	O
célula	B-Cell
perfil	O
de	O
ciclo	O
que	O
era	O
indistinguible	O
de	O
ES	O
células	B-Cell
teniendo	O
un	O
funcional	O
Atrx	B-Protein
alelo	B-Sequence
(	O
AtrxWT	O
o	O
Atrxflox	O
)	O
.	O

También	O
cuantificamos	O
específicamente	O
el	O
índice	O
mitótico	O
dentro	O
de	O
cada	O
población	O
mediante	O
citometría	O
de	O
flujo	O
después	O
de	O
teñir	O
ES	O
células	B-Cell
para	O
fosforilados	O
(	O
Ser10	O
)	O
histona	B-Chemical
H3	O
,	O
un	O
marcador	O
específico	O
de	O
mitosis	O
(	O
Figura	O
S1B	O
)	O
[	O
13	O
]	O
.	O

De	O
acuerdo	O
con	O
la	O
normalidad	O
célula	B-Cell
En	O
el	O
perfil	O
del	O
ciclo	O
observado	O
anteriormente	O
,	O
no	O
hubo	O
agotamiento	O
en	O
el	O
tamaño	O
de	O
la	O
población	O
mitótica	O
en	O
los	O
clones	O
Atrxnull	O
ES	O
,	O
a	O
pesar	O
de	O
su	O
lento	O
crecimiento	O
.	O

Finalmente	O
,	O
investigamos	O
si	O
el	O
defecto	O
de	O
crecimiento	O
en	O
Atrxnull	O
ES	O
células	B-Cell
se	O
debió	O
a	O
una	O
regulación	O
al	O
alza	O
de	O
la	O
apoptosis	O
por	O
tinción	O
células	B-Cell
con	O
Anexina	B-Protein
V	I-Protein
(	O
Figura	O
S2	O
)	O
y	O
encontró	O
que	O
la	O
proporción	O
de	O
células	B-Cell
apoptóticas	I-Cell
no	O
se	O
vio	O
afectado	O
significativamente	O
por	O
la	O
ausencia	O
de	O
Atrx	B-Protein
.	O

Así	O
,	O
el	O
defecto	O
de	O
crecimiento	O
observado	O
en	O
ES	O
células	B-Cell
carente	O
Atrx	B-Protein
no	O
se	O
debe	O
a	O
una	O
determinada	O
célula	B-Cell
bloqueo	O
del	O
ciclo	O
o	O
inducción	O
significativa	O
de	O
célula	B-Cell
muerte	O
.	O

Si	O
bien	O
la	O
causa	O
del	O
retraso	O
proliferativo	O
aún	O
no	O
está	O
clara	O
,	O
ya	O
que	O
Atrxnull	O
ES	O
células	B-Cell
parecen	O
sufrir	O
tasas	O
más	O
altas	O
de	O
diferenciación	O
espontánea	O
(	O
datos	O
no	O
publicados	O
)	O
,	O
parece	O
probable	O
que	O
el	O
defecto	O
de	O
crecimiento	O
observado	O
refleje	O
la	O
transición	O
espontánea	O
de	O
ES	O
indiferenciadas	O
de	O
ciclos	O
rápidos	O
células	B-Cell
en	O
ciclos	O
más	O
lentos	O
,	O
diferenciados	O
célula	B-Cell
tipos	O
en	O
estas	O
culturas	O
.	O

Se	O
ha	O
demostrado	O
que	O
las	O
enfermedades	O
que	O
causan	O
mutaciones	B-Sequence
en	O
el	O
atrx	B-Protein
humano	I-Protein
gene	B-Sequence
dar	O
lugar	O
a	O
cambios	O
en	O
el	O
patrón	O
normal	O
de	O
ADN	B-Sequence
metilación	O
en	O
varios	O
secuencias	B-Sequence
repetitivas	I-Sequence
dentro	O
de	O
humano	B-Taxon
genoma	B-Sequence
[	O
11	O
]	O
.	O

En	O
particular	O
,	O
la	O
región	O
transcrita	O
del	O
ribosomal	B-GENE
ADN	B-Sequence
(	O
ADNr	O
)	O
repetir	B-Sequence
se	O
encontró	O
que	O
estaba	O
significativamente	O
hipometilado	O
en	O
ATR-X	B-Protein
pacientes	O
en	O
relación	O
con	O
los	O
normales	O
individuos	B-Taxon
.	O

Uso	O
de	O
metilación	O
-	O
restricción	O
sensible	O
enzimas	B-Sequence
,	O
también	O
observamos	O
hipometilación	O
significativa	O
en	O
varios	O
sitios	B-Sequence
probado	O
dentro	O
del	O
ratón	B-Taxon
ADNr	O
repite	B-Sequence
en	O
Atrxnull	O
ES	O
células	B-Cell
y	O
12	O
-	O
d	O
cuerpos	O
embrioides	O
en	O
relación	O
con	O
ES	O
células	B-Cell
y	O
cuerpos	O
embrioides	O
que	O
llevan	O
un	O
funcional	O
Atrx	B-Protein
alelo	B-Sequence
(	O
AtrxWT	O
o	O
Atrxflox	O
)	O
(	O
Figura	O
3B	O
y	O
3C	O
)	O
.	O

La	O
observación	O
de	O
que	O
el	O
ADNr	O
está	O
hipometilado	O
en	O
ausencia	O
de	O
Atrx	B-Protein
,	O
incluso	O
en	O
ES	O
células	B-Cell
,	O
es	O
consistente	O
con	O
el	O
hallazgo	O
de	O
que	O
la	O
hipometilación	O
del	O
humano	B-Taxon
ADNr	O
repite	B-Sequence
es	O
detectable	O
desde	O
una	O
etapa	O
temprana	O
de	O
desarrollo	O
en	O
ATR	O
-	O
X	B-GENE
pacientes	O

Otro	O
ratón	B-Taxon
elementos	B-Sequence
de	I-Sequence
secuencia	I-Sequence
repetitiva	I-Sequence
encuestados	O
en	O
ES	O
célula	B-Cell
ADN	B-Sequence
incluir	O
la	O
heterocromático	B-GENE
importante	O
satélite	B-Sequence
(	I-Sequence
ensayado	I-Sequence
con	I-Sequence
MaeII	I-Sequence
)	I-Sequence
y	I-Sequence
satélite	I-Sequence
menor	I-Sequence
(	I-Sequence
ensayado	I-Sequence
con	I-Sequence
HpaII	I-Sequence
)	I-Sequence
repeticiones	I-Sequence
,	O
así	O
como	O
intercalados	O
retroviral	B-Taxon
repite	B-Sequence
del	O
tipo	O
partícula	O
intracisternal	O
A	O
(	O
IAP	O
)	O
y	O
de	O
las	O
familias	O
Line	O
1	O
y	O
Sine	O
B1	O
(	O
todos	O
ensayados	O
con	O
HpaII	O
)	O
.	O

Estas	O
repite	B-Sequence
se	O
encontraron	O
moderadamente	O
(	O
Línea	O
1	O
y	O
Sine	O
B1	O
)	O
o	O
altamente	O
(	O
IAP	O
,	O
mayor	O
satélite	B-Sequence
,	O
menor	O
satélite	B-Sequence
)	O
metilado	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
ES	O
células	B-Cell
,	O
y	O
esta	O
metilación	O
no	O
fue	O
perceptiblemente	O
perturbada	O
por	O
la	O
ausencia	O
de	O
Atrx	B-Protein
(	O
Figura	O
S3	O
y	O
datos	O
no	O
publicados	O
)	O
.	O

En	O
conjunto	O
,	O
estos	O
datos	O
indican	O
que	O
la	O
sutil	O
interacción	O
entre	O
el	O
ATRX	B-Protein
proteína	B-Chemical
y	O
ADN	B-Sequence
metilación	O
observada	O
en	O
humano	B-Taxon
los	O
pacientes	O
también	O
están	O
presentes	O
en	O
ratón	B-Taxon
células	B-Cell
.	O

Letalidad	O
embrionaria	O
temprana	O
en	O
Atrxnull	O
Male	O
Ratones	B-Taxon

Para	O
investigar	O
el	O
papel	O
de	O
la	O
Atrx	B-Protein
proteína	B-Chemical
durante	O
ratón	B-Taxon
desarrollo	O
,	O
inicialmente	O
establecimos	O
líneas	O
de	O
ratones	B-Taxon
teniendo	O
el	O
Atrxflox	O
alelo	B-Sequence
.	O

Dos	O
Atrxflox	O
ES	O
dirigidos	O
de	O
forma	O
independiente	O
célula	B-Cell
clones	O
con	O
cariotipo	O
masculino	O
normal	O
se	O
inyectaron	O
en	O
blastocistos	O
C57BL/6	O
para	O
producir	O
quimérico	O
ratones	B-Taxon
,	O
que	O
luego	O
se	O
utilizaron	O
para	O
obtener	O
la	O
transmisión	O
de	O
la	O
línea	O
germinal	O
.	O

Cruces	O
entre	O
machos	O
hemicigotos	O
(	O
Atrxflox	O
/	O
Y	O
)	O
y	O
hembras	O
heterocigotos	O
(	O
AtrxWT	O
/	O
flox	B-Sequence
)	O
Para	O
el	O
alelo	B-Sequence
flojo	I-Sequence
también	O
se	O
realizaron	O
para	O
generar	O
hembras	O
homocigóticas	O
(	O
Atrxflox	O
/	O
flox	B-Sequence
)	O
.	O

Varones	O
hemicigotos	O
y	O
mujeres	O
heterocigotos	O
u	O
homocigotos	O
para	O
el	O
Atrxflox	O
alelo	B-Sequence
eran	O
viables	O
,	O
parecían	O
saludables	O
y	O
se	O
reproducían	O
normalmente	O
,	O
lo	O
que	O
sugiere	O
que	O
,	O
como	O
se	O
esperaba	O
,	O
el	O
Atrxflox	O
alelo	B-Sequence
era	O
funcionalmente	O
normal	O
.	O

Para	O
generar	O
Atrxnull	O
ratones	B-Taxon
por	O
recombinación	O
mediada	O
por	O
Cre	O
,	O
el	O
Atrxflox	O
ratones	B-Taxon
se	O
cruzaron	O
con	O
ratones	B-Taxon
albergando	O
un	O
transgén	B-Sequence
en	O
el	O
que	O
la	O
recombinasa	O
Cre	O
se	O
expresa	O
bajo	O
el	O
control	O
de	O
la	O
elementos	B-Sequence
regulatorios	I-Sequence
de	O
El	O
ratón	B-Protein
GATA-1	I-Protein
gene	B-Sequence
(	O
GATA1	B-Protein
-	O
cre	O
)	O
[	O
14	O
]	O
.	O

Expresión	O
generalizada	O
de	O
la	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
se	O
ha	O
demostrado	O
durante	O
la	O
embriogénesis	O
temprana	O
[	O
14	O
]	O
.	O

Definimos	O
con	O
mayor	O
precisión	O
el	O
inicio	O
de	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
ROSA26	B-Protein
cepa	O
reportera	O
,	O
en	O
la	O
que	O
una	O
beta	O
-	O
galactosidasa	O
/	O
neor	O
gen	B-Sequence
reportero	I-Sequence
de	I-Sequence
fusión	I-Sequence
se	O
expresa	O
sólo	O
después	O
de	O
Cre	O
-	O
mediada	O
excisión	B-Sequence
de	O
loxP	B-Sequence
-	I-Sequence
flanqueado	I-Sequence
transcripción	O
y	O
señales	B-Sequence
de	I-Sequence
terminación	I-Sequence
de	I-Sequence
traducción	I-Sequence
[	O
14	O
]	O
.	O

Encontramos	O
que	O
el	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
ya	O
estaba	O
activo	O
en	O
el	O
16	O
-	O
célula	B-Cell
etapa	O
de	O
desarrollo	O
de	O
la	O
mórula	O
(	O
0	O
,	O
5	O
días	O
después	O
del	O
coito	O
[	O
dpc	O
]	O
)	O
(	O
Figura	O
4A	O
)	O
.	O

Para	O
generar	O
Atrxnull	O
ratones	B-Taxon
,	O
heterocigoto	O
flojo	B-Sequence
hembras	O
(	O
AtrxWT	O
/	O
flox	B-Sequence
)	O
fueron	O
apareados	O
con	O
homocigotos	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
machos	O
(	O
AtrxWT/Y	O
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
+	B-Sequence
)	O
.	O

No	O
hay	O
machos	O
Atrxnull	O
(	O
Atrxnull	O
/	O
Y	O
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
-	O
)	O
se	O
recuperaron	O
al	O
nacer	O
,	O
lo	O
que	O
indica	O
que	O
la	O
ausencia	O
de	O
Atrx	B-Protein
resulta	O
en	O
letalidad	O
embrionaria	O
.	O

Este	O
hallazgo	O
fue	O
inesperado	O
,	O
ya	O
que	O
humano	B-Taxon
ATR-	O
X	B-GENE
los	O
pacientes	O
claramente	O
sobreviven	O
hasta	O
la	O
edad	O
adulta	O
(	O
ver	O
Discusión	O
)	O
.	O

Los	O
embriones	O
se	O
diseccionaron	O
a	O
las	O
7	O
.	O
5	O
,	O
8	O
.	O
5	O
y	O
9	O
.	O
5	O
dpc	O
y	O
genotipado	O
por	O
análisis	O
PCR	O
de	O
ADN	B-Sequence
extraído	O
del	O
saco	O
vitelino	O
o	O
del	O
embrión	O
total	O
(	O
Figura	O
4B	O
y	O
Protocolo	O
S1	O
)	O
.	O

Los	O
machos	O
Atrxnull	O
estuvieron	O
presentes	O
en	O
las	O
proporciones	O
mendelianas	O
esperadas	O
(	O
~	O
25	O
%	O
)	O
en	O
ambos	O
7	O
.	O
5	O
dpc	O
y	O
8	O
.	O
5	O
dpc	O
(	O
Tabla	O
1	O
)	O
.	O

Sin	O
embargo	O
,	O
a	O
las	O
9	O
.	O
A	O
los	O
5	O
dpc	O
se	O
observó	O
depleción	O
tanto	O
en	O
el	O
número	O
de	O
machos	O
Atrxnull	O
(	O
7	O
%	O
)	O
como	O
en	O
el	O
número	O
total	O
de	O
machos	O
recuperados	O
(	O
31	O
%	O
)	O
.	O

No	O
se	O
recuperaron	O
machos	O
Atrxnull	O
después	O
de	O
9	O
.	O
5	O
dpc	O
.	O

Así	O
la	O
ausencia	O
de	O
Atrx	B-Protein
da	O
lugar	O
a	O
la	O
letalidad	O
embrionaria	O
en	O
ratones	B-Taxon
antes	O
de	O
las	O
9	O
5	O
dpc	O
.	O

Para	O
investigar	O
la	O
morfología	O
de	O
los	O
embriones	O
Atrxnull	O
antes	O
de	O
la	O
muerte	O
,	O
los	O
embriones	O
de	O
los	O
cruces	O
anteriores	O
se	O
diseccionaron	O
inicialmente	O
en	O
sus	O
deciduas	O
a	O
los	O
7	O
.	O
5	O
dpc	O
,	O
y	O
las	O
secciones	O
de	O
parafina	O
se	O
tiñeron	O
con	O
hematoxilina	O
(	O
Figura	O
5A	O
)	O
o	O
con	O
un	O
anti	O
-	O
ATRX	B-Protein
anticuerpo	B-GENE
(	O
Figura	O
5B-5E	O
)	O
.	O

La	O
tinción	O
inmunohistoquímica	O
reveló	O
que	O
Atrx	B-Protein
se	O
expresó	O
ampliamente	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
7	O
.	O
Embriones	O
de	O
5	O
dpc	O
(	O
Figura	O
5B	O
)	O
.	O

La	O
expresión	O
fue	O
máxima	O
en	O
la	O
región	O
embrionaria	O
(	O
Figura	O
5C	O
)	O
y	O
el	O
corion	O
(	O
Figura	O
5D	O
)	O
.	O

Se	O
observaron	O
niveles	O
de	O
expresión	O
detectables	O
pero	O
más	O
bajos	O
en	O
el	O
cono	O
ectoplacentario	O
(	O
Figura	O
5D	O
)	O
y	O
el	O
tejido	O
decidual	O
circundante	O
.	O

También	O
observamos	O
niveles	O
muy	O
altos	O
de	O
Atrx	B-Protein
expresión	O
en	O
células	B-Cell
gigantes	I-Cell
del	I-Cell
trofoblasto	I-Cell
(	O
TGC	O
)	O
que	O
rodean	O
el	O
Reichert	O
'	O
s	O
membrana	B-GENE
(	O
Figura	O
5E	O
)	O
.	O

dentro	O
de	O
los	O
grandes	O
núcleos	B-GENE
de	O
estos	O
TGC	O
,	O
el	O
típico	O
nuclear	B-GENE
Asociación	O
de	O
Atrx	B-Protein
con	O
bloques	O
de	O
heterocromatina	B-GENE
pericentromérica	I-GENE
[	O
15	O
]	O
era	O
claramente	O
observable	O
.	O

Sólo	O
se	O
observó	O
tinción	O
de	O
fondo	O
en	O
los	O
tejidos	O
embrionarios	O
de	O
Atrxnull	O
correspondientes	O
(	O
Figuras	O
5B-5D	O
)	O
,	O
mientras	O
que	O
la	O
expresión	O
en	O
el	O
tejido	O
decidual	O
circundante	O
(	O
de	O
origen	O
materno	O
)	O
fue	O
normal	O
y	O
sirvió	O
como	O
prueba	O
.	O
anticuerpo	B-GENE
control	O
de	O
tinción	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Morfológicamente	O
,	O
7	O
.	O
Los	O
embriones	O
de	O
5	O
dpc	O
Atrxnull	O
se	O
redujeron	O
drásticamente	O
en	O
tamaño	O
y	O
parecían	O
tener	O
un	O
retraso	O
en	O
el	O
desarrollo	O
en	O
relación	O
con	O
la	O
etapa	O
-	O
emparejados	O
tipo	B-Sequence
salvaje	I-Sequence
embriones	O
(	O
Figura	O
5A	O
y	O
5B	O
)	O
.	O

Sin	O
embargo	O
,	O
a	O
pesar	O
de	O
su	O
tamaño	O
reducido	O
,	O
la	O
morfología	O
general	O
y	O
la	O
organización	O
de	O
las	O
estructuras	O
embrionarias	O
en	O
Atrxnull	O
conceptuses	O
parecían	O
muy	O
normales	O
.	O

El	O
amnios	O
y	O
el	O
corion	O
estaban	O
claramente	O
presentes	O
y	O
se	O
distinguían	O
las	O
cavidades	O
amniótica	O
,	O
exocelómica	O
y	O
ectoplacentaria	O
,	O
al	O
igual	O
que	O
las	O
tres	O
capas	O
germinales	O
embrionarias	O
(	O
Figura	O
5A-5C	O
)	O
.	O

A	O
las	O
8	O
.	O
5	O
dpc	O
,	O
los	O
embriones	O
fueron	O
disecados	O
libres	O
de	O
deciduas	O
,	O
y	O
observados	O
en	O
montaje	O
completo	O
.	O

Los	O
conceptos	O
individuales	O
fueron	O
genotipados	O
por	O
PCR	O
utilizando	O
ADN	B-Sequence
aislado	O
del	O
saco	O
vitelino	O
como	O
se	O
describe	O
en	O
el	O
Protocolo	O
S1	O
.	O

De	O
acuerdo	O
con	O
las	O
observaciones	O
en	O
7	O
.	O
5	O
dpc	O
,	O
la	O
morfología	O
general	O
del	O
embrión	O
propiamente	O
dicho	O
de	O
Atrxnull	O
conceptuses	O
también	O
apareció	O
macroscópicamente	O
normal	O
a	O
los	O
8	O
.	O
5	O
dpc	O
.	O

El	O
pliegue	O
de	O
la	O
cabeza	O
se	O
había	O
formado	O
claramente	O
y	O
la	O
expresión	O
del	O
marcador	O
de	O
mesodermo	O
temprano	O
braquiuria	B-Protein
(	O
T	B-Protein
)	O
[	O
16	O
]	O
se	O
detectó	O
en	O
la	O
línea	O
primitiva	O
y	O
la	O
notocorda	O
emergente	O
mediante	O
hibridación	O
in	O
situ	O
de	O
montaje	O
completo	O
(	O
WMISH	O
)	O
(	O
Figura	O
5F	O
)	O
,	O
lo	O
que	O
indica	O
que	O
los	O
embriones	O
Atrxnull	O
se	O
habían	O
gastrulado	O
.	O

Para	O
investigar	O
si	O
el	O
tamaño	O
reducido	O
de	O
los	O
embriones	O
Atrxnull	O
se	O
debía	O
a	O
un	O
aumento	O
en	O
la	O
apoptosis	O
,	O
analizamos	O
secciones	O
de	O
7	O
incrustadas	O
en	O
parafina	O
.	O
Embriones	O
de	O
5	O
dpc	O
por	O
TDT	B-Protein
#	O
¿NOMBRE	O
?	O
dUTP	B-Chemical
ensayo	O
de	O
marcaje	O
del	O
extremo	O
de	O
la	O
muesca	O
(	O
TUNEL	O
)	O
(	O
Figura	O
6A	O
)	O
.	O

Muy	O
pocos	O
células	B-Cell
apoptóticas	I-Cell
fueron	O
detectados	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
7	O
.	O
Embriones	O
de	O
5	O
dpc	O
.	O

En	O
los	O
embriones	O
Atrxnull	O
,	O
fue	O
evidente	O
un	O
ligero	O
aumento	O
en	O
la	O
población	O
apoptótica	O
.	O

Sin	O
embargo	O
,	O
de	O
acuerdo	O
con	O
nuestra	O
observación	O
de	O
un	O
índice	O
apoptótico	O
muy	O
normal	O
en	O
Atrxnull	O
ES	O
células	B-Cell
(	O
Figura	O
S2	O
)	O
,	O
la	O
respuesta	O
apoptótica	O
observada	O
en	O
los	O
embriones	O
Atrxnull	O
tampoco	O
fue	O
uniforme	O
,	O
sino	O
que	O
se	O
restringió	O
a	O
un	O
bajo	O
número	O
de	O
TUNEL	O
positivos	O
dispersos	O
células	B-Cell
.	O

Dado	O
que	O
es	O
poco	O
probable	O
que	O
esta	O
pequeña	O
respuesta	O
apoptótica	O
explique	O
totalmente	O
el	O
déficit	O
de	O
tamaño	O
espectacular	O
observado	O
en	O
los	O
embriones	O
Atrxnull	O
,	O
también	O
se	O
investigó	O
un	O
posible	O
defecto	O
de	O
proliferación	O
mediante	O
tinción	O
inmunohistoquímica	O
de	O
7	O
.	O
Secciones	O
de	O
embrión	O
de	O
5	O
dpc	O
para	O
el	O
marcador	O
de	O
mitosis	O
fosforilado	O
(	O
Ser10	O
)	O
histona	B-Chemical
H3	O
[	O
13	O
]	O
.	O

En	O
relación	O
con	O
el	O
índice	O
mitótico	O
muy	O
alto	O
observado	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
embriones	O
,	O
la	O
proporción	O
de	O
mitosis	O
células	B-Cell
observado	O
en	O
embriones	O
Atrxnull	O
a	O
los	O
7	O
.	O
5	O
dpc	O
se	O
redujo	O
drásticamente	O
(	O
Figura	O
6B	O
)	O
.	O

Tomados	O
en	O
conjunto	O
,	O
estos	O
resultados	O
sugieren	O
que	O
el	O
déficit	O
de	O
tamaño	O
observado	O
en	O
los	O
embriones	O
Atrxnull	O
antes	O
de	O
la	O
letalidad	O
refleja	O
en	O
gran	O
medida	O
un	O
defecto	O
proliferativo	O
,	O
con	O
una	O
contribución	O
menor	O
pero	O
indirecta	O
del	O
aumento	O
de	O
la	O
apoptosis	O
.	O

Aunque	O
también	O
se	O
observó	O
un	O
defecto	O
de	O
crecimiento	O
en	O
Atrxnull	O
ES	O
células	B-Cell
(	O
Figura	O
3A	O
)	O
,	O
en	O
contraste	O
con	O
los	O
embriones	O
Atrxnull	O
,	O
el	O
índice	O
mitótico	O
de	O
la	O
ES	O
célula	B-Cell
población	O
(	O
medida	O
con	O
el	O
mismo	O
anticuerpo	B-GENE
)	O
no	O
se	O
agotó	O
(	O
Figura	O
S1B	O
)	O
.	O

Estas	O
observaciones	O
sugieren	O
que	O
es	O
poco	O
probable	O
que	O
el	O
defecto	O
mitótico	O
observado	O
en	O
los	O
embriones	O
sea	O
un	O
célula	B-Cell
#	O
¿NOMBRE	O
?	O
Atrx	B-Protein
y	O
es	O
más	O
probable	O
que	O
sea	O
un	O
efecto	O
secundario	O
resultante	O
de	O
la	O
falta	O
de	O
desarrollo	O
de	O
un	O
trofoblasto	O
normal	O
(	O
ver	O
más	O
abajo	O
)	O
.	O

Fracaso	O
del	O
trofoectodermo	O
en	O
embriones	O
Atrxnull	O

Observación	O
de	O
montaje	O
completo	O
de	O
8	O
.	O
Los	O
embriones	O
de	O
5	O
dpc	O
revelaron	O
que	O
,	O
en	O
contraste	O
con	O
la	O
morfología	O
básicamente	O
normal	O
aunque	O
retrasada	O
del	O
propio	O
embrión	O
,	O
los	O
tejidos	O
extraembrionarios	O
de	O
Atrxnull	O
conceptuses	O
parecían	O
muy	O
desorganizados	O
.	O

Cuando	O
se	O
extrajeron	O
los	O
embriones	O
de	O
las	O
deciduas	O
,	O
la	O
capa	O
de	O
trofoectodermo	O
circundante	O
apareció	O
dramáticamente	O
reducida	O
en	O
los	O
embriones	O
Atrxnull	O
en	O
relación	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
compañeros	O
de	O
camada	O
,	O
y	O
el	O
cono	O
ectoplacentario	O
subyacente	O
parecía	O
reducido	O
y	O
de	O
forma	O
anormal	O
(	O
Figura	O
7A	O
)	O
.	O

Deciduas	O
desocupadas	O
que	O
rodean	O
8	O
.	O
5	O
dpc	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
los	O
embriones	O
Atrxnull	O
fueron	O
divididos	O
en	O
dos	O
y	O
analizados	O
por	O
WMISH	O
para	O
la	O
expresión	O
de	O
lactógeno	B-Protein
placentario	I-Protein
-	I-Protein
1	I-Protein
(	O
pl	B-Protein
-	I-Protein
1	I-Protein
)	O
,	O
un	O
marcador	O
de	O
TGCs	O
terminalmente	O
diferenciados	O
.	O

El	O
número	O
de	O
pl	B-Protein
-	I-Protein
1	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
unido	O
a	O
la	O
pared	O
decidual	O
después	O
de	O
la	O
extracción	O
del	O
embrión	O
es	O
una	O
indicación	O
de	O
la	O
densidad	O
de	O
células	B-Cell
trofoblásticas	I-Cell
que	O
rodea	O
cada	O
sitio	O
de	O
implantación	O
[	O
17	O
]	O
.	O

Encontramos	O
que	O
la	O
población	O
de	O
pl	B-Protein
-	I-Protein
1	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
se	O
agotó	O
en	O
los	O
sitios	O
de	O
implantación	O
decidual	O
que	O
contenían	O
embriones	O
Atrxnull	O
en	O
relación	O
con	O
los	O
que	O
contenían	O
tipo	B-Sequence
salvaje	I-Sequence
compañeros	O
de	O
camada	O
(	O
Figura	O
7B	O
)	O
;	O
esto	O
también	O
fue	O
evidente	O
a	O
las	O
7	O
.	O
5	O
dpc	O
,	O
determinado	O
por	O
tinción	O
inmunohistoquímica	O
de	O
secciones	O
en	O
parafina	O
de	O
embriones	O
en	O
deciduas	O
con	O
un	O
anti	O
-	O
pl	B-Protein
-	I-Protein
1	I-Protein
anticuerpo	B-GENE
(	O
Figura	O
7C	O
)	O
.	O

Una	O
deficiencia	O
de	O
TGC	O
en	O
ausencia	O
de	O
Atrx	B-Protein
es	O
consistente	O
con	O
la	O
observación	O
de	O
que	O
Atrx	B-Protein
está	O
altamente	O
expresado	O
en	O
gigante	O
células	B-Cell
rodeando	O
tipo	B-Sequence
salvaje	I-Sequence
7	O
.	O
Embriones	O
de	O
5	O
dpc	O
(	O
Figura	O
5E	O
)	O
.	O

Para	O
investigar	O
si	O
el	O
defecto	O
del	O
trofoblasto	O
estaba	O
restringido	O
a	O
la	O
producción	O
de	O
TGC	O
secundarios	O
(	O
producidos	O
por	O
precursores	O
diploides	O
en	O
el	O
cono	O
ectoplacentario	O
y	O
derivados	O
originalmente	O
del	O
trofectodermo	O
polar	O
que	O
recubre	O
el	O
interior	O
célula	B-Cell
masa	O
del	O
blastocisto	O
)	O
o	O
también	O
afectó	O
la	O
producción	O
de	O
TGC	O
primarios	O
(	O
resultantes	O
de	O
la	O
diferenciación	O
del	O
trofectodermo	O
mural	O
del	O
blastocisto	O
)	O
,	O
blastocistos	O
(	O
3	O
,	O
5	O
dpc	O
)	O
de	O
cruces	O
entre	O
AtrxWT	O
/	O
flox	B-Sequence
hembras	O
y	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
machos	O
(	O
AtrxWT/Y	O
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
+	B-Sequence
)	O
se	O
cultivaron	O
in	O
vitro	O
durante	O
5	O
días	O
para	O
controlar	O
el	O
crecimiento	O
del	O
trofoblasto	O
primario	O
.	O

Después	O
de	O
5	O
días	O
,	O
los	O
cultivos	O
de	O
blastocistos	O
individuales	O
se	O
evaluaron	O
según	O
la	O
extensión	O
del	O
crecimiento	O
del	O
trofoblasto	O
primario	O
y	O
el	O
Atrx	B-Protein
genotipo	B-Sequence
y	O
el	O
sexo	O
del	O
blastocisto	O
se	O
determinaron	O
por	O
PCR	O
.	O

La	O
mayoría	O
de	O
los	O
blastocistos	O
eclosionaron	O
de	O
la	O
zona	O
pelúcida	O
dentro	O
de	O
las	O
24	O
h	O
,	O
y	O
células	B-Cell
trofoblásticas	I-Cell
extendiéndose	O
desde	O
el	O
interior	O
célula	B-Cell
por	O
lo	O
general	O
,	O
la	O
masa	O
podía	O
detectarse	O
dentro	O
de	O
las	O
48	O
h	O
posteriores	O
al	O
cultivo	O
.	O

No	O
se	O
observaron	O
diferencias	O
en	O
la	O
tasa	O
o	O
extensión	O
del	O
crecimiento	O
del	O
trofoblasto	O
durante	O
5	O
días	O
de	O
cultivo	O
entre	O
blastocistos	O
Atrxnull	O
(	O
Atrxnull	O
/	O
Y	O
,	O
n	O
=	O
6	O
)	O
y	O
blastocistos	O
con	O
AtrxWT	O
alelo	B-Sequence
(	O
AtrxWT	O
/	O
peso	B-Sequence
,	O
n	O
=	O
6	O
;	O
AtrxWT/nulo	O
,	O
n	O
=	O
6	O
;	O
AtrxWT	O
/	O
Y	O
,	O
n	O
=	O
6	O
)	O
(	O
ejemplos	O
mostrados	O
en	O
la	O
Figura	O
7D	O
)	O
,	O
lo	O
que	O
sugiere	O
que	O
el	O
defecto	O
involucra	O
específicamente	O
al	O
gigante	O
secundario	O
célula	B-Cell
compartimiento	O

Esto	O
es	O
consistente	O
con	O
la	O
observación	O
de	O
que	O
los	O
conceptos	O
Atrxnull	O
se	O
implantan	O
con	O
éxito	O
y	O
sobreviven	O
hasta	O
la	O
gastrulación	O
.	O

En	O
conjunto	O
,	O
estos	O
datos	O
sugieren	O
que	O
la	O
pérdida	O
de	O
Atrx	B-Protein
da	O
como	O
resultado	O
un	O
defecto	O
en	O
la	O
formación	O
del	O
trofoblasto	O
secundario	O
que	O
es	O
evidente	O
a	O
partir	O
de	O
7	O
.	O
5	O
dpc	O
.	O

A	O
pesar	O
de	O
iniciar	O
una	O
organización	O
normal	O
en	O
el	O
embrión	O
propiamente	O
dicho	O
,	O
los	O
embriones	O
Atrxnull	O
exhiben	O
un	O
defecto	O
proliferativo	O
por	O
7	O
.	O
5	O
dpc	O
y	O
muere	O
alrededor	O
de	O
9	O
.	O
5	O
dpc	O
,	O
probablemente	O
debido	O
a	O
un	O
déficit	O
nutricional	O
resultante	O
de	O
la	O
falta	O
de	O
desarrollo	O
de	O
un	O
trofoblasto	O
normal	O
.	O

Escapar	O
de	O
la	O
inactivación	O
impresa	O
del	O
AtrxWT	O
heredado	O
paternamente	O
alelo	B-Sequence
en	O
Tejidos	O
Extraembrionarios	O
de	O
Mujer	O
Portadora	O
Ratones	B-Taxon

Mujer	O
ratones	B-Taxon
llevando	O
un	O
Atrxnull	O
alelo	B-Sequence
(	O
AtrxWT/null	O
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
-	O
)	O
se	O
detectaron	O
a	O
las	O
9	O
.	O
5	O
dpc	O
(	O
Tabla	O
1	O
)	O
y	O
recuperadas	O
al	O
nacer	O
(	O
datos	O
no	O
publicados	O
)	O
,	O
aunque	O
en	O
ambos	O
momentos	O
el	O
número	O
de	O
hembras	O
portadoras	O
fue	O
menor	O
que	O
el	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
AtrxWT	O
/	O
peso	B-Sequence
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/-	O
)	O
hembras	O
,	O
lo	O
que	O
sugiere	O
que	O
una	O
proporción	O
de	O
embriones	O
hembras	O
portadoras	O
murieron	O
en	O
el	O
útero	O
.	O

Hembra	O
portadora	O
adulta	O
sobreviviente	O
ratones	B-Taxon
no	O
eran	O
fenotípicamente	O
normales	O
y	O
mostraban	O
leves	O
anomalías	O
de	O
comportamiento	O
,	O
aunque	O
algunos	O
podían	O
reproducirse	O
.	O

Para	O
todos	O
los	O
embriones	O
femeninos	O
AtrxWT	O
/	O
portadores	O
nulos	O
presentados	O
en	O
la	O
Tabla	O
1	O
,	O
el	O
AtrxWT	O
alelo	B-Sequence
fue	O
derivado	O
paternalmente	O
,	O
mientras	O
que	O
el	O
Atrxnull	O
alelo	B-Sequence
era	O
de	O
origen	O
materno	O
.	O

En	O
el	O
ratón	B-Taxon
,	O
cromosoma	B-GENE
X	I-GENE
la	O
inactivación	O
está	O
sujeta	O
a	O
la	O
impronta	O
parental	O
en	O
los	O
linajes	O
del	O
trofoectodermo	O
y	O
del	O
endodermo	O
primitivo	O
que	O
dan	O
lugar	O
a	O
los	O
tejidos	O
extraembrionarios	O
,	O
lo	O
que	O
da	O
como	O
resultado	O
la	O
inactivación	O
de	O
los	O
linajes	O
paternos	O
.	O
cromosoma	B-GENE
X	I-GENE
(	O
Xp	O
)	O
[	O
18	O
]	O
.	O

Por	O
el	O
contrario	O
,	O
en	O
los	O
tejidos	O
del	O
embrión	O
propiamente	O
dicho	O
(	O
derivados	O
del	O
interior	O
célula	B-Cell
masa	O
del	O
blastocisto	O
)	O
X	B-GENE
la	O
inactivación	O
es	O
aleatoria	O
[	O
19	O
]	O
.	O

Así	O
,	O
en	O
el	O
compartimento	O
extraembrionario	O
de	O
AtrxWT	O
/	O
hembras	O
portadoras	O
nulas	O
,	O
normal	O
impreso	O
X	B-GENE
#	O
¿NOMBRE	O
?	O
alelo	B-Sequence
,	O
dejando	O
solo	O
el	O
Atrxnull	O
alelo	B-Sequence
sobre	O
la	O
madre	O
activa	O
X	B-GENE
(	O
Xm	O
)	O
y	O
,	O
por	O
lo	O
tanto	O
,	O
anular	O
los	O
tejidos	O
extraembrionarios	O
para	O
la	O
longitud	O
completa	O
Atrx	B-Protein
proteína	B-Chemical
.	O

Sin	O
embargo	O
,	O
la	O
ausencia	O
de	O
Atrx	B-Protein
en	O
el	O
compartimento	O
extraembrionario	O
es	O
letal	O
en	O
machos	O
Atrxnull/Y	O
.	O

Esto	O
sugirió	O
la	O
posibilidad	O
de	O
un	O
escape	O
de	O
la	O
inactivación	O
impresa	O
del	O
AtrxWT	O
derivado	O
del	O
padre	O
.	O
alelo	B-Sequence
en	O
el	O
compartimiento	O
extraembrionario	O
de	O
una	O
proporción	O
de	O
embriones	O
femeninos	O
portadores	O
.	O

Para	O
investigar	O
más	O
a	O
fondo	O
,	O
cruzamos	O
homocigotos	O
Atrxflox/	O
flox	B-Sequence
mujeres	O
y	O
homocigotos	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
machos	O
(	O
AtrxWT/Y	O
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
+	B-Sequence
)	O
,	O
que	O
se	O
esperaría	O
que	O
produjera	O
sólo	O
machos	O
Atrxnull	O
(	O
Atrxnull	O
/	O
Y	O
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
-	O
)	O
y	O
hembras	O
portadoras	O
(	O
AtrxWT	O
/	O
null	O
;	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
-	O
)	O
.	O

En	O
estas	O
hembras	O
portadoras	O
,	O
el	O
AtrxWT	O
alelo	B-Sequence
se	O
hereda	O
paternamente	O
.	O

Los	O
embriones	O
se	O
diseccionaron	O
en	O
sus	O
deciduas	O
a	O
las	O
7	O
.	O
5	O
dpc	O
,	O
y	O
las	O
secciones	O
de	O
parafina	O
se	O
tiñeron	O
con	O
anti-	O
ATRX	B-Protein
anticuerpo	B-GENE
junto	O
con	O
secciones	O
de	O
un	O
tipo	B-Sequence
salvaje	I-Sequence
7	O
.	O
Embrión	O
de	O
5	O
dpc	O
para	O
comparación	O
(	O
Figura	O
8	O
)	O
.	O

Como	O
se	O
describió	O
anteriormente	O
,	O
Atrx	B-Protein
se	O
detectó	O
expresión	O
en	O
cada	O
célula	B-Cell
en	I-Cell
la	I-Cell
región	I-Cell
del	I-Cell
epiblasto	I-Cell
(	I-Cell
embrión	I-Cell
propiamente	I-Cell
dicho	I-Cell
)	I-Cell
de	O
tipo	B-Sequence
salvaje	I-Sequence
7	O
.	O
Embriones	O
de	O
5	O
dpc	O
(	O
Figura	O
8B	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
la	O
región	O
del	O
epiblasto	O
de	O
los	O
embriones	O
femeninos	O
portadores	O
estaba	O
compuesta	O
por	O
un	O
mosaico	O
de	O
pequeños	O
grupos	O
de	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
(	O
en	O
el	O
que	O
el	O
Atrxnull	O
alelo	B-Sequence
en	O
Xm	O
había	O
sido	O
desactivado	O
)	O
y	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
(	O
en	O
el	O
que	O
el	O
AtrxWT	O
alelo	B-Sequence
en	O
Xp	O
había	O
sido	O
desactivado	O
)	O
,	O
lo	O
que	O
indica	O
que	O
el	O
Atrx	B-Protein
gene	B-Sequence
estaba	O
sujeto	O
al	O
azar	O
normal	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

Notablemente	O
,	O
claro	O
Atrx	B-Protein
la	O
expresión	O
también	O
podría	O
detectarse	O
en	O
los	O
tejidos	O
extraembrionarios	O
de	O
hembras	O
portadoras	O
,	O
como	O
se	O
muestra	O
en	O
el	O
ectodermo	O
coriónico	O
derivado	O
del	O
extraembrionario	O
(	O
Figura	O
8C	O
)	O
.	O

Atrx	B-Protein
La	O
expresión	O
se	O
pudo	O
detectar	O
en	O
casi	O
todos	O
células	B-Cell
del	I-Cell
ectodermo	I-Cell
coriónico	I-Cell
.	O

Atrx	B-Protein
la	O
expresión	O
también	O
se	O
detectó	O
claramente	O
en	O
otras	O
estructuras	O
extraembrionarias	O
,	O
incluidos	O
los	O
TGC	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Escape	O
del	O
silenciamiento	O
de	O
un	O
Xp	O
-	O
AtrxWT	O
heredado	O
alelo	B-Sequence
también	O
se	O
observó	O
en	O
el	O
ectodermo	O
coriónico	O
de	O
hembras	O
portadoras	O
a	O
las	O
8	O
.	O
5	O
dpc	O
(	O
Figura	O
S4	O
)	O
.	O

Así	O
,	O
aunque	O
al	O
azar	O
X	B-GENE
-	O
la	O
inactivación	O
ocurre	O
normalmente	O
dentro	O
del	O
epiblasto	O
,	O
el	O
AtrxWT	O
alelo	B-Sequence
(	O
heredado	O
en	O
el	O
Xp	O
cromosoma	B-GENE
)	O
escapó	O
de	O
la	O
impresión	O
normal	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

Discusión	O

Investigamos	O
el	O
papel	O
de	O
la	O
Atrx	B-Protein
proteína	B-Chemical
en	O
ratón	B-Taxon
desarrollo	O
.	O

Mediante	O
el	O
uso	O
de	O
un	O
enfoque	O
de	O
eliminación	O
condicional	O
,	O
eliminamos	O
la	O
longitud	O
total	O
Atrx	B-Protein
proteína	B-Chemical
primero	O
en	O
ES	O
células	B-Cell
y	O
cuerpos	O
embrioides	O
,	O
y	O
luego	O
en	O
desarrollo	O
ratón	B-Taxon
embriones	O

Atrx	B-Protein
en	O
ES	O
Células	B-Cell

Atrxnull	O
ES	O
células	B-Cell
no	O
pudieron	O
recuperarse	O
mediante	O
la	O
focalización	O
directa	O
y	O
finalmente	O
se	O
generaron	O
mediante	O
la	O
adopción	O
de	O
un	O
enfoque	O
de	O
focalización	O
condicional	O
.	O

Esto	O
es	O
consistente	O
con	O
nuestra	O
observación	O
de	O
que	O
Atrx	B-Protein
está	O
altamente	O
expresado	O
en	O
ES	O
células	B-Cell
,	O
y	O
que	O
la	O
ausencia	O
de	O
material	O
de	O
larga	O
duración	O
Atrx	B-Protein
imparte	O
una	O
desventaja	O
de	O
crecimiento	O
en	O
relación	O
con	O
células	B-Cell
teniendo	O
un	O
funcional	O
Atrx	B-Protein
alelo	B-Sequence
.	O

En	O
la	O
actualidad	O
,	O
la	O
causa	O
del	O
retraso	O
proliferativo	O
en	O
Atrxnull	O
ES	O
células	B-Cell
no	O
es	O
conocido	O
.	O

Curiosamente	O
,	O
demostramos	O
que	O
la	O
apoptosis	O
no	O
se	O
regula	O
significativamente	O
en	O
ES	O
células	B-Cell
carente	O
Atrx	B-Protein
solo	O
está	O
levemente	O
elevado	O
en	O
Atrxnull	O
7	O
.	O
5	O
dpc	O
ratón	B-Taxon
embriones	O

Por	O
el	O
contrario	O
,	O
recientemente	O
se	O
demostró	O
que	O
la	O
pérdida	O
de	O
Atrx	B-Protein
aumentó	O
notablemente	O
la	O
población	O
apoptótica	O
en	O
la	O
diferenciación	O
células	B-Cell
de	O
la	O
corteza	O
embrionaria	O
y	O
el	O
hipocampo	O
posnatal	O
,	O
cuando	O
Atrx	B-Protein
la	O
expresión	O
fue	O
ablacionada	O
en	O
el	O
desarrollo	O
ratón	B-Taxon
cerebro	O
anterior	O
usando	O
el	O
Atrxflox	O
alelo	B-Sequence
descrito	O
aquí	O
[	O
20	O
]	O
.	O

los	O
atrx	B-Protein
humano	I-Protein
proteína	B-Chemical
se	O
ha	O
demostrado	O
que	O
se	O
asocia	O
en	O
un	O
complejo	B-GENE
con	O
Daxx	B-Protein
[	O
8	O
]	O
,	O
un	O
proteína	B-Chemical
que	O
ha	O
sido	O
implicado	O
en	O
múltiples	O
vías	O
para	O
la	O
regulación	O
de	O
la	O
apoptosis	O
[	O
21	O
]	O
.	O

Es	O
posible	O
que	O
la	O
interrupción	O
de	O
la	O
ratón	B-Protein
Atrx	I-Protein
-	I-Protein
Daxx	I-Protein
complejo	B-GENE
(	O
por	O
ablación	O
del	O
Atrx	B-Protein
proteína	B-Chemical
)	O
podría	O
haber	O
desencadenado	O
una	O
respuesta	O
proapoptótica	O
universal	O
.	O

Sin	O
embargo	O
,	O
nuestras	O
observaciones	O
en	O
ES	O
células	B-Cell
demostrar	O
que	O
la	O
inducción	O
de	O
la	O
apoptosis	O
no	O
es	O
una	O
respuesta	O
automática	O
provocada	O
por	O
la	O
eliminación	O
de	O
Atrx	B-Protein
en	O
todo	O
célula	B-Cell
tipos	O
,	O
y	O
sugieren	O
que	O
la	O
apoptosis	O
inapropiada	O
observada	O
en	O
el	O
Atrx	B-Protein
-	O
mutante	B-Sequence
cerebro	O
anterior	O
puede	O
reflejar	O
un	O
requisito	O
para	O
Atrx	B-Protein
durante	O
la	O
diferenciación	O
terminal	O
.	O

Un	O
papel	O
inesperado	O
para	O
Atrx	B-Protein
en	O
Desarrollo	O
de	O
la	O
Ratón	B-Taxon
trofoblasto	O

Mostramos	O
que	O
atrxnull	O
macho	O
ratones	B-Taxon
no	O
son	O
viables	O
y	O
los	O
embriones	O
mueren	O
alrededor	O
de	O
los	O
9	O
años	O
.	O
5	O
dpc	O
.	O

Antes	O
de	O
la	O
muerte	O
,	O
los	O
embriones	O
Atrxnull	O
exhiben	O
un	O
índice	O
mitótico	O
marcadamente	O
reducido	O
,	O
lo	O
que	O
sugiere	O
un	O
defecto	O
proliferativo	O
.	O

Aunque	O
el	O
compartimento	O
embrionario	O
del	O
producto	O
de	O
la	O
concepción	O
parece	O
inicialmente	O
normal	O
,	O
a	O
los	O
7	O
.	O
Los	O
embriones	O
Atrxnull	O
de	O
5	O
dpc	O
muestran	O
anomalías	O
en	O
el	O
desarrollo	O
del	O
trofoblasto	O
,	O
incluido	O
un	O
agotamiento	O
en	O
la	O
población	O
de	O
TGC	O
que	O
rodean	O
el	O
concepto	O
y	O
una	O
reducción	O
en	O
el	O
tamaño	O
del	O
cono	O
ectoplacentario	O
,	O
que	O
contiene	O
el	O
célula	B-Cell
gigante	I-Cell
diploide	I-Cell
precursores	O
[	O
22	O
]	O
.	O

Los	O
TGC	O
son	O
altamente	O
diferenciados	O
,	O
posmitóticos	O
.	O
células	B-Cell
que	O
finalmente	O
forman	O
una	O
capa	O
epitelial	O
en	O
la	O
periferia	O
de	O
la	O
placenta	O
,	O
que	O
interactúa	O
con	O
la	O
madre	O
células	B-Cell
de	O
la	O
decidua	O
[	O
23	O
]	O
.	O

Estos	O
altamente	O
invasivos	O
células	B-Cell
son	O
importantes	O
para	O
mediar	O
en	O
la	O
invasión	O
inicial	O
del	O
tejido	O
uterino	O
,	O
pero	O
también	O
participan	O
en	O
la	O
remodelación	O
de	O
la	O
decidua	O
materna	O
después	O
de	O
la	O
implantación	O
y	O
en	O
la	O
secreción	O
de	O
hormonas	O
que	O
regulan	O
el	O
crecimiento	O
materno	O
y	O
fetal	O
[	O
24	O
]	O
.	O

Dado	O
que	O
los	O
embriones	O
Atrxnull	O
parecen	O
implantarse	O
normalmente	O
,	O
es	O
probable	O
que	O
surja	O
la	O
letalidad	O
debido	O
a	O
una	O
falla	O
en	O
la	O
función	O
de	O
TGC	O
más	O
adelante	O
durante	O
el	O
desarrollo	O
.	O

Letalidad	O
embrionaria	O
en	O
ratones	B-Taxon
en	O
ausencia	O
de	O
Atrx	B-Protein
fue	O
un	O
hallazgo	O
sorprendente	O
,	O
ya	O
que	O
no	O
había	O
indicios	O
de	O
pérdida	O
fetal	O
en	O
el	O
humano	B-Taxon
ATR-X	B-Protein
síndrome	O

Es	O
posible	O
que	O
el	O
papel	O
de	O
Atrx	B-Protein
en	O
el	O
trofoblasto	O
es	O
específico	O
de	O
ratones	B-Taxon
y	O
eso	O
ATRX	B-Protein
no	O
tiene	O
ningún	O
papel	O
o	O
es	O
redundante	O
en	O
el	O
humano	B-Taxon
trofoblasto	O

De	O
hecho	O
,	O
el	O
peso	O
al	O
nacer	O
de	O
los	O
bebés	O
con	O
ATR-X	B-Protein
El	O
síndrome	O
suele	O
ser	O
normal	O
.	O

Una	O
explicación	O
alternativa	O
para	O
el	O
fenotipo	O
inesperadamente	O
severo	O
que	O
observamos	O
en	O
ratones	B-Taxon
es	O
que	O
el	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
supresión	B-Sequence
generado	O
por	O
la	O
recombinación	O
Cre	O
elimina	O
por	O
completo	O
toda	O
la	O
longitud	O
Atrx	B-Protein
proteína	B-Chemical
(	O
Figura	O
2E	O
)	O
.	O

Por	O
el	O
contrario	O
,	O
todas	O
las	O
enfermedades	O
que	O
causan	O
mutaciones	B-Sequence
caracterizado	O
en	O
humano	B-Taxon
ATR-	O
X	B-GENE
pedigríes	O
parecen	O
dar	O
lugar	O
a	O
hipomórficos	O
alelos	B-Sequence
.	O

Algunos	O
de	O
cuerpo	O
entero	O
ATRX	B-Protein
proteína	B-Chemical
se	O
detecta	O
en	O
los	O
casos	O
predichos	O
para	O
tener	O
truncamiento	O
mutaciones	B-Sequence
(	O
RJG	O
,	O
datos	O
no	O
publicados	O
)	O
,	O
y	O
actividad	O
ATPasa	O
residual	O
en	O
ATRX	B-Protein
Se	O
pueden	O
detectar	O
inmunoprecipitados	O
en	O
Virus	B-Taxon
de	I-Taxon
Epstein	I-Taxon
Barr	I-Taxon
#	O
¿NOMBRE	O
?	O
linfocitos	B-Cell
de	O
todo	O
humano	B-Taxon
pacientes	O
analizados	O
hasta	O
la	O
fecha	O
(	O
A.	O
Argentaro	O
y	O
M.	O
Mitson	O
,	O
datos	O
no	O
publicados	O
)	O
.	O

La	O
falta	O
de	O
observación	O
de	O
un	O
verdadero	O
nulo	O
ATRX	B-Protein
alelo	B-Sequence
entre	O
humano	B-Taxon
pacientes	O
sugiere	O
fuertemente	O
que	O
,	O
como	O
en	O
el	O
ratón	B-Taxon
,	O
la	O
ausencia	O
total	O
de	O
ATRX	B-Protein
proteína	B-Chemical
es	O
incompatible	O
con	O
humano	B-Taxon
supervivencia	O
fetal	O
.	O

Si	O
bien	O
este	O
estudio	O
ha	O
revelado	O
un	O
papel	O
inesperado	O
para	O
Atrx	B-Protein
en	O
el	O
murino	B-Taxon
trophectoderm	O
,	O
como	O
resultado	O
de	O
la	O
letalidad	O
temprana	O
observada	O
en	O
los	O
embriones	O
Atrxnull	O
no	O
es	O
posible	O
descartar	O
otras	O
funciones	O
para	O
Atrx	B-Protein
en	O
etapas	O
posteriores	O
de	O
desarrollo	O
en	O
los	O
tejidos	O
del	O
embrión	O
propiamente	O
dicho	O
.	O

En	O
efecto	O
,	O
mostramos	O
que	O
Atrx	B-Protein
se	O
expresa	O
altamente	O
en	O
todo	O
el	O
embrión	O
en	O
desarrollo	O
en	O
7	O
.	O
5	O
dpc	O
(	O
Figura	O
5B	O
)	O
,	O
y	O
es	O
probable	O
que	O
Atrx	B-Protein
función	O
resultará	O
ser	O
importante	O
para	O
otros	O
tejidos	O
diferenciadores	O
.	O

Experimentos	O
de	O
agregación	O
tetraploide	O
(	O
en	O
los	O
que	O
mutante	B-Sequence
los	O
embriones	O
son	O
rescatados	O
con	O
tipo	B-Sequence
salvaje	I-Sequence
tejidos	O
extraembrionarios	O
)	O
podría	O
arrojar	O
más	O
luz	O
sobre	O
el	O
papel	O
de	O
Atrx	B-Protein
durante	O
más	O
tarde	O
ratón	B-Taxon
desarrollo	O
,	O
pero	O
estos	O
problemas	O
se	O
pueden	O
diseccionar	O
más	O
sutilmente	O
combinando	O
el	O
Atrxflox	O
condicional	O
alelo	B-Sequence
que	O
hemos	O
generado	O
con	O
diferentes	O
tejidos	O
-	O
Cre	O
específicos	O
transgenes	B-Sequence
.	O

Como	O
se	O
mencionó	O
anteriormente	O
,	O
este	O
enfoque	O
ya	O
ha	O
revelado	O
un	O
papel	O
crítico	O
para	O
Atrx	B-Protein
durante	O
neuronales	B-Cell
diferenciación	O
en	O
adulto	O
ratones	B-Taxon
[	O
20	O
]	O
.	O

Más	O
pruebas	O
de	O
que	O
Atrx	B-Protein
también	O
se	O
requiere	O
en	O
etapas	O
posteriores	O
de	O
ratón	B-Taxon
el	O
desarrollo	O
es	O
proporcionado	O
por	O
el	O
dramático	O
sesgo	O
observado	O
contra	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
algunos	O
tejidos	O
somáticos	O
de	O
hembras	O
portadoras	O
ratones	B-Taxon
,	O
cuyos	O
tejidos	O
forman	O
inicialmente	O
un	O
mosaico	O
de	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
como	O
resultado	O
del	O
azar	O
X	B-GENE
-	O
inactivación	O
(	O
M.	O
Muers	O
,	O
comunicación	O
personal	O
)	O
.	O

Atrx	B-Protein
se	O
une	O
a	O
una	O
lista	O
en	O
expansión	O
de	O
ratón	B-Taxon
genes	B-Sequence
para	O
los	O
cuales	O
la	O
interrupción	O
dirigida	O
resulta	O
en	O
letalidad	O
peri-implantación	O
como	O
resultado	O
de	O
anomalías	O
trofoblásticas	O
o	O
placentarias	O
(	O
revisado	O
en	O
[	O
25	O
]	O
)	O
.	O

La	O
comparación	O
con	O
otros	O
fenotipos	O
podría	O
proporcionar	O
una	O
idea	O
del	O
papel	O
de	O
Atrx	B-Protein
en	O
el	O
desarrollo	O
del	O
trofoblasto	O
.	O

Atrx	B-Protein
-	O
mutante	B-Sequence
los	O
embriones	O
progresan	O
más	O
que	O
los	O
embriones	O
nulicigóticos	O
para	O
los	O
factores	O
involucrados	O
en	O
la	O
especificación	O
inicial	O
de	O
células	B-Cell
madre	I-Cell
del	I-Cell
trofoblasto	I-Cell
(	O
tal	O
como	O
cdx2	B-Protein
)	O
o	O
en	O
célula	B-Cell
madre	I-Cell
mantenimiento	O
y	O
proliferación	O
(	O
como	O
Eomas	B-Protein
)	O
.	O

cdx2	B-Protein
-	O
mutante	B-Sequence
los	O
embriones	O
no	O
se	O
implantan	O
y	O
mueren	O
entre	O
3	O
.	O
5	O
y	O
5	O
.	O
5	O
dpc	O
[	O
26	O
]	O
,	O
mientras	O
Eomas	B-Protein
-	O
mutante	B-Sequence
los	O
blastocistos	O
se	O
implantan	O
en	O
el	O
útero	O
,	O
pero	O
se	O
detienen	O
poco	O
después	O
de	O
la	O
implantación	O
sin	O
formar	O
estructuras	O
embrionarias	O
o	O
extraembrionarias	O
organizadas	O
[	O
27	O
]	O
.	O

A	O
diferencia	O
de	O
,	O
Atrx	B-Protein
-	O
mutante	B-Sequence
los	O
embriones	O
se	O
implantan	O
con	O
éxito	O
y	O
establecen	O
estructuras	O
embrionarias	O
organizadas	O
por	O
7	O
.	O
5	O
dpc	O
.	O

los	O
Atrx	B-Protein
-	O
mutante	B-Sequence
El	O
fenotipo	O
se	O
parece	O
mucho	O
al	O
observado	O
en	O
ratones	B-Taxon
nulizigoto	O
para	O
el	O
básico	B-Chemical
hélice	B-Sequence
-	O
lazo	O
-	O
hélice	B-Sequence
factor	O
de	O
transcripcion	O
mano1	B-Protein
.	O

mano1	B-Protein
-	O
mutante	B-Sequence
los	O
conceptuses	O
se	O
detienen	O
alrededor	O
de	O
los	O
7	O
.	O
5	O
dpc	O
y	O
muestra	O
un	O
compartimento	O
embrionario	O
normal	O
,	O
pero	O
,	O
como	O
Atrx	B-Protein
-	O
mutante	B-Sequence
embriones	O
,	O
ablación	O
de	O
mano1	B-Protein
provoca	O
una	O
reducción	O
del	O
tamaño	O
del	O
cono	O
ectoplacentario	O
y	O
de	O
la	O
densidad	O
de	O
los	O
TGC	O
[	O
28	O
]	O
.	O

Al	O
igual	O
que	O
con	O
Atrx	B-Protein
mutantes	B-Sequence
,	O
solo	O
detenido	O
o	O
reabsorbido	O
mano1	B-Protein
-	O
mutante	B-Sequence
los	O
conceptuses	O
se	O
recuperaron	O
después	O
de	O
8	O
.	O
5	O
dpc	O
.	O

También	O
como	O
Atrx	B-Protein
,	O
interrupción	O
de	O
mano1	B-Protein
Afecta	O
específicamente	O
al	O
gigante	O
secundario	O
.	O
célula	B-Cell
formación	O
y	O
excrecencias	O
de	O
trofoblastos	O
primarios	O
a	O
partir	O
de	O
blastocistos	O
parecían	O
normales	O
.	O

mano1	B-Protein
se	O
requiere	O
para	O
la	O
diferenciación	O
terminal	O
de	O
TGC	O
secundarios	O
,	O
y	O
en	O
su	O
ausencia	O
células	B-Cell
trofoblásticas	I-Cell
arresto	O
en	O
una	O
etapa	O
precursora	O
en	O
el	O
cono	O
ectoplacentario	O
[	O
17	O
,	O
28	O
]	O
.	O

Dada	O
la	O
similitud	O
de	O
los	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
mano1	B-Protein
-	O
mutante	B-Sequence
fenotipos	O
y	O
la	O
probabilidad	O
de	O
que	O
Atrx	B-Protein
Actúa	O
como	O
un	O
regulador	O
transcripcional	O
modificando	O
cromatina	B-GENE
estructura	O
,	O
será	O
de	O
interés	O
determinar	O
si	O
Atrx	B-Protein
es	O
en	O
sí	O
mismo	O
un	O
regulador	O
de	O
mano1	B-Protein
expresión	O
,	O
o	O
alternativamente	O
si	O
actúa	O
como	O
un	O
co-regulador	O
de	O
uno	O
o	O
más	O
de	O
los	O
objetivos	O
transcripcionales	O
aguas	O
abajo	O
de	O
mano1	B-Protein
.	O

Cabe	O
señalar	O
que	O
,	O
en	O
el	O
cerebro	O
-	O
específico	O
Atrx	B-Protein
knockear	O
ratones	B-Taxon
,	O
el	O
defecto	O
se	O
observó	O
en	O
la	O
diferenciación	O
terminal	O
neuronas	B-Cell
[	O
20	O
]	O
.	O

Las	O
TGC	O
secundarias	O
afectadas	O
en	O
el	O
universal	O
Atrx	B-Protein
knockout	O
reportados	O
aquí	O
representan	O
uno	O
de	O
los	O
primeros	O
tejidos	O
diferenciados	O
terminalmente	O
en	O
el	O
desarrollo	O
ratón	B-Taxon
,	O
y	O
esto	O
puede	O
señalar	O
el	O
requisito	O
de	O
Atrx	B-Protein
en	O
la	O
expresión	O
de	O
alto	O
nivel	O
de	O
algunos	O
tejidos	O
-	O
específicos	O
genes	B-Sequence
durante	O
las	O
etapas	O
finales	O
de	O
diferenciación	O
.	O

Curiosamente	O
,	O
el	O
alfa-	O
globina	B-Chemical
genes	B-Sequence
,	O
los	O
únicos	O
objetivos	O
transcripcionales	O
confirmados	O
de	O
regulación	O
por	O
atrx	B-Protein
humano	I-Protein
,	O
también	O
se	O
expresan	O
altamente	O
específicamente	O
durante	O
la	O
diferenciación	O
terminal	O
dentro	O
del	O
linaje	O
eritroide	O
.	O

Atrx	B-Protein
Escapes	O
impresos	O
X	B-GENE
#	O
¿NOMBRE	O
?	O
Ratones	B-Taxon

Otro	O
hallazgo	O
sorprendente	O
de	O
este	O
estudio	O
es	O
que	O
,	O
en	O
los	O
embriones	O
femeninos	O
portadores	O
,	O
un	O
AtrxWT	O
heredado	O
por	O
vía	O
paterna	O
alelo	B-Sequence
parece	O
escapar	O
del	O
proceso	O
de	O
impresión	O
X	B-GENE
-	O
inactivación	O
,	O
que	O
normalmente	O
silencia	O
el	O
Xp	O
cromosoma	B-GENE
en	O
el	O
compartimento	O
extraembrionario	O
de	O
la	O
hembra	O
murino	B-Taxon
tejidos	O
[	O
18	O
]	O
.	O

Silenciamiento	O
del	O
AtrxWT	O
alelo	B-Sequence
en	O
Xp	O
debería	O
hacer	O
que	O
estas	O
hembras	O
sean	O
nulas	O
para	O
Atrx	B-Protein
en	O
los	O
tejidos	O
extraembrionarios	O
,	O
ya	O
que	O
el	O
Xm	O
normalmente	O
activo	O
cromosoma	B-GENE
lleva	O
el	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
alelo	B-Sequence
.	O

Aunque	O
no	O
es	O
fenotípicamente	O
normal	O
,	O
algunos	O
Atrx	B-Protein
las	O
hembras	O
portadoras	O
se	O
desarrollaron	O
a	O
término	O
y	O
luego	O
se	O
reprodujeron	O
.	O

Por	O
lo	O
tanto	O
,	O
la	O
falla	O
en	O
silenciar	O
correctamente	O
el	O
AtrxWT	O
derivado	O
paternamente	O
alelo	B-Sequence
en	O
los	O
tejidos	O
extraembrionarios	O
de	O
las	O
hembras	O
portadoras	O
es	O
consistente	O
con	O
nuestras	O
observaciones	O
de	O
que	O
en	O
los	O
machos	O
Atrxnull	O
,	O
el	O
Atrx	B-Protein
proteína	B-Chemical
juega	O
un	O
papel	O
esencial	O
en	O
el	O
desarrollo	O
del	O
trofoblasto	O
y	O
es	O
necesario	O
para	O
la	O
supervivencia	O
en	O
el	O
útero	O
en	O
el	O
ratón	B-Taxon
.	O

la	O
supervivencia	O
de	O
Atrx	B-Protein
hembras	O
portadoras	O
contrasta	O
con	O
los	O
fenotipos	O
observados	O
en	O
portadoras	O
de	O
mutaciones	B-Sequence
de	O
otro	O
murino	B-Taxon
X	B-GENE
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
Se	O
sabe	O
que	O
es	O
esencial	O
en	O
el	O
compartimento	O
extraembrionario	O
.	O

Por	O
ejemplo	O
,	O
la	O
interrupción	O
dirigida	O
de	O
la	O
disquerina	B-Protein
(	O
Dkc1	B-Protein
)	O
,	O
glucosa	B-Protein
6	I-Protein
-	I-Protein
fosfato	I-Protein
deshidrogenasa	I-Protein
(	O
G6PD	B-Protein
)	O
,	O
y	O
coroideremia	B-Protein
(	O
Chm	B-Protein
)	O
genes	B-Sequence
causar	O
letalidad	O
embrionaria	O
en	O
embriones	O
masculinos	O
nulos	O
a	O
través	O
de	O
defectos	O
de	O
los	O
tejidos	O
derivados	O
del	O
extraembrionario	O
[	O
29	O
-	O
31	O
]	O
.	O

Mujer	O
ratones	B-Taxon
que	O
lleva	O
mutaciones	B-Sequence
de	O
estos	O
genes	B-Sequence
en	O
la	O
herencia	O
materna	O
cromosoma	B-GENE
X	I-GENE
también	O
mueren	O
en	O
el	O
útero	O
,	O
mientras	O
que	O
las	O
hembras	O
que	O
heredan	O
el	O
mutación	B-Sequence
en	O
el	O
XP	O
cromosoma	B-GENE
sobrevivir	O
.	O

Así	O
,	O
a	O
diferencia	O
de	O
Atrx	B-Protein
,	O
estas	O
genes	B-Sequence
y/o	O
sus	O
efectos	O
sobre	O
célula	B-Cell
crecimiento	O
son	O
incapaces	O
de	O
eludir	O
los	O
procesos	O
que	O
en	O
última	O
instancia	O
causan	O
todos	O
células	B-Cell
en	I-Cell
los	I-Cell
tejidos	I-Cell
extraembrionarios	I-Cell
para	O
expresar	O
sólo	O
el	O
derivado	O
materno	O
cromosoma	B-GENE
X	I-GENE
.	O

¿Cómo	O
podría	O
la	O
expresión	O
del	O
AtrxWT	O
paterno	O
alelo	B-Sequence
mantenerse	O
en	O
los	O
tejidos	O
extraembrionarios	O
del	O
Atrx	B-Protein
hembras	O
portadoras	O
?	O

Una	O
posibilidad	O
es	O
que	O
,	O
como	O
algunos	O
otros	O
X	B-GENE
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
,	O
silenciamiento	O
de	O
la	O
Atrx	B-Protein
gene	B-Sequence
en	O
Xp	O
está	O
incompleto	O
,	O
de	O
modo	O
que	O
siempre	O
hay	O
una	O
salida	O
de	O
bajo	O
nivel	O
y	O
con	O
fugas	O
de	O
Atrx	B-Protein
de	O
un	O
Xp	O
normalmente	O
inactivo	O
cromosoma	B-GENE
en	O
tejidos	O
extraembrionarios	O
.	O

Sin	O
embargo	O
,	O
recientemente	O
se	O
demostró	O
que	O
la	O
paternidad	O
Atrx	B-Protein
(	O
llamado	O
Xnp	O
)	O
alelo	B-Sequence
está	O
completamente	O
silenciado	O
en	O
un	O
ambiente	O
normal	O
ratón	B-Taxon
célula	B-Cell
madre	I-Cell
del	I-Cell
trofoblasto	I-Cell
línea	O
[	O
32	O
]	O
,	O
sugiriendo	O
que	O
Atrx	B-Protein
normalmente	O
no	O
escapa	O
impreso	O
X	B-GENE
#	O
¿NOMBRE	O
?	O
tipo	B-Sequence
salvaje	I-Sequence
hembras	O

Así	O
,	O
la	O
expresión	O
del	O
AtrxWT	O
ligado	O
a	O
Xp	O
alelo	B-Sequence
que	O
observamos	O
es	O
exclusivo	O
de	O
las	O
mujeres	O
portadoras	O
de	O
Atrxnull	O
alelo	B-Sequence
.	O

Tal	O
vez	O
una	O
explicación	O
más	O
probable	O
para	O
este	O
fenómeno	O
se	O
deriva	O
de	O
las	O
observaciones	O
experimentales	O
que	O
sugieren	O
que	O
impreso	O
X	B-GENE
#	O
¿NOMBRE	O
?	O
ratón	B-Taxon
tejidos	O
extraembrionarios	O
:	O
una	O
subpoblación	O
de	O
células	B-Cell
``	O
puede	O
escapar	O
de	O
este	O
proceso	O
y	O
hacer	O
una	O
``	O
''	O
elección	O
''	O
''	O
aleatoria	O
de	O
cuál	O
''	O
cromosoma	B-GENE
X	I-GENE
se	O
desactivará	O
.	O

En	O
promedio	O
,	O
el	O
50	O
%	O
de	O
los	O
células	B-Cell
en	O
esta	O
subpoblación	O
que	O
se	O
desactiva	O
aleatoriamente	O
se	O
esperaría	O
que	O
mantuviera	O
un	O
Xp	O
activo	O
cromosoma	B-GENE
.	O

En	O
apoyo	O
de	O
esta	O
hipótesis	O
,	O
se	O
ha	O
demostrado	O
que	O
la	O
expresión	O
de	O
transmisión	O
paterna	O
X	B-GENE
-	O
lacZ	O
vinculado	O
[	O
33	O
,	O
34	O
]	O
y	O
GFP	O
[	O
35	O
]	O
transgenes	B-Sequence
no	O
pudo	O
ser	O
silenciado	O
en	O
una	O
pequeña	O
subpoblación	O
de	O
células	B-Cell
extraembrionarias	I-Cell
.	O

Además	O
,	O
se	O
ha	O
demostrado	O
que	O
en	O
una	O
subpoblación	O
de	O
células	B-Cell
extraembrionarias	I-Cell
,	O
es	O
el	O
Xm	O
en	O
lugar	O
del	O
Xp	O
el	O
que	O
experimenta	O
una	O
replicación	O
tardía	O
,	O
una	O
molecular	B-Chemical
correlato	O
del	O
estado	O
inactivo	O
[	O
18	O
,	O
36	O
]	O
.	O

Aunque	O
inicialmente	O
pequeño	O
y	O
rápidamente	O
diluido	O
en	O
embriones	O
normales	O
,	O
el	O
celular	B-Cell
subpoblación	O
que	O
inactiva	O
el	O
Xm	O
cromosoma	B-GENE
podría	O
expandirse	O
rápidamente	O
para	O
reemplazar	O
el	O
normalmente	O
impreso	O
células	B-Cell
en	O
linajes	O
extraembrionarios	O
si	O
el	O
silenciamiento	O
normal	O
de	O
Xp	O
compromete	O
célula	B-Cell
crecimiento	O
o	O
diferenciación	O
.	O

Curiosamente	O
,	O
se	O
ha	O
sugerido	O
que	O
el	O
tamaño	O
de	O
la	O
población	O
que	O
inicialmente	O
escapa	O
a	O
la	O
impronta	O
puede	O
variar	O
ampliamente	O
(	O
de	O
0	O
%	O
a	O
30	O
%	O
)	O
,	O
incluso	O
entre	O
genéticamente	B-Sequence
embriones	O
idénticos	O
[	O
37	O
]	O
,	O
y	O
esto	O
puede	O
explicar	O
el	O
fenotipo	O
variable	O
observado	O
entre	O
las	O
hembras	O
que	O
tienen	O
ligado	O
a	O
Xm	O
alelos	B-Sequence
mutantes	I-Sequence
de	O
genes	B-Sequence
esencial	O
para	O
el	O
desarrollo	O
extraembrionario	O
normal	O
[	O
38	O
]	O
.	O

En	O
pocas	O
palabras	O
,	O
las	O
hembras	O
portadoras	O
con	O
una	O
pequeña	O
población	O
inicial	O
de	O
células	B-Cell
se	O
verían	O
más	O
gravemente	O
afectados	O
que	O
los	O
que	O
tienen	O
una	O
población	O
más	O
grande	O
.	O

Esto	O
podría	O
explicar	O
por	O
qué	O
hemos	O
observado	O
una	O
variación	O
fenotípica	O
significativa	O
entre	O
Atrx	B-Protein
hembras	O
portadoras	O
,	O
y	O
algunas	O
portadoras	O
mueren	O
en	O
el	O
útero	O
a	O
los	O
9	O
.	O
5	O
dpc	O
(	O
Cuadro	O
1	O
)	O
y	O
otros	O
en	O
desarrollo	O
a	O
término	O
.	O

Otro	O
posible	O
mecanismo	O
es	O
que	O
la	O
inactivación	O
del	O
sistema	O
paterno	O
X	B-GENE
transcurre	O
normalmente	O
en	O
todos	O
células	B-Cell
,	O
pero	O
posteriormente	O
la	O
Atrx	B-Protein
gene	B-Sequence
dentro	O
del	O
individuo	O
células	B-Cell
se	O
reactiva	O
.	O

Alternativamente	O
,	O
en	O
ausencia	O
de	O
Atrx	B-Protein
,	O
el	O
paterno	O
alelo	B-Sequence
puede	O
escapar	O
parcialmente	O
al	O
proceso	O
normal	O
de	O
silenciamiento	O
.	O

En	O
ambos	O
casos	O
,	O
otros	O
genes	B-Sequence
en	O
el	O
paterno	O
cromosoma	B-GENE
X	I-GENE
debe	O
ser	O
inactivado	O
y	O
permanecer	O
así	O
,	O
ya	O
que	O
bloquea	O
la	O
inactivación	O
de	O
todo	O
el	O
Xp	O
cromosoma	B-GENE
causa	O
letalidad	O
embrionaria	O
debido	O
a	O
la	O
expresión	O
bialélica	O
de	O
X	B-GENE
#	O
¿NOMBRE	O
?	O
genes	B-Sequence
en	O
el	O
trofoblasto	O
[	O
39	O
]	O
.	O

Resumen	O

ATR-	O
X	B-GENE
el	O
sindrome	O
es	O
el	O
primero	O
humano	B-Taxon
genético	B-Sequence
enfermedad	O
que	O
se	O
sabe	O
que	O
es	O
causada	O
por	O
mutaciones	B-Sequence
en	O
un	O
cromatina	B-GENE
factor	O
de	O
remodelación	O
.	O

Actualmente	O
no	O
sabemos	O
cómo	O
ATRX	B-Protein
influencias	O
gene	B-Sequence
expresión	O
o	O
qué	O
efecto	O
tiene	O
sobre	O
célula	B-Cell
conducta	O
.	O

Sin	O
embargo	O
,	O
hemos	O
señalado	O
anteriormente	O
que	O
ninguno	O
de	O
los	O
mutaciones	B-Sequence
naturales	I-Sequence
causando	O
ATR	O
-	O
X	B-GENE
síndrome	O
son	O
nulos	O
,	O
lo	O
que	O
sugiere	O
que	O
juega	O
un	O
papel	O
crítico	O
en	O
el	O
desarrollo	O
normal	O
.	O

Resultados	O
de	O
la	O
inactivación	O
condicional	O
de	O
Atrx	B-Protein
en	O
desarrollo	O
ratón	B-Taxon
cerebro	O
anterior	O
,	O
basado	O
en	O
el	O
Atrxflox	O
alelo	B-Sequence
descrito	O
aquí	O
,	O
muestra	O
que	O
Atrx	B-Protein
ejerce	O
un	O
efecto	O
importante	O
en	O
la	O
diferenciación	O
terminal	O
neuronas	B-Cell
.	O

Inactivación	O
condicional	O
de	O
Atrx	B-Protein
en	O
otros	O
tejidos	O
está	O
en	O
marcha	O
.	O

Aquí	O
hemos	O
demostrado	O
que	O
animal	B-Taxon
#	O
¿NOMBRE	O
?	O
Atrx	B-Protein
gene	B-Sequence
provoca	O
un	O
fenotipo	O
grave	O
embrionario	O
-	O
letal	O
,	O
revelando	O
un	O
papel	O
esencial	O
para	O
Atrx	B-Protein
en	O
la	O
formación	O
de	O
la	O
murino	B-Taxon
trofoblasto	O

Además	O
,	O
Atrx	B-Protein
parece	O
escapar	O
impreso	O
X	B-GENE
-	I-GENE
cromosoma	I-GENE
inactivación	O
en	O
los	O
tejidos	O
extraembrionarios	O
de	O
algunas	O
hembras	O
portadoras	O
ratones	B-Taxon
.	O

Materiales	O
y	O
métodos	O

Generación	O
de	O
ES	O
células	B-Cell
teniendo	O
el	O
Atrxflox	O
alelo	B-Sequence
.	O

Brevemente	O
,	O
la	O
orientación	O
vector	B-Sequence
(	O
que	O
se	O
muestra	O
en	O
la	O
Figura	O
2A	O
)	O
coloca	O
un	O
sitio	B-Sequence
loxP	I-Sequence
dentro	O
de	O
intrón	B-Sequence
18	O
y	O
un	O
loxP	B-Sequence
-	I-Sequence
flanqueado	I-Sequence
Selección	O
MC1neopA	O
casete	B-Sequence
en	O
intrón	B-Sequence
17	O
de	O
los	O
Atrx	B-Protein
gene	B-Sequence
.	O

Una	O
descripción	O
detallada	O
de	O
la	O
segmentación	O
.	O
construir	B-Sequence
se	O
proporciona	O
en	O
[	O
20	O
]	O
.	O

linealizado	O
plásmido	B-Sequence
(	O
150	O
mu	O
g	O
)	O
se	O
sometió	O
a	O
electroporación	O
en	O
1	O
x	O
108	O
E14Tg2a	O
ES	O
células	B-Cell
y	O
se	O
aislaron	O
colonias	O
resistentes	O
a	O
G418	O
y	O
ganciclovir	O
.	O

Los	O
eventos	O
de	O
direccionamiento	O
homólogos	O
fueron	O
identificados	O
por	O
Southern	O
blot	O
de	O
EcoRI	O
-	O
digeridos	O
ADN	B-Sequence
e	O
hibridación	O
con	O
un	O
5	O
'	O
Investigacion	B-Sequence
(	O
generado	O
con	O
cebadores	B-Sequence
PPS1	O
.	O
20	O
y	O
PPS1	O
.	O
27	O
)	O
y	O
un	O
3	O
'	O
Investigacion	B-Sequence
(	O
a	O
0	O
.	O
9	O
-	O
kb	O
HaeIII	O
fragmento	B-Sequence
)	O
como	O
se	O
muestra	O
en	O
la	O
Figura	O
2A	O
y	O
2B	O
.	O

ADN	B-Sequence
de	O
clones	O
dirigidos	O
correctamente	O
también	O
se	O
digirió	O
con	O
SacI	O
y	O
se	O
analizó	O
mediante	O
transferencia	O
Southern	O
e	O
hibridación	O
con	O
un	O
Investigacion	B-Sequence
desde	O
dentro	O
intrón	B-Sequence
17	O
(	O
un	O
producto	B-Sequence
PCR	I-Sequence
generado	O
con	O
cebadores	B-Sequence
PPS1	O
.	O
15	O
y	O
Xnp46	O
)	O
para	O
confirmar	O
que	O
el	O
sitio	B-Sequence
loxP	I-Sequence
dentro	O
de	O
intrón	B-Sequence
18	O
habían	O
sido	O
incluidos	O
dentro	O
del	O
cross-over	O
región	B-Sequence
(	O
Figura	O
2A	O
y	O
2C	O
)	O
.	O

Secuencias	B-Sequence
de	O
cebadores	B-Sequence
se	O
muestran	O
en	O
la	O
Tabla	O
S1	O
.	O

Cre	O
-	O
recombinación	O
y	O
caracterización	O
de	O
Atrxnull	O
ES	O
células	B-Cell
y	O
cuerpos	O
embrioides	O
.	O

ES	O
célula	B-Cell
clones	O
que	O
llevan	O
el	O
Atrxflox	O
alelo	B-Sequence
(	O
1x107	O
células	B-Cell
)	O
se	O
transfectaron	O
transitoriamente	O
con	O
50	O
µg	O
de	O
expresión	O
de	O
Cre	O
sin	O
cortar	O
plásmido	B-Sequence
(	O
pCAGGS	O
-	O
Cre	O
-	O
IRESpuro	O
)	O
[	O
40	O
]	O
.	O

Después	O
de	O
la	O
transfección	O
,	O
células	B-Cell
se	O
sembraron	O
en	O
placas	O
en	O
un	O
rango	O
de	O
densidades	O
clonales	O
en	O
medio	O
completo	O
sin	O
G418	O
,	O
y	O
los	O
subclones	O
aislados	O
se	O
recogieron	O
después	O
de	O
7	O
días	O
.	O

Los	O
subclones	O
se	O
expandieron	O
y	O
analizaron	O
para	O
detectar	O
la	O
presencia	O
de	O
un	O
recombinante	O
lugar	B-Sequence
inicialmente	O
por	O
PCR	O
,	O
para	O
detectar	O
supresión	B-Sequence
del	O
MC1neopA	O
casete	B-Sequence
y	O
luego	O
por	O
Southern	O
blot	O
e	O
hibridación	O
con	O
el	O
intrón	B-Sequence
17	O
Investigacion	B-Sequence
descrito	O
anteriormente	O
(	O
Figura	O
2A	O
y	O
2C	O
)	O
.	O

Las	O
transferencias	O
Northern	O
se	O
llevaron	O
a	O
cabo	O
de	O
acuerdo	O
con	O
técnicas	O
estándar	O
usando	O
20	O
µg	O
de	O
total	O
ARN	B-Sequence
aislado	O
usando	O
TRI	O
Reactivo	B-Chemical
(	O
Sigma-Aldrich	O
,	O
St.	O
Louis	O
,	O
Missouri	O
,	O
Estados	O
Unidos	O
)	O
.	O

El	O
blot	O
se	O
hibridó	O
con	O
un	O
Investigacion	B-Sequence
desde	O
dentro	O
exón	B-Sequence
10	O
de	O
los	O
Atrx	B-Protein
gene	B-Sequence
(	O
generado	O
con	O
cebadores	B-Sequence
Mxnp4	O
y	O
Mxnp28	O
[	O
Tabla	O
S1	O
]	O
)	O
.	O

Después	O
de	O
despojarla	O
,	O
la	O
membrana	O
se	O
hibridó	O
con	O
una	O
beta	B-Protein
-	I-Protein
actina	I-Protein
sonda	B-Sequence
de	I-Sequence
ADNc	I-Sequence
(	O
Clontech	O
,	O
Palo	O
Alto	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
.	O

Proteína	B-Chemical
extracción	O
y	O
detección	O
de	O
Atrx	B-Protein
por	O
Western	O
Blot	O
se	O
realizó	O
como	O
se	O
describió	O
anteriormente	O
[	O
4	O
]	O
,	O
utilizando	O
el	O
ratón	B-Taxon
anti	O
monoclonal	O
-	O
ATRX	B-Protein
anticuerpo	B-GENE
23C	O
[	O
15	O
]	O
.	O

Análisis	O
de	O
célula	B-Cell
El	O
ciclo	O
y	O
la	O
apoptosis	O
se	O
describen	O
en	O
el	O
Protocolo	O
S1	O
.	O

La	O
metilación	O
del	O
ADNr	O
se	O
analizó	O
en	O
ADN	B-Sequence
de	O
ES	O
célula	B-Cell
clones	O
o	O
de	O
cuerpos	O
embrioides	O
recuperados	O
después	O
de	O
7	O
días	O
de	O
diferenciación	O
in	O
vitro	O
como	O
se	O
describe	O
anteriormente	O
[	O
41	O
]	O
.	O

ADN	B-Sequence
genómico	I-Sequence
fue	O
digerido	O
con	O
metilación	O
-	O
restricción	O
sensible	O
enzimas	B-Sequence
como	O
se	O
describe	O
y	O
analiza	O
mediante	O
transferencia	O
de	O
Southern	O
.	O

RIB3	O
y	O
RIB4	O
sondas	B-Sequence
(	O
que	O
fueron	O
amplificados	O
de	O
humano	B-Taxon
ADN	B-Sequence
,	O
pero	O
reaccionar	O
de	O
forma	O
cruzada	O
con	O
el	O
ratón	B-Taxon
ADNr	O
repetir	B-Sequence
)	O
se	O
han	O
descrito	O
previamente	O
[	O
11	O
]	O
.	O

Sondas	B-Sequence
de	I-Sequence
oligonucleótidos	I-Sequence
para	O
detectar	O
la	O
Línea	O
1	O
y	O
el	O
Seno	O
B1	O
repite	B-Sequence
se	O
han	O
descrito	O
previamente	O
[	O
42	O
]	O
.	O

el	O
menor	O
sonda	B-Sequence
satelital	I-Sequence
era	O
un	O
27	O
-	O
mer	O
oligonucleótido	B-Sequence
(	O
mCENT2	O
)	O
.	O

El	O
mayor	O
sonda	B-Sequence
satelital	I-Sequence
era	O
un	O
27	O
-	O
mer	O
oligonucleótido	B-Sequence
(	O
DG27	O
)	O
.	O

el	O
PAI	O
Investigacion	B-Sequence
era	O
un	O
~	O
400	O
producto	B-Sequence
de	I-Sequence
PCR	I-Sequence
pb	I-Sequence
(	O
cebadores	B-Sequence
14A	O
y	O
13K	O
)	O
amplificados	O
desde	O
un	O
IAP	O
insertado	B-Sequence
en	O
el	O
agutí	B-Protein
de	I-Protein
ratón	I-Protein
gene	B-Sequence
[	O
43	O
]	O
y	O
fue	O
un	O
regalo	O
de	O
Peter	O
Warnecke	O
y	O
Tim	O
Bestor	O
.	O

los	O
producto	B-Sequence
PCR	I-Sequence
incluido	O
todo	O
el	O
5	B-Sequence
'	I-Sequence
litros	I-Sequence
de	O
la	O
IAP	O
.	O

Todos	O
secuencias	B-Sequence
de	I-Sequence
oligonucleótidos	I-Sequence
se	O
muestran	O
en	O
la	O
Tabla	O
S1	O
.	O

Generación	O
de	O
quimeras	O
,	O
flojo	B-Sequence
ratones	B-Taxon
,	O
y	O
mutante	B-Sequence
ratones	B-Taxon
.	O

Atrxflox	O
ES	O
dirigido	O
célula	B-Cell
los	O
clones	O
se	O
inyectaron	O
en	O
blastocistos	O
C57BL	O
/	O
6	O
y	O
se	O
transfirieron	O
a	O
2	O
.	O
Receptoras	O
pseudoembarazadas	O
de	O
5	O
dpc	O
mediante	O
técnicas	O
estándar	O
.	O

Las	O
quimeras	O
resultantes	O
se	O
cruzaron	O
con	O
C57BL/6	O
para	O
establecer	O
la	O
transmisión	O
de	O
la	O
línea	O
germinal	O
.	O

Descendencia	O
con	O
el	O
Atrxflox	O
alelo	B-Sequence
fueron	O
identificados	O
por	O
transferencia	O
de	O
Southern	O
de	O
SacI	O
-	O
cola	O
digerida	O
ADN	B-Sequence
utilizando	O
el	O
intrón	B-Sequence
17	O
Investigacion	B-Sequence
como	O
se	O
muestra	O
en	O
la	O
figura	O
2A	O
y	O
2C	O
.	O

Para	O
la	O
recombinación	O
Cre	O
,	O
Atrxflox	O
ratones	B-Taxon
se	O
cruzaron	O
con	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
como	O
se	O
describe	O
en	O
el	O
texto	O
.	O

recombinante	O
alelos	B-Sequence
fueron	O
detectados	O
por	O
transferencia	O
de	O
Southern	O
como	O
se	O
describe	O
anteriormente	O
o	O
por	O
PCR	O
como	O
se	O
describe	O
en	O
el	O
Protocolo	O
S1	O
.	O

Inmunohistoquímica	O
,	O
hibridación	O
in	O
situ	O
y	O
ensayo	O
TUNEL	O
.	O

7	O
.	O
Se	O
disecaron	O
hinchazones	O
deciduales	O
de	O
5	O
dpc	O
del	O
tejido	O
materno	O
y	O
se	O
fijaron	O
en	O
paraformaldehído	O
al	O
4	O
%	O
/PBS	O
durante	O
la	O
noche	O
a	O
4	O
grados	O
C	O
.	O

Después	O
de	O
lavar	O
completamente	O
los	O
embriones	O
en	O
PBS	O
,	O
se	O
deshidrataron	O
a	O
través	O
de	O
un	O
etanol	B-Chemical
serie	O
y	O
xileno	B-Chemical
,	O
incluido	O
en	O
parafina	O
,	O
y	O
seccionado	O
a	O
5	O
mu	O
m	O
.	O

Las	O
secciones	O
se	O
procesaron	O
para	O
inmunohistoquímica	O
utilizando	O
el	O
sistema	O
de	O
tinción	O
ABC	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Santa	O
Cruz	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
de	O
acuerdo	O
con	O
las	O
instrucciones	O
del	O
fabricante	O
.	O

Las	O
secciones	O
se	O
tiñeron	O
con	O
Conejo	B-Taxon
policlonal	O
anticuerpos	B-GENE
en	O
contra	O
ATRX	B-Protein
(	O
H	O
-	O
300	O
,	O
Santa	O
Cruz	O
Biotecnología	O
)	O
,	O
Lactógeno	B-Protein
placentario	I-Protein
-	I-Protein
I	I-Protein
(	O
AB1288	O
,	O
Chemicon	O
International	O
,	O
Temecula	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
y	O
fosfo	B-Chemical
(	O
Ser10	O
)	O
-	O
histona	B-Chemical
H3	O
(	O
06-570	O
,	O
Upstate	O
Biotechnology	O
,	O
Waltham	O
,	O
Massachusetts	O
,	O
Estados	O
Unidos	O
)	O
.	O

En	O
su	O
caso	O
,	O
las	O
secciones	O
adyacentes	O
se	O
tiñeron	O
con	O
hematoxilina	O
.	O

En	O
algunos	O
casos	O
,	O
también	O
se	O
analizaron	O
secciones	O
adyacentes	O
para	O
detectar	O
células	B-Cell
apoptóticas	I-Cell
por	O
TUNEL	O
utilizando	O
el	O
in	O
situ	O
célula	B-Cell
kit	O
de	O
detección	O
de	O
muertes	O
(	O
Roche	O
,	O
Basilea	O
,	O
Suiza	O
)	O
.	O

Después	O
del	O
etiquetado	O
,	O
estos	O
portaobjetos	O
se	O
montaron	O
en	O
Vectashield	O
que	O
contenía	O
DAPI	O
(	O
Vector	B-Sequence
Laboratories	O
,	O
Burlingame	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
y	O
visualizados	O
por	O
microscopía	O
de	O
fluorescencia	O
.	O

Se	O
realizaron	O
hibridaciones	O
in	O
situ	O
de	O
montaje	O
completo	O
en	O
8	O
.	O
Embriones	O
de	O
5	O
dpc	O
(	O
diseccionados	O
de	O
los	O
tejidos	O
maternos	O
y	O
extraembrionarios	O
)	O
utilizando	O
un	O
braquiuria	B-Protein
(	O
T	B-Protein
)	O
ribosonda	O
[	O
16	O
]	O
y	O
en	O
sitios	O
de	O
implantación	O
decidual	O
bisectados	O
de	O
los	O
cuales	O
se	O
extrajeron	O
embriones	O
(	O
8	O
.	O
5	O
dpc	O
)	O
utilizando	O
un	O
lactógeno	B-Protein
placentario	I-Protein
-	I-Protein
1	I-Protein
(	O
pl	B-Protein
-	I-Protein
1	I-Protein
)	O
ribosonda	O
(	O
ver	O
Protocolo	O
S1	O
para	O
más	O
detalles	O
)	O
.	O

Cultivos	O
de	O
excrecencias	O
de	O
blastocistos	O
.	O

Hembra	O
heterocigota	O
superovulada	O
ratones	B-Taxon
(	O
AtrxWT	O
/	O
flox	B-Sequence
)	O
fueron	O
apareados	O
con	O
homocigotos	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
#	B-Sequence
¿NOMBRE	I-Sequence
?	I-Sequence
machos	O
,	O
y	O
los	O
blastocistos	O
se	O
lavaron	O
de	O
los	O
cuernos	O
uterinos	O
con	O
medio	O
M2	O
(	O
Sigma	O
)	O
a	O
las	O
3	O
.	O
5	O
dpc	O
.	O

Los	O
blastocistos	O
individuales	O
se	O
cultivaron	O
en	O
placas	O
de	O
cultivo	O
de	O
tejidos	O
de	O
varios	O
pocillos	O
como	O
se	O
ha	O
descrito	O
anteriormente	O
[	O
44	O
]	O
.	O

Los	O
cultivos	O
se	O
inspeccionaron	O
y	O
fotografiaron	O
diariamente	O
y	O
se	O
anotó	O
la	O
extensión	O
del	O
crecimiento	O
.	O

Después	O
de	O
7	O
días	O
,	O
los	O
cultivos	O
fueron	O
cosechados	O
y	O
ADN	B-Sequence
extraído	O

los	O
Atrx	B-Protein
genotipo	B-Sequence
y	O
el	O
sexo	O
de	O
cada	O
cultivo	O
se	O
determinó	O
por	O
PCR	O
como	O
se	O
describe	O
en	O
el	O
Protocolo	O
S1	O
.	O

información	O
de	O
soporte	O

Figura	O
S1	O

Célula	B-Cell
Análisis	O
de	O
ciclo	O
de	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
Células	B-Cell

(	O
A	O
)	O
Perfiles	O
FACS	O
representativos	O
de	O
BrdU	O
-	O
ES	O
pulsado	O
células	B-Cell
cojinete	O
funcional	O
(	O
AtrxWT	O
o	O
Atrxflox	O
)	O
o	O
nulo	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
Atrx	B-Protein
alelos	B-Sequence
mostrando	O
BrdU	O
-	O
FITC	B-Chemical
(	O
eje	O
y	O
,	O
escala	O
logarítmica	O
)	O
contra	O
propidio	O
yoduro	B-Chemical
(	O
eje	O
x	O
,	O
escala	O
lineal	O
)	O
.	O

Las	O
poblaciones	O
cerradas	O
muestran	O
células	B-Cell
en	O
las	O
fases	O
G1	O
(	O
PIlow	O
,	O
BrdU	O
-	O
negativo	O
)	O
(	O
R1	O
)	O
,	O
S	O
(	O
BrdU	O
-	O
positivo	O
)	O
(	O
R2	O
)	O
y	O
G2	O
/	O
M	O
(	O
PIhi	O
,	O
BrdU	O
-	O
negativo	O
)	O
(	O
R3	O
)	O
del	O
célula	B-Cell
ciclo	O

continuación	O
se	O
muestra	O
la	O
cuantificación	O
de	O
las	O
poblaciones	O
cerradas	O
,	O
indicando	O
el	O
porcentaje	O
de	O
células	B-Cell
en	O
G1	O
,	O
S	O
y	O
G2/M	O
célula	B-Cell
#	O
¿NOMBRE	O
?	O

(	O
B	O
)	O
Perfiles	O
FACS	O
de	O
ES	O
células	B-Cell
cojinete	O
funcional	O
(	O
AtrxWT	O
o	O
Atrxflox	O
)	O
o	O
nulo	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
Atrx	B-Protein
alelos	B-Sequence
teñido	O
para	O
el	O
marcador	O
de	O
mitosis	O
fosforilado	O
(	O
Ser10	O
)	O
histona	B-Chemical
H3	O
(	O
FITC	B-Chemical
,	O
eje	O
y	O
,	O
escala	O
logarítmica	O
)	O
contra	O
propidio	O
yoduro	B-Chemical
(	O
eje	O
x	O
,	O
escala	O
lineal	O
)	O
.	O

El	O
tamaño	O
de	O
la	O
población	O
mitótica	O
(	O
fosfoH3S10-positivo	O
,	O
PIhi	O
)	O
(	O
puerta	O
R3	O
)	O
se	O
indica	O
para	O
cada	O
perfil	O
.	O

el	O
ES	O
célula	B-Cell
Se	O
indica	O
el	O
clon	O
analizado	O
en	O
cada	O
traza	O
.	O

(	O
3	O
.	O
PDF	O
de	O
2	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S2	O

Análisis	O
de	O
Apoptosis	O
en	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
Células	B-Cell

Análisis	O
FACS	O
de	O
ES	O
células	B-Cell
teniendo	O
diferentes	O
Atrx	B-Protein
alelos	B-Sequence
como	O
se	O
muestra	O
,	O
después	O
de	O
costaining	O
para	O
Anexina	B-Protein
V	I-Protein
(	O
FITC	O
,	O
eje	O
x	O
,	O
escala	O
logarítmica	O
)	O
y	O
propidio	O
yoduro	B-Chemical
(	O
eje	O
y	O
,	O
escala	O
logarítmica	O
)	O
.	O

El	O
tamaño	O
de	O
la	O
apoptosis	O
temprana	O
(	O
Anexina	B-Protein
-	O
positivo	O
,	O
PIlow	O
)	O
y	O
apoptótico	O
tardío	O
o	O
necrótico	O
(	O
Anexina	B-Protein
-	O
positivo	O
,	O
PIhi	O
)	O
poblaciones	O
se	O
indica	O
para	O
cada	O
genotipo	B-Sequence
.	O

(	O
PDF	O
de	O
223	O
KB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S3	O

Normal	O
ADN	B-Sequence
Metilación	O
en	O
Ratón	B-Taxon
Elementos	B-Sequence
repetitivos	I-Sequence
en	O
Atrxnull	O
ES	O
Células	B-Cell

ADN	B-Sequence
desde	O
Atrx	B-Protein
positivo	O
(	O
con	O
un	O
AtrxWT	O
o	O
Atrxflox	O
alelo	B-Sequence
)	O
o	O
Atrxnull	O
(	O
con	O
el	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
alelo	B-Sequence
)	O
ES	O
células	B-Cell
fue	O
digerido	O
con	O
un	O
CpG	O
-	O
metilación	O
-	O
sensible	O
enzima	B-Sequence
HpaII	O
(	O
H	O
)	O
o	O
su	O
isoesquizomero	O
insensible	O
a	O
la	O
metilación	O
MspI	O
(	O
M	O
)	O
como	O
se	O
indica	O
,	O
y	O
digerido	O
ADN	B-Sequence
fue	O
analizado	O
por	O
transferencia	O
de	O
Southern	O
.	O

Las	O
membranas	O
se	O
hibridaron	O
con	O
sondas	B-Sequence
específico	O
para	O
el	O
ratón	B-Taxon
Línea	O
1	O
(	O
A	O
)	O
,	O
Seno	O
B1	O
(	O
B	O
)	O
,	O
menor	O
satélite	B-Sequence
(	O
C	O
)	O
y	O
PAI	O
(	O
D	O
)	O
repetir	B-Sequence
elementos	I-Sequence
.	O

No	O
se	O
observó	O
una	O
pérdida	O
significativa	O
de	O
CpG	O
-	O
metilación	O
en	O
ninguno	O
de	O
estos	O
elementos	B-Sequence
repetitivos	I-Sequence
en	O
Atrxnull	O
ES	O
células	B-Cell
.	O

Como	O
control	O
positivo	O
para	O
la	O
pérdida	O
de	O
metilación	O
,	O
ADN	B-Sequence
de	O
ES	O
células	B-Cell
careciendo	O
ya	O
sea	O
del	O
Dnmt1	B-Protein
(	I-Protein
Dnmt1	I-Protein
-	I-Protein
/	I-Protein
-	I-Protein
)	I-Protein
o	I-Protein
las	I-Protein
ADN	I-Protein
metiltransferasas	I-Protein
Dnmt3a	I-Protein
y	I-Protein
Dnmt3b	I-Protein
(	I-Protein
Dnmt3a3b	I-Protein
-	I-Protein
/	I-Protein
-	I-Protein
)	I-Protein
se	O
incluyó	O
en	O
el	O
análisis	O
de	O
la	O
Línea	O
1	O
y	O
el	O
Seno	O
B1	O
repite	B-Sequence
.	O

La	O
pérdida	O
de	O
CpG	O
-	O
la	O
metilación	O
se	O
observó	O
claramente	O
en	O
estos	O
elementos	B-Sequence
repetitivos	I-Sequence
en	O
estos	O
célula	B-Cell
líneas	O
.	O

(	O
1	O
.	O
PDF	O
de	O
8	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S4	O

Escape	O
de	O
la	O
desactivación	O
impresa	O
en	O
8	O
.	O
Embrión	O
hembra	O
portadora	O
de	O
5	O
dpc	O

Se	O
realizó	O
un	O
cruce	O
entre	O
una	O
hembra	O
portadora	O
(	O
AtrxWT	O
/	O
null	O
)	O
y	O
tipo	B-Sequence
salvaje	I-Sequence
macho	O
(	O
AtrxWT	O
/	O
Y	O
)	O
,	O
y	O
los	O
embriones	O
se	O
diseccionaron	O
en	O
sus	O
deciduas	O
a	O
los	O
8	O
.	O
5	O
dpc	O
.	O

Cualquier	O
descendencia	O
femenina	O
portadora	O
de	O
este	O
cruce	O
llevará	O
un	O
AtrxWT	O
alelo	B-Sequence
en	O
el	O
XP	O
cromosoma	B-GENE
y	O
un	O
Atrxnull	O
alelo	B-Sequence
en	O
el	O
Xm	O
cromosoma	B-GENE
.	O

Las	O
secciones	O
transversales	O
de	O
parafina	O
se	O
tiñeron	O
con	O
el	O
anti	O
-	O
ATRX	B-Protein
anticuerpo	B-GENE
(	O
H-300	O
)	O
.	O

(	O
A	O
)	O
Imagen	O
de	O
gran	O
aumento	O
(	O
400x	O
)	O
de	O
la	O
región	O
del	O
pliegue	O
neural	O
(	O
nf	O
)	O
(	O
embrión	O
propiamente	O
dicho	O
)	O
de	O
un	O
embrión	O
hembra	O
portador	O
(	O
AtrxWT/null	O
)	O
.	O

Este	O
tejido	O
está	O
claramente	O
compuesto	O
por	O
un	O
mosaico	O
de	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
debido	O
al	O
azar	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

Esta	O
sección	O
se	O
contrastó	O
con	O
hematoxilina	O
.	O

(	O
B	O
)	O
Imagen	O
de	O
gran	O
aumento	O
(	O
400	O
x	O
)	O
del	O
mismo	O
embrión	O
representado	O
en	O
(	O
A	O
)	O
,	O
que	O
muestra	O
el	O
ectodermo	O
coriónico	O
derivado	O
extraembrionario	O
(	O
ce	O
)	O
y	O
el	O
endodermo	O
visceral	O
(	O
ve	O
)	O
,	O
dos	O
tejidos	O
que	O
se	O
someten	O
a	O
impresión	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

Aunque	O
Atrx	B-Protein
se	O
expresa	O
pobremente	O
en	O
el	O
endodermo	O
visceral	O
(	O
incluso	O
en	O
tipo	B-Sequence
salvaje	I-Sequence
hembras	O
[	O
datos	O
no	O
publicados	O
]	O
)	O
,	O
fuerte	O
expresión	O
de	O
Atrx	B-Protein
se	O
puede	O
ver	O
en	O
el	O
ectodermo	O
coriónico	O
,	O
lo	O
que	O
indica	O
que	O
el	O
AtrxWT	O
derivado	O
del	O
padre	O
alelo	B-Sequence
había	O
escapado	O
a	O
la	O
inactivación	O
en	O
este	O
tejido	O
.	O

(	O
1	O
.	O
PDF	O
de	O
7	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Protocolo	O
S1	O

Métodos	O
complementarios	O

(	O
42	O
KB	O
DOC	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Tabla	O
S1	O

imprimaciones	B-Sequence
Utilizado	O
en	O
este	O
estudio	O

(	O
20	O
KB	O
DOCUMENTO	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Números	O
de	O
acceso	O

La	O
herencia	O
mendeliana	O
en	O
línea	O
en	O
Hombre	B-Taxon
(	O
http	O
:	O
//	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
OMIM	O
)	O
número	O
de	O
acceso	O
para	O
ATR-	O
X	B-GENE
el	O
síndrome	O
es	O
301040	O
.	O

El	O
GeneID	O
(	O
www.ncbi.nlm.nih.gov/entrez/query.fcgi	O
?	O
db=gene	O
)	O
para	O
atrx	B-Protein
humano	I-Protein
es	O
546	O
y	O
para	O
ratón	B-Protein
atrx	I-Protein
es	O
22589	O
.	O

El	O
número	O
de	O
acceso	O
de	O
GenBank	O
(	O
http	O
:	O
//	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
)	O
para	O
el	O
menor	O
sonda	B-Sequence
satelital	I-Sequence
mCENT2	O
es	O
X14470	O
(	O
nucleótidos	B-Chemical
75	O
-	O
101	O
)	O
,	O
para	O
los	O
principales	O
sonda	B-Sequence
satelital	I-Sequence
DG27	O
es	O
M25032	O
(	O
nucleótidos	B-Sequence
146	O
-	O
172	O
)	O
,	O
y	O
para	O
la	O
IAP	O
Investigacion	B-Sequence
es	O
L33247	O
.	O

Agradecimientos	O

Nos	O
gustaría	O
agradecer	O
a	O
Stu	O
Orkin	O
por	O
proporcionar	O
acceso	O
a	O
la	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
,	O
Gillian	O
Morriss	O
-	O
Kay	O
por	O
sus	O
consejos	O
,	O
Peter	O
Warnecke	O
y	O
Tim	O
Bestor	O
por	O
la	O
IAP	O
Investigacion	B-Sequence
En	O
Li	O
por	O
el	O
nocaut	O
de	O
Dnmt	O
ES	O
células	B-Cell
,	O
Frank	O
Talamantes	O
para	O
el	O
pRSV	O
-	O
MPL	B-Protein
-	I-Protein
1	I-Protein
plásmido	B-Sequence
,	O
Ann	O
Atzberger	O
por	O
su	O
asistencia	O
con	O
la	O
citometría	O
de	O
flujo	O
,	O
y	O
Deb	O
Bogani	O
y	O
Terry	O
Hacker	O
por	O
su	O
asistencia	O
con	O
los	O
análisis	O
de	O
hibridación	O
in	O
situ	O
de	O
montaje	O
completo	O
y	O
el	O
seccionamiento	O
de	O
embriones	O
.	O

abreviaturas	O

BrdU	O
-	O
bromodesoxiuridina	O

dpc	O
-	O
días	O
poscoito	O

ES	O
células	B-Cell
#	O
¿NOMBRE	O
?	O
Células	B-Cell
madre	I-Cell

IAP	O
-	O
partícula	O
A	O
intracisternal	O

ADNr	O
-	O
ribosomal	B-GENE
ADN	B-Sequence

TGC-	O
célula	B-Cell
gigante	I-Cell
del	I-Cell
trofoblasto	I-Cell

TUNEL	O
-	O
TDT	B-Protein
#	O
¿NOMBRE	O
?	O
dUTP	B-Chemical
etiquetado	O
del	O
extremo	O
de	O
la	O
muesca	O

WMISH	O
-	O
completo	O
-	O
montaje	O
de	O
hibridación	O
in	O
situ	O

Figuras	O
y	O
Tablas	O

Figura	O
1	O

Representación	O
esquemática	O
de	O
la	O
ATRX	B-Protein
isoformas	B-Sequence

En	O
la	O
parte	O
superior	O
se	O
muestra	O
el	O
atrx	B-Protein
humano	I-Protein
ADNc	B-Sequence
.	O

Los	O
recuadros	O
representan	O
los	O
36	O
exones	B-Sequence
.	O

los	O
intrones	B-Sequence
no	O
están	O
a	O
escala	O
.	O

El	O
empalme	O
alternativo	O
de	O
exones	B-Sequence
6	O
y	O
7	O
se	O
indica	O
.	O

Debajo	O
se	O
muestran	O
los	O
dos	O
ATRX	B-Protein
proteína	O
isoformas	B-Sequence
.	O

Longitud	O
total	O
ATRX	B-Protein
(	O
~	O
280	O
kDa	O
)	O
está	O
codificado	O
por	O
el	O
mayor	O
marco	B-Sequence
de	I-Sequence
lectura	I-Sequence
abierto	I-Sequence
.	O

los	O
posiciones	B-Sequence
del	O
director	O
caracteristicas	B-Sequence
(	O
el	O
doctorado	O
-	O
como	O
dominio	B-Sequence
y	O
los	O
siete	O
motivos	O
similares	O
a	O
SWI/SNF	O
)	O
están	O
indicados	O
.	O

Por	O
encima	O
de	O
la	O
longitud	O
total	O
ATRX	B-Protein
se	O
muestra	O
el	O
ATRXt	O
truncado	O
isoforma	B-Sequence
(	O
aparente	O
molecular	B-Chemical
peso	O
de	O
~	O
200	O
kDa	O
)	O
que	O
surge	O
por	O
la	O
falta	O
de	O
empalme	O
intrón	B-Sequence
11	O
y	O
el	O
uso	O
de	O
un	O
señal	B-Sequence
intronic	I-Sequence
poli	I-Sequence
(	I-Sequence
A	I-Sequence
)	I-Sequence
.	O

los	O
intrón	B-Sequence
#	O
¿NOMBRE	O
?	O
región	B-Sequence
de	O
ATRXt	O
se	O
indica	O
como	O
un	O
cuadro	O
gris	O
relleno	O
.	O

Ubicaciones	B-Sequence
de	O
recombinante	O
proteinas	B-Chemical
(	O
A2	O
,	O
FXNP5	O
y	O
H-300	O
)	O
utilizados	O
para	O
generar	O
anticuerpos	B-GENE
son	O
exhibidos	O
.	O

La	O
barra	O
de	O
escala	O
representa	O
200	O
aminoácidos	B-Chemical
.	O

Figura	O
2	O

Cre	O
-	O
Ablación	O
mediada	O
de	O
longitud	O
total	O
Atrx	B-Protein
Proteína	B-Chemical
en	O
ES	O
Células	B-Cell

(	O
A	O
)	O
Estrategia	O
para	O
objetivos	O
supresión	B-Sequence
de	O
exón	B-Sequence
18	O
de	O
los	O
Atrx	B-Protein
gene	B-Sequence
.	O

La	O
línea	O
superior	O
muestra	O
la	O
alelo	B-Sequence
de	I-Sequence
tipo	I-Sequence
salvaje	I-Sequence
(	O
AtrxWT	O
)	O
en	O
el	O
región	B-Sequence
rodeando	O
exón	B-Sequence
18	O

A	O
continuación	O
se	O
muestra	O
la	O
orientación	O
vector	B-Sequence
y	O
el	O
objetivo	O
alelo	B-Sequence
(	O
Atrxflox	O
)	O
resultante	O
de	O
la	O
recombinación	O
homóloga	O
.	O

los	O
sitios	B-Sequence
de	I-Sequence
destino	I-Sequence
loxP	I-Sequence
de	O
la	O
recombinasa	O
Cre	O
se	O
muestran	O
como	O
triángulos	O
negros	O
,	O
y	O
se	O
indican	O
los	O
tres	O
posibles	O
eventos	O
de	O
recombinación	O
que	O
pueden	O
ser	O
mediados	O
por	O
la	O
recombinasa	O
Cre	O
(	O
etiquetados	O
A	O
,	O
B	O
y	O
C	O
en	O
el	O
Atrxflox	O
alelo	B-Sequence
)	O
.	O

En	O
la	O
parte	O
inferior	O
se	O
muestra	O
el	O
Cre	O
-	O
recombinado	O
alelo	B-Sequence
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
(	O
resultante	O
del	O
evento	O
de	O
recombinación	O
C	O
)	O
en	O
el	O
que	O
ambos	O
exón	B-Sequence
18	O
y	O
la	O
selección	O
de	O
MC1neopA	O
casete	B-Sequence
Ha	O
estado	O
eliminado	B-Sequence
.	O

EcoRI	O
(	O
etiquetado	O
E	O
)	O
y	O
SacI	O
(	O
etiquetado	O
S	O
)	O
sitios	B-Sequence
presente	O
en	O
la	O
cepa	O
129	O
objetivo	O
cromosoma	B-GENE
X	I-GENE
se	O
indican	O
.	O

Las	O
barras	O
negras	O
indican	O
la	O
posiciones	B-Sequence
de	O
El	O
sondas	B-Sequence
utilizado	O
en	O
transferencias	O
de	O
Southern	O
.	O

(	O
B	O
)	O
Análisis	O
de	O
transferencia	O
Southern	O
de	O
EcoRI	O
-	O
digerido	O
ADN	B-Sequence
desde	O
cualquiera	O
tipo	B-Sequence
salvaje	I-Sequence
ES	O
células	B-Cell
(	O
E14	O
)	O
o	O
ES	O
dirigido	O
célula	B-Cell
clones	O
que	O
llevan	O
el	O
Atrxflox	O
alelo	B-Sequence
(	O
1	O
/	O
F12	O
y	O
1	O
/	O
G11	O
)	O
se	O
hibridó	O
con	O
el	O
20	O
/	O
27	O
(	O
mancha	O
izquierda	O
)	O
o	O
Hae0	O
.	O
9	O
(	O
mancha	O
derecha	O
)	O
sondas	B-Sequence
.	O

El	O
EcoRI	O
fragmento	B-Sequence
del	O
AtrxWT	O
alelo	B-Sequence
(	O
18	O
.	O
5	O
kb	O
)	O
ha	O
sido	O
sustituido	B-Sequence
con	O
el	O
fragmentos	B-Sequence
esperados	I-Sequence
de	O
11	O
2	O
kb	O
(	O
20	O
/	O
27	O
Investigacion	B-Sequence
)	O
o	O
8	O
.	O
5	O
kb	O
(	O
Hae0	O
.	O
9	O
Investigacion	B-Sequence
)	O

(	O
C	O
)	O
Análisis	O
de	O
transferencia	O
Southern	O
de	O
SacI	O
-	O
digerido	O
ADN	B-Sequence
desde	O
cualquiera	O
tipo	B-Sequence
salvaje	I-Sequence
ES	O
células	B-Cell
(	O
E14	O
)	O
o	O
ES	O
dirigido	O
célula	B-Cell
clones	O
que	O
llevan	O
el	O
Atrxflox	O
alelo	B-Sequence
(	O
1	O
/	O
F12	O
y	O
1	O
/	O
G11	O
)	O
o	O
Cre	O
-	O
recombinante	O
clones	B-Sequence
derivados	O
de	O
estos	O
(	O
1	O
/	O
F12B1F12	O
y	O
1	O
/	O
G11D5	O
)	O
.	O

La	O
membrana	O
se	O
hibridó	O
con	O
el	O
intrón	B-Sequence
17	O
Investigacion	B-Sequence
indicado	O
en	O
(	O
A	O
)	O
.	O

Las	O
bandas	O
esperadas	O
de	O
6	O
.	O
2	O
(	O
AtrxWT	O
)	O
,	O
5	O
.	O
0	O
(	O
Atrxflox	O
)	O
,	O
y	O
2	O
.	O
Se	O
observaron	O
8	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
)	O
kb	O
.	O

(	O
D	O
)	O
Análisis	O
de	O
transferencia	O
Northern	O
de	O
ARN	B-Sequence
de	O
ES	O
células	B-Cell
se	O
muestra	O
en	O
(	O
C	O
)	O
.	O

La	O
membrana	O
se	O
hibridó	O
primero	O
a	O
un	O
Investigacion	B-Sequence
desde	O
exón	B-Sequence
10	O
de	O
los	O
Atrx	B-Protein
gene	B-Sequence
(	O
top	O
blot	O
)	O
y	O
posteriormente	O
a	O
un	O
beta	B-Protein
-	I-Protein
actina	I-Protein
sonda	B-Sequence
de	I-Sequence
ADNc	I-Sequence
como	O
control	O
de	O
carga	O
(	O
transferencia	O
inferior	O
)	O
.	O

los	O
transcripciones	B-Sequence
responsable	O
de	O
la	O
longitud	O
completa	O
Atrx	B-Protein
(	O
~	O
10	O
kb	O
)	O
y	O
el	O
Atrxt	O
truncado	O
isoformas	B-Sequence
(	O
~	O
7	O
kb	O
)	O
se	O
indican	O
.	O

(	O
E	O
)	O
Análisis	O
de	O
transferencia	O
Western	O
de	O
todo	O
-	O
célula	B-Cell
extractos	O
de	O
la	O
clones	B-Sequence
se	O
muestra	O
en	O
(	O
C	O
)	O
usando	O
un	O
anti	O
-	O
ATRX	B-Protein
monoclonal	O
anticuerpo	B-GENE
(	O
23C	O
,	O
levantado	O
contra	O
péptido	B-Sequence
A2	O
de	O
la	O
atrx	B-Protein
humano	I-Protein
proteína	B-Chemical
se	O
muestra	O
en	O
la	O
figura	O
1	O
)	O
.	O

La	O
longitud	O
completa	O
y	O
truncada	O
Atrx	B-Protein
isoformas	B-Sequence
se	O
indican	O
.	O

figura	O
3	O

Defectos	O
de	O
crecimiento	O
y	O
metilación	O
en	O
Atrxnull	O
ES	O
Células	B-Cell

(	O
A	O
)	O
Los	O
cultivos	O
se	O
inocularon	O
con	O
cantidades	O
equivalentes	O
de	O
ES	O
células	B-Cell
teniendo	O
diferentes	O
Atrx	B-Protein
alelos	B-Sequence
como	O
se	O
indica	O
,	O
y	O
fueron	O
aprobados	O
en	O
serie	O
.	O

Después	O
de	O
los	O
días	O
indicados	O
de	O
cocultivo	O
,	O
ADN	B-Sequence
extraído	O
de	O
una	O
muestra	O
de	O
células	B-Cell
fue	O
analizado	O
por	O
Southern	O
blot	O
para	O
detectar	O
la	O
Atrx	B-Protein
alelos	B-Sequence
.	O

ADN	B-Sequence
fue	O
digerido	O
con	O
SpeI	O
,	O
y	O
la	O
membrana	O
fue	O
hibridada	O
con	O
el	O
20/27	O
Investigacion	B-Sequence
se	O
muestra	O
en	O
la	O
figura	O
2A	O
.	O

Los	O
tamaños	O
esperados	O
de	O
los	O
diferentes	O
alelos	B-Sequence
se	O
indican	O
.	O

(	O
B	O
)	O
Diagrama	O
esquemático	O
de	O
la	O
parte	O
transcrita	O
del	O
ratón	B-Taxon
ADNr	O
repetir	B-Sequence
con	O
el	O
18S	B-Protein
,	O
5	B-Protein
.	I-Protein
8S	I-Protein
,	O
y	O
28S	B-Protein
genes	B-Sequence
indicado	O

los	O
posiciones	B-Sequence
del	I-Sequence
límite	I-Sequence
-	I-Sequence
enzimas	I-Sequence
digestivas	I-Sequence
BamH	O
(	O
etiquetado	O
B	O
)	O
y	O
EcoRI	O
(	O
etiquetado	O
E	O
)	O
y	O
el	O
sondas	B-Sequence
(	O
RIB3	O
y	O
RIB4	O
)	O
utilizados	O
en	O
las	O
transferencias	O
de	O
Southern	O
mostradas	O
en	O
(	O
C	O
)	O
.	O

A	O
continuación	O
se	O
muestran	O
los	O
ubicaciones	B-Sequence
de	O
la	O
metilación	O
-	O
sensible	O
enzimas	B-Sequence
(	O
SmaI	O
,	O
PvuI	O
y	O
MluI	O
)	O
cuyo	O
estado	O
de	O
metilación	O
se	O
ha	O
analizado	O
en	O
las	O
transferencias	O
Southern	O
que	O
se	O
muestran	O
en	O
(	O
C	O
)	O
.	O

(	O
C	O
)	O
ADN	B-Sequence
desde	O
Atrx	B-Protein
-	O
positivo	O
(	O
Atrx	B-Protein
+	O
,	O
con	O
AtrxWT	O
o	O
Atrxflox	O
alelo	B-Sequence
)	O
o	O
Atrxnull	O
(	O
con	O
el	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
alelo	B-Sequence
)	O
ES	O
células	B-Cell
y	O
7	O
-	O
d	O
cuerpos	O
embrioides	O
fueron	O
digeridos	O
con	O
el	O
enzimas	B-Sequence
mostrado	O
y	O
analizado	O
por	O
transferencia	O
de	O
Southern	O
usando	O
el	O
sondas	B-Sequence
indicado	O

Las	O
flechas	O
indican	O
las	O
copias	O
completamente	O
metiladas	O
(	O
cortadas	O
solo	O
por	O
el	O
límite	O
-	O
digerir	O
enzima	B-Sequence
)	O
.	O

A	O
continuación	O
se	O
muestra	O
la	O
cuantificación	O
del	O
Phosphorimager	O
de	O
las	O
transferencias	O
.	O

El	O
eje	O
y	O
muestra	O
el	O
porcentaje	O
de	O
copias	O
que	O
no	O
son	O
digeridas	O
por	O
la	O
metilación	O
-	O
sensible	O
enzima	B-Sequence
como	O
porcentaje	O
de	O
la	O
señal	O
total	O
de	O
rDNA	O
cortado	O
y	O
sin	O
cortar	O
.	O

Los	O
valores	O
medios	O
se	O
indican	O
mediante	O
líneas	O
horizontales	O
y	O
la	O
importancia	O
de	O
las	O
diferencias	O
entre	O
los	O
Atrx	B-Protein
#	O
¿NOMBRE	O
?	O
enzima	B-Sequence
.	O

Figura	O
4	O

Momento	O
de	O
inicio	O
de	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
Atrx	B-Protein
Alelos	B-Sequence

(	O
A	O
)	O
GATA1	B-Protein
#	O
¿NOMBRE	O
?	O
+	B-Sequence
/	O
#	B-Sequence
¿NOMBRE	I-Sequence
?	I-Sequence
machos	O
fueron	O
cruzados	O
con	O
hembras	O
de	O
la	O
ROSA26	B-Protein
cepa	O
reportera	O
(	O
ROSA26	B-Protein
+	B-Sequence
/	O
-	O
)	O
,	O
y	O
los	O
embriones	O
se	O
recuperaron	O
a	O
0	O
.	O
5	O
dpc	O
(	O
~	O
16	O
-	O
célula	B-Cell
estadio	O
de	O
mórula	O
)	O
y	O
teñido	O
con	O
X-gal	O
.	O

Activación	O
mediada	O
por	O
Cre	O
del	O
ROSA26	B-Protein
reportero	O
beta	O
-	O
galactosidasa	O
alelo	B-Sequence
se	O
detectó	O
en	O
todos	O
células	B-Cell
en	O
embriones	O
en	O
los	O
que	O
ambos	O
alelos	B-Sequence
son	O
coheredados	O
.	O

(	O
B	O
)	O
Gel	O
superior	O
:	O
genotipado	O
por	O
PCR	O
de	O
Atrx	B-Protein
alelos	B-Sequence
en	O
embriones	O
utilizando	O
cebadores	B-Sequence
PPS1	O
.	O
15	O
(	O
exón	B-Sequence
17	O
)	O
y	O
Mxnp30	O
(	O
exón	B-Sequence
20	O
)	O
como	O
se	O
describe	O
en	O
el	O
Protocolo	O
S1	O
.	O

Los	O
tamaños	O
de	O
productos	B-Sequence
PCR	I-Sequence
de	O
los	O
diferentes	O
alelos	B-Sequence
se	O
indican	O
.	O

Tanto	O
el	O
Atrx	O
Delta	O
18	O
(	O
resultado	O
del	O
evento	O
de	O
recombinación	O
B	O
en	O
la	O
Figura	O
2A	O
)	O
como	O
el	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
alelo	B-Sequence
(	O
resultantes	O
del	O
evento	O
de	O
recombinación	O
C	O
en	O
la	O
Figura	O
2A	O
)	O
son	O
nulos	O
para	O
los	O
de	O
longitud	O
completa	O
Atrx	B-Protein
proteína	B-Chemical
.	O

El	O
gel	O
inferior	O
muestra	O
productos	B-Sequence
de	I-Sequence
una	I-Sequence
reacción	I-Sequence
de	I-Sequence
PCR	I-Sequence
(	O
cebadores	B-Sequence
DG52/DG53	O
)	O
utilizado	O
para	O
sexar	O
embriones	O
como	O
se	O
describe	O
en	O
el	O
Protocolo	O
S1	O
.	O

un	O
450-	O
producto	B-Sequence
de	I-Sequence
PCR	I-Sequence
pb	I-Sequence
se	O
amplifica	O
de	O
un	O
ratón	B-Taxon
cromosoma	B-GENE
Y	I-GENE
#	O
¿NOMBRE	O
?	O
repetición	B-Sequence
de	I-Sequence
satélite	I-Sequence
.	O

Figura	O
5	O

Morfología	O
de	O
Embriones	O
Atrxnull	O
a	O
las	O
7	O
.	O
5	O
dpc	O
y	O
8	O
.	O
5	O
dpc	O

Secciones	O
de	O
parafina	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
o	O
Atrxnull	O
7	O
.	O
5	O
embriones	O
dpc	O
(	O
disecados	O
en	O
sus	O
deciduas	O
)	O
fueron	O
teñidos	O
con	O
hematoxilina	O
(	O
A	O
)	O
o	O
con	O
un	O
anti	O
-	O
ATRX	B-Protein
anticuerpo	B-GENE
(	O
H-300	O
,	O
Figura	O
1	O
)	O
(	O
B-E	O
)	O
.	O

Las	O
fotomicrografías	O
C-E	O
muestran	O
imágenes	O
de	O
mayor	O
aumento	O
(	O
200x	O
)	O
de	O
las	O
secciones	O
teñidas	O
que	O
se	O
muestran	O
en	O
(	O
B	O
)	O
(	O
40x	O
)	O
.	O

Las	O
barras	O
de	O
escala	O
representan	O
200	O
mu	O
m	O
(	O
aumento	O
de	O
40x	O
)	O
o	O
40	O
mum	O
(	O
aumento	O
de	O
200x	O
)	O
.	O

un	O
amnios	O
;	O
ac	O
,	O
cavidad	O
amniótica	O
;	O
c	O
,	O
corion	O
;	O
e	O
,	O
epiblasto	O
;	O
ce	O
,	O
cavidad	O
ectoplacentaria	O
;	O
ecc	O
,	O
cavidad	O
exocoelómica	O
;	O
ep	O
,	O
cono	O
ectoplacentario	O
;	O
ne	O
,	O
ectodermo	O
neural	O
;	O
rm	O
,	O
de	O
Reichert	O
membrana	B-GENE
;	O
tgc	O
,	O
célula	B-Cell
gigante	I-Cell
del	I-Cell
trofoblasto	I-Cell
.	O

(	O
F	O
)	O
Detección	O
de	O
braquiuria	B-Protein
(	O
T	B-Protein
)	O
expresión	O
en	O
Atrxnull	O
8	O
.	O
Embrión	O
de	O
5	O
dpc	O
(	O
etapa	O
de	O
pliegue	O
de	O
la	O
cabeza	O
)	O
por	O
WMISH	O
.	O

los	O
genotipo	B-Sequence
fue	O
determinado	O
por	O
PCR	O
(	O
como	O
se	O
muestra	O
en	O
el	O
Protocolo	O
S1	O
)	O
utilizando	O
ADN	B-Sequence
extraído	O
del	O
saco	O
vitelino	O
.	O

hf	O
,	O
pliegue	O
de	O
la	O
cabeza	O
;	O
n	O
,	O
notocorda	O
emergente	O
;	O
pd	O
,	O
racha	O
primitiva	O
.	O

Figura	O
6	O

Análisis	O
de	O
Apoptosis	O
y	O
Mitosis	O
en	O
Embriones	O
Atrxnull	O

(	O
A	O
)	O
Secciones	O
de	O
parafina	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
Atrxnull	O
7	O
.	O
Se	O
analizaron	O
5	O
embriones	O
dpc	O
(	O
diseccionados	O
en	O
sus	O
deciduas	O
)	O
mediante	O
ensayo	O
TUNEL	O
y	O
células	B-Cell
apoptóticas	I-Cell
etiquetado	O
con	O
fluoresceína	B-Chemical
-	O
dUTP	B-Chemical
.	O

Las	O
secciones	O
se	O
contrastaron	O
con	O
DAPI	O
.	O

(	O
B	O
)	O
secciones	O
de	O
parafina	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
o	O
Atrxnull	O
7	O
.	O
Se	O
tiñeron	O
5	O
embriones	O
dpc	O
con	O
un	O
anticuerpo	B-GENE
contra	O
el	O
marcador	O
de	O
mitosis	O
fosforilado	O
(	O
Ser10	O
)	O
histona	B-Chemical
H3	O
.	O

Las	O
secciones	O
se	O
contrastaron	O
con	O
hematoxilina	O
.	O

Tanto	O
para	O
(	O
A	O
)	O
como	O
para	O
(	O
B	O
)	O
,	O
la	O
presencia	O
o	O
ausencia	O
de	O
Atrx	B-Protein
en	O
cada	O
embrión	O
se	O
determinó	O
mediante	O
la	O
tinción	O
de	O
secciones	O
adyacentes	O
con	O
el	O
anti	O
-	O
ATRX	B-Protein
anticuerpo	B-GENE
(	O
H-300	O
)	O
como	O
en	O
la	O
Figura	O
5	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Figura	O
7	O

Defecto	O
del	O
trofoectodermo	O
en	O
embriones	O
Atrxnull	O

(	O
A	O
)	O
8	O
.	O
Se	O
diseccionaron	O
embriones	O
de	O
5	O
dpc	O
del	O
tejido	O
decidual	O
circundante	O
y	O
se	O
observaron	O
en	O
montaje	O
completo	O
.	O

los	O
genotipo	B-Sequence
de	O
cada	O
uno	O
(	O
indicado	O
arriba	O
)	O
fue	O
determinado	O
por	O
PCR	O
usando	O
ADN	B-Sequence
extraído	O
de	O
embriones	O
enteros	O
después	O
de	O
la	O
fotografía	O
.	O

En	O
la	O
imagen	O
de	O
la	O
izquierda	O
,	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
la	O
hembra	O
(	O
etapa	O
de	O
tres	O
somitas	O
,	O
izquierda	O
)	O
está	O
rodeada	O
por	O
trofoblasto	O
(	O
t	O
)	O
,	O
mientras	O
que	O
el	O
componente	O
trofoblástico	O
que	O
rodea	O
a	O
los	O
machos	O
Atrxnull	O
(	O
en	O
las	O
etapas	O
de	O
cabeza/presomita	O
[	O
medio	O
]	O
y	O
dos	O
somitas	O
[	O
derecha	O
]	O
,	O
respectivamente	O
)	O
está	O
severamente	O
reducido	O
.	O

En	O
la	O
imagen	O
de	O
la	O
derecha	O
,	O
el	O
trofoblasto	O
ha	O
sido	O
disecado	O
lejos	O
de	O
la	O
región	O
embrionaria	O
del	O
tipo	B-Sequence
salvaje	I-Sequence
embrión	O
,	O
para	O
revelar	O
el	O
pequeño	O
cono	O
ectoplacentario	O
(	O
epc	O
)	O
de	O
forma	O
anormal	O
del	O
mutante	B-Sequence
compañeros	O
de	O
camada	O

(	O
B	O
)	O
WMISH	O
para	O
detectar	O
la	O
expresión	O
de	O
pl	B-Protein
-	I-Protein
1	I-Protein
(	O
un	O
marcador	O
de	O
TGC	O
)	O
en	O
los	O
sitios	O
de	O
implantación	O
en	O
deciduas	O
desocupadas	O
que	O
habían	O
contenido	O
8	O
.	O
5	O
dpc	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
AtrxWT	O
/	O
peso	B-Sequence
)	O
o	O
embriones	O
Atrxnull	O
(	O
Atrx	O
Delta	O
18	O
Delta	O
neo	O
/	O
Y	O
)	O
.	O

los	O
genotipo	B-Sequence
se	O
determinó	O
por	O
PCR	O
utilizando	O
ADN	B-Sequence
extraído	O
de	O
embriones	O
enteros	O
.	O

Los	O
TGC	O
se	O
tiñen	O
con	O
pl	B-Protein
-	I-Protein
1	I-Protein
.	O

(	O
C	O
)	O
Secciones	O
de	O
parafina	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
o	O
Atrxnull	O
7	O
.	O
Se	O
tiñeron	O
5	O
embriones	O
dpc	O
(	O
disecados	O
en	O
sus	O
deciduas	O
)	O
con	O
un	O
anti	O
-	O
pl	B-Protein
-	I-Protein
1	I-Protein
anticuerpo	B-GENE
.	O

La	O
presencia	O
o	O
ausencia	O
de	O
Atrx	B-Protein
en	O
cada	O
embrión	O
se	O
determinó	O
mediante	O
la	O
tinción	O
de	O
secciones	O
adyacentes	O
con	O
el	O
anti	O
-	O
ATRX	B-Protein
anticuerpo	B-GENE
(	O
H-300	O
)	O
como	O
en	O
la	O
Figura	O
5	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

(	O
D	O
)	O
Ejemplos	O
de	O
cultivos	O
de	O
crecimiento	O
de	O
blastocistos	O
de	O
5	O
días	O
.	O

Extenso	O
trofoblasto	O
que	O
crece	O
desde	O
el	O
interior	O
célula	B-Cell
masa	O
(	O
icm	O
)	O
se	O
observó	O
en	O
todos	O
genotipos	B-Sequence
.	O

los	O
Atrx	B-Protein
genotipo	B-Sequence
y	O
el	O
sexo	O
del	O
blastocisto	O
indicado	O
se	O
determinaron	O
por	O
PCR	O
.	O

Figura	O
8	O

Escapar	O
de	O
la	O
inactivación	O
impresa	O
del	O
AtrxWT	O
heredado	O
paternamente	O
alelo	B-Sequence
en	O
Mujeres	O
Portadoras	O

Secciones	O
de	O
parafina	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
AtrxWT	O
/	O
Y	O
)	O
y	O
hembra	O
portadora	O
(	O
AtrxWT	O
/	O
null	O
)	O
7	O
.	O
5	O
embriones	O
dpc	O
(	O
diseccionados	O
en	O
sus	O
deciduas	O
)	O
fueron	O
teñidos	O
con	O
el	O
anti	O
-	O
ATRX	B-Protein
anticuerpo	B-GENE
(	O
H-300	O
)	O
.	O

Las	O
barras	O
de	O
escala	O
representan	O
200	O
mu	O
m	O
(	O
40	O
aumentos	O
)	O
o	O
20	O
mu	O
m	O
(	O
400	O
aumentos	O
)	O
.	O

(	O
A	O
)	O
Secciones	O
teñidas	O
que	O
muestran	O
embriones	O
completos	O
con	O
un	O
aumento	O
de	O
40x	O
.	O

un	O
amnios	O
;	O
c	O
,	O
corion	O
;	O
e	O
,	O
epiblasto	O
;	O
ep	O
,	O
cono	O
ectoplacentario	O
.	O

(	O
B	O
)	O
Imagen	O
de	O
mayor	O
aumento	O
(	O
400x	O
)	O
de	O
las	O
regiones	O
del	O
epiblasto	O
de	O
las	O
secciones	O
teñidas	O
que	O
se	O
muestran	O
en	O
(	O
A	O
)	O
.	O

(	O
C	O
)	O
Imagen	O
de	O
mayor	O
aumento	O
(	O
400x	O
)	O
que	O
muestra	O
el	O
ectodermo	O
coriónico	O
derivado	O
extraembrionario	O
de	O
las	O
secciones	O
teñidas	O
que	O
se	O
muestran	O
en	O
(	O
A	O
)	O
.	O

ce	O
,	O
ectodermo	O
coriónico	O
;	O
cm	O
,	O
mesodermo	O
coriónico	O
.	O

tabla	O
1	O

Distribución	O
de	O
Atrx	B-Protein
Genotipos	B-Sequence
en	O
apareamientos	O
cronometrados	O

notas	O
al	O
pie	O

Contribuciones	O
de	O
autor	O
.	O

DG	O
,	O
AJHS	O
,	O
WGW	O
,	O
DRH	O
y	O
RJG	O
concibieron	O
y	O
diseñaron	O
los	O
experimentos	O
.	O

DG	O
,	O
JAS	O
,	O
RA	O
y	O
RJG	O
realizaron	O
los	O
experimentos	O
.	O

DG	O
,	O
RA	O
,	O
WGW	O
,	O
DRH	O
y	O
RJG	O
analizaron	O
los	O
datos	O
.	O

LD	O
contribuyó	O
reactivos	B-Chemical
/	O
materiales	O
/	O
herramientas	O
de	O
análisis	O
.	O

LD	O
proporcionó	O
asistencia	O
técnica	O
.	O

DG	O
escribió	O
el	O
artículo	O
.	O

Conflicto	O
de	O
intereses	O
.	O

Los	O
autores	O
han	O
declarado	O
que	O
no	O
existen	O
intereses	O
contrapuestos	O
.	O

Financiamiento	O

Este	O
trabajo	O
fue	O
apoyado	O
por	O
el	O
Consejo	O
de	O
Investigación	O
Médica	O
del	O
Reino	O
Unido	O
.	O

Cita	O
:	O
Garrick	O
D	O
,	O
Sharpe	O
JA	O
,	O
Arkell	O
R	O
,	O
Dobbie	O
L	O
,	O
Smith	O
AJH	O
,	O
et	O
al	O
.	O

(	O
2006	O
)	O
Pérdida	O
de	O
Atrx	B-Protein
afecta	O
el	O
desarrollo	O
del	O
trofoblasto	O
y	O
el	O
patrón	O
de	O
X	B-GENE
#	O
¿NOMBRE	O
?	O

PLoS	O
Genet	O
2	O
(	O
4	O
)	O
:	O
e58	O
.	O

DOI	O
:	O
10	O
.	O
1371	O
/	O
diario	O
.	O
pgen	O
0020058	O

Poliposis	B-Protein
coli	I-Protein
adenomatosa	I-Protein
(	O
APC	B-Protein
)	O
es	O
necesario	O
para	O
el	O
desarrollo	O
normal	O
de	O
la	O
piel	O
y	O
el	O
timo	O

Resumen	O

El	O
supresor	O
de	O
tumores	O
gene	B-Sequence
APC	B-Protein
(	O
poliposis	B-Protein
coli	I-Protein
adenomatosa	I-Protein
)	O
es	O
un	O
miembro	O
de	O
la	O
vía	O
de	O
señalización	O
Wnt	O
que	O
participa	O
en	O
el	O
desarrollo	O
y	O
la	O
tumorigénesis	O
.	O

knockout	O
heterocigoto	O
ratones	B-Taxon
por	O
APC	B-Protein
tienen	O
un	O
fenotipo	O
de	O
predisposición	O
tumoral	O
y	O
la	O
homocigosidad	O
conduce	O
a	O
la	O
letalidad	O
embrionaria	O
.	O

Para	O
entender	O
el	O
papel	O
de	O
APC	B-Protein
en	O
desarrollo	O
generamos	O
un	O
alelo	B-Sequence
flojo	I-Sequence
.	O

Estas	O
ratones	B-Taxon
se	O
aparearon	O
con	O
una	O
cepa	O
portadora	O
de	O
la	O
recombinasa	O
Cre	O
bajo	O
el	O
control	O
de	O
la	O
queratina	B-Protein
humana	I-Protein
14	I-Protein
(	I-Protein
K14	I-Protein
)	O
promotor	B-Sequence
,	O
que	O
es	O
activo	O
en	O
basal	O
células	B-Cell
de	I-Cell
la	I-Cell
epidermis	I-Cell
y	I-Cell
otros	I-Cell
epitelios	I-Cell
estratificados	I-Cell
.	O

Ratones	B-Taxon
homocigoto	O
para	O
el	O
alelo	B-Sequence
flojo	I-Sequence
que	O
también	O
llevan	O
el	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
eran	O
viables	O
pero	O
tenían	O
un	O
crecimiento	O
atrofiado	O
y	O
morían	O
antes	O
del	O
destete	O
.	O

Los	O
exámenes	O
histológicos	O
e	O
inmunoquímicos	O
revelaron	O
que	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
la	O
pérdida	O
resultó	O
en	O
un	O
crecimiento	O
aberrante	O
en	O
muchos	O
epitelios	O
escamosos	O
derivados	O
del	O
ectodermo	O
,	O
incluidos	O
los	O
folículos	O
pilosos	O
,	O
los	O
dientes	O
y	O
los	O
epitelios	O
orales	O
y	O
corneales	O
.	O

Además	O
,	O
se	O
observó	O
metaplasia	O
escamosa	O
en	O
varios	O
tejidos	O
derivados	O
del	O
epitelio	O
,	O
incluido	O
el	O
timo	O
.	O

El	O
crecimiento	O
aberrante	O
de	O
los	O
folículos	O
pilosos	O
y	O
otros	O
apéndices	O
,	O
así	O
como	O
las	O
anomalías	O
tímicas	O
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
sugerir	O
el	O
APC	B-Protein
gene	B-Sequence
es	O
crucial	O
en	O
embrionario	O
células	B-Cell
para	O
especificar	O
Célula	B-Cell
epitelial	I-Cell
destinos	O
en	O
órganos	O
que	O
requieren	O
interacciones	O
epiteliales-mesenquimatosas	O
para	O
su	O
desarrollo	O
.	O

Sinopsis	O

Los	O
pacientes	O
con	O
poliposis	O
adenomatosa	O
familiar	O
(	O
FAP	O
)	O
y	O
su	O
variante	O
,	O
el	O
síndrome	O
de	O
Gardner	O
,	O
desarrollarán	O
cientos	O
de	O
pólipos	O
colorrectales	O
.	O

Es	O
una	O
enfermedad	O
hereditaria	O
que	O
está	O
ligada	O
a	O
un	O
Mutación	B-Sequence
genética	I-Sequence
en	O
el	O
supresor	O
de	O
tumores	O
gene	B-Sequence
APC	B-Protein
(	O
poliposis	B-Protein
coli	I-Protein
adenomatosa	I-Protein
)	O
.	O

Estas	O
individuos	B-Taxon
también	O
desarrollan	O
síntomas	O
extracolónicos	O
,	O
entre	O
los	O
que	O
se	O
encuentran	O
la	O
hipertrofia	O
congénita	O
del	O
epitelio	O
pigmentario	O
de	O
la	O
retina	O
,	O
tumores	O
desmoides	O
,	O
quistes	O
epidermoides	O
,	O
trastornos	O
de	O
los	O
huesos	O
maxilares	O
y	O
esqueléticos	O
y	O
anomalías	O
dentales	O
,	O
lo	O
que	O
sugiere	O
la	O
importancia	O
de	O
la	O
APC	B-Protein
funciones	O
en	O
estos	O
órganos	O
.	O

Para	O
entender	O
el	O
papel	O
de	O
APC	B-Protein
en	O
desarrollo	O
y	O
en	O
órganos	O
distintos	O
al	O
intestino	O
,	O
generamos	O
APC	B-Protein
mutante	B-Sequence
ratones	B-Taxon
que	O
puede	O
condicionalmente	O
Eliminar	B-Sequence
los	O
gene	B-Sequence
cuando	O
se	O
expone	O
a	O
la	O
recombinasa	O
Cre	O
.	O

Estas	O
ratones	B-Taxon
fueron	O
emparejados	O
con	O
K14	B-Protein
(	O
Queratina	B-Protein
14	I-Protein
)	O
-	O
cr	O
ratones	B-Taxon
que	O
expresan	O
Cre	O
recombinase	O
en	O
la	O
piel	O
y	O
sus	O
apéndices	O
.	O

Los	O
autores	O
encontraron	O
que	O
la	O
mutante	B-Sequence
ratones	B-Taxon
que	O
han	O
perdido	O
APC	B-Protein
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
-	O
los	O
tejidos	O
que	O
expresaban	O
eran	O
viables	O
,	O
pero	O
tenían	O
un	O
crecimiento	O
atrofiado	O
y	O
morían	O
antes	O
del	O
destete	O
.	O

Estas	O
mutante	B-Sequence
ratones	B-Taxon
mostró	O
anomalías	O
del	O
desarrollo	O
no	O
sólo	O
en	O
la	O
piel	O
sino	O
también	O
en	O
muchos	O
tejidos	O
derivados	O
del	O
epitelio	O
,	O
incluidos	O
los	O
dientes	O
y	O
el	O
timo	O
.	O

Este	O
trabajo	O
demuestra	O
la	O
importancia	O
de	O
APC	B-Protein
en	O
el	O
desarrollo	O
de	O
muchos	O
órganos	O
,	O
y	O
proporciona	O
nuevos	O
conocimientos	O
sobre	O
el	O
diagnóstico	O
y	O
manejo	O
de	O
pacientes	O
con	O
APC	B-Protein
mutaciones	B-Sequence
.	O

Introducción	O

Poliposis	B-Protein
coli	I-Protein
adenomatosa	I-Protein
(	O
APC	B-Protein
)	O
es	O
un	O
miembro	O
de	O
la	O
vía	O
de	O
señalización	O
Wnt	O
y	O
una	O
de	O
sus	O
funciones	O
conocidas	O
es	O
regular	O
los	O
niveles	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
.	O

Alteraciones	O
en	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
regulación	O
son	O
muy	O
comunes	O
en	O
humano	B-Taxon
tumores	O
[	O
1	O
]	O
.	O

Pérdida	O
de	O
APC	B-Protein
se	O
asocia	O
con	O
la	O
estabilización	O
de	O
la	O
citosólico	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
que	O
finalmente	O
resulta	O
en	O
su	O
migración	O
al	O
núcleo	B-GENE
y	O
activando	O
una	O
cascada	O
de	O
eventos	O
que	O
conducen	O
a	O
la	O
tumorigénesis	O
.	O

APC	B-Protein
también	O
interactúa	O
con	O
una	O
multitud	O
de	O
otros	O
celular	B-Cell
proteinas	B-Chemical
,	O
incluyendo	O
axina	B-Protein
-	I-Protein
2	I-Protein
(	O
AXIN2	B-Protein
)	O
,	O
placoglobina	B-Protein
(	O
SALTAR	B-Protein
)	O
,	O
Asef	B-Protein
(	O
ARHGEF4	B-Protein
)	O
,	O
superfamilia	B-Protein
de	I-Protein
cinesinas	I-Protein
-	I-Protein
proteína	I-Protein
asociada	I-Protein
3	I-Protein
(	O
KIFAP3	B-Protein
)	O
,	O
EB1	B-Protein
(	O
MAPRE1	B-Protein
)	O
,	O
microtúbulos	B-GENE
,	O
y	O
el	O
homólogo	B-Protein
humano	I-Protein
de	I-Protein
discos	I-Protein
de	I-Protein
Drosophila	I-Protein
grandes	I-Protein
(	O
DLG1	B-Protein
)	O
.	O

Estas	O
interacciones	O
sugieren	O
que	O
APC	B-Protein
potencialmente	O
puede	O
regular	O
muchos	O
celular	B-Cell
funciones	O
,	O
incluida	O
la	O
adhesión	O
intercelular	O
,	O
citoesquelético	B-GENE
organización	O
,	O
regulación	O
de	O
placoglobina	B-Protein
niveles	O
,	O
regulación	O
de	O
la	O
célula	B-Cell
ciclo	O
y	O
apoptosis	O
,	O
orientación	O
de	O
asimétrica	O
célula	B-Cell
madre	I-Cell
división	O
y	O
control	O
de	O
célula	B-Cell
polarización	O
[	O
2	O
,	O
3	O
]	O
.	O

APC	B-Protein
es	O
un	O
supresor	O
de	O
tumores	O
gene	B-Sequence
.	O

Somático	O
mutaciones	B-Sequence
en	O
APC	B-Protein
se	O
encuentran	O
con	O
frecuencia	O
en	O
muchos	O
tumores	O
esporádicos	O
del	O
colon	O
y	O
del	O
recto	O
.	O

Autosómico	B-GENE
línea	O
germinal	O
dominante	O
mutaciones	B-Sequence
en	O
APC	B-Protein
causar	O
pólipos	O
adenomatosos	O
familiares	O
(	O
FAP	O
)	O
y	O
su	O
variante	O
,	O
el	O
síndrome	O
de	O
Gardner	O
.	O

Los	O
pacientes	O
con	O
PAF	O
se	O
caracterizan	O
por	O
cientos	O
de	O
pólipos	O
colorrectales	O
adenomatosos	O
,	O
con	O
una	O
progresión	O
casi	O
inevitable	O
a	O
cáncer	O
colorrectal	O
en	O
la	O
tercera	O
y	O
cuarta	O
décadas	O
de	O
la	O
vida	O
[	O
4	O
,	O
5	O
]	O
.	O

Además	O
de	O
las	O
neoplasias	O
colorrectales	O
,	O
estas	O
individuos	B-Taxon
pueden	O
desarrollar	O
síntomas	O
extracolónicos	O
,	O
entre	O
los	O
que	O
se	O
encuentran	O
pólipos	O
del	O
tracto	O
gastrointestinal	O
superior	O
,	O
hipertrofia	O
congénita	O
del	O
epitelio	O
pigmentario	O
de	O
la	O
retina	O
,	O
tumores	O
desmoides	O
,	O
trastornos	O
de	O
los	O
huesos	O
maxilares	O
y	O
esqueléticos	O
y	O
anomalías	O
dentales	O
[	O
6	O
]	O
,	O
lo	O
que	O
sugiere	O
la	O
importancia	O
de	O
APC	B-Protein
gene	B-Sequence
funciones	O
en	O
estos	O
sistemas	O
de	O
órganos	O
.	O

Aunque	O
el	O
papel	O
de	O
APC	B-Protein
en	O
la	O
iniciación	O
de	O
humano	B-Taxon
el	O
cáncer	O
colorrectal	O
está	O
bien	O
establecido	O
,	O
su	O
papel	O
en	O
otros	O
tejidos	O
y	O
procesos	O
de	O
desarrollo	O
no	O
se	O
conocen	O
bien	O
.	O

Dada	O
la	O
importancia	O
de	O
la	O
regulación	O
de	O
la	O
señalización	O
de	O
Wnt	O
en	O
la	O
formación	O
de	O
patrones	O
embrionarios	O
y	O
la	O
morfogénesis	O
de	O
muchos	O
órganos	O
,	O
la	O
comprensión	O
mecanicista	O
de	O
APC	B-Protein
en	O
el	O
desarrollo	O
y	O
en	O
los	O
tejidos	O
extracolónicos	O
se	O
vuelve	O
fundamental	O
para	O
evaluar	O
mejor	O
los	O
posibles	O
eventos	O
adversos	O
en	O
humanos	B-Taxon
.	O

Un	O
enfoque	O
para	O
entender	O
el	O
papel	O
de	O
APC	B-Protein
en	O
desarrollo	O
es	O
desarrollar	O
ratones	B-Taxon
con	O
una	O
desactivación	O
APC	B-Protein
mutación	B-Sequence
.	O

Varios	O
genéticamente	B-Sequence
modificado	I-Sequence
ratón	B-Taxon
cepas	O
para	O
APC	B-Protein
han	O
sido	O
descritos	O
[	O
7	O
-	O
10	O
]	O
.	O

La	O
mayoría	O
de	O
estos	O
modelos	O
,	O
en	O
estado	O
heterocigoto	O
,	O
muestran	O
un	O
fenotipo	O
de	O
predisposición	O
gastrointestinal	O
y	O
otros	O
tumores	O
[	O
7-10	O
]	O
.	O

Ratón	B-Taxon
embriones	O
que	O
son	O
homocigotos	O
para	O
el	O
modificación	B-Sequence
genética	I-Sequence
mueren	O
durante	O
la	O
embriogénesis	O
,	O
y	O
algunos	O
de	O
los	O
modelos	O
no	O
sobreviven	O
más	O
allá	O
de	O
la	O
gastrulación	O
[	O
8	O
,	O
11	O
]	O
.	O

Un	O
enfoque	O
alternativo	O
para	O
entender	O
el	O
papel	O
de	O
APC	B-Protein
en	O
desarrollo	O
y/o	O
en	O
tejidos	O
específicos	O
es	O
generar	O
una	O
ratón	B-Taxon
cepa	O
que	O
lleva	O
un	O
condicionalmente	O
alelo	B-Sequence
modificado	I-Sequence
y	O
emparejarlo	O
con	O
un	O
ratón	B-Taxon
tensión	O
que	O
facilita	O
la	O
modificación	B-Sequence
del	O
condicional	O
alelo	B-Sequence
en	O
especifico	O
célula	B-Cell
linajes	O

Para	O
evaluar	O
el	O
papel	O
de	O
APC	B-Protein
en	O
diferentes	O
etapas	O
de	O
la	O
vida	O
de	O
manera	O
sistemática	O
,	O
generamos	O
ratones	B-Taxon
que	O
contiene	O
un	O
golpe	O
de	O
gracia	O
condicional	O
(	O
CKO	O
)	O
alelo	B-Sequence
mutante	I-Sequence
de	O
APC	B-Protein
(	O
ApcCKO	O
)	O
.	O

Estas	O
ratones	B-Taxon
se	O
aparearon	O
con	O
una	O
cepa	O
portadora	O
de	O
la	O
recombinasa	O
Cre	O
bajo	O
el	O
control	O
de	O
la	O
queratina	B-Protein
humana	I-Protein
14	I-Protein
(	I-Protein
K14	I-Protein
)	O
promotor	B-Sequence
,	O
que	O
es	O
activo	O
en	O
basal	O
células	B-Cell
de	I-Cell
la	I-Cell
epidermis	I-Cell
y	I-Cell
otros	I-Cell
epitelios	I-Cell
estratificados	I-Cell
.	O

Informamos	O
aquí	O
que	O
K14	B-Protein
promotor	B-Sequence
#	O
¿NOMBRE	O
?	O
APC	B-Protein
resultó	O
en	O
un	O
desarrollo	O
aberrante	O
de	O
varios	O
órganos	O
que	O
requieren	O
interacciones	O
inductivas	O
epiteliales	O
-	O
mesenquimales	O
,	O
incluidos	O
los	O
folículos	O
pilosos	O
,	O
los	O
dientes	O
y	O
el	O
timo	O
,	O
y	O
resultó	O
en	O
la	O
muerte	O
neonatal	O
en	O
ratones	B-Taxon
.	O

Encontramos	O
eso	O
APC	B-Protein
juega	O
un	O
papel	O
crucial	O
en	O
las	O
determinaciones	O
de	O
célula	B-Cell
destinos	O
durante	O
el	O
desarrollo	O
embrionario	O
,	O
posiblemente	O
a	O
través	O
de	O
la	O
regulación	O
temporal	O
y	O
específica	O
del	O
tejido	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
niveles	O
en	O
la	O
piel	O
,	O
sus	O
anejos	O
y	O
en	O
el	O
timo	O
.	O

Resultados	O

Generación	O
del	O
ApcCKO	O
y	O
Apc	O
Delta	O
580	O
Ratones	B-Taxon

Para	O
investigar	O
el	O
papel	O
de	O
APC	B-Protein
en	O
el	O
desarrollo	O
de	O
la	O
piel	O
y	O
sus	O
anejos	O
se	O
utilizó	O
el	O
Cre/	O
loxP	B-Sequence
tecnología	O
para	O
introducir	O
un	O
condicional	O
mutación	B-Sequence
de	O
El	O
APC	B-Protein
gene	B-Sequence
en	O
ratones	B-Taxon
.	O

Construimos	O
embrionario	O
células	B-Cell
madre	I-Cell
(	I-Cell
ES	I-Cell
)	I-Cell
y	O
ratones	B-Taxon
llevando	O
un	O
APC	B-Protein
alelo	B-Sequence
albergando	O
tanto	O
un	O
par	O
de	O
sitios	B-Sequence
loxP	I-Sequence
flanqueando	O
APC	B-Protein
exón	B-Sequence
14	O
y	O
un	O
par	O
de	O
Sitios	B-Sequence
de	I-Sequence
destino	I-Sequence
de	I-Sequence
reconocimiento	I-Sequence
de	I-Sequence
FLP	I-Sequence
(	I-Sequence
FRT	I-Sequence
)	I-Sequence
flanqueando	O
a	O
PGK	O
-	O
neomicina	B-Chemical
selección	O
casete	B-Sequence
por	O
recombinación	O
[	O
12	O
,	O
13	O
]	O
(	O
Figura	O
1A	O
,	O
ApcCKON	O
alelo	B-Sequence
,	O
N	O
para	O
neomicina	O
casete	B-Sequence
)	O
.	O

A	O
PGK	O
-	O
neomicina	O
casete	B-Sequence
era	O
insertado	B-Sequence
en	O
la	O
misma	O
orientación	O
transcripcional	O
que	O
APC	B-Protein
en	O
intrón	B-Sequence
14	O
de	O
los	O
endógenos	O
gene	B-Sequence
.	O

los	O
sitios	B-Sequence
loxP	I-Sequence
y	I-Sequence
FRT	I-Sequence
se	O
utilizaron	O
para	O
ayudar	O
a	O
la	O
recombinación	O
unidireccional	O
[	O
12	O
,	O
13	O
]	O
.	O

Dos	O
ratón	B-Taxon
líneas	O
que	O
contienen	O
lo	O
mismo	O
modificación	B-Sequence
se	O
generaron	O
a	O
partir	O
de	O
dos	O
clones	O
ES	O
independientes	O
para	O
asegurar	O
que	O
estas	O
dos	O
líneas	O
se	O
comportaran	O
de	O
la	O
misma	O
manera	O
.	O

Estos	O
ApcCKON	O
/	O
+	B-Sequence
ratones	B-Taxon
se	O
cruzaron	O
con	O
FLPe	O
-	O
eliminador	O
para	O
generar	O
ApcCKO	O
/	O
+	B-Sequence
ratones	B-Taxon
que	O
eran	O
heterocigotos	O
para	O
la	O
final	O
APC	B-Protein
condicional	O
(	O
ApcCKO	O
)	O
alelo	B-Sequence
que	O
remoto	B-Sequence
la	O
PGK	O
-	O
neomicina	O
casete	B-Sequence
y	O
contiene	O
solo	O
el	O
sitios	B-Sequence
loxP	I-Sequence
en	O
el	O
intrones	B-Sequence
flanqueando	O
exón	B-Sequence
14	O

Para	O
evaluar	O
el	O
efecto	O
de	O
eliminación	B-Sequence
de	I-Sequence
exón	I-Sequence
14	O
en	O
ratones	B-Taxon
,	O
ambas	O
líneas	O
de	O
ApcCKO	O
/	O
+	B-Sequence
ratones	B-Taxon
se	O
cruzaron	O
con	O
el	O
eliminador	O
de	O
Cre	O
para	O
generar	O
la	O
línea	O
germinal	O
knockout	O
de	O
APC	B-Protein
,	O
designado	O
Apc	O
Delta	O
580	O
/	O
+	B-Sequence
.	O

los	O
alelo	B-Sequence
mutante	I-Sequence
(	O
Apc	O
Delta	O
580	O
)	O
carece	O
exón	B-Sequence
14	O
(	O
Figura	O
1A	O
)	O
.	O

los	O
transcripción	B-Sequence
desde	O
pérdida	B-Sequence
de	O
exón	B-Sequence
14	O
da	O
como	O
resultado	O
un	O
cambio	B-Sequence
en	I-Sequence
el	I-Sequence
marco	I-Sequence
de	I-Sequence
lectura	I-Sequence
normal	I-Sequence
,	O
resultando	O
en	O
un	O
prematuro	O
codón	B-Sequence
de	I-Sequence
terminación	I-Sequence
de	I-Sequence
cadena	I-Sequence
que	O
,	O
si	O
se	O
utiliza	O
,	O
daría	O
como	O
resultado	O
un	O
truncado	O
polipéptido	B-Sequence
eso	O
es	O
605	O
Automóvil	B-Chemical
club	I-Chemical
británico	I-Chemical
de	O
longitud	O
,	O
de	O
los	O
cuales	O
los	O
primeros	O
580	O
Automóvil	B-Chemical
club	I-Chemical
británico	I-Chemical
corresponder	O
a	O
la	O
normalidad	O
APC	B-Protein
proteína	B-Chemical
.	O

Análisis	O
de	O
transferencia	O
de	O
Southern	O
de	O
la	O
cola	O
ADN	B-Sequence
de	O
la	O
descendencia	O
F1	O
de	O
las	O
líneas	O
ApcCKON	O
y	O
Apc	O
Delta	O
580	O
confirmó	O
la	O
transmisión	O
de	O
la	O
línea	O
germinal	O
de	O
modificado	B-Sequence
APC	B-Protein
alelo	B-Sequence
(	O
Figura	O
1B	O
)	O
.	O

Ratones	B-Taxon
que	O
son	O
heterocigotos	O
para	O
Apc	O
Delta	O
580	O
mutación	B-Sequence
son	O
viables	O
pero	O
tienen	O
una	O
vida	O
útil	O
significativamente	O
reducida	O
(	O
Figura	O
1C	O
)	O
.	O

Estos	O
resultados	O
sugirieron	O
que	O
supresión	B-Sequence
de	O
exón	B-Sequence
14	O
de	O
hecho	O
da	O
como	O
resultado	O
la	O
pérdida	O
o	O
la	O
función	O
anormal	O
del	O
APC	B-Protein
gene	B-Sequence
producto	O

Apc	O
Delta	O
580	O
/	O
+	B-Sequence
ratones	B-Taxon
tienen	O
una	O
mediana	O
de	O
supervivencia	O
de	O
5	O
meses	O
de	O
edad	O
(	O
Figura	O
1C	O
)	O
,	O
con	O
signos	O
progresivos	O
de	O
sangrado	O
rectal	O
y	O
anemia	O
.	O

Similar	O
a	O
los	O
resultados	O
informados	O
con	O
un	O
Apc	O
Delta	O
580	O
/	O
generado	O
de	O
forma	O
independiente	O
+	B-Sequence
condicional	O
ratón	B-Taxon
cepa	O
[	O
14	O
]	O
,	O
Apc	O
Delta	O
580	O
/	O
+	B-Sequence
ratones	B-Taxon
tenían	O
más	O
de	O
100	O
(	O
120	O
+/-	O
37	O
,	O
n	O
=	O
11	O
)	O
tumores	O
intestinales	O
en	O
el	O
momento	O
de	O
su	O
muerte	O
(	O
Figura	O
S1	O
)	O
.	O

Inactivación	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
APC	B-Protein
es	O
un	O
prerrequisito	O
importante	O
para	O
el	O
desarrollo	O
del	O
tumor	O
.	O

Analizamos	O
30	O
tumores	O
intestinales	O
de	O
Apc	O
Delta	O
580/	O
+	B-Sequence
ratones	B-Taxon
por	O
ensayo	O
de	O
transcripción	O
y	O
traducción	O
in	O
vitro	O
,	O
pero	O
ninguno	O
de	O
ellos	O
mostró	O
truncado	O
APC	B-Protein
productos	O
(	O
datos	O
no	O
publicados	O
)	O
,	O
lo	O
que	O
indica	O
que	O
el	O
mecanismo	O
más	O
probable	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
APC	B-Protein
la	O
inactivación	O
es	O
por	O
pérdida	B-Sequence
alélica	I-Sequence
.	O

los	O
alelo	B-Sequence
mutante	I-Sequence
tenía	O
que	O
ser	O
mantenido	O
y	O
transmitido	O
a	O
través	O
de	O
machos	O
ratones	B-Taxon
,	O
como	O
Apc	O
Delta	O
580	O
/	O
+	B-Sequence
las	O
hembras	O
con	O
frecuencia	O
no	O
estaban	O
lo	O
suficientemente	O
sanas	O
para	O
amamantar	O
con	O
éxito	O
a	O
sus	O
propios	O
cachorros	O
debido	O
a	O
la	O
carga	O
tumoral	O
.	O

ApcCKO	O
/	O
+	B-Sequence
ratones	B-Taxon
se	O
entrecruzaron	O
para	O
generar	O
descendencia	O
ApcCKO/CKO	O
.	O

Aproximadamente	O
una	O
cuarta	O
parte	O
de	O
la	O
descendencia	O
(	O
17	O
de	O
81	O
)	O
eran	O
homocigotos	O
para	O
ApcCKO	O
alelo	B-Sequence
.	O

Estas	O
ratones	B-Taxon
así	O
como	O
heterocigotos	O
ratones	B-Taxon
para	O
ApcCKO	O
alelo	B-Sequence
son	O
normales	O
,	O
no	O
mostrando	O
diferencias	O
en	O
su	O
supervivencia	O
a	O
la	O
tipo	B-Sequence
salvaje	I-Sequence
compañeros	O
de	O
camada	O
(	O
Figura	O
1C	O
)	O
.	O

Probamos	O
si	O
nuestro	O
ApcCKO	O
alelo	B-Sequence
puede	O
complementar	O
la	O
alelo	B-Sequence
de	I-Sequence
tipo	I-Sequence
salvaje	I-Sequence
cruzando	O
el	O
ApcCKO/CKO	O
hembra	O
con	O
Apc	O
Delta	O
580/	O
+	B-Sequence
masculino	O
ratón	B-Taxon
.	O

La	O
descendencia	O
ApcCKO/Delta	O
580	O
resultante	O
fue	O
viable	O
y	O
nació	O
en	O
la	O
proporción	O
mendeliana	O
,	O
lo	O
que	O
sugiere	O
que	O
la	O
presencia	O
de	O
sitios	B-Sequence
loxP	I-Sequence
en	O
intrones	B-Sequence
flanqueando	O
exón	B-Sequence
14	O
no	O
tienen	O
ningún	O
efecto	O
adverso	O
sobre	O
la	O
función	O
del	O
APC	B-Protein
gene	B-Sequence
.	O

K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
Resultados	O
en	O
retraso	O
severo	O
del	O
crecimiento	O
y	O
letalidad	O
temprana	O

para	O
introducir	O
el	O
mutación	B-Sequence
de	O
APC	B-Protein
dentro	O
células	B-Cell
expresando	O
K14	B-Protein
,	O
cruzamos	O
WW6	O
ES	O
célula	B-Cell
-	O
derivado	O
[	O
15	O
]	O
ApcCKO	O
/	O
+	B-Sequence
ratones	B-Taxon
con	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
en	O
fondo	O
FVB	O
[	O
16	O
]	O
.	O

los	O
K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-Sequence
ratones	B-Taxon
eran	O
de	O
apariencia	O
normal	O
y	O
eran	O
fértiles	O
.	O

K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-Sequence
los	O
machos	O
se	O
cruzaron	O
con	O
hembras	O
ApcCKO	O
/	O
CKO	O
para	O
evitar	O
el	O
efecto	O
eliminador	O
potencial	O
en	O
ovocitos	B-Cell
de	O
K14	B-Protein
-	O
cre	O
-	O
hembras	O
positivas	O
[	O
17	O
]	O
.	O

los	O
ratones	B-Taxon
se	O
entrecruzaron	O
a	O
partir	O
de	O
entonces	O
para	O
el	O
mantenimiento	O
;	O
por	O
lo	O
tanto	O
,	O
la	O
ratones	B-Taxon
utilizados	O
para	O
el	O
análisis	O
estaban	O
en	O
un	O
fondo	O
mixto	O
de	O
FVB	O
,	O
129/S	O
y	O
C57BL/6	O
en	O
proporciones	O
similares	O
,	O
con	O
una	O
contribución	O
mínima	O
de	O
SJ	O
.	O

los	O
K14	B-Protein
promotor	B-Sequence
es	O
un	O
uso	O
comun	O
célula	B-Cell
epidérmica	I-Cell
promotor	B-Sequence
debido	O
a	O
su	O
expresión	O
por	O
el	O
mitóticamente	O
activo	O
células	B-Cell
de	I-Cell
la	I-Cell
epidermis	I-Cell
y	O
sus	O
apéndices	O
en	O
la	O
piel	O
madura	O
[	O
18	O
]	O
,	O
pero	O
sobre	O
todo	O
es	O
activo	O
en	O
el	O
ectodermo	O
embrionario	O
ya	O
en	O
la	O
etapa	O
ectodérmica	O
de	O
una	O
sola	O
capa	O
del	O
día	O
embrionario	O
(	O
E	O
)	O
9	O
.	O
5	O
[	O
19	O
]	O
.	O

Una	O
expresión	O
restringida	O
de	O
K14	B-Protein
también	O
se	O
encuentra	O
en	O
el	O
timo	O
células	B-Cell
epiteliales	I-Cell
(	O
TEC	O
)	O
en	O
la	O
médula	O
del	O
timo	O
normal	O
[	O
20	O
]	O
.	O

Genotipamos	O
un	O
total	O
de	O
458	O
cachorros	O
(	O
8	O
-	O
10	O
d	O
de	O
edad	O
)	O
de	O
67	O
camadas	O
resultantes	O
de	O
cruces	O
entre	O
K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-Sequence
y	O
ApcCKO/CKO	O
ratones	B-Taxon
.	O

los	O
mutante	B-Sequence
ratones	B-Taxon
de	O
El	O
genotipo	B-Sequence
K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
(	O
en	O
adelante	O
,	O
KA	O
mutante	B-Sequence
)	O
nacieron	O
,	O
pero	O
la	O
frecuencia	O
observada	O
de	O
KA	O
mutantes	B-Sequence
fue	O
mucho	O
menor	O
de	O
lo	O
esperado	O
(	O
78	O
de	O
458	O
[	O
17	O
,	O
0	O
%	O
]	O
;	O
p	O
<	O
0,0005	O
Análisis	O
de	O
Chi	O
-	O
cuadrado	O
,	O
Tabla	O
1	O
)	O
.	O

Evaluar	O
la	O
base	O
de	O
la	O
letalidad	O
neonatal	O
de	O
KA	O
mutantes	B-Sequence
,	O
monitoreamos	O
tres	O
camadas	O
desde	O
el	O
nacimiento	O
hasta	O
el	O
destete	O
midiendo	O
el	O
peso	O
corporal	O
de	O
cada	O
cachorro	O
todos	O
los	O
días	O
.	O

Nacieron	O
un	O
total	O
de	O
25	O
crías	O
de	O
tres	O
camadas	O
,	O
de	O
las	O
cuales	O
7	O
(	O
28	O
%	O
)	O
fueron	O
confirmadas	O
como	O
K14	B-Protein
-	O
cre	O
;	O
ApcCKO/CKO	O
por	O
genotipado	O
,	O
indicando	O
que	O
KA	O
mutantes	B-Sequence
nacieron	O
en	O
la	O
proporción	O
mendeliana	O
esperada	O
.	O

el	O
ka	O
mutante	B-Sequence
las	O
crías	O
fueron	O
amamantadas	O
normalmente	O
y	O
tenían	O
leche	O
en	O
el	O
estómago	O
durante	O
los	O
primeros	O
2	O
o	O
3	O
días	O
después	O
del	O
nacimiento	O
,	O
pero	O
no	O
prosperaron	O
(	O
Figura	O
2	O
)	O
.	O

Para	O
el	O
día	O
postnatal	O
(	O
P	O
)	O
8	O
-	O
10	O
,	O
en	O
el	O
momento	O
del	O
genotipado	O
,	O
muchos	O
KA	O
mutante	B-Sequence
los	O
cachorros	O
eran	O
considerablemente	O
más	O
pequeños	O
que	O
sus	O
compañeros	O
de	O
camada	O
(	O
Figura	O
2B-2F	O
)	O
y	O
algunos	O
han	O
muerto	O
a	O
esta	O
edad	O
o	O
antes	O
.	O

Ninguno	O
de	O
KA	O
mutantes	B-Sequence
sobrevivió	O
hasta	O
la	O
edad	O
del	O
destete	O
.	O

La	O
capacidad	O
de	O
los	O
embriones	O
completos	O
para	O
excluir	O
el	O
azul	O
.	O
teñir	B-Chemical
se	O
utilizó	O
para	O
examinar	O
la	O
barrera	O
epidérmica	O
,	O
que	O
normalmente	O
se	O
adquiere	O
a	O
partir	O
de	O
E16	O
y	O
se	O
completa	O
en	O
E18	O
.	O
5	O
[	O
21	O
]	O
.	O

Análisis	O
de	O
E17	O
.	O
5	O
-	O
E18	O
.	O
5	O
ka	O
mutantes	B-Sequence
mostró	O
que	O
eran	O
capaces	O
de	O
excluir	O
azul	O
teñir	B-Chemical
,	O
lo	O
que	O
indica	O
que	O
la	O
barrera	O
epidérmica	O
estaba	O
intacta	O
(	O
Figura	O
S2	O
)	O
.	O

A	O
estas	O
edades	O
embrionarias	O
no	O
hubo	O
diferencias	O
de	O
tamaño	O
entre	O
los	O
mutantes	B-Sequence
y	O
sus	O
compañeros	O
de	O
camada	O
,	O
pero	O
el	O
mutantes	B-Sequence
``	O
mostraban	O
un	O
parche	O
de	O
``	O
''	O
marca	O
de	O
nacimiento	O
''	O
''	O
o	O
pigmentación	O
oscura	O
en	O
la	O
frente	O
y	O
una	O
línea	O
media	O
oscura	O
que	O
corría	O
caudalmente	O
desde	O
la	O
cabeza	O
hasta	O
la	O
cola	O
.	O
''	O

Sus	O
orejas	O
externas	O
o	O
pinnas	O
estaban	O
arrugadas	O
en	O
apariencia	O
y	O
pigmentadas	O
en	O
comparación	O
con	O
las	O
de	O
sus	O
compañeros	O
de	O
camada	O
.	O

Características	O
externas	O
de	O
KA	O
mutantes	B-Sequence
que	O
fueron	O
evidentes	O
en	O
E18	O
.	O
5	O
persistieron	O
después	O
del	O
nacimiento	O
y	O
se	O
hicieron	O
más	O
prominentes	O
a	O
medida	O
que	O
crecían	O
(	O
Figura	O
2A-2F	O
)	O
.	O

El	O
crecimiento	O
del	O
pelo	O
del	O
pelaje	O
generalmente	O
se	O
retrasó	O
en	O
el	O
mutantes	B-Sequence
.	O

Alrededor	O
de	O
P8	O
,	O
el	O
KA	O
mutantes	B-Sequence
no	O
tenían	O
pelo	O
y	O
tenían	O
la	O
piel	O
arrugada	O
,	O
mientras	O
que	O
sus	O
compañeros	O
de	O
camada	O
fenotípicamente	O
normales	O
tenían	O
una	O
fina	O
capa	O
de	O
pelo	O
suave	O
(	O
Figura	O
2B	O
)	O
.	O

A	O
esta	O
edad	O
,	O
dos	O
incisivos	O
inferiores	O
comienzan	O
a	O
erupcionar	O
en	O
compañeros	O
de	O
camada	O
normales	O
y	O
estos	O
estaban	O
ausentes	O
en	O
el	O
KA	O
mutantes	B-Sequence
(	O
Figura	O
2C	O
y	O
2D	O
)	O
.	O

animales	B-Taxon
también	O
tendían	O
a	O
ser	O
más	O
pequeños	O
y	O
alrededor	O
de	O
P10-P12	O
mostraban	O
vibrisas	O
anormalmente	O
cortas	O
y	O
deformes	O
y	O
pelos	O
de	O
pelaje	O
cortos	O
y	O
desgreñados	O
(	O
Figura	O
2C	O
y	O
2D	O
)	O
.	O

Se	O
notó	O
el	O
desarrollo	O
de	O
gruesas	O
protuberancias	O
en	O
la	O
piel	O
,	O
particularmente	O
alrededor	O
de	O
las	O
orejas	O
,	O
los	O
párpados	O
,	O
la	O
frente	O
,	O
la	O
nariz	O
y	O
las	O
patas	O
(	O
Figura	O
2E	O
)	O
.	O

Estas	O
regiones	O
parecían	O
escamosas	O
,	O
y	O
estas	O
animales	B-Taxon
apenas	O
mantenían	O
los	O
ojos	O
abiertos	O
.	O

En	O
contraste	O
con	O
los	O
compañeros	O
de	O
camada	O
normales	O
que	O
aumentaron	O
constantemente	O
su	O
peso	O
corporal	O
con	O
la	O
edad	O
,	O
sobreviviendo	O
KA	O
mutantes	B-Sequence
comenzó	O
a	O
perder	O
peso	O
desde	O
P10	O
en	O
adelante	O
;	O
por	O
P16-P17	O
estaban	O
todos	O
letárgicos	O
,	O
y	O
ninguno	O
de	O
ellos	O
sobrevivió	O
al	O
destete	O
(	O
Figura	O
2E	O
y	O
2F	O
)	O
.	O

En	O
el	O
momento	O
de	O
la	O
autopsia	O
todos	O
los	O
mutantes	B-Sequence
eran	O
desdentados	O
,	O
sin	O
incisivos	O
o	O
molares	O
,	O
y	O
sus	O
estómagos	O
eran	O
consistentemente	O
pequeños	O
y	O
no	O
tenían	O
sólidos	O
comida	B-Chemical
,	O
a	O
diferencia	O
de	O
sus	O
compañeros	O
de	O
camada	O
de	O
la	O
misma	O
edad	O
,	O
lo	O
que	O
sugiere	O
que	O
la	O
pérdida	O
de	O
peso	O
observada	O
podría	O
ser	O
el	O
resultado	O
de	O
la	O
falta	O
de	O
ingesta	O
de	O
sólidos	O
comida	B-Chemical
(	O
Figura	O
2F	O
)	O
.	O

Curiosamente	O
,	O
los	O
cambios	O
en	O
el	O
peso	O
corporal	O
y	O
el	O
momento	O
del	O
crecimiento	O
del	O
cabello	O
variaron	O
considerablemente	O
entre	O
mutante	B-Sequence
cachorros	O
incluso	O
si	O
eran	O
de	O
la	O
misma	O
camada	O
,	O
mientras	O
que	O
los	O
de	O
compañeros	O
de	O
camada	O
fenotípicamente	O
normales	O
tendían	O
a	O
ser	O
similares	O
.	O

Esta	O
diferencia	O
también	O
se	O
reflejó	O
en	O
la	O
variación	O
en	O
el	O
momento	O
de	O
la	O
muerte	O
en	O
mutantes	B-Sequence
:	O
algunos	O
mutante	B-Sequence
las	O
crías	O
nacían	O
vivas	O
pero	O
morían	O
en	O
uno	O
o	O
dos	O
días	O
,	O
algunas	O
sobrevivieron	O
cerca	O
de	O
la	O
edad	O
del	O
destete	O
.	O

Esta	O
variabilidad	O
de	O
la	O
mutante	B-Sequence
fenotipos	O
sugiere	O
una	O
posible	O
variación	O
en	O
el	O
momento	O
y	O
la	O
eficiencia	O
de	O
cremación	O
APC	B-Protein
supresión	B-Sequence
.	O

Es	O
posible	O
que	O
el	O
genético	B-Sequence
El	O
fondo	O
tiene	O
un	O
papel	O
que	O
desempeñar	O
en	O
esta	O
variabilidad	O
.	O

El	O
examen	O
macroscópico	O
de	O
los	O
órganos	O
internos	O
también	O
mostró	O
que	O
el	O
mutantes	B-Sequence
Los	O
timos	O
eran	O
consistentemente	O
discretos	O
y	O
muy	O
pequeños	O
para	O
su	O
edad	O
,	O
mientras	O
que	O
los	O
de	O
sus	O
compañeros	O
de	O
camada	O
tenían	O
un	O
tamaño	O
muy	O
prominente	O
(	O
Figura	O
2G	O
)	O
.	O

Esta	O
diferencia	O
fue	O
evidente	O
ya	O
en	O
P3	O
.	O

Con	O
bastante	O
frecuencia	O
mutante	B-Sequence
timio	O
en	O
P12	O
-	O
P17	O
mutante	B-Sequence
ratones	B-Taxon
también	O
contenía	O
depósitos	O
negros	O
dentro	O
del	O
tejido	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

mutante	B-Sequence
ratones	B-Taxon
también	O
fueron	O
examinados	O
para	O
detectar	O
anomalías	O
esqueléticas	O
mediante	O
la	O
preparación	O
de	O
muestras	O
esqueléticas	O
de	O
P16	O
-	O
P17	O
ratones	B-Taxon
teñido	O
con	O
rojo	B-Chemical
alizarina	I-Chemical
.	O

Sin	O
diferencias	O
entre	O
la	O
normal	O
y	O
la	O
KA	O
mutante	B-Sequence
ratones	B-Taxon
en	O
el	O
hueso	O
mandibular	O
se	O
puede	O
detectar	O
,	O
pero	O
el	O
mutante	B-Sequence
ratones	B-Taxon
carecían	O
o	O
tenían	O
un	O
conjunto	O
subdesarrollado	O
de	O
incisivos	O
superiores	O
y	O
molares	O
(	O
Figura	O
2H	O
)	O
.	O

No	O
detectamos	O
otras	O
anomalías	O
esqueléticas	O
importantes	O
.	O

Genotipo	B-Sequence
#	O
¿NOMBRE	O
?	O
APC	B-Protein
Transcripciones	B-Sequence

Para	O
evaluar	O
la	O
molecular	B-Chemical
efectos	O
de	O
la	O
K14	B-Protein
-	O
recombinación	O
mediada	O
por	O
cre	O
,	O
examinamos	O
la	O
presencia	O
de	O
eliminado	B-Sequence
APC	B-Protein
(	O
Apc	O
Delta	O
580	O
)	O
alelos	B-Sequence
.	O

ADN	B-Sequence
genómico	I-Sequence
fue	O
extraído	O
de	O
hígado	O
,	O
timo	O
y	O
piel	O
de	O
los	O
4	O
posibles	O
genotipos	B-Sequence
:	O
K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
,	O
K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-Sequence
,	O
ApcCKO	O
/	O
CKO	O
y	O
ApcCKO	O
/	O
+	B-Sequence
.	O

Genotipado	O
en	O
ADN	B-Sequence
genómico	I-Sequence
de	O
estos	O
tejidos	O
mostró	O
que	O
el	O
Apc	O
Delta	O
580	O
alelo	B-Sequence
(	O
500	O
-	O
pb	B-Sequence
producto	O
)	O
se	O
detectó	O
sólo	O
a	O
partir	O
de	O
la	O
piel	O
y	O
el	O
timo	O
de	O
la	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
.	O

La	O
presencia	O
de	O
mutante	B-Sequence
APC	B-Protein
alelo	B-Sequence
en	O
el	O
timo	O
de	O
K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-Sequence
ratones	B-Taxon
fue	O
consistentemente	O
mucho	O
menor	O
que	O
el	O
ADN	B-Sequence
de	O
la	O
piel	O
del	O
mismo	O
animal	B-Taxon
u	O
otros	O
tejidos	O
del	O
KA	O
mutantes	B-Sequence
.	O

Además	O
,	O
este	O
producto	O
no	O
se	O
detectó	O
en	O
absoluto	O
ni	O
en	O
el	O
hígado	O
ni	O
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratón	B-Taxon
muestras	O
de	O
tejidos	O
,	O
estableciendo	O
que	O
la	O
recombinación	O
mediada	O
por	O
Cre	O
ha	O
tenido	O
lugar	O
en	O
la	O
forma	O
específica	O
de	O
tejido	O
en	O
el	O
ratones	B-Taxon
que	O
heredó	O
K14	B-Protein
-cre	O
(	O
Figura	O
3A	O
)	O
.	O

APC	B-Protein
transcripciones	B-Sequence
también	O
fueron	O
analizados	O
por	O
RT	O
-	O
PCR	O
con	O
cebadores	B-Sequence
abarcando	O
exón	B-Sequence
14	O
(	O
Figura	O
1A	O
)	O
usando	O
total	O
ARN	B-Sequence
aislado	O
de	O
las	O
correspondientes	O
muestras	O
de	O
tejido	O
.	O

Detectamos	O
el	O
previsto	B-Sequence
RT-	O
producto	B-Sequence
PCR	I-Sequence
(	O
313	O
pb	B-Sequence
)	O
del	O
truncado	O
APC	B-Protein
(	O
Apc	O
Delta	O
580	O
)	O
alelo	B-Sequence
solo	O
en	O
los	O
tejidos	O
en	O
los	O
que	O
se	O
sabe	O
que	O
la	O
recombinasa	O
Cre	O
se	O
expresa	O
en	O
el	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
.	O

Sin	O
embargo	O
,	O
esto	O
producto	B-Sequence
no	O
se	O
detectó	O
en	O
ninguno	O
de	O
los	O
dos	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratón	B-Taxon
muestras	O
de	O
tejidos	O
o	O
el	O
hígado	O
de	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
,	O
y	O
solo	O
el	O
producto	B-Sequence
desde	O
el	O
alelo	B-Sequence
de	I-Sequence
tipo	I-Sequence
salvaje	I-Sequence
(	O
528	O
pb	B-Sequence
)	O
fue	O
detectado	O
a	O
partir	O
de	O
estos	O
ARN	B-Sequence
muestras	O
,	O
lo	O
que	O
confirma	O
aún	O
más	O
que	O
la	O
recombinación	O
mediada	O
por	O
Cre	O
ha	O
tenido	O
lugar	O
en	O
el	O
tejido	O
-	O
y	O
genotipo	B-Sequence
-	O
manera	O
específica	O
(	O
Figura	O
3B	O
)	O
.	O

K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
Pérdida	O
de	O
folículos	O
pilosos	O
aberrantes	O
inducidos	O
por	O
toda	O
la	O
epidermis	O

Comprender	O
la	O
base	O
del	O
desarrollo	O
anormal	O
y	O
retrasado	O
del	O
cabello	O
en	O
la	O
KA	O
mutantes	B-Sequence
,	O
realizamos	O
un	O
examen	O
histológico	O
e	O
inmunohistoquímico	O
(	O
Figura	O
4	O
)	O
.	O

El	O
folículo	O
piloso	O
es	O
un	O
apéndice	O
epidérmico	O
que	O
consta	O
de	O
una	O
porción	O
permanente	O
superior	O
y	O
una	O
porción	O
cíclica	O
inferior	O
que	O
produce	O
el	O
cabello	O
[	O
22	O
,	O
23	O
]	O
.	O

La	O
vaina	O
externa	O
de	O
la	O
raíz	O
(	O
SRO	O
)	O
es	O
contigua	O
y	O
bioquímicamente	O
similar	O
a	O
la	O
capa	O
basal	O
de	O
la	O
epidermis	O
.	O

Las	O
capas	O
internas	O
del	O
folículo	O
piloso	O
incluyen	O
tres	O
capas	O
concéntricas	O
de	O
la	O
vaina	O
interna	O
de	O
la	O
raíz	O
y	O
tres	O
capas	O
concéntricas	O
de	O
cabello	O
,	O
que	O
producen	O
células	B-Cell
.	O

``	O
En	O
la	O
base	O
del	O
folículo	O
piloso	O
se	O
encuentra	O
el	O
bulbo	O
germinativo	O
del	O
folículo	O
piloso	O
,	O
que	O
contiene	O
una	O
``	O
''	O
matriz	O
''	O
''	O
que	O
prolifera	O
rápidamente	O
.	O
''	O
células	B-Cell
que	O
se	O
diferencian	O
para	O
poblar	O
todas	O
las	O
capas	O
de	O
la	O
vaina	O
interna	O
de	O
la	O
raíz	O
y	O
el	O
propio	O
tallo	O
del	O
cabello	O
[	O
22	O
]	O
.	O

Durante	O
la	O
fase	O
anágena	O
del	O
ciclo	O
del	O
cabello	O
(	O
hasta	O
P15	O
)	O
,	O
los	O
folículos	O
pilosos	O
de	O
fenotípicamente	O
normal	O
ratones	B-Taxon
crecieron	O
profundamente	O
en	O
la	O
grasa	O
subcutánea	O
y	O
se	O
espaciaron	O
y	O
alinearon	O
uniformemente	O
en	O
conjuntos	O
paralelos	O
en	O
un	O
ángulo	O
específico	O
relativo	O
a	O
la	O
superficie	O
de	O
la	O
piel	O
(	O
Figura	O
4A	O
)	O
.	O

En	O
cambio	O
,	O
K.A	O
.	O
mutante	B-Sequence
Los	O
folículos	O
estaban	O
espaciados	O
irregularmente	O
y	O
,	O
a	O
menudo	O
,	O
se	O
veían	O
como	O
invaginaciones	O
desorientadas	O
y	O
atrapadas	O
en	O
P3	O
que	O
se	O
volvieron	O
aún	O
más	O
notables	O
en	O
P12	O
cuando	O
el	O
mutante	B-Sequence
ratones	B-Taxon
estaban	O
cubiertos	O
por	O
un	O
abrigo	O
de	O
piel	O
(	O
Figura	O
4F	O
)	O
.	O

Los	O
bulbos	O
a	O
menudo	O
se	O
doblaban	O
además	O
de	O
tener	O
ángulos	O
irregulares	O
entre	O
sí	O
y	O
sus	O
tamaños	O
y	O
ubicaciones	O
a	O
menudo	O
eran	O
variables	O
.	O

Se	O
observaron	O
con	O
frecuencia	O
racimos	O
de	O
múltiples	O
invaginaciones	O
o	O
estructuras	O
foliculares	O
displásicas	O
en	O
toda	O
la	O
epidermis	O
,	O
mientras	O
que	O
otras	O
regiones	O
mostraban	O
lagunas	O
sin	O
folículos	O
.	O

El	O
seccionamiento	O
en	O
serie	O
indicó	O
que	O
algunos	O
de	O
los	O
folículos	O
pilosos	O
en	O
el	O
P12	O
mutante	B-Sequence
la	O
piel	O
no	O
estaba	O
bien	O
formada	O
o	O
era	O
más	O
corta	O
de	O
lo	O
normal	O
.	O

En	O
conjunto	O
,	O
estas	O
características	O
podrían	O
explicar	O
el	O
aparente	O
retraso	O
,	O
seguido	O
por	O
una	O
extensión	O
,	O
del	O
abrigo	O
de	O
piel	O
corto	O
y	O
de	O
aspecto	O
desgreñado	O
de	O
estos	O
mutante	B-Sequence
ratones	B-Taxon
.	O

APC	B-Protein
es	O
un	O
regulador	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
eso	O
es	O
importante	O
para	O
la	O
señalización	O
de	O
Wnt	O
.	O

Examinamos	O
los	O
patrones	O
de	O
expresión	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
los	O
tejidos	O
afectados	O
.	O

En	O
la	O
piel	O
normal	O
,	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
,	O
miembro	O
de	O
la	O
complejo	B-GENE
de	I-GENE
unión	I-GENE
adherente	I-GENE
,	O
se	O
encontró	O
en	O
la	O
SRO	O
de	O
los	O
folículos	O
pilosos	O
y	O
la	O
capa	O
basal	O
de	O
la	O
epidermis	O
,	O
donde	O
K14	B-Protein
también	O
se	O
observa	O
expresión	O
(	O
Figura	O
4C	O
y	O
4D	O
)	O
,	O
mientras	O
que	O
la	O
expresión	O
de	O
K1	B-Protein
,	O
involucrina	B-Protein
,	O
y	O
loricrin	B-Protein
(	O
marcadores	O
de	O
las	O
capas	O
granular	O
y	O
espinosa	O
de	O
la	O
epidermis	O
)	O
sólo	O
se	O
observó	O
en	O
la	O
epidermis	O
no	O
basal	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Los	O
patrones	O
de	O
expresión	O
de	O
K14	B-Protein
,	O
K1	B-Protein
,	O
involucrina	B-Protein
,	O
y	O
loricrin	B-Protein
,	O
en	O
piel	O
de	O
mutante	B-Sequence
y	O
compañero	O
de	O
camada	O
normal	O
ratones	B-Taxon
en	O
P3-P17	O
,	O
no	O
mostró	O
diferencias	O
significativas	O
en	O
la	O
diferenciación	O
terminal	O
(	O
Figura	O
4A-4D	O
,	O
4F-4I	O
)	O
.	O

Del	O
mismo	O
modo	O
,	O
el	O
patrón	O
de	O
expresión	O
de	O
K6	B-Protein
,	O
que	O
normalmente	O
sólo	O
se	O
expresa	O
en	O
la	O
capa	O
suprabasal	O
o	O
interna	O
de	O
la	O
ORS	O
del	O
folículo	O
piloso	O
pero	O
no	O
en	O
la	O
epidermis	O
(	O
Figura	O
4E	O
)	O
,	O
no	O
cambió	O
.	O

Debido	O
a	O
la	O
estructura	O
anormal	O
y	O
desorganizada	O
de	O
los	O
propios	O
folículos	O
pilosos	O
,	O
K6	B-Protein
la	O
localización	O
resaltó	O
la	O
anormalidad	O
histológica	O
(	O
Figura	O
4J	O
)	O
.	O

Sin	O
embargo	O
,	O
como	O
en	O
la	O
piel	O
normal	O
,	O
K6	B-Protein
se	O
vio	O
principalmente	O
solo	O
en	O
la	O
capa	O
suprabasal	O
del	O
ORS	O
que	O
no	O
se	O
colocalizó	O
con	O
los	O
marcadores	O
basales	O
,	O
K14	B-Protein
o	O
K5	B-Protein
(	O
Figura	O
4I	O
y	O
4J	O
)	O
.	O

En	O
piel	O
normal	O
,	O
proliferante	O
células	B-Cell
se	O
detectaron	O
en	O
la	O
capa	O
basal	O
de	O
la	O
epidermis	O
o	O
en	O
los	O
bulbos	O
de	O
los	O
folículos	O
pilosos	O
germinativos	O
en	O
la	O
base	O
(	O
Figura	O
4B	O
)	O
.	O

En	O
el	O
mutante	B-Sequence
piel	O
,	O
ya	O
sea	O
BrdU	O
incorporación	B-Sequence
o	O
Ki67	B-Protein
expresión	O
se	O
observó	O
no	O
sólo	O
en	O
células	B-Cell
en	O
bulbos	O
en	O
la	O
base	O
del	O
folículo	O
piloso	O
pero	O
también	O
en	O
estructuras	O
similares	O
a	O
bulbos	O
que	O
brotaban	O
de	O
la	O
ORS	O
de	O
los	O
folículos	O
pilosos	O
existentes	O
(	O
Figura	O
4G	O
y	O
4G	O
'	O
)	O
.	O

Cada	O
punta	O
en	O
ciernes	O
se	O
estaba	O
volviendo	O
como	O
un	O
bulbo	O
de	O
folículo	O
piloso	O
que	O
contenía	O
proliferantes	O
células	B-Cell
.	O

Por	O
lo	O
tanto	O
,	O
a	O
pesar	O
de	O
la	O
histología	O
anormal	O
en	O
el	O
mutante	B-Sequence
piel	O
,	O
la	O
proliferación	O
parece	O
estar	O
confinada	O
a	O
estructuras	O
similares	O
a	O
bulbos	O
como	O
en	O
la	O
piel	O
normal	O
(	O
Figura	O
4G	O
y	O
4G	O
'	O
)	O
.	O

Las	O
ubicaciones	O
exactas	O
de	O
los	O
bulbos	O
de	O
los	O
folículos	O
pilosos	O
no	O
fueron	O
tan	O
fáciles	O
de	O
definir	O
para	O
algunos	O
mutante	B-Sequence
folículos	O
debido	O
a	O
sus	O
estructuras	O
desorganizadas	O
.	O

Curiosamente	O
,	O
en	O
el	O
mutante	B-Sequence
piel	O
,	O
además	O
de	O
difusa	O
membrana	B-GENE
-	O
localización	O
limitada	O
como	O
en	O
la	O
piel	O
normal	O
,	O
células	B-Cell
con	O
fuerte	O
citosólico	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
la	O
localización	O
también	O
se	O
observó	O
con	O
frecuencia	O
(	O
Figura	O
4H	O
y	O
4H	O
'	O
)	O
.	O

estos	O
elevados	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
generalmente	O
estaban	O
rodeados	O
de	O
proliferación	O
células	B-Cell
,	O
formando	O
estructuras	O
en	O
forma	O
de	O
bulbo	O
.	O

La	O
comparación	O
de	O
secciones	O
en	O
serie	O
teñidas	O
inmunoquímicamente	O
mostró	O
que	O
estos	O
intensos	O
citosólico	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
las	O
tinciones	O
generalmente	O
se	O
encontraron	O
en	O
cualquiera	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K1	B-Protein
#	O
¿NOMBRE	O
?	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K6	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
,	O
y	O
están	O
rodeados	O
por	O
la	O
proliferación	O
células	B-Cell
.	O

Determinar	O
el	O
inicio	O
de	O
la	O
morfogénesis	O
del	O
folículo	O
piloso	O
en	O
estos	O
mutantes	B-Sequence
,	O
examinamos	O
el	O
patrón	O
de	O
expresión	O
de	O
erizo	B-Protein
Sonic	I-Protein
(	O
Shh	B-Protein
)	O
,	O
factor	O
expresado	O
en	O
bulbos	O
pilosos	O
en	O
piel	O
embrionaria	O
(	O
Figura	O
5	O
)	O
.	O

La	O
morfogénesis	O
aberrante	O
del	O
folículo	O
piloso	O
es	O
evidente	O
ya	O
en	O
E14	O
.	O
5	O
en	O
mutante	B-Sequence
piel	O
embrionaria	O
,	O
por	O
expresión	O
apolarizada	O
múltiple	O
de	O
Shh	B-Protein
en	O
toda	O
la	O
epidermis	O
(	O
Figura	O
5B	O
)	O
,	O
mientras	O
que	O
la	O
de	O
los	O
embriones	O
de	O
control	O
estaba	O
bien	O
polarizada	O
y	O
regularmente	O
espaciada	O
(	O
Figura	O
5A	O
)	O
.	O

Con	O
desarrollo	O
,	O
control	O
ratón	B-Taxon
Los	O
folículos	O
pilosos	O
se	O
invaginan	O
hacia	O
abajo	O
de	O
manera	O
polarizada	O
(	O
Figura	O
5C	O
)	O
,	O
mientras	O
que	O
los	O
de	O
mutante	B-Sequence
los	O
embriones	O
eran	O
completamente	O
irregulares	O
y	O
apolarizados	O
(	O
Figura	O
5D	O
)	O
.	O

``	O
También	O
se	O
observó	O
que	O
el	O
tamaño	O
de	O
cada	O
folículo	O
``	O
''	O
en	O
ciernes	O
''	O
''	O
,	O
detectado	O
por	O
''	O
Shh	B-Protein
expresión	O
,	O
fue	O
variable	O
(	O
Figura	O
5D	O
)	O
.	O

la	O
intensidad	O
de	O
Shh	B-Protein
la	O
tinción	O
fue	O
generalmente	O
más	O
fuerte	O
en	O
mutante	B-Sequence
piel	O
que	O
en	O
la	O
piel	O
normal	O
.	O

La	O
iniciación	O
aberrante	O
de	O
múltiples	O
placodas	O
de	O
cabello	O
durante	O
la	O
morfogénesis	O
temprana	O
del	O
folículo	O
piloso	O
también	O
fue	O
evidente	O
por	O
la	O
hibridación	O
in	O
situ	O
(	O
ISH	O
)	O
de	O
E15	O
de	O
montaje	O
completo	O
.	O
5	O
mutante	B-Sequence
embriones	O
para	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
(	O
Figura	O
5F	O
y	O
5F	O
'	O
)	O
.	O

El	O
patrón	O
de	O
expresión	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
embriones	O
demostró	O
claramente	O
la	O
formación	O
de	O
arreglos	O
regulares	O
de	O
placodas	O
de	O
cabello	O
en	O
la	O
piel	O
embrionaria	O
normal	O
(	O
Figura	O
5E	O
y	O
5E	O
'	O
)	O
,	O
pero	O
tal	O
patrón	O
regular	O
se	O
perdió	O
,	O
y	O
a	O
menudo	O
se	O
iniciaron	O
placodas	O
de	O
cabello	O
anómalas	O
muy	O
agrupadas	O
en	O
mutante	B-Sequence
piel	O
embrionaria	O
(	O
Figura	O
5F	O
'	O
)	O
.	O

Placodas	O
de	O
cabello	O
aberrantes	O
también	O
fueron	O
evidentes	O
en	O
toda	O
la	O
superficie	O
de	O
la	O
piel	O
de	O
las	O
extremidades	O
en	O
E15	O
.	O
5	O
mutantes	B-Sequence
(	O
Figura	O
5F	O
)	O
,	O
mientras	O
que	O
los	O
de	O
los	O
embriones	O
de	O
control	O
aún	O
no	O
se	O
habían	O
formado	O
(	O
Figura	O
5E	O
)	O
.	O

Lo	O
más	O
interesante	O
,	O
en	O
el	O
mutante	B-Sequence
almohadillas	O
plantares	O
,	O
donde	O
normalmente	O
no	O
se	O
forman	O
placodas	O
pilosas	O
(	O
Figura	O
5G	O
)	O
,	O
también	O
encontramos	O
placodas	O
pilosas	O
ectópicas	O
de	O
tamaño	O
irregular	O
y	O
espaciadas	O
,	O
lo	O
que	O
indica	O
que	O
las	O
almohadillas	O
plantares	O
todavía	O
tienen	O
el	O
potencial	O
de	O
formar	O
placodas	O
pilosas	O
en	O
ausencia	O
de	O
la	O
APC	B-Protein
gene	B-Sequence
(	O
Figura	O
5H	O
)	O
.	O

Estos	O
resultados	O
sugieren	O
colectivamente	O
que	O
la	O
diferenciación	O
terminal	O
tiene	O
lugar	O
normalmente	O
en	O
el	O
mutante	B-Sequence
piel	O
,	O
pero	O
el	O
inicio	O
de	O
la	O
morfogénesis	O
del	O
folículo	O
piloso	O
embrionario	O
está	O
gravemente	O
interrumpido	O
,	O
acompañado	O
de	O
una	O
morfogénesis	O
continua	O
del	O
folículo	O
piloso	O
ectópico	O
en	O
el	O
posnatal	O
mutante	B-Sequence
piel	O
.	O

Efectos	O
de	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
en	O
otros	O
apéndices	O
epidérmicos	O

Similar	O
a	O
la	O
biología	O
de	O
los	O
folículos	O
pilosos	O
,	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
también	O
afectó	O
el	O
desarrollo	O
de	O
otros	O
apéndices	O
epidérmicos	O
que	O
dependen	O
de	O
interacciones	O
epiteliales-mesenquimatosas	O
para	O
su	O
formación	O
.	O

El	O
más	O
llamativo	O
de	O
estos	O
fue	O
la	O
displasia	O
dental	O
(	O
Figura	O
4K-4R	O
)	O
.	O

El	O
desarrollo	O
dentario	O
normalmente	O
se	O
inicia	O
entre	O
E11	O
y	O
E12	O
mediante	O
la	O
invaginación	O
del	O
epitelio	O
oral	O
derivado	O
ectodérmicamente	O
en	O
el	O
mesénquima	O
derivado	O
de	O
la	O
cresta	O
neural	O
craneal	O
subyacente	O
,	O
generando	O
un	O
germen	O
dental	O
.	O

A	O
pesar	O
del	O
fenotipo	O
extremadamente	O
desdentado	O
de	O
KA	O
mutantes	B-Sequence
,	O
el	O
análisis	O
histológico	O
de	O
sus	O
cavidades	O
bucales	O
reveló	O
la	O
formación	O
de	O
múltiples	O
brotes	O
dentales	O
en	O
cada	O
lugar	O
.	O

Estos	O
dientes	O
aberrantes	O
obviamente	O
no	O
crecieron	O
durante	O
la	O
transición	O
dietética	O
de	O
la	O
leche	O
a	O
los	O
alimentos	O
sólidos	O
.	O
comida	B-Chemical
.	O

Análoga	O
a	O
los	O
patrones	O
de	O
expresión	O
de	O
K14	B-Protein
y	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
la	O
piel	O
normal	O
,	O
difuso	O
membrana	B-GENE
#	O
¿NOMBRE	O
?	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
fue	O
detectado	O
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ameloblastos	B-Cell
de	O
normalidad	O
ratones	B-Taxon
.	O

En	O
mutantes	B-Sequence
,	O
algunos	O
de	O
los	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
también	O
se	O
mostró	O
fuerte	O
citosólico	B-GENE
/	O
nuclear	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
tinción	O
,	O
como	O
se	O
observa	O
en	O
la	O
mutante	B-Sequence
piel	O
(	O
Figura	O
4Q	O
,	O
4Q	O
'	O
y	O
4R	O
)	O
.	O

Iniciación	O
de	O
yemas	O
dentales	O
ectópicas	O
en	O
el	O
mutante	B-Sequence
ratones	B-Taxon
fue	O
evidente	O
en	O
E15	O
.	O
5	O
por	O
puntos	O
extra	O
de	O
Shh	B-Protein
expresión	O
adyacente	O
a	O
los	O
dientes	O
primarios	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Pérdida	O
de	O
APC	B-Protein
también	O
conduce	O
a	O
hiperplasia	O
en	O
el	O
epitelio	O
escamoso	O
de	O
la	O
córnea	O
,	O
glándulas	O
orales	O
,	O
salivales	O
y	O
de	O
Hardarian	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

En	O
estos	O
epitelios	O
también	O
se	O
observó	O
metaplasia	O
escamosa	O
a	O
estructuras	O
similares	O
a	O
folículos	O
pilosos	O
,	O
morfogénesis	O
de	O
folículos	O
pilosos	O
ectópicos	O
.	O

K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
Pérdida	O
de	O
resultados	O
en	O
hipoplásicos/atímicos	O
Ratones	B-Taxon

El	O
timo	O
es	O
un	O
órgano	O
que	O
también	O
se	O
sabe	O
que	O
tiene	O
K14	B-Protein
expresión	O
[	O
16	O
]	O
.	O

Representa	O
el	O
órgano	O
linfoide	O
primario	O
para	O
el	O
desarrollo	O
y	O
selección	O
de	O
timocitos	O
.	O

Distintas	O
poblaciones	O
de	O
TEC	O
de	O
la	O
corteza	O
y	O
la	O
médula	O
median	O
ambas	O
funciones	O
críticas	O
.	O

Los	O
subconjuntos	O
de	O
TEC	O
corticales	O
y	O
medulares	O
se	O
caracterizan	O
por	O
la	O
expresión	O
diferencial	O
de	O
cuatro	O
especies	O
de	O
queratina	O
:	O
K8	B-Protein
,	O
K18	B-Protein
,	O
K5	B-Protein
,	O
y	O
K14	B-Protein
.	O

El	O
timo	O
normal	O
es	O
un	O
órgano	O
linfoide	O
lobulado	O
,	O
cada	O
lóbulo	O
muestra	O
claramente	O
los	O
dos	O
compartimentos	O
TEC	O
distintos	O
,	O
una	O
corteza	O
externa	O
y	O
una	O
médula	O
interna	O
(	O
Figura	O
6	O
)	O
.	O

No	O
hubo	O
diferencias	O
importantes	O
en	O
la	O
histología	O
del	O
timo	O
entre	O
las	O
edades	O
P3	O
a	O
P17	O
en	O
compañeros	O
de	O
camada	O
fenotípicamente	O
normales	O
.	O

Como	O
se	O
muestra	O
en	O
la	O
tinción	O
H	O
&	O
E	O
del	O
timo	O
,	O
la	O
corteza	O
estaba	O
formada	O
por	O
tejido	O
linfoide	O
denso	O
que	O
carece	O
de	O
nódulos	O
(	O
Figura	O
6A	O
)	O
.	O

Dado	O
que	O
el	O
estroma	O
de	O
la	O
médula	O
está	O
menos	O
infiltrado	O
con	O
linfocitos	B-Cell
que	O
la	O
corteza	O
,	O
la	O
médula	O
se	O
tiñó	O
más	O
ligeramente	O
que	O
la	O
corteza	O
.	O

en	O
la	O
normalidad	O
ratones	B-Taxon
,	O
el	O
timo	O
retiene	O
su	O
tamaño	O
hasta	O
la	O
edad	O
adulta	O
joven	O
y	O
luego	O
retrocede	O
por	O
atrofia	O
.	O

En	O
los	O
jóvenes	O
normales	O
ratones	B-Taxon
examinamos	O
(	O
P3-P17	O
)	O
,	O
es	O
evidente	O
que	O
los	O
timocitos	O
eran	O
mitóticamente	O
activos	O
en	O
la	O
corteza	O
según	O
lo	O
determinado	O
por	O
la	O
inmunotinción	O
de	O
BrdU	O
(	O
Figura	O
6B	O
)	O
.	O

Inmunohistoquímica	O
del	O
timo	O
normal	O
de	O
P3	O
a	O
P17	O
ratones	B-Taxon
mostró	O
un	O
patrón	O
de	O
tinción	O
similar	O
para	O
K14	B-Protein
en	O
que	O
su	O
expresión	O
estaba	O
restringida	O
a	O
una	O
pequeña	O
población	O
de	O
TEC	O
en	O
la	O
región	O
medular	O
interna	O
y	O
en	O
el	O
queratinocitos	B-Cell
en	O
los	O
corpúsculos	O
de	O
Hassall	O
(	O
Figura	O
6D	O
)	O
.	O

Difuso	O
citoplasmático	B-GENE
tinción	O
para	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
también	O
se	O
detectó	O
en	O
la	O
médula	O
células	B-Cell
epiteliales	I-Cell
(	O
Figura	O
6C	O
)	O
.	O

En	O
contraste	O
con	O
K14	B-Protein
expresión	O
,	O
tinción	O
difusa	O
para	O
K8	B-Protein
fue	O
observado	O
en	O
células	B-Cell
epiteliales	I-Cell
tanto	O
en	O
la	O
médula	O
como	O
en	O
la	O
corteza	O
(	O
Figura	O
S3	O
)	O
.	O

K1	B-Protein
no	O
se	O
detectó	O
tinción	O
en	O
jóvenes	O
ratones	B-Taxon
en	O
P3	O
pero	O
en	O
mayores	O
ratones	B-Taxon
se	O
detectó	O
en	O
diferenciados	O
queratinocitos	B-Cell
en	O
algunos	O
de	O
los	O
corpúsculos	O
de	O
Hassall	O
(	O
Figura	O
S3	O
)	O
.	O

Las	O
anomalías	O
histológicas	O
del	O
timo	O
eran	O
evidentes	O
ya	O
en	O
P3	O
en	O
KA	O
mutantes	B-Sequence
(	O
Figura	O
6E	O
y	O
6H	O
)	O
.	O

El	O
timo	O
estaba	O
hecho	O
de	O
dos	O
lóbulos	O
como	O
en	O
el	O
normal	O
ratones	B-Taxon
pero	O
el	O
mutante	B-Sequence
el	O
timo	O
era	O
significativamente	O
más	O
pequeño	O
en	O
tamaño	O
que	O
el	O
de	O
los	O
controles	O
de	O
la	O
misma	O
edad	O
(	O
Figura	O
2G	O
)	O
.	O

Curiosamente	O
,	O
las	O
variaciones	O
en	O
la	O
severidad	O
fenotípica	O
de	O
la	O
mutante	B-Sequence
las	O
crías	O
en	O
P3	O
se	O
reflejaron	O
de	O
forma	O
destacada	O
en	O
la	O
extensión	O
de	O
las	O
anomalías	O
histológicas	O
del	O
timo	O
.	O

A	O
P3	O
KA	O
mutante	B-Sequence
el	O
cachorro	O
que	O
mostró	O
un	O
fenotipo	O
más	O
leve	O
con	O
un	O
peso	O
corporal	O
comparable	O
al	O
de	O
sus	O
compañeros	O
de	O
camada	O
normales	O
(	O
Figura	O
2A	O
,	O
M2	O
)	O
mostró	O
anomalías	O
del	O
timo	O
más	O
leves	O
(	O
Figura	O
6E	O
)	O
en	O
comparación	O
con	O
sus	O
compañeros	O
de	O
camada	O
más	O
graves	O
.	O
mutante	B-Sequence
compañero	O
de	O
camada	O
(	O
Figura	O
2A	O
,	O
M1	O
;	O
Figura	O
6H	O
)	O
.	O

El	O
P3	O
más	O
suave	O
mutante	B-Sequence
el	O
timo	O
ya	O
era	O
mucho	O
más	O
pequeño	O
en	O
tamaño	O
en	O
comparación	O
con	O
los	O
de	O
los	O
compañeros	O
de	O
camada	O
normales	O
(	O
datos	O
no	O
mostrados	O
)	O
,	O
pero	O
dos	O
compartimentos	O
epiteliales	O
del	O
timo	O
eran	O
todavía	O
distinguibles	O
histológicamente	O
,	O
con	O
una	O
colonización	O
de	O
timocitos	O
evidente	O
en	O
la	O
corteza	O
.	O

Sin	O
embargo	O
,	O
había	O
pequeñas	O
poblaciones	O
de	O
manchas	O
leves	O
.	O
células	B-Cell
por	O
H	O
&	O
E	O
que	O
se	O
extiende	O
desde	O
el	O
borde	O
de	O
la	O
corteza	O
externa	O
hacia	O
la	O
médula	O
interna	O
(	O
Figura	O
6E	O
)	O
,	O
y	O
estos	O
células	B-Cell
mostró	O
intenso	O
nuclear	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
tinción	O
mientras	O
que	O
el	O
resto	O
de	O
la	O
medular	O
células	B-Cell
mostró	O
difusa	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
patrón	O
de	O
tinción	O
similar	O
al	O
del	O
control	O
(	O
Figura	O
6F	O
)	O
.	O

Localización	O
de	O
K14	B-Protein
se	O
limitó	O
a	O
unos	O
pocos	O
células	B-Cell
en	O
la	O
médula	O
y	O
algunos	O
superpuestos	O
con	O
K8	B-Protein
localización	O
(	O
Figura	O
6G	O
)	O
.	O

En	O
el	O
otro	O
P3	O
mutante	B-Sequence
timo	O
los	O
distintos	O
compartimentos	O
epiteliales	O
tímicos	O
se	O
han	O
perdido	O
por	O
completo	O
,	O
y	O
sólo	O
unos	O
pocos	O
linfocitos	B-Cell
quedaron	O
en	O
los	O
bordes	O
y	O
algunas	O
en	O
el	O
medio	O
(	O
Figura	O
6H	O
)	O
.	O

Las	O
actividades	O
proliferativas	O
ya	O
no	O
se	O
observaron	O
en	O
los	O
timocitos	O
tan	O
prominentemente	O
como	O
en	O
el	O
timo	O
normal	O
,	O
pero	O
la	O
células	B-Cell
epiteliales	I-Cell
parecía	O
estar	O
formando	O
estructuras	O
concéntricas	O
(	O
Figura	O
6I	O
)	O
.	O

A	O
diferencia	O
de	O
los	O
normales	O
o	O
leves	O
mutante	B-Sequence
timi	O
,	O
el	O
severo	O
P3	O
mutante	B-Sequence
el	O
timo	O
mostró	O
extensa	O
K14	B-Protein
expresión	O
que	O
se	O
superpone	O
con	O
K8	B-Protein
expresión	O
(	O
Figura	O
6K	O
)	O
.	O

Estas	O
células	B-Cell
eran	O
más	O
como	O
células	B-Cell
basales	I-Cell
de	O
la	O
piel	O
que	O
los	O
TEC	O
y	O
estaban	O
adyacentes	O
a	O
los	O
más	O
inmaduros	O
células	B-Cell
que	O
se	O
mostraban	O
fuertes	O
nuclear	B-GENE
y	O
citoplasmático	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
tinción	O
(	O
Figura	O
6J	O
)	O
.	O

los	O
nuclear	B-GENE
tinción	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
no	O
se	O
observó	O
en	O
el	O
timo	O
normal	O
de	O
la	O
misma	O
edad	O
(	O
Figura	O
6C	O
)	O
.	O

En	O
particular	O
,	O
el	O
K14	B-Protein
y	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
los	O
patrones	O
de	O
tinción	O
eran	O
mutuamente	O
excluyentes	O
(	O
Figura	O
6J	O
y	O
6K	O
)	O
.	O

En	O
P10	O
-	O
P13	O
,	O
el	O
mutante	B-Sequence
El	O
timo	O
consistía	O
en	O
numerosas	O
estructuras	O
parecidas	O
a	O
corpúsculos	O
de	O
Hassall	O
agrandadas	O
,	O
hechas	O
de	O
arreglos	O
de	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K8	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
epiteliales	I-Cell
grandes	O
depósitos	O
de	O
queratina	O
circundantes	O
(	O
Figura	O
6L	O
y	O
6O	O
)	O
.	O

hubo	O
numerosos	O
neutrófilos	B-Cell
y	O
macrófagos	B-Cell
infiltrarse	O
en	O
el	O
timo	O
en	O
respuesta	O
a	O
estas	O
queratinas	O
;	O
por	O
lo	O
tanto	O
,	O
estas	O
estructuras	O
podrían	O
denominarse	O
piogranulomas	O
.	O

Diversos	O
grados	O
de	O
diferenciación	O
-	O
marcadores	O
específicos	O
dependiendo	O
de	O
la	O
edad	O
de	O
ratones	B-Taxon
,	O
en	O
este	O
caso	O
K1	B-Protein
y	O
involucrina	B-Protein
que	O
normalmente	O
están	O
presentes	O
sólo	O
en	O
los	O
corpúsculos	O
de	O
Hassall	O
,	O
también	O
se	O
detectaron	O
en	O
mutante	B-Sequence
timi	O
(	O
Figura	O
S3	O
)	O
.	O

En	O
estos	O
ratones	B-Taxon
no	O
se	O
detectaron	O
timocitos	O
.	O

BrdU	O
incorporación	B-Sequence
sólo	O
se	O
observó	O
en	O
muy	O
pocas	O
queratinización	O
células	B-Cell
epiteliales	I-Cell
,	O
luciendo	O
algo	O
similar	O
al	O
patrón	O
de	O
la	O
piel	O
madura	O
(	O
Figura	O
6M	O
)	O
.	O

La	O
expresión	O
difusa	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
también	O
estuvo	O
presente	O
en	O
estos	O
células	B-Cell
epiteliales	I-Cell
,	O
y	O
a	O
esta	O
edad	O
menos	O
células	B-Cell
fueron	O
positivos	O
para	O
nuclear	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
tinción	O
(	O
Figura	O
6N	O
)	O
.	O

Como	O
en	O
el	O
más	O
joven	O
mutante	B-Sequence
ratones	B-Taxon
,	O
sin	O
embargo	O
,	O
nuclear	B-GENE
localización	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
solo	O
se	O
observó	O
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
que	O
parecía	O
indiferenciado	O
células	B-Cell
basales	I-Cell
.	O

En	O
P17	O
más	O
antiguo	O
ratones	B-Taxon
,	O
la	O
histopatología	O
y	O
patrón	O
de	O
expresión	O
de	O
queratina	O
de	O
la	O
mutante	B-Sequence
timo	O
era	O
similar	O
a	O
la	O
de	O
P13	O
excepto	O
por	O
el	O
hecho	O
de	O
que	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
expresión	O
se	O
hizo	O
cada	O
vez	O
más	O
difusa	O
y	O
parecía	O
colocaralize	O
con	O
K8	B-Protein
/	O
K14	B-Protein
expresión	O
(	O
datos	O
no	O
mostrados	O
)	O
.	O

Esto	O
coincidió	O
con	O
menos	O
inmaduros	O
células	B-Cell
en	O
el	O
mayor	O
mutante	B-Sequence
timo	O

Colectivamente	O
,	O
estos	O
resultados	O
sugieren	O
que	O
la	O
pérdida	O
de	O
APC	B-Protein
y	O
la	O
consiguiente	O
estabilización	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
queratinocitos	B-Cell
,	O
causando	O
metaplasia	O
escamosa	O
masiva	O
,	O
en	O
lugar	O
de	O
formar	O
TEC	O
medulares	O
o	O
corticales	O
.	O

La	O
pérdida	O
de	O
compartimentos	O
TEC	O
apropiados	O
resultó	O
en	O
la	O
pérdida	O
de	O
timocitos	O
para	O
la	O
maduración	O
y	O
la	O
ratones	B-Taxon
``	O
ser	O
``	O
''	O
atímico	O
``	O
''	O
.	O
''	O

Discusión	O

APC	B-Protein
está	O
implicado	O
en	O
la	O
vía	O
de	O
señalización	O
Wnt	O
que	O
está	O
implicada	O
tanto	O
en	O
el	O
desarrollo	O
como	O
en	O
la	O
tumorigénesis	O
.	O

Humano	B-Taxon
línea	O
germinal	O
mutaciones	B-Sequence
en	O
APC	B-Protein
causan	O
FAP	O
[	O
4	O
,	O
5	O
]	O
,	O
que	O
se	O
caracteriza	O
por	O
cientos	O
de	O
pólipos	O
colorrectales	O
adenomatosos	O
,	O
con	O
una	O
progresión	O
casi	O
inevitable	O
a	O
cáncer	O
colorrectal	O
en	O
la	O
tercera	O
y	O
cuarta	O
década	O
de	O
la	O
vida	O
.	O

Las	O
características	O
fenotípicas	O
de	O
la	O
FAP	O
y	O
su	O
variante	O
,	O
el	O
síndrome	O
de	O
Gardner	O
,	O
pueden	O
ser	O
muy	O
variables	O
.	O

Además	O
de	O
los	O
pólipos	O
colorrectales	O
,	O
estos	O
individuos	B-Taxon
puede	O
desarrollar	O
síntomas	O
extracolónicos	O
,	O
entre	O
los	O
que	O
se	O
encuentran	O
pólipos	O
del	O
tracto	O
gastrointestinal	O
superior	O
,	O
hipertrofia	O
congénita	O
de	O
la	O
retina	O
pigmento	B-Chemical
epitelio	O
,	O
tumores	O
desmoides	O
,	O
trastornos	O
de	O
los	O
huesos	O
maxilares	O
y	O
esqueléticos	O
y	O
anomalías	O
dentales	O
[	O
6	O
]	O
.	O

Mientras	O
que	O
el	O
knockout	O
heterocigoto	O
ratones	B-Taxon
por	O
APC	B-Protein
desarrollan	O
pólipos	O
adenomatosos	O
predominantemente	O
en	O
el	O
intestino	O
delgado	O
,	O
los	O
embriones	O
homocigotos	O
mueren	O
antes	O
de	O
la	O
gastrulación	O
.	O

Para	O
obtener	O
más	O
información	O
sobre	O
los	O
efectos	O
de	O
APC	B-Protein
pérdida	O
en	O
tejidos	O
distintos	O
del	O
tracto	O
gastrointestinal	O
durante	O
la	O
vida	O
de	O
animales	B-Taxon
y	O
para	O
eludir	O
la	O
letalidad	O
embrionaria	O
asociada	O
con	O
APC	B-Protein
nullizigosidad	O
,	O
creamos	O
un	O
ratón	B-Taxon
tensión	O
que	O
lleva	O
un	O
condicional	O
alelo	B-Sequence
de	O
APC	B-Protein
(	O
ApcCKO	O
)	O
en	O
el	O
que	O
exón	B-Sequence
14	O
de	O
los	O
APC	B-Protein
es	O
flanqueado	B-Sequence
por	O
secuencias	B-Sequence
loxP	I-Sequence
.	O

el	O
homocigoto	O
ratones	B-Taxon
para	O
el	O
condicional	O
alelo	B-Sequence
son	O
viables	O
e	O
indistinguibles	O
de	O
los	O
normales	O
ratones	B-Taxon
,	O
permitiéndonos	O
estudiar	O
los	O
roles	O
de	O
APC	B-Protein
en	O
una	O
forma	O
específica	O
de	O
tejido	O
y	O
temporal	O
.	O

Evaluar	O
las	O
consecuencias	O
fenotípicas	O
de	O
la	O
inactivación	O
del	O
APC	B-Protein
gene	B-Sequence
en	O
células	B-Cell
que	O
expresan	O
K14	B-Protein
,	O
creamos	O
ratones	B-Taxon
que	O
son	O
homocigotos	O
para	O
el	O
ApcCKO	O
alelo	B-Sequence
y	O
contienen	O
un	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
.	O

Estas	O
ratones	B-Taxon
no	O
prosperó	O
y	O
murió	O
antes	O
del	O
destete	O
.	O

También	O
exhibieron	O
fenotipos	O
de	O
pelo	O
,	O
dientes	O
y	O
timo	O
.	O

APC	B-Protein
y	O
morfogénesis	O
del	O
folículo	O
piloso	O

Los	O
modelos	O
actuales	O
de	O
desarrollo	O
del	O
folículo	O
piloso	O
sugieren	O
que	O
el	O
establecimiento	O
de	O
una	O
matriz	O
regular	O
de	O
placodas	O
en	O
la	O
superficie	O
del	O
epitelio	O
en	O
respuesta	O
al	O
primer	O
mensaje	O
dérmico	O
se	O
logra	O
a	O
través	O
de	O
las	O
actividades	O
competitivas	O
de	O
moléculas	B-Chemical
que	O
promueven	O
o	O
reprimen	O
placoda	O
el	O
destino	O
[	O
24	O
]	O
.	O

Cada	O
vez	O
hay	O
más	O
pruebas	O
de	O
que	O
la	O
activación	O
de	O
la	O
vía	O
de	O
señalización	O
Wnt	O
en	O
la	O
dermis	O
puede	O
estar	O
involucrada	O
en	O
el	O
establecimiento	O
de	O
la	O
primera	O
señal	O
dérmica	O
.	O

Activación	O
experimental	O
del	O
epitelio	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
señalización	O
(	O
por	O
expresión	O
de	O
N-terminal	B-Sequence
-	O
truncado	O
,	O
constitutivamente	O
estabilizado	O
formularios	B-Sequence
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
o	O
expresión	O
ectópica	O
de	O
Lef1	B-Protein
)	O
induce	O
folículos	O
ectópicos	O
en	O
ambos	O
ratón	B-Taxon
y	O
piel	O
de	O
pollo	O
[	O
25	O
-	O
27	O
]	O
.	O

Por	O
el	O
contrario	O
,	O
la	O
regulación	O
a	O
la	O
baja	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
señalización	O
(	O
a	O
través	O
de	O
Lef1	B-Protein
knock	O
-	O
out	O
,	O
expresión	O
ectópica	O
del	O
inhibidor	O
de	O
Wnt	O
Dkk1	B-Protein
o	O
condicional	O
supresión	B-Sequence
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
la	O
epidermis	O
)	O
da	O
como	O
resultado	O
la	O
pérdida	O
de	O
vibrisas	O
y	O
algunos	O
folículos	O
del	O
pelaje	O
en	O
ratones	B-Taxon
[	O
28	O
-	O
30	O
]	O
.	O

Nuestro	O
hallazgo	O
de	O
que	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
pérdida	O
en	O
el	O
ectodermo	O
embrionario	O
resultó	O
en	O
una	O
iniciación	O
anormal	O
de	O
la	O
placoda	O
del	O
cabello	O
y	O
una	O
morfogénesis	O
del	O
folículo	O
irregularmente	O
espaciada	O
y	O
a	O
menudo	O
muy	O
agrupada	O
(	O
Figuras	O
4F	O
,	O
5B	O
,	O
5D	O
y	O
5F	O
)	O
así	O
como	O
en	O
el	O
desarrollo	O
de	O
múltiples	O
brotes	O
de	O
dientes	O
(	O
Figura	O
4O	O
y	O
4P	O
)	O
,	O
está	O
en	O
línea	O
con	O
los	O
efectos	O
vistos	O
en	O
la	O
activación	O
del	O
epitelio	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
señalización	O
durante	O
la	O
formación	O
de	O
placodas	O
,	O
lo	O
que	O
indica	O
el	O
papel	O
de	O
APC	B-Protein
en	O
la	O
especificación	O
de	O
embrionario	O
células	B-Cell
madre	I-Cell
ectodérmicas	I-Cell
para	O
producir	O
un	O
folículo	O
piloso	O
.	O

Dado	O
el	O
papel	O
de	O
APC	B-Protein
en	O
abajo	O
-	O
regulación	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
,	O
pérdida	O
de	O
APC	B-Protein
conduciría	O
inevitablemente	O
a	O
una	O
expresión	O
alterada	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
células	B-Cell
ectodérmicas	I-Cell
durante	O
la	O
formación	O
de	O
la	O
placoda	O
del	O
cabello	O
,	O
dando	O
lugar	O
a	O
un	O
crecimiento	O
folicular	O
aberrante	O
en	O
toda	O
la	O
epidermis	O
embrionaria	O
,	O
incluidas	O
las	O
almohadillas	O
de	O
las	O
patas	O
,	O
donde	O
normalmente	O
no	O
tienen	O
pelo	O
(	O
Figura	O
5B	O
,	O
5D	O
,	O
5F	O
y	O
5H	O
)	O
.	O

De	O
interés	O
son	O
las	O
similitudes	O
y	O
diferencias	O
fenotípicas	O
entre	O
nuestro	O
KA	O
mutante	B-Sequence
ratones	B-Taxon
y	O
lo	O
antes	O
descrito	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
expresando	O
estable	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
bajo	O
el	O
control	O
de	O
K14	B-Protein
promotor	B-Sequence
[	O
25	O
]	O
y	O
K14	B-Protein
-	O
Lef1	B-Protein
transgénico	B-Sequence
ratones	B-Taxon
[	O
27	O
]	O
.	O

Sorprendentemente	O
,	O
nuestro	O
mutante	B-Sequence
ratones	B-Taxon
compartió	O
más	O
similitudes	O
con	O
el	O
K14	B-Protein
-	O
Lef1	B-Protein
ratones	B-Taxon
que	O
la	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
.	O

Por	O
ejemplo	O
,	O
el	O
KA	O
mutante	B-Sequence
ratones	B-Taxon
mostró	O
los	O
bigotes	O
desorientados	O
,	O
cortos	O
y	O
rizados	O
que	O
se	O
ven	O
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
.	O

Además	O
,	O
K.A	O
.	O
mutante	B-Sequence
ratones	B-Taxon
exhibió	O
un	O
pelaje	O
desorganizado	O
a	O
partir	O
de	O
la	O
aparición	O
de	O
pelos	O
neonatales	O
,	O
similar	O
al	O
observado	O
en	O
K14	B-Protein
-	O
Lef1	B-Protein
ratones	B-Taxon
,	O
Mientras	O
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
,	O
la	O
morfogénesis	O
del	O
folículo	O
piloso	O
embrionario	O
no	O
se	O
vio	O
afectada	O
y	O
otros	O
cambios	O
en	O
la	O
piel	O
solo	O
surgieron	O
después	O
del	O
nacimiento	O
.	O

La	O
razón	O
de	O
esta	O
diferencia	O
podría	O
atribuirse	O
a	O
uno	O
oa	O
los	O
tres	O
posibles	O
factores	O
contribuyentes	O
.	O

(	O
1	O
)	O
Aunque	O
el	O
K14	B-Protein
promotor	B-Sequence
se	O
sabe	O
que	O
inicia	O
la	O
expresión	O
en	O
E9	O
.	O
5	O
y	O
elevado	O
dramáticamente	O
por	O
E13	O
.	O
5	O
-	O
E14	O
.	O
5	O
[	O
19	O
,	O
31	O
]	O
,	O
muchos	O
factores	O
podrían	O
influir	O
en	O
la	O
expresión	O
de	O
promotor	B-Sequence
/	O
construcción	B-Sequence
transgénica	I-Sequence
en	O
transgénico	B-Sequence
ratones	B-Taxon
.	O

Una	O
de	O
las	O
consideraciones	O
más	O
importantes	O
tiene	O
que	O
ver	O
con	O
la	O
sitio	B-Sequence
de	I-Sequence
integración	I-Sequence
de	O
El	O
transgén	B-Sequence
en	O
el	O
ratón	B-Taxon
genoma	B-Sequence
.	O

Dependiendo	O
de	O
lugar	B-Sequence
de	I-Sequence
integración	I-Sequence
,	O
la	O
actividad	O
transcripcional	O
de	O
incluso	O
el	O
mismo	O
transgén	B-Sequence
podría	O
variar	O
considerablemente	O
.	O

Es	O
posible	O
que	O
la	O
aparente	O
falta	O
de	O
función	O
de	O
Delta	O
N87	O
beta	O
cat	O
en	O
la	O
embriogénesis	O
se	O
deba	O
a	O
la	O
expresión	O
tardía	O
o	O
débil	O
de	O
la	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgén	B-Sequence
en	O
comparación	O
con	O
el	O
intrínseco	O
promotor	B-Sequence
.	O

Por	O
el	O
contrario	O
,	O
la	O
recombinación	O
mediada	O
por	O
Cre	O
se	O
observa	O
en	O
E13	O
.	O
5	O
piel	O
de	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
utilizado	O
en	O
este	O
estudio	O
[	O
16	O
]	O
y	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
gene	B-Sequence
es	O
probable	O
que	O
haya	O
ocurrido	O
para	O
entonces	O
,	O
a	O
tiempo	O
para	O
la	O
segunda	O
ola	O
de	O
morfogénesis	O
del	O
folículo	O
piloso	O
.	O

(	O
2	O
)	O
Otro	O
dato	O
importante	O
es	O
que	O
en	O
el	O
citado	O
transgénico	B-Sequence
modelar	O
la	O
sobreexpresión	O
de	O
transgén	B-Sequence
se	O
limita	O
a	O
la	O
base	O
células	B-Cell
de	I-Cell
la	I-Cell
epidermis	I-Cell
y	O
la	O
SRO	O
de	O
los	O
folículos	O
pilosos	O
,	O
donde	O
el	O
K14	B-Protein
promotor	B-Sequence
está	O
activo	O
.	O

la	O
expresión	O
de	O
transgén	B-Sequence
es	O
por	O
lo	O
tanto	O
transitorio	O
y	O
se	O
detiene	O
una	O
vez	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
diferenciar	O
terminalmente	O
.	O

Por	O
el	O
contrario	O
,	O
en	O
nuestro	O
modelo	O
,	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
supresión	B-Sequence
de	O
APC	B-Protein
resultaría	O
en	O
APC	B-Protein
mutación	B-Sequence
no	O
solo	O
en	O
K14	B-Protein
promotor	B-Sequence
activo	O
células	B-Cell
,	O
pero	O
sigue	O
siendo	O
así	O
en	O
todos	O
célula	B-Cell
capas	O
que	O
derivan	O
de	O
la	O
K14	B-Protein
promotor	B-Sequence
progenitores	O
activos	O
.	O

Estos	O
derivados	O
incluyen	O
la	O
epidermis	O
suprabasal	O
y	O
todo	O
el	O
epitelio	O
del	O
folículo	O
piloso	O
.	O

Estabilización	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
una	O
población	O
más	O
amplia	O
de	O
células	B-Cell
podría	O
explicar	O
algunas	O
de	O
las	O
diferencias	O
fenotípicas	O
.	O

Sin	O
embargo	O
,	O
no	O
detectamos	O
ningún	O
aumento	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
expresión	O
en	O
cualquiera	O
K1	B-Protein
#	O
¿NOMBRE	O
?	O
K6	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
en	O
posparto	O
mutante	B-Sequence
piel	O
.	O

Esto	O
indica	O
que	O
a	O
pesar	O
de	O
la	O
ausencia	O
de	O
APC	B-Protein
y	O
potencial	O
estabilización	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
derivados	O
de	O
K14	B-Protein
-	O
expresando	O
progenitores	O
,	O
elevado	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
expresión	O
y	O
posterior	O
célula	B-Cell
la	O
determinación	O
del	O
destino	O
sólo	O
puede	O
tener	O
lugar	O
en	O
células	B-Cell
basales	I-Cell
.	O

(	O
3	O
)	O
No	O
podemos	O
excluir	O
la	O
posibilidad	O
de	O
que	O
dadas	O
las	O
propiedades	O
multifuncionales	O
de	O
APC	B-Protein
,	O
interrupción	O
de	O
sus	O
funciones	O
distintas	O
de	O
la	O
regulación	O
a	O
la	O
baja	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
también	O
puede	O
haber	O
contribuido	O
al	O
fenotipo	O
manifiesto	O
observado	O
.	O

Si	O
bien	O
algunas	O
características	O
de	O
nuestro	O
mutante	B-Sequence
ratones	B-Taxon
eran	O
similares	O
a	O
estos	O
transgénico	B-Sequence
ratones	B-Taxon
,	O
otros	O
aspectos	O
fenotípicos	O
fueron	O
en	O
gran	O
parte	O
distintos	O
.	O

Además	O
de	O
la	O
morfogénesis	O
aberrante	O
del	O
folículo	O
piloso	O
,	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
provocó	O
la	O
formación	O
de	O
múltiples	O
brotes	O
dentales	O
que	O
,	O
al	O
igual	O
que	O
los	O
folículos	O
pilosos	O
,	O
se	O
sabía	O
que	O
se	O
desarrollaban	O
a	O
través	O
de	O
interacciones	O
inductivas	O
entre	O
el	O
epitelio	O
y	O
el	O
mesénquima	O
.	O

Esta	O
observación	O
fue	O
similar	O
a	O
las	O
yemas	O
dentales	O
ectópicas	O
encontradas	O
en	O
animales	B-Taxon
expresando	O
mal	O
Lef1	B-Protein
[	O
27	O
]	O
,	O
pero	O
más	O
grave	O
y	O
también	O
estuvo	O
presente	O
al	O
nacer	O
,	O
lo	O
que	O
indica	O
el	O
efecto	O
de	O
APC	B-Protein
pérdida	O
durante	O
el	O
inicio	O
del	O
desarrollo	O
del	O
diente	O
embrionario	O
,	O
que	O
fue	O
evidente	O
por	O
aberrante	O
Shh	B-Protein
expresión	O
en	O
E15	O
.	O
5	O
epitelio	O
bucal	O
embrionario	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

Cabe	O
señalar	O
que	O
,	O
aunque	O
histológicamente	O
se	O
veían	O
múltiples	O
brotes	O
dentales	O
(	O
Figuras	O
4O	O
y	O
4P	O
)	O
,	O
estos	O
dientes	O
nunca	O
se	O
rompieron	O
y	O
el	O
KA	O
mutante	B-Sequence
ratones	B-Taxon
apareció	O
sin	O
dientes	O
.	O

Este	O
defecto	O
dental	O
severo	O
e	O
inusual	O
es	O
exclusivo	O
de	O
estos	O
mutante	B-Sequence
ratones	B-Taxon
.	O

Además	O
,	O
ninguno	O
de	O
los	O
dos	O
transgénico	B-Sequence
ratones	B-Taxon
fue	O
postnatalmente	O
letal	O
como	O
en	O
el	O
KA	O
mutante	B-Sequence
ratones	B-Taxon
.	O

No	O
encontramos	O
ninguna	O
anormalidad	O
histopatológica	O
obvia	O
en	O
los	O
órganos	O
internos	O
de	O
KA	O
ratones	B-Taxon
que	O
podría	O
contribuir	O
a	O
la	O
letalidad	O
.	O

Sin	O
embargo	O
,	O
el	O
hecho	O
de	O
que	O
todos	O
los	O
mutantes	B-Sequence
tenían	O
menor	O
peso	O
(	O
Figura	O
2F	O
)	O
sin	O
apenas	O
evidencia	O
de	O
sólidos	O
comida	B-Chemical
en	O
su	O
estómago	O
indica	O
que	O
el	O
mutantes	B-Sequence
podría	O
haber	O
muerto	O
de	O
hambre	O
.	O

La	O
grasa	O
dérmica	O
se	O
redujo	O
en	O
el	O
mutante	B-Sequence
piel	O
,	O
posiblemente	O
como	O
consecuencia	O
de	O
una	O
mala	O
nutrición	O
provocada	O
por	O
la	O
ausencia	O
de	O
dientes	O
.	O

Dado	O
que	O
la	O
pérdida	O
de	O
peso	O
en	O
KA	O
mutantes	B-Sequence
comenzó	O
de	O
P8-P10	O
mientras	O
las	O
crías	O
aún	O
eran	O
amamantadas	O
por	O
sus	O
madres	O
,	O
el	O
hambre	O
debido	O
a	O
la	O
falta	O
de	O
dientes	O
no	O
puede	O
ser	O
la	O
única	O
causa	O
de	O
muerte	O
,	O
pero	O
es	O
probable	O
que	O
sea	O
un	O
factor	O
contribuyente	O
.	O

Se	O
ha	O
observado	O
ausencia	O
de	O
dientes	O
y	O
glándulas	O
mamarias	O
en	O
ratones	B-Taxon
deficiente	O
en	O
Lef1	B-Protein
y	O
expresando	O
ectópicamente	O
Dkk1	B-Protein
[	O
29	O
,	O
30	O
]	O
pero	O
su	O
ausencia	O
se	O
debió	O
al	O
bloque	O
en	O
desarrollo	O
antes	O
de	O
la	O
etapa	O
de	O
brote	O
.	O

Por	O
lo	O
tanto	O
,	O
ni	O
la	O
pérdida	O
ni	O
el	O
exceso	O
de	O
formación	O
de	O
yemas	O
dentales	O
permite	O
el	O
desarrollo	O
adecuado	O
de	O
los	O
dientes	O
para	O
ratones	B-Taxon
tener	O
una	O
dieta	O
sana	O
y	O
una	O
vida	O
normal	O
.	O

Estudios	O
mecanísticos	O
para	O
comprender	O
cómo	O
los	O
niveles	O
elevados	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
conduce	O
a	O
fenotipos	O
alterados	O
de	O
la	O
piel	O
y	O
los	O
dientes	O
.	O

APC	B-Protein
y	O
organogénesis	O
del	O
timo	O

En	O
este	O
estudio	O
,	O
observamos	O
que	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
resultó	O
en	O
un	O
timo	O
pequeño	O
con	O
metaplasia	O
escamosa	O
severa	O
que	O
condujo	O
a	O
la	O
formación	O
de	O
numerosos	O
piogranulomas	O
y	O
la	O
pérdida	O
de	O
la	O
estructura	O
de	O
malla	O
adecuada	O
para	O
la	O
maduración	O
de	O
los	O
timocitos	O
,	O
lo	O
que	O
hizo	O
que	O
el	O
ratones	B-Taxon
atímico	O

Estudios	O
previos	O
han	O
demostrado	O
que	O
en	O
el	O
timo	O
adulto	O
normal	O
K14	B-Protein
la	O
expresión	O
se	O
encuentra	O
junto	O
con	O
K5	B-Protein
en	O
los	O
TEC	O
medulares	O
estrellados	O
,	O
pero	O
no	O
en	O
asociación	O
con	O
K5	B-Protein
#	O
¿NOMBRE	O
?	O

Además	O
,	O
se	O
ha	O
demostrado	O
que	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K8	B-Protein
;	O
por	O
lo	O
tanto	O
,	O
hay	O
dos	O
subconjuntos	O
medulares	O
distintos	O
,	O
a	O
saber	O
,	O
un	O
K8	B-Protein
-	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K8	B-Protein
+	O
K14	B-Protein
-	O
subconjunto	O
globular	O
[	O
32	O
]	O
.	O

De	O
acuerdo	O
con	O
los	O
resultados	O
anteriores	O
,	O
en	O
P3	O
timo	O
normal	O
K14	B-Protein
expresión	O
se	O
restringió	O
a	O
TECs	O
medulares	O
estrellados	O
(	O
Figura	O
6D	O
)	O
,	O
mientras	O
que	O
K8	B-Protein
expresión	O
se	O
encontró	O
a	O
través	O
de	O
los	O
TEC	O
(	O
datos	O
no	O
publicados	O
)	O
.	O

No	O
pudimos	O
aclarar	O
si	O
estas	O
dos	O
queratinas	O
se	O
coexpresaron	O
en	O
las	O
mismas	O
TEC	O
sin	O
doble	O
tinción	O
.	O

Había	O
diferencias	O
individuales	O
entre	O
mutantes	B-Sequence
estos	O
se	O
reflejaron	O
de	O
manera	O
prominente	O
en	O
las	O
anomalías	O
histológicas	O
del	O
timo	O
en	O
P3	O
,	O
pero	O
como	O
los	O
más	O
antiguos	O
supervivientes	O
mutantes	B-Sequence
todos	O
mostraron	O
las	O
mismas	O
histopatologías	O
del	O
timo	O
,	O
el	O
mutante	B-Sequence
thymi	O
eventualmente	O
parecen	O
resultar	O
en	O
el	O
mismo	O
destino	O
.	O

No	O
está	O
claro	O
cuándo	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
mutante	B-Sequence
timo	O
,	O
pero	O
como	O
la	O
población	O
de	O
células	B-Cell
mostrando	O
un	O
fuerte	O
nuclear	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
tinción	O
,	O
así	O
como	O
la	O
células	B-Cell
expresando	O
K14	B-Protein
eran	O
pequeños	O
y	O
los	O
compartimentos	O
epiteliales	O
tímicos	O
todavía	O
existían	O
en	O
un	O
P3	O
leve	O
mutante	B-Sequence
timo	O
(	O
Figura	O
6E	O
y	O
6F	O
)	O
,	O
parece	O
que	O
la	O
diferenciación	O
inicial	O
a	O
TEC	O
medulares	O
y	O
corticales	O
y	O
la	O
colonización	O
de	O
timocitos	O
ya	O
han	O
tenido	O
lugar	O
antes	O
de	O
los	O
efectos	O
principales	O
de	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
pérdida	O
.	O

Sin	O
embargo	O
,	O
células	B-Cell
con	O
nuclear	B-GENE
beta	B-Protein
-	I-Protein
catenina	I-Protein
y	O
K8	B-Protein
+	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
epiteliales	I-Cell
aumentó	O
posteriormente	O
,	O
asociado	O
con	O
la	O
proliferación	O
activa	O
en	O
el	O
último	O
grupo	O
de	O
células	B-Cell
y	O
pérdida	O
de	O
compartimentos	O
TEC	O
.	O

Con	O
edad	O
,	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
patrón	O
de	O
expresión	O
se	O
hizo	O
más	O
difuso	O
y	O
menos	O
células	B-Cell
epiteliales	I-Cell
mostró	O
nuclear	B-GENE
localización	O
pero	O
K8	B-Protein
+	O
K14	B-Protein
+	O
células	B-Cell
permanecieron	O
,	O
formando	O
estructuras	O
concéntricas	O
de	O
células	B-Cell
epiteliales	I-Cell
lleno	O
de	O
depósitos	O
de	O
queratina	O
dura	O
e	O
infiltrado	O
con	O
gran	O
número	O
de	O
neutrófilos	B-Cell
y	O
macrófagos	B-Cell
.	O

Sólo	O
unos	O
pocos	O
células	B-Cell
epiteliales	I-Cell
se	O
estaban	O
dividiendo	O
y	O
apenas	O
había	O
timocitos	O
presentes	O
en	O
ese	O
momento	O
.	O

Estos	O
resultados	O
sugieren	O
que	O
con	O
la	O
supresión	B-Sequence
de	O
APC	B-Protein
en	O
TECs	O
,	O
estabilización	O
y	O
nuclear	B-GENE
localización	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
tuvo	O
lugar	O
y	O
posteriormente	O
estos	O
células	B-Cell
diferenciado	O
en	O
queratinocitos	B-Cell
que	O
expresó	O
ambos	O
K14	B-Protein
y	O
K8	B-Protein
,	O
Similar	O
a	O
células	B-Cell
basales	I-Cell
de	O
la	O
piel	O
,	O
en	O
lugar	O
de	O
subconjuntos	O
TEC	O
.	O

La	O
expansión	O
y	O
diferenciación	O
de	O
estos	O
queratinocitos	B-Cell
conducir	O
a	O
la	O
pérdida	O
de	O
los	O
compartimentos	O
epiteliales	O
tímicos	O
adecuados	O
y	O
,	O
a	O
su	O
vez	O
,	O
produjo	O
y	O
depositó	O
las	O
queratinas	O
duras	O
que	O
,	O
en	O
consecuencia	O
,	O
causaron	O
una	O
gran	O
cantidad	O
de	O
neutrófilos	B-Cell
y	O
macrófagos	B-Cell
infiltrarse	O
en	O
el	O
timo	O
.	O

Estas	O
estructuras	O
epiteliales	O
aberrantes	O
finalmente	O
han	O
superado	O
la	O
totalidad	O
del	O
timo	O
y	O
expulsado	O
a	O
los	O
timocitos	O
colonizados	O
.	O

K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
y	O
posterior	O
expresión	O
constitutiva	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
los	O
TEC	O
,	O
por	O
lo	O
tanto	O
,	O
los	O
han	O
desviado	O
al	O
mal	O
Célula	B-Cell
epitelial	I-Cell
destino	O
,	O
no	O
permitiendo	O
la	O
diferenciación	O
adecuada	O
a	O
TEC	O
corticales	O
o	O
medulares	O
,	O
lo	O
cual	O
es	O
esencial	O
para	O
el	O
desarrollo	O
normal	O
de	O
los	O
timocitos	O
.	O

Esto	O
no	O
sólo	O
es	O
evidente	O
por	O
la	O
falta	O
de	O
división	O
de	O
los	O
timocitos	O
en	O
el	O
mutante	B-Sequence
timo	O
por	O
P13	O
,	O
pero	O
también	O
por	O
el	O
patrón	O
de	O
expresión	O
diferencial	O
de	O
las	O
queratinas	O
,	O
que	O
eran	O
más	O
parecidas	O
a	O
la	O
piel	O
que	O
a	O
las	O
TEC	O
.	O

La	O
importancia	O
de	O
APC	B-Protein
función	O
en	O
el	O
desarrollo	O
tímico	O
ha	O
sido	O
demostrada	O
por	O
timocitos	O
-	O
pérdida	O
específica	O
de	O
APC	B-Protein
cruzando	O
una	O
cepa	O
diferente	O
de	O
APC	B-Protein
condicional	O
ratones	B-Taxon
y	O
LckCre	O
transgénico	B-Sequence
ratones	B-Taxon
[	O
33	O
]	O
.	O

Aquí	O
,	O
por	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
,	O
hemos	O
demostrado	O
su	O
importancia	O
en	O
el	O
desarrollo	O
del	O
timo	O
no	O
sólo	O
en	O
timocitos	O
sino	O
también	O
en	O
TECs	O
.	O

Es	O
de	O
interés	O
que	O
anomalías	O
dentales	O
,	O
tales	O
como	O
dientes	O
supernumerarios	O
e	O
impactados	O
similares	O
a	O
las	O
observadas	O
en	O
nuestro	O
mutante	B-Sequence
ratones	B-Taxon
,	O
se	O
observan	O
con	O
frecuencia	O
en	O
pacientes	O
con	O
síndrome	O
de	O
Gardner	O
,	O
portadores	O
de	O
APC	B-Protein
línea	O
germinal	O
mutación	B-Sequence
[	O
6	O
]	O
.	O

De	O
ahí	O
que	O
se	O
destaque	O
la	O
importancia	O
de	O
los	O
exámenes	O
odontoestomatológicos	O
como	O
medio	O
para	O
llegar	O
a	O
un	O
diagnóstico	O
presuntivo	O
,	O
cuya	O
confirmación	O
es	O
vital	O
para	O
el	O
paciente	O
.	O

Caracterización	O
adicional	O
del	O
mecanismo	O
de	O
tales	O
defectos	O
de	O
desarrollo	O
usando	O
nuestro	O
ratón	B-Taxon
El	O
modelo	O
debe	O
proporcionar	O
información	O
importante	O
sobre	O
APC	B-Protein
función	O
en	O
múltiples	O
sistemas	O
de	O
órganos	O
y	O
para	O
dar	O
una	O
mejor	O
comprensión	O
de	O
los	O
posibles	O
eventos	O
adversos	O
en	O
humano	B-Taxon
asignaturas	O
.	O

En	O
conclusión	O
,	O
hemos	O
demostrado	O
que	O
la	O
pérdida	O
de	O
APC	B-Protein
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
células	B-Cell
provoca	O
una	O
morfogénesis	O
aberrante	O
en	O
varios	O
apéndices	O
de	O
la	O
piel	O
,	O
incluidos	O
los	O
folículos	O
pilosos	O
y	O
los	O
dientes	O
,	O
y	O
una	O
organogénesis	O
anormal	O
del	O
timo	O
.	O

Nuestros	O
resultados	O
proporcionan	O
genético	B-Sequence
prueba	O
de	O
que	O
la	O
expresión	O
de	O
APC	B-Protein
es	O
esencial	O
para	O
la	O
regulación	O
de	O
célula	B-Cell
destinos	O
en	O
estos	O
órganos	O
que	O
requieren	O
interacciones	O
epiteliales-mesenquimales	O
.	O

Materiales	O
y	O
métodos	O

Construcción	O
de	O
focalización	O
vectores	B-Sequence
.	O

Para	O
apuntar	O
a	O
la	O
APC	B-Protein
lugar	B-Sequence
,	O
nosotros	O
obtuvimos	O
clon	B-Sequence
BAC	I-Sequence
RP23	O
-	O
233F17	O
que	O
contiene	O
todos	O
los	O
secuencia	B-Sequence
de	O
APC	B-Protein
excepto	O
por	O
el	O
5'UTR	B-Sequence
y	O
exón	B-Sequence
1	O
.	O

Usando	O
un	O
método	O
basado	O
en	O
recombinación	O
para	O
generar	O
condiciones	O
mutaciones	B-Sequence
[	O
12	O
,	O
13	O
]	O
,	O
subclonación	O
de	O
BAC	B-Sequence
y	O
además	O
modificaciones	B-Sequence
se	O
llevaron	O
a	O
cabo	O
.	O

los	O
secuencia	B-Sequence
genómica	I-Sequence
abarcando	O
APC	B-Protein
exones	B-Sequence
11	O
a	O
15	O
se	O
subclonó	O
por	O
primera	O
vez	O
en	O
pBR322	O
vector	B-Sequence
,	O
y	O
luego	O
un	O
sitio	B-Sequence
loxP	I-Sequence
era	O
introducido	B-Sequence
dentro	O
intrón	B-Sequence
13	O
seguido	O
de	O
loxP	B-Sequence
-	O
FRT	B-Sequence
-PGKneor-	O
FRT	B-Sequence
selección	O
casete	B-Sequence
en	O
el	O
intrón	O
14	O
del	O
APC	B-Protein
gene	B-Sequence
(	O
Figura	O
1A	O
)	O
.	O

Generación	O
de	O
ApcCKO	O
ES	O
células	B-Cell
y	O
ratones	B-Taxon
.	O

La	O
segmentación	O
linealizada	O
vectores	B-Sequence
fueron	O
electroporados	O
en	O
129	O
/	O
S	O
-	O
ES	O
derivado	O
células	B-Cell
,	O
WW6	O
células	B-Cell
[	O
15	O
]	O
.	O

Todos	O
los	O
clones	O
de	O
ES	O
resistentes	O
a	O
G418	O
candidatos	O
se	O
examinaron	O
mediante	O
análisis	O
de	O
largo	O
alcance	O
.	O
gene	B-Sequence
-	O
PCR	O
específica	O
usando	O
Expand	O
Long	O
Template	O
PCR	O
System	O
(	O
Roche	O
,	O
Indianápolis	O
,	O
Indiana	O
,	O
Estados	O
Unidos	O
)	O
,	O
seguida	O
de	O
secuenciación	O
para	O
validar	O
la	O
correcta	O
inserción	B-Sequence
del	O
soltero	O
sitio	B-Sequence
loxP	I-Sequence
y	O
la	O
selección	O
casete	B-Sequence
.	O

Dos	O
clones	O
ES	O
con	O
ApcCKON	O
correcto	O
/	O
#	B-Sequence
¿NOMBRE	I-Sequence
?	I-Sequence
fueron	O
inyectados	O
en	O
blastocistos	O
C57BL	O
/	O
6J	O
,	O
después	O
de	O
lo	O
cual	O
quimérico	O
ratones	B-Taxon
con	O
altos	O
niveles	O
de	O
ES	O
célula	B-Cell
contribución	O
se	O
retrocruzaron	O
con	O
hembras	O
C57BL/6J	O
para	O
producir	O
descendencia	O
F1	O
heterocigota	O
.	O

los	O
ADN	B-Sequence
genómico	I-Sequence
las	O
muestras	O
obtenidas	O
de	O
la	O
cola	O
de	O
la	O
descendencia	O
F1	O
se	O
analizaron	O
posteriormente	O
mediante	O
análisis	O
de	O
transferencia	O
Southern	O
para	O
confirmar	O
aún	O
más	O
la	O
recombinación	O
homóloga	O
correcta	O
.	O

Al	O
cruzar	O
el	O
heterocigoto	O
ratones	B-Taxon
al	O
eliminador	O
de	O
FLPe	O
ratones	B-Taxon
[	O
34	O
]	O
,	O
PGKneor	O
casete	B-Sequence
era	O
eliminado	B-Sequence
en	O
la	O
línea	O
germinal	O
por	O
FRT	B-Sequence
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
con	O
el	O
ApcCKO	O
final	O
alelo	B-Sequence
.	O

ApcCKO	O
heterocigoto	O
ratones	B-Taxon
se	O
cruzaron	O
para	O
generar	O
homocigotos	O
ratones	B-Taxon
,	O
y	O
la	O
descendencia	O
homocigótica	O
se	O
cruzó	O
para	O
el	O
mantenimiento	O
.	O

Generación	O
de	O
Apc	O
Delta	O
580	O
ratones	B-Taxon
.	O

Heterocigoto	O
ApcCKO	O
ratones	B-Taxon
se	O
cruzaron	O
con	O
Cre	O
deleter	O
ratones	B-Taxon
,	O
EIIA-cre	O
transgénico	B-Sequence
ratones	B-Taxon
que	O
expresan	O
Cre	O
en	O
el	O
embrión	O
temprano	O
[	O
35	O
]	O
,	O
para	O
eliminar	O
el	O
APC	B-Protein
alelo	B-Sequence
en	O
la	O
línea	O
germinal	O
,	O
creando	O
en	O
consecuencia	O
una	O
cepa	O
knockout	O
(	O
Figura	O
1A	O
)	O
.	O

El	O
resultante	O
Apc	O
Delta	O
580	O
/	O
+	B-Sequence
ratones	B-Taxon
se	O
mantuvieron	O
por	O
retrocruzamiento	O
con	O
hembras	O
C57BL/6J	O
.	O

Generación	O
de	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
.	O

los	O
ratones	B-Taxon
analizados	O
en	O
este	O
estudio	O
se	O
generaron	O
cruzando	O
heterocigotos	O
ApcCKO	O
ratones	B-Taxon
de	O
la	O
generación	O
F1	O
(	O
fondo	O
C57BL	O
/	O
6J	O
x	O
129	O
/	O
S	O
)	O
con	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transgénico	B-Sequence
ratones	B-Taxon
(	O
Fondo	O
FVB	O
)	O
.	O

K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
+	B-Sequence
masculino	O
ratones	B-Taxon
así	O
generadas	O
se	O
cruzaron	O
con	O
hembras	O
ApcCKO	O
/	O
CKO	O
para	O
generar	O
descendencia	O
ApcCKO	O
homocigota	O
y	O
heterocigota	O
con	O
o	O
sin	O
K14	B-Protein
-	O
cre	O
.	O

los	O
ratones	B-Taxon
se	O
entrecruzaron	O
a	O
partir	O
de	O
entonces	O
para	O
el	O
mantenimiento	O
.	O

Genotipado	O
de	O
ratones	B-Taxon
.	O

ADN	B-Sequence
genómico	I-Sequence
de	O
puntas	O
de	O
ratón	B-Taxon
Las	O
colas	O
obtenidas	O
a	O
los	O
~	O
10	O
días	O
de	O
edad	O
se	O
genotiparon	O
en	O
una	O
sola	O
reacción	O
de	O
PCR	O
con	O
lo	O
siguiente	O
cebadores	B-Sequence
:	O
APC	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
-	O
Int13R2	O
(	O
AGTGCTGTTTCTATGAGTCAAC	O
)	O
,	O
resultando	O
en	O
320	O
-	O
pb	B-Sequence
y	O
430	O
-	O
productos	B-Sequence
pb	I-Sequence
desde	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
ApcCKO	O
condicional	O
alelo	B-Sequence
respectivamente	O
.	O

Para	O
la	O
detección	O
de	O
Cre	O
-	O
mediada	O
eliminado	B-Sequence
APC	B-Protein
alelo	B-Sequence
,	O
Apc	O
Delta	O
580	O
,	O
el	O
cebador	B-Sequence
APC	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
-	O
Int13F2	O
resultó	O
en	O
500	O
-	O
producto	B-Sequence
pb	I-Sequence
.	O

imprimaciones	B-Sequence
Cre-F1	O
(	O
TCCAATTTACTGACCGTACACC	O
)	O
y	O
Cre-R1	O
(	O
CCGACGATGAAGCATGTTTAG	O
)	O
se	O
utilizaron	O
para	O
la	O
detección	O
de	O
cre	O
transgén	B-Sequence
en	O
la	O
línea	O
germinal	O
,	O
resultando	O
en	O
300	O
-	O
productos	B-Sequence
pb	I-Sequence
.	O

La	O
amplificación	O
se	O
realizó	O
en	O
un	O
volumen	O
de	O
25	O
µl	O
que	O
contenía	O
15	O
mM	O
tris	B-Chemical
-	O
HCl	B-Chemical
(	O
pH	O
8	O
,	O
3	O
)	O
,	O
50	O
mM	O
KCl	B-Chemical
,	O
2	O
.	O
5	O
mm	O
MgCl2	B-Chemical
,	O
0	O
.	O
2	O
mm	O
dNTP	B-Chemical
,	O
0	O
.	O
2	O
mu	O
M	O
de	O
cada	O
uno	O
cebador	B-Sequence
,	O
y	O
1	O
.	O
25	O
U	O
de	O
AmpliTaq	O
Oro	B-Chemical
(	O
Applied	O
Biosystems	O
,	O
Foster	O
City	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
.	O

Las	O
reacciones	O
se	O
calentaron	O
durante	O
10	O
min	O
a	O
94	O
grados	O
C	O
para	O
calentar	O
-	O
activar	O
el	O
enzima	B-Sequence
seguido	O
de	O
30	O
ciclos	O
de	O
PCR	O
a	O
94	O
°C	O
durante	O
30	O
s	O
,	O
58	O
°C	O
durante	O
30	O
s	O
y	O
72	O
°C	O
durante	O
45	O
s	O
,	O
seguido	O
de	O
la	O
extensión	O
final	O
durante	O
5	O
min	O
a	O
72	O
°C	O
.	O

Ensayo	O
de	O
permeabilidad	O
de	O
la	O
piel	O
.	O

E18	O
no	O
fijado	O
y	O
recién	O
aislado	O
.	O
Se	O
enjuagaron	O
5	O
embriones	O
en	O
PBS	O
y	O
luego	O
se	O
sumergieron	O
en	O
la	O
mezcla	O
de	O
reacción	O
X	O
-	O
gal	O
a	O
pH	O
4	O
.	O
5	O
(	O
100	O
mM	O
NaPO4	B-Chemical
1	O
.	O
3	O
mm	O
MgCl2	B-Chemical
,	O
3	O
mm	O
K3Fe	B-Chemical
(	I-Chemical
CN	I-Chemical
)	I-Chemical
6	I-Chemical
,	O
3	O
mm	O
K4Fe	B-Chemical
(	I-Chemical
CN	I-Chemical
)	I-Chemical
6	I-Chemical
,	O
y	O
1	O
mg	O
/	O
ml	O
X	O
-	O
gal	O
)	O
a	O
temperatura	O
ambiente	O
durante	O
la	O
noche	O
[	O
36	O
]	O
.	O

A	O
este	O
pH	O
en	O
ausencia	O
de	O
una	O
barrera	O
epidérmica	O
,	O
la	O
solución	O
penetra	O
en	O
la	O
epidermis	O
y	O
una	O
actividad	O
similar	O
a	O
la	O
beta-galactosidasa	O
endógena	O
cataliza	O
la	O
producción	O
de	O
un	O
precipitado	O
azul	O
.	O

Después	O
de	O
la	O
tinción	O
,	O
los	O
embriones	O
se	O
lavaron	O
dos	O
veces	O
en	O
PBS	O
,	O
se	O
fijaron	O
durante	O
la	O
noche	O
a	O
4	O
grados	O
C	O
en	O
paraformaldehído	O
al	O
4	O
%	O
y	O
se	O
fotografiaron	O
con	O
una	O
cámara	O
digital	O
Nikon	O
de	O
35	O
mm	O
.	O

Preparaciones	O
esqueléticas	O
.	O

Los	O
cuerpos	O
desollados	O
y	O
eviscerados	O
de	O
los	O
KA	O
supervivientes	O
más	O
antiguos	O
.	O
mutantes	B-Sequence
(	O
P16	O
-	O
P17	O
)	O
y	O
sus	O
compañeros	O
de	O
camada	O
de	O
la	O
misma	O
edad	O
fueron	O
colocados	O
en	O
1	O
%	O
hidróxido	B-Chemical
de	I-Chemical
potasio	I-Chemical
(	O
KOH	B-Chemical
)	O
durante	O
5	O
días	O
.	O

Los	O
cuerpos	O
se	O
transfirieron	O
a	O
una	O
solución	O
fresca	O
al	O
1	O
%	O
KOH	B-Chemical
que	O
contiene	O
unas	O
gotas	O
de	O
0	O
.	O
5	O
%	O
alizarina	B-Chemical
roja	I-Chemical
S	O
(	O
Sigma	O
,	O
St.	O
Louis	O
,	O
Missouri	O
,	O
Estados	O
Unidos	O
)	O
y	O
se	O
fue	O
por	O
otros	O
5	O
d	O
.	O

Los	O
cuerpos	O
teñidos	O
se	O
almacenaron	O
en	O
glicerina	O
y	O
se	O
observaron	O
bajo	O
un	O
microscopio	O
de	O
disección	O
.	O

Análisis	O
de	O
recombinación	O
específica	O
de	O
tejido	O
.	O

Genotipo	B-Sequence
/	O
tejido	O
-	O
recombinación	O
específica	O
del	O
condicional	O
alelo	B-Sequence
fue	O
examinado	O
tanto	O
por	O
PCR	O
como	O
por	O
RT-PCR	O
.	O

ADN	B-Sequence
las	O
muestras	O
extraídas	O
de	O
varios	O
tejidos	O
recolectados	O
en	O
el	O
momento	O
de	O
la	O
autopsia	O
se	O
examinaron	O
mediante	O
PCR	O
de	O
genotipado	O
como	O
se	O
describe	O
.	O

ARN	B-Sequence
extraído	O
de	O
varios	O
tejidos	O
homogeneizados	O
en	O
Trizol	O
reactivo	B-Chemical
fueron	O
examinados	O
para	O
la	O
expresión	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
y	O
truncado	O
APC	B-Protein
alelos	B-Sequence
por	O
SuperScript	O
One	O
-	O
Paso	O
RT	O
-	O
PCR	O
con	O
Platino	B-Chemical
Taq	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
,	O
siguiendo	O
el	O
protocolo	O
del	O
fabricante	O
.	O

Aproximadamente	O
200	O
ng	O
de	O
total	O
ARN	B-Sequence
de	O
piel	O
,	O
hígado	O
o	O
timo	O
de	O
cada	O
genotipo	B-Sequence
fue	O
al	O
revés	O
-	O
transcrito	O
usando	O
cebadores	B-Sequence
APC	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
-	O
R721	O
(	O
GCACTTCCCATGGCAATCATT	O
)	O
,	O
resultando	O
en	O
528	O
-	O
pb	B-Sequence
y	O
313	O
-	O
productos	B-Sequence
pb	I-Sequence
desde	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
/	O
ApcCKO	O
alelos	B-Sequence
y	O
Apc	O
Delta	O
580	O
alelo	B-Sequence
respectivamente	O
.	O

Etiquetado	O
BrdU	O
.	O

Ratones	B-Taxon
se	O
les	O
inyectó	O
por	O
vía	O
intraperitoneal	O
aproximadamente	O
50	O
µg/g	O
de	O
peso	O
corporal	O
de	O
BrdU	O
(	O
Sigma	O
)	O
disuelto	O
en	O
PBS	O
2	O
h	O
antes	O
de	O
su	O
muerte	O
.	O

Las	O
muestras	O
de	O
tejido	O
se	O
fijaron	O
en	O
Bouin	O
's	O
y	O
se	O
procesaron	O
como	O
se	O
describe	O
a	O
continuación	O
.	O

Análisis	O
histológico	O
e	O
inmunoquímico	O
.	O

mutante	B-Sequence
ratones	B-Taxon
y	O
hermanos	O
de	O
camada	O
de	O
la	O
misma	O
edad	O
fueron	O
asesinados	O
humanamente	O
a	O
varias	O
edades	O
por	O
CO2	B-Chemical
inhalación	O

Ratones	B-Taxon
fueron	O
desollados	O
y	O
los	O
pedazos	O
de	O
piel	O
fueron	O
congelados	O
instantáneamente	O
en	O
líquido	O
nitrógeno	B-Chemical
o	O
inmediatamente	O
homogeneizado	O
en	O
Trizol	O
reactivo	B-Chemical
y	O
almacenado	O
a	O
-80	O
grados	O
C	O
hasta	O
molecular	B-Chemical
análisis	O
,	O
o	O
fijado	O
sobre	O
una	O
toalla	O
de	O
papel	O
en	O
solución	O
de	O
Bouin	O
para	O
exámenes	O
histológicos	O
e	O
inmunohistoquímicos	O
.	O

los	O
ratones	B-Taxon
Luego	O
se	O
disecaron	O
para	O
un	O
examen	O
macroscópico	O
,	O
se	O
recolectaron	O
varios	O
tejidos	O
de	O
manera	O
similar	O
para	O
futuros	O
molecular	B-Chemical
análisis	O
,	O
y	O
luego	O
todo	O
el	O
cuerpo	O
fue	O
fijado	O
en	O
la	O
solución	O
de	O
Bouin	O
.	O

Luego	O
,	O
las	O
muestras	O
fueron	O
enviadas	O
a	O
Roedor	B-Taxon
Núcleo	O
Histopatológico	O
para	O
procesamiento	O
y	O
exámenes	O
histopatológicos	O
.	O

Para	O
la	O
inmunohistoquímica	O
,	O
se	O
desparafinizaron	O
secciones	O
de	O
tejido	O
embebidas	O
en	O
parafina	O
de	O
5	O
µm	O
en	O
xileno	B-Chemical
,	O
seguido	O
por	O
alcohol	B-Chemical
rehidratación	O

Después	O
de	O
extinguir	O
las	O
peroxidasas	O
endógenas	O
en	O
3	O
%	O
H2O2	B-Chemical
en	O
metanol	B-Chemical
,	O
los	O
portaobjetos	O
se	O
enjuagaron	O
en	O
agua	O
destilada	O
agua	B-Chemical
,	O
y	O
se	O
realizó	O
un	O
paso	O
de	O
recuperación	O
de	O
antígeno	O
en	O
un	O
horno	O
de	O
microondas	O
por	O
un	O
total	O
de	O
10	O
min	O
en	O
horno	O
precalentado	O
.	O
citrato	B-Chemical
tampón	O
(	O
pH	O
6,0	O
)	O
.	O

A	O
continuación	O
,	O
los	O
portaobjetos	O
se	O
incubaron	O
con	O
anticuerpos	B-GENE
a	O
temperatura	O
ambiente	O
durante	O
la	O
noche	O
.	O

anticuerpos	B-GENE
usados	O
fueron	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
(	O
BD	O
Transduction	O
Lab	O
,	O
San	O
Diego	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
,	O
queratinas	B-Protein
1	I-Protein
,	I-Protein
5	I-Protein
,	I-Protein
6	I-Protein
,	I-Protein
14	I-Protein
,	O
involucrina	B-Protein
,	O
loricrin	B-Protein
(	O
Covance	O
,	O
Berkeley	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
,	O
queratina	B-Protein
8	I-Protein
(	O
Abcam	O
,	O
Cambridge	O
,	O
Reino	O
Unido	O
)	O
,	O
Ki67	B-Protein
(	O
Laboratorios	O
Vector	O
,	O
Burlingame	O
,	O
California	O
,	O
Estados	O
Unidos	O
)	O
y	O
BrdU	O
(	O
Roche	O
)	O
.	O

secundaria	O
biotinilada	O
anticuerpos	B-GENE
(	O
Burro	B-Taxon
anti	O
-	O
Conejo	B-Taxon
y	O
cabra	B-Taxon
anti	O
-	O
ratón	B-Taxon
IgG	O
,	O
1:250	O
;	O
Jackson	O
ImmunoResearch	O
,	O
West	O
Grove	O
,	O
Pensilvania	O
,	O
Estados	O
Unidos	O
)	O
,	O
seguido	O
del	O
kit	O
Vectastain	O
Elite	O
ABC	O
(	O
Vector	O
Laboratories	O
)	O
para	O
la	O
detección	O
.	O

Los	O
portaobjetos	O
se	O
tiñeron	O
con	O
DAB	O
y	O
se	O
contrastaron	O
con	O
hematoxilina	O
de	O
Mayer	O
.	O

Hibridación	O
in	O
situ	O
.	O

Sección	O
ISH	O
usando	O
rata	B-Protein
shh	I-Protein
Investigacion	B-Sequence
[	O
37	O
]	O
e	O
ISH	O
de	O
montaje	O
completo	O
usando	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
Investigacion	B-Sequence
[	O
38	O
]	O
se	O
realizaron	O
como	O
se	O
describió	O
anteriormente	O
[	O
39	O
,	O
40	O
]	O
.	O

Las	O
ribosondas	O
marcadas	O
con	O
DIG	O
se	O
detectaron	O
con	O
solución	O
de	O
precipitación	O
de	O
sustrato	O
BM	O
púrpura	O
AP	O
(	O
Roche	O
)	O
.	O

información	O
de	O
soporte	O

Figura	O
S1	O

Neoplasia	O
Intestinal	O
Múltiple	O
en	O
Apc	O
Delta	O
580	O
Ratones	B-Taxon

(	O
A	O
)	O
Una	O
apariencia	O
representativa	O
del	O
intestino	O
delgado	O
de	O
4	O
meses	O
de	O
edad	O
ratón	B-Taxon
.	O

barra	O
de	O
escala	O
,	O
1	O
.	O
5mm	O

(	O
B	O
)	O
Análisis	O
histológico	O
de	O
la	O
sección	O
longitudinal	O
del	O
intestino	O
delgado	O
que	O
se	O
muestra	O
en	O
(	O
A	O
)	O
mediante	O
tinción	O
con	O
H	O
&	O
E	O
.	O

Barra	O
de	O
escala	O
,	O
100	O
mu	O
m	O
.	O

(	O
C	O
)	O
El	O
aspecto	O
histopatológico	O
típico	O
de	O
un	O
adenoma	O
mostrado	O
en	O
(	O
B	O
)	O
.	O

Barra	O
de	O
escala	O
,	O
20	O
mu	O
m	O
.	O

(	O
621	O
KB	O
PPT	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S2	O

Ensayo	O
de	O
Permeabilidad	O
de	O
la	O
Piel	O
y	O
Neonatal	O
Ratones	B-Taxon

A	O
)	O
Ensayo	O
de	O
permeabilidad	O
de	O
la	O
piel	O
de	O
E18	O
.	O
5	O
embriones	O
.	O

Ambos	O
normales	O
(	O
N	O
)	O
y	O
KA	O
mutante	B-Sequence
(	O
METRO	B-Sequence
)	O
los	O
embriones	O
pueden	O
excluir	O
el	O
azul	O
teñir	B-Chemical
a	O
esta	O
edad	O
,	O
sin	O
presentar	O
defectos	O
en	O
la	O
función	O
de	O
barrera	O
de	O
la	O
piel	O
.	O

``	O
Note	O
ligeras	O
pigmentaciones	O
en	O
pinnas	O
y	O
``	O
''	O
marcas	O
de	O
nacimiento	O
''	O
''	O
en	O
la	O
frente	O
de	O
''	O
mutante	B-Sequence
embrión	O
(	O
B	O
)	O
,	O
que	O
están	O
presentes	O
en	O
P1	O
(	O
C	O
)	O
,	O
y	O
se	O
vuelven	O
prominentes	O
a	O
medida	O
que	O
crecen	O
.	O

(	O
749	O
KB	O
PPT	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S3	O

Examen	O
inmunoquímico	O
de	O
P13	O
normal	O
y	O
mutante	B-Sequence
Timo	O

(	O
A-E	O
)	O
P13	O
timo	O
normal	O
.	O

(	O
F	O
-	O
K	O
)	O
P13	O
mutante	B-Sequence
timo	O

Teñido	O
con	O
K8	B-Protein
(	O
A	O
)	O
,	O
(	O
D	O
)	O
,	O
(	O
F	O
)	O
,	O
(	O
I	O
)	O
,	O
K1	B-Protein
(	O
B	O
)	O
,	O
(	O
E	O
)	O
,	O
(	O
G	O
)	O
,	O
(	O
J	O
)	O
,	O
y	O
involucrina	B-Protein
(	O
C	O
)	O
,	O
(	O
H	O
)	O
,	O
(	O
K	O
)	O
.	O

Barras	O
de	O
escala	O
,	O
100	O
mu	O
m	O
para	O
(	O
A-C	O
)	O
,	O
(	O
F-H	O
)	O
,	O
(	O
J-K	O
)	O
y	O
20	O
mu	O
m	O
para	O
(	O
D-E	O
)	O
,	O
(	O
I	O
)	O
.	O

Nótese	O
la	O
falta	O
de	O
involucrina	B-Protein
tinción	O
en	O
timo	O
normal	O
pero	O
grado	O
variable	O
de	O
positivo	O
células	B-Cell
en	O
mutante	B-Sequence
timo	O

(	O
6	O
.	O
PPT	O
de	O
4	O
MB	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Números	O
de	O
acceso	O

Los	O
números	O
de	O
acceso	O
de	O
GenBank	O
(	O
(	O
http	O
:	O
//	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Genbank	O
)	O
para	O
el	O
genes	B-Sequence
y	O
gene	B-Sequence
Los	O
productos	O
discutidos	O
en	O
este	O
documento	O
son	O
APC	B-Protein
(	O
NM_007462	O
)	O
,	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
(	O
NM_007614	O
)	O
,	O
AXINA	B-Protein
2	I-Protein
(	O
NM_004655	O
)	O
,	O
placoglobina	B-Protein
(	O
NM_002230	O
)	O
,	O
Asef	B-Protein
(	O
NM_015320	O
)	O
,	O
superfamilia	B-Protein
de	I-Protein
cinesinas	I-Protein
-	I-Protein
proteína	I-Protein
asociada	I-Protein
3	I-Protein
(	O
NM_014970	O
)	O
,	O
EB1	B-Protein
(	O
NM_012325	O
)	O
,	O
homólogo	B-Protein
humano	I-Protein
de	I-Protein
Drosophila	I-Protein
Discos	I-Protein
grandes	I-Protein
(	O
U13897	O
)	O
,	O
Lef1	B-Protein
(	O
NM_010703	O
)	O
,	O
Dkk1	B-Protein
(	O
NM_010051	O
)	O
,	O
K1	B-Protein
(	O
NM_008473	O
)	O
,	O
K5	B-Protein
(	O
NM_027011	O
)	O
,	O
K6	B-Protein
(	O
NM_008476	O
)	O
,	O
K8	B-Protein
(	O
NM_031170	O
)	O
,	O
K14	B-Protein
(	O
NM_016958	O
)	O
,	O
involucrina	B-Protein
(	O
NM_008412	O
)	O
,	O
loricrin	B-Protein
(	O
NM_008508	O
)	O
,	O
y	O
Shh	B-Protein
(	O
NM_009170	O
)	O
.	O

abreviaturas	O

APC	B-Protein
-	O
poliposis	B-Protein
coli	I-Protein
adenomatosa	I-Protein

CKO	O
-	O
nocaut	O
condicional	O

E	O
-	O
día	O
embrionario	O

ES	O
-	O
tallo	O
embrionario	O

FAP	O
-	O
poliposis	O
adenomatosa	O
familiar	O

FRT	B-Sequence
-	O
Objetivo	B-Sequence
de	I-Sequence
reconocimiento	I-Sequence
de	I-Sequence
FLP	I-Sequence

ISH	O
-	O
hibridación	O
in	O
situ	O

K14	B-Protein
-	O
queratina	B-Protein
14	I-Protein

SRO	O
-	O
vaina	O
externa	O
de	O
la	O
raíz	O

P	O
-	O
día	O
postnatal	O

TEC	O
-	O
timo	O
Célula	B-Cell
epitelial	I-Cell

Figuras	O
y	O
Tablas	O

Figura	O
1	O

Generación	O
del	O
Condicional	O
APC	B-Protein
alelo	B-Sequence

(	O
A	O
)	O
Diagrama	O
esquemático	O
de	O
exones	B-Sequence
14	O
y	O
15	O
de	O
la	O
APC	B-Protein
del	I-Protein
ratón	I-Protein
gene	B-Sequence
,	O
la	O
orientación	O
vector	B-Sequence
,	O
y	O
el	O
condicional	O
resultante	O
alelo	B-Sequence
con	O
2	O
sitios	B-Sequence
LoxP	I-Sequence
intercalando	O
el	O
exón	B-Sequence
14	O

El	O
PGK	O
-	O
neomicina	O
casete	B-Sequence
era	O
insertado	B-Sequence
dentro	O
de	O
intrón	B-Sequence
14	O
por	O
técnica	O
de	O
recombinación	O
.	O

Esta	O
casete	B-Sequence
es	O
emparedado	B-Sequence
por	O
2	O
sitios	B-Sequence
FRT	I-Sequence
eso	O
podria	O
ser	O
remoto	B-Sequence
cruzando	O
a	O
FLPe	O
-	O
expresando	O
ratones	B-Taxon
.	O

Posiciones	B-Sequence
de	O
PCR	O
cebadores	B-Sequence
Se	O
indican	O
los	O
utilizados	O
para	O
el	O
genotipado	O
PCR	O
(	O
F2	O
,	O
R2	O
,	O
R4	O
)	O
y	O
RT-PCR	O
(	O
F546	O
y	O
R721	O
)	O
.	O

Posiciones	B-Sequence
de	O
Investigacion	B-Sequence
utilizado	O
para	O
el	O
análisis	O
de	O
transferencia	O
Southern	O
con	O
NdeI	O
sitios	B-Sequence
también	O
se	O
muestran	O
.	O

Tras	O
la	O
recombinación	O
mediada	O
por	O
Cre	O
,	O
exón	B-Sequence
14	O
es	O
remoto	B-Sequence
y	O
conduce	O
a	O
truncado	O
APC	B-Protein
proteína	B-Chemical
,	O
de	O
los	O
cuales	O
los	O
primeros	O
580	O
Automóvil	B-Chemical
club	I-Chemical
británico	I-Chemical
corresponden	O
a	O
la	O
normalidad	O
.	O

(	O
B	O
)	O
Análisis	O
de	O
transferencia	O
Southern	O
de	O
NdeI	O
digerido	O
cola	B-Sequence
de	I-Sequence
ADN	I-Sequence
genómico	I-Sequence
aislado	O
de	O
F1	O
ratones	B-Taxon
de	O
diversas	O
APC	B-Protein
ratón	B-Taxon
líneas	O
(	O
ApcCKON	O
,	O
Apc	O
Delta	O
580	O
)	O
,	O
hibridadas	O
a	O
600	O
-	O
sonda	B-Sequence
de	I-Sequence
pb	I-Sequence
.	O

Cola	O
ADN	B-Sequence
genómico	I-Sequence
de	O
ApcCKON	O
F1	O
ratones	B-Taxon
derivado	O
de	O
un	O
modificado	B-Sequence
El	O
clon	O
ES	O
mostró	O
una	O
banda	O
de	O
12	O
kb	O
para	O
ApcCKON	O
alelo	B-Sequence
y	O
una	O
banda	O
de	O
10	O
kb	O
para	O
el	O
alelo	B-Sequence
de	I-Sequence
tipo	I-Sequence
salvaje	I-Sequence
,	O
mientras	O
que	O
ADN	B-Sequence
genómico	I-Sequence
del	O
Apc	O
Delta	O
580	O
ratón	B-Taxon
era	O
heterocigoto	O
para	O
el	O
Apc	O
Delta	O
580	O
alelo	B-Sequence
(	O
9	O
.	O
banda	O
de	O
2	O
kb	O
)	O
.	O

(	O
C	O
)	O
Gráfico	O
de	O
supervivencia	O
de	O
Kaplan	O
-	O
Meier	O
de	O
ApcCKO	O
/	O
+	B-Sequence
ratones	B-Taxon
(	O
línea	O
sólida	O
delgada	O
,	O
n	O
=	O
39	O
)	O
,	O
ApcCKO	O
/	O
CKO	O
ratones	B-Taxon
(	O
línea	O
punteada	O
delgada	O
,	O
n	O
=	O
57	O
)	O
,	O
Apc	O
Delta	O
580	O
/	O
+	B-Sequence
ratones	B-Taxon
línea	O
continua	O
,	O
n	O
=	O
51	O
)	O
,	O
y	O
tipo	B-Sequence
salvaje	I-Sequence
compañeros	O
de	O
camada	O
(	O
línea	O
discontinua	O
,	O
n	O
=	O
21	O
)	O
.	O

Heterocigosidad	O
del	O
Apc	O
Delta	O
580	O
alelo	B-Sequence
condujo	O
a	O
una	O
supervivencia	O
significativamente	O
más	O
corta	O
(	O
p	O
<	O
0,0001	O
)	O
,	O
mientras	O
que	O
los	O
heterocigotos	O
y	O
homocigotos	O
ApcCKO	O
ratones	B-Taxon
no	O
tuvo	O
una	O
diferencia	O
significativa	O
con	O
la	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
compañeros	O
de	O
camada	O

Figura	O
2	O

Mortalidad	O
posnatal	O
y	O
retraso	O
en	O
el	O
crecimiento	O
en	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
mutante	B-Sequence
Ratones	B-Taxon

animales	B-Taxon
cuyo	O
genotipo	B-Sequence
es	O
heterocigoto	O
u	O
homocigoto	O
para	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
APC	B-Protein
alelo	B-Sequence
se	O
denominan	O
normales	O
(	O
N	O
)	O
;	O
Esos	O
que	O
genotipo	B-Sequence
están	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
mutante	B-Sequence
APC	B-Protein
alelo	B-Sequence
son	O
llamados	O
mutante	B-Sequence
(	O
METRO	B-Sequence
)	O
.	O

(	O
A	O
)	O
Dos	O
P3	O
mutante	B-Sequence
ratones	B-Taxon
,	O
M1	O
y	O
M2	O
,	O
y	O
sus	O
compañeros	O
de	O
camada	O
normales	O
,	O
mostrando	O
variación	O
de	O
tamaño	O
entre	O
mutantes	B-Sequence
.	O

(	O
B	O
)	O
P8	O
mutante	B-Sequence
ratón	B-Taxon
(	O
derecha	O
)	O
y	O
un	O
compañero	O
de	O
camada	O
normal	O
.	O

Nótese	O
la	O
escasez	O
de	O
pelo	O
y	O
las	O
orejas	O
anormales	O
.	O

(	O
C	O
-	O
D	O
)	O
Las	O
vibrisas	O
de	O
las	O
almohadillas	O
de	O
los	O
bigotes	O
son	O
cortas	O
y	O
extrañamente	O
anguladas	O
en	O
un	O
P12	O
mutante	B-Sequence
ratón	B-Taxon
(	O
C	O
)	O
,	O
relativo	O
al	O
control	O
(	O
D	O
)	O
.	O

Nótese	O
la	O
falta	O
de	O
incisivos	O
en	O
el	O
mutante	B-Sequence
.	O

(	O
E	O
)	O
A	O
P17	O
mutante	B-Sequence
ratón	B-Taxon
(	O
derecha	O
)	O
con	O
su	O
camada	O
.	O

Su	O
frente	O
desnuda	O
,	O
línea	O
media	O
dorsal	O
y	O
orejas	O
anormales	O
son	O
evidentes	O
.	O

(	O
F	O
)	O
Curva	O
de	O
crecimiento	O
de	O
mutantes	B-Sequence
compañeros	O
de	O
camada	O
normales	O
.	O

mutantes	B-Sequence
muestran	O
retraso	O
en	O
el	O
crecimiento	O
,	O
que	O
se	O
hizo	O
más	O
prominente	O
a	O
medida	O
que	O
envejecían	O
,	O
y	O
pesan	O
significativamente	O
menos	O
que	O
los	O
compañeros	O
de	O
camada	O
de	O
P8	O
(	O
p	O
<	O
0,05	O
)	O
.	O

(	O
G	O
)	O
Comparación	O
de	O
mutante	B-Sequence
y	O
timo	O
normal	O
de	O
P3	O
ratones	B-Taxon
.	O

los	O
mutante	B-Sequence
timo	O
(	O
izquierda	O
)	O
es	O
dramáticamente	O
más	O
pequeño	O
para	O
su	O
edad	O
en	O
comparación	O
con	O
el	O
compañero	O
de	O
camada	O
normal	O
(	O
derecha	O
)	O
.	O

La	O
barra	O
de	O
escala	O
equivale	O
a	O
1	O
mm	O
.	O

(	O
H	O
)	O
Preparaciones	O
esqueléticas	O
de	O
normal	O
(	O
izquierda	O
)	O
y	O
mutante	B-Sequence
(	O
derecha	O
)	O
,	O
que	O
muestra	O
diferencias	O
en	O
el	O
desarrollo	O
de	O
los	O
dientes	O
incisivos	O
(	O
I	O
)	O
y	O
molares	O
(	O
M	O
)	O
.	O

figura	O
3	O

Tejido	O
-	O
Detección	O
específica	O
y	O
expresión	O
de	O
Eliminado	B-Sequence
APC	B-Protein
Alelos	B-Sequence

(	O
A	O
)	O
PCR	O
de	O
genotipado	O
específico	O
de	O
tejido	O
.	O

Solamente	O
ADN	B-Sequence
genómico	I-Sequence
muestras	O
de	O
piel	O
(	O
S	O
)	O
y	O
timo	O
(	O
T	O
)	O
,	O
pero	O
no	O
de	O
hígado	O
(	O
L	O
)	O
de	O
ratones	B-Taxon
positivo	O
para	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
eliminado	B-Sequence
Apc	O
Delta	O
580	O
alelo	B-Sequence
.	O

(	O
B	O
)	O
Genotipo	B-Sequence
#	O
¿NOMBRE	O
?	O
APC	B-Protein
transcripciones	B-Sequence
.	O

Un	O
gel	O
representativo	O
de	O
RT	O
-	O
PCR	O
utilizando	O
cebadores	B-Sequence
F546	O
y	O
R721	O
,	O
mostrando	O
que	O
solo	O
ARN	B-Sequence
de	O
la	O
piel	O
y	O
el	O
timo	O
pero	O
no	O
del	O
hígado	O
de	O
ratones	B-Taxon
positivo	O
para	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
transcripciones	B-Sequence
de	O
ambos	O
tipo	B-Sequence
salvaje	I-Sequence
(	O
528	O
pb	B-Sequence
)	O
y	O
eliminado	B-Sequence
(	O
313	O
pb	B-Sequence
)	O
APC	B-Protein
alelos	B-Sequence
.	O

Figura	O
4	O

Examen	O
histológico	O
e	O
inmunoquímico	O
de	O
piel	O
y	O
dientes	O
P12	O

(	O
A-E	O
)	O
P12	O
piel	O
normal	O
.	O

(	O
F-J	O
)	O
P12	O
mutante	B-Sequence
piel	O
.	O

(	O
K-N	O
)	O
P12	O
cavidad	O
oral	O
normal	O
.	O

(	O
O	O
-	O
R	O
)	O
P12	O
mutante	B-Sequence
cavidad	O
oral	O
.	O

Teñido	O
con	O
H	O
&	O
E	O
para	O
histología	O
(	O
A	O
,	O
F	O
,	O
K	O
-	O
L	O
,	O
O	O
-	O
P	O
)	O
,	O
Ki67	B-Protein
(	O
B	O
,	O
G	O
)	O
,	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
(	O
C	O
,	O
H	O
,	O
M	O
,	O
Q	O
)	O
,	O
K14	B-Protein
(	O
D	O
,	O
I	O
,	O
N	O
,	O
R	O
)	O
,	O
y	O
K6	B-Protein
(	O
E	O
,	O
J	O
)	O
.	O

Morfogénesis	O
folicular	O
aberrante	O
,	O
caracterizada	O
por	O
la	O
formación	O
de	O
folículos	O
pilosos	O
no	O
polarizados	O
irregularmente	O
espaciados	O
,	O
en	O
mutante	B-Sequence
la	O
piel	O
es	O
evidente	O
.	O

A	O
pesar	O
de	O
la	O
histología	O
anormal	O
,	O
la	O
proliferación	O
parece	O
limitarse	O
a	O
estructuras	O
similares	O
a	O
bulbos	O
pilosos	O
(	O
flechas	O
en	O
[	O
G	O
]	O
,	O
inserto	O
[	O
G	O
'	O
]	O
a	O
mayor	O
aumento	O
)	O
,	O
pero	O
en	O
mutante	B-Sequence
piel	O
(	O
flechas	O
en	O
[	O
H	O
]	O
,	O
recuadro	O
[	O
H	O
'	O
]	O
a	O
mayor	O
aumento	O
)	O
y	O
cavidad	O
oral	O
(	O
flechas	O
en	O
recuadros	O
[	O
Q	O
'	O
]	O
a	O
mayor	O
aumento	O
)	O
elevada	O
citosólico	B-GENE
localización	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
se	O
detecta	O
en	O
algunos	O
células	B-Cell
.	O

Barras	O
de	O
escala	O
:	O
50	O
mu	O
m	O
para	O
(	O
A-F	O
)	O
,	O
(	O
H-J	O
)	O
;	O
250	O
mu	O
m	O
para	O
(	O
K	O
)	O
y	O
(	O
O	O
)	O
;	O
100	O
mu	O
m	O
para	O
(	O
G	O
)	O
,	O
(	O
L-N	O
)	O
,	O
(	O
P-R	O
)	O
;	O
20	O
mu	O
m	O
para	O
(	O
Q	O
'	O
)	O
.	O

Figura	O
5	O

Expresión	O
de	O
Shh	B-Protein
y	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
Transcripciones	B-Sequence
en	O
Normal	O
(	O
ApcCKO/CKO	O
)	O
y	O
mutante	B-Sequence
(	O
K14	B-Protein
-	O
cre	O
;	O
ApcCKO	O
/	O
CKO	O
)	O
Piel	O
embrionaria	O

A	O
-	O
D	O
)	O
Sección	O
ISH	O
con	O
Shh	B-Protein
Investigacion	B-Sequence
en	O
E14	O
.	O
5	O
normales	O
(	O
A	O
)	O
,	O
E14	O
.	O
5	O
mutante	B-Sequence
(	O
B	O
)	O
,	O
E16	O
.	O
5	O
normales	O
(	O
C	O
)	O
,	O
y	O
E16	O
.	O
5	O
mutante	B-Sequence
(	O
D	O
)	O
piel	O
.	O

Las	O
líneas	O
discontinuas	O
indican	O
la	O
interfaz	O
entre	O
el	O
epitelio	O
y	O
el	O
mesénquima	O
.	O

Barras	O
de	O
escala	O
:	O
50	O
mu	O
m	O
.	O

Detección	O
in	O
situ	O
de	O
montaje	O
completo	O
de	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
en	O
E15	O
.	O
5	O
normales	O
(	O
E	O
,	O
G	O
)	O
,	O
mutante	B-Sequence
(	O
F	O
,	O
H	O
)	O
embriones	O
.	O

La	O
iniciación	O
aberrante	O
de	O
múltiples	O
placodas	O
de	O
cabello	O
es	O
evidente	O
en	O
E14	O
.	O
5	O
.	O

Pérdida	O
de	O
K14	B-Protein
#	O
¿NOMBRE	O
?	O
APC	B-Protein
la	O
pérdida	O
provocó	O
la	O
formación	O
de	O
un	O
patrón	O
aberrante	O
(	O
F	O
'	O
)	O
y	O
formó	O
placodas	O
ectópicas	O
de	O
pelo	O
en	O
almohadillas	O
normalmente	O
sin	O
pelo	O
(	O
H	O
,	O
flechas	O
)	O
que	O
están	O
ausentes	O
en	O
condiciones	O
normales	O
(	O
G	O
)	O
.	O

Figura	O
6	O

Examen	O
histológico	O
e	O
inmunoquímico	O
del	O
timo	O

(	O
A-D	O
)	O
P3	O
timo	O
normal	O
.	O

(	O
E	O
-	O
G	O
)	O
Leve	O
P3	O
mutante	B-Sequence
timo	O

(	O
H	O
-	O
K	O
)	O
Severo	O
P3	O
mutante	B-Sequence
timo	O

(	O
L-O	O
)	O
P13	O
mutante	B-Sequence
timo	O

Teñido	O
con	O
H	O
&	O
E	O
para	O
histología	O
(	O
A	O
,	O
E	O
,	O
H	O
,	O
L	O
)	O
,	O
BrdU	O
(	O
B	O
,	O
I	O
,	O
M	O
)	O
,	O
beta	B-Protein
-	I-Protein
catenina	I-Protein
(	O
C	O
,	O
F	O
,	O
J	O
,	O
N	O
)	O
,	O
y	O
K14	B-Protein
(	O
D	O
,	O
G	O
,	O
K	O
,	O
O	O
)	O
.	O

(	O
B	O
)	O
Los	O
timocitos	O
en	O
división	O
activa	O
son	O
visibles	O
en	O
el	O
borde	O
superficial	O
de	O
la	O
corteza	O
del	O
timo	O
P3	O
normal	O
.	O

Tenga	O
en	O
cuenta	O
la	O
progresión	O
de	O
las	O
anomalías	O
histológicas	O
en	O
el	O
mutante	B-Sequence
timo	O
de	O
leve	O
P3	O
,	O
severo	O
P3	O
a	O
P13	O
(	O
A	O
,	O
E	O
,	O
H	O
,	O
L	O
)	O
.	O

Barras	O
de	O
escala	O
,	O
20	O
mu	O
m	O
.	O

tabla	O
1	O

Genotipo	B-Sequence
Distribución	O
de	O
la	O
Progenie	O
de	O
los	O
Apareamientos	O

notas	O
al	O
pie	O

Conflicto	O
de	O
intereses	O
.	O

Los	O
autores	O
han	O
declarado	O
que	O
no	O
existen	O
intereses	O
contrapuestos	O
.	O

Una	O
versión	O
anterior	O
de	O
este	O
artículo	O
apareció	O
como	O
Publicación	O
anticipada	O
en	O
línea	O
el	O
28	O
de	O
julio	O
de	O
2006	O
(	O
DOI	O
:	O
10	O
.	O
1371/journal	O
.	O
pgen	O
.	O
0020146.	O
eor	O
)	O
.	O

Contribuciones	O
de	O
autor	O
.	O

m	O

Kuraguchi	O
y	O
R	O
.	O

Kucherlapati	O
concibió	O
y	O
diseñó	O
los	O
experimentos	O
.	O

m	O

Kuraguchi	O
,	O
X	O
.	O

Wang	O
,	O
R	O
.	O

Bronson	O
,	O
R	O
.	O

Rothenberg	O
,	O
N	O
.	O

Ohene-Baah	O
,	O
J	O
.	O

Lund	O
y	O
M	O
.	O

Kucherlapati	O
realizó	O
los	O
experimentos	O
.	O

m	O

Kuraguchi	O
analizó	O
los	O
datos	O
.	O

r	O

Maas	O
contribuyó	O
reactivos	B-Chemical
/	O
materiales	O
/	O
herramientas	O
de	O
análisis	O
.	O

m	O

Kuraguchi	O
escribió	O
el	O
artículo	O
.	O

Financiamiento	O

Este	O
trabajo	O
fue	O
apoyado	O
por	O
subvenciones	O
del	O
Instituto	O
Nacional	O
del	O
Cáncer	O
(	O
CA-084301	O
)	O
,	O
el	O
Instituto	O
Nacional	O
de	O
Ciencias	O
de	O
la	O
Salud	O
Ambiental	O
(	O
ES-11040	O
)	O
,	O
y	O
el	O
Instituto	O
Nacional	O
de	O
Investigaciones	O
Dentales	O
y	O
Craneofaciales	O
(	O
DE-11697	O
,	O
DE-16140	O
)	O
.	O

Supresión	B-Sequence
en	O
ITPR1	B-Protein
Subyace	O
a	O
la	O
ataxia	O
en	O
Ratones	B-Taxon
ataxia	O
espinocerebelosa	O
15	O
en	O
humanos	B-Taxon

Resumen	O

Observamos	O
una	O
severa	O
autosómico	B-GENE
trastorno	O
del	O
movimiento	O
recesivo	O
en	O
ratones	B-Taxon
utilizados	O
en	O
nuestro	O
laboratorio	O
.	O

Llevamos	O
a	O
cabo	O
una	O
serie	O
de	O
experimentos	O
para	O
definir	O
la	O
genético	B-Sequence
lesión	O
subyacente	O
a	O
este	O
trastorno	O
e	O
identificar	O
una	O
enfermedad	O
afín	O
en	O
humanos	B-Taxon
con	O
mutación	B-Sequence
al	O
mismo	O
lugar	B-Sequence
.	O

A	O
través	O
de	O
la	O
vinculación	O
y	O
secuencia	B-Sequence
análisis	O
mostramos	O
aquí	O
que	O
este	O
trastorno	O
es	O
causado	O
por	O
un	O
homocigoto	O
en	O
-	O
marco	B-Sequence
-18	O
eliminación	B-Sequence
de	I-Sequence
pb	I-Sequence
en	O
itpr1	B-Protein
(	O
Itpr1	O
Delta	O
18/Delta	O
18	O
)	O
,	O
codificación	O
inositol	B-Protein
1	I-Protein
,	I-Protein
4	I-Protein
,	I-Protein
5	I-Protein
-	I-Protein
receptor	I-Protein
trifosfato	I-Protein
1	I-Protein
.	O

Un	O
espontáneo	O
reportado	O
previamente	O
itpr1	B-Protein
mutación	B-Sequence
en	O
ratones	B-Taxon
provoca	O
un	O
fenotipo	O
idéntico	O
al	O
observado	O
aquí	O
.	O

En	O
ambos	O
modelos	O
en	O
-	O
borrado	B-Sequence
de	I-Sequence
fotogramas	I-Sequence
dentro	O
de	O
itpr1	B-Protein
conduce	O
a	O
una	O
disminución	O
en	O
el	O
nivel	O
normalmente	O
alto	O
de	O
itpr1	B-Protein
expresión	O
en	O
el	O
cerebelo	O
células	B-Cell
de	I-Cell
Purkinje	I-Cell
.	O

Ataxia	O
espinocerebelosa	O
15	O
(	O
SCA15	O
)	O
,	O
una	O
humano	B-Taxon
autosómico	B-GENE
trastorno	O
dominante	O
,	O
se	O
asigna	O
a	O
la	O
región	B-Sequence
genómica	I-Sequence
que	O
contiene	O
ITPR1	B-Protein
;	O
sin	O
embargo	O
,	O
hasta	O
la	O
fecha	O
no	O
hay	O
causal	O
mutaciones	B-Sequence
había	O
sido	O
identificado	O
.	O

Debido	O
a	O
que	O
la	O
ataxia	O
es	O
una	O
característica	O
prominente	O
en	O
itpr1	B-Protein
mutante	B-Sequence
ratones	B-Taxon
realizamos	O
una	O
serie	O
de	O
experimentos	O
para	O
probar	O
la	O
hipótesis	O
de	O
que	O
mutación	B-Sequence
en	O
ITPR1	B-Protein
puede	O
ser	O
la	O
causa	O
de	O
SCA15	O
.	O

Mostramos	O
aquí	O
que	O
los	O
heterocigotos	O
supresión	B-Sequence
de	O
los	O
5	O
'	O
parte	B-Sequence
del	I-Sequence
gen	I-Sequence
ITPR1	I-Sequence
,	O
abarcando	O
exones	B-Sequence
1	O
-	O
10	O
,	O
1	O
-	O
40	O
y	O
1	O
-	O
44	O
en	O
tres	O
familias	O
estudiadas	O
,	O
subyace	O
a	O
SCA15	O
en	O
humanos	B-Taxon
.	O

Resumen	O
del	O
autor	O

Hemos	O
identificado	O
un	O
espontáneo	O
en	O
-	O
mutación	B-Sequence
de	I-Sequence
eliminación	I-Sequence
de	I-Sequence
marco	I-Sequence
en	O
el	O
gene	B-Sequence
itpr1	B-Protein
que	O
causa	O
un	O
trastorno	O
del	O
movimiento	O
recesivo	O
en	O
ratones	B-Taxon
.	O

En	O
un	O
intento	O
por	O
definir	O
si	O
alguna	O
enfermedad	O
similar	O
ocurre	O
en	O
humanos	B-Taxon
realizamos	O
una	O
búsqueda	O
bibliográfica	O
de	O
enfermedades	O
vinculadas	O
a	O
la	O
humano	B-Taxon
región	B-Sequence
cromosómica	I-Sequence
que	O
contiene	O
ITPR1	B-Protein
.	O

Identificamos	O
la	O
enfermedad	O
ataxia	O
espinocerebelosa	O
15	O
como	O
vinculada	O
a	O
este	O
región	B-Sequence
.	O

Alta	O
densidad	O
genómico	B-Sequence
El	O
análisis	O
de	O
los	O
miembros	O
afectados	O
de	O
tres	O
familias	O
reveló	O
que	O
la	O
enfermedad	O
en	O
estos	O
pacientes	O
fue	O
causada	O
por	O
supresión	B-Sequence
de	O
un	O
gran	O
parte	B-Sequence
de	O
El	O
región	B-Sequence
que	O
contiene	O
ITPR1	B-Protein
.	O

Mostramos	O
aquí	O
que	O
este	O
mutación	B-Sequence
resulta	O
en	O
una	O
drástica	O
reducción	O
de	O
ITPR1	B-Protein
en	O
células	B-Cell
de	O
estos	O
pacientes	O
.	O

Estos	O
datos	O
muestran	O
de	O
manera	O
convincente	O
que	O
ITPR1	B-Protein
supresión	B-Sequence
subyace	O
en	O
la	O
ataxia	O
espinocerebelosa	O
15	O
en	O
humanos	B-Taxon
.	O

Introducción	O

El	O
uso	O
de	O
la	O
genética	O
directa	O
para	O
definir	O
nuevos	O
lugares	B-Sequence
de	O
interés	O
en	O
humano	B-Taxon
enfermedad	O
se	O
ha	O
vuelto	O
cada	O
vez	O
más	O
viable	O
con	O
la	O
implementación	O
de	O
programas	O
a	O
gran	O
escala	O
mutagénesis	B-Sequence
programas	O

Antes	O
de	O
estas	O
iniciativas	O
,	O
este	O
trabajo	O
se	O
llevó	O
a	O
cabo	O
en	O
parte	O
por	O
la	O
investigación	O
de	O
mutaciones	B-Sequence
que	O
causan	O
trastornos	O
en	O
ratón	B-Taxon
colonias	O
de	O
cría	O
.	O

La	O
observación	O
cuidadosa	O
de	O
estos	O
eventos	O
fortuitos	O
ha	O
llevado	O
al	O
establecimiento	O
y	O
estudio	O
de	O
muchos	O
modelos	O
de	O
enfermedades	O
in	O
vivo	O
[	O
3	O
]	O
.	O

Durante	O
la	O
generación	O
de	O
una	O
línea	O
eliminatoria	O
de	O
ratones	B-Taxon
notamos	O
un	O
trastorno	O
de	O
movimiento	O
temprano	O
que	O
se	O
heredó	O
independientemente	O
de	O
la	O
orientación	O
vector	B-Sequence
transmisión	O
.	O

Nos	O
embarcamos	O
en	O
una	O
serie	O
de	O
experimentos	O
para	O
identificar	O
el	O
genético	B-Sequence
lesión	O
subyacente	O
a	O
este	O
trastorno	O
del	O
movimiento	O
e	O
identificar	O
una	O
enfermedad	O
afín	O
y	O
la	O
correspondiente	O
mutación	B-Sequence
en	O
humanos	B-Taxon
.	O

Aquí	O
describimos	O
este	O
esfuerzo	O
y	O
el	O
descubrimiento	O
de	O
supresión	B-Sequence
en	O
el	O
ITPR1	B-Protein
lugar	B-Sequence
como	O
causa	O
de	O
este	O
trastorno	O
en	O
ratones	B-Taxon
y	O
de	O
ataxia	O
espinocerebelosa	O
15	O
(	O
SCA15	O
)	O
en	O
humanos	B-Taxon
.	O

Resultados	O
/	O
Discusión	O

Durante	O
la	O
generación	O
de	O
una	O
línea	O
de	O
ratones	B-Taxon
con	O
nocaut	O
de	O
la	O
gene	B-Sequence
parque7	B-Protein
notamos	O
un	O
trastorno	O
de	O
movimiento	O
temprano	O
que	O
se	O
heredó	O
independientemente	O
de	O
la	O
orientación	O
vector	B-Sequence
transmisión	O
.	O

Nuestras	O
observaciones	O
iniciales	O
sugirieron	O
que	O
los	O
afectados	O
ratones	B-Taxon
padecía	O
un	O
trastorno	O
del	O
movimiento	O
aparentemente	O
paroxístico	O
,	O
a	O
menudo	O
inducido	O
por	O
el	O
tacto	O
.	O

Los	O
movimientos	O
anormales	O
ocurrían	O
predominantemente	O
por	O
debajo	O
del	O
nivel	O
cervical	O
y	O
el	O
trastorno	O
parecía	O
progresivo	O
.	O

En	O
el	O
examen	O
inicial	O
,	O
un	O
humano	B-Taxon
especialista	O
en	O
trastornos	O
del	O
movimiento	O
(	O
K	O
.	O
G	O
.	O
-	O
H	O
.	O
)	O
comparó	O
el	O
trastorno	O
con	O
la	O
ataxia	O
intermitente	O
episódica	O
o	O
la	O
distonía	O
paroxística	O
cinesiógena	O
y	O
predijo	O
la	O
participación	O
de	O
un	O
ion	B-Chemical
canal	O
mutación	B-Sequence
en	O
la	O
etiología	O
.	O

Afectado	O
ratones	B-Taxon
se	O
presentó	O
aproximadamente	O
a	O
los	O
14	O
días	O
posnatales	O
,	O
y	O
el	O
tiempo	O
de	O
supervivencia	O
sin	O
destete	O
fue	O
en	O
promedio	O
de	O
4	O
semanas	O
después	O
del	O
inicio	O
.	O

Los	O
experimentos	O
de	O
reproducción	O
sugirieron	O
que	O
el	O
trastorno	O
observado	O
se	O
heredó	O
en	O
un	O
autosómico	B-GENE
manera	O
recesiva	O
.	O

Para	O
mapear	O
el	O
ubicación	B-Sequence
de	O
la	O
lesión	O
causante	O
de	O
la	O
enfermedad	O
,	O
realizamos	O
genoma	B-Sequence
#	O
¿NOMBRE	O
?	O
polimorfismos	B-Sequence
de	I-Sequence
un	I-Sequence
sólo	I-Sequence
nucleótido	I-Sequence
(	O
SNP	B-Sequence
)	O
a	O
120	O
lugares	B-Sequence
a	O
través	O
de	O
ratón	B-Taxon
genoma	B-Sequence
.	O

El	O
análisis	O
de	O
estos	O
datos	O
mostró	O
un	O
solo	O
región	B-Sequence
genómica	I-Sequence
con	O
un	O
vínculo	O
significativo	O
con	O
la	O
enfermedad	O
,	O
proporcionando	O
una	O
puntuación	O
LOD	O
de	O
dos	O
puntos	O
de	O
5	O
.	O
13	O
en	O
el	O
marcador	O
20	O
.	O
MMHAP85FLG2	O
en	O
Cromosoma	B-GENE
6qE1	O
.	O

el	O
vinculado	O
haplotipo	B-Sequence
sugirió	O
el	O
mutación	B-Sequence
había	O
ocurrido	O
en	O
el	O
fondo	O
129x1/SvJ	O
(	O
Figura	O
S1	O
)	O
.	O

Las	O
búsquedas	O
bibliográficas	O
revelaron	O
que	O
,	O
entre	O
las	O
líneas	O
de	O
enfermedad	O
asignadas	O
a	O
6qE1	O
,	O
la	O
espontánea	O
mutante	B-Sequence
optar	O
ratón	B-Taxon
muestra	O
una	O
presentación	O
sorprendentemente	O
similar	O
a	O
la	O
descrita	O
aquí	O
[	O
1	O
]	O
.	O

el	O
subyacente	O
genético	B-Sequence
lesión	O
que	O
causa	O
el	O
fenotipo	O
opt	O
es	O
un	O
homocigoto	O
en	O
-	O
borrado	B-Sequence
de	I-Sequence
fotogramas	I-Sequence
de	O
exones	B-Sequence
43	O
y	O
44	O
de	O
la	O
gene	B-Sequence
itpr1	B-Protein
(	O
Itpr1opt/opt	O
)	O
,	O
codificación	O
inositol	B-Protein
1	I-Protein
,	I-Protein
4	I-Protein
,	I-Protein
5	I-Protein
-	I-Protein
receptor	I-Protein
trifosfato	I-Protein
1	I-Protein
(	O
itpr1	B-Protein
)	O
.	O

secuenciación	O
de	O
todos	O
exones	B-Sequence
y	O
límites	B-Sequence
entre	I-Sequence
intrones	I-Sequence
y	I-Sequence
exones	I-Sequence
de	O
itpr1	B-Protein
en	O
afectados	O
ratones	B-Taxon
del	O
estudio	O
actual	O
reveló	O
una	O
sola	O
mutación	B-Sequence
dentro	O
de	O
itpr1	B-Protein
:	O
una	O
novela	O
en	O
-	O
borrado	B-Sequence
de	I-Sequence
fotogramas	I-Sequence
de	O
18	O
pb	B-Sequence
dentro	O
de	O
exón	B-Sequence
36	O
(	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
)	O
.	O

Para	O
confirmar	O
la	O
patogenicidad	O
de	O
este	O
mutación	B-Sequence
cruzamos	O
heterocigotos	O
ratones	B-Taxon
del	O
estudio	O
actual	O
(	O
Itpr1wt	O
/	O
Delta	O
18	O
)	O
con	O
ratones	B-Taxon
heterocigoto	O
para	O
el	O
opt	O
mutación	B-Sequence
(	O
Itpr1wt/opt	O
)	O
.	O

Esto	O
resultó	O
en	O
dos	O
litros	O
de	O
ratones	B-Taxon
con	O
un	O
total	O
de	O
cuatro	O
cachorros	O
Itpr1opt	O
/	O
Delta	O
18	O
afectados	O
(	O
de	O
un	O
total	O
de	O
15	O
)	O
con	O
un	O
fenotipo	O
indistinguible	O
del	O
de	O
los	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
e	O
Itpr1opt	O
/	O
opt	O
ratones	B-Taxon
[	O
1	O
]	O
.	O

Además	O
,	O
este	O
fenotipo	O
fue	O
similar	O
,	O
aunque	O
menos	O
grave	O
,	O
al	O
descrito	O
en	O
un	O
ratón	B-Taxon
línea	O
con	O
objetivo	O
supresión	B-Sequence
de	O
itpr1	B-Protein
,	O
donde	O
la	O
ataxia	O
se	O
describió	O
como	O
una	O
característica	O
destacada	O
[	O
4	O
]	O
.	O

Al	O
igual	O
que	O
con	O
el	O
Itpr1opt	O
/	O
opt	O
ratones	B-Taxon
,	O
donde	O
el	O
supresión	B-Sequence
de	O
exones	B-Sequence
43	O
y	O
44	O
también	O
se	O
predice	O
que	O
dejarán	O
la	O
traducción	O
marco	B-Sequence
de	I-Sequence
lectura	I-Sequence
no	O
afectado	O
,	O
el	O
en-	O
marco	B-Sequence
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mutación	B-Sequence
por	I-Sequence
deleción	I-Sequence
resulta	O
en	O
niveles	O
marcadamente	O
reducidos	O
de	O
itpr1	B-Protein
en	O
el	O
cerebelo	O
células	B-Cell
de	I-Cell
Purkinje	I-Cell
.	O

En	O
estos	O
dos	O
espontáneos	O
mutantes	B-Sequence
[	O
1	O
]	O
y	O
en	O
el	O
itpr1	B-Protein
#	O
¿NOMBRE	O
?	O
ratón	B-Taxon
[	O
4	O
]	O
generado	O
por	O
gene	B-Sequence
focalización	O
,	O
disminución	O
itpr1	B-Protein
expresión	O
está	O
asociada	O
con	O
el	O
mismo	O
autosómico	B-GENE
trastorno	O
del	O
movimiento	O
recesivo	O
(	O
Figura	O
1	O
)	O
.	O

Dado	O
nuestro	O
interés	O
en	O
humano	B-Taxon
enfermedad	O
neurológica	O
buscamos	O
identificar	O
cualquier	O
cognado	O
humano	B-Taxon
trastornos	O
en	O
los	O
que	O
se	O
había	O
establecido	O
un	O
vínculo	O
con	O
el	O
región	B-Sequence
sinténica	I-Sequence
de	O
El	O
humano	B-Taxon
genoma	B-Sequence
pero	O
donde	O
no	O
hay	O
causal	O
mutación	B-Sequence
había	O
sido	O
identificado	O
.	O

SCA15	O
,	O
un	O
inicio	O
en	O
adultos	O
autosómico	B-GENE
la	O
ataxia	O
progresiva	O
dominante	O
está	O
relacionada	O
con	O
esto	O
lugar	B-Sequence
[	O
5	O
]	O
.	O

aunque	O
sin	O
sentido	O
mutación	B-Sequence
de	O
ITPR1	B-Protein
previamente	O
había	O
sido	O
descartado	O
[	O
2	O
]	O
y	O
el	O
modo	O
de	O
herencia	O
era	O
inconsistente	O
con	O
el	O
observado	O
en	O
Itpr1	O
Delta	O
18	O
e	O
Itpr1opt	O
ratones	B-Taxon
,	O
la	O
presencia	O
fenotípica	O
de	O
ataxia	O
en	O
el	O
ratones	B-Taxon
nos	O
llevó	O
a	O
reexaminar	O
a	O
este	O
candidato	O
gene	B-Sequence
como	O
posible	O
causa	O
de	O
SCA15	O
.	O

Nosotros	O
obtuvimos	O
ADN	B-Sequence
genómico	I-Sequence
de	O
tres	O
miembros	O
de	O
la	O
familia	O
afectados	O
y	O
un	O
miembro	O
de	O
la	O
familia	O
con	O
estado	O
de	O
enfermedad	O
desconocido	O
de	O
la	O
familia	O
utilizada	O
originalmente	O
para	O
definir	O
y	O
mapear	O
SCA15	O
(	O
familia	O
AUS1	O
,	O
de	O
origen	O
anglocelta	O
australiano	O
)	O
[	O
2	O
]	O
.	O

Realizamos	O
dos	O
experimentos	O
simultáneamente	O
en	O
tres	O
miembros	O
afectados	O
de	O
esta	O
familia	O
:	O
secuencia	B-Sequence
análisis	O
de	O
la	O
codificando	B-Sequence
exones	I-Sequence
de	O
ITPR1	B-Protein
y	O
alta	O
-	O
densidad	O
genoma	B-Sequence
#	O
¿NOMBRE	O
?	O
SNP	B-Sequence
genotipado	O

Secuencia	B-Sequence
análisis	O
no	O
pudo	O
mostrar	O
ninguna	O
alteraciones	B-Sequence
de	I-Sequence
codificación	I-Sequence
segregar	O
con	O
enfermedad	O
o	O
cualquier	O
alteraciones	B-Sequence
que	O
eran	O
inconsistentes	O
con	O
los	O
patrones	O
mendelianos	O
de	O
herencia	O
dentro	O
de	O
la	O
familia	O
.	O

Sin	O
embargo	O
,	O
la	O
visualización	O
de	O
la	O
relación	O
log	O
R	O
y	O
B	O
alelo	B-Sequence
métricas	O
de	O
frecuencia	O
de	O
genoma	B-Sequence
#	O
¿NOMBRE	O
?	O
SNP	B-Sequence
experimentos	O
de	O
genotipado	O
mostraron	O
claramente	O
datos	O
consistentes	O
con	O
un	O
heterocigoto	O
deleción	B-Sequence
genómica	I-Sequence
a	O
través	O
del	O
primero	O
-	O
tercio	O
de	O
ITPR1	B-Protein
y	O
a	O
través	O
de	O
la	O
primera	O
mitad	O
de	O
un	O
vecino	O
gene	B-Sequence
,	O
SUMF1	B-Protein
(	O
Figura	O
2	O
)	O
.	O

Esta	O
supresión	B-Sequence
fue	O
evidente	O
en	O
los	O
tres	O
miembros	O
de	O
la	O
familia	O
afectados	O
estudiados	O
y	O
ausente	O
del	O
miembro	O
de	O
la	O
familia	O
con	O
estado	O
afectivo	O
desconocido	O
(	O
Figura	O
3	O
)	O
.	O

los	O
SNP	B-Sequence
los	O
datos	O
mostraron	O
un	O
supresión	B-Sequence
de	O
entre	O
188	O
kb	O
y	O
210	O
kb	O
de	O
tamaño	O
;	O
examen	O
de	O
SNP	B-Sequence
en	O
el	O
flanqueando	B-Sequence
regiones	I-Sequence
desconocidas	I-Sequence
de	O
esta	O
supresión	B-Sequence
nos	O
permitió	O
delimitar	O
bordes	B-Sequence
de	I-Sequence
la	I-Sequence
eliminación	I-Sequence
a	O
7	O
.	O
5	O
kb	O
en	O
el	O
telomérico	B-Sequence
lado	O
del	O
supresión	B-Sequence
(	O
entre	O
rs12634249	O
y	O
rs793396	O
)	O
y	O
~	O
14	O
.	O
4	O
kb	O
en	O
el	O
centromérico	B-Sequence
lado	O
del	O
supresión	B-Sequence
(	O
entre	O
rs4073665	O
y	O
rs17709863	O
)	O
.	O

En	O
un	O
intento	O
de	O
definir	O
si	O
este	O
variación	B-Sequence
era	O
un	O
benigno	O
polimorfismo	B-Sequence
Analizamos	O
genoma	B-Sequence
#	O
¿NOMBRE	O
?	O
SNP	B-Sequence
datos	O
en	O
este	O
lugar	B-Sequence
,	O
producido	O
usando	O
el	O
mismo	O
chip	O
de	O
genotipado	O
,	O
de	O
577	O
individuos	B-Taxon
descendientes	O
de	O
europeos	O
que	O
eran	O
controles	O
o	O
individuos	B-Taxon
con	O
un	O
trastorno	O
neurológico	O
no	O
relacionado	O
.	O

No	O
logramos	O
encontrar	O
ninguna	O
eliminaciones	B-Sequence
afectando	O
el	O
secuencia	B-Sequence
de	I-Sequence
codificación	I-Sequence
de	O
cualquiera	O
de	O
las	O
gene	B-Sequence
,	O
ITPR1	B-Protein
o	O
SUMF1	B-Protein
;	O
sin	O
embargo	O
,	O
identificamos	O
un	O
solo	O
individual	B-Taxon
con	O
un	O
posible	O
heterocigoto	O
supresión	B-Sequence
aproximadamente	O
6	O
kb	O
de	O
tamaño	O
dentro	O
intrón	B-Sequence
40	O
-	O
41	O
de	O
ITPR1	B-Protein
,	O
al	O
menos	O
a	O
5	O
kb	O
de	O
distancia	O
de	O
exón	B-Sequence
40	O
.	O

Dado	O
que	O
ubicación	B-Sequence
de	O
esta	O
modificación	B-Sequence
es	O
poco	O
probable	O
que	O
efectúe	O
la	O
expresión	O
o	O
empalme	O
de	O
ITPR1	B-Protein
.	O

En	O
un	O
intento	O
de	O
multar	O
-	O
mapear	O
el	O
puntos	B-Sequence
de	I-Sequence
ruptura	I-Sequence
de	I-Sequence
la	I-Sequence
enfermedad	I-Sequence
-	I-Sequence
que	I-Sequence
causan	I-Sequence
la	I-Sequence
eliminación	I-Sequence
realizamos	O
una	O
serie	O
de	O
experimentos	O
diseñados	O
para	O
refinar	O
lo	O
desconocido	O
intervalos	B-Sequence
en	O
el	O
bordes	B-Sequence
entre	O
definido	O
eliminado	B-Sequence
y	O
diploide	O
definido	O
secuencias	B-Sequence
.	O

Estos	O
datos	O
estrecharon	O
la	O
incógnita	O
fronteras	B-Sequence
a	O
~	O
4	O
kb	O
en	O
el	O
telomérico	B-Sequence
lado	O
y	O
~	O
7	O
kb	O
en	O
el	O
centromérico	B-Sequence
lado	O
.	O

Utilizamos	O
todas	O
las	O
combinaciones	O
posibles	O
de	O
cebadores	B-Sequence
de	I-Sequence
orientación	I-Sequence
directa	I-Sequence
diseñados	I-Sequence
dentro	O
de	O
la	O
recién	O
definida	O
límite	B-Sequence
telomérico	I-Sequence
y	O
de	O
cebadores	B-Sequence
de	I-Sequence
orientación	I-Sequence
inversa	I-Sequence
diseñados	I-Sequence
dentro	O
de	O
la	O
recién	O
definida	O
límite	B-Sequence
centromérico	I-Sequence
en	O
ensayos	O
de	O
PCR	O
en	O
un	O
intento	O
de	O
amplificar	O
a	O
través	O
del	O
supresión	B-Sequence
en	O
los	O
familiares	O
afectados	O
.	O

Usando	O
PCR	O
cebadores	B-Sequence
T3F	O
y	O
C11R	O
,	O
que	O
deberían	O
estar	O
separados	O
por	O
más	O
de	O
200	O
kb	O
,	O
pudimos	O
amplificar	O
un	O
fragmento	B-Sequence
953	O
pb	B-Sequence
en	O
tamaño	O
usando	O
ADN	B-Sequence
de	O
cada	O
uno	O
de	O
los	O
tres	O
familiares	O
afectados	O
como	O
plantilla	O
.	O

secuenciación	O
de	O
este	O
fragmento	B-Sequence
reveló	O
un	O
supresión	B-Sequence
de	O
201	O
,	O
509	O
pb	B-Sequence
(	O
Figura	O
S3	O
)	O
,	O
quitando	B-Sequence
los	O
tres	O
primeros	O
de	O
los	O
nueve	O
exones	B-Sequence
de	O
SUMF1	B-Protein
y	O
los	O
diez	O
primeros	O
de	O
los	O
58	O
exones	B-Sequence
de	O
ITPR1	B-Protein
.	O

No	O
pudimos	O
amplificar	O
el	O
supresión	B-Sequence
#	O
¿NOMBRE	O
?	O
fragmento	B-Sequence
en	O
el	O
familiar	O
de	O
estado	O
afectivo	O
desconocido	O
,	O
o	O
en	O
275	O
controles	O
neurológicamente	O
normales	O
.	O

Para	O
establecer	O
aún	O
más	O
deleción	B-Sequence
genética	I-Sequence
en	O
ITPR1	B-Protein
como	O
la	O
causa	O
de	O
SCA15	O
analizamos	O
dos	O
familias	O
adicionales	O
con	O
una	O
ataxia	O
cerebelosa	O
hereditaria	O
similar	O
a	O
la	O
descrita	O
en	O
la	O
familia	O
AUS1	O
,	O
comprobada	O
a	O
través	O
de	O
clínicas	O
de	O
neurología	O
en	O
Londres	O
,	O
Reino	O
Unido	O
.	O

ADN	B-Sequence
extraídos	O
de	O
probandos	O
de	O
estas	O
dos	O
familias	O
(	O
familia	O
H33	O
y	O
familia	O
H27	O
)	O
también	O
se	O
analizaron	O
utilizando	O
chips	O
de	O
genotipado	O
Illumina	O
Infinium	O
HumanHap550	O
.	O

Estos	O
experimentos	O
mostraron	O
supresión	B-Sequence
en	O
la	O
SCA15	O
lugar	B-Sequence
en	O
todos	O
los	O
miembros	O
afectados	O
ensayados	O
,	O
desde	O
SUMF1	B-Protein
a	O
través	O
de	O
ITPR1	B-Protein
.	O

Estas	O
mutaciones	B-Sequence
segregados	O
con	O
enfermedad	O
en	O
estas	O
dos	O
familias	O
(	O
Figura	O
S3	O
)	O
.	O

Una	O
estrategia	O
similar	O
a	O
la	O
descrita	O
anteriormente	O
nos	O
permitió	O
secuenciar	O
sobre	O
el	O
punto	B-Sequence
de	I-Sequence
interrupción	I-Sequence
en	O
la	O
familia	O
H27	O
pero	O
no	O
en	O
la	O
familia	O
H33	O
.	O

En	O
el	O
primero	O
,	O
el	O
supresión	B-Sequence
abarca	O
344	O
,	O
408	O
pb	B-Sequence
,	O
eliminando	B-Sequence
exones	I-Sequence
1	O
-	O
3	O
de	O
SUMF1	B-Protein
y	O
1	O
-	O
44	O
de	O
ITPR1	B-Protein
;	O
en	O
este	O
último	O
,	O
estimamos	O
que	O
el	O
supresión	B-Sequence
tiene	O
310	O
kb	O
de	O
longitud	O
y	O
que	O
elimina	B-Sequence
exones	I-Sequence
1	O
-	O
3	O
de	O
SUMF1	B-Protein
y	O
exones	B-Sequence
1	O
-	O
40	O
de	O
ITPR1	B-Protein
.	O

los	O
sitio	B-Sequence
de	O
mutación	B-Sequence
es	O
de	O
interés	O
,	O
particularmente	O
el	O
hecho	O
de	O
que	O
en	O
cada	O
una	O
de	O
las	O
tres	O
familias	O
el	O
telomérico	B-Sequence
fin	O
del	O
supresión	B-Sequence
está	O
anclado	O
entre	O
exones	B-Sequence
3	O
y	O
4	O
de	O
SUMF1	B-Protein
;	O
secuencia	B-Sequence
las	O
búsquedas	O
no	O
lograron	O
identificar	O
ningún	O
repetir	B-Sequence
secuencias	I-Sequence
que	O
podría	O
explicar	O
este	O
fenómeno	O
.	O

Con	O
tres	O
familias	O
de	O
ataxia	O
cerebelosa	O
segregando	O
un	O
SUMF1	B-Protein
-	O
ITPR1	B-Protein
supresión	B-Sequence
,	O
y	O
esto	O
supresión	B-Sequence
no	O
se	O
observa	O
en	O
una	O
población	O
de	O
control	O
,	O
podemos	O
concluir	O
razonablemente	O
que	O
la	O
asociación	O
es	O
causal	O
,	O
y	O
que	O
la	O
supresión	B-Sequence
es	O
de	O
hecho	O
el	O
genético	B-Sequence
base	O
de	O
la	O
enfermedad	O
,	O
con	O
SCA15	O
como	O
diagnóstico	O
en	O
las	O
dos	O
familias	O
británicas	O
,	O
así	O
como	O
en	O
la	O
familia	O
australiana	O
original	O
.	O

Es	O
improbable	O
que	O
la	O
heterocigosidad	O
para	O
el	O
supresión	B-Sequence
de	O
SUMF1	B-Protein
,	O
codificación	O
factor	B-Protein
modificador	I-Protein
de	I-Protein
sulfatasa	I-Protein
1	I-Protein
,	O
por	O
sí	O
mismo	O
causa	O
o	O
contribuye	O
a	O
SCA15	O
.	O

Homocigoto	O
mutación	B-Sequence
de	O
SUMF1	B-Protein
da	O
como	O
resultado	O
autosómico	B-GENE
deficiencia	O
recesiva	O
múltiple	O
de	O
sulfatasa	O
,	O
un	O
trastorno	O
metabólico	O
caracterizado	O
por	O
hepatoesplenomegalia	O
,	O
sordera	O
y	O
retraso	O
en	O
el	O
desarrollo	O
[	O
6	O
,	O
7	O
]	O
.	O

No	O
se	O
ha	O
descrito	O
la	O
aparición	O
simultánea	O
de	O
ataxia	O
en	O
padres	O
(	O
heterocigotos	O
)	O
de	O
pacientes	O
con	O
deficiencia	O
múltiple	O
de	O
sulfatasa	O
.	O

Por	O
el	O
contrario	O
,	O
mutación	B-Sequence
de	O
ITPR1	B-Protein
es	O
biológicamente	O
plausible	O
como	O
causa	O
de	O
ataxia	O
:	O
la	O
proteína	B-Chemical
está	O
muy	O
expresado	O
en	O
células	B-Cell
de	I-Cell
Purkinje	I-Cell
;	O
como	O
hemos	O
mostrado	O
aquí	O
,	O
ratones	B-Taxon
con	O
mutación	B-Sequence
en	O
esto	O
lugar	B-Sequence
presente	O
con	O
ataxia	O
;	O
y	O
perturbado	O
Ca2	B-Chemical
+	I-Chemical
la	O
señalización	O
se	O
ha	O
implicado	O
previamente	O
en	O
la	O
etiología	O
de	O
la	O
ataxia	O
,	O
especialmente	O
en	O
la	O
ataxia	O
episódica	O
tipo	O
2	O
y	O
SCA6	O
[	O
8	O
]	O
.	O

En	O
apoyo	O
adicional	O
de	O
esta	O
conclusión	O
,	O
el	O
análisis	O
de	O
proteína	B-Chemical
niveles	O
de	O
ITPR1	B-Protein
en	O
Virus	B-Taxon
de	I-Taxon
Epstein	I-Taxon
Barr	I-Taxon
(	O
VEB	B-Taxon
)	O
inmortalizado	O
linfocitos	B-Cell
de	O
miembros	O
de	O
la	O
familia	O
AUS1	O
afectados	O
y	O
no	O
afectados	O
reveló	O
que	O
todos	O
los	O
miembros	O
afectados	O
mostraron	O
una	O
disminución	O
dramática	O
en	O
ITPR1	B-Protein
niveles	O
en	O
comparación	O
con	O
el	O
miembro	O
de	O
la	O
familia	O
sin	O
la	O
supresión	B-Sequence
(	O
Figura	O
4	O
)	O
.	O

itpr1	B-Protein
contiene	O
tres	O
dominios	B-Sequence
,	O
un	O
Dominio	B-Sequence
de	I-Sequence
unión	I-Sequence
de	I-Sequence
trifosfato	I-Sequence
de	I-Sequence
inositol	I-Sequence
N	I-Sequence
-	I-Sequence
terminal	I-Sequence
,	O
un	O
acoplamiento	O
dominio	B-Sequence
,	O
y	O
un	O
C	B-Sequence
-	I-Sequence
dominio	I-Sequence
transmembrana	I-Sequence
terminal	I-Sequence
;	O
también	O
contiene	O
dos	O
proteína	B-Chemical
fosforilación	O
de	O
la	O
cinasa	O
A	O
sitios	B-Sequence
y	O
un	O
atp	B-Chemical
-	O
sitio	B-Sequence
de	I-Sequence
unión	I-Sequence
.	O

itpr1	B-Protein
está	O
acoplado	O
a	O
Ca2	B-Chemical
+	I-Chemical
canaliza	O
y	O
facilita	O
Ca2	B-Chemical
+	I-Chemical
liberación	O
de	O
la	O
retículo	B-GENE
endoplásmico	I-GENE
después	O
de	O
la	O
unión	O
por	O
el	O
intracelular	B-GENE
segundo	O
mensajero	O
inositol	B-Chemical
1	O
,	O
4	O
,	O
5	O
-	O
trifosfato	O
[	O
9	O
]	O
.	O

itpr1	B-Protein
se	O
enriquece	O
en	O
la	O
células	B-Cell
de	I-Cell
Purkinje	I-Cell
del	O
cerebelo	O
[	O
4	O
]	O
.	O

ITPR1	B-Protein
mutaciones	B-Sequence
tienen	O
más	O
de	O
un	O
mecanismo	O
patógeno	O
potencial	O
.	O

Primero	O
,	O
la	O
enfermedad	O
puede	O
ser	O
el	O
resultado	O
de	O
una	O
haploinsuficiencia	O
en	O
ITPR1	B-Protein
;	O
este	O
concepto	O
es	O
consistente	O
con	O
la	O
observación	O
de	O
que	O
los	O
heterocigotos	O
supresión	B-Sequence
conduce	O
a	O
un	O
trastorno	O
de	O
inicio	O
tardío	O
en	O
humanos	B-Taxon
,	O
mientras	O
que	O
homocigotos	O
supresión	B-Sequence
en	O
ratones	B-Taxon
conduce	O
a	O
un	O
trastorno	O
de	O
inicio	O
temprano	O
,	O
capaz	O
de	O
expresarse	O
dentro	O
de	O
la	O
vida	O
mucho	O
más	O
corta	O
de	O
la	O
ratón	B-Taxon
.	O

En	O
segundo	O
lugar	O
,	O
no	O
podemos	O
descartar	O
la	O
existencia	O
de	O
una	O
alternativa	O
sitio	B-Sequence
de	I-Sequence
inicio	I-Sequence
por	O
ITPR1	B-Protein
que	O
puede	O
dar	O
como	O
resultado	O
un	O
producto	O
que	O
confiere	O
una	O
ganancia	O
patógena	O
de	O
función	O
al	O
proteína	B-Chemical
;	O
sin	O
embargo	O
,	O
el	O
análisis	O
de	O
Western	O
blot	O
de	O
células	B-Cell
derivados	O
de	O
miembros	O
de	O
la	O
familia	O
AUS1	O
afectados	O
,	O
que	O
se	O
realizó	O
utilizando	O
un	O
anticuerpo	B-GENE
levantado	O
contra	O
el	O
C	B-Sequence
-	I-Sequence
porción	I-Sequence
terminal	I-Sequence
de	O
ITPR1	B-Protein
,	O
no	O
pudo	O
identificar	O
ninguna	O
enfermedad	O
-	O
truncado	O
específico	O
productos	B-Chemical
proteicos	I-Chemical
.	O

Claramente	O
,	O
la	O
identificación	O
de	O
distintos	O
ITPR1	B-Protein
mutaciones	B-Sequence
SCA15	O
subyacente	O
ayudará	O
a	O
dilucidar	O
el	O
mecanismo	O
patogénico	O
de	O
este	O
trastorno	O
.	O

Mostramos	O
aquí	O
la	O
utilidad	O
de	O
investigar	O
espontáneamente	O
ratón	B-Taxon
mutaciones	B-Sequence
en	O
entendimiento	O
humano	B-Taxon
enfermedad	O
.	O

Actualmente	O
,	O
el	O
pequeño	O
número	O
de	O
Itpr1wt/Delta	O
18	O
años	O
animales	B-Taxon
nos	O
impide	O
examinar	O
estos	O
ratones	B-Taxon
para	O
signos	O
y	O
síntomas	O
sutiles	O
similares	O
a	O
los	O
observados	O
en	O
pacientes	O
con	O
SCA15	O
;	O
sin	O
embargo	O
,	O
estos	O
ratones	B-Taxon
son	O
claramente	O
de	O
interés	O
para	O
nosotros	O
como	O
un	O
modelo	O
potencial	O
de	O
SCA15	O
.	O

Estos	O
datos	O
también	O
demuestran	O
que	O
genoma	B-Sequence
#	O
¿NOMBRE	O
?	O
SNP	B-Sequence
ensayo	O
puede	O
facilitar	O
la	O
detección	O
rápida	O
de	O
estructuras	O
mutaciones	B-Sequence
genómicas	I-Sequence
que	O
pueden	O
ser	O
la	O
base	O
de	O
la	O
enfermedad	O
.	O

Los	O
datos	O
proporcionados	O
por	O
estos	O
enfoques	O
brindan	O
evidencia	O
convincente	O
de	O
que	O
los	O
heterocigotos	O
supresión	B-Sequence
de	O
ITPR1	B-Protein
causa	O
SCA15	O
.	O

Claramente	O
,	O
secuencia	B-Sequence
análisis	O
de	O
ITPR1	B-Protein
en	O
casos	O
potenciales	O
de	O
SCA15	O
puede	O
proporcionar	O
información	O
adicional	O
sobre	O
la	O
enfermedad	O
,	O
particularmente	O
si	O
se	O
detiene	O
mutación	B-Sequence
debían	O
ser	O
identificados	O
;	O
sin	O
embargo	O
,	O
el	O
mutacional	B-Sequence
mecanismo	O
señalado	O
aquí	O
significa	O
que	O
los	O
enfoques	O
de	O
secuenciación	O
estándar	O
por	O
sí	O
solos	O
son	O
insuficientes	O
para	O
descartar	O
con	O
confianza	O
ITPR1	B-Protein
mutación	B-Sequence
como	O
causa	O
de	O
la	O
enfermedad	O
:	O
un	O
estudio	O
completo	O
gene	B-Sequence
También	O
se	O
requiere	O
un	O
enfoque	O
de	O
dosificación	O
.	O

Dado	O
que	O
SCA16	O
y	O
autosómico	B-GENE
La	O
ataxia	O
no	O
progresiva	O
congénita	O
dominante	O
se	O
ha	O
asignado	O
recientemente	O
a	O
regiones	B-Sequence
superpuestas	I-Sequence
con	O
el	O
SCA15	O
lugar	B-Sequence
[	O
10	O
,	O
11	O
]	O
,	O
ITPR1	B-Protein
es	O
un	O
gene	B-Sequence
de	O
importancia	O
para	O
el	O
tamizaje	O
en	O
estas	O
familias	O
.	O

Estos	O
datos	O
agregan	O
peso	O
a	O
un	O
papel	O
para	O
aberrante	O
intracelular	B-GENE
Ca2	B-Chemical
+	I-Chemical
señalización	O
en	O
células	B-Cell
de	I-Cell
Purkinje	I-Cell
en	O
la	O
patogenia	O
de	O
la	O
ataxia	O
espinocerebelosa	O
.	O

Materiales	O
y	O
métodos	O

genoma	B-Sequence
#	O
¿NOMBRE	O
?	O
ratones	B-Taxon
.	O

Ciento	O
veinte	O
fragmentos	B-Sequence
de	I-Sequence
ADN	I-Sequence
se	O
amplificaron	O
en	O
todo	O
el	O
genoma	B-Sequence
,	O
cada	O
uno	O
seleccionado	O
para	O
contener	O
una	O
o	O
más	O
cepas	O
específicas	O
SNP	B-Sequence
eso	O
diferenciaría	O
entre	O
las	O
cepas	O
consanguíneas	O
C57BL/6J	O
y	O
129x1/SvJ	O
[	O
12	O
]	O
.	O

Cada	O
fragmento	B-Sequence
se	O
amplificó	O
inicialmente	O
en	O
11	O
afectados	O
ratones	B-Taxon
y	O
nueve	O
no	O
afectados	O
ratones	B-Taxon
;	O
genotipo	B-Sequence
la	O
llamada	O
fue	O
realizada	O
por	O
teñir	B-Chemical
-	O
terminador	B-Sequence
secuenciación	O
de	O
estos	O
fragmentos	B-Sequence
.	O

El	O
análisis	O
de	O
ligamiento	O
utilizando	O
estos	O
datos	O
se	O
realizó	O
mediante	O
mlink	O
[	O
13	O
]	O
,	O
que	O
reveló	O
un	O
vínculo	O
positivo	O
en	O
Cromosoma	B-GENE
6qE1	O
,	O
en	O
el	O
fondo	O
129x1/SvJ	O
(	O
puntuación	O
LOD	O
de	O
dos	O
puntos	O
5	O
.	O
13	O
en	O
el	O
marcador	O
20	O
.	O
MMHAP85FLG2	O
)	O
.	O

En	O
un	O
intento	O
de	O
reducir	O
la	O
enfermedad	O
intervalo	B-Sequence
realizamos	O
experimentos	O
de	O
retrocruzamiento	O
que	O
resultaron	O
en	O
la	O
generación	O
de	O
tres	O
afectados	O
adicionales	O
ratones	B-Taxon
.	O

Genotipado	O
de	O
todos	O
los	O
afectados	O
ratones	B-Taxon
a	O
través	O
de	O
la	O
enfermedad	O
-	O
segregando	O
intervalo	B-Sequence
reveló	O
recombinantes	O
flanqueantes	O
y	O
un	O
candidato	O
región	B-Sequence
de	O
~	O
5	O
Mb	O
,	O
entre	O
los	O
marcadores	O
D6Mit37	O
y	O
44	O
.	O
MMHAP85FLG5	O
(	O
Figura	O
S1	O
)	O
.	O

Esta	O
región	B-Sequence
contiene	O
16	O
genes	B-Sequence
y	O
transcripciones	B-Sequence
previstas	I-Sequence
.	O

Identificación	O
del	O
subyacente	O
genético	B-Sequence
lesión	O
en	O
ratones	B-Taxon
.	O

Identificación	O
de	O
fenotipos	O
similares	O
en	O
ratones	B-Taxon
vinculado	O
al	O
6qE1	O
intervalo	B-Sequence
se	O
realizó	O
mediante	O
búsquedas	O
bibliográficas	O
.	O

Esto	O
reveló	O
el	O
Itpr1opt	O
/	O
opt	O
ratón	B-Taxon
,	O
en	O
el	O
que	O
la	O
enfermedad	O
es	O
causada	O
por	O
homocigotos	O
mutación	B-Sequence
por	I-Sequence
deleción	I-Sequence
de	O
exones	B-Sequence
43	O
y	O
44	O
de	O
itpr1	B-Protein
.	O

Cebador	B-Sequence
Se	O
diseñaron	O
pares	O
para	O
secuenciar	O
cada	O
uno	O
de	O
los	O
codificando	B-Sequence
exones	I-Sequence
y	O
al	O
menos	O
50	O
pb	B-Sequence
de	O
cada	O
secuencia	B-Sequence
intrónica	I-Sequence
flanqueante	I-Sequence
de	O
itpr1	B-Protein
.	O

Amplificación	O
por	O
PCR	O
de	O
cada	O
exón	B-Sequence
se	O
realizó	O
utilizando	O
ADN	B-Sequence
de	O
dos	O
afectados	O
ratones	B-Taxon
como	O
plantillas	O
.	O

El	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
mutación	B-Sequence
fue	O
confirmado	O
por	O
secuenciación	O
en	O
todos	O
los	O
afectados	O
ratones	B-Taxon
(	O
Figura	O
S2	O
)	O
.	O

Los	O
experimentos	O
de	O
reproducción	O
se	O
realizaron	O
entre	O
dos	O
hembras	O
ratones	B-Taxon
heterocigoto	O
para	O
el	O
actual	O
mutación	B-Sequence
(	O
Itpr1wt	O
/	O
Delta	O
18	O
)	O
y	O
un	O
macho	O
ratón	B-Taxon
heterocigoto	O
para	O
el	O
Itpr1opt	O
mutación	B-Sequence
(	O
Itpr1wt/opt	O
)	O
.	O

Esto	O
resultó	O
en	O
dos	O
litros	O
de	O
ratones	B-Taxon
con	O
un	O
total	O
de	O
cuatro	O
crías	O
Itpr1opt	O
/	O
Delta	O
18	O
afectadas	O
(	O
de	O
un	O
total	O
de	O
15	O
;	O
dos	O
de	O
siete	O
del	O
primer	O
apareamiento	O
;	O
dos	O
de	O
ocho	O
del	O
segundo	O
apareamiento	O
)	O
con	O
un	O
fenotipo	O
indistinguible	O
del	O
de	O
los	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
e	O
Itpr1opt	O
/	O
optar	O
ratones	B-Taxon
.	O

Análisis	O
de	O
itpr1	B-Protein
proteína	B-Chemical
en	O
ratones	B-Taxon
.	O

Realizamos	O
análisis	O
de	O
transferencia	O
Western	O
utilizando	O
técnicas	O
estándar	O
con	O
kits	O
de	O
detección	O
de	O
ECL	O
(	O
Amersham	O
,	O
http	O
:	O
//www.amersham.com	O
)	O
.	O

Brevemente	O
,	O
se	O
homogeneizaron	O
cerebros	O
enteros	O
diseccionados	O
de	O
compañeros	O
de	O
camada	O
del	O
día	O
21	O
posnatal	O
en	O
un	O
tampón	O
que	O
contenía	O
50	O
mM	O
tris	B-Chemical
-	O
HCl	B-Chemical
,	O
150	O
mm	O
NaCl	B-Chemical
,	O
1	O
mm	O
EDTA	B-Chemical
,	O
1	O
%	O
Tritón	O
X	O
-	O
100	O
,	O
1	O
%	O
desoxicolato	B-Chemical
de	I-Chemical
sodio	I-Chemical
,	O
0	O
.	O
1	O
%	O
SDS	B-Chemical
,	O
y	O
un	O
cóctel	O
de	O
Inhibidores	B-Chemical
de	I-Chemical
la	I-Chemical
proteasa	I-Chemical
(	O
Roche	O
,	O
http	O
:	O
//www.roche.com	O
)	O
.	O

Los	O
homogeneizados	O
se	O
diluyeron	O
apropiadamente	O
,	O
se	O
mezclaron	O
con	O
tampón	O
de	O
muestra	O
reductor	O
4x	O
y	O
se	O
cargaron	O
en	O
geles	O
de	O
gradiente	O
prefabricados	O
al	O
4	O
%	O
-12	O
%	O
(	O
Novex	O
,	O
http	O
:	O
//www.invitrogen.com	O
)	O
para	O
SDS	B-Chemical
#	O
¿NOMBRE	O
?	O

los	O
anticuerpos	B-GENE
para	O
itpr1	B-Protein
(	O
1	O
:	O
2	O
,	O
000	O
)	O
y	O
Actb	B-Protein
(	O
1	O
:	O
5	O
000	O
)	O
se	O
utilizaron	O
según	O
lo	O
recomendado	O
por	O
los	O
fabricantes	O
.	O

Inmunohistoquímica	O
.	O

Se	O
aislaron	O
cerebros	O
de	O
21	O
-	O
d	O
-	O
de	O
edad	O
ratones	B-Taxon
,	O
perfundido	O
con	O
paraformaldehído	O
al	O
4	O
%	O
en	O
PBS	O
,	O
y	O
fijado	O
posteriormente	O
durante	O
la	O
noche	O
en	O
el	O
mismo	O
fijador	O
.	O

Los	O
cerebros	O
se	O
incrustaron	O
en	O
gelatina	O
y	O
se	O
cortaron	O
secciones	O
sagitales	O
de	O
35	O
µm	O
utilizando	O
un	O
micrótomo	O
deslizante	O
(	O
NeuroScience	O
Associates	O
,	O
http	O
:	O
//www.neuroscienceassociates.com	O
)	O
.	O

Secciones	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
,	O
cerebros	O
heterocigotos	O
y	O
homocigotos	O
se	O
colocaron	O
en	O
la	O
plantilla	O
MultiBrain	O
.	O

Las	O
secciones	O
se	O
lavaron	O
en	O
1	O
x	O
PBS	O
antes	O
de	O
1	O
h	O
de	O
incubación	O
en	O
una	O
solución	O
de	O
bloque	O
que	O
contenía	O
1	O
x	O
PBS	O
con	O
un	O
20	O
%	O
de	O
normal	O
.	O
cabra	B-Taxon
suero	O
y	O
0	O
.	O
3	O
%	O
Tritón	O
X	O
-	O
100	O
(	O
pH	O
7	O
,	O
4	O
)	O
.	O

Las	O
secciones	O
se	O
incubaron	O
durante	O
la	O
noche	O
a	O
4	O
grados	O
C	O
en	O
primario	O
anticuerpos	B-GENE
:	O
policlonal	O
purificado	O
por	O
afinidad	O
itpr1	B-Protein
anticuerpo	B-GENE
(	O
1	O
:	O
2	O
,	O
000	O
,	O
Chemicon	O
International	O
,	O
http	O
:	O
//	O
www	O
.	O
chemicon	O
.	O
com	O
)	O
y	O
anti	O
-	O
Calb1	B-Protein
anticuerpo	B-GENE
(	O
1	O
:	O
6	O
000	O
,	O
Sigma	O
-	O
Aldrich	O
,	O
http	O
:	O
//	O
www	O
.	O
sigmaaldrich	O
.	O
com	O
)	O
diluido	O
en	O
solución	O
portadora	O
.	O

Después	O
de	O
lavados	O
extensos	O
(	O
en	O
6,0	O
ml	O
de	O
PBS	O
,	O
tres	O
veces	O
)	O
,	O
las	O
secciones	O
se	O
incubaron	O
con	O
anticuerpos	B-GENE
(	O
Alexa	O
Fluor	O
555	O
cabra	B-Taxon
anti	O
-	O
Conejo	B-Taxon
IgG	O
y	O
Alexa	O
Fluor	O
488	O
cabra	B-Taxon
anti	O
-	O
ratón	B-Taxon
IgG	O
[	O
Invitrogen	O
,	O
http	O
:	O
//www	O
.	O
invitrogeno	O
com	O
]	O
)	O
durante	O
1	O
hora	O
a	O
temperatura	O
ambiente	O
.	O

Las	O
secciones	O
se	O
lavaron	O
y	O
montaron	O
en	O
portaobjetos	O
de	O
vidrio	O
en	O
un	O
amortiguado	B-Chemical
medio	O
que	O
contiene	O
Mowiol	O
(	O
Calbiochem	O
,	O
http	O
:	O
//www.emdbiosciences.com	O
)	O
como	O
se	O
describe	O
anteriormente	O
[	O
14	O
]	O
.	O

Se	O
tomaron	O
imágenes	O
de	O
las	O
secciones	O
utilizando	O
un	O
microscopio	O
confocal	O
de	O
barrido	O
láser	O
(	O
LSM	O
510	O
;	O
Zeiss	O
,	O
http	O
:	O
//www.zeiss.com	O
)	O
.	O

Los	O
parámetros	O
de	O
imagen	O
(	O
estenopeico	O
,	O
ganancia	O
del	O
detector	O
,	O
potencia	O
del	O
láser	O
)	O
se	O
optimizaron	O
y	O
se	O
mantuvieron	O
constantes	O
durante	O
el	O
tipo	B-Sequence
salvaje	I-Sequence
,	O
heterocigotos	O
y	O
homocigotos	O
mutante	B-Sequence
cerebros	O

Especificidad	O
de	O
la	O
itpr1	B-Protein
anticuerpos	B-GENE
se	O
verificó	O
mediante	O
experimentos	O
de	O
control	O
de	O
preabsorción	O
.	O

Anticuerpo	B-GENE
diluciones	O
se	O
incubaron	O
durante	O
24	O
h	O
a	O
4	O
grados	O
C	O
con	O
el	O
inmunizante	O
péptido	B-Sequence
.	O

Las	O
secciones	O
de	O
tejido	O
se	O
incubaron	O
con	O
el	O
preabsorbido	O
anticuerpos	B-GENE
y	O
procesado	O
como	O
se	O
describe	O
anteriormente	O
.	O

En	O
estas	O
condiciones	O
,	O
no	O
se	O
detectó	O
tinción	O
por	O
encima	O
de	O
la	O
autofluorescencia	O
.	O

Análisis	O
de	O
ITPR1	B-Protein
en	O
pacientes	O
con	O
SCA15	O
.	O

ADN	B-Sequence
fue	O
extraído	O
de	O
VEB	B-Taxon
inmortalizado	O
linfocitos	B-Cell
,	O
derivados	O
de	O
miembros	O
de	O
la	O
familia	O
.	O

los	O
codificando	B-Sequence
exones	I-Sequence
y	O
al	O
menos	O
50	O
pb	B-Sequence
de	O
flanquear	O
intrones	B-Sequence
de	O
ITPR1	B-Protein
fueron	O
amplificados	O
por	O
PCR	O
y	O
secuenciados	O
usando	O
teñir	B-Chemical
-	O
terminador	B-Sequence
secuenciación	O
(	O
BigDye	O
versión	O
3.1	O
;	O
Applied	O
Biosystems	O
,	O
http	O
:	O
//www.appliedbiosystems.com	O
)	O
.	O

Secuencia	B-Sequence
las	O
reacciones	O
se	O
realizaron	O
en	O
un	O
secuenciador	O
automático	O
ABI3730XP	O
según	O
las	O
instrucciones	O
del	O
fabricante	O
(	O
Applied	O
Biosystems	O
)	O
.	O

Este	O
análisis	O
se	O
realizó	O
en	O
los	O
tres	O
miembros	O
de	O
la	O
familia	O
afectados	O
para	O
quienes	O
ADN	B-Sequence
genómico	I-Sequence
estaba	O
disponible	O
(	O
miembros	O
6	O
,	O
7	O
y	O
19	O
)	O
.	O

Secuencias	B-Sequence
de	I-Sequence
cebadores	I-Sequence
y	O
las	O
condiciones	O
están	O
disponibles	O
bajo	O
petición	O
.	O

Secuencia	B-Sequence
Los	O
datos	O
se	O
analizaron	O
utilizando	O
Sequencher	O
(	O
Gene	B-Sequence
Codes	O
Corporation	O
,	O
http	O
:	O
//www	O
.	O
códigos	O
genéticos	O
.	O
com	O
)	O
.	O

genoma	B-Sequence
#	O
¿NOMBRE	O
?	O
SNP	B-Sequence
el	O
genotipado	O
se	O
realizó	O
con	O
Infinium	O
HumanHap550	O
SNP	B-Sequence
chips	O
de	O
genotipado	O
según	O
el	O
protocolo	O
del	O
fabricante	O
(	O
Illumina	O
,	O
http	O
:	O
//www.illumina.com	O
)	O
.	O

Este	O
producto	O
analiza	O
555	O
,	O
352	O
únicos	O
SNP	B-Sequence
.	O

Los	O
datos	O
se	O
recopilaron	O
utilizando	O
el	O
escáner	O
Illumina	O
BeadStation	O
y	O
el	O
software	O
de	O
recopilación	O
de	O
datos	O
.	O

Genotipos	B-Sequence
se	O
produjeron	O
usando	O
el	O
módulo	O
de	O
genotipado	O
de	O
BeadStudio	O
(	O
versión	O
2	O
.	O
3	O
.	O
25	O
;	O
Illumina	O
)	O
,	O
y	O
log	O
R	O
ratio	O
y	O
B	O
alelo	B-Sequence
frecuencia	O
se	O
visualizaron	O
utilizando	O
el	O
genoma	B-Sequence
herramienta	O
de	O
visualización	O
dentro	O
de	O
este	O
paquete	O
.	O

Para	O
descartar	O
la	O
posibilidad	O
de	O
que	O
lo	O
observado	O
supresión	B-Sequence
dentro	O
de	O
ITPR1	B-Protein
era	O
una	O
variante	O
benigna	O
del	O
número	O
de	O
copias	O
,	O
examinamos	O
la	O
relación	O
log	O
R	O
y	O
B	O
alelo	B-Sequence
métricas	O
de	O
frecuencia	O
de	O
datos	O
de	O
genotipado	O
HumanHap550	O
en	O
este	O
lugar	B-Sequence
de	O
577	O
individuos	B-Taxon
de	O
ascendencia	O
del	O
norte	O
de	O
Europa	O
de	O
América	O
del	O
Norte	O
y	O
Europa	O
,	O
producido	O
por	O
nosotros	O
como	O
parte	O
de	O
un	O
estudio	O
en	O
curso	O
.	O

En	O
un	O
intento	O
de	O
reducir	O
lo	O
desconocido	O
intervalos	B-Sequence
flanqueando	O
el	O
supresión	B-Sequence
observado	O
en	O
la	O
familia	O
AUS1	O
,	O
diseñamos	O
cebadores	B-Sequence
para	O
30	O
amplificaciones	O
de	O
PCR	O
que	O
generarían	O
fragmentos	B-Sequence
superpuestos	I-Sequence
a	O
través	O
de	O
los	O
dos	O
regiones	B-Sequence
limítrofes	I-Sequence
(	O
secuencia	B-Sequence
de	I-Sequence
cebador	I-Sequence
y	O
condiciones	O
disponibles	O
bajo	O
petición	O
)	O
.	O

Había	O
diez	O
cebador	B-Sequence
pares	O
en	O
el	O
región	B-Sequence
flanqueante	I-Sequence
telomérica	I-Sequence
y	O
20	O
pares	O
en	O
el	O
región	B-Sequence
flanqueante	I-Sequence
centromérica	I-Sequence
(	O
Figura	O
S3	O
)	O
.	O

En	O
promedio	O
,	O
cada	O
producto	O
fue	O
~	O
750	O
pb	B-Sequence
de	O
tamaño	O
,	O
y	O
las	O
amplificaciones	O
se	O
realizaron	O
utilizando	O
ADN	B-Sequence
genómico	I-Sequence
de	O
cada	O
uno	O
de	O
los	O
tres	O
afectados	O
individuos	B-Taxon
(	O
miembros	O
de	O
la	O
familia	O
6	O
,	O
7	O
y	O
19	O
)	O
.	O

Teñir	B-Chemical
-	O
terminador	B-Sequence
La	O
secuenciación	O
de	O
cada	O
producto	O
se	O
realizó	O
mediante	O
el	O
cebadores	B-Sequence
directos	I-Sequence
e	I-Sequence
inversos	I-Sequence
diseñados	I-Sequence
para	O
amplificación	O
;	O
ejecución	O
y	O
análisis	O
de	O
cada	O
fragmento	B-Sequence
se	O
realizó	O
como	O
se	O
describió	O
anteriormente	O
.	O

Amplificación	O
de	O
un	O
fragmento	B-Sequence
de	O
un	O
diploide	O
normal	O
genoma	B-Sequence
se	O
denota	O
por	O
la	O
presencia	O
de	O
un	O
heterocigoto	O
polimorfismo	B-Sequence
;	O
amplificación	O
de	O
un	O
fragmento	B-Sequence
a	O
partir	O
de	O
una	O
región	B-Sequence
de	O
El	O
genoma	B-Sequence
que	O
alberga	O
un	O
heterocigoto	O
deleción	B-Sequence
genómica	I-Sequence
se	O
infirió	O
cuando	O
la	O
homocigosis	O
para	O
los	O
principales	O
alelo	B-Sequence
y	O
el	O
menor	O
alelo	B-Sequence
se	O
observaron	O
entre	O
los	O
tres	O
miembros	O
de	O
la	O
familia	O
afectados	O
(	O
es	O
decir	O
,	O
esto	O
es	O
incompatible	O
con	O
la	O
herencia	O
mendeliana	O
en	O
relación	O
individuos	B-Taxon
conocido	O
por	O
compartir	O
un	O
común	O
haplotipo	B-Sequence
)	O
.	O

Usando	O
los	O
datos	O
de	O
los	O
experimentos	O
descritos	O
anteriormente	O
,	O
pudimos	O
limitar	O
el	O
tamaño	O
de	O
desconocido	O
regiones	B-Sequence
flanqueando	O
el	O
supresión	B-Sequence
a	O
~	O
4	O
kb	O
en	O
el	O
telomérico	B-Sequence
lado	O
y	O
7	O
kb	O
en	O
el	O
centromérico	B-Sequence
lado	O
.	O

Todas	O
las	O
combinaciones	O
de	O
cebadores	B-Sequence
directos	I-Sequence
de	O
lo	O
recién	O
definido	O
región	B-Sequence
flanqueando	O
el	O
supresión	B-Sequence
sobre	O
el	O
telomérico	B-Sequence
lado	O
con	O
cebadores	B-Sequence
inversos	I-Sequence
de	O
lo	O
recién	O
definido	O
región	B-Sequence
flanqueando	O
el	O
supresión	B-Sequence
sobre	O
el	O
centromérico	B-Sequence
lado	O
se	O
utilizaron	O
en	O
reacciones	O
de	O
amplificación	O
por	O
PCR	O
realizadas	O
con	O
ADN	B-Sequence
de	O
los	O
tres	O
miembros	O
de	O
la	O
familia	O
afectados	O
y	O
miembros	O
individuales	O
de	O
la	O
familia	O
no	O
afectados	O
.	O

Este	O
experimento	O
se	O
realizó	O
en	O
un	O
intento	O
de	O
amplificar	O
a	O
través	O
de	O
la	O
fragmento	B-Sequence
eliminado	I-Sequence
y	O
definir	O
exactamente	O
punto	B-Sequence
de	I-Sequence
interrupción	I-Sequence
.	O

un	O
solo	O
fragmento	B-Sequence
se	O
obtuvo	O
de	O
la	O
tercera	O
cartilla	B-Sequence
delantera	I-Sequence
desde	O
el	O
telomérico	B-Sequence
lado	O
(	O
T3f	O
5	O
'	O
-	O
TGAATGCTCAATTTTCCAGC	O
-	O
3	O
'	O
)	O
con	O
la	O
11a	O
imprimación	B-Sequence
inversa	I-Sequence
desde	O
el	O
centromérico	B-Sequence
lateral	O
(	O
C11r	O
5	O
'	O
-	O
GGGAAAATGGATAGAGGGTG	O
-	O
3	O
'	O
)	O
.	O

los	O
fragmento	B-Sequence
,	O
que	O
es	O
953	O
pb	B-Sequence
de	O
tamaño	O
,	O
se	O
secuenció	O
como	O
se	O
describió	O
anteriormente	O
y	O
se	O
comparó	O
con	O
el	O
actual	O
construir	B-Sequence
de	O
El	O
humano	B-Taxon
genoma	B-Sequence
.	O

Se	O
realizó	O
una	O
serie	O
similar	O
de	O
experimentos	O
para	O
identificar	O
el	O
puntos	B-Sequence
de	I-Sequence
interrupción	I-Sequence
de	I-Sequence
eliminación	I-Sequence
en	O
las	O
familias	O
H27	O
y	O
H33	O
;	O
pudimos	O
amplificar	O
un	O
369	O
-	O
producto	B-Sequence
de	I-Sequence
PCR	I-Sequence
pb	I-Sequence
a	O
través	O
de	O
punto	B-Sequence
de	I-Sequence
interrupción	I-Sequence
encontrado	O
en	O
miembros	O
afectados	O
de	O
la	O
familia	O
H27	O
usando	O
cebador	B-Sequence
par	O
H27-11F	O
5'-GACCTCAAGAAGGCATGAATAC-3	O
'	O
y	O
H27-3R	O
5'-ATGGTGGCCAGGTACACAAG-3	O
'	O
(	O
Figura	O
S4	O
)	O
,	O
pero	O
hasta	O
la	O
fecha	O
no	O
hemos	O
podido	O
identificar	O
el	O
punto	B-Sequence
de	I-Sequence
interrupción	I-Sequence
en	O
la	O
familia	O
H33	O
.	O

Análisis	O
de	O
Western	O
blot	O
en	O
pacientes	O
con	O
SCA15	O
.	O

VEB	B-Taxon
linfoblastos	O
inmortalizados	O
de	O
tres	O
familiares	O
afectados	O
que	O
portan	O
el	O
supresión	B-Sequence
y	O
un	O
miembro	O
de	O
la	O
familia	O
sin	O
el	O
mutación	B-Sequence
fueron	O
utilizados	O
como	O
una	O
fuente	O
fácilmente	O
accesible	O
de	O
proteína	B-Chemical
;	O
todas	O
las	O
muestras	O
procedían	O
de	O
miembros	O
de	O
la	O
familia	O
AUS1	O
.	O

Proteína	B-Chemical
la	O
extracción	O
se	O
realizó	O
utilizando	O
tampón	O
de	O
lisis	O
que	O
contenía	O
1	O
x	O
TBS	O
,	O
1	O
%	O
Triton	O
X	O
-	O
100	O
y	O
un	O
cóctel	O
de	O
Inhibidores	B-Chemical
de	I-Chemical
la	I-Chemical
proteasa	I-Chemical
(	O
Roche	O
)	O
con	O
lisis	O
nocturna	O
a	O
-80	O
grados	O
C	O
.	O

Los	O
homogeneizados	O
se	O
diluyeron	O
apropiadamente	O
,	O
se	O
mezclaron	O
con	O
tampón	O
de	O
muestra	O
reductor	O
4x	O
y	O
se	O
cargaron	O
en	O
geles	O
de	O
gradiente	O
prefabricado	O
al	O
4	O
%	O
-	O
12	O
%	O
(	O
NuPAGE	O
,	O
Invitrogen	O
)	O
para	O
SDS	B-Chemical
#	O
¿NOMBRE	O
?	O

los	O
anticuerpos	B-GENE
para	O
ITPR1	B-Protein
(	O
1	O
:	O
1	O
,	O
000	O
)	O
y	O
ACTB	B-Protein
(	O
1	O
:	O
5	O
000	O
)	O
se	O
utilizaron	O
según	O
lo	O
recomendado	O
por	O
los	O
fabricantes	O
.	O

información	O
de	O
soporte	O

Figura	O
S1	O

Esquema	O
de	O
los	O
resultados	O
del	O
genotipado	O
en	O
Ratón	B-Taxon
Cromosoma	B-GENE
6	O
en	O
Afectados	O
Ratones	B-Taxon

Los	O
cuadrados	O
negros	O
son	O
indicativos	O
de	O
un	O
homocigoto	O
C57BL/6J	O
genotipo	B-Sequence
;	O
cuadrados	O
gris	O
claro	O
,	O
un	O
homocigoto	O
129x1	O
/	O
SvJ	O
genotipo	B-Sequence
;	O
cuadrados	O
grises	O
,	O
un	O
heterocigoto	O
C57BL/6J	O
129x1/SvJ	O
genotipo	B-Sequence
;	O
cuadrados	O
blancos	O
,	O
indeterminado	O
genotipo	B-Sequence
.	O

La	O
caja	O
negra	O
delimita	O
un	O
región	B-Sequence
de	O
homocigotos	O
129x1/SvJ	O
genotipos	B-Sequence
que	O
se	O
segregan	O
con	O
la	O
enfermedad	O
;	O
así	O
,	O
la	O
crítica	O
región	B-Sequence
se	O
determinó	O
que	O
estaba	O
entre	O
los	O
marcadores	O
D6Mit37	O
y	O
44	O
.	O
MMHAP85FLG5	O
.	O

(	O
10MB	O
TIF	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S2	O

Secuencia	B-Sequence
de	O
exón	B-Sequence
36	O
de	O
itpr1	B-Protein
de	O
cuatro	O
Ratones	B-Taxon

A	O
tipo	B-Sequence
salvaje	I-Sequence
homocigoto	O
C57BL/6J	O
ratón	B-Taxon
(	O
A	O
)	O
,	O
un	O
tipo	B-Sequence
salvaje	I-Sequence
homocigoto	O
129x1	O
/	O
SvJ	O
ratón	B-Taxon
(	O
B	O
)	O
,	O
un	O
129x1B6	O
afectado	O
ratones	B-Taxon
homocigoto	O
para	O
el	O
18	O
-	O
mutación	B-Sequence
por	I-Sequence
deleción	I-Sequence
de	I-Sequence
pb	I-Sequence
(	O
C	O
)	O
,	O
y	O
un	O
no	O
afectado	O
ratón	B-Taxon
heterocigoto	O
para	O
los	O
18	O
-	O
mutación	B-Sequence
por	I-Sequence
deleción	I-Sequence
de	I-Sequence
pb	I-Sequence
(	O
D	O
)	O
.	O

los	O
eliminado	B-Sequence
nucleótidos	B-Chemical
están	O
delimitados	O
por	O
una	O
caja	O
verde	O
.	O

(	O
5	O
.	O
1	O
MB	O
TIF	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S3	O

Familias	O
adicionales	O
que	O
albergan	O
Supresión	B-Sequence
en	O
la	O
SCA15	O
Lugar	B-Sequence

(	O
A	O
)	O
Familia	O
H33	O
;	O
(	O
B	O
)	O
familia	O
H27	O
.	O

El	O
panel	O
superior	O
muestra	O
la	O
relación	O
log	O
R	O
y	O
B	O
alelo	B-Sequence
métricas	O
de	O
frecuencia	O
generadas	O
a	O
partir	O
de	O
arreglos	O
Infinium	O
HumanHap550	O
para	O
un	O
familiar	O
afectado	O
de	O
cada	O
familia	O
.	O

La	O
relación	O
Log	O
R	O
es	O
la	O
relación	O
de	O
R	O
observada	O
normalizada	O
a	O
R	O
esperada	O
para	O
cada	O
SNP	B-Sequence
(	O
cada	O
SNP	B-Sequence
es	O
un	O
punto	O
azul	O
)	O
y	O
por	O
lo	O
tanto	O
sirve	O
como	O
sustituto	O
del	O
número	O
de	O
copia	O
en	O
cada	O
lugar	B-Sequence
.	O

B	O
alelo	B-Sequence
La	O
frecuencia	O
es	O
una	O
medida	O
del	O
número	O
de	O
veces	O
que	O
A	O
o	O
B	O
alelos	B-Sequence
se	O
detectan	O
en	O
cada	O
lugar	B-Sequence
(	O
cada	O
SNP	B-Sequence
se	O
indica	O
con	O
un	O
punto	O
azul	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
SNP	B-Sequence
con	O
una	O
B	O
alelo	B-Sequence
frecuencia	O
de	O
uno	O
son	O
aparentes	O
homocigotos	O
B	O
/	O
B	O
,	O
SNP	B-Sequence
con	O
una	O
B	O
alelo	B-Sequence
frecuencia	O
de	O
0	O
.	O
5	O
son	O
aparentes	O
heterocigotos	O
A	O
/	O
B	O
,	O
y	O
aquellos	O
con	O
un	O
B	O
alelo	B-Sequence
frecuencia	O
de	O
cero	O
son	O
aparentes	O
homocigotos	O
A/A	O
.	O

Estas	O
parcelas	O
muestran	O
una	O
contigua	O
región	B-Sequence
~	O
310	O
kb	O
de	O
largo	O
(	O
familia	O
H33	O
)	O
y	O
~	O
350	O
kb	O
de	O
largo	O
(	O
familia	O
H27	O
)	O
con	O
número	O
de	O
copias	O
reducido	O
y	O
aparente	O
homocigosidad	O
indicativa	O
de	O
un	O
deleción	B-Sequence
genómica	I-Sequence
(	O
gris	O
sombreado	O
)	O
.	O

Los	O
árboles	O
genealógicos	O
a	O
continuación	O
muestran	O
los	O
miembros	O
de	O
la	O
familia	O
disponibles	O
analizados	O
para	O
estos	O
eliminaciones	B-Sequence
,	O
todos	O
los	O
cuales	O
estaban	O
afectados	O
y	O
todos	O
los	O
cuales	O
llevaban	O
un	O
supresión	B-Sequence
en	O
esto	O
lugar	B-Sequence
.	O

(	O
6	O
.	O
8	O
MB	O
TIF	O
)	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Figura	O
S4	O

Regiones	B-Sequence
eliminadas	I-Sequence
Identificado	O
en	O
las	O
Familias	O
AUS1	O
y	O
H27	O

(	O
Arriba	O
)	O
Familia	O
AUS1	O
;	O
secuencia	B-Sequence
desde	O
el	O
producto	B-Sequence
PCR	I-Sequence
generado	O
usando	O
cebadores	B-Sequence
T3f	O
y	O
C11r	O
de	O
ADN	B-Sequence
genómico	I-Sequence
de	O
un	O
familiar	O
afectado	O
.	O

La	O
punta	O
de	O
flecha	O
roja	O
denota	O
el	O
punto	B-Sequence
de	I-Sequence
interrupción	I-Sequence
de	I-Sequence
eliminación	I-Sequence
;	O
los	O
supresión	B-Sequence
es	O
201	O
,	O
510	O
pb	B-Sequence
en	O
longitud	O
.	O

(	O
Abajo	O
)	O
Familia	O
H27	O
;	O
secuencia	B-Sequence
flanqueando	O
región	B-Sequence
eliminada	I-Sequence
.	O

La	O
fuente	O
verde	O
indica	O
nucleótidos	B-Chemical
telomérico	B-Sequence
al	O
supresión	B-Sequence
;	O
la	O
fuente	O
azul	O
indica	O
nucleótidos	B-Chemical
centromérico	B-Sequence
al	O
supresión	B-Sequence
.	O

los	O
supresión	B-Sequence
es	O
344	O
,	O
408	O
pb	B-Sequence
en	O
longitud	O
.	O

Posiciones	B-Sequence
de	I-Sequence
pares	I-Sequence
de	I-Sequence
bases	I-Sequence
se	O
basan	O
en	O
NCBI	O
construcción	B-Sequence
del	I-Sequence
genoma	I-Sequence
36	O
referencia	O
montaje	B-Sequence
.	O

(	O
876	O
KB	O
MB	O
TIF	O
)	O
.	O

Haga	O
clic	O
aquí	O
para	O
obtener	O
un	O
archivo	O
de	O
datos	O
adicional	O
.	O

Números	O
de	O
acceso	O

El	O
número	O
de	O
acceso	O
de	O
OMIM	O
(	O
http	O
:	O
//	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
entrez	O
/	O
query	O
.	O
fcgi	O
?	O
db	O
=	O
OMIM	O
)	O
para	O
SUMF1	B-Protein
es	O
607939	B-Protein
.	O

Agradecimientos	O

Agradecemos	O
a	O
los	O
miembros	O
de	O
la	O
familia	O
SCA15	O
por	O
participar	O
en	O
este	O
estudio	O
.	O

abreviaturas	O

VEB	B-Taxon
-	O
Virus	B-Taxon
de	I-Taxon
Epstein	I-Taxon
Barr	I-Taxon

SCA	O
[	O
número	O
]	O
-	O
ataxia	O
espinocerebelosa	O
[	O
número	O
]	O

SNP	B-Sequence
-	O
Polimorfismo	B-Sequence
de	I-Sequence
nucleótido	I-Sequence
simple	I-Sequence

Figuras	O
y	O
Tablas	O

Figura	O
1	O

Inmunohistoquímica	O
y	O
análisis	O
de	O
Western	O
Blot	O
de	O
ITPR1	B-Protein
Proteína	B-Chemical
Niveles	O
en	O
Ratón	B-Taxon
Cerebelo	O

(	O
A	O
-	O
F	O
)	O
Inmunohistoquímica	O
del	O
cerebelo	O
de	O
un	O
tipo	B-Sequence
salvaje	I-Sequence
ratón	B-Taxon
(	O
A	O
y	O
D	O
)	O
,	O
un	O
ratón	B-Taxon
heterocigoto	O
para	O
el	O
itpr1	B-Protein
-18	O
eliminación	B-Sequence
de	I-Sequence
pb	I-Sequence
(	O
B	O
y	O
E	O
)	O
,	O
y	O
un	O
ratón	B-Taxon
homocigoto	O
para	O
el	O
18	O
-	O
pb	B-Sequence
itpr1	B-Protein
supresión	B-Sequence
(	O
C	O
y	O
F	O
)	O
.	O

(	O
A	O
-	O
C	O
)	O
Inmunohistoquímica	O
usando	O
policlonal	O
itpr1	B-Protein
anti	O
-	O
Conejo	B-Taxon
anticuerpo	B-GENE
(	O
1	O
:	O
2	O
000	O
;	O
Alexa	O
Fluor	O
555	O
)	O
;	O
(	O
D	O
-	O
F	O
)	O
inmunohistoquímica	O
usando	O
monoclonal	O
Calb1	B-Protein
anti	O
-	O
ratón	B-Taxon
anticuerpo	B-GENE
(	O
1	O
:	O
6	O
000	O
;	O
Alexa	O
Fluor	O
488	O
)	O
.	O

Las	O
barras	O
de	O
escala	O
indican	O
100	O
mu	O
m	O
.	O

Como	O
se	O
describió	O
previamente	O
,	O
Iptr1	B-Protein
está	O
muy	O
expresada	O
en	O
la	O
células	B-Cell
de	I-Cell
Purkinje	I-Cell
.	O

En	O
particular	O
,	O
parece	O
haber	O
una	O
disminución	O
de	O
la	O
inmunorreactividad	O
a	O
itpr1	B-Protein
en	O
heterocigotos	O
y	O
homocigotos	O
mutante	B-Sequence
ratones	B-Taxon
.	O

(	O
G	O
)	O
Western	O
blot	O
realizado	O
para	O
examinar	O
itpr1	B-Protein
niveles	O
en	O
todo	O
el	O
cerebro	O
de	O
tipo	B-Sequence
salvaje	I-Sequence
Itpr1wt	O
/	O
Delta	O
18	O
e	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
ratones	B-Taxon
;	O
esto	O
muestra	O
claramente	O
una	O
reducción	O
de	O
itpr1	B-Protein
en	O
tejido	O
cerebral	O
de	O
Itpr1wt	O
/	O
Delta	O
18	O
ratones	B-Taxon
y	O
una	O
mayor	O
reducción	O
de	O
itpr1	B-Protein
en	O
Itpr1	O
Delta	O
18	O
/	O
Delta	O
18	O
ratones	B-Taxon
.	O

Figura	O
2	O

Métricas	O
derivadas	O
del	O
análisis	O
de	O
ADN	B-Sequence
de	O
un	O
miembro	O
de	O
la	O
familia	O
afectado	O
7	O
usando	O
chips	O
de	O
genotipado	O
Illumina	O
Infinium	O
HumanHap550	O

Las	O
parcelas	O
superior	O
e	O
inferior	O
son	O
log	O
R	O
ratio	O
y	O
B	O
alelo	B-Sequence
frecuencia	O
,	O
respectivamente	O
,	O
a	O
~	O
800	O
-	O
kb	O
segmento	B-Sequence
en	O
la	O
p	O
brazo	B-Sequence
de	I-Sequence
cromosoma	I-Sequence
3	O
.	O

La	O
relación	O
Log	O
R	O
es	O
la	O
relación	O
de	O
R	O
observada	O
normalizada	O
a	O
R	O
esperada	O
para	O
cada	O
SNP	B-Sequence
(	O
cada	O
SNP	B-Sequence
es	O
un	O
punto	O
azul	O
)	O
y	O
por	O
lo	O
tanto	O
sirve	O
como	O
sustituto	O
del	O
número	O
de	O
copia	O
en	O
cada	O
lugar	B-Sequence
.	O

B	O
alelo	B-Sequence
La	O
frecuencia	O
es	O
una	O
medida	O
del	O
número	O
de	O
veces	O
que	O
A	O
o	O
B	O
alelos	B-Sequence
se	O
detectan	O
en	O
cada	O
lugar	B-Sequence
(	O
cada	O
SNP	B-Sequence
se	O
indica	O
con	O
un	O
punto	O
azul	O
)	O
.	O

Por	O
lo	O
tanto	O
,	O
SNP	B-Sequence
con	O
una	O
B	O
alelo	B-Sequence
frecuencia	O
de	O
uno	O
son	O
aparentes	O
homocigotos	O
B	O
/	O
B	O
,	O
SNP	B-Sequence
con	O
una	O
B	O
alelo	B-Sequence
frecuencia	O
de	O
0	O
.	O
5	O
son	O
aparentes	O
heterocigotos	O
A	O
/	O
B	O
,	O
y	O
aquellos	O
con	O
un	O
B	O
alelo	B-Sequence
frecuencia	O
de	O
cero	O
son	O
aparentes	O
homocigotos	O
A/A	O
.	O

Claramente	O
,	O
estas	O
parcelas	O
muestran	O
una	O
contigua	O
región	B-Sequence
~	O
200	O
kb	O
de	O
largo	O
con	O
número	O
de	O
copias	O
reducido	O
y	O
aparente	O
homocigosidad	O
(	O
delimitado	O
por	O
un	O
recuadro	O
rojo	O
)	O
.	O

Como	O
hemos	O
demostrado	O
previamente	O
,	O
esto	O
es	O
indicativo	O
de	O
un	O
heterocigoto	O
deleción	B-Sequence
genómica	I-Sequence
[	O
15	O
]	O
.	O

Debajo	O
de	O
estos	O
gráficos	O
hay	O
un	O
esquema	O
de	O
los	O
dos	O
genes	B-Sequence
conocidos	I-Sequence
afectado	O
por	O
esto	O
supresión	B-Sequence
,	O
ITPR1	B-Protein
y	O
SUMF1	B-Protein
.	O

figura	O
3	O

Mutación	B-Sequence
Análisis	O
en	O
la	O
Familia	O
Australiana	O
SCA15	O

(	O
Arriba	O
)	O
Pedigree	O
de	O
parentesco	O
.	O

Los	O
símbolos	O
rellenos	O
indican	O
afectados	O
individuos	B-Taxon
;	O
símbolos	O
abiertos	O
,	O
no	O
afectados	O
individuos	B-Taxon
el	O
símbolo	O
gris	O
indica	O
un	O
estado	O
de	O
enfermedad	O
desconocido	O
;	O
el	O
símbolo	O
de	O
ojo	O
de	O
buey	O
denota	O
portador	O
obligado	O
.	O

w	B-Sequence
/	O
w	B-Sequence
,	O
tipo	B-Sequence
salvaje	I-Sequence
en	O
ITPR1	B-Protein
;	O
w	B-Sequence
/	O
metro	B-Sequence
,	O
portador	O
heterocigoto	O
del	O
ITPR1	B-Protein
supresión	B-Sequence
.	O

(	O
Medio	O
)	O
Esquema	O
de	O
cebador	B-Sequence
pares	O
utilizados	O
para	O
reducir	O
lo	O
desconocido	O
regiones	B-Sequence
Entre	O
secuencia	B-Sequence
eliminada	I-Sequence
conocida	I-Sequence
y	O
conocido	B-Sequence
diploide	O
secuencia	B-Sequence
en	O
la	O
SCA15	O
lugar	B-Sequence
.	O

Nueve	O
cebador	B-Sequence
pares	O
(	O
T1	O
-	O
T9	O
)	O
se	O
utilizaron	O
para	O
amplificar	O
a	O
través	O
de	O
la	O
desconocida	O
región	B-Sequence
telomérica	I-Sequence
al	O
región	B-Sequence
eliminada	I-Sequence
conocida	I-Sequence
;	O
19	O
cebador	B-Sequence
pares	O
(	O
C1	O
-	O
C19	O
)	O
se	O
utilizaron	O
para	O
amplificar	O
a	O
través	O
de	O
la	O
desconocida	O
región	B-Sequence
centromérica	I-Sequence
al	O
región	B-Sequence
eliminada	I-Sequence
conocida	I-Sequence
.	O

Todas	O
las	O
PCR	O
se	O
realizaron	O
en	O
los	O
tres	O
familiares	O
afectados	O
.	O

El	O
análisis	O
de	O
estos	O
datos	O
redujo	O
la	O
incógnita	O
región	B-Sequence
,	O
y	O
finalmente	O
pudimos	O
usar	O
cebador	B-Sequence
T3f	O
y	O
C11r	O
para	O
amplificar	O
a	O
través	O
del	O
punto	B-Sequence
de	I-Sequence
interrupción	I-Sequence
de	I-Sequence
eliminación	I-Sequence
en	O
los	O
tres	O
familiares	O
afectados	O
,	O
produciendo	O
un	O
fragmento	B-Sequence
de	O
953	O
pb	B-Sequence
en	O
afectados	O
individuos	B-Taxon
.	O

(	O
Abajo	O
)	O
Gel	O
que	O
muestra	O
la	O
amplificación	O
producto	B-Sequence
utilizando	O
cebador	B-Sequence
par	O
T3f	O
y	O
C11r	O
de	O
los	O
miembros	O
de	O
pedigrí	O
afectados	O
6	O
,	O
7	O
y	O
19	O
;	O
en	O
el	O
miembro	O
genealógico	O
23	O
,	O
con	O
estado	O
afectivo	O
de	O
enfermedad	O
desconocido	O
;	O
en	O
un	O
control	O
neurológicamente	O
normal	O
(	O
C	O
)	O
;	O
y	O
en	O
un	O
control	O
sin	O
plantilla	O
(	O
NC	O
)	O
.	O

Figura	O
4	O

Análisis	O
de	O
Western	O
Blot	O
de	O
ITPR1	B-Protein
Proteína	B-Chemical
Niveles	O
en	O
VEB	B-Taxon
Linfoblastos	O
inmortalizados	O
de	O
miembros	O
de	O
la	O
familia	O
AUS1	O

Western	O
blot	O
realizado	O
para	O
examinar	O
ITPR1	B-Protein
niveles	O
en	O
VEB	B-Taxon
inmortalizado	O
linfocitos	B-Cell
de	O
AUS1	O
miembros	O
de	O
la	O
familia	O
afectados	O
que	O
llevan	O
el	O
ITPR1	B-Protein
supresión	B-Sequence
y	O
de	O
un	O
miembro	O
de	O
la	O
familia	O
AUS1	O
con	O
estado	O
de	O
enfermedad	O
desconocido	O
que	O
no	O
porta	O
el	O
supresión	B-Sequence
.	O

Cabe	O
destacar	O
las	O
muestras	O
de	O
pacientes	O
con	O
ITPR1	B-Protein
supresión	B-Sequence
mostrar	O
una	O
drástica	O
disminución	O
de	O
ITPR1	B-Protein
niveles	O

Para	O
demostrar	O
la	O
misma	O
carga	O
,	O
estas	O
muestras	O
se	O
diluyeron	O
una	O
de	O
cada	O
cinco	O
y	O
se	O
repitió	O
el	O
Western	O
blot	O
usando	O
un	O
anticuerpo	B-GENE
en	O
contra	O
ACTB	B-Protein
.	O

notas	O
al	O
pie	O

Una	O
versión	O
anterior	O
de	O
este	O
artículo	O
apareció	O
como	O
Publicación	O
anticipada	O
en	O
línea	O
el	O
16	O
de	O
mayo	O
de	O
2007	O
(	O
doi	O
:	O
10	O
.	O
1371/journal	O
.	O
pgen	O
.	O
0030108.	O
eor	O
)	O
.	O

Contribuciones	O
de	O
autor	O
.	O

EMCF	O
,	O
JTR	O
y	O
ABS	O
concibieron	O
y	O
diseñaron	O
los	O
experimentos	O
.	O

JvdL	O
,	O
JC	O
,	O
MAK	O
,	O
LAH	O
,	O
SS	O
,	O
MRC	O
,	O
HCF	O
,	O
XL	O
,	O
DH	O
,	O
JSS	O
,	O
IR	O
y	O
HC	O
realizaron	O
los	O
experimentos	O
.	O

JvdL	O
,	O
JC	O
,	O
MAK	O
,	O
SS	O
,	O
MRC	O
,	O
KGH	O
,	O
HCF	O
,	O
JSS	O
,	O
JTR	O
y	O
ABS	O
analizaron	O
los	O
datos	O
.	O

HH	O
,	O
NWW	O
,	O
PG	O
,	O
JH	O
,	O
ES	O
,	O
RJMG	O
,	O
SMF	O
,	O
HC	O
y	O
ABS	O
contribuyeron	O
reactivos	B-Chemical
/	O
materiales	O
/	O
herramientas	O
de	O
análisis	O
.	O

RJMG	O
,	O
EMCF	O
y	O
ABS	O
escribieron	O
el	O
documento	O
.	O

Financiamiento	O

Esta	O
investigación	O
fue	O
financiada	O
en	O
parte	O
por	O
los	O
programas	O
internos	O
del	O
Instituto	O
Nacional	O
sobre	O
el	O
Envejecimiento	O
y	O
el	O
Instituto	O
Nacional	O
sobre	O
Trastornos	O
Neurológicos	O
y	O
Accidentes	O
Cerebrovasculares	O
(	O
NINDS	O
)	O
,	O
ambos	O
de	O
los	O
Institutos	O
Nacionales	O
de	O
Salud	O
,	O
Departamento	O
de	O
Salud	O
y	O
Humano	B-Taxon
Servicios	O
,	O
Estados	O
Unidos	O
de	O
América	O
.	O

MAK	O
fue	O
apoyado	O
por	O
una	O
beca	O
postdoctoral	O
competitiva	O
NINDS	O
.	O

HH	O
cuenta	O
con	O
el	O
apoyo	O
del	O
Consejo	O
de	O
Investigación	O
Médica	O
,	O
Reino	O
Unido	O
.	O

Conflicto	O
de	O
intereses	O
.	O

Los	O
autores	O
han	O
declarado	O
que	O
no	O
existen	O
intereses	O
contrapuestos	O
.	O

